
### [MONDO:0020009](http://purl.obolibrary.org/obo/MONDO_0020009)
**Label:** rare neurologic disease

**Subclasses:** [MONDO:0017259](http://purl.obolibrary.org/obo/MONDO_0017259) (systemic diseases with anterior uveitis), [MONDO:0017258](http://purl.obolibrary.org/obo/MONDO_0017258) (idiopathic panuveitis), [MONDO:0017255](http://purl.obolibrary.org/obo/MONDO_0017255) (panuveitis (disease)), [MONDO:0018587](http://purl.obolibrary.org/obo/MONDO_0018587) (non-recovering obstetric brachial plexus lesion), [MONDO:0018585](http://purl.obolibrary.org/obo/MONDO_0018585) (pediatric arterial ischemic stroke), [MONDO:0017257](http://purl.obolibrary.org/obo/MONDO_0017257) (idiopathic posterior uveitis), [MONDO:0017256](http://purl.obolibrary.org/obo/MONDO_0017256) (idiopathic anterior uveitis), [MONDO:0009630](http://purl.obolibrary.org/obo/MONDO_0009630) (microphthalmia, isolated, with coloboma 4), [MONDO:0008300](http://purl.obolibrary.org/obo/MONDO_0008300) (Prader-Willi syndrome), [MONDO:0018581](http://purl.obolibrary.org/obo/MONDO_0018581) (progressive encephalomyelitis with rigidity and myoclonus), [MONDO:0018580](http://purl.obolibrary.org/obo/MONDO_0018580) (PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome), [MONDO:0009637](http://purl.obolibrary.org/obo/MONDO_0009637) (mitochondrial myopathy), [MONDO:0008306](http://purl.obolibrary.org/obo/MONDO_0008306) (ABri amyloidosis), [MONDO:0009638](http://purl.obolibrary.org/obo/MONDO_0009638) (mitochondrial myopathy with a defect 1N Mitochondrial-protein transport), [MONDO:0009639](http://purl.obolibrary.org/obo/MONDO_0009639) (mitochondrial myopathy with lactic acidosis), [MONDO:0011957](http://purl.obolibrary.org/obo/MONDO_0011957) (retinal macular dystrophy type 2), [MONDO:0011952](http://purl.obolibrary.org/obo/MONDO_0011952) (amyotrophic lateral sclerosis type 7), [MONDO:0010621](http://purl.obolibrary.org/obo/MONDO_0010621) (child syndrome), [MONDO:0011951](http://purl.obolibrary.org/obo/MONDO_0011951) (amyotrophic lateral sclerosis type 6), [MONDO:0011950](http://purl.obolibrary.org/obo/MONDO_0011950) (infantile-onset autosomal recessive nonprogressive cerebellar ataxia), [MONDO:0011953](http://purl.obolibrary.org/obo/MONDO_0011953) (familial acute necrotizing encephalopathy), [MONDO:0018576](http://purl.obolibrary.org/obo/MONDO_0018576) (non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy), [MONDO:0018577](http://purl.obolibrary.org/obo/MONDO_0018577) (pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa), [MONDO:0018574](http://purl.obolibrary.org/obo/MONDO_0018574) (intellectual disability-expressive aphasia-facial dysmorphism syndrome), [MONDO:0018572](http://purl.obolibrary.org/obo/MONDO_0018572) (severe intellectual disability-hypotonia-strabismus-coarse face-planovalgus syndrome), [MONDO:0009620](http://purl.obolibrary.org/obo/MONDO_0009620) (Say-Barber-Miller syndrome), [MONDO:0009621](http://purl.obolibrary.org/obo/MONDO_0009621) (microcephaly-cervical spine fusion anomalies syndrome), [MONDO:0009622](http://purl.obolibrary.org/obo/MONDO_0009622) (Jawad syndrome), [MONDO:0017241](http://purl.obolibrary.org/obo/MONDO_0017241) (severe intellectual disability and progressive spastic paraplegia), [MONDO:0009624](http://purl.obolibrary.org/obo/MONDO_0009624) (microcephaly and chorioretinopathy 1), [MONDO:0009626](http://purl.obolibrary.org/obo/MONDO_0009626) (pseudo-TORCH syndrome), [MONDO:0009627](http://purl.obolibrary.org/obo/MONDO_0009627) (Galloway-Mowat syndrome), [MONDO:0010617](http://purl.obolibrary.org/obo/MONDO_0010617) (male hypergonadotropic hypogonadism-intellectual disability-skeletal anomalies syndrome), [MONDO:0010618](http://purl.obolibrary.org/obo/MONDO_0010618) (familial isolated hypoparathyroidism due to agenesis of parathyroid gland), [MONDO:0011948](http://purl.obolibrary.org/obo/MONDO_0011948) (pontocerebellar hypoplasia type 3), [MONDO:0010615](http://purl.obolibrary.org/obo/MONDO_0010615) (isolated growth hormone deficiency type III), [MONDO:0005277](http://purl.obolibrary.org/obo/MONDO_0005277) (migraine disorder), [MONDO:0010610](http://purl.obolibrary.org/obo/MONDO_0010610) (holoprosencephaly-hypokinesia-congenital contractures syndrome), [MONDO:0011945](http://purl.obolibrary.org/obo/MONDO_0011945) (Gaucher's disease perinatal lethal), [MONDO:0010614](http://purl.obolibrary.org/obo/MONDO_0010614) (X-linked congenital generalized hypertrichosis), [MONDO:0010611](http://purl.obolibrary.org/obo/MONDO_0010611) (hydrocephalus with stenosis of the aqueduct of sylvius), [MONDO:0010612](http://purl.obolibrary.org/obo/MONDO_0010612) (hydrocephaly-cerebellar agenesis syndrome), [MONDO:0018569](http://purl.obolibrary.org/obo/MONDO_0018569) (X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome), [MONDO:0017237](http://purl.obolibrary.org/obo/MONDO_0017237) (hereditary sensorimotor neuropathy with hyperelastic skin), [MONDO:0018567](http://purl.obolibrary.org/obo/MONDO_0018567) (autosomal dominant Charcot-Marie-tooth disease type 2 due to TFG mutation), [MONDO:0018568](http://purl.obolibrary.org/obo/MONDO_0018568) (COG2-CDG), [MONDO:0019896](http://purl.obolibrary.org/obo/MONDO_0019896) (Kleefstra syndrome due to 9q34 microdeletion), [MONDO:0017233](http://purl.obolibrary.org/obo/MONDO_0017233) (familial Alzheimer-like prion disease), [MONDO:0017232](http://purl.obolibrary.org/obo/MONDO_0017232) (recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome), [MONDO:0017234](http://purl.obolibrary.org/obo/MONDO_0017234) (inherited prion disease), [MONDO:0018564](http://purl.obolibrary.org/obo/MONDO_0018564) (3p25.3 microdeletion syndrome), [MONDO:0009616](http://purl.obolibrary.org/obo/MONDO_0009616) (microcephalic primordial dwarfism, Toriello type), [MONDO:0009617](http://purl.obolibrary.org/obo/MONDO_0009617) (microcephaly 1, primary, autosomal recessive), [MONDO:0009618](http://purl.obolibrary.org/obo/MONDO_0009618) (microcephaly-cardiomyopathy syndrome), [MONDO:0011936](http://purl.obolibrary.org/obo/MONDO_0011936) (microphthalmia with brain and digit anomalies), [MONDO:0011935](http://purl.obolibrary.org/obo/MONDO_0011935) (retinitis pigmentosa 30), [MONDO:0011930](http://purl.obolibrary.org/obo/MONDO_0011930) (epilepsy, familial adult myoclonic, 2), [MONDO:0011933](http://purl.obolibrary.org/obo/MONDO_0011933) (ALG2-CDG), [MONDO:0010600](http://purl.obolibrary.org/obo/MONDO_0010600) (granulomatous disease, chronic, X-linked), [MONDO:0017226](http://purl.obolibrary.org/obo/MONDO_0017226) (Pelizaeus-Merzbacher-like disease), [MONDO:0017225](http://purl.obolibrary.org/obo/MONDO_0017225) (null syndrome), [MONDO:0018556](http://purl.obolibrary.org/obo/MONDO_0018556) (Lambert-Eaton myasthenic syndrome), [MONDO:0018557](http://purl.obolibrary.org/obo/MONDO_0018557) (rare genetic autonomic nervous system disorder), [MONDO:0017222](http://purl.obolibrary.org/obo/MONDO_0017222) (Pelizaeus-Merzbacher disease, classic form), [MONDO:0017221](http://purl.obolibrary.org/obo/MONDO_0017221) (Pelizaeus-Merzbacher disease, connatal form), [MONDO:0017224](http://purl.obolibrary.org/obo/MONDO_0017224) (Pelizaeus-Merzbacher disease in female carriers), [MONDO:0014198](http://purl.obolibrary.org/obo/MONDO_0014198) (mitochondrial DNA depletion syndrome 13), [MONDO:0017223](http://purl.obolibrary.org/obo/MONDO_0017223) (Pelizaeus-Merzbacher disease, transitional form), [MONDO:0019884](http://purl.obolibrary.org/obo/MONDO_0019884) (distal trisomy 10q), [MONDO:0014199](http://purl.obolibrary.org/obo/MONDO_0014199) (epileptic encephalopathy, early infantile, 17), [MONDO:0018550](http://purl.obolibrary.org/obo/MONDO_0018550) (spastic paraplegia-optic atrophy-neuropathy and spastic paraplegia-optic atrophy-neuropathy-related disorder), [MONDO:0014195](http://purl.obolibrary.org/obo/MONDO_0014195) (microcornea-myopic chorioretinal atrophy-telecanthus syndrome), [MONDO:0009603](http://purl.obolibrary.org/obo/MONDO_0009603) (neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency), [MONDO:0009607](http://purl.obolibrary.org/obo/MONDO_0009607) (brain demyelination due to methionine adenosyltransferase deficiency), [MONDO:0011925](http://purl.obolibrary.org/obo/MONDO_0011925) (congenital merosin-deficient muscular dystrophy 1A), [MONDO:0009609](http://purl.obolibrary.org/obo/MONDO_0009609) (methylcobalamin deficiency type cblG), [MONDO:0011929](http://purl.obolibrary.org/obo/MONDO_0011929) (chromosome 1p36 deletion syndrome), [MONDO:0011928](http://purl.obolibrary.org/obo/MONDO_0011928) (caudal duplication), [MONDO:0011920](http://purl.obolibrary.org/obo/MONDO_0011920) (autosomal dominant nonsyndromic deafness 48), [MONDO:0001709](http://purl.obolibrary.org/obo/MONDO_0001709) (hypercalcemic sarcoidosis), [MONDO:0009671](http://purl.obolibrary.org/obo/MONDO_0009671) (intellectual disability-myopathy-short stature-endocrine defect syndrome), [MONDO:0017299](http://purl.obolibrary.org/obo/MONDO_0017299) (acute annular outer retinopathy), [MONDO:0008340](http://purl.obolibrary.org/obo/MONDO_0008340) (congenital ptosis (disease)), [MONDO:0010660](http://purl.obolibrary.org/obo/MONDO_0010660) (mental retardation, X-linked 9), [MONDO:0011992](http://purl.obolibrary.org/obo/MONDO_0011992) (hereditary spastic paraplegia 25), [MONDO:0001706](http://purl.obolibrary.org/obo/MONDO_0001706) (cerebral sarcoidosis), [MONDO:0010661](http://purl.obolibrary.org/obo/MONDO_0010661) (severe X-linked intellectual disability, Gustavson type), [MONDO:0009672](http://purl.obolibrary.org/obo/MONDO_0009672) (juvenile spinal muscular atrophy), [MONDO:0017298](http://purl.obolibrary.org/obo/MONDO_0017298) (acute zonal occult outer retinopathy), [MONDO:0011991](http://purl.obolibrary.org/obo/MONDO_0011991) (autosomal recessive nonsyndromic deafness 38), [MONDO:0008341](http://purl.obolibrary.org/obo/MONDO_0008341) (ptosis-strabismus-ectopic pupils syndrome), [MONDO:0011990](http://purl.obolibrary.org/obo/MONDO_0011990) (BFNS3), [MONDO:0001708](http://purl.obolibrary.org/obo/MONDO_0001708) (pulmonary sarcoidosis), [MONDO:0009673](http://purl.obolibrary.org/obo/MONDO_0009673) (intermediate spinal muscular atrophy), [MONDO:0001707](http://purl.obolibrary.org/obo/MONDO_0001707) (cardiac sarcoidosis), [MONDO:0009675](http://purl.obolibrary.org/obo/MONDO_0009675) (autosomal recessive limb-girdle muscular dystrophy type 2A), [MONDO:0017294](http://purl.obolibrary.org/obo/MONDO_0017294) (glycerol kinase deficiency, infantile form), [MONDO:0009676](http://purl.obolibrary.org/obo/MONDO_0009676) (autosomal recessive limb-girdle muscular dystrophy type 2B), [MONDO:0021313](http://purl.obolibrary.org/obo/MONDO_0021313) (eyelid cancer), [MONDO:0009677](http://purl.obolibrary.org/obo/MONDO_0009677) (autosomal recessive limb-girdle muscular dystrophy type 2C), [MONDO:0017297](http://purl.obolibrary.org/obo/MONDO_0017297) (CLIPPERS), [MONDO:0009678](http://purl.obolibrary.org/obo/MONDO_0009678) (Fukuyama congenital muscular dystrophy), [MONDO:0009679](http://purl.obolibrary.org/obo/MONDO_0009679) (arthrogryposis due to muscular dystrophy), [MONDO:0017291](http://purl.obolibrary.org/obo/MONDO_0017291) (reversible cerebral vasoconstriction syndrome), [MONDO:0010664](http://purl.obolibrary.org/obo/MONDO_0010664) (syndromic X-linked intellectual disability Snyder type), [MONDO:0010665](http://purl.obolibrary.org/obo/MONDO_0010665) (Wilson-Turner syndrome), [MONDO:0011995](http://purl.obolibrary.org/obo/MONDO_0011995) (cataract-congenital heart disease-neural tube defect syndrome), [MONDO:0010662](http://purl.obolibrary.org/obo/MONDO_0010662) (paraplegia-intellectual disability-hyperkeratosis syndrome), [MONDO:0011994](http://purl.obolibrary.org/obo/MONDO_0011994) (autosomal dominant nonsyndromic deafness 41), [MONDO:0010663](http://purl.obolibrary.org/obo/MONDO_0010663) (X-linked intellectual disability-hypotonic face syndrome), [MONDO:0010668](http://purl.obolibrary.org/obo/MONDO_0010668) (skeletal dysplasia-intellectual disability syndrome), [MONDO:0011998](http://purl.obolibrary.org/obo/MONDO_0011998) (autosomal dominant slowed nerve conduction velocity), [MONDO:0010666](http://purl.obolibrary.org/obo/MONDO_0010666) (Miles-Carpenter syndrome), [MONDO:0011997](http://purl.obolibrary.org/obo/MONDO_0011997) (Hermansky-Pudlak syndrome 2), [MONDO:0010667](http://purl.obolibrary.org/obo/MONDO_0010667) (Prieto syndrome), [MONDO:0009660](http://purl.obolibrary.org/obo/MONDO_0009660) (mucopolysaccharidosis type 4B), [MONDO:0010650](http://purl.obolibrary.org/obo/MONDO_0010650) (Melnick-Needles syndrome), [MONDO:0009661](http://purl.obolibrary.org/obo/MONDO_0009661) (mucopolysaccharidosis type 6), [MONDO:0009662](http://purl.obolibrary.org/obo/MONDO_0009662) (mucopolysaccharidosis type 7), [MONDO:0017284](http://purl.obolibrary.org/obo/MONDO_0017284) (Xp22.13p22.2 duplication syndrome), [MONDO:0008333](http://purl.obolibrary.org/obo/MONDO_0008333) (pseudoxanthoma elasticum, Forme Fruste), [MONDO:0017283](http://purl.obolibrary.org/obo/MONDO_0017283) (facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion), [MONDO:0009665](http://purl.obolibrary.org/obo/MONDO_0009665) (biotinidase deficiency), [MONDO:0009667](http://purl.obolibrary.org/obo/MONDO_0009667) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3), [MONDO:0008337](http://purl.obolibrary.org/obo/MONDO_0008337) (familial pterygium of the conjunctiva), [MONDO:0009669](http://purl.obolibrary.org/obo/MONDO_0009669) (Werdnig-Hoffmann disease), [MONDO:0017281](http://purl.obolibrary.org/obo/MONDO_0017281) (renal caliceal diverticuli-deafness syndrome), [MONDO:0010659](http://purl.obolibrary.org/obo/MONDO_0010659) (FRAXE intellectual disability), [MONDO:0007017](http://purl.obolibrary.org/obo/MONDO_0007017) (vitreous detachment), [MONDO:0007015](http://purl.obolibrary.org/obo/MONDO_0007015) (viral meningitis), [MONDO:0010653](http://purl.obolibrary.org/obo/MONDO_0010653) (Renpenning syndrome), [MONDO:0010654](http://purl.obolibrary.org/obo/MONDO_0010654) (Partington syndrome), [MONDO:0007011](http://purl.obolibrary.org/obo/MONDO_0007011) (uveoparotid fever), [MONDO:0010651](http://purl.obolibrary.org/obo/MONDO_0010651) (Menkes disease), [MONDO:0010652](http://purl.obolibrary.org/obo/MONDO_0010652) (X-linked intellectual disability-seizures-psoriasis syndrome), [MONDO:0010657](http://purl.obolibrary.org/obo/MONDO_0010657) (methylmalonic acidemia with homocystinuria, type cblX), [MONDO:0010658](http://purl.obolibrary.org/obo/MONDO_0010658) (syndromic X-linked intellectual disability 12), [MONDO:0011987](http://purl.obolibrary.org/obo/MONDO_0011987) (cone-rod dystrophy 13), [MONDO:0010655](http://purl.obolibrary.org/obo/MONDO_0010655) (X-linked intellectual disability with marfanoid habitus), [MONDO:0010656](http://purl.obolibrary.org/obo/MONDO_0010656) (mental retardation, X-linked 1), [MONDO:0011970](http://purl.obolibrary.org/obo/MONDO_0011970) (rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome), [MONDO:0017276](http://purl.obolibrary.org/obo/MONDO_0017276) (frontotemporal dementia), [MONDO:0017279](http://purl.obolibrary.org/obo/MONDO_0017279) (young-onset Parkinson disease), [MONDO:0009653](http://purl.obolibrary.org/obo/MONDO_0009653) (mucolipidosis type IV), [MONDO:0009654](http://purl.obolibrary.org/obo/MONDO_0009654) (Mucopolysaccharidoses, unclassified types), [MONDO:0017275](http://purl.obolibrary.org/obo/MONDO_0017275) (spastic paraplegia-facial-cutaneous lesions syndrome), [MONDO:0009655](http://purl.obolibrary.org/obo/MONDO_0009655) (Sanfilippo syndrome type A), [MONDO:0009656](http://purl.obolibrary.org/obo/MONDO_0009656) (Sanfilippo syndrome type B), [MONDO:0009657](http://purl.obolibrary.org/obo/MONDO_0009657) (Sanfilippo syndrome type C), [MONDO:0009658](http://purl.obolibrary.org/obo/MONDO_0009658) (Sanfilippo syndrome type D), [MONDO:0009659](http://purl.obolibrary.org/obo/MONDO_0009659) (mucopolysaccharidosis type 4A), [MONDO:0011979](http://purl.obolibrary.org/obo/MONDO_0011979) (adult-onset foveomacular vitelliform dystrophy), [MONDO:0011974](http://purl.obolibrary.org/obo/MONDO_0011974) (retinitis pigmentosa 7), [MONDO:0010642](http://purl.obolibrary.org/obo/MONDO_0010642) (Lesch-Nyhan phenotype with normal Hgprt), [MONDO:0010640](http://purl.obolibrary.org/obo/MONDO_0010640) (Leber optic atrophy, susceptibility to), [MONDO:0010646](http://purl.obolibrary.org/obo/MONDO_0010646) (macular dystrophy, X-linked), [MONDO:0011976](http://purl.obolibrary.org/obo/MONDO_0011976) (lipodystrophy-intellectual disability-deafness syndrome), [MONDO:0010645](http://purl.obolibrary.org/obo/MONDO_0010645) (oculocerebrorenal syndrome), [MONDO:0011975](http://purl.obolibrary.org/obo/MONDO_0011975) (paternal uniparental disomy of chromosome 14), [MONDO:0018598](http://purl.obolibrary.org/obo/MONDO_0018598) (neonatal adrenoleukodystrophy), [MONDO:0018599](http://purl.obolibrary.org/obo/MONDO_0018599) (congenital oculomotor nerve palsy), [MONDO:0009640](http://purl.obolibrary.org/obo/MONDO_0009640) (mitochondrial complex I deficiency), [MONDO:0018596](http://purl.obolibrary.org/obo/MONDO_0018596) (systemic polyarteritis nodosa), [MONDO:0009641](http://purl.obolibrary.org/obo/MONDO_0009641) (mitochondrial complex II deficiency), [MONDO:0009642](http://purl.obolibrary.org/obo/MONDO_0009642) (orofaciodigital syndrome type II), [MONDO:0018594](http://purl.obolibrary.org/obo/MONDO_0018594) (secondary polyarteritis nodosa), [MONDO:0018595](http://purl.obolibrary.org/obo/MONDO_0018595) (single-organ polyarteritis nodosa), [MONDO:0017261](http://purl.obolibrary.org/obo/MONDO_0017261) (systemic diseases with panuveitis), [MONDO:0009643](http://purl.obolibrary.org/obo/MONDO_0009643) (sulfite oxidase deficiency due to molybdenum cofactor deficiency type a), [MONDO:0018592](http://purl.obolibrary.org/obo/MONDO_0018592) (cutaneous polyarteritis nodosa), [MONDO:0017264](http://purl.obolibrary.org/obo/MONDO_0017264) (syndromic recessive X-linked ichthyosis), [MONDO:0009644](http://purl.obolibrary.org/obo/MONDO_0009644) (sulfite oxidase deficiency due to molybdenum cofactor deficiency type b), [MONDO:0018593](http://purl.obolibrary.org/obo/MONDO_0018593) (primary polyarteritis nodosa), [MONDO:0018591](http://purl.obolibrary.org/obo/MONDO_0018591) (ITM2B amyloidosis), [MONDO:0009647](http://purl.obolibrary.org/obo/MONDO_0009647) (Morquio syndrome C), [MONDO:0017260](http://purl.obolibrary.org/obo/MONDO_0017260) (systemic diseases with posterior uveitis), [MONDO:0009648](http://purl.obolibrary.org/obo/MONDO_0009648) (peripheral motor neuropathy-dysautonomia syndrome), [MONDO:0008318](http://purl.obolibrary.org/obo/MONDO_0008318) (Proteus syndrome), [MONDO:0009649](http://purl.obolibrary.org/obo/MONDO_0009649) (MYMY1), [MONDO:0010639](http://purl.obolibrary.org/obo/MONDO_0010639) (laryngeal abductor paralysis-intellectual disability syndrome), [MONDO:0011969](http://purl.obolibrary.org/obo/MONDO_0011969) (ALG8-CDG), [MONDO:0010637](http://purl.obolibrary.org/obo/MONDO_0010637) (keratosis follicularis spinulosa decalvans, X-linked), [MONDO:0011968](http://purl.obolibrary.org/obo/MONDO_0011968) (autosomal recessive limb-girdle muscular dystrophy type 2D), [MONDO:0010638](http://purl.obolibrary.org/obo/MONDO_0010638) (keratosis follicularis-dwarfism-cerebral atrophy syndrome), [MONDO:0010631](http://purl.obolibrary.org/obo/MONDO_0010631) (Bloch-Sulzberger syndrome), [MONDO:0011963](http://purl.obolibrary.org/obo/MONDO_0011963) (Joubert syndrome 2), [MONDO:0010632](http://purl.obolibrary.org/obo/MONDO_0010632) (epileptic encephalopathy, early infantile, 1), [MONDO:0011961](http://purl.obolibrary.org/obo/MONDO_0011961) (hereditary sensory and autonomic neuropathy type 1B), [MONDO:0011967](http://purl.obolibrary.org/obo/MONDO_0011967) (heterotopia, periventricular, associated with chromosome 5P anomalies), [MONDO:0011966](http://purl.obolibrary.org/obo/MONDO_0011966) (periventricular heterotopia with microcephaly, autosomal recessive), [MONDO:0011965](http://purl.obolibrary.org/obo/MONDO_0011965) (familial temporal lobe epilepsy 2), [MONDO:0011964](http://purl.obolibrary.org/obo/MONDO_0011964) (DPAGT1-CDG), [MONDO:0008380](http://purl.obolibrary.org/obo/MONDO_0008380) (retinoblastoma), [MONDO:0008381](http://purl.obolibrary.org/obo/MONDO_0008381) (dominant pericentral pigmentary retinopathy), [MONDO:0008386](http://purl.obolibrary.org/obo/MONDO_0008386) (Axenfeld-Rieger syndrome type 1), [MONDO:0019037](http://purl.obolibrary.org/obo/MONDO_0019037) (progressive supranuclear palsy), [MONDO:0008387](http://purl.obolibrary.org/obo/MONDO_0008387) (ring dermoid of cornea), [MONDO:0019032](http://purl.obolibrary.org/obo/MONDO_0019032) (X-linked intellectual disability with isolated growth hormone deficiency), [MONDO:0001743](http://purl.obolibrary.org/obo/MONDO_0001743) (paranasal sinus lymphoma), [MONDO:0001740](http://purl.obolibrary.org/obo/MONDO_0001740) (cornea squamous cell carcinoma), [MONDO:0012409](http://purl.obolibrary.org/obo/MONDO_0012409) (isolated microphthalmia 2), [MONDO:0012408](http://purl.obolibrary.org/obo/MONDO_0012408) (microphthalmia, isolated, with coloboma 3), [MONDO:0020022](http://purl.obolibrary.org/obo/MONDO_0020022) (central nervous system malformation), [MONDO:0007045](http://purl.obolibrary.org/obo/MONDO_0007045) (acrofacial dysostosis, Catania type), [MONDO:0013735](http://purl.obolibrary.org/obo/MONDO_0013735) (microcephaly-cerebellar hypoplasia-cardiac conduction defect syndrome), [MONDO:0013736](http://purl.obolibrary.org/obo/MONDO_0013736) (myopathy, centronuclear, 3), [MONDO:0012401](http://purl.obolibrary.org/obo/MONDO_0012401) (congenital stromal corneal dystrophy), [MONDO:0013737](http://purl.obolibrary.org/obo/MONDO_0013737) (hereditary spastic paraplegia 46), [MONDO:0007043](http://purl.obolibrary.org/obo/MONDO_0007043) (Pfeiffer syndrome), [MONDO:0012400](http://purl.obolibrary.org/obo/MONDO_0012400) (cortical dysplasia-focal epilepsy syndrome), [MONDO:0007042](http://purl.obolibrary.org/obo/MONDO_0007042) (Saethre-Chotzen syndrome), [MONDO:0013738](http://purl.obolibrary.org/obo/MONDO_0013738) (autosomal recessive nonsyndromic deafness 96), [MONDO:0012407](http://purl.obolibrary.org/obo/MONDO_0012407) (Pyridoxal phosphate-responsive seizures), [MONDO:0007041](http://purl.obolibrary.org/obo/MONDO_0007041) (Apert syndrome), [MONDO:0013731](http://purl.obolibrary.org/obo/MONDO_0013731) (early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome), [MONDO:0013734](http://purl.obolibrary.org/obo/MONDO_0013734) (microphthalmia, syndromic 11), [MONDO:0008370](http://purl.obolibrary.org/obo/MONDO_0008370) (reticular dystrophy of retinal pigment epithelium), [MONDO:0010690](http://purl.obolibrary.org/obo/MONDO_0010690) (congenital stationary night blindness 1A), [MONDO:0008372](http://purl.obolibrary.org/obo/MONDO_0008372) (retinal aplasia), [MONDO:0010693](http://purl.obolibrary.org/obo/MONDO_0010693) (nystagmus 1, congenital, X-linked), [MONDO:0019027](http://purl.obolibrary.org/obo/MONDO_0019027) (otopalatodigital syndrome), [MONDO:0008373](http://purl.obolibrary.org/obo/MONDO_0008373) (retinal arterial tortuosity (disease)), [MONDO:0008374](http://purl.obolibrary.org/obo/MONDO_0008374) (retinal cone dystrophy type 1), [MONDO:0010694](http://purl.obolibrary.org/obo/MONDO_0010694) (nystagmus, myoclonic), [MONDO:0010691](http://purl.obolibrary.org/obo/MONDO_0010691) (Norrie disease), [MONDO:0019026](http://purl.obolibrary.org/obo/MONDO_0019026) (autosomal recessive malignant osteopetrosis), [MONDO:0008377](http://purl.obolibrary.org/obo/MONDO_0008377) (retinitis pigmentosa 1), [MONDO:0008378](http://purl.obolibrary.org/obo/MONDO_0008378) (retinitis pigmentosa 9), [MONDO:0008379](http://purl.obolibrary.org/obo/MONDO_0008379) (retinitis pigmentosa 10), [MONDO:0019022](http://purl.obolibrary.org/obo/MONDO_0019022) (sensorineural hearing loss-early graying-essential tremor syndrome), [MONDO:0001758](http://purl.obolibrary.org/obo/MONDO_0001758) (paranasal sinus sarcoma), [MONDO:0020016](http://purl.obolibrary.org/obo/MONDO_0020016) (rare neurologic disease with psychiatric involvement), [MONDO:0019020](http://purl.obolibrary.org/obo/MONDO_0019020) (PANDAS), [MONDO:0020010](http://purl.obolibrary.org/obo/MONDO_0020010) (infectious disease of the nervous system), [MONDO:0020011](http://purl.obolibrary.org/obo/MONDO_0020011) (rare headache disorder), [MONDO:0010698](http://purl.obolibrary.org/obo/MONDO_0010698) (early-onset X-linked optic atrophy), [MONDO:0013726](http://purl.obolibrary.org/obo/MONDO_0013726) (lethal encephalopathy due to mitochondrial and peroxisomal fission defect), [MONDO:0007052](http://purl.obolibrary.org/obo/MONDO_0007052) (growth hormone secreting pituitary adenoma), [MONDO:0010699](http://purl.obolibrary.org/obo/MONDO_0010699) (Charcot-Marie-tooth disease X-linked recessive 5), [MONDO:0013722](http://purl.obolibrary.org/obo/MONDO_0013722) (hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism), [MONDO:0009690](http://purl.obolibrary.org/obo/MONDO_0009690) (congenital myasthenic syndrome 10), [MONDO:0019016](http://purl.obolibrary.org/obo/MONDO_0019016) (maternally-inherited progressive external ophthalmoplegia), [MONDO:0010682](http://purl.obolibrary.org/obo/MONDO_0010682) (myoclonic epilepsy, progressive), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0010683](http://purl.obolibrary.org/obo/MONDO_0010683) (X-linked centronuclear myopathy), [MONDO:0010680](http://purl.obolibrary.org/obo/MONDO_0010680) (X-linked Emery-Dreifuss muscular dystrophy), [MONDO:0009696](http://purl.obolibrary.org/obo/MONDO_0009696) (juvenile myoclonic epilepsy), [MONDO:0009697](http://purl.obolibrary.org/obo/MONDO_0009697) (Lafora disease), [MONDO:0009698](http://purl.obolibrary.org/obo/MONDO_0009698) (Unverricht-Lundborg syndrome), [MONDO:0001723](http://purl.obolibrary.org/obo/MONDO_0001723) (progressive peripheral pterygium), [MONDO:0009699](http://purl.obolibrary.org/obo/MONDO_0009699) (action myoclonus-renal failure syndrome), [MONDO:0020004](http://purl.obolibrary.org/obo/MONDO_0020004) (rare eye disease), [MONDO:0019011](http://purl.obolibrary.org/obo/MONDO_0019011) (Charcot-Marie-tooth disease type 1), [MONDO:0001722](http://purl.obolibrary.org/obo/MONDO_0001722) (central pterygium), [MONDO:0007029](http://purl.obolibrary.org/obo/MONDO_0007029) (branchio-oto-renal syndrome), [MONDO:0010686](http://purl.obolibrary.org/obo/MONDO_0010686) (N syndrome), [MONDO:0010684](http://purl.obolibrary.org/obo/MONDO_0010684) (X-linked myopathy with excessive autophagy), [MONDO:0013715](http://purl.obolibrary.org/obo/MONDO_0013715) (amyotrophic lateral sclerosis type 16), [MONDO:0013711](http://purl.obolibrary.org/obo/MONDO_0013711) (peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome), [MONDO:0010688](http://purl.obolibrary.org/obo/MONDO_0010688) (neuropathy, hereditary sensory, X-linked), [MONDO:0010689](http://purl.obolibrary.org/obo/MONDO_0010689) (Charcot-Marie-tooth disease X-linked recessive 4), [MONDO:0019009](http://purl.obolibrary.org/obo/MONDO_0019009) (isolated focal cortical dysplasia), [MONDO:0009680](http://purl.obolibrary.org/obo/MONDO_0009680) (congenital muscular dystrophy-infantile cataract-hypogonadism syndrome), [MONDO:0009681](http://purl.obolibrary.org/obo/MONDO_0009681) (Ullrich congenital muscular dystrophy 1), [MONDO:0009682](http://purl.obolibrary.org/obo/MONDO_0009682) (muscular dystrophy, congenital, with Rapid Progression), [MONDO:0010671](http://purl.obolibrary.org/obo/MONDO_0010671) (microphthalmia, syndromic 1), [MONDO:0010672](http://purl.obolibrary.org/obo/MONDO_0010672) (microphthalmia with linear skin defects syndrome), [MONDO:0009683](http://purl.obolibrary.org/obo/MONDO_0009683) (autosomal recessive limb-girdle muscular dystrophy type 2H), [MONDO:0010670](http://purl.obolibrary.org/obo/MONDO_0010670) (X-linked intellectual disability-spastic quadriparesis syndrome), [MONDO:0009685](http://purl.obolibrary.org/obo/MONDO_0009685) (Miyoshi myopathy), [MONDO:0021322](http://purl.obolibrary.org/obo/MONDO_0021322) (malignant tumor of meninges), [MONDO:0019002](http://purl.obolibrary.org/obo/MONDO_0019002) (Lhermitte-Duclos disease), [MONDO:0009687](http://purl.obolibrary.org/obo/MONDO_0009687) (myasthenia, congenital, refractory to acetylcholinesterase inhibitors), [MONDO:0001737](http://purl.obolibrary.org/obo/MONDO_0001737) (tetanus neonatorum), [MONDO:0009688](http://purl.obolibrary.org/obo/MONDO_0009688) (myasthenia gravis), [MONDO:0009689](http://purl.obolibrary.org/obo/MONDO_0009689) (congenital myasthenic syndrome 6), [MONDO:0019000](http://purl.obolibrary.org/obo/MONDO_0019000) (perineural cyst), [MONDO:0007039](http://purl.obolibrary.org/obo/MONDO_0007039) (neurofibromatosis type 2), [MONDO:0013706](http://purl.obolibrary.org/obo/MONDO_0013706) (MRT23), [MONDO:0013707](http://purl.obolibrary.org/obo/MONDO_0013707) (MRT24), [MONDO:0013708](http://purl.obolibrary.org/obo/MONDO_0013708) (MRT25), [MONDO:0013709](http://purl.obolibrary.org/obo/MONDO_0013709) (MRT28), [MONDO:0013702](http://purl.obolibrary.org/obo/MONDO_0013702) (mental retardation, autosomal recessive 27), [MONDO:0010675](http://purl.obolibrary.org/obo/MONDO_0010675) (muscular dystrophy, cardiac type), [MONDO:0013703](http://purl.obolibrary.org/obo/MONDO_0013703) (MRT33), [MONDO:0010676](http://purl.obolibrary.org/obo/MONDO_0010676) (muscular dystrophy, Hemizygous lethal type), [MONDO:0013704](http://purl.obolibrary.org/obo/MONDO_0013704) (MRT30), [MONDO:0010674](http://purl.obolibrary.org/obo/MONDO_0010674) (mucopolysaccharidosis type 2), [MONDO:0013705](http://purl.obolibrary.org/obo/MONDO_0013705) (MRT19), [MONDO:0010679](http://purl.obolibrary.org/obo/MONDO_0010679) (Duchenne muscular dystrophy), [MONDO:0010677](http://purl.obolibrary.org/obo/MONDO_0010677) (muscular dystrophy, Mabry type), [MONDO:0013701](http://purl.obolibrary.org/obo/MONDO_0013701) (MRT32), [MONDO:0010678](http://purl.obolibrary.org/obo/MONDO_0010678) (muscular dystrophy, progressive Pectorodorsal), [MONDO:0013772](http://purl.obolibrary.org/obo/MONDO_0013772) (congenital cataract-hearing loss-severe developmental delay syndrome), [MONDO:0013773](http://purl.obolibrary.org/obo/MONDO_0013773) (porencephaly 2), [MONDO:0013774](http://purl.obolibrary.org/obo/MONDO_0013774) (trigonocephaly 2), [MONDO:0012443](http://purl.obolibrary.org/obo/MONDO_0012443) (ANIB4), [MONDO:0012442](http://purl.obolibrary.org/obo/MONDO_0012442) (autosomal recessive nonsyndromic deafness 66), [MONDO:0004818](http://purl.obolibrary.org/obo/MONDO_0004818) (benign neurilemmoma), [MONDO:0012441](http://purl.obolibrary.org/obo/MONDO_0012441) (migraine with or without aura, susceptibility to, 11), [MONDO:0011110](http://purl.obolibrary.org/obo/MONDO_0011110) (dyssegmental dysplasia-glaucoma syndrome), [MONDO:0012440](http://purl.obolibrary.org/obo/MONDO_0012440) (migraine with or without aura, susceptibility to, 10), [MONDO:0004819](http://purl.obolibrary.org/obo/MONDO_0004819) (indolent myeloma), [MONDO:0004816](http://purl.obolibrary.org/obo/MONDO_0004816) (refractory plasma cell neoplasm), [MONDO:0019078](http://purl.obolibrary.org/obo/MONDO_0019078) (Ritscher-Schinzel syndrome), [MONDO:0000458](http://purl.obolibrary.org/obo/MONDO_0000458) (proneural glioblastoma), [MONDO:0020067](http://purl.obolibrary.org/obo/MONDO_0020067) (infectious encephalitis), [MONDO:0001789](http://purl.obolibrary.org/obo/MONDO_0001789) (neurofibroma of spinal cord), [MONDO:0020068](http://purl.obolibrary.org/obo/MONDO_0020068) (postinfectious encephalitis), [MONDO:0000459](http://purl.obolibrary.org/obo/MONDO_0000459) (mesenchymal glioblastoma), [MONDO:0019079](http://purl.obolibrary.org/obo/MONDO_0019079) (proximal spinal muscular atrophy), [MONDO:0004817](http://purl.obolibrary.org/obo/MONDO_0004817) (non-secretory myeloma), [MONDO:0020069](http://purl.obolibrary.org/obo/MONDO_0020069) (chronic encephalitis), [MONDO:0004815](http://purl.obolibrary.org/obo/MONDO_0004815) (osteosclerotic myeloma), [MONDO:0019074](http://purl.obolibrary.org/obo/MONDO_0019074) (bilateral acute depigmentation of the iris), [MONDO:0004812](http://purl.obolibrary.org/obo/MONDO_0004812) (acute dacryoadenitis), [MONDO:0019075](http://purl.obolibrary.org/obo/MONDO_0019075) (Bosley-Salih-Alorainy syndrome), [MONDO:0000455](http://purl.obolibrary.org/obo/MONDO_0000455) (cone dystrophy), [MONDO:0000456](http://purl.obolibrary.org/obo/MONDO_0000456) (cerebral creatine deficiency syndrome), [MONDO:0000457](http://purl.obolibrary.org/obo/MONDO_0000457) (classical glioblastoma), [MONDO:0016809](http://purl.obolibrary.org/obo/MONDO_0016809) (spinocerebellar ataxia with epilepsy), [MONDO:0020065](http://purl.obolibrary.org/obo/MONDO_0020065) (combined dystonia), [MONDO:0007089](http://purl.obolibrary.org/obo/MONDO_0007089) (Alzheimer's disease 2), [MONDO:0007087](http://purl.obolibrary.org/obo/MONDO_0007087) (alternating hemiplegia of childhood 1), [MONDO:0011114](http://purl.obolibrary.org/obo/MONDO_0011114) (familial multiple trichoepithelioma), [MONDO:0012445](http://purl.obolibrary.org/obo/MONDO_0012445) (autosomal recessive nonsyndromic deafness 59), [MONDO:0012444](http://purl.obolibrary.org/obo/MONDO_0012444) (neurodegeneration with brain iron accumulation 2b), [MONDO:0011113](http://purl.obolibrary.org/obo/MONDO_0011113) (Charcot-Marie-tooth disease type 4C), [MONDO:0007086](http://purl.obolibrary.org/obo/MONDO_0007086) (autosomal dominant Alport syndrome), [MONDO:0007085](http://purl.obolibrary.org/obo/MONDO_0007085) (alopecia-epilepsy-pyorrhea-intellectual disability syndrome), [MONDO:0011119](http://purl.obolibrary.org/obo/MONDO_0011119) (iridogoniodysgenesis), [MONDO:0013776](http://purl.obolibrary.org/obo/MONDO_0013776) (spastic ataxia 5), [MONDO:0012449](http://purl.obolibrary.org/obo/MONDO_0012449) (spinocerebellar ataxia type 23), [MONDO:0012448](http://purl.obolibrary.org/obo/MONDO_0012448) (hereditary spastic paraplegia 33), [MONDO:0013760](http://purl.obolibrary.org/obo/MONDO_0013760) (congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome), [MONDO:0013762](http://purl.obolibrary.org/obo/MONDO_0013762) (Lipoic acid synthetase deficiency), [MONDO:0013763](http://purl.obolibrary.org/obo/MONDO_0013763) (Joubert syndrome 15), [MONDO:0011101](http://purl.obolibrary.org/obo/MONDO_0011101) (peroxisome biogenesis disorder 1B), [MONDO:0012432](http://purl.obolibrary.org/obo/MONDO_0012432) (Joubert syndrome 5), [MONDO:0012430](http://purl.obolibrary.org/obo/MONDO_0012430) (cerebellar ataxia, mental retardation, and Dysequilibrium syndrome 2), [MONDO:0021389](http://purl.obolibrary.org/obo/MONDO_0021389) (neoplasm of aortic body), [MONDO:0019064](http://purl.obolibrary.org/obo/MONDO_0019064) (hereditary spastic paraplegia), [MONDO:0004820](http://purl.obolibrary.org/obo/MONDO_0004820) (peripheral nerve schwannoma), [MONDO:0000460](http://purl.obolibrary.org/obo/MONDO_0000460) (neural glioblastoma), [MONDO:0013768](http://purl.obolibrary.org/obo/MONDO_0013768) (arterial calcification, generalized, of infancy, 2), [MONDO:0011105](http://purl.obolibrary.org/obo/MONDO_0011105) (alacrima, congenital, autosomal recessive), [MONDO:0011103](http://purl.obolibrary.org/obo/MONDO_0011103) (autosomal dominant nonsyndromic deafness 3A), [MONDO:0007098](http://purl.obolibrary.org/obo/MONDO_0007098) (ACys amyloidosis), [MONDO:0007097](http://purl.obolibrary.org/obo/MONDO_0007097) (Finnish type amyloidosis), [MONDO:0011102](http://purl.obolibrary.org/obo/MONDO_0011102) (autosomal dominant nonsyndromic deafness 12), [MONDO:0012433](http://purl.obolibrary.org/obo/MONDO_0012433) (Senior-Loken syndrome 6), [MONDO:0013764](http://purl.obolibrary.org/obo/MONDO_0013764) (Joubert syndrome 16), [MONDO:0012439](http://purl.obolibrary.org/obo/MONDO_0012439) (Alagille syndrome due to a NOTCH2 point mutation), [MONDO:0012438](http://purl.obolibrary.org/obo/MONDO_0012438) (pontocerebellar hypoplasia type 5), [MONDO:0011107](http://purl.obolibrary.org/obo/MONDO_0011107) (congenital hypotrichosis with juvenile macular dystrophy), [MONDO:0011106](http://purl.obolibrary.org/obo/MONDO_0011106) (facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome), [MONDO:0012437](http://purl.obolibrary.org/obo/MONDO_0012437) (cataract 21 multiple types), [MONDO:0013751](http://purl.obolibrary.org/obo/MONDO_0013751) (cutis laxa, autosomal dominant 2), [MONDO:0012421](http://purl.obolibrary.org/obo/MONDO_0012421) (autosomal recessive nonsyndromic deafness 44), [MONDO:0012420](http://purl.obolibrary.org/obo/MONDO_0012420) (autosomal recessive nonsyndromic deafness 49), [MONDO:0019058](http://purl.obolibrary.org/obo/MONDO_0019058) (neurometabolic disease), [MONDO:0019059](http://purl.obolibrary.org/obo/MONDO_0019059) (rare parkinsonian disorder), [MONDO:0020045](http://purl.obolibrary.org/obo/MONDO_0020045) (autosomal recessive cerebellar ataxia due to a DNA repair defect), [MONDO:0019056](http://purl.obolibrary.org/obo/MONDO_0019056) (neuromuscular disease), [MONDO:0020046](http://purl.obolibrary.org/obo/MONDO_0020046) (autosomal recessive degenerative and progressive cerebellar ataxia), [MONDO:0020047](http://purl.obolibrary.org/obo/MONDO_0020047) (autosomal recessive syndromic cerebellar ataxia), [MONDO:0000438](http://purl.obolibrary.org/obo/MONDO_0000438) (ataxia with oculomotor apraxia type 2), [MONDO:0020048](http://purl.obolibrary.org/obo/MONDO_0020048) (internal carotid agenesis), [MONDO:0020043](http://purl.obolibrary.org/obo/MONDO_0020043) (autosomal recessive congenital cerebellar ataxia), [MONDO:0007068](http://purl.obolibrary.org/obo/MONDO_0007068) (Adenylosuccinate lyase deficiency), [MONDO:0020044](http://purl.obolibrary.org/obo/MONDO_0020044) (autosomal recessive metabolic cerebellar ataxia), [MONDO:0012425](http://purl.obolibrary.org/obo/MONDO_0012425) (FECD2), [MONDO:0013758](http://purl.obolibrary.org/obo/MONDO_0013758) (Charcot-Marie-tooth disease dominant intermediate E), [MONDO:0012423](http://purl.obolibrary.org/obo/MONDO_0012423) (MORM syndrome), [MONDO:0013753](http://purl.obolibrary.org/obo/MONDO_0013753) (Charcot-Marie-tooth disease axonal type 2P), [MONDO:0012429](http://purl.obolibrary.org/obo/MONDO_0012429) (Aicardi-Goutieres syndrome 2), [MONDO:0013754](http://purl.obolibrary.org/obo/MONDO_0013754) (cutis laxa, autosomal recessive, type 1B), [MONDO:0013755](http://purl.obolibrary.org/obo/MONDO_0013755) (PYCR1-related de Barsy syndrome), [MONDO:0008392](http://purl.obolibrary.org/obo/MONDO_0008392) (Roussy-LC)vy syndrome), [MONDO:0008393](http://purl.obolibrary.org/obo/MONDO_0008393) (Rubinstein-Taybi syndrome due to CREBBP mutations), [MONDO:0013741](http://purl.obolibrary.org/obo/MONDO_0013741) (familial temporal lobe epilepsy 5), [MONDO:0008395](http://purl.obolibrary.org/obo/MONDO_0008395) (Ruvalcaba syndrome), [MONDO:0019049](http://purl.obolibrary.org/obo/MONDO_0019049) (rare dystonia), [MONDO:0012410](http://purl.obolibrary.org/obo/MONDO_0012410) (finnish upper limb-onset distal myopathy), [MONDO:0008396](http://purl.obolibrary.org/obo/MONDO_0008396) (Oculodental syndrome, Rutherfurd type), [MONDO:0008397](http://purl.obolibrary.org/obo/MONDO_0008397) (aplasia of lacrimal and salivary glands), [MONDO:0019047](http://purl.obolibrary.org/obo/MONDO_0019047) (rare deafness), [MONDO:0008399](http://purl.obolibrary.org/obo/MONDO_0008399) (sarcoidosis, susceptibility to, 1), [MONDO:0019045](http://purl.obolibrary.org/obo/MONDO_0019045) (rare sleep disorder), [MONDO:0000448](http://purl.obolibrary.org/obo/MONDO_0000448) (paraganglioma), [MONDO:0019046](http://purl.obolibrary.org/obo/MONDO_0019046) (leukodystrophy), [MONDO:0020036](http://purl.obolibrary.org/obo/MONDO_0020036) (rare nervous system tumor), [MONDO:0004804](http://purl.obolibrary.org/obo/MONDO_0004804) (dacryoadenitis), [MONDO:0004800](http://purl.obolibrary.org/obo/MONDO_0004800) (chronic dacryoadenitis), [MONDO:0001773](http://purl.obolibrary.org/obo/MONDO_0001773) (post-vaccinal encephalitis), [MONDO:0007078](http://purl.obolibrary.org/obo/MONDO_0007078) (Albright's hereditary osteodystrophy), [MONDO:0012414](http://purl.obolibrary.org/obo/MONDO_0012414) (neuronal ceroid lipofuscinosis 10), [MONDO:0007077](http://purl.obolibrary.org/obo/MONDO_0007077) (Tietz syndrome), [MONDO:0012413](http://purl.obolibrary.org/obo/MONDO_0012413) (syndromic microphthalmia type 5), [MONDO:0012411](http://purl.obolibrary.org/obo/MONDO_0012411) (giant axonal neuropathy 2), [MONDO:0007075](http://purl.obolibrary.org/obo/MONDO_0007075) (alacrima, congenital, autosomal dominant), [MONDO:0012418](http://purl.obolibrary.org/obo/MONDO_0012418) (autosomal recessive nonsyndromic deafness 62), [MONDO:0013742](http://purl.obolibrary.org/obo/MONDO_0013742) (familial mesial temporal lobe epilepsy with febrile seizures), [MONDO:0007072](http://purl.obolibrary.org/obo/MONDO_0007072) (adult syndrome), [MONDO:0013744](http://purl.obolibrary.org/obo/MONDO_0013744) (cataract 37), [MONDO:0013745](http://purl.obolibrary.org/obo/MONDO_0013745) (Joubert syndrome 14), [MONDO:0012415](http://purl.obolibrary.org/obo/MONDO_0012415) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 4), [MONDO:0011152](http://purl.obolibrary.org/obo/MONDO_0011152) (PHGDH deficiency), [MONDO:0012483](http://purl.obolibrary.org/obo/MONDO_0012483) (cone-rod dystrophy 11), [MONDO:0011151](http://purl.obolibrary.org/obo/MONDO_0011151) (exudative vitreoretinopathy 4), [MONDO:0012482](http://purl.obolibrary.org/obo/MONDO_0012482) (West nile virus, susceptibility to), [MONDO:0012481](http://purl.obolibrary.org/obo/MONDO_0012481) (mevalonic aciduria), [MONDO:0012487](http://purl.obolibrary.org/obo/MONDO_0012487) (alopecia-mental retardation syndrome 2), [MONDO:0012485](http://purl.obolibrary.org/obo/MONDO_0012485) (autosomal recessive nonsyndromic deafness 68), [MONDO:0000498](http://purl.obolibrary.org/obo/MONDO_0000498) (arteritic anterior ischemic optic neuropathy), [MONDO:0004854](http://purl.obolibrary.org/obo/MONDO_0004854) (ophthalmia neonatorum), [MONDO:0004852](http://purl.obolibrary.org/obo/MONDO_0004852) (gonococcal keratitis), [MONDO:0004853](http://purl.obolibrary.org/obo/MONDO_0004853) (gonococcal endophthalmia), [MONDO:0015518](http://purl.obolibrary.org/obo/MONDO_0015518) (infantile bilateral striatal necrosis), [MONDO:0011159](http://purl.obolibrary.org/obo/MONDO_0011159) (autosomal dominant nonsyndromic deafness 13), [MONDO:0012489](http://purl.obolibrary.org/obo/MONDO_0012489) (cataract 23), [MONDO:0015519](http://purl.obolibrary.org/obo/MONDO_0015519) (congenital or early infantile CACH syndrome), [MONDO:0011157](http://purl.obolibrary.org/obo/MONDO_0011157) (GC3mez-LC3pez-Hern), [MONDO:0015515](http://purl.obolibrary.org/obo/MONDO_0015515) (carnitine palmitoyltransferase II deficiency), [MONDO:0016830](http://purl.obolibrary.org/obo/MONDO_0016830) (Emery-Dreifuss muscular dystrophy), [MONDO:0012472](http://purl.obolibrary.org/obo/MONDO_0012472) (Aicardi-Goutieres syndrome 4), [MONDO:0011140](http://purl.obolibrary.org/obo/MONDO_0011140) (benign familial neonatal-infantile seizures), [MONDO:0012471](http://purl.obolibrary.org/obo/MONDO_0012471) (Aicardi-Goutieres syndrome 3), [MONDO:0012476](http://purl.obolibrary.org/obo/MONDO_0012476) (hereditary spastic paraplegia 30), [MONDO:0011145](http://purl.obolibrary.org/obo/MONDO_0011145) (colobomatous microphthalmia-obesity-hypogenitalism-intellectual disability syndrome), [MONDO:0011144](http://purl.obolibrary.org/obo/MONDO_0011144) (neuronal ceroid lipofuscinosis 6), [MONDO:0012475](http://purl.obolibrary.org/obo/MONDO_0012475) (cone dystrophy with supernormal rod response), [MONDO:0011143](http://purl.obolibrary.org/obo/MONDO_0011143) (cone-rod dystrophy 6), [MONDO:0012474](http://purl.obolibrary.org/obo/MONDO_0012474) (autosomal dominant nocturnal frontal lobe epilepsy 4), [MONDO:0011142](http://purl.obolibrary.org/obo/MONDO_0011142) (Ehlers-Danlos syndrome, musculocontractural type), [MONDO:0004863](http://purl.obolibrary.org/obo/MONDO_0004863) (purulent endophthalmitis), [MONDO:0004862](http://purl.obolibrary.org/obo/MONDO_0004862) (vitreous abscess), [MONDO:0011147](http://purl.obolibrary.org/obo/MONDO_0011147) (chromosome 18q deletion syndrome), [MONDO:0011146](http://purl.obolibrary.org/obo/MONDO_0011146) (tetrasomy 12p), [MONDO:0012477](http://purl.obolibrary.org/obo/MONDO_0012477) (retinitis pigmentosa 33), [MONDO:0012460](http://purl.obolibrary.org/obo/MONDO_0012460) (autosomal recessive nonsyndromic deafness 67), [MONDO:0016821](http://purl.obolibrary.org/obo/MONDO_0016821) (shoulder and girdle defects-familial intellectual disability syndrome), [MONDO:0016820](http://purl.obolibrary.org/obo/MONDO_0016820) (Moyamoya disease), [MONDO:0011134](http://purl.obolibrary.org/obo/MONDO_0011134) (Curry-Jones syndrome), [MONDO:0012465](http://purl.obolibrary.org/obo/MONDO_0012465) (hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency), [MONDO:0013790](http://purl.obolibrary.org/obo/MONDO_0013790) (mirror movements 2), [MONDO:0012464](http://purl.obolibrary.org/obo/MONDO_0012464) (cone-rod dystrophy 10), [MONDO:0011133](http://purl.obolibrary.org/obo/MONDO_0011133) (Deaf blind hypopigmentation syndrome, Yemenite type), [MONDO:0003509](http://purl.obolibrary.org/obo/MONDO_0003509) (pineal region choriocarcinoma), [MONDO:0012463](http://purl.obolibrary.org/obo/MONDO_0012463) (retinitis pigmentosa 35), [MONDO:0012462](http://purl.obolibrary.org/obo/MONDO_0012462) (autosomal recessive frontotemporal pachygyria), [MONDO:0004837](http://purl.obolibrary.org/obo/MONDO_0004837) (neurofibroma of the esophagus), [MONDO:0003501](http://purl.obolibrary.org/obo/MONDO_0003501) (external ear squamous cell carcinoma), [MONDO:0016827](http://purl.obolibrary.org/obo/MONDO_0016827) (myopathy-growth delay-intellectual disability-hypospadias syndrome), [MONDO:0011137](http://purl.obolibrary.org/obo/MONDO_0011137) (retinitis pigmentosa 19), [MONDO:0012467](http://purl.obolibrary.org/obo/MONDO_0012467) (cold-induced sweating syndrome 2), [MONDO:0012466](http://purl.obolibrary.org/obo/MONDO_0012466) (Parkinson disease 13, autosomal dominant, susceptibility to), [MONDO:0016825](http://purl.obolibrary.org/obo/MONDO_0016825) (mitochondrial myopathy-lactic acidosis-deafness syndrome), [MONDO:0016824](http://purl.obolibrary.org/obo/MONDO_0016824) (myofibromatosis), [MONDO:0012450](http://purl.obolibrary.org/obo/MONDO_0012450) (spinocerebellar ataxia type 28), [MONDO:0013783](http://purl.obolibrary.org/obo/MONDO_0013783) (microphthalmia, isolated, with coloboma 7), [MONDO:0016810](http://purl.obolibrary.org/obo/MONDO_0016810) (autosomal recessive progressive external ophthalmoplegia), [MONDO:0013784](http://purl.obolibrary.org/obo/MONDO_0013784) (lethal neonatal spasticity-epileptic encephalopathy syndrome), [MONDO:0013785](http://purl.obolibrary.org/obo/MONDO_0013785) (mental retardation, autosomal recessive 34), [MONDO:0012453](http://purl.obolibrary.org/obo/MONDO_0012453) (hereditary spastic paraplegia 31), [MONDO:0013780](http://purl.obolibrary.org/obo/MONDO_0013780) (retinitis pigmentosa 63), [MONDO:0011121](http://purl.obolibrary.org/obo/MONDO_0011121) (paragangliomas 2), [MONDO:0012452](http://purl.obolibrary.org/obo/MONDO_0012452) (autosomal recessive nonsyndromic deafness 65), [MONDO:0011120](http://purl.obolibrary.org/obo/MONDO_0011120) (neural tube defects, folate-Sensitive), [MONDO:0019085](http://purl.obolibrary.org/obo/MONDO_0019085) (vernal keratoconjunctivitis), [MONDO:0019083](http://purl.obolibrary.org/obo/MONDO_0019083) (Leigh syndrome with cardiomyopathy), [MONDO:0020070](http://purl.obolibrary.org/obo/MONDO_0020070) (neonatal epilepsy syndrome), [MONDO:0020071](http://purl.obolibrary.org/obo/MONDO_0020071) (infantile epilepsy syndrome), [MONDO:0020072](http://purl.obolibrary.org/obo/MONDO_0020072) (childhood-onset epilepsy syndrome), [MONDO:0020073](http://purl.obolibrary.org/obo/MONDO_0020073) (adolescent-onset epilepsy syndrome), [MONDO:0020074](http://purl.obolibrary.org/obo/MONDO_0020074) (progressive myoclonic epilepsy), [MONDO:0016816](http://purl.obolibrary.org/obo/MONDO_0016816) (Leigh syndrome with nephrotic syndrome), [MONDO:0016815](http://purl.obolibrary.org/obo/MONDO_0016815) (Leigh syndrome with leukodystrophy), [MONDO:0012456](http://purl.obolibrary.org/obo/MONDO_0012456) (congenital aphakia), [MONDO:0012455](http://purl.obolibrary.org/obo/MONDO_0012455) (Kleefstra syndrome), [MONDO:0016817](http://purl.obolibrary.org/obo/MONDO_0016817) (Meier-Gorlin syndrome), [MONDO:0016812](http://purl.obolibrary.org/obo/MONDO_0016812) (Dopa-responsive dystonia), [MONDO:0013786](http://purl.obolibrary.org/obo/MONDO_0013786) (cone-rod dystrophy 16), [MONDO:0016814](http://purl.obolibrary.org/obo/MONDO_0016814) (maternally-inherited Leigh syndrome), [MONDO:0013788](http://purl.obolibrary.org/obo/MONDO_0013788) (Usher syndrome type 3B), [MONDO:0013789](http://purl.obolibrary.org/obo/MONDO_0013789) (DDOST-CDG), [MONDO:0011128](http://purl.obolibrary.org/obo/MONDO_0011128) (Sheldon-hall syndrome), [MONDO:0011196](http://purl.obolibrary.org/obo/MONDO_0011196) (amyotrophic lateral sclerosis type 5), [MONDO:0011195](http://purl.obolibrary.org/obo/MONDO_0011195) (Usher syndrome type 1E), [MONDO:0014223](http://purl.obolibrary.org/obo/MONDO_0014223) (amyotrophic lateral sclerosis type 19), [MONDO:0014224](http://purl.obolibrary.org/obo/MONDO_0014224) (developmental delay with autism spectrum disorder and gait instability), [MONDO:0011194](http://purl.obolibrary.org/obo/MONDO_0011194) (Alzheimer disease 5), [MONDO:0011193](http://purl.obolibrary.org/obo/MONDO_0011193) (cone dystrophy 3), [MONDO:0014220](http://purl.obolibrary.org/obo/MONDO_0014220) (myopathy due to Myoadenylate deaminase deficiency), [MONDO:0014221](http://purl.obolibrary.org/obo/MONDO_0014221) (triosephosphate isomerase deficiency), [MONDO:0011197](http://purl.obolibrary.org/obo/MONDO_0011197) (hereditary thermosensitive neuropathy), [MONDO:0011192](http://purl.obolibrary.org/obo/MONDO_0011192) (autosomal recessive nonsyndromic deafness 18A), [MONDO:0007926](http://purl.obolibrary.org/obo/MONDO_0007926) (Waldenstrom macroglobulinemia), [MONDO:0007924](http://purl.obolibrary.org/obo/MONDO_0007924) (Bannayan-Riley-Ruvalcaba syndrome), [MONDO:0007922](http://purl.obolibrary.org/obo/MONDO_0007922) (lymphedema-distichiasis syndrome), [MONDO:0002235](http://purl.obolibrary.org/obo/MONDO_0002235) (eyelid neoplasm), [MONDO:0007920](http://purl.obolibrary.org/obo/MONDO_0007920) (Meige disease), [MONDO:0019915](http://purl.obolibrary.org/obo/MONDO_0019915) (maternal uniparental disomy of chromosome 14), [MONDO:0014228](http://purl.obolibrary.org/obo/MONDO_0014228) (corneal dystrophy, Fuchs endothelial, 8), [MONDO:0014229](http://purl.obolibrary.org/obo/MONDO_0014229) (microphthalmia, syndromic 12), [MONDO:0011185](http://purl.obolibrary.org/obo/MONDO_0011185) (Thiel-Behnke corneal dystrophy), [MONDO:0011184](http://purl.obolibrary.org/obo/MONDO_0011184) (childhood apraxia of speech), [MONDO:0014212](http://purl.obolibrary.org/obo/MONDO_0014212) (sulfite oxidase deficiency due to molybdenum cofactor deficiency type c), [MONDO:0014213](http://purl.obolibrary.org/obo/MONDO_0014213) (intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome), [MONDO:0014210](http://purl.obolibrary.org/obo/MONDO_0014210) (intellectual disability-hypotonia-spasticity-sleep disorder syndrome), [MONDO:0011186](http://purl.obolibrary.org/obo/MONDO_0011186) (Usher syndrome type 1F), [MONDO:0007939](http://purl.obolibrary.org/obo/MONDO_0007939) (malignant hyperthermia, susceptibility to, 2), [MONDO:0011181](http://purl.obolibrary.org/obo/MONDO_0011181) (fibrosis of extraocular muscles, congenital, 2), [MONDO:0007936](http://purl.obolibrary.org/obo/MONDO_0007936) (macular dystrophy, Fenestrated sheen type), [MONDO:0007935](http://purl.obolibrary.org/obo/MONDO_0007935) (cystoid macular edema), [MONDO:0007934](http://purl.obolibrary.org/obo/MONDO_0007934) (benign concentric annular macular dystrophy), [MONDO:0007933](http://purl.obolibrary.org/obo/MONDO_0007933) (VMD1), [MONDO:0007931](http://purl.obolibrary.org/obo/MONDO_0007931) (best vitelliform macular dystrophy), [MONDO:0014219](http://purl.obolibrary.org/obo/MONDO_0014219) (alacrima, achalasia, and mental retardation syndrome), [MONDO:0015547](http://purl.obolibrary.org/obo/MONDO_0015547) (genetic dementia), [MONDO:0019902](http://purl.obolibrary.org/obo/MONDO_0019902) (monosomy 13q34), [MONDO:0014217](http://purl.obolibrary.org/obo/MONDO_0014217) (telangiectasia, hereditary hemorrhagic, type 5), [MONDO:0015548](http://purl.obolibrary.org/obo/MONDO_0015548) (Huntington disease-like syndrome), [MONDO:0016863](http://purl.obolibrary.org/obo/MONDO_0016863) (Okihiro syndrome due to 20q13 microdeletion), [MONDO:0014201](http://purl.obolibrary.org/obo/MONDO_0014201) (early infantile epileptic encephalopathy without suppression burst), [MONDO:0016862](http://purl.obolibrary.org/obo/MONDO_0016862) (Alagille syndrome due to a JAG1 point mutation), [MONDO:0016865](http://purl.obolibrary.org/obo/MONDO_0016865) (Kleefstra syndrome due to a point mutation), [MONDO:0016864](http://purl.obolibrary.org/obo/MONDO_0016864) (Okihiro syndrome due to a point mutation), [MONDO:0011178](http://purl.obolibrary.org/obo/MONDO_0011178) (infantile convulsions and choreoathetosis), [MONDO:0016861](http://purl.obolibrary.org/obo/MONDO_0016861) (Alagille syndrome due to 20p12 microdeletion), [MONDO:0015530](http://purl.obolibrary.org/obo/MONDO_0015530) (trigeminal autonomic cephalalgia), [MONDO:0011175](http://purl.obolibrary.org/obo/MONDO_0011175) (FRDA2), [MONDO:0007907](http://purl.obolibrary.org/obo/MONDO_0007907) (lipoma of the conjunctiva), [MONDO:0011170](http://purl.obolibrary.org/obo/MONDO_0011170) (autosomal recessive limb-girdle muscular dystrophy type 2G), [MONDO:0002214](http://purl.obolibrary.org/obo/MONDO_0002214) (brain germinoma), [MONDO:0007903](http://purl.obolibrary.org/obo/MONDO_0007903) (Li-Fraumeni syndrome 1), [MONDO:0002217](http://purl.obolibrary.org/obo/MONDO_0002217) (central nervous system sarcoma), [MONDO:0002216](http://purl.obolibrary.org/obo/MONDO_0002216) (brain sarcoma), [MONDO:0014208](http://purl.obolibrary.org/obo/MONDO_0014208) (Charcot-Marie-tooth disease type 2R), [MONDO:0014209](http://purl.obolibrary.org/obo/MONDO_0014209) (early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome), [MONDO:0014204](http://purl.obolibrary.org/obo/MONDO_0014204) (basal ganglia calcification, idiopathic, 5), [MONDO:0014205](http://purl.obolibrary.org/obo/MONDO_0014205) (severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome), [MONDO:0015521](http://purl.obolibrary.org/obo/MONDO_0015521) (juvenile or adult CACH syndrome), [MONDO:0011163](http://purl.obolibrary.org/obo/MONDO_0011163) (malignant hyperthermia, susceptibility to, 5), [MONDO:0015520](http://purl.obolibrary.org/obo/MONDO_0015520) (late infantile CACH syndrome), [MONDO:0011162](http://purl.obolibrary.org/obo/MONDO_0011162) (cataract 14 multiple types), [MONDO:0012491](http://purl.obolibrary.org/obo/MONDO_0012491) (WM2), [MONDO:0011160](http://purl.obolibrary.org/obo/MONDO_0011160) (autosomal recessive nonsyndromic deafness 15), [MONDO:0012498](http://purl.obolibrary.org/obo/MONDO_0012498) (congenital stationary night blindness autosomal dominant 1), [MONDO:0012497](http://purl.obolibrary.org/obo/MONDO_0012497) (congenital stationary night blindness autosomal dominant 3), [MONDO:0012496](http://purl.obolibrary.org/obo/MONDO_0012496) (Koolen de Vries syndrome), [MONDO:0011164](http://purl.obolibrary.org/obo/MONDO_0011164) (malignant hyperthermia, susceptibility to, 6), [MONDO:0007919](http://purl.obolibrary.org/obo/MONDO_0007919) (lymphedema, hereditary, 1A), [MONDO:0007918](http://purl.obolibrary.org/obo/MONDO_0007918) (microcephaly with or without chorioretinopathy, lymphedema, or mental retardation), [MONDO:0012490](http://purl.obolibrary.org/obo/MONDO_0012490) (cone-rod synaptic disorder, congenital nonprogressive), [MONDO:0003557](http://purl.obolibrary.org/obo/MONDO_0003557) (optic nerve sheath meningioma), [MONDO:0004882](http://purl.obolibrary.org/obo/MONDO_0004882) (angioid streaks of choroid), [MONDO:0015529](http://purl.obolibrary.org/obo/MONDO_0015529) (paroxysmal hemicrania), [MONDO:0016859](http://purl.obolibrary.org/obo/MONDO_0016859) (blepharophimosis-epicanthus inversus-ptosis due to copy number variations), [MONDO:0016856](http://purl.obolibrary.org/obo/MONDO_0016856) (Mowat-Wilson syndrome due to a ZEB2 point mutation), [MONDO:0016855](http://purl.obolibrary.org/obo/MONDO_0016855) (Mowat-Wilson syndrome due to monosomy 2q22), [MONDO:0015527](http://purl.obolibrary.org/obo/MONDO_0015527) (KlC<ver-Bucy syndrome), [MONDO:0016858](http://purl.obolibrary.org/obo/MONDO_0016858) (blepharophimosis-epicanthus inversus-ptosis due to a point mutation syndrome), [MONDO:0015526](http://purl.obolibrary.org/obo/MONDO_0015526) (cold-induced sweating syndrome), [MONDO:0016857](http://purl.obolibrary.org/obo/MONDO_0016857) (blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome), [MONDO:0018624](http://purl.obolibrary.org/obo/MONDO_0018624) (spontaneous intracranial hypotension), [MONDO:0019956](http://purl.obolibrary.org/obo/MONDO_0019956) (encephalitis), [MONDO:0018625](http://purl.obolibrary.org/obo/MONDO_0018625) (classic stiff person syndrome), [MONDO:0019953](http://purl.obolibrary.org/obo/MONDO_0019953) (Mega-cisterna magna), [MONDO:0015599](http://purl.obolibrary.org/obo/MONDO_0015599) (atopic keratoconjunctivitis), [MONDO:0019951](http://purl.obolibrary.org/obo/MONDO_0019951) (rigid spine syndrome), [MONDO:0015594](http://purl.obolibrary.org/obo/MONDO_0015594) (non-paraneoplastic limbic encephalitis), [MONDO:0018620](http://purl.obolibrary.org/obo/MONDO_0018620) (hypothalamic adipsic hypernatraemia syndrome), [MONDO:0015593](http://purl.obolibrary.org/obo/MONDO_0015593) (limbic encephalitis with nCMAgs antibodies), [MONDO:0019952](http://purl.obolibrary.org/obo/MONDO_0019952) (congenital myopathy), [MONDO:0015596](http://purl.obolibrary.org/obo/MONDO_0015596) (non-herpetic acute limbic encephalitis), [MONDO:0014265](http://purl.obolibrary.org/obo/MONDO_0014265) (Alzheimer's disease 18), [MONDO:0015595](http://purl.obolibrary.org/obo/MONDO_0015595) (Posttransplant acute limbic encephalitis), [MONDO:0019950](http://purl.obolibrary.org/obo/MONDO_0019950) (congenital muscular dystrophy), [MONDO:0015590](http://purl.obolibrary.org/obo/MONDO_0015590) (classic paraneoplastic limbic encephalitis), [MONDO:0015592](http://purl.obolibrary.org/obo/MONDO_0015592) (limbic encephalitis with LGI1 antibodies), [MONDO:0014261](http://purl.obolibrary.org/obo/MONDO_0014261) (growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome), [MONDO:0015591](http://purl.obolibrary.org/obo/MONDO_0015591) (limbic encephalitis associated with antibodies to cell membrane antigens), [MONDO:0007969](http://purl.obolibrary.org/obo/MONDO_0007969) (Melkersson-Rosenthal syndrome), [MONDO:0007967](http://purl.obolibrary.org/obo/MONDO_0007967) (melanoma and neural system tumor syndrome), [MONDO:0007966](http://purl.obolibrary.org/obo/MONDO_0007966) (susceptibility to uveal melanoma), [MONDO:0006634](http://purl.obolibrary.org/obo/MONDO_0006634) (pituitary gland acidophil adenoma), [MONDO:0007961](http://purl.obolibrary.org/obo/MONDO_0007961) (megalencephaly, autosomal dominant), [MONDO:0018629](http://purl.obolibrary.org/obo/MONDO_0018629) (focal stiff limb syndrome), [MONDO:0015587](http://purl.obolibrary.org/obo/MONDO_0015587) (rolandic epilepsy-speech dyspraxia syndrome), [MONDO:0018614](http://purl.obolibrary.org/obo/MONDO_0018614) (undetermined early-onset epileptic encephalopathy), [MONDO:0015586](http://purl.obolibrary.org/obo/MONDO_0015586) (benign familial mesial temporal lobe epilepsy), [MONDO:0014256](http://purl.obolibrary.org/obo/MONDO_0014256) (retinitis pigmentosa 67), [MONDO:0015589](http://purl.obolibrary.org/obo/MONDO_0015589) (paraneoplastic limbic encephalitis), [MONDO:0018611](http://purl.obolibrary.org/obo/MONDO_0018611) (early-onset lamellar cataract), [MONDO:0014258](http://purl.obolibrary.org/obo/MONDO_0014258) (congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome), [MONDO:0015588](http://purl.obolibrary.org/obo/MONDO_0015588) (limbic encephalitis), [MONDO:0019943](http://purl.obolibrary.org/obo/MONDO_0019943) (hereditary continuous muscle fiber activity), [MONDO:0019941](http://purl.obolibrary.org/obo/MONDO_0019941) (hereditary sensory and autonomic neuropathy type 2), [MONDO:0018610](http://purl.obolibrary.org/obo/MONDO_0018610) (early-onset posterior subcapsular cataract), [MONDO:0015585](http://purl.obolibrary.org/obo/MONDO_0015585) (cryptogenic late-onset epileptic spasms), [MONDO:0015584](http://purl.obolibrary.org/obo/MONDO_0015584) (febrile infection-related epilepsy syndrome), [MONDO:0007974](http://purl.obolibrary.org/obo/MONDO_0007974) (mental retardation, autosomal dominant 1), [MONDO:0014259](http://purl.obolibrary.org/obo/MONDO_0014259) (neuronopathy, distal hereditary motor, type 2D), [MONDO:0019948](http://purl.obolibrary.org/obo/MONDO_0019948) (reducing body myopathy), [MONDO:0018617](http://purl.obolibrary.org/obo/MONDO_0018617) (Baroreflex failure), [MONDO:0019949](http://purl.obolibrary.org/obo/MONDO_0019949) (zebra body myopathy), [MONDO:0019946](http://purl.obolibrary.org/obo/MONDO_0019946) (ligneous conjunctivitis), [MONDO:0018615](http://purl.obolibrary.org/obo/MONDO_0018615) (hemicrania continua), [MONDO:0018616](http://purl.obolibrary.org/obo/MONDO_0018616) (central serous chorioretinopathy), [MONDO:0019947](http://purl.obolibrary.org/obo/MONDO_0019947) (rippling muscle disease 2), [MONDO:0019933](http://purl.obolibrary.org/obo/MONDO_0019933) (acromegaly), [MONDO:0014244](http://purl.obolibrary.org/obo/MONDO_0014244) (hereditary sensory and autonomic neuropathy type 7), [MONDO:0014246](http://purl.obolibrary.org/obo/MONDO_0014246) (episodic pain syndrome, familial, 2), [MONDO:0018600](http://purl.obolibrary.org/obo/MONDO_0018600) (congenital abducens nerve palsy), [MONDO:0014247](http://purl.obolibrary.org/obo/MONDO_0014247) (familial episodic pain syndrome with predominantly lower limb involvement), [MONDO:0018601](http://purl.obolibrary.org/obo/MONDO_0018601) (autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome), [MONDO:0015572](http://purl.obolibrary.org/obo/MONDO_0015572) (cerebral malformation due to abnormal neuronal migration), [MONDO:0014240](http://purl.obolibrary.org/obo/MONDO_0014240) (periventricular nodular heterotopia 6), [MONDO:0014242](http://purl.obolibrary.org/obo/MONDO_0014242) (van Maldergem syndrome 2), [MONDO:0014243](http://purl.obolibrary.org/obo/MONDO_0014243) (Prader-Willi syndrome due to point mutation), [MONDO:0007949](http://purl.obolibrary.org/obo/MONDO_0007949) (Marshall syndrome), [MONDO:0007947](http://purl.obolibrary.org/obo/MONDO_0007947) (Marfan syndrome), [MONDO:0007946](http://purl.obolibrary.org/obo/MONDO_0007946) (jaw-winking syndrome), [MONDO:0007944](http://purl.obolibrary.org/obo/MONDO_0007944) (Treacher-Collins syndrome 1), [MONDO:0007943](http://purl.obolibrary.org/obo/MONDO_0007943) (Nager acrofacial dysostosis), [MONDO:0006611](http://purl.obolibrary.org/obo/MONDO_0006611) (skin sarcoidosis), [MONDO:0007940](http://purl.obolibrary.org/obo/MONDO_0007940) (malignant hyperthermia, susceptibility to, 3), [MONDO:0018608](http://purl.obolibrary.org/obo/MONDO_0018608) (pure autonomic failure), [MONDO:0019939](http://purl.obolibrary.org/obo/MONDO_0019939) (early-onset schizophrenia), [MONDO:0018609](http://purl.obolibrary.org/obo/MONDO_0018609) (syndromic hereditary optic neuropathy), [MONDO:0014248](http://purl.obolibrary.org/obo/MONDO_0014248) (autism spectrum disorder-epilepsy-arthrogryposis syndrome), [MONDO:0018606](http://purl.obolibrary.org/obo/MONDO_0018606) (extensive peripapillary myelinated nerve fibers), [MONDO:0018607](http://purl.obolibrary.org/obo/MONDO_0018607) (combined hamartoma of the retina and retinal pigment epithelium), [MONDO:0014233](http://purl.obolibrary.org/obo/MONDO_0014233) (early-onset Parkinson disease 20), [MONDO:0015567](http://purl.obolibrary.org/obo/MONDO_0015567) (cataract-glaucoma syndrome), [MONDO:0015566](http://purl.obolibrary.org/obo/MONDO_0015566) (2q24 microdeletion syndrome), [MONDO:0014236](http://purl.obolibrary.org/obo/MONDO_0014236) (Ehlers-Danlos syndrome, musculocontractural type 2), [MONDO:0014231](http://purl.obolibrary.org/obo/MONDO_0014231) (juvenile onset Parkinson disease 19A), [MONDO:0014232](http://purl.obolibrary.org/obo/MONDO_0014232) (craniosynostosis 5, susceptibility to), [MONDO:0007959](http://purl.obolibrary.org/obo/MONDO_0007959) (medulloblastoma), [MONDO:0007953](http://purl.obolibrary.org/obo/MONDO_0007953) (binder syndrome), [MONDO:0019928](http://purl.obolibrary.org/obo/MONDO_0019928) (48,XXXY syndrome), [MONDO:0019929](http://purl.obolibrary.org/obo/MONDO_0019929) (49,XXXXY syndrome), [MONDO:0014237](http://purl.obolibrary.org/obo/MONDO_0014237) (autosomal recessive nonsyndromic deafness 76), [MONDO:0019927](http://purl.obolibrary.org/obo/MONDO_0019927) (growth hormone-producing pituitary gland neoplasm), [MONDO:0014238](http://purl.obolibrary.org/obo/MONDO_0014238) (severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome), [MONDO:0016899](http://purl.obolibrary.org/obo/MONDO_0016899) (Duchenne and Becker muscular dystrophy), [MONDO:0017338](http://purl.obolibrary.org/obo/MONDO_0017338) (fatal multiple mitochondrial dysfunctions syndrome), [MONDO:0016006](http://purl.obolibrary.org/obo/MONDO_0016006) (Cockayne syndrome), [MONDO:0016001](http://purl.obolibrary.org/obo/MONDO_0016001) (2-hydroxyglutaric aciduria), [MONDO:0016000](http://purl.obolibrary.org/obo/MONDO_0016000) (familial isolated hypoparathyroidism due to impaired PTH secretion), [MONDO:0017333](http://purl.obolibrary.org/obo/MONDO_0017333) (hypomyelinating leukodystrophy with or without oligondontia and/or hypogonadism), [MONDO:0016002](http://purl.obolibrary.org/obo/MONDO_0016002) (Ehlers-Danlos syndrome, kyphoscoliotic type), [MONDO:0009710](http://purl.obolibrary.org/obo/MONDO_0009710) (myotonia congenita), [MONDO:0009711](http://purl.obolibrary.org/obo/MONDO_0009711) (congenital fiber-type disproportion myopathy), [MONDO:0009712](http://purl.obolibrary.org/obo/MONDO_0009712) (congenital multicore myopathy with external ophthalmoplegia), [MONDO:0009714](http://purl.obolibrary.org/obo/MONDO_0009714) (myosclerosis), [MONDO:0009715](http://purl.obolibrary.org/obo/MONDO_0009715) (myotonia congenita, autosomal recessive), [MONDO:0004016](http://purl.obolibrary.org/obo/MONDO_0004016) (pineal region mature teratoma), [MONDO:0009717](http://purl.obolibrary.org/obo/MONDO_0009717) (Schwartz-Jampel syndrome), [MONDO:0004017](http://purl.obolibrary.org/obo/MONDO_0004017) (pineal region immature teratoma), [MONDO:0010703](http://purl.obolibrary.org/obo/MONDO_0010703) (ornithine carbamoyltransferase deficiency), [MONDO:0004015](http://purl.obolibrary.org/obo/MONDO_0004015) (pineal region teratoma), [MONDO:0010704](http://purl.obolibrary.org/obo/MONDO_0010704) (Otopalatodigital syndrome type 1), [MONDO:0010709](http://purl.obolibrary.org/obo/MONDO_0010709) (early-onset parkinsonism-intellectual disability syndrome), [MONDO:0004012](http://purl.obolibrary.org/obo/MONDO_0004012) (adult botryoid rhabdomyosarcoma), [MONDO:0004013](http://purl.obolibrary.org/obo/MONDO_0004013) (adult vagina botryoid rhabdomyosarcoma), [MONDO:0006673](http://purl.obolibrary.org/obo/MONDO_0006673) (pituitary gland basophil adenoma), [MONDO:0010708](http://purl.obolibrary.org/obo/MONDO_0010708) (W syndrome), [MONDO:0006670](http://purl.obolibrary.org/obo/MONDO_0006670) (bacterial meningitis), [MONDO:0010702](http://purl.obolibrary.org/obo/MONDO_0010702) (orofaciodigital syndrome I), [MONDO:0017325](http://purl.obolibrary.org/obo/MONDO_0017325) (early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation), [MONDO:0014299](http://purl.obolibrary.org/obo/MONDO_0014299) (Schwannomatosis 2), [MONDO:0018658](http://purl.obolibrary.org/obo/MONDO_0018658) (19p13.3 microduplication syndrome), [MONDO:0018655](http://purl.obolibrary.org/obo/MONDO_0018655) (hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome), [MONDO:0018656](http://purl.obolibrary.org/obo/MONDO_0018656) (tremor-ataxia-central hypomyelination syndrome), [MONDO:0014295](http://purl.obolibrary.org/obo/MONDO_0014295) (hereditary spastic paraplegia 57), [MONDO:0014296](http://purl.obolibrary.org/obo/MONDO_0014296) (Warburg micro syndrome 4), [MONDO:0018654](http://purl.obolibrary.org/obo/MONDO_0018654) (idiopathic dropped head syndrome), [MONDO:0014297](http://purl.obolibrary.org/obo/MONDO_0014297) (Joubert syndrome 22), [MONDO:0014298](http://purl.obolibrary.org/obo/MONDO_0014298) (chromosome 5q12 deletion syndrome), [MONDO:0014291](http://purl.obolibrary.org/obo/MONDO_0014291) (autosomal dominant nonsyndromic deafness 54), [MONDO:0014292](http://purl.obolibrary.org/obo/MONDO_0014292) (leukoencephalopathy with mild cerebellar ataxia and white matter edema), [MONDO:0014293](http://purl.obolibrary.org/obo/MONDO_0014293) (autosomal dominant nonsyndromic deafness 58), [MONDO:0009703](http://purl.obolibrary.org/obo/MONDO_0009703) (myopathy with abnormal lipid metabolism), [MONDO:0014290](http://purl.obolibrary.org/obo/MONDO_0014290) (neurodegeneration with brain iron accumulation 6), [MONDO:0009704](http://purl.obolibrary.org/obo/MONDO_0009704) (carnitine palmitoyl transferase II deficiency, myopathic form), [MONDO:0009706](http://purl.obolibrary.org/obo/MONDO_0009706) (hereditary myopathy with lactic acidosis due to ISCU deficiency), [MONDO:0006687](http://purl.obolibrary.org/obo/MONDO_0006687) (burning mouth syndrome), [MONDO:0009708](http://purl.obolibrary.org/obo/MONDO_0009708) (myopathy, Myosin storage, autosomal recessive), [MONDO:0009709](http://purl.obolibrary.org/obo/MONDO_0009709) (myopathy, centronuclear, 2), [MONDO:0004024](http://purl.obolibrary.org/obo/MONDO_0004024) (spinal cord neuroblastoma), [MONDO:0004022](http://purl.obolibrary.org/obo/MONDO_0004022) (parasagittal meningioma), [MONDO:0014288](http://purl.obolibrary.org/obo/MONDO_0014288) (Joubert syndrome 21), [MONDO:0019977](http://purl.obolibrary.org/obo/MONDO_0019977) (parkinsonism with dementia of Guadeloupe), [MONDO:0014289](http://purl.obolibrary.org/obo/MONDO_0014289) (macrocephaly-developmental delay syndrome), [MONDO:0018644](http://purl.obolibrary.org/obo/MONDO_0018644) (autosomal dominant complex spastic paraplegia type 9B), [MONDO:0017316](http://purl.obolibrary.org/obo/MONDO_0017316) (short stature-deafness-neutrophil dysfunction-dysmorphism syndrome), [MONDO:0019976](http://purl.obolibrary.org/obo/MONDO_0019976) (dementia pugilistica), [MONDO:0017315](http://purl.obolibrary.org/obo/MONDO_0017315) (short stature-webbed neck-heart disease syndrome), [MONDO:0019973](http://purl.obolibrary.org/obo/MONDO_0019973) (persistent placoid maculopathy), [MONDO:0017312](http://purl.obolibrary.org/obo/MONDO_0017312) (Perrault syndrome), [MONDO:0014286](http://purl.obolibrary.org/obo/MONDO_0014286) (neuropathy, hereditary sensory, type 1F), [MONDO:0019972](http://purl.obolibrary.org/obo/MONDO_0019972) (dural sinus malformation), [MONDO:0014282](http://purl.obolibrary.org/obo/MONDO_0014282) (hereditary spastic paraplegia 72), [MONDO:0014283](http://purl.obolibrary.org/obo/MONDO_0014283) (autosomal dominant nonsyndromic deafness 56), [MONDO:0007989](http://purl.obolibrary.org/obo/MONDO_0007989) (congenital microcoria), [MONDO:0007988](http://purl.obolibrary.org/obo/MONDO_0007988) (autosomal dominant microcephaly), [MONDO:0005324](http://purl.obolibrary.org/obo/MONDO_0005324) (seasonal allergic rhinitis), [MONDO:0005321](http://purl.obolibrary.org/obo/MONDO_0005321) (Fuchs' endothelial dystrophy), [MONDO:0006651](http://purl.obolibrary.org/obo/MONDO_0006651) (anterior uveitis (disease)), [MONDO:0007981](http://purl.obolibrary.org/obo/MONDO_0007981) (metachromatic leukodystrophy, adult-onset, with normal arylsulfatase a), [MONDO:0002293](http://purl.obolibrary.org/obo/MONDO_0002293) (cutaneous ganglioneuroma), [MONDO:0017318](http://purl.obolibrary.org/obo/MONDO_0017318) (phakomatosis pigmentovascularis), [MONDO:0018649](http://purl.obolibrary.org/obo/MONDO_0018649) (cerebral visual impairment), [MONDO:0017303](http://purl.obolibrary.org/obo/MONDO_0017303) (qualitative or quantitative defects of tropomyosin), [MONDO:0017302](http://purl.obolibrary.org/obo/MONDO_0017302) (qualitative or quantitative defects of troponin), [MONDO:0018633](http://purl.obolibrary.org/obo/MONDO_0018633) (20q11.2 microdeletion syndrome), [MONDO:0017305](http://purl.obolibrary.org/obo/MONDO_0017305) (syndromic oculocutaneous albinism), [MONDO:0017304](http://purl.obolibrary.org/obo/MONDO_0017304) (ocular albinism (disease)), [MONDO:0014273](http://purl.obolibrary.org/obo/MONDO_0014273) (microcephaly-thin corpus callosum-intellectual disability syndrome), [MONDO:0018632](http://purl.obolibrary.org/obo/MONDO_0018632) (11q22.2q22.3 microdeletion syndrome), [MONDO:0014270](http://purl.obolibrary.org/obo/MONDO_0014270) (STT3A-CDG), [MONDO:0014271](http://purl.obolibrary.org/obo/MONDO_0014271) (STT3B-CDG), [MONDO:0006668](http://purl.obolibrary.org/obo/MONDO_0006668) (bacterial conjunctivitis), [MONDO:0007999](http://purl.obolibrary.org/obo/MONDO_0007999) (holoprosencephaly 2), [MONDO:0007998](http://purl.obolibrary.org/obo/MONDO_0007998) (Microspherophakia-metaphyseal dysplasia syndrome), [MONDO:0004004](http://purl.obolibrary.org/obo/MONDO_0004004) (motor neuritis), [MONDO:0007995](http://purl.obolibrary.org/obo/MONDO_0007995) (MCOPCT1), [MONDO:0006662](http://purl.obolibrary.org/obo/MONDO_0006662) (aseptic meningitis), [MONDO:0007992](http://purl.obolibrary.org/obo/MONDO_0007992) (microcornea-glaucoma-absent frontal sinuses syndrome), [MONDO:0007991](http://purl.obolibrary.org/obo/MONDO_0007991) (microcephaly-deafness-intellectual disability syndrome), [MONDO:0017308](http://purl.obolibrary.org/obo/MONDO_0017308) (Marfan syndrome type 2), [MONDO:0016049](http://purl.obolibrary.org/obo/MONDO_0016049) (congenital myopathy, Paradas type), [MONDO:0017379](http://purl.obolibrary.org/obo/MONDO_0017379) (polyneuropathy-intellectual disability-acromicria-premature menopause syndrome), [MONDO:0016047](http://purl.obolibrary.org/obo/MONDO_0016047) (endophthalmitis), [MONDO:0017378](http://purl.obolibrary.org/obo/MONDO_0017378) (polymicrogyria-turricephaly-hypogenitalism syndrome), [MONDO:0017377](http://purl.obolibrary.org/obo/MONDO_0017377) (preaxial polydactyly-colobomata-intellectual disability syndrome), [MONDO:0009751](http://purl.obolibrary.org/obo/MONDO_0009751) (neuropathy, hereditary sensory, atypical), [MONDO:0016040](http://purl.obolibrary.org/obo/MONDO_0016040) (harlequin syndrome), [MONDO:0017373](http://purl.obolibrary.org/obo/MONDO_0017373) (poliomyelitis), [MONDO:0016042](http://purl.obolibrary.org/obo/MONDO_0016042) (late-onset isolated ACTH deficiency), [MONDO:0008425](http://purl.obolibrary.org/obo/MONDO_0008425) (omphalocele syndrome, Shprintzen-Goldberg type), [MONDO:0009756](http://purl.obolibrary.org/obo/MONDO_0009756) (Niemann-Pick disease type A), [MONDO:0008426](http://purl.obolibrary.org/obo/MONDO_0008426) (Shprintzen-Goldberg syndrome), [MONDO:0009757](http://purl.obolibrary.org/obo/MONDO_0009757) (Niemann-Pick disease, type C1), [MONDO:0009758](http://purl.obolibrary.org/obo/MONDO_0009758) (congenital stationary night blindness 1B), [MONDO:0008428](http://purl.obolibrary.org/obo/MONDO_0008428) (septooptic dysplasia), [MONDO:0010749](http://purl.obolibrary.org/obo/MONDO_0010749) (trigonocephaly-short stature-developmental delay syndrome), [MONDO:0010747](http://purl.obolibrary.org/obo/MONDO_0010747) (X-linked dystonia-parkinsonism), [MONDO:0018699](http://purl.obolibrary.org/obo/MONDO_0018699) (pseudohypoparathyroidism with Albright hereditary osteodystrophy), [MONDO:0018697](http://purl.obolibrary.org/obo/MONDO_0018697) (1p35.2 microdeletion syndrome), [MONDO:0017364](http://purl.obolibrary.org/obo/MONDO_0017364) (POEMS syndrome), [MONDO:0016033](http://purl.obolibrary.org/obo/MONDO_0016033) (Cornelia de Lange syndrome), [MONDO:0018696](http://purl.obolibrary.org/obo/MONDO_0018696) (Corticobasal syndrome), [MONDO:0009740](http://purl.obolibrary.org/obo/MONDO_0009740) (Neurofaciodigitorenal syndrome), [MONDO:0016035](http://purl.obolibrary.org/obo/MONDO_0016035) (Nelson syndrome), [MONDO:0017361](http://purl.obolibrary.org/obo/MONDO_0017361) (congenital rubella syndrome), [MONDO:0009741](http://purl.obolibrary.org/obo/MONDO_0009741) (neuroblastoma, susceptibility to), [MONDO:0009742](http://purl.obolibrary.org/obo/MONDO_0009742) (neuroectodermal melanolysosomal disease), [MONDO:0018692](http://purl.obolibrary.org/obo/MONDO_0018692) (Variably protease-sensitive prionopathy), [MONDO:0017362](http://purl.obolibrary.org/obo/MONDO_0017362) (neuralgic amyotrophy), [MONDO:0009744](http://purl.obolibrary.org/obo/MONDO_0009744) (neuronal ceroid lipofuscinosis 1), [MONDO:0009745](http://purl.obolibrary.org/obo/MONDO_0009745) (neuronal ceroid lipofuscinosis 5), [MONDO:0009746](http://purl.obolibrary.org/obo/MONDO_0009746) (hereditary sensory and autonomic neuropathy type 4), [MONDO:0018690](http://purl.obolibrary.org/obo/MONDO_0018690) (Holmes-Adie syndrome), [MONDO:0009748](http://purl.obolibrary.org/obo/MONDO_0009748) (hereditary sensory and autonomic neuropathy with spastic paraplegia), [MONDO:0009749](http://purl.obolibrary.org/obo/MONDO_0009749) (giant axonal neuropathy 1), [MONDO:0004065](http://purl.obolibrary.org/obo/MONDO_0004065) (intermediate cell type choroid melanoma), [MONDO:0004066](http://purl.obolibrary.org/obo/MONDO_0004066) (intermediate cell type ciliary body melanoma), [MONDO:0004063](http://purl.obolibrary.org/obo/MONDO_0004063) (intermediate cell type iris melanoma), [MONDO:0010731](http://purl.obolibrary.org/obo/MONDO_0010731) (Simpson-Golabi-Behmel syndrome), [MONDO:0004064](http://purl.obolibrary.org/obo/MONDO_0004064) (iris melanoma), [MONDO:0004062](http://purl.obolibrary.org/obo/MONDO_0004062) (intermediate cell type uveal melanoma), [MONDO:0010735](http://purl.obolibrary.org/obo/MONDO_0010735) (Kennedy's disease), [MONDO:0010732](http://purl.obolibrary.org/obo/MONDO_0010732) (spastic paraparesis-deafness syndrome), [MONDO:0010733](http://purl.obolibrary.org/obo/MONDO_0010733) (hereditary spastic paraplegia 2), [MONDO:0016027](http://purl.obolibrary.org/obo/MONDO_0016027) (benign neonatal seizures), [MONDO:0017357](http://purl.obolibrary.org/obo/MONDO_0017357) (transient hyperammonemia of the newborn), [MONDO:0016026](http://purl.obolibrary.org/obo/MONDO_0016026) (infant epilepsy with migrant focal crisis), [MONDO:0016029](http://purl.obolibrary.org/obo/MONDO_0016029) (esthesioneuroblastoma), [MONDO:0016028](http://purl.obolibrary.org/obo/MONDO_0016028) (erythromelalgia), [MONDO:0016023](http://purl.obolibrary.org/obo/MONDO_0016023) (ocular coloboma), [MONDO:0018686](http://purl.obolibrary.org/obo/MONDO_0018686) (acquired Creutzfeldt-Jakob disease), [MONDO:0017354](http://purl.obolibrary.org/obo/MONDO_0017354) (infantile glycine encephalopathy), [MONDO:0016022](http://purl.obolibrary.org/obo/MONDO_0016022) (early myoclonic encephalopathy), [MONDO:0017353](http://purl.obolibrary.org/obo/MONDO_0017353) (neonatal glycine encephalopathy), [MONDO:0018687](http://purl.obolibrary.org/obo/MONDO_0018687) (progressive muscular atrophy), [MONDO:0016025](http://purl.obolibrary.org/obo/MONDO_0016025) (myoclonic-astastic epilepsy), [MONDO:0018682](http://purl.obolibrary.org/obo/MONDO_0018682) (congenital insensitivity to pain with severe intellectual disability), [MONDO:0009730](http://purl.obolibrary.org/obo/MONDO_0009730) (Nephrosialidosis), [MONDO:0009731](http://purl.obolibrary.org/obo/MONDO_0009731) (nephrosis-deafness-urinary tract-digital malformations syndrome), [MONDO:0016021](http://purl.obolibrary.org/obo/MONDO_0016021) (early infantile epileptic encephalopathy), [MONDO:0018681](http://purl.obolibrary.org/obo/MONDO_0018681) (neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome), [MONDO:0016020](http://purl.obolibrary.org/obo/MONDO_0016020) (frontal encephalocele), [MONDO:0009735](http://purl.obolibrary.org/obo/MONDO_0009735) (Netherton syndrome), [MONDO:0009736](http://purl.obolibrary.org/obo/MONDO_0009736) (Neu-Laxova syndrome 1), [MONDO:0009737](http://purl.obolibrary.org/obo/MONDO_0009737) (Galactosialidosis), [MONDO:0008406](http://purl.obolibrary.org/obo/MONDO_0008406) (autosomal recessive Emery-Dreifuss muscular dystrophy), [MONDO:0009738](http://purl.obolibrary.org/obo/MONDO_0009738) (sialidosis type 2), [MONDO:0008407](http://purl.obolibrary.org/obo/MONDO_0008407) (neurogenic scapuloperoneal syndrome, Kaeser type), [MONDO:0010728](http://purl.obolibrary.org/obo/MONDO_0010728) (SCARF syndrome), [MONDO:0008408](http://purl.obolibrary.org/obo/MONDO_0008408) (scapuloperoneal spinal muscular atrophy), [MONDO:0009739](http://purl.obolibrary.org/obo/MONDO_0009739) (neurodegeneration with brain iron accumulation 2a), [MONDO:0008409](http://purl.obolibrary.org/obo/MONDO_0008409) (MYH7-related late-onset scapuloperoneal muscular dystrophy), [MONDO:0010725](http://purl.obolibrary.org/obo/MONDO_0010725) (X-linked retinoschisis), [MONDO:0010726](http://purl.obolibrary.org/obo/MONDO_0010726) (Rett syndrome), [MONDO:0004034](http://purl.obolibrary.org/obo/MONDO_0004034) (eye lymphoma), [MONDO:0010729](http://purl.obolibrary.org/obo/MONDO_0010729) (X-linked intellectual disability, Schimke type), [MONDO:0006691](http://purl.obolibrary.org/obo/MONDO_0006691) (causalgia), [MONDO:0010723](http://purl.obolibrary.org/obo/MONDO_0010723) (retinitis pigmentosa 2), [MONDO:0010722](http://purl.obolibrary.org/obo/MONDO_0010722) (X-linked retinal dysplasia), [MONDO:0018675](http://purl.obolibrary.org/obo/MONDO_0018675) (IgG4-related ophthalmic disease), [MONDO:0016011](http://purl.obolibrary.org/obo/MONDO_0016011) (fetal alcohol syndrome), [MONDO:0018673](http://purl.obolibrary.org/obo/MONDO_0018673) (IgG4-related pachymeningitis), [MONDO:0009721](http://purl.obolibrary.org/obo/MONDO_0009721) (Nathalie syndrome), [MONDO:0018670](http://purl.obolibrary.org/obo/MONDO_0018670) (symptomatic form of fragile X syndrome in female carrier), [MONDO:0009722](http://purl.obolibrary.org/obo/MONDO_0009722) (Native american myopathy), [MONDO:0009723](http://purl.obolibrary.org/obo/MONDO_0009723) (Leigh syndrome), [MONDO:0009725](http://purl.obolibrary.org/obo/MONDO_0009725) (nemaline myopathy 2), [MONDO:0009727](http://purl.obolibrary.org/obo/MONDO_0009727) (atelosteogenesis type II), [MONDO:0010717](http://purl.obolibrary.org/obo/MONDO_0010717) (pyruvate dehydrogenase E1-alpha deficiency), [MONDO:0009729](http://purl.obolibrary.org/obo/MONDO_0009729) (nephropathy-deafness-hyperparathyroidism syndrome), [MONDO:0010714](http://purl.obolibrary.org/obo/MONDO_0010714) (Pelizaeus-Merzbacher disease), [MONDO:0004045](http://purl.obolibrary.org/obo/MONDO_0004045) (pediatric intraocular retinoblastoma), [MONDO:0004046](http://purl.obolibrary.org/obo/MONDO_0004046) (childhood brain meningioma), [MONDO:0010712](http://purl.obolibrary.org/obo/MONDO_0010712) (panhypopituitarism, X-linked), [MONDO:0016019](http://purl.obolibrary.org/obo/MONDO_0016019) (Rasmussen subacute encephalitis), [MONDO:0019119](http://purl.obolibrary.org/obo/MONDO_0019119) (muscular channelopathy), [MONDO:0019117](http://purl.obolibrary.org/obo/MONDO_0019117) (rare genetic neurological disorder), [MONDO:0019118](http://purl.obolibrary.org/obo/MONDO_0019118) (retinal dystrophy), [MONDO:0016089](http://purl.obolibrary.org/obo/MONDO_0016089) (infantile Krabbe disease), [MONDO:0016088](http://purl.obolibrary.org/obo/MONDO_0016088) (hypoxanthine-guanine phosphoribosyltransferase deficiency), [MONDO:0009793](http://purl.obolibrary.org/obo/MONDO_0009793) (orofaciodigital syndrome III), [MONDO:0010782](http://purl.obolibrary.org/obo/MONDO_0010782) (myopathy, lactic acidosis, and sideroblastic anemia 3), [MONDO:0009794](http://purl.obolibrary.org/obo/MONDO_0009794) (orofaciodigital syndrome IV), [MONDO:0019113](http://purl.obolibrary.org/obo/MONDO_0019113) (benign paroxysmal torticollis of infancy), [MONDO:0010780](http://purl.obolibrary.org/obo/MONDO_0010780) (mitochondrial myopathy with reversible cytochrome c oxidase deficiency), [MONDO:0019114](http://purl.obolibrary.org/obo/MONDO_0019114) (psychogenic movement disorders), [MONDO:0009796](http://purl.obolibrary.org/obo/MONDO_0009796) (gyrate atrophy), [MONDO:0019112](http://purl.obolibrary.org/obo/MONDO_0019112) (cancer-associated retinopathy), [MONDO:0008467](http://purl.obolibrary.org/obo/MONDO_0008467) (Czeizel-Losonci syndrome), [MONDO:0009798](http://purl.obolibrary.org/obo/MONDO_0009798) (intellectual disability-cataracts-calcified pinnae-myopathy syndrome), [MONDO:0019110](http://purl.obolibrary.org/obo/MONDO_0019110) (rare central nervous system and retinal vascular disease), [MONDO:0016090](http://purl.obolibrary.org/obo/MONDO_0016090) (late-infantile/juvenile Krabbe disease), [MONDO:0004098](http://purl.obolibrary.org/obo/MONDO_0004098) (malignant melanocytic peripheral nerve sheath tumor of mediastinum), [MONDO:0007124](http://purl.obolibrary.org/obo/MONDO_0007124) (ankyloblepharon-ectodermal defects-cleft lip/palate syndrome), [MONDO:0007123](http://purl.obolibrary.org/obo/MONDO_0007123) (ankyloblepharon filiforme adnatum-cleft palate syndrome), [MONDO:0013819](http://purl.obolibrary.org/obo/MONDO_0013819) (mental retardation, autosomal dominant 14), [MONDO:0004096](http://purl.obolibrary.org/obo/MONDO_0004096) (spinal cord dermoid cyst), [MONDO:0010785](http://purl.obolibrary.org/obo/MONDO_0010785) (maternally-inherited diabetes and deafness), [MONDO:0013812](http://purl.obolibrary.org/obo/MONDO_0013812) (Baraitser-winter syndrome 2), [MONDO:0013813](http://purl.obolibrary.org/obo/MONDO_0013813) (dystonia 21), [MONDO:0007120](http://purl.obolibrary.org/obo/MONDO_0007120) (aniridia-absent patella syndrome), [MONDO:0004094](http://purl.obolibrary.org/obo/MONDO_0004094) (multiple skull base meningioma), [MONDO:0010783](http://purl.obolibrary.org/obo/MONDO_0010783) (Alzheimer disease, susceptibility to, mitochondrial), [MONDO:0010789](http://purl.obolibrary.org/obo/MONDO_0010789) (MELAS syndrome), [MONDO:0010787](http://purl.obolibrary.org/obo/MONDO_0010787) (Kearns-Sayre syndrome), [MONDO:0013810](http://purl.obolibrary.org/obo/MONDO_0013810) (COG6-CGD), [MONDO:0010788](http://purl.obolibrary.org/obo/MONDO_0010788) (Leber hereditary optic neuropathy), [MONDO:0019109](http://purl.obolibrary.org/obo/MONDO_0019109) (CANOMAD syndrome), [MONDO:0009780](http://purl.obolibrary.org/obo/MONDO_0009780) (lethal omphalocele-cleft palate syndrome), [MONDO:0008450](http://purl.obolibrary.org/obo/MONDO_0008450) (spinal arachnoiditis), [MONDO:0019104](http://purl.obolibrary.org/obo/MONDO_0019104) (Sandifer syndrome), [MONDO:0000507](http://purl.obolibrary.org/obo/MONDO_0000507) (inclusion body myopathy with Paget disease of bone and frontotemporal dementia), [MONDO:0008451](http://purl.obolibrary.org/obo/MONDO_0008451) (distal hereditary motor neuropathy type 1), [MONDO:0009783](http://purl.obolibrary.org/obo/MONDO_0009783) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal recessive 1), [MONDO:0019102](http://purl.obolibrary.org/obo/MONDO_0019102) (dentinogenesis imperfecta-short stature-hearing loss-intellectual disability syndrome), [MONDO:0008452](http://purl.obolibrary.org/obo/MONDO_0008452) (spinal muscular atrophy, facioscapulohumeral type), [MONDO:0016079](http://purl.obolibrary.org/obo/MONDO_0016079) (sporadic Creutzfeldt-Jakob disease), [MONDO:0008453](http://purl.obolibrary.org/obo/MONDO_0008453) (adult-onset proximal spinal muscular atrophy, autosomal dominant), [MONDO:0019103](http://purl.obolibrary.org/obo/MONDO_0019103) (benign exophthalmos syndrome), [MONDO:0019100](http://purl.obolibrary.org/obo/MONDO_0019100) (neuromyelitis optica), [MONDO:0008454](http://purl.obolibrary.org/obo/MONDO_0008454) (spinal intradural arachnoid cysts), [MONDO:0019101](http://purl.obolibrary.org/obo/MONDO_0019101) (retinal capillary malformation), [MONDO:0016073](http://purl.obolibrary.org/obo/MONDO_0016073) (syndromic microphthalmia), [MONDO:0008455](http://purl.obolibrary.org/obo/MONDO_0008455) (spinal muscular atrophy, segmental), [MONDO:0009786](http://purl.obolibrary.org/obo/MONDO_0009786) (OPA6), [MONDO:0009787](http://purl.obolibrary.org/obo/MONDO_0009787) (3-methylglutaconic aciduria type 3), [MONDO:0008457](http://purl.obolibrary.org/obo/MONDO_0008457) (spinocerebellar ataxia type 6), [MONDO:0008458](http://purl.obolibrary.org/obo/MONDO_0008458) (spinocerebellar ataxia type 2), [MONDO:0000500](http://purl.obolibrary.org/obo/MONDO_0000500) (tongue squamous cell carcinoma), [MONDO:0007138](http://purl.obolibrary.org/obo/MONDO_0007138) (anterior segment mesenchymal dysgenesis), [MONDO:0013805](http://purl.obolibrary.org/obo/MONDO_0013805) (mental retardation, autosomal dominant 13), [MONDO:0013807](http://purl.obolibrary.org/obo/MONDO_0013807) (congenital stationary night blindness 1E), [MONDO:0013801](http://purl.obolibrary.org/obo/MONDO_0013801) (epileptic encephalopathy, early infantile, 13), [MONDO:0010774](http://purl.obolibrary.org/obo/MONDO_0010774) (striatonigral degeneration, infantile, mitochondrial), [MONDO:0013802](http://purl.obolibrary.org/obo/MONDO_0013802) (infantile cerebellar-retinal degeneration), [MONDO:0010775](http://purl.obolibrary.org/obo/MONDO_0010775) (retinitis pigmentosa-deafness syndrome), [MONDO:0010772](http://purl.obolibrary.org/obo/MONDO_0010772) (Leber optic atrophy and dystonia), [MONDO:0010773](http://purl.obolibrary.org/obo/MONDO_0010773) (myopathy and diabetes mellitus), [MONDO:0013804](http://purl.obolibrary.org/obo/MONDO_0013804) (mental retardation, autosomal dominant 12), [MONDO:0010779](http://purl.obolibrary.org/obo/MONDO_0010779) (mitochondrial non-syndromic sensorineural deafness), [MONDO:0017398](http://purl.obolibrary.org/obo/MONDO_0017398) (3MC syndrome), [MONDO:0009770](http://purl.obolibrary.org/obo/MONDO_0009770) (3MC syndrome 1), [MONDO:0008440](http://purl.obolibrary.org/obo/MONDO_0008440) (spastic paraplegia-nephritis-deafness syndrome), [MONDO:0009771](http://purl.obolibrary.org/obo/MONDO_0009771) (Oculotrichodysplasia), [MONDO:0008442](http://purl.obolibrary.org/obo/MONDO_0008442) (spastic paraplegia-neuropathy-poikiloderma syndrome), [MONDO:0017399](http://purl.obolibrary.org/obo/MONDO_0017399) (frontotemporal dementia, right temporal atrophy variant), [MONDO:0008443](http://purl.obolibrary.org/obo/MONDO_0008443) (spastic paraplegia-precocious puberty syndrome), [MONDO:0009775](http://purl.obolibrary.org/obo/MONDO_0009775) (Oguchi disease-1), [MONDO:0017393](http://purl.obolibrary.org/obo/MONDO_0017393) (blepharophimosis-intellectual disability syndrome), [MONDO:0016065](http://purl.obolibrary.org/obo/MONDO_0016065) (cleft palate-short stature-vertebral anomalies syndrome), [MONDO:0008445](http://purl.obolibrary.org/obo/MONDO_0008445) (delayed speech-facial asymmetry-strabismus-ear lobe creases syndrome), [MONDO:0009777](http://purl.obolibrary.org/obo/MONDO_0009777) (Oliver syndrome), [MONDO:0008448](http://purl.obolibrary.org/obo/MONDO_0008448) (spheroid body myopathy), [MONDO:0008449](http://purl.obolibrary.org/obo/MONDO_0008449) (spina bifida (disease)), [MONDO:0017392](http://purl.obolibrary.org/obo/MONDO_0017392) (Pre-Descemet corneal dystrophy), [MONDO:0017391](http://purl.obolibrary.org/obo/MONDO_0017391) (Grayson-Wilbrandt corneal dystrophy), [MONDO:0007105](http://purl.obolibrary.org/obo/MONDO_0007105) (frontotemporal dementia with motor neuron disease 1), [MONDO:0007104](http://purl.obolibrary.org/obo/MONDO_0007104) (amyotrophic lateral sclerosis-parkinsonism-dementia complex), [MONDO:0007103](http://purl.obolibrary.org/obo/MONDO_0007103) (amyotrophic lateral sclerosis type 1), [MONDO:0007100](http://purl.obolibrary.org/obo/MONDO_0007100) (familial amyloid neuropathy), [MONDO:0010764](http://purl.obolibrary.org/obo/MONDO_0010764) (DFNY1), [MONDO:0010761](http://purl.obolibrary.org/obo/MONDO_0010761) (retinitis pigmentosa Y-linked), [MONDO:0004071](http://purl.obolibrary.org/obo/MONDO_0004071) (childhood cerebral astrocytoma), [MONDO:0016059](http://purl.obolibrary.org/obo/MONDO_0016059) (cleft lip/palate-deafness-sacral lipoma syndrome), [MONDO:0016056](http://purl.obolibrary.org/obo/MONDO_0016056) (isolated congenital microcephaly), [MONDO:0016055](http://purl.obolibrary.org/obo/MONDO_0016055) (syndrome with corpus callosum agenesis /dysgenesis as a major feature), [MONDO:0009760](http://purl.obolibrary.org/obo/MONDO_0009760) (Norman-Roberts syndrome), [MONDO:0017386](http://purl.obolibrary.org/obo/MONDO_0017386) (pleomorphic rhabdomyosarcoma), [MONDO:0016058](http://purl.obolibrary.org/obo/MONDO_0016058) (paroxysmal dystonia), [MONDO:0001818](http://purl.obolibrary.org/obo/MONDO_0001818) (facial neuralgia), [MONDO:0017389](http://purl.obolibrary.org/obo/MONDO_0017389) (tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria), [MONDO:0016057](http://purl.obolibrary.org/obo/MONDO_0016057) (isolated encephalocele), [MONDO:0009762](http://purl.obolibrary.org/obo/MONDO_0009762) (nystagmus, congenital, autosomal recessive), [MONDO:0016052](http://purl.obolibrary.org/obo/MONDO_0016052) (atypical autism), [MONDO:0009764](http://purl.obolibrary.org/obo/MONDO_0009764) (ocular motor apraxia, Cogan type), [MONDO:0016051](http://purl.obolibrary.org/obo/MONDO_0016051) (cleft lip-retinopathy syndrome), [MONDO:0008434](http://purl.obolibrary.org/obo/MONDO_0008434) (Smith-Magenis syndrome), [MONDO:0017385](http://purl.obolibrary.org/obo/MONDO_0017385) (malignant migrating partial seizures of infancy), [MONDO:0016054](http://purl.obolibrary.org/obo/MONDO_0016054) (cerebral malformation), [MONDO:0016053](http://purl.obolibrary.org/obo/MONDO_0016053) (isolated cerebellar vermis hypoplasia), [MONDO:0009767](http://purl.obolibrary.org/obo/MONDO_0009767) (oculocerebral hypopigmentation syndrome, cross type), [MONDO:0008436](http://purl.obolibrary.org/obo/MONDO_0008436) (Sneddon syndrome), [MONDO:0009768](http://purl.obolibrary.org/obo/MONDO_0009768) (oculodentodigital dysplasia, autosomal recessive), [MONDO:0008437](http://purl.obolibrary.org/obo/MONDO_0008437) (hereditary spastic paraplegia 3A), [MONDO:0009769](http://purl.obolibrary.org/obo/MONDO_0009769) (Oculo-palato-cerebral syndrome), [MONDO:0016050](http://purl.obolibrary.org/obo/MONDO_0016050) (thiamine-responsive encephalopathy), [MONDO:0008438](http://purl.obolibrary.org/obo/MONDO_0008438) (hereditary spastic paraplegia 4), [MONDO:0008439](http://purl.obolibrary.org/obo/MONDO_0008439) (spastic paraplegia-epilepsy-intellectual disability syndrome), [MONDO:0007119](http://purl.obolibrary.org/obo/MONDO_0007119) (isolated aniridia), [MONDO:0010758](http://purl.obolibrary.org/obo/MONDO_0010758) (intellectual disability-developmental delay-contractures syndrome), [MONDO:0007116](http://purl.obolibrary.org/obo/MONDO_0007116) (hereditary neurocutaneous malformation), [MONDO:0007113](http://purl.obolibrary.org/obo/MONDO_0007113) (Angelman syndrome), [MONDO:0007111](http://purl.obolibrary.org/obo/MONDO_0007111) (ANIB1), [MONDO:0004085](http://purl.obolibrary.org/obo/MONDO_0004085) (choroid epithelioid cell melanoma), [MONDO:0010752](http://purl.obolibrary.org/obo/MONDO_0010752) (Vacterl association, X-linked, with or without hydrocephalus), [MONDO:0004086](http://purl.obolibrary.org/obo/MONDO_0004086) (ciliary body epithelioid cell melanoma), [MONDO:0010754](http://purl.obolibrary.org/obo/MONDO_0010754) (van den Bosch syndrome), [MONDO:0020144](http://purl.obolibrary.org/obo/MONDO_0020144) (cerebrovascular dementia), [MONDO:0020145](http://purl.obolibrary.org/obo/MONDO_0020145) (developmental defect of the eye), [MONDO:0019153](http://purl.obolibrary.org/obo/MONDO_0019153) (brain malformation-congenital heart disease-postaxial polydactyly syndrome), [MONDO:0020146](http://purl.obolibrary.org/obo/MONDO_0020146) (major induction processes eye anomaly), [MONDO:0020147](http://purl.obolibrary.org/obo/MONDO_0020147) (anophthalmia-microphthalmia syndrome), [MONDO:0020148](http://purl.obolibrary.org/obo/MONDO_0020148) (syndromic aniridia), [MONDO:0019151](http://purl.obolibrary.org/obo/MONDO_0019151) (Oligocone trichromacy), [MONDO:0020149](http://purl.obolibrary.org/obo/MONDO_0020149) (rare eye disease due to a differentiation anomaly), [MONDO:0019152](http://purl.obolibrary.org/obo/MONDO_0019152) (Oguchi disease), [MONDO:0020140](http://purl.obolibrary.org/obo/MONDO_0020140) (late-onset ataxia with dementia), [MONDO:0020141](http://purl.obolibrary.org/obo/MONDO_0020141) (infectious disease with dementia), [MONDO:0007168](http://purl.obolibrary.org/obo/MONDO_0007168) (atelosteogenesis type III), [MONDO:0020142](http://purl.obolibrary.org/obo/MONDO_0020142) (metabolic disease with dementia), [MONDO:0020143](http://purl.obolibrary.org/obo/MONDO_0020143) (cerebral lipidosis with dementia), [MONDO:0012523](http://purl.obolibrary.org/obo/MONDO_0012523) (retinitis pigmentosa 36), [MONDO:0007165](http://purl.obolibrary.org/obo/MONDO_0007165) (spastic ataxia 7), [MONDO:0007164](http://purl.obolibrary.org/obo/MONDO_0007164) (spastic ataxia 1), [MONDO:0013858](http://purl.obolibrary.org/obo/MONDO_0013858) (pontine tegmental cap dysplasia), [MONDO:0012521](http://purl.obolibrary.org/obo/MONDO_0012521) (herpes simplex encephalitis), [MONDO:0007163](http://purl.obolibrary.org/obo/MONDO_0007163) (episodic ataxia type 2), [MONDO:0013859](http://purl.obolibrary.org/obo/MONDO_0013859) (cataract 38), [MONDO:0013853](http://purl.obolibrary.org/obo/MONDO_0013853) (pontocerebellar hypoplasia type 1B), [MONDO:0012527](http://purl.obolibrary.org/obo/MONDO_0012527) (cataract 11 multiple types), [MONDO:0007160](http://purl.obolibrary.org/obo/MONDO_0007160) (Stickler syndrome type 1), [MONDO:0012525](http://purl.obolibrary.org/obo/MONDO_0012525) (Leber congenital amaurosis 12), [MONDO:0008490](http://purl.obolibrary.org/obo/MONDO_0008490) (Stickler syndrome type 3), [MONDO:0008491](http://purl.obolibrary.org/obo/MONDO_0008491) (stiff-person syndrome), [MONDO:0013840](http://purl.obolibrary.org/obo/MONDO_0013840) (encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome), [MONDO:0020133](http://purl.obolibrary.org/obo/MONDO_0020133) (posterior fossa malformation), [MONDO:0020134](http://purl.obolibrary.org/obo/MONDO_0020134) (cystic malformation of the posterior fossa), [MONDO:0020135](http://purl.obolibrary.org/obo/MONDO_0020135) (non-syndromic pontocerebellar hypoplasia), [MONDO:0000549](http://purl.obolibrary.org/obo/MONDO_0000549) (cervical neuroblastoma), [MONDO:0020136](http://purl.obolibrary.org/obo/MONDO_0020136) (neurodegenerative disease with dementia), [MONDO:0020137](http://purl.obolibrary.org/obo/MONDO_0020137) (frontotemporal degeneration with dementia), [MONDO:0020138](http://purl.obolibrary.org/obo/MONDO_0020138) (ataxia with dementia), [MONDO:0020139](http://purl.obolibrary.org/obo/MONDO_0020139) (early-onset ataxia with dementia), [MONDO:0012519](http://purl.obolibrary.org/obo/MONDO_0012519) (Rubinstein-Taybi syndrome due to 16p13.3 microdeletion), [MONDO:0012518](http://purl.obolibrary.org/obo/MONDO_0012518) (congenital myasthenic syndrome 12), [MONDO:0013849](http://purl.obolibrary.org/obo/MONDO_0013849) (microcephaly 8, primary, autosomal recessive), [MONDO:0020130](http://purl.obolibrary.org/obo/MONDO_0020130) (malformation of the cerebellar vermis), [MONDO:0020131](http://purl.obolibrary.org/obo/MONDO_0020131) (malformation of the cerebellar hemispheres), [MONDO:0020132](http://purl.obolibrary.org/obo/MONDO_0020132) (cranial nerve and nuclear aplasia), [MONDO:0007176](http://purl.obolibrary.org/obo/MONDO_0007176) (helicoid peripapillary chorioretinal degeneration), [MONDO:0013847](http://purl.obolibrary.org/obo/MONDO_0013847) (chromosome 16p11.2 duplication syndrome), [MONDO:0013848](http://purl.obolibrary.org/obo/MONDO_0013848) (dilated cardiomyopathy 2B), [MONDO:0012517](http://purl.obolibrary.org/obo/MONDO_0012517) (atypical Gaucher's disease due to saposin c deficiency), [MONDO:0012516](http://purl.obolibrary.org/obo/MONDO_0012516) (mandibulofacial dysostosis-microcephaly syndrome), [MONDO:0012514](http://purl.obolibrary.org/obo/MONDO_0012514) (hypomyelinating leukodystrophy 5), [MONDO:0000517](http://purl.obolibrary.org/obo/MONDO_0000517) (brain stem medulloblastoma), [MONDO:0019137](http://purl.obolibrary.org/obo/MONDO_0019137) (non-24-hour sleep-wake syndrome), [MONDO:0000518](http://purl.obolibrary.org/obo/MONDO_0000518) (sacrum chordoma), [MONDO:0008484](http://purl.obolibrary.org/obo/MONDO_0008484) (stapes ankylosis with broad thumbs and toes), [MONDO:0000519](http://purl.obolibrary.org/obo/MONDO_0000519) (corpus callosum oligodendroglioma), [MONDO:0019133](http://purl.obolibrary.org/obo/MONDO_0019133) (visceral neuropathy-brain anomalies-facial dysmorphism-developmental delay syndrome), [MONDO:0020122](http://purl.obolibrary.org/obo/MONDO_0020122) (idiopathic inflammatory myopathy), [MONDO:0008488](http://purl.obolibrary.org/obo/MONDO_0008488) (holoprosencephaly-radial heart renal anomalies syndrome), [MONDO:0019134](http://purl.obolibrary.org/obo/MONDO_0019134) (central neurocytoma), [MONDO:0020123](http://purl.obolibrary.org/obo/MONDO_0020123) (metabolic myopathy), [MONDO:0020124](http://purl.obolibrary.org/obo/MONDO_0020124) (neuromuscular junction disease), [MONDO:0019131](http://purl.obolibrary.org/obo/MONDO_0019131) (ossification anomalies-psychomotor developmental delay syndrome), [MONDO:0020125](http://purl.obolibrary.org/obo/MONDO_0020125) (acquired neuromuscular junction disease), [MONDO:0019132](http://purl.obolibrary.org/obo/MONDO_0019132) (spinal muscular atrophy-Dandy-Walker malformation-cataracts syndrome), [MONDO:0020126](http://purl.obolibrary.org/obo/MONDO_0020126) (rare peripheral neuropathy), [MONDO:0020127](http://purl.obolibrary.org/obo/MONDO_0020127) (genetic peripheral neuropathy), [MONDO:0020128](http://purl.obolibrary.org/obo/MONDO_0020128) (motor neuron disease), [MONDO:0020129](http://purl.obolibrary.org/obo/MONDO_0020129) (acquired motor neuron disease), [MONDO:0012508](http://purl.obolibrary.org/obo/MONDO_0012508) (agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome), [MONDO:0012507](http://purl.obolibrary.org/obo/MONDO_0012507) (retinal cone dystrophy 4), [MONDO:0013838](http://purl.obolibrary.org/obo/MONDO_0013838) (coenzyme Q10 deficiency, primary, 3), [MONDO:0013839](http://purl.obolibrary.org/obo/MONDO_0013839) (hereditary sensory and autonomic neuropathy type 6), [MONDO:0020120](http://purl.obolibrary.org/obo/MONDO_0020120) (skeletal muscle disease), [MONDO:0020121](http://purl.obolibrary.org/obo/MONDO_0020121) (muscular dystrophy), [MONDO:0013835](http://purl.obolibrary.org/obo/MONDO_0013835) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 7), [MONDO:0007143](http://purl.obolibrary.org/obo/MONDO_0007143) (aortic arch anomaly-facial dysmorphism-intellectual disability syndrome), [MONDO:0007142](http://purl.obolibrary.org/obo/MONDO_0007142) (Townes-Brocks syndrome), [MONDO:0013836](http://purl.obolibrary.org/obo/MONDO_0013836) (familial steroid-resistant nephrotic syndrome with sensorineural deafness), [MONDO:0013837](http://purl.obolibrary.org/obo/MONDO_0013837) (deafness-encephaloneuropathy-obesity-valvulopathy syndrome), [MONDO:0013830](http://purl.obolibrary.org/obo/MONDO_0013830) (KTCN5), [MONDO:0013831](http://purl.obolibrary.org/obo/MONDO_0013831) (KTCN6), [MONDO:0013832](http://purl.obolibrary.org/obo/MONDO_0013832) (KTCN8), [MONDO:0013833](http://purl.obolibrary.org/obo/MONDO_0013833) (KTCN7), [MONDO:0020119](http://purl.obolibrary.org/obo/MONDO_0020119) (X-linked syndromic intellectual disability), [MONDO:0019129](http://purl.obolibrary.org/obo/MONDO_0019129) (global developmental delay-osteopenia-ectodermal defect syndrome), [MONDO:0010792](http://purl.obolibrary.org/obo/MONDO_0010792) (lethal infantile mitochondrial myopathy), [MONDO:0008472](http://purl.obolibrary.org/obo/MONDO_0008472) (spondyloepiphyseal dysplasia, MacDermot type), [MONDO:0016099](http://purl.obolibrary.org/obo/MONDO_0016099) (overlap myositis), [MONDO:0019127](http://purl.obolibrary.org/obo/MONDO_0019127) (polymyositis), [MONDO:0001859](http://purl.obolibrary.org/obo/MONDO_0001859) (algoneurodystrophy), [MONDO:0010790](http://purl.obolibrary.org/obo/MONDO_0010790) (MERRF syndrome), [MONDO:0019124](http://purl.obolibrary.org/obo/MONDO_0019124) (microscopic polyangiitis), [MONDO:0010791](http://purl.obolibrary.org/obo/MONDO_0010791) (myoglobinuria, recurrent), [MONDO:0016095](http://purl.obolibrary.org/obo/MONDO_0016095) (vaginal rhabdomyosarcoma), [MONDO:0019123](http://purl.obolibrary.org/obo/MONDO_0019123) (continuous spikes and waves during sleep), [MONDO:0016098](http://purl.obolibrary.org/obo/MONDO_0016098) (immune-mediated necrotizing myopathy), [MONDO:0016097](http://purl.obolibrary.org/obo/MONDO_0016097) (symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers), [MONDO:0000520](http://purl.obolibrary.org/obo/MONDO_0000520) (parietal lobe ependymal tumor), [MONDO:0016091](http://purl.obolibrary.org/obo/MONDO_0016091) (adult Krabbe disease), [MONDO:0013827](http://purl.obolibrary.org/obo/MONDO_0013827) (hyperekplexia 3), [MONDO:0007159](http://purl.obolibrary.org/obo/MONDO_0007159) (arthrogryposis-like hand anomaly-sensorineural deafness syndrome), [MONDO:0013828](http://purl.obolibrary.org/obo/MONDO_0013828) (hyperekplexia 2), [MONDO:0010796](http://purl.obolibrary.org/obo/MONDO_0010796) (Parkinson disease, mitochondrial), [MONDO:0013823](http://purl.obolibrary.org/obo/MONDO_0013823) (autosomal dominant nonsyndromic deafness 4B), [MONDO:0007154](http://purl.obolibrary.org/obo/MONDO_0007154) (arteriovenous malformations of the brain), [MONDO:0013824](http://purl.obolibrary.org/obo/MONDO_0013824) (Joubert syndrome 17), [MONDO:0010794](http://purl.obolibrary.org/obo/MONDO_0010794) (NARP syndrome), [MONDO:0013826](http://purl.obolibrary.org/obo/MONDO_0013826) (autosomal recessive nonsyndromic deafness 86), [MONDO:0013820](http://purl.obolibrary.org/obo/MONDO_0013820) (mental retardation, autosomal dominant 15), [MONDO:0013821](http://purl.obolibrary.org/obo/MONDO_0013821) (mental retardation, autosomal dominant 16), [MONDO:0010799](http://purl.obolibrary.org/obo/MONDO_0010799) (mitochondrial non-syndromic sensorineural deafness with susceptibility to aminoglycoside exposure), [MONDO:0011233](http://purl.obolibrary.org/obo/MONDO_0011233) (Axenfeld-Rieger syndrome type 3), [MONDO:0011232](http://purl.obolibrary.org/obo/MONDO_0011232) (migraine, familial hemiplegic, 2), [MONDO:0012563](http://purl.obolibrary.org/obo/MONDO_0012563) (holoprosencephaly 9), [MONDO:0012562](http://purl.obolibrary.org/obo/MONDO_0012562) (holoprosencephaly 7), [MONDO:0013890](http://purl.obolibrary.org/obo/MONDO_0013890) (congenital myopathy with internal nuclei and atypical cores), [MONDO:0013891](http://purl.obolibrary.org/obo/MONDO_0013891) (amyotrophic lateral sclerosis type 18), [MONDO:0020188](http://purl.obolibrary.org/obo/MONDO_0020188) (congenital absence of the eyebrow/eyelashes), [MONDO:0020189](http://purl.obolibrary.org/obo/MONDO_0020189) (eyebrow/eyelashes structural anomaly), [MONDO:0019197](http://purl.obolibrary.org/obo/MONDO_0019197) (Folinic acid-responsive seizures), [MONDO:0019198](http://purl.obolibrary.org/obo/MONDO_0019198) (sympathetic ophthalmia), [MONDO:0019195](http://purl.obolibrary.org/obo/MONDO_0019195) (hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome), [MONDO:0019196](http://purl.obolibrary.org/obo/MONDO_0019196) (Foix-Alajouanine syndrome), [MONDO:0020180](http://purl.obolibrary.org/obo/MONDO_0020180) (palpebral piliary tumor), [MONDO:0020181](http://purl.obolibrary.org/obo/MONDO_0020181) (mesenchymatous palpebral tumor), [MONDO:0020182](http://purl.obolibrary.org/obo/MONDO_0020182) (palpebral tumor with a vascular malformation), [MONDO:0020183](http://purl.obolibrary.org/obo/MONDO_0020183) (neurogenic palpebral tumor), [MONDO:0020184](http://purl.obolibrary.org/obo/MONDO_0020184) (rare eyebrow/eyelashes anomaly), [MONDO:0020185](http://purl.obolibrary.org/obo/MONDO_0020185) (eyebrow/eyelashes hypertrichosis), [MONDO:0020186](http://purl.obolibrary.org/obo/MONDO_0020186) (eyebrow hypertrophy), [MONDO:0020187](http://purl.obolibrary.org/obo/MONDO_0020187) (eyelashes hypertrophy), [MONDO:0013896](http://purl.obolibrary.org/obo/MONDO_0013896) (Joubert syndrome 18), [MONDO:0011239](http://purl.obolibrary.org/obo/MONDO_0011239) (colobomatous macrophthalmia-microcornea syndrome), [MONDO:0013899](http://purl.obolibrary.org/obo/MONDO_0013899) (Weill-Marchesani syndrome 3), [MONDO:0013882](http://purl.obolibrary.org/obo/MONDO_0013882) (hyperphosphatasia with mental retardation syndrome 2), [MONDO:0013883](http://purl.obolibrary.org/obo/MONDO_0013883) (congenital myasthenic syndrome 13), [MONDO:0013884](http://purl.obolibrary.org/obo/MONDO_0013884) (neuronopathy, distal hereditary motor, type 5B), [MONDO:0012553](http://purl.obolibrary.org/obo/MONDO_0012553) (Cerebrooculofacioskeletal syndrome 2), [MONDO:0011220](http://purl.obolibrary.org/obo/MONDO_0011220) (PARK3), [MONDO:0013880](http://purl.obolibrary.org/obo/MONDO_0013880) (facial paresis, hereditary congenital, 3), [MONDO:0019188](http://purl.obolibrary.org/obo/MONDO_0019188) (Rubinstein-Taybi syndrome), [MONDO:0020177](http://purl.obolibrary.org/obo/MONDO_0020177) (pigmented palpebral tumor), [MONDO:0020178](http://purl.obolibrary.org/obo/MONDO_0020178) (palpebral lentiginosis), [MONDO:0020179](http://purl.obolibrary.org/obo/MONDO_0020179) (palpebral nevus), [MONDO:0019187](http://purl.obolibrary.org/obo/MONDO_0019187) (Axenfeld-Rieger syndrome), [MONDO:0019191](http://purl.obolibrary.org/obo/MONDO_0019191) (IgG4-related dacryoadenitis and sialadenitis), [MONDO:0020170](http://purl.obolibrary.org/obo/MONDO_0020170) (congenital upper palpebral retraction), [MONDO:0020172](http://purl.obolibrary.org/obo/MONDO_0020172) (palpebral epidermal tumor), [MONDO:0020173](http://purl.obolibrary.org/obo/MONDO_0020173) (benign tumor of palpebral epidermis), [MONDO:0020174](http://purl.obolibrary.org/obo/MONDO_0020174) (precancerous lesion of palpebral epidermis), [MONDO:0020175](http://purl.obolibrary.org/obo/MONDO_0020175) (malignant tumor of palpebral epidermis), [MONDO:0020176](http://purl.obolibrary.org/obo/MONDO_0020176) (palpebral sebaceous gland tumor), [MONDO:0013889](http://purl.obolibrary.org/obo/MONDO_0013889) (short stature-optic atrophy-Pelger-HuC+t anomaly syndrome), [MONDO:0011226](http://purl.obolibrary.org/obo/MONDO_0011226) (autosomal dominant nonsyndromic deafness 15), [MONDO:0012555](http://purl.obolibrary.org/obo/MONDO_0012555) (Cornelia de Lange syndrome 3), [MONDO:0011224](http://purl.obolibrary.org/obo/MONDO_0011224) (monomelic amyotrophy), [MONDO:0012554](http://purl.obolibrary.org/obo/MONDO_0012554) (Cerebrooculofacioskeletal syndrome 4), [MONDO:0011223](http://purl.obolibrary.org/obo/MONDO_0011223) (amyotrophic lateral sclerosis type 4), [MONDO:0013885](http://purl.obolibrary.org/obo/MONDO_0013885) (Malan overgrowth syndrome), [MONDO:0013886](http://purl.obolibrary.org/obo/MONDO_0013886) (nonprogressive cerebellar atxia with mental retardation), [MONDO:0007191](http://purl.obolibrary.org/obo/MONDO_0007191) (Behcet's syndrome), [MONDO:0013870](http://purl.obolibrary.org/obo/MONDO_0013870) (TMEM165-CDG), [MONDO:0013871](http://purl.obolibrary.org/obo/MONDO_0013871) (Seckel syndrome 6), [MONDO:0012541](http://purl.obolibrary.org/obo/MONDO_0012541) (deafness with labyrinthine aplasia, microtia, and microdontia), [MONDO:0000557](http://purl.obolibrary.org/obo/MONDO_0000557) (hereditary ataxia), [MONDO:0019177](http://purl.obolibrary.org/obo/MONDO_0019177) (odontoleukodystrophy), [MONDO:0020167](http://purl.obolibrary.org/obo/MONDO_0020167) (malposition of external canthus), [MONDO:0000559](http://purl.obolibrary.org/obo/MONDO_0000559) (X-linked hereditary ataxia), [MONDO:0020168](http://purl.obolibrary.org/obo/MONDO_0020168) (Kinetic eyelid anomaly), [MONDO:0020169](http://purl.obolibrary.org/obo/MONDO_0020169) (rare disorder with ptosis), [MONDO:0019173](http://purl.obolibrary.org/obo/MONDO_0019173) (rabies), [MONDO:0019174](http://purl.obolibrary.org/obo/MONDO_0019174) (infantile Refsum disease), [MONDO:0019172](http://purl.obolibrary.org/obo/MONDO_0019172) (aniridia), [MONDO:0019180](http://purl.obolibrary.org/obo/MONDO_0019180) (hereditary hemorrhagic telangiectasia), [MONDO:0019181](http://purl.obolibrary.org/obo/MONDO_0019181) (non-syndromic X-linked intellectual disability), [MONDO:0000550](http://purl.obolibrary.org/obo/MONDO_0000550) (extra-adrenal sympathetic paraganglioma), [MONDO:0000551](http://purl.obolibrary.org/obo/MONDO_0000551) (retroperitoneal neuroblastoma), [MONDO:0020160](http://purl.obolibrary.org/obo/MONDO_0020160) (secondary entropion), [MONDO:0020161](http://purl.obolibrary.org/obo/MONDO_0020161) (congenital ectropion), [MONDO:0020162](http://purl.obolibrary.org/obo/MONDO_0020162) (secondary ectropion), [MONDO:0020163](http://purl.obolibrary.org/obo/MONDO_0020163) (Canthal anomaly), [MONDO:0020164](http://purl.obolibrary.org/obo/MONDO_0020164) (Epicanthal fold), [MONDO:0020165](http://purl.obolibrary.org/obo/MONDO_0020165) (syndromic epicanthus), [MONDO:0007188](http://purl.obolibrary.org/obo/MONDO_0007188) (primary basilar invagination), [MONDO:0007187](http://purl.obolibrary.org/obo/MONDO_0007187) (nevoid basal cell carcinoma syndrome), [MONDO:0012545](http://purl.obolibrary.org/obo/MONDO_0012545) (neutral lipid storage myopathy), [MONDO:0012543](http://purl.obolibrary.org/obo/MONDO_0012543) (OPA5), [MONDO:0013875](http://purl.obolibrary.org/obo/MONDO_0013875) (3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome), [MONDO:0012549](http://purl.obolibrary.org/obo/MONDO_0012549) (autosomal recessive ataxia, Beauce type), [MONDO:0007182](http://purl.obolibrary.org/obo/MONDO_0007182) (Machado-Joseph disease), [MONDO:0013877](http://purl.obolibrary.org/obo/MONDO_0013877) (mitochondrial pyruvate carrier deficiency), [MONDO:0012547](http://purl.obolibrary.org/obo/MONDO_0012547) (Noonan syndrome 4), [MONDO:0013861](http://purl.obolibrary.org/obo/MONDO_0013861) (amyotrophic lateral sclerosis type 17), [MONDO:0012531](http://purl.obolibrary.org/obo/MONDO_0012531) (xeroderma pigmentosum group B), [MONDO:0019169](http://purl.obolibrary.org/obo/MONDO_0019169) (pyruvate dehydrogenase deficiency), [MONDO:0020155](http://purl.obolibrary.org/obo/MONDO_0020155) (eyelid border anomaly), [MONDO:0020156](http://purl.obolibrary.org/obo/MONDO_0020156) (syndromic ankyloblepharon), [MONDO:0004924](http://purl.obolibrary.org/obo/MONDO_0004924) (chronic canaliculitis), [MONDO:0020157](http://purl.obolibrary.org/obo/MONDO_0020157) (syndromic palpebral coloboma), [MONDO:0021488](http://purl.obolibrary.org/obo/MONDO_0021488) (benign neoplasm of lacrimal gland), [MONDO:0020158](http://purl.obolibrary.org/obo/MONDO_0020158) (eyelids malposition disorder), [MONDO:0020159](http://purl.obolibrary.org/obo/MONDO_0020159) (congenital entropion), [MONDO:0019160](http://purl.obolibrary.org/obo/MONDO_0019160) (primary progressive freezing gait), [MONDO:0001892](http://purl.obolibrary.org/obo/MONDO_0001892) (spinal cord lymphoma), [MONDO:0019170](http://purl.obolibrary.org/obo/MONDO_0019170) (polyarteritis nodosa), [MONDO:0000561](http://purl.obolibrary.org/obo/MONDO_0000561) (spinocerebellar ataxia type 16), [MONDO:0001894](http://purl.obolibrary.org/obo/MONDO_0001894) (spinal cord sarcoma), [MONDO:0000563](http://purl.obolibrary.org/obo/MONDO_0000563) (GRID2-related autosomal dominant spinocerebellar ataxia), [MONDO:0020150](http://purl.obolibrary.org/obo/MONDO_0020150) (rare palpebral, lacrimal system and conjunctival disease), [MONDO:0020151](http://purl.obolibrary.org/obo/MONDO_0020151) (rare palpebral disease), [MONDO:0020152](http://purl.obolibrary.org/obo/MONDO_0020152) (eyelid malformation), [MONDO:0020153](http://purl.obolibrary.org/obo/MONDO_0020153) (cryptophthalmia), [MONDO:0020154](http://purl.obolibrary.org/obo/MONDO_0020154) (Microblepharon-ablephara syndrome), [MONDO:0013867](http://purl.obolibrary.org/obo/MONDO_0013867) (brown-Vialetto-van Laere syndrome 2), [MONDO:0011202](http://purl.obolibrary.org/obo/MONDO_0011202) (RHYNS syndrome), [MONDO:0012532](http://purl.obolibrary.org/obo/MONDO_0012532) (HHT4), [MONDO:0012539](http://purl.obolibrary.org/obo/MONDO_0012539) (Joubert syndrome 6), [MONDO:0013864](http://purl.obolibrary.org/obo/MONDO_0013864) (Cornelia de Lange syndrome 4), [MONDO:0012538](http://purl.obolibrary.org/obo/MONDO_0012538) (nemaline myopathy 7), [MONDO:0013866](http://purl.obolibrary.org/obo/MONDO_0013866) (neuronal ceroid lipofuscinosis 11), [MONDO:0011273](http://purl.obolibrary.org/obo/MONDO_0011273) (H syndrome), [MONDO:0014300](http://purl.obolibrary.org/obo/MONDO_0014300) (proximal myopathy with extrapyramidal signs), [MONDO:0011272](http://purl.obolibrary.org/obo/MONDO_0011272) (retinitis pigmentosa 25), [MONDO:0015633](http://purl.obolibrary.org/obo/MONDO_0015633) (Bazex syndrome), [MONDO:0011271](http://purl.obolibrary.org/obo/MONDO_0011271) (rigid spine muscular dystrophy 1), [MONDO:0015632](http://purl.obolibrary.org/obo/MONDO_0015632) (FASTKD2-related infantile mitochondrial encephalomyopathy), [MONDO:0014302](http://purl.obolibrary.org/obo/MONDO_0014302) (hereditary spastic paraplegia 62), [MONDO:0004976](http://purl.obolibrary.org/obo/MONDO_0004976) (amyotrophic lateral sclerosis), [MONDO:0004974](http://purl.obolibrary.org/obo/MONDO_0004974) (adrenal gland pheochromocytoma), [MONDO:0015639](http://purl.obolibrary.org/obo/MONDO_0015639) (benign partial epilepsy with secondarily generalized seizures in infancy), [MONDO:0014308](http://purl.obolibrary.org/obo/MONDO_0014308) (familial temporal lobe epilepsy 6), [MONDO:0015638](http://purl.obolibrary.org/obo/MONDO_0015638) (benign partial epilepsy of infancy with complex partial seizures), [MONDO:0011279](http://purl.obolibrary.org/obo/MONDO_0011279) (autosomal recessive nonsyndromic deafness 17), [MONDO:0014303](http://purl.obolibrary.org/obo/MONDO_0014303) (hereditary spastic paraplegia 64), [MONDO:0014304](http://purl.obolibrary.org/obo/MONDO_0014304) (hereditary spastic paraplegia 61), [MONDO:0015637](http://purl.obolibrary.org/obo/MONDO_0015637) (benign non-familial infantile seizures), [MONDO:0014305](http://purl.obolibrary.org/obo/MONDO_0014305) (hereditary spastic paraplegia 63), [MONDO:0012593](http://purl.obolibrary.org/obo/MONDO_0012593) (brain-lung-thyroid syndrome), [MONDO:0011261](http://purl.obolibrary.org/obo/MONDO_0011261) (spondyloepiphyseal dysplasia, Nishimura type), [MONDO:0011266](http://purl.obolibrary.org/obo/MONDO_0011266) (myotonic dystrophy type 2), [MONDO:0012596](http://purl.obolibrary.org/obo/MONDO_0012596) (PSAT deficiency), [MONDO:0012595](http://purl.obolibrary.org/obo/MONDO_0012595) (leprosy, susceptibility to, 4), [MONDO:0011264](http://purl.obolibrary.org/obo/MONDO_0011264) (torsion dystonia 6), [MONDO:0003655](http://purl.obolibrary.org/obo/MONDO_0003655) (cerebral lymphoma), [MONDO:0011268](http://purl.obolibrary.org/obo/MONDO_0011268) (renal tubular acidosis, distal, autosomal recessive), [MONDO:0015626](http://purl.obolibrary.org/obo/MONDO_0015626) (Charcot-Marie-tooth disease), [MONDO:0015611](http://purl.obolibrary.org/obo/MONDO_0015611) (neutral lipid storage disease), [MONDO:0011259](http://purl.obolibrary.org/obo/MONDO_0011259) (retinitis pigmentosa 22), [MONDO:0011258](http://purl.obolibrary.org/obo/MONDO_0011258) (branchiootic syndrome 1), [MONDO:0012589](http://purl.obolibrary.org/obo/MONDO_0012589) (Pitt-Hopkins syndrome), [MONDO:0011257](http://purl.obolibrary.org/obo/MONDO_0011257) (MPI-CDG), [MONDO:0012588](http://purl.obolibrary.org/obo/MONDO_0012588) (neuronal ceroid lipofuscinosis 7), [MONDO:0015600](http://purl.obolibrary.org/obo/MONDO_0015600) (X-linked intellectual disability, Cilliers type), [MONDO:0012575](http://purl.obolibrary.org/obo/MONDO_0012575) (branchiootorenal syndrome 2), [MONDO:0012574](http://purl.obolibrary.org/obo/MONDO_0012574) (Potocki-Luspski syndrome), [MONDO:0011242](http://purl.obolibrary.org/obo/MONDO_0011242) (Bartter disease type 4a), [MONDO:0020199](http://purl.obolibrary.org/obo/MONDO_0020199) (conjunctival vascular anomaly), [MONDO:0003638](http://purl.obolibrary.org/obo/MONDO_0003638) (lung meningioma), [MONDO:0020191](http://purl.obolibrary.org/obo/MONDO_0020191) (eyebrow/eyelashes pigmentation anomaly), [MONDO:0020192](http://purl.obolibrary.org/obo/MONDO_0020192) (rare lacrimal system disease), [MONDO:0002301](http://purl.obolibrary.org/obo/MONDO_0002301) (frontal sinus squamous cell carcinoma), [MONDO:0020193](http://purl.obolibrary.org/obo/MONDO_0020193) (secretory apparatus of the lacrimal system anomaly), [MONDO:0020194](http://purl.obolibrary.org/obo/MONDO_0020194) (congenital alacrima), [MONDO:0020195](http://purl.obolibrary.org/obo/MONDO_0020195) (excretory apparatus of the lacrimal system anomaly), [MONDO:0015609](http://purl.obolibrary.org/obo/MONDO_0015609) (advanced sleep phase syndrome), [MONDO:0020196](http://purl.obolibrary.org/obo/MONDO_0020196) (anomaly of the secretory and excretory apparatus of the lacrimal system), [MONDO:0020197](http://purl.obolibrary.org/obo/MONDO_0020197) (EEC syndrome and related syndrome), [MONDO:0020198](http://purl.obolibrary.org/obo/MONDO_0020198) (rare conjunctival disease), [MONDO:0011248](http://purl.obolibrary.org/obo/MONDO_0011248) (distal monosomy 13q), [MONDO:0011246](http://purl.obolibrary.org/obo/MONDO_0011246) (megaconial type congenital muscular dystrophy), [MONDO:0012576](http://purl.obolibrary.org/obo/MONDO_0012576) (PSNP3), [MONDO:0011245](http://purl.obolibrary.org/obo/MONDO_0011245) (ichthyosis, hystrix-like, with deafness), [MONDO:0015602](http://purl.obolibrary.org/obo/MONDO_0015602) (developmental delay-deafness syndrome, Hildebrand type), [MONDO:0015601](http://purl.obolibrary.org/obo/MONDO_0015601) (X-linked intellectual disability, van Esch type), [MONDO:0011249](http://purl.obolibrary.org/obo/MONDO_0011249) (torsion dystonia with onset in infancy), [MONDO:0020190](http://purl.obolibrary.org/obo/MONDO_0020190) (eyebrow/eyelashes distichiasis), [MONDO:0018701](http://purl.obolibrary.org/obo/MONDO_0018701) (congenital nemaline myopathy), [MONDO:0015674](http://purl.obolibrary.org/obo/MONDO_0015674) (late infantile neuronal ceroid lipofuscinosis), [MONDO:0014345](http://purl.obolibrary.org/obo/MONDO_0014345) (retinitis pigmentosa 69), [MONDO:0013010](http://purl.obolibrary.org/obo/MONDO_0013010) (autosomal recessive nonsyndromic deafness 71), [MONDO:0018709](http://purl.obolibrary.org/obo/MONDO_0018709) (X-linked intellectual disability-hypotonia-movement disorder syndrome), [MONDO:0018705](http://purl.obolibrary.org/obo/MONDO_0018705) (infantile-onset axonal motor and sensory neuropathy-optic atrophy-neurodegenerative syndrome), [MONDO:0014348](http://purl.obolibrary.org/obo/MONDO_0014348) (mental retardation, autosomal recessive 42), [MONDO:0018706](http://purl.obolibrary.org/obo/MONDO_0018706) (syndromic sensorineural deafness due to combined oxidative phosphorylation defect), [MONDO:0013018](http://purl.obolibrary.org/obo/MONDO_0013018) (keratosis follicularis spinulosa decalvans, autosomal dominant), [MONDO:0014349](http://purl.obolibrary.org/obo/MONDO_0014349) (pontocerebellar hypoplasia type 10), [MONDO:0016995](http://purl.obolibrary.org/obo/MONDO_0016995) (familial multiple meningioma), [MONDO:0016994](http://purl.obolibrary.org/obo/MONDO_0016994) (microcephalic osteodysplastic primordial dwarfism types i and III), [MONDO:0014333](http://purl.obolibrary.org/obo/MONDO_0014333) (polymicrogyria, bilateral perisylvian, autosomal recessive), [MONDO:0013002](http://purl.obolibrary.org/obo/MONDO_0013002) (cone-rod dystrophy 9), [MONDO:0016997](http://purl.obolibrary.org/obo/MONDO_0016997) (hereditary epidermolysis bullosa associated with ocular features), [MONDO:0014335](http://purl.obolibrary.org/obo/MONDO_0014335) (diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome), [MONDO:0016991](http://purl.obolibrary.org/obo/MONDO_0016991) (acute necrotizing encephalopathy of childhood), [MONDO:0015660](http://purl.obolibrary.org/obo/MONDO_0015660) (sporadic fetal brain disruption sequence), [MONDO:0013000](http://purl.obolibrary.org/obo/MONDO_0013000) (porphyria due to ALA dehydratase deficiency), [MONDO:0014331](http://purl.obolibrary.org/obo/MONDO_0014331) (Moyamoya disease with early-onset achalasia), [MONDO:0001036](http://purl.obolibrary.org/obo/MONDO_0001036) (hypopyon), [MONDO:0001035](http://purl.obolibrary.org/obo/MONDO_0001035) (hypopyon ulcer), [MONDO:0001030](http://purl.obolibrary.org/obo/MONDO_0001030) (keratoconus, stable condition), [MONDO:0013005](http://purl.obolibrary.org/obo/MONDO_0013005) (EAST syndrome), [MONDO:0014336](http://purl.obolibrary.org/obo/MONDO_0014336) (intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency), [MONDO:0013006](http://purl.obolibrary.org/obo/MONDO_0013006) (isolated growth hormone deficiency type ib), [MONDO:0014339](http://purl.obolibrary.org/obo/MONDO_0014339) (autosomal recessive spinocerebellar ataxia 16), [MONDO:0015653](http://purl.obolibrary.org/obo/MONDO_0015653) (monogenic disease with epilepsy), [MONDO:0015652](http://purl.obolibrary.org/obo/MONDO_0015652) (chromosomal anomaly with epilepsy as a major feature), [MONDO:0015655](http://purl.obolibrary.org/obo/MONDO_0015655) (cerebral malformation with epilepsy), [MONDO:0014323](http://purl.obolibrary.org/obo/MONDO_0014323) (retinitis pigmentosa 68), [MONDO:0015654](http://purl.obolibrary.org/obo/MONDO_0015654) (idiopathic or cryptogenic familial epilepsy syndrome with identified loci/genes), [MONDO:0011299](http://purl.obolibrary.org/obo/MONDO_0011299) (Huntington disease-like 1), [MONDO:0016980](http://purl.obolibrary.org/obo/MONDO_0016980) (ATR-X-related syndrome), [MONDO:0011297](http://purl.obolibrary.org/obo/MONDO_0011297) (autosomal dominant nocturnal frontal lobe epilepsy 2), [MONDO:0015651](http://purl.obolibrary.org/obo/MONDO_0015651) (neurocutaneous syndrome with epilepsy), [MONDO:0011296](http://purl.obolibrary.org/obo/MONDO_0011296) (Meckel syndrome, type 2), [MONDO:0014320](http://purl.obolibrary.org/obo/MONDO_0014320) (optic atrophy-intellectual disability syndrome), [MONDO:0015650](http://purl.obolibrary.org/obo/MONDO_0015650) (epilepsy syndrome), [MONDO:0016981](http://purl.obolibrary.org/obo/MONDO_0016981) (infantile spams-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome), [MONDO:0011291](http://purl.obolibrary.org/obo/MONDO_0011291) (congenital disorder of glycosylation type 1C), [MONDO:0001007](http://purl.obolibrary.org/obo/MONDO_0001007) (chronic meningitis), [MONDO:0015657](http://purl.obolibrary.org/obo/MONDO_0015657) (inflammatory and autoimmune disease with epilepsy), [MONDO:0016987](http://purl.obolibrary.org/obo/MONDO_0016987) (neuroacanthocytosis), [MONDO:0014326](http://purl.obolibrary.org/obo/MONDO_0014326) (nemaline myopathy 9), [MONDO:0015656](http://purl.obolibrary.org/obo/MONDO_0015656) (metabolic diseases with epilepsy), [MONDO:0015659](http://purl.obolibrary.org/obo/MONDO_0015659) (infectious disease with epilepsy), [MONDO:0014328](http://purl.obolibrary.org/obo/MONDO_0014328) (epileptic encephalopathy, early infantile, 19), [MONDO:0015658](http://purl.obolibrary.org/obo/MONDO_0015658) (cerebral diseases of vascular origin with epilepsy), [MONDO:0016989](http://purl.obolibrary.org/obo/MONDO_0016989) (Fuchs heterochromic iridocyclitis), [MONDO:0015642](http://purl.obolibrary.org/obo/MONDO_0015642) (benign partial infantile seizures), [MONDO:0015641](http://purl.obolibrary.org/obo/MONDO_0015641) (benign infantile focal epilepsy with midline spikes and wave during sleep), [MONDO:0014311](http://purl.obolibrary.org/obo/MONDO_0014311) (autosomal recessive spinocerebellar ataxia 15), [MONDO:0015644](http://purl.obolibrary.org/obo/MONDO_0015644) (audiogenic seizures), [MONDO:0015643](http://purl.obolibrary.org/obo/MONDO_0015643) (photosensitive epilepsy), [MONDO:0011281](http://purl.obolibrary.org/obo/MONDO_0011281) (congenital myasthenic syndrome 5), [MONDO:0011286](http://purl.obolibrary.org/obo/MONDO_0011286) (autosomal recessive nonsyndromic deafness 13), [MONDO:0015640](http://purl.obolibrary.org/obo/MONDO_0015640) (benign infantile seizures associated with mild gastroenteritis), [MONDO:0016971](http://purl.obolibrary.org/obo/MONDO_0016971) (limb-girdle muscular dystrophy), [MONDO:0001015](http://purl.obolibrary.org/obo/MONDO_0001015) (eosinophilic meningitis), [MONDO:0006701](http://purl.obolibrary.org/obo/MONDO_0006701) (chromophobe adenoma), [MONDO:0002340](http://purl.obolibrary.org/obo/MONDO_0002340) (tactile epilepsy), [MONDO:0014318](http://purl.obolibrary.org/obo/MONDO_0014318) (hyperphosphatasia with mental retardation syndrome 4), [MONDO:0015649](http://purl.obolibrary.org/obo/MONDO_0015649) (micturation-induced seizures), [MONDO:0015646](http://purl.obolibrary.org/obo/MONDO_0015646) (orgasm-induced seizures), [MONDO:0014314](http://purl.obolibrary.org/obo/MONDO_0014314) (sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome), [MONDO:0015645](http://purl.obolibrary.org/obo/MONDO_0015645) (eating seizures), [MONDO:0015648](http://purl.obolibrary.org/obo/MONDO_0015648) (startle epilepsy), [MONDO:0016979](http://purl.obolibrary.org/obo/MONDO_0016979) (MRCS syndrome), [MONDO:0014316](http://purl.obolibrary.org/obo/MONDO_0014316) (Alzheimer's disease 19), [MONDO:0015647](http://purl.obolibrary.org/obo/MONDO_0015647) (thinking seizures), [MONDO:0013056](http://purl.obolibrary.org/obo/MONDO_0013056) (epileptic encephalopathy with global cerebral demyelination), [MONDO:0014387](http://purl.obolibrary.org/obo/MONDO_0014387) (leukoencephalopathy, progressive, with ovarian failure), [MONDO:0018743](http://purl.obolibrary.org/obo/MONDO_0018743) (immune-mediated acquired neuromuscular junction disease), [MONDO:0013058](http://purl.obolibrary.org/obo/MONDO_0013058) (cystic leukoencephalopathy without megalencephaly), [MONDO:0018744](http://purl.obolibrary.org/obo/MONDO_0018744) (oligodendroglial tumor), [MONDO:0013059](http://purl.obolibrary.org/obo/MONDO_0013059) (Aicardi-Goutieres syndrome 5), [MONDO:0014383](http://purl.obolibrary.org/obo/MONDO_0014383) (myopathy, tubular aggregate, 2), [MONDO:0013052](http://purl.obolibrary.org/obo/MONDO_0013052) (retinitis pigmentosa 42), [MONDO:0017410](http://purl.obolibrary.org/obo/MONDO_0017410) (porencephaly), [MONDO:0014380](http://purl.obolibrary.org/obo/MONDO_0014380) (colobomatous microphthalmia-rhizomelic dysplasia syndrome), [MONDO:0013051](http://purl.obolibrary.org/obo/MONDO_0013051) (autosomal recessive cutis laxa type 2B), [MONDO:0014382](http://purl.obolibrary.org/obo/MONDO_0014382) (tall stature-intellectual disability-facial dysmorphism syndrome), [MONDO:0006753](http://purl.obolibrary.org/obo/MONDO_0006753) (escherichia coli meningitis), [MONDO:0017416](http://purl.obolibrary.org/obo/MONDO_0017416) (postpoliomyelitis syndrome), [MONDO:0014376](http://purl.obolibrary.org/obo/MONDO_0014376) (mental retardation, autosomal dominant 27), [MONDO:0013046](http://purl.obolibrary.org/obo/MONDO_0013046) (glycogen storage disease due to muscle beta-enolase deficiency), [MONDO:0014377](http://purl.obolibrary.org/obo/MONDO_0014377) (epileptic encephalopathy, early infantile, 24), [MONDO:0018732](http://purl.obolibrary.org/obo/MONDO_0018732) (primary central nervous system lymphoma), [MONDO:0017404](http://purl.obolibrary.org/obo/MONDO_0017404) (distal Xq28 microduplication syndrome), [MONDO:0013047](http://purl.obolibrary.org/obo/MONDO_0013047) (glycogen storage disease due to lactate dehydrogenase M-subunit deficiency), [MONDO:0013048](http://purl.obolibrary.org/obo/MONDO_0013048) (hereditary spastic paraplegia 50), [MONDO:0014379](http://purl.obolibrary.org/obo/MONDO_0014379) (ADNP-related multiple congenital anomalies-intellectual disability-autism spectrum disorder), [MONDO:0018733](http://purl.obolibrary.org/obo/MONDO_0018733) (intellectual disability syndrome due to a DYRK1A point mutation), [MONDO:0014372](http://purl.obolibrary.org/obo/MONDO_0014372) (cone-rod dystrophy 19), [MONDO:0014370](http://purl.obolibrary.org/obo/MONDO_0014370) (pontocerebellar hypoplasia type 2E), [MONDO:0014371](http://purl.obolibrary.org/obo/MONDO_0014371) (early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome), [MONDO:0004108](http://purl.obolibrary.org/obo/MONDO_0004108) (diaphragma sellae meningioma), [MONDO:0006764](http://purl.obolibrary.org/obo/MONDO_0006764) (fungal meningitis), [MONDO:0017409](http://purl.obolibrary.org/obo/MONDO_0017409) (fetal cytomegalovirus syndrome), [MONDO:0017406](http://purl.obolibrary.org/obo/MONDO_0017406) (hypogonadotropic hypogonadism-severe microcephaly-sensorineural hearing loss-dysmorphism syndrome), [MONDO:0013049](http://purl.obolibrary.org/obo/MONDO_0013049) (DPM3-CDG), [MONDO:0017405](http://purl.obolibrary.org/obo/MONDO_0017405) (1p21.3 microdeletion syndrome), [MONDO:0018724](http://purl.obolibrary.org/obo/MONDO_0018724) (X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome), [MONDO:0013036](http://purl.obolibrary.org/obo/MONDO_0013036) (Zechi-Ceide syndrome), [MONDO:0014367](http://purl.obolibrary.org/obo/MONDO_0014367) (Aicardi-Goutieres syndrome 7), [MONDO:0014361](http://purl.obolibrary.org/obo/MONDO_0014361) (autism spectrum disorder due to AUTS2 deficiency), [MONDO:0013030](http://purl.obolibrary.org/obo/MONDO_0013030) (dilated cardiomyopathy 1BB), [MONDO:0013031](http://purl.obolibrary.org/obo/MONDO_0013031) (chromosome 5Q14.3 deletion syndrome, distal), [MONDO:0014363](http://purl.obolibrary.org/obo/MONDO_0014363) (autosomal recessive nonsyndromic deafness 101), [MONDO:0013033](http://purl.obolibrary.org/obo/MONDO_0013033) (cerebral palsy, spastic quadriplegic, 2), [MONDO:0014360](http://purl.obolibrary.org/obo/MONDO_0014360) (epileptic encephalopathy, early infantile, 21), [MONDO:0018725](http://purl.obolibrary.org/obo/MONDO_0018725) (corpus callosum agenesis-macrocephaly-hypertelorism syndrome), [MONDO:0014354](http://purl.obolibrary.org/obo/MONDO_0014354) (mental retardation, autosomal recessive 43), [MONDO:0018710](http://purl.obolibrary.org/obo/MONDO_0018710) (megalencephaly-severe kyphoscoliosis-overgrowth syndrome), [MONDO:0018711](http://purl.obolibrary.org/obo/MONDO_0018711) (intellectual disability-muscle weakness-short stature-facial dysmorphism syndrome), [MONDO:0014357](http://purl.obolibrary.org/obo/MONDO_0014357) (mental retardation, autosomal dominant 24), [MONDO:0013026](http://purl.obolibrary.org/obo/MONDO_0013026) (subepithelial mucinous corneal dystrophy), [MONDO:0014350](http://purl.obolibrary.org/obo/MONDO_0014350) (Seckel syndrome 8), [MONDO:0013020](http://purl.obolibrary.org/obo/MONDO_0013020) (NRCLP5), [MONDO:0014351](http://purl.obolibrary.org/obo/MONDO_0014351) (pontocerebellar hypoplasia type 9), [MONDO:0015681](http://purl.obolibrary.org/obo/MONDO_0015681) (childhood disintegrative disorder), [MONDO:0014353](http://purl.obolibrary.org/obo/MONDO_0014353) (PGM3-CDG), [MONDO:0015680](http://purl.obolibrary.org/obo/MONDO_0015680) (rare pervasive developmental disorder), [MONDO:0001055](http://purl.obolibrary.org/obo/MONDO_0001055) (conjunctival pterygium), [MONDO:0001052](http://purl.obolibrary.org/obo/MONDO_0001052) (chronic fungal otitis externa), [MONDO:0002383](http://purl.obolibrary.org/obo/MONDO_0002383) (Pacinian tumor), [MONDO:0001054](http://purl.obolibrary.org/obo/MONDO_0001054) (double pterygium), [MONDO:0013027](http://purl.obolibrary.org/obo/MONDO_0013027) (posterior amorphous corneal dystrophy), [MONDO:0014358](http://purl.obolibrary.org/obo/MONDO_0014358) (AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome), [MONDO:0013028](http://purl.obolibrary.org/obo/MONDO_0013028) (adenosine monophosphate deaminase deficiency), [MONDO:0013029](http://purl.obolibrary.org/obo/MONDO_0013029) (cerebellar ataxia type 9), [MONDO:0018789](http://purl.obolibrary.org/obo/MONDO_0018789) (COL4A1 or COL4A2-related cerebral small vessel disease with ischemic tendancy), [MONDO:0016126](http://purl.obolibrary.org/obo/MONDO_0016126) (viral myositis), [MONDO:0016125](http://purl.obolibrary.org/obo/MONDO_0016125) (infectious, fungal or parasitic myopathy), [MONDO:0018787](http://purl.obolibrary.org/obo/MONDO_0018787) (genetic cerebral small vessel disease), [MONDO:0016128](http://purl.obolibrary.org/obo/MONDO_0016128) (parasitic myositis), [MONDO:0018788](http://purl.obolibrary.org/obo/MONDO_0018788) (COL4A1 or COL4A2-related cerebral small vessel disease), [MONDO:0016127](http://purl.obolibrary.org/obo/MONDO_0016127) (bacterial myositis), [MONDO:0016122](http://purl.obolibrary.org/obo/MONDO_0016122) (periodic paralysis (disease)), [MONDO:0013096](http://purl.obolibrary.org/obo/MONDO_0013096) (GLM7), [MONDO:0016121](http://purl.obolibrary.org/obo/MONDO_0016121) (congenital myotonia), [MONDO:0013097](http://purl.obolibrary.org/obo/MONDO_0013097) (GLM8), [MONDO:0018786](http://purl.obolibrary.org/obo/MONDO_0018786) (pontine autosomal dominant microangiopathy with leukoencephalopathy), [MONDO:0016124](http://purl.obolibrary.org/obo/MONDO_0016124) (drug and/or toxic myopathy), [MONDO:0013099](http://purl.obolibrary.org/obo/MONDO_0013099) (combined pituitary hormone deficiencies, genetic forms), [MONDO:0016123](http://purl.obolibrary.org/obo/MONDO_0016123) (muscular tumor), [MONDO:0018784](http://purl.obolibrary.org/obo/MONDO_0018784) (pediatric multiple sclerosis), [MONDO:0018781](http://purl.obolibrary.org/obo/MONDO_0018781) (KID syndrome), [MONDO:0013092](http://purl.obolibrary.org/obo/MONDO_0013092) (glioma susceptibility 2), [MONDO:0013093](http://purl.obolibrary.org/obo/MONDO_0013093) (glioma susceptibility 3), [MONDO:0009830](http://purl.obolibrary.org/obo/MONDO_0009830) (autosomal recessive early-onset Parkinson disease 15), [MONDO:0016120](http://purl.obolibrary.org/obo/MONDO_0016120) (myotonic syndrome), [MONDO:0013094](http://purl.obolibrary.org/obo/MONDO_0013094) (GLM5), [MONDO:0008501](http://purl.obolibrary.org/obo/MONDO_0008501) (Sturge-Weber syndrome), [MONDO:0013095](http://purl.obolibrary.org/obo/MONDO_0013095) (GLM6), [MONDO:0018780](http://purl.obolibrary.org/obo/MONDO_0018780) (congenital generalized hypercontractile muscle stiffness syndrome), [MONDO:0008503](http://purl.obolibrary.org/obo/MONDO_0008503) (Worster-Drought syndrome), [MONDO:0013090](http://purl.obolibrary.org/obo/MONDO_0013090) (chromosome 19q13.11 deletion syndrome), [MONDO:0009835](http://purl.obolibrary.org/obo/MONDO_0009835) (subacute sclerosing panencephalitis), [MONDO:0009837](http://purl.obolibrary.org/obo/MONDO_0009837) (choroid plexus papilloma), [MONDO:0010827](http://purl.obolibrary.org/obo/MONDO_0010827) (retinitis pigmentosa 14), [MONDO:0009839](http://purl.obolibrary.org/obo/MONDO_0009839) (progressive supranuclear palsy-parkinsonism syndrome), [MONDO:0010824](http://purl.obolibrary.org/obo/MONDO_0010824) (disorder of sex development-intellectual disability syndrome), [MONDO:0010825](http://purl.obolibrary.org/obo/MONDO_0010825) (atrioventricular defect-blepharophimosis-radial and anal defect syndrome), [MONDO:0004133](http://purl.obolibrary.org/obo/MONDO_0004133) (pituitary gland mixed eosinophil-basophil adenoma), [MONDO:0005462](http://purl.obolibrary.org/obo/MONDO_0005462) (primitive neuroectodermal tumor), [MONDO:0010828](http://purl.obolibrary.org/obo/MONDO_0010828) (retinitis pigmentosa 11), [MONDO:0010829](http://purl.obolibrary.org/obo/MONDO_0010829) (CARASIL), [MONDO:0010822](http://purl.obolibrary.org/obo/MONDO_0010822) (Warburg micro syndrome 1), [MONDO:0010823](http://purl.obolibrary.org/obo/MONDO_0010823) (rhizomelic chondrodysplasia punctata type 3), [MONDO:0010820](http://purl.obolibrary.org/obo/MONDO_0010820) (autosomal recessive juvenile Parkinson disease 2), [MONDO:0010821](http://purl.obolibrary.org/obo/MONDO_0010821) (familial developmental dysphasia), [MONDO:0016115](http://purl.obolibrary.org/obo/MONDO_0016115) (bulbospinal muscular atrophy of adult), [MONDO:0018778](http://purl.obolibrary.org/obo/MONDO_0018778) (intermediate Charcot-Marie-tooth disease), [MONDO:0018779](http://purl.obolibrary.org/obo/MONDO_0018779) (hypercontractile muscle stiffness syndrome), [MONDO:0016114](http://purl.obolibrary.org/obo/MONDO_0016114) (bulbospinal muscular atrophy of childhood), [MONDO:0018776](http://purl.obolibrary.org/obo/MONDO_0018776) (demyelinating hereditary motor and sensory neuropathy), [MONDO:0016117](http://purl.obolibrary.org/obo/MONDO_0016117) (muscular lipidosis), [MONDO:0016116](http://purl.obolibrary.org/obo/MONDO_0016116) (generalized bulbospinal muscular atrophy), [MONDO:0013085](http://purl.obolibrary.org/obo/MONDO_0013085) (NBLST5), [MONDO:0016111](http://purl.obolibrary.org/obo/MONDO_0016111) (non-dystrophic myopathy with collagen 6 anomaly), [MONDO:0018775](http://purl.obolibrary.org/obo/MONDO_0018775) (axonal hereditary motor and sensory neuropathy), [MONDO:0013086](http://purl.obolibrary.org/obo/MONDO_0013086) (NBLST6), [MONDO:0016110](http://purl.obolibrary.org/obo/MONDO_0016110) (non-dystrophic myopathy), [MONDO:0016113](http://purl.obolibrary.org/obo/MONDO_0016113) (bulbospinal muscular atrophy), [MONDO:0018772](http://purl.obolibrary.org/obo/MONDO_0018772) (Joubert syndrome), [MONDO:0018773](http://purl.obolibrary.org/obo/MONDO_0018773) (autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome), [MONDO:0016112](http://purl.obolibrary.org/obo/MONDO_0016112) (inclusion myopathy), [MONDO:0013082](http://purl.obolibrary.org/obo/MONDO_0013082) (Hirschsprung disease-ganglioneuroblastoma syndrome), [MONDO:0013083](http://purl.obolibrary.org/obo/MONDO_0013083) (neuroblastoma, susceptibility to, 3), [MONDO:0009820](http://purl.obolibrary.org/obo/MONDO_0009820) (osteoporosis-pseudoglioma syndrome), [MONDO:0013084](http://purl.obolibrary.org/obo/MONDO_0013084) (NBLST4), [MONDO:0010816](http://purl.obolibrary.org/obo/MONDO_0010816) (Qazi Markouizos syndrome), [MONDO:0004146](http://purl.obolibrary.org/obo/MONDO_0004146) (transitional meningioma), [MONDO:0010819](http://purl.obolibrary.org/obo/MONDO_0010819) (Stargardt disease 3), [MONDO:0005475](http://purl.obolibrary.org/obo/MONDO_0005475) (migraine with aura), [MONDO:0004144](http://purl.obolibrary.org/obo/MONDO_0004144) (fibrous meningioma), [MONDO:0004145](http://purl.obolibrary.org/obo/MONDO_0004145) (meningothelial meningioma), [MONDO:0010817](http://purl.obolibrary.org/obo/MONDO_0010817) (autosomal dominant nonsyndromic deafness 2A), [MONDO:0010818](http://purl.obolibrary.org/obo/MONDO_0010818) (retinitis pigmentosa 12), [MONDO:0004143](http://purl.obolibrary.org/obo/MONDO_0004143) (psammomatous meningioma), [MONDO:0016118](http://purl.obolibrary.org/obo/MONDO_0016118) (muscular glycogenosis), [MONDO:0016104](http://purl.obolibrary.org/obo/MONDO_0016104) (infectious disease with peripheral neuropathy), [MONDO:0016103](http://purl.obolibrary.org/obo/MONDO_0016103) (isolated asymptomatic elevation of creatine phosphokinase), [MONDO:0016106](http://purl.obolibrary.org/obo/MONDO_0016106) (progressive muscular dystrophy), [MONDO:0016105](http://purl.obolibrary.org/obo/MONDO_0016105) (acquired skeletal muscle disease), [MONDO:0016100](http://purl.obolibrary.org/obo/MONDO_0016100) (rippling muscle disease with myasthenia gravis), [MONDO:0018763](http://purl.obolibrary.org/obo/MONDO_0018763) (Tubulinopathy-associated dysgyria), [MONDO:0013075](http://purl.obolibrary.org/obo/MONDO_0013075) (herpes simplex encephalitis, susceptibility to, 2), [MONDO:0018764](http://purl.obolibrary.org/obo/MONDO_0018764) (microcephalic primordial dwarfism due to RTTN deficiency), [MONDO:0016102](http://purl.obolibrary.org/obo/MONDO_0016102) (subacute inflammatory demyelinating polyneuropathy), [MONDO:0013071](http://purl.obolibrary.org/obo/MONDO_0013071) (Emery-Dreifuss muscular dystrophy 4, autosomal dominant), [MONDO:0018760](http://purl.obolibrary.org/obo/MONDO_0018760) (WAC-related facial dysmorphism-developmental delay-behavioral abnormalities syndrome), [MONDO:0013072](http://purl.obolibrary.org/obo/MONDO_0013072) (Emery-Dreifuss muscular dystrophy 5, autosomal dominant), [MONDO:0009814](http://purl.obolibrary.org/obo/MONDO_0009814) (Osteopenia-intellectual disability-sparse hair syndrome), [MONDO:0009815](http://purl.obolibrary.org/obo/MONDO_0009815) (autosomal recessive osteopetrosis 1), [MONDO:0009816](http://purl.obolibrary.org/obo/MONDO_0009816) (autosomal recessive osteopetrosis 2), [MONDO:0006775](http://purl.obolibrary.org/obo/MONDO_0006775) (haemophilus influenzae meningitis), [MONDO:0010808](http://purl.obolibrary.org/obo/MONDO_0010808) (fatal familial insomnia), [MONDO:0010806](http://purl.obolibrary.org/obo/MONDO_0010806) (retinitis pigmentosa 13), [MONDO:0010807](http://purl.obolibrary.org/obo/MONDO_0010807) (autosomal recessive nonsyndromic deafness 2), [MONDO:0010800](http://purl.obolibrary.org/obo/MONDO_0010800) (Wolfram syndrome, mitochondrial form), [MONDO:0016108](http://purl.obolibrary.org/obo/MONDO_0016108) (autosomal dominant distal myopathy), [MONDO:0016107](http://purl.obolibrary.org/obo/MONDO_0016107) (myotonic dystrophy), [MONDO:0016109](http://purl.obolibrary.org/obo/MONDO_0016109) (autosomal recessive distal myopathy), [MONDO:0014398](http://purl.obolibrary.org/obo/MONDO_0014398) (combined oxidative phosphorylation defect type 21), [MONDO:0018756](http://purl.obolibrary.org/obo/MONDO_0018756) (euthyroid Graves orbitopathy), [MONDO:0014399](http://purl.obolibrary.org/obo/MONDO_0014399) (PCNA-related progressive neurodegenerative photosensitivy syndrome), [MONDO:0013069](http://purl.obolibrary.org/obo/MONDO_0013069) (autosomal recessive optic atrophy, OPA7 type), [MONDO:0018752](http://purl.obolibrary.org/obo/MONDO_0018752) (exercise-induced malignant hyperthermia), [MONDO:0018753](http://purl.obolibrary.org/obo/MONDO_0018753) (rare disease with malignant hyperthermia), [MONDO:0013064](http://purl.obolibrary.org/obo/MONDO_0013064) (multiple synostoses syndrome 3), [MONDO:0014395](http://purl.obolibrary.org/obo/MONDO_0014395) (FTDALS2), [MONDO:0014396](http://purl.obolibrary.org/obo/MONDO_0014396) (dilated cardiomyopathy 1NN), [MONDO:0014397](http://purl.obolibrary.org/obo/MONDO_0014397) (combined oxidative phosphorylation defect type 20), [MONDO:0013060](http://purl.obolibrary.org/obo/MONDO_0013060) (autosomal recessive Parkinson disease 14), [MONDO:0013061](http://purl.obolibrary.org/obo/MONDO_0013061) (myofibrillar myopathy 6), [MONDO:0014392](http://purl.obolibrary.org/obo/MONDO_0014392) (epileptic encephalopathy, early infantile, 25), [MONDO:0014393](http://purl.obolibrary.org/obo/MONDO_0014393) (lymphedema, hereditary, 1D), [MONDO:0001096](http://purl.obolibrary.org/obo/MONDO_0001096) (mediastinum ganglioneuroblastoma), [MONDO:0001095](http://purl.obolibrary.org/obo/MONDO_0001095) (mediastinum neuroblastoma), [MONDO:0018759](http://purl.obolibrary.org/obo/MONDO_0018759) (childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome), [MONDO:0018349](http://purl.obolibrary.org/obo/MONDO_0018349) (MAN1B1-CDG), [MONDO:0018347](http://purl.obolibrary.org/obo/MONDO_0018347) (severe intellectual disability-progressive postnatal microcephaly- midline stereotypic hand movements syndrome), [MONDO:0018348](http://purl.obolibrary.org/obo/MONDO_0018348) (polyglucosan body myopathy type 1), [MONDO:0018346](http://purl.obolibrary.org/obo/MONDO_0018346) (Ferro-cerebro-cutaneous syndrome), [MONDO:0018343](http://purl.obolibrary.org/obo/MONDO_0018343) (periodic paralysis with later-onset distal motor neuropathy), [MONDO:0018344](http://purl.obolibrary.org/obo/MONDO_0018344) (periodic paralysis with transient compartment-like syndrome), [MONDO:0018341](http://purl.obolibrary.org/obo/MONDO_0018341) (3q27.3 microdeletion syndrome), [MONDO:0018342](http://purl.obolibrary.org/obo/MONDO_0018342) (Joubert syndrome with Jeune asphyxiating thoracic dystrophy), [MONDO:0011716](http://purl.obolibrary.org/obo/MONDO_0011716) (acute hemorrhagic leukoencephalitis), [MONDO:0011715](http://purl.obolibrary.org/obo/MONDO_0011715) (Seckel syndrome 2), [MONDO:0007688](http://purl.obolibrary.org/obo/MONDO_0007688) (Myhre syndrome), [MONDO:0007684](http://purl.obolibrary.org/obo/MONDO_0007684) (granulomatous disease, chronic, autosomal dominant type), [MONDO:0018339](http://purl.obolibrary.org/obo/MONDO_0018339) (PrP systemic amyloidosis), [MONDO:0018334](http://purl.obolibrary.org/obo/MONDO_0018334) (chronic hiccup), [MONDO:0018332](http://purl.obolibrary.org/obo/MONDO_0018332) (multiple acyl-CoA dehydrogenase deficiency, severe neonatal type), [MONDO:0018333](http://purl.obolibrary.org/obo/MONDO_0018333) (multiple acyl-CoA dehydrogenase deficiency, mild type), [MONDO:0019661](http://purl.obolibrary.org/obo/MONDO_0019661) (Pfeiffer syndrome type 3), [MONDO:0018331](http://purl.obolibrary.org/obo/MONDO_0018331) (rare genetic dystonia), [MONDO:0019660](http://purl.obolibrary.org/obo/MONDO_0019660) (Pfeiffer syndrome type 2), [MONDO:0011707](http://purl.obolibrary.org/obo/MONDO_0011707) (familial dyskinesia and facial myokymia), [MONDO:0011706](http://purl.obolibrary.org/obo/MONDO_0011706) (Kufor-Rakeb syndrome), [MONDO:0006369](http://purl.obolibrary.org/obo/MONDO_0006369) (pineal parenchymal tumor of intermediate differentiation), [MONDO:0005035](http://purl.obolibrary.org/obo/MONDO_0005035) (ganglioneuroblastoma (disease)), [MONDO:0006366](http://purl.obolibrary.org/obo/MONDO_0006366) (Peutz-Jeghers polyp of the stomach), [MONDO:0005033](http://purl.obolibrary.org/obo/MONDO_0005033) (ganglioneuroma (disease)), [MONDO:0011708](http://purl.obolibrary.org/obo/MONDO_0011708) (autosomal dominant nonsyndromic deafness 36), [MONDO:0007691](http://purl.obolibrary.org/obo/MONDO_0007691) (Guillain-Barre syndrome), [MONDO:0011703](http://purl.obolibrary.org/obo/MONDO_0011703) (spongiform encephalopathy with neuropsychiatric features), [MONDO:0011702](http://purl.obolibrary.org/obo/MONDO_0011702) (dilated cardiomyopathy 1L), [MONDO:0019659](http://purl.obolibrary.org/obo/MONDO_0019659) (Pfeiffer syndrome type 1), [MONDO:0018325](http://purl.obolibrary.org/obo/MONDO_0018325) (juvenile myasthenia gravis), [MONDO:0018326](http://purl.obolibrary.org/obo/MONDO_0018326) (transient neonatal myasthenia gravis), [MONDO:0015297](http://purl.obolibrary.org/obo/MONDO_0015297) (microcephaly-digital anomalies-intellectual disability syndrome), [MONDO:0018323](http://purl.obolibrary.org/obo/MONDO_0018323) (HSD10 disease, neonatal type), [MONDO:0018324](http://purl.obolibrary.org/obo/MONDO_0018324) (adult-onset myasthenia gravis), [MONDO:0018321](http://purl.obolibrary.org/obo/MONDO_0018321) (atypical juvenile parkinsonism), [MONDO:0015298](http://purl.obolibrary.org/obo/MONDO_0015298) (Pellucid marginal degeneration), [MONDO:0018322](http://purl.obolibrary.org/obo/MONDO_0018322) (HSD10 disease, infantile type), [MONDO:0018320](http://purl.obolibrary.org/obo/MONDO_0018320) (primary microcephaly-mild intellectual disability-young-onset diabetes syndrome), [MONDO:0015292](http://purl.obolibrary.org/obo/MONDO_0015292) (endotheliitis), [MONDO:0015291](http://purl.obolibrary.org/obo/MONDO_0015291) (stromal keratitis), [MONDO:0015290](http://purl.obolibrary.org/obo/MONDO_0015290) (neurotrophic keratopathy), [MONDO:0007666](http://purl.obolibrary.org/obo/MONDO_0007666) (glaucoma-sleep apnea syndrome), [MONDO:0007662](http://purl.obolibrary.org/obo/MONDO_0007662) (iridogoniodysgenesis, type 2), [MONDO:0018329](http://purl.obolibrary.org/obo/MONDO_0018329) (persistent combined dystonia), [MONDO:0018316](http://purl.obolibrary.org/obo/MONDO_0018316) (fatal post-viral neurodegenerative disorder), [MONDO:0015289](http://purl.obolibrary.org/obo/MONDO_0015289) (infectious epithelial keratitis), [MONDO:0018314](http://purl.obolibrary.org/obo/MONDO_0018314) (infantile-onset mesial temporal lobe epilepsy with severe cognitive regression), [MONDO:0015288](http://purl.obolibrary.org/obo/MONDO_0015288) (herpes simplex virus keratitis), [MONDO:0008996](http://purl.obolibrary.org/obo/MONDO_0008996) (Joubert syndrome with hepatic defect), [MONDO:0008998](http://purl.obolibrary.org/obo/MONDO_0008998) (Cockayne syndrome type 3), [MONDO:0008999](http://purl.obolibrary.org/obo/MONDO_0008999) (Cohen syndrome), [MONDO:0015280](http://purl.obolibrary.org/obo/MONDO_0015280) (cardiofaciocutaneous syndrome), [MONDO:0007679](http://purl.obolibrary.org/obo/MONDO_0007679) (GMS syndrome), [MONDO:0007672](http://purl.obolibrary.org/obo/MONDO_0007672) (Glomuvenous malformation), [MONDO:0018319](http://purl.obolibrary.org/obo/MONDO_0018319) (familial episodic pain syndrome), [MONDO:0017056](http://purl.obolibrary.org/obo/MONDO_0017056) (DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion), [MONDO:0017059](http://purl.obolibrary.org/obo/MONDO_0017059) (neural tube closure defect), [MONDO:0017058](http://purl.obolibrary.org/obo/MONDO_0017058) (autosomal recessive intermediate Charcot-Marie-tooth disease), [MONDO:0008104](http://purl.obolibrary.org/obo/MONDO_0008104) (Noonan syndrome 1), [MONDO:0009435](http://purl.obolibrary.org/obo/MONDO_0009435) (hypospadias-intellectual disability, Goldblatt type syndrome), [MONDO:0008106](http://purl.obolibrary.org/obo/MONDO_0008106) (NYS2), [MONDO:0008107](http://purl.obolibrary.org/obo/MONDO_0008107) (nystagmus, hereditary vertical), [MONDO:0008108](http://purl.obolibrary.org/obo/MONDO_0008108) (Oculocerebrocutaneous syndrome), [MONDO:0017050](http://purl.obolibrary.org/obo/MONDO_0017050) (intraocular medulloepithelioma), [MONDO:0010428](http://purl.obolibrary.org/obo/MONDO_0010428) (chromosome Xp11.23-p11.22 duplication syndrome), [MONDO:0011759](http://purl.obolibrary.org/obo/MONDO_0011759) (Hurler-Scheie syndrome), [MONDO:0010429](http://purl.obolibrary.org/obo/MONDO_0010429) (mental retardation, X-linked 96), [MONDO:0010422](http://purl.obolibrary.org/obo/MONDO_0010422) (Alzheimer's disease 16), [MONDO:0010426](http://purl.obolibrary.org/obo/MONDO_0010426) (X-linked endothelial corneal dystrophy), [MONDO:0011758](http://purl.obolibrary.org/obo/MONDO_0011758) (Hurler syndrome), [MONDO:0010427](http://purl.obolibrary.org/obo/MONDO_0010427) (syndromic X-linked intellectual disability Raymond type), [MONDO:0011756](http://purl.obolibrary.org/obo/MONDO_0011756) (Senior-Loken syndrome 4), [MONDO:0010425](http://purl.obolibrary.org/obo/MONDO_0010425) (Lisch epithelial corneal dystrophy), [MONDO:0011755](http://purl.obolibrary.org/obo/MONDO_0011755) (SLSN3), [MONDO:0017046](http://purl.obolibrary.org/obo/MONDO_0017046) (neuroepithelioma), [MONDO:0017045](http://purl.obolibrary.org/obo/MONDO_0017045) (neuroectodermal-endocrine syndrome), [MONDO:0017047](http://purl.obolibrary.org/obo/MONDO_0017047) (infantile axonal neuropathy), [MONDO:0017041](http://purl.obolibrary.org/obo/MONDO_0017041) (osteochondrodysplatic nanism-deafness-retinitis pigmentosa syndrome), [MONDO:0009426](http://purl.obolibrary.org/obo/MONDO_0009426) (hypoparathyroidism-retardation-dysmorphism syndrome), [MONDO:0018370](http://purl.obolibrary.org/obo/MONDO_0018370) (KLHL9-related early-onset distal myopathy), [MONDO:0018371](http://purl.obolibrary.org/obo/MONDO_0018371) (nebulin-related early-onset distal myopathy), [MONDO:0011749](http://purl.obolibrary.org/obo/MONDO_0011749) (oculocutaneous albinism type 1B), [MONDO:0010417](http://purl.obolibrary.org/obo/MONDO_0010417) (syndromic X-linked intellectual disability Najm type), [MONDO:0010418](http://purl.obolibrary.org/obo/MONDO_0010418) (hereditary spastic paraplegia 34), [MONDO:0011748](http://purl.obolibrary.org/obo/MONDO_0011748) (Usher syndrome type 1G), [MONDO:0011743](http://purl.obolibrary.org/obo/MONDO_0011743) (Alzheimer's disease 4), [MONDO:0010412](http://purl.obolibrary.org/obo/MONDO_0010412) (X-linked intellectual disability-craniofacioskeletal syndrome), [MONDO:0010415](http://purl.obolibrary.org/obo/MONDO_0010415) (myopathy, reducing body, X-linked, childhood-onset), [MONDO:0005072](http://purl.obolibrary.org/obo/MONDO_0005072) (neuroblastoma), [MONDO:0010413](http://purl.obolibrary.org/obo/MONDO_0010413) (MRX95), [MONDO:0010414](http://purl.obolibrary.org/obo/MONDO_0010414) (myopathy, reducing body, X-linked, early-onset, severe), [MONDO:0018362](http://purl.obolibrary.org/obo/MONDO_0018362) (persistent idiopathic facial pain), [MONDO:0009417](http://purl.obolibrary.org/obo/MONDO_0009417) (hypergonadotropic hypogonadism-cataract syndrome), [MONDO:0009419](http://purl.obolibrary.org/obo/MONDO_0009419) (Woodhouse-Sakati syndrome), [MONDO:0010409](http://purl.obolibrary.org/obo/MONDO_0010409) (syndromic X-linked intellectual disability Shrimpton type), [MONDO:0010406](http://purl.obolibrary.org/obo/MONDO_0010406) (chromosome Xp11.22 duplication syndrome), [MONDO:0011738](http://purl.obolibrary.org/obo/MONDO_0011738) (bilateral frontoparietal polymicrogyria), [MONDO:0010407](http://purl.obolibrary.org/obo/MONDO_0010407) (syndromic X-linked intellectual disability Turner type), [MONDO:0011737](http://purl.obolibrary.org/obo/MONDO_0011737) (PARK10), [MONDO:0010400](http://purl.obolibrary.org/obo/MONDO_0010400) (X-linked scapuloperoneal muscular dystrophy), [MONDO:0006373](http://purl.obolibrary.org/obo/MONDO_0006373) (pituitary gland adenoma), [MONDO:0010401](http://purl.obolibrary.org/obo/MONDO_0010401) (X-linked myopathy with postural muscle atrophy), [MONDO:0011730](http://purl.obolibrary.org/obo/MONDO_0011730) (Fumaric aciduria), [MONDO:0006372](http://purl.obolibrary.org/obo/MONDO_0006372) (pituicytoma), [MONDO:0010404](http://purl.obolibrary.org/obo/MONDO_0010404) (X-linked non progressive cerebellar ataxia), [MONDO:0010402](http://purl.obolibrary.org/obo/MONDO_0010402) (syndromic X-linked intellectual disability 94), [MONDO:0010403](http://purl.obolibrary.org/obo/MONDO_0010403) (albinism-deafness syndrome), [MONDO:0018354](http://purl.obolibrary.org/obo/MONDO_0018354) (Prader-Willi-like syndrome), [MONDO:0018355](http://purl.obolibrary.org/obo/MONDO_0018355) (Prader-Willi-like syndrome due to point mutation), [MONDO:0009400](http://purl.obolibrary.org/obo/MONDO_0009400) (hyperprolinemia type 1), [MONDO:0009401](http://purl.obolibrary.org/obo/MONDO_0009401) (hyperprolinemia type 2), [MONDO:0019681](http://purl.obolibrary.org/obo/MONDO_0019681) (juvenile sialidosis type 2), [MONDO:0019682](http://purl.obolibrary.org/obo/MONDO_0019682) (congenital sialidosis type 2), [MONDO:0009404](http://purl.obolibrary.org/obo/MONDO_0009404) (hypertelorism, microtia, facial clefting syndrome), [MONDO:0009405](http://purl.obolibrary.org/obo/MONDO_0009405) (cervical hypertrichosis-peripheral neuropathy syndrome), [MONDO:0006389](http://purl.obolibrary.org/obo/MONDO_0006389) (prostate rhabdomyosarcoma), [MONDO:0006388](http://purl.obolibrary.org/obo/MONDO_0006388) (prolactin-producing pituitary gland carcinoma), [MONDO:0011721](http://purl.obolibrary.org/obo/MONDO_0011721) (distal myopathy with anterior tibial onset), [MONDO:0011724](http://purl.obolibrary.org/obo/MONDO_0011724) (encephalopathy due to GLUT1 deficiency), [MONDO:0011722](http://purl.obolibrary.org/obo/MONDO_0011722) (intellectual disability-obesity-prognathism-eye and skin anomalies syndrome), [MONDO:0011790](http://purl.obolibrary.org/obo/MONDO_0011790) (Amish lethal microcephaly), [MONDO:0009470](http://purl.obolibrary.org/obo/MONDO_0009470) (Baraitser-Winter syndrome 1), [MONDO:0011794](http://purl.obolibrary.org/obo/MONDO_0011794) (Dravet syndrome), [MONDO:0010462](http://purl.obolibrary.org/obo/MONDO_0010462) (syndromic X-linked intellectual disability Chudley-Schwartz type), [MONDO:0010463](http://purl.obolibrary.org/obo/MONDO_0010463) (X-linked dominant chondrodysplasia, Chassaing-Lacombe type), [MONDO:0010460](http://purl.obolibrary.org/obo/MONDO_0010460) (syndromic X-linked intellectual disability 17), [MONDO:0010461](http://purl.obolibrary.org/obo/MONDO_0010461) (syndromic X-linked intellectual disability Nascimento type), [MONDO:0009477](http://purl.obolibrary.org/obo/MONDO_0009477) (Stromme syndrome), [MONDO:0017097](http://purl.obolibrary.org/obo/MONDO_0017097) (isolated focal cortical dysplasia type ib), [MONDO:0017096](http://purl.obolibrary.org/obo/MONDO_0017096) (isolated focal cortical dysplasia type Ia), [MONDO:0009479](http://purl.obolibrary.org/obo/MONDO_0009479) (Johanson-Blizzard syndrome), [MONDO:0017099](http://purl.obolibrary.org/obo/MONDO_0017099) (facioscapulohumeral dystrophy), [MONDO:0017098](http://purl.obolibrary.org/obo/MONDO_0017098) (isolated focal cortical dysplasia type Ic), [MONDO:0017093](http://purl.obolibrary.org/obo/MONDO_0017093) (unilateral focal polymicrogyria), [MONDO:0017092](http://purl.obolibrary.org/obo/MONDO_0017092) (unilateral polymicrogyria), [MONDO:0017095](http://purl.obolibrary.org/obo/MONDO_0017095) (isolated focal cortical dysplasia type i), [MONDO:0017094](http://purl.obolibrary.org/obo/MONDO_0017094) (cerebral cortical dysplasia), [MONDO:0010466](http://purl.obolibrary.org/obo/MONDO_0010466) (multiple congenital anomalies-hypotonia-seizures syndrome 2), [MONDO:0014824](http://purl.obolibrary.org/obo/MONDO_0014824) (craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome), [MONDO:0011797](http://purl.obolibrary.org/obo/MONDO_0011797) (infantile-onset ascending hereditary spastic paralysis), [MONDO:0010464](http://purl.obolibrary.org/obo/MONDO_0010464) (X-linked cerebral-cerebellar-coloboma syndrome syndrome), [MONDO:0014827](http://purl.obolibrary.org/obo/MONDO_0014827) (hereditary spastic paraplegia 76), [MONDO:0010465](http://purl.obolibrary.org/obo/MONDO_0010465) (Kabuki syndrome 2), [MONDO:0010468](http://purl.obolibrary.org/obo/MONDO_0010468) (ANIB5), [MONDO:0014823](http://purl.obolibrary.org/obo/MONDO_0014823) (hypotonia, infantile, with psychomotor retardation and characteristic facies 3; IHPRF3), [MONDO:0011799](http://purl.obolibrary.org/obo/MONDO_0011799) (autosomal recessive nonsyndromic deafness 33), [MONDO:0008130](http://purl.obolibrary.org/obo/MONDO_0008130) (ophthalmoplegia-intellectual disability-lingua scrotalis syndrome), [MONDO:0010451](http://purl.obolibrary.org/obo/MONDO_0010451) (mental retardation, X-linked 41), [MONDO:0011783](http://purl.obolibrary.org/obo/MONDO_0011783) (ALG12-CDG), [MONDO:0008131](http://purl.obolibrary.org/obo/MONDO_0008131) (optic atrophy, hearing loss, and peripheral neuropathy, autosomal dominant), [MONDO:0017089](http://purl.obolibrary.org/obo/MONDO_0017089) (isolated megalencephaly), [MONDO:0010452](http://purl.obolibrary.org/obo/MONDO_0010452) (mental retardation, X-linked 90), [MONDO:0002849](http://purl.obolibrary.org/obo/MONDO_0002849) (liver rhabdomyosarcoma), [MONDO:0008132](http://purl.obolibrary.org/obo/MONDO_0008132) (optic atrophy with demyelinating disease of CNS), [MONDO:0011781](http://purl.obolibrary.org/obo/MONDO_0011781) (spinocerebellar ataxia type 17), [MONDO:0008133](http://purl.obolibrary.org/obo/MONDO_0008133) (autosomal dominant optic atrophy and cataract), [MONDO:0010450](http://purl.obolibrary.org/obo/MONDO_0010450) (MRX89), [MONDO:0008134](http://purl.obolibrary.org/obo/MONDO_0008134) (autosomal dominant optic atrophy, classic form), [MONDO:0017086](http://purl.obolibrary.org/obo/MONDO_0017086) (primary tethered cord syndrome), [MONDO:0017085](http://purl.obolibrary.org/obo/MONDO_0017085) (malformation of the neurenteric canal, spinal cord and column), [MONDO:0008136](http://purl.obolibrary.org/obo/MONDO_0008136) (isolated optic nerve hypoplasia), [MONDO:0002848](http://purl.obolibrary.org/obo/MONDO_0002848) (skeletal muscle neoplasm), [MONDO:0009468](http://purl.obolibrary.org/obo/MONDO_0009468) (pseudotumor cerebri), [MONDO:0008137](http://purl.obolibrary.org/obo/MONDO_0008137) (orofaciodigital syndrome X), [MONDO:0017088](http://purl.obolibrary.org/obo/MONDO_0017088) (isolated amyelia), [MONDO:0001516](http://purl.obolibrary.org/obo/MONDO_0001516) (spinal muscular atrophy), [MONDO:0002847](http://purl.obolibrary.org/obo/MONDO_0002847) (skeletal muscle cancer), [MONDO:0017087](http://purl.obolibrary.org/obo/MONDO_0017087) (neurenteric cyst), [MONDO:0008138](http://purl.obolibrary.org/obo/MONDO_0008138) (syndromic orbital border hypoplasia), [MONDO:0017082](http://purl.obolibrary.org/obo/MONDO_0017082) (basal encephalocele), [MONDO:0017081](http://purl.obolibrary.org/obo/MONDO_0017081) (parietal encephalocele), [MONDO:0017084](http://purl.obolibrary.org/obo/MONDO_0017084) (Leptomyelolipoma), [MONDO:0017083](http://purl.obolibrary.org/obo/MONDO_0017083) (lipoma associated with neurospinal dysraphism), [MONDO:0017091](http://purl.obolibrary.org/obo/MONDO_0017091) (bilateral polymicrogyria), [MONDO:0017090](http://purl.obolibrary.org/obo/MONDO_0017090) (midline cerebral malformation), [MONDO:0011787](http://purl.obolibrary.org/obo/MONDO_0011787) (autosomal recessive limb-girdle muscular dystrophy type 2I), [MONDO:0014813](http://purl.obolibrary.org/obo/MONDO_0014813) (hypomyelinating leukodystrophy 13), [MONDO:0014814](http://purl.obolibrary.org/obo/MONDO_0014814) (advanced sleep phase syndrome 3), [MONDO:0011786](http://purl.obolibrary.org/obo/MONDO_0011786) (allergic rhinitis), [MONDO:0010453](http://purl.obolibrary.org/obo/MONDO_0010453) (MRX92), [MONDO:0014815](http://purl.obolibrary.org/obo/MONDO_0014815) (mental retardation, autosomal recessive 52), [MONDO:0011785](http://purl.obolibrary.org/obo/MONDO_0011785) (hereditary spastic paraplegia 19), [MONDO:0010454](http://purl.obolibrary.org/obo/MONDO_0010454) (MRX88), [MONDO:0011784](http://purl.obolibrary.org/obo/MONDO_0011784) (Moyamoya disease 2), [MONDO:0010459](http://purl.obolibrary.org/obo/MONDO_0010459) (amyotrophic lateral sclerosis type 15), [MONDO:0011789](http://purl.obolibrary.org/obo/MONDO_0011789) (familial meningioma), [MONDO:0011772](http://purl.obolibrary.org/obo/MONDO_0011772) (B4GALT1-CDG), [MONDO:0008120](http://purl.obolibrary.org/obo/MONDO_0008120) (spinocerebellar ataxia type 7), [MONDO:0017079](http://purl.obolibrary.org/obo/MONDO_0017079) (cranial meningocele), [MONDO:0009452](http://purl.obolibrary.org/obo/MONDO_0009452) (Vici syndrome), [MONDO:0010441](http://purl.obolibrary.org/obo/MONDO_0010441) (CK syndrome), [MONDO:0011771](http://purl.obolibrary.org/obo/MONDO_0011771) (distal spinal muscular atrophy type 3), [MONDO:0017078](http://purl.obolibrary.org/obo/MONDO_0017078) (Cephalocele (disease)), [MONDO:0017075](http://purl.obolibrary.org/obo/MONDO_0017075) (upper thoracic spina bifida cystica), [MONDO:0017074](http://purl.obolibrary.org/obo/MONDO_0017074) (Cervicothoracic spina bifida cystica), [MONDO:0017077](http://purl.obolibrary.org/obo/MONDO_0017077) (Myelocystocele), [MONDO:0008127](http://purl.obolibrary.org/obo/MONDO_0008127) (Ophthalmomandibulomelic dysplasia), [MONDO:0017076](http://purl.obolibrary.org/obo/MONDO_0017076) (posterior meningocele), [MONDO:0017071](http://purl.obolibrary.org/obo/MONDO_0017071) (Thoracolumbosacral spina bifida cystica), [MONDO:0009459](http://purl.obolibrary.org/obo/MONDO_0009459) (channelopathy-associated congenital insensitivity to pain), [MONDO:0017070](http://purl.obolibrary.org/obo/MONDO_0017070) (total spina bifida cystica), [MONDO:0017073](http://purl.obolibrary.org/obo/MONDO_0017073) (cervical spina bifida cystica), [MONDO:0017072](http://purl.obolibrary.org/obo/MONDO_0017072) (lumbosacral spina bifida cystica), [MONDO:0017080](http://purl.obolibrary.org/obo/MONDO_0017080) (occipital encephalocele), [MONDO:0014806](http://purl.obolibrary.org/obo/MONDO_0014806) (spinal muscular atrophy with congenital bone fractures 1), [MONDO:0014807](http://purl.obolibrary.org/obo/MONDO_0014807) (spinal muscular atrophy with congenital bone fractures 2), [MONDO:0011776](http://purl.obolibrary.org/obo/MONDO_0011776) (CINCA syndrome), [MONDO:0014803](http://purl.obolibrary.org/obo/MONDO_0014803) (spasticity-ataxia-gait anomalies syndrome), [MONDO:0011774](http://purl.obolibrary.org/obo/MONDO_0011774) (autosomal recessive nonsyndromic deafness 30), [MONDO:0005085](http://purl.obolibrary.org/obo/MONDO_0005085) (pterygium), [MONDO:0010443](http://purl.obolibrary.org/obo/MONDO_0010443) (macular degeneration, X-linked atrophic), [MONDO:0010448](http://purl.obolibrary.org/obo/MONDO_0010448) (Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome), [MONDO:0010446](http://purl.obolibrary.org/obo/MONDO_0010446) (X-linked cone dysfunction syndrome with myopia), [MONDO:0014800](http://purl.obolibrary.org/obo/MONDO_0014800) (progressive scapulohumeroperoneal distal myopathy), [MONDO:0010447](http://purl.obolibrary.org/obo/MONDO_0010447) (mental retardation, X-linked 19), [MONDO:0011777](http://purl.obolibrary.org/obo/MONDO_0011777) (Alzheimer's disease 8), [MONDO:0011761](http://purl.obolibrary.org/obo/MONDO_0011761) (autosomal dominant nonsyndromic deafness 21), [MONDO:0017068](http://purl.obolibrary.org/obo/MONDO_0017068) (upper thoracic spina bifida aperta), [MONDO:0009440](http://purl.obolibrary.org/obo/MONDO_0009440) (ichthyosiform erythroderma, corneal involvement, and deafness), [MONDO:0011760](http://purl.obolibrary.org/obo/MONDO_0011760) (Scheie syndrome), [MONDO:0017067](http://purl.obolibrary.org/obo/MONDO_0017067) (Cervicothoracic spina bifida aperta), [MONDO:0010430](http://purl.obolibrary.org/obo/MONDO_0010430) (mental retardation, X-linked 97), [MONDO:0008111](http://purl.obolibrary.org/obo/MONDO_0008111) (oculodentodigital dysplasia), [MONDO:0008112](http://purl.obolibrary.org/obo/MONDO_0008112) (Goldenhar syndrome), [MONDO:0017069](http://purl.obolibrary.org/obo/MONDO_0017069) (spina bifida cystica), [MONDO:0009444](http://purl.obolibrary.org/obo/MONDO_0009444) (ichthyosis-alopecia-eclabion-ectropion-intellectual disability syndrome), [MONDO:0017064](http://purl.obolibrary.org/obo/MONDO_0017064) (Thoracolumbosacral spina bifida aperta), [MONDO:0009445](http://purl.obolibrary.org/obo/MONDO_0009445) (ichthyosis-hepatosplenomegaly-cerebellar degeneration syndrome), [MONDO:0017063](http://purl.obolibrary.org/obo/MONDO_0017063) (total spina bifida aperta), [MONDO:0017066](http://purl.obolibrary.org/obo/MONDO_0017066) (cervical spina bifida aperta), [MONDO:0017065](http://purl.obolibrary.org/obo/MONDO_0017065) (lumbosacral spina bifida aperta), [MONDO:0008116](http://purl.obolibrary.org/obo/MONDO_0008116) (oculopharyngeal muscular dystrophy), [MONDO:0008117](http://purl.obolibrary.org/obo/MONDO_0008117) (Oculopharyngodistal myopathy), [MONDO:0017060](http://purl.obolibrary.org/obo/MONDO_0017060) (open iniencephaly), [MONDO:0017062](http://purl.obolibrary.org/obo/MONDO_0017062) (spina bifida aperta), [MONDO:0008119](http://purl.obolibrary.org/obo/MONDO_0008119) (spinocerebellar ataxia type 1), [MONDO:0017061](http://purl.obolibrary.org/obo/MONDO_0017061) (Closed iniencephaly), [MONDO:0011764](http://purl.obolibrary.org/obo/MONDO_0011764) (autosomal dominant Parkinson disease 8), [MONDO:0010431](http://purl.obolibrary.org/obo/MONDO_0010431) (Joubert syndrome 10), [MONDO:0011762](http://purl.obolibrary.org/obo/MONDO_0011762) (autosomal recessive nonsyndromic deafness 22), [MONDO:0010437](http://purl.obolibrary.org/obo/MONDO_0010437) (severe X-linked mitochondrial encephalomyopathy), [MONDO:0011768](http://purl.obolibrary.org/obo/MONDO_0011768) (myasthenia gravis with thymus hyperplasia), [MONDO:0011767](http://purl.obolibrary.org/obo/MONDO_0011767) (autosomal recessive nonsyndromic deafness 31), [MONDO:0010435](http://purl.obolibrary.org/obo/MONDO_0010435) (nystagmus 6, congenital, X-linked), [MONDO:0010436](http://purl.obolibrary.org/obo/MONDO_0010436) (chromosome Xq28 duplication syndrome), [MONDO:0008182](http://purl.obolibrary.org/obo/MONDO_0008182) (Nasopalpebral lipoma-coloboma syndrome), [MONDO:0013531](http://purl.obolibrary.org/obo/MONDO_0013531) (PSPH deficiency), [MONDO:0014862](http://purl.obolibrary.org/obo/MONDO_0014862) (cerebral palsy, spastic quadriplegic, 3; CPSQ3), [MONDO:0012200](http://purl.obolibrary.org/obo/MONDO_0012200) (posterior polymorphous corneal dystrophy 3), [MONDO:0000215](http://purl.obolibrary.org/obo/MONDO_0000215) (epilepsy, familial focal, with variable foci), [MONDO:0000211](http://purl.obolibrary.org/obo/MONDO_0000211) (striatal degeneration, autosomal dominant), [MONDO:0021155](http://purl.obolibrary.org/obo/MONDO_0021155) (X-linked cone-rod dystrophy), [MONDO:0014868](http://purl.obolibrary.org/obo/MONDO_0014868) (epileptic encephalopathy, early infantile, 38; EIEE38), [MONDO:0013537](http://purl.obolibrary.org/obo/MONDO_0013537) (autosomal recessive nonsyndromic deafness 29), [MONDO:0012205](http://purl.obolibrary.org/obo/MONDO_0012205) (autosomal dominant striatal neurodegeneration type 1), [MONDO:0012209](http://purl.obolibrary.org/obo/MONDO_0012209) (Branchiogenic deafness syndrome), [MONDO:0014866](http://purl.obolibrary.org/obo/MONDO_0014866) (Charcot-Marie-tooth disease axonal type 2T), [MONDO:0008192](http://purl.obolibrary.org/obo/MONDO_0008192) (paragangliomas 1), [MONDO:0014867](http://purl.obolibrary.org/obo/MONDO_0014867) (spinocerebellar ataxia 43; SCA43), [MONDO:0010492](http://purl.obolibrary.org/obo/MONDO_0010492) (pituitary adenoma, growth hormone-secreting, 2), [MONDO:0013520](http://purl.obolibrary.org/obo/MONDO_0013520) (dyskeratosis congenita, autosomal recessive 3), [MONDO:0010490](http://purl.obolibrary.org/obo/MONDO_0010490) (SSR4-CDG), [MONDO:0013521](http://purl.obolibrary.org/obo/MONDO_0013521) (dyskeratosis congenita, autosomal dominant 2), [MONDO:0010496](http://purl.obolibrary.org/obo/MONDO_0010496) (X-linked intellectual disability-short stature-overweight syndrome), [MONDO:0008178](http://purl.obolibrary.org/obo/MONDO_0008178) (inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1), [MONDO:0010494](http://purl.obolibrary.org/obo/MONDO_0010494) (linear skin defects with multiple congenital anomalies 3), [MONDO:0008179](http://purl.obolibrary.org/obo/MONDO_0008179) (paroxysmal extreme pain disorder), [MONDO:0021142](http://purl.obolibrary.org/obo/MONDO_0021142) (acquired rippling muscle disease), [MONDO:0013526](http://purl.obolibrary.org/obo/MONDO_0013526) (progressive myoclonic epilepsy type 6), [MONDO:0010499](http://purl.obolibrary.org/obo/MONDO_0010499) (Ritscher-Schinzel syndrome 2), [MONDO:0014858](http://purl.obolibrary.org/obo/MONDO_0014858) (mental retardation, autosomal dominant 43; MRD43), [MONDO:0013527](http://purl.obolibrary.org/obo/MONDO_0013527) (lissencephaly 4), [MONDO:0013528](http://purl.obolibrary.org/obo/MONDO_0013528) (mental retardation, autosomal recessive 14), [MONDO:0010497](http://purl.obolibrary.org/obo/MONDO_0010497) (mental retardation, X-linked 102), [MONDO:0014859](http://purl.obolibrary.org/obo/MONDO_0014859) (epileptic encephalopathy, early infantile, 37; EIEE37), [MONDO:0010498](http://purl.obolibrary.org/obo/MONDO_0010498) (MEND syndrome), [MONDO:0014853](http://purl.obolibrary.org/obo/MONDO_0014853) (autosomal dominant nonsyndromic deafness 70), [MONDO:0013522](http://purl.obolibrary.org/obo/MONDO_0013522) (dyskeratosis congenita, autosomal dominant 3), [MONDO:0014854](http://purl.obolibrary.org/obo/MONDO_0014854) (autosomal dominant nonsyndromic deafness 66), [MONDO:0014855](http://purl.obolibrary.org/obo/MONDO_0014855) (mental retardation, autosomal dominant 42; MRD42), [MONDO:0014856](http://purl.obolibrary.org/obo/MONDO_0014856) (combined oxidative phosphorylation defect type 30), [MONDO:0009493](http://purl.obolibrary.org/obo/MONDO_0009493) (Richards-Rundle syndrome), [MONDO:0009495](http://purl.obolibrary.org/obo/MONDO_0009495) (Keutel syndrome), [MONDO:0010484](http://purl.obolibrary.org/obo/MONDO_0010484) (deafness, X-linked 6), [MONDO:0010485](http://purl.obolibrary.org/obo/MONDO_0010485) (X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome), [MONDO:0010482](http://purl.obolibrary.org/obo/MONDO_0010482) (X-linked parkinsonism-spasticity syndrome), [MONDO:0010483](http://purl.obolibrary.org/obo/MONDO_0010483) (X-linked intellectual disability, Cantagrel type), [MONDO:0009499](http://purl.obolibrary.org/obo/MONDO_0009499) (Krabbe disease), [MONDO:0002856](http://purl.obolibrary.org/obo/MONDO_0002856) (gallbladder rhabdomyosarcoma), [MONDO:0002859](http://purl.obolibrary.org/obo/MONDO_0002859) (breast rhabdomyosarcoma), [MONDO:0002858](http://purl.obolibrary.org/obo/MONDO_0002858) (ovary rhabdomyosarcoma), [MONDO:0002853](http://purl.obolibrary.org/obo/MONDO_0002853) (rectum rhabdomyosarcoma), [MONDO:0002851](http://purl.obolibrary.org/obo/MONDO_0002851) (mediastinum rhabdomyosarcoma), [MONDO:0002850](http://purl.obolibrary.org/obo/MONDO_0002850) (central nervous system rhabdomyosarcoma), [MONDO:0021131](http://purl.obolibrary.org/obo/MONDO_0021131) (frontal lobe ependymal tumor), [MONDO:0013519](http://purl.obolibrary.org/obo/MONDO_0013519) (dyskeratosis congenita, autosomal recessive 2), [MONDO:0014846](http://purl.obolibrary.org/obo/MONDO_0014846) (autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency), [MONDO:0010488](http://purl.obolibrary.org/obo/MONDO_0010488) (mental retardation, X-linked 100), [MONDO:0013516](http://purl.obolibrary.org/obo/MONDO_0013516) (retinitis pigmentosa 60), [MONDO:0010489](http://purl.obolibrary.org/obo/MONDO_0010489) (mental retardation, X-linked 101), [MONDO:0013517](http://purl.obolibrary.org/obo/MONDO_0013517) (beta-thalassemia HBB/LCRB), [MONDO:0014849](http://purl.obolibrary.org/obo/MONDO_0014849) (autosomal recessive nonsyndromic deafness 105), [MONDO:0013518](http://purl.obolibrary.org/obo/MONDO_0013518) (pituitary hormone deficiency, combined, 6), [MONDO:0010487](http://purl.obolibrary.org/obo/MONDO_0010487) (mental retardation, X-linked 99), [MONDO:0014842](http://purl.obolibrary.org/obo/MONDO_0014842) (mental retardation, autosomal dominant 41; MRD41), [MONDO:0013512](http://purl.obolibrary.org/obo/MONDO_0013512) (hemoglobin H disease), [MONDO:0014845](http://purl.obolibrary.org/obo/MONDO_0014845) (spinocerebellar ataxia, autosomal recessive 22; SCAR22), [MONDO:0009480](http://purl.obolibrary.org/obo/MONDO_0009480) (Joubert syndrome with oculorenal defect), [MONDO:0009483](http://purl.obolibrary.org/obo/MONDO_0009483) (Kapur-Toriello syndrome), [MONDO:0010473](http://purl.obolibrary.org/obo/MONDO_0010473) (X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome), [MONDO:0000209](http://purl.obolibrary.org/obo/MONDO_0000209) (spinal muscular atrophy with congenital bone fractures), [MONDO:0009485](http://purl.obolibrary.org/obo/MONDO_0009485) (oculocerebrofacial syndrome, Kaufman type), [MONDO:0010474](http://purl.obolibrary.org/obo/MONDO_0010474) (linear skin defects with multiple congenital anomalies 2), [MONDO:0010471](http://purl.obolibrary.org/obo/MONDO_0010471) (Cornelia de Lange syndrome 5), [MONDO:0010472](http://purl.obolibrary.org/obo/MONDO_0010472) (ALG13-CDG), [MONDO:0008156](http://purl.obolibrary.org/obo/MONDO_0008156) (autosomal dominant osteopetrosis 2), [MONDO:0000208](http://purl.obolibrary.org/obo/MONDO_0000208) (microcephaly, short stature, and impaired glucose metabolism), [MONDO:0002864](http://purl.obolibrary.org/obo/MONDO_0002864) (anus rhabdomyosarcoma), [MONDO:0002863](http://purl.obolibrary.org/obo/MONDO_0002863) (mixed type rhabdomyosarcoma), [MONDO:0002860](http://purl.obolibrary.org/obo/MONDO_0002860) (testis rhabdomyosarcoma), [MONDO:0000200](http://purl.obolibrary.org/obo/MONDO_0000200) (Zimmermann-Laband syndrome), [MONDO:0013509](http://purl.obolibrary.org/obo/MONDO_0013509) (mental retardation, autosomal dominant 6), [MONDO:0010477](http://purl.obolibrary.org/obo/MONDO_0010477) (blepharophimosis-intellectual disability syndrome, MKB type), [MONDO:0014835](http://purl.obolibrary.org/obo/MONDO_0014835) (striatal degeneration, autosomal dominant 2; ADSD2), [MONDO:0010478](http://purl.obolibrary.org/obo/MONDO_0010478) (SLC35A2-CDG), [MONDO:0014836](http://purl.obolibrary.org/obo/MONDO_0014836) (Charcot-Marie-tooth disease axonal type 2CC), [MONDO:0014838](http://purl.obolibrary.org/obo/MONDO_0014838) (Coffin-Siris syndrome 5; CSS5), [MONDO:0013507](http://purl.obolibrary.org/obo/MONDO_0013507) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3), [MONDO:0010476](http://purl.obolibrary.org/obo/MONDO_0010476) (neurodegeneration with brain iron accumulation 5), [MONDO:0013501](http://purl.obolibrary.org/obo/MONDO_0013501) (amyotrophic lateral sclerosis type 14), [MONDO:0014832](http://purl.obolibrary.org/obo/MONDO_0014832) (mental retardation, autosomal recessive 53; MRT53), [MONDO:0010479](http://purl.obolibrary.org/obo/MONDO_0010479) (Charcot-Marie-tooth disease X-linked dominant 6), [MONDO:0012241](http://purl.obolibrary.org/obo/MONDO_0012241) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 3), [MONDO:0017931](http://purl.obolibrary.org/obo/MONDO_0017931) (hereditary inclusion body myopathy type 4), [MONDO:0012240](http://purl.obolibrary.org/obo/MONDO_0012240) (nemaline myopathy 4), [MONDO:0012245](http://purl.obolibrary.org/obo/MONDO_0012245) (epileptic encephalopathy, early infantile, 3), [MONDO:0001588](http://purl.obolibrary.org/obo/MONDO_0001588) (chronic lacrimal gland enlargement), [MONDO:0005942](http://purl.obolibrary.org/obo/MONDO_0005942) (Reye syndrome), [MONDO:0001586](http://purl.obolibrary.org/obo/MONDO_0001586) (mucopolysaccharidosis type 1), [MONDO:0017939](http://purl.obolibrary.org/obo/MONDO_0017939) (classic multiminicore myopathy), [MONDO:0012248](http://purl.obolibrary.org/obo/MONDO_0012248) (autosomal recessive limb-girdle muscular dystrophy type 2K), [MONDO:0017937](http://purl.obolibrary.org/obo/MONDO_0017937) (autosomal dominant intermediate Charcot-Marie-tooth disease with neuropathic pain), [MONDO:0016609](http://purl.obolibrary.org/obo/MONDO_0016609) (inflammatory myopathy with abundant macrophages), [MONDO:0012247](http://purl.obolibrary.org/obo/MONDO_0012247) (spinocerebellar ataxia type 27), [MONDO:0012246](http://purl.obolibrary.org/obo/MONDO_0012246) (spinocerebellar ataxia type 26), [MONDO:0016608](http://purl.obolibrary.org/obo/MONDO_0016608) (megalencephaly (disease)), [MONDO:0017936](http://purl.obolibrary.org/obo/MONDO_0017936) (benign Samaritan congenital myopathy), [MONDO:0013578](http://purl.obolibrary.org/obo/MONDO_0013578) (DYRK1A-related intellectual disability syndrome), [MONDO:0021191](http://purl.obolibrary.org/obo/MONDO_0021191) (malignant ependymoma), [MONDO:0017934](http://purl.obolibrary.org/obo/MONDO_0017934) (Aphonia-deafness-retinal dystrophy-bifid halluces-intellectual disability syndrome), [MONDO:0017920](http://purl.obolibrary.org/obo/MONDO_0017920) (deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome), [MONDO:0013563](http://purl.obolibrary.org/obo/MONDO_0013563) (multiple congenital anomalies-hypotonia-seizures syndrome 1), [MONDO:0017921](http://purl.obolibrary.org/obo/MONDO_0017921) (hearing loss-familial salivary gland insensitivity to aldosterone syndrome), [MONDO:0014894](http://purl.obolibrary.org/obo/MONDO_0014894) (Meier-Gorlin syndrome 7; MGORS7), [MONDO:0014895](http://purl.obolibrary.org/obo/MONDO_0014895) (epileptic encephalopathy, early infantile, 40; EIEE40), [MONDO:0014896](http://purl.obolibrary.org/obo/MONDO_0014896) (muscular dystrophy, congenital, Davignon-Chauveau type; MDCDC), [MONDO:0012234](http://purl.obolibrary.org/obo/MONDO_0012234) (LFS3), [MONDO:0012233](http://purl.obolibrary.org/obo/MONDO_0012233) (Li-Fraumeni syndrome 2), [MONDO:0014890](http://purl.obolibrary.org/obo/MONDO_0014890) (cold-induced sweating syndrome 3; CISS3), [MONDO:0013560](http://purl.obolibrary.org/obo/MONDO_0013560) (Hermansky-Pudlak syndrome 8), [MONDO:0012231](http://purl.obolibrary.org/obo/MONDO_0012231) (Charcot-Marie-tooth disease type 2A2), [MONDO:0014892](http://purl.obolibrary.org/obo/MONDO_0014892) (micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome), [MONDO:0000262](http://purl.obolibrary.org/obo/MONDO_0000262) (otomycosis), [MONDO:0017928](http://purl.obolibrary.org/obo/MONDO_0017928) (9p13 microdeletion syndrome), [MONDO:0012238](http://purl.obolibrary.org/obo/MONDO_0012238) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 2), [MONDO:0012237](http://purl.obolibrary.org/obo/MONDO_0012237) (nemaline myopathy 6), [MONDO:0017929](http://purl.obolibrary.org/obo/MONDO_0017929) (congenital achiasma), [MONDO:0017926](http://purl.obolibrary.org/obo/MONDO_0017926) (multiple paragangliomas associated with polycythemia), [MONDO:0012236](http://purl.obolibrary.org/obo/MONDO_0012236) (KTCN4), [MONDO:0012235](http://purl.obolibrary.org/obo/MONDO_0012235) (autosomal recessive spinocerebellar ataxia 7), [MONDO:0017924](http://purl.obolibrary.org/obo/MONDO_0017924) (central nervous system calcification-deafness-tubular acidosis-anemia syndrome), [MONDO:0014898](http://purl.obolibrary.org/obo/MONDO_0014898) (progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3; PEOB3), [MONDO:0017922](http://purl.obolibrary.org/obo/MONDO_0017922) (deafness-onychodystrophy syndrome), [MONDO:0014899](http://purl.obolibrary.org/obo/MONDO_0014899) (adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency), [MONDO:0012239](http://purl.obolibrary.org/obo/MONDO_0012239) (nemaline myopathy 1), [MONDO:0017923](http://purl.obolibrary.org/obo/MONDO_0017923) (multiple synostoses syndrome), [MONDO:0014882](http://purl.obolibrary.org/obo/MONDO_0014882) (hereditary spastic paraplegia 77), [MONDO:0013551](http://purl.obolibrary.org/obo/MONDO_0013551) (hereditary spastic paraplegia 47), [MONDO:0013552](http://purl.obolibrary.org/obo/MONDO_0013552) (hereditary spastic paraplegia 52), [MONDO:0014885](http://purl.obolibrary.org/obo/MONDO_0014885) (Hermansky-Pudlak syndrome 10; HPS10), [MONDO:0012222](http://purl.obolibrary.org/obo/MONDO_0012222) (alpha-N-acetylgalactosaminidase deficiency type 2), [MONDO:0012221](http://purl.obolibrary.org/obo/MONDO_0012221) (alpha-N-acetylgalactosaminidase deficiency type 1), [MONDO:0014880](http://purl.obolibrary.org/obo/MONDO_0014880) (Duane retraction syndrome 3 with or without deafness; DURS3), [MONDO:0013550](http://purl.obolibrary.org/obo/MONDO_0013550) (distal myopathy with posterior leg and anterior hand involvement), [MONDO:0012220](http://purl.obolibrary.org/obo/MONDO_0012220) (Griscelli syndrome type 3), [MONDO:0001569](http://purl.obolibrary.org/obo/MONDO_0001569) (acoustic neuroma), [MONDO:0002899](http://purl.obolibrary.org/obo/MONDO_0002899) (differentiating neuroblastoma), [MONDO:0002892](http://purl.obolibrary.org/obo/MONDO_0002892) (skull base chordoma), [MONDO:0002894](http://purl.obolibrary.org/obo/MONDO_0002894) (spinal chordoma), [MONDO:0017917](http://purl.obolibrary.org/obo/MONDO_0017917) (maternally-inherited spastic paraplegia), [MONDO:0013559](http://purl.obolibrary.org/obo/MONDO_0013559) (Hermansky-Pudlak syndrome 7), [MONDO:0017918](http://purl.obolibrary.org/obo/MONDO_0017918) (white matter hypoplasia-corpus callosum agenesis-intellectual disability syndrome), [MONDO:0012225](http://purl.obolibrary.org/obo/MONDO_0012225) (Senior-Loken syndrome 5), [MONDO:0017915](http://purl.obolibrary.org/obo/MONDO_0017915) (pure or complex autosomal recessive spastic paraplegia), [MONDO:0017916](http://purl.obolibrary.org/obo/MONDO_0017916) (pure or complex X-linked spastic paraplegia), [MONDO:0014886](http://purl.obolibrary.org/obo/MONDO_0014886) (mental retardation, autosomal recessive 55; MRT55), [MONDO:0013555](http://purl.obolibrary.org/obo/MONDO_0013555) (Hermansky-Pudlak syndrome 3), [MONDO:0017913](http://purl.obolibrary.org/obo/MONDO_0017913) (pure or complex hereditary spastic paraplegia), [MONDO:0013556](http://purl.obolibrary.org/obo/MONDO_0013556) (Hermansky-Pudlak syndrome 4), [MONDO:0017914](http://purl.obolibrary.org/obo/MONDO_0017914) (pure or complex autosomal dominant spastic paraplegia), [MONDO:0013557](http://purl.obolibrary.org/obo/MONDO_0013557) (Hermansky-Pudlak syndrome 5), [MONDO:0014889](http://purl.obolibrary.org/obo/MONDO_0014889) (striatonigral degeneration, childhood-onset; SNDC), [MONDO:0017912](http://purl.obolibrary.org/obo/MONDO_0017912) (X-linked pure spastic paraplegia), [MONDO:0013558](http://purl.obolibrary.org/obo/MONDO_0013558) (Hermansky-Pudlak syndrome 6), [MONDO:0013540](http://purl.obolibrary.org/obo/MONDO_0013540) (deafness-lymphedema-leukemia syndrome), [MONDO:0014871](http://purl.obolibrary.org/obo/MONDO_0014871) (retinitis pigmentosa 75), [MONDO:0008193](http://purl.obolibrary.org/obo/MONDO_0008193) (paralysis agitans, juvenile, of Hunt), [MONDO:0014872](http://purl.obolibrary.org/obo/MONDO_0014872) (congenital stationary night blindness 1H), [MONDO:0013541](http://purl.obolibrary.org/obo/MONDO_0013541) (complex cortical dysplasia with other brain malformations 1), [MONDO:0008195](http://purl.obolibrary.org/obo/MONDO_0008195) (Paramyotonia congenita of von Eulenburg), [MONDO:0013542](http://purl.obolibrary.org/obo/MONDO_0013542) (Moyamoya disease 5), [MONDO:0014874](http://purl.obolibrary.org/obo/MONDO_0014874) (pontocerebellar hypoplasia, type 2F; PCH2F), [MONDO:0008197](http://purl.obolibrary.org/obo/MONDO_0008197) (parietal foramina 1), [MONDO:0012211](http://purl.obolibrary.org/obo/MONDO_0012211) (MPDU1-CDG), [MONDO:0008199](http://purl.obolibrary.org/obo/MONDO_0008199) (Parkinson disease, late-onset), [MONDO:0012210](http://purl.obolibrary.org/obo/MONDO_0012210) (migraine with aura, susceptibility to, 7), [MONDO:0012216](http://purl.obolibrary.org/obo/MONDO_0012216) (foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome), [MONDO:0012215](http://purl.obolibrary.org/obo/MONDO_0012215) (myofibrillar myopathy 3), [MONDO:0012213](http://purl.obolibrary.org/obo/MONDO_0012213) (hereditary spastic paraplegia 26), [MONDO:0014876](http://purl.obolibrary.org/obo/MONDO_0014876) (mental retardation, autosomal recessive 54; MRT54), [MONDO:0014877](http://purl.obolibrary.org/obo/MONDO_0014877) (myopathy, distal, 5; MPD5), [MONDO:0015312](http://purl.obolibrary.org/obo/MONDO_0015312) (choanal atresia, unilateral), [MONDO:0015311](http://purl.obolibrary.org/obo/MONDO_0015311) (autism-facial port-wine stain syndrome), [MONDO:0016642](http://purl.obolibrary.org/obo/MONDO_0016642) (meningioma (disease)), [MONDO:0016644](http://purl.obolibrary.org/obo/MONDO_0016644) (Logopenic progressive aphasia), [MONDO:0015313](http://purl.obolibrary.org/obo/MONDO_0015313) (choanal atresia, bilateral), [MONDO:0012289](http://purl.obolibrary.org/obo/MONDO_0012289) (myofibrillar myopathy 5), [MONDO:0012287](http://purl.obolibrary.org/obo/MONDO_0012287) (Stickler syndrome, type i, nonsyndromic ocular), [MONDO:0015310](http://purl.obolibrary.org/obo/MONDO_0015310) (syndromic optic nerve hypoplasia), [MONDO:0012286](http://purl.obolibrary.org/obo/MONDO_0012286) (myopathy, Autophagic vacuolar, infantile-onset), [MONDO:0003327](http://purl.obolibrary.org/obo/MONDO_0003327) (peripheral ganglioneuroblastoma), [MONDO:0012281](http://purl.obolibrary.org/obo/MONDO_0012281) (sarcoidosis, early-onset), [MONDO:0012280](http://purl.obolibrary.org/obo/MONDO_0012280) (Goldberg-Shprintzen megacolon syndrome), [MONDO:0003325](http://purl.obolibrary.org/obo/MONDO_0003325) (nodular ganglioneuroblastoma), [MONDO:0004657](http://purl.obolibrary.org/obo/MONDO_0004657) (disseminated chorioretinitis), [MONDO:0003326](http://purl.obolibrary.org/obo/MONDO_0003326) (intermixed schwannian stroma-rich ganglioneuroblastoma), [MONDO:0004650](http://purl.obolibrary.org/obo/MONDO_0004650) (malignant carotid body paraganglioma), [MONDO:0005981](http://purl.obolibrary.org/obo/MONDO_0005981) (tick paralysis), [MONDO:0000290](http://purl.obolibrary.org/obo/MONDO_0000290) (primary amebic meningoencephalitis), [MONDO:0000291](http://purl.obolibrary.org/obo/MONDO_0000291) (granulomatous amebic encephalitis), [MONDO:0016647](http://purl.obolibrary.org/obo/MONDO_0016647) (autosomal recessive Stickler syndrome), [MONDO:0015316](http://purl.obolibrary.org/obo/MONDO_0015316) (congenital laryngeal palsy), [MONDO:0015315](http://purl.obolibrary.org/obo/MONDO_0015315) (neonatal brainstem dysfunction), [MONDO:0016646](http://purl.obolibrary.org/obo/MONDO_0016646) (autosomal dominant optic atrophy and peripheral neuropathy), [MONDO:0016649](http://purl.obolibrary.org/obo/MONDO_0016649) (Warburg micro syndrome), [MONDO:0012273](http://purl.obolibrary.org/obo/MONDO_0012273) (autosomal recessive nonsyndromic deafness 48), [MONDO:0015300](http://purl.obolibrary.org/obo/MONDO_0015300) (cataract-microcornea syndrome), [MONDO:0012278](http://purl.obolibrary.org/obo/MONDO_0012278) (PSNP2), [MONDO:0012277](http://purl.obolibrary.org/obo/MONDO_0012277) (myofibrillar myopathy 4), [MONDO:0012276](http://purl.obolibrary.org/obo/MONDO_0012276) (generalized epilepsy-paroxysmal dyskinesia syndrome), [MONDO:0012270](http://purl.obolibrary.org/obo/MONDO_0012270) (Tukel syndrome), [MONDO:0003338](http://purl.obolibrary.org/obo/MONDO_0003338) (von Economo's disease), [MONDO:0003336](http://purl.obolibrary.org/obo/MONDO_0003336) (acute necrotizing encephalitis), [MONDO:0003337](http://purl.obolibrary.org/obo/MONDO_0003337) (acute hemorrhagic encephalitis), [MONDO:0002000](http://purl.obolibrary.org/obo/MONDO_0002000) (anaerobic meningitis), [MONDO:0012279](http://purl.obolibrary.org/obo/MONDO_0012279) (congenital muscular dystrophy merosin-positive), [MONDO:0015304](http://purl.obolibrary.org/obo/MONDO_0015304) (arachnoiditis), [MONDO:0015307](http://purl.obolibrary.org/obo/MONDO_0015307) (Madras motor neuron disease), [MONDO:0016621](http://purl.obolibrary.org/obo/MONDO_0016621) (juvenile Huntington disease), [MONDO:0012262](http://purl.obolibrary.org/obo/MONDO_0012262) (CFEOM3C), [MONDO:0012260](http://purl.obolibrary.org/obo/MONDO_0012260) (cataract 35), [MONDO:0012267](http://purl.obolibrary.org/obo/MONDO_0012267) (holoprosencephaly 8), [MONDO:0017950](http://purl.obolibrary.org/obo/MONDO_0017950) (microcephalic primordial dwarfism), [MONDO:0013593](http://purl.obolibrary.org/obo/MONDO_0013593) (autosomal dominant nonsyndromic deafness 64), [MONDO:0013594](http://purl.obolibrary.org/obo/MONDO_0013594) (spinocerebellar ataxia type 36), [MONDO:0005969](http://purl.obolibrary.org/obo/MONDO_0005969) (st. Louis encephalitis), [MONDO:0013590](http://purl.obolibrary.org/obo/MONDO_0013590) (Stickler syndrome, type 4), [MONDO:0003305](http://purl.obolibrary.org/obo/MONDO_0003305) (cellular neurofibroma), [MONDO:0003306](http://purl.obolibrary.org/obo/MONDO_0003306) (atypical neurofibroma), [MONDO:0003303](http://purl.obolibrary.org/obo/MONDO_0003303) (neurofibroma of gallbladder), [MONDO:0003304](http://purl.obolibrary.org/obo/MONDO_0003304) (plexiform neurofibroma (disease)), [MONDO:0003302](http://purl.obolibrary.org/obo/MONDO_0003302) (epithelioid neurofibroma), [MONDO:0000276](http://purl.obolibrary.org/obo/MONDO_0000276) (Powassan encephalitis), [MONDO:0000273](http://purl.obolibrary.org/obo/MONDO_0000273) (Kunjin encephalitis), [MONDO:0017942](http://purl.obolibrary.org/obo/MONDO_0017942) (Hendra virus infection), [MONDO:0013584](http://purl.obolibrary.org/obo/MONDO_0013584) (hereditary sensory neuropathy-deafness-dementia syndrome), [MONDO:0016610](http://purl.obolibrary.org/obo/MONDO_0016610) (idiopathic eosinophilic myositis), [MONDO:0012251](http://purl.obolibrary.org/obo/MONDO_0012251) (MEDNIK syndrome), [MONDO:0013585](http://purl.obolibrary.org/obo/MONDO_0013585) (hydrolethalus syndrome 2), [MONDO:0012250](http://purl.obolibrary.org/obo/MONDO_0012250) (Charcot-Marie-tooth disease type 4H), [MONDO:0016612](http://purl.obolibrary.org/obo/MONDO_0016612) (X-linked cerebellar ataxia), [MONDO:0017940](http://purl.obolibrary.org/obo/MONDO_0017940) (autosomal dominant Charcot-Marie-tooth disease type 2 due to KIF5A mutation), [MONDO:0013580](http://purl.obolibrary.org/obo/MONDO_0013580) (pyruvate dehydrogenase E1-beta deficiency), [MONDO:0012256](http://purl.obolibrary.org/obo/MONDO_0012256) (hereditary spastic paraplegia 28), [MONDO:0013581](http://purl.obolibrary.org/obo/MONDO_0013581) (mental retardation, autosomal dominant 2), [MONDO:0013583](http://purl.obolibrary.org/obo/MONDO_0013583) (occipital pachygyria and polymicrogyria), [MONDO:0005977](http://purl.obolibrary.org/obo/MONDO_0005977) (tabes dorsalis), [MONDO:0016618](http://purl.obolibrary.org/obo/MONDO_0016618) (rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies), [MONDO:0016617](http://purl.obolibrary.org/obo/MONDO_0016617) (rheumatoid factor-negative juvenile idiopathic arthritis with anti-nuclear antibodies), [MONDO:0017948](http://purl.obolibrary.org/obo/MONDO_0017948) (ABetaA21G amyloidosis), [MONDO:0016619](http://purl.obolibrary.org/obo/MONDO_0016619) (autosomal recessive hypohidrotic ectodermal dysplasia), [MONDO:0017949](http://purl.obolibrary.org/obo/MONDO_0017949) (ABeta amyloidosis, Arctic type), [MONDO:0017946](http://purl.obolibrary.org/obo/MONDO_0017946) (ABeta amyloidosis, Iowa type), [MONDO:0013588](http://purl.obolibrary.org/obo/MONDO_0013588) (Perrault syndrome 3), [MONDO:0016614](http://purl.obolibrary.org/obo/MONDO_0016614) (autosomal recessive ataxia due to PEX10 deficiency), [MONDO:0017947](http://purl.obolibrary.org/obo/MONDO_0017947) (ABeta amyloidosis, Italian type), [MONDO:0016616](http://purl.obolibrary.org/obo/MONDO_0016616) (Oligoarticular juvenile idiopathic arthritis without anti-nuclear antibodies), [MONDO:0017945](http://purl.obolibrary.org/obo/MONDO_0017945) (ABetaL34V amyloidosis), [MONDO:0016615](http://purl.obolibrary.org/obo/MONDO_0016615) (Oligoarticular juvenile idiopathic arthritis with anti-nuclear antibodies), [MONDO:0014024](http://purl.obolibrary.org/obo/MONDO_0014024) (hereditary spastic paraplegia 43), [MONDO:0014025](http://purl.obolibrary.org/obo/MONDO_0014025) (lower motor neuron syndrome with late-adult onset), [MONDO:0015355](http://purl.obolibrary.org/obo/MONDO_0015355) (distal hereditary motor neuropathy type 7), [MONDO:0015358](http://purl.obolibrary.org/obo/MONDO_0015358) (hereditary motor and sensory neuropathy), [MONDO:0014026](http://purl.obolibrary.org/obo/MONDO_0014026) (congenital stationary night blindness 1F), [MONDO:0016683](http://purl.obolibrary.org/obo/MONDO_0016683) (gliomatosis cerebri), [MONDO:0014020](http://purl.obolibrary.org/obo/MONDO_0014020) (hereditary spastic paraplegia 55), [MONDO:0015352](http://purl.obolibrary.org/obo/MONDO_0015352) (distal hereditary motor neuropathy type 2), [MONDO:0015351](http://purl.obolibrary.org/obo/MONDO_0015351) (neuropathy with hearing impairment), [MONDO:0014021](http://purl.obolibrary.org/obo/MONDO_0014021) (familial episodic pain syndrome with predominantly upper body involvement), [MONDO:0016682](http://purl.obolibrary.org/obo/MONDO_0016682) (giant cell glioblastoma), [MONDO:0014022](http://purl.obolibrary.org/obo/MONDO_0014022) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10), [MONDO:0015354](http://purl.obolibrary.org/obo/MONDO_0015354) (hereditary sensory and autonomic neuropathy with deafness and global delay), [MONDO:0015353](http://purl.obolibrary.org/obo/MONDO_0015353) (distal hereditary motor neuropathy type 5), [MONDO:0014023](http://purl.obolibrary.org/obo/MONDO_0014023) (congenital muscular dystrophy with intellectual disability and severe epilepsy), [MONDO:0016684](http://purl.obolibrary.org/obo/MONDO_0016684) (anaplastic astrocytoma), [MONDO:0015350](http://purl.obolibrary.org/obo/MONDO_0015350) (17q11.2 microduplication syndrome), [MONDO:0016681](http://purl.obolibrary.org/obo/MONDO_0016681) (gliosarcoma), [MONDO:0016680](http://purl.obolibrary.org/obo/MONDO_0016680) (high grade astrocytic tumor), [MONDO:0007724](http://purl.obolibrary.org/obo/MONDO_0007724) (Hirsutism-skeletal dysplasia-intellectual disability syndrome), [MONDO:0015359](http://purl.obolibrary.org/obo/MONDO_0015359) (autosomal dominant hereditary demyelinating motor and sensory neuropathy), [MONDO:0015345](http://purl.obolibrary.org/obo/MONDO_0015345) (Perioral myoclonia with absences), [MONDO:0015344](http://purl.obolibrary.org/obo/MONDO_0015344) (idiopathic acute transverse myelitis), [MONDO:0014015](http://purl.obolibrary.org/obo/MONDO_0014015) (hereditary spastic paraplegia 56), [MONDO:0015346](http://purl.obolibrary.org/obo/MONDO_0015346) (Jeavons syndrome), [MONDO:0014016](http://purl.obolibrary.org/obo/MONDO_0014016) (hereditary spastic paraplegia 49), [MONDO:0015343](http://purl.obolibrary.org/obo/MONDO_0015343) (secondary acute transverse myelitis), [MONDO:0014012](http://purl.obolibrary.org/obo/MONDO_0014012) (Charcot-Marie-tooth disease axonal type 2Q), [MONDO:0015342](http://purl.obolibrary.org/obo/MONDO_0015342) (acute transverse myelitis), [MONDO:0007739](http://purl.obolibrary.org/obo/MONDO_0007739) (Huntington's disease), [MONDO:0007735](http://purl.obolibrary.org/obo/MONDO_0007735) (congenital Horner syndrome (disease)), [MONDO:0007734](http://purl.obolibrary.org/obo/MONDO_0007734) (holoprosencephaly 4), [MONDO:0007733](http://purl.obolibrary.org/obo/MONDO_0007733) (holoprosencephaly 3), [MONDO:0015349](http://purl.obolibrary.org/obo/MONDO_0015349) (progressive cavitating leukoencephalopathy), [MONDO:0015348](http://purl.obolibrary.org/obo/MONDO_0015348) (leukoencephalopathy with bilateral anterior temporal lobe cysts), [MONDO:0016679](http://purl.obolibrary.org/obo/MONDO_0016679) (rare tumor of neuroepithelial tissue), [MONDO:0014018](http://purl.obolibrary.org/obo/MONDO_0014018) (hereditary spastic paraplegia 54), [MONDO:0014019](http://purl.obolibrary.org/obo/MONDO_0014019) (dystonia 24), [MONDO:0014002](http://purl.obolibrary.org/obo/MONDO_0014002) (autosomal dominant nocturnal frontal lobe epilepsy 5), [MONDO:0017998](http://purl.obolibrary.org/obo/MONDO_0017998) (PLA2G6-associated neurodegeneration), [MONDO:0014003](http://purl.obolibrary.org/obo/MONDO_0014003) (epileptic encephalopathy, early infantile, 15), [MONDO:0017995](http://purl.obolibrary.org/obo/MONDO_0017995) (spondylocostal dysostosis-hypospadias-intellectual disability syndrome), [MONDO:0014004](http://purl.obolibrary.org/obo/MONDO_0014004) (basal ganglia calcification, idiopathic, 4), [MONDO:0017996](http://purl.obolibrary.org/obo/MONDO_0017996) (blepharophimosis-intellectual disability syndrome due to UBE3B deficiency), [MONDO:0017993](http://purl.obolibrary.org/obo/MONDO_0017993) (cerebral sinovenous thrombosis), [MONDO:0016660](http://purl.obolibrary.org/obo/MONDO_0016660) (autosomal recessive primary microcephaly), [MONDO:0014001](http://purl.obolibrary.org/obo/MONDO_0014001) (Usher syndrome type 1K), [MONDO:0003349](http://purl.obolibrary.org/obo/MONDO_0003349) (central nervous system leiomyosarcoma), [MONDO:0003346](http://purl.obolibrary.org/obo/MONDO_0003346) (central nervous system vasculitis), [MONDO:0003343](http://purl.obolibrary.org/obo/MONDO_0003343) (retinal hemangioblastoma), [MONDO:0004674](http://purl.obolibrary.org/obo/MONDO_0004674) (chorioretinitis (disease)), [MONDO:0004675](http://purl.obolibrary.org/obo/MONDO_0004675) (mitochondrial encephalomyopathy), [MONDO:0014006](http://purl.obolibrary.org/obo/MONDO_0014006) (intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome), [MONDO:0014007](http://purl.obolibrary.org/obo/MONDO_0014007) (Aicardi-Goutieres syndrome 6), [MONDO:0017999](http://purl.obolibrary.org/obo/MONDO_0017999) (fatty acid hydroxylase-associated neurodegeneration), [MONDO:0015339](http://purl.obolibrary.org/obo/MONDO_0015339) (adrenomyeloneuropathy), [MONDO:0012296](http://purl.obolibrary.org/obo/MONDO_0012296) (lipomyelomeningocele), [MONDO:0017987](http://purl.obolibrary.org/obo/MONDO_0017987) (syringomyelia), [MONDO:0015325](http://purl.obolibrary.org/obo/MONDO_0015325) (cataract-deafness-hypogonadism syndrome), [MONDO:0015324](http://purl.obolibrary.org/obo/MONDO_0015324) (cataract-intellectual disability-anal atresia-urinary defects syndrome), [MONDO:0012293](http://purl.obolibrary.org/obo/MONDO_0012293) (autosomal recessive nonsyndromic deafness 23), [MONDO:0012299](http://purl.obolibrary.org/obo/MONDO_0012299) (nanophthalmos 2), [MONDO:0012297](http://purl.obolibrary.org/obo/MONDO_0012297) (SPOAN syndrome), [MONDO:0007716](http://purl.obolibrary.org/obo/MONDO_0007716) (alpha thalassemia-intellectual disability syndrome type 1), [MONDO:0012290](http://purl.obolibrary.org/obo/MONDO_0012290) (CEDNIK syndrome), [MONDO:0007714](http://purl.obolibrary.org/obo/MONDO_0007714) (migraine, familial hemiplegic, 1), [MONDO:0007713](http://purl.obolibrary.org/obo/MONDO_0007713) (Clonic hemifacial spasm), [MONDO:0007710](http://purl.obolibrary.org/obo/MONDO_0007710) (facial hemiatrophy), [MONDO:0004686](http://purl.obolibrary.org/obo/MONDO_0004686) (lattice corneal dystrophy (disease)), [MONDO:0003350](http://purl.obolibrary.org/obo/MONDO_0003350) (granular cell leiomyosarcoma), [MONDO:0014068](http://purl.obolibrary.org/obo/MONDO_0014068) (cone-rod dystrophy 17), [MONDO:0019757](http://purl.obolibrary.org/obo/MONDO_0019757) (Alobar holoprosencephaly), [MONDO:0019758](http://purl.obolibrary.org/obo/MONDO_0019758) (midline interhemispheric variant of holoprosencephaly), [MONDO:0018425](http://purl.obolibrary.org/obo/MONDO_0018425) (Huntington disease-like syndrome due to C9ORF72 expansions), [MONDO:0019756](http://purl.obolibrary.org/obo/MONDO_0019756) (lobar holoprosencephaly), [MONDO:0018422](http://purl.obolibrary.org/obo/MONDO_0018422) (autosomal recessive spastic paraplegia type 70), [MONDO:0018423](http://purl.obolibrary.org/obo/MONDO_0018423) (autosomal recessive spastic paraplegia type 71), [MONDO:0018420](http://purl.obolibrary.org/obo/MONDO_0018420) (autosomal recessive spastic paraplegia type 68), [MONDO:0018421](http://purl.obolibrary.org/obo/MONDO_0018421) (autosomal recessive spastic paraplegia type 69), [MONDO:0014067](http://purl.obolibrary.org/obo/MONDO_0014067) (short ulna-dysmorphism-hypotonia-intellectual disability syndrome), [MONDO:0014060](http://purl.obolibrary.org/obo/MONDO_0014060) (progressive retinal dystrophy due to retinol transport defect), [MONDO:0015394](http://purl.obolibrary.org/obo/MONDO_0015394) (nasal encephalocele), [MONDO:0014062](http://purl.obolibrary.org/obo/MONDO_0014062) (mitochondrial DNA deletion syndrome with progressive myopathy), [MONDO:0015393](http://purl.obolibrary.org/obo/MONDO_0015393) (nasal ganglioglioma), [MONDO:0007765](http://purl.obolibrary.org/obo/MONDO_0007765) (hyperostosis cranialis interna (disease)), [MONDO:0002072](http://purl.obolibrary.org/obo/MONDO_0002072) (melanotic neuroectodermal tumor), [MONDO:0018428](http://purl.obolibrary.org/obo/MONDO_0018428) (9q31.1q31.3 microdeletion syndrome), [MONDO:0018429](http://purl.obolibrary.org/obo/MONDO_0018429) (14q24.1q24.3 microdeletion syndrome), [MONDO:0018416](http://purl.obolibrary.org/obo/MONDO_0018416) (autosomal recessive spastic paraplegia type 59), [MONDO:0014059](http://purl.obolibrary.org/obo/MONDO_0014059) (microphthalmia, isolated, with coloboma 9), [MONDO:0015387](http://purl.obolibrary.org/obo/MONDO_0015387) (nasolacrimal duct cyst), [MONDO:0014055](http://purl.obolibrary.org/obo/MONDO_0014055) (FAME4), [MONDO:0014050](http://purl.obolibrary.org/obo/MONDO_0014050) (isolated microphthalmia 8), [MONDO:0014052](http://purl.obolibrary.org/obo/MONDO_0014052) (congenital myasthenic syndrome 8), [MONDO:0007779](http://purl.obolibrary.org/obo/MONDO_0007779) (autosomal dominant Opitz G/BBB syndrome), [MONDO:0018419](http://purl.obolibrary.org/obo/MONDO_0018419) (autosomal recessive spastic paraplegia type 67), [MONDO:0018417](http://purl.obolibrary.org/obo/MONDO_0018417) (autosomal recessive spastic paraplegia type 60), [MONDO:0018418](http://purl.obolibrary.org/obo/MONDO_0018418) (autosomal recessive spastic paraplegia type 66), [MONDO:0019734](http://purl.obolibrary.org/obo/MONDO_0019734) (juvenile polymyositis), [MONDO:0015374](http://purl.obolibrary.org/obo/MONDO_0015374) (primary central nervous system vasculitis), [MONDO:0014043](http://purl.obolibrary.org/obo/MONDO_0014043) (microcephalic primordial dwarfism due to ZNF335 deficiency), [MONDO:0015373](http://purl.obolibrary.org/obo/MONDO_0015373) (Saldino-Mainzer syndrome), [MONDO:0014044](http://purl.obolibrary.org/obo/MONDO_0014044) (dysmorphism-conductive hearing loss-heart defect syndrome), [MONDO:0014040](http://purl.obolibrary.org/obo/MONDO_0014040) (autosomal recessive osteopetrosis 8), [MONDO:0007740](http://purl.obolibrary.org/obo/MONDO_0007740) (Wagner disease), [MONDO:0014035](http://purl.obolibrary.org/obo/MONDO_0014035) (severe intellectual disability-progressive spastic diplegia syndrome), [MONDO:0019725](http://purl.obolibrary.org/obo/MONDO_0019725) (pediatric systemic lupus erythematosus), [MONDO:0014036](http://purl.obolibrary.org/obo/MONDO_0014036) (Alzheimer's disease 17), [MONDO:0015366](http://purl.obolibrary.org/obo/MONDO_0015366) (autosomal recessive hereditary sensory and autonomic neuropathy), [MONDO:0015369](http://purl.obolibrary.org/obo/MONDO_0015369) (Joubert syndrome and related disorders), [MONDO:0015368](http://purl.obolibrary.org/obo/MONDO_0015368) (Neuro-ophthalmological disease), [MONDO:0015363](http://purl.obolibrary.org/obo/MONDO_0015363) (autosomal recessive distal hereditary motor neuropathy), [MONDO:0014031](http://purl.obolibrary.org/obo/MONDO_0014031) (microcephalic primordial dwarfism, Alazami type), [MONDO:0015362](http://purl.obolibrary.org/obo/MONDO_0015362) (autosomal dominant distal hereditary motor neuropathy), [MONDO:0015365](http://purl.obolibrary.org/obo/MONDO_0015365) (autosomal dominant hereditary sensory and autonomic neuropathy), [MONDO:0014033](http://purl.obolibrary.org/obo/MONDO_0014033) (dystonia 25), [MONDO:0016696](http://purl.obolibrary.org/obo/MONDO_0016696) (anaplastic oligodendroglioma), [MONDO:0015364](http://purl.obolibrary.org/obo/MONDO_0015364) (hereditary sensory and autonomic neuropathy), [MONDO:0016695](http://purl.obolibrary.org/obo/MONDO_0016695) (oligodendroglioma), [MONDO:0014034](http://purl.obolibrary.org/obo/MONDO_0014034) (severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome), [MONDO:0015361](http://purl.obolibrary.org/obo/MONDO_0015361) (autosomal recessive hereditary demyelinating motor and sensory neuropathy), [MONDO:0015360](http://purl.obolibrary.org/obo/MONDO_0015360) (autosomal dominant hereditary axonal motor and sensory neuropathy), [MONDO:0006426](http://purl.obolibrary.org/obo/MONDO_0006426) (spinal cord primitive neuroectodermal tumor), [MONDO:0003399](http://purl.obolibrary.org/obo/MONDO_0003399) (pineal region yolk sac tumor), [MONDO:0019726](http://purl.obolibrary.org/obo/MONDO_0019726) (type II mixed cryoglobulinemia), [MONDO:0019727](http://purl.obolibrary.org/obo/MONDO_0019727) (mixed cryoglobulinemia type III), [MONDO:0017138](http://purl.obolibrary.org/obo/MONDO_0017138) (Opitz G/BBB syndrome), [MONDO:0019799](http://purl.obolibrary.org/obo/MONDO_0019799) (hepatoerythropoietic porphyria), [MONDO:0018466](http://purl.obolibrary.org/obo/MONDO_0018466) (late onset Parkinson disease), [MONDO:0019798](http://purl.obolibrary.org/obo/MONDO_0019798) (acute hepatic porphyria), [MONDO:0018464](http://purl.obolibrary.org/obo/MONDO_0018464) (severe phosphoribosylpyrophosphate synthetase superactivity), [MONDO:0017135](http://purl.obolibrary.org/obo/MONDO_0017135) (olivopontocerebellar atrophy-deafness syndrome), [MONDO:0018462](http://purl.obolibrary.org/obo/MONDO_0018462) (Angelman syndrome due to imprinting defect in 15q11-q13), [MONDO:0019793](http://purl.obolibrary.org/obo/MONDO_0019793) (autosomal dominant cerebellar ataxia type 3), [MONDO:0019794](http://purl.obolibrary.org/obo/MONDO_0019794) (autosomal dominant cerebellar ataxia type 4), [MONDO:0018463](http://purl.obolibrary.org/obo/MONDO_0018463) (mild phosphoribosylpyrophosphate synthetase superactivity), [MONDO:0019791](http://purl.obolibrary.org/obo/MONDO_0019791) (recessive mitochondrial ataxia syndrome), [MONDO:0018460](http://purl.obolibrary.org/obo/MONDO_0018460) (Eales disease), [MONDO:0009513](http://purl.obolibrary.org/obo/MONDO_0009513) (laryngo-onycho-cutaneous syndrome), [MONDO:0018461](http://purl.obolibrary.org/obo/MONDO_0018461) (Angelman syndrome due to a point mutation), [MONDO:0019792](http://purl.obolibrary.org/obo/MONDO_0019792) (autosomal dominant cerebellar ataxia type I), [MONDO:0009514](http://purl.obolibrary.org/obo/MONDO_0009514) (Laurence-Moon syndrome), [MONDO:0019790](http://purl.obolibrary.org/obo/MONDO_0019790) (neuroleptic malignant syndrome), [MONDO:0009515](http://purl.obolibrary.org/obo/MONDO_0009515) (Norum disease), [MONDO:0011839](http://purl.obolibrary.org/obo/MONDO_0011839) (Newfoundland cone-rod dystrophy), [MONDO:0009518](http://purl.obolibrary.org/obo/MONDO_0009518) (leprosy, susceptibility to, 3), [MONDO:0010508](http://purl.obolibrary.org/obo/MONDO_0010508) (mental retardation, X-linked 103; MRX103), [MONDO:0011838](http://purl.obolibrary.org/obo/MONDO_0011838) (Bothnia retinal dystrophy), [MONDO:0010505](http://purl.obolibrary.org/obo/MONDO_0010505) (intellectual disability-balding-patella luxation-acromicria syndrome), [MONDO:0010506](http://purl.obolibrary.org/obo/MONDO_0010506) (mental retardation, X-linked 61; MRX61), [MONDO:0005145](http://purl.obolibrary.org/obo/MONDO_0005145) (sporadic amyotrophic lateral sclerosis), [MONDO:0010509](http://purl.obolibrary.org/obo/MONDO_0010509) (mental retardation, X-linked 104; MRX104), [MONDO:0005144](http://purl.obolibrary.org/obo/MONDO_0005144) (familial amyotrophic lateral sclerosis), [MONDO:0011830](http://purl.obolibrary.org/obo/MONDO_0011830) (lissencephaly due to LIS1 mutation), [MONDO:0010500](http://purl.obolibrary.org/obo/MONDO_0010500) (mental retardation, X-linked, syndromic 33), [MONDO:0011835](http://purl.obolibrary.org/obo/MONDO_0011835) (sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome), [MONDO:0011834](http://purl.obolibrary.org/obo/MONDO_0011834) (spinocerebellar ataxia type 18), [MONDO:0011833](http://purl.obolibrary.org/obo/MONDO_0011833) (spinocerebellar ataxia type 21), [MONDO:0010501](http://purl.obolibrary.org/obo/MONDO_0010501) (syndromic X-linked intellectual disability 34), [MONDO:0011832](http://purl.obolibrary.org/obo/MONDO_0011832) (autosomal dominant nonsyndromic deafness 44), [MONDO:0010502](http://purl.obolibrary.org/obo/MONDO_0010502) (mental retardation, X-linked 99, syndromic, female-restricted; MRXS99F), [MONDO:0019788](http://purl.obolibrary.org/obo/MONDO_0019788) (non-secreting paraganglioma), [MONDO:0019786](http://purl.obolibrary.org/obo/MONDO_0019786) (severe intellectual disability-epilepsy-anal anomalies-distal phalangeal hypoplasia), [MONDO:0017122](http://purl.obolibrary.org/obo/MONDO_0017122) (genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature), [MONDO:0019784](http://purl.obolibrary.org/obo/MONDO_0019784) (12q14 microdeletion syndrome), [MONDO:0017125](http://purl.obolibrary.org/obo/MONDO_0017125) (oculofaciocardiodental syndrome), [MONDO:0018451](http://purl.obolibrary.org/obo/MONDO_0018451) (X-linked distal hereditary motor neuropathy), [MONDO:0014093](http://purl.obolibrary.org/obo/MONDO_0014093) (retinitis pigmentosa 66), [MONDO:0019783](http://purl.obolibrary.org/obo/MONDO_0019783) (neovascular glaucoma), [MONDO:0009500](http://purl.obolibrary.org/obo/MONDO_0009500) (kuru, susceptibility to), [MONDO:0017121](http://purl.obolibrary.org/obo/MONDO_0017121) (syndrome with a Dandy-Walker malformation as major feature), [MONDO:0009501](http://purl.obolibrary.org/obo/MONDO_0009501) (metabolic myopathy due to lactate transporter defect), [MONDO:0014095](http://purl.obolibrary.org/obo/MONDO_0014095) (dilated cardiomyopathy 1JJ), [MONDO:0017120](http://purl.obolibrary.org/obo/MONDO_0017120) (other syndrome with a central nervous system malformation as major feature), [MONDO:0014096](http://purl.obolibrary.org/obo/MONDO_0014096) (microcephaly-intellectual disability-phalangeal and neurological anomalies syndrome), [MONDO:0018450](http://purl.obolibrary.org/obo/MONDO_0018450) (spinal muscular atrophy with respiratory distress type 2), [MONDO:0009502](http://purl.obolibrary.org/obo/MONDO_0009502) (pyruvate dehydrogenase E2 deficiency), [MONDO:0009503](http://purl.obolibrary.org/obo/MONDO_0009503) (pyruvate dehydrogenase E3-binding protein deficiency), [MONDO:0009504](http://purl.obolibrary.org/obo/MONDO_0009504) (mitochondrial DNA depletion syndrome 9), [MONDO:0011828](http://purl.obolibrary.org/obo/MONDO_0011828) (mental retardation, autosomal recessive 2), [MONDO:0009509](http://purl.obolibrary.org/obo/MONDO_0009509) (Landau-Kleffner syndrome), [MONDO:0006486](http://purl.obolibrary.org/obo/MONDO_0006486) (uveal melanoma), [MONDO:0011829](http://purl.obolibrary.org/obo/MONDO_0011829) (coenzyme Q10 deficiency, primary, 1), [MONDO:0011823](http://purl.obolibrary.org/obo/MONDO_0011823) (developmental malformations-deafness-dystonia syndrome), [MONDO:0011821](http://purl.obolibrary.org/obo/MONDO_0011821) (Meckel syndrome, type 3), [MONDO:0019779](http://purl.obolibrary.org/obo/MONDO_0019779) (Renier-Gabreels-Jasper syndrome), [MONDO:0017116](http://purl.obolibrary.org/obo/MONDO_0017116) (congenital communicating hydrocephalus), [MONDO:0018446](http://purl.obolibrary.org/obo/MONDO_0018446) (autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome), [MONDO:0017118](http://purl.obolibrary.org/obo/MONDO_0017118) (syndrome with a cerebellar malformation as major feature), [MONDO:0019777](http://purl.obolibrary.org/obo/MONDO_0019777) (Carpenter-Waziri syndrome), [MONDO:0019778](http://purl.obolibrary.org/obo/MONDO_0019778) (Smith-Fineman-Myers syndrome), [MONDO:0017117](http://purl.obolibrary.org/obo/MONDO_0017117) (congenital non-communicating hydrocephalus), [MONDO:0019775](http://purl.obolibrary.org/obo/MONDO_0019775) (Chudley-Lowry-Hoar syndrome), [MONDO:0017112](http://purl.obolibrary.org/obo/MONDO_0017112) (isolated unilateral hemispheric cerebellar hypoplasia), [MONDO:0019776](http://purl.obolibrary.org/obo/MONDO_0019776) (Juberg-Marsidi syndrome), [MONDO:0017111](http://purl.obolibrary.org/obo/MONDO_0017111) (isolated Dandy-Walker malformation without hydrocephalus), [MONDO:0017114](http://purl.obolibrary.org/obo/MONDO_0017114) (global cerebellar malformation), [MONDO:0019773](http://purl.obolibrary.org/obo/MONDO_0019773) (myelomeningocele), [MONDO:0014088](http://purl.obolibrary.org/obo/MONDO_0014088) (advanced sleep phase syndrome 2), [MONDO:0018443](http://purl.obolibrary.org/obo/MONDO_0018443) (FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome), [MONDO:0019774](http://purl.obolibrary.org/obo/MONDO_0019774) (Holmes-Gang syndrome), [MONDO:0014089](http://purl.obolibrary.org/obo/MONDO_0014089) (corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome), [MONDO:0017113](http://purl.obolibrary.org/obo/MONDO_0017113) (isolated bilateral hemispheric cerebellar hypoplasia), [MONDO:0018440](http://purl.obolibrary.org/obo/MONDO_0018440) (autosomal recessive distal renal tubular acidosis), [MONDO:0019771](http://purl.obolibrary.org/obo/MONDO_0019771) (oromandibular dystonia), [MONDO:0019772](http://purl.obolibrary.org/obo/MONDO_0019772) (blepharospasm-oromandibular dystonia syndrome), [MONDO:0014084](http://purl.obolibrary.org/obo/MONDO_0014084) (ataxia with oculomotor apraxia type 3), [MONDO:0017110](http://purl.obolibrary.org/obo/MONDO_0017110) (isolated Dandy-Walker malformation with hydrocephalus), [MONDO:0014085](http://purl.obolibrary.org/obo/MONDO_0014085) (hydrocephalus, nonsyndromic, autosomal recessive 2), [MONDO:0019770](http://purl.obolibrary.org/obo/MONDO_0019770) (X-linked dominant intellectual disability-epilepsy syndrome), [MONDO:0005127](http://purl.obolibrary.org/obo/MONDO_0005127) (lepromatous leprosy), [MONDO:0005125](http://purl.obolibrary.org/obo/MONDO_0005125) (borderline leprosy), [MONDO:0007787](http://purl.obolibrary.org/obo/MONDO_0007787) (Ambras type hypertrichosis universalis congenita), [MONDO:0005126](http://purl.obolibrary.org/obo/MONDO_0005126) (tuberculoid leprosy), [MONDO:0002096](http://purl.obolibrary.org/obo/MONDO_0002096) (malignant conjunctival melanoma), [MONDO:0005124](http://purl.obolibrary.org/obo/MONDO_0005124) (leprosy), [MONDO:0011819](http://purl.obolibrary.org/obo/MONDO_0011819) (spinocerebellar ataxia type 19/22), [MONDO:0011818](http://purl.obolibrary.org/obo/MONDO_0011818) (isolated focal cortical dysplasia type II), [MONDO:0007783](http://purl.obolibrary.org/obo/MONDO_0007783) (malignant hyperthermia, susceptibility to, 1), [MONDO:0017119](http://purl.obolibrary.org/obo/MONDO_0017119) (syndrome with microcephaly as major feature), [MONDO:0011812](http://purl.obolibrary.org/obo/MONDO_0011812) (Duane-radial ray syndrome), [MONDO:0011811](http://purl.obolibrary.org/obo/MONDO_0011811) (autosomal recessive cerebellar ataxia-saccadic intrusion syndrome), [MONDO:0011810](http://purl.obolibrary.org/obo/MONDO_0011810) (horizontal gaze palsy with progressive scoliosis), [MONDO:0019768](http://purl.obolibrary.org/obo/MONDO_0019768) (X-linked intellectual disability, Golabi-Ito-hall type), [MONDO:0017105](http://purl.obolibrary.org/obo/MONDO_0017105) (Glioependymal/ependymal cyst), [MONDO:0019769](http://purl.obolibrary.org/obo/MONDO_0019769) (X-linked intellectual disability, Sutherland-Haan type), [MONDO:0017104](http://purl.obolibrary.org/obo/MONDO_0017104) (central nervous system cystic malformation), [MONDO:0017107](http://purl.obolibrary.org/obo/MONDO_0017107) (isolated cerebellar vermis agenesis), [MONDO:0019766](http://purl.obolibrary.org/obo/MONDO_0019766) (X-linked intellectual disability, Porteous type), [MONDO:0017106](http://purl.obolibrary.org/obo/MONDO_0017106) (Retrocerebellar cyst (disease)), [MONDO:0019767](http://purl.obolibrary.org/obo/MONDO_0019767) (Hamel cerebro-palato-cardiac syndrome), [MONDO:0014075](http://purl.obolibrary.org/obo/MONDO_0014075) (cataract 39 multiple types), [MONDO:0017101](http://purl.obolibrary.org/obo/MONDO_0017101) (isolated focal cortical dysplasia type IIa), [MONDO:0014076](http://purl.obolibrary.org/obo/MONDO_0014076) (dyskeratosis congenita, autosomal recessive 5), [MONDO:0017100](http://purl.obolibrary.org/obo/MONDO_0017100) (neutropenia-monocytopenia-deafness syndrome), [MONDO:0017103](http://purl.obolibrary.org/obo/MONDO_0017103) (Encephaloclastic disorder), [MONDO:0014077](http://purl.obolibrary.org/obo/MONDO_0014077) (cobblestone lissencephaly without muscular or ocular involvement), [MONDO:0018431](http://purl.obolibrary.org/obo/MONDO_0018431) (cold-induced sweating syndrome-hyperthermia spectrum), [MONDO:0017102](http://purl.obolibrary.org/obo/MONDO_0017102) (isolated focal cortical dysplasia type IIb), [MONDO:0014071](http://purl.obolibrary.org/obo/MONDO_0014071) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11), [MONDO:0014072](http://purl.obolibrary.org/obo/MONDO_0014072) (d,L-2-hydroxyglutaric aciduria), [MONDO:0018430](http://purl.obolibrary.org/obo/MONDO_0018430) (partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome), [MONDO:0014073](http://purl.obolibrary.org/obo/MONDO_0014073) (dilated cardiomyopathy 1II), [MONDO:0014074](http://purl.obolibrary.org/obo/MONDO_0014074) (Charcot-Marie-tooth disease dominant intermediate f), [MONDO:0014070](http://purl.obolibrary.org/obo/MONDO_0014070) (oculocutaneous albinism type 7), [MONDO:0011803](http://purl.obolibrary.org/obo/MONDO_0011803) (hereditary spastic paraplegia 7), [MONDO:0007797](http://purl.obolibrary.org/obo/MONDO_0007797) (hypoparathyroidism-deafness-renal disease syndrome), [MONDO:0007796](http://purl.obolibrary.org/obo/MONDO_0007796) (hypoparathyroidism, familial isolated), [MONDO:0011808](http://purl.obolibrary.org/obo/MONDO_0011808) (cataract 27), [MONDO:0007790](http://purl.obolibrary.org/obo/MONDO_0007790) (Charcot-Marie-tooth disease type 3), [MONDO:0017109](http://purl.obolibrary.org/obo/MONDO_0017109) (isolated partial cerebellar vermis agenesis), [MONDO:0017108](http://purl.obolibrary.org/obo/MONDO_0017108) (isolated total cerebellar vermis agenesis), [MONDO:0011801](http://purl.obolibrary.org/obo/MONDO_0011801) (spinocerebellar ataxia type 1 with axonal neuropathy), [MONDO:0011800](http://purl.obolibrary.org/obo/MONDO_0011800) (GLM4), [MONDO:0002919](http://purl.obolibrary.org/obo/MONDO_0002919) (posterior cranial fossa meningioma), [MONDO:0011871](http://purl.obolibrary.org/obo/MONDO_0011871) (Niemann-Pick disease type B), [MONDO:0002916](http://purl.obolibrary.org/obo/MONDO_0002916) (brainstem intraparenchymal clear cell meningioma), [MONDO:0010540](http://purl.obolibrary.org/obo/MONDO_0010540) (bullous dystrophy, macular type), [MONDO:0008221](http://purl.obolibrary.org/obo/MONDO_0008221) (Prolidase deficiency), [MONDO:0002918](http://purl.obolibrary.org/obo/MONDO_0002918) (clear cell meningioma), [MONDO:0008222](http://purl.obolibrary.org/obo/MONDO_0008222) (Andersen-Tawil syndrome), [MONDO:0017179](http://purl.obolibrary.org/obo/MONDO_0017179) (limbic encephalitis with caspr2 antibodies), [MONDO:0009554](http://purl.obolibrary.org/obo/MONDO_0009554) (3MC syndrome 3), [MONDO:0017174](http://purl.obolibrary.org/obo/MONDO_0017174) (Machado-Joseph disease type 1), [MONDO:0008223](http://purl.obolibrary.org/obo/MONDO_0008223) (hypokalemic periodic paralysis), [MONDO:0002911](http://purl.obolibrary.org/obo/MONDO_0002911) (brain stem glioma), [MONDO:0008224](http://purl.obolibrary.org/obo/MONDO_0008224) (hyperkalemic periodic paralysis), [MONDO:0017176](http://purl.obolibrary.org/obo/MONDO_0017176) (Machado-Joseph disease type 3), [MONDO:0017175](http://purl.obolibrary.org/obo/MONDO_0017175) (Machado-Joseph disease type 2), [MONDO:0009558](http://purl.obolibrary.org/obo/MONDO_0009558) (Treacher Collins syndrome 3), [MONDO:0017170](http://purl.obolibrary.org/obo/MONDO_0017170) (idiopathic recurrent stupor), [MONDO:0017172](http://purl.obolibrary.org/obo/MONDO_0017172) (mucopolysaccharidosis type 6, slowly progressing), [MONDO:0017171](http://purl.obolibrary.org/obo/MONDO_0017171) (mucopolysaccharidosis type 6, rapidly progressing), [MONDO:0010549](http://purl.obolibrary.org/obo/MONDO_0010549) (Charcot-Marie-tooth disease X-linked dominant 1), [MONDO:0014906](http://purl.obolibrary.org/obo/MONDO_0014906) (Charcot-Marie-tooth disease, axonal, autosomal recessive, type 2a2b;), [MONDO:0014908](http://purl.obolibrary.org/obo/MONDO_0014908) (microcephaly 17, primary, autosomal recessive; MCPH17), [MONDO:0010543](http://purl.obolibrary.org/obo/MONDO_0010543) (Barth syndrome), [MONDO:0011875](http://purl.obolibrary.org/obo/MONDO_0011875) (epilepsy, idiopathic generalized, susceptibility to, 11), [MONDO:0010544](http://purl.obolibrary.org/obo/MONDO_0010544) (cataract 40), [MONDO:0011873](http://purl.obolibrary.org/obo/MONDO_0011873) (Niemann-Pick disease, type C2), [MONDO:0014903](http://purl.obolibrary.org/obo/MONDO_0014903) (seizures, benign familial infantile, 5; BFIS5), [MONDO:0010542](http://purl.obolibrary.org/obo/MONDO_0010542) (dilated cardiomyopathy 3B), [MONDO:0011872](http://purl.obolibrary.org/obo/MONDO_0011872) (Griscelli syndrome type 2), [MONDO:0010547](http://purl.obolibrary.org/obo/MONDO_0010547) (X-linked progressive cerebellar ataxia), [MONDO:0011879](http://purl.obolibrary.org/obo/MONDO_0011879) (neuronopathy, distal hereditary motor, type 7B), [MONDO:0005181](http://purl.obolibrary.org/obo/MONDO_0005181) (progressive external ophthalmoplegia), [MONDO:0010548](http://purl.obolibrary.org/obo/MONDO_0010548) (spinocerebellar ataxia, X-linked 2), [MONDO:0010545](http://purl.obolibrary.org/obo/MONDO_0010545) (Nance-Horan syndrome), [MONDO:0011876](http://purl.obolibrary.org/obo/MONDO_0011876) (juvenile absence epilepsy), [MONDO:0014900](http://purl.obolibrary.org/obo/MONDO_0014900) (autosomal recessive limb-girdle muscular dystrophy type 2Y), [MONDO:0011860](http://purl.obolibrary.org/obo/MONDO_0011860) (LPRS2), [MONDO:0018497](http://purl.obolibrary.org/obo/MONDO_0018497) (rare autonomic nervous system disorder), [MONDO:0008210](http://purl.obolibrary.org/obo/MONDO_0008210) (patterned macular dystrophy 1), [MONDO:0018495](http://purl.obolibrary.org/obo/MONDO_0018495) (X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome), [MONDO:0009543](http://purl.obolibrary.org/obo/MONDO_0009543) (prominent glabella-microcephaly-hypogenitalism syndrome), [MONDO:0009544](http://purl.obolibrary.org/obo/MONDO_0009544) (macrocephaly/megalencephaly syndrome, autosomal recessive), [MONDO:0018496](http://purl.obolibrary.org/obo/MONDO_0018496) (ARX-related encephalopathy-brain malformation spectrum), [MONDO:0018493](http://purl.obolibrary.org/obo/MONDO_0018493) (malignant hyperthermia (disease)), [MONDO:0008215](http://purl.obolibrary.org/obo/MONDO_0008215) (adult-onset autosomal dominant demyelinating leukodystrophy), [MONDO:0018491](http://purl.obolibrary.org/obo/MONDO_0018491) (3-phosphoglycerate dehydrogenase deficiency), [MONDO:0009548](http://purl.obolibrary.org/obo/MONDO_0009548) (renal hypomagnesemia 5 with ocular involvement), [MONDO:0017161](http://purl.obolibrary.org/obo/MONDO_0017161) (frontotemporal dementia with motor neuron disease), [MONDO:0009549](http://purl.obolibrary.org/obo/MONDO_0009549) (severe early-childhood-onset retinal dystrophy), [MONDO:0017160](http://purl.obolibrary.org/obo/MONDO_0017160) (behavioral variant of frontotemporal dementia), [MONDO:0018490](http://purl.obolibrary.org/obo/MONDO_0018490) (Cono-spondylar dysplasia), [MONDO:0010539](http://purl.obolibrary.org/obo/MONDO_0010539) (X-linked mandibulofacial dysostosis), [MONDO:0010532](http://purl.obolibrary.org/obo/MONDO_0010532) (infantile-onset X-linked spinal muscular atrophy), [MONDO:0010533](http://purl.obolibrary.org/obo/MONDO_0010533) (Arts syndrome), [MONDO:0011862](http://purl.obolibrary.org/obo/MONDO_0011862) (hereditary spastic paraplegia 24), [MONDO:0010531](http://purl.obolibrary.org/obo/MONDO_0010531) (contractures-ectodermal dysplasia-cleft lip/palate syndrome), [MONDO:0010537](http://purl.obolibrary.org/obo/MONDO_0010537) (Borjeson-Forssman-Lehmann syndrome), [MONDO:0010534](http://purl.obolibrary.org/obo/MONDO_0010534) (X-linked spinocerebellar ataxia type 4), [MONDO:0011866](http://purl.obolibrary.org/obo/MONDO_0011866) (pontocerebellar hypoplasia type 1A), [MONDO:0010535](http://purl.obolibrary.org/obo/MONDO_0010535) (Bazex-DuprC)-Christol syndrome), [MONDO:0011865](http://purl.obolibrary.org/obo/MONDO_0011865) (COL4A1-related familial vascular leukoencephalopathy), [MONDO:0018489](http://purl.obolibrary.org/obo/MONDO_0018489) (autoimmune encephalopathy with parasomnia and obstructive sleep apnea), [MONDO:0018486](http://purl.obolibrary.org/obo/MONDO_0018486) (visual snow syndrome), [MONDO:0008200](http://purl.obolibrary.org/obo/MONDO_0008200) (autosomal dominant Parkinson disease 1), [MONDO:0009532](http://purl.obolibrary.org/obo/MONDO_0009532) (Miller-Dieker lissencephaly syndrome), [MONDO:0008201](http://purl.obolibrary.org/obo/MONDO_0008201) (Perry syndrome), [MONDO:0018485](http://purl.obolibrary.org/obo/MONDO_0018485) (glycogen storage disease due to acid maltase deficiency, late-onset), [MONDO:0009535](http://purl.obolibrary.org/obo/MONDO_0009535) (lymphedema, congenital recessive), [MONDO:0008206](http://purl.obolibrary.org/obo/MONDO_0008206) (benign paroxysmal tonic upgaze of childhood with ataxia), [MONDO:0008209](http://purl.obolibrary.org/obo/MONDO_0008209) (Char syndrome), [MONDO:0010529](http://purl.obolibrary.org/obo/MONDO_0010529) (X-linked spinocerebellar ataxia type 3), [MONDO:0010527](http://purl.obolibrary.org/obo/MONDO_0010527) (microphthalmia-ankyloblepharon-intellectual disability syndrome), [MONDO:0011859](http://purl.obolibrary.org/obo/MONDO_0011859) (distal myopathy with early respiratory muscle involvement), [MONDO:0011851](http://purl.obolibrary.org/obo/MONDO_0011851) (migraine with or without aura, susceptibility to, 6), [MONDO:0010520](http://purl.obolibrary.org/obo/MONDO_0010520) (X-linked Alport syndrome), [MONDO:0011850](http://purl.obolibrary.org/obo/MONDO_0011850) (migraine with or without aura, susceptibility to, 5), [MONDO:0010525](http://purl.obolibrary.org/obo/MONDO_0010525) (neural tube defects, X-linked), [MONDO:0010526](http://purl.obolibrary.org/obo/MONDO_0010526) (Fabry disease), [MONDO:0010523](http://purl.obolibrary.org/obo/MONDO_0010523) (X-linked reticulate pigmentary disorder), [MONDO:0011855](http://purl.obolibrary.org/obo/MONDO_0011855) (granular corneal dystrophy type II), [MONDO:0010524](http://purl.obolibrary.org/obo/MONDO_0010524) (X-linked sideroblastic anemia with ataxia), [MONDO:0018477](http://purl.obolibrary.org/obo/MONDO_0018477) (bilirubin encephalopathy), [MONDO:0018475](http://purl.obolibrary.org/obo/MONDO_0018475) (PRKAR1B-related neurodegenerative dementia with intermediate filaments), [MONDO:0018476](http://purl.obolibrary.org/obo/MONDO_0018476) (dystonia-aphonia syndrome), [MONDO:0018474](http://purl.obolibrary.org/obo/MONDO_0018474) (13q12.3 microdeletion syndrome), [MONDO:0002900](http://purl.obolibrary.org/obo/MONDO_0002900) (cerebral neuroblastoma), [MONDO:0017140](http://purl.obolibrary.org/obo/MONDO_0017140) (L1 syndrome), [MONDO:0009524](http://purl.obolibrary.org/obo/MONDO_0009524) (intellectual disability-spasticity-ectrodactyly syndrome), [MONDO:0009529](http://purl.obolibrary.org/obo/MONDO_0009529) (pyruvate dehydrogenase E3 deficiency), [MONDO:0010519](http://purl.obolibrary.org/obo/MONDO_0010519) (alpha thalassemia-X-linked intellectual disability syndrome), [MONDO:0010516](http://purl.obolibrary.org/obo/MONDO_0010516) (midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis; MFHIEN), [MONDO:0011847](http://purl.obolibrary.org/obo/MONDO_0011847) (migraine without aura), [MONDO:0010510](http://purl.obolibrary.org/obo/MONDO_0010510) (mental retardation, X-linked 105; MRX105), [MONDO:0011842](http://purl.obolibrary.org/obo/MONDO_0011842) (Grn-related frontotemporal lobar degeneration with Tdp43 inclusions), [MONDO:0011841](http://purl.obolibrary.org/obo/MONDO_0011841) (biotin-responsive basal ganglia disease), [MONDO:0011840](http://purl.obolibrary.org/obo/MONDO_0011840) (dilated cardiomyopathy 1M), [MONDO:0011845](http://purl.obolibrary.org/obo/MONDO_0011845) (migraine with or without aura, susceptibility to, 3), [MONDO:0010512](http://purl.obolibrary.org/obo/MONDO_0010512) (mental retardation, X-linked, syndromic, Bain type; MRXSB), [MONDO:0011844](http://purl.obolibrary.org/obo/MONDO_0011844) (myoclonic dystonia 15), [MONDO:0010513](http://purl.obolibrary.org/obo/MONDO_0010513) (mental retardation, X-linked, syndromic, Borck type; MRXSBRK), [MONDO:0009590](http://purl.obolibrary.org/obo/MONDO_0009590) (metachromatic leukodystrophy due to saposin b deficiency), [MONDO:0009591](http://purl.obolibrary.org/obo/MONDO_0009591) (metachromatic leukodystrophy, juvenile form), [MONDO:0010584](http://purl.obolibrary.org/obo/MONDO_0010584) (dyskeratosis congenita, X-linked), [MONDO:0010582](http://purl.obolibrary.org/obo/MONDO_0010582) (diabetes insipidus, neurohypophyseal type), [MONDO:0008267](http://purl.obolibrary.org/obo/MONDO_0008267) (orofaciodigital syndrome V), [MONDO:0009599](http://purl.obolibrary.org/obo/MONDO_0009599) (metaphyseal dysostosis-intellectual disability-conductive deafness syndrome), [MONDO:0014949](http://purl.obolibrary.org/obo/MONDO_0014949) (epileptic encephalopathy, early infantile, 47; EIEE47), [MONDO:0013614](http://purl.obolibrary.org/obo/MONDO_0013614) (hypertelorism-preauricular sinus-punctual pits-deafness syndrome), [MONDO:0014945](http://purl.obolibrary.org/obo/MONDO_0014945) (myopathy, distal, with rimmed vacuoles; DMRV), [MONDO:0010588](http://purl.obolibrary.org/obo/MONDO_0010588) (exudative vitreoretinopathy 2, X-linked), [MONDO:0014947](http://purl.obolibrary.org/obo/MONDO_0014947) (epileptic encephalopathy, early infantile, 46; EIEE46), [MONDO:0010585](http://purl.obolibrary.org/obo/MONDO_0010585) (X-linked hypohidrotic ectodermal dysplasia), [MONDO:0013610](http://purl.obolibrary.org/obo/MONDO_0013610) (retinitis pigmentosa 61), [MONDO:0013611](http://purl.obolibrary.org/obo/MONDO_0013611) (retinitis pigmentosa 62), [MONDO:0014942](http://purl.obolibrary.org/obo/MONDO_0014942) (epileptic encephalopathy, early infantile, 45; EIEE45), [MONDO:0010589](http://purl.obolibrary.org/obo/MONDO_0010589) (Aarskog-Scott syndrome, X-linked), [MONDO:0014944](http://purl.obolibrary.org/obo/MONDO_0014944) (short stature-brachydactyly-obesity-global developmental delay syndrome), [MONDO:0013613](http://purl.obolibrary.org/obo/MONDO_0013613) (Leber congenital amaurosis 16), [MONDO:0009580](http://purl.obolibrary.org/obo/MONDO_0009580) (mental retardation, autosomal recessive 1), [MONDO:0008250](http://purl.obolibrary.org/obo/MONDO_0008250) (isolated growth hormone deficiency type II), [MONDO:0009581](http://purl.obolibrary.org/obo/MONDO_0009581) (intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome), [MONDO:0009582](http://purl.obolibrary.org/obo/MONDO_0009582) (Mietens syndrome), [MONDO:0010572](http://purl.obolibrary.org/obo/MONDO_0010572) (occipital horn syndrome), [MONDO:0009583](http://purl.obolibrary.org/obo/MONDO_0009583) (blepharophimosis-intellectual disability syndrome, Ohdo type), [MONDO:0009584](http://purl.obolibrary.org/obo/MONDO_0009584) (intellectual disability, Buenos-Aires type), [MONDO:0010570](http://purl.obolibrary.org/obo/MONDO_0010570) (craniofrontonasal syndrome), [MONDO:0009585](http://purl.obolibrary.org/obo/MONDO_0009585) (encephalopathy due to beta-mercaptolactate-cysteine disulfiduria), [MONDO:0010571](http://purl.obolibrary.org/obo/MONDO_0010571) (Otopalatodigital syndrome type 2), [MONDO:0021222](http://purl.obolibrary.org/obo/MONDO_0021222) (lacrimal gland neoplasm), [MONDO:0014938](http://purl.obolibrary.org/obo/MONDO_0014938) (aniridia 3; AN3), [MONDO:0013608](http://purl.obolibrary.org/obo/MONDO_0013608) (Joubert syndrome 13), [MONDO:0014939](http://purl.obolibrary.org/obo/MONDO_0014939) (congenital myasthenic syndrome 20), [MONDO:0013609](http://purl.obolibrary.org/obo/MONDO_0013609) (Meckel syndrome, type 10), [MONDO:0010576](http://purl.obolibrary.org/obo/MONDO_0010576) (X-linked mixed deafness with perilymphatic gusher), [MONDO:0014934](http://purl.obolibrary.org/obo/MONDO_0014934) (spinocerebellar ataxia, autosomal recessive 24; SCAR24), [MONDO:0010577](http://purl.obolibrary.org/obo/MONDO_0010577) (deafness, X-linked 1), [MONDO:0014935](http://purl.obolibrary.org/obo/MONDO_0014935) (Frontometaphyseal dysplasia 2; FMD2), [MONDO:0010574](http://purl.obolibrary.org/obo/MONDO_0010574) (syndromic X-linked intellectual disability 5), [MONDO:0013605](http://purl.obolibrary.org/obo/MONDO_0013605) (brittle cornea syndrome 2), [MONDO:0013606](http://purl.obolibrary.org/obo/MONDO_0013606) (Hermansky-Pudlak syndrome 9), [MONDO:0010575](http://purl.obolibrary.org/obo/MONDO_0010575) (deafness-hypogonadism syndrome), [MONDO:0014937](http://purl.obolibrary.org/obo/MONDO_0014937) (aniridia 2; AN2), [MONDO:0014930](http://purl.obolibrary.org/obo/MONDO_0014930) (mental retardation, autosomal recessive 56; MRT56), [MONDO:0010578](http://purl.obolibrary.org/obo/MONDO_0010578) (deafness dystonia syndrome), [MONDO:0014932](http://purl.obolibrary.org/obo/MONDO_0014932) (orofaciodigital syndrome XV), [MONDO:0010579](http://purl.obolibrary.org/obo/MONDO_0010579) (X-linked corneal dermoid), [MONDO:0013602](http://purl.obolibrary.org/obo/MONDO_0013602) (paragangliomas 5), [MONDO:0014933](http://purl.obolibrary.org/obo/MONDO_0014933) (epileptic encephalopathy, early infantile, 44; EIEE44), [MONDO:0009570](http://purl.obolibrary.org/obo/MONDO_0009570) (McDonough syndrome), [MONDO:0009571](http://purl.obolibrary.org/obo/MONDO_0009571) (Meckel syndrome, type 1), [MONDO:0010561](http://purl.obolibrary.org/obo/MONDO_0010561) (Coffin-Lowry syndrome), [MONDO:0011893](http://purl.obolibrary.org/obo/MONDO_0011893) (autosomal dominant nonsyndromic deafness 52), [MONDO:0011892](http://purl.obolibrary.org/obo/MONDO_0011892) (epilepsy, idiopathic generalized, susceptibility to, 9), [MONDO:0008243](http://purl.obolibrary.org/obo/MONDO_0008243) (Pick disease), [MONDO:0009575](http://purl.obolibrary.org/obo/MONDO_0009575) (thiamine-responsive megaloblastic anemia syndrome), [MONDO:0008244](http://purl.obolibrary.org/obo/MONDO_0008244) (piebaldism), [MONDO:0011890](http://purl.obolibrary.org/obo/MONDO_0011890) (Charcot-Marie-tooth disease type 1D), [MONDO:0009577](http://purl.obolibrary.org/obo/MONDO_0009577) (megalocornea-intellectual disability syndrome), [MONDO:0008246](http://purl.obolibrary.org/obo/MONDO_0008246) (pigmented paravenous retinochoroidal atrophy), [MONDO:0009578](http://purl.obolibrary.org/obo/MONDO_0009578) (neurocutaneous melanocytosis), [MONDO:0017192](http://purl.obolibrary.org/obo/MONDO_0017192) (sporadic secreting paraganglioma), [MONDO:0017191](http://purl.obolibrary.org/obo/MONDO_0017191) (sporadic pheochromocytoma), [MONDO:0014927](http://purl.obolibrary.org/obo/MONDO_0014927) (Joubert syndrome 27), [MONDO:0014928](http://purl.obolibrary.org/obo/MONDO_0014928) (Joubert syndrome 28), [MONDO:0014929](http://purl.obolibrary.org/obo/MONDO_0014929) (retinitis pigmentosa 76; RP76), [MONDO:0011897](http://purl.obolibrary.org/obo/MONDO_0011897) (hypomyelinating leukodystrophy 7 with or without oligodontia and-or hypogonadotropic hypogonadism), [MONDO:0011896](http://purl.obolibrary.org/obo/MONDO_0011896) (Parkinson disease 11, autosomal dominant, susceptibility to), [MONDO:0010566](http://purl.obolibrary.org/obo/MONDO_0010566) (X-linked cone-rod dystrophy 1), [MONDO:0014924](http://purl.obolibrary.org/obo/MONDO_0014924) (epilepsy, familial focal, with variable foci 2; FFEVF2), [MONDO:0010563](http://purl.obolibrary.org/obo/MONDO_0010563) (blue cone monochromacy), [MONDO:0014925](http://purl.obolibrary.org/obo/MONDO_0014925) (epilepsy, familial focal, with variable foci 3; FFEVF3), [MONDO:0011894](http://purl.obolibrary.org/obo/MONDO_0011894) (Charcot-Marie-tooth disease type 2E), [MONDO:0014926](http://purl.obolibrary.org/obo/MONDO_0014926) (Bardet-Biedl syndrome 20; BBS20), [MONDO:0010569](http://purl.obolibrary.org/obo/MONDO_0010569) (X-linked complicated corpus callosum dysgenesis), [MONDO:0014920](http://purl.obolibrary.org/obo/MONDO_0014920) (patterned macular dystrophy 3), [MONDO:0011899](http://purl.obolibrary.org/obo/MONDO_0011899) (Noonan syndrome-like disorder with loose anagen hair), [MONDO:0010567](http://purl.obolibrary.org/obo/MONDO_0010567) (cone dystrophy, X-linked, with Tapetal-like sheen), [MONDO:0014921](http://purl.obolibrary.org/obo/MONDO_0014921) (epileptic encephalopathy, early infantile, 43; EIEE43), [MONDO:0010568](http://purl.obolibrary.org/obo/MONDO_0010568) (Aicardi syndrome), [MONDO:0014922](http://purl.obolibrary.org/obo/MONDO_0014922) (myopathy, myofibrillar, 7; MFM7), [MONDO:0011898](http://purl.obolibrary.org/obo/MONDO_0011898) (Charcot-Marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive), [MONDO:0009561](http://purl.obolibrary.org/obo/MONDO_0009561) (alpha-mannosidosis), [MONDO:0010550](http://purl.obolibrary.org/obo/MONDO_0010550) (Charcot-Marie-tooth disease X-linked recessive 2), [MONDO:0009562](http://purl.obolibrary.org/obo/MONDO_0009562) (beta-mannosidosis), [MONDO:0010551](http://purl.obolibrary.org/obo/MONDO_0010551) (Charcot-Marie-tooth disease X-linked recessive 3), [MONDO:0009564](http://purl.obolibrary.org/obo/MONDO_0009564) (Marden-Walker syndrome), [MONDO:0009565](http://purl.obolibrary.org/obo/MONDO_0009565) (microcephaly-glomerulonephritis-marfanoid habitus syndrome), [MONDO:0009566](http://purl.obolibrary.org/obo/MONDO_0009566) (marfanoid habitus-autosomal recessive intellectual disability syndrome), [MONDO:0009567](http://purl.obolibrary.org/obo/MONDO_0009567) (Marinesco-SjC6gren syndrome), [MONDO:0009568](http://purl.obolibrary.org/obo/MONDO_0009568) (mast syndrome), [MONDO:0008237](http://purl.obolibrary.org/obo/MONDO_0008237) (phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome), [MONDO:0017181](http://purl.obolibrary.org/obo/MONDO_0017181) (hypnic headache (disease)), [MONDO:0017190](http://purl.obolibrary.org/obo/MONDO_0017190) (sporadic pheochromocytoma/secreting paraganglioma), [MONDO:0014916](http://purl.obolibrary.org/obo/MONDO_0014916) (epileptic encephalopathy, early infantile, 41; EIEE41), [MONDO:0014917](http://purl.obolibrary.org/obo/MONDO_0014917) (epileptic encephalopathy, early infantile, 42; EIEE42), [MONDO:0011886](http://purl.obolibrary.org/obo/MONDO_0011886) (torsion dystonia 13), [MONDO:0010555](http://purl.obolibrary.org/obo/MONDO_0010555) (X-linked chondrodysplasia punctata 1), [MONDO:0011885](http://purl.obolibrary.org/obo/MONDO_0011885) (tubulointerstitial nephritis and uveitis syndrome), [MONDO:0010558](http://purl.obolibrary.org/obo/MONDO_0010558) (choroideremia-deafness-obesity syndrome), [MONDO:0010559](http://purl.obolibrary.org/obo/MONDO_0010559) (MASA syndrome), [MONDO:0011889](http://purl.obolibrary.org/obo/MONDO_0011889) (Charcot-Marie-tooth disease type 2I), [MONDO:0010556](http://purl.obolibrary.org/obo/MONDO_0010556) (X-linked chondrodysplasia punctata), [MONDO:0010557](http://purl.obolibrary.org/obo/MONDO_0010557) (choroideremia), [MONDO:0013651](http://purl.obolibrary.org/obo/MONDO_0013651) (mental retardation, autosomal recessive 18), [MONDO:0014983](http://purl.obolibrary.org/obo/MONDO_0014983) (congenital myasthenic syndrome 21), [MONDO:0013652](http://purl.obolibrary.org/obo/MONDO_0013652) (narcolepsy 7), [MONDO:0013653](http://purl.obolibrary.org/obo/MONDO_0013653) (Parkinson disease 18, autosomal dominant, susceptibility to), [MONDO:0012322](http://purl.obolibrary.org/obo/MONDO_0012322) (holoprosencephaly 5), [MONDO:0012321](http://purl.obolibrary.org/obo/MONDO_0012321) (Alzheimer's disease 10), [MONDO:0012320](http://purl.obolibrary.org/obo/MONDO_0012320) (migraine, familial hemiplegic, 3), [MONDO:0002999](http://purl.obolibrary.org/obo/MONDO_0002999) (central nervous system germinoma), [MONDO:0000339](http://purl.obolibrary.org/obo/MONDO_0000339) (spinal polio), [MONDO:0002996](http://purl.obolibrary.org/obo/MONDO_0002996) (cavernous sinus meningioma), [MONDO:0002998](http://purl.obolibrary.org/obo/MONDO_0002998) (skull base meningioma), [MONDO:0002997](http://purl.obolibrary.org/obo/MONDO_0002997) (anterior cranial fossa meningioma), [MONDO:0001666](http://purl.obolibrary.org/obo/MONDO_0001666) (retinal dystrophies primarily involving bruch's membrane), [MONDO:0021275](http://purl.obolibrary.org/obo/MONDO_0021275) (papilloma of eyelid), [MONDO:0013658](http://purl.obolibrary.org/obo/MONDO_0013658) (mental retardation, autosomal dominant 11), [MONDO:0012326](http://purl.obolibrary.org/obo/MONDO_0012326) (autosomal recessive nonsyndromic deafness 42), [MONDO:0013659](http://purl.obolibrary.org/obo/MONDO_0013659) (microcephaly-capillary malformation syndrome), [MONDO:0013654](http://purl.obolibrary.org/obo/MONDO_0013654) (ANIB11), [MONDO:0013655](http://purl.obolibrary.org/obo/MONDO_0013655) (mental retardation, autosomal dominant 8), [MONDO:0013656](http://purl.obolibrary.org/obo/MONDO_0013656) (mental retardation, autosomal dominant 9), [MONDO:0013657](http://purl.obolibrary.org/obo/MONDO_0013657) (mental retardation, autosomal dominant 10), [MONDO:0012327](http://purl.obolibrary.org/obo/MONDO_0012327) (autosomal recessive nonsyndromic deafness 46), [MONDO:0013640](http://purl.obolibrary.org/obo/MONDO_0013640) (familial retinal arterial macroaneurysm), [MONDO:0013641](http://purl.obolibrary.org/obo/MONDO_0013641) (Warburg micro syndrome 2), [MONDO:0008294](http://purl.obolibrary.org/obo/MONDO_0008294) (acute intermittent porphyria), [MONDO:0013642](http://purl.obolibrary.org/obo/MONDO_0013642) (holoprosencephaly 11), [MONDO:0008295](http://purl.obolibrary.org/obo/MONDO_0008295) (sporadic porphyria cutanea tarda), [MONDO:0008296](http://purl.obolibrary.org/obo/MONDO_0008296) (familial porphyria cutanea tarda), [MONDO:0012310](http://purl.obolibrary.org/obo/MONDO_0012310) (fibrosis of extraocular muscles, congenital, with Synergistic Divergence), [MONDO:0008297](http://purl.obolibrary.org/obo/MONDO_0008297) (variegate porphyria), [MONDO:0000340](http://purl.obolibrary.org/obo/MONDO_0000340) (bulbospinal polio), [MONDO:0000341](http://purl.obolibrary.org/obo/MONDO_0000341) (paralytic poliomyelitis), [MONDO:0013647](http://purl.obolibrary.org/obo/MONDO_0013647) (primary microcephaly-epilepsy-permanent neonatal diabetes syndrome), [MONDO:0013644](http://purl.obolibrary.org/obo/MONDO_0013644) (Charcot-Marie-tooth disease axonal type 2O), [MONDO:0014975](http://purl.obolibrary.org/obo/MONDO_0014975) (spastic paraplegia 78, autosomal recessive; SPG78), [MONDO:0014976](http://purl.obolibrary.org/obo/MONDO_0014976) (lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome), [MONDO:0013645](http://purl.obolibrary.org/obo/MONDO_0013645) (autosomal recessive spinocerebellar ataxia 11), [MONDO:0014977](http://purl.obolibrary.org/obo/MONDO_0014977) (muscular dystrophy, limb-girdle, type 2z; LGMD2Z), [MONDO:0013646](http://purl.obolibrary.org/obo/MONDO_0013646) (chromosome 8q21.11 deletion syndrome), [MONDO:0013630](http://purl.obolibrary.org/obo/MONDO_0013630) (Meckel syndrome, type 9), [MONDO:0014962](http://purl.obolibrary.org/obo/MONDO_0014962) (mental retardation, autosomal recessive 57; MRT57), [MONDO:0008289](http://purl.obolibrary.org/obo/MONDO_0008289) (porencephaly 1), [MONDO:0012309](http://purl.obolibrary.org/obo/MONDO_0012309) (parietal foramina 2), [MONDO:0012304](http://purl.obolibrary.org/obo/MONDO_0012304) (PPR2), [MONDO:0012303](http://purl.obolibrary.org/obo/MONDO_0012303) (migraine with or without aura, susceptibility to, 8), [MONDO:0013638](http://purl.obolibrary.org/obo/MONDO_0013638) (Warburg micro syndrome 3), [MONDO:0012302](http://purl.obolibrary.org/obo/MONDO_0012302) (PFM3), [MONDO:0013639](http://purl.obolibrary.org/obo/MONDO_0013639) (NRCLP6), [MONDO:0013632](http://purl.obolibrary.org/obo/MONDO_0013632) (autosomal dominant nonsyndromic deafness 33), [MONDO:0012308](http://purl.obolibrary.org/obo/MONDO_0012308) (Joubert syndrome 4), [MONDO:0013633](http://purl.obolibrary.org/obo/MONDO_0013633) (encephalopathy, acute, infection-induced, susceptibility to, 4), [MONDO:0013634](http://purl.obolibrary.org/obo/MONDO_0013634) (neuropathy, hereditary sensory, type 2C), [MONDO:0014966](http://purl.obolibrary.org/obo/MONDO_0014966) (periventricular nodular heterotopia 7; PVNH7), [MONDO:0012305](http://purl.obolibrary.org/obo/MONDO_0012305) (PPR3), [MONDO:0010591](http://purl.obolibrary.org/obo/MONDO_0010591) (fingerprint body myopathy), [MONDO:0013620](http://purl.obolibrary.org/obo/MONDO_0013620) (congenital myasthenic syndrome 16), [MONDO:0014951](http://purl.obolibrary.org/obo/MONDO_0014951) (Sotos syndrome 3; SOTOS3), [MONDO:0010592](http://purl.obolibrary.org/obo/MONDO_0010592) (focal dermal hypoplasia), [MONDO:0002981](http://purl.obolibrary.org/obo/MONDO_0002981) (peripheral primitive neuroectodermal tumor of bone), [MONDO:0002982](http://purl.obolibrary.org/obo/MONDO_0002982) (peripheral primitive neuroectodermal tumor of soft tissues), [MONDO:0013629](http://purl.obolibrary.org/obo/MONDO_0013629) (MRT16), [MONDO:0013625](http://purl.obolibrary.org/obo/MONDO_0013625) (Parkinson disease 17), [MONDO:0013628](http://purl.obolibrary.org/obo/MONDO_0013628) (hyperphosphatasia with mental retardation syndrome 3), [MONDO:0014952](http://purl.obolibrary.org/obo/MONDO_0014952) (intellectual disability-epilepsy-extrapyramidal syndrome), [MONDO:0008280](http://purl.obolibrary.org/obo/MONDO_0008280) (Peutz-Jeghers syndrome), [MONDO:0014955](http://purl.obolibrary.org/obo/MONDO_0014955) (retinal dystrophy with or without extraocular anomalies; RDEOA), [MONDO:0013624](http://purl.obolibrary.org/obo/MONDO_0013624) (mental retardation, autosomal recessive 15), [MONDO:0012362](http://purl.obolibrary.org/obo/MONDO_0012362) (dilated cardiomyopathy 1P), [MONDO:0013694](http://purl.obolibrary.org/obo/MONDO_0013694) (MRT31), [MONDO:0011031](http://purl.obolibrary.org/obo/MONDO_0011031) (autosomal dominant nonsyndromic deafness 10), [MONDO:0016722](http://purl.obolibrary.org/obo/MONDO_0016722) (pineoblastoma), [MONDO:0016721](http://purl.obolibrary.org/obo/MONDO_0016721) (pineal tumor of neuroepithelial tissue), [MONDO:0013697](http://purl.obolibrary.org/obo/MONDO_0013697) (MRT29), [MONDO:0013690](http://purl.obolibrary.org/obo/MONDO_0013690) (Pitt-Hopkins-like syndrome 2), [MONDO:0012364](http://purl.obolibrary.org/obo/MONDO_0012364) (dilated cardiomyopathy 1Q), [MONDO:0012363](http://purl.obolibrary.org/obo/MONDO_0012363) (retinitis pigmentosa 32), [MONDO:0011032](http://purl.obolibrary.org/obo/MONDO_0011032) (autosomal dominant nonsyndromic deafness 11), [MONDO:0003405](http://purl.obolibrary.org/obo/MONDO_0003405) (adult central nervous system germ cell tumor), [MONDO:0003401](http://purl.obolibrary.org/obo/MONDO_0003401) (central nervous system endodermal sinus tumor), [MONDO:0016727](http://purl.obolibrary.org/obo/MONDO_0016727) (Extraventricular neurocytoma), [MONDO:0011038](http://purl.obolibrary.org/obo/MONDO_0011038) (cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome), [MONDO:0012368](http://purl.obolibrary.org/obo/MONDO_0012368) (neurological conditions associated with aminoacylase 1 deficiency), [MONDO:0012367](http://purl.obolibrary.org/obo/MONDO_0012367) (retinitis pigmentosa 31), [MONDO:0011036](http://purl.obolibrary.org/obo/MONDO_0011036) (porencephaly-cerebellar hypoplasia-internal malformations syndrome), [MONDO:0016729](http://purl.obolibrary.org/obo/MONDO_0016729) (mixed neuronal-glial tumor), [MONDO:0016724](http://purl.obolibrary.org/obo/MONDO_0016724) (papillary tumor of the pineal region), [MONDO:0016723](http://purl.obolibrary.org/obo/MONDO_0016723) (pineocytoma (disease)), [MONDO:0016726](http://purl.obolibrary.org/obo/MONDO_0016726) (neuronal tumor), [MONDO:0016725](http://purl.obolibrary.org/obo/MONDO_0016725) (pineal parenchymal tumor of intermediate differenciation), [MONDO:0016711](http://purl.obolibrary.org/obo/MONDO_0016711) (desmoplastic/nodular medulloblastoma), [MONDO:0013686](http://purl.obolibrary.org/obo/MONDO_0013686) (myopathy, distal, Tateyama type), [MONDO:0016710](http://purl.obolibrary.org/obo/MONDO_0016710) (medulloblastoma with extensive nodularity), [MONDO:0012355](http://purl.obolibrary.org/obo/MONDO_0012355) (autosomal recessive nonsyndromic deafness 28), [MONDO:0013681](http://purl.obolibrary.org/obo/MONDO_0013681) (alpha-methylacyl-CoA racemase deficiency), [MONDO:0004746](http://purl.obolibrary.org/obo/MONDO_0004746) (myopathy of extraocular muscle), [MONDO:0011028](http://purl.obolibrary.org/obo/MONDO_0011028) (autosomal recessive limb-girdle muscular dystrophy type 2F), [MONDO:0012358](http://purl.obolibrary.org/obo/MONDO_0012358) (LPRS1), [MONDO:0011026](http://purl.obolibrary.org/obo/MONDO_0011026) (autosomal recessive congenital ichthyosis 4A), [MONDO:0016719](http://purl.obolibrary.org/obo/MONDO_0016719) (microcephaly-seizures-intellectual disability-heart disease syndrome), [MONDO:0016718](http://purl.obolibrary.org/obo/MONDO_0016718) (choroid plexus carcinoma), [MONDO:0011025](http://purl.obolibrary.org/obo/MONDO_0011025) (Cayman type cerebellar ataxia), [MONDO:0013687](http://purl.obolibrary.org/obo/MONDO_0013687) (autosomal recessive spinocerebellar ataxia 12), [MONDO:0016713](http://purl.obolibrary.org/obo/MONDO_0016713) (central nervous system ewing sarcoma/peripheral primitive neuroectodermal tumor), [MONDO:0016712](http://purl.obolibrary.org/obo/MONDO_0016712) (classic medulloblastoma), [MONDO:0016715](http://purl.obolibrary.org/obo/MONDO_0016715) (ependymoblastoma), [MONDO:0013673](http://purl.obolibrary.org/obo/MONDO_0013673) (Wolfram-like syndrome), [MONDO:0013674](http://purl.obolibrary.org/obo/MONDO_0013674) (neurodegeneration with brain iron accumulation 4), [MONDO:0016700](http://purl.obolibrary.org/obo/MONDO_0016700) (anaplastic ependymoma), [MONDO:0013675](http://purl.obolibrary.org/obo/MONDO_0013675) (multiple mitochondrial dysfunctions syndrome 2), [MONDO:0012344](http://purl.obolibrary.org/obo/MONDO_0012344) (Alzheimer's disease 11), [MONDO:0011013](http://purl.obolibrary.org/obo/MONDO_0011013) (autosomal dominant hypocalcemia 1), [MONDO:0011011](http://purl.obolibrary.org/obo/MONDO_0011011) (skeletal dysplasia-epilepsy-short stature syndrome), [MONDO:0013670](http://purl.obolibrary.org/obo/MONDO_0013670) (myopia, high, with cataract and vitreoretinal degeneration), [MONDO:0011010](http://purl.obolibrary.org/obo/MONDO_0011010) (Matthew-wood syndrome), [MONDO:0000355](http://purl.obolibrary.org/obo/MONDO_0000355) (Ullrich congenital muscular dystrophy), [MONDO:0004714](http://purl.obolibrary.org/obo/MONDO_0004714) (atrophic muscular disease), [MONDO:0016709](http://purl.obolibrary.org/obo/MONDO_0016709) (anaplastic/large cell medulloblastoma), [MONDO:0016706](http://purl.obolibrary.org/obo/MONDO_0016706) (chordoid glioma), [MONDO:0016705](http://purl.obolibrary.org/obo/MONDO_0016705) (angiocentric glioma), [MONDO:0016708](http://purl.obolibrary.org/obo/MONDO_0016708) (embryonal tumor of neuroepithelial tissue), [MONDO:0012346](http://purl.obolibrary.org/obo/MONDO_0012346) (GEFSP4), [MONDO:0011015](http://purl.obolibrary.org/obo/MONDO_0011015) (cataract 24), [MONDO:0016707](http://purl.obolibrary.org/obo/MONDO_0016707) (astroblastoma), [MONDO:0013676](http://purl.obolibrary.org/obo/MONDO_0013676) (hypermethioninemia due to adenosine kinase deficiency), [MONDO:0016702](http://purl.obolibrary.org/obo/MONDO_0016702) (oligoastrocytoma), [MONDO:0016701](http://purl.obolibrary.org/obo/MONDO_0016701) (oligoastrocytic tumor), [MONDO:0013677](http://purl.obolibrary.org/obo/MONDO_0013677) (Emery-Dreifuss muscular dystrophy 7, autosomal dominant), [MONDO:0013678](http://purl.obolibrary.org/obo/MONDO_0013678) (EDICT syndrome), [MONDO:0016704](http://purl.obolibrary.org/obo/MONDO_0016704) (glial tumor of neuroepithelial tissue with unknown origin), [MONDO:0016703](http://purl.obolibrary.org/obo/MONDO_0016703) (anaplastic oligoastrocytoma), [MONDO:0014992](http://purl.obolibrary.org/obo/MONDO_0014992) (lissencephaly 8; LIS8), [MONDO:0014993](http://purl.obolibrary.org/obo/MONDO_0014993) (myopathy, myofibrillar, 8; MFM8), [MONDO:0013664](http://purl.obolibrary.org/obo/MONDO_0013664) (46,XY disorder of sex development due to testicular 17,20-desmolase deficiency), [MONDO:0011002](http://purl.obolibrary.org/obo/MONDO_0011002) (neuropathy, hereditary motor and sensory, type 6A), [MONDO:0012333](http://purl.obolibrary.org/obo/MONDO_0012333) (autosomal recessive nonsyndromic deafness 53), [MONDO:0012331](http://purl.obolibrary.org/obo/MONDO_0012331) (migraine with aura, susceptibility to, 9), [MONDO:0014991](http://purl.obolibrary.org/obo/MONDO_0014991) (Seckel syndrome 10; SCKL10), [MONDO:0011006](http://purl.obolibrary.org/obo/MONDO_0011006) (hereditary spastic paraplegia 9A), [MONDO:0012336](http://purl.obolibrary.org/obo/MONDO_0012336) (cataract 22 multiple types), [MONDO:0011004](http://purl.obolibrary.org/obo/MONDO_0011004) (lissencephaly type 3-metacarpal bone dysplasia syndrome), [MONDO:0011003](http://purl.obolibrary.org/obo/MONDO_0011003) (dilated cardiomyopathy 1E), [MONDO:0012334](http://purl.obolibrary.org/obo/MONDO_0012334) (hereditary spastic paraplegia 29), [MONDO:0014996](http://purl.obolibrary.org/obo/MONDO_0014996) (mental retardation, autosomal recessive 58; MRT58), [MONDO:0013665](http://purl.obolibrary.org/obo/MONDO_0013665) (EJM9), [MONDO:0013666](http://purl.obolibrary.org/obo/MONDO_0013666) (Stickler syndrome, type 5), [MONDO:0011075](http://purl.obolibrary.org/obo/MONDO_0011075) (retinitis pigmentosa 18), [MONDO:0016764](http://purl.obolibrary.org/obo/MONDO_0016764) (isolated anophthalmia-microphthalmia syndrome), [MONDO:0014101](http://purl.obolibrary.org/obo/MONDO_0014101) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12), [MONDO:0011074](http://purl.obolibrary.org/obo/MONDO_0011074) (autosomal dominant nonsyndromic deafness 7), [MONDO:0014104](http://purl.obolibrary.org/obo/MONDO_0014104) (cerebellar ataxia, mental retardation, and Dysequilibrium syndrome 4), [MONDO:0016760](http://purl.obolibrary.org/obo/MONDO_0016760) (microcephaly-microcornea syndrome, Seemanova type), [MONDO:0015431](http://purl.obolibrary.org/obo/MONDO_0015431) (ring chromosome 10), [MONDO:0016762](http://purl.obolibrary.org/obo/MONDO_0016762) (microcornea-corectopia-macular hypoplasia syndrome), [MONDO:0011076](http://purl.obolibrary.org/obo/MONDO_0011076) (myofibrillar myopathy 1), [MONDO:0011070](http://purl.obolibrary.org/obo/MONDO_0011070) (van Maldergem syndrome 1), [MONDO:0007803](http://purl.obolibrary.org/obo/MONDO_0007803) (multiple system atrophy), [MONDO:0004775](http://purl.obolibrary.org/obo/MONDO_0004775) (lens-induced iridocyclitis), [MONDO:0007800](http://purl.obolibrary.org/obo/MONDO_0007800) (chromosome 18p deletion syndrome), [MONDO:0004773](http://purl.obolibrary.org/obo/MONDO_0004773) (iridocyclitis (disease)), [MONDO:0004774](http://purl.obolibrary.org/obo/MONDO_0004774) (gonococcal iridocyclitis), [MONDO:0004772](http://purl.obolibrary.org/obo/MONDO_0004772) (glaucomatocyclitic crisis), [MONDO:0014109](http://purl.obolibrary.org/obo/MONDO_0014109) (NGLY1-deficiency), [MONDO:0015436](http://purl.obolibrary.org/obo/MONDO_0015436) (ring chromosome 20), [MONDO:0012395](http://purl.obolibrary.org/obo/MONDO_0012395) (cataract 18), [MONDO:0016752](http://purl.obolibrary.org/obo/MONDO_0016752) (benign peripheral nerve sheath tumor), [MONDO:0012394](http://purl.obolibrary.org/obo/MONDO_0012394) (multiple synostoses syndrome 2), [MONDO:0012393](http://purl.obolibrary.org/obo/MONDO_0012393) (congenital brain dysgenesis due to glutamine synthetase deficiency), [MONDO:0016755](http://purl.obolibrary.org/obo/MONDO_0016755) (neurofibroma), [MONDO:0011062](http://purl.obolibrary.org/obo/MONDO_0011062) (aprosencephaly cerebellar dysgenesis), [MONDO:0012392](http://purl.obolibrary.org/obo/MONDO_0012392) (2-methylbutyryl-CoA dehydrogenase deficiency), [MONDO:0016754](http://purl.obolibrary.org/obo/MONDO_0016754) (vestibular schwannoma (disease)), [MONDO:0012399](http://purl.obolibrary.org/obo/MONDO_0012399) (complex cortical dysplasia with other brain malformations 7), [MONDO:0012398](http://purl.obolibrary.org/obo/MONDO_0012398) (retinal cone dystrophy 3A), [MONDO:0011067](http://purl.obolibrary.org/obo/MONDO_0011067) (autosomal recessive nonsyndromic deafness 12), [MONDO:0016751](http://purl.obolibrary.org/obo/MONDO_0016751) (malignant perineurioma), [MONDO:0011066](http://purl.obolibrary.org/obo/MONDO_0011066) (Charcot-Marie-tooth disease type 4B1), [MONDO:0016750](http://purl.obolibrary.org/obo/MONDO_0016750) (microcephaly-cleft palate syndrome), [MONDO:0007819](http://purl.obolibrary.org/obo/MONDO_0007819) (solitary median maxillary central incisor syndrome), [MONDO:0012391](http://purl.obolibrary.org/obo/MONDO_0012391) (neuronal ceroid lipofuscinosis 8 northern epilepsy variant), [MONDO:0011060](http://purl.obolibrary.org/obo/MONDO_0011060) (early-onset non-syndromic cataract), [MONDO:0007812](http://purl.obolibrary.org/obo/MONDO_0007812) (ichthyosis, lamellar, autosomal dominant), [MONDO:0003453](http://purl.obolibrary.org/obo/MONDO_0003453) (conjunctival intraepithelial neoplasm), [MONDO:0003454](http://purl.obolibrary.org/obo/MONDO_0003454) (conjunctival cancer), [MONDO:0015429](http://purl.obolibrary.org/obo/MONDO_0015429) (choroideremia-hypopituitarism syndrome), [MONDO:0016757](http://purl.obolibrary.org/obo/MONDO_0016757) (malignant triton tumor), [MONDO:0016756](http://purl.obolibrary.org/obo/MONDO_0016756) (inherited nervous system cancer-predisposing syndrome), [MONDO:0016759](http://purl.obolibrary.org/obo/MONDO_0016759) (pontocerebellar hypoplasia type 2), [MONDO:0015427](http://purl.obolibrary.org/obo/MONDO_0015427) (paroxysmal dyskinesia), [MONDO:0016758](http://purl.obolibrary.org/obo/MONDO_0016758) (microcephaly-brain defect-spasticity-hypernatremia syndrome), [MONDO:0016742](http://purl.obolibrary.org/obo/MONDO_0016742) (mixed germ cell tumor of central nervous system), [MONDO:0011053](http://purl.obolibrary.org/obo/MONDO_0011053) (intellectual disability-sparse hair-brachydactyly syndrome), [MONDO:0012382](http://purl.obolibrary.org/obo/MONDO_0012382) (hyperinsulinemic hypoglycemia, familial, 4), [MONDO:0016744](http://purl.obolibrary.org/obo/MONDO_0016744) (primary melanocytic tumor of central nervous system), [MONDO:0016743](http://purl.obolibrary.org/obo/MONDO_0016743) (tumor of meninges), [MONDO:0016740](http://purl.obolibrary.org/obo/MONDO_0016740) (choriocarcinoma of the central nervous system), [MONDO:0003429](http://purl.obolibrary.org/obo/MONDO_0003429) (functioning pituitary gland adenoma), [MONDO:0012380](http://purl.obolibrary.org/obo/MONDO_0012380) (autosomal dominant nonsyndromic deafness 53), [MONDO:0004752](http://purl.obolibrary.org/obo/MONDO_0004752) (neurofibroma of the heart), [MONDO:0016749](http://purl.obolibrary.org/obo/MONDO_0016749) (tumor of cranial and spinal nerves), [MONDO:0011059](http://purl.obolibrary.org/obo/MONDO_0011059) (holoprosencephaly-craniosynostosis syndrome), [MONDO:0011058](http://purl.obolibrary.org/obo/MONDO_0011058) (autosomal dominant nonsyndromic deafness 9), [MONDO:0000390](http://purl.obolibrary.org/obo/MONDO_0000390) (vitelliform macular dystrophy), [MONDO:0016746](http://purl.obolibrary.org/obo/MONDO_0016746) (meningeal melanocytoma), [MONDO:0016745](http://purl.obolibrary.org/obo/MONDO_0016745) (diffuse leptomeningeal melanocytosis), [MONDO:0016748](http://purl.obolibrary.org/obo/MONDO_0016748) (hemangioblastoma), [MONDO:0016747](http://purl.obolibrary.org/obo/MONDO_0016747) (primary melanoma of the central nervous system), [MONDO:0016731](http://purl.obolibrary.org/obo/MONDO_0016731) (desmoplastic infantile astrocytoma/ganglioglioma), [MONDO:0016730](http://purl.obolibrary.org/obo/MONDO_0016730) (gangliocytoma), [MONDO:0016733](http://purl.obolibrary.org/obo/MONDO_0016733) (ganglioglioma), [MONDO:0012371](http://purl.obolibrary.org/obo/MONDO_0012371) (Noonan syndrome 3), [MONDO:0012370](http://purl.obolibrary.org/obo/MONDO_0012370) (autosomal recessive nonsyndromic deafness 51), [MONDO:0012376](http://purl.obolibrary.org/obo/MONDO_0012376) (autosomal recessive nonsyndromic deafness 55), [MONDO:0011045](http://purl.obolibrary.org/obo/MONDO_0011045) (MMEP syndrome), [MONDO:0012375](http://purl.obolibrary.org/obo/MONDO_0012375) (autosomal recessive nonsyndromic deafness 47), [MONDO:0002109](http://purl.obolibrary.org/obo/MONDO_0002109) (pituitary cancer), [MONDO:0016739](http://purl.obolibrary.org/obo/MONDO_0016739) (yolk sac tumor of central nervous system), [MONDO:0011049](http://purl.obolibrary.org/obo/MONDO_0011049) (Fine-Lubinsky syndrome), [MONDO:0016738](http://purl.obolibrary.org/obo/MONDO_0016738) (primary germ cell tumor of central nervous system), [MONDO:0015407](http://purl.obolibrary.org/obo/MONDO_0015407) (cerebrofacial arteriovenous metameric syndrome type 3), [MONDO:0011048](http://purl.obolibrary.org/obo/MONDO_0011048) (epilepsy-microcephaly-skeletal dysplasia syndrome), [MONDO:0011047](http://purl.obolibrary.org/obo/MONDO_0011047) (deafness-epiphyseal dysplasia-short stature syndrome), [MONDO:0016735](http://purl.obolibrary.org/obo/MONDO_0016735) (papillary glioneuronal tumor), [MONDO:0016734](http://purl.obolibrary.org/obo/MONDO_0016734) (anaplastic ganglioglioma), [MONDO:0015406](http://purl.obolibrary.org/obo/MONDO_0015406) (cerebrofacial arteriovenous metameric syndrome type 1), [MONDO:0015405](http://purl.obolibrary.org/obo/MONDO_0015405) (cerebrofacial arteriovenous metameric syndrome), [MONDO:0016736](http://purl.obolibrary.org/obo/MONDO_0016736) (Rosette-forming glioneuronal tumor of fourth ventricule), [MONDO:0014145](http://purl.obolibrary.org/obo/MONDO_0014145) (Leber congenital amaurosis 17), [MONDO:0019834](http://purl.obolibrary.org/obo/MONDO_0019834) (pituitary hormone deficiency from meningeal origin), [MONDO:0019835](http://purl.obolibrary.org/obo/MONDO_0019835) (primary hypophysitis), [MONDO:0014146](http://purl.obolibrary.org/obo/MONDO_0014146) (autosomal dominant hypocalcemia 2), [MONDO:0019832](http://purl.obolibrary.org/obo/MONDO_0019832) (acquired pituitary hormone deficiency), [MONDO:0014147](http://purl.obolibrary.org/obo/MONDO_0014147) (neuronal ceroid lipofuscinosis 13), [MONDO:0019833](http://purl.obolibrary.org/obo/MONDO_0019833) (pituitary hormone deficiency from tumoral origin), [MONDO:0014141](http://purl.obolibrary.org/obo/MONDO_0014141) (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14), [MONDO:0015473](http://purl.obolibrary.org/obo/MONDO_0015473) (cryptorchidism-arachnodactyly-intellectual disability syndrome), [MONDO:0014142](http://purl.obolibrary.org/obo/MONDO_0014142) (autosomal recessive limb-girdle muscular dystrophy type 2T), [MONDO:0014143](http://purl.obolibrary.org/obo/MONDO_0014143) (Noonan syndrome 8), [MONDO:0014144](http://purl.obolibrary.org/obo/MONDO_0014144) (autosomal recessive limb-girdle muscular dystrophy type 2S), [MONDO:0015471](http://purl.obolibrary.org/obo/MONDO_0015471) (benign focal seizures of adolescence), [MONDO:0014140](http://purl.obolibrary.org/obo/MONDO_0014140) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14), [MONDO:0015470](http://purl.obolibrary.org/obo/MONDO_0015470) (familial isolated dilated cardiomyopathy), [MONDO:0007848](http://purl.obolibrary.org/obo/MONDO_0007848) (autosomal dominant keratitis), [MONDO:0007846](http://purl.obolibrary.org/obo/MONDO_0007846) (KBG syndrome), [MONDO:0007845](http://purl.obolibrary.org/obo/MONDO_0007845) (Kaposi sarcoma, susceptibility to), [MONDO:0007843](http://purl.obolibrary.org/obo/MONDO_0007843) (Kabuki syndrome 1), [MONDO:0003480](http://purl.obolibrary.org/obo/MONDO_0003480) (pineal region dysgerminoma), [MONDO:0014149](http://purl.obolibrary.org/obo/MONDO_0014149) (fetal akinesia-cerebral and retinal hemorrhage syndrome), [MONDO:0018507](http://purl.obolibrary.org/obo/MONDO_0018507) (microcephaly-complex motor and sensory axonal neuropathy syndrome), [MONDO:0019838](http://purl.obolibrary.org/obo/MONDO_0019838) (adenohypophysitis), [MONDO:0019839](http://purl.obolibrary.org/obo/MONDO_0019839) (panhypophysitis), [MONDO:0016796](http://purl.obolibrary.org/obo/MONDO_0016796) (mitochondrial DNA depletion syndrome, encephalomyopathic form), [MONDO:0014131](http://purl.obolibrary.org/obo/MONDO_0014131) (hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome), [MONDO:0014132](http://purl.obolibrary.org/obo/MONDO_0014132) (multiple mitochondrial dysfunctions syndrome 3), [MONDO:0014133](http://purl.obolibrary.org/obo/MONDO_0014133) (epileptic encephalopathy, early infantile, 16), [MONDO:0015463](http://purl.obolibrary.org/obo/MONDO_0015463) (craniodigital syndrome-intellectual disability syndrome), [MONDO:0007852](http://purl.obolibrary.org/obo/MONDO_0007852) (palmoplantar keratoderma-deafness syndrome), [MONDO:0007851](http://purl.obolibrary.org/obo/MONDO_0007851) (keratoconus 1), [MONDO:0007850](http://purl.obolibrary.org/obo/MONDO_0007850) (autosomal dominant keratitis-ichthyosis-deafness syndrome), [MONDO:0002164](http://purl.obolibrary.org/obo/MONDO_0002164) (focal chorioretinitis), [MONDO:0003492](http://purl.obolibrary.org/obo/MONDO_0003492) (lacrimal gland squamous cell carcinoma), [MONDO:0014138](http://purl.obolibrary.org/obo/MONDO_0014138) (nemaline myopathy 8), [MONDO:0015455](http://purl.obolibrary.org/obo/MONDO_0015455) (gonococcal conjunctivitis), [MONDO:0011097](http://purl.obolibrary.org/obo/MONDO_0011097) (Axenfeld-Rieger syndrome type 2), [MONDO:0015457](http://purl.obolibrary.org/obo/MONDO_0015457) (corpus callosum agenesis-double urinary collecting system syndrome), [MONDO:0011095](http://purl.obolibrary.org/obo/MONDO_0011095) (dilated cardiomyopathy 1D), [MONDO:0014126](http://purl.obolibrary.org/obo/MONDO_0014126) (Perrault syndrome 4), [MONDO:0011094](http://purl.obolibrary.org/obo/MONDO_0011094) (dilated cardiomyopathy 1C), [MONDO:0016782](http://purl.obolibrary.org/obo/MONDO_0016782) (paternal 14q32.2 hypomethylation syndrome), [MONDO:0014120](http://purl.obolibrary.org/obo/MONDO_0014120) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13), [MONDO:0016781](http://purl.obolibrary.org/obo/MONDO_0016781) (maternal 14q32.2 microdeletion syndrome), [MONDO:0014121](http://purl.obolibrary.org/obo/MONDO_0014121) (autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures), [MONDO:0011099](http://purl.obolibrary.org/obo/MONDO_0011099) (Athabaskan brainstem dysgenesis syndrome), [MONDO:0015453](http://purl.obolibrary.org/obo/MONDO_0015453) (Cogan syndrome), [MONDO:0015452](http://purl.obolibrary.org/obo/MONDO_0015452) (Coffin-Siris syndrome), [MONDO:0014122](http://purl.obolibrary.org/obo/MONDO_0014122) (myofibromatosis, infantile, 2), [MONDO:0016783](http://purl.obolibrary.org/obo/MONDO_0016783) (maternal 14q32.2 hypermethylation syndrome), [MONDO:0016780](http://purl.obolibrary.org/obo/MONDO_0016780) (paternal 14q32.2 microdeletion syndrome), [MONDO:0011093](http://purl.obolibrary.org/obo/MONDO_0011093) (mucopolysaccharidosis type 9), [MONDO:0011091](http://purl.obolibrary.org/obo/MONDO_0011091) (Charcot-Marie-tooth disease type 2D), [MONDO:0011090](http://purl.obolibrary.org/obo/MONDO_0011090) (isolated hereditary congenital facial paralysis), [MONDO:0004796](http://purl.obolibrary.org/obo/MONDO_0004796) (infectious meningitis), [MONDO:0014127](http://purl.obolibrary.org/obo/MONDO_0014127) (oculocutaneous albinism type 5), [MONDO:0015458](http://purl.obolibrary.org/obo/MONDO_0015458) (intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome), [MONDO:0014128](http://purl.obolibrary.org/obo/MONDO_0014128) (craniosynostosis 3), [MONDO:0014129](http://purl.obolibrary.org/obo/MONDO_0014129) (autosomal recessive limb-girdle muscular dystrophy type 2R), [MONDO:0014112](http://purl.obolibrary.org/obo/MONDO_0014112) (cardiofaciocutaneous syndrome 2), [MONDO:0014113](http://purl.obolibrary.org/obo/MONDO_0014113) (cardiofaciocutaneous syndrome 3), [MONDO:0011085](http://purl.obolibrary.org/obo/MONDO_0011085) (Charcot-Marie-tooth disease type 4D), [MONDO:0016777](http://purl.obolibrary.org/obo/MONDO_0016777) (Inhalational botulism), [MONDO:0014114](http://purl.obolibrary.org/obo/MONDO_0014114) (cardiofaciocutaneous syndrome 4), [MONDO:0014115](http://purl.obolibrary.org/obo/MONDO_0014115) (hypomyelination with brain stem and spinal cord involvement and leg spasticity), [MONDO:0011088](http://purl.obolibrary.org/obo/MONDO_0011088) (congenital myasthenic syndrome 1A), [MONDO:0014110](http://purl.obolibrary.org/obo/MONDO_0014110) (cataract 15 multiple types), [MONDO:0014111](http://purl.obolibrary.org/obo/MONDO_0014111) (cataract 19 multiple types), [MONDO:0007839](http://purl.obolibrary.org/obo/MONDO_0007839) (Aase-Smith syndrome), [MONDO:0007838](http://purl.obolibrary.org/obo/MONDO_0007838) (Jacobsen syndrome), [MONDO:0007837](http://purl.obolibrary.org/obo/MONDO_0007837) (Johnson neuroectodermal syndrome), [MONDO:0011080](http://purl.obolibrary.org/obo/MONDO_0011080) (progressive deafness with stapes fixation), [MONDO:0003477](http://purl.obolibrary.org/obo/MONDO_0003477) (brain stem ependymoma), [MONDO:0003473](http://purl.obolibrary.org/obo/MONDO_0003473) (spinal cord ependymoma), [MONDO:0016779](http://purl.obolibrary.org/obo/MONDO_0016779) (multiple congenital anomalies due to 14q32.2 maternally expressed gene defect), [MONDO:0014117](http://purl.obolibrary.org/obo/MONDO_0014117) (Charcot-Marie-tooth disease type 4B3), [MONDO:0019806](http://purl.obolibrary.org/obo/MONDO_0019806) (primary progressive aphasia), [MONDO:0016778](http://purl.obolibrary.org/obo/MONDO_0016778) (Iatrogenic botulism), [MONDO:0014119](http://purl.obolibrary.org/obo/MONDO_0014119) (intellectual disability-strabismus syndrome), [MONDO:0019878](http://purl.obolibrary.org/obo/MONDO_0019878) (3q26 microduplication syndrome), [MONDO:0018546](http://purl.obolibrary.org/obo/MONDO_0018546) (serotonin syndrome), [MONDO:0018543](http://purl.obolibrary.org/obo/MONDO_0018543) (autosomal dominant hypocalcemia), [MONDO:0017211](http://purl.obolibrary.org/obo/MONDO_0017211) (infectious panuveitis), [MONDO:0018544](http://purl.obolibrary.org/obo/MONDO_0018544) (X-linked adrenoleukodystrophy), [MONDO:0017210](http://purl.obolibrary.org/obo/MONDO_0017210) (infectious anterior uveitis), [MONDO:0014186](http://purl.obolibrary.org/obo/MONDO_0014186) (retinitis pigmentosa with or without situs inversus), [MONDO:0017212](http://purl.obolibrary.org/obo/MONDO_0017212) (paraneoplastic uveitis), [MONDO:0014181](http://purl.obolibrary.org/obo/MONDO_0014181) (amyotrophic lateral sclerosis type 20), [MONDO:0014182](http://purl.obolibrary.org/obo/MONDO_0014182) (autosomal recessive nonsyndromic deafness 88), [MONDO:0019871](http://purl.obolibrary.org/obo/MONDO_0019871) (distal trisomy 2p), [MONDO:0014183](http://purl.obolibrary.org/obo/MONDO_0014183) (myopia 23, autosomal recessive), [MONDO:0011916](http://purl.obolibrary.org/obo/MONDO_0011916) (Charcot-Marie-tooth disease axonal type 2K), [MONDO:0011913](http://purl.obolibrary.org/obo/MONDO_0011913) (Alzheimer's disease 3), [MONDO:0011912](http://purl.obolibrary.org/obo/MONDO_0011912) (autosomal recessive nonsyndromic deafness 37), [MONDO:0017219](http://purl.obolibrary.org/obo/MONDO_0017219) (Microform holoprosencephaly), [MONDO:0017218](http://purl.obolibrary.org/obo/MONDO_0017218) (Septopreoptic holoprosencephaly), [MONDO:0018549](http://purl.obolibrary.org/obo/MONDO_0018549) (late-onset scapuloperoneal muscular dystrophy with hyaline bodies), [MONDO:0011910](http://purl.obolibrary.org/obo/MONDO_0011910) (autosomal dominant limb-girdle muscular dystrophy type 1C), [MONDO:0014178](http://purl.obolibrary.org/obo/MONDO_0014178) (inclusion body myopathy with early-onset Paget disease With or without frontotemporal dementia 2), [MONDO:0017204](http://purl.obolibrary.org/obo/MONDO_0017204) (toxic maculopathy due to antimalarial drugs), [MONDO:0017203](http://purl.obolibrary.org/obo/MONDO_0017203) (chronic endophthalmitis), [MONDO:0014179](http://purl.obolibrary.org/obo/MONDO_0014179) (inclusion body myopathy with early-onset Paget disease With or without frontotemporal dementia 3), [MONDO:0017206](http://purl.obolibrary.org/obo/MONDO_0017206) (primary intraocular lymphoma), [MONDO:0017205](http://purl.obolibrary.org/obo/MONDO_0017205) (primary oculocerebral lymphoma), [MONDO:0019863](http://purl.obolibrary.org/obo/MONDO_0019863) (Acro-renal-ocular syndrome), [MONDO:0014175](http://purl.obolibrary.org/obo/MONDO_0014175) (mitochondrial DNA depletion syndrome 12), [MONDO:0014176](http://purl.obolibrary.org/obo/MONDO_0014176) (hypotonia, infantile, with psychomotor retardation and characteristic facies), [MONDO:0019861](http://purl.obolibrary.org/obo/MONDO_0019861) (thyroid hypoplasia), [MONDO:0017202](http://purl.obolibrary.org/obo/MONDO_0017202) (acute endophthalmitis), [MONDO:0017201](http://purl.obolibrary.org/obo/MONDO_0017201) (Spasmus nutans (disease)), [MONDO:0019860](http://purl.obolibrary.org/obo/MONDO_0019860) (thyroid hemiagenesis), [MONDO:0014173](http://purl.obolibrary.org/obo/MONDO_0014173) (microcephaly 11, primary, autosomal recessive), [MONDO:0011904](http://purl.obolibrary.org/obo/MONDO_0011904) (seizures, benign familial infantile, 3), [MONDO:0005235](http://purl.obolibrary.org/obo/MONDO_0005235) (asymptomatic myeloma), [MONDO:0011903](http://purl.obolibrary.org/obo/MONDO_0011903) (Charcot-Marie-tooth disease type 2J), [MONDO:0011902](http://purl.obolibrary.org/obo/MONDO_0011902) (Charcot-Marie-tooth disease type 1F), [MONDO:0011909](http://purl.obolibrary.org/obo/MONDO_0011909) (Charcot-Marie-tooth disease dominant intermediate d), [MONDO:0007893](http://purl.obolibrary.org/obo/MONDO_0007893) (Noonan syndrome with multiple lentigines), [MONDO:0007892](http://purl.obolibrary.org/obo/MONDO_0007892) (Lenz-Majewski hyperostotic dwarfism), [MONDO:0011901](http://purl.obolibrary.org/obo/MONDO_0011901) (Charcot-Marie-tooth disease axonal type 2H), [MONDO:0017209](http://purl.obolibrary.org/obo/MONDO_0017209) (infectious posterior uveitis), [MONDO:0014167](http://purl.obolibrary.org/obo/MONDO_0014167) (epilepsy, familial adult myoclonic, 5), [MONDO:0019854](http://purl.obolibrary.org/obo/MONDO_0019854) (thyroid ectopia), [MONDO:0019855](http://purl.obolibrary.org/obo/MONDO_0019855) (Athyreosis), [MONDO:0014163](http://purl.obolibrary.org/obo/MONDO_0014163) (left ventricular noncompaction 10), [MONDO:0015494](http://purl.obolibrary.org/obo/MONDO_0015494) (isolated dystonia), [MONDO:0014164](http://purl.obolibrary.org/obo/MONDO_0014164) (Meckel syndrome, type 11), [MONDO:0014165](http://purl.obolibrary.org/obo/MONDO_0014165) (multiple congenital anomalies-hypotonia-seizures syndrome 3), [MONDO:0007868](http://purl.obolibrary.org/obo/MONDO_0007868) (hyperekplexia 1), [MONDO:0007866](http://purl.obolibrary.org/obo/MONDO_0007866) (Bart-Pumphrey syndrome), [MONDO:0007863](http://purl.obolibrary.org/obo/MONDO_0007863) (Kleine-Levin syndrome), [MONDO:0007862](http://purl.obolibrary.org/obo/MONDO_0007862) (Waardenburg syndrome type 3), [MONDO:0018529](http://purl.obolibrary.org/obo/MONDO_0018529) (qualitative or quantitative defects of Torsin-1A-interacting protein 1), [MONDO:0018528](http://purl.obolibrary.org/obo/MONDO_0018528) (congenital myopathy with myasthenic-like onset), [MONDO:0019845](http://purl.obolibrary.org/obo/MONDO_0019845) (Iatrogenic or traumatic pituitary deficiency), [MONDO:0014157](http://purl.obolibrary.org/obo/MONDO_0014157) (mandibular hypoplasia-deafness-progeroid syndrome), [MONDO:0019843](http://purl.obolibrary.org/obo/MONDO_0019843) (pituitary hormone deficiency secondary to a granulomatous disease), [MONDO:0014159](http://purl.obolibrary.org/obo/MONDO_0014159) (autosomal recessive spinocerebellar ataxia 14), [MONDO:0019844](http://purl.obolibrary.org/obo/MONDO_0019844) (pituitary hormone deficiency secondary to storage disease), [MONDO:0014152](http://purl.obolibrary.org/obo/MONDO_0014152) (left ventricular noncompaction 8), [MONDO:0019841](http://purl.obolibrary.org/obo/MONDO_0019841) (pituitary hormone defiency from vascular origin), [MONDO:0014153](http://purl.obolibrary.org/obo/MONDO_0014153) (cone-rod dystrophy 18), [MONDO:0015486](http://purl.obolibrary.org/obo/MONDO_0015486) (keratoconus (disease)), [MONDO:0014154](http://purl.obolibrary.org/obo/MONDO_0014154) (Charcot-Marie-tooth disease recessive intermediate c), [MONDO:0014150](http://purl.obolibrary.org/obo/MONDO_0014150) (childhood onset epileptic encephalopathy), [MONDO:0007876](http://purl.obolibrary.org/obo/MONDO_0007876) (laryngeal abductor paralysis), [MONDO:0007874](http://purl.obolibrary.org/obo/MONDO_0007874) (trichorhinophalangeal syndrome type II), [MONDO:0005212](http://purl.obolibrary.org/obo/MONDO_0005212) (rhabdomyosarcoma (disease)), [MONDO:0007872](http://purl.obolibrary.org/obo/MONDO_0007872) (LADD syndrome), [MONDO:0007871](http://purl.obolibrary.org/obo/MONDO_0007871) (familial congenital nasolacrimal duct obstruction), [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0019439](http://purl.obolibrary.org/obo/MONDO_0019439) (AA amyloidosis), [MONDO:0018105](http://purl.obolibrary.org/obo/MONDO_0018105) (Wolfram syndrome), [MONDO:0019437](http://purl.obolibrary.org/obo/MONDO_0019437) (Enthesitis-related juvenile idiopathic arthritis), [MONDO:0008780](http://purl.obolibrary.org/obo/MONDO_0008780) (amyotrophic lateral sclerosis type 2), [MONDO:0008781](http://purl.obolibrary.org/obo/MONDO_0008781) (juvenile amyotrophic lateral sclerosis with dementia), [MONDO:0008782](http://purl.obolibrary.org/obo/MONDO_0008782) (amyotrophic lateral sclerosis with polyglucosan bodies), [MONDO:0019432](http://purl.obolibrary.org/obo/MONDO_0019432) (rheumatoid factor-negative juvenile idiopathic arthritis), [MONDO:0019433](http://purl.obolibrary.org/obo/MONDO_0019433) (Oligoarticular juvenile idiopathic arthritis), [MONDO:0008783](http://purl.obolibrary.org/obo/MONDO_0008783) (Tangier disease), [MONDO:0018102](http://purl.obolibrary.org/obo/MONDO_0018102) (corneal dystrophy (disease)), [MONDO:0019430](http://purl.obolibrary.org/obo/MONDO_0019430) (X-linked intellectual disability-ataxia-apraxia syndrome), [MONDO:0012806](http://purl.obolibrary.org/obo/MONDO_0012806) (ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, autosomal dominant), [MONDO:0012805](http://purl.obolibrary.org/obo/MONDO_0012805) (childhood onset GLUT1 deficiency syndrome 2), [MONDO:0007443](http://purl.obolibrary.org/obo/MONDO_0007443) (congenital unilateral hypoplasia of depressor anguli oris), [MONDO:0012808](http://purl.obolibrary.org/obo/MONDO_0012808) (dilated cardiomyopathy 1AA), [MONDO:0012802](http://purl.obolibrary.org/obo/MONDO_0012802) (oculoauricular syndrome), [MONDO:0012800](http://purl.obolibrary.org/obo/MONDO_0012800) (trichoepithelioma, multiple familial, 2), [MONDO:0019427](http://purl.obolibrary.org/obo/MONDO_0019427) (X-linked neurodegenerative syndrome, Bertini type), [MONDO:0019425](http://purl.obolibrary.org/obo/MONDO_0019425) (X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome), [MONDO:0019426](http://purl.obolibrary.org/obo/MONDO_0019426) (X-linked intellectual disability-corpus callosum agenesis-spastic quadriparesis syndrome), [MONDO:0016397](http://purl.obolibrary.org/obo/MONDO_0016397) (lysosomal disease with epilepsy), [MONDO:0019423](http://purl.obolibrary.org/obo/MONDO_0019423) (X-linked intellectual disability, Stoll type), [MONDO:0016396](http://purl.obolibrary.org/obo/MONDO_0016396) (pontocerebellar hypoplasia type 1), [MONDO:0019424](http://purl.obolibrary.org/obo/MONDO_0019424) (X-linked intellectual disability-acromegaly-hyperactivity syndrome), [MONDO:0016399](http://purl.obolibrary.org/obo/MONDO_0016399) (amino acid or protein metabolism disease with epilepsy), [MONDO:0019421](http://purl.obolibrary.org/obo/MONDO_0019421) (X-linked intellectual disability, Seemanova type), [MONDO:0016398](http://purl.obolibrary.org/obo/MONDO_0016398) (peroxisomal disease with epilepsy), [MONDO:0019422](http://purl.obolibrary.org/obo/MONDO_0019422) (X-linked intellectual disability, Stevenson type), [MONDO:0000821](http://purl.obolibrary.org/obo/MONDO_0000821) (cerebral cavernous malformation 3), [MONDO:0016392](http://purl.obolibrary.org/obo/MONDO_0016392) (cerebellar hypoplasia-tapetoretinal degeneration syndrome), [MONDO:0019420](http://purl.obolibrary.org/obo/MONDO_0019420) (X-linked intellectual disability, Pai type), [MONDO:0016395](http://purl.obolibrary.org/obo/MONDO_0016395) (foveal hypoplasia-presenile cataract syndrome), [MONDO:0016394](http://purl.obolibrary.org/obo/MONDO_0016394) (sporadic infantile bilateral striatal necrosis), [MONDO:0008777](http://purl.obolibrary.org/obo/MONDO_0008777) (gelatinous drop-like corneal dystrophy), [MONDO:0016390](http://purl.obolibrary.org/obo/MONDO_0016390) (familial isolated hypoparathyroidism), [MONDO:0006128](http://purl.obolibrary.org/obo/MONDO_0006128) (central nervous system anaplastic large cell lymphoma), [MONDO:0006123](http://purl.obolibrary.org/obo/MONDO_0006123) (cardiac rhabdomyoma (disease)), [MONDO:0007450](http://purl.obolibrary.org/obo/MONDO_0007450) (neurohypophyseal diabetes insipidus), [MONDO:0003092](http://purl.obolibrary.org/obo/MONDO_0003092) (lacrimal gland mucoepidermoid carcinoma), [MONDO:0019429](http://purl.obolibrary.org/obo/MONDO_0019429) (X-linked neurodegenerative syndrome, Hamel type), [MONDO:0019416](http://purl.obolibrary.org/obo/MONDO_0019416) (X-linked intellectual disability-hypogammaglobulinemia-progressive neurological deterioration syndrome), [MONDO:0015059](http://purl.obolibrary.org/obo/MONDO_0015059) (progressive non-fluent aphasia), [MONDO:0019417](http://purl.obolibrary.org/obo/MONDO_0019417) (X-linked intellectual disability-precocious puberty-obesity syndrome), [MONDO:0019414](http://purl.obolibrary.org/obo/MONDO_0019414) (BRESEK syndrome), [MONDO:0016386](http://purl.obolibrary.org/obo/MONDO_0016386) (hypogonadotropic hypogonadism-retinitis pigmentosa syndrome), [MONDO:0008762](http://purl.obolibrary.org/obo/MONDO_0008762) (autosomal recessive Alport syndrome), [MONDO:0016381](http://purl.obolibrary.org/obo/MONDO_0016381) (hypertrichosis lanuginosa congenita), [MONDO:0008763](http://purl.obolibrary.org/obo/MONDO_0008763) (Alstrom syndrome), [MONDO:0008764](http://purl.obolibrary.org/obo/MONDO_0008764) (Leber congenital amaurosis 1), [MONDO:0008765](http://purl.obolibrary.org/obo/MONDO_0008765) (Leber congenital amaurosis 2), [MONDO:0008766](http://purl.obolibrary.org/obo/MONDO_0008766) (amaurosis-hypertrichosis syndrome), [MONDO:0008767](http://purl.obolibrary.org/obo/MONDO_0008767) (neuronal ceroid lipofuscinosis 3), [MONDO:0008768](http://purl.obolibrary.org/obo/MONDO_0008768) (neuronal ceroid lipofuscinosis 4A), [MONDO:0007429](http://purl.obolibrary.org/obo/MONDO_0007429) (optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy), [MONDO:0008769](http://purl.obolibrary.org/obo/MONDO_0008769) (neuronal ceroid lipofuscinosis 2), [MONDO:0007428](http://purl.obolibrary.org/obo/MONDO_0007428) (deafness-craniofacial syndrome), [MONDO:0007424](http://purl.obolibrary.org/obo/MONDO_0007424) (autosomal dominant nonsyndromic deafness 1), [MONDO:0004397](http://purl.obolibrary.org/obo/MONDO_0004397) (benign mediastinal psammomatous neurilemmoma), [MONDO:0004398](http://purl.obolibrary.org/obo/MONDO_0004398) (mediastinal schwannoma), [MONDO:0007422](http://purl.obolibrary.org/obo/MONDO_0007422) (keratoderma hereditarium mutilans), [MONDO:0007421](http://purl.obolibrary.org/obo/MONDO_0007421) (deafness-ear malformation-facial palsy syndrome), [MONDO:0007420](http://purl.obolibrary.org/obo/MONDO_0007420) (autosomal dominant deafness-onychodystrophy syndrome), [MONDO:0004394](http://purl.obolibrary.org/obo/MONDO_0004394) (maxillary sinus squamous cell carcinoma), [MONDO:0019418](http://purl.obolibrary.org/obo/MONDO_0019418) (X-linked intellectual disability-epilepsy-progressive joint contractures-dysmorphism syndrome), [MONDO:0019419](http://purl.obolibrary.org/obo/MONDO_0019419) (X-linked intellectual disability-macrocephaly-macroorchidism syndrome), [MONDO:0019405](http://purl.obolibrary.org/obo/MONDO_0019405) (facial onset sensory and motor neuronopathy), [MONDO:0019404](http://purl.obolibrary.org/obo/MONDO_0019404) (perineurioma), [MONDO:0016375](http://purl.obolibrary.org/obo/MONDO_0016375) (acquired peripheral movement disorder), [MONDO:0015043](http://purl.obolibrary.org/obo/MONDO_0015043) (extramedullary soft tissue plasmacytoma), [MONDO:0019402](http://purl.obolibrary.org/obo/MONDO_0019402) (beta thalassemia), [MONDO:0016374](http://purl.obolibrary.org/obo/MONDO_0016374) (cranial neuralgia), [MONDO:0016377](http://purl.obolibrary.org/obo/MONDO_0016377) (Pitt-Hopkins-like syndrome), [MONDO:0016371](http://purl.obolibrary.org/obo/MONDO_0016371) (combined hyperactive dysfunction syndrome of the cranial nerves), [MONDO:0008752](http://purl.obolibrary.org/obo/MONDO_0008752) (Alexander disease), [MONDO:0016370](http://purl.obolibrary.org/obo/MONDO_0016370) (Marchiafava-Bignami disease), [MONDO:0008753](http://purl.obolibrary.org/obo/MONDO_0008753) (alkaptonuria), [MONDO:0016373](http://purl.obolibrary.org/obo/MONDO_0016373) (isolated facial myokymia), [MONDO:0008754](http://purl.obolibrary.org/obo/MONDO_0008754) (alopecia-contractures-dwarfism-intellectual disability syndrome), [MONDO:0016372](http://purl.obolibrary.org/obo/MONDO_0016372) (glossopharyngeal neuralgia), [MONDO:0015042](http://purl.obolibrary.org/obo/MONDO_0015042) (primary plasmacytoma of the bone), [MONDO:0008755](http://purl.obolibrary.org/obo/MONDO_0008755) (Moynahan syndrome), [MONDO:0008756](http://purl.obolibrary.org/obo/MONDO_0008756) (alopecia-intellectual disability syndrome), [MONDO:0008758](http://purl.obolibrary.org/obo/MONDO_0008758) (mitochondrial DNA depletion syndrome 4a), [MONDO:0008759](http://purl.obolibrary.org/obo/MONDO_0008759) (Oxoglutaricaciduria), [MONDO:0006105](http://purl.obolibrary.org/obo/MONDO_0006105) (benign conjunctival neoplasm), [MONDO:0007435](http://purl.obolibrary.org/obo/MONDO_0007435) (dentatorubral-pallidoluysian atrophy), [MONDO:0006104](http://purl.obolibrary.org/obo/MONDO_0006104) (benign carotid body paraganglioma), [MONDO:0006103](http://purl.obolibrary.org/obo/MONDO_0006103) (benign adrenal gland pheochromocytoma), [MONDO:0003076](http://purl.obolibrary.org/obo/MONDO_0003076) (unilateral retinoblastoma), [MONDO:0003075](http://purl.obolibrary.org/obo/MONDO_0003075) (bilateral retinoblastoma), [MONDO:0007432](http://purl.obolibrary.org/obo/MONDO_0007432) (CADASIL), [MONDO:0003078](http://purl.obolibrary.org/obo/MONDO_0003078) (extraocular retinoblastoma), [MONDO:0003077](http://purl.obolibrary.org/obo/MONDO_0003077) (intraocular retinoblastoma), [MONDO:0003074](http://purl.obolibrary.org/obo/MONDO_0003074) (familial retinoblastoma), [MONDO:0003073](http://purl.obolibrary.org/obo/MONDO_0003073) (trilateral retinoblastoma), [MONDO:0019407](http://purl.obolibrary.org/obo/MONDO_0019407) (microcephalic osteodysplastic dysplasia, Saul-Wilson type), [MONDO:0018149](http://purl.obolibrary.org/obo/MONDO_0018149) (GM1 gangliosidosis), [MONDO:0018147](http://purl.obolibrary.org/obo/MONDO_0018147) (idiopathic macular telangiectasia type 3), [MONDO:0018148](http://purl.obolibrary.org/obo/MONDO_0018148) (vasoproliferative tumor of retina), [MONDO:0000859](http://purl.obolibrary.org/obo/MONDO_0000859) (spina bifida occulta (disease)), [MONDO:0018145](http://purl.obolibrary.org/obo/MONDO_0018145) (congenital retinal arteriovenous communication), [MONDO:0018146](http://purl.obolibrary.org/obo/MONDO_0018146) (idiopathic macular telangiectasia type 1), [MONDO:0020463](http://purl.obolibrary.org/obo/MONDO_0020463) (isolated congenital ectropion), [MONDO:0018144](http://purl.obolibrary.org/obo/MONDO_0018144) (congenital myasthenic syndromes with glycosylation defect), [MONDO:0020464](http://purl.obolibrary.org/obo/MONDO_0020464) (Euryblepharon), [MONDO:0020465](http://purl.obolibrary.org/obo/MONDO_0020465) (congenital eyelid retraction), [MONDO:0020466](http://purl.obolibrary.org/obo/MONDO_0020466) (monosomy X), [MONDO:0000857](http://purl.obolibrary.org/obo/MONDO_0000857) (Charcot-Marie-tooth disease type 7), [MONDO:0020467](http://purl.obolibrary.org/obo/MONDO_0020467) (mosaic monosomy X), [MONDO:0020469](http://purl.obolibrary.org/obo/MONDO_0020469) (48,XYYY syndrome), [MONDO:0011519](http://purl.obolibrary.org/obo/MONDO_0011519) (autosomal dominant nonsyndromic deafness 23), [MONDO:0011518](http://purl.obolibrary.org/obo/MONDO_0011518) (Wiedemann-Steiner syndrome), [MONDO:0012849](http://purl.obolibrary.org/obo/MONDO_0012849) (Joubert syndrome 9), [MONDO:0012848](http://purl.obolibrary.org/obo/MONDO_0012848) (Meckel syndrome, type 6), [MONDO:0007488](http://purl.obolibrary.org/obo/MONDO_0007488) (Lewy body dementia), [MONDO:0020461](http://purl.obolibrary.org/obo/MONDO_0020461) (Epiblepharon), [MONDO:0020462](http://purl.obolibrary.org/obo/MONDO_0020462) (tarsal kink syndrome), [MONDO:0007486](http://purl.obolibrary.org/obo/MONDO_0007486) (hereditary benign intraepithelial dyskeratosis), [MONDO:0011512](http://purl.obolibrary.org/obo/MONDO_0011512) (Brooke-Spiegler syndrome), [MONDO:0007485](http://purl.obolibrary.org/obo/MONDO_0007485) (dyskeratosis congenita, autosomal dominant 1), [MONDO:0011510](http://purl.obolibrary.org/obo/MONDO_0011510) (Bohring-Opitz syndrome), [MONDO:0012847](http://purl.obolibrary.org/obo/MONDO_0012847) (autosomal recessive congenital ichthyosis 6), [MONDO:0012846](http://purl.obolibrary.org/obo/MONDO_0012846) (GEFSP6), [MONDO:0011513](http://purl.obolibrary.org/obo/MONDO_0011513) (Alzheimer disease, familial early-onset, with Coexisting amyloid and prion pathology), [MONDO:0018138](http://purl.obolibrary.org/obo/MONDO_0018138) (ocular albinism with congenital sensorineural deafness), [MONDO:0018136](http://purl.obolibrary.org/obo/MONDO_0018136) (minimal pigment oculocutaneous albinism type 1), [MONDO:0018137](http://purl.obolibrary.org/obo/MONDO_0018137) (temperature-sensitive oculocutaneous albinism type 1), [MONDO:0018135](http://purl.obolibrary.org/obo/MONDO_0018135) (oculocutaneous albinism type 1), [MONDO:0018132](http://purl.obolibrary.org/obo/MONDO_0018132) (congenital muscular alpha-dystroglycanopathy with brain and eye anomalies), [MONDO:0000865](http://purl.obolibrary.org/obo/MONDO_0000865) (congenital fiber-type disproportion), [MONDO:0018133](http://purl.obolibrary.org/obo/MONDO_0018133) (attenuated Chdiak-Higashi syndrome), [MONDO:0018130](http://purl.obolibrary.org/obo/MONDO_0018130) (brain dopamine-serotonin vesicular transport disease), [MONDO:0018131](http://purl.obolibrary.org/obo/MONDO_0018131) (neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to 9q21 microdeletion), [MONDO:0011506](http://purl.obolibrary.org/obo/MONDO_0011506) (familial infantile myoclonic epilepsy), [MONDO:0007496](http://purl.obolibrary.org/obo/MONDO_0007496) (dystonia 12), [MONDO:0007495](http://purl.obolibrary.org/obo/MONDO_0007495) (dystonia 5), [MONDO:0007494](http://purl.obolibrary.org/obo/MONDO_0007494) (episodic kinesigenic dyskinesia 1), [MONDO:0007493](http://purl.obolibrary.org/obo/MONDO_0007493) (torsion dystonia 4), [MONDO:0007492](http://purl.obolibrary.org/obo/MONDO_0007492) (torsion dystonia 1), [MONDO:0011504](http://purl.obolibrary.org/obo/MONDO_0011504) (NDE1-related microhydranencephaly), [MONDO:0012833](http://purl.obolibrary.org/obo/MONDO_0012833) (Crouzon syndrome-acanthosis nigricans syndrome), [MONDO:0011502](http://purl.obolibrary.org/obo/MONDO_0011502) (Wolfram syndrome 2), [MONDO:0018129](http://purl.obolibrary.org/obo/MONDO_0018129) (autosomal recessive cerebellar ataxia with late-onset spasticity), [MONDO:0018125](http://purl.obolibrary.org/obo/MONDO_0018125) (focal epilepsy-intellectual disability-cerebro-cerebellar malformation), [MONDO:0015099](http://purl.obolibrary.org/obo/MONDO_0015099) (unilateral hemispheric polymicrogyria), [MONDO:0018126](http://purl.obolibrary.org/obo/MONDO_0018126) (progressive myoclonic epilepsy with dystonia), [MONDO:0018123](http://purl.obolibrary.org/obo/MONDO_0018123) (intellectual disability-obesity-brain malformations-facial dysmorphism syndrome), [MONDO:0015094](http://purl.obolibrary.org/obo/MONDO_0015094) (subependymal nodular heterotopia), [MONDO:0018122](http://purl.obolibrary.org/obo/MONDO_0018122) (digital anomalies-intellectual disability-short stature syndrome), [MONDO:0015095](http://purl.obolibrary.org/obo/MONDO_0015095) (Peters anomaly-cataract syndrome), [MONDO:0019450](http://purl.obolibrary.org/obo/MONDO_0019450) (lissencephaly with cerebellar hypoplasia), [MONDO:0015090](http://purl.obolibrary.org/obo/MONDO_0015090) (autosomal recessive pure spastic paraplegia), [MONDO:0015091](http://purl.obolibrary.org/obo/MONDO_0015091) (autosomal dominant spastic paraplegia type 9), [MONDO:0015093](http://purl.obolibrary.org/obo/MONDO_0015093) (sub-cortical nodular heterotopia), [MONDO:0007464](http://purl.obolibrary.org/obo/MONDO_0007464) (isolated distichiasis), [MONDO:0006131](http://purl.obolibrary.org/obo/MONDO_0006131) (cerebellar liponeurocytoma), [MONDO:0012824](http://purl.obolibrary.org/obo/MONDO_0012824) (hypomyelinating leukodystrophy 4), [MONDO:0019449](http://purl.obolibrary.org/obo/MONDO_0019449) (lissencephaly type 3-familial fetal akinesia sequence syndrome), [MONDO:0018116](http://purl.obolibrary.org/obo/MONDO_0018116) (galactosemia), [MONDO:0019448](http://purl.obolibrary.org/obo/MONDO_0019448) (benign adult familial myoclonic epilepsy), [MONDO:0008791](http://purl.obolibrary.org/obo/MONDO_0008791) (isolated anencephaly/exencephaly), [MONDO:0015087](http://purl.obolibrary.org/obo/MONDO_0015087) (autosomal dominant complex spastic paraplegia), [MONDO:0018114](http://purl.obolibrary.org/obo/MONDO_0018114) (isolated brachycephaly), [MONDO:0015088](http://purl.obolibrary.org/obo/MONDO_0015088) (autosomal dominant pure spastic paraplegia), [MONDO:0018115](http://purl.obolibrary.org/obo/MONDO_0018115) (epidermal nevus syndrome), [MONDO:0015089](http://purl.obolibrary.org/obo/MONDO_0015089) (autosomal recessive complex spastic paraplegia), [MONDO:0018112](http://purl.obolibrary.org/obo/MONDO_0018112) (isolated scaphocephaly), [MONDO:0019444](http://purl.obolibrary.org/obo/MONDO_0019444) (Trichinellosis), [MONDO:0018113](http://purl.obolibrary.org/obo/MONDO_0018113) (isolated plagiocephaly), [MONDO:0019441](http://purl.obolibrary.org/obo/MONDO_0019441) (ATTRV122I amyloidosis), [MONDO:0008795](http://purl.obolibrary.org/obo/MONDO_0008795) (aniridia-cerebellar ataxia-intellectual disability syndrome), [MONDO:0015083](http://purl.obolibrary.org/obo/MONDO_0015083) (nuclear oculomotor paralysis), [MONDO:0008796](http://purl.obolibrary.org/obo/MONDO_0008796) (aniridia-renal agenesis-psychomotor retardation syndrome), [MONDO:0008799](http://purl.obolibrary.org/obo/MONDO_0008799) (anophthalmia/microphthalmia-esophageal atresia syndrome), [MONDO:0012815](http://purl.obolibrary.org/obo/MONDO_0012815) (Coats plus syndrome), [MONDO:0006145](http://purl.obolibrary.org/obo/MONDO_0006145) (chondroid chordoma), [MONDO:0012810](http://purl.obolibrary.org/obo/MONDO_0012810) (ANIB7), [MONDO:0007473](http://purl.obolibrary.org/obo/MONDO_0007473) (Duane retraction syndrome), [MONDO:0007472](http://purl.obolibrary.org/obo/MONDO_0007472) (basal laminar drusen), [MONDO:0007471](http://purl.obolibrary.org/obo/MONDO_0007471) (Doyne honeycomb retinal dystrophy), [MONDO:0012813](http://purl.obolibrary.org/obo/MONDO_0012813) (retinitis pigmentosa 29), [MONDO:0012812](http://purl.obolibrary.org/obo/MONDO_0012812) (epileptic encephalopathy, early infantile, 4), [MONDO:0012811](http://purl.obolibrary.org/obo/MONDO_0012811) (ANIB8), [MONDO:0011551](http://purl.obolibrary.org/obo/MONDO_0011551) (autosomal recessive dopa-responsive dystonia), [MONDO:0010221](http://purl.obolibrary.org/obo/MONDO_0010221) (CHIME syndrome), [MONDO:0003927](http://purl.obolibrary.org/obo/MONDO_0003927) (posterior uveal melanoma), [MONDO:0018189](http://purl.obolibrary.org/obo/MONDO_0018189) (autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome), [MONDO:0009235](http://purl.obolibrary.org/obo/MONDO_0009235) (familial benign flecked retina), [MONDO:0009236](http://purl.obolibrary.org/obo/MONDO_0009236) (Kandori fleck retina), [MONDO:0003926](http://purl.obolibrary.org/obo/MONDO_0003926) (neurilemmoma of the pleura), [MONDO:0003921](http://purl.obolibrary.org/obo/MONDO_0003921) (posterior foramen magnum meningioma), [MONDO:0018190](http://purl.obolibrary.org/obo/MONDO_0018190) (autosomal dominant childhood-onset proximal spinal muscular atrophy), [MONDO:0015918](http://purl.obolibrary.org/obo/MONDO_0015918) (rare neurodegenerative disease), [MONDO:0015917](http://purl.obolibrary.org/obo/MONDO_0015917) (malignant glioma), [MONDO:0015919](http://purl.obolibrary.org/obo/MONDO_0015919) (syndromic neurometabolic disease with non-X-linked intellectual disability), [MONDO:0010224](http://purl.obolibrary.org/obo/MONDO_0010224) (corpus callosum agenesis-abnormal genitalia syndrome), [MONDO:0015914](http://purl.obolibrary.org/obo/MONDO_0015914) (primary orthostatic hypotension), [MONDO:0012885](http://purl.obolibrary.org/obo/MONDO_0012885) (SRD5A3-CDG), [MONDO:0010222](http://purl.obolibrary.org/obo/MONDO_0010222) (X-linked Opitz G/BBB syndrome), [MONDO:0015916](http://purl.obolibrary.org/obo/MONDO_0015916) (rare neuroinflammatory or neuroimmunological disease), [MONDO:0015915](http://purl.obolibrary.org/obo/MONDO_0015915) (cerebellar malformation), [MONDO:0011553](http://purl.obolibrary.org/obo/MONDO_0011553) (autosomal recessive nonsyndromic deafness 26), [MONDO:0010228](http://purl.obolibrary.org/obo/MONDO_0010228) (DFNX3), [MONDO:0012889](http://purl.obolibrary.org/obo/MONDO_0012889) (SS3), [MONDO:0011558](http://purl.obolibrary.org/obo/MONDO_0011558) (Usher syndrome type 2C), [MONDO:0012888](http://purl.obolibrary.org/obo/MONDO_0012888) (sarcoidosis, susceptibility to, 2), [MONDO:0010227](http://purl.obolibrary.org/obo/MONDO_0010227) (retinitis pigmentosa 3), [MONDO:0010210](http://purl.obolibrary.org/obo/MONDO_0010210) (xeroderma pigmentosum group A), [MONDO:0012871](http://purl.obolibrary.org/obo/MONDO_0012871) (Jervell and Lange-Nielsen syndrome 2), [MONDO:0011540](http://purl.obolibrary.org/obo/MONDO_0011540) (spinocerebellar ataxia type 14), [MONDO:0020496](http://purl.obolibrary.org/obo/MONDO_0020496) (familial porencephaly), [MONDO:0018177](http://purl.obolibrary.org/obo/MONDO_0018177) (glioblastoma (disease)), [MONDO:0020497](http://purl.obolibrary.org/obo/MONDO_0020497) (Turcot syndrome with polyposis), [MONDO:0020499](http://purl.obolibrary.org/obo/MONDO_0020499) (Nipah virus disease), [MONDO:0009227](http://purl.obolibrary.org/obo/MONDO_0009227) (myofibromatosis, infantile, 1), [MONDO:0003932](http://purl.obolibrary.org/obo/MONDO_0003932) (childhood optic nerve glioma), [MONDO:0003931](http://purl.obolibrary.org/obo/MONDO_0003931) (childhood optic tract astrocytoma), [MONDO:0020491](http://purl.obolibrary.org/obo/MONDO_0020491) (subcortical band heterotopia), [MONDO:0020492](http://purl.obolibrary.org/obo/MONDO_0020492) (Hemimegalencephaly), [MONDO:0020493](http://purl.obolibrary.org/obo/MONDO_0020493) (Haddad syndrome), [MONDO:0020495](http://purl.obolibrary.org/obo/MONDO_0020495) (PEHO-like syndrome), [MONDO:0011545](http://purl.obolibrary.org/obo/MONDO_0011545) (autosomal dominant nocturnal frontal lobe epilepsy 3), [MONDO:0010213](http://purl.obolibrary.org/obo/MONDO_0010213) (xeroderma pigmentosum group E), [MONDO:0011544](http://purl.obolibrary.org/obo/MONDO_0011544) (paragangliomas 3), [MONDO:0010214](http://purl.obolibrary.org/obo/MONDO_0010214) (xeroderma pigmentosum variant type), [MONDO:0010211](http://purl.obolibrary.org/obo/MONDO_0010211) (xeroderma pigmentosum group C), [MONDO:0010212](http://purl.obolibrary.org/obo/MONDO_0010212) (xeroderma pigmentosum group D), [MONDO:0010215](http://purl.obolibrary.org/obo/MONDO_0010215) (xeroderma pigmentosum group F), [MONDO:0011547](http://purl.obolibrary.org/obo/MONDO_0011547) (cataract 31 multiple types), [MONDO:0010216](http://purl.obolibrary.org/obo/MONDO_0010216) (xeroderma pigmentosum group G), [MONDO:0018169](http://purl.obolibrary.org/obo/MONDO_0018169) (morning glory syndrome), [MONDO:0003908](http://purl.obolibrary.org/obo/MONDO_0003908) (clivus meningioma), [MONDO:0018168](http://purl.obolibrary.org/obo/MONDO_0018168) (primary non-essential cutis verticis gyrata), [MONDO:0019499](http://purl.obolibrary.org/obo/MONDO_0019499) (Turner syndrome), [MONDO:0020485](http://purl.obolibrary.org/obo/MONDO_0020485) (king-Denborough syndrome), [MONDO:0019497](http://purl.obolibrary.org/obo/MONDO_0019497) (nonsyndromic deafness), [MONDO:0018163](http://purl.obolibrary.org/obo/MONDO_0018163) (autosomal recessive cutis laxa type 2A), [MONDO:0003901](http://purl.obolibrary.org/obo/MONDO_0003901) (cerebellar hemangioblastoma), [MONDO:0003902](http://purl.obolibrary.org/obo/MONDO_0003902) (brain stem hemangioblastoma), [MONDO:0020488](http://purl.obolibrary.org/obo/MONDO_0020488) (atypical progressive supranuclear palsy syndrome), [MONDO:0018161](http://purl.obolibrary.org/obo/MONDO_0018161) (non-hereditary retinoblastoma), [MONDO:0009218](http://purl.obolibrary.org/obo/MONDO_0009218) (Farber lipogranulomatosis), [MONDO:0018162](http://purl.obolibrary.org/obo/MONDO_0018162) (neurometabolic disorder due to serine deficiency), [MONDO:0019491](http://purl.obolibrary.org/obo/MONDO_0019491) (rare intellectual disability), [MONDO:0018160](http://purl.obolibrary.org/obo/MONDO_0018160) (hereditary retinoblastoma), [MONDO:0010208](http://purl.obolibrary.org/obo/MONDO_0010208) (Wrinkly skin syndrome), [MONDO:0011539](http://purl.obolibrary.org/obo/MONDO_0011539) (nemaline myopathy 5), [MONDO:0020480](http://purl.obolibrary.org/obo/MONDO_0020480) (sulfite oxidase deficiency due to molybdenum cofactor deficiency), [MONDO:0020481](http://purl.obolibrary.org/obo/MONDO_0020481) (myotonia fluctuans), [MONDO:0020482](http://purl.obolibrary.org/obo/MONDO_0020482) (myotonia permanens), [MONDO:0020483](http://purl.obolibrary.org/obo/MONDO_0020483) (Acetazolamide-responsive myotonia), [MONDO:0011534](http://purl.obolibrary.org/obo/MONDO_0011534) (Charcot-Marie-tooth disease type 4G), [MONDO:0010203](http://purl.obolibrary.org/obo/MONDO_0010203) (intellectual disability, Wolff type), [MONDO:0011533](http://purl.obolibrary.org/obo/MONDO_0011533) (temtamy preaxial brachydactyly syndrome), [MONDO:0010200](http://purl.obolibrary.org/obo/MONDO_0010200) (Wilson disease), [MONDO:0011532](http://purl.obolibrary.org/obo/MONDO_0011532) (hereditary spastic paraplegia 13), [MONDO:0006173](http://purl.obolibrary.org/obo/MONDO_0006173) (conjunctival squamous cell carcinoma), [MONDO:0011531](http://purl.obolibrary.org/obo/MONDO_0011531) (Noonan syndrome 2), [MONDO:0012869](http://purl.obolibrary.org/obo/MONDO_0012869) (mental retardation, autosomal dominant 22), [MONDO:0006172](http://purl.obolibrary.org/obo/MONDO_0006172) (conjunctival nevus), [MONDO:0011537](http://purl.obolibrary.org/obo/MONDO_0011537) (macrocephaly-autism syndrome), [MONDO:0011536](http://purl.obolibrary.org/obo/MONDO_0011536) (OPA4), [MONDO:0012867](http://purl.obolibrary.org/obo/MONDO_0012867) (hereditary spastic paraplegia 38), [MONDO:0012866](http://purl.obolibrary.org/obo/MONDO_0012866) (hereditary spastic paraplegia 35), [MONDO:0003918](http://purl.obolibrary.org/obo/MONDO_0003918) (angiomatous meningioma), [MONDO:0019487](http://purl.obolibrary.org/obo/MONDO_0019487) (epilepsy with myoclonic absences), [MONDO:0019488](http://purl.obolibrary.org/obo/MONDO_0019488) (myoclonic epilepsy in non-progressive encephalopathies), [MONDO:0019485](http://purl.obolibrary.org/obo/MONDO_0019485) (idiopathic hemiconvulsion-hemiplegia syndrome), [MONDO:0019486](http://purl.obolibrary.org/obo/MONDO_0019486) (myoclonic epilepsy of infancy), [MONDO:0018155](http://purl.obolibrary.org/obo/MONDO_0018155) (lateral sclerosis), [MONDO:0000889](http://purl.obolibrary.org/obo/MONDO_0000889) (haemophilus meningitis), [MONDO:0020476](http://purl.obolibrary.org/obo/MONDO_0020476) (mesial temporal lobe epilepsy with hippocampal sclerosis), [MONDO:0003912](http://purl.obolibrary.org/obo/MONDO_0003912) (malignant ciliary body melanoma), [MONDO:0018152](http://purl.obolibrary.org/obo/MONDO_0018152) (serpiginous choroiditis), [MONDO:0003913](http://purl.obolibrary.org/obo/MONDO_0003913) (choroid mixed cell melanoma), [MONDO:0019484](http://purl.obolibrary.org/obo/MONDO_0019484) (hypothalamic hamartomas with gelastic seizures), [MONDO:0018150](http://purl.obolibrary.org/obo/MONDO_0018150) (Gaucher disease), [MONDO:0003910](http://purl.obolibrary.org/obo/MONDO_0003910) (mixed cell uveal melanoma), [MONDO:0020478](http://purl.obolibrary.org/obo/MONDO_0020478) (Leber plus disease), [MONDO:0018151](http://purl.obolibrary.org/obo/MONDO_0018151) (coenzyme Q10 deficiency), [MONDO:0020479](http://purl.obolibrary.org/obo/MONDO_0020479) (pituitary gigantism), [MONDO:0003911](http://purl.obolibrary.org/obo/MONDO_0003911) (ciliary body mixed cell melanoma), [MONDO:0011529](http://purl.obolibrary.org/obo/MONDO_0011529) (spinocerebellar ataxia type 13), [MONDO:0020472](http://purl.obolibrary.org/obo/MONDO_0020472) (Turner syndrome due to structural X chromosome anomalies), [MONDO:0012854](http://purl.obolibrary.org/obo/MONDO_0012854) (bilateral microtia-deafness-cleft palate syndrome), [MONDO:0011523](http://purl.obolibrary.org/obo/MONDO_0011523) (Bardet-Biedl syndrome 6), [MONDO:0011522](http://purl.obolibrary.org/obo/MONDO_0011522) (hereditary spastic paraplegia 14), [MONDO:0012858](http://purl.obolibrary.org/obo/MONDO_0012858) (primary CD59 deficiency), [MONDO:0011527](http://purl.obolibrary.org/obo/MONDO_0011527) (Charcot-Marie-tooth disease type 4E), [MONDO:0012856](http://purl.obolibrary.org/obo/MONDO_0012856) (Birk-Barel syndrome), [MONDO:0012855](http://purl.obolibrary.org/obo/MONDO_0012855) (Joubert syndrome 8), [MONDO:0011592](http://purl.obolibrary.org/obo/MONDO_0011592) (EVR3), [MONDO:0009271](http://purl.obolibrary.org/obo/MONDO_0009271) (geroderma osteodysplastica), [MONDO:0010261](http://purl.obolibrary.org/obo/MONDO_0010261) (microphthalmia, syndromic 2), [MONDO:0011591](http://purl.obolibrary.org/obo/MONDO_0011591) (cataract 26 multiple types), [MONDO:0014620](http://purl.obolibrary.org/obo/MONDO_0014620) (myoclonic dystonia 26), [MONDO:0015952](http://purl.obolibrary.org/obo/MONDO_0015952) (genetic neurodegenerative disease), [MONDO:0010264](http://purl.obolibrary.org/obo/MONDO_0010264) (X-linked adrenal hypoplasia congenita), [MONDO:0010265](http://purl.obolibrary.org/obo/MONDO_0010265) (Simpson-Golabi-Behmel syndrome type 2), [MONDO:0009278](http://purl.obolibrary.org/obo/MONDO_0009278) (hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency), [MONDO:0010263](http://purl.obolibrary.org/obo/MONDO_0010263) (Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome), [MONDO:0011593](http://purl.obolibrary.org/obo/MONDO_0011593) (seizures, benign familial infantile, 2), [MONDO:0009279](http://purl.obolibrary.org/obo/MONDO_0009279) (triple-a syndrome), [MONDO:0001307](http://purl.obolibrary.org/obo/MONDO_0001307) (corneal abscess), [MONDO:0010268](http://purl.obolibrary.org/obo/MONDO_0010268) (X-linked lissencephaly with abnormal genitalia), [MONDO:0014626](http://purl.obolibrary.org/obo/MONDO_0014626) (spinocerebellar ataxia type 41), [MONDO:0015957](http://purl.obolibrary.org/obo/MONDO_0015957) (rare genetic movement disorder), [MONDO:0011599](http://purl.obolibrary.org/obo/MONDO_0011599) (birdshot chorioretinopathy), [MONDO:0010269](http://purl.obolibrary.org/obo/MONDO_0010269) (Coats disease), [MONDO:0014627](http://purl.obolibrary.org/obo/MONDO_0014627) (dystonia 27), [MONDO:0010266](http://purl.obolibrary.org/obo/MONDO_0010266) (mental retardation, X-linked 58), [MONDO:0014628](http://purl.obolibrary.org/obo/MONDO_0014628) (basal ganglia calcification, idiopathic, 6), [MONDO:0015954](http://purl.obolibrary.org/obo/MONDO_0015954) (rare genetic headache disorder), [MONDO:0015953](http://purl.obolibrary.org/obo/MONDO_0015953) (genetic central nervous system and retinal vascular disease), [MONDO:0014623](http://purl.obolibrary.org/obo/MONDO_0014623) (microcephaly 14, primary, autosomal recessive), [MONDO:0015955](http://purl.obolibrary.org/obo/MONDO_0015955) (rare genetic epilepsy), [MONDO:0009281](http://purl.obolibrary.org/obo/MONDO_0009281) (Glutaryl-CoA dehydrogenase deficiency), [MONDO:0014625](http://purl.obolibrary.org/obo/MONDO_0014625) (epileptic encephalopathy, early infantile, 33), [MONDO:0009260](http://purl.obolibrary.org/obo/MONDO_0009260) (GM1 gangliosidosis type 1), [MONDO:0011580](http://purl.obolibrary.org/obo/MONDO_0011580) (cerebellar ataxia and hypergonadotropic hypogonadism), [MONDO:0009261](http://purl.obolibrary.org/obo/MONDO_0009261) (GM1 gangliosidosis type 2), [MONDO:0010250](http://purl.obolibrary.org/obo/MONDO_0010250) (MRX49), [MONDO:0015941](http://purl.obolibrary.org/obo/MONDO_0015941) (epiphyseal dysplasia-hearing loss-dysmorphism syndrome), [MONDO:0009262](http://purl.obolibrary.org/obo/MONDO_0009262) (GM1 gangliosidosis type 3), [MONDO:0014610](http://purl.obolibrary.org/obo/MONDO_0014610) (lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome), [MONDO:0009263](http://purl.obolibrary.org/obo/MONDO_0009263) (GAPO syndrome), [MONDO:0010253](http://purl.obolibrary.org/obo/MONDO_0010253) (migraine, familial Typical, susceptibility to, 2), [MONDO:0011585](http://purl.obolibrary.org/obo/MONDO_0011585) (autosomal recessive distal spinal muscular atrophy 2), [MONDO:0009265](http://purl.obolibrary.org/obo/MONDO_0009265) (Gaucher's disease type I), [MONDO:0009266](http://purl.obolibrary.org/obo/MONDO_0009266) (Gaucher's disease type II), [MONDO:0011583](http://purl.obolibrary.org/obo/MONDO_0011583) (cerebral amyloid angiopathy, App-related), [MONDO:0010251](http://purl.obolibrary.org/obo/MONDO_0010251) (MRX50), [MONDO:0009267](http://purl.obolibrary.org/obo/MONDO_0009267) (Gaucher's disease type III), [MONDO:0010252](http://purl.obolibrary.org/obo/MONDO_0010252) (mental retardation, X-linked, with panhypopituitarism), [MONDO:0011582](http://purl.obolibrary.org/obo/MONDO_0011582) (multiple mitochondrial dysfunctions syndrome 1), [MONDO:0009268](http://purl.obolibrary.org/obo/MONDO_0009268) (Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome), [MONDO:0001316](http://purl.obolibrary.org/obo/MONDO_0001316) (streptococcal meningitis), [MONDO:0011589](http://purl.obolibrary.org/obo/MONDO_0011589) (MCOPCB2), [MONDO:0010258](http://purl.obolibrary.org/obo/MONDO_0010258) (MEHMO syndrome), [MONDO:0014617](http://purl.obolibrary.org/obo/MONDO_0014617) (mental retardation, autosomal dominant 38), [MONDO:0011587](http://purl.obolibrary.org/obo/MONDO_0011587) (cataract 25), [MONDO:0010256](http://purl.obolibrary.org/obo/MONDO_0010256) (mental retardation, X-linked 21), [MONDO:0014618](http://purl.obolibrary.org/obo/MONDO_0014618) (retinitis pigmentosa 71), [MONDO:0015943](http://purl.obolibrary.org/obo/MONDO_0015943) (eosinophilic granulomatosis with polyangiitis), [MONDO:0014611](http://purl.obolibrary.org/obo/MONDO_0014611) (multiple mitochondrial dysfunctions syndrome 4), [MONDO:0015942](http://purl.obolibrary.org/obo/MONDO_0015942) (frontometaphyseal dysplasia), [MONDO:0010259](http://purl.obolibrary.org/obo/MONDO_0010259) (retinitis pigmentosa 24), [MONDO:0014614](http://purl.obolibrary.org/obo/MONDO_0014614) (congenital stationary night blindness 1G), [MONDO:0011570](http://purl.obolibrary.org/obo/MONDO_0011570) (Charcot-Marie-tooth disease type 2B2), [MONDO:0009253](http://purl.obolibrary.org/obo/MONDO_0009253) (Fryns syndrome), [MONDO:0009255](http://purl.obolibrary.org/obo/MONDO_0009255) (galactokinase deficiency), [MONDO:0010241](http://purl.obolibrary.org/obo/MONDO_0010241) (congenital stationary night blindness 2A), [MONDO:0009257](http://purl.obolibrary.org/obo/MONDO_0009257) (galactose epimerase deficiency), [MONDO:0009258](http://purl.obolibrary.org/obo/MONDO_0009258) (classic galactosemia), [MONDO:0014608](http://purl.obolibrary.org/obo/MONDO_0014608) (mandibulofacial dysostosis with alopecia), [MONDO:0014609](http://purl.obolibrary.org/obo/MONDO_0014609) (cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome), [MONDO:0010246](http://purl.obolibrary.org/obo/MONDO_0010246) (early infantile epileptic encephalopathy 9), [MONDO:0014604](http://purl.obolibrary.org/obo/MONDO_0014604) (Parkinson disease 21), [MONDO:0010247](http://purl.obolibrary.org/obo/MONDO_0010247) (X-linked cerebral adrenoleukodystrophy), [MONDO:0014605](http://purl.obolibrary.org/obo/MONDO_0014605) (microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome), [MONDO:0014606](http://purl.obolibrary.org/obo/MONDO_0014606) (intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome), [MONDO:0010245](http://purl.obolibrary.org/obo/MONDO_0010245) (X-linked cone-rod dystrophy 2), [MONDO:0011575](http://purl.obolibrary.org/obo/MONDO_0011575) (Cerebrooculonasal syndrome), [MONDO:0015937](http://purl.obolibrary.org/obo/MONDO_0015937) (rare inflammatory eye disease), [MONDO:0014607](http://purl.obolibrary.org/obo/MONDO_0014607) (epileptic encephalopathy, early infantile, 32), [MONDO:0014600](http://purl.obolibrary.org/obo/MONDO_0014600) (dyskeratosis congenita, autosomal recessive 6), [MONDO:0014601](http://purl.obolibrary.org/obo/MONDO_0014601) (autosomal recessive spinocerebellar ataxia 20), [MONDO:0014602](http://purl.obolibrary.org/obo/MONDO_0014602) (intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome), [MONDO:0014603](http://purl.obolibrary.org/obo/MONDO_0014603) (autosomal dominant nonsyndromic deafness 40), [MONDO:0011579](http://purl.obolibrary.org/obo/MONDO_0011579) (late-onset retinal degenration), [MONDO:0012890](http://purl.obolibrary.org/obo/MONDO_0012890) (pontocerebellar hypoplasia type 2B), [MONDO:0009241](http://purl.obolibrary.org/obo/MONDO_0009241) (Fountain syndrome), [MONDO:0009242](http://purl.obolibrary.org/obo/MONDO_0009242) (brittle cornea syndrome), [MONDO:0010231](http://purl.obolibrary.org/obo/MONDO_0010231) (MRX20), [MONDO:0011562](http://purl.obolibrary.org/obo/MONDO_0011562) (autosomal dominant Parkinson disease 4), [MONDO:0012892](http://purl.obolibrary.org/obo/MONDO_0012892) (connective tissue disorder due to lysyl hydroxylase-3 deficiency), [MONDO:0011561](http://purl.obolibrary.org/obo/MONDO_0011561) (Alzheimer's disease 6), [MONDO:0009245](http://purl.obolibrary.org/obo/MONDO_0009245) (Friedreich ataxia), [MONDO:0012891](http://purl.obolibrary.org/obo/MONDO_0012891) (pontocerebellar hypoplasia type 2C), [MONDO:0010230](http://purl.obolibrary.org/obo/MONDO_0010230) (MRX23), [MONDO:0003958](http://purl.obolibrary.org/obo/MONDO_0003958) (childhood central nervous system immature teratoma), [MONDO:0018198](http://purl.obolibrary.org/obo/MONDO_0018198) (acute encephalopathy with biphasic seizures and late reduced diffusion), [MONDO:0009247](http://purl.obolibrary.org/obo/MONDO_0009247) (Frontofacionasal dysplasia), [MONDO:0018199](http://purl.obolibrary.org/obo/MONDO_0018199) (new-onset refractory status epilepticus), [MONDO:0018197](http://purl.obolibrary.org/obo/MONDO_0018197) (mitochondrial DNA depletion syndrome, hepatocerebrorenal form), [MONDO:0003957](http://purl.obolibrary.org/obo/MONDO_0003957) (adult pineoblastoma), [MONDO:0003952](http://purl.obolibrary.org/obo/MONDO_0003952) (adult central nervous system choriocarcinoma), [MONDO:0003953](http://purl.obolibrary.org/obo/MONDO_0003953) (pediatric CNS choriocarcinoma), [MONDO:0011567](http://purl.obolibrary.org/obo/MONDO_0011567) (dilated cardiomyopathy 1K), [MONDO:0010235](http://purl.obolibrary.org/obo/MONDO_0010235) (X-linked intellectual disability-psychosis-macroorchidism syndrome), [MONDO:0012898](http://purl.obolibrary.org/obo/MONDO_0012898) (NRCLP4), [MONDO:0010236](http://purl.obolibrary.org/obo/MONDO_0010236) (MRX14), [MONDO:0010233](http://purl.obolibrary.org/obo/MONDO_0010233) (heterotopia, periventricular, X-linked dominant), [MONDO:0012895](http://purl.obolibrary.org/obo/MONDO_0012895) (torsion dystonia 17), [MONDO:0011564](http://purl.obolibrary.org/obo/MONDO_0011564) (cone-rod dystrophy 8), [MONDO:0010239](http://purl.obolibrary.org/obo/MONDO_0010239) (lissencephaly type 1 due to doublecortin gene mutation), [MONDO:0015921](http://purl.obolibrary.org/obo/MONDO_0015921) (ARX-related epileptic encephalopathy), [MONDO:0015920](http://purl.obolibrary.org/obo/MONDO_0015920) (syndromic neurometabolic disease with X-linked intellectual disability), [MONDO:0011569](http://purl.obolibrary.org/obo/MONDO_0011569) (Charcot-Marie-tooth disease type 2B1), [MONDO:0010237](http://purl.obolibrary.org/obo/MONDO_0010237) (X-linked intellectual disability-plagiocephaly syndrome), [MONDO:0015923](http://purl.obolibrary.org/obo/MONDO_0015923) (acquired peripheral neuropathy), [MONDO:0011568](http://purl.obolibrary.org/obo/MONDO_0011568) (autosomal dominant nonsyndromic deafness 25), [MONDO:0010238](http://purl.obolibrary.org/obo/MONDO_0010238) (deafness, X-linked 4), [MONDO:0015922](http://purl.obolibrary.org/obo/MONDO_0015922) (channelopathy with epilepsy), [MONDO:0015994](http://purl.obolibrary.org/obo/MONDO_0015994) (muscular dystrophy-white matter spongiosis syndrome), [MONDO:0014662](http://purl.obolibrary.org/obo/MONDO_0014662) (congenital insensitivity to pain-hypohidrosis syndrome), [MONDO:0015993](http://purl.obolibrary.org/obo/MONDO_0015993) (cone-rod dystrophy), [MONDO:0014664](http://purl.obolibrary.org/obo/MONDO_0014664) (Joubert syndrome 23), [MONDO:0014665](http://purl.obolibrary.org/obo/MONDO_0014665) (Charcot-Marie-tooth disease axonal type 2V), [MONDO:0015990](http://purl.obolibrary.org/obo/MONDO_0015990) (focal, segmental or multifocal dystonia), [MONDO:0012003](http://purl.obolibrary.org/obo/MONDO_0012003) (autosomal recessive nonsyndromic deafness 39), [MONDO:0012002](http://purl.obolibrary.org/obo/MONDO_0012002) (autosomal recessive nonsyndromic deafness 40), [MONDO:0014660](http://purl.obolibrary.org/obo/MONDO_0014660) (microcephaly 15, primary, autosomal recessive), [MONDO:0005708](http://purl.obolibrary.org/obo/MONDO_0005708) (Colorado tick fever), [MONDO:0001347](http://purl.obolibrary.org/obo/MONDO_0001347) (facioscapulohumeral muscular dystrophy), [MONDO:0002675](http://purl.obolibrary.org/obo/MONDO_0002675) (neurofibrosarcoma), [MONDO:0013339](http://purl.obolibrary.org/obo/MONDO_0013339) (dilated cardiomyopathy 1GG), [MONDO:0014666](http://purl.obolibrary.org/obo/MONDO_0014666) (hypomyelinating leukodystrophy 11), [MONDO:0015998](http://purl.obolibrary.org/obo/MONDO_0015998) (isolated ectopia lentis), [MONDO:0015997](http://purl.obolibrary.org/obo/MONDO_0015997) (ectopia lentis-chorioretinal dystrophy-myopia syndrome), [MONDO:0013336](http://purl.obolibrary.org/obo/MONDO_0013336) (chromosome 19p13.13 deletion syndrome), [MONDO:0013337](http://purl.obolibrary.org/obo/MONDO_0013337) (neuropathy, hereditary sensory and autonomic, type 1C), [MONDO:0014669](http://purl.obolibrary.org/obo/MONDO_0014669) (cone-rod dystrophy 21), [MONDO:0013338](http://purl.obolibrary.org/obo/MONDO_0013338) (Charcot-Marie-tooth disease recessive intermediate b), [MONDO:0015983](http://purl.obolibrary.org/obo/MONDO_0015983) (rare genetic syndromic intellectual disability), [MONDO:0010293](http://purl.obolibrary.org/obo/MONDO_0010293) (hypohidrotic ectodermal dysplasia with immunodeficiency), [MONDO:0014651](http://purl.obolibrary.org/obo/MONDO_0014651) (acrofacial dysostosis Cincinnati type), [MONDO:0015982](http://purl.obolibrary.org/obo/MONDO_0015982) (rare genetic intellectual disability), [MONDO:0014652](http://purl.obolibrary.org/obo/MONDO_0014652) (exudative vitreoretinopathy 6), [MONDO:0013322](http://purl.obolibrary.org/obo/MONDO_0013322) (FAME3), [MONDO:0014653](http://purl.obolibrary.org/obo/MONDO_0014653) (retinitis pigmentosa 72), [MONDO:0014654](http://purl.obolibrary.org/obo/MONDO_0014654) (Ullrich congenital muscular dystrophy 2), [MONDO:0010298](http://purl.obolibrary.org/obo/MONDO_0010298) (Lesch-Nyhan syndrome), [MONDO:0014650](http://purl.obolibrary.org/obo/MONDO_0014650) (familial temporal lobe epilepsy 8), [MONDO:0005715](http://purl.obolibrary.org/obo/MONDO_0005715) (congenital toxoplasmosis), [MONDO:0005712](http://purl.obolibrary.org/obo/MONDO_0005712) (congenital nystagmus), [MONDO:0013328](http://purl.obolibrary.org/obo/MONDO_0013328) (retinitis pigmentosa 58), [MONDO:0010299](http://purl.obolibrary.org/obo/MONDO_0010299) (hypoxanthine guanine phosphoribosyltransferase partial deficiency), [MONDO:0014655](http://purl.obolibrary.org/obo/MONDO_0014655) (Bethlem myopathy 2), [MONDO:0013325](http://purl.obolibrary.org/obo/MONDO_0013325) (COG5-CDG), [MONDO:0014656](http://purl.obolibrary.org/obo/MONDO_0014656) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal recessive 2), [MONDO:0013326](http://purl.obolibrary.org/obo/MONDO_0013326) (Senior-Loken syndrome 7), [MONDO:0014640](http://purl.obolibrary.org/obo/MONDO_0014640) (FTDALS3), [MONDO:0009293](http://purl.obolibrary.org/obo/MONDO_0009293) (glycogen storage disease V), [MONDO:0014641](http://purl.obolibrary.org/obo/MONDO_0014641) (FTDALS4), [MONDO:0010283](http://purl.obolibrary.org/obo/MONDO_0010283) (syndromic X-linked intellectual disability Lubs type), [MONDO:0009295](http://purl.obolibrary.org/obo/MONDO_0009295) (glycogen storage disease VII), [MONDO:0010280](http://purl.obolibrary.org/obo/MONDO_0010280) (ptosis, hereditary congenital 2), [MONDO:0010281](http://purl.obolibrary.org/obo/MONDO_0010281) (Danon disease), [MONDO:0013312](http://purl.obolibrary.org/obo/MONDO_0013312) (retinitis pigmentosa 55), [MONDO:0014643](http://purl.obolibrary.org/obo/MONDO_0014643) (congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome), [MONDO:0010286](http://purl.obolibrary.org/obo/MONDO_0010286) (syndromic X-linked intellectual disability Siderius type), [MONDO:0010287](http://purl.obolibrary.org/obo/MONDO_0010287) (hereditary spastic paraplegia 16), [MONDO:0010284](http://purl.obolibrary.org/obo/MONDO_0010284) (Armfield syndrome), [MONDO:0010285](http://purl.obolibrary.org/obo/MONDO_0010285) (syndromic X-linked intellectual disability Abidi type), [MONDO:0003980](http://purl.obolibrary.org/obo/MONDO_0003980) (schwannoma of jugular foramen), [MONDO:0014648](http://purl.obolibrary.org/obo/MONDO_0014648) (Al-Raqad syndrome), [MONDO:0014649](http://purl.obolibrary.org/obo/MONDO_0014649) (mental retardation, autosomal recessive 50), [MONDO:0010289](http://purl.obolibrary.org/obo/MONDO_0010289) (mental retardation, X-linked 72), [MONDO:0014644](http://purl.obolibrary.org/obo/MONDO_0014644) (hereditary spastic paraplegia 74), [MONDO:0013314](http://purl.obolibrary.org/obo/MONDO_0013314) (retinitis pigmentosa 56), [MONDO:0013315](http://purl.obolibrary.org/obo/MONDO_0013315) (retinitis pigmentosa 57), [MONDO:0014646](http://purl.obolibrary.org/obo/MONDO_0014646) (Zimmermann-Laband syndrome 2), [MONDO:0014647](http://purl.obolibrary.org/obo/MONDO_0014647) (CAD-CDG), [MONDO:0013316](http://purl.obolibrary.org/obo/MONDO_0013316) (occult macular dystrophy), [MONDO:0009282](http://purl.obolibrary.org/obo/MONDO_0009282) (multiple acyl-CoA dehydrogenase deficiency), [MONDO:0010271](http://purl.obolibrary.org/obo/MONDO_0010271) (X-linked myotubular myopathy-abnormal genitalia syndrome), [MONDO:0009283](http://purl.obolibrary.org/obo/MONDO_0009283) (glutaric acidemia type 3), [MONDO:0010272](http://purl.obolibrary.org/obo/MONDO_0010272) (syndromic X-linked intellectual disability type 10), [MONDO:0010270](http://purl.obolibrary.org/obo/MONDO_0010270) (syndromic X-linked intellectual disability 7), [MONDO:0014632](http://purl.obolibrary.org/obo/MONDO_0014632) (hypomyelinating leukodystrophy 10), [MONDO:0001334](http://purl.obolibrary.org/obo/MONDO_0001334) (hypertrichosis of eyelid), [MONDO:0003994](http://purl.obolibrary.org/obo/MONDO_0003994) (vagina botryoid rhabdomyosarcoma), [MONDO:0003992](http://purl.obolibrary.org/obo/MONDO_0003992) (childhood botryoid rhabdomyosarcoma), [MONDO:0003993](http://purl.obolibrary.org/obo/MONDO_0003993) (childhood vagina botryoid rhabdomyosarcoma), [MONDO:0013307](http://purl.obolibrary.org/obo/MONDO_0013307) (myopathy, lactic acidosis, and sideroblastic anemia 2), [MONDO:0010277](http://purl.obolibrary.org/obo/MONDO_0010277) (syndromic X-linked intellectual disability Shashi type), [MONDO:0014639](http://purl.obolibrary.org/obo/MONDO_0014639) (familial temporal lobe epilepsy 7), [MONDO:0010278](http://purl.obolibrary.org/obo/MONDO_0010278) (Christianson syndrome), [MONDO:0015965](http://purl.obolibrary.org/obo/MONDO_0015965) (rare genetic refraction anomaly), [MONDO:0014633](http://purl.obolibrary.org/obo/MONDO_0014633) (myoclonic-atonic epilepsy), [MONDO:0009290](http://purl.obolibrary.org/obo/MONDO_0009290) (glycogen storage disease II), [MONDO:0015964](http://purl.obolibrary.org/obo/MONDO_0015964) (rare genetic palpebral, lacrimal system and conjunctival disease), [MONDO:0014635](http://purl.obolibrary.org/obo/MONDO_0014635) (microphthalmia, isolated, with coloboma 10), [MONDO:0009292](http://purl.obolibrary.org/obo/MONDO_0009292) (glycogen storage disease due to glycogen branching enzyme deficiency), [MONDO:0014636](http://purl.obolibrary.org/obo/MONDO_0014636) (combined oxidative phosphorylation defect type 25), [MONDO:0013305](http://purl.obolibrary.org/obo/MONDO_0013305) (autosomal dominant nonsyndromic deafness 51), [MONDO:0016401](http://purl.obolibrary.org/obo/MONDO_0016401) (energy metabolism disorder with epilepsy), [MONDO:0012043](http://purl.obolibrary.org/obo/MONDO_0012043) (Reis-Bucklers corneal dystrophy), [MONDO:0017732](http://purl.obolibrary.org/obo/MONDO_0017732) (alpha-mannosidosis, infantile form), [MONDO:0013376](http://purl.obolibrary.org/obo/MONDO_0013376) (microphthalmia, isolated, with coloboma 6), [MONDO:0016400](http://purl.obolibrary.org/obo/MONDO_0016400) (metal transport or utilization disorder with epilepsy), [MONDO:0016403](http://purl.obolibrary.org/obo/MONDO_0016403) (mitochondrial disease with peripheral neuropathy), [MONDO:0013377](http://purl.obolibrary.org/obo/MONDO_0013377) (isolated microphthalmia 7), [MONDO:0016402](http://purl.obolibrary.org/obo/MONDO_0016402) (mitochondrial disease with epilepsy), [MONDO:0017733](http://purl.obolibrary.org/obo/MONDO_0017733) (alpha-mannosidosis, adult form), [MONDO:0013371](http://purl.obolibrary.org/obo/MONDO_0013371) (dilated cardiomyopathy 1U), [MONDO:0017730](http://purl.obolibrary.org/obo/MONDO_0017730) (metachromatic leukodystrophy, adult form), [MONDO:0013373](http://purl.obolibrary.org/obo/MONDO_0013373) (dilated cardiomyopathy 1V), [MONDO:0012044](http://purl.obolibrary.org/obo/MONDO_0012044) (corneal dystrophy, lattice type 3A), [MONDO:0001386](http://purl.obolibrary.org/obo/MONDO_0001386) (visual epilepsy), [MONDO:0000050](http://purl.obolibrary.org/obo/MONDO_0000050) (isolated growth hormone deficiency), [MONDO:0013379](http://purl.obolibrary.org/obo/MONDO_0013379) (Noonan syndrome 7), [MONDO:0016405](http://purl.obolibrary.org/obo/MONDO_0016405) (sterol metabolism disorder with epilepsy), [MONDO:0016404](http://purl.obolibrary.org/obo/MONDO_0016404) (metabolic neurotransmission anomaly with epilepsy), [MONDO:0017737](http://purl.obolibrary.org/obo/MONDO_0017737) (intermediate severe Salla disease), [MONDO:0016406](http://purl.obolibrary.org/obo/MONDO_0016406) (other metabolic disease with epilepsy), [MONDO:0013364](http://purl.obolibrary.org/obo/MONDO_0013364) (Rubinstein-Taybi syndrome due to EP300 haploinsufficiency), [MONDO:0014695](http://purl.obolibrary.org/obo/MONDO_0014695) (glioma susceptibility 9), [MONDO:0017721](http://purl.obolibrary.org/obo/MONDO_0017721) (Sandhoff disease, infantile form), [MONDO:0017720](http://purl.obolibrary.org/obo/MONDO_0017720) (GM2 gangliosidosis), [MONDO:0014696](http://purl.obolibrary.org/obo/MONDO_0014696) (Cerebrooculofacioskeletal syndrome 3), [MONDO:0013365](http://purl.obolibrary.org/obo/MONDO_0013365) (autosomal recessive nonsyndromic deafness 83), [MONDO:0017723](http://purl.obolibrary.org/obo/MONDO_0017723) (Sandhoff disease, adult form), [MONDO:0012030](http://purl.obolibrary.org/obo/MONDO_0012030) (autosomal dominant nonsyndromic deafness 43), [MONDO:0017722](http://purl.obolibrary.org/obo/MONDO_0017722) (Sandhoff disease, juvenile form), [MONDO:0014698](http://purl.obolibrary.org/obo/MONDO_0014698) (microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome), [MONDO:0014691](http://purl.obolibrary.org/obo/MONDO_0014691) (Noonan syndrome 9), [MONDO:0014692](http://purl.obolibrary.org/obo/MONDO_0014692) (retinitis pigmentosa 74), [MONDO:0012034](http://purl.obolibrary.org/obo/MONDO_0012034) (autosomal dominant limb-girdle muscular dystrophy type 1F), [MONDO:0013362](http://purl.obolibrary.org/obo/MONDO_0013362) (THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome), [MONDO:0014693](http://purl.obolibrary.org/obo/MONDO_0014693) (Noonan syndrome 10), [MONDO:0012033](http://purl.obolibrary.org/obo/MONDO_0012033) (bradyopsia), [MONDO:0004429](http://purl.obolibrary.org/obo/MONDO_0004429) (skin meningioma), [MONDO:0014690](http://purl.obolibrary.org/obo/MONDO_0014690) (dyskeratosis congenita, autosomal dominant 6), [MONDO:0004426](http://purl.obolibrary.org/obo/MONDO_0004426) (frontal convexity meningioma), [MONDO:0004423](http://purl.obolibrary.org/obo/MONDO_0004423) (central nervous system osteosarcoma), [MONDO:0004422](http://purl.obolibrary.org/obo/MONDO_0004422) (cerebral falx meningioma), [MONDO:0001393](http://purl.obolibrary.org/obo/MONDO_0001393) (peripheral focal chorioretinitis), [MONDO:0017729](http://purl.obolibrary.org/obo/MONDO_0017729) (metachromatic leukodystrophy, late infantile form), [MONDO:0017728](http://purl.obolibrary.org/obo/MONDO_0017728) (Tay-Sachs disease, B1 variant), [MONDO:0001391](http://purl.obolibrary.org/obo/MONDO_0001391) (indeterminate leprosy), [MONDO:0012037](http://purl.obolibrary.org/obo/MONDO_0012037) (mental retardation, autosomal recessive 3), [MONDO:0017725](http://purl.obolibrary.org/obo/MONDO_0017725) (Tay-Sachs disease, b variant, juvenile form), [MONDO:0014699](http://purl.obolibrary.org/obo/MONDO_0014699) (mental retardation, autosomal dominant 40), [MONDO:0017724](http://purl.obolibrary.org/obo/MONDO_0017724) (Tay-Sachs disease, b variant, infantile form), [MONDO:0017726](http://purl.obolibrary.org/obo/MONDO_0017726) (Tay-Sachs disease, b variant, adult form), [MONDO:0014685](http://purl.obolibrary.org/obo/MONDO_0014685) (progressive myoclonic epilepsy type 9), [MONDO:0013354](http://purl.obolibrary.org/obo/MONDO_0013354) (spastic ataxia 4), [MONDO:0014687](http://purl.obolibrary.org/obo/MONDO_0014687) (retinitis pigmentosa 73), [MONDO:0014680](http://purl.obolibrary.org/obo/MONDO_0014680) (herpes simplex encephalitis, susceptibility to, 7), [MONDO:0012025](http://purl.obolibrary.org/obo/MONDO_0012025) (branchiootic syndrome 3), [MONDO:0012024](http://purl.obolibrary.org/obo/MONDO_0012024) (retinitis pigmentosa 26), [MONDO:0012023](http://purl.obolibrary.org/obo/MONDO_0012023) (autosomal dominant nonsyndromic deafness 49), [MONDO:0013351](http://purl.obolibrary.org/obo/MONDO_0013351) (infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly), [MONDO:0014683](http://purl.obolibrary.org/obo/MONDO_0014683) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9), [MONDO:0013352](http://purl.obolibrary.org/obo/MONDO_0013352) (intellectual disability-severe speech delay-mild dysmorphism syndrome), [MONDO:0005723](http://purl.obolibrary.org/obo/MONDO_0005723) (cryptococcal meningitis), [MONDO:0012029](http://purl.obolibrary.org/obo/MONDO_0012029) (microcephaly 6, primary, autosomal recessive), [MONDO:0017719](http://purl.obolibrary.org/obo/MONDO_0017719) (gangliosidosis), [MONDO:0012026](http://purl.obolibrary.org/obo/MONDO_0012026) (myotonia, potassium-aggravated), [MONDO:0013357](http://purl.obolibrary.org/obo/MONDO_0013357) (chromosome 17q11.2 deletion syndrome, 1.4Mb), [MONDO:0014688](http://purl.obolibrary.org/obo/MONDO_0014688) (short-rib thoracic dysplasia 14 with polydactyly), [MONDO:0013358](http://purl.obolibrary.org/obo/MONDO_0013358) (Seckel syndrome 4), [MONDO:0014689](http://purl.obolibrary.org/obo/MONDO_0014689) (Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome), [MONDO:0014673](http://purl.obolibrary.org/obo/MONDO_0014673) (cataract 44), [MONDO:0013342](http://purl.obolibrary.org/obo/MONDO_0013342) (hereditary spastic paraplegia 48), [MONDO:0013344](http://purl.obolibrary.org/obo/MONDO_0013344) (migraine, with or without aura, susceptibility to, 13), [MONDO:0014675](http://purl.obolibrary.org/obo/MONDO_0014675) (autosomal recessive nonsyndromic deafness 104), [MONDO:0017701](http://purl.obolibrary.org/obo/MONDO_0017701) (glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form), [MONDO:0014676](http://purl.obolibrary.org/obo/MONDO_0014676) (Emery-Dreifuss muscular dystrophy 3, autosomal recessive), [MONDO:0013345](http://purl.obolibrary.org/obo/MONDO_0013345) (d-2-Hydroxyglutaric aciduria 2), [MONDO:0017700](http://purl.obolibrary.org/obo/MONDO_0017700) (glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form), [MONDO:0012014](http://purl.obolibrary.org/obo/MONDO_0012014) (Charcot-Marie-tooth disease recessive intermediate a), [MONDO:0012013](http://purl.obolibrary.org/obo/MONDO_0012013) (glaucoma-ectopia-microspherophakia-stiff joints-short stature syndrome), [MONDO:0014671](http://purl.obolibrary.org/obo/MONDO_0014671) (neuropathy, hereditary motor and sensory, type 6B), [MONDO:0012012](http://purl.obolibrary.org/obo/MONDO_0012012) (Charcot-Marie-tooth disease dominant intermediate c), [MONDO:0013340](http://purl.obolibrary.org/obo/MONDO_0013340) (Parkinson disease 5, autosomal dominant, susceptibility to), [MONDO:0004407](http://purl.obolibrary.org/obo/MONDO_0004407) (stroma-dominant and stroma-poor composite ganglioneuroblastoma), [MONDO:0004408](http://purl.obolibrary.org/obo/MONDO_0004408) (schwannian stroma-rich and stroma-poor composite ganglioneuroblastoma), [MONDO:0005736](http://purl.obolibrary.org/obo/MONDO_0005736) (eastern equine encephalitis), [MONDO:0004406](http://purl.obolibrary.org/obo/MONDO_0004406) (adult central nervous system mixed germ cell tumor), [MONDO:0012018](http://purl.obolibrary.org/obo/MONDO_0012018) (myopathy, Myosin storage, autosomal dominant), [MONDO:0012015](http://purl.obolibrary.org/obo/MONDO_0012015) (NYS3), [MONDO:0014677](http://purl.obolibrary.org/obo/MONDO_0014677) (achromatopsia 7), [MONDO:0013346](http://purl.obolibrary.org/obo/MONDO_0013346) (brain calcification, Rajab type), [MONDO:0014678](http://purl.obolibrary.org/obo/MONDO_0014678) (mental retardation, autosomal dominant 39), [MONDO:0013348](http://purl.obolibrary.org/obo/MONDO_0013348) (cone-rod dystrophy 15), [MONDO:0014679](http://purl.obolibrary.org/obo/MONDO_0014679) (polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis), [MONDO:0017704](http://purl.obolibrary.org/obo/MONDO_0017704) (familial partial epilepsy), [MONDO:0013349](http://purl.obolibrary.org/obo/MONDO_0013349) (ALG11-CDG), [MONDO:0012086](http://purl.obolibrary.org/obo/MONDO_0012086) (autosomal dominant nonsyndromic deafness 31), [MONDO:0017778](http://purl.obolibrary.org/obo/MONDO_0017778) (lamellar ichthyosis), [MONDO:0012084](http://purl.obolibrary.org/obo/MONDO_0012084) (aromatic L-amino acid decarboxylase deficiency), [MONDO:0016446](http://purl.obolibrary.org/obo/MONDO_0016446) (acquired cutis laxa), [MONDO:0016441](http://purl.obolibrary.org/obo/MONDO_0016441) (acquired pseudoxanthoma elasticum), [MONDO:0012083](http://purl.obolibrary.org/obo/MONDO_0012083) (autosomal dominant nonsyndromic deafness 28), [MONDO:0008823](http://purl.obolibrary.org/obo/MONDO_0008823) (neurogenic arthrogryposis multiplex congenita), [MONDO:0012081](http://purl.obolibrary.org/obo/MONDO_0012081) (15q11q13 microduplication syndrome), [MONDO:0012080](http://purl.obolibrary.org/obo/MONDO_0012080) (neuronopathy, distal hereditary motor, type 2B), [MONDO:0004452](http://purl.obolibrary.org/obo/MONDO_0004452) (childhood central nervous system germinoma), [MONDO:0003122](http://purl.obolibrary.org/obo/MONDO_0003122) (striatonigral degeneration), [MONDO:0003121](http://purl.obolibrary.org/obo/MONDO_0003121) (middle cranial fossa meningioma), [MONDO:0000090](http://purl.obolibrary.org/obo/MONDO_0000090) (progressive external ophthalmoplegia with mitochondrial DNA deletions), [MONDO:0017779](http://purl.obolibrary.org/obo/MONDO_0017779) (alpha-N-acetylgalactosaminidase deficiency), [MONDO:0015102](http://purl.obolibrary.org/obo/MONDO_0015102) (non-secreting chemodectoma), [MONDO:0016433](http://purl.obolibrary.org/obo/MONDO_0016433) (dysmorphism-short stature-deafness-disorder of sex development syndrome), [MONDO:0015104](http://purl.obolibrary.org/obo/MONDO_0015104) (porphyria cutanea tarda), [MONDO:0012073](http://purl.obolibrary.org/obo/MONDO_0012073) (Ribose-5-P isomerase deficiency), [MONDO:0016430](http://purl.obolibrary.org/obo/MONDO_0016430) (BalC3 concentric sclerosis), [MONDO:0012078](http://purl.obolibrary.org/obo/MONDO_0012078) (Joubert syndrome 3), [MONDO:0015101](http://purl.obolibrary.org/obo/MONDO_0015101) (Marin-Amat syndrome), [MONDO:0012077](http://purl.obolibrary.org/obo/MONDO_0012077) (amyotrophic lateral sclerosis type 8), [MONDO:0016431](http://purl.obolibrary.org/obo/MONDO_0016431) (autosomal dominant Charcot-Marie-tooth disease type 2M), [MONDO:0008811](http://purl.obolibrary.org/obo/MONDO_0008811) (XK aprosencephaly), [MONDO:0012070](http://purl.obolibrary.org/obo/MONDO_0012070) (autosomal dominant Charcot-Marie-tooth disease type 2G), [MONDO:0008813](http://purl.obolibrary.org/obo/MONDO_0008813) (arachnoid cyst), [MONDO:0008816](http://purl.obolibrary.org/obo/MONDO_0008816) (Arnold-Chiari malformation type II), [MONDO:0008818](http://purl.obolibrary.org/obo/MONDO_0008818) (arterial tortuosity syndrome), [MONDO:0015107](http://purl.obolibrary.org/obo/MONDO_0015107) (rare genetic eye disease), [MONDO:0017768](http://purl.obolibrary.org/obo/MONDO_0017768) (reflex epilepsy), [MONDO:0015108](http://purl.obolibrary.org/obo/MONDO_0015108) (rare non-syndromic intellectual disability), [MONDO:0012064](http://purl.obolibrary.org/obo/MONDO_0012064) (choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome), [MONDO:0012062](http://purl.obolibrary.org/obo/MONDO_0012062) (dilated cardiomyopathy 1O), [MONDO:0016424](http://purl.obolibrary.org/obo/MONDO_0016424) (progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome), [MONDO:0012069](http://purl.obolibrary.org/obo/MONDO_0012069) (KTCN3), [MONDO:0013394](http://purl.obolibrary.org/obo/MONDO_0013394) (porencephaly-microcephaly-bilateral congenital cataract syndrome), [MONDO:0013395](http://purl.obolibrary.org/obo/MONDO_0013395) (retinitis pigmentosa 4), [MONDO:0016420](http://purl.obolibrary.org/obo/MONDO_0016420) (familial flecked retinopathy), [MONDO:0003109](http://purl.obolibrary.org/obo/MONDO_0003109) (foramen magnum meningioma), [MONDO:0013390](http://purl.obolibrary.org/obo/MONDO_0013390) (autosomal recessive limb-girdle muscular dystrophy type 2Q), [MONDO:0013391](http://purl.obolibrary.org/obo/MONDO_0013391) (leukoencephalopathy-dystonia-motor neuropathy syndrome), [MONDO:0013392](http://purl.obolibrary.org/obo/MONDO_0013392) (autosomal recessive spinocerebellar ataxia 10), [MONDO:0005769](http://purl.obolibrary.org/obo/MONDO_0005769) (geniculate herpes zoster), [MONDO:0008800](http://purl.obolibrary.org/obo/MONDO_0008800) (microphthalmia with limb anomalies), [MONDO:0012060](http://purl.obolibrary.org/obo/MONDO_0012060) (autosomal recessive nonsyndromic deafness 35), [MONDO:0004439](http://purl.obolibrary.org/obo/MONDO_0004439) (periocular meningioma), [MONDO:0005761](http://purl.obolibrary.org/obo/MONDO_0005761) (filarial elephantiasis), [MONDO:0008809](http://purl.obolibrary.org/obo/MONDO_0008809) (polyneuropathy-hand defect syndrome), [MONDO:0000075](http://purl.obolibrary.org/obo/MONDO_0000075) (neuronopathy, distal hereditary motor), [MONDO:0016429](http://purl.obolibrary.org/obo/MONDO_0016429) (Marburg acute multiple sclerosis), [MONDO:0016428](http://purl.obolibrary.org/obo/MONDO_0016428) (multiple sclerosis variant), [MONDO:0013386](http://purl.obolibrary.org/obo/MONDO_0013386) (autosomal recessive nonsyndromic deafness 74), [MONDO:0013387](http://purl.obolibrary.org/obo/MONDO_0013387) (KCNQ2-related epileptic encephalopathy), [MONDO:0012053](http://purl.obolibrary.org/obo/MONDO_0012053) (ANIB2), [MONDO:0012052](http://purl.obolibrary.org/obo/MONDO_0012052) (ALG1-CDG), [MONDO:0013388](http://purl.obolibrary.org/obo/MONDO_0013388) (epileptic encephalopathy, early infantile, 11), [MONDO:0016414](http://purl.obolibrary.org/obo/MONDO_0016414) (hypotrichosis-intellectual disability, Lopes type), [MONDO:0013389](http://purl.obolibrary.org/obo/MONDO_0013389) (epileptic encephalopathy, early infantile, 12), [MONDO:0013382](http://purl.obolibrary.org/obo/MONDO_0013382) (progressive demyelinating neuropathy with bilateral striatal necrosis), [MONDO:0012056](http://purl.obolibrary.org/obo/MONDO_0012056) (Leber congenital amaurosis 9), [MONDO:0013385](http://purl.obolibrary.org/obo/MONDO_0013385) (Treacher Collins syndrome 2), [MONDO:0013380](http://purl.obolibrary.org/obo/MONDO_0013380) (leopard syndrome 3), [MONDO:0013381](http://purl.obolibrary.org/obo/MONDO_0013381) (neuropathy, hereditary sensory, type 1D), [MONDO:0004447](http://purl.obolibrary.org/obo/MONDO_0004447) (pituitary stalk meningioma), [MONDO:0000087](http://purl.obolibrary.org/obo/MONDO_0000087) (polymicrogyria), [MONDO:0004446](http://purl.obolibrary.org/obo/MONDO_0004446) (olfactory groove meningioma), [MONDO:0005773](http://purl.obolibrary.org/obo/MONDO_0005773) (Gerstmann syndrome), [MONDO:0017746](http://purl.obolibrary.org/obo/MONDO_0017746) (atypical Rett syndrome), [MONDO:0016418](http://purl.obolibrary.org/obo/MONDO_0016418) (multiple system atrophy, cerebellar type), [MONDO:0019515](http://purl.obolibrary.org/obo/MONDO_0019515) (rare dementia), [MONDO:0020504](http://purl.obolibrary.org/obo/MONDO_0020504) (genetic recurrent myoglobinuria), [MONDO:0019516](http://purl.obolibrary.org/obo/MONDO_0019516) (exudative vitreoretinopathy), [MONDO:0020505](http://purl.obolibrary.org/obo/MONDO_0020505) (Ravine syndrome), [MONDO:0020506](http://purl.obolibrary.org/obo/MONDO_0020506) (ovarioleukodystrophy), [MONDO:0020507](http://purl.obolibrary.org/obo/MONDO_0020507) (Cree leukoencephalopathy), [MONDO:0020508](http://purl.obolibrary.org/obo/MONDO_0020508) (primary syringomyelia), [MONDO:0016485](http://purl.obolibrary.org/obo/MONDO_0016485) (Usher syndrome type 3), [MONDO:0020509](http://purl.obolibrary.org/obo/MONDO_0020509) (secondary syringomyelia), [MONDO:0016484](http://purl.obolibrary.org/obo/MONDO_0016484) (Usher syndrome type 2), [MONDO:0016487](http://purl.obolibrary.org/obo/MONDO_0016487) (beta-thalassemia intermedia), [MONDO:0016486](http://purl.obolibrary.org/obo/MONDO_0016486) (beta-thalassemia major), [MONDO:0015150](http://purl.obolibrary.org/obo/MONDO_0015150) (complex hereditary spastic paraplegia), [MONDO:0016483](http://purl.obolibrary.org/obo/MONDO_0016483) (intracranial berry aneurysm), [MONDO:0015151](http://purl.obolibrary.org/obo/MONDO_0015151) (autosomal dominant limb-girdle muscular dystrophy), [MONDO:0008864](http://purl.obolibrary.org/obo/MONDO_0008864) (Biemond syndrome type 2), [MONDO:0015152](http://purl.obolibrary.org/obo/MONDO_0015152) (autosomal recessive limb-girdle muscular dystrophy), [MONDO:0008865](http://purl.obolibrary.org/obo/MONDO_0008865) (Bietti crystalline corneoretinal dystrophy), [MONDO:0003168](http://purl.obolibrary.org/obo/MONDO_0003168) (pilocytic astrocytoma of cerebellum), [MONDO:0008869](http://purl.obolibrary.org/obo/MONDO_0008869) (Seckel syndrome 1), [MONDO:0003169](http://purl.obolibrary.org/obo/MONDO_0003169) (diencephalic astrocytomas), [MONDO:0003163](http://purl.obolibrary.org/obo/MONDO_0003163) (cauda equina intradural extramedullary astrocytoma), [MONDO:0007520](http://purl.obolibrary.org/obo/MONDO_0007520) (ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 1), [MONDO:0004495](http://purl.obolibrary.org/obo/MONDO_0004495) (myotonic cataract), [MONDO:0003165](http://purl.obolibrary.org/obo/MONDO_0003165) (cerebellar astrocytoma), [MONDO:0019517](http://purl.obolibrary.org/obo/MONDO_0019517) (Waardenburg syndrome type 2), [MONDO:0019518](http://purl.obolibrary.org/obo/MONDO_0019518) (Waardenburg-Shah syndrome), [MONDO:0019504](http://purl.obolibrary.org/obo/MONDO_0019504) (superior limbic keratoconjunctivitis), [MONDO:0015146](http://purl.obolibrary.org/obo/MONDO_0015146) (classic lissencephaly), [MONDO:0019505](http://purl.obolibrary.org/obo/MONDO_0019505) (hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome), [MONDO:0015147](http://purl.obolibrary.org/obo/MONDO_0015147) (other syndrome with lissencephaly as a major feature), [MONDO:0019502](http://purl.obolibrary.org/obo/MONDO_0019502) (autosomal recessive non-syndromic intellectual disability), [MONDO:0015148](http://purl.obolibrary.org/obo/MONDO_0015148) (lissencephaly type 3), [MONDO:0015149](http://purl.obolibrary.org/obo/MONDO_0015149) (pure hereditary spastic paraplegia), [MONDO:0000909](http://purl.obolibrary.org/obo/MONDO_0000909) (Bartter disease type 4b), [MONDO:0019503](http://purl.obolibrary.org/obo/MONDO_0019503) (anterior segment dysgenesis), [MONDO:0000902](http://purl.obolibrary.org/obo/MONDO_0000902) (agenesis of the corpus callosum with peripheral neuropathy), [MONDO:0015142](http://purl.obolibrary.org/obo/MONDO_0015142) (rare ataxia), [MONDO:0000903](http://purl.obolibrary.org/obo/MONDO_0000903) (myoclonus-dystonia syndrome), [MONDO:0015143](http://purl.obolibrary.org/obo/MONDO_0015143) (rare movement disorder), [MONDO:0019501](http://purl.obolibrary.org/obo/MONDO_0019501) (Usher syndrome), [MONDO:0015144](http://purl.obolibrary.org/obo/MONDO_0015144) (brain inflammatory disease), [MONDO:0015145](http://purl.obolibrary.org/obo/MONDO_0015145) (Neurovascular malformation), [MONDO:0015140](http://purl.obolibrary.org/obo/MONDO_0015140) (early-onset autosomal dominant Alzheimer disease), [MONDO:0008852](http://purl.obolibrary.org/obo/MONDO_0008852) (congenital central hypoventilation syndrome), [MONDO:0008853](http://purl.obolibrary.org/obo/MONDO_0008853) (Barber-Say syndrome), [MONDO:0015141](http://purl.obolibrary.org/obo/MONDO_0015141) (medullar disease), [MONDO:0008854](http://purl.obolibrary.org/obo/MONDO_0008854) (Bardet-Biedl syndrome 1), [MONDO:0007537](http://purl.obolibrary.org/obo/MONDO_0007537) (lateral meningocele syndrome), [MONDO:0008858](http://purl.obolibrary.org/obo/MONDO_0008858) (Behr syndrome), [MONDO:0003174](http://purl.obolibrary.org/obo/MONDO_0003174) (spinal cord astrocytoma), [MONDO:0006200](http://purl.obolibrary.org/obo/MONDO_0006200) (epithelioid cell uveal melanoma), [MONDO:0003171](http://purl.obolibrary.org/obo/MONDO_0003171) (pineal gland astrocytoma), [MONDO:0003173](http://purl.obolibrary.org/obo/MONDO_0003173) (brain stem astrocytic neoplasm), [MONDO:0016468](http://purl.obolibrary.org/obo/MONDO_0016468) (toxin-mediated infectious botulism), [MONDO:0017794](http://purl.obolibrary.org/obo/MONDO_0017794) (Xq12-q13.3 duplication syndrome), [MONDO:0008840](http://purl.obolibrary.org/obo/MONDO_0008840) (ataxia telangiectasia), [MONDO:0017792](http://purl.obolibrary.org/obo/MONDO_0017792) (7p22.1 microduplication syndrome), [MONDO:0008841](http://purl.obolibrary.org/obo/MONDO_0008841) (ataxia-telangiectasia with generalized skin pigmentation and early death), [MONDO:0008842](http://purl.obolibrary.org/obo/MONDO_0008842) (ataxia with oculomotor apraxia type 1), [MONDO:0007509](http://purl.obolibrary.org/obo/MONDO_0007509) (ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant), [MONDO:0007508](http://purl.obolibrary.org/obo/MONDO_0007508) (Rapp-Hodgkin syndrome), [MONDO:0008843](http://purl.obolibrary.org/obo/MONDO_0008843) (atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome), [MONDO:0007504](http://purl.obolibrary.org/obo/MONDO_0007504) (thickened earlobes-conductive deafness syndrome), [MONDO:0004477](http://purl.obolibrary.org/obo/MONDO_0004477) (adrenal gland ganglioneuroblastoma), [MONDO:0003144](http://purl.obolibrary.org/obo/MONDO_0003144) (medulloepithelioma), [MONDO:0015139](http://purl.obolibrary.org/obo/MONDO_0015139) (rare epilepsy), [MONDO:0012098](http://purl.obolibrary.org/obo/MONDO_0012098) (spinocerebellar ataxia type 20), [MONDO:0017786](http://purl.obolibrary.org/obo/MONDO_0017786) (2q23.1 microduplication syndrome), [MONDO:0012096](http://purl.obolibrary.org/obo/MONDO_0012096) (Charcot-Marie-tooth disease axonal type 2L), [MONDO:0017789](http://purl.obolibrary.org/obo/MONDO_0017789) (idiopathic linear interstitial keratitis), [MONDO:0012095](http://purl.obolibrary.org/obo/MONDO_0012095) (intellectual disability-brachydactyly-Pierre robin syndrome), [MONDO:0016457](http://purl.obolibrary.org/obo/MONDO_0016457) (ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome), [MONDO:0015120](http://purl.obolibrary.org/obo/MONDO_0015120) (rare acquired eye disease), [MONDO:0016452](http://purl.obolibrary.org/obo/MONDO_0016452) (idiopathic hypersomnia without long sleep time), [MONDO:0017782](http://purl.obolibrary.org/obo/MONDO_0017782) (developmental and speech delay due to SOX5 deficiency), [MONDO:0015121](http://purl.obolibrary.org/obo/MONDO_0015121) (rare eye tumor), [MONDO:0016451](http://purl.obolibrary.org/obo/MONDO_0016451) (idiopathic hypersomnia with long sleep time), [MONDO:0016454](http://purl.obolibrary.org/obo/MONDO_0016454) (severe early-onset axonal neuropathy due to NEFL deficiency), [MONDO:0016453](http://purl.obolibrary.org/obo/MONDO_0016453) (foodborne botulism), [MONDO:0012099](http://purl.obolibrary.org/obo/MONDO_0012099) (AICA-ribosiduria), [MONDO:0012090](http://purl.obolibrary.org/obo/MONDO_0012090) (autosomal dominant nonsyndromic deafness 47), [MONDO:0008830](http://purl.obolibrary.org/obo/MONDO_0008830) (aspartylglucosaminuria), [MONDO:0017780](http://purl.obolibrary.org/obo/MONDO_0017780) (20p13 microdeletion syndrome), [MONDO:0012092](http://purl.obolibrary.org/obo/MONDO_0012092) (hereditary sensory and autonomic neuropathy type 5), [MONDO:0012091](http://purl.obolibrary.org/obo/MONDO_0012091) (autosomal recessive nonsyndromic deafness 32), [MONDO:0007514](http://purl.obolibrary.org/obo/MONDO_0007514) (ectopia lentis 1, isolated, autosomal dominant), [MONDO:0008838](http://purl.obolibrary.org/obo/MONDO_0008838) (ataxia-deafness-intellectual disability syndrome), [MONDO:0003153](http://purl.obolibrary.org/obo/MONDO_0003153) (adult brain stem glioma), [MONDO:0003152](http://purl.obolibrary.org/obo/MONDO_0003152) (adult brainstem gliosarcoma), [MONDO:0016459](http://purl.obolibrary.org/obo/MONDO_0016459) (2q23.1 microdeletion syndrome), [MONDO:0000939](http://purl.obolibrary.org/obo/MONDO_0000939) (intracranial abscess), [MONDO:0020548](http://purl.obolibrary.org/obo/MONDO_0020548) (ocular pemphigoid), [MONDO:0018226](http://purl.obolibrary.org/obo/MONDO_0018226) (infantile epileptic-dyskinetic encephalopathy), [MONDO:0000936](http://purl.obolibrary.org/obo/MONDO_0000936) (syphilitic meningitis), [MONDO:0015198](http://purl.obolibrary.org/obo/MONDO_0015198) (aniridia-ptosis-intellectual disability-familial obesity syndrome), [MONDO:0000937](http://purl.obolibrary.org/obo/MONDO_0000937) (syphilitic encephalitis), [MONDO:0015199](http://purl.obolibrary.org/obo/MONDO_0015199) (aniridia-intellectual disability syndrome), [MONDO:0018222](http://purl.obolibrary.org/obo/MONDO_0018222) (X-linked intellectual disability due to GRIA3 anomalies), [MONDO:0019551](http://purl.obolibrary.org/obo/MONDO_0019551) (hereditary motor and sensory neuropathy type 6), [MONDO:0015196](http://purl.obolibrary.org/obo/MONDO_0015196) (vein of Galen aneurysm), [MONDO:0019550](http://purl.obolibrary.org/obo/MONDO_0019550) (hereditary motor and sensory neuropathy with acrodystrophy), [MONDO:0006239](http://purl.obolibrary.org/obo/MONDO_0006239) (head and neck paraganglioma), [MONDO:0012928](http://purl.obolibrary.org/obo/MONDO_0012928) (hereditary spastic paraplegia 42), [MONDO:0012927](http://purl.obolibrary.org/obo/MONDO_0012927) (chromosome 1q41-q42 deletion syndrome), [MONDO:0006238](http://purl.obolibrary.org/obo/MONDO_0006238) (growth hormone-producing pituitary gland adenoma), [MONDO:0007566](http://purl.obolibrary.org/obo/MONDO_0007566) (multiple self-healing squamous epithelioma), [MONDO:0007565](http://purl.obolibrary.org/obo/MONDO_0007565) (familial cylindromatosis), [MONDO:0012929](http://purl.obolibrary.org/obo/MONDO_0012929) (Compton-North congenital myopathy), [MONDO:0007560](http://purl.obolibrary.org/obo/MONDO_0007560) (reading seizures), [MONDO:0019548](http://purl.obolibrary.org/obo/MONDO_0019548) (autosomal dominant intermediate Charcot-Marie-tooth disease), [MONDO:0018217](http://purl.obolibrary.org/obo/MONDO_0018217) (Koolen-de Vries syndrome due to a point mutation), [MONDO:0018218](http://purl.obolibrary.org/obo/MONDO_0018218) (autosomal recessive cerebral atrophy), [MONDO:0019549](http://purl.obolibrary.org/obo/MONDO_0019549) (severe early-onset axonal neuropathy due to MFN2 deficiency), [MONDO:0018215](http://purl.obolibrary.org/obo/MONDO_0018215) (paraneoplastic neurologic syndrome), [MONDO:0018216](http://purl.obolibrary.org/obo/MONDO_0018216) (17q21.31 microdeletion syndrome), [MONDO:0008890](http://purl.obolibrary.org/obo/MONDO_0008890) (progressive bulbar palsy), [MONDO:0018213](http://purl.obolibrary.org/obo/MONDO_0018213) (hereditary sensory and autonomic neuropathy type 1), [MONDO:0008891](http://purl.obolibrary.org/obo/MONDO_0008891) (riboflavin transporter deficiency), [MONDO:0018214](http://purl.obolibrary.org/obo/MONDO_0018214) (generalized epilepsy with febrile seizures plus), [MONDO:0018211](http://purl.obolibrary.org/obo/MONDO_0018211) (Balint syndrome), [MONDO:0018212](http://purl.obolibrary.org/obo/MONDO_0018212) (familial cervical artery dissection), [MONDO:0008893](http://purl.obolibrary.org/obo/MONDO_0008893) (c syndrome), [MONDO:0019543](http://purl.obolibrary.org/obo/MONDO_0019543) (acquired aneurysmal subarachnoid hemorrhage), [MONDO:0008894](http://purl.obolibrary.org/obo/MONDO_0008894) (cataract-hypertrichosis-intellectual disability syndrome), [MONDO:0018210](http://purl.obolibrary.org/obo/MONDO_0018210) (Alexander disease type II), [MONDO:0000943](http://purl.obolibrary.org/obo/MONDO_0000943) (acute hydrops keratoconus), [MONDO:0019541](http://purl.obolibrary.org/obo/MONDO_0019541) (non-infectious posterior uveitis), [MONDO:0007574](http://purl.obolibrary.org/obo/MONDO_0007574) (spinocerebellar ataxia type 34), [MONDO:0007571](http://purl.obolibrary.org/obo/MONDO_0007571) (primary erythermalgia), [MONDO:0012913](http://purl.obolibrary.org/obo/MONDO_0012913) (wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome), [MONDO:0012912](http://purl.obolibrary.org/obo/MONDO_0012912) (pseudopseudohypoparathyroidism), [MONDO:0012911](http://purl.obolibrary.org/obo/MONDO_0012911) (pseudohypoparathyroidism type 1C), [MONDO:0018206](http://purl.obolibrary.org/obo/MONDO_0018206) (childhood-onset autosomal recessive myopathy with external ophthalmoplegia), [MONDO:0018207](http://purl.obolibrary.org/obo/MONDO_0018207) (2p13.2 microdeletion syndrome), [MONDO:0018204](http://purl.obolibrary.org/obo/MONDO_0018204) (20q11.2 microduplication syndrome), [MONDO:0018205](http://purl.obolibrary.org/obo/MONDO_0018205) (distal monosomy 1q), [MONDO:0000914](http://purl.obolibrary.org/obo/MONDO_0000914) (CADASIL 1), [MONDO:0018200](http://purl.obolibrary.org/obo/MONDO_0018200) (acute encephalopathy with inflammation-mediated status epilepticus), [MONDO:0000910](http://purl.obolibrary.org/obo/MONDO_0000910) (retinitis pigmentosa 6), [MONDO:0008885](http://purl.obolibrary.org/obo/MONDO_0008885) (Branchioskeletogenital syndrome), [MONDO:0000911](http://purl.obolibrary.org/obo/MONDO_0000911) (dilated cardiomyopathy 1T), [MONDO:0000912](http://purl.obolibrary.org/obo/MONDO_0000912) (autosomal recessive nonsyndromic deafness 5), [MONDO:0012905](http://purl.obolibrary.org/obo/MONDO_0012905) (hypomyelinating leukodystrophy 6), [MONDO:0012904](http://purl.obolibrary.org/obo/MONDO_0012904) (epilepsy, progressive myoclonic, 1B), [MONDO:0012903](http://purl.obolibrary.org/obo/MONDO_0012903) (autosomal recessive nonsyndromic deafness 45), [MONDO:0012907](http://purl.obolibrary.org/obo/MONDO_0012907) (blindness-scoliosis-arachnodactyly syndrome), [MONDO:0012902](http://purl.obolibrary.org/obo/MONDO_0012902) (autosomal dominant nonsyndromic deafness 27), [MONDO:0018208](http://purl.obolibrary.org/obo/MONDO_0018208) (neurofibromatosis type 1 due to NF1 mutation or intragenic deletion), [MONDO:0018209](http://purl.obolibrary.org/obo/MONDO_0018209) (Alexander disease type i), [MONDO:0000928](http://purl.obolibrary.org/obo/MONDO_0000928) (eyelid melanoma), [MONDO:0016499](http://purl.obolibrary.org/obo/MONDO_0016499) (acute pandysautonomia), [MONDO:0019524](http://purl.obolibrary.org/obo/MONDO_0019524) (infantile Bartter syndrome with sensorineural deafness), [MONDO:0019522](http://purl.obolibrary.org/obo/MONDO_0019522) (recessive dystrophic epidermolysis bullosa-generalized other), [MONDO:0016496](http://purl.obolibrary.org/obo/MONDO_0016496) (pharyngeal-cervical-brachial variant of Guillain-BarrC) syndrome), [MONDO:0019523](http://purl.obolibrary.org/obo/MONDO_0019523) (Walker-Warburg syndrome), [MONDO:0016495](http://purl.obolibrary.org/obo/MONDO_0016495) (functional variant of Guillain-BarrC) syndrome), [MONDO:0008870](http://purl.obolibrary.org/obo/MONDO_0008870) (bird headed-dwarfism, Montreal type), [MONDO:0016498](http://purl.obolibrary.org/obo/MONDO_0016498) (acute pure sensory neuropathy), [MONDO:0016497](http://purl.obolibrary.org/obo/MONDO_0016497) (Paraparetic variant of Guillain-BarrC) syndrome), [MONDO:0008871](http://purl.obolibrary.org/obo/MONDO_0008871) (microcephalic osteodysplastic primordial dwarfism type i), [MONDO:0008872](http://purl.obolibrary.org/obo/MONDO_0008872) (microcephalic osteodysplastic primordial dwarfism type II), [MONDO:0008873](http://purl.obolibrary.org/obo/MONDO_0008873) (microcephalic osteodysplastic primordial dwarfism, type 3), [MONDO:0015162](http://purl.obolibrary.org/obo/MONDO_0015162) (rare syndromic intellectual disability), [MONDO:0016494](http://purl.obolibrary.org/obo/MONDO_0016494) (regional variant of Guillain-BarrC) syndrome), [MONDO:0008875](http://purl.obolibrary.org/obo/MONDO_0008875) (blepharophimosis-ptosis-esotropia-syndactyly-short stature syndrome), [MONDO:0020510](http://purl.obolibrary.org/obo/MONDO_0020510) (idiopathic syringomyelia), [MONDO:0016493](http://purl.obolibrary.org/obo/MONDO_0016493) (variant of Guillain-Barre syndrome), [MONDO:0008879](http://purl.obolibrary.org/obo/MONDO_0008879) (Bowen-Conradi syndrome), [MONDO:0007559](http://purl.obolibrary.org/obo/MONDO_0007559) (PPR1), [MONDO:0007558](http://purl.obolibrary.org/obo/MONDO_0007558) (benign occipital epilepsy), [MONDO:0019529](http://purl.obolibrary.org/obo/MONDO_0019529) (radiation myelitis), [MONDO:0012960](http://purl.obolibrary.org/obo/MONDO_0012960) (mental retardation, autosomal dominant 5), [MONDO:0018266](http://purl.obolibrary.org/obo/MONDO_0018266) (ataxia-telangiectasia variant), [MONDO:0009310](http://purl.obolibrary.org/obo/MONDO_0009310) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2), [MONDO:0018267](http://purl.obolibrary.org/obo/MONDO_0018267) (combined cervical dystonia), [MONDO:0018264](http://purl.obolibrary.org/obo/MONDO_0018264) (oculocutaneous albinism type 6), [MONDO:0018265](http://purl.obolibrary.org/obo/MONDO_0018265) (rare disorder with dystonia and other neurologic or systemic manifestation), [MONDO:0009313](http://purl.obolibrary.org/obo/MONDO_0009313) (Grubben-de Cock-Borghgraef syndrome), [MONDO:0009314](http://purl.obolibrary.org/obo/MONDO_0009314) (GTP cyclohydrolase i deficiency), [MONDO:0019591](http://purl.obolibrary.org/obo/MONDO_0019591) (panhypopituitarism), [MONDO:0009316](http://purl.obolibrary.org/obo/MONDO_0009316) (hair defect-photosensitivity-intellectual disability syndrome), [MONDO:0009318](http://purl.obolibrary.org/obo/MONDO_0009318) (Hallermann-Streiff syndrome), [MONDO:0009319](http://purl.obolibrary.org/obo/MONDO_0009319) (pantothenate kinase-associated neurodegeneration), [MONDO:0010309](http://purl.obolibrary.org/obo/MONDO_0010309) (MRX42), [MONDO:0010307](http://purl.obolibrary.org/obo/MONDO_0010307) (MRX73), [MONDO:0011638](http://purl.obolibrary.org/obo/MONDO_0011638) (neuroferritinopathy), [MONDO:0011633](http://purl.obolibrary.org/obo/MONDO_0011633) (Charcot-Marie-tooth disease axonal type 2C), [MONDO:0010302](http://purl.obolibrary.org/obo/MONDO_0010302) (Ito hypomelanosis), [MONDO:0011632](http://purl.obolibrary.org/obo/MONDO_0011632) (amyotrophic lateral sclerosis type 21), [MONDO:0010300](http://purl.obolibrary.org/obo/MONDO_0010300) (MRX53), [MONDO:0011630](http://purl.obolibrary.org/obo/MONDO_0011630) (retinitis pigmentosa 28), [MONDO:0010305](http://purl.obolibrary.org/obo/MONDO_0010305) (creatine transporter deficiency), [MONDO:0012968](http://purl.obolibrary.org/obo/MONDO_0012968) (Usher syndrome type 1H), [MONDO:0010306](http://purl.obolibrary.org/obo/MONDO_0010306) (X-linked intellectual disability, Cabezas type), [MONDO:0010303](http://purl.obolibrary.org/obo/MONDO_0010303) (colobomatous microphthalmia), [MONDO:0011634](http://purl.obolibrary.org/obo/MONDO_0011634) (rippling muscle disease), [MONDO:0012965](http://purl.obolibrary.org/obo/MONDO_0012965) (BFIS4), [MONDO:0018257](http://purl.obolibrary.org/obo/MONDO_0018257) (familial syringomyelia), [MONDO:0019588](http://purl.obolibrary.org/obo/MONDO_0019588) (autosomal recessive nonsyndromic deafness), [MONDO:0019589](http://purl.obolibrary.org/obo/MONDO_0019589) (syndromic genetic deafness), [MONDO:0019586](http://purl.obolibrary.org/obo/MONDO_0019586) (X-linked nonsyndromic deafness), [MONDO:0019587](http://purl.obolibrary.org/obo/MONDO_0019587) (autosomal dominant nonsyndromic deafness), [MONDO:0009300](http://purl.obolibrary.org/obo/MONDO_0009300) (Perrault syndrome 1), [MONDO:0018253](http://purl.obolibrary.org/obo/MONDO_0018253) (intellectual disability-facial dysmorphism-hand anomalies syndrome), [MONDO:0009307](http://purl.obolibrary.org/obo/MONDO_0009307) (granulomatous disease with defect 1N neutrophil chemotaxis), [MONDO:0009308](http://purl.obolibrary.org/obo/MONDO_0009308) (granulomatous disease, chronic, autosomal recessive, cytochrome b-negative), [MONDO:0009309](http://purl.obolibrary.org/obo/MONDO_0009309) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1), [MONDO:0011629](http://purl.obolibrary.org/obo/MONDO_0011629) (MOGS-CDG), [MONDO:0006288](http://purl.obolibrary.org/obo/MONDO_0006288) (malignant adrenal gland pheochromocytoma), [MONDO:0020572](http://purl.obolibrary.org/obo/MONDO_0020572) (complex regional pain syndrome type 2), [MONDO:0012950](http://purl.obolibrary.org/obo/MONDO_0012950) (ANIB10), [MONDO:0011625](http://purl.obolibrary.org/obo/MONDO_0011625) (autosomal dominant nonsyndromic deafness 18), [MONDO:0011623](http://purl.obolibrary.org/obo/MONDO_0011623) (spinocerebellar ataxia, autosomal recessive 1), [MONDO:0018248](http://purl.obolibrary.org/obo/MONDO_0018248) (intellectual disability-seizures-macrocephaly-obesity syndrome), [MONDO:0018247](http://purl.obolibrary.org/obo/MONDO_0018247) (CADDS), [MONDO:0019573](http://purl.obolibrary.org/obo/MONDO_0019573) (autosomal recessive cutis laxa type 2), [MONDO:0018243](http://purl.obolibrary.org/obo/MONDO_0018243) (intellectual disability-hyperkinetic movement-truncal ataxia syndrome), [MONDO:0019571](http://purl.obolibrary.org/obo/MONDO_0019571) (autosomal dominant cutis laxa), [MONDO:0019572](http://purl.obolibrary.org/obo/MONDO_0019572) (autosomal recessive cutis laxa type 1), [MONDO:0019570](http://purl.obolibrary.org/obo/MONDO_0019570) (Cockayne syndrome type 2), [MONDO:0020569](http://purl.obolibrary.org/obo/MONDO_0020569) (intermediate DEND syndrome), [MONDO:0012949](http://purl.obolibrary.org/obo/MONDO_0012949) (ANIB9), [MONDO:0012948](http://purl.obolibrary.org/obo/MONDO_0012948) (chromosome 6pter-p24 deletion syndrome), [MONDO:0007589](http://purl.obolibrary.org/obo/MONDO_0007589) (exudative vitreoretinopathy 1), [MONDO:0012947](http://purl.obolibrary.org/obo/MONDO_0012947) (mental retardation, autosomal dominant 4), [MONDO:0011616](http://purl.obolibrary.org/obo/MONDO_0011616) (holoprosencephaly 6), [MONDO:0020560](http://purl.obolibrary.org/obo/MONDO_0020560) (atypical teratoid rhabdoid tumor), [MONDO:0012946](http://purl.obolibrary.org/obo/MONDO_0012946) (mental retardation, autosomal dominant 3), [MONDO:0012945](http://purl.obolibrary.org/obo/MONDO_0012945) (amyotrophic lateral sclerosis type 11), [MONDO:0011613](http://purl.obolibrary.org/obo/MONDO_0011613) (autosomal recessive early-onset Parkinson disease 6), [MONDO:0012943](http://purl.obolibrary.org/obo/MONDO_0012943) (retinitis pigmentosa 46), [MONDO:0011612](http://purl.obolibrary.org/obo/MONDO_0011612) (glycine encephalopathy), [MONDO:0020559](http://purl.obolibrary.org/obo/MONDO_0020559) (O'Sullivan-McLeod syndrome), [MONDO:0019569](http://purl.obolibrary.org/obo/MONDO_0019569) (Cockayne syndrome type 1), [MONDO:0019563](http://purl.obolibrary.org/obo/MONDO_0019563) (crest syndrome), [MONDO:0020558](http://purl.obolibrary.org/obo/MONDO_0020558) (autosomal dominant Charcot-Marie-tooth disease type 2K), [MONDO:0011607](http://purl.obolibrary.org/obo/MONDO_0011607) (NRCLP2), [MONDO:0011600](http://purl.obolibrary.org/obo/MONDO_0011600) (congenital myasthenic syndrome 4A), [MONDO:0006262](http://purl.obolibrary.org/obo/MONDO_0006262) (lacrimal gland adenoid cystic carcinoma), [MONDO:0007592](http://purl.obolibrary.org/obo/MONDO_0007592) (familial recurrent peripheral facial palsy), [MONDO:0011604](http://purl.obolibrary.org/obo/MONDO_0011604) (Spondylo-ocular syndrome), [MONDO:0011603](http://purl.obolibrary.org/obo/MONDO_0011603) (GNE myopathy), [MONDO:0011602](http://purl.obolibrary.org/obo/MONDO_0011602) (autosomal recessive nonsyndromic deafness 27), [MONDO:0009352](http://purl.obolibrary.org/obo/MONDO_0009352) (classic homocystinuria), [MONDO:0002718](http://purl.obolibrary.org/obo/MONDO_0002718) (central nervous system teratoma), [MONDO:0011673](http://purl.obolibrary.org/obo/MONDO_0011673) (autosomal dominant nonsyndromic deafness 30), [MONDO:0009353](http://purl.obolibrary.org/obo/MONDO_0009353) (homocystinuria due to methylene tetrahydrofolate reductase deficiency), [MONDO:0008023](http://purl.obolibrary.org/obo/MONDO_0008023) (muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome), [MONDO:0011671](http://purl.obolibrary.org/obo/MONDO_0011671) (Huntington disease-like 2), [MONDO:0009354](http://purl.obolibrary.org/obo/MONDO_0009354) (methylcobalamin deficiency type cblE), [MONDO:0008024](http://purl.obolibrary.org/obo/MONDO_0008024) (neuronopathy, distal hereditary motor, type 7A), [MONDO:0008025](http://purl.obolibrary.org/obo/MONDO_0008025) (neuronopathy, distal hereditary motor, type 2A), [MONDO:0008026](http://purl.obolibrary.org/obo/MONDO_0008026) (autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures), [MONDO:0008028](http://purl.obolibrary.org/obo/MONDO_0008028) (muscular dystrophy, Barnes type), [MONDO:0008029](http://purl.obolibrary.org/obo/MONDO_0008029) (Bethlem myopathy), [MONDO:0014708](http://purl.obolibrary.org/obo/MONDO_0014708) (ring chromosome 14), [MONDO:0014709](http://purl.obolibrary.org/obo/MONDO_0014709) (Heimler syndrome 2), [MONDO:0011676](http://purl.obolibrary.org/obo/MONDO_0011676) (PHACE syndrome), [MONDO:0010346](http://purl.obolibrary.org/obo/MONDO_0010346) (MRX52), [MONDO:0011675](http://purl.obolibrary.org/obo/MONDO_0011675) (Charcot-Marie-tooth disease dominant intermediate a), [MONDO:0014705](http://purl.obolibrary.org/obo/MONDO_0014705) (craniosynostosis 6), [MONDO:0011674](http://purl.obolibrary.org/obo/MONDO_0011674) (Charcot-Marie-tooth disease dominant intermediate b), [MONDO:0014706](http://purl.obolibrary.org/obo/MONDO_0014706) (cutis laxa, autosomal dominant 3), [MONDO:0010344](http://purl.obolibrary.org/obo/MONDO_0010344) (mental retardation, X-linked 45), [MONDO:0014700](http://purl.obolibrary.org/obo/MONDO_0014700) (neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to a point mutation), [MONDO:0010347](http://purl.obolibrary.org/obo/MONDO_0010347) (MRX84), [MONDO:0014702](http://purl.obolibrary.org/obo/MONDO_0014702) (hereditary spastic paraplegia 9B), [MONDO:0010330](http://purl.obolibrary.org/obo/MONDO_0010330) (primary ciliary dyskinesia-retinitis pigmentosa syndrome), [MONDO:0009341](http://purl.obolibrary.org/obo/MONDO_0009341) (Mowat-Wilson syndrome), [MONDO:0009342](http://purl.obolibrary.org/obo/MONDO_0009342) (Hirschsprung disease-deafness-polydactyly syndrome), [MONDO:0018299](http://purl.obolibrary.org/obo/MONDO_0018299) (sphingolipidosis with epilepsy), [MONDO:0011660](http://purl.obolibrary.org/obo/MONDO_0011660) (autosomal dominant nonsyndromic deafness 22), [MONDO:0012990](http://purl.obolibrary.org/obo/MONDO_0012990) (Leber congenital amaurosis 13), [MONDO:0018297](http://purl.obolibrary.org/obo/MONDO_0018297) (hypotonia-speech impairment-severe cognitive delay syndrome), [MONDO:0018295](http://purl.obolibrary.org/obo/MONDO_0018295) (congenital disorder of glycosylation with deafness as a major feature), [MONDO:0008018](http://purl.obolibrary.org/obo/MONDO_0008018) (Muir-Torre syndrome), [MONDO:0009349](http://purl.obolibrary.org/obo/MONDO_0009349) (holoprosencephaly 1), [MONDO:0010334](http://purl.obolibrary.org/obo/MONDO_0010334) (severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome), [MONDO:0012996](http://purl.obolibrary.org/obo/MONDO_0012996) (AGAT deficiency), [MONDO:0010335](http://purl.obolibrary.org/obo/MONDO_0010335) (X-linked cone-rod dystrophy 3), [MONDO:0010332](http://purl.obolibrary.org/obo/MONDO_0010332) (X-linked intellectual disability-cubitus valgus-dysmorphism syndrome), [MONDO:0012994](http://purl.obolibrary.org/obo/MONDO_0012994) (Dopa-responsive dystonia due to sepiapterin reductase deficiency), [MONDO:0010333](http://purl.obolibrary.org/obo/MONDO_0010333) (corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome), [MONDO:0011663](http://purl.obolibrary.org/obo/MONDO_0011663) (juvenile primary lateral sclerosis), [MONDO:0010338](http://purl.obolibrary.org/obo/MONDO_0010338) (X-linked distal spinal muscular atrophy type 3), [MONDO:0010339](http://purl.obolibrary.org/obo/MONDO_0010339) (X-linked epilepsy-learning disabilities-behavior disorders syndrome), [MONDO:0012999](http://purl.obolibrary.org/obo/MONDO_0012999) (guanidinoacetate methyltransferase deficiency), [MONDO:0010336](http://purl.obolibrary.org/obo/MONDO_0010336) (orofaciodigital syndrome VIII), [MONDO:0010337](http://purl.obolibrary.org/obo/MONDO_0010337) (X-linked intellectual disability-cerebellar hypoplasia syndrome), [MONDO:0012982](http://purl.obolibrary.org/obo/MONDO_0012982) (episodic ataxia type 6), [MONDO:0008000](http://purl.obolibrary.org/obo/MONDO_0008000) (migraine with or without aura, susceptibility to, 1), [MONDO:0010320](http://purl.obolibrary.org/obo/MONDO_0010320) (retinitis pigmentosa 23), [MONDO:0008002](http://purl.obolibrary.org/obo/MONDO_0008002) (mirror movements 1), [MONDO:0008003](http://purl.obolibrary.org/obo/MONDO_0008003) (autosomal dominant progressive external ophthalmoplegia), [MONDO:0018286](http://purl.obolibrary.org/obo/MONDO_0018286) (non-X-linked congenital disorder of glycosylation with intellectual disability as a major feature), [MONDO:0018287](http://purl.obolibrary.org/obo/MONDO_0018287) (congenital disorder of glycosylation with epilepsy as a major feature), [MONDO:0008005](http://purl.obolibrary.org/obo/MONDO_0008005) (Cardiospondylocarpofacial syndrome), [MONDO:0018284](http://purl.obolibrary.org/obo/MONDO_0018284) (congenital disorder of glycosylation with neurological involvement), [MONDO:0008006](http://purl.obolibrary.org/obo/MONDO_0008006) (Mobius syndrome), [MONDO:0009337](http://purl.obolibrary.org/obo/MONDO_0009337) (Hennekam lymphangiectasia-lymphedema syndrome 1), [MONDO:0018285](http://purl.obolibrary.org/obo/MONDO_0018285) (X-linked congenital disorder of glycosylation with intellectual disability as a major feature), [MONDO:0018282](http://purl.obolibrary.org/obo/MONDO_0018282) (qualitative or quantitative defects of alpha-dystroglycan), [MONDO:0018283](http://purl.obolibrary.org/obo/MONDO_0018283) (primary qualitative or quantitative defects of alpha-dystroglycan), [MONDO:0018280](http://purl.obolibrary.org/obo/MONDO_0018280) (muscle-eye-brain disease with bilateral multicystic leucodystrophy), [MONDO:0000995](http://purl.obolibrary.org/obo/MONDO_0000995) (familial periodic paralysis), [MONDO:0018281](http://purl.obolibrary.org/obo/MONDO_0018281) (congenital muscular dystrophy with hyperlaxity), [MONDO:0010329](http://purl.obolibrary.org/obo/MONDO_0010329) (MRX77), [MONDO:0011655](http://purl.obolibrary.org/obo/MONDO_0011655) (alveolar soft part sarcoma (disease)), [MONDO:0010323](http://purl.obolibrary.org/obo/MONDO_0010323) (Atkin-Flaitz syndrome), [MONDO:0012986](http://purl.obolibrary.org/obo/MONDO_0012986) (bilateral parasagittal parieto-occipital polymicrogyria), [MONDO:0010324](http://purl.obolibrary.org/obo/MONDO_0010324) (MRX81), [MONDO:0012984](http://purl.obolibrary.org/obo/MONDO_0012984) (PHARC syndrome), [MONDO:0011652](http://purl.obolibrary.org/obo/MONDO_0011652) (monosomy 22q13), [MONDO:0012983](http://purl.obolibrary.org/obo/MONDO_0012983) (cone-rod dystrophy 12), [MONDO:0010322](http://purl.obolibrary.org/obo/MONDO_0010322) (MRX2), [MONDO:0010327](http://purl.obolibrary.org/obo/MONDO_0010327) (HSD10 disease), [MONDO:0012989](http://purl.obolibrary.org/obo/MONDO_0012989) (microcephaly 7, primary, autosomal recessive), [MONDO:0011658](http://purl.obolibrary.org/obo/MONDO_0011658) (autosomal recessive early-onset Parkinson disease 7), [MONDO:0011657](http://purl.obolibrary.org/obo/MONDO_0011657) (autosomal dominant nonsyndromic deafness 24), [MONDO:0006291](http://purl.obolibrary.org/obo/MONDO_0006291) (malignant jugulotympanic paraganglioma), [MONDO:0010325](http://purl.obolibrary.org/obo/MONDO_0010325) (X-linked intellectual disability, Stocco dos Santos type), [MONDO:0010326](http://purl.obolibrary.org/obo/MONDO_0010326) (mental retardation, X-linked 46), [MONDO:0018279](http://purl.obolibrary.org/obo/MONDO_0018279) (congenital muscular dystrophy without intellectual disability), [MONDO:0011640](http://purl.obolibrary.org/obo/MONDO_0011640) (Genitopatellar syndrome), [MONDO:0009320](http://purl.obolibrary.org/obo/MONDO_0009320) (hall-Riggs syndrome), [MONDO:0018277](http://purl.obolibrary.org/obo/MONDO_0018277) (congenital muscular dystrophy with cerebellar involvement), [MONDO:0018278](http://purl.obolibrary.org/obo/MONDO_0018278) (congenital muscular dystrophy with intellectual disability), [MONDO:0018275](http://purl.obolibrary.org/obo/MONDO_0018275) (salt and pepper syndrome), [MONDO:0009324](http://purl.obolibrary.org/obo/MONDO_0009324) (Hartnup disease), [MONDO:0018276](http://purl.obolibrary.org/obo/MONDO_0018276) (muscular dystrophy-dystroglycanopathy), [MONDO:0018273](http://purl.obolibrary.org/obo/MONDO_0018273) (XYLT1-CDG), [MONDO:0009325](http://purl.obolibrary.org/obo/MONDO_0009325) (deafness-enamel hypoplasia-nail defects syndrome), [MONDO:0018274](http://purl.obolibrary.org/obo/MONDO_0018274) (GM3 synthase deficiency), [MONDO:0018271](http://purl.obolibrary.org/obo/MONDO_0018271) (peripheral primitive neuroectodermal tumor), [MONDO:0010319](http://purl.obolibrary.org/obo/MONDO_0010319) (syndromic X-linked intellectual disability Hedera type), [MONDO:0011644](http://purl.obolibrary.org/obo/MONDO_0011644) (pars planitis), [MONDO:0012975](http://purl.obolibrary.org/obo/MONDO_0012975) (autosomal dominant nonsyndromic deafness 3B), [MONDO:0012974](http://purl.obolibrary.org/obo/MONDO_0012974) (autosomal dominant nonsyndromic deafness 59), [MONDO:0010313](http://purl.obolibrary.org/obo/MONDO_0010313) (mental retardation, X-linked 63), [MONDO:0010311](http://purl.obolibrary.org/obo/MONDO_0010311) (Becker muscular dystrophy), [MONDO:0011648](http://purl.obolibrary.org/obo/MONDO_0011648) (meningioma, radiation-induced), [MONDO:0011647](http://purl.obolibrary.org/obo/MONDO_0011647) (Alzheimer's disease 7), [MONDO:0010317](http://purl.obolibrary.org/obo/MONDO_0010317) (mental retardation, X-linked, with or without seizures, Arx-related), [MONDO:0010314](http://purl.obolibrary.org/obo/MONDO_0010314) (BPPX), [MONDO:0012977](http://purl.obolibrary.org/obo/MONDO_0012977) (autosomal recessive nonsyndromic deafness 1B), [MONDO:0012976](http://purl.obolibrary.org/obo/MONDO_0012976) (autosomal dominant nonsyndromic deafness 2B), [MONDO:0008061](http://purl.obolibrary.org/obo/MONDO_0008061) (nail-patella syndrome), [MONDO:0008062](http://purl.obolibrary.org/obo/MONDO_0008062) (narcolepsy 1), [MONDO:0010382](http://purl.obolibrary.org/obo/MONDO_0010382) (fragile X-associated tremor/ataxia syndrome), [MONDO:0014740](http://purl.obolibrary.org/obo/MONDO_0014740) (autosomal dominant nonsyndromic deafness 68), [MONDO:0014741](http://purl.obolibrary.org/obo/MONDO_0014741) (facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation), [MONDO:0014742](http://purl.obolibrary.org/obo/MONDO_0014742) (Parkinson disease 22, autosomal dominant; PARK22), [MONDO:0013411](http://purl.obolibrary.org/obo/MONDO_0013411) (cataract 16 multiple types), [MONDO:0009398](http://purl.obolibrary.org/obo/MONDO_0009398) (hyperphosphatasia with mental retardation syndrome 1), [MONDO:0010383](http://purl.obolibrary.org/obo/MONDO_0010383) (fragile X syndrome), [MONDO:0008069](http://purl.obolibrary.org/obo/MONDO_0008069) (necrotizing encephalomyelopathy, subacute, of Leigh, adult), [MONDO:0021035](http://purl.obolibrary.org/obo/MONDO_0021035) (alopecia-mental retardation syndrome 1), [MONDO:0001426](http://purl.obolibrary.org/obo/MONDO_0001426) (mediastinum neurofibroma), [MONDO:0021037](http://purl.obolibrary.org/obo/MONDO_0021037) (genetic neurodegenerative disease with dementia), [MONDO:0002754](http://purl.obolibrary.org/obo/MONDO_0002754) (extramedullary plasmacytoma), [MONDO:0002756](http://purl.obolibrary.org/obo/MONDO_0002756) (solitary plasmacytoma of chest wall), [MONDO:0001424](http://purl.obolibrary.org/obo/MONDO_0001424) (sarcoid meningitis), [MONDO:0002755](http://purl.obolibrary.org/obo/MONDO_0002755) (solitary osseous plasmacytoma), [MONDO:0014748](http://purl.obolibrary.org/obo/MONDO_0014748) (progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome), [MONDO:0010388](http://purl.obolibrary.org/obo/MONDO_0010388) (rolandic epilepsy, mental retardation, and speech dyspraxia, X-linked), [MONDO:0014743](http://purl.obolibrary.org/obo/MONDO_0014743) (rhizomelic chondrodysplasia punctata type 5), [MONDO:0014744](http://purl.obolibrary.org/obo/MONDO_0014744) (acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome), [MONDO:0013413](http://purl.obolibrary.org/obo/MONDO_0013413) (retinitis pigmentosa 45), [MONDO:0014745](http://purl.obolibrary.org/obo/MONDO_0014745) (congenital myasthenic syndrome 19), [MONDO:0013414](http://purl.obolibrary.org/obo/MONDO_0013414) (retinitis pigmentosa 44), [MONDO:0008070](http://purl.obolibrary.org/obo/MONDO_0008070) (nemaline myopathy 3), [MONDO:0014746](http://purl.obolibrary.org/obo/MONDO_0014746) (SLC39A8-CDG), [MONDO:0008050](http://purl.obolibrary.org/obo/MONDO_0008050) (Laing early-onset distal myopathy), [MONDO:0010370](http://purl.obolibrary.org/obo/MONDO_0010370) (Cornelia de Lange syndrome 2), [MONDO:0008051](http://purl.obolibrary.org/obo/MONDO_0008051) (tubular aggregate myopathy), [MONDO:0010371](http://purl.obolibrary.org/obo/MONDO_0010371) (Aland island eye disease), [MONDO:0014730](http://purl.obolibrary.org/obo/MONDO_0014730) (microcephaly 16, primary, autosomal recessive; MCPH16), [MONDO:0014731](http://purl.obolibrary.org/obo/MONDO_0014731) (seizures-scoliosis-macrocephaly syndrome), [MONDO:0008054](http://purl.obolibrary.org/obo/MONDO_0008054) (juvenile dermatomyositis), [MONDO:0010374](http://purl.obolibrary.org/obo/MONDO_0010374) (retinitis pigmentosa 34), [MONDO:0008055](http://purl.obolibrary.org/obo/MONDO_0008055) (myotonia congenita, autosomal dominant), [MONDO:0010375](http://purl.obolibrary.org/obo/MONDO_0010375) (hyperekplexia-epilepsy syndrome), [MONDO:0008056](http://purl.obolibrary.org/obo/MONDO_0008056) (myotonic dystrophy type 1), [MONDO:0008058](http://purl.obolibrary.org/obo/MONDO_0008058) (cylindrical spirals myopathy), [MONDO:0021022](http://purl.obolibrary.org/obo/MONDO_0021022) (hereditary hyperekplexia), [MONDO:0013405](http://purl.obolibrary.org/obo/MONDO_0013405) (retinitis pigmentosa 49), [MONDO:0014736](http://purl.obolibrary.org/obo/MONDO_0014736) (Charcot-Marie-tooth disease axonal type 2Z), [MONDO:0010378](http://purl.obolibrary.org/obo/MONDO_0010378) (X-linked hereditary sensory and autonomic neuropathy with deafness), [MONDO:0010379](http://purl.obolibrary.org/obo/MONDO_0010379) (Brunner syndrome), [MONDO:0010376](http://purl.obolibrary.org/obo/MONDO_0010376) (Brooks-Wisniewski-brown syndrome), [MONDO:0013407](http://purl.obolibrary.org/obo/MONDO_0013407) (retinitis pigmentosa 47), [MONDO:0014738](http://purl.obolibrary.org/obo/MONDO_0014738) (autosomal dominant nonsyndromic deafness 69), [MONDO:0014739](http://purl.obolibrary.org/obo/MONDO_0014739) (autosomal recessive nonsyndromic deafness 97), [MONDO:0013401](http://purl.obolibrary.org/obo/MONDO_0013401) (hereditary spastic paraplegia 51), [MONDO:0014732](http://purl.obolibrary.org/obo/MONDO_0014732) (hypomyelinating leukodystrophy 12), [MONDO:0014733](http://purl.obolibrary.org/obo/MONDO_0014733) (Charcot-Marie-tooth disease type 4K), [MONDO:0013402](http://purl.obolibrary.org/obo/MONDO_0013402) (retinitis pigmentosa 27), [MONDO:0013404](http://purl.obolibrary.org/obo/MONDO_0013404) (hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase), [MONDO:0014735](http://purl.obolibrary.org/obo/MONDO_0014735) (Charcot-Marie-tooth disease type 2Y), [MONDO:0011691](http://purl.obolibrary.org/obo/MONDO_0011691) (amyotrophic lateral sclerosis type 3), [MONDO:0009370](http://purl.obolibrary.org/obo/MONDO_0009370) (L-2-hydroxyglutaric aciduria), [MONDO:0010360](http://purl.obolibrary.org/obo/MONDO_0010360) (PARK12), [MONDO:0009372](http://purl.obolibrary.org/obo/MONDO_0009372) (encephalopathy due to hydroxykynureninuria), [MONDO:0008041](http://purl.obolibrary.org/obo/MONDO_0008041) (myoclonic epilepsy, Hartung type), [MONDO:0014720](http://purl.obolibrary.org/obo/MONDO_0014720) (autosomal dominant optic atrophy plus syndrome), [MONDO:0008043](http://purl.obolibrary.org/obo/MONDO_0008043) (myoclonus-cerebellar ataxia-deafness syndrome), [MONDO:0011695](http://purl.obolibrary.org/obo/MONDO_0011695) (melanoma, uveal, susceptibility to, 1), [MONDO:0010363](http://purl.obolibrary.org/obo/MONDO_0010363) (mental retardation, X-linked 91), [MONDO:0008044](http://purl.obolibrary.org/obo/MONDO_0008044) (myoclonic dystonia 11), [MONDO:0010364](http://purl.obolibrary.org/obo/MONDO_0010364) (X-linked intellectual disability-retinitis pigmentosa syndrome), [MONDO:0011694](http://purl.obolibrary.org/obo/MONDO_0011694) (spinocerebellar ataxia type 15/16), [MONDO:0008045](http://purl.obolibrary.org/obo/MONDO_0008045) (spinal muscular atrophy-progressive myoclonic epilepsy syndrome), [MONDO:0010361](http://purl.obolibrary.org/obo/MONDO_0010361) (mental retardation, X-linked 30), [MONDO:0008046](http://purl.obolibrary.org/obo/MONDO_0008046) (autosomal dominant myoglobinuria), [MONDO:0010362](http://purl.obolibrary.org/obo/MONDO_0010362) (glycogen storage disease IXd), [MONDO:0011692](http://purl.obolibrary.org/obo/MONDO_0011692) (IBGC2), [MONDO:0009378](http://purl.obolibrary.org/obo/MONDO_0009378) (hyper-beta-alaninemia), [MONDO:0008047](http://purl.obolibrary.org/obo/MONDO_0008047) (episodic ataxia type 1), [MONDO:0008048](http://purl.obolibrary.org/obo/MONDO_0008048) (autosomal dominant centronuclear myopathy), [MONDO:0008049](http://purl.obolibrary.org/obo/MONDO_0008049) (myopathy, distal, infantile-onset), [MONDO:0021018](http://purl.obolibrary.org/obo/MONDO_0021018) (autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6)), [MONDO:0001400](http://purl.obolibrary.org/obo/MONDO_0001400) (schwannoma of ureter), [MONDO:0021019](http://purl.obolibrary.org/obo/MONDO_0021019) (X-linked recessive ocular albinism), [MONDO:0014729](http://purl.obolibrary.org/obo/MONDO_0014729) (hereditary spastic paraplegia 75), [MONDO:0021011](http://purl.obolibrary.org/obo/MONDO_0021011) (Hereditary progressive chorea without dementia), [MONDO:0014725](http://purl.obolibrary.org/obo/MONDO_0014725) (spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome), [MONDO:0014726](http://purl.obolibrary.org/obo/MONDO_0014726) (Charcot-Marie-tooth disease axonal type 2X), [MONDO:0010365](http://purl.obolibrary.org/obo/MONDO_0010365) (CFTDX), [MONDO:0011697](http://purl.obolibrary.org/obo/MONDO_0011697) (Waardenburg syndrome type 2C), [MONDO:0014728](http://purl.obolibrary.org/obo/MONDO_0014728) (combined oxidative phosphorylation defect type 27), [MONDO:0011696](http://purl.obolibrary.org/obo/MONDO_0011696) (melanoma, uveal, susceptibility to, 2), [MONDO:0014722](http://purl.obolibrary.org/obo/MONDO_0014722) (Roifman syndrome), [MONDO:0014723](http://purl.obolibrary.org/obo/MONDO_0014723) (PMP22-RAI1 contiguous gene duplication syndrome), [MONDO:0010369](http://purl.obolibrary.org/obo/MONDO_0010369) (NYS5), [MONDO:0014724](http://purl.obolibrary.org/obo/MONDO_0014724) (Joubert syndrome 24), [MONDO:0011680](http://purl.obolibrary.org/obo/MONDO_0011680) (autosomal recessive congenital ichthyosis 3), [MONDO:0009360](http://purl.obolibrary.org/obo/MONDO_0009360) (hydrocephalus, nonsyndromic, autosomal recessive 1), [MONDO:0008030](http://purl.obolibrary.org/obo/MONDO_0008030) (facioscapulohumeral muscular dystrophy 1), [MONDO:0009361](http://purl.obolibrary.org/obo/MONDO_0009361) (hydrocephalus due to congenital stenosis of aqueduct of sylvius), [MONDO:0008031](http://purl.obolibrary.org/obo/MONDO_0008031) (facioscapulohumeral muscular dystrophy 2), [MONDO:0008032](http://purl.obolibrary.org/obo/MONDO_0008032) (autosomal dominant limb-girdle muscular dystrophy type 1A), [MONDO:0010352](http://purl.obolibrary.org/obo/MONDO_0010352) (MRX82), [MONDO:0010353](http://purl.obolibrary.org/obo/MONDO_0010353) (deafness-intellectual disability, Martin-Probst type syndrome), [MONDO:0011683](http://purl.obolibrary.org/obo/MONDO_0011683) (oculocutaneous albinism type 4), [MONDO:0008033](http://purl.obolibrary.org/obo/MONDO_0008033) (autosomal dominant limb-girdle muscular dystrophy type 1B), [MONDO:0009364](http://purl.obolibrary.org/obo/MONDO_0009364) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1), [MONDO:0009365](http://purl.obolibrary.org/obo/MONDO_0009365) (hydrolethalus syndrome 1), [MONDO:0011682](http://purl.obolibrary.org/obo/MONDO_0011682) (episodic ataxia type 3), [MONDO:0008034](http://purl.obolibrary.org/obo/MONDO_0008034) (muscular dystrophy, pseudohypertrophic, with Internalized capillaries), [MONDO:0011681](http://purl.obolibrary.org/obo/MONDO_0011681) (episodic ataxia type 4), [MONDO:0009366](http://purl.obolibrary.org/obo/MONDO_0009366) (normal pressure hydrocephalus), [MONDO:0008036](http://purl.obolibrary.org/obo/MONDO_0008036) (myasthenia, limb-girdle, autoimmune), [MONDO:0008038](http://purl.obolibrary.org/obo/MONDO_0008038) (ataxia-pancytopenia syndrome), [MONDO:0002749](http://purl.obolibrary.org/obo/MONDO_0002749) (extracranial neuroblastoma), [MONDO:0008039](http://purl.obolibrary.org/obo/MONDO_0008039) (tropical spastic paraparesis), [MONDO:0014718](http://purl.obolibrary.org/obo/MONDO_0014718) (epileptic encephalopathy, early infantile, 34; EIEE34), [MONDO:0014719](http://purl.obolibrary.org/obo/MONDO_0014719) (ITPA-related encephalopathy), [MONDO:0011688](http://purl.obolibrary.org/obo/MONDO_0011688) (muscular dystrophy-dystroglycanopathy type B5), [MONDO:0014714](http://purl.obolibrary.org/obo/MONDO_0014714) (progressive microcephaly-seizures-cortical blindness-developmental delay syndrome), [MONDO:0010357](http://purl.obolibrary.org/obo/MONDO_0010357) (MRX78), [MONDO:0011687](http://purl.obolibrary.org/obo/MONDO_0011687) (Charcot-Marie-tooth disease axonal type 2F), [MONDO:0010354](http://purl.obolibrary.org/obo/MONDO_0010354) (Allan-Herndon-Dudley syndrome), [MONDO:0014716](http://purl.obolibrary.org/obo/MONDO_0014716) (macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome), [MONDO:0010355](http://purl.obolibrary.org/obo/MONDO_0010355) (syndromic X-linked intellectual disability Claes-Jensen type), [MONDO:0014717](http://purl.obolibrary.org/obo/MONDO_0014717) (early-onset Lafora body disease), [MONDO:0014711](http://purl.obolibrary.org/obo/MONDO_0014711) (Charcot-Marie-tooth disease, axonal type 2W), [MONDO:0014712](http://purl.obolibrary.org/obo/MONDO_0014712) (Senior-Loken syndrome 9; SLSN9), [MONDO:0013452](http://purl.obolibrary.org/obo/MONDO_0013452) (multisystemic smooth muscle dysfunction syndrome), [MONDO:0012120](http://purl.obolibrary.org/obo/MONDO_0012120) (pyruvate dehydrogenase phosphatase deficiency), [MONDO:0014784](http://purl.obolibrary.org/obo/MONDO_0014784) (severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome), [MONDO:0013453](http://purl.obolibrary.org/obo/MONDO_0013453) (Leber congenital amaurosis 8), [MONDO:0013454](http://purl.obolibrary.org/obo/MONDO_0013454) (Leber congenital amaurosis 11), [MONDO:0017811](http://purl.obolibrary.org/obo/MONDO_0017811) (severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion), [MONDO:0014785](http://purl.obolibrary.org/obo/MONDO_0014785) (microcephaly, short stature, and impaired glucose metabolism 2; MSSGM2), [MONDO:0012123](http://purl.obolibrary.org/obo/MONDO_0012123) (congenital disorder of glycosylation type 1E), [MONDO:0014780](http://purl.obolibrary.org/obo/MONDO_0014780) (hyperphosphatasia with mental retardation syndrome 6; HPMRS6), [MONDO:0012122](http://purl.obolibrary.org/obo/MONDO_0012122) (MYMY3), [MONDO:0013450](http://purl.obolibrary.org/obo/MONDO_0013450) (congenital stationary night blindness 1D), [MONDO:0013451](http://purl.obolibrary.org/obo/MONDO_0013451) (progressive myoclonic epilepsy type 5), [MONDO:0014782](http://purl.obolibrary.org/obo/MONDO_0014782) (autosomal recessive limb-girdle muscular dystrophy type 2X), [MONDO:0000136](http://purl.obolibrary.org/obo/MONDO_0000136) (keratosis follicularis spinulosa decalvans), [MONDO:0002797](http://purl.obolibrary.org/obo/MONDO_0002797) (childhood medulloblastoma), [MONDO:0002799](http://purl.obolibrary.org/obo/MONDO_0002799) (nodular medulloblastoma), [MONDO:0021072](http://purl.obolibrary.org/obo/MONDO_0021072) (sympathetic paraganglioma), [MONDO:0002794](http://purl.obolibrary.org/obo/MONDO_0002794) (adult medulloblastoma), [MONDO:0002793](http://purl.obolibrary.org/obo/MONDO_0002793) (medullomyoblastoma), [MONDO:0002796](http://purl.obolibrary.org/obo/MONDO_0002796) (melanotic medulloblastoma), [MONDO:0002792](http://purl.obolibrary.org/obo/MONDO_0002792) (cerebellar vermis medulloblastoma), [MONDO:0002791](http://purl.obolibrary.org/obo/MONDO_0002791) (large cell medulloblastoma), [MONDO:0017817](http://purl.obolibrary.org/obo/MONDO_0017817) (primary localized amyloidosis), [MONDO:0017816](http://purl.obolibrary.org/obo/MONDO_0017816) (primary systemic amyloidosis), [MONDO:0012127](http://purl.obolibrary.org/obo/MONDO_0012127) (autosomal recessive limb-girdle muscular dystrophy type 2J), [MONDO:0012125](http://purl.obolibrary.org/obo/MONDO_0012125) (hypomyelinating leukodystrophy 2), [MONDO:0013456](http://purl.obolibrary.org/obo/MONDO_0013456) (constitutional megaloblastic anemia with severe neurologic disease), [MONDO:0017813](http://purl.obolibrary.org/obo/MONDO_0017813) (van Maldergem syndrome), [MONDO:0014787](http://purl.obolibrary.org/obo/MONDO_0014787) (severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome), [MONDO:0014788](http://purl.obolibrary.org/obo/MONDO_0014788) (autosomal recessive limb-girdle muscular dystrophy type 2W), [MONDO:0013457](http://purl.obolibrary.org/obo/MONDO_0013457) (Leber congenital amaurosis 15), [MONDO:0017815](http://purl.obolibrary.org/obo/MONDO_0017815) (acquired porencephaly), [MONDO:0014773](http://purl.obolibrary.org/obo/MONDO_0014773) (cardiac anomalies-developmental delay-facial dysmorphism syndrome), [MONDO:0014774](http://purl.obolibrary.org/obo/MONDO_0014774) (neuroblastoma, susceptibility to, 7; NBLST7), [MONDO:0013443](http://purl.obolibrary.org/obo/MONDO_0013443) (Seckel syndrome 5), [MONDO:0008097](http://purl.obolibrary.org/obo/MONDO_0008097) (linear nevus sebaceus syndrome), [MONDO:0008099](http://purl.obolibrary.org/obo/MONDO_0008099) (congenital stationary night blindness autosomal dominant 2), [MONDO:0014770](http://purl.obolibrary.org/obo/MONDO_0014770) (Joubert syndrome 25), [MONDO:0013440](http://purl.obolibrary.org/obo/MONDO_0013440) (autosomal recessive limb-girdle muscular dystrophy type 2P), [MONDO:0014771](http://purl.obolibrary.org/obo/MONDO_0014771) (Joubert syndrome 26), [MONDO:0004502](http://purl.obolibrary.org/obo/MONDO_0004502) (parapharyngeal meningioma), [MONDO:0004503](http://purl.obolibrary.org/obo/MONDO_0004503) (upper clivus meningioma), [MONDO:0021061](http://purl.obolibrary.org/obo/MONDO_0021061) (neurofibromatosis), [MONDO:0017809](http://purl.obolibrary.org/obo/MONDO_0017809) (parkinsonism due to ATP13A2 deficiency), [MONDO:0021064](http://purl.obolibrary.org/obo/MONDO_0021064) (jugulotympanic paraganglioma), [MONDO:0001471](http://purl.obolibrary.org/obo/MONDO_0001471) (histoplasmosis meningitis), [MONDO:0012117](http://purl.obolibrary.org/obo/MONDO_0012117) (ALG9-CDG), [MONDO:0017806](http://purl.obolibrary.org/obo/MONDO_0017806) (15q overgrowth syndrome), [MONDO:0013449](http://purl.obolibrary.org/obo/MONDO_0013449) (Leber congenital amaurosis 7), [MONDO:0017805](http://purl.obolibrary.org/obo/MONDO_0017805) (intellectual disability-hypotonia-brachycephaly-pyloric stenosis-cryptorchidism syndrome), [MONDO:0012116](http://purl.obolibrary.org/obo/MONDO_0012116) (spinocerebellar ataxia type 8), [MONDO:0017808](http://purl.obolibrary.org/obo/MONDO_0017808) (duplication of the pituitary gland), [MONDO:0014776](http://purl.obolibrary.org/obo/MONDO_0014776) (spinocerebellar ataxia type 42), [MONDO:0014777](http://purl.obolibrary.org/obo/MONDO_0014777) (hypotonia, infantile, with psychomotor retardation and characteristic facies 2; IHPRF2), [MONDO:0013446](http://purl.obolibrary.org/obo/MONDO_0013446) (Leber congenital amaurosis 6), [MONDO:0017804](http://purl.obolibrary.org/obo/MONDO_0017804) (autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome), [MONDO:0013447](http://purl.obolibrary.org/obo/MONDO_0013447) (retinitis pigmentosa 48), [MONDO:0012118](http://purl.obolibrary.org/obo/MONDO_0012118) (COG7-CDG), [MONDO:0013448](http://purl.obolibrary.org/obo/MONDO_0013448) (GEFSP8), [MONDO:0017803](http://purl.obolibrary.org/obo/MONDO_0017803) (primary progressive apraxia of speech), [MONDO:0008083](http://purl.obolibrary.org/obo/MONDO_0008083) (neuronal ceroid lipofuscinosis 4B), [MONDO:0013430](http://purl.obolibrary.org/obo/MONDO_0013430) (Meier-Gorlin syndrome 3), [MONDO:0013431](http://purl.obolibrary.org/obo/MONDO_0013431) (Meier-Gorlin syndrome 4), [MONDO:0013432](http://purl.obolibrary.org/obo/MONDO_0013432) (Meier-Gorlin syndrome 5), [MONDO:0008086](http://purl.obolibrary.org/obo/MONDO_0008086) (neuropathy, hereditary sensory and autonomic, type 1A), [MONDO:0014764](http://purl.obolibrary.org/obo/MONDO_0014764) (spastic paraplegia-severe developmental delay-epilepsy syndrome), [MONDO:0008087](http://purl.obolibrary.org/obo/MONDO_0008087) (hereditary neuropathy with liability to pressure palsies), [MONDO:0005808](http://purl.obolibrary.org/obo/MONDO_0005808) (inclusion conjunctivitis), [MONDO:0002772](http://purl.obolibrary.org/obo/MONDO_0002772) (intraventricular meningioma), [MONDO:0021052](http://purl.obolibrary.org/obo/MONDO_0021052) (parasympathetic paraganglioma), [MONDO:0002773](http://purl.obolibrary.org/obo/MONDO_0002773) (third ventricle chordoid glioma), [MONDO:0021053](http://purl.obolibrary.org/obo/MONDO_0021053) (carotid body paraganglioma), [MONDO:0013438](http://purl.obolibrary.org/obo/MONDO_0013438) (pontocerebellar hypoplasia type 2D), [MONDO:0012106](http://purl.obolibrary.org/obo/MONDO_0012106) (microcephaly 5, primary, autosomal recessive), [MONDO:0012105](http://purl.obolibrary.org/obo/MONDO_0012105) (Wegener's granulomatosis), [MONDO:0012103](http://purl.obolibrary.org/obo/MONDO_0012103) (spinocerebellar ataxia type 25), [MONDO:0014767](http://purl.obolibrary.org/obo/MONDO_0014767) (Seckel syndrome 9; SCKL9), [MONDO:0013436](http://purl.obolibrary.org/obo/MONDO_0013436) (retinitis pigmentosa 39), [MONDO:0014768](http://purl.obolibrary.org/obo/MONDO_0014768) (CADASIL 2), [MONDO:0013437](http://purl.obolibrary.org/obo/MONDO_0013437) (retinitis pigmentosa 43), [MONDO:0010392](http://purl.obolibrary.org/obo/MONDO_0010392) (glycogen storage disease due to phosphoglycerate kinase 1 deficiency), [MONDO:0010393](http://purl.obolibrary.org/obo/MONDO_0010393) (mental retardation, X-linked 93), [MONDO:0014751](http://purl.obolibrary.org/obo/MONDO_0014751) (palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome), [MONDO:0010390](http://purl.obolibrary.org/obo/MONDO_0010390) (ocular albinism with late-onset sensorineural deafness), [MONDO:0008075](http://purl.obolibrary.org/obo/MONDO_0008075) (neurofibromatosis type 3), [MONDO:0014753](http://purl.obolibrary.org/obo/MONDO_0014753) (autosomal recessive isolated optic atrophy), [MONDO:0008076](http://purl.obolibrary.org/obo/MONDO_0008076) (amyotrophic neuralgia), [MONDO:0010396](http://purl.obolibrary.org/obo/MONDO_0010396) (epileptic encephalopathy, early infantile, 2), [MONDO:0010397](http://purl.obolibrary.org/obo/MONDO_0010397) (severe neonatal-onset encephalopathy with microcephaly), [MONDO:0010394](http://purl.obolibrary.org/obo/MONDO_0010394) (leukoencephalopathy-metaphyseal chondrodysplasia syndrome), [MONDO:0008078](http://purl.obolibrary.org/obo/MONDO_0008078) (neurofibromatosis, familial spinal), [MONDO:0010395](http://purl.obolibrary.org/obo/MONDO_0010395) (phosphoribosylpyrophosphate synthetase superactivity), [MONDO:0002787](http://purl.obolibrary.org/obo/MONDO_0002787) (adamantinous craniopharyngioma), [MONDO:0002788](http://purl.obolibrary.org/obo/MONDO_0002788) (papillary craniopharyngioma), [MONDO:0014759](http://purl.obolibrary.org/obo/MONDO_0014759) (mental retardation, autosomal recessive 51; MRT51), [MONDO:0013428](http://purl.obolibrary.org/obo/MONDO_0013428) (Meier-Gorlin syndrome 2), [MONDO:0010398](http://purl.obolibrary.org/obo/MONDO_0010398) (syndromic X-linked intellectual disability 14), [MONDO:0013429](http://purl.obolibrary.org/obo/MONDO_0013429) (retinitis pigmentosa 40), [MONDO:0014754](http://purl.obolibrary.org/obo/MONDO_0014754) (coenzyme Q10 deficiency, primary, 8; COQ10D8), [MONDO:0013424](http://purl.obolibrary.org/obo/MONDO_0013424) (3p- syndrome), [MONDO:0008080](http://purl.obolibrary.org/obo/MONDO_0008080) (neurofibromatosis, type III, mixed central and peripheral), [MONDO:0008081](http://purl.obolibrary.org/obo/MONDO_0008081) (neurofibromatosis, type IV, of Riccardi), [MONDO:0013425](http://purl.obolibrary.org/obo/MONDO_0013425) (retinitis pigmentosa 20), [MONDO:0016522](http://purl.obolibrary.org/obo/MONDO_0016522) (Kousseff syndrome), [MONDO:0017852](http://purl.obolibrary.org/obo/MONDO_0017852) (infantile spasms-broad thumbs syndrome), [MONDO:0012162](http://purl.obolibrary.org/obo/MONDO_0012162) (patterned macular dystrophy 2), [MONDO:0013492](http://purl.obolibrary.org/obo/MONDO_0013492) (APMR3), [MONDO:0013495](http://purl.obolibrary.org/obo/MONDO_0013495) (autosomal recessive congenital ichthyosis 8), [MONDO:0017850](http://purl.obolibrary.org/obo/MONDO_0017850) (sirenomelia), [MONDO:0013490](http://purl.obolibrary.org/obo/MONDO_0013490) (megalencephalic leukoencephalopathy with subcortical cysts 2A), [MONDO:0013491](http://purl.obolibrary.org/obo/MONDO_0013491) (megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, With or without mental retardation), [MONDO:0000179](http://purl.obolibrary.org/obo/MONDO_0000179) (Neu-Laxova syndrome), [MONDO:0008901](http://purl.obolibrary.org/obo/MONDO_0008901) (Tel Hashomer camptodactyly syndrome), [MONDO:0003202](http://purl.obolibrary.org/obo/MONDO_0003202) (pituitary gland basophilic carcinoma), [MONDO:0000171](http://purl.obolibrary.org/obo/MONDO_0000171) (muscular dystrophy-dystroglycanopathy, type A), [MONDO:0008907](http://purl.obolibrary.org/obo/MONDO_0008907) (PMM2-CDG), [MONDO:0000172](http://purl.obolibrary.org/obo/MONDO_0000172) (muscular dystrophy-dystroglycanopathy, type B), [MONDO:0008908](http://purl.obolibrary.org/obo/MONDO_0008908) (MGAT2-CDG), [MONDO:0000173](http://purl.obolibrary.org/obo/MONDO_0000173) (muscular dystrophy-dystroglycanopathy, type C), [MONDO:0016526](http://purl.obolibrary.org/obo/MONDO_0016526) (trisomy 9p), [MONDO:0017857](http://purl.obolibrary.org/obo/MONDO_0017857) (spina bifida-hypospadias syndrome), [MONDO:0017856](http://purl.obolibrary.org/obo/MONDO_0017856) (X-linked spasticity-intellectual disability-epilepsy syndrome), [MONDO:0012153](http://purl.obolibrary.org/obo/MONDO_0012153) (AD9), [MONDO:0017842](http://purl.obolibrary.org/obo/MONDO_0017842) (Senior-Loken syndrome), [MONDO:0013485](http://purl.obolibrary.org/obo/MONDO_0013485) (spinocerebellar ataxia type 35), [MONDO:0013486](http://purl.obolibrary.org/obo/MONDO_0013486) (spinocerebellar ataxia type 32), [MONDO:0016512](http://purl.obolibrary.org/obo/MONDO_0016512) (Kabuki syndrome), [MONDO:0012157](http://purl.obolibrary.org/obo/MONDO_0012157) (congenital myasthenic syndrome 4C), [MONDO:0013481](http://purl.obolibrary.org/obo/MONDO_0013481) (chromosome 13q14 deletion syndrome), [MONDO:0012156](http://purl.obolibrary.org/obo/MONDO_0012156) (myasthenic syndrome, congenital, 1B, fast-channel), [MONDO:0013482](http://purl.obolibrary.org/obo/MONDO_0013482) (Meckel syndrome, type 8), [MONDO:0012155](http://purl.obolibrary.org/obo/MONDO_0012155) (choanal atresia), [MONDO:0012154](http://purl.obolibrary.org/obo/MONDO_0012154) (myopia 6), [MONDO:0005878](http://purl.obolibrary.org/obo/MONDO_0005878) (ocular onchocerciasis), [MONDO:0004544](http://purl.obolibrary.org/obo/MONDO_0004544) (chordoid meningioma), [MONDO:0004545](http://purl.obolibrary.org/obo/MONDO_0004545) (adult malignant schwannoma), [MONDO:0000182](http://purl.obolibrary.org/obo/MONDO_0000182) (congenital myasthenic syndrome with tubular aggregates), [MONDO:0004540](http://purl.obolibrary.org/obo/MONDO_0004540) (epithelioid malignant peripheral nerve sheath tumor), [MONDO:0000181](http://purl.obolibrary.org/obo/MONDO_0000181) (microcephaly and chorioretinopathy), [MONDO:0012158](http://purl.obolibrary.org/obo/MONDO_0012158) (KTCN2), [MONDO:0013489](http://purl.obolibrary.org/obo/MONDO_0013489) (autosomal recessive nonsyndromic deafness 89), [MONDO:0017846](http://purl.obolibrary.org/obo/MONDO_0017846) (autosomal dominant spastic ataxia), [MONDO:0017845](http://purl.obolibrary.org/obo/MONDO_0017845) (spastic ataxia), [MONDO:0017847](http://purl.obolibrary.org/obo/MONDO_0017847) (autosomal recessive spastic ataxia), [MONDO:0016500](http://purl.obolibrary.org/obo/MONDO_0016500) (acute sensory ataxic neuropathy), [MONDO:0017831](http://purl.obolibrary.org/obo/MONDO_0017831) (mild Canavan disease), [MONDO:0017830](http://purl.obolibrary.org/obo/MONDO_0017830) (severe Canavan disease), [MONDO:0016502](http://purl.obolibrary.org/obo/MONDO_0016502) (Hermansky-Pudlak syndrome without pulmonary fibrosis), [MONDO:0016501](http://purl.obolibrary.org/obo/MONDO_0016501) (Hermansky-Pudlak syndrome with pulmonary fibrosis), [MONDO:0013470](http://purl.obolibrary.org/obo/MONDO_0013470) (generalized epilepsy with febrile seizures plus, type 7), [MONDO:0013471](http://purl.obolibrary.org/obo/MONDO_0013471) (autosomal recessive nonsyndromic deafness 61), [MONDO:0013472](http://purl.obolibrary.org/obo/MONDO_0013472) (myofibrillar myopathy 7), [MONDO:0012144](http://purl.obolibrary.org/obo/MONDO_0012144) (Waardenburg syndrome type 2D), [MONDO:0012143](http://purl.obolibrary.org/obo/MONDO_0012143) (hereditary cryohydrocytosis with reduced stomatin), [MONDO:0004513](http://purl.obolibrary.org/obo/MONDO_0004513) (adult pleomorphic rhabdomyosarcoma), [MONDO:0004514](http://purl.obolibrary.org/obo/MONDO_0004514) (chronic rhinitis), [MONDO:0005845](http://purl.obolibrary.org/obo/MONDO_0005845) (meningoencephalitis), [MONDO:0004511](http://purl.obolibrary.org/obo/MONDO_0004511) (lower clivus meningioma), [MONDO:0004512](http://purl.obolibrary.org/obo/MONDO_0004512) (meningeal melanomatosis), [MONDO:0016509](http://purl.obolibrary.org/obo/MONDO_0016509) (microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome), [MONDO:0013479](http://purl.obolibrary.org/obo/MONDO_0013479) (dilated cardiomyopathy 1HH), [MONDO:0014794](http://purl.obolibrary.org/obo/MONDO_0014794) (Meier-Gorlin syndrome 6; MGORS6), [MONDO:0012130](http://purl.obolibrary.org/obo/MONDO_0012130) (myofibrillar myopathy 2), [MONDO:0013464](http://purl.obolibrary.org/obo/MONDO_0013464) (episodic ataxia type 5), [MONDO:0013465](http://purl.obolibrary.org/obo/MONDO_0013465) (achromatopsia 4), [MONDO:0014796](http://purl.obolibrary.org/obo/MONDO_0014796) (autosomal recessive early-onset Parksinson disease 23), [MONDO:0017822](http://purl.obolibrary.org/obo/MONDO_0017822) (mixed functioning pituitary adenoma), [MONDO:0012134](http://purl.obolibrary.org/obo/MONDO_0012134) (EJM3), [MONDO:0000169](http://purl.obolibrary.org/obo/MONDO_0000169) (microphthalmia, isolated, with cataract), [MONDO:0021083](http://purl.obolibrary.org/obo/MONDO_0021083) (congenital fibrosis of extraocular muscles type 1), [MONDO:0005854](http://purl.obolibrary.org/obo/MONDO_0005854) (mixed connective tissue disease), [MONDO:0005851](http://purl.obolibrary.org/obo/MONDO_0005851) (Miller Fisher syndrome), [MONDO:0000167](http://purl.obolibrary.org/obo/MONDO_0000167) (Huntington disease and related disorders), [MONDO:0000160](http://purl.obolibrary.org/obo/MONDO_0000160) (epilepsy, familial adult myoclonic), [MONDO:0021088](http://purl.obolibrary.org/obo/MONDO_0021088) (papillary meningioma), [MONDO:0012139](http://purl.obolibrary.org/obo/MONDO_0012139) (macular dystrophy, retinal, 3), [MONDO:0017827](http://purl.obolibrary.org/obo/MONDO_0017827) (malignant peripheral nerve sheath tumor), [MONDO:0012138](http://purl.obolibrary.org/obo/MONDO_0012138) (muscular dystrophy-dystroglycanopathy type B6), [MONDO:0001490](http://purl.obolibrary.org/obo/MONDO_0001490) (corneal granular dystrophy), [MONDO:0012136](http://purl.obolibrary.org/obo/MONDO_0012136) (carnitine palmitoyl transferase II deficiency, neonatal form), [MONDO:0017824](http://purl.obolibrary.org/obo/MONDO_0017824) (familial isolated pituitary adenoma), [MONDO:0013468](http://purl.obolibrary.org/obo/MONDO_0013468) (retinitis pigmentosa 59), [MONDO:0014799](http://purl.obolibrary.org/obo/MONDO_0014799) (cataract 45), [MONDO:0017823](http://purl.obolibrary.org/obo/MONDO_0017823) (Somatomammotropinoma), [MONDO:0013469](http://purl.obolibrary.org/obo/MONDO_0013469) (retinitis pigmentosa 38), [MONDO:0017826](http://purl.obolibrary.org/obo/MONDO_0017826) (null pituitary adenoma), [MONDO:0021081](http://purl.obolibrary.org/obo/MONDO_0021081) (anti-NMDA receptor encephalitis), [MONDO:0017825](http://purl.obolibrary.org/obo/MONDO_0017825) (silent pituitary adenoma), [MONDO:0015234](http://purl.obolibrary.org/obo/MONDO_0015234) (arachnodactyly-abnormal ossification-intellectual disability syndrome), [MONDO:0016568](http://purl.obolibrary.org/obo/MONDO_0016568) (Lowe-Kohn-Cohen syndrome), [MONDO:0016567](http://purl.obolibrary.org/obo/MONDO_0016567) (Locked-in syndrome), [MONDO:0016562](http://purl.obolibrary.org/obo/MONDO_0016562) (progressive supranuclear palsy-pure akinesia with gait freezing syndrome), [MONDO:0017892](http://purl.obolibrary.org/obo/MONDO_0017892) (autosomal recessive myogenic arthrogryposis multiplex congenita), [MONDO:0016564](http://purl.obolibrary.org/obo/MONDO_0016564) (progressive supranuclear palsy-progressive non-fluent aphasia syndrome), [MONDO:0016563](http://purl.obolibrary.org/obo/MONDO_0016563) (progressive supranuclear palsy-corticobasal syndrome), [MONDO:0015233](http://purl.obolibrary.org/obo/MONDO_0015233) (caudal appendage-deafness syndrome), [MONDO:0016560](http://purl.obolibrary.org/obo/MONDO_0016560) (ptosis-syndactyly-learning difficulties syndrome), [MONDO:0008940](http://purl.obolibrary.org/obo/MONDO_0008940) (endosteal sclerosis-cerebellar hypoplasia syndrome), [MONDO:0008941](http://purl.obolibrary.org/obo/MONDO_0008941) (hepatic fibrosis-renal cysts-intellectual disability syndrome), [MONDO:0008943](http://purl.obolibrary.org/obo/MONDO_0008943) (autosomal recessive spinocerebellar ataxia 2), [MONDO:0008944](http://purl.obolibrary.org/obo/MONDO_0008944) (Joubert syndrome 1), [MONDO:0008945](http://purl.obolibrary.org/obo/MONDO_0008945) (myoclonic cerebellar dyssynergia), [MONDO:0008947](http://purl.obolibrary.org/obo/MONDO_0008947) (bilateral striopallidodentate calcinosis), [MONDO:0008948](http://purl.obolibrary.org/obo/MONDO_0008948) (cerebrotendinous xanthomatosis), [MONDO:0012196](http://purl.obolibrary.org/obo/MONDO_0012196) (autosomal dominant auditory neuropathy 1), [MONDO:0012194](http://purl.obolibrary.org/obo/MONDO_0012194) (ANIB3), [MONDO:0015220](http://purl.obolibrary.org/obo/MONDO_0015220) (syndrome with a central nervous system malformation as major feature), [MONDO:0012199](http://purl.obolibrary.org/obo/MONDO_0012199) (posterior polymorphous corneal dystrophy 2), [MONDO:0012198](http://purl.obolibrary.org/obo/MONDO_0012198) (PCWH syndrome), [MONDO:0012193](http://purl.obolibrary.org/obo/MONDO_0012193) (autosomal dominant limb-girdle muscular dystrophy type 1G), [MONDO:0012192](http://purl.obolibrary.org/obo/MONDO_0012192) (permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome), [MONDO:0007617](http://purl.obolibrary.org/obo/MONDO_0007617) (Coffin-Siris syndrome 1), [MONDO:0012190](http://purl.obolibrary.org/obo/MONDO_0012190) (nephrotic syndrome-deafness-pretibial epidermolysis bullosa syndrome), [MONDO:0007614](http://purl.obolibrary.org/obo/MONDO_0007614) (congenital fibrosis of extraocular muscles), [MONDO:0008935](http://purl.obolibrary.org/obo/MONDO_0008935) (cerebellar ataxia-hypogonadism syndrome), [MONDO:0003256](http://purl.obolibrary.org/obo/MONDO_0003256) (neurohypophysis granular cell tumor), [MONDO:0004589](http://purl.obolibrary.org/obo/MONDO_0004589) (hereditary retinal dystrophy), [MONDO:0007612](http://purl.obolibrary.org/obo/MONDO_0007612) (gingival fibromatosis-progressive deafness syndrome), [MONDO:0003257](http://purl.obolibrary.org/obo/MONDO_0003257) (posterior pituitary gland neoplasm), [MONDO:0008938](http://purl.obolibrary.org/obo/MONDO_0008938) (early-onset cerebellar ataxia with retained tendon reflexes), [MONDO:0008939](http://purl.obolibrary.org/obo/MONDO_0008939) (isolated cerebellar hypoplasia/agenesis), [MONDO:0016558](http://purl.obolibrary.org/obo/MONDO_0016558) (familial congenital mirror movements), [MONDO:0015229](http://purl.obolibrary.org/obo/MONDO_0015229) (Bardet-Biedl syndrome), [MONDO:0016543](http://purl.obolibrary.org/obo/MONDO_0016543) (hyperphenylalaninemia), [MONDO:0016546](http://purl.obolibrary.org/obo/MONDO_0016546) (primary orthostatic tremor), [MONDO:0012189](http://purl.obolibrary.org/obo/MONDO_0012189) (Amish infantile epilepsy syndrome), [MONDO:0012188](http://purl.obolibrary.org/obo/MONDO_0012188) (neuronal ceroid lipofuscinosis 9), [MONDO:0004559](http://purl.obolibrary.org/obo/MONDO_0004559) (malignant glandular tumor of peripheral nerve sheath), [MONDO:0012181](http://purl.obolibrary.org/obo/MONDO_0012181) (hereditary spastic paraplegia 27), [MONDO:0008922](http://purl.obolibrary.org/obo/MONDO_0008922) (Sengers syndrome), [MONDO:0003223](http://purl.obolibrary.org/obo/MONDO_0003223) (meninges hemangiopericytoma), [MONDO:0008924](http://purl.obolibrary.org/obo/MONDO_0008924) (congenital cataract-ichthyosis syndrome), [MONDO:0008925](http://purl.obolibrary.org/obo/MONDO_0008925) (cataract 46 juvenile-onset), [MONDO:0008926](http://purl.obolibrary.org/obo/MONDO_0008926) (COFS syndrome), [MONDO:0008927](http://purl.obolibrary.org/obo/MONDO_0008927) (colobomatous optic disc-macular atrophy-chorioretinopathy syndrome), [MONDO:0008928](http://purl.obolibrary.org/obo/MONDO_0008928) (cataract-ataxia-deafness syndrome), [MONDO:0005883](http://purl.obolibrary.org/obo/MONDO_0005883) (ophthalmic herpes zoster), [MONDO:0008929](http://purl.obolibrary.org/obo/MONDO_0008929) (cataract-intellectual disability-hypogonadism syndrome), [MONDO:0015217](http://purl.obolibrary.org/obo/MONDO_0015217) (non-syndromic developmental defect of the eye), [MONDO:0015218](http://purl.obolibrary.org/obo/MONDO_0015218) (syndromic developmental defect of the eye), [MONDO:0015219](http://purl.obolibrary.org/obo/MONDO_0015219) (non-syndromic central nervous system malformation), [MONDO:0015201](http://purl.obolibrary.org/obo/MONDO_0015201) (ankyloblepharon filiforme-imperforate anus syndrome), [MONDO:0016532](http://purl.obolibrary.org/obo/MONDO_0016532) (Lennox-Gastaut syndrome), [MONDO:0016535](http://purl.obolibrary.org/obo/MONDO_0016535) (hypohidrotic ectodermal dysplasia), [MONDO:0012173](http://purl.obolibrary.org/obo/MONDO_0012173) (long chain 3-hydroxyacyl-CoA dehydrogenase deficiency), [MONDO:0015204](http://purl.obolibrary.org/obo/MONDO_0015204) (Microlissencephaly), [MONDO:0016534](http://purl.obolibrary.org/obo/MONDO_0016534) (infundibulo-neurohypophysitis), [MONDO:0012172](http://purl.obolibrary.org/obo/MONDO_0012172) (mitochondrial trifunctional protein deficiency), [MONDO:0012179](http://purl.obolibrary.org/obo/MONDO_0012179) (NRCLP3), [MONDO:0012177](http://purl.obolibrary.org/obo/MONDO_0012177) (posterior column ataxia-retinitis pigmentosa syndrome), [MONDO:0012170](http://purl.obolibrary.org/obo/MONDO_0012170) (autosomal recessive nonsyndromic deafness 36), [MONDO:0003234](http://purl.obolibrary.org/obo/MONDO_0003234) (optic nerve astrocytoma), [MONDO:0003235](http://purl.obolibrary.org/obo/MONDO_0003235) (optic nerve glioma), [MONDO:0008919](http://purl.obolibrary.org/obo/MONDO_0008919) (systemic primary carnitine deficiency disease), [MONDO:0003231](http://purl.obolibrary.org/obo/MONDO_0003231) (nonparalytic poliomyelitis), [MONDO:0017868](http://purl.obolibrary.org/obo/MONDO_0017868) (diencephalic-mesencephalic junction dysplasia), [MONDO:0015205](http://purl.obolibrary.org/obo/MONDO_0015205) (isolated lissencephaly type 1 without known genetic defects), [MONDO:0017867](http://purl.obolibrary.org/obo/MONDO_0017867) (distal 17p13.1 microdeletion syndrome), [MONDO:0017869](http://purl.obolibrary.org/obo/MONDO_0017869) (chondroectodermal dysplasia with night blindness), [MONDO:0018305](http://purl.obolibrary.org/obo/MONDO_0018305) (chronic granulomatous disease), [MONDO:0018306](http://purl.obolibrary.org/obo/MONDO_0018306) (Griscelli syndrome), [MONDO:0018303](http://purl.obolibrary.org/obo/MONDO_0018303) (generalized isolated dystonia), [MONDO:0019632](http://purl.obolibrary.org/obo/MONDO_0019632) (lyme disease), [MONDO:0019630](http://purl.obolibrary.org/obo/MONDO_0019630) (congenital ectropion uveae), [MONDO:0008980](http://purl.obolibrary.org/obo/MONDO_0008980) (ataxia-hypogonadism-choroidal dystrophy syndrome), [MONDO:0019631](http://purl.obolibrary.org/obo/MONDO_0019631) (persistent hyperplastic primary vitreous), [MONDO:0008981](http://purl.obolibrary.org/obo/MONDO_0008981) (infantile choroidocerebral calcification syndrome), [MONDO:0015270](http://purl.obolibrary.org/obo/MONDO_0015270) (Butyrylcholinesterase deficiency), [MONDO:0008982](http://purl.obolibrary.org/obo/MONDO_0008982) (central areolar choroidal dystrophy), [MONDO:0015271](http://purl.obolibrary.org/obo/MONDO_0015271) (idiopathic camptocormia), [MONDO:0006316](http://purl.obolibrary.org/obo/MONDO_0006316) (neuroblastic tumor), [MONDO:0007646](http://purl.obolibrary.org/obo/MONDO_0007646) (Gamstorp-Wohlfart syndrome), [MONDO:0007640](http://purl.obolibrary.org/obo/MONDO_0007640) (Sorsby's fundus dystrophy), [MONDO:0018307](http://purl.obolibrary.org/obo/MONDO_0018307) (neurodegeneration with brain iron accumulation), [MONDO:0019626](http://purl.obolibrary.org/obo/MONDO_0019626) (isolated ankyloblepharon filiforme adnatum), [MONDO:0015269](http://purl.obolibrary.org/obo/MONDO_0015269) (symmetrical thalamic calcifications), [MONDO:0016594](http://purl.obolibrary.org/obo/MONDO_0016594) (superficial siderosis), [MONDO:0016596](http://purl.obolibrary.org/obo/MONDO_0016596) (hyperphosphatasia-intellectual disability syndrome), [MONDO:0016591](http://purl.obolibrary.org/obo/MONDO_0016591) (sporadic adult-onset ataxia of unknown etiology), [MONDO:0008972](http://purl.obolibrary.org/obo/MONDO_0008972) (rhizomelic chondrodysplasia punctata type 1), [MONDO:0016593](http://purl.obolibrary.org/obo/MONDO_0016593) (acquired ataxia), [MONDO:0016592](http://purl.obolibrary.org/obo/MONDO_0016592) (non-hereditary degenerative ataxia), [MONDO:0006329](http://purl.obolibrary.org/obo/MONDO_0006329) (olfactory neuroblastoma), [MONDO:0008978](http://purl.obolibrary.org/obo/MONDO_0008978) (chordoma (disease)), [MONDO:0008979](http://purl.obolibrary.org/obo/MONDO_0008979) (chorea, benign familial), [MONDO:0007656](http://purl.obolibrary.org/obo/MONDO_0007656) (Gerstmann-Straussler-Scheinker syndrome), [MONDO:0019627](http://purl.obolibrary.org/obo/MONDO_0019627) (isolated congenital alacrima), [MONDO:0019628](http://purl.obolibrary.org/obo/MONDO_0019628) (Rieger anomaly), [MONDO:0019614](http://purl.obolibrary.org/obo/MONDO_0019614) (pituitary deficiency due to Rathke's pouch cysts), [MONDO:0019615](http://purl.obolibrary.org/obo/MONDO_0019615) (pituitary dermoid and epidermoid cysts), [MONDO:0019612](http://purl.obolibrary.org/obo/MONDO_0019612) (functioning gonadotropic adenoma), [MONDO:0015259](http://purl.obolibrary.org/obo/MONDO_0015259) (brachydactyly-mesomelia-intellectual disability-heart defects syndrome), [MONDO:0019613](http://purl.obolibrary.org/obo/MONDO_0019613) (non-functioning pituitary adenoma), [MONDO:0016589](http://purl.obolibrary.org/obo/MONDO_0016589) (progressive cerebello-cerebral atrophy), [MONDO:0015252](http://purl.obolibrary.org/obo/MONDO_0015252) (severe microbrachycephaly-intellectual disability-athetoid cerebral palsy syndrome), [MONDO:0019611](http://purl.obolibrary.org/obo/MONDO_0019611) (TSH-secreting pituitary adenoma), [MONDO:0015255](http://purl.obolibrary.org/obo/MONDO_0015255) (blepharophimosis-radioulnar synostosis syndrome), [MONDO:0008960](http://purl.obolibrary.org/obo/MONDO_0008960) (Charcot-Marie-tooth disease-deafness-intellectual disability syndrome), [MONDO:0008961](http://purl.obolibrary.org/obo/MONDO_0008961) (Charcot-Marie-tooth disease type 4A), [MONDO:0008962](http://purl.obolibrary.org/obo/MONDO_0008962) (Griscelli syndrome type 1), [MONDO:0015250](http://purl.obolibrary.org/obo/MONDO_0015250) (spinal atrophy-ophthalmoplegia-pyramidal syndrome), [MONDO:0008963](http://purl.obolibrary.org/obo/MONDO_0008963) (Chediak-Higashi syndrome), [MONDO:0008965](http://purl.obolibrary.org/obo/MONDO_0008965) (CHARGE syndrome), [MONDO:0008967](http://purl.obolibrary.org/obo/MONDO_0008967) (congenital bile acid synthesis defect 4), [MONDO:0007626](http://purl.obolibrary.org/obo/MONDO_0007626) (familial congenital palsy of trochlear nerve), [MONDO:0007624](http://purl.obolibrary.org/obo/MONDO_0007624) (Flynn-Aird syndrome), [MONDO:0007621](http://purl.obolibrary.org/obo/MONDO_0007621) (Floating-Harbor syndrome), [MONDO:0007620](http://purl.obolibrary.org/obo/MONDO_0007620) (fish-eye disease), [MONDO:0003262](http://purl.obolibrary.org/obo/MONDO_0003262) (rhabdoid meningioma), [MONDO:0003261](http://purl.obolibrary.org/obo/MONDO_0003261) (papillary meningioma of the cerebellum), [MONDO:0019618](http://purl.obolibrary.org/obo/MONDO_0019618) (Sheehan syndrome), [MONDO:0019617](http://purl.obolibrary.org/obo/MONDO_0019617) (pituitary deficiency due to empty sella turcica syndrome), [MONDO:0019603](http://purl.obolibrary.org/obo/MONDO_0019603) (osteopenia-myopia-hearing loss-intellectual disability-facial dysmorphism syndrome), [MONDO:0015247](http://purl.obolibrary.org/obo/MONDO_0015247) (Opsoclonus-myoclonus syndrome), [MONDO:0019601](http://purl.obolibrary.org/obo/MONDO_0019601) (autosomal recessive axonal hereditary motor and sensory neuropathy), [MONDO:0015248](http://purl.obolibrary.org/obo/MONDO_0015248) (ataxia-photosensitivity-short stature syndrome), [MONDO:0019600](http://purl.obolibrary.org/obo/MONDO_0019600) (xeroderma pigmentosum), [MONDO:0016572](http://purl.obolibrary.org/obo/MONDO_0016572) (central bilateral macrogyria), [MONDO:0015244](http://purl.obolibrary.org/obo/MONDO_0015244) (autosomal recessive cerebellar ataxia), [MONDO:0008950](http://purl.obolibrary.org/obo/MONDO_0008950) (cerebral sclerosis similar to Pelizaeus-Merzbacher disease), [MONDO:0016571](http://purl.obolibrary.org/obo/MONDO_0016571) (macrocephaly-short stature-paraplegia syndrome), [MONDO:0008952](http://purl.obolibrary.org/obo/MONDO_0008952) (Cerebrofaciothoracic dysplasia), [MONDO:0008953](http://purl.obolibrary.org/obo/MONDO_0008953) (peroxisome biogenesis disorder 1A (Zellweger)), [MONDO:0008954](http://purl.obolibrary.org/obo/MONDO_0008954) (peroxisome biogenesis disorder 2A (Zellweger)), [MONDO:0007639](http://purl.obolibrary.org/obo/MONDO_0007639) (fundus albipunctatus), [MONDO:0008955](http://purl.obolibrary.org/obo/MONDO_0008955) (Cerebrooculofacioskeletal syndrome 1), [MONDO:0007637](http://purl.obolibrary.org/obo/MONDO_0007637) (corneal dystrophy, Fuchs endothelial, 1), [MONDO:0008956](http://purl.obolibrary.org/obo/MONDO_0008956) (congenital neuronal ceroid lipofuscinosis), [MONDO:0006303](http://purl.obolibrary.org/obo/MONDO_0006303) (middle ear squamous cell carcinoma), [MONDO:0006300](http://purl.obolibrary.org/obo/MONDO_0006300) (medullomyoblastoma with myogenic differentiation), [MONDO:0007630](http://purl.obolibrary.org/obo/MONDO_0007630) (North Carolina macular dystrophy), [MONDO:0019609](http://purl.obolibrary.org/obo/MONDO_0019609) (Zellweger syndrome), [MONDO:0019606](http://purl.obolibrary.org/obo/MONDO_0019606) (simple cryoglobulinemia), [MONDO:0016169](http://purl.obolibrary.org/obo/MONDO_0016169) (chronic acquired demyelinating polyneuropathy), [MONDO:0001907](http://purl.obolibrary.org/obo/MONDO_0001907) (adult dermatomyositis), [MONDO:0016167](http://purl.obolibrary.org/obo/MONDO_0016167) (optic pathway glioma), [MONDO:0016162](http://purl.obolibrary.org/obo/MONDO_0016162) (bilateral frontal polymicrogyria), [MONDO:0016161](http://purl.obolibrary.org/obo/MONDO_0016161) (cerebral gigantism-jaw cysts syndrome), [MONDO:0009875](http://purl.obolibrary.org/obo/MONDO_0009875) (achromatopsia 3), [MONDO:0008545](http://purl.obolibrary.org/obo/MONDO_0008545) (thalassemia, beta+, silent Allele), [MONDO:0016163](http://purl.obolibrary.org/obo/MONDO_0016163) (autosomal dominant cerebellar ataxia type 2), [MONDO:0009876](http://purl.obolibrary.org/obo/MONDO_0009876) (isolated growth hormone deficiency type IA), [MONDO:0009878](http://purl.obolibrary.org/obo/MONDO_0009878) (pituitary hormone deficiency, combined, 2), [MONDO:0016160](http://purl.obolibrary.org/obo/MONDO_0016160) (X-linked intellectual disability-epilepsy syndrome), [MONDO:0009879](http://purl.obolibrary.org/obo/MONDO_0009879) (short stature due to growth hormone qualitative anomaly), [MONDO:0010868](http://purl.obolibrary.org/obo/MONDO_0010868) (RMD1), [MONDO:0007202](http://purl.obolibrary.org/obo/MONDO_0007202) (blepharoptosis-myopia-ectopia lentis syndrome), [MONDO:0007201](http://purl.obolibrary.org/obo/MONDO_0007201) (blepharophimosis, ptosis, and epicanthus inversus syndrome), [MONDO:0007200](http://purl.obolibrary.org/obo/MONDO_0007200) (blepharonasofacial malformation syndrome), [MONDO:0010860](http://purl.obolibrary.org/obo/MONDO_0010860) (autosomal recessive nonsyndromic deafness 3), [MONDO:0010865](http://purl.obolibrary.org/obo/MONDO_0010865) (Pseudoaminopterin syndrome), [MONDO:0016159](http://purl.obolibrary.org/obo/MONDO_0016159) (Gemignani syndrome), [MONDO:0016158](http://purl.obolibrary.org/obo/MONDO_0016158) (narcolepsy-cataplexy syndrome), [MONDO:0016155](http://purl.obolibrary.org/obo/MONDO_0016155) (qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan), [MONDO:0016154](http://purl.obolibrary.org/obo/MONDO_0016154) (qualitative or quantitative defects of myotubularin), [MONDO:0016157](http://purl.obolibrary.org/obo/MONDO_0016157) (qualitative or quantitative defects of fukutin), [MONDO:0009861](http://purl.obolibrary.org/obo/MONDO_0009861) (phenylketonuria), [MONDO:0016156](http://purl.obolibrary.org/obo/MONDO_0016156) (qualitative or quantitative defects of FKRP), [MONDO:0009862](http://purl.obolibrary.org/obo/MONDO_0009862) (dihydropteridine reductase deficiency), [MONDO:0016151](http://purl.obolibrary.org/obo/MONDO_0016151) (qualitative or quantitative defects of perlecan), [MONDO:0009863](http://purl.obolibrary.org/obo/MONDO_0009863) (Bh4-deficient hyperphenylalaninemia a), [MONDO:0016150](http://purl.obolibrary.org/obo/MONDO_0016150) (qualitative or quantitative defects of integrin alpha-7), [MONDO:0016153](http://purl.obolibrary.org/obo/MONDO_0016153) (qualitative or quantitative defects of TRIM32), [MONDO:0009865](http://purl.obolibrary.org/obo/MONDO_0009865) (glycogen storage disease due to phosphoglycerate mutase deficiency), [MONDO:0016152](http://purl.obolibrary.org/obo/MONDO_0016152) (qualitative or quantitative defects of calpain), [MONDO:0008535](http://purl.obolibrary.org/obo/MONDO_0008535) (telangiectasia, hereditary hemorrhagic, of Rendu, Osler, and Weber), [MONDO:0009868](http://purl.obolibrary.org/obo/MONDO_0009868) (glycogen storage disease IXb), [MONDO:0008537](http://purl.obolibrary.org/obo/MONDO_0008537) (telecanthus), [MONDO:0008538](http://purl.obolibrary.org/obo/MONDO_0008538) (temporal arteritis), [MONDO:0009869](http://purl.obolibrary.org/obo/MONDO_0009869) (Weissenbacher-Zweymuller syndrome), [MONDO:0010857](http://purl.obolibrary.org/obo/MONDO_0010857) (semantic dementia), [MONDO:0010858](http://purl.obolibrary.org/obo/MONDO_0010858) (macrocephaly-spastic paraplegia-dysmorphism syndrome), [MONDO:0004188](http://purl.obolibrary.org/obo/MONDO_0004188) (iris spindle cell melanoma), [MONDO:0010851](http://purl.obolibrary.org/obo/MONDO_0010851) (Lowry-MacLean syndrome), [MONDO:0016148](http://purl.obolibrary.org/obo/MONDO_0016148) (qualitative or quantitative defects of collagen 6), [MONDO:0016147](http://purl.obolibrary.org/obo/MONDO_0016147) (qualitative or quantitative defects of dystrophin), [MONDO:0016149](http://purl.obolibrary.org/obo/MONDO_0016149) (qualitative or quantitative defects of merosin), [MONDO:0016144](http://purl.obolibrary.org/obo/MONDO_0016144) (qualitative or quantitative defects of delta-sarcoglycan), [MONDO:0016143](http://purl.obolibrary.org/obo/MONDO_0016143) (qualitative or quantitative defects of gamma-sarcoglycan), [MONDO:0016146](http://purl.obolibrary.org/obo/MONDO_0016146) (caveolinopathy), [MONDO:0016145](http://purl.obolibrary.org/obo/MONDO_0016145) (qualitative or quantitative defects of dysferlin), [MONDO:0016140](http://purl.obolibrary.org/obo/MONDO_0016140) (qualitative or quantitative defects of sarcoglycan), [MONDO:0016142](http://purl.obolibrary.org/obo/MONDO_0016142) (qualitative or quantitative defects of beta-sarcoglycan), [MONDO:0008523](http://purl.obolibrary.org/obo/MONDO_0008523) (Blau syndrome), [MONDO:0016141](http://purl.obolibrary.org/obo/MONDO_0016141) (qualitative or quantitative defects of alpha-sarcoglycan), [MONDO:0009856](http://purl.obolibrary.org/obo/MONDO_0009856) (Peters plus syndrome), [MONDO:0008525](http://purl.obolibrary.org/obo/MONDO_0008525) (syringomyelia, isolated), [MONDO:0009858](http://purl.obolibrary.org/obo/MONDO_0009858) (Pfeiffer-Palm-Teller syndrome), [MONDO:0010848](http://purl.obolibrary.org/obo/MONDO_0010848) (spinocerebellar ataxia type 5), [MONDO:0010847](http://purl.obolibrary.org/obo/MONDO_0010847) (spinocerebellar ataxia type 4), [MONDO:0004155](http://purl.obolibrary.org/obo/MONDO_0004155) (adult central nervous system embryonal carcinoma), [MONDO:0004153](http://purl.obolibrary.org/obo/MONDO_0004153) (pediatric CNS embryonal cell carcinoma), [MONDO:0010840](http://purl.obolibrary.org/obo/MONDO_0010840) (pachygyria-intellectual disability-epilepsy syndrome), [MONDO:0004151](http://purl.obolibrary.org/obo/MONDO_0004151) (spinal meninges cancer), [MONDO:0010841](http://purl.obolibrary.org/obo/MONDO_0010841) (Waardenburg syndrome type 2B), [MONDO:0016137](http://purl.obolibrary.org/obo/MONDO_0016137) (acute and subacute inflammatory demyelinating polyneuropathy), [MONDO:0016136](http://purl.obolibrary.org/obo/MONDO_0016136) (cerebellar ataxia with peripheral neuropathy), [MONDO:0016139](http://purl.obolibrary.org/obo/MONDO_0016139) (qualitative or quantitative protein defects in neuromuscular diseases), [MONDO:0016133](http://purl.obolibrary.org/obo/MONDO_0016133) (rare hereditary metabolic disease with peripheral neuropathy), [MONDO:0016132](http://purl.obolibrary.org/obo/MONDO_0016132) (rare hereditary disease with peripheral neuropathy), [MONDO:0016135](http://purl.obolibrary.org/obo/MONDO_0016135) (rare hereditary neurologic disease with peripheral neuropathy), [MONDO:0016134](http://purl.obolibrary.org/obo/MONDO_0016134) (rare hereditary systemic disease with peripheral neuropathy), [MONDO:0018792](http://purl.obolibrary.org/obo/MONDO_0018792) (Moyamoya syndrome), [MONDO:0009841](http://purl.obolibrary.org/obo/MONDO_0009841) (PEHO syndrome), [MONDO:0018790](http://purl.obolibrary.org/obo/MONDO_0018790) (COL4A1 or COL4A2-related cerebral small vessel disease with hemorrhagic tendancy), [MONDO:0016131](http://purl.obolibrary.org/obo/MONDO_0016131) (spinal muscular atrophy associated with central nervous system anomaly), [MONDO:0009843](http://purl.obolibrary.org/obo/MONDO_0009843) (hypomyelinating leukodystrophy 3), [MONDO:0018791](http://purl.obolibrary.org/obo/MONDO_0018791) (Moyomoya angiopathy), [MONDO:0016130](http://purl.obolibrary.org/obo/MONDO_0016130) (fungal myositis), [MONDO:0010835](http://purl.obolibrary.org/obo/MONDO_0010835) (pterygium colli-intellectual disability-digital anomalies syndrome), [MONDO:0008519](http://purl.obolibrary.org/obo/MONDO_0008519) (multiple synostoses syndrome 1), [MONDO:0005499](http://purl.obolibrary.org/obo/MONDO_0005499) (brain glioma), [MONDO:0010836](http://purl.obolibrary.org/obo/MONDO_0010836) (NNO1), [MONDO:0005498](http://purl.obolibrary.org/obo/MONDO_0005498) (botulism), [MONDO:0010839](http://purl.obolibrary.org/obo/MONDO_0010839) (autosomal dominant congenital benign spinal muscular atrophy), [MONDO:0010830](http://purl.obolibrary.org/obo/MONDO_0010830) (neuronal ceroid lipofuscinosis 8), [MONDO:0010831](http://purl.obolibrary.org/obo/MONDO_0010831) (familial caudal dysgenesis), [MONDO:0010832](http://purl.obolibrary.org/obo/MONDO_0010832) (Bardet-Biedl syndrome 3), [MONDO:0020229](http://purl.obolibrary.org/obo/MONDO_0020229) (cerebral disease with cataract), [MONDO:0019234](http://purl.obolibrary.org/obo/MONDO_0019234) (peroxisome biogenesis disorder), [MONDO:0020222](http://purl.obolibrary.org/obo/MONDO_0020222) (rare disease with glaucoma as a major feature), [MONDO:0008588](http://purl.obolibrary.org/obo/MONDO_0008588) (hereditary geniospasm), [MONDO:0020223](http://purl.obolibrary.org/obo/MONDO_0020223) (lens and zonula anomaly), [MONDO:0020224](http://purl.obolibrary.org/obo/MONDO_0020224) (rare cataract), [MONDO:0001945](http://purl.obolibrary.org/obo/MONDO_0001945) (postencephalitic Parkinson disease), [MONDO:0020225](http://purl.obolibrary.org/obo/MONDO_0020225) (syndromic cataract), [MONDO:0020226](http://purl.obolibrary.org/obo/MONDO_0020226) (chromosomal anomaly with cataract), [MONDO:0020227](http://purl.obolibrary.org/obo/MONDO_0020227) (systemic disease with cataract), [MONDO:0020228](http://purl.obolibrary.org/obo/MONDO_0020228) (cataract associated with a metabolic disease), [MONDO:0012609](http://purl.obolibrary.org/obo/MONDO_0012609) (Alzheimer's disease 12), [MONDO:0012608](http://purl.obolibrary.org/obo/MONDO_0012608) (autosomal recessive lower motor neuron disease with childhood onset), [MONDO:0007247](http://purl.obolibrary.org/obo/MONDO_0007247) (basal ganglia calcification, idiopathic, childhood-onset), [MONDO:0013937](http://purl.obolibrary.org/obo/MONDO_0013937) (peroxisome biogenesis disorder 6B), [MONDO:0013938](http://purl.obolibrary.org/obo/MONDO_0013938) (peroxisome biogenesis disorder 7A (Zellweger)), [MONDO:0013939](http://purl.obolibrary.org/obo/MONDO_0013939) (peroxisome biogenesis disorder 7B), [MONDO:0013933](http://purl.obolibrary.org/obo/MONDO_0013933) (peroxisome biogenesis disorder 5B), [MONDO:0013935](http://purl.obolibrary.org/obo/MONDO_0013935) (Usher syndrome type 1J), [MONDO:0013936](http://purl.obolibrary.org/obo/MONDO_0013936) (peroxisome biogenesis disorder 6A (Zellweger)), [MONDO:0012604](http://purl.obolibrary.org/obo/MONDO_0012604) (isolated microphthalmia 3), [MONDO:0013930](http://purl.obolibrary.org/obo/MONDO_0013930) (peroxisome biogenesis disorder 4A (Zellweger)), [MONDO:0012603](http://purl.obolibrary.org/obo/MONDO_0012603) (episodic kinesigenic dyskinesia 2), [MONDO:0013931](http://purl.obolibrary.org/obo/MONDO_0013931) (peroxisome biogenesis disorder 4B), [MONDO:0012602](http://purl.obolibrary.org/obo/MONDO_0012602) (autosomal recessive nonsyndromic deafness 24), [MONDO:0013932](http://purl.obolibrary.org/obo/MONDO_0013932) (peroxisome biogenesis disorder 5A (Zellweger)), [MONDO:0008570](http://purl.obolibrary.org/obo/MONDO_0008570) (thyrotoxic periodic paralysis, susceptibility to, 1), [MONDO:0016199](http://purl.obolibrary.org/obo/MONDO_0016199) (qualitative or quantitative defects of protein SERCA1), [MONDO:0010892](http://purl.obolibrary.org/obo/MONDO_0010892) (mitochondrial myopathy and sideroblastic anemia), [MONDO:0016198](http://purl.obolibrary.org/obo/MONDO_0016198) (qualitative or quantitative defects of plectin), [MONDO:0010890](http://purl.obolibrary.org/obo/MONDO_0010890) (Acrocardiofacial syndrome), [MONDO:0020210](http://purl.obolibrary.org/obo/MONDO_0020210) (syndromic hyperopia), [MONDO:0016195](http://purl.obolibrary.org/obo/MONDO_0016195) (qualitative or quantitative defects of beta-myosin heavy chain (MYH7)), [MONDO:0020211](http://purl.obolibrary.org/obo/MONDO_0020211) (syndromic keratoconus), [MONDO:0016194](http://purl.obolibrary.org/obo/MONDO_0016194) (qualitative or quantitative defects of nebulin), [MONDO:0016197](http://purl.obolibrary.org/obo/MONDO_0016197) (qualitative or quantitative defects of selenoprotein N1), [MONDO:0020212](http://purl.obolibrary.org/obo/MONDO_0020212) (superficial corneal dystrophy), [MONDO:0016196](http://purl.obolibrary.org/obo/MONDO_0016196) (qualitative or quantitative defects of emerin), [MONDO:0020213](http://purl.obolibrary.org/obo/MONDO_0020213) (stromal corneal dystrophy), [MONDO:0016191](http://purl.obolibrary.org/obo/MONDO_0016191) (qualitative or quantitative defects of titin), [MONDO:0021546](http://purl.obolibrary.org/obo/MONDO_0021546) (ependymal tumor of spinal cord), [MONDO:0020214](http://purl.obolibrary.org/obo/MONDO_0020214) (posterior corneal dystrophy), [MONDO:0016190](http://purl.obolibrary.org/obo/MONDO_0016190) (qualitative or quantitative defects of protein ZASP), [MONDO:0020215](http://purl.obolibrary.org/obo/MONDO_0020215) (syndromic corneal dystrophy), [MONDO:0016193](http://purl.obolibrary.org/obo/MONDO_0016193) (qualitative or quantitative defects of alpha-actin), [MONDO:0021548](http://purl.obolibrary.org/obo/MONDO_0021548) (total early-onset cataract), [MONDO:0016192](http://purl.obolibrary.org/obo/MONDO_0016192) (qualitative or quantitative defects of telethonin), [MONDO:0007259](http://purl.obolibrary.org/obo/MONDO_0007259) (craniofaciofrontodigital syndrome), [MONDO:0013927](http://purl.obolibrary.org/obo/MONDO_0013927) (peroxisome biogenesis disorder 3A (Zellweger)), [MONDO:0013928](http://purl.obolibrary.org/obo/MONDO_0013928) (dystonia 23), [MONDO:0013929](http://purl.obolibrary.org/obo/MONDO_0013929) (autosomal recessive nonsyndromic deafness 98), [MONDO:0013922](http://purl.obolibrary.org/obo/MONDO_0013922) (microcephalic primordial dwarfism, Dauber type), [MONDO:0013923](http://purl.obolibrary.org/obo/MONDO_0013923) (microcephaly 9, primary, autosomal recessive), [MONDO:0010893](http://purl.obolibrary.org/obo/MONDO_0010893) (malignant hyperthermia, susceptibility to, 4), [MONDO:0010899](http://purl.obolibrary.org/obo/MONDO_0010899) (autosomal dominant nocturnal frontal lobe epilepsy 1), [MONDO:0013920](http://purl.obolibrary.org/obo/MONDO_0013920) (herpes simplex encephalitis, susceptibility to, 3), [MONDO:0013921](http://purl.obolibrary.org/obo/MONDO_0013921) (herpes simplex encephalitis, susceptibility to, 4), [MONDO:0010898](http://purl.obolibrary.org/obo/MONDO_0010898) (familial temporal lobe epilepsy 1), [MONDO:0020207](http://purl.obolibrary.org/obo/MONDO_0020207) (rare isolated myopia), [MONDO:0020208](http://purl.obolibrary.org/obo/MONDO_0020208) (syndromic myopia), [MONDO:0020209](http://purl.obolibrary.org/obo/MONDO_0020209) (rare hyperopia and astigmatism), [MONDO:0009890](http://purl.obolibrary.org/obo/MONDO_0009890) (polycystic kidney disease, Potter type i, with Microbrachycephaly, hypertelorism, and Brachymelia), [MONDO:0010880](http://purl.obolibrary.org/obo/MONDO_0010880) (telangiectasia, hereditary hemorrhagic, type 2), [MONDO:0016188](http://purl.obolibrary.org/obo/MONDO_0016188) (qualitative or quantitative defects of alphaB-cristallin), [MONDO:0001925](http://purl.obolibrary.org/obo/MONDO_0001925) (retinal dystrophy in systemic or cerebroretinal lipidoses), [MONDO:0016187](http://purl.obolibrary.org/obo/MONDO_0016187) (qualitative or quantitative defects of desmin), [MONDO:0016189](http://purl.obolibrary.org/obo/MONDO_0016189) (qualitative or quantitative defects of filamin c), [MONDO:0008564](http://purl.obolibrary.org/obo/MONDO_0008564) (DiGeorge syndrome), [MONDO:0019210](http://purl.obolibrary.org/obo/MONDO_0019210) (cutaneous neuroendocrine carcinoma), [MONDO:0016184](http://purl.obolibrary.org/obo/MONDO_0016184) (qualitative or quantitative defects of protein O-mannosyltransferase 1), [MONDO:0016183](http://purl.obolibrary.org/obo/MONDO_0016183) (qualitative or quantitative defects of protein glycosyltransferase-like), [MONDO:0020200](http://purl.obolibrary.org/obo/MONDO_0020200) (conjunctival hemangioma or hemolymphangioma), [MONDO:0009897](http://purl.obolibrary.org/obo/MONDO_0009897) (adult polyglucosan body disease), [MONDO:0001924](http://purl.obolibrary.org/obo/MONDO_0001924) (dystrophies primarily involving the retinal pigment epithelium), [MONDO:0016186](http://purl.obolibrary.org/obo/MONDO_0016186) (qualitative or quantitative defects of myofibrillar proteins), [MONDO:0020201](http://purl.obolibrary.org/obo/MONDO_0020201) (conjunctival telangiectasia (disease)), [MONDO:0001923](http://purl.obolibrary.org/obo/MONDO_0001923) (vitreoretinal dystrophy), [MONDO:0016185](http://purl.obolibrary.org/obo/MONDO_0016185) (qualitative or quantitative defects of protein O-mannosyltransferase 2), [MONDO:0020202](http://purl.obolibrary.org/obo/MONDO_0020202) (conjunctival lymphangiectasia), [MONDO:0020203](http://purl.obolibrary.org/obo/MONDO_0020203) (pigmented conjunctival lesion), [MONDO:0020204](http://purl.obolibrary.org/obo/MONDO_0020204) (conjunctival tumor), [MONDO:0008569](http://purl.obolibrary.org/obo/MONDO_0008569) (thyroid hormone resistance, generalized, autosomal dominant), [MONDO:0016182](http://purl.obolibrary.org/obo/MONDO_0016182) (qualitative or quantitative defects of protein O-mannose beta1,2N-acetylglucosaminyltransferase), [MONDO:0020205](http://purl.obolibrary.org/obo/MONDO_0020205) (bulbar conjunctival dermoid or conjunctival dermolipoma), [MONDO:0020206](http://purl.obolibrary.org/obo/MONDO_0020206) (rare refraction anomaly), [MONDO:0016181](http://purl.obolibrary.org/obo/MONDO_0016181) (solid tumor associated with an acquired peripheral neuropathy), [MONDO:0013917](http://purl.obolibrary.org/obo/MONDO_0013917) (nephronophthisis 15), [MONDO:0013918](http://purl.obolibrary.org/obo/MONDO_0013918) (distal tetrasomy 15q), [MONDO:0010884](http://purl.obolibrary.org/obo/MONDO_0010884) (muscular dystrophy, Scapulohumeral), [MONDO:0010886](http://purl.obolibrary.org/obo/MONDO_0010886) (2q37 microdeletion syndrome), [MONDO:0019207](http://purl.obolibrary.org/obo/MONDO_0019207) (DEND syndrome), [MONDO:0021527](http://purl.obolibrary.org/obo/MONDO_0021527) (benign neoplasm of meninges), [MONDO:0019208](http://purl.obolibrary.org/obo/MONDO_0019208) (Bickerstaff brainstem encephalitis), [MONDO:0009880](http://purl.obolibrary.org/obo/MONDO_0009880) (short stature-pituitary and cerebellar defects-small sella turcica syndrome), [MONDO:0016177](http://purl.obolibrary.org/obo/MONDO_0016177) (systemic inflammatory disease associated with an acquired peripheral neuropathy), [MONDO:0016176](http://purl.obolibrary.org/obo/MONDO_0016176) (axonal polyneuropathy associated with IgG/IgM/IgA monoclonal gammopathy), [MONDO:0010870](http://purl.obolibrary.org/obo/MONDO_0010870) (tibial muscular dystrophy), [MONDO:0016179](http://purl.obolibrary.org/obo/MONDO_0016179) (acquired amyloid peripheral neuropathy), [MONDO:0019201](http://purl.obolibrary.org/obo/MONDO_0019201) (thyrotoxic periodic paralysis), [MONDO:0019202](http://purl.obolibrary.org/obo/MONDO_0019202) (myxofibrosarcoma), [MONDO:0016178](http://purl.obolibrary.org/obo/MONDO_0016178) (peripheral neuropathy associated with monoclonal gammopathy), [MONDO:0016173](http://purl.obolibrary.org/obo/MONDO_0016173) (non-paraneoplastic sensory ganglionopathy), [MONDO:0016172](http://purl.obolibrary.org/obo/MONDO_0016172) (acquired sensory ganglionopathy), [MONDO:0019200](http://purl.obolibrary.org/obo/MONDO_0019200) (retinitis pigmentosa), [MONDO:0016175](http://purl.obolibrary.org/obo/MONDO_0016175) (cutis laxa), [MONDO:0016174](http://purl.obolibrary.org/obo/MONDO_0016174) (paraneoplastic sensory ganglionopathy), [MONDO:0016171](http://purl.obolibrary.org/obo/MONDO_0016171) (polyradiculoneuropathy associated with IgG/IgA/IgM monoclonal gammopathy without known antibodies), [MONDO:0016170](http://purl.obolibrary.org/obo/MONDO_0016170) (chronic polyradiculoneuropathy), [MONDO:0013908](http://purl.obolibrary.org/obo/MONDO_0013908) (TTPP3), [MONDO:0013904](http://purl.obolibrary.org/obo/MONDO_0013904) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8), [MONDO:0007236](http://purl.obolibrary.org/obo/MONDO_0007236) (branchiootorenal syndrome 1), [MONDO:0013905](http://purl.obolibrary.org/obo/MONDO_0013905) (autosomal recessive spinocerebellar ataxia 13), [MONDO:0013907](http://purl.obolibrary.org/obo/MONDO_0013907) (bilateral generalized polymicrogyria), [MONDO:0010873](http://purl.obolibrary.org/obo/MONDO_0010873) (band heterotopia of brain), [MONDO:0013900](http://purl.obolibrary.org/obo/MONDO_0013900) (alternating hemiplegia of childhood 2), [MONDO:0013903](http://purl.obolibrary.org/obo/MONDO_0013903) (NYS7), [MONDO:0010877](http://purl.obolibrary.org/obo/MONDO_0010877) (Charcot-Marie-tooth disease type 5), [MONDO:0010878](http://purl.obolibrary.org/obo/MONDO_0010878) (hereditary spastic paraplegia 6), [MONDO:0019209](http://purl.obolibrary.org/obo/MONDO_0019209) (Japanese encephalitis), [MONDO:0007290](http://purl.obolibrary.org/obo/MONDO_0007290) (cataract 5 multiple types), [MONDO:0013970](http://purl.obolibrary.org/obo/MONDO_0013970) (branched-chain keto acid dehydrogenase kinase deficiency), [MONDO:0013971](http://purl.obolibrary.org/obo/MONDO_0013971) (leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome), [MONDO:0013972](http://purl.obolibrary.org/obo/MONDO_0013972) (Perrault syndrome 2), [MONDO:0012640](http://purl.obolibrary.org/obo/MONDO_0012640) (Charcot-Marie-tooth disease type 4J), [MONDO:0020265](http://purl.obolibrary.org/obo/MONDO_0020265) (mitochondrial disease with eye involvement), [MONDO:0020266](http://purl.obolibrary.org/obo/MONDO_0020266) (genodermatosis with ocular features), [MONDO:0020267](http://purl.obolibrary.org/obo/MONDO_0020267) (genetic keratinization disorder associated with ocular features), [MONDO:0020268](http://purl.obolibrary.org/obo/MONDO_0020268) (ichthyosis associated with ocular features), [MONDO:0020269](http://purl.obolibrary.org/obo/MONDO_0020269) (syndromic ichthyosis associated with ocular features), [MONDO:0020260](http://purl.obolibrary.org/obo/MONDO_0020260) (myasthenic syndrome with eye involvement), [MONDO:0020261](http://purl.obolibrary.org/obo/MONDO_0020261) (abnormal eye movements), [MONDO:0020262](http://purl.obolibrary.org/obo/MONDO_0020262) (nervous system anomaly with eye involvement), [MONDO:0020263](http://purl.obolibrary.org/obo/MONDO_0020263) (spinocerebellar ataxia with oculomotor anomaly), [MONDO:0007289](http://purl.obolibrary.org/obo/MONDO_0007289) (cataract 13 with adult I phenotype), [MONDO:0020264](http://purl.obolibrary.org/obo/MONDO_0020264) (spinocerebellar degenerescence and spastic paraparesis with an oculomotor anomaly), [MONDO:0007288](http://purl.obolibrary.org/obo/MONDO_0007288) (cataract 6 multiple types), [MONDO:0007287](http://purl.obolibrary.org/obo/MONDO_0007287) (cataract 41), [MONDO:0011313](http://purl.obolibrary.org/obo/MONDO_0011313) (megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1), [MONDO:0007286](http://purl.obolibrary.org/obo/MONDO_0007286) (cataract 30), [MONDO:0013978](http://purl.obolibrary.org/obo/MONDO_0013978) (autosomal recessive nonsyndromic deafness 70), [MONDO:0012643](http://purl.obolibrary.org/obo/MONDO_0012643) (hereditary spastic paraplegia 32), [MONDO:0007284](http://purl.obolibrary.org/obo/MONDO_0007284) (cataract 20 multiple types), [MONDO:0007283](http://purl.obolibrary.org/obo/MONDO_0007283) (cataract 42), [MONDO:0007282](http://purl.obolibrary.org/obo/MONDO_0007282) (cataract 29), [MONDO:0012647](http://purl.obolibrary.org/obo/MONDO_0012647) (generalized epilepsy with febrile seizures plus, type 3), [MONDO:0007280](http://purl.obolibrary.org/obo/MONDO_0007280) (cataract 8 multiple types), [MONDO:0013960](http://purl.obolibrary.org/obo/MONDO_0013960) (sinoatrial node dysfunction and deafness), [MONDO:0012630](http://purl.obolibrary.org/obo/MONDO_0012630) (Alzheimer's disease 13), [MONDO:0020254](http://purl.obolibrary.org/obo/MONDO_0020254) (craniostenosis associated with a strabismus), [MONDO:0020255](http://purl.obolibrary.org/obo/MONDO_0020255) (oculomotor palsy), [MONDO:0021588](http://purl.obolibrary.org/obo/MONDO_0021588) (eyelid sebaceous gland carcinoma), [MONDO:0020256](http://purl.obolibrary.org/obo/MONDO_0020256) (congenital trochlear nerve palsy), [MONDO:0020257](http://purl.obolibrary.org/obo/MONDO_0020257) (supranuclear oculomotor palsy), [MONDO:0019264](http://purl.obolibrary.org/obo/MONDO_0019264) (alpha-N-acetylgalactosaminidase deficiency type 3), [MONDO:0019261](http://purl.obolibrary.org/obo/MONDO_0019261) (infantile neuronal ceroid lipofuscinosis), [MONDO:0001995](http://purl.obolibrary.org/obo/MONDO_0001995) (sphenoid sinus squamous cell carcinoma), [MONDO:0020258](http://purl.obolibrary.org/obo/MONDO_0020258) (oculomotor apraxia or related oculomotor disease), [MONDO:0019262](http://purl.obolibrary.org/obo/MONDO_0019262) (juvenile neuronal ceroid lipofuscinosis), [MONDO:0020259](http://purl.obolibrary.org/obo/MONDO_0020259) (myopathy with eye involvement), [MONDO:0019260](http://purl.obolibrary.org/obo/MONDO_0019260) (adult neuronal ceroid lipofuscinosis), [MONDO:0001990](http://purl.obolibrary.org/obo/MONDO_0001990) (malignant cardiac peripheral nerve sheath neoplasm), [MONDO:0012639](http://purl.obolibrary.org/obo/MONDO_0012639) (hereditary spastic paraplegia 18), [MONDO:0020250](http://purl.obolibrary.org/obo/MONDO_0020250) (autosomal dominant optic atrophy), [MONDO:0020251](http://purl.obolibrary.org/obo/MONDO_0020251) (rare strabismus and restriction syndrome), [MONDO:0020252](http://purl.obolibrary.org/obo/MONDO_0020252) (essential strabismus), [MONDO:0007299](http://purl.obolibrary.org/obo/MONDO_0007299) (Sotos syndrome 1), [MONDO:0020253](http://purl.obolibrary.org/obo/MONDO_0020253) (syndrome with a symptomatic strabismus), [MONDO:0007298](http://purl.obolibrary.org/obo/MONDO_0007298) (spinocerebellar ataxia type 29), [MONDO:0007297](http://purl.obolibrary.org/obo/MONDO_0007297) (ADan amyloidosis), [MONDO:0013967](http://purl.obolibrary.org/obo/MONDO_0013967) (peroxisome biogenesis disorder 14B), [MONDO:0012632](http://purl.obolibrary.org/obo/MONDO_0012632) (Alzheimer's disease 15), [MONDO:0007296](http://purl.obolibrary.org/obo/MONDO_0007296) (spinocerebellar ataxia type 31), [MONDO:0007295](http://purl.obolibrary.org/obo/MONDO_0007295) (rolandic epilepsy), [MONDO:0012631](http://purl.obolibrary.org/obo/MONDO_0012631) (Alzheimer's disease 14), [MONDO:0013969](http://purl.obolibrary.org/obo/MONDO_0013969) (combined oxidative phosphorylation defect type 11), [MONDO:0012638](http://purl.obolibrary.org/obo/MONDO_0012638) (microphthalmia-brain atrophy syndrome), [MONDO:0007294](http://purl.obolibrary.org/obo/MONDO_0007294) (central core myopathy), [MONDO:0013962](http://purl.obolibrary.org/obo/MONDO_0013962) (hereditary spastic paraplegia 53), [MONDO:0012637](http://purl.obolibrary.org/obo/MONDO_0012637) (COG1-CDG), [MONDO:0013963](http://purl.obolibrary.org/obo/MONDO_0013963) (autosomal recessive nonsyndromic deafness 93), [MONDO:0011305](http://purl.obolibrary.org/obo/MONDO_0011305) (cerebral cavernous malformations 3), [MONDO:0007291](http://purl.obolibrary.org/obo/MONDO_0007291) (familial cerebral cavernous malformation), [MONDO:0011304](http://purl.obolibrary.org/obo/MONDO_0011304) (cerebral cavernous malformation 2), [MONDO:0012635](http://purl.obolibrary.org/obo/MONDO_0012635) (COG8-CDG), [MONDO:0013950](http://purl.obolibrary.org/obo/MONDO_0013950) (peroxisome biogenesis disorder 11B), [MONDO:0019258](http://purl.obolibrary.org/obo/MONDO_0019258) (mild phenylketonuria), [MONDO:0001969](http://purl.obolibrary.org/obo/MONDO_0001969) (mixed gonadal dysgenesis), [MONDO:0019259](http://purl.obolibrary.org/obo/MONDO_0019259) (classic phenylketonuria), [MONDO:0020243](http://purl.obolibrary.org/obo/MONDO_0020243) (colobomatous and areolar dystrophy), [MONDO:0020244](http://purl.obolibrary.org/obo/MONDO_0020244) (unclassified primitive or secondary maculopathy), [MONDO:0020245](http://purl.obolibrary.org/obo/MONDO_0020245) (disease predisposing to age-related macular degeneration), [MONDO:0019253](http://purl.obolibrary.org/obo/MONDO_0019253) (metabolic disease involving other neurotransmitter deficiency), [MONDO:0020246](http://purl.obolibrary.org/obo/MONDO_0020246) (vitreoretinopathy), [MONDO:0020247](http://purl.obolibrary.org/obo/MONDO_0020247) (congenital vitreoretinal dysplasia), [MONDO:0020248](http://purl.obolibrary.org/obo/MONDO_0020248) (vitreoretinal degeneration), [MONDO:0020249](http://purl.obolibrary.org/obo/MONDO_0020249) (hereditary optic neuropathy), [MONDO:0012629](http://purl.obolibrary.org/obo/MONDO_0012629) (paroxysmal nonkinesigenic dyskinesia 2), [MONDO:0013959](http://purl.obolibrary.org/obo/MONDO_0013959) (Charcot-Marie-tooth disease type 4F), [MONDO:0007269](http://purl.obolibrary.org/obo/MONDO_0007269) (dilated cardiomyopathy 1A), [MONDO:0021570](http://purl.obolibrary.org/obo/MONDO_0021570) (Hauptmann-Thannhauser muscular dystrophy), [MONDO:0020240](http://purl.obolibrary.org/obo/MONDO_0020240) (syndromic retinitis pigmentosa), [MONDO:0020241](http://purl.obolibrary.org/obo/MONDO_0020241) (unclassified familial retinal dystrophy), [MONDO:0020242](http://purl.obolibrary.org/obo/MONDO_0020242) (genetic macular dystrophy), [MONDO:0012623](http://purl.obolibrary.org/obo/MONDO_0012623) (MRT4), [MONDO:0007265](http://purl.obolibrary.org/obo/MONDO_0007265) (cardiofaciocutaneous syndrome 1), [MONDO:0012622](http://purl.obolibrary.org/obo/MONDO_0012622) (leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome), [MONDO:0012621](http://purl.obolibrary.org/obo/MONDO_0012621) (deafness-infertility syndrome), [MONDO:0013951](http://purl.obolibrary.org/obo/MONDO_0013951) (peroxisome biogenesis disorder 12A (Zellweger)), [MONDO:0012627](http://purl.obolibrary.org/obo/MONDO_0012627) (epilepsy, idiopathic generalized, susceptibility to, 13), [MONDO:0013952](http://purl.obolibrary.org/obo/MONDO_0013952) (peroxisome biogenesis disorder 13A (Zellweger)), [MONDO:0012626](http://purl.obolibrary.org/obo/MONDO_0012626) (Meckel syndrome, type 4), [MONDO:0012625](http://purl.obolibrary.org/obo/MONDO_0012625) (retinitis pigmentosa 37), [MONDO:0019249](http://purl.obolibrary.org/obo/MONDO_0019249) (mucopolysaccharidosis), [MONDO:0008591](http://purl.obolibrary.org/obo/MONDO_0008591) (tremor-nystagmus-duodenal ulcer syndrome), [MONDO:0020232](http://purl.obolibrary.org/obo/MONDO_0020232) (musculoskeletal disease with cataract), [MONDO:0020233](http://purl.obolibrary.org/obo/MONDO_0020233) (Dentocutaneous disease with cataract), [MONDO:0008599](http://purl.obolibrary.org/obo/MONDO_0008599) (trigeminal neuralgia), [MONDO:0020234](http://purl.obolibrary.org/obo/MONDO_0020234) (craniofacial anomaly with cataract), [MONDO:0020235](http://purl.obolibrary.org/obo/MONDO_0020235) (lens size anomaly), [MONDO:0020236](http://purl.obolibrary.org/obo/MONDO_0020236) (lens position anomaly), [MONDO:0000642](http://purl.obolibrary.org/obo/MONDO_0000642) (brain meningioma), [MONDO:0020237](http://purl.obolibrary.org/obo/MONDO_0020237) (lens shape anomaly), [MONDO:0020238](http://purl.obolibrary.org/obo/MONDO_0020238) (genetic vitreous-retinal disease), [MONDO:0021569](http://purl.obolibrary.org/obo/MONDO_0021569) (Emery-Dreifuss muscular dystrophy 2, autosomal dominant), [MONDO:0012619](http://purl.obolibrary.org/obo/MONDO_0012619) (MRT11), [MONDO:0012618](http://purl.obolibrary.org/obo/MONDO_0012618) (MRT10), [MONDO:0012617](http://purl.obolibrary.org/obo/MONDO_0012617) (MRT9), [MONDO:0013948](http://purl.obolibrary.org/obo/MONDO_0013948) (peroxisome biogenesis disorder 10A (Zellweger)), [MONDO:0013949](http://purl.obolibrary.org/obo/MONDO_0013949) (peroxisome biogenesis disorder 11A (Zellweger)), [MONDO:0007279](http://purl.obolibrary.org/obo/MONDO_0007279) (cataract 7), [MONDO:0020230](http://purl.obolibrary.org/obo/MONDO_0020230) (renal disease with cataract), [MONDO:0007278](http://purl.obolibrary.org/obo/MONDO_0007278) (cataract 32 multiple types), [MONDO:0007277](http://purl.obolibrary.org/obo/MONDO_0007277) (cataract-aberrant oral frenula-growth delay syndrome), [MONDO:0020231](http://purl.obolibrary.org/obo/MONDO_0020231) (cardiac disease with cataract), [MONDO:0007276](http://purl.obolibrary.org/obo/MONDO_0007276) (cat-eye syndrome), [MONDO:0012612](http://purl.obolibrary.org/obo/MONDO_0012612) (mental retardation, autosomal recessive 12), [MONDO:0007275](http://purl.obolibrary.org/obo/MONDO_0007275) (carpal tunnel syndrome), [MONDO:0013945](http://purl.obolibrary.org/obo/MONDO_0013945) (peroxisome biogenesis disorder 9B), [MONDO:0013947](http://purl.obolibrary.org/obo/MONDO_0013947) (young adult-onset distal hereditary motor neuropathy), [MONDO:0007273](http://purl.obolibrary.org/obo/MONDO_0007273) (paragangliomas 4), [MONDO:0012616](http://purl.obolibrary.org/obo/MONDO_0012616) (MRT8), [MONDO:0012615](http://purl.obolibrary.org/obo/MONDO_0012615) (mental retardation, autosomal recessive 7), [MONDO:0013942](http://purl.obolibrary.org/obo/MONDO_0013942) (peroxisome biogenesis disorder 8A (Zellweger)), [MONDO:0012614](http://purl.obolibrary.org/obo/MONDO_0012614) (mental retardation, autosomal recessive 6), [MONDO:0013943](http://purl.obolibrary.org/obo/MONDO_0013943) (peroxisome biogenesis disorder 8B), [MONDO:0012613](http://purl.obolibrary.org/obo/MONDO_0012613) (mental retardation, autosomal recessive 5), [MONDO:0011350](http://purl.obolibrary.org/obo/MONDO_0011350) (autosomal dominant nonsyndromic deafness 17), [MONDO:0009033](http://purl.obolibrary.org/obo/MONDO_0009033) (temtamy syndrome), [MONDO:0012683](http://purl.obolibrary.org/obo/MONDO_0012683) (pontocerebellar hypoplasia type 6), [MONDO:0009036](http://purl.obolibrary.org/obo/MONDO_0009036) (cardiocranial syndrome, Pfeiffer type), [MONDO:0011351](http://purl.obolibrary.org/obo/MONDO_0011351) (autosomal recessive nonsyndromic deafness 21), [MONDO:0010021](http://purl.obolibrary.org/obo/MONDO_0010021) (seizures, benign familial neonatal, autosomal recessive), [MONDO:0010026](http://purl.obolibrary.org/obo/MONDO_0010026) (short syndrome), [MONDO:0010027](http://purl.obolibrary.org/obo/MONDO_0010027) (Free sialic acid storage disease, infantile form), [MONDO:0012688](http://purl.obolibrary.org/obo/MONDO_0012688) (cataract 17 multiple types), [MONDO:0012687](http://purl.obolibrary.org/obo/MONDO_0012687) (familial cavitary optic disc anomaly), [MONDO:0011355](http://purl.obolibrary.org/obo/MONDO_0011355) (cone-rod dystrophy 7), [MONDO:0015712](http://purl.obolibrary.org/obo/MONDO_0015712) (non-distal trisomy 10q), [MONDO:0010028](http://purl.obolibrary.org/obo/MONDO_0010028) (sialuria), [MONDO:0012670](http://purl.obolibrary.org/obo/MONDO_0012670) (autosomal recessive nonsyndromic deafness 63), [MONDO:0009020](http://purl.obolibrary.org/obo/MONDO_0009020) (macular corneal dystrophy), [MONDO:0009021](http://purl.obolibrary.org/obo/MONDO_0009021) (Toriello-Carey syndrome), [MONDO:0010011](http://purl.obolibrary.org/obo/MONDO_0010011) (schizencephaly), [MONDO:0011342](http://purl.obolibrary.org/obo/MONDO_0011342) (SLC35A1-CDG), [MONDO:0009024](http://purl.obolibrary.org/obo/MONDO_0009024) (cortical blindness-intellectual disability-polydactyly syndrome), [MONDO:0010010](http://purl.obolibrary.org/obo/MONDO_0010010) (Schinzel-Giedion syndrome), [MONDO:0009026](http://purl.obolibrary.org/obo/MONDO_0009026) (Costello syndrome), [MONDO:0020298](http://purl.obolibrary.org/obo/MONDO_0020298) (Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15), [MONDO:0009028](http://purl.obolibrary.org/obo/MONDO_0009028) (Crane-Heise syndrome), [MONDO:0003734](http://purl.obolibrary.org/obo/MONDO_0003734) (adult central nervous system immature teratoma), [MONDO:0003735](http://purl.obolibrary.org/obo/MONDO_0003735) (central nervous system immature teratoma), [MONDO:0003732](http://purl.obolibrary.org/obo/MONDO_0003732) (adult central nervous system mature teratoma), [MONDO:0003733](http://purl.obolibrary.org/obo/MONDO_0003733) (central nervous system mature teratoma), [MONDO:0003731](http://purl.obolibrary.org/obo/MONDO_0003731) (adult central nervous system teratoma), [MONDO:0015705](http://purl.obolibrary.org/obo/MONDO_0015705) (autosomal recessive centronuclear myopathy), [MONDO:0010015](http://purl.obolibrary.org/obo/MONDO_0010015) (congenital cataract microcornea with corneal opacity), [MONDO:0012676](http://purl.obolibrary.org/obo/MONDO_0012676) (autosomal recessive osteopetrosis 4), [MONDO:0013993](http://purl.obolibrary.org/obo/MONDO_0013993) (pontocerebellar hypoplasia type 7), [MONDO:0013994](http://purl.obolibrary.org/obo/MONDO_0013994) (Joubert syndrome 20), [MONDO:0009012](http://purl.obolibrary.org/obo/MONDO_0009012) (multiple pterygium-malignant hyperthermia syndrome), [MONDO:0010001](http://purl.obolibrary.org/obo/MONDO_0010001) (ectodermal dysplasia-blindness syndrome), [MONDO:0012662](http://purl.obolibrary.org/obo/MONDO_0012662) (Usher syndrome type 2D), [MONDO:0011330](http://purl.obolibrary.org/obo/MONDO_0011330) (spinocerebellar ataxia type 10), [MONDO:0009014](http://purl.obolibrary.org/obo/MONDO_0009014) (cornea plana 2), [MONDO:0013990](http://purl.obolibrary.org/obo/MONDO_0013990) (pontocerebellar hypoplasia type 8), [MONDO:0009015](http://purl.obolibrary.org/obo/MONDO_0009015) (corneal dystrophy-perceptive deafness syndrome), [MONDO:0003705](http://purl.obolibrary.org/obo/MONDO_0003705) (adult brainstem mixed glioma), [MONDO:0003706](http://purl.obolibrary.org/obo/MONDO_0003706) (adult brainstem astrocytoma), [MONDO:0009016](http://purl.obolibrary.org/obo/MONDO_0009016) (band keratopathy), [MONDO:0009018](http://purl.obolibrary.org/obo/MONDO_0009018) (central cloudy dystrophy of FranC'ois), [MONDO:0009019](http://purl.obolibrary.org/obo/MONDO_0009019) (congenital hereditary endothelial dystrophy of cornea), [MONDO:0020280](http://purl.obolibrary.org/obo/MONDO_0020280) (metabolic disease with cataract), [MONDO:0020281](http://purl.obolibrary.org/obo/MONDO_0020281) (metabolic disease with pigmentary retinitis), [MONDO:0020282](http://purl.obolibrary.org/obo/MONDO_0020282) (metabolic disease with macular cherry-red spot), [MONDO:0020283](http://purl.obolibrary.org/obo/MONDO_0020283) (uveitis (disease)), [MONDO:0010004](http://purl.obolibrary.org/obo/MONDO_0010004) (EEC syndrome), [MONDO:0012667](http://purl.obolibrary.org/obo/MONDO_0012667) (dilated cardiomyopathy 1W), [MONDO:0013999](http://purl.obolibrary.org/obo/MONDO_0013999) (optic nerve edema-splenomegaly syndrome), [MONDO:0010002](http://purl.obolibrary.org/obo/MONDO_0010002) (Rothmund-Thomson syndrome), [MONDO:0011334](http://purl.obolibrary.org/obo/MONDO_0011334) (limb-mammary syndrome), [MONDO:0012665](http://purl.obolibrary.org/obo/MONDO_0012665) (cataract 33), [MONDO:0012664](http://purl.obolibrary.org/obo/MONDO_0012664) (spastic ataxia 3), [MONDO:0010009](http://purl.obolibrary.org/obo/MONDO_0010009) (SC phocomelia syndrome), [MONDO:0011339](http://purl.obolibrary.org/obo/MONDO_0011339) (hereditary spastic paraplegia 8), [MONDO:0010006](http://purl.obolibrary.org/obo/MONDO_0010006) (Sandhoff disease), [MONDO:0010007](http://purl.obolibrary.org/obo/MONDO_0010007) (Microbrachycephaly-ptosis-cleft lip syndrome), [MONDO:0013981](http://purl.obolibrary.org/obo/MONDO_0013981) (familial cortical myoclonus), [MONDO:0013982](http://purl.obolibrary.org/obo/MONDO_0013982) (ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant), [MONDO:0013983](http://purl.obolibrary.org/obo/MONDO_0013983) (ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive), [MONDO:0012652](http://purl.obolibrary.org/obo/MONDO_0012652) (autosomal recessive limb-girdle muscular dystrophy type 2L), [MONDO:0012651](http://purl.obolibrary.org/obo/MONDO_0012651) (spastic ataxia 2), [MONDO:0009001](http://purl.obolibrary.org/obo/MONDO_0009001) (macular coloboma-cleft palate-hallux valgus syndrome), [MONDO:0009002](http://purl.obolibrary.org/obo/MONDO_0009002) (coloboma, ocular, autosomal recessive), [MONDO:0009003](http://purl.obolibrary.org/obo/MONDO_0009003) (achromatopsia 2), [MONDO:0020276](http://purl.obolibrary.org/obo/MONDO_0020276) (pigmentation disorder with eye involvement, excluding albinism), [MONDO:0000689](http://purl.obolibrary.org/obo/MONDO_0000689) (survival motor neuron spinal muscular atrophy), [MONDO:0020277](http://purl.obolibrary.org/obo/MONDO_0020277) (ectodermal malformation syndrome associated with ocular features), [MONDO:0020278](http://purl.obolibrary.org/obo/MONDO_0020278) (metabolic disease associated with ocular features), [MONDO:0020279](http://purl.obolibrary.org/obo/MONDO_0020279) (metabolic disease with corneal opacity), [MONDO:0020270](http://purl.obolibrary.org/obo/MONDO_0020270) (pigmentation disorder with eye involvement), [MONDO:0020271](http://purl.obolibrary.org/obo/MONDO_0020271) (phakomatosis with eye involvement), [MONDO:0020272](http://purl.obolibrary.org/obo/MONDO_0020272) (connective tissue disease with eye involvement), [MONDO:0020273](http://purl.obolibrary.org/obo/MONDO_0020273) (disease with potential neoplastic degeneration associated with ocular features), [MONDO:0020274](http://purl.obolibrary.org/obo/MONDO_0020274) (onycho-patellar syndrome with eye involvement), [MONDO:0020275](http://purl.obolibrary.org/obo/MONDO_0020275) (oculocutaneous or ocular albinism), [MONDO:0013989](http://purl.obolibrary.org/obo/MONDO_0013989) (epileptic encephalopathy, early infantile, 14), [MONDO:0012655](http://purl.obolibrary.org/obo/MONDO_0012655) (EJM4), [MONDO:0012653](http://purl.obolibrary.org/obo/MONDO_0012653) (PHPVAD), [MONDO:0013984](http://purl.obolibrary.org/obo/MONDO_0013984) (autosomal recessive nonsyndromic deafness 84B), [MONDO:0011329](http://purl.obolibrary.org/obo/MONDO_0011329) (cerebral palsy, spastic quadriplegic, 1), [MONDO:0013985](http://purl.obolibrary.org/obo/MONDO_0013985) (autosomal recessive nonsyndromic deafness 18B), [MONDO:0011327](http://purl.obolibrary.org/obo/MONDO_0011327) (neuronal intranuclear inclusion disease), [MONDO:0009073](http://purl.obolibrary.org/obo/MONDO_0009073) (Ritscher-Schinzel syndrome 1), [MONDO:0015752](http://purl.obolibrary.org/obo/MONDO_0015752) (intellectual disability-cataracts-kyphosis syndrome), [MONDO:0010062](http://purl.obolibrary.org/obo/MONDO_0010062) (spinocerebellar ataxia-dysmorphism syndrome), [MONDO:0009074](http://purl.obolibrary.org/obo/MONDO_0009074) (facial dysmorphism-macrocephaly-myopia-Dandy-Walker malformation syndrome), [MONDO:0010063](http://purl.obolibrary.org/obo/MONDO_0010063) (corneal-cerebellar syndrome), [MONDO:0015751](http://purl.obolibrary.org/obo/MONDO_0015751) (craniosynostosis-hydrocephalus-Arnold-Chiari malformation type i-radioulnar synostosis syndrome), [MONDO:0009075](http://purl.obolibrary.org/obo/MONDO_0009075) (Dandy-Walker malformation-postaxial polydactyly syndrome), [MONDO:0010060](http://purl.obolibrary.org/obo/MONDO_0010060) (infantile onset spinocerebellar ataxia), [MONDO:0011392](http://purl.obolibrary.org/obo/MONDO_0011392) (autosomal recessive nonsyndromic deafness 20), [MONDO:0015753](http://purl.obolibrary.org/obo/MONDO_0015753) (cap myopathy), [MONDO:0011391](http://purl.obolibrary.org/obo/MONDO_0011391) (megalencephalic leukoencephalopathy with subcortical cysts), [MONDO:0010061](http://purl.obolibrary.org/obo/MONDO_0010061) (autosomal recessive cerebellar ataxia-blindness-deafness syndrome), [MONDO:0009076](http://purl.obolibrary.org/obo/MONDO_0009076) (autosomal recessive nonsyndromic deafness 1A), [MONDO:0011397](http://purl.obolibrary.org/obo/MONDO_0011397) (autosomal dominant cerebellar ataxia, deafness and narcolepsy), [MONDO:0009078](http://purl.obolibrary.org/obo/MONDO_0009078) (Jervell and Lange-Nielsen syndrome), [MONDO:0010064](http://purl.obolibrary.org/obo/MONDO_0010064) (spastic ataxia-corneal dystrophy syndrome), [MONDO:0009079](http://purl.obolibrary.org/obo/MONDO_0009079) (DOORS syndrome), [MONDO:0011395](http://purl.obolibrary.org/obo/MONDO_0011395) (cone-rod dystrophy 3), [MONDO:0010065](http://purl.obolibrary.org/obo/MONDO_0010065) (spinocerebellar degeneration with slow eye movements), [MONDO:0003765](http://purl.obolibrary.org/obo/MONDO_0003765) (adult leptomeningeal melanoma), [MONDO:0003764](http://purl.obolibrary.org/obo/MONDO_0003764) (pediatric leptomeningeal melanoma), [MONDO:0003761](http://purl.obolibrary.org/obo/MONDO_0003761) (meningeal melanoma), [MONDO:0003762](http://purl.obolibrary.org/obo/MONDO_0003762) (malignant leptomeningeal tumor), [MONDO:0014428](http://purl.obolibrary.org/obo/MONDO_0014428) (autosomal recessive nonsyndromic deafness 102), [MONDO:0010069](http://purl.obolibrary.org/obo/MONDO_0010069) (spondylocostal dysostosis-anal and genitourinary malformations syndrome), [MONDO:0009080](http://purl.obolibrary.org/obo/MONDO_0009080) (split hand-foot malformation 1 with sensorineural hearing loss), [MONDO:0015755](http://purl.obolibrary.org/obo/MONDO_0015755) (myopathy with hexagonally cross-linked tubular arrays), [MONDO:0009082](http://purl.obolibrary.org/obo/MONDO_0009082) (high myopia-sensorineural deafness syndrome), [MONDO:0014426](http://purl.obolibrary.org/obo/MONDO_0014426) (nanophthalmos 4), [MONDO:0009083](http://purl.obolibrary.org/obo/MONDO_0009083) (conductive deafness-malformed external ear syndrome), [MONDO:0014427](http://purl.obolibrary.org/obo/MONDO_0014427) (cone-rod dystrophy 20), [MONDO:0010051](http://purl.obolibrary.org/obo/MONDO_0010051) (spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome), [MONDO:0011382](http://purl.obolibrary.org/obo/MONDO_0011382) (sickle cell anemia), [MONDO:0009063](http://purl.obolibrary.org/obo/MONDO_0009063) (ventriculomegaly-cystic kidney disease), [MONDO:0014410](http://purl.obolibrary.org/obo/MONDO_0014410) (spinocerebellar ataxia type 37), [MONDO:0009064](http://purl.obolibrary.org/obo/MONDO_0009064) (ocular cystinosis), [MONDO:0011381](http://purl.obolibrary.org/obo/MONDO_0011381) (dominant beta-thalassemia), [MONDO:0011380](http://purl.obolibrary.org/obo/MONDO_0011380) (leukoencephalopathy with vanishing white matter), [MONDO:0015742](http://purl.obolibrary.org/obo/MONDO_0015742) (periventricular leukomalacia), [MONDO:0010056](http://purl.obolibrary.org/obo/MONDO_0010056) (adult spinal muscular atrophy), [MONDO:0009069](http://purl.obolibrary.org/obo/MONDO_0009069) (congenital lactic acidosis, Saguenay-Lac-saint-Jean type), [MONDO:0006806](http://purl.obolibrary.org/obo/MONDO_0006806) (intermediate uveitis (disease)), [MONDO:0003774](http://purl.obolibrary.org/obo/MONDO_0003774) (cerebral convexity meningioma), [MONDO:0003775](http://purl.obolibrary.org/obo/MONDO_0003775) (lateral ventricle meningioma), [MONDO:0003772](http://purl.obolibrary.org/obo/MONDO_0003772) (cerebral meningioma), [MONDO:0003773](http://purl.obolibrary.org/obo/MONDO_0003773) (intracerebral cystic meningioma), [MONDO:0003771](http://purl.obolibrary.org/obo/MONDO_0003771) (jugular foramen meningioma), [MONDO:0014417](http://purl.obolibrary.org/obo/MONDO_0014417) (spinocerebellar ataxia type 38), [MONDO:0015749](http://purl.obolibrary.org/obo/MONDO_0015749) (6q16 deletion syndrome), [MONDO:0014418](http://purl.obolibrary.org/obo/MONDO_0014418) (myopathy, centronuclear, 5), [MONDO:0014419](http://purl.obolibrary.org/obo/MONDO_0014419) (ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome), [MONDO:0010057](http://purl.obolibrary.org/obo/MONDO_0010057) (spinal muscular atrophy, Ryukyuan type), [MONDO:0011389](http://purl.obolibrary.org/obo/MONDO_0011389) (autosomal dominant nonsyndromic deafness 16), [MONDO:0010058](http://purl.obolibrary.org/obo/MONDO_0010058) (spinal muscular atrophy, scapuloperoneal), [MONDO:0015745](http://purl.obolibrary.org/obo/MONDO_0015745) (microcephaly-polymicrogyria-corpus callosum agenesis syndrome), [MONDO:0014413](http://purl.obolibrary.org/obo/MONDO_0014413) (orofaciodigital syndrome type 14), [MONDO:0009072](http://purl.obolibrary.org/obo/MONDO_0009072) (Dandy-Walker syndrome), [MONDO:0011372](http://purl.obolibrary.org/obo/MONDO_0011372) (microcephaly with simplified Gyral pattern), [MONDO:0010041](http://purl.obolibrary.org/obo/MONDO_0010041) (Charlevoix-Saguenay spastic ataxia), [MONDO:0009052](http://purl.obolibrary.org/obo/MONDO_0009052) (cutis laxa, autosomal recessive, type 1A), [MONDO:0011370](http://purl.obolibrary.org/obo/MONDO_0011370) (Stargardt disease 4), [MONDO:0009053](http://purl.obolibrary.org/obo/MONDO_0009053) (ALDH18A1-related de Barsy syndrome), [MONDO:0014400](http://purl.obolibrary.org/obo/MONDO_0014400) (retinitis pigmentosa 70), [MONDO:0009054](http://purl.obolibrary.org/obo/MONDO_0009054) (autosomal recessive cutis laxa type 2, classic type), [MONDO:0010044](http://purl.obolibrary.org/obo/MONDO_0010044) (hereditary spastic paraplegia 15), [MONDO:0010045](http://purl.obolibrary.org/obo/MONDO_0010045) (paraplegia-brachydactyly-cone-shaped epiphysis syndrome), [MONDO:0010043](http://purl.obolibrary.org/obo/MONDO_0010043) (hereditary spastic paraplegia 17), [MONDO:0002416](http://purl.obolibrary.org/obo/MONDO_0002416) (ethmoid sinus squamous cell carcinoma), [MONDO:0003745](http://purl.obolibrary.org/obo/MONDO_0003745) (choroid spindle cell melanoma), [MONDO:0003746](http://purl.obolibrary.org/obo/MONDO_0003746) (ciliary body spindle cell melanoma), [MONDO:0015738](http://purl.obolibrary.org/obo/MONDO_0015738) (childhood-onset nemaline myopathy), [MONDO:0015737](http://purl.obolibrary.org/obo/MONDO_0015737) (Typical nemaline myopathy), [MONDO:0010049](http://purl.obolibrary.org/obo/MONDO_0010049) (spastic paraplegia-glaucoma-intellectual disability syndrome), [MONDO:0014407](http://purl.obolibrary.org/obo/MONDO_0014407) (megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2), [MONDO:0010046](http://purl.obolibrary.org/obo/MONDO_0010046) (hereditary spastic paraplegia 23), [MONDO:0014408](http://purl.obolibrary.org/obo/MONDO_0014408) (megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3), [MONDO:0014409](http://purl.obolibrary.org/obo/MONDO_0014409) (mental retardation, autosomal recessive 44), [MONDO:0015739](http://purl.obolibrary.org/obo/MONDO_0015739) (adult-onset nemaline myopathy), [MONDO:0010047](http://purl.obolibrary.org/obo/MONDO_0010047) (hereditary spastic paraplegia 5A), [MONDO:0014402](http://purl.obolibrary.org/obo/MONDO_0014402) (severe neurodegenerative syndrome with lipodystrophy), [MONDO:0015736](http://purl.obolibrary.org/obo/MONDO_0015736) (intermediate nemaline myopathy), [MONDO:0015735](http://purl.obolibrary.org/obo/MONDO_0015735) (severe congenital nemaline myopathy), [MONDO:0010030](http://purl.obolibrary.org/obo/MONDO_0010030) (Sjogren syndrome), [MONDO:0011360](http://purl.obolibrary.org/obo/MONDO_0011360) (autosomal recessive nonsyndromic deafness 14), [MONDO:0012691](http://purl.obolibrary.org/obo/MONDO_0012691) (leopard syndrome 2), [MONDO:0009042](http://purl.obolibrary.org/obo/MONDO_0009042) (Craniotelencephalic dysplasia), [MONDO:0012690](http://purl.obolibrary.org/obo/MONDO_0012690) (Noonan syndrome 5), [MONDO:0009043](http://purl.obolibrary.org/obo/MONDO_0009043) (generalized resistance to thyroid hormone), [MONDO:0011365](http://purl.obolibrary.org/obo/MONDO_0011365) (blepharophimosis-intellectual disability syndrome, SBBYS type), [MONDO:0011364](http://purl.obolibrary.org/obo/MONDO_0011364) (autosomal recessive nonsyndromic deafness 16), [MONDO:0012695](http://purl.obolibrary.org/obo/MONDO_0012695) (Meckel syndrome, type 5), [MONDO:0009045](http://purl.obolibrary.org/obo/MONDO_0009045) (cataract-nephropathy-encephalopathy syndrome), [MONDO:0009046](http://purl.obolibrary.org/obo/MONDO_0009046) (Fraser syndrome), [MONDO:0010031](http://purl.obolibrary.org/obo/MONDO_0010031) (Sjogren-Larsson syndrome), [MONDO:0012694](http://purl.obolibrary.org/obo/MONDO_0012694) (Joubert syndrome 7), [MONDO:0011362](http://purl.obolibrary.org/obo/MONDO_0011362) (hereditary proximal myopathy with early respiratory failure), [MONDO:0003750](http://purl.obolibrary.org/obo/MONDO_0003750) (central nervous system childhood germ cell tumor), [MONDO:0015726](http://purl.obolibrary.org/obo/MONDO_0015726) (distal trisomy 14q), [MONDO:0012699](http://purl.obolibrary.org/obo/MONDO_0012699) (autosomal recessive limb-girdle muscular dystrophy type 2M), [MONDO:0010035](http://purl.obolibrary.org/obo/MONDO_0010035) (Smith-Lemli-Opitz syndrome), [MONDO:0012698](http://purl.obolibrary.org/obo/MONDO_0012698) (Waardenburg syndrome type 2E), [MONDO:0015728](http://purl.obolibrary.org/obo/MONDO_0015728) (distal trisomy 15q), [MONDO:0010039](http://purl.obolibrary.org/obo/MONDO_0010039) (congenital heart defect-round face-developmental delay syndrome), [MONDO:0009050](http://purl.obolibrary.org/obo/MONDO_0009050) (ACTH-secreting pituitary adenoma), [MONDO:0014464](http://purl.obolibrary.org/obo/MONDO_0014464) (progressive encephalopathy with leukodystrophy due to DECR deficiency), [MONDO:0018822](http://purl.obolibrary.org/obo/MONDO_0018822) (global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome), [MONDO:0018823](http://purl.obolibrary.org/obo/MONDO_0018823) (X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome), [MONDO:0018820](http://purl.obolibrary.org/obo/MONDO_0018820) (recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome), [MONDO:0014466](http://purl.obolibrary.org/obo/MONDO_0014466) (Neu-Laxova syndrome 2), [MONDO:0014467](http://purl.obolibrary.org/obo/MONDO_0014467) (Charcot-Marie-tooth disease recessive intermediate d), [MONDO:0018821](http://purl.obolibrary.org/obo/MONDO_0018821) (X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability), [MONDO:0013130](http://purl.obolibrary.org/obo/MONDO_0013130) (isolated microphthalmia 4), [MONDO:0015794](http://purl.obolibrary.org/obo/MONDO_0015794) (antenatal multiminicore disease with arthrogryposis multiplex congenita), [MONDO:0013132](http://purl.obolibrary.org/obo/MONDO_0013132) (hereditary spastic paraplegia 36), [MONDO:0015793](http://purl.obolibrary.org/obo/MONDO_0015793) (moderate multiminicore disease with hand involvement), [MONDO:0005505](http://purl.obolibrary.org/obo/MONDO_0005505) (dysembryoplastic neuroepithelial tumor), [MONDO:0001147](http://purl.obolibrary.org/obo/MONDO_0001147) (meningocele (disease)), [MONDO:0006836](http://purl.obolibrary.org/obo/MONDO_0006836) (Listeria meningitis), [MONDO:0002475](http://purl.obolibrary.org/obo/MONDO_0002475) (lacrimal gland adenocarcinoma), [MONDO:0018828](http://purl.obolibrary.org/obo/MONDO_0018828) (UPS18 deficiency), [MONDO:0018829](http://purl.obolibrary.org/obo/MONDO_0018829) (familial schizencephaly), [MONDO:0013137](http://purl.obolibrary.org/obo/MONDO_0013137) (choroidal dystrophy, central areolar 2), [MONDO:0014468](http://purl.obolibrary.org/obo/MONDO_0014468) (congenital myasthenic syndrome 7), [MONDO:0018826](http://purl.obolibrary.org/obo/MONDO_0018826) (Lewis-Sumner syndrome), [MONDO:0018827](http://purl.obolibrary.org/obo/MONDO_0018827) (familial Chilblain lupus), [MONDO:0014469](http://purl.obolibrary.org/obo/MONDO_0014469) (autosomal recessive nonsyndromic deafness 103), [MONDO:0018825](http://purl.obolibrary.org/obo/MONDO_0018825) (PYCR2-related microcephaly-progressive leukoencephalopathy), [MONDO:0010095](http://purl.obolibrary.org/obo/MONDO_0010095) (ataxia-tapetoretinal degeneration syndrome), [MONDO:0015785](http://purl.obolibrary.org/obo/MONDO_0015785) (Prader-Willi syndrome due to translocation), [MONDO:0015784](http://purl.obolibrary.org/obo/MONDO_0015784) (Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2), [MONDO:0014454](http://purl.obolibrary.org/obo/MONDO_0014454) (Hennekam lymphangiectasia-lymphedema syndrome 2), [MONDO:0014455](http://purl.obolibrary.org/obo/MONDO_0014455) (cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome), [MONDO:0015786](http://purl.obolibrary.org/obo/MONDO_0015786) (Prader-Willi syndrome due to imprinting mutation), [MONDO:0018810](http://purl.obolibrary.org/obo/MONDO_0018810) (lethal hydranencephaly-diaphragmatic hernia syndrome), [MONDO:0015781](http://purl.obolibrary.org/obo/MONDO_0015781) (facial dysmorphism-shawl scrotum-joint laxity syndrome), [MONDO:0010099](http://purl.obolibrary.org/obo/MONDO_0010099) (Tay-Sachs disease AB variant), [MONDO:0015780](http://purl.obolibrary.org/obo/MONDO_0015780) (dyskeratosis congenita), [MONDO:0015783](http://purl.obolibrary.org/obo/MONDO_0015783) (Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1), [MONDO:0010091](http://purl.obolibrary.org/obo/MONDO_0010091) (Crisponi syndrome), [MONDO:0010092](http://purl.obolibrary.org/obo/MONDO_0010092) (Filippi syndrome), [MONDO:0005514](http://purl.obolibrary.org/obo/MONDO_0005514) (nanophthalmia), [MONDO:0018817](http://purl.obolibrary.org/obo/MONDO_0018817) (autosomal recessive limb-girdle muscular dystrophy type 2Z), [MONDO:0018818](http://purl.obolibrary.org/obo/MONDO_0018818) (facial diplegia with paresthesias), [MONDO:0014457](http://purl.obolibrary.org/obo/MONDO_0014457) (hyperphosphatasia with mental retardation syndrome 5), [MONDO:0013129](http://purl.obolibrary.org/obo/MONDO_0013129) (cone dystrophy 4), [MONDO:0014442](http://purl.obolibrary.org/obo/MONDO_0014442) (Bardet-Biedl syndrome 14), [MONDO:0010085](http://purl.obolibrary.org/obo/MONDO_0010085) (Schilder disease), [MONDO:0009096](http://purl.obolibrary.org/obo/MONDO_0009096) (hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia), [MONDO:0014443](http://purl.obolibrary.org/obo/MONDO_0014443) (Bardet-Biedl syndrome 15), [MONDO:0015776](http://purl.obolibrary.org/obo/MONDO_0015776) (rhizomelic chondrodysplasia punctata), [MONDO:0010082](http://purl.obolibrary.org/obo/MONDO_0010082) (subaortic stenosis-short stature syndrome), [MONDO:0009097](http://purl.obolibrary.org/obo/MONDO_0009097) (persistent hyperplastic primary vitreous, autosomal recessive), [MONDO:0014444](http://purl.obolibrary.org/obo/MONDO_0014444) (Bardet-Biedl syndrome 16), [MONDO:0010083](http://purl.obolibrary.org/obo/MONDO_0010083) (succinic semialdehyde dehydrogenase deficiency), [MONDO:0013114](http://purl.obolibrary.org/obo/MONDO_0013114) (autosomal dominant nonsyndromic deafness 50), [MONDO:0014445](http://purl.obolibrary.org/obo/MONDO_0014445) (Bardet-Biedl syndrome 17), [MONDO:0010088](http://purl.obolibrary.org/obo/MONDO_0010088) (mucosulfatidosis), [MONDO:0010089](http://purl.obolibrary.org/obo/MONDO_0010089) (isolated sulfite oxidase deficiency), [MONDO:0014440](http://purl.obolibrary.org/obo/MONDO_0014440) (Bardet-Biedl syndrome 12), [MONDO:0013110](http://purl.obolibrary.org/obo/MONDO_0013110) (neurodegenerative syndrome due to cerebral folate transport deficiency), [MONDO:0014441](http://purl.obolibrary.org/obo/MONDO_0014441) (Bardet-Biedl syndrome 13), [MONDO:0001129](http://purl.obolibrary.org/obo/MONDO_0001129) (nasal cavity olfactory neuroblastoma), [MONDO:0010080](http://purl.obolibrary.org/obo/MONDO_0010080) (familial infantile bilateral striatal necrosis), [MONDO:0002457](http://purl.obolibrary.org/obo/MONDO_0002457) (Treacher-Collins syndrome), [MONDO:0013119](http://purl.obolibrary.org/obo/MONDO_0013119) (autosomal recessive nonsyndromic deafness 77), [MONDO:0013115](http://purl.obolibrary.org/obo/MONDO_0013115) (RIN2 syndrome), [MONDO:0014446](http://purl.obolibrary.org/obo/MONDO_0014446) (Bardet-Biedl syndrome 18), [MONDO:0013116](http://purl.obolibrary.org/obo/MONDO_0013116) (congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome), [MONDO:0014447](http://purl.obolibrary.org/obo/MONDO_0014447) (Bardet-Biedl syndrome 19), [MONDO:0013117](http://purl.obolibrary.org/obo/MONDO_0013117) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 5), [MONDO:0010073](http://purl.obolibrary.org/obo/MONDO_0010073) (spondyloepiphyseal dysplasia tarda, Kohn type), [MONDO:0014432](http://purl.obolibrary.org/obo/MONDO_0014432) (Bardet-Biedl syndrome 2), [MONDO:0009085](http://purl.obolibrary.org/obo/MONDO_0009085) (deafness-vitiligo-achalasia syndrome), [MONDO:0014433](http://purl.obolibrary.org/obo/MONDO_0014433) (Bardet-Biedl syndrome 4), [MONDO:0009086](http://purl.obolibrary.org/obo/MONDO_0009086) (deafness-small bowel diverticulosis-neuropathy syndrome), [MONDO:0015765](http://purl.obolibrary.org/obo/MONDO_0015765) (congenital myopathy with cores), [MONDO:0013103](http://purl.obolibrary.org/obo/MONDO_0013103) (epilepsy, idiopathic generalized, susceptibility to, 10), [MONDO:0014434](http://purl.obolibrary.org/obo/MONDO_0014434) (Bardet-Biedl syndrome 5), [MONDO:0009089](http://purl.obolibrary.org/obo/MONDO_0009089) (deafness-oligodontia syndrome), [MONDO:0014430](http://purl.obolibrary.org/obo/MONDO_0014430) (mental retardation, autosomal recessive 45), [MONDO:0006825](http://purl.obolibrary.org/obo/MONDO_0006825) (kuru), [MONDO:0002469](http://purl.obolibrary.org/obo/MONDO_0002469) (lacrimal gland carcinoma ex pleomorphic adenoma), [MONDO:0002464](http://purl.obolibrary.org/obo/MONDO_0002464) (lacrimal gland cancer), [MONDO:0002463](http://purl.obolibrary.org/obo/MONDO_0002463) (lacrimal gland carcinoma), [MONDO:0001130](http://purl.obolibrary.org/obo/MONDO_0001130) (nasal cavity lymphoma), [MONDO:0014439](http://purl.obolibrary.org/obo/MONDO_0014439) (Bardet-Biedl syndrome 11), [MONDO:0010079](http://purl.obolibrary.org/obo/MONDO_0010079) (Canavan disease), [MONDO:0009090](http://purl.obolibrary.org/obo/MONDO_0009090) (deafness, sensorineural, autosomal-mitochondrial type), [MONDO:0009091](http://purl.obolibrary.org/obo/MONDO_0009091) (non-acquired combined pituitary hormone deficiency with spine abnormalities), [MONDO:0014435](http://purl.obolibrary.org/obo/MONDO_0014435) (Bardet-Biedl syndrome 7), [MONDO:0014436](http://purl.obolibrary.org/obo/MONDO_0014436) (Bardet-Biedl syndrome 8), [MONDO:0009092](http://purl.obolibrary.org/obo/MONDO_0009092) (Nasu-Hakola disease), [MONDO:0014437](http://purl.obolibrary.org/obo/MONDO_0014437) (Bardet-Biedl syndrome 9), [MONDO:0009093](http://purl.obolibrary.org/obo/MONDO_0009093) (Dermatoleukodystrophy), [MONDO:0014438](http://purl.obolibrary.org/obo/MONDO_0014438) (Bardet-Biedl syndrome 10), [MONDO:0015768](http://purl.obolibrary.org/obo/MONDO_0015768) (trisomy 5p), [MONDO:0009094](http://purl.obolibrary.org/obo/MONDO_0009094) (Dermochondrocorneal dystrophy), [MONDO:0018866](http://purl.obolibrary.org/obo/MONDO_0018866) (Aicardi-Goutieres syndrome), [MONDO:0013177](http://purl.obolibrary.org/obo/MONDO_0013177) (congenital muscular dystrophy due to integrin alpha-7 deficiency), [MONDO:0016202](http://purl.obolibrary.org/obo/MONDO_0016202) (autosomal dominant rhegmatogenous retinal detachment), [MONDO:0013178](http://purl.obolibrary.org/obo/MONDO_0013178) (congenital muscular dystrophy due to LMNA mutation), [MONDO:0013179](http://purl.obolibrary.org/obo/MONDO_0013179) (hereditary spastic paraplegia 44), [MONDO:0016205](http://purl.obolibrary.org/obo/MONDO_0016205) (IRVAN syndrome), [MONDO:0013173](http://purl.obolibrary.org/obo/MONDO_0013173) (mental retardation, autosomal recessive 13), [MONDO:0016201](http://purl.obolibrary.org/obo/MONDO_0016201) (qualitative or quantitative defects of myotilin), [MONDO:0013175](http://purl.obolibrary.org/obo/MONDO_0013175) (retinitis pigmentosa 50), [MONDO:0018860](http://purl.obolibrary.org/obo/MONDO_0018860) (Microlissencephaly-micromelia syndrome), [MONDO:0016200](http://purl.obolibrary.org/obo/MONDO_0016200) (qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase -), [MONDO:0013176](http://purl.obolibrary.org/obo/MONDO_0013176) (ichthyosis-short stature-brachydactyly-microspherophakia syndrome), [MONDO:0018861](http://purl.obolibrary.org/obo/MONDO_0018861) (Zellweger-like syndrome without peroxisomal anomalies), [MONDO:0013170](http://purl.obolibrary.org/obo/MONDO_0013170) (cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies), [MONDO:0013172](http://purl.obolibrary.org/obo/MONDO_0013172) (polymicrogyria with optic nerve hypoplasia), [MONDO:0009910](http://purl.obolibrary.org/obo/MONDO_0009910) (Wiedemann-Rautenstrauch syndrome), [MONDO:0004218](http://purl.obolibrary.org/obo/MONDO_0004218) (childhood germ cell brain tumor), [MONDO:0004216](http://purl.obolibrary.org/obo/MONDO_0004216) (pineal region germinoma), [MONDO:0005547](http://purl.obolibrary.org/obo/MONDO_0005547) (desmoplastic medulloblastoma), [MONDO:0004217](http://purl.obolibrary.org/obo/MONDO_0004217) (childhood brain germinoma), [MONDO:0009918](http://purl.obolibrary.org/obo/MONDO_0009918) (fundus dystrophy, pseudoinflammatory, recessive form), [MONDO:0009919](http://purl.obolibrary.org/obo/MONDO_0009919) (peroxisomal acyl-CoA oxidase deficiency), [MONDO:0010905](http://purl.obolibrary.org/obo/MONDO_0010905) (cone-rod dystrophy 1), [MONDO:0016207](http://purl.obolibrary.org/obo/MONDO_0016207) (phacoanaphylactic uveitis), [MONDO:0016206](http://purl.obolibrary.org/obo/MONDO_0016206) (idiopathic uveal effusion syndrome), [MONDO:0010900](http://purl.obolibrary.org/obo/MONDO_0010900) (intrauterine growth retardation with increased mitomycin c sensitivity), [MONDO:0018868](http://purl.obolibrary.org/obo/MONDO_0018868) (metachromatic leukodystrophy), [MONDO:0016209](http://purl.obolibrary.org/obo/MONDO_0016209) (benign familial nocturnal alternating hemiplegia of childhood), [MONDO:0018869](http://purl.obolibrary.org/obo/MONDO_0018869) (cobblestone lissencephaly), [MONDO:0014497](http://purl.obolibrary.org/obo/MONDO_0014497) (polyendocrine-polyneuropathy syndrome), [MONDO:0013166](http://purl.obolibrary.org/obo/MONDO_0013166) (GABA aminotransferase deficiency), [MONDO:0013167](http://purl.obolibrary.org/obo/MONDO_0013167) (PARK16), [MONDO:0013168](http://purl.obolibrary.org/obo/MONDO_0013168) (dilated cardiomyopathy 1DD), [MONDO:0014499](http://purl.obolibrary.org/obo/MONDO_0014499) (mental retardation, autosomal recessive 46), [MONDO:0013169](http://purl.obolibrary.org/obo/MONDO_0013169) (chromosome 5p13 duplication syndrome), [MONDO:0013162](http://purl.obolibrary.org/obo/MONDO_0013162) (autosomal recessive limb-girdle muscular dystrophy type 2N), [MONDO:0018852](http://purl.obolibrary.org/obo/MONDO_0018852) (achromatopsia), [MONDO:0013164](http://purl.obolibrary.org/obo/MONDO_0013164) (beta-ureidopropionase deficiency), [MONDO:0014495](http://purl.obolibrary.org/obo/MONDO_0014495) (retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome), [MONDO:0013165](http://purl.obolibrary.org/obo/MONDO_0013165) (hereditary spastic paraplegia 45), [MONDO:0013160](http://purl.obolibrary.org/obo/MONDO_0013160) (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2), [MONDO:0013161](http://purl.obolibrary.org/obo/MONDO_0013161) (autosomal recessive limb-girdle muscular dystrophy type 2O), [MONDO:0009903](http://purl.obolibrary.org/obo/MONDO_0009903) (postaxial acrofacial dysostosis), [MONDO:0006888](http://purl.obolibrary.org/obo/MONDO_0006888) (paraneoplastic polyneuropathy), [MONDO:0009905](http://purl.obolibrary.org/obo/MONDO_0009905) (urban-Rogers-Meyer syndrome), [MONDO:0006885](http://purl.obolibrary.org/obo/MONDO_0006885) (panuveitis), [MONDO:0006884](http://purl.obolibrary.org/obo/MONDO_0006884) (panophthalmitis), [MONDO:0009908](http://purl.obolibrary.org/obo/MONDO_0009908) (dehydratase deficiency), [MONDO:0006881](http://purl.obolibrary.org/obo/MONDO_0006881) (orbital cellulitis), [MONDO:0018859](http://purl.obolibrary.org/obo/MONDO_0018859) (Leigh disease), [MONDO:0013155](http://purl.obolibrary.org/obo/MONDO_0013155) (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3), [MONDO:0014486](http://purl.obolibrary.org/obo/MONDO_0014486) (mental retardation, autosomal dominant 30), [MONDO:0018845](http://purl.obolibrary.org/obo/MONDO_0018845) (focal myositis), [MONDO:0013156](http://purl.obolibrary.org/obo/MONDO_0013156) (muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4), [MONDO:0013157](http://purl.obolibrary.org/obo/MONDO_0013157) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5), [MONDO:0014489](http://purl.obolibrary.org/obo/MONDO_0014489) (limb-girdle muscular dystrophy due to POMK deficiency), [MONDO:0013158](http://purl.obolibrary.org/obo/MONDO_0013158) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6), [MONDO:0018843](http://purl.obolibrary.org/obo/MONDO_0018843) (embryonal carcinoma of the central nervous system), [MONDO:0013151](http://purl.obolibrary.org/obo/MONDO_0013151) (CACD3), [MONDO:0014482](http://purl.obolibrary.org/obo/MONDO_0014482) (mental retardation, autosomal dominant 29), [MONDO:0014483](http://purl.obolibrary.org/obo/MONDO_0014483) (retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies), [MONDO:0014484](http://purl.obolibrary.org/obo/MONDO_0014484) (microcephaly 12, primary, autosomal recessive), [MONDO:0013154](http://purl.obolibrary.org/obo/MONDO_0013154) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2), [MONDO:0014485](http://purl.obolibrary.org/obo/MONDO_0014485) (pontocerebellar hypoplasia, type 1C), [MONDO:0013150](http://purl.obolibrary.org/obo/MONDO_0013150) (infantile dystonia-parkinsonism), [MONDO:0005526](http://purl.obolibrary.org/obo/MONDO_0005526) (tetanus), [MONDO:0013159](http://purl.obolibrary.org/obo/MONDO_0013159) (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1), [MONDO:0018833](http://purl.obolibrary.org/obo/MONDO_0018833) (rare idiopathic macular telangiectasia), [MONDO:0014475](http://purl.obolibrary.org/obo/MONDO_0014475) (spinocerebellar ataxia type 40), [MONDO:0014476](http://purl.obolibrary.org/obo/MONDO_0014476) (episodic ataxia type 8), [MONDO:0018834](http://purl.obolibrary.org/obo/MONDO_0018834) (Adenylosuccinate synthetase-like 1-related distal myopathy), [MONDO:0018831](http://purl.obolibrary.org/obo/MONDO_0018831) (HTRA1-related cerebral small vessel disease), [MONDO:0014477](http://purl.obolibrary.org/obo/MONDO_0014477) (epileptic encephalopathy, early infantile, 26), [MONDO:0013147](http://purl.obolibrary.org/obo/MONDO_0013147) (dilated cardiomyopathy 1CC), [MONDO:0018832](http://purl.obolibrary.org/obo/MONDO_0018832) (HTRA1-related autosomal dominant cerebral small vessel disease), [MONDO:0014478](http://purl.obolibrary.org/obo/MONDO_0014478) (mirror movements 3), [MONDO:0014473](http://purl.obolibrary.org/obo/MONDO_0014473) (microcephaly 13, primary, autosomal recessive), [MONDO:0013142](http://purl.obolibrary.org/obo/MONDO_0013142) (neuropathy, hereditary sensory and autonomic, type 2B), [MONDO:0014474](http://purl.obolibrary.org/obo/MONDO_0014474) (autosomal recessive limb-girdle muscular dystrophy type 2U), [MONDO:0014470](http://purl.obolibrary.org/obo/MONDO_0014470) (autosomal dominant nonsyndromic deafness 65), [MONDO:0006866](http://purl.obolibrary.org/obo/MONDO_0006866) (neonatal myasthenia gravis), [MONDO:0018839](http://purl.obolibrary.org/obo/MONDO_0018839) (acquired schizencephaly), [MONDO:0018838](http://purl.obolibrary.org/obo/MONDO_0018838) (lissencephaly (disease)), [MONDO:0017577](http://purl.obolibrary.org/obo/MONDO_0017577) (spontaneous periodic hypothermia), [MONDO:0017579](http://purl.obolibrary.org/obo/MONDO_0017579) (Baraitser-winter cerebrofrontofacial syndrome), [MONDO:0017575](http://purl.obolibrary.org/obo/MONDO_0017575) (mitochondrial neurogastrointestinal encephalomyopathy), [MONDO:0009952](http://purl.obolibrary.org/obo/MONDO_0009952) (radioulnar synostosis-developmental delay-hypotonia syndrome), [MONDO:0016241](http://purl.obolibrary.org/obo/MONDO_0016241) (alternating hemiplegia of childhood), [MONDO:0017572](http://purl.obolibrary.org/obo/MONDO_0017572) (tick-borne encephalitis), [MONDO:0009953](http://purl.obolibrary.org/obo/MONDO_0009953) (leukocyte adhesion deficiency type II), [MONDO:0009958](http://purl.obolibrary.org/obo/MONDO_0009958) (adult Refsum disease), [MONDO:0009959](http://purl.obolibrary.org/obo/MONDO_0009959) (peroxisome biogenesis disorder type 3B), [MONDO:0010948](http://purl.obolibrary.org/obo/MONDO_0010948) (cataract 10 multiple types), [MONDO:0010945](http://purl.obolibrary.org/obo/MONDO_0010945) (retinitis pigmentosa 17), [MONDO:0004257](http://purl.obolibrary.org/obo/MONDO_0004257) (childhood central nervous system mixed germ cell tumor), [MONDO:0010949](http://purl.obolibrary.org/obo/MONDO_0010949) (Charcot-Marie-tooth disease type 2B), [MONDO:0018899](http://purl.obolibrary.org/obo/MONDO_0018899) (posterior cortical atrophy), [MONDO:0017569](http://purl.obolibrary.org/obo/MONDO_0017569) (de Barsy syndrome), [MONDO:0018893](http://purl.obolibrary.org/obo/MONDO_0018893) (Cobb syndrome), [MONDO:0018894](http://purl.obolibrary.org/obo/MONDO_0018894) (distal hereditary motor neuropathy), [MONDO:0018892](http://purl.obolibrary.org/obo/MONDO_0018892) (Wyburn-Mason syndrome), [MONDO:0008612](http://purl.obolibrary.org/obo/MONDO_0008612) (tuberous sclerosis 1), [MONDO:0009945](http://purl.obolibrary.org/obo/MONDO_0009945) (pyridoxine-dependent epilepsy), [MONDO:0010936](http://purl.obolibrary.org/obo/MONDO_0010936) (frontotemporal dementia, chromosome 3-linked), [MONDO:0005598](http://purl.obolibrary.org/obo/MONDO_0005598) (dopaminergic neuroblastoma), [MONDO:0010935](http://purl.obolibrary.org/obo/MONDO_0010935) (neuronopathy, distal hereditary motor, type 5A), [MONDO:0004263](http://purl.obolibrary.org/obo/MONDO_0004263) (pediatric infratentorial ependymoblastoma), [MONDO:0010932](http://purl.obolibrary.org/obo/MONDO_0010932) (progressive bifocal chorioretinal atrophy), [MONDO:0010933](http://purl.obolibrary.org/obo/MONDO_0010933) (autosomal recessive nonsyndromic deafness 4), [MONDO:0013199](http://purl.obolibrary.org/obo/MONDO_0013199) (tuberous sclerosis 2), [MONDO:0018888](http://purl.obolibrary.org/obo/MONDO_0018888) (congenital cornea plana), [MONDO:0016225](http://purl.obolibrary.org/obo/MONDO_0016225) (specific learning disability), [MONDO:0018889](http://purl.obolibrary.org/obo/MONDO_0018889) (hyaline body myopathy), [MONDO:0016224](http://purl.obolibrary.org/obo/MONDO_0016224) (autosomal dominant proximal spinal muscular atrophy), [MONDO:0016227](http://purl.obolibrary.org/obo/MONDO_0016227) (hereditary episodic ataxia), [MONDO:0016226](http://purl.obolibrary.org/obo/MONDO_0016226) (specific language disorder), [MONDO:0018885](http://purl.obolibrary.org/obo/MONDO_0018885) (orbital leiomyoma), [MONDO:0013198](http://purl.obolibrary.org/obo/MONDO_0013198) (dilated cardiomyopathy 1EE), [MONDO:0013193](http://purl.obolibrary.org/obo/MONDO_0013193) (thyrotoxic periodic paralysis, susceptibility to, 2), [MONDO:0008603](http://purl.obolibrary.org/obo/MONDO_0008603) (trigonocephaly 1), [MONDO:0004238](http://purl.obolibrary.org/obo/MONDO_0004238) (petrous apex meningioma), [MONDO:0010924](http://purl.obolibrary.org/obo/MONDO_0010924) (D-2-hydroxyglutaric aciduria), [MONDO:0008608](http://purl.obolibrary.org/obo/MONDO_0008608) (down syndrome), [MONDO:0004233](http://purl.obolibrary.org/obo/MONDO_0004233) (childhood pleomorphic rhabdomyosarcoma), [MONDO:0018877](http://purl.obolibrary.org/obo/MONDO_0018877) (retinitis punctata albescens), [MONDO:0013188](http://purl.obolibrary.org/obo/MONDO_0013188) (cerebellar ataxia, mental retardation, and Dysequilibrium syndrome 3), [MONDO:0018878](http://purl.obolibrary.org/obo/MONDO_0018878) (branchiootic syndrome), [MONDO:0018875](http://purl.obolibrary.org/obo/MONDO_0018875) (Li-Fraumeni syndrome), [MONDO:0016215](http://purl.obolibrary.org/obo/MONDO_0016215) (spastic quadriplegia), [MONDO:0018873](http://purl.obolibrary.org/obo/MONDO_0018873) (anterior cutaneous nerve entrapment syndrome), [MONDO:0016210](http://purl.obolibrary.org/obo/MONDO_0016210) (alternating hemiplegia), [MONDO:0013185](http://purl.obolibrary.org/obo/MONDO_0013185) (leprosy, susceptibility to, 5), [MONDO:0013186](http://purl.obolibrary.org/obo/MONDO_0013186) (Noonan syndrome 6), [MONDO:0013182](http://purl.obolibrary.org/obo/MONDO_0013182) (chromosome 17p13.3 duplication syndrome), [MONDO:0013183](http://purl.obolibrary.org/obo/MONDO_0013183) (congenital stationary night blindness 1C), [MONDO:0009920](http://purl.obolibrary.org/obo/MONDO_0009920) (Acrootoocular syndrome), [MONDO:0009921](http://purl.obolibrary.org/obo/MONDO_0009921) (holoprosencephaly-postaxial polydactyly syndrome), [MONDO:0009925](http://purl.obolibrary.org/obo/MONDO_0009925) (pseudoxanthoma elasticum), [MONDO:0010914](http://purl.obolibrary.org/obo/MONDO_0010914) (carnitine palmitoyl transferase II deficiency, severe infantile form), [MONDO:0010915](http://purl.obolibrary.org/obo/MONDO_0010915) (autosomal dominant nonsyndromic deafness 4A), [MONDO:0004245](http://purl.obolibrary.org/obo/MONDO_0004245) (ependymal tumor of brain), [MONDO:0009927](http://purl.obolibrary.org/obo/MONDO_0009927) (3MC syndrome 2), [MONDO:0010912](http://purl.obolibrary.org/obo/MONDO_0010912) (fibrosis of extraocular muscles, congenital, 3A, with or without Extraocular involvement), [MONDO:0016218](http://purl.obolibrary.org/obo/MONDO_0016218) (Guillain-Barre syndrome), [MONDO:0010911](http://purl.obolibrary.org/obo/MONDO_0010911) (prolactin-producing pituitary gland adenoma), [MONDO:0019317](http://purl.obolibrary.org/obo/MONDO_0019317) (follicular atrophoderma-basal cell carcinoma), [MONDO:0020307](http://purl.obolibrary.org/obo/MONDO_0020307) (benign childhood occipital epilepsy, Panayiotopoulos type), [MONDO:0020308](http://purl.obolibrary.org/obo/MONDO_0020308) (benign childhood occipital epilepsy, Gastaut type), [MONDO:0019313](http://purl.obolibrary.org/obo/MONDO_0019313) (hereditary lymphedema), [MONDO:0009990](http://purl.obolibrary.org/obo/MONDO_0009990) (Revesz syndrome), [MONDO:0009992](http://purl.obolibrary.org/obo/MONDO_0009992) (myoglobinuria, acute recurrent, autosomal recessive), [MONDO:0009993](http://purl.obolibrary.org/obo/MONDO_0009993) (embryonal rhabdomyosarcoma (disease)), [MONDO:0019312](http://purl.obolibrary.org/obo/MONDO_0019312) (Hermansky-Pudlak syndrome), [MONDO:0008662](http://purl.obolibrary.org/obo/MONDO_0008662) (autosomal dominant vitreoretinochoroidopathy), [MONDO:0009994](http://purl.obolibrary.org/obo/MONDO_0009994) (alveolar rhabdomyosarcoma (disease)), [MONDO:0008663](http://purl.obolibrary.org/obo/MONDO_0008663) (Snowflake vitreoretinal degeneration), [MONDO:0008664](http://purl.obolibrary.org/obo/MONDO_0008664) (autosomal dominant neovascular inflammatory vitreoretinopathy), [MONDO:0016282](http://purl.obolibrary.org/obo/MONDO_0016282) (rhabdomyosarcoma of the cervix uteri), [MONDO:0019310](http://purl.obolibrary.org/obo/MONDO_0019310) (recessive dystrophic epidermolysis bullosa inversa), [MONDO:0020300](http://purl.obolibrary.org/obo/MONDO_0020300) (autosomal dominant nocturnal frontal lobe epilepsy), [MONDO:0008665](http://purl.obolibrary.org/obo/MONDO_0008665) (ptosis-vocal cord paralysis syndrome), [MONDO:0009997](http://purl.obolibrary.org/obo/MONDO_0009997) (Roberts syndrome), [MONDO:0020301](http://purl.obolibrary.org/obo/MONDO_0020301) (Prader-Willi syndrome due to paternal 15q11q13 deletion), [MONDO:0008667](http://purl.obolibrary.org/obo/MONDO_0008667) (von Hippel-Lindau disease), [MONDO:0020302](http://purl.obolibrary.org/obo/MONDO_0020302) (Angelman syndrome due to maternal 15q11q13 deletion), [MONDO:0020303](http://purl.obolibrary.org/obo/MONDO_0020303) (Angelman syndrome due to paternal uniparental disomy of chromosome 15), [MONDO:0007326](http://purl.obolibrary.org/obo/MONDO_0007326) (paroxysmal nonkinesigenic dyskinesia 1), [MONDO:0007324](http://purl.obolibrary.org/obo/MONDO_0007324) (chorea), [MONDO:0010983](http://purl.obolibrary.org/obo/MONDO_0010983) (dystonia 9), [MONDO:0010984](http://purl.obolibrary.org/obo/MONDO_0010984) (Usher syndrome type 1D), [MONDO:0010987](http://purl.obolibrary.org/obo/MONDO_0010987) (autosomal recessive nonsyndromic deafness 8), [MONDO:0010988](http://purl.obolibrary.org/obo/MONDO_0010988) (aplasia cutis-myopia syndrome), [MONDO:0010985](http://purl.obolibrary.org/obo/MONDO_0010985) (FAME1), [MONDO:0010986](http://purl.obolibrary.org/obo/MONDO_0010986) (autosomal recessive nonsyndromic deafness 9), [MONDO:0021627](http://purl.obolibrary.org/obo/MONDO_0021627) (eyelid capillary hemangioma), [MONDO:0019302](http://purl.obolibrary.org/obo/MONDO_0019302) (mucopolysaccharidosis with skin involvement), [MONDO:0000700](http://purl.obolibrary.org/obo/MONDO_0000700) (familial hemiplegic migraine), [MONDO:0009983](http://purl.obolibrary.org/obo/MONDO_0009983) (retinitis pigmentosa-intellectual disability-deafness-hypogenitalism syndrome), [MONDO:0009984](http://purl.obolibrary.org/obo/MONDO_0009984) (late-adult onset retinitis pigmentosa), [MONDO:0008654](http://purl.obolibrary.org/obo/MONDO_0008654) (NYS4), [MONDO:0009987](http://purl.obolibrary.org/obo/MONDO_0009987) (autosomal recessive pericentral pigmentary retinopathy), [MONDO:0009989](http://purl.obolibrary.org/obo/MONDO_0009989) (enhanced S-cone syndrome), [MONDO:0006009](http://purl.obolibrary.org/obo/MONDO_0006009) (viral encephalitis), [MONDO:0007339](http://purl.obolibrary.org/obo/MONDO_0007339) (Blepharo-cheilo-odontic syndrome), [MONDO:0006005](http://purl.obolibrary.org/obo/MONDO_0006005) (Venezuelan equine encephalitis), [MONDO:0006004](http://purl.obolibrary.org/obo/MONDO_0006004) (vasomotor rhinitis), [MONDO:0007334](http://purl.obolibrary.org/obo/MONDO_0007334) (autosomal dominant popliteal pterygium syndrome), [MONDO:0010973](http://purl.obolibrary.org/obo/MONDO_0010973) (autosomal dominant nonsyndromic deafness 5), [MONDO:0010977](http://purl.obolibrary.org/obo/MONDO_0010977) (Brody myopathy), [MONDO:0017596](http://purl.obolibrary.org/obo/MONDO_0017596) (diffuse large B-cell lymphoma of the central nervous system), [MONDO:0008641](http://purl.obolibrary.org/obo/MONDO_0008641) (retinal vasculopathy and cerebral leukoencephalopathy), [MONDO:0016260](http://purl.obolibrary.org/obo/MONDO_0016260) (uterine corpus rhabdomyosarcoma), [MONDO:0009974](http://purl.obolibrary.org/obo/MONDO_0009974) (familial hemophagocytic lymphohistiocytosis type 1), [MONDO:0016263](http://purl.obolibrary.org/obo/MONDO_0016263) (primitive neuroectodermal tumor of the corpus uteri), [MONDO:0008644](http://purl.obolibrary.org/obo/MONDO_0008644) (velocardiofacial syndrome), [MONDO:0017593](http://purl.obolibrary.org/obo/MONDO_0017593) (juvenile amyotrophic lateral sclerosis), [MONDO:0007309](http://purl.obolibrary.org/obo/MONDO_0007309) (Charcot-Marie-tooth disease type 1A), [MONDO:0009977](http://purl.obolibrary.org/obo/MONDO_0009977) (Knobloch syndrome), [MONDO:0009978](http://purl.obolibrary.org/obo/MONDO_0009978) (retinal degeneration-nanophthalmos-glaucoma syndrome), [MONDO:0007308](http://purl.obolibrary.org/obo/MONDO_0007308) (Charcot-Marie-tooth disease type 2A1), [MONDO:0007307](http://purl.obolibrary.org/obo/MONDO_0007307) (Charcot-Marie-tooth disease type 1B), [MONDO:0009979](http://purl.obolibrary.org/obo/MONDO_0009979) (reticular dystrophy of the retinal pigment epithelium), [MONDO:0010969](http://purl.obolibrary.org/obo/MONDO_0010969) (cone-rod dystrophy 5), [MONDO:0010967](http://purl.obolibrary.org/obo/MONDO_0010967) (autosomal recessive nonsyndromic deafness 7), [MONDO:0004279](http://purl.obolibrary.org/obo/MONDO_0004279) (glossopharyngeal motor neuropathy), [MONDO:0007300](http://purl.obolibrary.org/obo/MONDO_0007300) (cerebral sarcoma), [MONDO:0010965](http://purl.obolibrary.org/obo/MONDO_0010965) (autosomal recessive nonsyndromic deafness 6), [MONDO:0010963](http://purl.obolibrary.org/obo/MONDO_0010963) (autosomal dominant nonsyndromic deafness 6), [MONDO:0021605](http://purl.obolibrary.org/obo/MONDO_0021605) (benign eyelid neoplasm), [MONDO:0017585](http://purl.obolibrary.org/obo/MONDO_0017585) (painful orbital and systemic neurofibromas-marfanoid habitus syndrome), [MONDO:0016256](http://purl.obolibrary.org/obo/MONDO_0016256) (Hennekam syndrome), [MONDO:0017580](http://purl.obolibrary.org/obo/MONDO_0017580) (11p15.4 microduplication syndrome), [MONDO:0009962](http://purl.obolibrary.org/obo/MONDO_0009962) (Senior-Loken syndrome 1), [MONDO:0009963](http://purl.obolibrary.org/obo/MONDO_0009963) (Ulbright-Hodes syndrome), [MONDO:0017582](http://purl.obolibrary.org/obo/MONDO_0017582) (pituitary adenocarcinoma (disease)), [MONDO:0009964](http://purl.obolibrary.org/obo/MONDO_0009964) (short-rib thoracic dysplasia 9 with or without polydactyly), [MONDO:0009966](http://purl.obolibrary.org/obo/MONDO_0009966) (NPHP3-related Meckel-like syndrome), [MONDO:0007318](http://purl.obolibrary.org/obo/MONDO_0007318) (Alagille syndrome), [MONDO:0009968](http://purl.obolibrary.org/obo/MONDO_0009968) (renal tubular acidosis, distal, with progressive nerve deafness), [MONDO:0007316](http://purl.obolibrary.org/obo/MONDO_0007316) (Arnold-Chiari malformation type i), [MONDO:0007311](http://purl.obolibrary.org/obo/MONDO_0007311) (Charcot-Marie-tooth disease type 1E), [MONDO:0007310](http://purl.obolibrary.org/obo/MONDO_0007310) (Charcot-Marie-tooth disease, Guadalajara neuronal type), [MONDO:0010951](http://purl.obolibrary.org/obo/MONDO_0010951) (dilated cardiomyopathy 1B), [MONDO:0004280](http://purl.obolibrary.org/obo/MONDO_0004280) (asymmetric motor neuropathy), [MONDO:0010952](http://purl.obolibrary.org/obo/MONDO_0010952) (hereditary hyperferritinemia with congenital cataracts), [MONDO:0018028](http://purl.obolibrary.org/obo/MONDO_0018028) (tetrasomy 5p), [MONDO:0019357](http://purl.obolibrary.org/obo/MONDO_0019357) (congenital narrowing of cervical spinal canal), [MONDO:0018027](http://purl.obolibrary.org/obo/MONDO_0018027) (duplication/inversion 15q11), [MONDO:0019358](http://purl.obolibrary.org/obo/MONDO_0019358) (encephalopathy due to sulfite oxidase deficiency), [MONDO:0019353](http://purl.obolibrary.org/obo/MONDO_0019353) (Stargardt disease), [MONDO:0020342](http://purl.obolibrary.org/obo/MONDO_0020342) (congenital myopathy with excess of thin filaments), [MONDO:0019354](http://purl.obolibrary.org/obo/MONDO_0019354) (Stickler syndrome), [MONDO:0020343](http://purl.obolibrary.org/obo/MONDO_0020343) (alpha-crystallinopathy), [MONDO:0000734](http://purl.obolibrary.org/obo/MONDO_0000734) (Ohdo syndrome and variants), [MONDO:0019351](http://purl.obolibrary.org/obo/MONDO_0019351) (isolated spina bifida), [MONDO:0020344](http://purl.obolibrary.org/obo/MONDO_0020344) (postsynaptic congenital myasthenic syndrome), [MONDO:0018021](http://purl.obolibrary.org/obo/MONDO_0018021) (hypotrichosis-deafness syndrome), [MONDO:0020345](http://purl.obolibrary.org/obo/MONDO_0020345) (presynaptic congenital myasthenic syndrome), [MONDO:0020346](http://purl.obolibrary.org/obo/MONDO_0020346) (synaptic congenital myasthenic syndrome), [MONDO:0020347](http://purl.obolibrary.org/obo/MONDO_0020347) (acute inflammatory demyelinating polyradiculoneuropathy), [MONDO:0020348](http://purl.obolibrary.org/obo/MONDO_0020348) (acute motor and sensory axonal neuropathy), [MONDO:0020349](http://purl.obolibrary.org/obo/MONDO_0020349) (acute motor axonal neuropathy), [MONDO:0007369](http://purl.obolibrary.org/obo/MONDO_0007369) (hereditary coproporphyria), [MONDO:0006037](http://purl.obolibrary.org/obo/MONDO_0006037) (hydrolethalus syndrome), [MONDO:0020340](http://purl.obolibrary.org/obo/MONDO_0020340) (bilateral perisylvian polymicrogyria), [MONDO:0007366](http://purl.obolibrary.org/obo/MONDO_0007366) (seizures, benign familial neonatal, 2), [MONDO:0020341](http://purl.obolibrary.org/obo/MONDO_0020341) (periventricular nodular heterotopia), [MONDO:0007365](http://purl.obolibrary.org/obo/MONDO_0007365) (seizures, benign familial neonatal, 1), [MONDO:0006033](http://purl.obolibrary.org/obo/MONDO_0006033) (diffuse intrinsic pontine glioma), [MONDO:0007363](http://purl.obolibrary.org/obo/MONDO_0007363) (congenital contractural arachnodactyly), [MONDO:0012721](http://purl.obolibrary.org/obo/MONDO_0012721) (progressive myoclonic epilepsy type 3), [MONDO:0012720](http://purl.obolibrary.org/obo/MONDO_0012720) (Krabbe disease, atypical, due to saposin a deficiency), [MONDO:0007362](http://purl.obolibrary.org/obo/MONDO_0007362) (cone-rod dystrophy 2), [MONDO:0012726](http://purl.obolibrary.org/obo/MONDO_0012726) (autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome), [MONDO:0007360](http://purl.obolibrary.org/obo/MONDO_0007360) (branchiootic syndrome 2), [MONDO:0012723](http://purl.obolibrary.org/obo/MONDO_0012723) (Leber congenital amaurosis 10), [MONDO:0020339](http://purl.obolibrary.org/obo/MONDO_0020339) (X-linked complex spastic paraplegia), [MONDO:0008690](http://purl.obolibrary.org/obo/MONDO_0008690) (xeroderma pigmentosum, autosomal dominant, mild), [MONDO:0019349](http://purl.obolibrary.org/obo/MONDO_0019349) (Sotos syndrome), [MONDO:0019346](http://purl.obolibrary.org/obo/MONDO_0019346) (sialidosis type 1), [MONDO:0008692](http://purl.obolibrary.org/obo/MONDO_0008692) (abetalipoproteinemia), [MONDO:0008693](http://purl.obolibrary.org/obo/MONDO_0008693) (ablepharon macrostomia syndrome), [MONDO:0008694](http://purl.obolibrary.org/obo/MONDO_0008694) (Pseudoprogeria syndrome), [MONDO:0019344](http://purl.obolibrary.org/obo/MONDO_0019344) (Antisynthetase syndrome), [MONDO:0008695](http://purl.obolibrary.org/obo/MONDO_0008695) (chorea-acanthocytosis), [MONDO:0019342](http://purl.obolibrary.org/obo/MONDO_0019342) (Seckel syndrome), [MONDO:0018011](http://purl.obolibrary.org/obo/MONDO_0018011) (juvenile overlap myositis), [MONDO:0019341](http://purl.obolibrary.org/obo/MONDO_0019341) (tuberous sclerosis complex), [MONDO:0018010](http://purl.obolibrary.org/obo/MONDO_0018010) (juvenile idiopathic inflammatory myopathy), [MONDO:0020336](http://purl.obolibrary.org/obo/MONDO_0020336) (autosomal dominant Emery-Dreifuss muscular dystrophy), [MONDO:0012719](http://purl.obolibrary.org/obo/MONDO_0012719) (encephalopathy due to prosaposin deficiency), [MONDO:0007379](http://purl.obolibrary.org/obo/MONDO_0007379) (Meesmann corneal dystrophy), [MONDO:0007378](http://purl.obolibrary.org/obo/MONDO_0007378) (posterior polymorphous corneal dystrophy 1), [MONDO:0007377](http://purl.obolibrary.org/obo/MONDO_0007377) (granular corneal dystrophy type i), [MONDO:0007376](http://purl.obolibrary.org/obo/MONDO_0007376) (fleck corneal dystrophy), [MONDO:0007375](http://purl.obolibrary.org/obo/MONDO_0007375) (epithelial basement membrane dystrophy), [MONDO:0007374](http://purl.obolibrary.org/obo/MONDO_0007374) (Schnyder corneal dystrophy), [MONDO:0006042](http://purl.obolibrary.org/obo/MONDO_0006042) (meningeal tuberculosis), [MONDO:0007372](http://purl.obolibrary.org/obo/MONDO_0007372) (CNA1), [MONDO:0012715](http://purl.obolibrary.org/obo/MONDO_0012715) (MGR12), [MONDO:0012714](http://purl.obolibrary.org/obo/MONDO_0012714) (early-onset myopathy with fatal cardiomyopathy), [MONDO:0018006](http://purl.obolibrary.org/obo/MONDO_0018006) (adult-onset distal myopathy due to VCP mutation), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0008681](http://purl.obolibrary.org/obo/MONDO_0008681) (WAGR syndrome), [MONDO:0019335](http://purl.obolibrary.org/obo/MONDO_0019335) (mild hyperphenylalaninemia), [MONDO:0019336](http://purl.obolibrary.org/obo/MONDO_0019336) (Gardner syndrome), [MONDO:0018005](http://purl.obolibrary.org/obo/MONDO_0018005) (spastic paraplegia-Paget disease of bone syndrome), [MONDO:0018002](http://purl.obolibrary.org/obo/MONDO_0018002) (adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy), [MONDO:0008684](http://purl.obolibrary.org/obo/MONDO_0008684) (wolf-Hirschhorn syndrome), [MONDO:0018003](http://purl.obolibrary.org/obo/MONDO_0018003) (limbic encephalitis with DPP6 antibodies), [MONDO:0000711](http://purl.obolibrary.org/obo/MONDO_0000711) (amyotrophic lateral sclerosis type 13), [MONDO:0000712](http://purl.obolibrary.org/obo/MONDO_0000712) (FTDALS1), [MONDO:0012708](http://purl.obolibrary.org/obo/MONDO_0012708) (PLSA1), [MONDO:0012706](http://purl.obolibrary.org/obo/MONDO_0012706) (familial temporal lobe epilepsy 4), [MONDO:0012705](http://purl.obolibrary.org/obo/MONDO_0012705) (ETL3), [MONDO:0007346](http://purl.obolibrary.org/obo/MONDO_0007346) (cochleosaccular degeneration-cataract syndrome), [MONDO:0012709](http://purl.obolibrary.org/obo/MONDO_0012709) (microphthalmia, isolated, with coloboma 5), [MONDO:0012704](http://purl.obolibrary.org/obo/MONDO_0012704) (dilated cardiomyopathy 1X), [MONDO:0012703](http://purl.obolibrary.org/obo/MONDO_0012703) (lissencephaly due to TUBA1A mutation), [MONDO:0019326](http://purl.obolibrary.org/obo/MONDO_0019326) (phakomatosis cesiomarmorata), [MONDO:0019327](http://purl.obolibrary.org/obo/MONDO_0019327) (phakomatosis spilorosea), [MONDO:0016298](http://purl.obolibrary.org/obo/MONDO_0016298) (postlingual non-syndromic genetic deafness), [MONDO:0008670](http://purl.obolibrary.org/obo/MONDO_0008670) (Waardenburg syndrome type 1), [MONDO:0016297](http://purl.obolibrary.org/obo/MONDO_0016297) (prelingual non-syndromic genetic deafness), [MONDO:0008671](http://purl.obolibrary.org/obo/MONDO_0008671) (Waardenburg syndrome type 2A), [MONDO:0019325](http://purl.obolibrary.org/obo/MONDO_0019325) (phakomatosis cesioflammea), [MONDO:0000727](http://purl.obolibrary.org/obo/MONDO_0000727) (scapuloperoneal myopathy), [MONDO:0016299](http://purl.obolibrary.org/obo/MONDO_0016299) (holoprosencephaly-caudal dysgenesis syndrome), [MONDO:0008675](http://purl.obolibrary.org/obo/MONDO_0008675) (Freeman-Sheldon syndrome), [MONDO:0016293](http://purl.obolibrary.org/obo/MONDO_0016293) (congenital stationary night blindness), [MONDO:0020310](http://purl.obolibrary.org/obo/MONDO_0020310) (familial focal epilepsy with variable foci), [MONDO:0021640](http://purl.obolibrary.org/obo/MONDO_0021640) (grade III glioma), [MONDO:0016296](http://purl.obolibrary.org/obo/MONDO_0016296) (holoprosencephaly), [MONDO:0016295](http://purl.obolibrary.org/obo/MONDO_0016295) (neuronal ceroid lipofuscinosis), [MONDO:0008678](http://purl.obolibrary.org/obo/MONDO_0008678) (Williams syndrome), [MONDO:0016290](http://purl.obolibrary.org/obo/MONDO_0016290) (Hern), [MONDO:0016292](http://purl.obolibrary.org/obo/MONDO_0016292) (nodular neuronal heterotopia), [MONDO:0007355](http://purl.obolibrary.org/obo/MONDO_0007355) (uveal coloboma-cleft lip and palate-intellectual disability), [MONDO:0007353](http://purl.obolibrary.org/obo/MONDO_0007353) (coloboma of macula-brachydactyly type B syndrome), [MONDO:0007352](http://purl.obolibrary.org/obo/MONDO_0007352) (renal coloboma syndrome), [MONDO:0010995](http://purl.obolibrary.org/obo/MONDO_0010995) (Charcot-Marie-tooth disease type 1C), [MONDO:0010992](http://purl.obolibrary.org/obo/MONDO_0010992) (AymC)-Gripp syndrome), [MONDO:0007351](http://purl.obolibrary.org/obo/MONDO_0007351) (coloboma of macula), [MONDO:0007350](http://purl.obolibrary.org/obo/MONDO_0007350) (coloboma, ocular, autosomal dominant), [MONDO:0010993](http://purl.obolibrary.org/obo/MONDO_0010993) (Harrod syndrome), [MONDO:0010998](http://purl.obolibrary.org/obo/MONDO_0010998) (ALG3-CDG), [MONDO:0010999](http://purl.obolibrary.org/obo/MONDO_0010999) (fallot complex-intellectual disability-growth delay syndrome), [MONDO:0010996](http://purl.obolibrary.org/obo/MONDO_0010996) (HHT3), [MONDO:0010997](http://purl.obolibrary.org/obo/MONDO_0010997) (classic progressive supranuclear palsy syndrome), [MONDO:0010100](http://purl.obolibrary.org/obo/MONDO_0010100) (Tay-Sachs disease), [MONDO:0011430](http://purl.obolibrary.org/obo/MONDO_0011430) (cataract 2 multiple types), [MONDO:0018068](http://purl.obolibrary.org/obo/MONDO_0018068) (trisomy 13), [MONDO:0009112](http://purl.obolibrary.org/obo/MONDO_0009112) (rhizomelic chondrodysplasia punctata type 2), [MONDO:0019399](http://purl.obolibrary.org/obo/MONDO_0019399) (Isaac syndrome), [MONDO:0019397](http://purl.obolibrary.org/obo/MONDO_0019397) (unknown leukodystrophy), [MONDO:0018067](http://purl.obolibrary.org/obo/MONDO_0018067) (Triploidy), [MONDO:0019398](http://purl.obolibrary.org/obo/MONDO_0019398) (desmin-related myopathy with Mallory body-like inclusions), [MONDO:0018065](http://purl.obolibrary.org/obo/MONDO_0018065) (isolated trigonocephaly), [MONDO:0020380](http://purl.obolibrary.org/obo/MONDO_0020380) (autosomal dominant cerebellar ataxia), [MONDO:0020381](http://purl.obolibrary.org/obo/MONDO_0020381) (patterned macular dystrophy), [MONDO:0020382](http://purl.obolibrary.org/obo/MONDO_0020382) (multifocal pattern dystrophy simulating fundus flavimaculatus), [MONDO:0020383](http://purl.obolibrary.org/obo/MONDO_0020383) (fundus pulverulentus), [MONDO:0012766](http://purl.obolibrary.org/obo/MONDO_0012766) (hereditary spastic paraplegia 37), [MONDO:0011435](http://purl.obolibrary.org/obo/MONDO_0011435) (microcephaly 2, primary, autosomal recessive, with or without cortical malformations), [MONDO:0006076](http://purl.obolibrary.org/obo/MONDO_0006076) (adrenal gland neuroblastoma), [MONDO:0012765](http://purl.obolibrary.org/obo/MONDO_0012765) (LMPH1B), [MONDO:0012764](http://purl.obolibrary.org/obo/MONDO_0012764) (RIDDLE syndrome), [MONDO:0011432](http://purl.obolibrary.org/obo/MONDO_0011432) (blepharophimosis-intellectual disability syndrome, Verloes type), [MONDO:0011439](http://purl.obolibrary.org/obo/MONDO_0011439) (spinocerebellar ataxia type 12), [MONDO:0010105](http://purl.obolibrary.org/obo/MONDO_0010105) (teratoma, pineal), [MONDO:0011437](http://purl.obolibrary.org/obo/MONDO_0011437) (microcephaly 4, primary, autosomal recessive), [MONDO:0011436](http://purl.obolibrary.org/obo/MONDO_0011436) (autosomal recessive distal spinal muscular atrophy 1), [MONDO:0018059](http://purl.obolibrary.org/obo/MONDO_0018059) (meningococcal meningitis), [MONDO:0019388](http://purl.obolibrary.org/obo/MONDO_0019388) (pelvis syndrome), [MONDO:0009101](http://purl.obolibrary.org/obo/MONDO_0009101) (Wolfram syndrome 1), [MONDO:0019389](http://purl.obolibrary.org/obo/MONDO_0019389) (X-linked recessive intellectual disability-macrocephaly-ciliary dysfunction syndrome), [MONDO:0020375](http://purl.obolibrary.org/obo/MONDO_0020375) (coralliform cataract), [MONDO:0019386](http://purl.obolibrary.org/obo/MONDO_0019386) (rubella panencephalitis), [MONDO:0020376](http://purl.obolibrary.org/obo/MONDO_0020376) (early-onset nuclear cataract), [MONDO:0019384](http://purl.obolibrary.org/obo/MONDO_0019384) (encephalitis lethargica), [MONDO:0020377](http://purl.obolibrary.org/obo/MONDO_0020377) (early-onset partial cataract), [MONDO:0019385](http://purl.obolibrary.org/obo/MONDO_0019385) (steroid-responsive encephalopathy associated with autoimmune thyroiditis), [MONDO:0009106](http://purl.obolibrary.org/obo/MONDO_0009106) (diastematomyelia), [MONDO:0020378](http://purl.obolibrary.org/obo/MONDO_0020378) (early-onset posterior polar cataract), [MONDO:0020379](http://purl.obolibrary.org/obo/MONDO_0020379) (early-onset zonular cataract), [MONDO:0019383](http://purl.obolibrary.org/obo/MONDO_0019383) (acute disseminated encephalomyelitis), [MONDO:0019380](http://purl.obolibrary.org/obo/MONDO_0019380) (western equine encephalitis), [MONDO:0019390](http://purl.obolibrary.org/obo/MONDO_0019390) (Susac syndrome), [MONDO:0020370](http://purl.obolibrary.org/obo/MONDO_0020370) (Cogan-Reese syndrome), [MONDO:0020371](http://purl.obolibrary.org/obo/MONDO_0020371) (essential iris atrophy), [MONDO:0020372](http://purl.obolibrary.org/obo/MONDO_0020372) (early-onset sutural cataract), [MONDO:0020373](http://purl.obolibrary.org/obo/MONDO_0020373) (early-onset anterior polar cataract), [MONDO:0020374](http://purl.obolibrary.org/obo/MONDO_0020374) (cerulean cataract), [MONDO:0012755](http://purl.obolibrary.org/obo/MONDO_0012755) (episodic ataxia type 7), [MONDO:0012754](http://purl.obolibrary.org/obo/MONDO_0012754) (NNO3), [MONDO:0011423](http://purl.obolibrary.org/obo/MONDO_0011423) (autosomal recessive limb-girdle muscular dystrophy type 2E), [MONDO:0012753](http://purl.obolibrary.org/obo/MONDO_0012753) (amyotrophic lateral sclerosis type 9), [MONDO:0012752](http://purl.obolibrary.org/obo/MONDO_0012752) (ANIB6), [MONDO:0011428](http://purl.obolibrary.org/obo/MONDO_0011428) (ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3), [MONDO:0011426](http://purl.obolibrary.org/obo/MONDO_0011426) (aceruloplasminemia), [MONDO:0012756](http://purl.obolibrary.org/obo/MONDO_0012756) (proximal 16p11.2 microdeletion syndrome), [MONDO:0011425](http://purl.obolibrary.org/obo/MONDO_0011425) (dilated cardiomyopathy 1H), [MONDO:0019377](http://purl.obolibrary.org/obo/MONDO_0019377) (Mycoplasma encephalitis), [MONDO:0019378](http://purl.obolibrary.org/obo/MONDO_0019378) (la Crosse encephalitis), [MONDO:0019375](http://purl.obolibrary.org/obo/MONDO_0019375) (megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome), [MONDO:0020364](http://purl.obolibrary.org/obo/MONDO_0020364) (posterior polymorphous corneal dystrophy), [MONDO:0018044](http://purl.obolibrary.org/obo/MONDO_0018044) (idiopathic hypersomnia), [MONDO:0020365](http://purl.obolibrary.org/obo/MONDO_0020365) (congenital hereditary endothelial dystrophy type i), [MONDO:0019376](http://purl.obolibrary.org/obo/MONDO_0019376) (West-nile encephalitis), [MONDO:0000756](http://purl.obolibrary.org/obo/MONDO_0000756) (parameningeal embryonal rhabdomyosarcoma), [MONDO:0018045](http://purl.obolibrary.org/obo/MONDO_0018045) (Hoyeraal-Hreidarsson syndrome), [MONDO:0019374](http://purl.obolibrary.org/obo/MONDO_0019374) (CAMOS syndrome), [MONDO:0019371](http://purl.obolibrary.org/obo/MONDO_0019371) (narcolepsy without cataplexy), [MONDO:0020369](http://purl.obolibrary.org/obo/MONDO_0020369) (Chandler syndrome), [MONDO:0006059](http://purl.obolibrary.org/obo/MONDO_0006059) (nasal cavity squamous cell carcinoma), [MONDO:0020360](http://purl.obolibrary.org/obo/MONDO_0020360) (complete cryptophthalmia), [MONDO:0020361](http://purl.obolibrary.org/obo/MONDO_0020361) (partial cryptophthalmia), [MONDO:0020362](http://purl.obolibrary.org/obo/MONDO_0020362) (Inverse Marcus-Gunn phenomenon), [MONDO:0020363](http://purl.obolibrary.org/obo/MONDO_0020363) (Honey-droplet corneal dystrophy), [MONDO:0007387](http://purl.obolibrary.org/obo/MONDO_0007387) (Cornelia de Lange syndrome 1), [MONDO:0012744](http://purl.obolibrary.org/obo/MONDO_0012744) (dilated cardiomyopathy 1Y), [MONDO:0011412](http://purl.obolibrary.org/obo/MONDO_0011412) (familial encephalopathy with neuroserpin inclusion bodies), [MONDO:0007384](http://purl.obolibrary.org/obo/MONDO_0007384) (congenital trigeminal anesthesia), [MONDO:0011411](http://purl.obolibrary.org/obo/MONDO_0011411) (Chudley-McCullough syndrome), [MONDO:0007383](http://purl.obolibrary.org/obo/MONDO_0007383) (Stern-Lubinsky-Durrie syndrome), [MONDO:0007382](http://purl.obolibrary.org/obo/MONDO_0007382) (Ramos-Arroyo syndrome), [MONDO:0007381](http://purl.obolibrary.org/obo/MONDO_0007381) (epithelial recurrent erosion dystrophy), [MONDO:0011416](http://purl.obolibrary.org/obo/MONDO_0011416) (generalized epilepsy with febrile seizures plus, type 1), [MONDO:0011415](http://purl.obolibrary.org/obo/MONDO_0011415) (Leber congenital amaurosis 3), [MONDO:0007380](http://purl.obolibrary.org/obo/MONDO_0007380) (lattice corneal dystrophy type i), [MONDO:0012746](http://purl.obolibrary.org/obo/MONDO_0012746) (dilated cardiomyopathy 2A), [MONDO:0011414](http://purl.obolibrary.org/obo/MONDO_0011414) (Peters anomaly (disease)), [MONDO:0012745](http://purl.obolibrary.org/obo/MONDO_0012745) (dilated cardiomyopathy 1Z), [MONDO:0019369](http://purl.obolibrary.org/obo/MONDO_0019369) (complex regional pain syndrome), [MONDO:0019366](http://purl.obolibrary.org/obo/MONDO_0019366) (Free sialic acid storage disease), [MONDO:0020353](http://purl.obolibrary.org/obo/MONDO_0020353) (von Hippel anomaly), [MONDO:0000766](http://purl.obolibrary.org/obo/MONDO_0000766) (corneal endothelial dystrophy), [MONDO:0021684](http://purl.obolibrary.org/obo/MONDO_0021684) (central nervous system infections), [MONDO:0020354](http://purl.obolibrary.org/obo/MONDO_0020354) (coloboma of choroid and retina), [MONDO:0020355](http://purl.obolibrary.org/obo/MONDO_0020355) (coloboma of eye lens), [MONDO:0020356](http://purl.obolibrary.org/obo/MONDO_0020356) (coloboma of iris (disease)), [MONDO:0020357](http://purl.obolibrary.org/obo/MONDO_0020357) (coloboma of eyelid), [MONDO:0000763](http://purl.obolibrary.org/obo/MONDO_0000763) (epithelial and subepithelial dystrophy), [MONDO:0020358](http://purl.obolibrary.org/obo/MONDO_0020358) (coloboma of optic disc), [MONDO:0020359](http://purl.obolibrary.org/obo/MONDO_0020359) (congenital symblepharon), [MONDO:0000764](http://purl.obolibrary.org/obo/MONDO_0000764) (epithelial-stromal TGFBI dystrophy), [MONDO:0000765](http://purl.obolibrary.org/obo/MONDO_0000765) (stromal dystrophy), [MONDO:0012739](http://purl.obolibrary.org/obo/MONDO_0012739) (microtia-eye coloboma-imperforation of the nasolacrimal duct syndrome), [MONDO:0011408](http://purl.obolibrary.org/obo/MONDO_0011408) (hereditary spastic paraplegia 10), [MONDO:0011407](http://purl.obolibrary.org/obo/MONDO_0011407) (HCFP2), [MONDO:0007399](http://purl.obolibrary.org/obo/MONDO_0007399) (craniosynostosis 1), [MONDO:0020351](http://purl.obolibrary.org/obo/MONDO_0020351) (Blake pouch cyst), [MONDO:0006068](http://purl.obolibrary.org/obo/MONDO_0006068) (ACTH-producing pituitary gland adenoma), [MONDO:0020352](http://purl.obolibrary.org/obo/MONDO_0020352) (multiple system atrophy, parkinsonian type), [MONDO:0011402](http://purl.obolibrary.org/obo/MONDO_0011402) (congenital cataracts-facial dysmorphism-neuropathy syndrome), [MONDO:0012733](http://purl.obolibrary.org/obo/MONDO_0012733) (bestrophinopathy), [MONDO:0011401](http://purl.obolibrary.org/obo/MONDO_0011401) (Alzheimer disease without Neurofibrillary tangles), [MONDO:0007395](http://purl.obolibrary.org/obo/MONDO_0007395) (craniofacial-deafness-hand syndrome), [MONDO:0011400](http://purl.obolibrary.org/obo/MONDO_0011400) (dilated cardiomyopathy 1G), [MONDO:0012735](http://purl.obolibrary.org/obo/MONDO_0012735) (Temple-Baraitser syndrome), [MONDO:0009152](http://purl.obolibrary.org/obo/MONDO_0009152) (ectopia lentis 2, isolated, autosomal recessive), [MONDO:0009153](http://purl.obolibrary.org/obo/MONDO_0009153) (ectopia lentis et pupillae), [MONDO:0009154](http://purl.obolibrary.org/obo/MONDO_0009154) (hypothyroidism, congenital, Nongoitrous, 5), [MONDO:0011475](http://purl.obolibrary.org/obo/MONDO_0011475) (Charcot-Marie-tooth disease type 4B2), [MONDO:0009155](http://purl.obolibrary.org/obo/MONDO_0009155) (EEM syndrome), [MONDO:0011473](http://purl.obolibrary.org/obo/MONDO_0011473) (Leber congenital amaurosis 5), [MONDO:0011472](http://purl.obolibrary.org/obo/MONDO_0011472) (epidermolysis bullosa simplex due to plakophilin deficiency), [MONDO:0003849](http://purl.obolibrary.org/obo/MONDO_0003849) (clivus chordoma), [MONDO:0003842](http://purl.obolibrary.org/obo/MONDO_0003842) (childhood cerebellar astrocytic neoplasm), [MONDO:0014509](http://purl.obolibrary.org/obo/MONDO_0014509) (macular dystrophy, vitelliform, 5), [MONDO:0011479](http://purl.obolibrary.org/obo/MONDO_0011479) (orthostatic intolerance), [MONDO:0014505](http://purl.obolibrary.org/obo/MONDO_0014505) (epileptic encephalopathy, early infantile, 27), [MONDO:0014506](http://purl.obolibrary.org/obo/MONDO_0014506) (hypomyelinating leukodystrophy 9), [MONDO:0014507](http://purl.obolibrary.org/obo/MONDO_0014507) (Catel-Manzke syndrome), [MONDO:0014508](http://purl.obolibrary.org/obo/MONDO_0014508) (macular dystrophy, vitelliform, 4), [MONDO:0014503](http://purl.obolibrary.org/obo/MONDO_0014503) (autosomal recessive spinocerebellar ataxia 17), [MONDO:0014504](http://purl.obolibrary.org/obo/MONDO_0014504) (Perrault syndrome 5), [MONDO:0012791](http://purl.obolibrary.org/obo/MONDO_0012791) (mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria), [MONDO:0012790](http://purl.obolibrary.org/obo/MONDO_0012790) (amyotrophic lateral sclerosis type 10), [MONDO:0009141](http://purl.obolibrary.org/obo/MONDO_0009141) (torsion dystonia 2), [MONDO:0009143](http://purl.obolibrary.org/obo/MONDO_0009143) (Meier-Gorlin syndrome 1), [MONDO:0011464](http://purl.obolibrary.org/obo/MONDO_0011464) (spinocerebellar ataxia type 11), [MONDO:0012794](http://purl.obolibrary.org/obo/MONDO_0012794) (ANE syndrome), [MONDO:0011461](http://purl.obolibrary.org/obo/MONDO_0011461) (generalized epilepsy with febrile seizures plus, type 2), [MONDO:0009146](http://purl.obolibrary.org/obo/MONDO_0009146) (ectodermal dysplasia-sensorineural deafness syndrome), [MONDO:0012792](http://purl.obolibrary.org/obo/MONDO_0012792) (mitochondrial DNA depletion syndrome 8a), [MONDO:0010131](http://purl.obolibrary.org/obo/MONDO_0010131) (thyroid hormone resistance, generalized, autosomal recessive), [MONDO:0009147](http://purl.obolibrary.org/obo/MONDO_0009147) (ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive), [MONDO:0018099](http://purl.obolibrary.org/obo/MONDO_0018099) (Whipple disease), [MONDO:0009148](http://purl.obolibrary.org/obo/MONDO_0009148) (Rosselli-Gulienetti syndrome), [MONDO:0018097](http://purl.obolibrary.org/obo/MONDO_0018097) (West syndrome), [MONDO:0018098](http://purl.obolibrary.org/obo/MONDO_0018098) (autosomal dominant limb-girdle muscular dystrophy type 1E (DES)), [MONDO:0018095](http://purl.obolibrary.org/obo/MONDO_0018095) (Weaver-Williams syndrome), [MONDO:0018096](http://purl.obolibrary.org/obo/MONDO_0018096) (Weill-Marchesani syndrome), [MONDO:0018094](http://purl.obolibrary.org/obo/MONDO_0018094) (Waardenburg's syndrome), [MONDO:0003850](http://purl.obolibrary.org/obo/MONDO_0003850) (clivus chondroid chordoma), [MONDO:0011468](http://purl.obolibrary.org/obo/MONDO_0011468) (hereditary motor and sensory neuropathy, Okinawa type), [MONDO:0010134](http://purl.obolibrary.org/obo/MONDO_0010134) (Pendred syndrome), [MONDO:0011466](http://purl.obolibrary.org/obo/MONDO_0011466) (distal myopathy, Welander type), [MONDO:0012796](http://purl.obolibrary.org/obo/MONDO_0012796) (retinitis pigmentosa 41), [MONDO:0009131](http://purl.obolibrary.org/obo/MONDO_0009131) (Riley-Day syndrome), [MONDO:0012784](http://purl.obolibrary.org/obo/MONDO_0012784) (autosomal recessive ataxia due to ubiquinone deficiency), [MONDO:0012783](http://purl.obolibrary.org/obo/MONDO_0012783) (RFT1-CDG), [MONDO:0009133](http://purl.obolibrary.org/obo/MONDO_0009133) (dysequilibrium syndrome), [MONDO:0003828](http://purl.obolibrary.org/obo/MONDO_0003828) (growth hormone-producing pituitary gland carcinoma), [MONDO:0009136](http://purl.obolibrary.org/obo/MONDO_0009136) (dyskeratosis congenita, autosomal recessive 1), [MONDO:0018091](http://purl.obolibrary.org/obo/MONDO_0018091) (microcephaly-brachydactyly-kyphoscoliosis syndrome), [MONDO:0018092](http://purl.obolibrary.org/obo/MONDO_0018092) (Vogt-Koyanagi-Harada disease), [MONDO:0010125](http://purl.obolibrary.org/obo/MONDO_0010125) (upper limb defect-eye and ear abnormalities syndrome), [MONDO:0011457](http://purl.obolibrary.org/obo/MONDO_0011457) (ataxia-telangiectasia-like disorder), [MONDO:0012787](http://purl.obolibrary.org/obo/MONDO_0012787) (hereditary spastic paraplegia 39), [MONDO:0012786](http://purl.obolibrary.org/obo/MONDO_0012786) (juvenile cataract-microcornea-renal glucosuria syndrome), [MONDO:0006094](http://purl.obolibrary.org/obo/MONDO_0006094) (Askin tumor), [MONDO:0011458](http://purl.obolibrary.org/obo/MONDO_0011458) (Leber congenital amaurosis 4), [MONDO:0012789](http://purl.obolibrary.org/obo/MONDO_0012789) (dystonia 16), [MONDO:0011442](http://purl.obolibrary.org/obo/MONDO_0011442) (advanced sleep phase syndrome 1), [MONDO:0010111](http://purl.obolibrary.org/obo/MONDO_0010111) (odontotrichomelic syndrome), [MONDO:0011441](http://purl.obolibrary.org/obo/MONDO_0011441) (reflex sympathetic dystrophy), [MONDO:0009123](http://purl.obolibrary.org/obo/MONDO_0009123) (dopamine beta-hydroxylase deficiency), [MONDO:0009124](http://purl.obolibrary.org/obo/MONDO_0009124) (Dubowitz syndrome), [MONDO:0003837](http://purl.obolibrary.org/obo/MONDO_0003837) (TSH producing pituitary tumor), [MONDO:0018075](http://purl.obolibrary.org/obo/MONDO_0018075) (neural tube defect), [MONDO:0003836](http://purl.obolibrary.org/obo/MONDO_0003836) (malignant thyroid stimulating hormone producing neoplasm of pituitary gland), [MONDO:0002501](http://purl.obolibrary.org/obo/MONDO_0002501) (brain glioblastoma), [MONDO:0018071](http://purl.obolibrary.org/obo/MONDO_0018071) (trisomy 18), [MONDO:0015807](http://purl.obolibrary.org/obo/MONDO_0015807) (myopic macular degeneration), [MONDO:0015804](http://purl.obolibrary.org/obo/MONDO_0015804) (infant botulism), [MONDO:0011445](http://purl.obolibrary.org/obo/MONDO_0011445) (hereditary spastic paraplegia 11), [MONDO:0015803](http://purl.obolibrary.org/obo/MONDO_0015803) (wound botulism), [MONDO:0011444](http://purl.obolibrary.org/obo/MONDO_0011444) (Duane retraction syndrome 2), [MONDO:0015806](http://purl.obolibrary.org/obo/MONDO_0015806) (adult intestinal botulism), [MONDO:0012774](http://purl.obolibrary.org/obo/MONDO_0012774) (chromosome 15q13.3 microdeletion syndrome), [MONDO:0015805](http://purl.obolibrary.org/obo/MONDO_0015805) (intestinal botulism), [MONDO:0011449](http://purl.obolibrary.org/obo/MONDO_0011449) (Salla disease), [MONDO:0015802](http://purl.obolibrary.org/obo/MONDO_0015802) (autosomal dominant non-syndromic intellectual disability), [MONDO:0014541](http://purl.obolibrary.org/obo/MONDO_0014541) (motor developmental delay due to 14q32.2 paternally expressed gene defect), [MONDO:0013210](http://purl.obolibrary.org/obo/MONDO_0013210) (autosomal recessive nonsyndromic deafness 25), [MONDO:0013211](http://purl.obolibrary.org/obo/MONDO_0013211) (dilated cardiomyopathy 1FF), [MONDO:0010184](http://purl.obolibrary.org/obo/MONDO_0010184) (methylmalonic aciduria and homocystinuria type cblC), [MONDO:0014542](http://purl.obolibrary.org/obo/MONDO_0014542) (congenital myasthenic syndrome 15), [MONDO:0014543](http://purl.obolibrary.org/obo/MONDO_0014543) (congenital myasthenic syndrome 14), [MONDO:0013212](http://purl.obolibrary.org/obo/MONDO_0013212) (Charcot-Marie-tooth disease axonal type 2N), [MONDO:0010181](http://purl.obolibrary.org/obo/MONDO_0010181) (oculogastrointestinal muscular dystrophy), [MONDO:0009196](http://purl.obolibrary.org/obo/MONDO_0009196) (Ermine phenotype), [MONDO:0010188](http://purl.obolibrary.org/obo/MONDO_0010188) (familial isolated deficiency of vitamin E), [MONDO:0010185](http://purl.obolibrary.org/obo/MONDO_0010185) (methylmalonic aciduria and homocystinuria type cblD), [MONDO:0006918](http://purl.obolibrary.org/obo/MONDO_0006918) (posterior uveitis), [MONDO:0002559](http://purl.obolibrary.org/obo/MONDO_0002559) (plexiform schwannoma), [MONDO:0002556](http://purl.obolibrary.org/obo/MONDO_0002556) (macrocystic neurilemmoma), [MONDO:0006913](http://purl.obolibrary.org/obo/MONDO_0006913) (pneumococcal meningitis), [MONDO:0002555](http://purl.obolibrary.org/obo/MONDO_0002555) (neurilemmoma of the fifth cranial nerve), [MONDO:0002558](http://purl.obolibrary.org/obo/MONDO_0002558) (melanotic neurilemmoma), [MONDO:0006910](http://purl.obolibrary.org/obo/MONDO_0006910) (pituitary-dependent Cushing's disease), [MONDO:0003882](http://purl.obolibrary.org/obo/MONDO_0003882) (central nervous system fibrosarcoma), [MONDO:0002554](http://purl.obolibrary.org/obo/MONDO_0002554) (sympathetic neurilemmoma), [MONDO:0018907](http://purl.obolibrary.org/obo/MONDO_0018907) (craniopharyngioma), [MONDO:0013218](http://purl.obolibrary.org/obo/MONDO_0013218) (exudative vitreoretinopathy 5), [MONDO:0014545](http://purl.obolibrary.org/obo/MONDO_0014545) (progressive myoclonic epilepsy type 8), [MONDO:0014546](http://purl.obolibrary.org/obo/MONDO_0014546) (myopathy due to calsequestrin and SERCA1 protein overload), [MONDO:0013215](http://purl.obolibrary.org/obo/MONDO_0013215) (autosomal recessive nonsyndromic deafness 79), [MONDO:0015878](http://purl.obolibrary.org/obo/MONDO_0015878) (rare disease with autism), [MONDO:0010172](http://purl.obolibrary.org/obo/MONDO_0010172) (VACTERL with hydrocephalus), [MONDO:0014530](http://purl.obolibrary.org/obo/MONDO_0014530) (autosomal recessive spinocerebellar ataxia 18), [MONDO:0014531](http://purl.obolibrary.org/obo/MONDO_0014531) (amyotrohpic lateral sclerosis type 22), [MONDO:0013201](http://purl.obolibrary.org/obo/MONDO_0013201) (Waardenburg syndrome type 4B), [MONDO:0014532](http://purl.obolibrary.org/obo/MONDO_0014532) (autosomal dominant mitochondrial myopathy with exercise intolerance), [MONDO:0010170](http://purl.obolibrary.org/obo/MONDO_0010170) (Usher syndrome type 3A), [MONDO:0013202](http://purl.obolibrary.org/obo/MONDO_0013202) (Waardenburg syndrome type 4C), [MONDO:0010171](http://purl.obolibrary.org/obo/MONDO_0010171) (Usher syndrome type 1C), [MONDO:0014533](http://purl.obolibrary.org/obo/MONDO_0014533) (epileptic encephalopathy, early infantile, 28), [MONDO:0010176](http://purl.obolibrary.org/obo/MONDO_0010176) (Joubert syndrome with orofaciodigital defect), [MONDO:0009187](http://purl.obolibrary.org/obo/MONDO_0009187) (celiac disease-epilepsy-cerebral calcification syndrome), [MONDO:0009188](http://purl.obolibrary.org/obo/MONDO_0009188) (epilepsy-telangiectasia syndrome), [MONDO:0006928](http://purl.obolibrary.org/obo/MONDO_0006928) (proliferative vitreoretinopathy), [MONDO:0003894](http://purl.obolibrary.org/obo/MONDO_0003894) (mediastinal melanocytic neurilemmoma), [MONDO:0014538](http://purl.obolibrary.org/obo/MONDO_0014538) (fibrosis of extraocular muscles, congenital, 5), [MONDO:0013207](http://purl.obolibrary.org/obo/MONDO_0013207) (FECD7), [MONDO:0013208](http://purl.obolibrary.org/obo/MONDO_0013208) (cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome), [MONDO:0014534](http://purl.obolibrary.org/obo/MONDO_0014534) (lissencephaly 6 with microcephaly), [MONDO:0013203](http://purl.obolibrary.org/obo/MONDO_0013203) (corneal dystrophy, Fuchs endothelial, 3), [MONDO:0013204](http://purl.obolibrary.org/obo/MONDO_0013204) (corneal dystrophy, Fuchs endothelial, 4), [MONDO:0013205](http://purl.obolibrary.org/obo/MONDO_0013205) (FECD5), [MONDO:0013206](http://purl.obolibrary.org/obo/MONDO_0013206) (corneal dystrophy, Fuchs endothelial, 6), [MONDO:0011493](http://purl.obolibrary.org/obo/MONDO_0011493) (Stickler syndrome type 2), [MONDO:0010161](http://purl.obolibrary.org/obo/MONDO_0010161) (tyrosinemia type i), [MONDO:0014521](http://purl.obolibrary.org/obo/MONDO_0014521) (progressive myoclonic epilepsy type 7), [MONDO:0010160](http://purl.obolibrary.org/obo/MONDO_0010160) (tyrosinemia type II), [MONDO:0009175](http://purl.obolibrary.org/obo/MONDO_0009175) (eosinophilic fasciitis (disease)), [MONDO:0014522](http://purl.obolibrary.org/obo/MONDO_0014522) (retinal dystrophy and obesity), [MONDO:0009179](http://purl.obolibrary.org/obo/MONDO_0009179) (recessive dystrophic epidermolysis bullosa), [MONDO:0003868](http://purl.obolibrary.org/obo/MONDO_0003868) (anterior foramen magnum meningioma), [MONDO:0003869](http://purl.obolibrary.org/obo/MONDO_0003869) (childhood brain stem glioma), [MONDO:0001203](http://purl.obolibrary.org/obo/MONDO_0001203) (prolapse of lacrimal gland), [MONDO:0003862](http://purl.obolibrary.org/obo/MONDO_0003862) (melanocytic psammomatous MPNST), [MONDO:0003863](http://purl.obolibrary.org/obo/MONDO_0003863) (malignant melanocytic neoplasm of the peripheral nerve sheath), [MONDO:0003860](http://purl.obolibrary.org/obo/MONDO_0003860) (cerebellopontine angle meningioma), [MONDO:0010169](http://purl.obolibrary.org/obo/MONDO_0010169) (Usher syndrome type 2A), [MONDO:0010167](http://purl.obolibrary.org/obo/MONDO_0010167) (Urocanic aciduria (disease)), [MONDO:0014529](http://purl.obolibrary.org/obo/MONDO_0014529) (cerebellar-facial-dental syndrome), [MONDO:0011499](http://purl.obolibrary.org/obo/MONDO_0011499) (Okamoto syndrome), [MONDO:0010168](http://purl.obolibrary.org/obo/MONDO_0010168) (Usher syndrome type 1), [MONDO:0014523](http://purl.obolibrary.org/obo/MONDO_0014523) (juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome), [MONDO:0014524](http://purl.obolibrary.org/obo/MONDO_0014524) (mental retardation, autosomal recessive 47), [MONDO:0014525](http://purl.obolibrary.org/obo/MONDO_0014525) (combined oxidative phosphorylation defect type 23), [MONDO:0009181](http://purl.obolibrary.org/obo/MONDO_0009181) (epidermolysis bullosa simplex with muscular dystrophy), [MONDO:0014526](http://purl.obolibrary.org/obo/MONDO_0014526) (polyglucosan body myopathy type 2), [MONDO:0009182](http://purl.obolibrary.org/obo/MONDO_0009182) (junctional epidermolysis bullosa Herlitz type), [MONDO:0011482](http://purl.obolibrary.org/obo/MONDO_0011482) (dilated cardiomyopathy 1I), [MONDO:0014510](http://purl.obolibrary.org/obo/MONDO_0014510) (severe intellectual disability-epilepsy-cataract syndrome due to fatty acyl-CoA reductase 1 deficiency), [MONDO:0011480](http://purl.obolibrary.org/obo/MONDO_0011480) (autosomal dominant nonsyndromic deafness 20), [MONDO:0014511](http://purl.obolibrary.org/obo/MONDO_0014511) (Charcot-Marie-tooth disease axonal type 2S), [MONDO:0009165](http://purl.obolibrary.org/obo/MONDO_0009165) (Aicardi-Goutieres syndrome 1), [MONDO:0011486](http://purl.obolibrary.org/obo/MONDO_0011486) (congenital muscular dystrophy 1B), [MONDO:0011485](http://purl.obolibrary.org/obo/MONDO_0011485) (autosomal recessive congenital ichthyosis 5), [MONDO:0010155](http://purl.obolibrary.org/obo/MONDO_0010155) (Dorfman-Chanarin disease), [MONDO:0009166](http://purl.obolibrary.org/obo/MONDO_0009166) (pontocerebellar hypoplasia type 4), [MONDO:0009167](http://purl.obolibrary.org/obo/MONDO_0009167) (Bonnemann-Meinecke-Reich syndrome), [MONDO:0009168](http://purl.obolibrary.org/obo/MONDO_0009168) (Fowler syndrome), [MONDO:0006908](http://purl.obolibrary.org/obo/MONDO_0006908) (pituitary apoplexy), [MONDO:0002549](http://purl.obolibrary.org/obo/MONDO_0002549) (schwannoma of twelfth cranial nerve), [MONDO:0001217](http://purl.obolibrary.org/obo/MONDO_0001217) (pseudomembranous conjunctivitis), [MONDO:0002548](http://purl.obolibrary.org/obo/MONDO_0002548) (cellular schwannoma), [MONDO:0003878](http://purl.obolibrary.org/obo/MONDO_0003878) (malignant choroid melanoma), [MONDO:0002544](http://purl.obolibrary.org/obo/MONDO_0002544) (brain oligodendroglioma), [MONDO:0003875](http://purl.obolibrary.org/obo/MONDO_0003875) (childhood central nervous system mature teratoma), [MONDO:0002546](http://purl.obolibrary.org/obo/MONDO_0002546) (schwannoma), [MONDO:0003876](http://purl.obolibrary.org/obo/MONDO_0003876) (eyelid carcinoma), [MONDO:0002541](http://purl.obolibrary.org/obo/MONDO_0002541) (spinal cord oligodendroglioma), [MONDO:0002540](http://purl.obolibrary.org/obo/MONDO_0002540) (childhood oligodendroglioma), [MONDO:0002543](http://purl.obolibrary.org/obo/MONDO_0002543) (adult oligodendroglioma), [MONDO:0002542](http://purl.obolibrary.org/obo/MONDO_0002542) (spinal cord glioma), [MONDO:0003870](http://purl.obolibrary.org/obo/MONDO_0003870) (childhood brainstem astrocytoma), [MONDO:0014516](http://purl.obolibrary.org/obo/MONDO_0014516) (microcephaly and chorioretinopathy 2), [MONDO:0010159](http://purl.obolibrary.org/obo/MONDO_0010159) (constitutional mismatch repair deficiency syndrome), [MONDO:0014517](http://purl.obolibrary.org/obo/MONDO_0014517) (generalized epilepsy with febrile seizures plus, type 9), [MONDO:0011489](http://purl.obolibrary.org/obo/MONDO_0011489) (hereditary spastic paraplegia 12), [MONDO:0011488](http://purl.obolibrary.org/obo/MONDO_0011488) (microcephaly 3, primary, autosomal recessive), [MONDO:0010156](http://purl.obolibrary.org/obo/MONDO_0010156) (Troyer syndrome), [MONDO:0011487](http://purl.obolibrary.org/obo/MONDO_0011487) (Huntington disease-like 3), [MONDO:0014512](http://purl.obolibrary.org/obo/MONDO_0014512) (PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation), [MONDO:0014513](http://purl.obolibrary.org/obo/MONDO_0014513) (nemaline myopathy 10), [MONDO:0014515](http://purl.obolibrary.org/obo/MONDO_0014515) (macular dystrophy with central cone involvement), [MONDO:0013254](http://purl.obolibrary.org/obo/MONDO_0013254) (microcephaly, seizures, and developmental delay), [MONDO:0018943](http://purl.obolibrary.org/obo/MONDO_0018943) (myofibrillar myopathy (disease)), [MONDO:0017611](http://purl.obolibrary.org/obo/MONDO_0017611) (pituitary tumor), [MONDO:0014585](http://purl.obolibrary.org/obo/MONDO_0014585) (congenital myasthenic syndrome 3C), [MONDO:0014586](http://purl.obolibrary.org/obo/MONDO_0014586) (congenital myasthenic syndrome 4B), [MONDO:0013256](http://purl.obolibrary.org/obo/MONDO_0013256) (chromosome 15q24 deletion syndrome), [MONDO:0014587](http://purl.obolibrary.org/obo/MONDO_0014587) (congenital myasthenic syndrome 9), [MONDO:0017613](http://purl.obolibrary.org/obo/MONDO_0017613) (intellectual disability-hypotonia-skin hyperpigmentation syndrome), [MONDO:0013257](http://purl.obolibrary.org/obo/MONDO_0013257) (LPRS6), [MONDO:0018942](http://purl.obolibrary.org/obo/MONDO_0018942) (macrophagic myofasciitis), [MONDO:0014588](http://purl.obolibrary.org/obo/MONDO_0014588) (congenital myasthenic syndrome 11), [MONDO:0014581](http://purl.obolibrary.org/obo/MONDO_0014581) (congenital myasthenic syndrome 2A), [MONDO:0013250](http://purl.obolibrary.org/obo/MONDO_0013250) (autosomal recessive nonsyndromic deafness 85), [MONDO:0018940](http://purl.obolibrary.org/obo/MONDO_0018940) (congenital myasthenic syndrome), [MONDO:0014582](http://purl.obolibrary.org/obo/MONDO_0014582) (congenital myasthenic syndrome 2C), [MONDO:0014583](http://purl.obolibrary.org/obo/MONDO_0014583) (congenital myasthenic syndrome 3A), [MONDO:0014584](http://purl.obolibrary.org/obo/MONDO_0014584) (congenital myasthenic syndrome 3B), [MONDO:0014580](http://purl.obolibrary.org/obo/MONDO_0014580) (mental retardation, autosomal dominant 33), [MONDO:0005620](http://purl.obolibrary.org/obo/MONDO_0005620) (cerebral amyloid angiopathy), [MONDO:0006952](http://purl.obolibrary.org/obo/MONDO_0006952) (retinopathy of prematurity), [MONDO:0006950](http://purl.obolibrary.org/obo/MONDO_0006950) (retinal vasculitis), [MONDO:0001263](http://purl.obolibrary.org/obo/MONDO_0001263) (histoplasmosis retinitis), [MONDO:0018949](http://purl.obolibrary.org/obo/MONDO_0018949) (distal myopathy), [MONDO:0017615](http://purl.obolibrary.org/obo/MONDO_0017615) (benign familial infantile epilepsy), [MONDO:0018947](http://purl.obolibrary.org/obo/MONDO_0018947) (centronuclear myopathy), [MONDO:0018948](http://purl.obolibrary.org/obo/MONDO_0018948) (multiminicore myopathy), [MONDO:0013259](http://purl.obolibrary.org/obo/MONDO_0013259) (Oguchi disease-2), [MONDO:0017614](http://purl.obolibrary.org/obo/MONDO_0017614) (X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome), [MONDO:0018945](http://purl.obolibrary.org/obo/MONDO_0018945) (McLeod neuroacanthocytosis syndrome), [MONDO:0017616](http://purl.obolibrary.org/obo/MONDO_0017616) (X-linked intellectual disability, Schutz type), [MONDO:0018946](http://purl.obolibrary.org/obo/MONDO_0018946) (rhombencephalosynapsis), [MONDO:0013243](http://purl.obolibrary.org/obo/MONDO_0013243) (neuronopathy, distal hereditary motor, type 2C), [MONDO:0013245](http://purl.obolibrary.org/obo/MONDO_0013245) (syndromic multisystem autoimmune disease due to itch deficiency), [MONDO:0018930](http://purl.obolibrary.org/obo/MONDO_0018930) (monosomy 21), [MONDO:0014571](http://purl.obolibrary.org/obo/MONDO_0014571) (optic atrophy 8), [MONDO:0014572](http://purl.obolibrary.org/obo/MONDO_0014572) (autosomal recessive spinocerebellar ataxia 19), [MONDO:0013241](http://purl.obolibrary.org/obo/MONDO_0013241) (spinocerebellar ataxia type 30), [MONDO:0004308](http://purl.obolibrary.org/obo/MONDO_0004308) (meninges sarcoma), [MONDO:0004307](http://purl.obolibrary.org/obo/MONDO_0004307) (sarcomatosis of the meninges), [MONDO:0001275](http://purl.obolibrary.org/obo/MONDO_0001275) (spinal meningioma), [MONDO:0017607](http://purl.obolibrary.org/obo/MONDO_0017607) (caudal regression sequence), [MONDO:0018938](http://purl.obolibrary.org/obo/MONDO_0018938) (mucopolysaccharidosis type 4), [MONDO:0018939](http://purl.obolibrary.org/obo/MONDO_0018939) (muscle-eye-brain disease), [MONDO:0014578](http://purl.obolibrary.org/obo/MONDO_0014578) (congenital myasthenic syndrome 17), [MONDO:0018937](http://purl.obolibrary.org/obo/MONDO_0018937) (mucopolysaccharidosis type 3), [MONDO:0014579](http://purl.obolibrary.org/obo/MONDO_0014579) (Senior-Loken syndrome 8), [MONDO:0017606](http://purl.obolibrary.org/obo/MONDO_0017606) (facial nerve palsy due to herpes zoster infection), [MONDO:0013249](http://purl.obolibrary.org/obo/MONDO_0013249) (autosomal recessive nonsyndromic deafness 84A), [MONDO:0018921](http://purl.obolibrary.org/obo/MONDO_0018921) (Meckel syndrome), [MONDO:0014563](http://purl.obolibrary.org/obo/MONDO_0014563) (mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency), [MONDO:0013234](http://purl.obolibrary.org/obo/MONDO_0013234) (hypokalemic periodic paralysis, type 2), [MONDO:0014565](http://purl.obolibrary.org/obo/MONDO_0014565) (cataract 43), [MONDO:0014566](http://purl.obolibrary.org/obo/MONDO_0014566) (Charcot-Marie-tooth disease axonal type 2U), [MONDO:0014561](http://purl.obolibrary.org/obo/MONDO_0014561) (3-methylglutaconic aciduria with cataracts, neurologic involvement and neutropenia), [MONDO:0013230](http://purl.obolibrary.org/obo/MONDO_0013230) (HWE2), [MONDO:0013231](http://purl.obolibrary.org/obo/MONDO_0013231) (Leber congenital amaurosis 14), [MONDO:0014562](http://purl.obolibrary.org/obo/MONDO_0014562) (neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome), [MONDO:0002578](http://purl.obolibrary.org/obo/MONDO_0002578) (botryoid rhabdomyosarcoma), [MONDO:0002577](http://purl.obolibrary.org/obo/MONDO_0002577) (bile duct rhabdomyosarcoma), [MONDO:0002574](http://purl.obolibrary.org/obo/MONDO_0002574) (prostate embryonal rhabdomyosarcoma), [MONDO:0002576](http://purl.obolibrary.org/obo/MONDO_0002576) (embryonal extrahepatic bile duct rhabdomyosarcoma), [MONDO:0006930](http://purl.obolibrary.org/obo/MONDO_0006930) (pseudobulbar palsy), [MONDO:0002571](http://purl.obolibrary.org/obo/MONDO_0002571) (central nervous system lymphoma), [MONDO:0018927](http://purl.obolibrary.org/obo/MONDO_0018927) (SUNCT syndrome), [MONDO:0018925](http://purl.obolibrary.org/obo/MONDO_0018925) (familial or sporadic hemiplegic migraine), [MONDO:0014567](http://purl.obolibrary.org/obo/MONDO_0014567) (postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome), [MONDO:0014568](http://purl.obolibrary.org/obo/MONDO_0014568) (hereditary spastic paraplegia 73), [MONDO:0013237](http://purl.obolibrary.org/obo/MONDO_0013237) (mononeuropathy of the median nerve, mild), [MONDO:0018926](http://purl.obolibrary.org/obo/MONDO_0018926) (human prion disease), [MONDO:0018923](http://purl.obolibrary.org/obo/MONDO_0018923) (22q11.2 deletion syndrome), [MONDO:0013239](http://purl.obolibrary.org/obo/MONDO_0013239) (hereditary spastic paraplegia 41), [MONDO:0018924](http://purl.obolibrary.org/obo/MONDO_0018924) (microphthalmia, Lenz type), [MONDO:0014552](http://purl.obolibrary.org/obo/MONDO_0014552) (lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome), [MONDO:0015884](http://purl.obolibrary.org/obo/MONDO_0015884) (autosomal dominant hypohidrotic ectodermal dysplasia), [MONDO:0018910](http://purl.obolibrary.org/obo/MONDO_0018910) (oculocutaneous albinism), [MONDO:0010194](http://purl.obolibrary.org/obo/MONDO_0010194) (Weill-Marchesani syndrome 1), [MONDO:0013221](http://purl.obolibrary.org/obo/MONDO_0013221) (MMD2), [MONDO:0013222](http://purl.obolibrary.org/obo/MONDO_0013222) (distal anoctaminopathy), [MONDO:0010192](http://purl.obolibrary.org/obo/MONDO_0010192) (Waardenburg syndrome type 4A), [MONDO:0014554](http://purl.obolibrary.org/obo/MONDO_0014554) (infantile multisystem neurologic-endocrine-pancreatic disease), [MONDO:0013224](http://purl.obolibrary.org/obo/MONDO_0013224) (rhabdoid tumor predisposition syndrome 2), [MONDO:0010193](http://purl.obolibrary.org/obo/MONDO_0010193) (Weaver syndrome), [MONDO:0010196](http://purl.obolibrary.org/obo/MONDO_0010196) (Werner syndrome), [MONDO:0010197](http://purl.obolibrary.org/obo/MONDO_0010197) (whistling face syndrome, recessive form), [MONDO:0005615](http://purl.obolibrary.org/obo/MONDO_0005615) (plasmacytoma), [MONDO:0010190](http://purl.obolibrary.org/obo/MONDO_0010190) (pontocerebellar hypoplasia type 2A), [MONDO:0002581](http://purl.obolibrary.org/obo/MONDO_0002581) (spindle cell rhabdomyosarcoma), [MONDO:0013229](http://purl.obolibrary.org/obo/MONDO_0013229) (hot water reflex epilepsy), [MONDO:0013225](http://purl.obolibrary.org/obo/MONDO_0013225) (congenital generalized lipodystrophy type 4), [MONDO:0014556](http://purl.obolibrary.org/obo/MONDO_0014556) (congenital contractures of the limbs and face, hypotonia, and developmental delay), [MONDO:0014557](http://purl.obolibrary.org/obo/MONDO_0014557) (ataxia-oculomotor apraxia type 4), [MONDO:0014558](http://purl.obolibrary.org/obo/MONDO_0014558) (autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome), [MONDO:0014559](http://purl.obolibrary.org/obo/MONDO_0014559) (progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome), [MONDO:0017655](http://purl.obolibrary.org/obo/MONDO_0017655) (progressive epilepsy and/or ataxia with myoclonus as a major feature), [MONDO:0018988](http://purl.obolibrary.org/obo/MONDO_0018988) (Iridocorneal endothelial syndrome), [MONDO:0017654](http://purl.obolibrary.org/obo/MONDO_0017654) (non progressive epilepsy and/or ataxia with myoclonus as a major feature), [MONDO:0017657](http://purl.obolibrary.org/obo/MONDO_0017657) (rare paroxysmal movement disorder), [MONDO:0017656](http://purl.obolibrary.org/obo/MONDO_0017656) (motor stereotypies), [MONDO:0018983](http://purl.obolibrary.org/obo/MONDO_0018983) (Tolosa-Hunt syndrome), [MONDO:0017651](http://purl.obolibrary.org/obo/MONDO_0017651) (primary myoclonus), [MONDO:0017650](http://purl.obolibrary.org/obo/MONDO_0017650) (rare myoclonus), [MONDO:0018981](http://purl.obolibrary.org/obo/MONDO_0018981) (benign idiopathic neonatal seizures), [MONDO:0017653](http://purl.obolibrary.org/obo/MONDO_0017653) (epilepsy and/or ataxia with myoclonus as major feature), [MONDO:0017652](http://purl.obolibrary.org/obo/MONDO_0017652) (rare disease with myoclonus as a major feature), [MONDO:0018982](http://purl.obolibrary.org/obo/MONDO_0018982) (Niemann-Pick disease type C), [MONDO:0013297](http://purl.obolibrary.org/obo/MONDO_0013297) (autosomal dominant limb-girdle muscular dystrophy type 1H), [MONDO:0013291](http://purl.obolibrary.org/obo/MONDO_0013291) (glycogen storage disease XV), [MONDO:0013293](http://purl.obolibrary.org/obo/MONDO_0013293) (isolated microphthalmia 6), [MONDO:0008708](http://purl.obolibrary.org/obo/MONDO_0008708) (acrocallosal syndrome), [MONDO:0003000](http://purl.obolibrary.org/obo/MONDO_0003000) (central nervous system germ cell tumor), [MONDO:0004330](http://purl.obolibrary.org/obo/MONDO_0004330) (leptomeninges sarcoma), [MONDO:0006990](http://purl.obolibrary.org/obo/MONDO_0006990) (suppurative uveitis), [MONDO:0017659](http://purl.obolibrary.org/obo/MONDO_0017659) (sporadic hyperekplexia), [MONDO:0017658](http://purl.obolibrary.org/obo/MONDO_0017658) (hyperekplexia), [MONDO:0017644](http://purl.obolibrary.org/obo/MONDO_0017644) (rare tremor disorder), [MONDO:0018976](http://purl.obolibrary.org/obo/MONDO_0018976) (Schisis association), [MONDO:0018977](http://purl.obolibrary.org/obo/MONDO_0018977) (polyneuropathy associated with IgM monoclonal gammapathy with anti-MAG), [MONDO:0017643](http://purl.obolibrary.org/obo/MONDO_0017643) (frontotemporal neurodegeneration with movement disorder), [MONDO:0016315](http://purl.obolibrary.org/obo/MONDO_0016315) (mucopolysaccharidosis type 2, severe form), [MONDO:0017646](http://purl.obolibrary.org/obo/MONDO_0017646) (neurodegenerative disease with chorea), [MONDO:0018975](http://purl.obolibrary.org/obo/MONDO_0018975) (neurofibromatosis type 1), [MONDO:0017645](http://purl.obolibrary.org/obo/MONDO_0017645) (rare choreic movement disorder), [MONDO:0017640](http://purl.obolibrary.org/obo/MONDO_0017640) (cyanide-induced parkinsonism), [MONDO:0018973](http://purl.obolibrary.org/obo/MONDO_0018973) (patterned dystrophy of the retinal pigment epithelium), [MONDO:0017642](http://purl.obolibrary.org/obo/MONDO_0017642) (intellectual disability-microcephaly-phalangeal-facial abnormalities syndrome), [MONDO:0017641](http://purl.obolibrary.org/obo/MONDO_0017641) (miscellaneous movement disorder due to neurodegenerative disease), [MONDO:0016310](http://purl.obolibrary.org/obo/MONDO_0016310) (Niemann-Pick disease type C, adult neurologic onset), [MONDO:0018971](http://purl.obolibrary.org/obo/MONDO_0018971) (isolated oxycephaly), [MONDO:0013281](http://purl.obolibrary.org/obo/MONDO_0013281) (COG4-CDG), [MONDO:0004349](http://purl.obolibrary.org/obo/MONDO_0004349) (retina lymphoma), [MONDO:0003014](http://purl.obolibrary.org/obo/MONDO_0003014) (rhinitis), [MONDO:0004345](http://purl.obolibrary.org/obo/MONDO_0004345) (childhood malignant schwannoma), [MONDO:0005676](http://purl.obolibrary.org/obo/MONDO_0005676) (borna disease), [MONDO:0016317](http://purl.obolibrary.org/obo/MONDO_0016317) (limbic encephalitis with NMDA receptor antibodies), [MONDO:0017648](http://purl.obolibrary.org/obo/MONDO_0017648) (Sydenham chorea), [MONDO:0017647](http://purl.obolibrary.org/obo/MONDO_0017647) (postinfectious autoimmune disease with chorea), [MONDO:0016316](http://purl.obolibrary.org/obo/MONDO_0016316) (mucopolysaccharidosis type 2, attenuated form), [MONDO:0016319](http://purl.obolibrary.org/obo/MONDO_0016319) (congenital insensitivity to pain with hyperhidrosis), [MONDO:0016318](http://purl.obolibrary.org/obo/MONDO_0016318) (progressive multifocal leukoencephalopathy), [MONDO:0018979](http://purl.obolibrary.org/obo/MONDO_0018979) (multifocal motor neuropathy), [MONDO:0017649](http://purl.obolibrary.org/obo/MONDO_0017649) (hemidystonia-hemiatrophy syndrome), [MONDO:0018965](http://purl.obolibrary.org/obo/MONDO_0018965) (Alport syndrome), [MONDO:0013277](http://purl.obolibrary.org/obo/MONDO_0013277) (epileptic encephalopathy, early infantile, 5), [MONDO:0017635](http://purl.obolibrary.org/obo/MONDO_0017635) (rare parkinsonian syndrome due to neurodegenerative disease), [MONDO:0013278](http://purl.obolibrary.org/obo/MONDO_0013278) (lymphedema, hereditary, 1C), [MONDO:0016304](http://purl.obolibrary.org/obo/MONDO_0016304) (classic pantothenate kinase-associated neurodegeneration), [MONDO:0018964](http://purl.obolibrary.org/obo/MONDO_0018964) (homocystinuria without methylmalonic aciduria), [MONDO:0017634](http://purl.obolibrary.org/obo/MONDO_0017634) (non-infectious anterior uveitis), [MONDO:0013274](http://purl.obolibrary.org/obo/MONDO_0013274) (retinitis pigmentosa 51), [MONDO:0017630](http://purl.obolibrary.org/obo/MONDO_0017630) (X-linked complicated spastic paraplegia type 1), [MONDO:0013270](http://purl.obolibrary.org/obo/MONDO_0013270) (Rett syndrome, congenital variant), [MONDO:0004313](http://purl.obolibrary.org/obo/MONDO_0004313) (Gasserian ganglion meningioma), [MONDO:0004312](http://purl.obolibrary.org/obo/MONDO_0004312) (suprasellar meningioma), [MONDO:0004310](http://purl.obolibrary.org/obo/MONDO_0004310) (adult ependymoblastoma), [MONDO:0016309](http://purl.obolibrary.org/obo/MONDO_0016309) (Niemann-Pick disease type C, juvenile neurologic onset), [MONDO:0001280](http://purl.obolibrary.org/obo/MONDO_0001280) (choroiditis), [MONDO:0016306](http://purl.obolibrary.org/obo/MONDO_0016306) (Niemann-Pick disease type C, severe perinatal form), [MONDO:0018969](http://purl.obolibrary.org/obo/MONDO_0018969) (Craniorachischisis (disease)), [MONDO:0017637](http://purl.obolibrary.org/obo/MONDO_0017637) (rare parkinsonian syndrome due to intoxication), [MONDO:0017636](http://purl.obolibrary.org/obo/MONDO_0017636) (Hemiparkinsonism-hemiatrophy syndrome), [MONDO:0016305](http://purl.obolibrary.org/obo/MONDO_0016305) (atypical pantothenate kinase-associated neurodegeneration), [MONDO:0018967](http://purl.obolibrary.org/obo/MONDO_0018967) (short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia), [MONDO:0016308](http://purl.obolibrary.org/obo/MONDO_0016308) (Niemann-Pick disease type C, late infantile neurologic onset), [MONDO:0017639](http://purl.obolibrary.org/obo/MONDO_0017639) (carbon monoxide-induced parkinsonism), [MONDO:0016307](http://purl.obolibrary.org/obo/MONDO_0016307) (Niemann-Pick disease type C, severe early infantile neurologic onset), [MONDO:0017638](http://purl.obolibrary.org/obo/MONDO_0017638) (manganese poisoning), [MONDO:0018968](http://purl.obolibrary.org/obo/MONDO_0018968) (iniencephaly), [MONDO:0014596](http://purl.obolibrary.org/obo/MONDO_0014596) (lissencephaly 7 with cerebellar hypoplasia), [MONDO:0013266](http://purl.obolibrary.org/obo/MONDO_0013266) (mental retardation, autosomal dominant 20), [MONDO:0014598](http://purl.obolibrary.org/obo/MONDO_0014598) (epileptic encephalopathy, early infantile, 31), [MONDO:0018953](http://purl.obolibrary.org/obo/MONDO_0018953) (parietal foramina), [MONDO:0014599](http://purl.obolibrary.org/obo/MONDO_0014599) (mental retardation, autosomal dominant 34), [MONDO:0013261](http://purl.obolibrary.org/obo/MONDO_0013261) (dilated cardiomyopathy 1R), [MONDO:0014592](http://purl.obolibrary.org/obo/MONDO_0014592) (microcephaly and chorioretinopathy 3), [MONDO:0014593](http://purl.obolibrary.org/obo/MONDO_0014593) (epileptic encephalopathy, early infantile, 29), [MONDO:0013262](http://purl.obolibrary.org/obo/MONDO_0013262) (dilated cardiomyopathy 1S), [MONDO:0018951](http://purl.obolibrary.org/obo/MONDO_0018951) (distal myopathy with vocal cord weakness), [MONDO:0014594](http://purl.obolibrary.org/obo/MONDO_0014594) (autosomal dominant nonsyndromic deafness 67), [MONDO:0013263](http://purl.obolibrary.org/obo/MONDO_0013263) (retinitis pigmentosa 54), [MONDO:0014595](http://purl.obolibrary.org/obo/MONDO_0014595) (epileptic encephalopathy, early infantile, 30), [MONDO:0013264](http://purl.obolibrary.org/obo/MONDO_0013264) (amyotrophic lateral sclerosis type 12), [MONDO:0014590](http://purl.obolibrary.org/obo/MONDO_0014590) (congenital myasthenic syndrome 18), [MONDO:0005659](http://purl.obolibrary.org/obo/MONDO_0005659) (atrophic rhinitis), [MONDO:0017629](http://purl.obolibrary.org/obo/MONDO_0017629) (sodium channelopathy-related small fiber neuropathy), [MONDO:0018958](http://purl.obolibrary.org/obo/MONDO_0018958) (nemaline myopathy), [MONDO:0013269](http://purl.obolibrary.org/obo/MONDO_0013269) (autosomal recessive nonsyndromic deafness 91), [MONDO:0018959](http://purl.obolibrary.org/obo/MONDO_0018959) (potassium-aggravated myotonia), [MONDO:0018957](http://purl.obolibrary.org/obo/MONDO_0018957) (pudendal neuralgia), [MONDO:0017627](http://purl.obolibrary.org/obo/MONDO_0017627) (congenital hereditary facial paralysis-variable hearing loss syndrome), [MONDO:0017699](http://purl.obolibrary.org/obo/MONDO_0017699) (glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form), [MONDO:0016368](http://purl.obolibrary.org/obo/MONDO_0016368) (Rothmund-Thomson syndrome type 1), [MONDO:0015036](http://purl.obolibrary.org/obo/MONDO_0015036) (lissencephaly with cerebellar hypoplasia type C), [MONDO:0016367](http://purl.obolibrary.org/obo/MONDO_0016367) (dermatomyositis), [MONDO:0017698](http://purl.obolibrary.org/obo/MONDO_0017698) (glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form), [MONDO:0015037](http://purl.obolibrary.org/obo/MONDO_0015037) (lissencephaly with cerebellar hypoplasia type D), [MONDO:0015038](http://purl.obolibrary.org/obo/MONDO_0015038) (lissencephaly with cerebellar hypoplasia type E), [MONDO:0016369](http://purl.obolibrary.org/obo/MONDO_0016369) (Rothmund-Thomson syndrome type 2), [MONDO:0015039](http://purl.obolibrary.org/obo/MONDO_0015039) (lissencephaly with cerebellar hypoplasia type F), [MONDO:0016364](http://purl.obolibrary.org/obo/MONDO_0016364) (Joubert syndrome with ocular defect), [MONDO:0017695](http://purl.obolibrary.org/obo/MONDO_0017695) (glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form), [MONDO:0015032](http://purl.obolibrary.org/obo/MONDO_0015032) (intraneural perineurioma), [MONDO:0017694](http://purl.obolibrary.org/obo/MONDO_0017694) (glycogen storage disease due to acid maltase deficiency, infantile onset), [MONDO:0015033](http://purl.obolibrary.org/obo/MONDO_0015033) (ABeta amyloidosis, dutch type), [MONDO:0016366](http://purl.obolibrary.org/obo/MONDO_0016366) (maternal phenylketonuria), [MONDO:0017697](http://purl.obolibrary.org/obo/MONDO_0017697) (glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form), [MONDO:0015034](http://purl.obolibrary.org/obo/MONDO_0015034) (lissencephaly with cerebellar hypoplasia type A), [MONDO:0017696](http://purl.obolibrary.org/obo/MONDO_0017696) (glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form), [MONDO:0015035](http://purl.obolibrary.org/obo/MONDO_0015035) (lissencephaly with cerebellar hypoplasia type B), [MONDO:0008740](http://purl.obolibrary.org/obo/MONDO_0008740) (agnathia-otocephaly complex), [MONDO:0017691](http://purl.obolibrary.org/obo/MONDO_0017691) (erythrocyte galactose epimerase deficiency), [MONDO:0015030](http://purl.obolibrary.org/obo/MONDO_0015030) (sclerosing perineurioma), [MONDO:0008743](http://purl.obolibrary.org/obo/MONDO_0008743) (Stimmler syndrome), [MONDO:0017692](http://purl.obolibrary.org/obo/MONDO_0017692) (generalized galactose epimerase deficiency), [MONDO:0015031](http://purl.obolibrary.org/obo/MONDO_0015031) (Extraneural perineurioma), [MONDO:0008745](http://purl.obolibrary.org/obo/MONDO_0008745) (oculocutaneous albinism type 1A), [MONDO:0007407](http://purl.obolibrary.org/obo/MONDO_0007407) (Cryoglobulinemic vasculitis), [MONDO:0008746](http://purl.obolibrary.org/obo/MONDO_0008746) (oculocutaneous albinism type 2), [MONDO:0008747](http://purl.obolibrary.org/obo/MONDO_0008747) (oculocutaneous albinism type 3), [MONDO:0007405](http://purl.obolibrary.org/obo/MONDO_0007405) (Crouzon syndrome), [MONDO:0008748](http://purl.obolibrary.org/obo/MONDO_0008748) (Hermansky-Pudlak syndrome 1), [MONDO:0007404](http://purl.obolibrary.org/obo/MONDO_0007404) (Cri-du-chat syndrome), [MONDO:0007403](http://purl.obolibrary.org/obo/MONDO_0007403) (inherited Creutzfeldt-Jakob disease), [MONDO:0004378](http://purl.obolibrary.org/obo/MONDO_0004378) (pediatric cerebral ependymoblastoma), [MONDO:0007401](http://purl.obolibrary.org/obo/MONDO_0007401) (craniosynostosis-Dandy-Walker malformation-hydrocephalus syndrome), [MONDO:0004373](http://purl.obolibrary.org/obo/MONDO_0004373) (adult papillary meningioma), [MONDO:0004371](http://purl.obolibrary.org/obo/MONDO_0004371) (spinal multifocal clear cell meningioma), [MONDO:0004370](http://purl.obolibrary.org/obo/MONDO_0004370) (sphenocavernous meningioma), [MONDO:0015025](http://purl.obolibrary.org/obo/MONDO_0015025) (epileptic encephalopathy, early infantile, 51; EIEE51), [MONDO:0015026](http://purl.obolibrary.org/obo/MONDO_0015026) (cerebroretinal microangiopathy with calcifications and cysts 2;), [MONDO:0015028](http://purl.obolibrary.org/obo/MONDO_0015028) (48,XXYY syndrome), [MONDO:0017683](http://purl.obolibrary.org/obo/MONDO_0017683) (methylcobalamin deficiency type cblDv1), [MONDO:0015023](http://purl.obolibrary.org/obo/MONDO_0015023) (nemaline myopathy 11), [MONDO:0016355](http://purl.obolibrary.org/obo/MONDO_0016355) (Semilobar holoprosencephaly), [MONDO:0016354](http://purl.obolibrary.org/obo/MONDO_0016354) (xeroderma pigmentosum-Cockayne syndrome complex), [MONDO:0017685](http://purl.obolibrary.org/obo/MONDO_0017685) (vitamin B12-responsive methylmalonic acidemia, type cblDv2), [MONDO:0017682](http://purl.obolibrary.org/obo/MONDO_0017682) (intellectual disability-polydactyly-uncombable hair syndrome), [MONDO:0015020](http://purl.obolibrary.org/obo/MONDO_0015020) (mental retardation, autosomal recessive 59; MRT59), [MONDO:0008732](http://purl.obolibrary.org/obo/MONDO_0008732) (adrenal hypoplasia, Cytomegalic type), [MONDO:0008736](http://purl.obolibrary.org/obo/MONDO_0008736) (peroxisome biogenesis disorder 2B), [MONDO:0003058](http://purl.obolibrary.org/obo/MONDO_0003058) (microcystic meningioma), [MONDO:0003057](http://purl.obolibrary.org/obo/MONDO_0003057) (pediatric meningioma), [MONDO:0007413](http://purl.obolibrary.org/obo/MONDO_0007413) (Cyprus facial-neuromusculoskeletal syndrome), [MONDO:0003054](http://purl.obolibrary.org/obo/MONDO_0003054) (benign meningioma), [MONDO:0007411](http://purl.obolibrary.org/obo/MONDO_0007411) (cutis laxa, autosomal dominant 1), [MONDO:0003053](http://purl.obolibrary.org/obo/MONDO_0003053) (choroid plexus meningioma), [MONDO:0007410](http://purl.obolibrary.org/obo/MONDO_0007410) (isolated cryptophthalmia), [MONDO:0003056](http://purl.obolibrary.org/obo/MONDO_0003056) (lymphoplasmacyte-rich meningioma), [MONDO:0003055](http://purl.obolibrary.org/obo/MONDO_0003055) (secretory meningioma), [MONDO:0004383](http://purl.obolibrary.org/obo/MONDO_0004383) (adult central nervous system germinoma), [MONDO:0015029](http://purl.obolibrary.org/obo/MONDO_0015029) (reticular perineurioma), [MONDO:0015016](http://purl.obolibrary.org/obo/MONDO_0015016) (anterior segment dysgenesis 6; ASGD6), [MONDO:0015017](http://purl.obolibrary.org/obo/MONDO_0015017) (anterior segment dysgenesis 8; ASGD8), [MONDO:0015010](http://purl.obolibrary.org/obo/MONDO_0015010) (atypical glycine encephalopathy), [MONDO:0015011](http://purl.obolibrary.org/obo/MONDO_0015011) (optic atrophy 11; OPA11), [MONDO:0015012](http://purl.obolibrary.org/obo/MONDO_0015012) (mucopolysaccharidosis-plus syndrome; MPSPS), [MONDO:0016344](http://purl.obolibrary.org/obo/MONDO_0016344) (hydranencephaly (disease)), [MONDO:0015013](http://purl.obolibrary.org/obo/MONDO_0015013) (retinitis pigmentosa 77; RP77), [MONDO:0008720](http://purl.obolibrary.org/obo/MONDO_0008720) (adrenocorticotropic hormone deficiency (disease)), [MONDO:0008722](http://purl.obolibrary.org/obo/MONDO_0008722) (short chain acyl-CoA dehydrogenase deficiency), [MONDO:0008723](http://purl.obolibrary.org/obo/MONDO_0008723) (very long chain acyl-CoA dehydrogenase deficiency), [MONDO:0003021](http://purl.obolibrary.org/obo/MONDO_0003021) (central nervous system angiosarcoma), [MONDO:0005684](http://purl.obolibrary.org/obo/MONDO_0005684) (bulbar polio), [MONDO:0004351](http://purl.obolibrary.org/obo/MONDO_0004351) (intraocular lymphoma), [MONDO:0004352](http://purl.obolibrary.org/obo/MONDO_0004352) (adult brain ependymoma), [MONDO:0004350](http://purl.obolibrary.org/obo/MONDO_0004350) (pediatric extraocular retinoblastoma), [MONDO:0016349](http://purl.obolibrary.org/obo/MONDO_0016349) (congenital hydrocephalus), [MONDO:0018998](http://purl.obolibrary.org/obo/MONDO_0018998) (Leber congenital amaurosis), [MONDO:0017665](http://purl.obolibrary.org/obo/MONDO_0017665) (rare genetic disease with myoclonus as a major feature), [MONDO:0016334](http://purl.obolibrary.org/obo/MONDO_0016334) (neuromuscular disease with dilated cardiomyopathy), [MONDO:0018999](http://purl.obolibrary.org/obo/MONDO_0018999) (LCAT deficiency), [MONDO:0017668](http://purl.obolibrary.org/obo/MONDO_0017668) (intellectual disability-short stature-hypertelorism syndrome), [MONDO:0018996](http://purl.obolibrary.org/obo/MONDO_0018996) (spinocerebellar ataxia with axonal neuropathy type 2), [MONDO:0015005](http://purl.obolibrary.org/obo/MONDO_0015005) (epilepsy, early-onset, vitamin B6-dependent; EPVB6D), [MONDO:0018997](http://purl.obolibrary.org/obo/MONDO_0018997) (Noonan syndrome), [MONDO:0018994](http://purl.obolibrary.org/obo/MONDO_0018994) (Charcot-Marie-tooth disease type X), [MONDO:0017662](http://purl.obolibrary.org/obo/MONDO_0017662) (miscellaneous movement disorder due to genetic neurodegenerative disease), [MONDO:0017661](http://purl.obolibrary.org/obo/MONDO_0017661) (rare parkinsonian syndrome due to genetic neurodegenerative disease), [MONDO:0018995](http://purl.obolibrary.org/obo/MONDO_0018995) (Charcot-Marie-tooth disease type 4), [MONDO:0015000](http://purl.obolibrary.org/obo/MONDO_0015000) (epileptic encephalopathy, early infantile, 48; EIEE48), [MONDO:0017664](http://purl.obolibrary.org/obo/MONDO_0017664) (rare genetic myoclonus), [MONDO:0018993](http://purl.obolibrary.org/obo/MONDO_0018993) (Charcot-Marie-tooth disease type 2), [MONDO:0017663](http://purl.obolibrary.org/obo/MONDO_0017663) (rare genetic tremor disorder), [MONDO:0015002](http://purl.obolibrary.org/obo/MONDO_0015002) (epileptic encephalopathy, early infantile, 49; EIEE49), [MONDO:0017660](http://purl.obolibrary.org/obo/MONDO_0017660) (rare genetic parkinsonian disorder), [MONDO:0008714](http://purl.obolibrary.org/obo/MONDO_0008714) (acrofacial dysostosis Rodriguez type), [MONDO:0004368](http://purl.obolibrary.org/obo/MONDO_0004368) (sphenoorbital meningioma), [MONDO:0004367](http://purl.obolibrary.org/obo/MONDO_0004367) (petroclival meningioma), [MONDO:0008718](http://purl.obolibrary.org/obo/MONDO_0008718) (Morvan syndrome), [MONDO:0004364](http://purl.obolibrary.org/obo/MONDO_0004364) (choroid necrotic melanoma), [MONDO:0005695](http://purl.obolibrary.org/obo/MONDO_0005695) (central nervous system AIDS arteritis), [MONDO:0005696](http://purl.obolibrary.org/obo/MONDO_0005696) (central nervous system tuberculosis), [MONDO:0004365](http://purl.obolibrary.org/obo/MONDO_0004365) (necrotic uveal melanoma), [MONDO:0004363](http://purl.obolibrary.org/obo/MONDO_0004363) (adult spinal cord glioblastoma multiforme), [MONDO:0004361](http://purl.obolibrary.org/obo/MONDO_0004361) (adult spinal cord ependymoma), 

**Mapped go classes:** [GO:0061452](http://purl.obolibrary.org/obo/GO_0061452) (retrotrapezoid nucleus neuron differentiation), [GO:0060121](http://purl.obolibrary.org/obo/GO_0060121) (vestibular receptor cell stereocilium organization), [GO:0060122](http://purl.obolibrary.org/obo/GO_0060122) (inner ear receptor cell stereocilium organization), [GO:0019915](http://purl.obolibrary.org/obo/GO_0019915) (lipid storage), [GO:0060123](http://purl.obolibrary.org/obo/GO_0060123) (regulation of growth hormone secretion), [GO:0060124](http://purl.obolibrary.org/obo/GO_0060124) (positive regulation of growth hormone secretion), [GO:0035162](http://purl.obolibrary.org/obo/GO_0035162) (embryonic hemopoiesis), [GO:0019918](http://purl.obolibrary.org/obo/GO_0019918) (peptidyl-arginine methylation, to symmetrical-dimethyl arginine), [GO:1901224](http://purl.obolibrary.org/obo/GO_1901224) (positive regulation of NIK/NF-kappaB signaling), [GO:0060125](http://purl.obolibrary.org/obo/GO_0060125) (negative regulation of growth hormone secretion), [GO:0006600](http://purl.obolibrary.org/obo/GO_0006600) (creatine metabolic process), [GO:0060126](http://purl.obolibrary.org/obo/GO_0060126) (somatotropin secreting cell differentiation), [GO:0006601](http://purl.obolibrary.org/obo/GO_0006601) (creatine biosynthetic process), [GO:0061458](http://purl.obolibrary.org/obo/GO_0061458) (reproductive system development), [GO:0061459](http://purl.obolibrary.org/obo/GO_0061459) (L-arginine transmembrane transporter activity), [GO:0048485](http://purl.obolibrary.org/obo/GO_0048485) (sympathetic nervous system development), [GO:0050795](http://purl.obolibrary.org/obo/GO_0050795) (regulation of behavior), [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development), [GO:0050796](http://purl.obolibrary.org/obo/GO_0050796) (regulation of insulin secretion), [GO:0050793](http://purl.obolibrary.org/obo/GO_0050793) (regulation of developmental process), [GO:0048483](http://purl.obolibrary.org/obo/GO_0048483) (autonomic nervous system development), [GO:0050794](http://purl.obolibrary.org/obo/GO_0050794) (regulation of cellular process), [GO:0048489](http://purl.obolibrary.org/obo/GO_0048489) (synaptic vesicle transport), [GO:0048488](http://purl.obolibrary.org/obo/GO_0048488) (synaptic vesicle endocytosis), [GO:0050792](http://purl.obolibrary.org/obo/GO_0050792) (regulation of viral process), [GO:0072102](http://purl.obolibrary.org/obo/GO_0072102) (glomerulus morphogenesis), [GO:0072101](http://purl.obolibrary.org/obo/GO_0072101) (specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway), [GO:0048487](http://purl.obolibrary.org/obo/GO_0048487) (beta-tubulin binding), [GO:0050790](http://purl.obolibrary.org/obo/GO_0050790) (regulation of catalytic activity), [GO:0048486](http://purl.obolibrary.org/obo/GO_0048486) (parasympathetic nervous system development), [GO:0097402](http://purl.obolibrary.org/obo/GO_0097402) (neuroblast migration), [GO:0072107](http://purl.obolibrary.org/obo/GO_0072107) (positive regulation of ureteric bud formation), [GO:0072106](http://purl.obolibrary.org/obo/GO_0072106) (regulation of ureteric bud formation), [GO:0098735](http://purl.obolibrary.org/obo/GO_0098735) (positive regulation of the force of heart contraction), [GO:2000111](http://purl.obolibrary.org/obo/GO_2000111) (positive regulation of macrophage apoptotic process), [GO:0072104](http://purl.obolibrary.org/obo/GO_0072104) (glomerular capillary formation), [GO:2000110](http://purl.obolibrary.org/obo/GO_2000110) (negative regulation of macrophage apoptotic process), [GO:2000117](http://purl.obolibrary.org/obo/GO_2000117) (negative regulation of cysteine-type endopeptidase activity), [GO:0097409](http://purl.obolibrary.org/obo/GO_0097409) (glial cytoplasmic inclusion), [GO:2000114](http://purl.obolibrary.org/obo/GO_2000114) (regulation of establishment of cell polarity), [GO:0072108](http://purl.obolibrary.org/obo/GO_0072108) (positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis), [GO:0019902](http://purl.obolibrary.org/obo/GO_0019902) (phosphatase binding), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0060112](http://purl.obolibrary.org/obo/GO_0060112) (generation of ovulation cycle rhythm), [GO:0060113](http://purl.obolibrary.org/obo/GO_0060113) (inner ear receptor cell differentiation), [GO:0019903](http://purl.obolibrary.org/obo/GO_0019903) (protein phosphatase binding), [GO:0019905](http://purl.obolibrary.org/obo/GO_0019905) (syntaxin binding), [GO:0019907](http://purl.obolibrary.org/obo/GO_0019907) (cyclin-dependent protein kinase activating kinase holoenzyme complex), [GO:0060118](http://purl.obolibrary.org/obo/GO_0060118) (vestibular receptor cell development), [GO:0060119](http://purl.obolibrary.org/obo/GO_0060119) (inner ear receptor cell development), [GO:0006611](http://purl.obolibrary.org/obo/GO_0006611) (protein export from nucleus), [GO:0006612](http://purl.obolibrary.org/obo/GO_0006612) (protein targeting to membrane), [GO:0060117](http://purl.obolibrary.org/obo/GO_0060117) (auditory receptor cell development), [GO:0048496](http://purl.obolibrary.org/obo/GO_0048496) (maintenance of animal organ identity), [GO:0006605](http://purl.obolibrary.org/obo/GO_0006605) (protein targeting), [GO:0048499](http://purl.obolibrary.org/obo/GO_0048499) (synaptic vesicle membrane organization), [GO:0006606](http://purl.obolibrary.org/obo/GO_0006606) (protein import into nucleus), [GO:0098742](http://purl.obolibrary.org/obo/GO_0098742) (cell-cell adhesion via plasma-membrane adhesion molecules), [GO:0097414](http://purl.obolibrary.org/obo/GO_0097414) (classical Lewy body), [GO:0006607](http://purl.obolibrary.org/obo/GO_0006607) (NLS-bearing protein import into nucleus), [GO:0098743](http://purl.obolibrary.org/obo/GO_0098743) (cell aggregation), [GO:0097413](http://purl.obolibrary.org/obo/GO_0097413) (Lewy body), [GO:0097418](http://purl.obolibrary.org/obo/GO_0097418) (neurofibrillary tangle), [GO:2000121](http://purl.obolibrary.org/obo/GO_2000121) (regulation of removal of superoxide radicals), [GO:0035148](http://purl.obolibrary.org/obo/GO_0035148) (tube formation), [GO:0048490](http://purl.obolibrary.org/obo/GO_0048490) (anterograde synaptic vesicle transport), [GO:0019911](http://purl.obolibrary.org/obo/GO_0019911) (structural constituent of myelin sheath), [GO:0035143](http://purl.obolibrary.org/obo/GO_0035143) (caudal fin morphogenesis), [GO:0035145](http://purl.obolibrary.org/obo/GO_0035145) (exon-exon junction complex), [GO:0036477](http://purl.obolibrary.org/obo/GO_0036477) (somatodendritic compartment), [GO:0061470](http://purl.obolibrary.org/obo/GO_0061470) (T follicular helper cell differentiation), [GO:1902572](http://purl.obolibrary.org/obo/GO_1902572) (negative regulation of serine-type peptidase activity), [GO:0035141](http://purl.obolibrary.org/obo/GO_0035141) (medial fin morphogenesis), [GO:1901249](http://purl.obolibrary.org/obo/GO_1901249) (regulation of lung goblet cell differentiation), [GO:0047173](http://purl.obolibrary.org/obo/GO_0047173) (phosphatidylcholine-retinol O-acyltransferase activity), [GO:0072125](http://purl.obolibrary.org/obo/GO_0072125) (negative regulation of glomerular mesangial cell proliferation), [GO:0098711](http://purl.obolibrary.org/obo/GO_0098711) (iron ion import across plasma membrane), [GO:0098712](http://purl.obolibrary.org/obo/GO_0098712) (L-glutamate import across plasma membrane), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0072126](http://purl.obolibrary.org/obo/GO_0072126) (positive regulation of glomerular mesangial cell proliferation), [GO:0035136](http://purl.obolibrary.org/obo/GO_0035136) (forelimb morphogenesis), [GO:0098719](http://purl.obolibrary.org/obo/GO_0098719) (sodium ion import across plasma membrane), [GO:0035137](http://purl.obolibrary.org/obo/GO_0035137) (hindlimb morphogenesis), [GO:0036468](http://purl.obolibrary.org/obo/GO_0036468) (L-dopa decarboxylase activity), [GO:2000137](http://purl.obolibrary.org/obo/GO_2000137) (negative regulation of cell proliferation involved in heart morphogenesis), [GO:0035138](http://purl.obolibrary.org/obo/GO_0035138) (pectoral fin morphogenesis), [GO:0019900](http://purl.obolibrary.org/obo/GO_0019900) (kinase binding), [GO:0036464](http://purl.obolibrary.org/obo/GO_0036464) (cytoplasmic ribonucleoprotein granule), [GO:0060133](http://purl.obolibrary.org/obo/GO_0060133) (somatotropin secreting cell development), [GO:0060134](http://purl.obolibrary.org/obo/GO_0060134) (prepulse inhibition), [GO:0036466](http://purl.obolibrary.org/obo/GO_0036466) (synaptic vesicle recycling via endosome), [GO:1901250](http://purl.obolibrary.org/obo/GO_1901250) (negative regulation of lung goblet cell differentiation), [GO:0060135](http://purl.obolibrary.org/obo/GO_0060135) (maternal process involved in female pregnancy), [GO:1901255](http://purl.obolibrary.org/obo/GO_1901255) (nucleotide-excision repair involved in interstrand cross-link repair), [GO:0061469](http://purl.obolibrary.org/obo/GO_0061469) (regulation of type B pancreatic cell proliferation), [GO:0060139](http://purl.obolibrary.org/obo/GO_0060139) (positive regulation of apoptotic process by virus), [GO:0047184](http://purl.obolibrary.org/obo/GO_0047184) (1-acylglycerophosphocholine O-acyltransferase activity), [GO:0072114](http://purl.obolibrary.org/obo/GO_0072114) (pronephros morphogenesis), [GO:0072112](http://purl.obolibrary.org/obo/GO_0072112) (glomerular visceral epithelial cell differentiation), [GO:0072111](http://purl.obolibrary.org/obo/GO_0072111) (cell proliferation involved in kidney development), [GO:2000146](http://purl.obolibrary.org/obo/GO_2000146) (negative regulation of cell motility), [GO:0098727](http://purl.obolibrary.org/obo/GO_0098727) (maintenance of cell number), [GO:2000145](http://purl.obolibrary.org/obo/GO_2000145) (regulation of cell motility), [GO:2000144](http://purl.obolibrary.org/obo/GO_2000144) (positive regulation of DNA-templated transcription, initiation), [GO:0072116](http://purl.obolibrary.org/obo/GO_0072116) (pronephros formation), [GO:0035125](http://purl.obolibrary.org/obo/GO_0035125) (embryonic anal fin morphogenesis), [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex), [GO:0036458](http://purl.obolibrary.org/obo/GO_0036458) (hepatocyte growth factor binding), [GO:2000147](http://purl.obolibrary.org/obo/GO_2000147) (positive regulation of cell motility), [GO:0036459](http://purl.obolibrary.org/obo/GO_0036459) (thiol-dependent ubiquitinyl hydrolase activity), [GO:0019957](http://purl.obolibrary.org/obo/GO_0019957) (C-C chemokine binding), [GO:0061410](http://purl.obolibrary.org/obo/GO_0061410) (positive regulation of transcription from RNA polymerase II promoter in response to ethanol), [GO:1902513](http://purl.obolibrary.org/obo/GO_1902513) (regulation of organelle transport along microtubule), [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process), [GO:1902510](http://purl.obolibrary.org/obo/GO_1902510) (regulation of apoptotic DNA fragmentation), [GO:0006644](http://purl.obolibrary.org/obo/GO_0006644) (phospholipid metabolic process), [GO:0005314](http://purl.obolibrary.org/obo/GO_0005314) (high-affinity glutamate transmembrane transporter activity), [GO:0006642](http://purl.obolibrary.org/obo/GO_0006642) (triglyceride mobilization), [GO:0005313](http://purl.obolibrary.org/obo/GO_0005313) (L-glutamate transmembrane transporter activity), [GO:0032924](http://purl.obolibrary.org/obo/GO_0032924) (activin receptor signaling pathway), [GO:0006637](http://purl.obolibrary.org/obo/GO_0006637) (acyl-CoA metabolic process), [GO:0032922](http://purl.obolibrary.org/obo/GO_0032922) (circadian regulation of gene expression), [GO:0006635](http://purl.obolibrary.org/obo/GO_0006635) (fatty acid beta-oxidation), [GO:0005307](http://purl.obolibrary.org/obo/GO_0005307) (choline:sodium symporter activity), [GO:0050750](http://purl.obolibrary.org/obo/GO_0050750) (low-density lipoprotein particle receptor binding), [GO:0006636](http://purl.obolibrary.org/obo/GO_0006636) (unsaturated fatty acid biosynthetic process), [GO:0005309](http://purl.obolibrary.org/obo/GO_0005309) (creatine:sodium symporter activity), [GO:0005308](http://purl.obolibrary.org/obo/GO_0005308) (creatine transmembrane transporter activity), [GO:0032926](http://purl.obolibrary.org/obo/GO_0032926) (negative regulation of activin receptor signaling pathway), [GO:0032927](http://purl.obolibrary.org/obo/GO_0032927) (positive regulation of activin receptor signaling pathway), [GO:0106019](http://purl.obolibrary.org/obo/GO_0106019) (phosphatidylinositol-4,5-bisphosphate phosphatase activity), [GO:0035198](http://purl.obolibrary.org/obo/GO_0035198) (miRNA binding), [GO:0035196](http://purl.obolibrary.org/obo/GO_0035196) (production of miRNAs involved in gene silencing by miRNA), [GO:2000173](http://purl.obolibrary.org/obo/GO_2000173) (negative regulation of branching morphogenesis of a nerve), [GO:0006651](http://purl.obolibrary.org/obo/GO_0006651) (diacylglycerol biosynthetic process), [GO:0006650](http://purl.obolibrary.org/obo/GO_0006650) (glycerophospholipid metabolic process), [GO:0006656](http://purl.obolibrary.org/obo/GO_0006656) (phosphatidylcholine biosynthetic process), [GO:0006653](http://purl.obolibrary.org/obo/GO_0006653) (1,2-diacyl-sn-glycero-3-phosphocholine metabolic process), [GO:0005324](http://purl.obolibrary.org/obo/GO_0005324) (long-chain fatty acid transporter activity), [GO:0006654](http://purl.obolibrary.org/obo/GO_0006654) (phosphatidic acid biosynthetic process), [GO:0006649](http://purl.obolibrary.org/obo/GO_0006649) (phospholipid transfer to membrane), [GO:0032914](http://purl.obolibrary.org/obo/GO_0032914) (positive regulation of transforming growth factor beta1 production), [GO:0005315](http://purl.obolibrary.org/obo/GO_0005315) (inorganic phosphate transmembrane transporter activity), [GO:0006646](http://purl.obolibrary.org/obo/GO_0006646) (phosphatidylethanolamine biosynthetic process), [GO:0032912](http://purl.obolibrary.org/obo/GO_0032912) (negative regulation of transforming growth factor beta2 production), [GO:0032918](http://purl.obolibrary.org/obo/GO_0032918) (spermidine acetylation), [GO:0005319](http://purl.obolibrary.org/obo/GO_0005319) (lipid transporter activity), [GO:0050768](http://purl.obolibrary.org/obo/GO_0050768) (negative regulation of neurogenesis), [GO:0050769](http://purl.obolibrary.org/obo/GO_0050769) (positive regulation of neurogenesis), [GO:0050766](http://purl.obolibrary.org/obo/GO_0050766) (positive regulation of phagocytosis), [GO:0019953](http://purl.obolibrary.org/obo/GO_0019953) (sexual reproduction), [GO:0050767](http://purl.obolibrary.org/obo/GO_0050767) (regulation of neurogenesis), [GO:0019955](http://purl.obolibrary.org/obo/GO_0019955) (cytokine binding), [GO:0050764](http://purl.obolibrary.org/obo/GO_0050764) (regulation of phagocytosis), [GO:0050765](http://purl.obolibrary.org/obo/GO_0050765) (negative regulation of phagocytosis), [GO:0061430](http://purl.obolibrary.org/obo/GO_0061430) (bone trabecula morphogenesis), [GO:0060100](http://purl.obolibrary.org/obo/GO_0060100) (positive regulation of phagocytosis, engulfment), [GO:0019934](http://purl.obolibrary.org/obo/GO_0019934) (cGMP-mediated signaling), [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex), [GO:1903861](http://purl.obolibrary.org/obo/GO_1903861) (positive regulation of dendrite extension), [GO:1903862](http://purl.obolibrary.org/obo/GO_1903862) (positive regulation of oxidative phosphorylation), [GO:1902531](http://purl.obolibrary.org/obo/GO_1902531) (regulation of intracellular signal transduction), [GO:1901202](http://purl.obolibrary.org/obo/GO_1901202) (negative regulation of extracellular matrix assembly), [GO:0047127](http://purl.obolibrary.org/obo/GO_0047127) (thiomorpholine-carboxylate dehydrogenase activity), [GO:1902533](http://purl.obolibrary.org/obo/GO_1902533) (positive regulation of intracellular signal transduction), [GO:0006622](http://purl.obolibrary.org/obo/GO_0006622) (protein targeting to lysosome), [GO:0006623](http://purl.obolibrary.org/obo/GO_0006623) (protein targeting to vacuole), [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier), [GO:0006620](http://purl.obolibrary.org/obo/GO_0006620) (posttranslational protein targeting to endoplasmic reticulum membrane), [GO:0006621](http://purl.obolibrary.org/obo/GO_0006621) (protein retention in ER lumen), [GO:1901207](http://purl.obolibrary.org/obo/GO_1901207) (regulation of heart looping), [GO:0050773](http://purl.obolibrary.org/obo/GO_0050773) (regulation of dendrite development), [GO:0050774](http://purl.obolibrary.org/obo/GO_0050774) (negative regulation of dendrite morphogenesis), [GO:0006616](http://purl.obolibrary.org/obo/GO_0006616) (SRP-dependent cotranslational protein targeting to membrane, translocation), [GO:0050771](http://purl.obolibrary.org/obo/GO_0050771) (negative regulation of axonogenesis), [GO:0006613](http://purl.obolibrary.org/obo/GO_0006613) (cotranslational protein targeting to membrane), [GO:0032901](http://purl.obolibrary.org/obo/GO_0032901) (positive regulation of neurotrophin production), [GO:0050772](http://purl.obolibrary.org/obo/GO_0050772) (positive regulation of axonogenesis), [GO:0050770](http://purl.obolibrary.org/obo/GO_0050770) (regulation of axonogenesis), [GO:0047134](http://purl.obolibrary.org/obo/GO_0047134) (protein-disulfide reductase activity), [GO:2000179](http://purl.obolibrary.org/obo/GO_2000179) (positive regulation of neural precursor cell proliferation), [GO:2000178](http://purl.obolibrary.org/obo/GO_2000178) (negative regulation of neural precursor cell proliferation), [GO:2000177](http://purl.obolibrary.org/obo/GO_2000177) (regulation of neural precursor cell proliferation), [GO:0050775](http://purl.obolibrary.org/obo/GO_0050775) (positive regulation of dendrite morphogenesis), [GO:0050776](http://purl.obolibrary.org/obo/GO_0050776) (regulation of immune response), [GO:0035176](http://purl.obolibrary.org/obo/GO_0035176) (social behavior), [GO:0035173](http://purl.obolibrary.org/obo/GO_0035173) (histone kinase activity), [GO:0035175](http://purl.obolibrary.org/obo/GO_0035175) (histone kinase activity (H3-S10 specific)), [GO:1901210](http://purl.obolibrary.org/obo/GO_1901210) (regulation of cardiac chamber formation), [GO:0061428](http://purl.obolibrary.org/obo/GO_0061428) (negative regulation of transcription from RNA polymerase II promoter in response to hypoxia), [GO:0048469](http://purl.obolibrary.org/obo/GO_0048469) (cell maturation), [GO:1901215](http://purl.obolibrary.org/obo/GO_1901215) (negative regulation of neuron death), [GO:0047138](http://purl.obolibrary.org/obo/GO_0047138) (aquacobalamin reductase activity), [GO:0061429](http://purl.obolibrary.org/obo/GO_0061429) (positive regulation of transcription from RNA polymerase II promoter by oleic acid), [GO:0048468](http://purl.obolibrary.org/obo/GO_0048468) (cell development), [GO:1901214](http://purl.obolibrary.org/obo/GO_1901214) (regulation of neuron death), [GO:0006633](http://purl.obolibrary.org/obo/GO_0006633) (fatty acid biosynthetic process), [GO:0061424](http://purl.obolibrary.org/obo/GO_0061424) (positive regulation of peroxisome organization by positive regulation of transcription from RNA polymerase II promoter), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0061425](http://purl.obolibrary.org/obo/GO_0061425) (positive regulation of ethanol catabolic process by positive regulation of transcription from RNA polymerase II promoter), [GO:0005302](http://purl.obolibrary.org/obo/GO_0005302) (L-tyrosine transmembrane transporter activity), [GO:0006626](http://purl.obolibrary.org/obo/GO_0006626) (protein targeting to mitochondrion), [GO:0106044](http://purl.obolibrary.org/obo/GO_0106044) (guanine deglycation), [GO:0006627](http://purl.obolibrary.org/obo/GO_0006627) (protein processing involved in protein targeting to mitochondrion), [GO:0006624](http://purl.obolibrary.org/obo/GO_0006624) (vacuolar protein processing), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0006625](http://purl.obolibrary.org/obo/GO_0006625) (protein targeting to peroxisome), [GO:0048478](http://purl.obolibrary.org/obo/GO_0048478) (replication fork protection), [GO:0048477](http://purl.obolibrary.org/obo/GO_0048477) (oogenesis), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:2000189](http://purl.obolibrary.org/obo/GO_2000189) (positive regulation of cholesterol homeostasis), [GO:0019933](http://purl.obolibrary.org/obo/GO_0019933) (cAMP-mediated signaling), [GO:0106046](http://purl.obolibrary.org/obo/GO_0106046) (guanine deglycation, glyoxal removal), [GO:0106045](http://purl.obolibrary.org/obo/GO_0106045) (guanine deglycation, methylglyoxal removal), [GO:0043626](http://purl.obolibrary.org/obo/GO_0043626) (PCNA complex), [GO:0043625](http://purl.obolibrary.org/obo/GO_0043625) (delta DNA polymerase complex), [GO:0043628](http://purl.obolibrary.org/obo/GO_0043628) (ncRNA 3'-end processing), [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0006680](http://purl.obolibrary.org/obo/GO_0006680) (glucosylceramide catabolic process), [GO:0006681](http://purl.obolibrary.org/obo/GO_0006681) (galactosylceramide metabolic process), [GO:0004021](http://purl.obolibrary.org/obo/GO_0004021) (L-alanine:2-oxoglutarate aminotransferase activity), [GO:0005351](http://purl.obolibrary.org/obo/GO_0005351) (sugar:proton symporter activity), [GO:0006685](http://purl.obolibrary.org/obo/GO_0006685) (sphingomyelin catabolic process), [GO:0006683](http://purl.obolibrary.org/obo/GO_0006683) (galactosylceramide catabolic process), [GO:0004022](http://purl.obolibrary.org/obo/GO_0004022) (alcohol dehydrogenase (NAD) activity), [GO:0006688](http://purl.obolibrary.org/obo/GO_0006688) (glycosphingolipid biosynthetic process), [GO:0072193](http://purl.obolibrary.org/obo/GO_0072193) (ureter smooth muscle cell differentiation), [GO:0043621](http://purl.obolibrary.org/obo/GO_0043621) (protein self-association), [GO:0006689](http://purl.obolibrary.org/obo/GO_0006689) (ganglioside catabolic process), [GO:0004024](http://purl.obolibrary.org/obo/GO_0004024) (alcohol dehydrogenase activity, zinc-dependent), [GO:0005355](http://purl.obolibrary.org/obo/GO_0005355) (glucose transmembrane transporter activity), [GO:0072192](http://purl.obolibrary.org/obo/GO_0072192) (ureter epithelial cell differentiation), [GO:0043623](http://purl.obolibrary.org/obo/GO_0043623) (cellular protein complex assembly), [GO:0006687](http://purl.obolibrary.org/obo/GO_0006687) (glycosphingolipid metabolic process), [GO:0097493](http://purl.obolibrary.org/obo/GO_0097493) (structural molecule activity conferring elasticity), [GO:0004018](http://purl.obolibrary.org/obo/GO_0004018) (N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity), [GO:0032968](http://purl.obolibrary.org/obo/GO_0032968) (positive regulation of transcription elongation from RNA polymerase II promoter), [GO:0031638](http://purl.obolibrary.org/obo/GO_0031638) (zymogen activation), [GO:0097484](http://purl.obolibrary.org/obo/GO_0097484) (dendrite extension), [GO:0004017](http://purl.obolibrary.org/obo/GO_0004017) (adenylate kinase activity), [GO:0030307](http://purl.obolibrary.org/obo/GO_0030307) (positive regulation of cell growth), [GO:0032967](http://purl.obolibrary.org/obo/GO_0032967) (positive regulation of collagen biosynthetic process), [GO:0004019](http://purl.obolibrary.org/obo/GO_0004019) (adenylosuccinate synthase activity), [GO:0030308](http://purl.obolibrary.org/obo/GO_0030308) (negative regulation of cell growth), [GO:0031639](http://purl.obolibrary.org/obo/GO_0031639) (plasminogen activation), [GO:0072189](http://purl.obolibrary.org/obo/GO_0072189) (ureter development), [GO:0016010](http://purl.obolibrary.org/obo/GO_0016010) (dystrophin-associated glycoprotein complex), [GO:0016011](http://purl.obolibrary.org/obo/GO_0016011) (dystroglycan complex), [GO:0016012](http://purl.obolibrary.org/obo/GO_0016012) (sarcoglycan complex), [GO:0030301](http://purl.obolibrary.org/obo/GO_0030301) (cholesterol transport), [GO:0032962](http://purl.obolibrary.org/obo/GO_0032962) (positive regulation of inositol trisphosphate biosynthetic process), [GO:0032963](http://purl.obolibrary.org/obo/GO_0032963) (collagen metabolic process), [GO:0042306](http://purl.obolibrary.org/obo/GO_0042306) (regulation of protein import into nucleus), [GO:0042307](http://purl.obolibrary.org/obo/GO_0042307) (positive regulation of protein import into nucleus), [GO:0042309](http://purl.obolibrary.org/obo/GO_0042309) (homoiothermy), [GO:0060196](http://purl.obolibrary.org/obo/GO_0060196) (positive regulation of antisense RNA transcription), [GO:0004030](http://purl.obolibrary.org/obo/GO_0004030) (aldehyde dehydrogenase [NAD(P)+] activity), [GO:0060197](http://purl.obolibrary.org/obo/GO_0060197) (cloacal septation), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0004032](http://purl.obolibrary.org/obo/GO_0004032) (alditol:NADP+ 1-oxidoreductase activity), [GO:0006696](http://purl.obolibrary.org/obo/GO_0006696) (ergosterol biosynthetic process), [GO:0004034](http://purl.obolibrary.org/obo/GO_0004034) (aldose 1-epimerase activity), [GO:0043631](http://purl.obolibrary.org/obo/GO_0043631) (RNA polyadenylation), [GO:0006693](http://purl.obolibrary.org/obo/GO_0006693) (prostaglandin metabolic process), [GO:0006694](http://purl.obolibrary.org/obo/GO_0006694) (steroid biosynthetic process), [GO:0004033](http://purl.obolibrary.org/obo/GO_0004033) (aldo-keto reductase (NADP) activity), [GO:0042301](http://purl.obolibrary.org/obo/GO_0042301) (phosphate ion binding), [GO:0006699](http://purl.obolibrary.org/obo/GO_0006699) (bile acid biosynthetic process), [GO:0072182](http://purl.obolibrary.org/obo/GO_0072182) (regulation of nephron tubule epithelial cell differentiation), [GO:0072180](http://purl.obolibrary.org/obo/GO_0072180) (mesonephric duct morphogenesis), [GO:0004029](http://purl.obolibrary.org/obo/GO_0004029) (aldehyde dehydrogenase (NAD) activity), [GO:0032957](http://purl.obolibrary.org/obo/GO_0032957) (inositol trisphosphate metabolic process), [GO:0072175](http://purl.obolibrary.org/obo/GO_0072175) (epithelial tube formation), [GO:0004028](http://purl.obolibrary.org/obo/GO_0004028) (3-chloroallyl aldehyde dehydrogenase activity), [GO:0032958](http://purl.obolibrary.org/obo/GO_0032958) (inositol phosphate biosynthetic process), [GO:0031624](http://purl.obolibrary.org/obo/GO_0031624) (ubiquitin conjugating enzyme binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0032956](http://purl.obolibrary.org/obo/GO_0032956) (regulation of actin cytoskeleton organization), [GO:0072179](http://purl.obolibrary.org/obo/GO_0072179) (nephric duct formation), [GO:0097499](http://purl.obolibrary.org/obo/GO_0097499) (protein localization to non-motile cilium), [GO:0031628](http://purl.obolibrary.org/obo/GO_0031628) (opioid receptor binding), [GO:0072178](http://purl.obolibrary.org/obo/GO_0072178) (nephric duct morphogenesis), [GO:0032959](http://purl.obolibrary.org/obo/GO_0032959) (inositol trisphosphate biosynthetic process), [GO:0031629](http://purl.obolibrary.org/obo/GO_0031629) (synaptic vesicle fusion to presynaptic active zone membrane), [GO:0072177](http://purl.obolibrary.org/obo/GO_0072177) (mesonephric duct development), [GO:0031622](http://purl.obolibrary.org/obo/GO_0031622) (positive regulation of fever generation), [GO:0031623](http://purl.obolibrary.org/obo/GO_0031623) (receptor internalization), [GO:0031620](http://purl.obolibrary.org/obo/GO_0031620) (regulation of fever generation), [GO:0005330](http://purl.obolibrary.org/obo/GO_0005330) (dopamine:sodium symporter activity), [GO:0004001](http://purl.obolibrary.org/obo/GO_0004001) (adenosine kinase activity), [GO:0042310](http://purl.obolibrary.org/obo/GO_0042310) (vasoconstriction), [GO:0005332](http://purl.obolibrary.org/obo/GO_0005332) (gamma-aminobutyric acid:sodium symporter activity), [GO:0006660](http://purl.obolibrary.org/obo/GO_0006660) (phosphatidylserine catabolic process), [GO:0004000](http://purl.obolibrary.org/obo/GO_0004000) (adenosine deaminase activity), [GO:0006661](http://purl.obolibrary.org/obo/GO_0006661) (phosphatidylinositol biosynthetic process), [GO:0042311](http://purl.obolibrary.org/obo/GO_0042311) (vasodilation), [GO:0097470](http://purl.obolibrary.org/obo/GO_0097470) (ribbon synapse), [GO:0004003](http://purl.obolibrary.org/obo/GO_0004003) (ATP-dependent DNA helicase activity), [GO:0005333](http://purl.obolibrary.org/obo/GO_0005333) (norepinephrine transmembrane transporter activity), [GO:0006664](http://purl.obolibrary.org/obo/GO_0006664) (glycolipid metabolic process), [GO:0006665](http://purl.obolibrary.org/obo/GO_0006665) (sphingolipid metabolic process), [GO:0004004](http://purl.obolibrary.org/obo/GO_0004004) (ATP-dependent RNA helicase activity), [GO:0006659](http://purl.obolibrary.org/obo/GO_0006659) (phosphatidylserine biosynthetic process), [GO:0032947](http://purl.obolibrary.org/obo/GO_0032947) (protein complex scaffold activity), [GO:0031616](http://purl.obolibrary.org/obo/GO_0031616) (spindle pole centrosome), [GO:0097462](http://purl.obolibrary.org/obo/GO_0097462) (Lewy neurite), [GO:0005326](http://purl.obolibrary.org/obo/GO_0005326) (neurotransmitter transporter activity), [GO:0098793](http://purl.obolibrary.org/obo/GO_0098793) (presynapse), [GO:0005329](http://purl.obolibrary.org/obo/GO_0005329) (dopamine transmembrane transporter activity), [GO:0098794](http://purl.obolibrary.org/obo/GO_0098794) (postsynapse), [GO:0005328](http://purl.obolibrary.org/obo/GO_0005328) (neurotransmitter:sodium symporter activity), [GO:0031619](http://purl.obolibrary.org/obo/GO_0031619) (homologous chromosome orientation involved in meiotic metaphase I plate congression), [GO:0097466](http://purl.obolibrary.org/obo/GO_0097466) (ubiquitin-dependent glycoprotein ERAD pathway), [GO:0098797](http://purl.obolibrary.org/obo/GO_0098797) (plasma membrane protein complex), [GO:0031618](http://purl.obolibrary.org/obo/GO_0031618) (nuclear pericentric heterochromatin), [GO:0019985](http://purl.obolibrary.org/obo/GO_0019985) (translesion synthesis), [GO:0032940](http://purl.obolibrary.org/obo/GO_0032940) (secretion by cell), [GO:0042327](http://purl.obolibrary.org/obo/GO_0042327) (positive regulation of phosphorylation), [GO:0018636](http://purl.obolibrary.org/obo/GO_0018636) (phenanthrene 9,10-monooxygenase activity), [GO:0042328](http://purl.obolibrary.org/obo/GO_0042328) (heparan sulfate N-acetylglucosaminyltransferase activity), [GO:0043651](http://purl.obolibrary.org/obo/GO_0043651) (linoleic acid metabolic process), [GO:0006673](http://purl.obolibrary.org/obo/GO_0006673) (inositol phosphoceramide metabolic process), [GO:0004012](http://purl.obolibrary.org/obo/GO_0004012) (phospholipid-translocating ATPase activity), [GO:0043653](http://purl.obolibrary.org/obo/GO_0043653) (mitochondrial fragmentation involved in apoptotic process), [GO:0005343](http://purl.obolibrary.org/obo/GO_0005343) (organic acid:sodium symporter activity), [GO:0042321](http://purl.obolibrary.org/obo/GO_0042321) (negative regulation of circadian sleep/wake cycle, sleep), [GO:0043652](http://purl.obolibrary.org/obo/GO_0043652) (engulfment of apoptotic cell), [GO:0006672](http://purl.obolibrary.org/obo/GO_0006672) (ceramide metabolic process), [GO:0043654](http://purl.obolibrary.org/obo/GO_0043654) (recognition of apoptotic cell), [GO:0005344](http://purl.obolibrary.org/obo/GO_0005344) (oxygen carrier activity), [GO:0042324](http://purl.obolibrary.org/obo/GO_0042324) (hypocretin receptor binding), [GO:0004013](http://purl.obolibrary.org/obo/GO_0004013) (adenosylhomocysteinase activity), [GO:0006678](http://purl.obolibrary.org/obo/GO_0006678) (glucosylceramide metabolic process), [GO:0004016](http://purl.obolibrary.org/obo/GO_0004016) (adenylate cyclase activity), [GO:0042325](http://purl.obolibrary.org/obo/GO_0042325) (regulation of phosphorylation), [GO:0042326](http://purl.obolibrary.org/obo/GO_0042326) (negative regulation of phosphorylation), [GO:0072198](http://purl.obolibrary.org/obo/GO_0072198) (mesenchymal cell proliferation involved in ureter development), [GO:0005338](http://purl.obolibrary.org/obo/GO_0005338) (nucleotide-sugar transmembrane transporter activity), [GO:0005337](http://purl.obolibrary.org/obo/GO_0005337) (nucleoside transmembrane transporter activity), [GO:0072197](http://purl.obolibrary.org/obo/GO_0072197) (ureter morphogenesis), [GO:0032933](http://purl.obolibrary.org/obo/GO_0032933) (SREBP signaling pathway), [GO:0072196](http://purl.obolibrary.org/obo/GO_0072196) (proximal/distal pattern formation involved in pronephric nephron development), [GO:0004008](http://purl.obolibrary.org/obo/GO_0004008) (copper-exporting ATPase activity), [GO:0032934](http://purl.obolibrary.org/obo/GO_0032934) (sterol binding), [GO:0097475](http://purl.obolibrary.org/obo/GO_0097475) (motor neuron migration), [GO:0097477](http://purl.obolibrary.org/obo/GO_0097477) (lateral motor column neuron migration), [GO:0060165](http://purl.obolibrary.org/obo/GO_0060165) (regulation of timing of subpallium neuron differentiation), [GO:0060166](http://purl.obolibrary.org/obo/GO_0060166) (olfactory pit development), [GO:0005391](http://purl.obolibrary.org/obo/GO_0005391) (sodium:potassium-exchanging ATPase activity), [GO:0031681](http://purl.obolibrary.org/obo/GO_0031681) (G-protein beta-subunit binding), [GO:0060163](http://purl.obolibrary.org/obo/GO_0060163) (subpallium neuron fate commitment), [GO:0004065](http://purl.obolibrary.org/obo/GO_0004065) (arylsulfatase activity), [GO:1902598](http://purl.obolibrary.org/obo/GO_1902598) (creatine transmembrane transport), [GO:0004066](http://purl.obolibrary.org/obo/GO_0004066) (asparagine synthase (glutamine-hydrolyzing) activity), [GO:0098780](http://purl.obolibrary.org/obo/GO_0098780) (response to mitochondrial depolarisation), [GO:0097450](http://purl.obolibrary.org/obo/GO_0097450) (astrocyte end-foot), [GO:0098773](http://purl.obolibrary.org/obo/GO_0098773) (skin epidermis development), [GO:0097441](http://purl.obolibrary.org/obo/GO_0097441) (basal dendrite), [GO:0097440](http://purl.obolibrary.org/obo/GO_0097440) (apical dendrite), [GO:0016050](http://purl.obolibrary.org/obo/GO_0016050) (vesicle organization), [GO:0016051](http://purl.obolibrary.org/obo/GO_0016051) (carbohydrate biosynthetic process), [GO:0016052](http://purl.obolibrary.org/obo/GO_0016052) (carbohydrate catabolic process), [GO:0097447](http://purl.obolibrary.org/obo/GO_0097447) (dendritic tree), [GO:0072144](http://purl.obolibrary.org/obo/GO_0072144) (glomerular mesangial cell development), [GO:0097449](http://purl.obolibrary.org/obo/GO_0097449) (astrocyte projection), [GO:0031673](http://purl.obolibrary.org/obo/GO_0031673) (H zone), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0031674](http://purl.obolibrary.org/obo/GO_0031674) (I band), [GO:0072149](http://purl.obolibrary.org/obo/GO_0072149) (glomerular visceral epithelial cell fate commitment), [GO:0016056](http://purl.obolibrary.org/obo/GO_0016056) (rhodopsin mediated signaling pathway), [GO:0060170](http://purl.obolibrary.org/obo/GO_0060170) (ciliary membrane), [GO:0030343](http://purl.obolibrary.org/obo/GO_0030343) (vitamin D3 25-hydroxylase activity), [GO:0072148](http://purl.obolibrary.org/obo/GO_0072148) (epithelial cell fate commitment), [GO:0031672](http://purl.obolibrary.org/obo/GO_0031672) (A band), [GO:0060171](http://purl.obolibrary.org/obo/GO_0060171) (stereocilium membrane), [GO:0030346](http://purl.obolibrary.org/obo/GO_0030346) (protein phosphatase 2B binding), [GO:0061485](http://purl.obolibrary.org/obo/GO_0061485) (memory T cell proliferation), [GO:0060155](http://purl.obolibrary.org/obo/GO_0060155) (platelet dense granule organization), [GO:0004070](http://purl.obolibrary.org/obo/GO_0004070) (aspartate carbamoyltransferase activity), [GO:0060157](http://purl.obolibrary.org/obo/GO_0060157) (urinary bladder development), [GO:0031670](http://purl.obolibrary.org/obo/GO_0031670) (cellular response to nutrient), [GO:0060152](http://purl.obolibrary.org/obo/GO_0060152) (microtubule-based peroxisome localization), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:0060158](http://purl.obolibrary.org/obo/GO_0060158) (phospholipase C-activating dopamine receptor signaling pathway), [GO:0060159](http://purl.obolibrary.org/obo/GO_0060159) (regulation of dopamine receptor signaling pathway), [GO:0097451](http://purl.obolibrary.org/obo/GO_0097451) (glial limiting end-foot), [GO:0030337](http://purl.obolibrary.org/obo/GO_0030337) (DNA polymerase processivity factor activity), [GO:0031668](http://purl.obolibrary.org/obo/GO_0031668) (cellular response to extracellular stimulus), [GO:0097453](http://purl.obolibrary.org/obo/GO_0097453) (mesaxon), [GO:0031669](http://purl.obolibrary.org/obo/GO_0031669) (cellular response to nutrient levels), [GO:0072136](http://purl.obolibrary.org/obo/GO_0072136) (metanephric mesenchymal cell proliferation involved in metanephros development), [GO:0097458](http://purl.obolibrary.org/obo/GO_0097458) (neuron part), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0016043](http://purl.obolibrary.org/obo/GO_0016043) (cellular component organization), [GO:0032993](http://purl.obolibrary.org/obo/GO_0032993) (protein-DNA complex), [GO:0072139](http://purl.obolibrary.org/obo/GO_0072139) (glomerular parietal epithelial cell differentiation), [GO:0031663](http://purl.obolibrary.org/obo/GO_0031663) (lipopolysaccharide-mediated signaling pathway), [GO:0032994](http://purl.obolibrary.org/obo/GO_0032994) (protein-lipid complex), [GO:0072138](http://purl.obolibrary.org/obo/GO_0072138) (mesenchymal cell proliferation involved in ureteric bud development), [GO:0030332](http://purl.obolibrary.org/obo/GO_0030332) (cyclin binding), [GO:0030331](http://purl.obolibrary.org/obo/GO_0030331) (estrogen receptor binding), [GO:0072137](http://purl.obolibrary.org/obo/GO_0072137) (condensed mesenchymal cell proliferation), [GO:0060160](http://purl.obolibrary.org/obo/GO_0060160) (negative regulation of dopamine receptor signaling pathway), [GO:0030334](http://purl.obolibrary.org/obo/GO_0030334) (regulation of cell migration), [GO:0031667](http://purl.obolibrary.org/obo/GO_0031667) (response to nutrient levels), [GO:0016048](http://purl.obolibrary.org/obo/GO_0016048) (detection of temperature stimulus), [GO:0030336](http://purl.obolibrary.org/obo/GO_0030336) (negative regulation of cell migration), [GO:0016049](http://purl.obolibrary.org/obo/GO_0016049) (cell growth), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0060187](http://purl.obolibrary.org/obo/GO_0060187) (cell pole), [GO:0005372](http://purl.obolibrary.org/obo/GO_0005372) (water transmembrane transporter activity), [GO:0005371](http://purl.obolibrary.org/obo/GO_0005371) (tricarboxylate secondary active transmembrane transporter activity), [GO:0004043](http://purl.obolibrary.org/obo/GO_0004043) (L-aminoadipate-semialdehyde dehydrogenase activity), [GO:0004045](http://purl.obolibrary.org/obo/GO_0004045) (aminoacyl-tRNA hydrolase activity), [GO:0005375](http://purl.obolibrary.org/obo/GO_0005375) (copper ion transmembrane transporter activity), [GO:0072172](http://purl.obolibrary.org/obo/GO_0072172) (mesonephric tubule formation), [GO:0004047](http://purl.obolibrary.org/obo/GO_0004047) (aminomethyltransferase activity), [GO:0004046](http://purl.obolibrary.org/obo/GO_0004046) (aminoacylase activity), [GO:0031659](http://purl.obolibrary.org/obo/GO_0031659) (positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle), [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis), [GO:0072164](http://purl.obolibrary.org/obo/GO_0072164) (mesonephric tubule development), [GO:0097421](http://purl.obolibrary.org/obo/GO_0097421) (liver regeneration), [GO:0031658](http://purl.obolibrary.org/obo/GO_0031658) (negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle), [GO:0072162](http://purl.obolibrary.org/obo/GO_0072162) (metanephric mesenchymal cell differentiation), [GO:0098754](http://purl.obolibrary.org/obo/GO_0098754) (detoxification), [GO:0016031](http://purl.obolibrary.org/obo/GO_0016031) (tRNA import into mitochondrion), [GO:0032982](http://purl.obolibrary.org/obo/GO_0032982) (myosin filament), [GO:0016032](http://purl.obolibrary.org/obo/GO_0016032) (viral process), [GO:0032983](http://purl.obolibrary.org/obo/GO_0032983) (kainate selective glutamate receptor complex), [GO:0030321](http://purl.obolibrary.org/obo/GO_0030321) (transepithelial chloride transport), [GO:0032981](http://purl.obolibrary.org/obo/GO_0032981) (mitochondrial respiratory chain complex I assembly), [GO:0097428](http://purl.obolibrary.org/obo/GO_0097428) (protein maturation by iron-sulfur cluster transfer), [GO:0016035](http://purl.obolibrary.org/obo/GO_0016035) (zeta DNA polymerase complex), [GO:0030323](http://purl.obolibrary.org/obo/GO_0030323) (respiratory tube development), [GO:0030322](http://purl.obolibrary.org/obo/GO_0030322) (stabilization of membrane potential), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:0016038](http://purl.obolibrary.org/obo/GO_0016038) (absorption of visible light), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0043615](http://purl.obolibrary.org/obo/GO_0043615) (astrocyte cell migration), [GO:0043616](http://purl.obolibrary.org/obo/GO_0043616) (keratinocyte proliferation), [GO:0060179](http://purl.obolibrary.org/obo/GO_0060179) (male mating behavior), [GO:0043619](http://purl.obolibrary.org/obo/GO_0043619) (regulation of transcription from RNA polymerase II promoter in response to oxidative stress), [GO:0060173](http://purl.obolibrary.org/obo/GO_0060173) (limb development), [GO:0060174](http://purl.obolibrary.org/obo/GO_0060174) (limb bud formation), [GO:1901299](http://purl.obolibrary.org/obo/GO_1901299) (negative regulation of hydrogen peroxide-mediated programmed cell death), [GO:0005385](http://purl.obolibrary.org/obo/GO_0005385) (zinc ion transmembrane transporter activity), [GO:0072161](http://purl.obolibrary.org/obo/GO_0072161) (mesenchymal cell differentiation involved in kidney development), [GO:0004058](http://purl.obolibrary.org/obo/GO_0004058) (aromatic-L-amino-acid decarboxylase activity), [GO:0005388](http://purl.obolibrary.org/obo/GO_0005388) (calcium-transporting ATPase activity), [GO:0098770](http://purl.obolibrary.org/obo/GO_0098770) (FBXO family protein binding), [GO:0072160](http://purl.obolibrary.org/obo/GO_0072160) (nephron tubule epithelial cell differentiation), [GO:0030316](http://purl.obolibrary.org/obo/GO_0030316) (osteoclast differentiation), [GO:0032979](http://purl.obolibrary.org/obo/GO_0032979) (protein insertion into mitochondrial membrane from inner side), [GO:0031648](http://purl.obolibrary.org/obo/GO_0031648) (protein destabilization), [GO:0030315](http://purl.obolibrary.org/obo/GO_0030315) (T-tubule), [GO:0030318](http://purl.obolibrary.org/obo/GO_0030318) (melanocyte differentiation), [GO:0098761](http://purl.obolibrary.org/obo/GO_0098761) (cellular response to interleukin-7), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0097431](http://purl.obolibrary.org/obo/GO_0097431) (mitotic spindle pole), [GO:0030317](http://purl.obolibrary.org/obo/GO_0030317) (flagellated sperm motility), [GO:0097433](http://purl.obolibrary.org/obo/GO_0097433) (dense body), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0097435](http://purl.obolibrary.org/obo/GO_0097435) (supramolecular fiber organization), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0031641](http://purl.obolibrary.org/obo/GO_0031641) (regulation of myelination), [GO:0032972](http://purl.obolibrary.org/obo/GO_0032972) (regulation of muscle filament sliding speed), [GO:0031642](http://purl.obolibrary.org/obo/GO_0031642) (negative regulation of myelination), [GO:0030314](http://purl.obolibrary.org/obo/GO_0030314) (junctional membrane complex), [GO:0032974](http://purl.obolibrary.org/obo/GO_0032974) (amino acid transmembrane export from vacuole), [GO:0031643](http://purl.obolibrary.org/obo/GO_0031643) (positive regulation of myelination), [GO:0016028](http://purl.obolibrary.org/obo/GO_0016028) (rhabdomere), [GO:0043585](http://purl.obolibrary.org/obo/GO_0043585) (nose morphogenesis), [GO:0043584](http://purl.obolibrary.org/obo/GO_0043584) (nose development), [GO:0042254](http://purl.obolibrary.org/obo/GO_0042254) (ribosome biogenesis), [GO:0043587](http://purl.obolibrary.org/obo/GO_0043587) (tongue morphogenesis), [GO:0043586](http://purl.obolibrary.org/obo/GO_0043586) (tongue development), [GO:0043589](http://purl.obolibrary.org/obo/GO_0043589) (skin morphogenesis), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0001702](http://purl.obolibrary.org/obo/GO_0001702) (gastrulation with mouth forming second), [GO:0031594](http://purl.obolibrary.org/obo/GO_0031594) (neuromuscular junction), [GO:0001706](http://purl.obolibrary.org/obo/GO_0001706) (endoderm formation), [GO:0001707](http://purl.obolibrary.org/obo/GO_0001707) (mesoderm formation), [GO:0001708](http://purl.obolibrary.org/obo/GO_0001708) (cell fate specification), [GO:0001709](http://purl.obolibrary.org/obo/GO_0001709) (cell fate determination), [GO:0030267](http://purl.obolibrary.org/obo/GO_0030267) (glyoxylate reductase (NADP) activity), [GO:0031593](http://purl.obolibrary.org/obo/GO_0031593) (polyubiquitin modification-dependent protein binding), [GO:0042264](http://purl.obolibrary.org/obo/GO_0042264) (peptidyl-aspartic acid hydroxylation), [GO:0043596](http://purl.obolibrary.org/obo/GO_0043596) (nuclear replication fork), [GO:0042267](http://purl.obolibrary.org/obo/GO_0042267) (natural killer cell mediated cytotoxicity), [GO:0042272](http://purl.obolibrary.org/obo/GO_0042272) (nuclear RNA export factor complex), [GO:0042273](http://purl.obolibrary.org/obo/GO_0042273) (ribosomal large subunit biogenesis), [GO:0042274](http://purl.obolibrary.org/obo/GO_0042274) (ribosomal small subunit biogenesis), [GO:0031585](http://purl.obolibrary.org/obo/GO_0031585) (regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity), [GO:0030252](http://purl.obolibrary.org/obo/GO_0030252) (growth hormone secretion), [GO:0031584](http://purl.obolibrary.org/obo/GO_0031584) (activation of phospholipase D activity), [GO:0030258](http://purl.obolibrary.org/obo/GO_0030258) (lipid modification), [GO:0031588](http://purl.obolibrary.org/obo/GO_0031588) (nucleotide-activated protein kinase complex), [GO:0005290](http://purl.obolibrary.org/obo/GO_0005290) (L-histidine transmembrane transporter activity), [GO:0030250](http://purl.obolibrary.org/obo/GO_0030250) (guanylate cyclase activator activity), [GO:0042276](http://purl.obolibrary.org/obo/GO_0042276) (error-prone translesion synthesis), [GO:0042277](http://purl.obolibrary.org/obo/GO_0042277) (peptide binding), [GO:0030249](http://purl.obolibrary.org/obo/GO_0030249) (guanylate cyclase regulator activity), [GO:0042281](http://purl.obolibrary.org/obo/GO_0042281) (dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity), [GO:0042283](http://purl.obolibrary.org/obo/GO_0042283) (dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity), [GO:0042285](http://purl.obolibrary.org/obo/GO_0042285) (xylosyltransferase activity), [GO:0030242](http://purl.obolibrary.org/obo/GO_0030242) (autophagy of peroxisome), [GO:0030241](http://purl.obolibrary.org/obo/GO_0030241) (skeletal muscle myosin thick filament assembly), [GO:0031572](http://purl.obolibrary.org/obo/GO_0031572) (G2 DNA damage checkpoint), [GO:0031573](http://purl.obolibrary.org/obo/GO_0031573) (intra-S DNA damage checkpoint), [GO:0030246](http://purl.obolibrary.org/obo/GO_0030246) (carbohydrate binding), [GO:0031578](http://purl.obolibrary.org/obo/GO_0031578) (mitotic spindle orientation checkpoint), [GO:0031579](http://purl.obolibrary.org/obo/GO_0031579) (membrane raft organization), [GO:0030247](http://purl.obolibrary.org/obo/GO_0030247) (polysaccharide binding), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:0030240](http://purl.obolibrary.org/obo/GO_0030240) (skeletal muscle thin filament assembly), [GO:0042288](http://purl.obolibrary.org/obo/GO_0042288) (MHC class I protein binding), [GO:0042289](http://purl.obolibrary.org/obo/GO_0042289) (MHC class II protein binding), [GO:0030239](http://purl.obolibrary.org/obo/GO_0030239) (myofibril assembly), [GO:0030238](http://purl.obolibrary.org/obo/GO_0030238) (male sex determination), [GO:0030235](http://purl.obolibrary.org/obo/GO_0030235) (nitric-oxide synthase regulator activity), [GO:0030234](http://purl.obolibrary.org/obo/GO_0030234) (enzyme regulator activity), [GO:0043549](http://purl.obolibrary.org/obo/GO_0043549) (regulation of kinase activity), [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0043541](http://purl.obolibrary.org/obo/GO_0043541) (UDP-N-acetylglucosamine transferase complex), [GO:0000414](http://purl.obolibrary.org/obo/GO_0000414) (regulation of histone H3-K36 methylation), [GO:0043542](http://purl.obolibrary.org/obo/GO_0043542) (endothelial cell migration), [GO:0043547](http://purl.obolibrary.org/obo/GO_0043547) (positive regulation of GTPase activity), [GO:0044878](http://purl.obolibrary.org/obo/GO_0044878) (mitotic cytokinesis checkpoint), [GO:0001750](http://purl.obolibrary.org/obo/GO_0001750) (photoreceptor outer segment), [GO:0043546](http://purl.obolibrary.org/obo/GO_0043546) (molybdopterin cofactor binding), [GO:0044877](http://purl.obolibrary.org/obo/GO_0044877) (macromolecular complex binding), [GO:0001740](http://purl.obolibrary.org/obo/GO_0001740) (Barr body), [GO:0001741](http://purl.obolibrary.org/obo/GO_0001741) (XY body), [GO:0001743](http://purl.obolibrary.org/obo/GO_0001743) (optic placode formation), [GO:0043550](http://purl.obolibrary.org/obo/GO_0043550) (regulation of lipid kinase activity), [GO:0043552](http://purl.obolibrary.org/obo/GO_0043552) (positive regulation of phosphatidylinositol 3-kinase activity), [GO:0042220](http://purl.obolibrary.org/obo/GO_0042220) (response to cocaine), [GO:0043551](http://purl.obolibrary.org/obo/GO_0043551) (regulation of phosphatidylinositol 3-kinase activity), [GO:0043553](http://purl.obolibrary.org/obo/GO_0043553) (negative regulation of phosphatidylinositol 3-kinase activity), [GO:0000423](http://purl.obolibrary.org/obo/GO_0000423) (mitophagy), [GO:0000422](http://purl.obolibrary.org/obo/GO_0000422) (autophagy of mitochondrion), [GO:0000421](http://purl.obolibrary.org/obo/GO_0000421) (autophagosome membrane), [GO:0072097](http://purl.obolibrary.org/obo/GO_0072097) (negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway), [GO:0001754](http://purl.obolibrary.org/obo/GO_0001754) (eye photoreceptor cell differentiation), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0001756](http://purl.obolibrary.org/obo/GO_0001756) (somitogenesis), [GO:0001757](http://purl.obolibrary.org/obo/GO_0001757) (somite specification), [GO:0043560](http://purl.obolibrary.org/obo/GO_0043560) (insulin receptor substrate binding), [GO:0001758](http://purl.obolibrary.org/obo/GO_0001758) (retinal dehydrogenase activity), [GO:0001759](http://purl.obolibrary.org/obo/GO_0001759) (organ induction), [GO:0030297](http://purl.obolibrary.org/obo/GO_0030297) (transmembrane receptor protein tyrosine kinase activator activity), [GO:0030296](http://purl.obolibrary.org/obo/GO_0030296) (protein tyrosine kinase activator activity), [GO:0030291](http://purl.obolibrary.org/obo/GO_0030291) (protein serine/threonine kinase inhibitor activity), [GO:0030295](http://purl.obolibrary.org/obo/GO_0030295) (protein kinase activator activity), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0043567](http://purl.obolibrary.org/obo/GO_0043567) (regulation of insulin-like growth factor receptor signaling pathway), [GO:0043569](http://purl.obolibrary.org/obo/GO_0043569) (negative regulation of insulin-like growth factor receptor signaling pathway), [GO:0043568](http://purl.obolibrary.org/obo/GO_0043568) (positive regulation of insulin-like growth factor receptor signaling pathway), [GO:0097386](http://purl.obolibrary.org/obo/GO_0097386) (glial cell projection), [GO:0043570](http://purl.obolibrary.org/obo/GO_0043570) (maintenance of DNA repeat elements), [GO:0001725](http://purl.obolibrary.org/obo/GO_0001725) (stress fiber), [GO:0001726](http://purl.obolibrary.org/obo/GO_0001726) (ruffle), [GO:0030286](http://purl.obolibrary.org/obo/GO_0030286) (dynein complex), [GO:0001727](http://purl.obolibrary.org/obo/GO_0001727) (lipid kinase activity), [GO:0030285](http://purl.obolibrary.org/obo/GO_0030285) (integral component of synaptic vesicle membrane), [GO:0001729](http://purl.obolibrary.org/obo/GO_0001729) (ceramide kinase activity), [GO:0030282](http://purl.obolibrary.org/obo/GO_0030282) (bone mineralization), [GO:0000407](http://purl.obolibrary.org/obo/GO_0000407) (phagophore assembly site), [GO:0030284](http://purl.obolibrary.org/obo/GO_0030284) (estrogen receptor activity), [GO:0030283](http://purl.obolibrary.org/obo/GO_0030283) (testosterone dehydrogenase [NAD(P)] activity), [GO:0000406](http://purl.obolibrary.org/obo/GO_0000406) (double-strand/single-strand DNA junction binding), [GO:0000405](http://purl.obolibrary.org/obo/GO_0000405) (bubble DNA binding), [GO:0000404](http://purl.obolibrary.org/obo/GO_0000404) (heteroduplex DNA loop binding), [GO:0043576](http://purl.obolibrary.org/obo/GO_0043576) (regulation of respiratory gaseous exchange), [GO:0000403](http://purl.obolibrary.org/obo/GO_0000403) (Y-form DNA binding), [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration), [GO:0043577](http://purl.obolibrary.org/obo/GO_0043577) (chemotropism), [GO:0000400](http://purl.obolibrary.org/obo/GO_0000400) (four-way junction DNA binding), [GO:0043583](http://purl.obolibrary.org/obo/GO_0043583) (ear development), [GO:0001736](http://purl.obolibrary.org/obo/GO_0001736) (establishment of planar polarity), [GO:0030275](http://purl.obolibrary.org/obo/GO_0030275) (LRR domain binding), [GO:0001738](http://purl.obolibrary.org/obo/GO_0001738) (morphogenesis of a polarized epithelium), [GO:0030277](http://purl.obolibrary.org/obo/GO_0030277) (maintenance of gastrointestinal epithelium), [GO:0001739](http://purl.obolibrary.org/obo/GO_0001739) (sex chromatin), [GO:0030276](http://purl.obolibrary.org/obo/GO_0030276) (clathrin binding), [GO:0030279](http://purl.obolibrary.org/obo/GO_0030279) (negative regulation of ossification), [GO:0030278](http://purl.obolibrary.org/obo/GO_0030278) (regulation of ossification), [GO:0050718](http://purl.obolibrary.org/obo/GO_0050718) (positive regulation of interleukin-1 beta secretion), [GO:1903800](http://purl.obolibrary.org/obo/GO_1903800) (positive regulation of production of miRNAs involved in gene silencing by miRNA), [GO:0000454](http://purl.obolibrary.org/obo/GO_0000454) (snoRNA guided rRNA pseudouridine synthesis), [GO:0000463](http://purl.obolibrary.org/obo/GO_0000463) (maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0001784](http://purl.obolibrary.org/obo/GO_0001784) (phosphotyrosine residue binding), [GO:0000462](http://purl.obolibrary.org/obo/GO_0000462) (maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0001786](http://purl.obolibrary.org/obo/GO_0001786) (phosphatidylserine binding), [GO:0000460](http://purl.obolibrary.org/obo/GO_0000460) (maturation of 5.8S rRNA), [GO:0050715](http://purl.obolibrary.org/obo/GO_0050715) (positive regulation of cytokine secretion), [GO:0050713](http://purl.obolibrary.org/obo/GO_0050713) (negative regulation of interleukin-1 beta secretion), [GO:0050714](http://purl.obolibrary.org/obo/GO_0050714) (positive regulation of protein secretion), [GO:0050728](http://purl.obolibrary.org/obo/GO_0050728) (negative regulation of inflammatory response), [GO:0050729](http://purl.obolibrary.org/obo/GO_0050729) (positive regulation of inflammatory response), [GO:0000469](http://purl.obolibrary.org/obo/GO_0000469) (cleavage involved in rRNA processing), [GO:0000467](http://purl.obolibrary.org/obo/GO_0000467) (exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0048406](http://purl.obolibrary.org/obo/GO_0048406) (nerve growth factor binding), [GO:0000472](http://purl.obolibrary.org/obo/GO_0000472) (endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0000470](http://purl.obolibrary.org/obo/GO_0000470) (maturation of LSU-rRNA), [GO:0050727](http://purl.obolibrary.org/obo/GO_0050727) (regulation of inflammatory response), [GO:0000439](http://purl.obolibrary.org/obo/GO_0000439) (core TFIIH complex), [GO:0000435](http://purl.obolibrary.org/obo/GO_0000435) (positive regulation of transcription from RNA polymerase II promoter by galactose), [GO:0000433](http://purl.obolibrary.org/obo/GO_0000433) (negative regulation of transcription from RNA polymerase II promoter by glucose), [GO:0001771](http://purl.obolibrary.org/obo/GO_0001771) (immunological synapse formation), [GO:0001772](http://purl.obolibrary.org/obo/GO_0001772) (immunological synapse), [GO:1903818](http://purl.obolibrary.org/obo/GO_1903818) (positive regulation of voltage-gated potassium channel activity), [GO:0050730](http://purl.obolibrary.org/obo/GO_0050730) (regulation of peptidyl-tyrosine phosphorylation), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0000448](http://purl.obolibrary.org/obo/GO_0000448) (cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:1903833](http://purl.obolibrary.org/obo/GO_1903833) (positive regulation of cellular response to amino acid starvation), [GO:0000447](http://purl.obolibrary.org/obo/GO_0000447) (endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0000446](http://purl.obolibrary.org/obo/GO_0000446) (nucleoplasmic THO complex), [GO:0001780](http://purl.obolibrary.org/obo/GO_0001780) (neutrophil homeostasis), [GO:0000445](http://purl.obolibrary.org/obo/GO_0000445) (THO complex part of transcription export complex), [GO:0001781](http://purl.obolibrary.org/obo/GO_0001781) (neutrophil apoptotic process), [GO:0001782](http://purl.obolibrary.org/obo/GO_0001782) (B cell homeostasis), [GO:0001774](http://purl.obolibrary.org/obo/GO_0001774) (microglial cell activation), [GO:0001775](http://purl.obolibrary.org/obo/GO_0001775) (cell activation), [GO:1903827](http://purl.obolibrary.org/obo/GO_1903827) (regulation of cellular protein localization), [GO:1903828](http://purl.obolibrary.org/obo/GO_1903828) (negative regulation of cellular protein localization), [GO:0001778](http://purl.obolibrary.org/obo/GO_0001778) (plasma membrane repair), [GO:0001779](http://purl.obolibrary.org/obo/GO_0001779) (natural killer cell differentiation), [GO:0036455](http://purl.obolibrary.org/obo/GO_0036455) (iron-sulfur transferase activity), [GO:0042297](http://purl.obolibrary.org/obo/GO_0042297) (vocal learning), [GO:0035118](http://purl.obolibrary.org/obo/GO_0035118) (embryonic pectoral fin morphogenesis), [GO:0036449](http://purl.obolibrary.org/obo/GO_0036449) (microtubule minus-end), [GO:0035115](http://purl.obolibrary.org/obo/GO_0035115) (embryonic forelimb morphogenesis), [GO:0035116](http://purl.obolibrary.org/obo/GO_0035116) (embryonic hindlimb morphogenesis), [GO:0036444](http://purl.obolibrary.org/obo/GO_0036444) (mitochondrial calcium uptake), [GO:0036438](http://purl.obolibrary.org/obo/GO_0036438) (maintenance of lens transparency), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0036435](http://purl.obolibrary.org/obo/GO_0036435) (K48-linked polyubiquitin modification-dependent protein binding), [GO:2000203](http://purl.obolibrary.org/obo/GO_2000203) (regulation of ribosomal large subunit export from nucleus), [GO:0035106](http://purl.obolibrary.org/obo/GO_0035106) (operant conditioning), [GO:0035102](http://purl.obolibrary.org/obo/GO_0035102) (PRC1 complex), [GO:0000478](http://purl.obolibrary.org/obo/GO_0000478) (endonucleolytic cleavage involved in rRNA processing), [GO:0000480](http://purl.obolibrary.org/obo/GO_0000480) (endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:2000212](http://purl.obolibrary.org/obo/GO_2000212) (negative regulation of glutamate metabolic process), [GO:2000210](http://purl.obolibrary.org/obo/GO_2000210) (positive regulation of anoikis), [GO:0050708](http://purl.obolibrary.org/obo/GO_0050708) (regulation of protein secretion), [GO:0050709](http://purl.obolibrary.org/obo/GO_0050709) (negative regulation of protein secretion), [GO:0050707](http://purl.obolibrary.org/obo/GO_0050707) (regulation of cytokine secretion), [GO:0000495](http://purl.obolibrary.org/obo/GO_0000495) (box H/ACA snoRNA 3'-end processing), [GO:0000492](http://purl.obolibrary.org/obo/GO_0000492) (box C/D snoRNP assembly), [GO:2000223](http://purl.obolibrary.org/obo/GO_2000223) (regulation of BMP signaling pathway involved in heart jogging), [GO:2000222](http://purl.obolibrary.org/obo/GO_2000222) (positive regulation of pseudohyphal growth), [GO:2000221](http://purl.obolibrary.org/obo/GO_2000221) (negative regulation of pseudohyphal growth), [GO:0050700](http://purl.obolibrary.org/obo/GO_0050700) (CARD domain binding), [GO:0050701](http://purl.obolibrary.org/obo/GO_0050701) (interleukin-1 secretion), [GO:2000224](http://purl.obolibrary.org/obo/GO_2000224) (regulation of testosterone biosynthetic process), [GO:0060242](http://purl.obolibrary.org/obo/GO_0060242) (contact inhibition), [GO:0061576](http://purl.obolibrary.org/obo/GO_0061576) (acyl-CoA ceramide synthase complex), [GO:0035282](http://purl.obolibrary.org/obo/GO_0035282) (segmentation), [GO:1903763](http://purl.obolibrary.org/obo/GO_1903763) (gap junction channel activity involved in cell communication by electrical coupling), [GO:0035284](http://purl.obolibrary.org/obo/GO_0035284) (brain segmentation), [GO:1902430](http://purl.obolibrary.org/obo/GO_1902430) (negative regulation of amyloid-beta formation), [GO:0035280](http://purl.obolibrary.org/obo/GO_0035280) (miRNA loading onto RISC involved in gene silencing by miRNA), [GO:0061578](http://purl.obolibrary.org/obo/GO_0061578) (Lys63-specific deubiquitinase activity), [GO:0060249](http://purl.obolibrary.org/obo/GO_0060249) (anatomical structure homeostasis), [GO:0006720](http://purl.obolibrary.org/obo/GO_0006720) (isoprenoid metabolic process), [GO:0006714](http://purl.obolibrary.org/obo/GO_0006714) (sesquiterpenoid metabolic process), [GO:0098850](http://purl.obolibrary.org/obo/GO_0098850) (extrinsic component of synaptic vesicle membrane), [GO:0098855](http://purl.obolibrary.org/obo/GO_0098855) (HCN channel complex), [GO:0072223](http://purl.obolibrary.org/obo/GO_0072223) (metanephric glomerular mesangium development), [GO:0072221](http://purl.obolibrary.org/obo/GO_0072221) (metanephric distal convoluted tubule development), [GO:0097526](http://purl.obolibrary.org/obo/GO_0097526) (spliceosomal tri-snRNP complex), [GO:0097525](http://purl.obolibrary.org/obo/GO_0097525) (spliceosomal snRNP complex), [GO:0097527](http://purl.obolibrary.org/obo/GO_0097527) (necroptotic signaling pathway), [GO:0060231](http://purl.obolibrary.org/obo/GO_0060231) (mesenchymal to epithelial transition), [GO:0035276](http://purl.obolibrary.org/obo/GO_0035276) (ethanol binding), [GO:0061564](http://purl.obolibrary.org/obo/GO_0061564) (axon development), [GO:2000010](http://purl.obolibrary.org/obo/GO_2000010) (positive regulation of protein localization to cell surface), [GO:1902443](http://purl.obolibrary.org/obo/GO_1902443) (negative regulation of ripoptosome assembly involved in necroptotic process), [GO:0035270](http://purl.obolibrary.org/obo/GO_0035270) (endocrine system development), [GO:0060235](http://purl.obolibrary.org/obo/GO_0060235) (lens induction in camera-type eye), [GO:0060236](http://purl.obolibrary.org/obo/GO_0060236) (regulation of mitotic spindle organization), [GO:0006730](http://purl.obolibrary.org/obo/GO_0006730) (one-carbon metabolic process), [GO:0060237](http://purl.obolibrary.org/obo/GO_0060237) (regulation of fungal-type cell wall organization), [GO:0006725](http://purl.obolibrary.org/obo/GO_0006725) (cellular aromatic compound metabolic process), [GO:2000008](http://purl.obolibrary.org/obo/GO_2000008) (regulation of protein localization to cell surface), [GO:0006729](http://purl.obolibrary.org/obo/GO_0006729) (tetrahydrobiopterin biosynthetic process), [GO:0097535](http://purl.obolibrary.org/obo/GO_0097535) (lymphoid lineage cell migration into thymus), [GO:0072210](http://purl.obolibrary.org/obo/GO_0072210) (metanephric nephron development), [GO:0098869](http://purl.obolibrary.org/obo/GO_0098869) (cellular oxidant detoxification), [GO:2000001](http://purl.obolibrary.org/obo/GO_2000001) (regulation of DNA damage checkpoint), [GO:0097539](http://purl.obolibrary.org/obo/GO_0097539) (ciliary transition fiber), [GO:0098868](http://purl.obolibrary.org/obo/GO_0098868) (bone growth), [GO:2000007](http://purl.obolibrary.org/obo/GO_2000007) (negative regulation of metanephric comma-shaped body morphogenesis), [GO:0035268](http://purl.obolibrary.org/obo/GO_0035268) (protein mannosylation), [GO:0035269](http://purl.obolibrary.org/obo/GO_0035269) (protein O-linked mannosylation), [GO:2000005](http://purl.obolibrary.org/obo/GO_2000005) (negative regulation of metanephric S-shaped body morphogenesis), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0035265](http://purl.obolibrary.org/obo/GO_0035265) (organ growth), [GO:0061598](http://purl.obolibrary.org/obo/GO_0061598) (molybdopterin adenylyltransferase activity), [GO:0035267](http://purl.obolibrary.org/obo/GO_0035267) (NuA4 histone acetyltransferase complex), [GO:0061591](http://purl.obolibrary.org/obo/GO_0061591) (calcium activated galactosylceramide scrambling), [GO:0035261](http://purl.obolibrary.org/obo/GO_0035261) (external genitalia morphogenesis), [GO:0061599](http://purl.obolibrary.org/obo/GO_0061599) (molybdopterin molybdotransferase activity), [GO:1902459](http://purl.obolibrary.org/obo/GO_1902459) (positive regulation of stem cell population maintenance), [GO:2000019](http://purl.obolibrary.org/obo/GO_2000019) (negative regulation of male gonad development), [GO:0097500](http://purl.obolibrary.org/obo/GO_0097500) (receptor localization to non-motile cilium), [GO:0097502](http://purl.obolibrary.org/obo/GO_0097502) (mannosylation), [GO:0098830](http://purl.obolibrary.org/obo/GO_0098830) (presynaptic endosome), [GO:0098831](http://purl.obolibrary.org/obo/GO_0098831) (presynaptic active zone cytoplasmic component), [GO:0097504](http://purl.obolibrary.org/obo/GO_0097504) (Gemini of coiled bodies), [GO:0047293](http://purl.obolibrary.org/obo/GO_0047293) (4-hydroxybenzoate nonaprenyltransferase activity), [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding), [GO:0035258](http://purl.obolibrary.org/obo/GO_0035258) (steroid hormone receptor binding), [GO:0035259](http://purl.obolibrary.org/obo/GO_0035259) (glucocorticoid receptor binding), [GO:0047291](http://purl.obolibrary.org/obo/GO_0047291) (lactosylceramide alpha-2,3-sialyltransferase activity), [GO:0098839](http://purl.obolibrary.org/obo/GO_0098839) (postsynaptic density membrane), [GO:0035253](http://purl.obolibrary.org/obo/GO_0035253) (ciliary rootlet), [GO:0060253](http://purl.obolibrary.org/obo/GO_0060253) (negative regulation of glial cell proliferation), [GO:0035254](http://purl.obolibrary.org/obo/GO_0035254) (glutamate receptor binding), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0035256](http://purl.obolibrary.org/obo/GO_0035256) (G-protein coupled glutamate receptor binding), [GO:0061580](http://purl.obolibrary.org/obo/GO_0061580) (colon epithelial cell migration), [GO:0035250](http://purl.obolibrary.org/obo/GO_0035250) (UDP-galactosyltransferase activity), [GO:1902462](http://purl.obolibrary.org/obo/GO_1902462) (positive regulation of mesenchymal stem cell proliferation), [GO:0061582](http://purl.obolibrary.org/obo/GO_0061582) (intestinal epithelial cell migration), [GO:1903793](http://purl.obolibrary.org/obo/GO_1903793) (positive regulation of anion transport), [GO:0035251](http://purl.obolibrary.org/obo/GO_0035251) (UDP-glucosyltransferase activity), [GO:0060251](http://purl.obolibrary.org/obo/GO_0060251) (regulation of glial cell proliferation), [GO:0060252](http://purl.obolibrary.org/obo/GO_0060252) (positive regulation of glial cell proliferation), [GO:0035252](http://purl.obolibrary.org/obo/GO_0035252) (UDP-xylosyltransferase activity), [GO:1903799](http://purl.obolibrary.org/obo/GO_1903799) (negative regulation of production of miRNAs involved in gene silencing by miRNA), [GO:1901135](http://purl.obolibrary.org/obo/GO_1901135) (carbohydrate derivative metabolic process), [GO:1901137](http://purl.obolibrary.org/obo/GO_1901137) (carbohydrate derivative biosynthetic process), [GO:0061588](http://purl.obolibrary.org/obo/GO_0061588) (calcium activated phospholipid scrambling), [GO:0060259](http://purl.obolibrary.org/obo/GO_0060259) (regulation of feeding behavior), [GO:0098840](http://purl.obolibrary.org/obo/GO_0098840) (protein transport along microtubule), [GO:0006701](http://purl.obolibrary.org/obo/GO_0006701) (progesterone biosynthetic process), [GO:0006707](http://purl.obolibrary.org/obo/GO_0006707) (cholesterol catabolic process), [GO:0097512](http://purl.obolibrary.org/obo/GO_0097512) (cardiac myofibril), [GO:0006709](http://purl.obolibrary.org/obo/GO_0006709) (progesterone catabolic process), [GO:0061590](http://purl.obolibrary.org/obo/GO_0061590) (calcium activated phosphatidylcholine scrambling), [GO:0035246](http://purl.obolibrary.org/obo/GO_0035246) (peptidyl-arginine N-methylation), [GO:2000027](http://purl.obolibrary.org/obo/GO_2000027) (regulation of organ morphogenesis), [GO:0035249](http://purl.obolibrary.org/obo/GO_0035249) (synaptic transmission, glutamatergic), [GO:2000026](http://purl.obolibrary.org/obo/GO_2000026) (regulation of multicellular organismal development), [GO:2000042](http://purl.obolibrary.org/obo/GO_2000042) (negative regulation of double-strand break repair via homologous recombination), [GO:0061537](http://purl.obolibrary.org/obo/GO_0061537) (glycine secretion, neurotransmission), [GO:0048557](http://purl.obolibrary.org/obo/GO_0048557) (embryonic digestive tract morphogenesis), [GO:1903721](http://purl.obolibrary.org/obo/GO_1903721) (positive regulation of I-kappaB phosphorylation), [GO:0006760](http://purl.obolibrary.org/obo/GO_0006760) (folic acid-containing compound metabolic process), [GO:0004102](http://purl.obolibrary.org/obo/GO_0004102) (choline O-acetyltransferase activity), [GO:0061534](http://purl.obolibrary.org/obo/GO_0061534) (gamma-aminobutyric acid secretion, neurotransmission), [GO:0061535](http://purl.obolibrary.org/obo/GO_0061535) (glutamate secretion, neurotransmission), [GO:0004103](http://purl.obolibrary.org/obo/GO_0004103) (choline kinase activity), [GO:0060205](http://purl.obolibrary.org/obo/GO_0060205) (cytoplasmic vesicle lumen), [GO:0050872](http://purl.obolibrary.org/obo/GO_0050872) (white fat cell differentiation), [GO:0048562](http://purl.obolibrary.org/obo/GO_0048562) (embryonic organ morphogenesis), [GO:0050873](http://purl.obolibrary.org/obo/GO_0050873) (brown fat cell differentiation), [GO:0050870](http://purl.obolibrary.org/obo/GO_0050870) (positive regulation of T cell activation), [GO:0048560](http://purl.obolibrary.org/obo/GO_0048560) (establishment of anatomical structure orientation), [GO:0050871](http://purl.obolibrary.org/obo/GO_0050871) (positive regulation of B cell activation), [GO:0048566](http://purl.obolibrary.org/obo/GO_0048566) (embryonic digestive tract development), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0048563](http://purl.obolibrary.org/obo/GO_0048563) (post-embryonic animal organ morphogenesis), [GO:0098815](http://purl.obolibrary.org/obo/GO_0098815) (modulation of excitatory postsynaptic potential), [GO:0050878](http://purl.obolibrary.org/obo/GO_0050878) (regulation of body fluid levels), [GO:0050877](http://purl.obolibrary.org/obo/GO_0050877) (nervous system process), [GO:2000050](http://purl.obolibrary.org/obo/GO_2000050) (regulation of non-canonical Wnt signaling pathway), [GO:2000052](http://purl.obolibrary.org/obo/GO_2000052) (positive regulation of non-canonical Wnt signaling pathway), [GO:2000051](http://purl.obolibrary.org/obo/GO_2000051) (negative regulation of non-canonical Wnt signaling pathway), [GO:0047238](http://purl.obolibrary.org/obo/GO_0047238) (glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity), [GO:0048568](http://purl.obolibrary.org/obo/GO_0048568) (embryonic organ development), [GO:0006776](http://purl.obolibrary.org/obo/GO_0006776) (vitamin A metabolic process), [GO:0006777](http://purl.obolibrary.org/obo/GO_0006777) (Mo-molybdopterin cofactor biosynthetic process), [GO:0004112](http://purl.obolibrary.org/obo/GO_0004112) (cyclic-nucleotide phosphodiesterase activity), [GO:0004115](http://purl.obolibrary.org/obo/GO_0004115) (3',5'-cyclic-AMP phosphodiesterase activity), [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity), [GO:0061525](http://purl.obolibrary.org/obo/GO_0061525) (hindgut development), [GO:0050883](http://purl.obolibrary.org/obo/GO_0050883) (musculoskeletal movement, spinal reflex action), [GO:0050884](http://purl.obolibrary.org/obo/GO_0050884) (neuromuscular process controlling posture), [GO:0050881](http://purl.obolibrary.org/obo/GO_0050881) (musculoskeletal movement), [GO:0006768](http://purl.obolibrary.org/obo/GO_0006768) (biotin metabolic process), [GO:0048570](http://purl.obolibrary.org/obo/GO_0048570) (notochord morphogenesis), [GO:0050882](http://purl.obolibrary.org/obo/GO_0050882) (voluntary musculoskeletal movement), [GO:0031702](http://purl.obolibrary.org/obo/GO_0031702) (type 1 angiotensin receptor binding), [GO:0050880](http://purl.obolibrary.org/obo/GO_0050880) (regulation of blood vessel size), [GO:0031708](http://purl.obolibrary.org/obo/GO_0031708) (endothelin B receptor binding), [GO:0004109](http://purl.obolibrary.org/obo/GO_0004109) (coproporphyrinogen oxidase activity), [GO:2000047](http://purl.obolibrary.org/obo/GO_2000047) (regulation of cell-cell adhesion mediated by cadherin), [GO:0098826](http://purl.obolibrary.org/obo/GO_0098826) (endoplasmic reticulum tubular network membrane), [GO:0050885](http://purl.obolibrary.org/obo/GO_0050885) (neuromuscular process controlling balance), [GO:2000048](http://purl.obolibrary.org/obo/GO_2000048) (negative regulation of cell-cell adhesion mediated by cadherin), [GO:0061551](http://purl.obolibrary.org/obo/GO_0061551) (trigeminal ganglion development), [GO:2000060](http://purl.obolibrary.org/obo/GO_2000060) (positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0060221](http://purl.obolibrary.org/obo/GO_0060221) (retinal rod cell differentiation), [GO:2000063](http://purl.obolibrary.org/obo/GO_2000063) (positive regulation of ureter smooth muscle cell differentiation), [GO:2000062](http://purl.obolibrary.org/obo/GO_2000062) (negative regulation of ureter smooth muscle cell differentiation), [GO:0061550](http://purl.obolibrary.org/obo/GO_0061550) (cranial ganglion development), [GO:0060228](http://purl.obolibrary.org/obo/GO_0060228) (phosphatidylcholine-sterol O-acyltransferase activator activity), [GO:0090076](http://purl.obolibrary.org/obo/GO_0090076) (relaxation of skeletal muscle), [GO:0090074](http://purl.obolibrary.org/obo/GO_0090074) (negative regulation of protein homodimerization activity), [GO:0006744](http://purl.obolibrary.org/obo/GO_0006744) (ubiquinone biosynthetic process), [GO:0090073](http://purl.obolibrary.org/obo/GO_0090073) (positive regulation of protein homodimerization activity), [GO:0006741](http://purl.obolibrary.org/obo/GO_0006741) (NADP biosynthetic process), [GO:0090071](http://purl.obolibrary.org/obo/GO_0090071) (negative regulation of ribosome biogenesis), [GO:0090080](http://purl.obolibrary.org/obo/GO_0090080) (positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway), [GO:0006734](http://purl.obolibrary.org/obo/GO_0006734) (NADH metabolic process), [GO:0050893](http://purl.obolibrary.org/obo/GO_0050893) (sensory processing), [GO:0050890](http://purl.obolibrary.org/obo/GO_0050890) (cognition), [GO:0072200](http://purl.obolibrary.org/obo/GO_0072200) (negative regulation of mesenchymal cell proliferation involved in ureter development), [GO:2000058](http://purl.obolibrary.org/obo/GO_2000058) (regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0072205](http://purl.obolibrary.org/obo/GO_0072205) (metanephric collecting duct development), [GO:0072203](http://purl.obolibrary.org/obo/GO_0072203) (cell proliferation involved in metanephros development), [GO:0050896](http://purl.obolibrary.org/obo/GO_0050896) (response to stimulus), [GO:0050897](http://purl.obolibrary.org/obo/GO_0050897) (cobalt ion binding), [GO:2000059](http://purl.obolibrary.org/obo/GO_2000059) (negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0072207](http://purl.obolibrary.org/obo/GO_0072207) (metanephric epithelium development), [GO:0060211](http://purl.obolibrary.org/obo/GO_0060211) (regulation of nuclear-transcribed mRNA poly(A) tail shortening), [GO:0035295](http://purl.obolibrary.org/obo/GO_0035295) (tube development), [GO:0060218](http://purl.obolibrary.org/obo/GO_0060218) (hematopoietic stem cell differentiation), [GO:0061549](http://purl.obolibrary.org/obo/GO_0061549) (sympathetic ganglion development), [GO:0060219](http://purl.obolibrary.org/obo/GO_0060219) (camera-type eye photoreceptor cell differentiation), [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth), [GO:0090086](http://purl.obolibrary.org/obo/GO_0090086) (negative regulation of protein deubiquitination), [GO:0006754](http://purl.obolibrary.org/obo/GO_0006754) (ATP biosynthetic process), [GO:0090083](http://purl.obolibrary.org/obo/GO_0090083) (regulation of inclusion body assembly), [GO:0090084](http://purl.obolibrary.org/obo/GO_0090084) (negative regulation of inclusion body assembly), [GO:0060214](http://purl.obolibrary.org/obo/GO_0060214) (endocardium formation), [GO:0060215](http://purl.obolibrary.org/obo/GO_0060215) (primitive hemopoiesis), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:1903758](http://purl.obolibrary.org/obo/GO_1903758) (negative regulation of transcription from RNA polymerase II promoter by histone modification), [GO:0090090](http://purl.obolibrary.org/obo/GO_0090090) (negative regulation of canonical Wnt signaling pathway), [GO:0006747](http://purl.obolibrary.org/obo/GO_0006747) (FAD biosynthetic process), [GO:0048593](http://purl.obolibrary.org/obo/GO_0048593) (camera-type eye morphogenesis), [GO:0048592](http://purl.obolibrary.org/obo/GO_0048592) (eye morphogenesis), [GO:0048599](http://purl.obolibrary.org/obo/GO_0048599) (oocyte development), [GO:0048598](http://purl.obolibrary.org/obo/GO_0048598) (embryonic morphogenesis), [GO:0006749](http://purl.obolibrary.org/obo/GO_0006749) (glutathione metabolic process), [GO:0048596](http://purl.obolibrary.org/obo/GO_0048596) (embryonic camera-type eye morphogenesis), [GO:0042415](http://purl.obolibrary.org/obo/GO_0042415) (norepinephrine metabolic process), [GO:0042416](http://purl.obolibrary.org/obo/GO_0042416) (dopamine biosynthetic process), [GO:0042417](http://purl.obolibrary.org/obo/GO_0042417) (dopamine metabolic process), [GO:1901184](http://purl.obolibrary.org/obo/GO_1901184) (regulation of ERBB signaling pathway), [GO:0042418](http://purl.obolibrary.org/obo/GO_0042418) (epinephrine biosynthetic process), [GO:0004140](http://purl.obolibrary.org/obo/GO_0004140) (dephospho-CoA kinase activity), [GO:0005471](http://purl.obolibrary.org/obo/GO_0005471) (ATP:ADP antiporter activity), [GO:0004143](http://purl.obolibrary.org/obo/GO_0004143) (diacylglycerol kinase activity), [GO:0004146](http://purl.obolibrary.org/obo/GO_0004146) (dihydrofolate reductase activity), [GO:0004145](http://purl.obolibrary.org/obo/GO_0004145) (diamine N-acetyltransferase activity), [GO:0004148](http://purl.obolibrary.org/obo/GO_0004148) (dihydrolipoyl dehydrogenase activity), [GO:0042414](http://purl.obolibrary.org/obo/GO_0042414) (epinephrine metabolic process), [GO:0030426](http://purl.obolibrary.org/obo/GO_0030426) (growth cone), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0004138](http://purl.obolibrary.org/obo/GO_0004138) (deoxyguanosine kinase activity), [GO:0030427](http://purl.obolibrary.org/obo/GO_0030427) (site of polarized growth), [GO:0030429](http://purl.obolibrary.org/obo/GO_0030429) (kynureninase activity), [GO:0016132](http://purl.obolibrary.org/obo/GO_0016132) (brassinosteroid biosynthetic process), [GO:0030422](http://purl.obolibrary.org/obo/GO_0030422) (production of siRNA involved in RNA interference), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0030423](http://purl.obolibrary.org/obo/GO_0030423) (targeting of mRNA for destruction involved in RNA interference), [GO:0042427](http://purl.obolibrary.org/obo/GO_0042427) (serotonin biosynthetic process), [GO:0042428](http://purl.obolibrary.org/obo/GO_0042428) (serotonin metabolic process), [GO:2000096](http://purl.obolibrary.org/obo/GO_2000096) (positive regulation of Wnt signaling pathway, planar cell polarity pathway), [GO:0004151](http://purl.obolibrary.org/obo/GO_0004151) (dihydroorotase activity), [GO:2000095](http://purl.obolibrary.org/obo/GO_2000095) (regulation of Wnt signaling pathway, planar cell polarity pathway), [GO:0005484](http://purl.obolibrary.org/obo/GO_0005484) (SNAP receptor activity), [GO:0004152](http://purl.obolibrary.org/obo/GO_0004152) (dihydroorotate dehydrogenase activity), [GO:0042420](http://purl.obolibrary.org/obo/GO_0042420) (dopamine catabolic process), [GO:0004155](http://purl.obolibrary.org/obo/GO_0004155) (6,7-dihydropteridine reductase activity), [GO:0042421](http://purl.obolibrary.org/obo/GO_0042421) (norepinephrine biosynthetic process), [GO:0005487](http://purl.obolibrary.org/obo/GO_0005487) (nuclear pore activity), [GO:0042423](http://purl.obolibrary.org/obo/GO_0042423) (catecholamine biosynthetic process), [GO:0042424](http://purl.obolibrary.org/obo/GO_0042424) (catecholamine catabolic process), [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0031749](http://purl.obolibrary.org/obo/GO_0031749) (D2 dopamine receptor binding), [GO:0016125](http://purl.obolibrary.org/obo/GO_0016125) (sterol metabolic process), [GO:0016126](http://purl.obolibrary.org/obo/GO_0016126) (sterol biosynthetic process), [GO:0042438](http://purl.obolibrary.org/obo/GO_0042438) (melanin biosynthetic process), [GO:0006783](http://purl.obolibrary.org/obo/GO_0006783) (heme biosynthetic process), [GO:0006784](http://purl.obolibrary.org/obo/GO_0006784) (heme a biosynthetic process), [GO:0004122](http://purl.obolibrary.org/obo/GO_0004122) (cystathionine beta-synthase activity), [GO:0006782](http://purl.obolibrary.org/obo/GO_0006782) (protoporphyrinogen IX biosynthetic process), [GO:0005452](http://purl.obolibrary.org/obo/GO_0005452) (inorganic anion exchanger activity), [GO:0097584](http://purl.obolibrary.org/obo/GO_0097584) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt5p-Pmt2p dimer complex), [GO:0097583](http://purl.obolibrary.org/obo/GO_0097583) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt1p-Pmt3p dimer complex), [GO:0097586](http://purl.obolibrary.org/obo/GO_0097586) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt4p homodimer complex), [GO:0006778](http://purl.obolibrary.org/obo/GO_0006778) (porphyrin-containing compound metabolic process), [GO:0006779](http://purl.obolibrary.org/obo/GO_0006779) (porphyrin-containing compound biosynthetic process), [GO:0004118](http://purl.obolibrary.org/obo/GO_0004118) (cGMP-stimulated cyclic-nucleotide phosphodiesterase activity), [GO:0097585](http://purl.obolibrary.org/obo/GO_0097585) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt5p-Pmt3p dimer complex), [GO:0097587](http://purl.obolibrary.org/obo/GO_0097587) (MutLgamma complex), [GO:0042448](http://purl.obolibrary.org/obo/GO_0042448) (progesterone metabolic process), [GO:0006790](http://purl.obolibrary.org/obo/GO_0006790) (sulfur compound metabolic process), [GO:0042443](http://purl.obolibrary.org/obo/GO_0042443) (phenylethylamine metabolic process), [GO:0006798](http://purl.obolibrary.org/obo/GO_0006798) (polyphosphate catabolic process), [GO:0042445](http://purl.obolibrary.org/obo/GO_0042445) (hormone metabolic process), [GO:0004137](http://purl.obolibrary.org/obo/GO_0004137) (deoxycytidine kinase activity), [GO:0006796](http://purl.obolibrary.org/obo/GO_0006796) (phosphate-containing compound metabolic process), [GO:0042446](http://purl.obolibrary.org/obo/GO_0042446) (hormone biosynthetic process), [GO:0006797](http://purl.obolibrary.org/obo/GO_0006797) (polyphosphate metabolic process), [GO:0005459](http://purl.obolibrary.org/obo/GO_0005459) (UDP-galactose transmembrane transporter activity), [GO:0004129](http://purl.obolibrary.org/obo/GO_0004129) (cytochrome-c oxidase activity), [GO:0097598](http://purl.obolibrary.org/obo/GO_0097598) (sperm cytoplasmic droplet), [GO:0031727](http://purl.obolibrary.org/obo/GO_0031727) (CCR2 chemokine receptor binding), [GO:0042450](http://purl.obolibrary.org/obo/GO_0042450) (arginine biosynthetic process via ornithine), [GO:0031721](http://purl.obolibrary.org/obo/GO_0031721) (hemoglobin alpha binding), [GO:0031722](http://purl.obolibrary.org/obo/GO_0031722) (hemoglobin beta binding), [GO:0031720](http://purl.obolibrary.org/obo/GO_0031720) (haptoglobin binding), [GO:0060287](http://purl.obolibrary.org/obo/GO_0060287) (epithelial cilium movement involved in determination of left/right asymmetry), [GO:0004180](http://purl.obolibrary.org/obo/GO_0004180) (carboxypeptidase activity), [GO:0004181](http://purl.obolibrary.org/obo/GO_0004181) (metallocarboxypeptidase activity), [GO:1902476](http://purl.obolibrary.org/obo/GO_1902476) (chloride transmembrane transport), [GO:1901142](http://purl.obolibrary.org/obo/GO_1901142) (insulin metabolic process), [GO:0004185](http://purl.obolibrary.org/obo/GO_0004185) (serine-type carboxypeptidase activity), [GO:0072264](http://purl.obolibrary.org/obo/GO_0072264) (metanephric glomerular endothelium development), [GO:0072262](http://purl.obolibrary.org/obo/GO_0072262) (metanephric glomerular mesangial cell proliferation involved in metanephros development), [GO:0016174](http://purl.obolibrary.org/obo/GO_0016174) (NAD(P)H oxidase activity), [GO:0016175](http://purl.obolibrary.org/obo/GO_0016175) (superoxide-generating NADPH oxidase activity), [GO:0016176](http://purl.obolibrary.org/obo/GO_0016176) (superoxide-generating NADPH oxidase activator activity), [GO:0060290](http://purl.obolibrary.org/obo/GO_0060290) (transdifferentiation), [GO:0060291](http://purl.obolibrary.org/obo/GO_0060291) (long-term synaptic potentiation), [GO:0060292](http://purl.obolibrary.org/obo/GO_0060292) (long term synaptic depression), [GO:0030466](http://purl.obolibrary.org/obo/GO_0030466) (chromatin silencing at silent mating-type cassette), [GO:0031798](http://purl.obolibrary.org/obo/GO_0031798) (type 1 metabotropic glutamate receptor binding), [GO:0004190](http://purl.obolibrary.org/obo/GO_0004190) (aspartic-type endopeptidase activity), [GO:0060271](http://purl.obolibrary.org/obo/GO_0060271) (cilium assembly), [GO:0060272](http://purl.obolibrary.org/obo/GO_0060272) (embryonic skeletal joint morphogenesis), [GO:0004197](http://purl.obolibrary.org/obo/GO_0004197) (cysteine-type endopeptidase activity), [GO:0004198](http://purl.obolibrary.org/obo/GO_0004198) (calcium-dependent cysteine-type endopeptidase activity), [GO:0097582](http://purl.obolibrary.org/obo/GO_0097582) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt1p-Pmt2p dimer complex), [GO:0072255](http://purl.obolibrary.org/obo/GO_0072255) (metanephric glomerular mesangial cell development), [GO:0016165](http://purl.obolibrary.org/obo/GO_0016165) (linoleate 13S-lipoxygenase activity), [GO:0001917](http://purl.obolibrary.org/obo/GO_0001917) (photoreceptor inner segment), [GO:0001918](http://purl.obolibrary.org/obo/GO_0001918) (farnesylated protein binding), [GO:0001919](http://purl.obolibrary.org/obo/GO_0001919) (regulation of receptor recycling), [GO:1902495](http://purl.obolibrary.org/obo/GO_1902495) (transmembrane transporter complex), [GO:1901166](http://purl.obolibrary.org/obo/GO_1901166) (neural crest cell migration involved in autonomic nervous system development), [GO:0005497](http://purl.obolibrary.org/obo/GO_0005497) (androgen binding), [GO:0005496](http://purl.obolibrary.org/obo/GO_0005496) (steroid binding), [GO:0004169](http://purl.obolibrary.org/obo/GO_0004169) (dolichyl-phosphate-mannose-protein mannosyltransferase activity), [GO:0030447](http://purl.obolibrary.org/obo/GO_0030447) (filamentous growth), [GO:0097542](http://purl.obolibrary.org/obo/GO_0097542) (ciliary tip), [GO:0097541](http://purl.obolibrary.org/obo/GO_0097541) (axonemal basal plate), [GO:0097544](http://purl.obolibrary.org/obo/GO_0097544) (ciliary shaft), [GO:0072289](http://purl.obolibrary.org/obo/GO_0072289) (metanephric nephron tubule formation), [GO:0097543](http://purl.obolibrary.org/obo/GO_0097543) (ciliary inversin compartment), [GO:0016151](http://purl.obolibrary.org/obo/GO_0016151) (nickel cation binding), [GO:0097546](http://purl.obolibrary.org/obo/GO_0097546) (ciliary base), [GO:0031772](http://purl.obolibrary.org/obo/GO_0031772) (type 2 hypocretin receptor binding), [GO:0016153](http://purl.obolibrary.org/obo/GO_0016153) (urocanate hydratase activity), [GO:0031771](http://purl.obolibrary.org/obo/GO_0031771) (type 1 hypocretin receptor binding), [GO:0016139](http://purl.obolibrary.org/obo/GO_0016139) (glycoside catabolic process), [GO:0060297](http://purl.obolibrary.org/obo/GO_0060297) (regulation of sarcomere organization), [GO:0042406](http://purl.obolibrary.org/obo/GO_0042406) (extrinsic component of endoplasmic reticulum membrane), [GO:0042407](http://purl.obolibrary.org/obo/GO_0042407) (cristae formation), [GO:0004170](http://purl.obolibrary.org/obo/GO_0004170) (dUTP diphosphatase activity), [GO:0060296](http://purl.obolibrary.org/obo/GO_0060296) (regulation of cilium beat frequency involved in ciliary motility), [GO:0004175](http://purl.obolibrary.org/obo/GO_0004175) (endopeptidase activity), [GO:0004174](http://purl.obolibrary.org/obo/GO_0004174) (electron-transferring-flavoprotein dehydrogenase activity), [GO:0004177](http://purl.obolibrary.org/obo/GO_0004177) (aminopeptidase activity), [GO:0004176](http://purl.obolibrary.org/obo/GO_0004176) (ATP-dependent peptidase activity), [GO:0042402](http://purl.obolibrary.org/obo/GO_0042402) (cellular biogenic amine catabolic process), [GO:0042403](http://purl.obolibrary.org/obo/GO_0042403) (thyroid hormone metabolic process), [GO:0030437](http://purl.obolibrary.org/obo/GO_0030437) (ascospore formation), [GO:0097550](http://purl.obolibrary.org/obo/GO_0097550) (transcriptional preinitiation complex), [GO:0097553](http://purl.obolibrary.org/obo/GO_0097553) (calcium ion transmembrane import into cytosol), [GO:0072277](http://purl.obolibrary.org/obo/GO_0072277) (metanephric glomerular capillary formation), [GO:0030431](http://purl.obolibrary.org/obo/GO_0030431) (sleep), [GO:0030433](http://purl.obolibrary.org/obo/GO_0030433) (ubiquitin-dependent ERAD pathway), [GO:0031765](http://purl.obolibrary.org/obo/GO_0031765) (type 2 galanin receptor binding), [GO:0030432](http://purl.obolibrary.org/obo/GO_0030432) (peristalsis), [GO:0031766](http://purl.obolibrary.org/obo/GO_0031766) (type 3 galanin receptor binding), [GO:0030435](http://purl.obolibrary.org/obo/GO_0030435) (sporulation resulting in formation of a cellular spore), [GO:0031763](http://purl.obolibrary.org/obo/GO_0031763) (galanin receptor binding), [GO:0031764](http://purl.obolibrary.org/obo/GO_0031764) (type 1 galanin receptor binding), [GO:0016094](http://purl.obolibrary.org/obo/GO_0016094) (polyprenol biosynthetic process), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0042382](http://purl.obolibrary.org/obo/GO_0042382) (paraspeckles), [GO:0016095](http://purl.obolibrary.org/obo/GO_0016095) (polyprenol catabolic process), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0001823](http://purl.obolibrary.org/obo/GO_0001823) (mesonephros development), [GO:0001824](http://purl.obolibrary.org/obo/GO_0001824) (blastocyst development), [GO:0001825](http://purl.obolibrary.org/obo/GO_0001825) (blastocyst formation), [GO:0030388](http://purl.obolibrary.org/obo/GO_0030388) (fructose 1,6-bisphosphate metabolic process), [GO:0065004](http://purl.obolibrary.org/obo/GO_0065004) (protein-DNA complex assembly), [GO:0000506](http://purl.obolibrary.org/obo/GO_0000506) (glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex), [GO:0065001](http://purl.obolibrary.org/obo/GO_0065001) (specification of axis polarity), [GO:0030382](http://purl.obolibrary.org/obo/GO_0030382) (sperm mitochondrion organization), [GO:0065002](http://purl.obolibrary.org/obo/GO_0065002) (intracellular protein transmembrane transport), [GO:0000502](http://purl.obolibrary.org/obo/GO_0000502) (proteasome complex), [GO:0000500](http://purl.obolibrary.org/obo/GO_0000500) (RNA polymerase I upstream activating factor complex), [GO:0016080](http://purl.obolibrary.org/obo/GO_0016080) (synaptic vesicle targeting), [GO:0001830](http://purl.obolibrary.org/obo/GO_0001830) (trophectodermal cell fate commitment), [GO:0016081](http://purl.obolibrary.org/obo/GO_0016081) (synaptic vesicle docking), [GO:0042391](http://purl.obolibrary.org/obo/GO_0042391) (regulation of membrane potential), [GO:0016082](http://purl.obolibrary.org/obo/GO_0016082) (synaptic vesicle priming), [GO:0001833](http://purl.obolibrary.org/obo/GO_0001833) (inner cell mass cell proliferation), [GO:0042393](http://purl.obolibrary.org/obo/GO_0042393) (histone binding), [GO:0001835](http://purl.obolibrary.org/obo/GO_0001835) (blastocyst hatching), [GO:0001836](http://purl.obolibrary.org/obo/GO_0001836) (release of cytochrome c from mitochondria), [GO:0030374](http://purl.obolibrary.org/obo/GO_0030374) (ligand-dependent nuclear receptor transcription coactivator activity), [GO:0001837](http://purl.obolibrary.org/obo/GO_0001837) (epithelial to mesenchymal transition), [GO:0001838](http://purl.obolibrary.org/obo/GO_0001838) (embryonic epithelial tube formation), [GO:0001839](http://purl.obolibrary.org/obo/GO_0001839) (neural plate morphogenesis), [GO:0004081](http://purl.obolibrary.org/obo/GO_0004081) (bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity), [GO:0004082](http://purl.obolibrary.org/obo/GO_0004082) (bisphosphoglycerate mutase activity), [GO:0004085](http://purl.obolibrary.org/obo/GO_0004085) (butyryl-CoA dehydrogenase activity), [GO:0004087](http://purl.obolibrary.org/obo/GO_0004087) (carbamoyl-phosphate synthase (ammonia) activity), [GO:0004089](http://purl.obolibrary.org/obo/GO_0004089) (carbonate dehydratase activity), [GO:0004088](http://purl.obolibrary.org/obo/GO_0004088) (carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity), [GO:0016070](http://purl.obolibrary.org/obo/GO_0016070) (RNA metabolic process), [GO:0016075](http://purl.obolibrary.org/obo/GO_0016075) (rRNA catabolic process), [GO:0001805](http://purl.obolibrary.org/obo/GO_0001805) (positive regulation of type III hypersensitivity), [GO:0016079](http://purl.obolibrary.org/obo/GO_0016079) (synaptic vesicle exocytosis), [GO:0030366](http://purl.obolibrary.org/obo/GO_0030366) (molybdopterin synthase activity), [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding), [GO:0004090](http://purl.obolibrary.org/obo/GO_0004090) (carbonyl reductase (NADPH) activity), [GO:0004095](http://purl.obolibrary.org/obo/GO_0004095) (carnitine O-palmitoyltransferase activity), [GO:0004098](http://purl.obolibrary.org/obo/GO_0004098) (cerebroside-sulfatase activity), [GO:0004097](http://purl.obolibrary.org/obo/GO_0004097) (catechol oxidase activity), [GO:0016062](http://purl.obolibrary.org/obo/GO_0016062) (adaptation of rhodopsin mediated signaling), [GO:0001812](http://purl.obolibrary.org/obo/GO_0001812) (positive regulation of type I hypersensitivity), [GO:0016064](http://purl.obolibrary.org/obo/GO_0016064) (immunoglobulin mediated immune response), [GO:0031685](http://purl.obolibrary.org/obo/GO_0031685) (adenosine receptor binding), [GO:0001816](http://purl.obolibrary.org/obo/GO_0001816) (cytokine production), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), [GO:0001817](http://purl.obolibrary.org/obo/GO_0001817) (regulation of cytokine production), [GO:0001818](http://purl.obolibrary.org/obo/GO_0001818) (negative regulation of cytokine production), [GO:0001819](http://purl.obolibrary.org/obo/GO_0001819) (positive regulation of cytokine production), [GO:0043666](http://purl.obolibrary.org/obo/GO_0043666) (regulation of phosphoprotein phosphatase activity), [GO:0001867](http://purl.obolibrary.org/obo/GO_0001867) (complement activation, lectin pathway), [GO:0012510](http://purl.obolibrary.org/obo/GO_0012510) (trans-Golgi network transport vesicle membrane), [GO:0042345](http://purl.obolibrary.org/obo/GO_0042345) (regulation of NF-kappaB import into nucleus), [GO:0042346](http://purl.obolibrary.org/obo/GO_0042346) (positive regulation of NF-kappaB import into nucleus), [GO:0001881](http://purl.obolibrary.org/obo/GO_0001881) (receptor recycling), [GO:0043679](http://purl.obolibrary.org/obo/GO_0043679) (axon terminus), [GO:0042347](http://purl.obolibrary.org/obo/GO_0042347) (negative regulation of NF-kappaB import into nucleus), [GO:0001882](http://purl.obolibrary.org/obo/GO_0001882) (nucleoside binding), [GO:0001878](http://purl.obolibrary.org/obo/GO_0001878) (response to yeast), [GO:0043686](http://purl.obolibrary.org/obo/GO_0043686) (co-translational protein modification), [GO:0043687](http://purl.obolibrary.org/obo/GO_0043687) (post-translational protein modification), [GO:0001840](http://purl.obolibrary.org/obo/GO_0001840) (neural plate development), [GO:0001841](http://purl.obolibrary.org/obo/GO_0001841) (neural tube formation), [GO:0001842](http://purl.obolibrary.org/obo/GO_0001842) (neural fold formation), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0043691](http://purl.obolibrary.org/obo/GO_0043691) (reverse cholesterol transport), [GO:0042360](http://purl.obolibrary.org/obo/GO_0042360) (vitamin E metabolic process), [GO:0001845](http://purl.obolibrary.org/obo/GO_0001845) (phagolysosome assembly), [GO:0001848](http://purl.obolibrary.org/obo/GO_0001848) (complement binding), [GO:0001849](http://purl.obolibrary.org/obo/GO_0001849) (complement component C1q binding), [GO:0043697](http://purl.obolibrary.org/obo/GO_0043697) (cell dedifferentiation), [GO:0042371](http://purl.obolibrary.org/obo/GO_0042371) (vitamin K biosynthetic process), [GO:0012506](http://purl.obolibrary.org/obo/GO_0012506) (vesicle membrane), [GO:0012507](http://purl.obolibrary.org/obo/GO_0012507) (ER to Golgi transport vesicle membrane), [GO:0012505](http://purl.obolibrary.org/obo/GO_0012505) (endomembrane system), [GO:0012501](http://purl.obolibrary.org/obo/GO_0012501) (programmed cell death), [GO:0050839](http://purl.obolibrary.org/obo/GO_0050839) (cell adhesion molecule binding), [GO:0048515](http://purl.obolibrary.org/obo/GO_0048515) (spermatid differentiation), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0090055](http://purl.obolibrary.org/obo/GO_0090055) (positive regulation of chromatin silencing at silent mating-type cassette), [GO:0048513](http://purl.obolibrary.org/obo/GO_0048513) (animal organ development), [GO:0000578](http://purl.obolibrary.org/obo/GO_0000578) (embryonic axis specification), [GO:0048512](http://purl.obolibrary.org/obo/GO_0048512) (circadian behavior), [GO:0090050](http://purl.obolibrary.org/obo/GO_0090050) (positive regulation of cell migration involved in sprouting angiogenesis), [GO:0102490](http://purl.obolibrary.org/obo/GO_0102490) (8-oxo-dGTP phosphohydrolase activity), [GO:0048520](http://purl.obolibrary.org/obo/GO_0048520) (positive regulation of behavior), [GO:0050832](http://purl.obolibrary.org/obo/GO_0050832) (defense response to fungus), [GO:0050833](http://purl.obolibrary.org/obo/GO_0050833) (pyruvate transmembrane transporter activity), [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium), [GO:0050849](http://purl.obolibrary.org/obo/GO_0050849) (negative regulation of calcium-mediated signaling), [GO:0050840](http://purl.obolibrary.org/obo/GO_0050840) (extracellular matrix binding), [GO:0050847](http://purl.obolibrary.org/obo/GO_0050847) (progesterone receptor signaling pathway), [GO:0036515](http://purl.obolibrary.org/obo/GO_0036515) (serotonergic neuron axon guidance), [GO:0050848](http://purl.obolibrary.org/obo/GO_0050848) (regulation of calcium-mediated signaling), [GO:1990938](http://purl.obolibrary.org/obo/GO_1990938) (peptidyl-aspartic acid autophosphorylation), [GO:1990939](http://purl.obolibrary.org/obo/GO_1990939) (ATP-dependent microtubule motor activity), [GO:0036513](http://purl.obolibrary.org/obo/GO_0036513) (Derlin-1 retrotranslocation complex), [GO:0036514](http://purl.obolibrary.org/obo/GO_0036514) (dopaminergic neuron axon guidance), [GO:0090038](http://purl.obolibrary.org/obo/GO_0090038) (negative regulation of protein kinase C signaling), [GO:0090037](http://purl.obolibrary.org/obo/GO_0090037) (positive regulation of protein kinase C signaling), [GO:0061515](http://purl.obolibrary.org/obo/GO_0061515) (myeloid cell development), [GO:0090032](http://purl.obolibrary.org/obo/GO_0090032) (negative regulation of steroid hormone biosynthetic process), [GO:0048536](http://purl.obolibrary.org/obo/GO_0048536) (spleen development), [GO:0048535](http://purl.obolibrary.org/obo/GO_0048535) (lymph node development), [GO:0090031](http://purl.obolibrary.org/obo/GO_0090031) (positive regulation of steroid hormone biosynthetic process), [GO:0048534](http://purl.obolibrary.org/obo/GO_0048534) (hematopoietic or lymphoid organ development), [GO:0001890](http://purl.obolibrary.org/obo/GO_0001890) (placenta development), [GO:0061511](http://purl.obolibrary.org/obo/GO_0061511) (centriole elongation), [GO:0001891](http://purl.obolibrary.org/obo/GO_0001891) (phagocytic cup), [GO:0061512](http://purl.obolibrary.org/obo/GO_0061512) (protein localization to cilium), [GO:0001892](http://purl.obolibrary.org/obo/GO_0001892) (embryonic placenta development), [GO:0048539](http://purl.obolibrary.org/obo/GO_0048539) (bone marrow development), [GO:0001893](http://purl.obolibrary.org/obo/GO_0001893) (maternal placenta development), [GO:0048538](http://purl.obolibrary.org/obo/GO_0048538) (thymus development), [GO:0050850](http://purl.obolibrary.org/obo/GO_0050850) (positive regulation of calcium-mediated signaling), [GO:0001885](http://purl.obolibrary.org/obo/GO_0001885) (endothelial cell development), [GO:0001886](http://purl.obolibrary.org/obo/GO_0001886) (endothelial cell morphogenesis), [GO:0036508](http://purl.obolibrary.org/obo/GO_0036508) (protein alpha-1,2-demannosylation), [GO:0036509](http://purl.obolibrary.org/obo/GO_0036509) (trimming of terminal mannose on B branch), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0050856](http://purl.obolibrary.org/obo/GO_0050856) (regulation of T cell receptor signaling pathway), [GO:0036500](http://purl.obolibrary.org/obo/GO_0036500) (ATF6-mediated unfolded protein response), [GO:0050852](http://purl.obolibrary.org/obo/GO_0050852) (T cell receptor signaling pathway), [GO:0036503](http://purl.obolibrary.org/obo/GO_0036503) (ERAD pathway), [GO:0050853](http://purl.obolibrary.org/obo/GO_0050853) (B cell receptor signaling pathway), [GO:0048546](http://purl.obolibrary.org/obo/GO_0048546) (digestive tract morphogenesis), [GO:0048545](http://purl.obolibrary.org/obo/GO_0048545) (response to steroid hormone), [GO:1903715](http://purl.obolibrary.org/obo/GO_1903715) (regulation of aerobic respiration), [GO:0048549](http://purl.obolibrary.org/obo/GO_0048549) (positive regulation of pinocytosis), [GO:0001894](http://purl.obolibrary.org/obo/GO_0001894) (tissue homeostasis), [GO:0001895](http://purl.obolibrary.org/obo/GO_0001895) (retina homeostasis), [GO:1903706](http://purl.obolibrary.org/obo/GO_1903706) (regulation of hemopoiesis), [GO:0050860](http://purl.obolibrary.org/obo/GO_0050860) (negative regulation of T cell receptor signaling pathway), [GO:0047223](http://purl.obolibrary.org/obo/GO_0047223) (beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity), [GO:1990955](http://purl.obolibrary.org/obo/GO_1990955) (G-rich single-stranded DNA binding), [GO:0035242](http://purl.obolibrary.org/obo/GO_0035242) (protein-arginine omega-N asymmetric methyltransferase activity), [GO:0035243](http://purl.obolibrary.org/obo/GO_0035243) (protein-arginine omega-N symmetric methyltransferase activity), [GO:0090017](http://purl.obolibrary.org/obo/GO_0090017) (anterior neural plate formation), [GO:0035240](http://purl.obolibrary.org/obo/GO_0035240) (dopamine binding), [GO:0035241](http://purl.obolibrary.org/obo/GO_0035241) (protein-arginine omega-N monomethyltransferase activity), [GO:1990966](http://purl.obolibrary.org/obo/GO_1990966) (ATP generation from poly-ADP-D-ribose), [GO:0035235](http://purl.obolibrary.org/obo/GO_0035235) (ionotropic glutamate receptor signaling pathway), [GO:0035238](http://purl.obolibrary.org/obo/GO_0035238) (vitamin A biosynthetic process), [GO:0035234](http://purl.obolibrary.org/obo/GO_0035234) (ectopic germ cell programmed cell death), [GO:0090026](http://purl.obolibrary.org/obo/GO_0090026) (positive regulation of monocyte chemotaxis), [GO:0050808](http://purl.obolibrary.org/obo/GO_0050808) (synapse organization), [GO:0050805](http://purl.obolibrary.org/obo/GO_0050805) (negative regulation of synaptic transmission), [GO:0090023](http://purl.obolibrary.org/obo/GO_0090023) (positive regulation of neutrophil chemotaxis), [GO:0050806](http://purl.obolibrary.org/obo/GO_0050806) (positive regulation of synaptic transmission), [GO:0090022](http://purl.obolibrary.org/obo/GO_0090022) (regulation of neutrophil chemotaxis), [GO:0050803](http://purl.obolibrary.org/obo/GO_0050803) (regulation of synapse structure or activity), [GO:0050804](http://purl.obolibrary.org/obo/GO_0050804) (modulation of chemical synaptic transmission), [GO:0050801](http://purl.obolibrary.org/obo/GO_0050801) (ion homeostasis), [GO:0050810](http://purl.obolibrary.org/obo/GO_0050810) (regulation of steroid biosynthetic process), [GO:0050811](http://purl.obolibrary.org/obo/GO_0050811) (GABA receptor binding), [GO:0050829](http://purl.obolibrary.org/obo/GO_0050829) (defense response to Gram-negative bacterium), [GO:0048505](http://purl.obolibrary.org/obo/GO_0048505) (regulation of timing of cell differentiation), [GO:2000107](http://purl.obolibrary.org/obo/GO_2000107) (negative regulation of leukocyte apoptotic process), [GO:0048511](http://purl.obolibrary.org/obo/GO_0048511) (rhythmic process), [GO:0050821](http://purl.obolibrary.org/obo/GO_0050821) (protein stabilization), [GO:2000105](http://purl.obolibrary.org/obo/GO_2000105) (positive regulation of DNA-dependent DNA replication), [GO:0090009](http://purl.obolibrary.org/obo/GO_0090009) (primitive streak formation), [GO:2000104](http://purl.obolibrary.org/obo/GO_2000104) (negative regulation of DNA-dependent DNA replication), [GO:0050820](http://purl.obolibrary.org/obo/GO_0050820) (positive regulation of coagulation), [GO:0036257](http://purl.obolibrary.org/obo/GO_0036257) (multivesicular body organization), [GO:0036250](http://purl.obolibrary.org/obo/GO_0036250) (peroxisome transport along microtubule), [GO:1904970](http://purl.obolibrary.org/obo/GO_1904970) (brush border assembly), [GO:0048239](http://purl.obolibrary.org/obo/GO_0048239) (negative regulation of DNA recombination at telomere), [GO:1903644](http://purl.obolibrary.org/obo/GO_1903644) (regulation of chaperone-mediated protein folding), [GO:0048237](http://purl.obolibrary.org/obo/GO_0048237) (rough endoplasmic reticulum lumen), [GO:0048240](http://purl.obolibrary.org/obo/GO_0048240) (sperm capacitation), [GO:0048247](http://purl.obolibrary.org/obo/GO_0048247) (lymphocyte chemotaxis), [GO:0051881](http://purl.obolibrary.org/obo/GO_0051881) (regulation of mitochondrial membrane potential), [GO:0048246](http://purl.obolibrary.org/obo/GO_0048246) (macrophage chemotaxis), [GO:0048244](http://purl.obolibrary.org/obo/GO_0048244) (phytanoyl-CoA dioxygenase activity), [GO:2000353](http://purl.obolibrary.org/obo/GO_2000353) (positive regulation of endothelial cell apoptotic process), [GO:2000352](http://purl.obolibrary.org/obo/GO_2000352) (negative regulation of endothelial cell apoptotic process), [GO:2000358](http://purl.obolibrary.org/obo/GO_2000358) (positive regulation of kidney smooth muscle cell differentiation), [GO:2000357](http://purl.obolibrary.org/obo/GO_2000357) (negative regulation of kidney smooth muscle cell differentiation), [GO:0036245](http://purl.obolibrary.org/obo/GO_0036245) (cellular response to menadione), [GO:0061205](http://purl.obolibrary.org/obo/GO_0061205) (paramesonephric duct development), [GO:0051895](http://purl.obolibrary.org/obo/GO_0051895) (negative regulation of focal adhesion assembly), [GO:0051896](http://purl.obolibrary.org/obo/GO_0051896) (regulation of protein kinase B signaling), [GO:0051893](http://purl.obolibrary.org/obo/GO_0051893) (regulation of focal adhesion assembly), [GO:0048251](http://purl.obolibrary.org/obo/GO_0048251) (elastic fiber assembly), [GO:0050560](http://purl.obolibrary.org/obo/GO_0050560) (aspartate-tRNA(Asn) ligase activity), [GO:0050561](http://purl.obolibrary.org/obo/GO_0050561) (glutamate-tRNA(Gln) ligase activity), [GO:0048255](http://purl.obolibrary.org/obo/GO_0048255) (mRNA stabilization), [GO:2000366](http://purl.obolibrary.org/obo/GO_2000366) (positive regulation of STAT protein import into nucleus), [GO:0098506](http://purl.obolibrary.org/obo/GO_0098506) (polynucleotide 3' dephosphorylation), [GO:0098504](http://purl.obolibrary.org/obo/GO_0098504) (DNA 3' dephosphorylation involved in DNA repair), [GO:0098505](http://purl.obolibrary.org/obo/GO_0098505) (G-rich strand telomeric DNA binding), [GO:0051899](http://purl.obolibrary.org/obo/GO_0051899) (membrane depolarization), [GO:2000369](http://purl.obolibrary.org/obo/GO_2000369) (regulation of clathrin-dependent endocytosis), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0098508](http://purl.obolibrary.org/obo/GO_0098508) (endothelial to hematopoietic transition), [GO:0051898](http://purl.obolibrary.org/obo/GO_0051898) (negative regulation of protein kinase B signaling), [GO:0036233](http://purl.obolibrary.org/obo/GO_0036233) (glycine import), [GO:2000381](http://purl.obolibrary.org/obo/GO_2000381) (negative regulation of mesoderm development), [GO:1904999](http://purl.obolibrary.org/obo/GO_1904999) (positive regulation of leukocyte adhesion to arterial endothelial cell), [GO:1901006](http://purl.obolibrary.org/obo/GO_1901006) (ubiquinone-6 biosynthetic process), [GO:0048259](http://purl.obolibrary.org/obo/GO_0048259) (regulation of receptor-mediated endocytosis), [GO:1904996](http://purl.obolibrary.org/obo/GO_1904996) (positive regulation of leukocyte adhesion to vascular endothelial cell), [GO:0000278](http://purl.obolibrary.org/obo/GO_0000278) (mitotic cell cycle), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0048265](http://purl.obolibrary.org/obo/GO_0048265) (response to pain), [GO:0048264](http://purl.obolibrary.org/obo/GO_0048264) (determination of ventral identity), [GO:0048263](http://purl.obolibrary.org/obo/GO_0048263) (determination of dorsal identity), [GO:0000285](http://purl.obolibrary.org/obo/GO_0000285) (1-phosphatidylinositol-3-phosphate 5-kinase activity), [GO:0048262](http://purl.obolibrary.org/obo/GO_0048262) (determination of dorsal/ventral asymmetry), [GO:0000282](http://purl.obolibrary.org/obo/GO_0000282) (cellular bud site selection), [GO:0000281](http://purl.obolibrary.org/obo/GO_0000281) (mitotic cytokinesis), [GO:0048266](http://purl.obolibrary.org/obo/GO_0048266) (behavioral response to pain), [GO:0000280](http://purl.obolibrary.org/obo/GO_0000280) (nuclear division), [GO:2000377](http://purl.obolibrary.org/obo/GO_2000377) (regulation of reactive oxygen species metabolic process), [GO:0048260](http://purl.obolibrary.org/obo/GO_0048260) (positive regulation of receptor-mediated endocytosis), [GO:2000379](http://purl.obolibrary.org/obo/GO_2000379) (positive regulation of reactive oxygen species metabolic process), [GO:2000378](http://purl.obolibrary.org/obo/GO_2000378) (negative regulation of reactive oxygen species metabolic process), [GO:1903670](http://purl.obolibrary.org/obo/GO_1903670) (regulation of sprouting angiogenesis), [GO:2000391](http://purl.obolibrary.org/obo/GO_2000391) (positive regulation of neutrophil extravasation), [GO:0036221](http://purl.obolibrary.org/obo/GO_0036221) (UTP diphosphatase activity), [GO:0036222](http://purl.obolibrary.org/obo/GO_0036222) (XTP diphosphatase activity), [GO:2000393](http://purl.obolibrary.org/obo/GO_2000393) (negative regulation of lamellipodium morphogenesis), [GO:1903672](http://purl.obolibrary.org/obo/GO_1903672) (positive regulation of sprouting angiogenesis), [GO:0036220](http://purl.obolibrary.org/obo/GO_0036220) (ITP diphosphatase activity), [GO:1901017](http://purl.obolibrary.org/obo/GO_1901017) (negative regulation of potassium ion transmembrane transporter activity), [GO:1901016](http://purl.obolibrary.org/obo/GO_1901016) (regulation of potassium ion transmembrane transporter activity), [GO:0000289](http://purl.obolibrary.org/obo/GO_0000289) (nuclear-transcribed mRNA poly(A) tail shortening), [GO:0048278](http://purl.obolibrary.org/obo/GO_0048278) (vesicle docking), [GO:0000290](http://purl.obolibrary.org/obo/GO_0000290) (deadenylation-dependent decapping of nuclear-transcribed mRNA), [GO:0036218](http://purl.obolibrary.org/obo/GO_0036218) (dTTP diphosphatase activity), [GO:0036219](http://purl.obolibrary.org/obo/GO_0036219) (GTP diphosphatase activity), [GO:0036217](http://purl.obolibrary.org/obo/GO_0036217) (dGTP diphosphatase activity), [GO:0036294](http://purl.obolibrary.org/obo/GO_0036294) (cellular response to decreased oxygen levels), [GO:0036295](http://purl.obolibrary.org/obo/GO_0036295) (cellular response to increased oxygen levels), [GO:0036297](http://purl.obolibrary.org/obo/GO_0036297) (interstrand cross-link repair), [GO:1904937](http://purl.obolibrary.org/obo/GO_1904937) (sensory neuron migration), [GO:0006402](http://purl.obolibrary.org/obo/GO_0006402) (mRNA catabolic process), [GO:0006403](http://purl.obolibrary.org/obo/GO_0006403) (RNA localization), [GO:1904935](http://purl.obolibrary.org/obo/GO_1904935) (positive regulation of cell proliferation in midbrain), [GO:0006400](http://purl.obolibrary.org/obo/GO_0006400) (tRNA modification), [GO:0006401](http://purl.obolibrary.org/obo/GO_0006401) (RNA catabolic process), [GO:0050510](http://purl.obolibrary.org/obo/GO_0050510) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity), [GO:0050518](http://purl.obolibrary.org/obo/GO_0050518) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity), [GO:0019722](http://purl.obolibrary.org/obo/GO_0019722) (calcium-mediated signaling), [GO:0019706](http://purl.obolibrary.org/obo/GO_0019706) (protein-cysteine S-palmitoyltransferase activity), [GO:0036289](http://purl.obolibrary.org/obo/GO_0036289) (peptidyl-serine autophosphorylation), [GO:0006413](http://purl.obolibrary.org/obo/GO_0006413) (translational initiation), [GO:0006414](http://purl.obolibrary.org/obo/GO_0006414) (translational elongation), [GO:0006412](http://purl.obolibrary.org/obo/GO_0006412) (translation), [GO:0048208](http://purl.obolibrary.org/obo/GO_0048208) (COPII vesicle coating), [GO:0006406](http://purl.obolibrary.org/obo/GO_0006406) (mRNA export from nucleus), [GO:0006405](http://purl.obolibrary.org/obo/GO_0006405) (RNA export from nucleus), [GO:1904938](http://purl.obolibrary.org/obo/GO_1904938) (planar cell polarity pathway involved in axon guidance), [GO:0048213](http://purl.obolibrary.org/obo/GO_0048213) (Golgi vesicle prefusion complex stabilization), [GO:0006409](http://purl.obolibrary.org/obo/GO_0006409) (tRNA export from nucleus), [GO:0036275](http://purl.obolibrary.org/obo/GO_0036275) (response to 5-fluorouracil), [GO:1903621](http://purl.obolibrary.org/obo/GO_1903621) (protein localization to photoreceptor connecting cilium), [GO:1904959](http://purl.obolibrary.org/obo/GO_1904959) (regulation of cytochrome-c oxidase activity), [GO:0048219](http://purl.obolibrary.org/obo/GO_0048219) (inter-Golgi cisterna vesicle-mediated transport), [GO:1904949](http://purl.obolibrary.org/obo/GO_1904949) (ATPase complex), [GO:0036269](http://purl.obolibrary.org/obo/GO_0036269) (swimming behavior), [GO:0051866](http://purl.obolibrary.org/obo/GO_0051866) (general adaptation syndrome), [GO:0051864](http://purl.obolibrary.org/obo/GO_0051864) (histone demethylase activity (H3-K36 specific)), [GO:0019702](http://purl.obolibrary.org/obo/GO_0019702) (protein-arginine N5-methyltransferase activity), [GO:0051865](http://purl.obolibrary.org/obo/GO_0051865) (protein autoubiquitination), [GO:1990907](http://purl.obolibrary.org/obo/GO_1990907) (beta-catenin-TCF complex), [GO:0036267](http://purl.obolibrary.org/obo/GO_0036267) (invasive filamentous growth), [GO:0036268](http://purl.obolibrary.org/obo/GO_0036268) (swimming), [GO:1902305](http://purl.obolibrary.org/obo/GO_1902305) (regulation of sodium ion transmembrane transport), [GO:0051871](http://purl.obolibrary.org/obo/GO_0051871) (dihydrofolic acid binding), [GO:0051870](http://purl.obolibrary.org/obo/GO_0051870) (methotrexate binding), [GO:0051879](http://purl.obolibrary.org/obo/GO_0051879) (Hsp90 protein binding), [GO:0051877](http://purl.obolibrary.org/obo/GO_0051877) (pigment granule aggregation in cell center), [GO:0051875](http://purl.obolibrary.org/obo/GO_0051875) (pigment granule localization), [GO:0051876](http://purl.obolibrary.org/obo/GO_0051876) (pigment granule dispersal), [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye), [GO:1902394](http://purl.obolibrary.org/obo/GO_1902394) (positive regulation of exodeoxyribonuclease activity), [GO:0061299](http://purl.obolibrary.org/obo/GO_0061299) (retina vasculature morphogenesis in camera-type eye), [GO:0005112](http://purl.obolibrary.org/obo/GO_0005112) (Notch binding), [GO:0097250](http://purl.obolibrary.org/obo/GO_0097250) (mitochondrial respiratory chain supercomplex assembly), [GO:0006446](http://purl.obolibrary.org/obo/GO_0006446) (regulation of translational initiation), [GO:0005113](http://purl.obolibrary.org/obo/GO_0005113) (patched binding), [GO:0032727](http://purl.obolibrary.org/obo/GO_0032727) (positive regulation of interferon-alpha production), [GO:0097242](http://purl.obolibrary.org/obo/GO_0097242) (amyloid-beta clearance), [GO:0005109](http://purl.obolibrary.org/obo/GO_0005109) (frizzled binding), [GO:0006437](http://purl.obolibrary.org/obo/GO_0006437) (tyrosyl-tRNA aminoacylation), [GO:0006438](http://purl.obolibrary.org/obo/GO_0006438) (valyl-tRNA aminoacylation), [GO:0098574](http://purl.obolibrary.org/obo/GO_0098574) (cytoplasmic side of lysosomal membrane), [GO:0032728](http://purl.obolibrary.org/obo/GO_0032728) (positive regulation of interferon-beta production), [GO:0032729](http://purl.obolibrary.org/obo/GO_0032729) (positive regulation of interferon-gamma production), [GO:0017101](http://purl.obolibrary.org/obo/GO_0017101) (aminoacyl-tRNA synthetase multienzyme complex), [GO:0017102](http://purl.obolibrary.org/obo/GO_0017102) (methionyl glutamyl tRNA synthetase complex), [GO:0032722](http://purl.obolibrary.org/obo/GO_0032722) (positive regulation of chemokine production), [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production), [GO:1901077](http://purl.obolibrary.org/obo/GO_1901077) (regulation of relaxation of muscle), [GO:0006450](http://purl.obolibrary.org/obo/GO_0006450) (regulation of translational fidelity), [GO:1901076](http://purl.obolibrary.org/obo/GO_1901076) (positive regulation of engulfment of apoptotic cell), [GO:0005121](http://purl.obolibrary.org/obo/GO_0005121) (Toll binding), [GO:0005123](http://purl.obolibrary.org/obo/GO_0005123) (death receptor binding), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0006457](http://purl.obolibrary.org/obo/GO_0006457) (protein folding), [GO:0006458](http://purl.obolibrary.org/obo/GO_0006458) ('de novo' protein folding), [GO:0044721](http://purl.obolibrary.org/obo/GO_0044721) (protein import into peroxisome matrix, substrate release), [GO:0005127](http://purl.obolibrary.org/obo/GO_0005127) (ciliary neurotrophic factor receptor binding), [GO:0032715](http://purl.obolibrary.org/obo/GO_0032715) (negative regulation of interleukin-6 production), [GO:0098586](http://purl.obolibrary.org/obo/GO_0098586) (cellular response to virus), [GO:0005119](http://purl.obolibrary.org/obo/GO_0005119) (smoothened binding), [GO:0061290](http://purl.obolibrary.org/obo/GO_0061290) (canonical Wnt signaling pathway involved in metanephric kidney development), [GO:0019752](http://purl.obolibrary.org/obo/GO_0019752) (carboxylic acid metabolic process), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0043408](http://purl.obolibrary.org/obo/GO_0043408) (regulation of MAPK cascade), [GO:0043407](http://purl.obolibrary.org/obo/GO_0043407) (negative regulation of MAP kinase activity), [GO:0043409](http://purl.obolibrary.org/obo/GO_0043409) (negative regulation of MAPK cascade), [GO:0006420](http://purl.obolibrary.org/obo/GO_0006420) (arginyl-tRNA aminoacylation), [GO:0006424](http://purl.obolibrary.org/obo/GO_0006424) (glutamyl-tRNA aminoacylation), [GO:0098560](http://purl.obolibrary.org/obo/GO_0098560) (cytoplasmic side of late endosome membrane), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0006425](http://purl.obolibrary.org/obo/GO_0006425) (glutaminyl-tRNA aminoacylation), [GO:0006422](http://purl.obolibrary.org/obo/GO_0006422) (aspartyl-tRNA aminoacylation), [GO:0043403](http://purl.obolibrary.org/obo/GO_0043403) (skeletal muscle tissue regeneration), [GO:0006423](http://purl.obolibrary.org/obo/GO_0006423) (cysteinyl-tRNA aminoacylation), [GO:0006417](http://purl.obolibrary.org/obo/GO_0006417) (regulation of translation), [GO:0006418](http://purl.obolibrary.org/obo/GO_0006418) (tRNA aminoacylation for protein translation), [GO:0032703](http://purl.obolibrary.org/obo/GO_0032703) (negative regulation of interleukin-2 production), [GO:0097222](http://purl.obolibrary.org/obo/GO_0097222) (mitochondrial mRNA polyadenylation), [GO:0097225](http://purl.obolibrary.org/obo/GO_0097225) (sperm midpiece), [GO:0006419](http://purl.obolibrary.org/obo/GO_0006419) (alanyl-tRNA aminoacylation), [GO:0097228](http://purl.obolibrary.org/obo/GO_0097228) (sperm principal piece), [GO:0098559](http://purl.obolibrary.org/obo/GO_0098559) (cytoplasmic side of early endosome membrane), [GO:0032700](http://purl.obolibrary.org/obo/GO_0032700) (negative regulation of interleukin-17 production), [GO:0019725](http://purl.obolibrary.org/obo/GO_0019725) (cellular homeostasis), [GO:1901094](http://purl.obolibrary.org/obo/GO_1901094) (negative regulation of protein homotetramerization), [GO:1901097](http://purl.obolibrary.org/obo/GO_1901097) (negative regulation of autophagosome maturation), [GO:0043418](http://purl.obolibrary.org/obo/GO_0043418) (homocysteine catabolic process), [GO:1901098](http://purl.obolibrary.org/obo/GO_1901098) (positive regulation of autophagosome maturation), [GO:0006431](http://purl.obolibrary.org/obo/GO_0006431) (methionyl-tRNA aminoacylation), [GO:0006432](http://purl.obolibrary.org/obo/GO_0006432) (phenylalanyl-tRNA aminoacylation), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0006430](http://purl.obolibrary.org/obo/GO_0006430) (lysyl-tRNA aminoacylation), [GO:0006435](http://purl.obolibrary.org/obo/GO_0006435) (threonyl-tRNA aminoacylation), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0005104](http://purl.obolibrary.org/obo/GO_0005104) (fibroblast growth factor receptor binding), [GO:0006428](http://purl.obolibrary.org/obo/GO_0006428) (isoleucyl-tRNA aminoacylation), [GO:0006429](http://purl.obolibrary.org/obo/GO_0006429) (leucyl-tRNA aminoacylation), [GO:0006426](http://purl.obolibrary.org/obo/GO_0006426) (glycyl-tRNA aminoacylation), [GO:0006427](http://purl.obolibrary.org/obo/GO_0006427) (histidyl-tRNA aminoacylation), [GO:0097236](http://purl.obolibrary.org/obo/GO_0097236) (positive regulation of transcription from RNA polymerase II promoter in response to zinc ion starvation), [GO:0097235](http://purl.obolibrary.org/obo/GO_0097235) (positive regulation of fatty acid beta-oxidation by positive regulation of transcription from RNA polymerase II promoter), [GO:0019731](http://purl.obolibrary.org/obo/GO_0019731) (antibacterial humoral response), [GO:0006482](http://purl.obolibrary.org/obo/GO_0006482) (protein demethylation), [GO:0032770](http://purl.obolibrary.org/obo/GO_0032770) (positive regulation of monooxygenase activity), [GO:0006486](http://purl.obolibrary.org/obo/GO_0006486) (protein glycosylation), [GO:0005154](http://purl.obolibrary.org/obo/GO_0005154) (epidermal growth factor receptor binding), [GO:1902358](http://purl.obolibrary.org/obo/GO_1902358) (sulfate transmembrane transport), [GO:0006487](http://purl.obolibrary.org/obo/GO_0006487) (protein N-linked glycosylation), [GO:0005158](http://purl.obolibrary.org/obo/GO_0005158) (insulin receptor binding), [GO:0006488](http://purl.obolibrary.org/obo/GO_0006488) (dolichol-linked oligosaccharide biosynthetic process), [GO:0006489](http://purl.obolibrary.org/obo/GO_0006489) (dolichyl diphosphate biosynthetic process), [GO:0005159](http://purl.obolibrary.org/obo/GO_0005159) (insulin-like growth factor receptor binding), [GO:0048286](http://purl.obolibrary.org/obo/GO_0048286) (lung alveolus development), [GO:0097201](http://purl.obolibrary.org/obo/GO_0097201) (negative regulation of transcription from RNA polymerase II promoter in response to stress), [GO:0098535](http://purl.obolibrary.org/obo/GO_0098535) (de novo centriole assembly involved in multi-ciliated epithelial cell differentiation), [GO:0097202](http://purl.obolibrary.org/obo/GO_0097202) (activation of cysteine-type endopeptidase activity), [GO:0098536](http://purl.obolibrary.org/obo/GO_0098536) (deuterosome), [GO:0097205](http://purl.obolibrary.org/obo/GO_0097205) (renal filtration), [GO:0098534](http://purl.obolibrary.org/obo/GO_0098534) (centriole assembly), [GO:0032762](http://purl.obolibrary.org/obo/GO_0032762) (mast cell cytokine production), [GO:0031432](http://purl.obolibrary.org/obo/GO_0031432) (titin binding), [GO:0017144](http://purl.obolibrary.org/obo/GO_0017144) (drug metabolic process), [GO:0032760](http://purl.obolibrary.org/obo/GO_0032760) (positive regulation of tumor necrosis factor production), [GO:0097209](http://purl.obolibrary.org/obo/GO_0097209) (epidermal lamellar body), [GO:0017145](http://purl.obolibrary.org/obo/GO_0017145) (stem cell division), [GO:0031430](http://purl.obolibrary.org/obo/GO_0031430) (M band), [GO:0030100](http://purl.obolibrary.org/obo/GO_0030100) (regulation of endocytosis), [GO:0017146](http://purl.obolibrary.org/obo/GO_0017146) (NMDA selective glutamate receptor complex), [GO:0017147](http://purl.obolibrary.org/obo/GO_0017147) (Wnt-protein binding), [GO:0032767](http://purl.obolibrary.org/obo/GO_0032767) (copper-dependent protein binding), [GO:0017148](http://purl.obolibrary.org/obo/GO_0017148) (negative regulation of translation), [GO:0031433](http://purl.obolibrary.org/obo/GO_0031433) (telethonin binding), [GO:0030104](http://purl.obolibrary.org/obo/GO_0030104) (water homeostasis), [GO:0031434](http://purl.obolibrary.org/obo/GO_0031434) (mitogen-activated protein kinase kinase binding), [GO:0048280](http://purl.obolibrary.org/obo/GO_0048280) (vesicle fusion with Golgi apparatus), [GO:0006490](http://purl.obolibrary.org/obo/GO_0006490) (oligosaccharide-lipid intermediate biosynthetic process), [GO:1902362](http://purl.obolibrary.org/obo/GO_1902362) (melanocyte apoptotic process), [GO:1903690](http://purl.obolibrary.org/obo/GO_1903690) (negative regulation of wound healing, spreading of epidermal cells), [GO:0006493](http://purl.obolibrary.org/obo/GO_0006493) (protein O-linked glycosylation), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0005160](http://purl.obolibrary.org/obo/GO_0005160) (transforming growth factor beta receptor binding), [GO:1902366](http://purl.obolibrary.org/obo/GO_1902366) (regulation of Notch signaling pathway involved in somitogenesis), [GO:0006491](http://purl.obolibrary.org/obo/GO_0006491) (N-glycan processing), [GO:0005163](http://purl.obolibrary.org/obo/GO_0005163) (nerve growth factor receptor binding), [GO:0006497](http://purl.obolibrary.org/obo/GO_0006497) (protein lipidation), [GO:0005164](http://purl.obolibrary.org/obo/GO_0005164) (tumor necrosis factor receptor binding), [GO:0005166](http://purl.obolibrary.org/obo/GO_0005166) (neurotrophin p75 receptor binding), [GO:0005169](http://purl.obolibrary.org/obo/GO_0005169) (neurotrophin TRKB receptor binding), [GO:0031428](http://purl.obolibrary.org/obo/GO_0031428) (box C/D snoRNP complex), [GO:0048298](http://purl.obolibrary.org/obo/GO_0048298) (positive regulation of isotype switching to IgA isotypes), [GO:0031429](http://purl.obolibrary.org/obo/GO_0031429) (box H/ACA snoRNP complex), [GO:0032757](http://purl.obolibrary.org/obo/GO_0032757) (positive regulation of interleukin-8 production), [GO:0031427](http://purl.obolibrary.org/obo/GO_0031427) (response to methotrexate), [GO:0017133](http://purl.obolibrary.org/obo/GO_0017133) (mitochondrial electron transfer flavoprotein complex), [GO:0017134](http://purl.obolibrary.org/obo/GO_0017134) (fibroblast growth factor binding), [GO:0019797](http://purl.obolibrary.org/obo/GO_0019797) (procollagen-proline 3-dioxygenase activity), [GO:0031424](http://purl.obolibrary.org/obo/GO_0031424) (keratinization), [GO:0032755](http://purl.obolibrary.org/obo/GO_0032755) (positive regulation of interleukin-6 production), [GO:0017137](http://purl.obolibrary.org/obo/GO_0017137) (Rab GTPase binding), [GO:0018467](http://purl.obolibrary.org/obo/GO_0018467) (formaldehyde dehydrogenase activity), [GO:0032753](http://purl.obolibrary.org/obo/GO_0032753) (positive regulation of interleukin-4 production), [GO:0032754](http://purl.obolibrary.org/obo/GO_0032754) (positive regulation of interleukin-5 production), [GO:0017119](http://purl.obolibrary.org/obo/GO_0017119) (Golgi transport complex), [GO:1902373](http://purl.obolibrary.org/obo/GO_1902373) (negative regulation of mRNA catabolic process), [GO:0006461](http://purl.obolibrary.org/obo/GO_0006461) (protein complex assembly), [GO:0006464](http://purl.obolibrary.org/obo/GO_0006464) (cellular protein modification process), [GO:0006465](http://purl.obolibrary.org/obo/GO_0006465) (signal peptide processing), [GO:0005131](http://purl.obolibrary.org/obo/GO_0005131) (growth hormone receptor binding), [GO:0005134](http://purl.obolibrary.org/obo/GO_0005134) (interleukin-2 receptor binding), [GO:0005133](http://purl.obolibrary.org/obo/GO_0005133) (interferon-gamma receptor binding), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0006469](http://purl.obolibrary.org/obo/GO_0006469) (negative regulation of protein kinase activity), [GO:0005138](http://purl.obolibrary.org/obo/GO_0005138) (interleukin-6 receptor binding), [GO:0031418](http://purl.obolibrary.org/obo/GO_0031418) (L-ascorbic acid binding), [GO:0031415](http://purl.obolibrary.org/obo/GO_0031415) (NatA complex), [GO:0032747](http://purl.obolibrary.org/obo/GO_0032747) (positive regulation of interleukin-23 production), [GO:0031419](http://purl.obolibrary.org/obo/GO_0031419) (cobalamin binding), [GO:0032740](http://purl.obolibrary.org/obo/GO_0032740) (positive regulation of interleukin-17 production), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0032741](http://purl.obolibrary.org/obo/GO_0032741) (positive regulation of interleukin-18 production), [GO:0017124](http://purl.obolibrary.org/obo/GO_0017124) (SH3 domain binding), [GO:0018454](http://purl.obolibrary.org/obo/GO_0018454) (acetoacetyl-CoA reductase activity), [GO:0031413](http://purl.obolibrary.org/obo/GO_0031413) (regulation of buoyancy), [GO:0017126](http://purl.obolibrary.org/obo/GO_0017126) (nucleologenesis), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:0032743](http://purl.obolibrary.org/obo/GO_0032743) (positive regulation of interleukin-2 production), [GO:0017128](http://purl.obolibrary.org/obo/GO_0017128) (phospholipid scramblase activity), [GO:0019789](http://purl.obolibrary.org/obo/GO_0019789) (SUMO transferase activity), [GO:0017108](http://purl.obolibrary.org/obo/GO_0017108) (5'-flap endonuclease activity), [GO:0006471](http://purl.obolibrary.org/obo/GO_0006471) (protein ADP-ribosylation), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:0006475](http://purl.obolibrary.org/obo/GO_0006475) (internal protein amino acid acetylation), [GO:0006476](http://purl.obolibrary.org/obo/GO_0006476) (protein deacetylation), [GO:0006473](http://purl.obolibrary.org/obo/GO_0006473) (protein acetylation), [GO:0006474](http://purl.obolibrary.org/obo/GO_0006474) (N-terminal protein amino acid acetylation), [GO:0006479](http://purl.obolibrary.org/obo/GO_0006479) (protein methylation), [GO:0005149](http://purl.obolibrary.org/obo/GO_0005149) (interleukin-1 receptor binding), [GO:0006477](http://purl.obolibrary.org/obo/GO_0006477) (protein sulfation), [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding), [GO:0032735](http://purl.obolibrary.org/obo/GO_0032735) (positive regulation of interleukin-12 production), [GO:0032736](http://purl.obolibrary.org/obo/GO_0032736) (positive regulation of interleukin-13 production), [GO:0017110](http://purl.obolibrary.org/obo/GO_0017110) (nucleoside-diphosphatase activity), [GO:0098528](http://purl.obolibrary.org/obo/GO_0098528) (skeletal muscle fiber differentiation), [GO:0017111](http://purl.obolibrary.org/obo/GO_0017111) (nucleoside-triphosphatase activity), [GO:0017112](http://purl.obolibrary.org/obo/GO_0017112) (Rab guanyl-nucleotide exchange factor activity), [GO:0031402](http://purl.obolibrary.org/obo/GO_0031402) (sodium ion binding), [GO:0031403](http://purl.obolibrary.org/obo/GO_0031403) (lithium ion binding), [GO:0017116](http://purl.obolibrary.org/obo/GO_0017116) (single-stranded DNA-dependent ATP-dependent DNA helicase activity), [GO:0032731](http://purl.obolibrary.org/obo/GO_0032731) (positive regulation of interleukin-1 beta production), [GO:0031401](http://purl.obolibrary.org/obo/GO_0031401) (positive regulation of protein modification process), [GO:0005070](http://purl.obolibrary.org/obo/GO_0005070) (SH3/SH2 adaptor activity), [GO:0031362](http://purl.obolibrary.org/obo/GO_0031362) (anchored component of external side of plasma membrane), [GO:0030031](http://purl.obolibrary.org/obo/GO_0030031) (cell projection assembly), [GO:0030030](http://purl.obolibrary.org/obo/GO_0030030) (cell projection organization), [GO:0032691](http://purl.obolibrary.org/obo/GO_0032691) (negative regulation of interleukin-1 beta production), [GO:0005078](http://purl.obolibrary.org/obo/GO_0005078) (MAP-kinase scaffold activity), [GO:0018394](http://purl.obolibrary.org/obo/GO_0018394) (peptidyl-lysine acetylation), [GO:0017069](http://purl.obolibrary.org/obo/GO_0017069) (snRNA binding), [GO:0030026](http://purl.obolibrary.org/obo/GO_0030026) (cellular manganese ion homeostasis), [GO:0032689](http://purl.obolibrary.org/obo/GO_0032689) (negative regulation of interferon-gamma production), [GO:0030027](http://purl.obolibrary.org/obo/GO_0030027) (lamellipodium), [GO:0032688](http://purl.obolibrary.org/obo/GO_0032688) (negative regulation of interferon-beta production), [GO:0005080](http://purl.obolibrary.org/obo/GO_0005080) (protein kinase C binding), [GO:0032682](http://purl.obolibrary.org/obo/GO_0032682) (negative regulation of chemokine production), [GO:0005086](http://purl.obolibrary.org/obo/GO_0005086) (ARF guanyl-nucleotide exchange factor activity), [GO:0005085](http://purl.obolibrary.org/obo/GO_0005085) (guanyl-nucleotide exchange factor activity), [GO:0032680](http://purl.obolibrary.org/obo/GO_0032680) (regulation of tumor necrosis factor production), [GO:0005088](http://purl.obolibrary.org/obo/GO_0005088) (Ras guanyl-nucleotide exchange factor activity), [GO:0005089](http://purl.obolibrary.org/obo/GO_0005089) (Rho guanyl-nucleotide exchange factor activity), [GO:0042026](http://purl.obolibrary.org/obo/GO_0042026) (protein refolding), [GO:0030018](http://purl.obolibrary.org/obo/GO_0030018) (Z disc), [GO:0044692](http://purl.obolibrary.org/obo/GO_0044692) (exoribonuclease activator activity), [GO:0042030](http://purl.obolibrary.org/obo/GO_0042030) (ATPase inhibitor activity), [GO:0017053](http://purl.obolibrary.org/obo/GO_0017053) (transcriptional repressor complex), [GO:0030011](http://purl.obolibrary.org/obo/GO_0030011) (maintenance of cell polarity), [GO:0017056](http://purl.obolibrary.org/obo/GO_0017056) (structural constituent of nuclear pore), [GO:0030010](http://purl.obolibrary.org/obo/GO_0030010) (establishment of cell polarity), [GO:0032675](http://purl.obolibrary.org/obo/GO_0032675) (regulation of interleukin-6 production), [GO:0017059](http://purl.obolibrary.org/obo/GO_0017059) (serine C-palmitoyltransferase complex), [GO:0030017](http://purl.obolibrary.org/obo/GO_0030017) (sarcomere), [GO:0030016](http://purl.obolibrary.org/obo/GO_0030016) (myofibril), [GO:0006383](http://purl.obolibrary.org/obo/GO_0006383) (transcription by RNA polymerase III), [GO:0031340](http://purl.obolibrary.org/obo/GO_0031340) (positive regulation of vesicle fusion), [GO:0005053](http://purl.obolibrary.org/obo/GO_0005053) (peroxisome matrix targeting signal-2 binding), [GO:0006382](http://purl.obolibrary.org/obo/GO_0006382) (adenosine to inosine editing), [GO:0005052](http://purl.obolibrary.org/obo/GO_0005052) (peroxisome matrix targeting signal-1 binding), [GO:0097191](http://purl.obolibrary.org/obo/GO_0097191) (extrinsic apoptotic signaling pathway), [GO:0006388](http://purl.obolibrary.org/obo/GO_0006388) (tRNA splicing, via endonucleolytic cleavage and ligation), [GO:0097190](http://purl.obolibrary.org/obo/GO_0097190) (apoptotic signaling pathway), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0005057](http://purl.obolibrary.org/obo/GO_0005057) (signal transducer activity, downstream of receptor), [GO:0042035](http://purl.obolibrary.org/obo/GO_0042035) (regulation of cytokine biosynthetic process), [GO:0097192](http://purl.obolibrary.org/obo/GO_0097192) (extrinsic apoptotic signaling pathway in absence of ligand), [GO:0043369](http://purl.obolibrary.org/obo/GO_0043369) (CD4-positive or CD8-positive, alpha-beta T cell lineage commitment), [GO:0097194](http://purl.obolibrary.org/obo/GO_0097194) (execution phase of apoptosis), [GO:0097197](http://purl.obolibrary.org/obo/GO_0097197) (tetraspanin-enriched microdomain), [GO:0030008](http://purl.obolibrary.org/obo/GO_0030008) (TRAPP complex), [GO:0030007](http://purl.obolibrary.org/obo/GO_0030007) (cellular potassium ion homeostasis), [GO:0031338](http://purl.obolibrary.org/obo/GO_0031338) (regulation of vesicle fusion), [GO:0043370](http://purl.obolibrary.org/obo/GO_0043370) (regulation of CD4-positive, alpha-beta T cell differentiation), [GO:0017040](http://purl.obolibrary.org/obo/GO_0017040) (ceramidase activity), [GO:0070981](http://purl.obolibrary.org/obo/GO_0070981) (L-asparagine biosynthetic process), [GO:0031333](http://purl.obolibrary.org/obo/GO_0031333) (negative regulation of protein complex assembly), [GO:0017046](http://purl.obolibrary.org/obo/GO_0017046) (peptide hormone binding), [GO:0033993](http://purl.obolibrary.org/obo/GO_0033993) (response to lipid), [GO:0030001](http://purl.obolibrary.org/obo/GO_0030001) (metal ion transport), [GO:0017048](http://purl.obolibrary.org/obo/GO_0017048) (Rho GTPase binding), [GO:0030004](http://purl.obolibrary.org/obo/GO_0030004) (cellular monovalent inorganic cation homeostasis), [GO:0070988](http://purl.obolibrary.org/obo/GO_0070988) (demethylation), [GO:0030003](http://purl.obolibrary.org/obo/GO_0030003) (cellular cation homeostasis), [GO:0070986](http://purl.obolibrary.org/obo/GO_0070986) (left/right axis specification), [GO:0031334](http://purl.obolibrary.org/obo/GO_0031334) (positive regulation of protein complex assembly), [GO:0031335](http://purl.obolibrary.org/obo/GO_0031335) (regulation of sulfur amino acid metabolic process), [GO:0070987](http://purl.obolibrary.org/obo/GO_0070987) (error-free translesion synthesis), [GO:0006390](http://purl.obolibrary.org/obo/GO_0006390) (mitochondrial transcription), [GO:0042044](http://purl.obolibrary.org/obo/GO_0042044) (fluid transport), [GO:0042045](http://purl.obolibrary.org/obo/GO_0042045) (epithelial fluid transport), [GO:0006396](http://purl.obolibrary.org/obo/GO_0006396) (RNA processing), [GO:0006397](http://purl.obolibrary.org/obo/GO_0006397) (mRNA processing), [GO:0042048](http://purl.obolibrary.org/obo/GO_0042048) (olfactory behavior), [GO:0033989](http://purl.obolibrary.org/obo/GO_0033989) (3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity), [GO:0042051](http://purl.obolibrary.org/obo/GO_0042051) (compound eye photoreceptor development), [GO:0042053](http://purl.obolibrary.org/obo/GO_0042053) (regulation of dopamine metabolic process), [GO:0019693](http://purl.obolibrary.org/obo/GO_0019693) (ribose phosphate metabolic process), [GO:0042054](http://purl.obolibrary.org/obo/GO_0042054) (histone methyltransferase activity), [GO:0031321](http://purl.obolibrary.org/obo/GO_0031321) (ascospore-type prospore assembly), [GO:0070973](http://purl.obolibrary.org/obo/GO_0070973) (protein localization to endoplasmic reticulum exit site), [GO:0070974](http://purl.obolibrary.org/obo/GO_0070974) (POU domain binding), [GO:0070971](http://purl.obolibrary.org/obo/GO_0070971) (endoplasmic reticulum exit site), [GO:0070972](http://purl.obolibrary.org/obo/GO_0070972) (protein localization to endoplasmic reticulum), [GO:0070977](http://purl.obolibrary.org/obo/GO_0070977) (bone maturation), [GO:0031323](http://purl.obolibrary.org/obo/GO_0031323) (regulation of cellular metabolic process), [GO:0070976](http://purl.obolibrary.org/obo/GO_0070976) (TIR domain binding), [GO:0043306](http://purl.obolibrary.org/obo/GO_0043306) (positive regulation of mast cell degranulation), [GO:0030071](http://purl.obolibrary.org/obo/GO_0030071) (regulation of mitotic metaphase/anaphase transition), [GO:0030073](http://purl.obolibrary.org/obo/GO_0030073) (insulin secretion), [GO:0030072](http://purl.obolibrary.org/obo/GO_0030072) (peptide hormone secretion), [GO:0043303](http://purl.obolibrary.org/obo/GO_0043303) (mast cell degranulation), [GO:0045964](http://purl.obolibrary.org/obo/GO_0045964) (positive regulation of dopamine metabolic process), [GO:0002830](http://purl.obolibrary.org/obo/GO_0002830) (positive regulation of type 2 immune response), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0097167](http://purl.obolibrary.org/obo/GO_0097167) (circadian regulation of translation), [GO:0001502](http://purl.obolibrary.org/obo/GO_0001502) (cartilage condensation), [GO:0014819](http://purl.obolibrary.org/obo/GO_0014819) (regulation of skeletal muscle contraction), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0014816](http://purl.obolibrary.org/obo/GO_0014816) (skeletal muscle satellite cell differentiation), [GO:0001505](http://purl.obolibrary.org/obo/GO_0001505) (regulation of neurotransmitter levels), [GO:0031398](http://purl.obolibrary.org/obo/GO_0031398) (positive regulation of protein ubiquitination), [GO:0014814](http://purl.obolibrary.org/obo/GO_0014814) (axon regeneration at neuromuscular junction), [GO:0001508](http://purl.obolibrary.org/obo/GO_0001508) (action potential), [GO:0031396](http://purl.obolibrary.org/obo/GO_0031396) (regulation of protein ubiquitination), [GO:0014813](http://purl.obolibrary.org/obo/GO_0014813) (skeletal muscle satellite cell commitment), [GO:0014812](http://purl.obolibrary.org/obo/GO_0014812) (muscle cell migration), [GO:0031397](http://purl.obolibrary.org/obo/GO_0031397) (negative regulation of protein ubiquitination), [GO:0044648](http://purl.obolibrary.org/obo/GO_0044648) (histone H3-K4 dimethylation), [GO:0030060](http://purl.obolibrary.org/obo/GO_0030060) (L-malate dehydrogenase activity), [GO:0070914](http://purl.obolibrary.org/obo/GO_0070914) (UV-damage excision repair), [GO:0102336](http://purl.obolibrary.org/obo/GO_0102336) (3-oxo-arachidoyl-CoA synthase activity), [GO:0030061](http://purl.obolibrary.org/obo/GO_0030061) (mitochondrial crista), [GO:0102338](http://purl.obolibrary.org/obo/GO_0102338) (3-oxo-lignoceronyl-CoA synthase activity), [GO:0102337](http://purl.obolibrary.org/obo/GO_0102337) (3-oxo-cerotoyl-CoA synthase activity), [GO:0043310](http://purl.obolibrary.org/obo/GO_0043310) (negative regulation of eosinophil degranulation), [GO:0045977](http://purl.obolibrary.org/obo/GO_0045977) (positive regulation of mitotic cell cycle, embryonic), [GO:0043316](http://purl.obolibrary.org/obo/GO_0043316) (cytotoxic T cell degranulation), [GO:0017091](http://purl.obolibrary.org/obo/GO_0017091) (AU-rich element binding), [GO:0001510](http://purl.obolibrary.org/obo/GO_0001510) (RNA methylation), [GO:0014829](http://purl.obolibrary.org/obo/GO_0014829) (vascular smooth muscle contraction), [GO:0001514](http://purl.obolibrary.org/obo/GO_0001514) (selenocysteine incorporation), [GO:0001515](http://purl.obolibrary.org/obo/GO_0001515) (opioid peptide activity), [GO:0001516](http://purl.obolibrary.org/obo/GO_0001516) (prostaglandin biosynthetic process), [GO:0014826](http://purl.obolibrary.org/obo/GO_0014826) (vein smooth muscle contraction), [GO:0001517](http://purl.obolibrary.org/obo/GO_0001517) (N-acetylglucosamine 6-O-sulfotransferase activity), [GO:0017099](http://purl.obolibrary.org/obo/GO_0017099) (very-long-chain-acyl-CoA dehydrogenase activity), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0001518](http://purl.obolibrary.org/obo/GO_0001518) (voltage-gated sodium channel complex), [GO:0030057](http://purl.obolibrary.org/obo/GO_0030057) (desmosome), [GO:0014824](http://purl.obolibrary.org/obo/GO_0014824) (artery smooth muscle contraction), [GO:0014823](http://purl.obolibrary.org/obo/GO_0014823) (response to activity), [GO:0030056](http://purl.obolibrary.org/obo/GO_0030056) (hemidesmosome), [GO:0005093](http://purl.obolibrary.org/obo/GO_0005093) (Rab GDP-dissociation inhibitor activity), [GO:0005092](http://purl.obolibrary.org/obo/GO_0005092) (GDP-dissociation inhibitor activity), [GO:0005095](http://purl.obolibrary.org/obo/GO_0005095) (GTPase inhibitor activity), [GO:0030050](http://purl.obolibrary.org/obo/GO_0030050) (vesicle transport along actin filament), [GO:0031384](http://purl.obolibrary.org/obo/GO_0031384) (regulation of initiation of mating projection growth), [GO:0005096](http://purl.obolibrary.org/obo/GO_0005096) (GTPase activator activity), [GO:0045984](http://purl.obolibrary.org/obo/GO_0045984) (negative regulation of pyrimidine nucleobase metabolic process), [GO:0043320](http://purl.obolibrary.org/obo/GO_0043320) (natural killer cell degranulation), [GO:0043325](http://purl.obolibrary.org/obo/GO_0043325) (phosphatidylinositol-3,4-bisphosphate binding), [GO:0097151](http://purl.obolibrary.org/obo/GO_0097151) (positive regulation of inhibitory postsynaptic potential), [GO:0045988](http://purl.obolibrary.org/obo/GO_0045988) (negative regulation of striated muscle contraction), [GO:0097150](http://purl.obolibrary.org/obo/GO_0097150) (neuronal stem cell population maintenance), [GO:0097152](http://purl.obolibrary.org/obo/GO_0097152) (mesenchymal cell apoptotic process), [GO:0017080](http://purl.obolibrary.org/obo/GO_0017080) (sodium channel regulator activity), [GO:0017081](http://purl.obolibrary.org/obo/GO_0017081) (chloride channel regulator activity), [GO:0017084](http://purl.obolibrary.org/obo/GO_0017084) (delta1-pyrroline-5-carboxylate synthetase activity), [GO:0017085](http://purl.obolibrary.org/obo/GO_0017085) (response to insecticide), [GO:0043330](http://purl.obolibrary.org/obo/GO_0043330) (response to exogenous dsRNA), [GO:0070940](http://purl.obolibrary.org/obo/GO_0070940) (dephosphorylation of RNA polymerase II C-terminal domain), [GO:0030043](http://purl.obolibrary.org/obo/GO_0030043) (actin filament fragmentation), [GO:0030046](http://purl.obolibrary.org/obo/GO_0030046) (parallel actin filament bundle assembly), [GO:0030048](http://purl.obolibrary.org/obo/GO_0030048) (actin filament-based movement), [GO:0030049](http://purl.obolibrary.org/obo/GO_0030049) (muscle filament sliding), [GO:0070935](http://purl.obolibrary.org/obo/GO_0070935) (3'-UTR-mediated mRNA stabilization), [GO:0070936](http://purl.obolibrary.org/obo/GO_0070936) (protein K48-linked ubiquitination), [GO:0070939](http://purl.obolibrary.org/obo/GO_0070939) (Dsl1/NZR complex), [GO:0030042](http://purl.obolibrary.org/obo/GO_0030042) (actin filament depolymerization), [GO:0030041](http://purl.obolibrary.org/obo/GO_0030041) (actin filament polymerization), [GO:0045995](http://purl.obolibrary.org/obo/GO_0045995) (regulation of embryonic development), [GO:0043332](http://purl.obolibrary.org/obo/GO_0043332) (mating projection tip), [GO:0045994](http://purl.obolibrary.org/obo/GO_0045994) (positive regulation of translational initiation by iron), [GO:0044666](http://purl.obolibrary.org/obo/GO_0044666) (MLL3/4 complex), [GO:0043335](http://purl.obolibrary.org/obo/GO_0043335) (protein unfolding), [GO:0017070](http://purl.obolibrary.org/obo/GO_0017070) (U6 snRNA binding), [GO:0097154](http://purl.obolibrary.org/obo/GO_0097154) (GABAergic neuron differentiation), [GO:0097157](http://purl.obolibrary.org/obo/GO_0097157) (pre-mRNA intronic binding), [GO:0017071](http://purl.obolibrary.org/obo/GO_0017071) (intracellular cyclic nucleotide activated cation channel complex), [GO:0014808](http://purl.obolibrary.org/obo/GO_0014808) (release of sequestered calcium ion into cytosol by sarcoplasmic reticulum), [GO:0097159](http://purl.obolibrary.org/obo/GO_0097159) (organic cyclic compound binding), [GO:0014807](http://purl.obolibrary.org/obo/GO_0014807) (regulation of somitogenesis), [GO:0017075](http://purl.obolibrary.org/obo/GO_0017075) (syntaxin-1 binding), [GO:0030033](http://purl.obolibrary.org/obo/GO_0030033) (microvillus assembly), [GO:0002827](http://purl.obolibrary.org/obo/GO_0002827) (positive regulation of T-helper 1 type immune response), [GO:0030032](http://purl.obolibrary.org/obo/GO_0030032) (lamellipodium assembly), [GO:0014802](http://purl.obolibrary.org/obo/GO_0014802) (terminal cisterna), [GO:0030035](http://purl.obolibrary.org/obo/GO_0030035) (microspike assembly), [GO:0002829](http://purl.obolibrary.org/obo/GO_0002829) (negative regulation of type 2 immune response), [GO:0030037](http://purl.obolibrary.org/obo/GO_0030037) (actin filament reorganization involved in cell cycle), [GO:0031369](http://purl.obolibrary.org/obo/GO_0031369) (translation initiation factor binding), [GO:0030036](http://purl.obolibrary.org/obo/GO_0030036) (actin cytoskeleton organization), [GO:0070932](http://purl.obolibrary.org/obo/GO_0070932) (histone H3 deacetylation), [GO:1990809](http://purl.obolibrary.org/obo/GO_1990809) (endoplasmic reticulum tubular network membrane organization), [GO:0014861](http://purl.obolibrary.org/obo/GO_0014861) (regulation of skeletal muscle contraction via regulation of action potential), [GO:0000217](http://purl.obolibrary.org/obo/GO_0000217) (DNA secondary structure binding), [GO:0000214](http://purl.obolibrary.org/obo/GO_0000214) (tRNA-intron endonuclease complex), [GO:0000213](http://purl.obolibrary.org/obo/GO_0000213) (tRNA-intron endonuclease activity), [GO:0001552](http://purl.obolibrary.org/obo/GO_0001552) (ovarian follicle atresia), [GO:0000221](http://purl.obolibrary.org/obo/GO_0000221) (vacuolar proton-transporting V-type ATPase, V1 domain), [GO:0000220](http://purl.obolibrary.org/obo/GO_0000220) (vacuolar proton-transporting V-type ATPase, V0 domain), [GO:0002876](http://purl.obolibrary.org/obo/GO_0002876) (positive regulation of chronic inflammatory response to antigenic stimulus), [GO:0001547](http://purl.obolibrary.org/obo/GO_0001547) (antral ovarian follicle growth), [GO:0014858](http://purl.obolibrary.org/obo/GO_0014858) (positive regulation of skeletal muscle cell proliferation), [GO:0014857](http://purl.obolibrary.org/obo/GO_0014857) (regulation of skeletal muscle cell proliferation), [GO:0051800](http://purl.obolibrary.org/obo/GO_0051800) (phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity), [GO:0014853](http://purl.obolibrary.org/obo/GO_0014853) (regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction), [GO:0014873](http://purl.obolibrary.org/obo/GO_0014873) (response to muscle activity involved in regulation of muscle adaptation), [GO:0000228](http://purl.obolibrary.org/obo/GO_0000228) (nuclear chromosome), [GO:0000226](http://purl.obolibrary.org/obo/GO_0000226) (microtubule cytoskeleton organization), [GO:0000225](http://purl.obolibrary.org/obo/GO_0000225) (N-acetylglucosaminylphosphatidylinositol deacetylase activity), [GO:0000224](http://purl.obolibrary.org/obo/GO_0000224) (peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity), [GO:0001561](http://purl.obolibrary.org/obo/GO_0001561) (fatty acid alpha-oxidation), [GO:2000406](http://purl.obolibrary.org/obo/GO_2000406) (positive regulation of T cell migration), [GO:0001555](http://purl.obolibrary.org/obo/GO_0001555) (oocyte growth), [GO:2000405](http://purl.obolibrary.org/obo/GO_2000405) (negative regulation of T cell migration), [GO:0001556](http://purl.obolibrary.org/obo/GO_0001556) (oocyte maturation), [GO:0001558](http://purl.obolibrary.org/obo/GO_0001558) (regulation of cell growth), [GO:0030099](http://purl.obolibrary.org/obo/GO_0030099) (myeloid cell differentiation), [GO:1990812](http://purl.obolibrary.org/obo/GO_1990812) (growth cone filopodium), [GO:1990816](http://purl.obolibrary.org/obo/GO_1990816) (vacuole-mitochondrion membrane contact site), [GO:0014866](http://purl.obolibrary.org/obo/GO_0014866) (skeletal myofibril assembly), [GO:0030091](http://purl.obolibrary.org/obo/GO_0030091) (protein repair), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0001530](http://purl.obolibrary.org/obo/GO_0001530) (lipopolysaccharide binding), [GO:0001522](http://purl.obolibrary.org/obo/GO_0001522) (pseudouridine synthesis), [GO:0001523](http://purl.obolibrary.org/obo/GO_0001523) (retinoid metabolic process), [GO:0102391](http://purl.obolibrary.org/obo/GO_0102391) (decanoate--CoA ligase activity), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001527](http://purl.obolibrary.org/obo/GO_0001527) (microfibril), [GO:1990825](http://purl.obolibrary.org/obo/GO_1990825) (sequence-specific mRNA binding), [GO:0014834](http://purl.obolibrary.org/obo/GO_0014834) (skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration), [GO:0014832](http://purl.obolibrary.org/obo/GO_0014832) (urinary bladder smooth muscle contraction), [GO:0051823](http://purl.obolibrary.org/obo/GO_0051823) (regulation of synapse structural plasticity), [GO:0014831](http://purl.obolibrary.org/obo/GO_0014831) (gastro-intestinal system smooth muscle contraction), [GO:1990829](http://purl.obolibrary.org/obo/GO_1990829) (C-rich single-stranded DNA binding), [GO:0014850](http://purl.obolibrary.org/obo/GO_0014850) (response to muscle activity), [GO:0000209](http://purl.obolibrary.org/obo/GO_0000209) (protein polyubiquitination), [GO:0000208](http://purl.obolibrary.org/obo/GO_0000208) (MAPK import into nucleus involved in osmosensory signaling pathway), [GO:0050509](http://purl.obolibrary.org/obo/GO_0050509) (N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity), [GO:1904925](http://purl.obolibrary.org/obo/GO_1904925) (positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization), [GO:0001540](http://purl.obolibrary.org/obo/GO_0001540) (amyloid-beta binding), [GO:1904924](http://purl.obolibrary.org/obo/GO_1904924) (negative regulation of mitophagy in response to mitochondrial depolarization), [GO:0001541](http://purl.obolibrary.org/obo/GO_0001541) (ovarian follicle development), [GO:1990830](http://purl.obolibrary.org/obo/GO_1990830) (cellular response to leukemia inhibitory factor), [GO:0001537](http://purl.obolibrary.org/obo/GO_0001537) (N-acetylgalactosamine 4-O-sulfotransferase activity), [GO:0051835](http://purl.obolibrary.org/obo/GO_0051835) (positive regulation of synapse structural plasticity), [GO:1990837](http://purl.obolibrary.org/obo/GO_1990837) (sequence-specific double-stranded DNA binding), [GO:2000425](http://purl.obolibrary.org/obo/GO_2000425) (regulation of apoptotic cell clearance), [GO:0014842](http://purl.obolibrary.org/obo/GO_0014842) (regulation of skeletal muscle satellite cell proliferation), [GO:0014841](http://purl.obolibrary.org/obo/GO_0014841) (skeletal muscle satellite cell proliferation), [GO:0050501](http://purl.obolibrary.org/obo/GO_0050501) (hyaluronan synthase activity), [GO:0042056](http://purl.obolibrary.org/obo/GO_0042056) (chemoattractant activity), [GO:0001591](http://purl.obolibrary.org/obo/GO_0001591) (dopamine neurotransmitter receptor activity, coupled via Gi/Go), [GO:0043388](http://purl.obolibrary.org/obo/GO_0043388) (positive regulation of DNA binding), [GO:0042059](http://purl.obolibrary.org/obo/GO_0042059) (negative regulation of epidermal growth factor receptor signaling pathway), [GO:2000439](http://purl.obolibrary.org/obo/GO_2000439) (positive regulation of monocyte extravasation), [GO:0042060](http://purl.obolibrary.org/obo/GO_0042060) (wound healing), [GO:0001588](http://purl.obolibrary.org/obo/GO_0001588) (dopamine neurotransmitter receptor activity, coupled via Gs), [GO:2000438](http://purl.obolibrary.org/obo/GO_2000438) (negative regulation of monocyte extravasation), [GO:0043392](http://purl.obolibrary.org/obo/GO_0043392) (negative regulation of DNA binding), [GO:0000262](http://purl.obolibrary.org/obo/GO_0000262) (mitochondrial chromosome), [GO:1990841](http://purl.obolibrary.org/obo/GO_1990841) (promoter-specific chromatin binding), [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding), [GO:0043393](http://purl.obolibrary.org/obo/GO_0043393) (regulation of protein binding), [GO:0042063](http://purl.obolibrary.org/obo/GO_0042063) (gliogenesis), [GO:0043395](http://purl.obolibrary.org/obo/GO_0043395) (heparan sulfate proteoglycan binding), [GO:0014898](http://purl.obolibrary.org/obo/GO_0014898) (cardiac muscle hypertrophy in response to stress), [GO:0042069](http://purl.obolibrary.org/obo/GO_0042069) (regulation of catecholamine metabolic process), [GO:0000268](http://purl.obolibrary.org/obo/GO_0000268) (peroxisome targeting sequence binding), [GO:0000266](http://purl.obolibrary.org/obo/GO_0000266) (mitochondrial fission), [GO:0042073](http://purl.obolibrary.org/obo/GO_0042073) (intraciliary transport), [GO:0042074](http://purl.obolibrary.org/obo/GO_0042074) (cell migration involved in gastrulation), [GO:0000271](http://purl.obolibrary.org/obo/GO_0000271) (polysaccharide biosynthetic process), [GO:1990854](http://purl.obolibrary.org/obo/GO_1990854) (vacuole-ER tethering), [GO:0070990](http://purl.obolibrary.org/obo/GO_0070990) (snRNP binding), [GO:0070997](http://purl.obolibrary.org/obo/GO_0070997) (neuron death), [GO:0014883](http://purl.obolibrary.org/obo/GO_0014883) (transition between fast and slow fiber), [GO:0014881](http://purl.obolibrary.org/obo/GO_0014881) (regulation of myofibril size), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0001571](http://purl.obolibrary.org/obo/GO_0001571) (non-tyrosine kinase fibroblast growth factor receptor activity), [GO:0000235](http://purl.obolibrary.org/obo/GO_0000235) (astral microtubule), [GO:0001573](http://purl.obolibrary.org/obo/GO_0001573) (ganglioside metabolic process), [GO:0000242](http://purl.obolibrary.org/obo/GO_0000242) (pericentriolar material), [GO:0001565](http://purl.obolibrary.org/obo/GO_0001565) (phorbol ester receptor activity), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0001569](http://purl.obolibrary.org/obo/GO_0001569) (branching involved in blood vessel morphogenesis), [GO:1990869](http://purl.obolibrary.org/obo/GO_1990869) (cellular response to chemokine), [GO:2000451](http://purl.obolibrary.org/obo/GO_2000451) (positive regulation of CD8-positive, alpha-beta T cell extravasation), [GO:0014876](http://purl.obolibrary.org/obo/GO_0014876) (response to injury involved in regulation of muscle adaptation), [GO:0014894](http://purl.obolibrary.org/obo/GO_0014894) (response to denervation involved in regulation of muscle adaptation), [GO:0042088](http://purl.obolibrary.org/obo/GO_0042088) (T-helper 1 type immune response), [GO:0001580](http://purl.obolibrary.org/obo/GO_0001580) (detection of chemical stimulus involved in sensory perception of bitter taste), [GO:0000247](http://purl.obolibrary.org/obo/GO_0000247) (C-8 sterol isomerase activity), [GO:0000245](http://purl.obolibrary.org/obo/GO_0000245) (spliceosomal complex assembly), [GO:0000244](http://purl.obolibrary.org/obo/GO_0000244) (spliceosomal tri-snRNP complex assembly), [GO:0000252](http://purl.obolibrary.org/obo/GO_0000252) (C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity), [GO:0042093](http://purl.obolibrary.org/obo/GO_0042093) (T-helper cell differentiation), [GO:1990872](http://purl.obolibrary.org/obo/GO_1990872) (negative regulation of sterol import by negative regulation of transcription from RNA polymerase II promoter), [GO:0001578](http://purl.obolibrary.org/obo/GO_0001578) (microtubule bundle formation), [GO:0000250](http://purl.obolibrary.org/obo/GO_0000250) (lanosterol synthase activity), [GO:0001579](http://purl.obolibrary.org/obo/GO_0001579) (medium-chain fatty acid transport), [GO:0042098](http://purl.obolibrary.org/obo/GO_0042098) (T cell proliferation), [GO:2000464](http://purl.obolibrary.org/obo/GO_2000464) (positive regulation of astrocyte chemotaxis), [GO:1990879](http://purl.obolibrary.org/obo/GO_1990879) (CST complex), [GO:2000463](http://purl.obolibrary.org/obo/GO_2000463) (positive regulation of excitatory postsynaptic potential), [GO:0014889](http://purl.obolibrary.org/obo/GO_0014889) (muscle atrophy), [GO:0036376](http://purl.obolibrary.org/obo/GO_0036376) (sodium ion export across plasma membrane), [GO:0061333](http://purl.obolibrary.org/obo/GO_0061333) (renal tubule morphogenesis), [GO:0060002](http://purl.obolibrary.org/obo/GO_0060002) (plus-end directed microfilament motor activity), [GO:0060003](http://purl.obolibrary.org/obo/GO_0060003) (copper ion export), [GO:1904851](http://purl.obolibrary.org/obo/GO_1904851) (positive regulation of establishment of protein localization to telomere), [GO:0036372](http://purl.obolibrary.org/obo/GO_0036372) (opsin transport), [GO:0060008](http://purl.obolibrary.org/obo/GO_0060008) (Sertoli cell differentiation), [GO:0060009](http://purl.obolibrary.org/obo/GO_0060009) (Sertoli cell development), [GO:1903522](http://purl.obolibrary.org/obo/GO_1903522) (regulation of blood circulation), [GO:0060005](http://purl.obolibrary.org/obo/GO_0060005) (vestibular reflex), [GO:0061337](http://purl.obolibrary.org/obo/GO_0061337) (cardiac conduction), [GO:0060007](http://purl.obolibrary.org/obo/GO_0060007) (linear vestibuloocular reflex), [GO:0050672](http://purl.obolibrary.org/obo/GO_0050672) (negative regulation of lymphocyte proliferation), [GO:0050673](http://purl.obolibrary.org/obo/GO_0050673) (epithelial cell proliferation), [GO:0048368](http://purl.obolibrary.org/obo/GO_0048368) (lateral mesoderm development), [GO:0050671](http://purl.obolibrary.org/obo/GO_0050671) (positive regulation of lymphocyte proliferation), [GO:0048365](http://purl.obolibrary.org/obo/GO_0048365) (Rac GTPase binding), [GO:2000232](http://purl.obolibrary.org/obo/GO_2000232) (regulation of rRNA processing), [GO:0050678](http://purl.obolibrary.org/obo/GO_0050678) (regulation of epithelial cell proliferation), [GO:0035037](http://purl.obolibrary.org/obo/GO_0035037) (sperm entry), [GO:2000238](http://purl.obolibrary.org/obo/GO_2000238) (regulation of tRNA export from nucleus), [GO:0036368](http://purl.obolibrary.org/obo/GO_0036368) (cone photoresponse recovery), [GO:0050679](http://purl.obolibrary.org/obo/GO_0050679) (positive regulation of epithelial cell proliferation), [GO:2000235](http://purl.obolibrary.org/obo/GO_2000235) (regulation of tRNA processing), [GO:0035035](http://purl.obolibrary.org/obo/GO_0035035) (histone acetyltransferase binding), [GO:2000251](http://purl.obolibrary.org/obo/GO_2000251) (positive regulation of actin cytoskeleton reorganization), [GO:1904861](http://purl.obolibrary.org/obo/GO_1904861) (excitatory synapse assembly), [GO:0061325](http://purl.obolibrary.org/obo/GO_0061325) (cell proliferation involved in outflow tract morphogenesis), [GO:0061326](http://purl.obolibrary.org/obo/GO_0061326) (renal tubule development), [GO:1903538](http://purl.obolibrary.org/obo/GO_1903538) (regulation of meiotic cell cycle process involved in oocyte maturation), [GO:0023051](http://purl.obolibrary.org/obo/GO_0023051) (regulation of signaling), [GO:0050681](http://purl.obolibrary.org/obo/GO_0050681) (androgen receptor binding), [GO:0048378](http://purl.obolibrary.org/obo/GO_0048378) (regulation of lateral mesodermal cell fate specification), [GO:0050682](http://purl.obolibrary.org/obo/GO_0050682) (AF-2 domain binding), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:0047045](http://purl.obolibrary.org/obo/GO_0047045) (testosterone 17-beta-dehydrogenase (NADP+) activity), [GO:0050689](http://purl.obolibrary.org/obo/GO_0050689) (negative regulation of defense response to virus by host), [GO:2000249](http://purl.obolibrary.org/obo/GO_2000249) (regulation of actin cytoskeleton reorganization), [GO:0050687](http://purl.obolibrary.org/obo/GO_0050687) (negative regulation of defense response to virus), [GO:0050688](http://purl.obolibrary.org/obo/GO_0050688) (regulation of defense response to virus), [GO:0060022](http://purl.obolibrary.org/obo/GO_0060022) (hard palate development), [GO:0035022](http://purl.obolibrary.org/obo/GO_0035022) (positive regulation of Rac protein signal transduction), [GO:0035023](http://purl.obolibrary.org/obo/GO_0035023) (regulation of Rho protein signal transduction), [GO:0060023](http://purl.obolibrary.org/obo/GO_0060023) (soft palate development), [GO:0060024](http://purl.obolibrary.org/obo/GO_0060024) (rhythmic synaptic transmission), [GO:0035024](http://purl.obolibrary.org/obo/GO_0035024) (negative regulation of Rho protein signal transduction), [GO:0061355](http://purl.obolibrary.org/obo/GO_0061355) (Wnt protein secretion), [GO:0035025](http://purl.obolibrary.org/obo/GO_0035025) (positive regulation of Rho protein signal transduction), [GO:0060025](http://purl.obolibrary.org/obo/GO_0060025) (regulation of synaptic activity), [GO:1904874](http://purl.obolibrary.org/obo/GO_1904874) (positive regulation of telomerase RNA localization to Cajal body), [GO:1903543](http://purl.obolibrary.org/obo/GO_1903543) (positive regulation of exosomal secretion), [GO:0061351](http://purl.obolibrary.org/obo/GO_0061351) (neural precursor cell proliferation), [GO:0060020](http://purl.obolibrary.org/obo/GO_0060020) (Bergmann glial cell differentiation), [GO:1904872](http://purl.obolibrary.org/obo/GO_1904872) (regulation of telomerase RNA localization to Cajal body), [GO:0036351](http://purl.obolibrary.org/obo/GO_0036351) (histone H2A-K13 ubiquitination), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:1904871](http://purl.obolibrary.org/obo/GO_1904871) (positive regulation of protein localization to Cajal body), [GO:0035021](http://purl.obolibrary.org/obo/GO_0035021) (negative regulation of Rac protein signal transduction), [GO:0036352](http://purl.obolibrary.org/obo/GO_0036352) (histone H2A-K15 ubiquitination), [GO:1903546](http://purl.obolibrary.org/obo/GO_1903546) (protein localization to photoreceptor outer segment), [GO:0060026](http://purl.obolibrary.org/obo/GO_0060026) (convergent extension), [GO:0060027](http://purl.obolibrary.org/obo/GO_0060027) (convergent extension involved in gastrulation), [GO:0060028](http://purl.obolibrary.org/obo/GO_0060028) (convergent extension involved in axis elongation), [GO:0000398](http://purl.obolibrary.org/obo/GO_0000398) (mRNA splicing, via spliceosome), [GO:0060029](http://purl.obolibrary.org/obo/GO_0060029) (convergent extension involved in organogenesis), [GO:0048386](http://purl.obolibrary.org/obo/GO_0048386) (positive regulation of retinoic acid receptor signaling pathway), [GO:0048385](http://purl.obolibrary.org/obo/GO_0048385) (regulation of retinoic acid receptor signaling pathway), [GO:0048384](http://purl.obolibrary.org/obo/GO_0048384) (retinoic acid receptor signaling pathway), [GO:0072001](http://purl.obolibrary.org/obo/GO_0072001) (renal system development), [GO:0048387](http://purl.obolibrary.org/obo/GO_0048387) (negative regulation of retinoic acid receptor signaling pathway), [GO:0023041](http://purl.obolibrary.org/obo/GO_0023041) (neuronal signal transduction), [GO:0050691](http://purl.obolibrary.org/obo/GO_0050691) (regulation of defense response to virus by host), [GO:0035019](http://purl.obolibrary.org/obo/GO_0035019) (somatic stem cell population maintenance), [GO:0072006](http://purl.obolibrary.org/obo/GO_0072006) (nephron development), [GO:2000253](http://purl.obolibrary.org/obo/GO_2000253) (positive regulation of feeding behavior), [GO:0048382](http://purl.obolibrary.org/obo/GO_0048382) (mesendoderm development), [GO:0050699](http://purl.obolibrary.org/obo/GO_0050699) (WW domain binding), [GO:0036342](http://purl.obolibrary.org/obo/GO_0036342) (post-anal tail morphogenesis), [GO:0060011](http://purl.obolibrary.org/obo/GO_0060011) (Sertoli cell proliferation), [GO:0060012](http://purl.obolibrary.org/obo/GO_0060012) (synaptic transmission, glycinergic), [GO:0036343](http://purl.obolibrary.org/obo/GO_0036343) (psychomotor behavior), [GO:0060013](http://purl.obolibrary.org/obo/GO_0060013) (righting reflex), [GO:0035014](http://purl.obolibrary.org/obo/GO_0035014) (phosphatidylinositol 3-kinase regulator activity), [GO:0060014](http://purl.obolibrary.org/obo/GO_0060014) (granulosa cell differentiation), [GO:2000273](http://purl.obolibrary.org/obo/GO_2000273) (positive regulation of receptor activity), [GO:1904884](http://purl.obolibrary.org/obo/GO_1904884) (positive regulation of telomerase catalytic core complex assembly), [GO:2000272](http://purl.obolibrary.org/obo/GO_2000272) (negative regulation of receptor activity), [GO:2000271](http://purl.obolibrary.org/obo/GO_2000271) (positive regulation of fibroblast apoptotic process), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0061346](http://purl.obolibrary.org/obo/GO_0061346) (planar cell polarity pathway involved in heart morphogenesis), [GO:0060017](http://purl.obolibrary.org/obo/GO_0060017) (parathyroid gland development), [GO:0098609](http://purl.obolibrary.org/obo/GO_0098609) (cell-cell adhesion), [GO:0048392](http://purl.obolibrary.org/obo/GO_0048392) (intermediate mesodermal cell differentiation), [GO:0036336](http://purl.obolibrary.org/obo/GO_0036336) (dendritic cell migration), [GO:2000269](http://purl.obolibrary.org/obo/GO_2000269) (regulation of fibroblast apoptotic process), [GO:0035088](http://purl.obolibrary.org/obo/GO_0035088) (establishment or maintenance of apical/basal cell polarity), [GO:0019835](http://purl.obolibrary.org/obo/GO_0019835) (cytolysis), [GO:0019838](http://purl.obolibrary.org/obo/GO_0019838) (growth factor binding), [GO:0035087](http://purl.obolibrary.org/obo/GO_0035087) (siRNA loading onto RISC involved in RNA interference), [GO:0006520](http://purl.obolibrary.org/obo/GO_0006520) (cellular amino acid metabolic process), [GO:0035082](http://purl.obolibrary.org/obo/GO_0035082) (axoneme assembly), [GO:0032809](http://purl.obolibrary.org/obo/GO_0032809) (neuronal cell body membrane), [GO:0006523](http://purl.obolibrary.org/obo/GO_0006523) (alanine biosynthetic process), [GO:0006524](http://purl.obolibrary.org/obo/GO_0006524) (alanine catabolic process), [GO:0048318](http://purl.obolibrary.org/obo/GO_0048318) (axial mesoderm development), [GO:0048320](http://purl.obolibrary.org/obo/GO_0048320) (axial mesoderm formation), [GO:0006516](http://purl.obolibrary.org/obo/GO_0006516) (glycoprotein catabolic process), [GO:0006517](http://purl.obolibrary.org/obo/GO_0006517) (protein deglycosylation), [GO:0032801](http://purl.obolibrary.org/obo/GO_0032801) (receptor catabolic process), [GO:0006515](http://purl.obolibrary.org/obo/GO_0006515) (protein quality control for misfolded or incompletely synthesized proteins), [GO:0032807](http://purl.obolibrary.org/obo/GO_0032807) (DNA ligase IV complex), [GO:0032808](http://purl.obolibrary.org/obo/GO_0032808) (lacrimal gland development), [GO:0006518](http://purl.obolibrary.org/obo/GO_0006518) (peptide metabolic process), [GO:2000277](http://purl.obolibrary.org/obo/GO_2000277) (positive regulation of oxidative phosphorylation uncoupler activity), [GO:2000276](http://purl.obolibrary.org/obo/GO_2000276) (negative regulation of oxidative phosphorylation uncoupler activity), [GO:0051967](http://purl.obolibrary.org/obo/GO_0051967) (negative regulation of synaptic transmission, glutamatergic), [GO:0019841](http://purl.obolibrary.org/obo/GO_0019841) (retinol binding), [GO:0051968](http://purl.obolibrary.org/obo/GO_0051968) (positive regulation of synaptic transmission, glutamatergic), [GO:0051965](http://purl.obolibrary.org/obo/GO_0051965) (positive regulation of synapse assembly), [GO:0019843](http://purl.obolibrary.org/obo/GO_0019843) (rRNA binding), [GO:0051966](http://purl.obolibrary.org/obo/GO_0051966) (regulation of synaptic transmission, glutamatergic), [GO:0032800](http://purl.obolibrary.org/obo/GO_0032800) (receptor biosynthetic process), [GO:0019842](http://purl.obolibrary.org/obo/GO_0019842) (vitamin binding), [GO:0050632](http://purl.obolibrary.org/obo/GO_0050632) (propionyl-CoA C2-trimethyltridecanoyltransferase activity), [GO:0051963](http://purl.obolibrary.org/obo/GO_0051963) (regulation of synapse assembly), [GO:2000279](http://purl.obolibrary.org/obo/GO_2000279) (negative regulation of DNA biosynthetic process), [GO:0019825](http://purl.obolibrary.org/obo/GO_0019825) (oxygen binding), [GO:2000291](http://purl.obolibrary.org/obo/GO_2000291) (regulation of myoblast proliferation), [GO:0019827](http://purl.obolibrary.org/obo/GO_0019827) (stem cell population maintenance), [GO:0019829](http://purl.obolibrary.org/obo/GO_0019829) (cation-transporting ATPase activity), [GO:0019828](http://purl.obolibrary.org/obo/GO_0019828) (aspartic-type endopeptidase inhibitor activity), [GO:0006531](http://purl.obolibrary.org/obo/GO_0006531) (aspartate metabolic process), [GO:0005200](http://purl.obolibrary.org/obo/GO_0005200) (structural constituent of cytoskeleton), [GO:0005201](http://purl.obolibrary.org/obo/GO_0005201) (extracellular matrix structural constituent), [GO:0006535](http://purl.obolibrary.org/obo/GO_0006535) (cysteine biosynthetic process from serine), [GO:0048329](http://purl.obolibrary.org/obo/GO_0048329) (negative regulation of axial mesodermal cell fate specification), [GO:0006527](http://purl.obolibrary.org/obo/GO_0006527) (arginine catabolic process), [GO:0051973](http://purl.obolibrary.org/obo/GO_0051973) (positive regulation of telomerase activity), [GO:0051970](http://purl.obolibrary.org/obo/GO_0051970) (negative regulation of transmission of nerve impulse), [GO:0006526](http://purl.obolibrary.org/obo/GO_0006526) (arginine biosynthetic process), [GO:0051971](http://purl.obolibrary.org/obo/GO_0051971) (positive regulation of transmission of nerve impulse), [GO:0048333](http://purl.obolibrary.org/obo/GO_0048333) (mesodermal cell differentiation), [GO:0006529](http://purl.obolibrary.org/obo/GO_0006529) (asparagine biosynthetic process), [GO:2000288](http://purl.obolibrary.org/obo/GO_2000288) (positive regulation of myoblast proliferation), [GO:0051978](http://purl.obolibrary.org/obo/GO_0051978) (lysophospholipid transporter activity), [GO:0051977](http://purl.obolibrary.org/obo/GO_0051977) (lysophospholipid transport), [GO:0051974](http://purl.obolibrary.org/obo/GO_0051974) (negative regulation of telomerase activity), [GO:0035066](http://purl.obolibrary.org/obo/GO_0035066) (positive regulation of histone acetylation), [GO:0035067](http://purl.obolibrary.org/obo/GO_0035067) (negative regulation of histone acetylation), [GO:0061312](http://purl.obolibrary.org/obo/GO_0061312) (BMP signaling pathway involved in heart development), [GO:0035063](http://purl.obolibrary.org/obo/GO_0035063) (nuclear speck organization), [GO:0035064](http://purl.obolibrary.org/obo/GO_0035064) (methylated histone binding), [GO:0035065](http://purl.obolibrary.org/obo/GO_0035065) (regulation of histone acetylation), [GO:0048339](http://purl.obolibrary.org/obo/GO_0048339) (paraxial mesoderm development), [GO:0047006](http://purl.obolibrary.org/obo/GO_0047006) (17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity), [GO:1903507](http://purl.obolibrary.org/obo/GO_1903507) (negative regulation of nucleic acid-templated transcription), [GO:0061316](http://purl.obolibrary.org/obo/GO_0061316) (canonical Wnt signaling pathway involved in heart development), [GO:0048341](http://purl.obolibrary.org/obo/GO_0048341) (paraxial mesoderm formation), [GO:0051984](http://purl.obolibrary.org/obo/GO_0051984) (positive regulation of chromosome segregation), [GO:0050650](http://purl.obolibrary.org/obo/GO_0050650) (chondroitin sulfate proteoglycan biosynthetic process), [GO:0047015](http://purl.obolibrary.org/obo/GO_0047015) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity), [GO:0047012](http://purl.obolibrary.org/obo/GO_0047012) (sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity), [GO:0048343](http://purl.obolibrary.org/obo/GO_0048343) (paraxial mesodermal cell fate commitment), [GO:2000298](http://purl.obolibrary.org/obo/GO_2000298) (regulation of Rho-dependent protein serine/threonine kinase activity), [GO:0051987](http://purl.obolibrary.org/obo/GO_0051987) (positive regulation of attachment of spindle microtubules to kinetochore), [GO:0050654](http://purl.obolibrary.org/obo/GO_0050654) (chondroitin sulfate proteoglycan metabolic process), [GO:0050655](http://purl.obolibrary.org/obo/GO_0050655) (dermatan sulfate proteoglycan metabolic process), [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development), [GO:0019805](http://purl.obolibrary.org/obo/GO_0019805) (quinolinate biosynthetic process), [GO:0019807](http://purl.obolibrary.org/obo/GO_0019807) (aspartoacylase activity), [GO:0019809](http://purl.obolibrary.org/obo/GO_0019809) (spermidine binding), [GO:0019808](http://purl.obolibrary.org/obo/GO_0019808) (polyamine binding), [GO:0048348](http://purl.obolibrary.org/obo/GO_0048348) (paraxial mesodermal cell fate specification), [GO:0061309](http://purl.obolibrary.org/obo/GO_0061309) (cardiac neural crest cell development involved in outflow tract morphogenesis), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0061303](http://purl.obolibrary.org/obo/GO_0061303) (cornea development in camera-type eye), [GO:0006513](http://purl.obolibrary.org/obo/GO_0006513) (protein monoubiquitination), [GO:0061304](http://purl.obolibrary.org/obo/GO_0061304) (retinal blood vessel morphogenesis), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0006505](http://purl.obolibrary.org/obo/GO_0006505) (GPI anchor metabolic process), [GO:0006506](http://purl.obolibrary.org/obo/GO_0006506) (GPI anchor biosynthetic process), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0047020](http://purl.obolibrary.org/obo/GO_0047020) (15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity), [GO:0050662](http://purl.obolibrary.org/obo/GO_0050662) (coenzyme binding), [GO:0006509](http://purl.obolibrary.org/obo/GO_0006509) (membrane protein ectodomain proteolysis), [GO:0051990](http://purl.obolibrary.org/obo/GO_0051990) ((R)-2-hydroxyglutarate dehydrogenase activity), [GO:0050660](http://purl.obolibrary.org/obo/GO_0050660) (flavin adenine dinucleotide binding), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0047023](http://purl.obolibrary.org/obo/GO_0047023) (androsterone dehydrogenase activity), [GO:0050667](http://purl.obolibrary.org/obo/GO_0050667) (homocysteine metabolic process), [GO:0060088](http://purl.obolibrary.org/obo/GO_0060088) (auditory receptor cell stereocilium organization), [GO:0043507](http://purl.obolibrary.org/obo/GO_0043507) (positive regulation of JUN kinase activity), [GO:0044838](http://purl.obolibrary.org/obo/GO_0044838) (cell quiescence), [GO:0043506](http://purl.obolibrary.org/obo/GO_0043506) (regulation of JUN kinase activity), [GO:0006560](http://purl.obolibrary.org/obo/GO_0006560) (proline metabolic process), [GO:1902275](http://purl.obolibrary.org/obo/GO_1902275) (regulation of chromatin organization), [GO:0006563](http://purl.obolibrary.org/obo/GO_0006563) (L-serine metabolic process), [GO:0006564](http://purl.obolibrary.org/obo/GO_0006564) (L-serine biosynthetic process), [GO:0005230](http://purl.obolibrary.org/obo/GO_0005230) (extracellular ligand-gated ion channel activity), [GO:0006561](http://purl.obolibrary.org/obo/GO_0006561) (proline biosynthetic process), [GO:0044830](http://purl.obolibrary.org/obo/GO_0044830) (modulation by host of viral RNA genome replication), [GO:0006562](http://purl.obolibrary.org/obo/GO_0006562) (proline catabolic process), [GO:0097371](http://purl.obolibrary.org/obo/GO_0097371) (MDM2/MDM4 family protein binding), [GO:0043501](http://purl.obolibrary.org/obo/GO_0043501) (skeletal muscle adaptation), [GO:0072073](http://purl.obolibrary.org/obo/GO_0072073) (kidney epithelium development), [GO:0006568](http://purl.obolibrary.org/obo/GO_0006568) (tryptophan metabolic process), [GO:0005234](http://purl.obolibrary.org/obo/GO_0005234) (extracellularly glutamate-gated ion channel activity), [GO:0006566](http://purl.obolibrary.org/obo/GO_0006566) (threonine metabolic process), [GO:0005227](http://purl.obolibrary.org/obo/GO_0005227) (calcium activated cation channel activity), [GO:0097363](http://purl.obolibrary.org/obo/GO_0097363) (protein O-GlcNAc transferase activity), [GO:0031514](http://purl.obolibrary.org/obo/GO_0031514) (motile cilium), [GO:0006558](http://purl.obolibrary.org/obo/GO_0006558) (L-phenylalanine metabolic process), [GO:0006559](http://purl.obolibrary.org/obo/GO_0006559) (L-phenylalanine catabolic process), [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding), [GO:0031519](http://purl.obolibrary.org/obo/GO_0031519) (PcG protein complex), [GO:0097369](http://purl.obolibrary.org/obo/GO_0097369) (sodium ion import), [GO:0060091](http://purl.obolibrary.org/obo/GO_0060091) (kinocilium), [GO:0019882](http://purl.obolibrary.org/obo/GO_0019882) (antigen processing and presentation), [GO:0060092](http://purl.obolibrary.org/obo/GO_0060092) (regulation of synaptic transmission, glycinergic), [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II), [GO:0019889](http://purl.obolibrary.org/obo/GO_0019889) (pteridine metabolic process), [GO:0019888](http://purl.obolibrary.org/obo/GO_0019888) (protein phosphatase regulator activity), [GO:0060077](http://purl.obolibrary.org/obo/GO_0060077) (inhibitory synapse), [GO:0019869](http://purl.obolibrary.org/obo/GO_0019869) (chloride channel inhibitor activity), [GO:0060078](http://purl.obolibrary.org/obo/GO_0060078) (regulation of postsynaptic membrane potential), [GO:0043515](http://purl.obolibrary.org/obo/GO_0043515) (kinetochore binding), [GO:0043518](http://purl.obolibrary.org/obo/GO_0043518) (negative regulation of DNA damage response, signal transduction by p53 class mediator), [GO:1902282](http://purl.obolibrary.org/obo/GO_1902282) (voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization), [GO:0060079](http://purl.obolibrary.org/obo/GO_0060079) (excitatory postsynaptic potential), [GO:0043517](http://purl.obolibrary.org/obo/GO_0043517) (positive regulation of DNA damage response, signal transduction by p53 class mediator), [GO:0006570](http://purl.obolibrary.org/obo/GO_0006570) (tyrosine metabolic process), [GO:0060074](http://purl.obolibrary.org/obo/GO_0060074) (synapse maturation), [GO:0006571](http://purl.obolibrary.org/obo/GO_0006571) (tyrosine biosynthetic process), [GO:0060075](http://purl.obolibrary.org/obo/GO_0060075) (regulation of resting membrane potential), [GO:0060076](http://purl.obolibrary.org/obo/GO_0060076) (excitatory synapse), [GO:0006574](http://purl.obolibrary.org/obo/GO_0006574) (valine catabolic process), [GO:0005242](http://purl.obolibrary.org/obo/GO_0005242) (inward rectifier potassium channel activity), [GO:0005244](http://purl.obolibrary.org/obo/GO_0005244) (voltage-gated ion channel activity), [GO:0006572](http://purl.obolibrary.org/obo/GO_0006572) (tyrosine catabolic process), [GO:0005243](http://purl.obolibrary.org/obo/GO_0005243) (gap junction channel activity), [GO:0005246](http://purl.obolibrary.org/obo/GO_0005246) (calcium channel regulator activity), [GO:0005245](http://purl.obolibrary.org/obo/GO_0005245) (voltage-gated calcium channel activity), [GO:0005248](http://purl.obolibrary.org/obo/GO_0005248) (voltage-gated sodium channel activity), [GO:0005247](http://purl.obolibrary.org/obo/GO_0005247) (voltage-gated chloride channel activity), [GO:0031505](http://purl.obolibrary.org/obo/GO_0031505) (fungal-type cell wall organization), [GO:0032836](http://purl.obolibrary.org/obo/GO_0032836) (glomerular basement membrane development), [GO:0097374](http://purl.obolibrary.org/obo/GO_0097374) (sensory neuron axon guidance), [GO:0072053](http://purl.obolibrary.org/obo/GO_0072053) (renal inner medulla development), [GO:0006569](http://purl.obolibrary.org/obo/GO_0006569) (tryptophan catabolic process), [GO:0032834](http://purl.obolibrary.org/obo/GO_0032834) (positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response), [GO:0032835](http://purl.obolibrary.org/obo/GO_0032835) (glomerulus development), [GO:0097376](http://purl.obolibrary.org/obo/GO_0097376) (interneuron axon guidance), [GO:0031507](http://purl.obolibrary.org/obo/GO_0031507) (heterochromatin assembly), [GO:0019870](http://purl.obolibrary.org/obo/GO_0019870) (potassium channel inhibitor activity), [GO:0032839](http://purl.obolibrary.org/obo/GO_0032839) (dendrite cytoplasm), [GO:0060080](http://purl.obolibrary.org/obo/GO_0060080) (inhibitory postsynaptic potential), [GO:0060081](http://purl.obolibrary.org/obo/GO_0060081) (membrane hyperpolarization), [GO:0019871](http://purl.obolibrary.org/obo/GO_0019871) (sodium channel inhibitor activity), [GO:0031501](http://purl.obolibrary.org/obo/GO_0031501) (mannosyltransferase complex), [GO:0019878](http://purl.obolibrary.org/obo/GO_0019878) (lysine biosynthetic process via aminoadipic acid), [GO:0120013](http://purl.obolibrary.org/obo/GO_0120013) (intermembrane lipid transfer activity), [GO:0120017](http://purl.obolibrary.org/obo/GO_0120017) (intermembrane ceramide transfer activity), [GO:0072091](http://purl.obolibrary.org/obo/GO_0072091) (regulation of stem cell proliferation), [GO:0006541](http://purl.obolibrary.org/obo/GO_0006541) (glutamine metabolic process), [GO:0006542](http://purl.obolibrary.org/obo/GO_0006542) (glutamine biosynthetic process), [GO:0006540](http://purl.obolibrary.org/obo/GO_0006540) (glutamate decarboxylation to succinate), [GO:0043523](http://purl.obolibrary.org/obo/GO_0043523) (regulation of neuron apoptotic process), [GO:0072095](http://purl.obolibrary.org/obo/GO_0072095) (regulation of branch elongation involved in ureteric bud branching), [GO:0006545](http://purl.obolibrary.org/obo/GO_0006545) (glycine biosynthetic process), [GO:0044853](http://purl.obolibrary.org/obo/GO_0044853) (plasma membrane raft), [GO:0005212](http://purl.obolibrary.org/obo/GO_0005212) (structural constituent of eye lens), [GO:0006546](http://purl.obolibrary.org/obo/GO_0006546) (glycine catabolic process), [GO:0043522](http://purl.obolibrary.org/obo/GO_0043522) (leucine zipper domain binding), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0006544](http://purl.obolibrary.org/obo/GO_0006544) (glycine metabolic process), [GO:0097350](http://purl.obolibrary.org/obo/GO_0097350) (neutrophil clearance), [GO:0006538](http://purl.obolibrary.org/obo/GO_0006538) (glutamate catabolic process), [GO:0097342](http://purl.obolibrary.org/obo/GO_0097342) (ripoptosome), [GO:0006536](http://purl.obolibrary.org/obo/GO_0006536) (glutamate metabolic process), [GO:0006537](http://purl.obolibrary.org/obo/GO_0006537) (glutamate biosynthetic process), [GO:0043539](http://purl.obolibrary.org/obo/GO_0043539) (protein serine/threonine kinase activator activity), [GO:0035095](http://purl.obolibrary.org/obo/GO_0035095) (behavioral response to nicotine), [GO:0035097](http://purl.obolibrary.org/obo/GO_0035097) (histone methyltransferase complex), [GO:0120008](http://purl.obolibrary.org/obo/GO_0120008) (positive regulation of glutamatergic neuron differentiation), [GO:0035098](http://purl.obolibrary.org/obo/GO_0035098) (ESC/E(Z) complex), [GO:0035091](http://purl.obolibrary.org/obo/GO_0035091) (phosphatidylinositol binding), [GO:0006552](http://purl.obolibrary.org/obo/GO_0006552) (leucine catabolic process), [GO:0005220](http://purl.obolibrary.org/obo/GO_0005220) (inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity), [GO:0120009](http://purl.obolibrary.org/obo/GO_0120009) (intermembrane lipid transfer), [GO:0005222](http://purl.obolibrary.org/obo/GO_0005222) (intracellular cAMP activated cation channel activity), [GO:0006550](http://purl.obolibrary.org/obo/GO_0006550) (isoleucine catabolic process), [GO:0043531](http://purl.obolibrary.org/obo/GO_0043531) (ADP binding), [GO:0035094](http://purl.obolibrary.org/obo/GO_0035094) (response to nicotine), [GO:0005221](http://purl.obolibrary.org/obo/GO_0005221) (intracellular cyclic nucleotide activated cation channel activity), [GO:0006556](http://purl.obolibrary.org/obo/GO_0006556) (S-adenosylmethionine biosynthetic process), [GO:0043534](http://purl.obolibrary.org/obo/GO_0043534) (blood vessel endothelial cell migration), [GO:0005223](http://purl.obolibrary.org/obo/GO_0005223) (intracellular cGMP activated cation channel activity), [GO:0043533](http://purl.obolibrary.org/obo/GO_0043533) (inositol 1,3,4,5 tetrakisphosphate binding), [GO:0043536](http://purl.obolibrary.org/obo/GO_0043536) (positive regulation of blood vessel endothelial cell migration), [GO:0006555](http://purl.obolibrary.org/obo/GO_0006555) (methionine metabolic process), [GO:0043535](http://purl.obolibrary.org/obo/GO_0043535) (regulation of blood vessel endothelial cell migration), [GO:0005216](http://purl.obolibrary.org/obo/GO_0005216) (ion channel activity), [GO:0097352](http://purl.obolibrary.org/obo/GO_0097352) (autophagosome maturation), [GO:0005219](http://purl.obolibrary.org/obo/GO_0005219) (ryanodine-sensitive calcium-release channel activity), [GO:0072075](http://purl.obolibrary.org/obo/GO_0072075) (metanephric mesenchyme development), [GO:0006547](http://purl.obolibrary.org/obo/GO_0006547) (histidine metabolic process), [GO:0032813](http://purl.obolibrary.org/obo/GO_0032813) (tumor necrosis factor receptor superfamily binding), [GO:0006548](http://purl.obolibrary.org/obo/GO_0006548) (histidine catabolic process), [GO:0032816](http://purl.obolibrary.org/obo/GO_0032816) (positive regulation of natural killer cell activation), [GO:0019855](http://purl.obolibrary.org/obo/GO_0019855) (calcium channel inhibitor activity), [GO:0060044](http://purl.obolibrary.org/obo/GO_0060044) (negative regulation of cardiac muscle cell proliferation), [GO:0060045](http://purl.obolibrary.org/obo/GO_0060045) (positive regulation of cardiac muscle cell proliferation), [GO:1902230](http://purl.obolibrary.org/obo/GO_1902230) (negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage), [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle), [GO:0060046](http://purl.obolibrary.org/obo/GO_0060046) (regulation of acrosome reaction), [GO:0060047](http://purl.obolibrary.org/obo/GO_0060047) (heart contraction), [GO:0061371](http://purl.obolibrary.org/obo/GO_0061371) (determination of heart left/right asymmetry), [GO:0060040](http://purl.obolibrary.org/obo/GO_0060040) (retinal bipolar neuron differentiation), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:1903565](http://purl.obolibrary.org/obo/GO_1903565) (negative regulation of protein localization to cilium), [GO:0060042](http://purl.obolibrary.org/obo/GO_0060042) (retina morphogenesis in camera-type eye), [GO:0061373](http://purl.obolibrary.org/obo/GO_0061373) (mammillary axonal complex development), [GO:0005272](http://purl.obolibrary.org/obo/GO_0005272) (sodium channel activity), [GO:0060043](http://purl.obolibrary.org/obo/GO_0060043) (regulation of cardiac muscle cell proliferation), [GO:1903568](http://purl.obolibrary.org/obo/GO_1903568) (negative regulation of protein localization to ciliary membrane), [GO:1904899](http://purl.obolibrary.org/obo/GO_1904899) (positive regulation of hepatic stellate cell proliferation), [GO:0005277](http://purl.obolibrary.org/obo/GO_0005277) (acetylcholine transmembrane transporter activity), [GO:1903566](http://purl.obolibrary.org/obo/GO_1903566) (positive regulation of protein localization to cilium), [GO:1902236](http://purl.obolibrary.org/obo/GO_1902236) (negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway), [GO:0060048](http://purl.obolibrary.org/obo/GO_0060048) (cardiac muscle contraction), [GO:0060049](http://purl.obolibrary.org/obo/GO_0060049) (regulation of protein glycosylation), [GO:0032889](http://purl.obolibrary.org/obo/GO_0032889) (regulation of vacuole fusion, non-autophagic), [GO:0030229](http://purl.obolibrary.org/obo/GO_0030229) (very-low-density lipoprotein particle receptor activity), [GO:0097324](http://purl.obolibrary.org/obo/GO_0097324) (melanocyte migration), [GO:0098656](http://purl.obolibrary.org/obo/GO_0098656) (anion transmembrane transport), [GO:0097326](http://purl.obolibrary.org/obo/GO_0097326) (melanocyte adhesion), [GO:0098655](http://purl.obolibrary.org/obo/GO_0098655) (cation transmembrane transport), [GO:0097325](http://purl.obolibrary.org/obo/GO_0097325) (melanocyte proliferation), [GO:0030220](http://purl.obolibrary.org/obo/GO_0030220) (platelet formation), [GO:0031550](http://purl.obolibrary.org/obo/GO_0031550) (positive regulation of brain-derived neurotrophic factor receptor signaling pathway), [GO:0030222](http://purl.obolibrary.org/obo/GO_0030222) (eosinophil differentiation), [GO:0030221](http://purl.obolibrary.org/obo/GO_0030221) (basophil differentiation), [GO:0030224](http://purl.obolibrary.org/obo/GO_0030224) (monocyte differentiation), [GO:0030223](http://purl.obolibrary.org/obo/GO_0030223) (neutrophil differentiation), [GO:0030225](http://purl.obolibrary.org/obo/GO_0030225) (macrophage differentiation), [GO:0032886](http://purl.obolibrary.org/obo/GO_0032886) (regulation of microtubule-based process), [GO:0044803](http://purl.obolibrary.org/obo/GO_0044803) (multi-organism membrane organization), [GO:0060034](http://purl.obolibrary.org/obo/GO_0060034) (notochord cell differentiation), [GO:0060035](http://purl.obolibrary.org/obo/GO_0060035) (notochord cell development), [GO:0044804](http://purl.obolibrary.org/obo/GO_0044804) (autophagy of nucleus), [GO:0060036](http://purl.obolibrary.org/obo/GO_0060036) (notochord cell vacuolation), [GO:0061360](http://purl.obolibrary.org/obo/GO_0061360) (optic chiasma development), [GO:0032880](http://purl.obolibrary.org/obo/GO_0032880) (regulation of protein localization), [GO:0060030](http://purl.obolibrary.org/obo/GO_0060030) (dorsal convergence), [GO:1903573](http://purl.obolibrary.org/obo/GO_1903573) (negative regulation of response to endoplasmic reticulum stress), [GO:0060032](http://purl.obolibrary.org/obo/GO_0060032) (notochord regression), [GO:0005283](http://purl.obolibrary.org/obo/GO_0005283) (sodium:amino acid symporter activity), [GO:0060037](http://purl.obolibrary.org/obo/GO_0060037) (pharyngeal system development), [GO:0061368](http://purl.obolibrary.org/obo/GO_0061368) (behavioral response to formalin induced pain), [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation), [GO:0060039](http://purl.obolibrary.org/obo/GO_0060039) (pericardium development), [GO:0097340](http://purl.obolibrary.org/obo/GO_0097340) (inhibition of cysteine-type endopeptidase activity), [GO:0072011](http://purl.obolibrary.org/obo/GO_0072011) (glomerular endothelium development), [GO:0030217](http://purl.obolibrary.org/obo/GO_0030217) (T cell differentiation), [GO:0072010](http://purl.obolibrary.org/obo/GO_0072010) (glomerular epithelium development), [GO:0098664](http://purl.obolibrary.org/obo/GO_0098664) (G-protein coupled serotonin receptor signaling pathway), [GO:0030216](http://purl.obolibrary.org/obo/GO_0030216) (keratinocyte differentiation), [GO:0047086](http://purl.obolibrary.org/obo/GO_0047086) (ketosteroid monooxygenase activity), [GO:0031547](http://purl.obolibrary.org/obo/GO_0031547) (brain-derived neurotrophic factor receptor signaling pathway), [GO:0030219](http://purl.obolibrary.org/obo/GO_0030219) (megakaryocyte differentiation), [GO:0030218](http://purl.obolibrary.org/obo/GO_0030218) (erythrocyte differentiation), [GO:0072015](http://purl.obolibrary.org/obo/GO_0072015) (glomerular visceral epithelial cell development), [GO:0032872](http://purl.obolibrary.org/obo/GO_0032872) (regulation of stress-activated MAPK cascade), [GO:0032873](http://purl.obolibrary.org/obo/GO_0032873) (negative regulation of stress-activated MAPK cascade), [GO:0072017](http://purl.obolibrary.org/obo/GO_0072017) (distal tubule development), [GO:0032870](http://purl.obolibrary.org/obo/GO_0032870) (cellular response to hormone stimulus), [GO:0061370](http://purl.obolibrary.org/obo/GO_0061370) (testosterone biosynthetic process), [GO:0030210](http://purl.obolibrary.org/obo/GO_0030210) (heparin biosynthetic process), [GO:0032876](http://purl.obolibrary.org/obo/GO_0032876) (negative regulation of DNA endoreduplication), [GO:0030213](http://purl.obolibrary.org/obo/GO_0030213) (hyaluronan biosynthetic process), [GO:0030212](http://purl.obolibrary.org/obo/GO_0030212) (hyaluronan metabolic process), [GO:0032874](http://purl.obolibrary.org/obo/GO_0032874) (positive regulation of stress-activated MAPK cascade), [GO:0030215](http://purl.obolibrary.org/obo/GO_0030215) (semaphorin receptor binding), [GO:0030214](http://purl.obolibrary.org/obo/GO_0030214) (hyaluronan catabolic process), [GO:0060068](http://purl.obolibrary.org/obo/GO_0060068) (vagina development), [GO:0061393](http://purl.obolibrary.org/obo/GO_0061393) (positive regulation of transcription from RNA polymerase II promoter in response to osmotic stress), [GO:0006582](http://purl.obolibrary.org/obo/GO_0006582) (melanin metabolic process), [GO:0005251](http://purl.obolibrary.org/obo/GO_0005251) (delayed rectifier potassium channel activity), [GO:1902254](http://purl.obolibrary.org/obo/GO_1902254) (negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator), [GO:0060065](http://purl.obolibrary.org/obo/GO_0060065) (uterus development), [GO:0005250](http://purl.obolibrary.org/obo/GO_0005250) (A-type (transient outward) potassium channel activity), [GO:0006585](http://purl.obolibrary.org/obo/GO_0006585) (dopamine biosynthetic process from tyrosine), [GO:1902257](http://purl.obolibrary.org/obo/GO_1902257) (negative regulation of apoptotic process involved in outflow tract morphogenesis), [GO:0006583](http://purl.obolibrary.org/obo/GO_0006583) (melanin biosynthetic process from tyrosine), [GO:0006584](http://purl.obolibrary.org/obo/GO_0006584) (catecholamine metabolic process), [GO:0005254](http://purl.obolibrary.org/obo/GO_0005254) (chloride channel activity), [GO:0006589](http://purl.obolibrary.org/obo/GO_0006589) (octopamine biosynthetic process), [GO:0072050](http://purl.obolibrary.org/obo/GO_0072050) (S-shaped body morphogenesis), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0072044](http://purl.obolibrary.org/obo/GO_0072044) (collecting duct development), [GO:0030206](http://purl.obolibrary.org/obo/GO_0030206) (chondroitin sulfate biosynthetic process), [GO:0005249](http://purl.obolibrary.org/obo/GO_0005249) (voltage-gated potassium channel activity), [GO:0030208](http://purl.obolibrary.org/obo/GO_0030208) (dermatan sulfate biosynthetic process), [GO:0097300](http://purl.obolibrary.org/obo/GO_0097300) (programmed necrotic cell death), [GO:0032868](http://purl.obolibrary.org/obo/GO_0032868) (response to insulin), [GO:0030209](http://purl.obolibrary.org/obo/GO_0030209) (dermatan sulfate catabolic process), [GO:0072045](http://purl.obolibrary.org/obo/GO_0072045) (convergent extension involved in nephron morphogenesis), [GO:0097306](http://purl.obolibrary.org/obo/GO_0097306) (cellular response to alcohol), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0030200](http://purl.obolibrary.org/obo/GO_0030200) (heparan sulfate proteoglycan catabolic process), [GO:0060071](http://purl.obolibrary.org/obo/GO_0060071) (Wnt signaling pathway, planar cell polarity pathway), [GO:0060072](http://purl.obolibrary.org/obo/GO_0060072) (large conductance calcium-activated potassium channel activity), [GO:0030201](http://purl.obolibrary.org/obo/GO_0030201) (heparan sulfate proteoglycan metabolic process), [GO:0032866](http://purl.obolibrary.org/obo/GO_0032866) (D-xylose:NADP reductase activity), [GO:0031532](http://purl.obolibrary.org/obo/GO_0031532) (actin cytoskeleton reorganization), [GO:0030203](http://purl.obolibrary.org/obo/GO_0030203) (glycosaminoglycan metabolic process), [GO:0061386](http://purl.obolibrary.org/obo/GO_0061386) (closure of optic fissure), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:0060055](http://purl.obolibrary.org/obo/GO_0060055) (angiogenesis involved in wound healing), [GO:0060056](http://purl.obolibrary.org/obo/GO_0060056) (mammary gland involution), [GO:0060058](http://purl.obolibrary.org/obo/GO_0060058) (positive regulation of apoptotic process involved in mammary gland involution), [GO:0044829](http://purl.obolibrary.org/obo/GO_0044829) (positive regulation by host of viral genome replication), [GO:0006592](http://purl.obolibrary.org/obo/GO_0006592) (ornithine biosynthetic process), [GO:0006593](http://purl.obolibrary.org/obo/GO_0006593) (ornithine catabolic process), [GO:0044828](http://purl.obolibrary.org/obo/GO_0044828) (negative regulation by host of viral genome replication), [GO:0060052](http://purl.obolibrary.org/obo/GO_0060052) (neurofilament cytoskeleton organization), [GO:0005262](http://purl.obolibrary.org/obo/GO_0005262) (calcium channel activity), [GO:0061384](http://purl.obolibrary.org/obo/GO_0061384) (heart trabecula morphogenesis), [GO:0060053](http://purl.obolibrary.org/obo/GO_0060053) (neurofilament cytoskeleton), [GO:0005261](http://purl.obolibrary.org/obo/GO_0005261) (cation channel activity), [GO:0006591](http://purl.obolibrary.org/obo/GO_0006591) (ornithine metabolic process), [GO:0060054](http://purl.obolibrary.org/obo/GO_0060054) (positive regulation of epithelial cell proliferation involved in wound healing), [GO:0006596](http://purl.obolibrary.org/obo/GO_0006596) (polyamine biosynthetic process), [GO:0006597](http://purl.obolibrary.org/obo/GO_0006597) (spermine biosynthetic process), [GO:1903599](http://purl.obolibrary.org/obo/GO_1903599) (positive regulation of autophagy of mitochondrion), [GO:0006595](http://purl.obolibrary.org/obo/GO_0006595) (polyamine metabolic process), [GO:0060059](http://purl.obolibrary.org/obo/GO_0060059) (embryonic retina morphogenesis in camera-type eye), [GO:0005267](http://purl.obolibrary.org/obo/GO_0005267) (potassium channel activity), [GO:0006598](http://purl.obolibrary.org/obo/GO_0006598) (polyamine catabolic process), [GO:0031527](http://purl.obolibrary.org/obo/GO_0031527) (filopodium membrane), [GO:0031528](http://purl.obolibrary.org/obo/GO_0031528) (microvillus membrane), [GO:0031526](http://purl.obolibrary.org/obo/GO_0031526) (brush border membrane), [GO:0031529](http://purl.obolibrary.org/obo/GO_0031529) (ruffle organization), [GO:0019894](http://purl.obolibrary.org/obo/GO_0019894) (kinesin binding), [GO:0019896](http://purl.obolibrary.org/obo/GO_0019896) (axonal transport of mitochondrion), [GO:0060060](http://purl.obolibrary.org/obo/GO_0060060) (post-embryonic retina morphogenesis in camera-type eye), [GO:0019898](http://purl.obolibrary.org/obo/GO_0019898) (extrinsic component of membrane), [GO:0019897](http://purl.obolibrary.org/obo/GO_0019897) (extrinsic component of plasma membrane), [GO:0120053](http://purl.obolibrary.org/obo/GO_0120053) (ribitol beta-1,4-xylosyltransferase activity), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0030150](http://purl.obolibrary.org/obo/GO_0030150) (protein import into mitochondrial matrix), [GO:0030151](http://purl.obolibrary.org/obo/GO_0030151) (molybdenum ion binding), [GO:0005198](http://purl.obolibrary.org/obo/GO_0005198) (structural molecule activity), [GO:0042134](http://purl.obolibrary.org/obo/GO_0042134) (rRNA primary transcript binding), [GO:0042135](http://purl.obolibrary.org/obo/GO_0042135) (neurotransmitter catabolic process), [GO:0042136](http://purl.obolibrary.org/obo/GO_0042136) (neurotransmitter biosynthetic process), [GO:0044798](http://purl.obolibrary.org/obo/GO_0044798) (nuclear transcription factor complex), [GO:1990760](http://purl.obolibrary.org/obo/GO_1990760) (osmolarity-sensing cation channel activity), [GO:1990761](http://purl.obolibrary.org/obo/GO_1990761) (growth cone lamellipodium), [GO:0017183](http://purl.obolibrary.org/obo/GO_0017183) (peptidyl-diphthamide biosynthetic process from peptidyl-histidine), [GO:0043473](http://purl.obolibrary.org/obo/GO_0043473) (pigmentation), [GO:0017185](http://purl.obolibrary.org/obo/GO_0017185) (peptidyl-lysine hydroxylation), [GO:1990769](http://purl.obolibrary.org/obo/GO_1990769) (proximal neuron projection), [GO:0030145](http://purl.obolibrary.org/obo/GO_0030145) (manganese ion binding), [GO:0031477](http://purl.obolibrary.org/obo/GO_0031477) (myosin VII complex), [GO:0030148](http://purl.obolibrary.org/obo/GO_0030148) (sphingolipid biosynthetic process), [GO:0030141](http://purl.obolibrary.org/obo/GO_0030141) (secretory granule), [GO:0030140](http://purl.obolibrary.org/obo/GO_0030140) (trans-Golgi network transport vesicle), [GO:0042144](http://purl.obolibrary.org/obo/GO_0042144) (vacuole fusion, non-autophagic), [GO:0042147](http://purl.obolibrary.org/obo/GO_0042147) (retrograde transport, endosome to Golgi), [GO:0042149](http://purl.obolibrary.org/obo/GO_0042149) (cellular response to glucose starvation), [GO:0030139](http://purl.obolibrary.org/obo/GO_0030139) (endocytic vesicle), [GO:0017171](http://purl.obolibrary.org/obo/GO_0017171) (serine hydrolase activity), [GO:0043484](http://purl.obolibrary.org/obo/GO_0043484) (regulation of RNA splicing), [GO:1990778](http://purl.obolibrary.org/obo/GO_1990778) (protein localization to cell periphery), [GO:0002925](http://purl.obolibrary.org/obo/GO_0002925) (positive regulation of humoral immune response mediated by circulating immunoglobulin), [GO:0031464](http://purl.obolibrary.org/obo/GO_0031464) (Cul4A-RING E3 ubiquitin ligase complex), [GO:0017176](http://purl.obolibrary.org/obo/GO_0017176) (phosphatidylinositol N-acetylglucosaminyltransferase activity), [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex), [GO:0014902](http://purl.obolibrary.org/obo/GO_0014902) (myotube differentiation), [GO:0031465](http://purl.obolibrary.org/obo/GO_0031465) (Cul4B-RING E3 ubiquitin ligase complex), [GO:0032793](http://purl.obolibrary.org/obo/GO_0032793) (positive regulation of CREB transcription factor activity), [GO:0031462](http://purl.obolibrary.org/obo/GO_0031462) (Cul2-RING ubiquitin ligase complex), [GO:0030134](http://purl.obolibrary.org/obo/GO_0030134) (COPII-coated ER to Golgi transport vesicle), [GO:0120072](http://purl.obolibrary.org/obo/GO_0120072) (positive regulation of pyloric antrum smooth muscle contraction), [GO:0030133](http://purl.obolibrary.org/obo/GO_0030133) (transport vesicle), [GO:0032794](http://purl.obolibrary.org/obo/GO_0032794) (GTPase activating protein binding), [GO:0031463](http://purl.obolibrary.org/obo/GO_0031463) (Cul3-RING ubiquitin ligase complex), [GO:0030136](http://purl.obolibrary.org/obo/GO_0030136) (clathrin-coated vesicle), [GO:0031468](http://purl.obolibrary.org/obo/GO_0031468) (nuclear envelope reassembly), [GO:0030135](http://purl.obolibrary.org/obo/GO_0030135) (coated vesicle), [GO:0032797](http://purl.obolibrary.org/obo/GO_0032797) (SMN complex), [GO:0030137](http://purl.obolibrary.org/obo/GO_0030137) (COPI-coated vesicle), [GO:0005172](http://purl.obolibrary.org/obo/GO_0005172) (vascular endothelial growth factor receptor binding), [GO:0005171](http://purl.obolibrary.org/obo/GO_0005171) (hepatocyte growth factor receptor binding), [GO:0031461](http://purl.obolibrary.org/obo/GO_0031461) (cullin-RING ubiquitin ligase complex), [GO:0032792](http://purl.obolibrary.org/obo/GO_0032792) (negative regulation of CREB transcription factor activity), [GO:0005173](http://purl.obolibrary.org/obo/GO_0005173) (stem cell factor receptor binding), [GO:0043486](http://purl.obolibrary.org/obo/GO_0043486) (histone exchange), [GO:0005178](http://purl.obolibrary.org/obo/GO_0005178) (integrin binding), [GO:0043488](http://purl.obolibrary.org/obo/GO_0043488) (regulation of mRNA stability), [GO:0042157](http://purl.obolibrary.org/obo/GO_0042157) (lipoprotein metabolic process), [GO:0042158](http://purl.obolibrary.org/obo/GO_0042158) (lipoprotein biosynthetic process), [GO:0042159](http://purl.obolibrary.org/obo/GO_0042159) (lipoprotein catabolic process), [GO:0005179](http://purl.obolibrary.org/obo/GO_0005179) (hormone activity), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0043491](http://purl.obolibrary.org/obo/GO_0043491) (protein kinase B signaling), [GO:0043490](http://purl.obolibrary.org/obo/GO_0043490) (malate-aspartate shuttle), [GO:0042162](http://purl.obolibrary.org/obo/GO_0042162) (telomeric DNA binding), [GO:0043495](http://purl.obolibrary.org/obo/GO_0043495) (protein membrane anchor), [GO:0030121](http://purl.obolibrary.org/obo/GO_0030121) (AP-1 adaptor complex), [GO:0032784](http://purl.obolibrary.org/obo/GO_0032784) (regulation of DNA-templated transcription, elongation), [GO:0017166](http://purl.obolibrary.org/obo/GO_0017166) (vinculin binding), [GO:0030123](http://purl.obolibrary.org/obo/GO_0030123) (AP-3 adaptor complex), [GO:0030122](http://purl.obolibrary.org/obo/GO_0030122) (AP-2 adaptor complex), [GO:0030125](http://purl.obolibrary.org/obo/GO_0030125) (clathrin vesicle coat), [GO:0030124](http://purl.obolibrary.org/obo/GO_0030124) (AP-4 adaptor complex), [GO:0032786](http://purl.obolibrary.org/obo/GO_0032786) (positive regulation of DNA-templated transcription, elongation), [GO:0030126](http://purl.obolibrary.org/obo/GO_0030126) (COPI vesicle coat), [GO:0032780](http://purl.obolibrary.org/obo/GO_0032780) (negative regulation of ATPase activity), [GO:0032781](http://purl.obolibrary.org/obo/GO_0032781) (positive regulation of ATPase activity), [GO:0005185](http://purl.obolibrary.org/obo/GO_0005185) (neurohypophyseal hormone activity), [GO:0005184](http://purl.obolibrary.org/obo/GO_0005184) (neuropeptide hormone activity), [GO:0043497](http://purl.obolibrary.org/obo/GO_0043497) (regulation of protein heterodimerization activity), [GO:0042166](http://purl.obolibrary.org/obo/GO_0042166) (acetylcholine binding), [GO:0043496](http://purl.obolibrary.org/obo/GO_0043496) (regulation of protein homodimerization activity), [GO:0042168](http://purl.obolibrary.org/obo/GO_0042168) (heme metabolic process), [GO:0042169](http://purl.obolibrary.org/obo/GO_0042169) (SH2 domain binding), [GO:0030117](http://purl.obolibrary.org/obo/GO_0030117) (membrane coat), [GO:0031448](http://purl.obolibrary.org/obo/GO_0031448) (positive regulation of fast-twitch skeletal muscle fiber contraction), [GO:0031449](http://purl.obolibrary.org/obo/GO_0031449) (regulation of slow-twitch skeletal muscle fiber contraction), [GO:0042171](http://purl.obolibrary.org/obo/GO_0042171) (lysophosphatidic acid acyltransferase activity), [GO:1990798](http://purl.obolibrary.org/obo/GO_1990798) (pancreas regeneration), [GO:0017151](http://purl.obolibrary.org/obo/GO_0017151) (DEAD/H-box RNA helicase binding), [GO:1990799](http://purl.obolibrary.org/obo/GO_1990799) (mitochondrial tRNA wobble position uridine thiolation), [GO:0018484](http://purl.obolibrary.org/obo/GO_0018484) (4-hydroxybenzaldehyde dehydrogenase activity), [GO:0002902](http://purl.obolibrary.org/obo/GO_0002902) (regulation of B cell apoptotic process), [GO:0017153](http://purl.obolibrary.org/obo/GO_0017153) (sodium:dicarboxylate symporter activity), [GO:0042175](http://purl.obolibrary.org/obo/GO_0042175) (nuclear outer membrane-endoplasmic reticulum membrane network), [GO:0032773](http://purl.obolibrary.org/obo/GO_0032773) (positive regulation of monophenol monooxygenase activity), [GO:0017154](http://purl.obolibrary.org/obo/GO_0017154) (semaphorin receptor activity), [GO:0031443](http://purl.obolibrary.org/obo/GO_0031443) (fast-twitch skeletal muscle fiber contraction), [GO:0017156](http://purl.obolibrary.org/obo/GO_0017156) (calcium ion regulated exocytosis), [GO:0017157](http://purl.obolibrary.org/obo/GO_0017157) (regulation of exocytosis), [GO:0030111](http://purl.obolibrary.org/obo/GO_0030111) (regulation of Wnt signaling pathway), [GO:0017158](http://purl.obolibrary.org/obo/GO_0017158) (regulation of calcium ion-dependent exocytosis), [GO:0032777](http://purl.obolibrary.org/obo/GO_0032777) (Piccolo NuA4 histone acetyltransferase complex), [GO:0031444](http://purl.obolibrary.org/obo/GO_0031444) (slow-twitch skeletal muscle fiber contraction), [GO:0030116](http://purl.obolibrary.org/obo/GO_0030116) (glial cell-derived neurotrophic factor receptor binding), [GO:0032776](http://purl.obolibrary.org/obo/GO_0032776) (DNA methylation on cytosine), [GO:0030195](http://purl.obolibrary.org/obo/GO_0030195) (negative regulation of blood coagulation), [GO:0043420](http://purl.obolibrary.org/obo/GO_0043420) (anthranilate metabolic process), [GO:0044753](http://purl.obolibrary.org/obo/GO_0044753) (amphisome), [GO:0043422](http://purl.obolibrary.org/obo/GO_0043422) (protein kinase B binding), [GO:0044754](http://purl.obolibrary.org/obo/GO_0044754) (autolysosome), [GO:0043426](http://purl.obolibrary.org/obo/GO_0043426) (MRF binding), [GO:0043425](http://purl.obolibrary.org/obo/GO_0043425) (bHLH transcription factor binding), [GO:0043438](http://purl.obolibrary.org/obo/GO_0043438) (acetoacetic acid metabolic process), [GO:0030183](http://purl.obolibrary.org/obo/GO_0030183) (B cell differentiation), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0000309](http://purl.obolibrary.org/obo/GO_0000309) (nicotinamide-nucleotide adenylyltransferase activity), [GO:0000307](http://purl.obolibrary.org/obo/GO_0000307) (cyclin-dependent protein kinase holoenzyme complex), [GO:0000306](http://purl.obolibrary.org/obo/GO_0000306) (extrinsic component of vacuolar membrane), [GO:0042100](http://purl.obolibrary.org/obo/GO_0042100) (B cell proliferation), [GO:0043433](http://purl.obolibrary.org/obo/GO_0043433) (negative regulation of DNA binding transcription factor activity), [GO:0000304](http://purl.obolibrary.org/obo/GO_0000304) (response to singlet oxygen), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0000303](http://purl.obolibrary.org/obo/GO_0000303) (response to superoxide), [GO:0000302](http://purl.obolibrary.org/obo/GO_0000302) (response to reactive oxygen species), [GO:0043434](http://purl.obolibrary.org/obo/GO_0043434) (response to peptide hormone), [GO:0000301](http://purl.obolibrary.org/obo/GO_0000301) (retrograde transport, vesicle recycling within Golgi), [GO:0001640](http://purl.obolibrary.org/obo/GO_0001640) (adenylate cyclase inhibiting G-protein coupled glutamate receptor activity), [GO:0030176](http://purl.obolibrary.org/obo/GO_0030176) (integral component of endoplasmic reticulum membrane), [GO:0030175](http://purl.obolibrary.org/obo/GO_0030175) (filopodium), [GO:0001639](http://purl.obolibrary.org/obo/GO_0001639) (PLC activating G-protein coupled glutamate receptor activity), [GO:0030178](http://purl.obolibrary.org/obo/GO_0030178) (negative regulation of Wnt signaling pathway), [GO:0030177](http://purl.obolibrary.org/obo/GO_0030177) (positive regulation of Wnt signaling pathway), [GO:0042118](http://purl.obolibrary.org/obo/GO_0042118) (endothelial cell activation), [GO:0030170](http://purl.obolibrary.org/obo/GO_0030170) (pyridoxal phosphate binding), [GO:0030172](http://purl.obolibrary.org/obo/GO_0030172) (troponin C binding), [GO:0030174](http://purl.obolibrary.org/obo/GO_0030174) (regulation of DNA-dependent DNA replication initiation), [GO:0030173](http://purl.obolibrary.org/obo/GO_0030173) (integral component of Golgi membrane), [GO:0042110](http://purl.obolibrary.org/obo/GO_0042110) (T cell activation), [GO:0044773](http://purl.obolibrary.org/obo/GO_0044773) (mitotic DNA damage checkpoint), [GO:0042113](http://purl.obolibrary.org/obo/GO_0042113) (B cell activation), [GO:0097272](http://purl.obolibrary.org/obo/GO_0097272) (ammonia homeostasis), [GO:0042116](http://purl.obolibrary.org/obo/GO_0042116) (macrophage activation), [GO:0042117](http://purl.obolibrary.org/obo/GO_0042117) (monocyte activation), [GO:0098597](http://purl.obolibrary.org/obo/GO_0098597) (observational learning), [GO:0097264](http://purl.obolibrary.org/obo/GO_0097264) (self proteolysis), [GO:0098598](http://purl.obolibrary.org/obo/GO_0098598) (learned vocalization behavior or vocal learning), [GO:0002930](http://purl.obolibrary.org/obo/GO_0002930) (trabecular meshwork development), [GO:0002931](http://purl.obolibrary.org/obo/GO_0002931) (response to ischemia), [GO:0044782](http://purl.obolibrary.org/obo/GO_0044782) (cilium organization), [GO:0098599](http://purl.obolibrary.org/obo/GO_0098599) (palmitoyl hydrolase activity), [GO:0002934](http://purl.obolibrary.org/obo/GO_0002934) (desmosome organization), [GO:0014916](http://purl.obolibrary.org/obo/GO_0014916) (regulation of lung blood pressure), [GO:0030165](http://purl.obolibrary.org/obo/GO_0030165) (PDZ domain binding), [GO:0031497](http://purl.obolibrary.org/obo/GO_0031497) (chromatin assembly), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0030166](http://purl.obolibrary.org/obo/GO_0030166) (proteoglycan biosynthetic process), [GO:0031496](http://purl.obolibrary.org/obo/GO_0031496) (positive regulation of mating type switching), [GO:0030168](http://purl.obolibrary.org/obo/GO_0030168) (platelet activation), [GO:0042129](http://purl.obolibrary.org/obo/GO_0042129) (regulation of T cell proliferation), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0031493](http://purl.obolibrary.org/obo/GO_0031493) (nucleosomal histone binding), [GO:0030160](http://purl.obolibrary.org/obo/GO_0030160) (GKAP/Homer scaffold activity), [GO:0030163](http://purl.obolibrary.org/obo/GO_0030163) (protein catabolic process), [GO:0031491](http://purl.obolibrary.org/obo/GO_0031491) (nucleosome binding), [GO:0031492](http://purl.obolibrary.org/obo/GO_0031492) (nucleosomal DNA binding), [GO:0030162](http://purl.obolibrary.org/obo/GO_0030162) (regulation of proteolysis), [GO:0044783](http://purl.obolibrary.org/obo/GO_0044783) (G1 DNA damage checkpoint), [GO:0043457](http://purl.obolibrary.org/obo/GO_0043457) (regulation of cellular respiration), [GO:0043456](http://purl.obolibrary.org/obo/GO_0043456) (regulation of pentose-phosphate shunt), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0042128](http://purl.obolibrary.org/obo/GO_0042128) (nitrate assimilation), [GO:0097276](http://purl.obolibrary.org/obo/GO_0097276) (cellular creatinine homeostasis), [GO:0097275](http://purl.obolibrary.org/obo/GO_0097275) (cellular ammonia homeostasis), [GO:0097278](http://purl.obolibrary.org/obo/GO_0097278) (complement-dependent cytotoxicity), [GO:0097277](http://purl.obolibrary.org/obo/GO_0097277) (cellular urea homeostasis), [GO:0044791](http://purl.obolibrary.org/obo/GO_0044791) (positive regulation by host of viral release from host cell), [GO:0044790](http://purl.obolibrary.org/obo/GO_0044790) (negative regulation by host of viral release from host cell), [GO:0001614](http://purl.obolibrary.org/obo/GO_0001614) (purinergic nucleotide receptor activity), [GO:0042130](http://purl.obolibrary.org/obo/GO_0042130) (negative regulation of T cell proliferation), [GO:0043462](http://purl.obolibrary.org/obo/GO_0043462) (regulation of ATPase activity), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0017198](http://purl.obolibrary.org/obo/GO_0017198) (N-terminal peptidyl-serine acetylation), [GO:0001618](http://purl.obolibrary.org/obo/GO_0001618) (virus receptor activity), [GO:0030155](http://purl.obolibrary.org/obo/GO_0030155) (regulation of cell adhesion), [GO:0030158](http://purl.obolibrary.org/obo/GO_0030158) (protein xylosyltransferase activity), [GO:0031489](http://purl.obolibrary.org/obo/GO_0031489) (myosin V binding), [GO:0030159](http://purl.obolibrary.org/obo/GO_0030159) (receptor signaling complex scaffold activity), [GO:0051928](http://purl.obolibrary.org/obo/GO_0051928) (positive regulation of calcium ion transport), [GO:0000338](http://purl.obolibrary.org/obo/GO_0000338) (protein deneddylation), [GO:0001671](http://purl.obolibrary.org/obo/GO_0001671) (ATPase activator activity), [GO:0000333](http://purl.obolibrary.org/obo/GO_0000333) (telomerase catalytic core complex), [GO:0001664](http://purl.obolibrary.org/obo/GO_0001664) (G-protein coupled receptor binding), [GO:0000340](http://purl.obolibrary.org/obo/GO_0000340) (RNA 7-methylguanosine cap binding), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0001669](http://purl.obolibrary.org/obo/GO_0001669) (acrosomal vesicle), [GO:0051926](http://purl.obolibrary.org/obo/GO_0051926) (negative regulation of calcium ion transport), [GO:0051923](http://purl.obolibrary.org/obo/GO_0051923) (sulfation), [GO:0051924](http://purl.obolibrary.org/obo/GO_0051924) (regulation of calcium ion transport), [GO:0051938](http://purl.obolibrary.org/obo/GO_0051938) (L-glutamate import), [GO:0051939](http://purl.obolibrary.org/obo/GO_0051939) (gamma-aminobutyric acid import), [GO:0000349](http://purl.obolibrary.org/obo/GO_0000349) (generation of catalytic spliceosome for first transesterification step), [GO:0001675](http://purl.obolibrary.org/obo/GO_0001675) (acrosome assembly), [GO:0001676](http://purl.obolibrary.org/obo/GO_0001676) (long-chain fatty acid metabolic process), [GO:0001678](http://purl.obolibrary.org/obo/GO_0001678) (cellular glucose homeostasis), [GO:0051935](http://purl.obolibrary.org/obo/GO_0051935) (glutamate reuptake), [GO:0051932](http://purl.obolibrary.org/obo/GO_0051932) (synaptic transmission, GABAergic), [GO:0051930](http://purl.obolibrary.org/obo/GO_0051930) (regulation of sensory perception of pain), [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center), [GO:0001642](http://purl.obolibrary.org/obo/GO_0001642) (group III metabotropic glutamate receptor activity), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0102279](http://purl.obolibrary.org/obo/GO_0102279) (lecithin:11-cis retinol acyltransferase activity), [GO:0051946](http://purl.obolibrary.org/obo/GO_0051946) (regulation of glutamate uptake involved in transmission of nerve impulse), [GO:0000329](http://purl.obolibrary.org/obo/GO_0000329) (fungal-type vacuole membrane), [GO:0048306](http://purl.obolibrary.org/obo/GO_0048306) (calcium-dependent protein binding), [GO:0000328](http://purl.obolibrary.org/obo/GO_0000328) (fungal-type vacuole lumen), [GO:0048304](http://purl.obolibrary.org/obo/GO_0048304) (positive regulation of isotype switching to IgG isotypes), [GO:0000324](http://purl.obolibrary.org/obo/GO_0000324) (fungal-type vacuole), [GO:0048309](http://purl.obolibrary.org/obo/GO_0048309) (endoplasmic reticulum inheritance), [GO:0001662](http://purl.obolibrary.org/obo/GO_0001662) (behavioral fear response), [GO:0001654](http://purl.obolibrary.org/obo/GO_0001654) (eye development), [GO:0001655](http://purl.obolibrary.org/obo/GO_0001655) (urogenital system development), [GO:0001656](http://purl.obolibrary.org/obo/GO_0001656) (metanephros development), [GO:0001657](http://purl.obolibrary.org/obo/GO_0001657) (ureteric bud development), [GO:0001658](http://purl.obolibrary.org/obo/GO_0001658) (branching involved in ureteric bud morphogenesis), [GO:0048311](http://purl.obolibrary.org/obo/GO_0048311) (mitochondrion distribution), [GO:1990712](http://purl.obolibrary.org/obo/GO_1990712) (HFE-transferrin receptor complex), [GO:0048310](http://purl.obolibrary.org/obo/GO_0048310) (nucleus inheritance), [GO:0001659](http://purl.obolibrary.org/obo/GO_0001659) (temperature homeostasis), [GO:2000309](http://purl.obolibrary.org/obo/GO_2000309) (positive regulation of tumor necrosis factor (ligand) superfamily member 11 production), [GO:0030198](http://purl.obolibrary.org/obo/GO_0030198) (extracellular matrix organization), [GO:2000300](http://purl.obolibrary.org/obo/GO_2000300) (regulation of synaptic vesicle exocytosis), [GO:0051959](http://purl.obolibrary.org/obo/GO_0051959) (dynein light intermediate chain binding), [GO:1990715](http://purl.obolibrary.org/obo/GO_1990715) (mRNA CDS binding), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:2000304](http://purl.obolibrary.org/obo/GO_2000304) (positive regulation of ceramide biosynthetic process), [GO:0023019](http://purl.obolibrary.org/obo/GO_0023019) (signal transduction involved in regulation of gene expression), [GO:0042176](http://purl.obolibrary.org/obo/GO_0042176) (regulation of protein catabolic process), [GO:0042177](http://purl.obolibrary.org/obo/GO_0042177) (negative regulation of protein catabolic process), [GO:0000379](http://purl.obolibrary.org/obo/GO_0000379) (tRNA-type intron splice site recognition and cleavage), [GO:0023014](http://purl.obolibrary.org/obo/GO_0023014) (signal transduction by protein phosphorylation), [GO:0023016](http://purl.obolibrary.org/obo/GO_0023016) (signal transduction by trans-phosphorylation), [GO:0000386](http://purl.obolibrary.org/obo/GO_0000386) (second spliceosomal transesterification activity), [GO:0023021](http://purl.obolibrary.org/obo/GO_0023021) (termination of signal transduction), [GO:0000381](http://purl.obolibrary.org/obo/GO_0000381) (regulation of alternative mRNA splicing, via spliceosome), [GO:0000380](http://purl.obolibrary.org/obo/GO_0000380) (alternative mRNA splicing, via spliceosome), [GO:0036328](http://purl.obolibrary.org/obo/GO_0036328) (VEGF-C-activated receptor activity), [GO:2000311](http://purl.obolibrary.org/obo/GO_2000311) (regulation of AMPA receptor activity), [GO:2000310](http://purl.obolibrary.org/obo/GO_2000310) (regulation of NMDA receptor activity), [GO:2000314](http://purl.obolibrary.org/obo/GO_2000314) (negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation), [GO:2000313](http://purl.obolibrary.org/obo/GO_2000313) (regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation), [GO:0000388](http://purl.obolibrary.org/obo/GO_0000388) (spliceosome conformational change to release U4 (or U4atac) and U1 (or U11)), [GO:0000387](http://purl.obolibrary.org/obo/GO_0000387) (spliceosomal snRNP assembly), [GO:1990730](http://purl.obolibrary.org/obo/GO_1990730) (VCP-NSFL1C complex), [GO:0000390](http://purl.obolibrary.org/obo/GO_0000390) (spliceosomal complex disassembly), [GO:0036317](http://purl.obolibrary.org/obo/GO_0036317) (tyrosyl-RNA phosphodiesterase activity), [GO:2000321](http://purl.obolibrary.org/obo/GO_2000321) (positive regulation of T-helper 17 cell differentiation), [GO:2000324](http://purl.obolibrary.org/obo/GO_2000324) (positive regulation of glucocorticoid receptor signaling pathway), [GO:0036310](http://purl.obolibrary.org/obo/GO_0036310) (annealing helicase activity), [GO:0036312](http://purl.obolibrary.org/obo/GO_0036312) (phosphatidylinositol 3-kinase regulatory subunit binding), [GO:0001691](http://purl.obolibrary.org/obo/GO_0001691) (pseudophosphatase activity), [GO:0001695](http://purl.obolibrary.org/obo/GO_0001695) (histamine catabolic process), [GO:2000338](http://purl.obolibrary.org/obo/GO_2000338) (regulation of chemokine (C-X-C motif) ligand 1 production), [GO:1990745](http://purl.obolibrary.org/obo/GO_1990745) (EARP complex), [GO:0051903](http://purl.obolibrary.org/obo/GO_0051903) (S-(hydroxymethyl)glutathione dehydrogenase activity), [GO:0051904](http://purl.obolibrary.org/obo/GO_0051904) (pigment granule transport), [GO:0036302](http://purl.obolibrary.org/obo/GO_0036302) (atrioventricular canal development), [GO:0036303](http://purl.obolibrary.org/obo/GO_0036303) (lymph vessel morphogenesis), [GO:2000334](http://purl.obolibrary.org/obo/GO_2000334) (positive regulation of blood microparticle formation), [GO:2000350](http://purl.obolibrary.org/obo/GO_2000350) (positive regulation of CD40 signaling pathway), [GO:0000372](http://purl.obolibrary.org/obo/GO_0000372) (Group I intron splicing), [GO:2000344](http://purl.obolibrary.org/obo/GO_2000344) (positive regulation of acrosome reaction), [GO:2000343](http://purl.obolibrary.org/obo/GO_2000343) (positive regulation of chemokine (C-X-C motif) ligand 2 production), [GO:2000341](http://purl.obolibrary.org/obo/GO_2000341) (regulation of chemokine (C-X-C motif) ligand 2 production), [GO:2000346](http://purl.obolibrary.org/obo/GO_2000346) (negative regulation of hepatocyte proliferation), [GO:2000345](http://purl.obolibrary.org/obo/GO_2000345) (regulation of hepatocyte proliferation), [GO:0016407](http://purl.obolibrary.org/obo/GO_0016407) (acetyltransferase activity), [GO:0016409](http://purl.obolibrary.org/obo/GO_0016409) (palmitoyltransferase activity), [GO:0005751](http://purl.obolibrary.org/obo/GO_0005751) (mitochondrial respiratory chain complex IV), [GO:0004423](http://purl.obolibrary.org/obo/GO_0004423) (iduronate-2-sulfatase activity), [GO:0004422](http://purl.obolibrary.org/obo/GO_0004422) (hypoxanthine phosphoribosyltransferase activity), [GO:0005745](http://purl.obolibrary.org/obo/GO_0005745) (m-AAA complex), [GO:0072583](http://purl.obolibrary.org/obo/GO_0072583) (clathrin-dependent endocytosis), [GO:0005747](http://purl.obolibrary.org/obo/GO_0005747) (mitochondrial respiratory chain complex I), [GO:0004416](http://purl.obolibrary.org/obo/GO_0004416) (hydroxyacylglutathione hydrolase activity), [GO:0005746](http://purl.obolibrary.org/obo/GO_0005746) (mitochondrial respiratory chain), [GO:0004415](http://purl.obolibrary.org/obo/GO_0004415) (hyalurononglucosaminidase activity), [GO:0005749](http://purl.obolibrary.org/obo/GO_0005749) (mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)), [GO:0030705](http://purl.obolibrary.org/obo/GO_0030705) (cytoskeleton-dependent intracellular transport), [GO:0004418](http://purl.obolibrary.org/obo/GO_0004418) (hydroxymethylbilane synthase activity), [GO:0072584](http://purl.obolibrary.org/obo/GO_0072584) (caveolin-mediated endocytosis), [GO:0071257](http://purl.obolibrary.org/obo/GO_0071257) (cellular response to electrical stimulus), [GO:0072589](http://purl.obolibrary.org/obo/GO_0072589) (box H/ACA scaRNP complex), [GO:0060594](http://purl.obolibrary.org/obo/GO_0060594) (mammary gland specification), [GO:0042703](http://purl.obolibrary.org/obo/GO_0042703) (menstruation), [GO:0042706](http://purl.obolibrary.org/obo/GO_0042706) (eye photoreceptor cell fate commitment), [GO:0060591](http://purl.obolibrary.org/obo/GO_0060591) (chondroblast differentiation), [GO:0060592](http://purl.obolibrary.org/obo/GO_0060592) (mammary gland formation), [GO:0005761](http://purl.obolibrary.org/obo/GO_0005761) (mitochondrial ribosome), [GO:0004430](http://purl.obolibrary.org/obo/GO_0004430) (1-phosphatidylinositol 4-kinase activity), [GO:0005760](http://purl.obolibrary.org/obo/GO_0005760) (gamma DNA polymerase complex), [GO:0003100](http://purl.obolibrary.org/obo/GO_0003100) (regulation of systemic arterial blood pressure by endothelin), [GO:0060599](http://purl.obolibrary.org/obo/GO_0060599) (lateral sprouting involved in mammary gland duct morphogenesis), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0072572](http://purl.obolibrary.org/obo/GO_0072572) (poly-ADP-D-ribose binding), [GO:0005758](http://purl.obolibrary.org/obo/GO_0005758) (mitochondrial intermembrane space), [GO:0005757](http://purl.obolibrary.org/obo/GO_0005757) (mitochondrial permeability transition pore complex), [GO:0071244](http://purl.obolibrary.org/obo/GO_0071244) (cellular response to carbon dioxide), [GO:0005759](http://purl.obolibrary.org/obo/GO_0005759) (mitochondrial matrix), [GO:0071242](http://purl.obolibrary.org/obo/GO_0071242) (cellular response to ammonium ion), [GO:0072579](http://purl.obolibrary.org/obo/GO_0072579) (glycine receptor clustering), [GO:0072577](http://purl.obolibrary.org/obo/GO_0072577) (endothelial cell apoptotic process), [GO:0016401](http://purl.obolibrary.org/obo/GO_0016401) (palmitoyl-CoA oxidase activity), [GO:0042719](http://purl.obolibrary.org/obo/GO_0042719) (mitochondrial intermembrane space protein transporter complex), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0071280](http://purl.obolibrary.org/obo/GO_0071280) (cellular response to copper ion), [GO:0071281](http://purl.obolibrary.org/obo/GO_0071281) (cellular response to iron ion), [GO:0005732](http://purl.obolibrary.org/obo/GO_0005732) (small nucleolar ribonucleoprotein complex), [GO:0042711](http://purl.obolibrary.org/obo/GO_0042711) (maternal behavior), [GO:0005724](http://purl.obolibrary.org/obo/GO_0005724) (nuclear telomeric heterochromatin), [GO:0071277](http://purl.obolibrary.org/obo/GO_0071277) (cellular response to calcium ion), [GO:0005729](http://purl.obolibrary.org/obo/GO_0005729) (2-micrometer circle DNA), [GO:0071276](http://purl.obolibrary.org/obo/GO_0071276) (cellular response to cadmium ion), [GO:0034284](http://purl.obolibrary.org/obo/GO_0034284) (response to monosaccharide), [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane), [GO:0005740](http://purl.obolibrary.org/obo/GO_0005740) (mitochondrial envelope), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0042721](http://purl.obolibrary.org/obo/GO_0042721) (mitochondrial inner membrane protein insertion complex), [GO:0004411](http://purl.obolibrary.org/obo/GO_0004411) (homogentisate 1,2-dioxygenase activity), [GO:0005742](http://purl.obolibrary.org/obo/GO_0005742) (mitochondrial outer membrane translocase complex), [GO:0072593](http://purl.obolibrary.org/obo/GO_0072593) (reactive oxygen species metabolic process), [GO:0004402](http://purl.obolibrary.org/obo/GO_0004402) (histone acetyltransferase activity), [GO:0071260](http://purl.obolibrary.org/obo/GO_0071260) (cellular response to mechanical stimulus), [GO:0005736](http://purl.obolibrary.org/obo/GO_0005736) (DNA-directed RNA polymerase I complex), [GO:0004407](http://purl.obolibrary.org/obo/GO_0004407) (histone deacetylase activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0004408](http://purl.obolibrary.org/obo/GO_0004408) (holocytochrome-c synthase activity), [GO:0071268](http://purl.obolibrary.org/obo/GO_0071268) (homocysteine biosynthetic process), [GO:0060561](http://purl.obolibrary.org/obo/GO_0060561) (apoptotic process involved in morphogenesis), [GO:0015114](http://purl.obolibrary.org/obo/GO_0015114) (phosphate ion transmembrane transporter activity), [GO:0060563](http://purl.obolibrary.org/obo/GO_0060563) (neuroepithelial cell differentiation), [GO:1901660](http://purl.obolibrary.org/obo/GO_1901660) (calcium ion export), [GO:0015111](http://purl.obolibrary.org/obo/GO_0015111) (iodide transmembrane transporter activity), [GO:0005790](http://purl.obolibrary.org/obo/GO_0005790) (smooth endoplasmic reticulum), [GO:1902990](http://purl.obolibrary.org/obo/GO_1902990) (mitotic telomere maintenance via semi-conservative replication), [GO:0061890](http://purl.obolibrary.org/obo/GO_0061890) (positive regulation of astrocyte activation), [GO:1902991](http://purl.obolibrary.org/obo/GO_1902991) (regulation of amyloid precursor protein catabolic process), [GO:0004461](http://purl.obolibrary.org/obo/GO_0004461) (lactose synthase activity), [GO:0003130](http://purl.obolibrary.org/obo/GO_0003130) (BMP signaling pathway involved in heart induction), [GO:0005791](http://purl.obolibrary.org/obo/GO_0005791) (rough endoplasmic reticulum), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0005793](http://purl.obolibrary.org/obo/GO_0005793) (endoplasmic reticulum-Golgi intermediate compartment), [GO:1902995](http://purl.obolibrary.org/obo/GO_1902995) (positive regulation of phospholipid efflux), [GO:0060566](http://purl.obolibrary.org/obo/GO_0060566) (positive regulation of DNA-templated transcription, termination), [GO:0005795](http://purl.obolibrary.org/obo/GO_0005795) (Golgi stack), [GO:0005798](http://purl.obolibrary.org/obo/GO_0005798) (Golgi-associated vesicle), [GO:0004467](http://purl.obolibrary.org/obo/GO_0004467) (long-chain fatty acid-CoA ligase activity), [GO:0060567](http://purl.obolibrary.org/obo/GO_0060567) (negative regulation of DNA-templated transcription, termination), [GO:0005797](http://purl.obolibrary.org/obo/GO_0005797) (Golgi medial cisterna), [GO:0004466](http://purl.obolibrary.org/obo/GO_0004466) (long-chain-acyl-CoA dehydrogenase activity), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0004458](http://purl.obolibrary.org/obo/GO_0004458) (D-lactate dehydrogenase (cytochrome) activity), [GO:0005788](http://purl.obolibrary.org/obo/GO_0005788) (endoplasmic reticulum lumen), [GO:0004457](http://purl.obolibrary.org/obo/GO_0004457) (lactate dehydrogenase activity), [GO:0004459](http://purl.obolibrary.org/obo/GO_0004459) (L-lactate dehydrogenase activity), [GO:0047598](http://purl.obolibrary.org/obo/GO_0047598) (7-dehydrocholesterol reductase activity), [GO:0071216](http://purl.obolibrary.org/obo/GO_0071216) (cellular response to biotic stimulus), [GO:0072545](http://purl.obolibrary.org/obo/GO_0072545) (tyrosine binding), [GO:0072544](http://purl.obolibrary.org/obo/GO_0072544) (L-DOPA binding), [GO:0015108](http://purl.obolibrary.org/obo/GO_0015108) (chloride transmembrane transporter activity), [GO:0015106](http://purl.obolibrary.org/obo/GO_0015106) (bicarbonate transmembrane transporter activity), [GO:0030742](http://purl.obolibrary.org/obo/GO_0030742) (GTP-dependent protein binding), [GO:0060550](http://purl.obolibrary.org/obo/GO_0060550) (positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity), [GO:0060552](http://purl.obolibrary.org/obo/GO_0060552) (positive regulation of fructose 1,6-bisphosphate metabolic process), [GO:1901671](http://purl.obolibrary.org/obo/GO_1901671) (positive regulation of superoxide dismutase activity), [GO:1901673](http://purl.obolibrary.org/obo/GO_1901673) (regulation of mitotic spindle assembly), [GO:0003140](http://purl.obolibrary.org/obo/GO_0003140) (determination of left/right asymmetry in lateral mesoderm), [GO:1901674](http://purl.obolibrary.org/obo/GO_1901674) (regulation of histone H3-K27 acetylation), [GO:0060559](http://purl.obolibrary.org/obo/GO_0060559) (positive regulation of calcidiol 1-monooxygenase activity), [GO:0003143](http://purl.obolibrary.org/obo/GO_0003143) (embryonic heart tube morphogenesis), [GO:0004476](http://purl.obolibrary.org/obo/GO_0004476) (mannose-6-phosphate isomerase activity), [GO:0004475](http://purl.obolibrary.org/obo/GO_0004475) (mannose-1-phosphate guanylyltransferase activity), [GO:0003146](http://purl.obolibrary.org/obo/GO_0003146) (heart jogging), [GO:0004478](http://purl.obolibrary.org/obo/GO_0004478) (methionine adenosyltransferase activity), [GO:0004477](http://purl.obolibrary.org/obo/GO_0004477) (methenyltetrahydrofolate cyclohydrolase activity), [GO:0060557](http://purl.obolibrary.org/obo/GO_0060557) (positive regulation of vitamin D biosynthetic process), [GO:0003147](http://purl.obolibrary.org/obo/GO_0003147) (neural crest cell migration involved in heart formation), [GO:0004468](http://purl.obolibrary.org/obo/GO_0004468) (lysine N-acetyltransferase activity, acting on acetyl phosphate as donor), [GO:0003138](http://purl.obolibrary.org/obo/GO_0003138) (primary heart field specification), [GO:0003139](http://purl.obolibrary.org/obo/GO_0003139) (secondary heart field specification), [GO:2001016](http://purl.obolibrary.org/obo/GO_2001016) (positive regulation of skeletal muscle cell differentiation), [GO:0071205](http://purl.obolibrary.org/obo/GO_0071205) (protein localization to juxtaparanode region of axon), [GO:0016441](http://purl.obolibrary.org/obo/GO_0016441) (posttranscriptional gene silencing), [GO:0071203](http://purl.obolibrary.org/obo/GO_0071203) (WASH complex), [GO:2001012](http://purl.obolibrary.org/obo/GO_2001012) (mesenchymal cell differentiation involved in renal system development), [GO:0030730](http://purl.obolibrary.org/obo/GO_0030730) (sequestering of triglyceride), [GO:2001013](http://purl.obolibrary.org/obo/GO_2001013) (epithelial cell proliferation involved in renal tubule morphogenesis), [GO:2001014](http://purl.obolibrary.org/obo/GO_2001014) (regulation of skeletal muscle cell differentiation), [GO:2001015](http://purl.obolibrary.org/obo/GO_2001015) (negative regulation of skeletal muscle cell differentiation), [GO:0015116](http://purl.obolibrary.org/obo/GO_0015116) (sulfate transmembrane transporter activity), [GO:0016446](http://purl.obolibrary.org/obo/GO_0016446) (somatic hypermutation of immunoglobulin genes), [GO:0030731](http://purl.obolibrary.org/obo/GO_0030731) (guanidinoacetate N-methyltransferase activity), [GO:2001032](http://purl.obolibrary.org/obo/GO_2001032) (regulation of double-strand break repair via nonhomologous end joining), [GO:0060586](http://purl.obolibrary.org/obo/GO_0060586) (multicellular organismal iron ion homeostasis), [GO:0016428](http://purl.obolibrary.org/obo/GO_0016428) (tRNA (cytosine-5-)-methyltransferase activity), [GO:0016429](http://purl.obolibrary.org/obo/GO_0016429) (tRNA (adenine-N1-)-methyltransferase activity), [GO:0005770](http://purl.obolibrary.org/obo/GO_0005770) (late endosome), [GO:0005771](http://purl.obolibrary.org/obo/GO_0005771) (multivesicular body), [GO:0005774](http://purl.obolibrary.org/obo/GO_0005774) (vacuolar membrane), [GO:0005773](http://purl.obolibrary.org/obo/GO_0005773) (vacuole), [GO:0004445](http://purl.obolibrary.org/obo/GO_0004445) (inositol-polyphosphate 5-phosphatase activity), [GO:0005776](http://purl.obolibrary.org/obo/GO_0005776) (autophagosome), [GO:0005775](http://purl.obolibrary.org/obo/GO_0005775) (vacuolar lumen), [GO:0003104](http://purl.obolibrary.org/obo/GO_0003104) (positive regulation of glomerular filtration), [GO:0071230](http://purl.obolibrary.org/obo/GO_0071230) (cellular response to amino acid stimulus), [GO:0004435](http://purl.obolibrary.org/obo/GO_0004435) (phosphatidylinositol phospholipase C activity), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0004438](http://purl.obolibrary.org/obo/GO_0004438) (phosphatidylinositol-3-phosphatase activity), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0071233](http://purl.obolibrary.org/obo/GO_0071233) (cellular response to leucine), [GO:0004439](http://purl.obolibrary.org/obo/GO_0004439) (phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity), [GO:0071231](http://purl.obolibrary.org/obo/GO_0071231) (cellular response to folic acid), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:2001028](http://purl.obolibrary.org/obo/GO_2001028) (positive regulation of endothelial cell chemotaxis), [GO:2001043](http://purl.obolibrary.org/obo/GO_2001043) (positive regulation of cell separation after cytokinesis), [GO:0060575](http://purl.obolibrary.org/obo/GO_0060575) (intestinal epithelial cell differentiation), [GO:1900364](http://purl.obolibrary.org/obo/GO_1900364) (negative regulation of mRNA polyadenylation), [GO:0060571](http://purl.obolibrary.org/obo/GO_0060571) (morphogenesis of an epithelial fold), [GO:2001040](http://purl.obolibrary.org/obo/GO_2001040) (positive regulation of cellular response to drug), [GO:0004450](http://purl.obolibrary.org/obo/GO_0004450) (isocitrate dehydrogenase (NADP+) activity), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0005782](http://purl.obolibrary.org/obo/GO_0005782) (peroxisomal matrix), [GO:0005785](http://purl.obolibrary.org/obo/GO_0005785) (signal recognition particle receptor complex), [GO:0060577](http://purl.obolibrary.org/obo/GO_0060577) (pulmonary vein morphogenesis), [GO:0005784](http://purl.obolibrary.org/obo/GO_0005784) (Sec61 translocon complex), [GO:1900369](http://purl.obolibrary.org/obo/GO_1900369) (negative regulation of RNA interference), [GO:0060578](http://purl.obolibrary.org/obo/GO_0060578) (superior vena cava morphogenesis), [GO:0060579](http://purl.obolibrary.org/obo/GO_0060579) (ventral spinal cord interneuron fate commitment), [GO:0005778](http://purl.obolibrary.org/obo/GO_0005778) (peroxisomal membrane), [GO:0005777](http://purl.obolibrary.org/obo/GO_0005777) (peroxisome), [GO:0004449](http://purl.obolibrary.org/obo/GO_0004449) (isocitrate dehydrogenase (NAD+) activity), [GO:0046294](http://purl.obolibrary.org/obo/GO_0046294) (formaldehyde catabolic process), [GO:0005779](http://purl.obolibrary.org/obo/GO_0005779) (integral component of peroxisomal membrane), [GO:0004448](http://purl.obolibrary.org/obo/GO_0004448) (isocitrate dehydrogenase activity), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0072554](http://purl.obolibrary.org/obo/GO_0072554) (blood vessel lumenization), [GO:0071223](http://purl.obolibrary.org/obo/GO_0071223) (cellular response to lipoteichoic acid), [GO:0071226](http://purl.obolibrary.org/obo/GO_0071226) (cellular response to molecule of fungal origin), [GO:0072558](http://purl.obolibrary.org/obo/GO_0072558) (NLRP1 inflammasome complex), [GO:0071224](http://purl.obolibrary.org/obo/GO_0071224) (cellular response to peptidoglycan), [GO:0046292](http://purl.obolibrary.org/obo/GO_0046292) (formaldehyde metabolic process), [GO:0016423](http://purl.obolibrary.org/obo/GO_0016423) (tRNA (guanine) methyltransferase activity), [GO:0072559](http://purl.obolibrary.org/obo/GO_0072559) (NLRP3 inflammasome complex), [GO:0071229](http://purl.obolibrary.org/obo/GO_0071229) (cellular response to acid chemical), [GO:2001037](http://purl.obolibrary.org/obo/GO_2001037) (positive regulation of tongue muscle cell differentiation), [GO:2001054](http://purl.obolibrary.org/obo/GO_2001054) (negative regulation of mesenchymal cell apoptotic process), [GO:2001055](http://purl.obolibrary.org/obo/GO_2001055) (positive regulation of mesenchymal cell apoptotic process), [GO:0003170](http://purl.obolibrary.org/obo/GO_0003170) (heart valve development), [GO:0003171](http://purl.obolibrary.org/obo/GO_0003171) (atrioventricular valve development), [GO:0042770](http://purl.obolibrary.org/obo/GO_0042770) (signal transduction in response to DNA damage), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0042773](http://purl.obolibrary.org/obo/GO_0042773) (ATP synthesis coupled electron transport), [GO:0042775](http://purl.obolibrary.org/obo/GO_0042775) (mitochondrial ATP synthesis coupled electron transport), [GO:0003179](http://purl.obolibrary.org/obo/GO_0003179) (heart valve morphogenesis), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0016493](http://purl.obolibrary.org/obo/GO_0016493) (C-C chemokine receptor activity), [GO:0042780](http://purl.obolibrary.org/obo/GO_0042780) (tRNA 3'-end processing), [GO:2001045](http://purl.obolibrary.org/obo/GO_2001045) (negative regulation of integrin-mediated signaling pathway), [GO:2001046](http://purl.obolibrary.org/obo/GO_2001046) (positive regulation of integrin-mediated signaling pathway), [GO:0003180](http://purl.obolibrary.org/obo/GO_0003180) (aortic valve morphogenesis), [GO:0000904](http://purl.obolibrary.org/obo/GO_0000904) (cell morphogenesis involved in differentiation), [GO:0003181](http://purl.obolibrary.org/obo/GO_0003181) (atrioventricular valve morphogenesis), [GO:0000902](http://purl.obolibrary.org/obo/GO_0000902) (cell morphogenesis), [GO:0003183](http://purl.obolibrary.org/obo/GO_0003183) (mitral valve morphogenesis), [GO:0003184](http://purl.obolibrary.org/obo/GO_0003184) (pulmonary valve morphogenesis), [GO:0000900](http://purl.obolibrary.org/obo/GO_0000900) (translation repressor activity, nucleic acid binding), [GO:0003185](http://purl.obolibrary.org/obo/GO_0003185) (sinoatrial valve morphogenesis), [GO:0003187](http://purl.obolibrary.org/obo/GO_0003187) (ventriculo bulbo valve morphogenesis), [GO:0042787](http://purl.obolibrary.org/obo/GO_0042787) (protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0042788](http://purl.obolibrary.org/obo/GO_0042788) (polysomal ribosome), [GO:0042790](http://purl.obolibrary.org/obo/GO_0042790) (transcription of nucleolar large rRNA by RNA polymerase I), [GO:0042791](http://purl.obolibrary.org/obo/GO_0042791) (5S class rRNA transcription from RNA polymerase III type 1 promoter), [GO:0016485](http://purl.obolibrary.org/obo/GO_0016485) (protein processing), [GO:0016488](http://purl.obolibrary.org/obo/GO_0016488) (farnesol catabolic process), [GO:0052106](http://purl.obolibrary.org/obo/GO_0052106) (quorum sensing involved in interaction with host), [GO:0015137](http://purl.obolibrary.org/obo/GO_0015137) (citrate transmembrane transporter activity), [GO:0015136](http://purl.obolibrary.org/obo/GO_0015136) (sialic acid transmembrane transporter activity), [GO:2001070](http://purl.obolibrary.org/obo/GO_2001070) (starch binding), [GO:0003150](http://purl.obolibrary.org/obo/GO_0003150) (muscular septum morphogenesis), [GO:0003151](http://purl.obolibrary.org/obo/GO_0003151) (outflow tract morphogenesis), [GO:1905206](http://purl.obolibrary.org/obo/GO_1905206) (positive regulation of hydrogen peroxide-induced cell death), [GO:0004487](http://purl.obolibrary.org/obo/GO_0004487) (methylenetetrahydrofolate dehydrogenase (NAD+) activity), [GO:0004489](http://purl.obolibrary.org/obo/GO_0004489) (methylenetetrahydrofolate reductase (NAD(P)H) activity), [GO:0004488](http://purl.obolibrary.org/obo/GO_0004488) (methylenetetrahydrofolate dehydrogenase (NADP+) activity), [GO:0042799](http://purl.obolibrary.org/obo/GO_0042799) (histone methyltransferase activity (H4-K20 specific)), [GO:0003148](http://purl.obolibrary.org/obo/GO_0003148) (outflow tract septum morphogenesis), [GO:0003149](http://purl.obolibrary.org/obo/GO_0003149) (membranous septum morphogenesis), [GO:0016471](http://purl.obolibrary.org/obo/GO_0016471) (vacuolar proton-transporting V-type ATPase complex), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0015129](http://purl.obolibrary.org/obo/GO_0015129) (lactate transmembrane transporter activity), [GO:0015127](http://purl.obolibrary.org/obo/GO_0015127) (bilirubin transmembrane transporter activity), [GO:0016458](http://purl.obolibrary.org/obo/GO_0016458) (gene silencing), [GO:0016459](http://purl.obolibrary.org/obo/GO_0016459) (myosin complex), [GO:0003160](http://purl.obolibrary.org/obo/GO_0003160) (endocardium morphogenesis), [GO:0015142](http://purl.obolibrary.org/obo/GO_0015142) (tricarboxylic acid transmembrane transporter activity), [GO:0003161](http://purl.obolibrary.org/obo/GO_0003161) (cardiac conduction system development), [GO:0015141](http://purl.obolibrary.org/obo/GO_0015141) (succinate transmembrane transporter activity), [GO:0004496](http://purl.obolibrary.org/obo/GO_0004496) (mevalonate kinase activity), [GO:0003165](http://purl.obolibrary.org/obo/GO_0003165) (Purkinje myocyte development), [GO:0004497](http://purl.obolibrary.org/obo/GO_0004497) (monooxygenase activity), [GO:0016461](http://purl.obolibrary.org/obo/GO_0016461) (unconventional myosin complex), [GO:0016462](http://purl.obolibrary.org/obo/GO_0016462) (pyrophosphatase activity), [GO:0042734](http://purl.obolibrary.org/obo/GO_0042734) (presynaptic membrane), [GO:0000938](http://purl.obolibrary.org/obo/GO_0000938) (GARP complex), [GO:0015195](http://purl.obolibrary.org/obo/GO_0015195) (L-threonine transmembrane transporter activity), [GO:0000932](http://purl.obolibrary.org/obo/GO_0000932) (P-body), [GO:0015194](http://purl.obolibrary.org/obo/GO_0015194) (L-serine transmembrane transporter activity), [GO:0015193](http://purl.obolibrary.org/obo/GO_0015193) (L-proline transmembrane transporter activity), [GO:0000930](http://purl.obolibrary.org/obo/GO_0000930) (gamma-tubulin complex), [GO:0042733](http://purl.obolibrary.org/obo/GO_0042733) (embryonic digit morphogenesis), [GO:0071294](http://purl.obolibrary.org/obo/GO_0071294) (cellular response to zinc ion), [GO:0042745](http://purl.obolibrary.org/obo/GO_0042745) (circadian sleep/wake cycle), [GO:0042746](http://purl.obolibrary.org/obo/GO_0042746) (circadian sleep/wake cycle, wakefulness), [GO:0000947](http://purl.obolibrary.org/obo/GO_0000947) (amino acid catabolic process to alcohol via Ehrlich pathway), [GO:0000940](http://purl.obolibrary.org/obo/GO_0000940) (condensed chromosome outer kinetochore), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0042743](http://purl.obolibrary.org/obo/GO_0042743) (hydrogen peroxide metabolic process), [GO:0042744](http://purl.obolibrary.org/obo/GO_0042744) (hydrogen peroxide catabolic process), [GO:0071285](http://purl.obolibrary.org/obo/GO_0071285) (cellular response to lithium ion), [GO:0071286](http://purl.obolibrary.org/obo/GO_0071286) (cellular response to magnesium ion), [GO:0071287](http://purl.obolibrary.org/obo/GO_0071287) (cellular response to manganese ion), [GO:0042758](http://purl.obolibrary.org/obo/GO_0042758) (long-chain fatty acid catabolic process), [GO:0042759](http://purl.obolibrary.org/obo/GO_0042759) (long-chain fatty acid biosynthetic process), [GO:0003190](http://purl.obolibrary.org/obo/GO_0003190) (atrioventricular valve formation), [GO:0015175](http://purl.obolibrary.org/obo/GO_0015175) (neutral amino acid transmembrane transporter activity), [GO:0000910](http://purl.obolibrary.org/obo/GO_0000910) (cytokinesis), [GO:0015172](http://purl.obolibrary.org/obo/GO_0015172) (acidic amino acid transmembrane transporter activity), [GO:0003197](http://purl.obolibrary.org/obo/GO_0003197) (endocardial cushion development), [GO:0015171](http://purl.obolibrary.org/obo/GO_0015171) (amino acid transmembrane transporter activity), [GO:0003198](http://purl.obolibrary.org/obo/GO_0003198) (epithelial to mesenchymal transition involved in endocardial cushion formation), [GO:0042752](http://purl.obolibrary.org/obo/GO_0042752) (regulation of circadian rhythm), [GO:0042753](http://purl.obolibrary.org/obo/GO_0042753) (positive regulation of circadian rhythm), [GO:0042754](http://purl.obolibrary.org/obo/GO_0042754) (negative regulation of circadian rhythm), [GO:0042755](http://purl.obolibrary.org/obo/GO_0042755) (eating behavior), [GO:0042769](http://purl.obolibrary.org/obo/GO_0042769) (DNA damage response, detection of DNA damage), [GO:0015189](http://purl.obolibrary.org/obo/GO_0015189) (L-lysine transmembrane transporter activity), [GO:0015187](http://purl.obolibrary.org/obo/GO_0015187) (glycine transmembrane transporter activity), [GO:0000922](http://purl.obolibrary.org/obo/GO_0000922) (spindle pole), [GO:0015184](http://purl.obolibrary.org/obo/GO_0015184) (L-cystine transmembrane transporter activity), [GO:0015183](http://purl.obolibrary.org/obo/GO_0015183) (L-aspartate transmembrane transporter activity), [GO:0042760](http://purl.obolibrary.org/obo/GO_0042760) (very long-chain fatty acid catabolic process), [GO:0000921](http://purl.obolibrary.org/obo/GO_0000921) (septin ring assembly), [GO:0042761](http://purl.obolibrary.org/obo/GO_0042761) (very long-chain fatty acid biosynthetic process), [GO:0000920](http://purl.obolibrary.org/obo/GO_0000920) (cell separation after cytokinesis), [GO:0015180](http://purl.obolibrary.org/obo/GO_0015180) (L-alanine transmembrane transporter activity), [GO:0042764](http://purl.obolibrary.org/obo/GO_0042764) (ascospore-type prospore), [GO:0042765](http://purl.obolibrary.org/obo/GO_0042765) (GPI-anchor transamidase complex), [GO:0042766](http://purl.obolibrary.org/obo/GO_0042766) (nucleosome mobilization), [GO:1905144](http://purl.obolibrary.org/obo/GO_1905144) (response to acetylcholine), [GO:0090336](http://purl.obolibrary.org/obo/GO_0090336) (positive regulation of brown fat cell differentiation), [GO:0090334](http://purl.obolibrary.org/obo/GO_0090334) (regulation of cell wall (1->3)-beta-D-glucan biosynthetic process), [GO:0090331](http://purl.obolibrary.org/obo/GO_0090331) (negative regulation of platelet aggregation), [GO:0048808](http://purl.obolibrary.org/obo/GO_0048808) (male genitalia morphogenesis), [GO:0048807](http://purl.obolibrary.org/obo/GO_0048807) (female genitalia morphogenesis), [GO:0048806](http://purl.obolibrary.org/obo/GO_0048806) (genitalia development), [GO:0090344](http://purl.obolibrary.org/obo/GO_0090344) (negative regulation of cell aging), [GO:0009200](http://purl.obolibrary.org/obo/GO_0009200) (deoxyribonucleoside triphosphate metabolic process), [GO:0090342](http://purl.obolibrary.org/obo/GO_0090342) (regulation of cell aging), [GO:0009202](http://purl.obolibrary.org/obo/GO_0009202) (deoxyribonucleoside triphosphate biosynthetic process), [GO:1905150](http://purl.obolibrary.org/obo/GO_1905150) (regulation of voltage-gated sodium channel activity), [GO:0090315](http://purl.obolibrary.org/obo/GO_0090315) (negative regulation of protein targeting to membrane), [GO:0090316](http://purl.obolibrary.org/obo/GO_0090316) (positive regulation of intracellular protein transport), [GO:1905165](http://purl.obolibrary.org/obo/GO_1905165) (regulation of lysosomal protein catabolic process), [GO:0090314](http://purl.obolibrary.org/obo/GO_0090314) (positive regulation of protein targeting to membrane), [GO:0090312](http://purl.obolibrary.org/obo/GO_0090312) (positive regulation of protein deacetylation), [GO:1905168](http://purl.obolibrary.org/obo/GO_1905168) (positive regulation of double-strand break repair via homologous recombination), [GO:0048812](http://purl.obolibrary.org/obo/GO_0048812) (neuron projection morphogenesis), [GO:0015095](http://purl.obolibrary.org/obo/GO_0015095) (magnesium ion transmembrane transporter activity), [GO:0048814](http://purl.obolibrary.org/obo/GO_0048814) (regulation of dendrite morphogenesis), [GO:0048813](http://purl.obolibrary.org/obo/GO_0048813) (dendrite morphogenesis), [GO:1905176](http://purl.obolibrary.org/obo/GO_1905176) (positive regulation of vascular smooth muscle cell dedifferentiation), [GO:0090325](http://purl.obolibrary.org/obo/GO_0090325) (regulation of locomotion involved in locomotory behavior), [GO:0048823](http://purl.obolibrary.org/obo/GO_0048823) (nucleate erythrocyte development), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0048820](http://purl.obolibrary.org/obo/GO_0048820) (hair follicle maturation), [GO:1902902](http://purl.obolibrary.org/obo/GO_1902902) (negative regulation of autophagosome assembly), [GO:0040038](http://purl.obolibrary.org/obo/GO_0040038) (polar body extrusion after meiotic divisions), [GO:0040037](http://purl.obolibrary.org/obo/GO_0040037) (negative regulation of fibroblast growth factor receptor signaling pathway), [GO:0040036](http://purl.obolibrary.org/obo/GO_0040036) (regulation of fibroblast growth factor receptor signaling pathway), [GO:1905103](http://purl.obolibrary.org/obo/GO_1905103) (integral component of lysosomal membrane), [GO:0042693](http://purl.obolibrary.org/obo/GO_0042693) (muscle cell fate commitment), [GO:0042694](http://purl.obolibrary.org/obo/GO_0042694) (muscle cell fate specification), [GO:0009236](http://purl.obolibrary.org/obo/GO_0009236) (cobalamin biosynthetic process), [GO:0009235](http://purl.obolibrary.org/obo/GO_0009235) (cobalamin metabolic process), [GO:0042696](http://purl.obolibrary.org/obo/GO_0042696) (menarche), [GO:0009234](http://purl.obolibrary.org/obo/GO_0009234) (menaquinone biosynthetic process), [GO:0042698](http://purl.obolibrary.org/obo/GO_0042698) (ovulation cycle), [GO:0035518](http://purl.obolibrary.org/obo/GO_0035518) (histone H2A monoubiquitination), [GO:0040040](http://purl.obolibrary.org/obo/GO_0040040) (thermosensory behavior), [GO:0010216](http://purl.obolibrary.org/obo/GO_0010216) (maintenance of DNA methylation), [GO:0035517](http://purl.obolibrary.org/obo/GO_0035517) (PR-DUB complex), [GO:0010212](http://purl.obolibrary.org/obo/GO_0010212) (response to ionizing radiation), [GO:0090305](http://purl.obolibrary.org/obo/GO_0090305) (nucleic acid phosphodiester bond hydrolysis), [GO:0090303](http://purl.obolibrary.org/obo/GO_0090303) (positive regulation of wound healing), [GO:0090301](http://purl.obolibrary.org/obo/GO_0090301) (negative regulation of neural crest formation), [GO:0009249](http://purl.obolibrary.org/obo/GO_0009249) (protein lipoylation), [GO:0035509](http://purl.obolibrary.org/obo/GO_0035509) (negative regulation of myosin-light-chain-phosphatase activity), [GO:0010225](http://purl.obolibrary.org/obo/GO_0010225) (response to UV-C), [GO:0090309](http://purl.obolibrary.org/obo/GO_0090309) (positive regulation of methylation-dependent chromatin silencing), [GO:0010224](http://purl.obolibrary.org/obo/GO_0010224) (response to UV-B), [GO:0090306](http://purl.obolibrary.org/obo/GO_0090306) (spindle assembly involved in meiosis), [GO:0090307](http://purl.obolibrary.org/obo/GO_0090307) (mitotic spindle assembly), [GO:1905123](http://purl.obolibrary.org/obo/GO_1905123) (regulation of glucosylceramidase activity), [GO:1905122](http://purl.obolibrary.org/obo/GO_1905122) (polyamine import), [GO:0009213](http://purl.obolibrary.org/obo/GO_0009213) (pyrimidine deoxyribonucleoside triphosphate catabolic process), [GO:0009217](http://purl.obolibrary.org/obo/GO_0009217) (purine deoxyribonucleoside triphosphate catabolic process), [GO:0035562](http://purl.obolibrary.org/obo/GO_0035562) (negative regulation of chromatin binding), [GO:0009272](http://purl.obolibrary.org/obo/GO_0009272) (fungal-type cell wall biogenesis), [GO:0035563](http://purl.obolibrary.org/obo/GO_0035563) (positive regulation of chromatin binding), [GO:0060520](http://purl.obolibrary.org/obo/GO_0060520) (activation of prostate induction by androgen receptor signaling pathway), [GO:0009277](http://purl.obolibrary.org/obo/GO_0009277) (fungal-type cell wall), [GO:0048878](http://purl.obolibrary.org/obo/GO_0048878) (chemical homeostasis), [GO:1901620](http://purl.obolibrary.org/obo/GO_1901620) (regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:1902953](http://purl.obolibrary.org/obo/GO_1902953) (positive regulation of ER to Golgi vesicle-mediated transport), [GO:0061857](http://purl.obolibrary.org/obo/GO_0061857) (endoplasmic reticulum stress-induced pre-emptive quality control), [GO:0048877](http://purl.obolibrary.org/obo/GO_0048877) (homeostasis of number of retina cells), [GO:1901622](http://purl.obolibrary.org/obo/GO_1901622) (positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:0060527](http://purl.obolibrary.org/obo/GO_0060527) (prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis), [GO:0047545](http://purl.obolibrary.org/obo/GO_0047545) (2-hydroxyglutarate dehydrogenase activity), [GO:1901621](http://purl.obolibrary.org/obo/GO_1901621) (negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:0048875](http://purl.obolibrary.org/obo/GO_0048875) (chemical homeostasis within a tissue), [GO:0060523](http://purl.obolibrary.org/obo/GO_0060523) (prostate epithelial cord elongation), [GO:1901626](http://purl.obolibrary.org/obo/GO_1901626) (regulation of postsynaptic membrane organization), [GO:0048881](http://purl.obolibrary.org/obo/GO_0048881) (mechanosensory lateral line system development), [GO:0060529](http://purl.obolibrary.org/obo/GO_0060529) (squamous basal epithelial stem cell differentiation involved in prostate gland acinus development), [GO:0048884](http://purl.obolibrary.org/obo/GO_0048884) (neuromast development), [GO:0010259](http://purl.obolibrary.org/obo/GO_0010259) (multicellular organism aging), [GO:0034225](http://purl.obolibrary.org/obo/GO_0034225) (regulation of transcription from RNA polymerase II promoter in response to zinc ion starvation), [GO:0010255](http://purl.obolibrary.org/obo/GO_0010255) (glucose mediated signaling pathway), [GO:0072507](http://purl.obolibrary.org/obo/GO_0072507) (divalent inorganic cation homeostasis), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0010257](http://purl.obolibrary.org/obo/GO_0010257) (NADH dehydrogenase complex assembly), [GO:0010256](http://purl.obolibrary.org/obo/GO_0010256) (endomembrane system organization), [GO:0010273](http://purl.obolibrary.org/obo/GO_0010273) (detoxification of copper ion), [GO:0034221](http://purl.obolibrary.org/obo/GO_0034221) (fungal-type cell wall chitin biosynthetic process), [GO:0034220](http://purl.obolibrary.org/obo/GO_0034220) (ion transmembrane transport), [GO:0060516](http://purl.obolibrary.org/obo/GO_0060516) (primary prostatic bud elongation), [GO:0047555](http://purl.obolibrary.org/obo/GO_0047555) (3',5'-cyclic-GMP phosphodiesterase activity), [GO:0060510](http://purl.obolibrary.org/obo/GO_0060510) (Type II pneumocyte differentiation), [GO:0060512](http://purl.obolibrary.org/obo/GO_0060512) (prostate gland morphogenesis), [GO:0060513](http://purl.obolibrary.org/obo/GO_0060513) (prostatic bud formation), [GO:0048890](http://purl.obolibrary.org/obo/GO_0048890) (lateral line ganglion development), [GO:0048894](http://purl.obolibrary.org/obo/GO_0048894) (efferent axon development in a lateral line nerve), [GO:0034214](http://purl.obolibrary.org/obo/GO_0034214) (protein hexamerization), [GO:0035549](http://purl.obolibrary.org/obo/GO_0035549) (positive regulation of interferon-beta secretion), [GO:0034212](http://purl.obolibrary.org/obo/GO_0034212) (peptide N-acetyltransferase activity), [GO:0034219](http://purl.obolibrary.org/obo/GO_0034219) (carbohydrate transmembrane transport), [GO:0035545](http://purl.obolibrary.org/obo/GO_0035545) (determination of left/right asymmetry in nervous system), [GO:0061870](http://purl.obolibrary.org/obo/GO_0061870) (positive regulation of hepatic stellate cell migration), [GO:0060541](http://purl.obolibrary.org/obo/GO_0060541) (respiratory system development), [GO:0035542](http://purl.obolibrary.org/obo/GO_0035542) (regulation of SNARE complex assembly), [GO:0090399](http://purl.obolibrary.org/obo/GO_0090399) (replicative senescence), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0009259](http://purl.obolibrary.org/obo/GO_0009259) (ribonucleotide metabolic process), [GO:1901642](http://purl.obolibrary.org/obo/GO_1901642) (nucleoside transmembrane transport), [GO:0060547](http://purl.obolibrary.org/obo/GO_0060547) (negative regulation of necrotic cell death), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0048899](http://purl.obolibrary.org/obo/GO_0048899) (anterior lateral line development), [GO:0009257](http://purl.obolibrary.org/obo/GO_0009257) (10-formyltetrahydrofolate biosynthetic process), [GO:0090394](http://purl.obolibrary.org/obo/GO_0090394) (negative regulation of excitatory postsynaptic potential), [GO:0061874](http://purl.obolibrary.org/obo/GO_0061874) (positive regulation of hepatic stellate cell contraction), [GO:1902977](http://purl.obolibrary.org/obo/GO_1902977) (mitotic DNA replication preinitiation complex assembly), [GO:0060546](http://purl.obolibrary.org/obo/GO_0060546) (negative regulation of necroptotic process), [GO:0072520](http://purl.obolibrary.org/obo/GO_0072520) (seminiferous tubule development), [GO:0034203](http://purl.obolibrary.org/obo/GO_0034203) (glycolipid translocation), [GO:0034205](http://purl.obolibrary.org/obo/GO_0034205) (amyloid-beta formation), [GO:0009262](http://purl.obolibrary.org/obo/GO_0009262) (deoxyribonucleotide metabolic process), [GO:0009266](http://purl.obolibrary.org/obo/GO_0009266) (response to temperature stimulus), [GO:0009263](http://purl.obolibrary.org/obo/GO_0009263) (deoxyribonucleotide biosynthetic process), [GO:0060536](http://purl.obolibrary.org/obo/GO_0060536) (cartilage morphogenesis), [GO:1901653](http://purl.obolibrary.org/obo/GO_1901653) (cellular response to peptide), [GO:0060537](http://purl.obolibrary.org/obo/GO_0060537) (muscle tissue development), [GO:0009268](http://purl.obolibrary.org/obo/GO_0009268) (response to pH), [GO:0060538](http://purl.obolibrary.org/obo/GO_0060538) (skeletal muscle organ development), [GO:0009267](http://purl.obolibrary.org/obo/GO_0009267) (cellular response to starvation), [GO:0060539](http://purl.obolibrary.org/obo/GO_0060539) (diaphragm development), [GO:0035529](http://purl.obolibrary.org/obo/GO_0035529) (NADH pyrophosphatase activity), [GO:0072513](http://purl.obolibrary.org/obo/GO_0072513) (positive regulation of secondary heart field cardioblast proliferation), [GO:0010243](http://purl.obolibrary.org/obo/GO_0010243) (response to organonitrogen compound), [GO:0035522](http://purl.obolibrary.org/obo/GO_0035522) (monoubiquitinated histone H2A deubiquitination), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0090370](http://purl.obolibrary.org/obo/GO_0090370) (negative regulation of cholesterol efflux), [GO:1902910](http://purl.obolibrary.org/obo/GO_1902910) (positive regulation of melanosome transport), [GO:1902906](http://purl.obolibrary.org/obo/GO_1902906) (proteasome storage granule assembly), [GO:0048841](http://purl.obolibrary.org/obo/GO_0048841) (regulation of axon extension involved in axon guidance), [GO:0048840](http://purl.obolibrary.org/obo/GO_0048840) (otolith development), [GO:1902908](http://purl.obolibrary.org/obo/GO_1902908) (regulation of melanosome transport), [GO:0034260](http://purl.obolibrary.org/obo/GO_0034260) (negative regulation of GTPase activity), [GO:0090389](http://purl.obolibrary.org/obo/GO_0090389) (phagosome-lysosome fusion involved in apoptotic cell clearance), [GO:0035591](http://purl.obolibrary.org/obo/GO_0035591) (signaling adaptor activity), [GO:0048845](http://purl.obolibrary.org/obo/GO_0048845) (venous blood vessel morphogenesis), [GO:0048844](http://purl.obolibrary.org/obo/GO_0048844) (artery morphogenesis), [GO:0005721](http://purl.obolibrary.org/obo/GO_0005721) (pericentric heterochromatin), [GO:0048846](http://purl.obolibrary.org/obo/GO_0048846) (axon extension involved in axon guidance), [GO:0005720](http://purl.obolibrary.org/obo/GO_0005720) (nuclear heterochromatin), [GO:0005712](http://purl.obolibrary.org/obo/GO_0005712) (chiasma), [GO:0048852](http://purl.obolibrary.org/obo/GO_0048852) (diencephalon morphogenesis), [GO:0048850](http://purl.obolibrary.org/obo/GO_0048850) (hypophysis morphogenesis), [GO:0034258](http://purl.obolibrary.org/obo/GO_0034258) (nicotinamide riboside transport), [GO:0005719](http://purl.obolibrary.org/obo/GO_0005719) (nuclear euchromatin), [GO:0034257](http://purl.obolibrary.org/obo/GO_0034257) (nicotinamide riboside transmembrane transporter activity), [GO:0035583](http://purl.obolibrary.org/obo/GO_0035583) (sequestering of TGFbeta in extracellular matrix), [GO:0035584](http://purl.obolibrary.org/obo/GO_0035584) (calcium-mediated signaling using intracellular calcium source), [GO:0009298](http://purl.obolibrary.org/obo/GO_0009298) (GDP-mannose biosynthetic process), [GO:0060503](http://purl.obolibrary.org/obo/GO_0060503) (bud dilation involved in lung branching), [GO:0048856](http://purl.obolibrary.org/obo/GO_0048856) (anatomical structure development), [GO:0048855](http://purl.obolibrary.org/obo/GO_0048855) (adenohypophysis morphogenesis), [GO:0048854](http://purl.obolibrary.org/obo/GO_0048854) (brain morphogenesis), [GO:0048853](http://purl.obolibrary.org/obo/GO_0048853) (forebrain morphogenesis), [GO:0048859](http://purl.obolibrary.org/obo/GO_0048859) (formation of anatomical boundary), [GO:0060501](http://purl.obolibrary.org/obo/GO_0060501) (positive regulation of epithelial cell proliferation involved in lung morphogenesis), [GO:0060502](http://purl.obolibrary.org/obo/GO_0060502) (epithelial cell proliferation involved in lung morphogenesis), [GO:0048863](http://purl.obolibrary.org/obo/GO_0048863) (stem cell differentiation), [GO:0034247](http://purl.obolibrary.org/obo/GO_0034247) (snoRNA splicing), [GO:0035579](http://purl.obolibrary.org/obo/GO_0035579) (specific granule membrane), [GO:0035574](http://purl.obolibrary.org/obo/GO_0035574) (histone H4-K20 demethylation), [GO:0035575](http://purl.obolibrary.org/obo/GO_0035575) (histone demethylase activity (H4-K20 specific)), [GO:0034244](http://purl.obolibrary.org/obo/GO_0034244) (negative regulation of transcription elongation from RNA polymerase II promoter), [GO:0034243](http://purl.obolibrary.org/obo/GO_0034243) (regulation of transcription elongation from RNA polymerase II promoter), [GO:0034241](http://purl.obolibrary.org/obo/GO_0034241) (positive regulation of macrophage fusion), [GO:0090365](http://purl.obolibrary.org/obo/GO_0090365) (regulation of mRNA modification), [GO:0048865](http://purl.obolibrary.org/obo/GO_0048865) (stem cell fate commitment), [GO:0048864](http://purl.obolibrary.org/obo/GO_0048864) (stem cell development), [GO:0046208](http://purl.obolibrary.org/obo/GO_0046208) (spermine catabolic process), [GO:1901612](http://purl.obolibrary.org/obo/GO_1901612) (cardiolipin binding), [GO:0061820](http://purl.obolibrary.org/obo/GO_0061820) (telomeric D-loop disassembly), [GO:0061821](http://purl.obolibrary.org/obo/GO_0061821) (telomeric D-loop binding), [GO:0048870](http://purl.obolibrary.org/obo/GO_0048870) (cell motility), [GO:1902936](http://purl.obolibrary.org/obo/GO_1902936) (phosphatidylinositol bisphosphate binding), [GO:0048873](http://purl.obolibrary.org/obo/GO_0048873) (homeostasis of number of cells within a tissue), [GO:0048872](http://purl.obolibrary.org/obo/GO_0048872) (homeostasis of number of cells), [GO:0048871](http://purl.obolibrary.org/obo/GO_0048871) (multicellular organismal homeostasis), [GO:0034237](http://purl.obolibrary.org/obo/GO_0034237) (protein kinase A regulatory subunit binding), [GO:0035566](http://purl.obolibrary.org/obo/GO_0035566) (regulation of metanephros size), [GO:0035567](http://purl.obolibrary.org/obo/GO_0035567) (non-canonical Wnt signaling pathway), [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0042813](http://purl.obolibrary.org/obo/GO_0042813) (Wnt-activated receptor activity), [GO:0016528](http://purl.obolibrary.org/obo/GO_0016528) (sarcoplasm), [GO:0016529](http://purl.obolibrary.org/obo/GO_0016529) (sarcoplasmic reticulum), [GO:0005871](http://purl.obolibrary.org/obo/GO_0005871) (kinesin complex), [GO:0004540](http://purl.obolibrary.org/obo/GO_0004540) (ribonuclease activity), [GO:0003210](http://purl.obolibrary.org/obo/GO_0003210) (cardiac atrium formation), [GO:0071380](http://purl.obolibrary.org/obo/GO_0071380) (cellular response to prostaglandin E stimulus), [GO:0003211](http://purl.obolibrary.org/obo/GO_0003211) (cardiac ventricle formation), [GO:0005875](http://purl.obolibrary.org/obo/GO_0005875) (microtubule associated complex), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0003203](http://purl.obolibrary.org/obo/GO_0003203) (endocardial cushion morphogenesis), [GO:0004535](http://purl.obolibrary.org/obo/GO_0004535) (poly(A)-specific ribonuclease activity), [GO:0005865](http://purl.obolibrary.org/obo/GO_0005865) (striated muscle thin filament), [GO:0005868](http://purl.obolibrary.org/obo/GO_0005868) (cytoplasmic dynein complex), [GO:0003205](http://purl.obolibrary.org/obo/GO_0003205) (cardiac chamber development), [GO:0003206](http://purl.obolibrary.org/obo/GO_0003206) (cardiac chamber morphogenesis), [GO:0030823](http://purl.obolibrary.org/obo/GO_0030823) (regulation of cGMP metabolic process), [GO:0071371](http://purl.obolibrary.org/obo/GO_0071371) (cellular response to gonadotropin stimulus), [GO:0045095](http://purl.obolibrary.org/obo/GO_0045095) (keratin filament), [GO:0071376](http://purl.obolibrary.org/obo/GO_0071376) (cellular response to corticotropin-releasing hormone stimulus), [GO:0005869](http://purl.obolibrary.org/obo/GO_0005869) (dynactin complex), [GO:0003208](http://purl.obolibrary.org/obo/GO_0003208) (cardiac ventricle morphogenesis), [GO:0030828](http://purl.obolibrary.org/obo/GO_0030828) (positive regulation of cGMP biosynthetic process), [GO:0045098](http://purl.obolibrary.org/obo/GO_0045098) (type III intermediate filament), [GO:0003209](http://purl.obolibrary.org/obo/GO_0003209) (cardiac atrium morphogenesis), [GO:0071374](http://purl.obolibrary.org/obo/GO_0071374) (cellular response to parathyroid hormone stimulus), [GO:0071379](http://purl.obolibrary.org/obo/GO_0071379) (cellular response to prostaglandin stimulus), [GO:0016532](http://purl.obolibrary.org/obo/GO_0016532) (superoxide dismutase copper chaperone activity), [GO:0042823](http://purl.obolibrary.org/obo/GO_0042823) (pyridoxal phosphate biosynthetic process), [GO:0016514](http://purl.obolibrary.org/obo/GO_0016514) (SWI/SNF complex), [GO:0033093](http://purl.obolibrary.org/obo/GO_0033093) (Weibel-Palade body), [GO:0042826](http://purl.obolibrary.org/obo/GO_0042826) (histone deacetylase binding), [GO:0042827](http://purl.obolibrary.org/obo/GO_0042827) (platelet dense granule), [GO:0030819](http://purl.obolibrary.org/obo/GO_0030819) (positive regulation of cAMP biosynthetic process), [GO:0005880](http://purl.obolibrary.org/obo/GO_0005880) (nuclear microtubule), [GO:0005882](http://purl.obolibrary.org/obo/GO_0005882) (intermediate filament), [GO:0004551](http://purl.obolibrary.org/obo/GO_0004551) (nucleotide diphosphatase activity), [GO:0005881](http://purl.obolibrary.org/obo/GO_0005881) (cytoplasmic microtubule), [GO:0004550](http://purl.obolibrary.org/obo/GO_0004550) (nucleoside diphosphate kinase activity), [GO:0004553](http://purl.obolibrary.org/obo/GO_0004553) (hydrolase activity, hydrolyzing O-glycosyl compounds), [GO:0005884](http://purl.obolibrary.org/obo/GO_0005884) (actin filament), [GO:0033092](http://purl.obolibrary.org/obo/GO_0033092) (positive regulation of immature T cell proliferation in thymus), [GO:0005883](http://purl.obolibrary.org/obo/GO_0005883) (neurofilament), [GO:0003222](http://purl.obolibrary.org/obo/GO_0003222) (ventricular trabecula myocardium morphogenesis), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0003223](http://purl.obolibrary.org/obo/GO_0003223) (ventricular compact myocardium morphogenesis), [GO:0071361](http://purl.obolibrary.org/obo/GO_0071361) (cellular response to ethanol), [GO:0003214](http://purl.obolibrary.org/obo/GO_0003214) (cardiac left ventricle morphogenesis), [GO:0005876](http://purl.obolibrary.org/obo/GO_0005876) (spindle microtubule), [GO:0003215](http://purl.obolibrary.org/obo/GO_0003215) (cardiac right ventricle morphogenesis), [GO:0005879](http://purl.obolibrary.org/obo/GO_0005879) (axonemal microtubule), [GO:0071360](http://purl.obolibrary.org/obo/GO_0071360) (cellular response to exogenous dsRNA), [GO:0070034](http://purl.obolibrary.org/obo/GO_0070034) (telomerase RNA binding), [GO:0030814](http://purl.obolibrary.org/obo/GO_0030814) (regulation of cAMP metabolic process), [GO:0071363](http://purl.obolibrary.org/obo/GO_0071363) (cellular response to growth factor stimulus), [GO:0070032](http://purl.obolibrary.org/obo/GO_0070032) (synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex), [GO:0071364](http://purl.obolibrary.org/obo/GO_0071364) (cellular response to epidermal growth factor stimulus), [GO:0030816](http://purl.obolibrary.org/obo/GO_0030816) (positive regulation of cAMP metabolic process), [GO:0070037](http://purl.obolibrary.org/obo/GO_0070037) (rRNA (pseudouridine) methyltransferase activity), [GO:0016520](http://purl.obolibrary.org/obo/GO_0016520) (growth hormone-releasing hormone receptor activity), [GO:0033085](http://purl.obolibrary.org/obo/GO_0033085) (negative regulation of T cell differentiation in thymus), [GO:0042834](http://purl.obolibrary.org/obo/GO_0042834) (peptidoglycan binding), [GO:1900272](http://purl.obolibrary.org/obo/GO_1900272) (negative regulation of long-term synaptic potentiation), [GO:0016504](http://purl.obolibrary.org/obo/GO_0016504) (peptidase activator activity), [GO:1900271](http://purl.obolibrary.org/obo/GO_1900271) (regulation of long-term synaptic potentiation), [GO:0033089](http://purl.obolibrary.org/obo/GO_0033089) (positive regulation of T cell differentiation in thymus), [GO:0033088](http://purl.obolibrary.org/obo/GO_0033088) (negative regulation of immature T cell proliferation in thymus), [GO:1900273](http://purl.obolibrary.org/obo/GO_1900273) (positive regulation of long-term synaptic potentiation), [GO:0016507](http://purl.obolibrary.org/obo/GO_0016507) (mitochondrial fatty acid beta-oxidation multienzyme complex), [GO:0016508](http://purl.obolibrary.org/obo/GO_0016508) (long-chain-enoyl-CoA hydratase activity), [GO:0016509](http://purl.obolibrary.org/obo/GO_0016509) (long-chain-3-hydroxyacyl-CoA dehydrogenase activity), [GO:0004520](http://purl.obolibrary.org/obo/GO_0004520) (endodeoxyribonuclease activity), [GO:0033081](http://purl.obolibrary.org/obo/GO_0033081) (regulation of T cell differentiation in thymus), [GO:0005851](http://purl.obolibrary.org/obo/GO_0005851) (eukaryotic translation initiation factor 2B complex), [GO:0005850](http://purl.obolibrary.org/obo/GO_0005850) (eukaryotic translation initiation factor 2 complex), [GO:0005853](http://purl.obolibrary.org/obo/GO_0005853) (eukaryotic translation elongation factor 1 complex), [GO:0004521](http://purl.obolibrary.org/obo/GO_0004521) (endoribonuclease activity), [GO:0042832](http://purl.obolibrary.org/obo/GO_0042832) (defense response to protozoan), [GO:0005844](http://purl.obolibrary.org/obo/GO_0005844) (polysome), [GO:0071394](http://purl.obolibrary.org/obo/GO_0071394) (cellular response to testosterone stimulus), [GO:0070063](http://purl.obolibrary.org/obo/GO_0070063) (RNA polymerase binding), [GO:0070064](http://purl.obolibrary.org/obo/GO_0070064) (proline-rich region binding), [GO:0071395](http://purl.obolibrary.org/obo/GO_0071395) (cellular response to jasmonic acid stimulus), [GO:0071392](http://purl.obolibrary.org/obo/GO_0071392) (cellular response to estradiol stimulus), [GO:0070061](http://purl.obolibrary.org/obo/GO_0070061) (fructose binding), [GO:0004515](http://purl.obolibrary.org/obo/GO_0004515) (nicotinate-nucleotide adenylyltransferase activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0004517](http://purl.obolibrary.org/obo/GO_0004517) (nitric-oxide synthase activity), [GO:0004519](http://purl.obolibrary.org/obo/GO_0004519) (endonuclease activity), [GO:0004518](http://purl.obolibrary.org/obo/GO_0004518) (nuclease activity), [GO:0005849](http://purl.obolibrary.org/obo/GO_0005849) (mRNA cleavage factor complex), [GO:0071397](http://purl.obolibrary.org/obo/GO_0071397) (cellular response to cholesterol), [GO:0070069](http://purl.obolibrary.org/obo/GO_0070069) (cytochrome complex), [GO:0033077](http://purl.obolibrary.org/obo/GO_0033077) (T cell differentiation in thymus), [GO:0005862](http://purl.obolibrary.org/obo/GO_0005862) (muscle thin filament tropomyosin), [GO:0005861](http://purl.obolibrary.org/obo/GO_0005861) (troponin complex), [GO:0071391](http://purl.obolibrary.org/obo/GO_0071391) (cellular response to estrogen stimulus), [GO:0042843](http://purl.obolibrary.org/obo/GO_0042843) (D-xylose catabolic process), [GO:0005863](http://purl.obolibrary.org/obo/GO_0005863) (striated muscle myosin thick filament), [GO:0071383](http://purl.obolibrary.org/obo/GO_0071383) (cellular response to steroid hormone stimulus), [GO:0004523](http://purl.obolibrary.org/obo/GO_0004523) (RNA-DNA hybrid ribonuclease activity), [GO:0071384](http://purl.obolibrary.org/obo/GO_0071384) (cellular response to corticosteroid stimulus), [GO:0070050](http://purl.obolibrary.org/obo/GO_0070050) (neuron cellular homeostasis), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0004525](http://purl.obolibrary.org/obo/GO_0004525) (ribonuclease III activity), [GO:0005859](http://purl.obolibrary.org/obo/GO_0005859) (muscle myosin complex), [GO:0004527](http://purl.obolibrary.org/obo/GO_0004527) (exonuclease activity), [GO:0070058](http://purl.obolibrary.org/obo/GO_0070058) (tRNA gene clustering), [GO:0070059](http://purl.obolibrary.org/obo/GO_0070059) (intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress), [GO:0034399](http://purl.obolibrary.org/obo/GO_0034399) (nuclear periphery), [GO:0016569](http://purl.obolibrary.org/obo/GO_0016569) (covalent chromatin modification), [GO:0060684](http://purl.obolibrary.org/obo/GO_0060684) (epithelial-mesenchymal cell signaling), [GO:0015234](http://purl.obolibrary.org/obo/GO_0015234) (thiamine transmembrane transporter activity), [GO:0060685](http://purl.obolibrary.org/obo/GO_0060685) (regulation of prostatic bud formation), [GO:0015232](http://purl.obolibrary.org/obo/GO_0015232) (heme transporter activity), [GO:1900210](http://purl.obolibrary.org/obo/GO_1900210) (positive regulation of cardiolipin metabolic process), [GO:0003250](http://purl.obolibrary.org/obo/GO_0003250) (regulation of cell proliferation involved in heart valve morphogenesis), [GO:0004582](http://purl.obolibrary.org/obo/GO_0004582) (dolichyl-phosphate beta-D-mannosyltransferase activity), [GO:1900212](http://purl.obolibrary.org/obo/GO_1900212) (negative regulation of mesenchymal cell apoptotic process involved in metanephros development), [GO:0004584](http://purl.obolibrary.org/obo/GO_0004584) (dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity), [GO:0045047](http://purl.obolibrary.org/obo/GO_0045047) (protein targeting to ER), [GO:0003253](http://purl.obolibrary.org/obo/GO_0003253) (cardiac neural crest cell migration involved in outflow tract morphogenesis), [GO:0060686](http://purl.obolibrary.org/obo/GO_0060686) (negative regulation of prostatic bud formation), [GO:0003254](http://purl.obolibrary.org/obo/GO_0003254) (regulation of membrane depolarization), [GO:0060687](http://purl.obolibrary.org/obo/GO_0060687) (regulation of branching involved in prostate gland morphogenesis), [GO:0004585](http://purl.obolibrary.org/obo/GO_0004585) (ornithine carbamoyltransferase activity), [GO:1900215](http://purl.obolibrary.org/obo/GO_1900215) (negative regulation of apoptotic process involved in metanephric collecting duct development), [GO:1901546](http://purl.obolibrary.org/obo/GO_1901546) (regulation of synaptic vesicle lumen acidification), [GO:0060688](http://purl.obolibrary.org/obo/GO_0060688) (regulation of morphogenesis of a branching structure), [GO:1900218](http://purl.obolibrary.org/obo/GO_1900218) (negative regulation of apoptotic process involved in metanephric nephron tubule development), [GO:0060689](http://purl.obolibrary.org/obo/GO_0060689) (cell differentiation involved in salivary gland development), [GO:0004587](http://purl.obolibrary.org/obo/GO_0004587) (ornithine-oxo-acid transaminase activity), [GO:0004579](http://purl.obolibrary.org/obo/GO_0004579) (dolichyl-diphosphooligosaccharide-protein glycotransferase activity), [GO:0030866](http://purl.obolibrary.org/obo/GO_0030866) (cortical actin cytoskeleton organization), [GO:0045053](http://purl.obolibrary.org/obo/GO_0045053) (protein retention in Golgi apparatus), [GO:0004578](http://purl.obolibrary.org/obo/GO_0004578) (chitobiosyldiphosphodolichol beta-mannosyltransferase activity), [GO:0030867](http://purl.obolibrary.org/obo/GO_0030867) (rough endoplasmic reticulum membrane), [GO:0045056](http://purl.obolibrary.org/obo/GO_0045056) (transcytosis), [GO:0030869](http://purl.obolibrary.org/obo/GO_0030869) (RENT complex), [GO:0072663](http://purl.obolibrary.org/obo/GO_0072663) (establishment of protein localization to peroxisome), [GO:0071333](http://purl.obolibrary.org/obo/GO_0071333) (cellular response to glucose stimulus), [GO:0045055](http://purl.obolibrary.org/obo/GO_0045055) (regulated exocytosis), [GO:0016571](http://purl.obolibrary.org/obo/GO_0016571) (histone methylation), [GO:0016572](http://purl.obolibrary.org/obo/GO_0016572) (histone phosphorylation), [GO:0016573](http://purl.obolibrary.org/obo/GO_0016573) (histone acetylation), [GO:0016574](http://purl.obolibrary.org/obo/GO_0016574) (histone ubiquitination), [GO:0016575](http://purl.obolibrary.org/obo/GO_0016575) (histone deacetylation), [GO:0030862](http://purl.obolibrary.org/obo/GO_0030862) (positive regulation of polarized epithelial cell differentiation), [GO:0016576](http://purl.obolibrary.org/obo/GO_0016576) (histone dephosphorylation), [GO:0030864](http://purl.obolibrary.org/obo/GO_0030864) (cortical actin cytoskeleton), [GO:0016577](http://purl.obolibrary.org/obo/GO_0016577) (histone demethylation), [GO:0071339](http://purl.obolibrary.org/obo/GO_0071339) (MLL1 complex), [GO:0016578](http://purl.obolibrary.org/obo/GO_0016578) (histone deubiquitination), [GO:0015226](http://purl.obolibrary.org/obo/GO_0015226) (carnitine transmembrane transporter activity), [GO:0016557](http://purl.obolibrary.org/obo/GO_0016557) (peroxisome membrane biogenesis), [GO:0016558](http://purl.obolibrary.org/obo/GO_0016558) (protein import into peroxisome matrix), [GO:0060672](http://purl.obolibrary.org/obo/GO_0060672) (epithelial cell morphogenesis involved in placental branching), [GO:0016559](http://purl.obolibrary.org/obo/GO_0016559) (peroxisome fission), [GO:0015245](http://purl.obolibrary.org/obo/GO_0015245) (fatty acid transmembrane transporter activity), [GO:1900221](http://purl.obolibrary.org/obo/GO_1900221) (regulation of amyloid-beta clearance), [GO:0004591](http://purl.obolibrary.org/obo/GO_0004591) (oxoglutarate dehydrogenase (succinyl-transferring) activity), [GO:1900223](http://purl.obolibrary.org/obo/GO_1900223) (positive regulation of amyloid-beta clearance), [GO:1900222](http://purl.obolibrary.org/obo/GO_1900222) (negative regulation of amyloid-beta clearance), [GO:1902884](http://purl.obolibrary.org/obo/GO_1902884) (positive regulation of response to oxidative stress), [GO:0004595](http://purl.obolibrary.org/obo/GO_0004595) (pantetheine-phosphate adenylyltransferase activity), [GO:0045059](http://purl.obolibrary.org/obo/GO_0045059) (positive thymic T cell selection), [GO:1900224](http://purl.obolibrary.org/obo/GO_1900224) (positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry), [GO:0004594](http://purl.obolibrary.org/obo/GO_0004594) (pantothenate kinase activity), [GO:0004597](http://purl.obolibrary.org/obo/GO_0004597) (peptide-aspartate beta-dioxygenase activity), [GO:0060675](http://purl.obolibrary.org/obo/GO_0060675) (ureteric bud morphogenesis), [GO:0004596](http://purl.obolibrary.org/obo/GO_0004596) (peptide alpha-N-acetyltransferase activity), [GO:0060676](http://purl.obolibrary.org/obo/GO_0060676) (ureteric bud formation), [GO:0030855](http://purl.obolibrary.org/obo/GO_0030855) (epithelial cell differentiation), [GO:0045063](http://purl.obolibrary.org/obo/GO_0045063) (T-helper 1 cell differentiation), [GO:0045064](http://purl.obolibrary.org/obo/GO_0045064) (T-helper 2 cell differentiation), [GO:0030857](http://purl.obolibrary.org/obo/GO_0030857) (negative regulation of epithelial cell differentiation), [GO:0045061](http://purl.obolibrary.org/obo/GO_0045061) (thymic T cell selection), [GO:0030856](http://purl.obolibrary.org/obo/GO_0030856) (regulation of epithelial cell differentiation), [GO:0030859](http://purl.obolibrary.org/obo/GO_0030859) (polarized epithelial cell differentiation), [GO:0030858](http://purl.obolibrary.org/obo/GO_0030858) (positive regulation of epithelial cell differentiation), [GO:0071322](http://purl.obolibrary.org/obo/GO_0071322) (cellular response to carbohydrate stimulus), [GO:0071320](http://purl.obolibrary.org/obo/GO_0071320) (cellular response to cAMP), [GO:0072657](http://purl.obolibrary.org/obo/GO_0072657) (protein localization to membrane), [GO:0016560](http://purl.obolibrary.org/obo/GO_0016560) (protein import into peroxisome matrix, docking), [GO:0072656](http://purl.obolibrary.org/obo/GO_0072656) (maintenance of protein location in mitochondrion), [GO:0016561](http://purl.obolibrary.org/obo/GO_0016561) (protein import into peroxisome matrix, translocation), [GO:0072655](http://purl.obolibrary.org/obo/GO_0072655) (establishment of protein localization to mitochondrion), [GO:0016562](http://purl.obolibrary.org/obo/GO_0016562) (protein import into peroxisome matrix, receptor recycling), [GO:0030851](http://purl.obolibrary.org/obo/GO_0030851) (granulocyte differentiation), [GO:0030850](http://purl.obolibrary.org/obo/GO_0030850) (prostate gland development), [GO:0045060](http://purl.obolibrary.org/obo/GO_0045060) (negative thymic T cell selection), [GO:0072659](http://purl.obolibrary.org/obo/GO_0072659) (protein localization to plasma membrane), [GO:0015238](http://purl.obolibrary.org/obo/GO_0015238) (drug transmembrane transporter activity), [GO:0030853](http://purl.obolibrary.org/obo/GO_0030853) (negative regulation of granulocyte differentiation), [GO:0016567](http://purl.obolibrary.org/obo/GO_0016567) (protein ubiquitination), [GO:1902894](http://purl.obolibrary.org/obo/GO_1902894) (negative regulation of pri-miRNA transcription by RNA polymerase II), [GO:1902891](http://purl.obolibrary.org/obo/GO_1902891) (negative regulation of root hair elongation), [GO:0005891](http://purl.obolibrary.org/obo/GO_0005891) (voltage-gated calcium channel complex), [GO:0005890](http://purl.obolibrary.org/obo/GO_0005890) (sodium:potassium-exchanging ATPase complex), [GO:1902895](http://purl.obolibrary.org/obo/GO_1902895) (positive regulation of pri-miRNA transcription by RNA polymerase II), [GO:0003230](http://purl.obolibrary.org/obo/GO_0003230) (cardiac atrium development), [GO:0004561](http://purl.obolibrary.org/obo/GO_0004561) (alpha-N-acetylglucosaminidase activity), [GO:0003231](http://purl.obolibrary.org/obo/GO_0003231) (cardiac ventricle development), [GO:0005892](http://purl.obolibrary.org/obo/GO_0005892) (acetylcholine-gated channel complex), [GO:0003232](http://purl.obolibrary.org/obo/GO_0003232) (bulbus arteriosus development), [GO:0004563](http://purl.obolibrary.org/obo/GO_0004563) (beta-N-acetylhexosaminidase activity), [GO:0004566](http://purl.obolibrary.org/obo/GO_0004566) (beta-glucuronidase activity), [GO:0004565](http://purl.obolibrary.org/obo/GO_0004565) (beta-galactosidase activity), [GO:0004557](http://purl.obolibrary.org/obo/GO_0004557) (alpha-galactosidase activity), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0004556](http://purl.obolibrary.org/obo/GO_0004556) (alpha-amylase activity), [GO:0003226](http://purl.obolibrary.org/obo/GO_0003226) (right ventricular compact myocardium morphogenesis), [GO:0071351](http://purl.obolibrary.org/obo/GO_0071351) (cellular response to interleukin-18), [GO:0004559](http://purl.obolibrary.org/obo/GO_0004559) (alpha-mannosidase activity), [GO:0004558](http://purl.obolibrary.org/obo/GO_0004558) (alpha-1,4-glucosidase activity), [GO:0072686](http://purl.obolibrary.org/obo/GO_0072686) (mitotic spindle), [GO:0030847](http://purl.obolibrary.org/obo/GO_0030847) (termination of RNA polymerase II transcription, exosome-dependent), [GO:0071353](http://purl.obolibrary.org/obo/GO_0071353) (cellular response to interleukin-4), [GO:0071356](http://purl.obolibrary.org/obo/GO_0071356) (cellular response to tumor necrosis factor), [GO:0070025](http://purl.obolibrary.org/obo/GO_0070025) (carbon monoxide binding), [GO:0070026](http://purl.obolibrary.org/obo/GO_0070026) (nitric oxide binding), [GO:0072687](http://purl.obolibrary.org/obo/GO_0072687) (meiotic spindle), [GO:0045070](http://purl.obolibrary.org/obo/GO_0045070) (positive regulation of viral genome replication), [GO:0016553](http://purl.obolibrary.org/obo/GO_0016553) (base conversion or substitution editing), [GO:0045071](http://purl.obolibrary.org/obo/GO_0045071) (negative regulation of viral genome replication), [GO:0015205](http://purl.obolibrary.org/obo/GO_0015205) (nucleobase transmembrane transporter activity), [GO:0042800](http://purl.obolibrary.org/obo/GO_0042800) (histone methyltransferase activity (H3-K4 specific)), [GO:0060693](http://purl.obolibrary.org/obo/GO_0060693) (regulation of branching involved in salivary gland morphogenesis), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0016539](http://purl.obolibrary.org/obo/GO_0016539) (intein-mediated protein splicing), [GO:0042805](http://purl.obolibrary.org/obo/GO_0042805) (actinin binding), [GO:0015220](http://purl.obolibrary.org/obo/GO_0015220) (choline transmembrane transporter activity), [GO:0004571](http://purl.obolibrary.org/obo/GO_0004571) (mannosyl-oligosaccharide 1,2-alpha-mannosidase activity), [GO:1900244](http://purl.obolibrary.org/obo/GO_1900244) (positive regulation of synaptic vesicle endocytosis), [GO:0004573](http://purl.obolibrary.org/obo/GO_0004573) (mannosyl-oligosaccharide glucosidase activity), [GO:0004574](http://purl.obolibrary.org/obo/GO_0004574) (oligo-1,6-glucosidase activity), [GO:0004577](http://purl.obolibrary.org/obo/GO_0004577) (N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity), [GO:0004576](http://purl.obolibrary.org/obo/GO_0004576) (oligosaccharyl transferase activity), [GO:0030833](http://purl.obolibrary.org/obo/GO_0030833) (regulation of actin filament polymerization), [GO:0072671](http://purl.obolibrary.org/obo/GO_0072671) (mitochondria-associated ubiquitin-dependent protein catabolic process), [GO:0030832](http://purl.obolibrary.org/obo/GO_0030832) (regulation of actin filament length), [GO:0071340](http://purl.obolibrary.org/obo/GO_0071340) (skeletal muscle acetylcholine-gated channel clustering), [GO:0045086](http://purl.obolibrary.org/obo/GO_0045086) (positive regulation of interleukin-2 biosynthetic process), [GO:0004567](http://purl.obolibrary.org/obo/GO_0004567) (beta-mannosidase activity), [GO:0030835](http://purl.obolibrary.org/obo/GO_0030835) (negative regulation of actin filament depolymerization), [GO:0045084](http://purl.obolibrary.org/obo/GO_0045084) (positive regulation of interleukin-12 biosynthetic process), [GO:0045089](http://purl.obolibrary.org/obo/GO_0045089) (positive regulation of innate immune response), [GO:0030837](http://purl.obolibrary.org/obo/GO_0030837) (negative regulation of actin filament polymerization), [GO:0030836](http://purl.obolibrary.org/obo/GO_0030836) (positive regulation of actin filament depolymerization), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0030838](http://purl.obolibrary.org/obo/GO_0030838) (positive regulation of actin filament polymerization), [GO:0045088](http://purl.obolibrary.org/obo/GO_0045088) (regulation of innate immune response), [GO:0071347](http://purl.obolibrary.org/obo/GO_0071347) (cellular response to interleukin-1), [GO:0072679](http://purl.obolibrary.org/obo/GO_0072679) (thymocyte migration), [GO:0016540](http://purl.obolibrary.org/obo/GO_0016540) (protein autoprocessing), [GO:0071345](http://purl.obolibrary.org/obo/GO_0071345) (cellular response to cytokine stimulus), [GO:0071346](http://purl.obolibrary.org/obo/GO_0071346) (cellular response to interferon-gamma), [GO:0072676](http://purl.obolibrary.org/obo/GO_0072676) (lymphocyte migration), [GO:0045080](http://purl.obolibrary.org/obo/GO_0045080) (positive regulation of chemokine biosynthetic process), [GO:0015279](http://purl.obolibrary.org/obo/GO_0015279) (store-operated calcium channel activity), [GO:0015278](http://purl.obolibrary.org/obo/GO_0015278) (calcium-release channel activity), [GO:0015277](http://purl.obolibrary.org/obo/GO_0015277) (kainate selective glutamate receptor activity), [GO:0015276](http://purl.obolibrary.org/obo/GO_0015276) (ligand-gated ion channel activity), [GO:0003290](http://purl.obolibrary.org/obo/GO_0003290) (atrial septum secundum morphogenesis), [GO:0015272](http://purl.obolibrary.org/obo/GO_0015272) (ATP-activated inward rectifier potassium channel activity), [GO:0042891](http://purl.obolibrary.org/obo/GO_0042891) (antibiotic transport), [GO:0015271](http://purl.obolibrary.org/obo/GO_0015271) (outward rectifier potassium channel activity), [GO:0042895](http://purl.obolibrary.org/obo/GO_0042895) (antibiotic transmembrane transporter activity), [GO:0090502](http://purl.obolibrary.org/obo/GO_0090502) (RNA phosphodiester bond hydrolysis, endonucleolytic), [GO:0090503](http://purl.obolibrary.org/obo/GO_0090503) (RNA phosphodiester bond hydrolysis, exonucleolytic), [GO:0090501](http://purl.obolibrary.org/obo/GO_0090501) (RNA phosphodiester bond hydrolysis), [GO:0030899](http://purl.obolibrary.org/obo/GO_0030899) (calcium-dependent ATPase activity), [GO:0030898](http://purl.obolibrary.org/obo/GO_0030898) (actin-dependent ATPase activity), [GO:0030891](http://purl.obolibrary.org/obo/GO_0030891) (VCB complex), [GO:0030890](http://purl.obolibrary.org/obo/GO_0030890) (positive regulation of B cell proliferation), [GO:0030893](http://purl.obolibrary.org/obo/GO_0030893) (meiotic cohesin complex), [GO:0030897](http://purl.obolibrary.org/obo/GO_0030897) (HOPS complex), [GO:0090504](http://purl.obolibrary.org/obo/GO_0090504) (epiboly), [GO:0015252](http://purl.obolibrary.org/obo/GO_0015252) (proton channel activity), [GO:0015250](http://purl.obolibrary.org/obo/GO_0015250) (water channel activity), [GO:0003279](http://purl.obolibrary.org/obo/GO_0003279) (cardiac septum development), [GO:0030889](http://purl.obolibrary.org/obo/GO_0030889) (negative regulation of B cell proliferation), [GO:0016591](http://purl.obolibrary.org/obo/GO_0016591) (DNA-directed RNA polymerase II, holoenzyme), [GO:0016592](http://purl.obolibrary.org/obo/GO_0016592) (mediator complex), [GO:0016594](http://purl.obolibrary.org/obo/GO_0016594) (glycine binding), [GO:0016595](http://purl.obolibrary.org/obo/GO_0016595) (glutamate binding), [GO:0030881](http://purl.obolibrary.org/obo/GO_0030881) (beta-2-microglobulin binding), [GO:0016596](http://purl.obolibrary.org/obo/GO_0016596) (thienylcyclohexylpiperidine binding), [GO:0016597](http://purl.obolibrary.org/obo/GO_0016597) (amino acid binding), [GO:0015248](http://purl.obolibrary.org/obo/GO_0015248) (sterol transporter activity), [GO:0016579](http://purl.obolibrary.org/obo/GO_0016579) (protein deubiquitination), [GO:0015269](http://purl.obolibrary.org/obo/GO_0015269) (calcium-activated potassium channel activity), [GO:0015267](http://purl.obolibrary.org/obo/GO_0015267) (channel activity), [GO:0015266](http://purl.obolibrary.org/obo/GO_0015266), [GO:0003281](http://purl.obolibrary.org/obo/GO_0003281) (ventricular septum development), [GO:0003283](http://purl.obolibrary.org/obo/GO_0003283) (atrial septum development), [GO:0003289](http://purl.obolibrary.org/obo/GO_0003289) (atrial septum primum morphogenesis), [GO:0030877](http://purl.obolibrary.org/obo/GO_0030877) (beta-catenin destruction complex), [GO:0030879](http://purl.obolibrary.org/obo/GO_0030879) (mammary gland development), [GO:0030878](http://purl.obolibrary.org/obo/GO_0030878) (thyroid gland development), [GO:0016581](http://purl.obolibrary.org/obo/GO_0016581) (NuRD complex), [GO:0016584](http://purl.obolibrary.org/obo/GO_0016584) (nucleosome positioning), [GO:0030870](http://purl.obolibrary.org/obo/GO_0030870) (Mre11 complex), [GO:0030874](http://purl.obolibrary.org/obo/GO_0030874) (nucleolar chromatin), [GO:0042851](http://purl.obolibrary.org/obo/GO_0042851) (L-alanine metabolic process), [GO:0042853](http://purl.obolibrary.org/obo/GO_0042853) (L-alanine catabolic process), [GO:0070085](http://purl.obolibrary.org/obo/GO_0070085) (glycosylation), [GO:0070086](http://purl.obolibrary.org/obo/GO_0070086) (ubiquitin-dependent endocytosis), [GO:0070087](http://purl.obolibrary.org/obo/GO_0070087) (chromo shadow domain binding), [GO:0009405](http://purl.obolibrary.org/obo/GO_0009405) (pathogenesis), [GO:0009404](http://purl.obolibrary.org/obo/GO_0009404) (toxin metabolic process), [GO:0070080](http://purl.obolibrary.org/obo/GO_0070080) (titin Z domain binding), [GO:0070072](http://purl.obolibrary.org/obo/GO_0070072) (vacuolar proton-transporting V-type ATPase complex assembly), [GO:0015299](http://purl.obolibrary.org/obo/GO_0015299) (solute:proton antiporter activity), [GO:0015297](http://purl.obolibrary.org/obo/GO_0015297) (antiporter activity), [GO:0015295](http://purl.obolibrary.org/obo/GO_0015295) (solute:proton symporter activity), [GO:0015293](http://purl.obolibrary.org/obo/GO_0015293) (symporter activity), [GO:0015292](http://purl.obolibrary.org/obo/GO_0015292) (uniporter activity), [GO:0070094](http://purl.obolibrary.org/obo/GO_0070094) (positive regulation of glucagon secretion), [GO:0070095](http://purl.obolibrary.org/obo/GO_0070095) (fructose-6-phosphate binding), [GO:0070098](http://purl.obolibrary.org/obo/GO_0070098) (chemokine-mediated signaling pathway), [GO:0048919](http://purl.obolibrary.org/obo/GO_0048919) (posterior lateral line neuromast development), [GO:0048918](http://purl.obolibrary.org/obo/GO_0048918) (posterior lateral line nerve development), [GO:0048917](http://purl.obolibrary.org/obo/GO_0048917) (posterior lateral line ganglion development), [GO:0048916](http://purl.obolibrary.org/obo/GO_0048916) (posterior lateral line development), [GO:0000979](http://purl.obolibrary.org/obo/GO_0000979) (RNA polymerase II core promoter sequence-specific DNA binding), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0009314](http://purl.obolibrary.org/obo/GO_0009314) (response to radiation), [GO:0000976](http://purl.obolibrary.org/obo/GO_0000976) (transcription regulatory region sequence-specific DNA binding), [GO:0009313](http://purl.obolibrary.org/obo/GO_0009313) (oligosaccharide catabolic process), [GO:0009312](http://purl.obolibrary.org/obo/GO_0009312) (oligosaccharide biosynthetic process), [GO:0009311](http://purl.obolibrary.org/obo/GO_0009311) (oligosaccharide metabolic process), [GO:0000972](http://purl.obolibrary.org/obo/GO_0000972) (transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery), [GO:0000980](http://purl.obolibrary.org/obo/GO_0000980) (RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0048929](http://purl.obolibrary.org/obo/GO_0048929) (efferent axon development in posterior lateral line nerve), [GO:1905037](http://purl.obolibrary.org/obo/GO_1905037) (autophagosome organization), [GO:0000989](http://purl.obolibrary.org/obo/GO_0000989) (transcription factor activity, transcription factor binding), [GO:0000988](http://purl.obolibrary.org/obo/GO_0000988) (transcription factor activity, protein binding), [GO:0048922](http://purl.obolibrary.org/obo/GO_0048922) (posterior lateral line neuromast deposition), [GO:0000987](http://purl.obolibrary.org/obo/GO_0000987) (proximal promoter sequence-specific DNA binding), [GO:0048920](http://purl.obolibrary.org/obo/GO_0048920) (posterior lateral line neuromast primordium migration), [GO:0000983](http://purl.obolibrary.org/obo/GO_0000983) (transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding), [GO:0048925](http://purl.obolibrary.org/obo/GO_0048925) (lateral line system development), [GO:0000982](http://purl.obolibrary.org/obo/GO_0000982) (transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0048923](http://purl.obolibrary.org/obo/GO_0048923) (posterior lateral line neuromast hair cell differentiation), [GO:0000990](http://purl.obolibrary.org/obo/GO_0000990) (transcription factor activity, core RNA polymerase binding), [GO:0000958](http://purl.obolibrary.org/obo/GO_0000958) (mitochondrial mRNA catabolic process), [GO:0000957](http://purl.obolibrary.org/obo/GO_0000957) (mitochondrial RNA catabolic process), [GO:0000956](http://purl.obolibrary.org/obo/GO_0000956) (nuclear-transcribed mRNA catabolic process), [GO:0048932](http://purl.obolibrary.org/obo/GO_0048932) (myelination of posterior lateral line nerve axons), [GO:0048936](http://purl.obolibrary.org/obo/GO_0048936) (peripheral nervous system neuron axonogenesis), [GO:0048935](http://purl.obolibrary.org/obo/GO_0048935) (peripheral nervous system neuron development), [GO:0009303](http://purl.obolibrary.org/obo/GO_0009303) (rRNA transcription), [GO:0000965](http://purl.obolibrary.org/obo/GO_0000965) (mitochondrial RNA 3'-end processing), [GO:0000964](http://purl.obolibrary.org/obo/GO_0000964) (mitochondrial RNA 5'-end processing), [GO:0000962](http://purl.obolibrary.org/obo/GO_0000962) (positive regulation of mitochondrial RNA catabolic process), [GO:0009306](http://purl.obolibrary.org/obo/GO_0009306) (protein secretion), [GO:0047620](http://purl.obolibrary.org/obo/GO_0047620) (acylglycerol kinase activity), [GO:1905050](http://purl.obolibrary.org/obo/GO_1905050) (positive regulation of metallopeptidase activity), [GO:0035640](http://purl.obolibrary.org/obo/GO_0035640) (exploration behavior), [GO:0035641](http://purl.obolibrary.org/obo/GO_0035641) (locomotory exploration behavior), [GO:0008023](http://purl.obolibrary.org/obo/GO_0008023) (transcription elongation factor complex), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0009353](http://purl.obolibrary.org/obo/GO_0009353) (mitochondrial oxoglutarate dehydrogenase complex), [GO:0008021](http://purl.obolibrary.org/obo/GO_0008021) (synaptic vesicle), [GO:0008020](http://purl.obolibrary.org/obo/GO_0008020) (G-protein coupled photoreceptor activity), [GO:0008026](http://purl.obolibrary.org/obo/GO_0008026) (ATP-dependent helicase activity), [GO:0008024](http://purl.obolibrary.org/obo/GO_0008024) (cyclin/CDK positive transcription elongation factor complex), [GO:0008028](http://purl.obolibrary.org/obo/GO_0008028) (monocarboxylic acid transmembrane transporter activity), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0035631](http://purl.obolibrary.org/obo/GO_0035631) (CD40 receptor complex), [GO:0090419](http://purl.obolibrary.org/obo/GO_0090419) (negative regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0035633](http://purl.obolibrary.org/obo/GO_0035633) (maintenance of permeability of blood-brain barrier), [GO:0008033](http://purl.obolibrary.org/obo/GO_0008033) (tRNA processing), [GO:0008038](http://purl.obolibrary.org/obo/GO_0008038) (neuron recognition), [GO:0009368](http://purl.obolibrary.org/obo/GO_0009368) (endopeptidase Clp complex), [GO:0035625](http://purl.obolibrary.org/obo/GO_0035625) (epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway), [GO:0035627](http://purl.obolibrary.org/obo/GO_0035627) (ceramide transport), [GO:0035621](http://purl.obolibrary.org/obo/GO_0035621) (ER to Golgi ceramide transport), [GO:0035622](http://purl.obolibrary.org/obo/GO_0035622) (intrahepatic bile duct development), [GO:0090427](http://purl.obolibrary.org/obo/GO_0090427) (activation of meiosis), [GO:1905006](http://purl.obolibrary.org/obo/GO_1905006) (negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation), [GO:0000999](http://purl.obolibrary.org/obo/GO_0000999) (RNA polymerase III type 1 promoter transcriptional preinitiation complex assembly), [GO:0008009](http://purl.obolibrary.org/obo/GO_0008009) (chemokine activity), [GO:0000994](http://purl.obolibrary.org/obo/GO_0000994) (RNA polymerase III core binding), [GO:0000993](http://purl.obolibrary.org/obo/GO_0000993) (RNA polymerase II core binding), [GO:0010314](http://purl.obolibrary.org/obo/GO_0010314) (phosphatidylinositol-5-phosphate binding), [GO:0035610](http://purl.obolibrary.org/obo/GO_0035610) (protein side chain deglutamylation), [GO:0035611](http://purl.obolibrary.org/obo/GO_0035611) (protein branching point deglutamylation), [GO:0035612](http://purl.obolibrary.org/obo/GO_0035612) (AP-2 adaptor complex binding), [GO:0008016](http://purl.obolibrary.org/obo/GO_0008016) (regulation of heart contraction), [GO:0008015](http://purl.obolibrary.org/obo/GO_0008015) (blood circulation), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0008017](http://purl.obolibrary.org/obo/GO_0008017) (microtubule binding), [GO:0048901](http://purl.obolibrary.org/obo/GO_0048901) (anterior lateral line neuromast development), [GO:0035607](http://purl.obolibrary.org/obo/GO_0035607) (fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development), [GO:0035608](http://purl.obolibrary.org/obo/GO_0035608) (protein deglutamylation), [GO:0035609](http://purl.obolibrary.org/obo/GO_0035609) (C-terminal protein deglutamylation), [GO:0008063](http://purl.obolibrary.org/obo/GO_0008063) (Toll signaling pathway), [GO:0010385](http://purl.obolibrary.org/obo/GO_0010385) (double-stranded methylated DNA binding), [GO:0034354](http://purl.obolibrary.org/obo/GO_0034354) ('de novo' NAD biosynthetic process from tryptophan), [GO:0008066](http://purl.obolibrary.org/obo/GO_0008066) (glutamate receptor activity), [GO:0009396](http://purl.obolibrary.org/obo/GO_0009396) (folic acid-containing compound biosynthetic process), [GO:0008064](http://purl.obolibrary.org/obo/GO_0008064) (regulation of actin polymerization or depolymerization), [GO:0009395](http://purl.obolibrary.org/obo/GO_0009395) (phospholipid catabolic process), [GO:0034351](http://purl.obolibrary.org/obo/GO_0034351) (negative regulation of glial cell apoptotic process), [GO:0045005](http://purl.obolibrary.org/obo/GO_0045005) (DNA-dependent DNA replication maintenance of fidelity), [GO:0045006](http://purl.obolibrary.org/obo/GO_0045006) (DNA deamination), [GO:0046337](http://purl.obolibrary.org/obo/GO_0046337) (phosphatidylethanolamine metabolic process), [GO:0045004](http://purl.obolibrary.org/obo/GO_0045004) (DNA replication proofreading), [GO:0046338](http://purl.obolibrary.org/obo/GO_0046338) (phosphatidylethanolamine catabolic process), [GO:0060644](http://purl.obolibrary.org/obo/GO_0060644) (mammary gland epithelial cell differentiation), [GO:0045010](http://purl.obolibrary.org/obo/GO_0045010) (actin nucleation), [GO:0033014](http://purl.obolibrary.org/obo/GO_0033014) (tetrapyrrole biosynthetic process), [GO:0035676](http://purl.obolibrary.org/obo/GO_0035676) (anterior lateral line neuromast hair cell development), [GO:0035677](http://purl.obolibrary.org/obo/GO_0035677) (posterior lateral line neuromast hair cell development), [GO:0033017](http://purl.obolibrary.org/obo/GO_0033017) (sarcoplasmic reticulum membrane), [GO:0035678](http://purl.obolibrary.org/obo/GO_0035678) (neuromast hair cell morphogenesis), [GO:0008074](http://purl.obolibrary.org/obo/GO_0008074) (guanylate cyclase complex, soluble), [GO:0072619](http://purl.obolibrary.org/obo/GO_0072619) (interleukin-21 secretion), [GO:0035674](http://purl.obolibrary.org/obo/GO_0035674) (tricarboxylic acid transmembrane transport), [GO:0008078](http://purl.obolibrary.org/obo/GO_0008078) (mesodermal cell migration), [GO:0010390](http://purl.obolibrary.org/obo/GO_0010390) (histone monoubiquitination), [GO:0033010](http://purl.obolibrary.org/obo/GO_0033010) (paranodal junction), [GO:0034341](http://purl.obolibrary.org/obo/GO_0034341) (response to interferon-gamma), [GO:0008076](http://purl.obolibrary.org/obo/GO_0008076) (voltage-gated potassium channel complex), [GO:0045014](http://purl.obolibrary.org/obo/GO_0045014) (negative regulation of transcription by glucose), [GO:0045019](http://purl.obolibrary.org/obo/GO_0045019) (negative regulation of nitric oxide biosynthetic process), [GO:0045022](http://purl.obolibrary.org/obo/GO_0045022) (early endosome to late endosome transport), [GO:0034334](http://purl.obolibrary.org/obo/GO_0034334) (adherens junction maintenance), [GO:0033002](http://purl.obolibrary.org/obo/GO_0033002) (muscle cell proliferation), [GO:0034333](http://purl.obolibrary.org/obo/GO_0034333) (adherens junction assembly), [GO:0010389](http://purl.obolibrary.org/obo/GO_0010389) (regulation of G2/M transition of mitotic cell cycle), [GO:0035666](http://purl.obolibrary.org/obo/GO_0035666) (TRIF-dependent toll-like receptor signaling pathway), [GO:0060662](http://purl.obolibrary.org/obo/GO_0060662) (salivary gland cavitation), [GO:0035663](http://purl.obolibrary.org/obo/GO_0035663) (Toll-like receptor 2 binding), [GO:0008045](http://purl.obolibrary.org/obo/GO_0008045) (motor neuron axon guidance), [GO:0008043](http://purl.obolibrary.org/obo/GO_0008043) (intracellular ferritin complex), [GO:0008049](http://purl.obolibrary.org/obo/GO_0008049) (male courtship behavior), [GO:0045027](http://purl.obolibrary.org/obo/GO_0045027) (DNA end binding), [GO:0008048](http://purl.obolibrary.org/obo/GO_0008048) (calcium sensitive guanylate cyclase activator activity), [GO:0046359](http://purl.obolibrary.org/obo/GO_0046359) (butyrate catabolic process), [GO:0008047](http://purl.obolibrary.org/obo/GO_0008047) (enzyme activator activity), [GO:0045025](http://purl.obolibrary.org/obo/GO_0045025) (mitochondrial degradosome), [GO:0009378](http://purl.obolibrary.org/obo/GO_0009378) (four-way junction helicase activity), [GO:1901522](http://purl.obolibrary.org/obo/GO_1901522) (positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus), [GO:1902857](http://purl.obolibrary.org/obo/GO_1902857) (positive regulation of non-motile cilium assembly), [GO:0060664](http://purl.obolibrary.org/obo/GO_0060664) (epithelial cell proliferation involved in salivary gland morphogenesis), [GO:0060665](http://purl.obolibrary.org/obo/GO_0060665) (regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling), [GO:1902855](http://purl.obolibrary.org/obo/GO_1902855) (regulation of non-motile cilium assembly), [GO:1902856](http://purl.obolibrary.org/obo/GO_1902856) (negative regulation of non-motile cilium assembly), [GO:0071310](http://purl.obolibrary.org/obo/GO_0071310) (cellular response to organic substance), [GO:0045033](http://purl.obolibrary.org/obo/GO_0045033) (peroxisome inheritance), [GO:0071313](http://purl.obolibrary.org/obo/GO_0071313) (cellular response to caffeine), [GO:0072643](http://purl.obolibrary.org/obo/GO_0072643) (interferon-gamma secretion), [GO:0010359](http://purl.obolibrary.org/obo/GO_0010359) (regulation of anion channel activity), [GO:0071318](http://purl.obolibrary.org/obo/GO_0071318) (cellular response to ATP), [GO:0034329](http://purl.obolibrary.org/obo/GO_0034329) (cell junction assembly), [GO:0035655](http://purl.obolibrary.org/obo/GO_0035655) (interleukin-18-mediated signaling pathway), [GO:0071316](http://purl.obolibrary.org/obo/GO_0071316) (cellular response to nicotine), [GO:0010370](http://purl.obolibrary.org/obo/GO_0010370) (perinucleolar chromocenter), [GO:0008053](http://purl.obolibrary.org/obo/GO_0008053) (mitochondrial fusion), [GO:0009384](http://purl.obolibrary.org/obo/GO_0009384) (N-acylmannosamine kinase activity), [GO:1901532](http://purl.obolibrary.org/obo/GO_1901532) (regulation of hematopoietic progenitor cell differentiation), [GO:0045039](http://purl.obolibrary.org/obo/GO_0045039) (protein import into mitochondrial inner membrane), [GO:1901534](http://purl.obolibrary.org/obo/GO_1901534) (positive regulation of hematopoietic progenitor cell differentiation), [GO:1901533](http://purl.obolibrary.org/obo/GO_1901533) (negative regulation of hematopoietic progenitor cell differentiation), [GO:1901536](http://purl.obolibrary.org/obo/GO_1901536) (negative regulation of DNA demethylation), [GO:0045041](http://purl.obolibrary.org/obo/GO_0045041) (protein import into mitochondrial intermembrane space), [GO:0046373](http://purl.obolibrary.org/obo/GO_0046373) (L-arabinose metabolic process), [GO:0071300](http://purl.obolibrary.org/obo/GO_0071300) (cellular response to retinoic acid), [GO:0045046](http://purl.obolibrary.org/obo/GO_0045046) (protein import into peroxisome membrane), [GO:0010369](http://purl.obolibrary.org/obo/GO_0010369) (chromocenter), [GO:0035646](http://purl.obolibrary.org/obo/GO_0035646) (endosome to melanosome transport), [GO:0035649](http://purl.obolibrary.org/obo/GO_0035649) (Nrd1 complex), [GO:0035643](http://purl.obolibrary.org/obo/GO_0035643) (L-DOPA receptor activity), [GO:0035645](http://purl.obolibrary.org/obo/GO_0035645) (enteric smooth muscle cell differentiation), [GO:0034394](http://purl.obolibrary.org/obo/GO_0034394) (protein localization to cell surface), [GO:0034393](http://purl.obolibrary.org/obo/GO_0034393) (positive regulation of smooth muscle cell apoptotic process), [GO:1905065](http://purl.obolibrary.org/obo/GO_1905065) (positive regulation of vascular smooth muscle cell differentiation), [GO:0034398](http://purl.obolibrary.org/obo/GO_0034398) (telomere tethering at nuclear periphery), [GO:0090494](http://purl.obolibrary.org/obo/GO_0090494) (dopamine uptake), [GO:0060603](http://purl.obolibrary.org/obo/GO_0060603) (mammary gland duct morphogenesis), [GO:0004500](http://purl.obolibrary.org/obo/GO_0004500) (dopamine beta-monooxygenase activity), [GO:0005828](http://purl.obolibrary.org/obo/GO_0005828) (kinetochore microtubule), [GO:0005827](http://purl.obolibrary.org/obo/GO_0005827) (polar microtubule), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0034389](http://purl.obolibrary.org/obo/GO_0034389) (lipid particle organization), [GO:1905064](http://purl.obolibrary.org/obo/GO_1905064) (negative regulation of vascular smooth muscle cell differentiation), [GO:0034380](http://purl.obolibrary.org/obo/GO_0034380) (high-density lipoprotein particle assembly), [GO:0034386](http://purl.obolibrary.org/obo/GO_0034386) (4-aminobutyrate:2-oxoglutarate transaminase activity), [GO:0005840](http://purl.obolibrary.org/obo/GO_0005840) (ribosome), [GO:1902803](http://purl.obolibrary.org/obo/GO_1902803) (regulation of synaptic vesicle transport), [GO:0004511](http://purl.obolibrary.org/obo/GO_0004511) (tyrosine 3-monooxygenase activity), [GO:0004510](http://purl.obolibrary.org/obo/GO_0004510) (tryptophan 5-monooxygenase activity), [GO:0005833](http://purl.obolibrary.org/obo/GO_0005833) (hemoglobin complex), [GO:0005832](http://purl.obolibrary.org/obo/GO_0005832) (chaperonin-containing T-complex), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0004503](http://purl.obolibrary.org/obo/GO_0004503) (monophenol monooxygenase activity), [GO:0004505](http://purl.obolibrary.org/obo/GO_0004505) (phenylalanine 4-monooxygenase activity), [GO:0005839](http://purl.obolibrary.org/obo/GO_0005839) (proteasome core complex), [GO:0034377](http://purl.obolibrary.org/obo/GO_0034377) (plasma lipoprotein particle assembly), [GO:0034372](http://purl.obolibrary.org/obo/GO_0034372) (very-low-density lipoprotein particle remodeling), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0008089](http://purl.obolibrary.org/obo/GO_0008089) (anterograde axonal transport), [GO:0008088](http://purl.obolibrary.org/obo/GO_0008088) (axo-dendritic transport), [GO:0034375](http://purl.obolibrary.org/obo/GO_0034375) (high-density lipoprotein particle remodeling), [GO:0061953](http://purl.obolibrary.org/obo/GO_0061953) (mRNA (adenine-N1-)-methyltransferase activity), [GO:0060623](http://purl.obolibrary.org/obo/GO_0060623) (regulation of chromosome condensation), [GO:1902807](http://purl.obolibrary.org/obo/GO_1902807) (negative regulation of cell cycle G1/S phase transition), [GO:0005802](http://purl.obolibrary.org/obo/GO_0005802) (trans-Golgi network), [GO:0005801](http://purl.obolibrary.org/obo/GO_0005801) (cis-Golgi network), [GO:0046322](http://purl.obolibrary.org/obo/GO_0046322) (negative regulation of fatty acid oxidation), [GO:1902808](http://purl.obolibrary.org/obo/GO_1902808) (positive regulation of cell cycle G1/S phase transition), [GO:0072602](http://purl.obolibrary.org/obo/GO_0072602) (interleukin-4 secretion), [GO:0034368](http://purl.obolibrary.org/obo/GO_0034368) (protein-lipid complex remodeling), [GO:0008081](http://purl.obolibrary.org/obo/GO_0008081) (phosphoric diester hydrolase activity), [GO:0008080](http://purl.obolibrary.org/obo/GO_0008080) (N-acetyltransferase activity), [GO:0035694](http://purl.obolibrary.org/obo/GO_0035694) (mitochondrial protein catabolic process), [GO:0008094](http://purl.obolibrary.org/obo/GO_0008094) (DNA-dependent ATPase activity), [GO:0008093](http://purl.obolibrary.org/obo/GO_0008093) (cytoskeletal adaptor activity), [GO:1905098](http://purl.obolibrary.org/obo/GO_1905098) (negative regulation of guanyl-nucleotide exchange factor activity), [GO:0034364](http://purl.obolibrary.org/obo/GO_0034364) (high-density lipoprotein particle), [GO:0035690](http://purl.obolibrary.org/obo/GO_0035690) (cellular response to drug), [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle), [GO:0033032](http://purl.obolibrary.org/obo/GO_0033032) (regulation of myeloid cell apoptotic process), [GO:0008097](http://purl.obolibrary.org/obo/GO_0008097) (5S rRNA binding), [GO:0060613](http://purl.obolibrary.org/obo/GO_0060613) (fat pad development), [GO:0046325](http://purl.obolibrary.org/obo/GO_0046325) (negative regulation of glucose import), [GO:0046326](http://purl.obolibrary.org/obo/GO_0046326) (positive regulation of glucose import), [GO:0046323](http://purl.obolibrary.org/obo/GO_0046323) (glucose import), [GO:0046324](http://purl.obolibrary.org/obo/GO_0046324) (regulation of glucose import), [GO:0046329](http://purl.obolibrary.org/obo/GO_0046329) (negative regulation of JNK cascade), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0046328](http://purl.obolibrary.org/obo/GO_0046328) (regulation of JNK cascade), [GO:0005811](http://purl.obolibrary.org/obo/GO_0005811) (lipid droplet), [GO:1902817](http://purl.obolibrary.org/obo/GO_1902817) (negative regulation of protein localization to microtubule), [GO:0005813](http://purl.obolibrary.org/obo/GO_0005813) (centrosome), [GO:0005815](http://purl.obolibrary.org/obo/GO_0005815) (microtubule organizing center), [GO:0046332](http://purl.obolibrary.org/obo/GO_0046332) (SMAD binding), [GO:0005814](http://purl.obolibrary.org/obo/GO_0005814) (centriole), [GO:0046333](http://purl.obolibrary.org/obo/GO_0046333) (octopamine metabolic process), [GO:0046330](http://purl.obolibrary.org/obo/GO_0046330) (positive regulation of JNK cascade), [GO:0005816](http://purl.obolibrary.org/obo/GO_0005816) (spindle pole body), [GO:0005819](http://purl.obolibrary.org/obo/GO_0005819) (spindle), [GO:0033026](http://purl.obolibrary.org/obo/GO_0033026) (negative regulation of mast cell apoptotic process), [GO:1905090](http://purl.obolibrary.org/obo/GO_1905090) (negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization), [GO:0008092](http://purl.obolibrary.org/obo/GO_0008092) (cytoskeletal protein binding), [GO:0035686](http://purl.obolibrary.org/obo/GO_0035686) (sperm fibrous sheath), [GO:0008091](http://purl.obolibrary.org/obo/GO_0008091) (spectrin), [GO:0008090](http://purl.obolibrary.org/obo/GO_0008090) (retrograde axonal transport), [GO:0060363](http://purl.obolibrary.org/obo/GO_0060363) (cranial suture morphogenesis), [GO:0060364](http://purl.obolibrary.org/obo/GO_0060364) (frontal suture morphogenesis), [GO:1900131](http://purl.obolibrary.org/obo/GO_1900131) (negative regulation of lipid binding), [GO:0006842](http://purl.obolibrary.org/obo/GO_0006842) (tricarboxylic acid transport), [GO:0006843](http://purl.obolibrary.org/obo/GO_0006843) (mitochondrial citrate transport), [GO:0072341](http://purl.obolibrary.org/obo/GO_0072341) (modified amino acid binding), [GO:0098971](http://purl.obolibrary.org/obo/GO_0098971) (anterograde dendritic transport of neurotransmitter receptor complex), [GO:0006836](http://purl.obolibrary.org/obo/GO_0006836) (neurotransmitter transport), [GO:0005502](http://purl.obolibrary.org/obo/GO_0005502) (11-cis retinal binding), [GO:0006833](http://purl.obolibrary.org/obo/GO_0006833) (water transport), [GO:0098970](http://purl.obolibrary.org/obo/GO_0098970) (postsynaptic neurotransmitter receptor diffusion trapping), [GO:0005504](http://purl.obolibrary.org/obo/GO_0005504) (fatty acid binding), [GO:0071013](http://purl.obolibrary.org/obo/GO_0071013) (catalytic step 2 spliceosome), [GO:0005507](http://purl.obolibrary.org/obo/GO_0005507) (copper ion binding), [GO:0072345](http://purl.obolibrary.org/obo/GO_0072345) (NAADP-sensitive calcium-release channel activity), [GO:0006839](http://purl.obolibrary.org/obo/GO_0006839) (mitochondrial transport), [GO:0046068](http://purl.obolibrary.org/obo/GO_0046068) (cGMP metabolic process), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0046069](http://purl.obolibrary.org/obo/GO_0046069) (cGMP catabolic process), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0071011](http://purl.obolibrary.org/obo/GO_0071011) (precatalytic spliceosome), [GO:2001209](http://purl.obolibrary.org/obo/GO_2001209) (positive regulation of transcription elongation from RNA polymerase I promoter), [GO:2001204](http://purl.obolibrary.org/obo/GO_2001204) (regulation of osteoclast development), [GO:2001206](http://purl.obolibrary.org/obo/GO_2001206) (positive regulation of osteoclast development), [GO:0046061](http://purl.obolibrary.org/obo/GO_0046061) (dATP catabolic process), [GO:0047391](http://purl.obolibrary.org/obo/GO_0047391) (alkylglycerophosphoethanolamine phosphodiesterase activity), [GO:0034063](http://purl.obolibrary.org/obo/GO_0034063) (stress granule assembly), [GO:0018812](http://purl.obolibrary.org/obo/GO_0018812) (3-hydroxyacyl-CoA dehydratase activity), [GO:0034067](http://purl.obolibrary.org/obo/GO_0034067) (protein localization to Golgi apparatus), [GO:0060351](http://purl.obolibrary.org/obo/GO_0060351) (cartilage development involved in endochondral bone morphogenesis), [GO:0006850](http://purl.obolibrary.org/obo/GO_0006850) (mitochondrial pyruvate transmembrane transport), [GO:1900145](http://purl.obolibrary.org/obo/GO_1900145) (regulation of nodal signaling pathway involved in determination of left/right asymmetry), [GO:0005521](http://purl.obolibrary.org/obo/GO_0005521) (lamin binding), [GO:0005520](http://purl.obolibrary.org/obo/GO_0005520) (insulin-like growth factor binding), [GO:0098990](http://purl.obolibrary.org/obo/GO_0098990) (AMPA selective glutamate receptor signaling pathway), [GO:0061689](http://purl.obolibrary.org/obo/GO_0061689) (tricellular tight junction), [GO:0005523](http://purl.obolibrary.org/obo/GO_0005523) (tropomyosin binding), [GO:0006851](http://purl.obolibrary.org/obo/GO_0006851) (mitochondrial calcium ion transmembrane transport), [GO:0005522](http://purl.obolibrary.org/obo/GO_0005522) (profilin binding), [GO:0005513](http://purl.obolibrary.org/obo/GO_0005513) (detection of calcium ion), [GO:0005516](http://purl.obolibrary.org/obo/GO_0005516) (calmodulin binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005518](http://purl.obolibrary.org/obo/GO_0005518) (collagen binding), [GO:0072334](http://purl.obolibrary.org/obo/GO_0072334) (UDP-galactose transmembrane transport), [GO:0072332](http://purl.obolibrary.org/obo/GO_0072332) (intrinsic apoptotic signaling pathway by p53 class mediator), [GO:0071001](http://purl.obolibrary.org/obo/GO_0071001) (U4/U6 snRNP), [GO:0071004](http://purl.obolibrary.org/obo/GO_0071004) (U2-type prespliceosome), [GO:0034058](http://purl.obolibrary.org/obo/GO_0034058) (endosomal vesicle fusion), [GO:0046070](http://purl.obolibrary.org/obo/GO_0046070) (dGTP metabolic process), [GO:0060385](http://purl.obolibrary.org/obo/GO_0060385) (axonogenesis involved in innervation), [GO:0035385](http://purl.obolibrary.org/obo/GO_0035385) (Roundabout signaling pathway), [GO:0060388](http://purl.obolibrary.org/obo/GO_0060388) (vitelline envelope), [GO:1900153](http://purl.obolibrary.org/obo/GO_1900153) (positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay), [GO:0060381](http://purl.obolibrary.org/obo/GO_0060381) (positive regulation of single-stranded telomeric DNA binding), [GO:1900152](http://purl.obolibrary.org/obo/GO_1900152) (negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay), [GO:0034056](http://purl.obolibrary.org/obo/GO_0034056) (estrogen response element binding), [GO:0010084](http://purl.obolibrary.org/obo/GO_0010084) (specification of animal organ axis polarity), [GO:0060383](http://purl.obolibrary.org/obo/GO_0060383) (positive regulation of DNA strand elongation), [GO:0060384](http://purl.obolibrary.org/obo/GO_0060384) (innervation), [GO:1900158](http://purl.obolibrary.org/obo/GO_1900158) (negative regulation of bone mineralization involved in bone maturation), [GO:0060389](http://purl.obolibrary.org/obo/GO_0060389) (pathway-restricted SMAD protein phosphorylation), [GO:0006820](http://purl.obolibrary.org/obo/GO_0006820) (anion transport), [GO:0006821](http://purl.obolibrary.org/obo/GO_0006821) (chloride transport), [GO:0006813](http://purl.obolibrary.org/obo/GO_0006813) (potassium ion transport), [GO:0006814](http://purl.obolibrary.org/obo/GO_0006814) (sodium ion transport), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0006812](http://purl.obolibrary.org/obo/GO_0006812) (cation transport), [GO:0046085](http://purl.obolibrary.org/obo/GO_0046085) (adenosine metabolic process), [GO:0071035](http://purl.obolibrary.org/obo/GO_0071035) (nuclear polyadenylation-dependent rRNA catabolic process), [GO:0006817](http://purl.obolibrary.org/obo/GO_0006817) (phosphate ion transport), [GO:0006816](http://purl.obolibrary.org/obo/GO_0006816) (calcium ion transport), [GO:0071034](http://purl.obolibrary.org/obo/GO_0071034) (CUT catabolic process), [GO:0072369](http://purl.obolibrary.org/obo/GO_0072369) (regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter), [GO:0060391](http://purl.obolibrary.org/obo/GO_0060391) (positive regulation of SMAD protein import into nucleus), [GO:0071038](http://purl.obolibrary.org/obo/GO_0071038) (nuclear polyadenylation-dependent tRNA catabolic process), [GO:0046083](http://purl.obolibrary.org/obo/GO_0046083) (adenine metabolic process), [GO:2001223](http://purl.obolibrary.org/obo/GO_2001223) (negative regulation of neuron migration), [GO:2001224](http://purl.obolibrary.org/obo/GO_2001224) (positive regulation of neuron migration), [GO:1901491](http://purl.obolibrary.org/obo/GO_1901491) (negative regulation of lymphangiogenesis), [GO:0043813](http://purl.obolibrary.org/obo/GO_0043813) (phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity), [GO:0060374](http://purl.obolibrary.org/obo/GO_0060374) (mast cell differentiation), [GO:0043812](http://purl.obolibrary.org/obo/GO_0043812) (phosphatidylinositol-4-phosphate phosphatase activity), [GO:2001240](http://purl.obolibrary.org/obo/GO_2001240) (negative regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:2001241](http://purl.obolibrary.org/obo/GO_2001241) (positive regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:0035376](http://purl.obolibrary.org/obo/GO_0035376) (sterol import), [GO:2001242](http://purl.obolibrary.org/obo/GO_2001242) (regulation of intrinsic apoptotic signaling pathway), [GO:1901492](http://purl.obolibrary.org/obo/GO_1901492) (positive regulation of lymphangiogenesis), [GO:0034046](http://purl.obolibrary.org/obo/GO_0034046) (poly(G) binding), [GO:0060371](http://purl.obolibrary.org/obo/GO_0060371) (regulation of atrial cardiac muscle cell membrane depolarization), [GO:0034045](http://purl.obolibrary.org/obo/GO_0034045) (phagophore assembly site membrane), [GO:0035371](http://purl.obolibrary.org/obo/GO_0035371) (microtubule plus-end), [GO:0060372](http://purl.obolibrary.org/obo/GO_0060372) (regulation of atrial cardiac muscle cell membrane repolarization), [GO:0035372](http://purl.obolibrary.org/obo/GO_0035372) (protein localization to microtubule), [GO:0060373](http://purl.obolibrary.org/obo/GO_0060373) (regulation of ventricular cardiac muscle cell membrane depolarization), [GO:1900168](http://purl.obolibrary.org/obo/GO_1900168) (positive regulation of glial cell-derived neurotrophic factor secretion), [GO:0005501](http://purl.obolibrary.org/obo/GO_0005501) (retinoid binding), [GO:0006824](http://purl.obolibrary.org/obo/GO_0006824) (cobalt ion transport), [GO:0006825](http://purl.obolibrary.org/obo/GO_0006825) (copper ion transport), [GO:0046098](http://purl.obolibrary.org/obo/GO_0046098) (guanine metabolic process), [GO:0072350](http://purl.obolibrary.org/obo/GO_0072350) (tricarboxylic acid metabolic process), [GO:0006828](http://purl.obolibrary.org/obo/GO_0006828) (manganese ion transport), [GO:0006829](http://purl.obolibrary.org/obo/GO_0006829) (zinc II ion transport), [GO:0072355](http://purl.obolibrary.org/obo/GO_0072355) (histone H3-T3 phosphorylation), [GO:0072354](http://purl.obolibrary.org/obo/GO_0072354) (histone kinase activity (H3-T3 specific)), [GO:0006826](http://purl.obolibrary.org/obo/GO_0006826) (iron ion transport), [GO:0071028](http://purl.obolibrary.org/obo/GO_0071028) (nuclear mRNA surveillance), [GO:2001236](http://purl.obolibrary.org/obo/GO_2001236) (regulation of extrinsic apoptotic signaling pathway), [GO:2001237](http://purl.obolibrary.org/obo/GO_2001237) (negative regulation of extrinsic apoptotic signaling pathway), [GO:0072359](http://purl.obolibrary.org/obo/GO_0072359) (circulatory system development), [GO:0072358](http://purl.obolibrary.org/obo/GO_0072358) (cardiovascular system development), [GO:2001238](http://purl.obolibrary.org/obo/GO_2001238) (positive regulation of extrinsic apoptotic signaling pathway), [GO:2001239](http://purl.obolibrary.org/obo/GO_2001239) (regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:0098967](http://purl.obolibrary.org/obo/GO_0098967) (exocytic insertion of neurotransmitter receptor to postsynaptic membrane), [GO:2001233](http://purl.obolibrary.org/obo/GO_2001233) (regulation of apoptotic signaling pathway), [GO:2001234](http://purl.obolibrary.org/obo/GO_2001234) (negative regulation of apoptotic signaling pathway), [GO:2001235](http://purl.obolibrary.org/obo/GO_2001235) (positive regulation of apoptotic signaling pathway), [GO:0046092](http://purl.obolibrary.org/obo/GO_0046092) (deoxycytidine metabolic process), [GO:0016206](http://purl.obolibrary.org/obo/GO_0016206) (catechol O-methyltransferase activity), [GO:2001252](http://purl.obolibrary.org/obo/GO_2001252) (positive regulation of chromosome organization), [GO:0016208](http://purl.obolibrary.org/obo/GO_0016208) (AMP binding), [GO:0060322](http://purl.obolibrary.org/obo/GO_0060322) (head development), [GO:0016209](http://purl.obolibrary.org/obo/GO_0016209) (antioxidant activity), [GO:0047349](http://purl.obolibrary.org/obo/GO_0047349) (D-ribitol-5-phosphate cytidylyltransferase activity), [GO:0006882](http://purl.obolibrary.org/obo/GO_0006882) (cellular zinc ion homeostasis), [GO:0048679](http://purl.obolibrary.org/obo/GO_0048679) (regulation of axon regeneration), [GO:0006883](http://purl.obolibrary.org/obo/GO_0006883) (cellular sodium ion homeostasis), [GO:0048678](http://purl.obolibrary.org/obo/GO_0048678) (response to axon injury), [GO:0046015](http://purl.obolibrary.org/obo/GO_0046015) (regulation of transcription by glucose), [GO:0006880](http://purl.obolibrary.org/obo/GO_0006880) (intracellular sequestering of iron ion), [GO:0048677](http://purl.obolibrary.org/obo/GO_0048677) (axon extension involved in regeneration), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:0060323](http://purl.obolibrary.org/obo/GO_0060323) (head morphogenesis), [GO:0004222](http://purl.obolibrary.org/obo/GO_0004222) (metalloendopeptidase activity), [GO:0006887](http://purl.obolibrary.org/obo/GO_0006887) (exocytosis), [GO:0060324](http://purl.obolibrary.org/obo/GO_0060324) (face development), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0006885](http://purl.obolibrary.org/obo/GO_0006885) (regulation of pH), [GO:0005547](http://purl.obolibrary.org/obo/GO_0005547) (phosphatidylinositol-3,4,5-trisphosphate binding), [GO:0006879](http://purl.obolibrary.org/obo/GO_0006879) (cellular iron ion homeostasis), [GO:0046020](http://purl.obolibrary.org/obo/GO_0046020) (negative regulation of transcription from RNA polymerase II promoter by pheromones), [GO:0005546](http://purl.obolibrary.org/obo/GO_0005546) (phosphatidylinositol-4,5-bisphosphate binding), [GO:0030502](http://purl.obolibrary.org/obo/GO_0030502) (negative regulation of bone mineralization), [GO:0048681](http://purl.obolibrary.org/obo/GO_0048681) (negative regulation of axon regeneration), [GO:0006878](http://purl.obolibrary.org/obo/GO_0006878) (cellular copper ion homeostasis), [GO:0005548](http://purl.obolibrary.org/obo/GO_0005548) (phospholipid transporter activity), [GO:0048680](http://purl.obolibrary.org/obo/GO_0048680) (positive regulation of axon regeneration), [GO:0030507](http://purl.obolibrary.org/obo/GO_0030507) (spectrin binding), [GO:0030506](http://purl.obolibrary.org/obo/GO_0030506) (ankyrin binding), [GO:0072300](http://purl.obolibrary.org/obo/GO_0072300) (positive regulation of metanephric glomerulus development), [GO:0030509](http://purl.obolibrary.org/obo/GO_0030509) (BMP signaling pathway), [GO:0031838](http://purl.obolibrary.org/obo/GO_0031838) (haptoglobin-hemoglobin complex), [GO:0072305](http://purl.obolibrary.org/obo/GO_0072305) (negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis), [GO:0097602](http://purl.obolibrary.org/obo/GO_0097602) (cullin family protein binding), [GO:0097604](http://purl.obolibrary.org/obo/GO_0097604) (temperature-gated cation channel activity), [GO:2001243](http://purl.obolibrary.org/obo/GO_2001243) (negative regulation of intrinsic apoptotic signaling pathway), [GO:0050998](http://purl.obolibrary.org/obo/GO_0050998) (nitric-oxide synthase binding), [GO:2001244](http://purl.obolibrary.org/obo/GO_2001244) (positive regulation of intrinsic apoptotic signaling pathway), [GO:0030501](http://purl.obolibrary.org/obo/GO_0030501) (positive regulation of bone mineralization), [GO:0072307](http://purl.obolibrary.org/obo/GO_0072307) (regulation of metanephric nephron tubule epithelial cell differentiation), [GO:0050995](http://purl.obolibrary.org/obo/GO_0050995) (negative regulation of lipid catabolic process), [GO:0030500](http://purl.obolibrary.org/obo/GO_0030500) (regulation of bone mineralization), [GO:0050996](http://purl.obolibrary.org/obo/GO_0050996) (positive regulation of lipid catabolic process), [GO:0060311](http://purl.obolibrary.org/obo/GO_0060311) (negative regulation of elastin catabolic process), [GO:0006890](http://purl.obolibrary.org/obo/GO_0006890) (retrograde vesicle-mediated transport, Golgi to ER), [GO:0006893](http://purl.obolibrary.org/obo/GO_0006893) (Golgi to plasma membrane transport), [GO:1900101](http://purl.obolibrary.org/obo/GO_1900101) (regulation of endoplasmic reticulum unfolded protein response), [GO:0006891](http://purl.obolibrary.org/obo/GO_0006891) (intra-Golgi vesicle-mediated transport), [GO:0006892](http://purl.obolibrary.org/obo/GO_0006892) (post-Golgi vesicle-mediated transport), [GO:0060319](http://purl.obolibrary.org/obo/GO_0060319) (primitive erythrocyte differentiation), [GO:0006897](http://purl.obolibrary.org/obo/GO_0006897) (endocytosis), [GO:0060312](http://purl.obolibrary.org/obo/GO_0060312) (regulation of blood vessel remodeling), [GO:1900106](http://purl.obolibrary.org/obo/GO_1900106) (positive regulation of hyaluranon cable assembly), [GO:0006898](http://purl.obolibrary.org/obo/GO_0006898) (receptor-mediated endocytosis), [GO:0060314](http://purl.obolibrary.org/obo/GO_0060314) (regulation of ryanodine-sensitive calcium-release channel activity), [GO:0006895](http://purl.obolibrary.org/obo/GO_0006895) (Golgi to endosome transport), [GO:0006896](http://purl.obolibrary.org/obo/GO_0006896) (Golgi to vacuole transport), [GO:0060315](http://purl.obolibrary.org/obo/GO_0060315) (negative regulation of ryanodine-sensitive calcium-release channel activity), [GO:0061646](http://purl.obolibrary.org/obo/GO_0061646) (positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization), [GO:0006888](http://purl.obolibrary.org/obo/GO_0006888) (ER to Golgi vesicle-mediated transport), [GO:0048698](http://purl.obolibrary.org/obo/GO_0048698) (negative regulation of collateral sprouting in absence of injury), [GO:0098943](http://purl.obolibrary.org/obo/GO_0098943) (neurotransmitter receptor transport, postsynaptic endosome to lysosome), [GO:0046033](http://purl.obolibrary.org/obo/GO_0046033) (AMP metabolic process), [GO:0031826](http://purl.obolibrary.org/obo/GO_0031826) (type 2A serotonin receptor binding), [GO:0046034](http://purl.obolibrary.org/obo/GO_0046034) (ATP metabolic process), [GO:2001258](http://purl.obolibrary.org/obo/GO_2001258) (negative regulation of cation channel activity), [GO:2001259](http://purl.obolibrary.org/obo/GO_2001259) (positive regulation of cation channel activity), [GO:0031821](http://purl.obolibrary.org/obo/GO_0031821) (G-protein coupled serotonin receptor binding), [GO:0016202](http://purl.obolibrary.org/obo/GO_0016202) (regulation of striated muscle tissue development), [GO:0016203](http://purl.obolibrary.org/obo/GO_0016203) (muscle attachment), [GO:2001256](http://purl.obolibrary.org/obo/GO_2001256) (regulation of store-operated calcium entry), [GO:0034097](http://purl.obolibrary.org/obo/GO_0034097) (response to cytokine), [GO:0060341](http://purl.obolibrary.org/obo/GO_0060341) (regulation of cellular localization), [GO:0060342](http://purl.obolibrary.org/obo/GO_0060342) (photoreceptor inner segment membrane), [GO:2001275](http://purl.obolibrary.org/obo/GO_2001275) (positive regulation of glucose import in response to insulin stimulus), [GO:1900111](http://purl.obolibrary.org/obo/GO_1900111) (positive regulation of histone H3-K9 dimethylation), [GO:0034098](http://purl.obolibrary.org/obo/GO_0034098) (VCP-NPL4-UFD1 AAA ATPase complex), [GO:0060340](http://purl.obolibrary.org/obo/GO_0060340) (positive regulation of type I interferon-mediated signaling pathway), [GO:0060349](http://purl.obolibrary.org/obo/GO_0060349) (bone morphogenesis), [GO:0046039](http://purl.obolibrary.org/obo/GO_0046039) (GTP metabolic process), [GO:0090197](http://purl.obolibrary.org/obo/GO_0090197) (positive regulation of chemokine secretion), [GO:0046037](http://purl.obolibrary.org/obo/GO_0046037) (GMP metabolic process), [GO:0048699](http://purl.obolibrary.org/obo/GO_0048699) (generation of neurons), [GO:0046038](http://purl.obolibrary.org/obo/GO_0046038) (GMP catabolic process), [GO:0090193](http://purl.obolibrary.org/obo/GO_0090193) (positive regulation of glomerulus development), [GO:0090194](http://purl.obolibrary.org/obo/GO_0090194) (negative regulation of glomerulus development), [GO:0006865](http://purl.obolibrary.org/obo/GO_0006865) (amino acid transport), [GO:0060346](http://purl.obolibrary.org/obo/GO_0060346) (bone trabecula formation), [GO:0090191](http://purl.obolibrary.org/obo/GO_0090191) (negative regulation of branching involved in ureteric bud morphogenesis), [GO:0060347](http://purl.obolibrary.org/obo/GO_0060347) (heart trabecula formation), [GO:0005534](http://purl.obolibrary.org/obo/GO_0005534) (galactose binding), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0006855](http://purl.obolibrary.org/obo/GO_0006855) (drug transmembrane transport), [GO:0046040](http://purl.obolibrary.org/obo/GO_0046040) (IMP metabolic process), [GO:0047372](http://purl.obolibrary.org/obo/GO_0047372) (acylglycerol lipase activity), [GO:0072321](http://purl.obolibrary.org/obo/GO_0072321) (chaperone-mediated protein transport), [GO:2001269](http://purl.obolibrary.org/obo/GO_2001269) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway), [GO:0098911](http://purl.obolibrary.org/obo/GO_0098911) (regulation of ventricular cardiac muscle cell action potential), [GO:0098912](http://purl.obolibrary.org/obo/GO_0098912) (membrane depolarization during atrial cardiac muscle cell action potential), [GO:0060333](http://purl.obolibrary.org/obo/GO_0060333) (interferon-gamma-mediated signaling pathway), [GO:1900122](http://purl.obolibrary.org/obo/GO_1900122) (positive regulation of receptor binding), [GO:0034088](http://purl.obolibrary.org/obo/GO_0034088) (maintenance of mitotic sister chromatid cohesion), [GO:0034087](http://purl.obolibrary.org/obo/GO_0034087) (establishment of mitotic sister chromatid cohesion), [GO:1900121](http://purl.obolibrary.org/obo/GO_1900121) (negative regulation of receptor binding), [GO:0061669](http://purl.obolibrary.org/obo/GO_0061669) (spontaneous neurotransmitter secretion), [GO:0060339](http://purl.obolibrary.org/obo/GO_0060339) (negative regulation of type I interferon-mediated signaling pathway), [GO:0005540](http://purl.obolibrary.org/obo/GO_0005540) (hyaluronic acid binding), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:0006875](http://purl.obolibrary.org/obo/GO_0006875) (cellular metal ion homeostasis), [GO:0005542](http://purl.obolibrary.org/obo/GO_0005542) (folic acid binding), [GO:1900127](http://purl.obolibrary.org/obo/GO_1900127) (positive regulation of hyaluronan biosynthetic process), [GO:0060335](http://purl.obolibrary.org/obo/GO_0060335) (positive regulation of interferon-gamma-mediated signaling pathway), [GO:0006873](http://purl.obolibrary.org/obo/GO_0006873) (cellular ion homeostasis), [GO:0005545](http://purl.obolibrary.org/obo/GO_0005545) (1-phosphatidylinositol binding), [GO:0005544](http://purl.obolibrary.org/obo/GO_0005544) (calcium-dependent phospholipid binding), [GO:0006874](http://purl.obolibrary.org/obo/GO_0006874) (cellular calcium ion homeostasis), [GO:0060337](http://purl.obolibrary.org/obo/GO_0060337) (type I interferon signaling pathway), [GO:0005536](http://purl.obolibrary.org/obo/GO_0005536) (glucose binding), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0005537](http://purl.obolibrary.org/obo/GO_0005537) (mannose binding), [GO:0005539](http://purl.obolibrary.org/obo/GO_0005539) (glycosaminoglycan binding), [GO:0046058](http://purl.obolibrary.org/obo/GO_0046058) (cAMP metabolic process), [GO:0072318](http://purl.obolibrary.org/obo/GO_0072318) (clathrin coat disassembly), [GO:0042537](http://purl.obolibrary.org/obo/GO_0042537) (benzene-containing compound metabolic process), [GO:0042538](http://purl.obolibrary.org/obo/GO_0042538) (hyperosmotic salinity response), [GO:0005592](http://purl.obolibrary.org/obo/GO_0005592) (collagen type XI trimer), [GO:0042531](http://purl.obolibrary.org/obo/GO_0042531) (positive regulation of tyrosine phosphorylation of STAT protein), [GO:0042532](http://purl.obolibrary.org/obo/GO_0042532) (negative regulation of tyrosine phosphorylation of STAT protein), [GO:0042535](http://purl.obolibrary.org/obo/GO_0042535) (positive regulation of tumor necrosis factor biosynthetic process), [GO:0016250](http://purl.obolibrary.org/obo/GO_0016250) (N-sulfoglucosamine sulfohydrolase activity), [GO:0031870](http://purl.obolibrary.org/obo/GO_0031870) (thromboxane A2 receptor binding), [GO:0030540](http://purl.obolibrary.org/obo/GO_0030540) (female genitalia development), [GO:0016255](http://purl.obolibrary.org/obo/GO_0016255) (attachment of GPI anchor to protein), [GO:0030543](http://purl.obolibrary.org/obo/GO_0030543) (2-micrometer plasmid partitioning), [GO:0030544](http://purl.obolibrary.org/obo/GO_0030544) (Hsp70 protein binding), [GO:0016239](http://purl.obolibrary.org/obo/GO_0016239) (positive regulation of macroautophagy), [GO:0042541](http://purl.obolibrary.org/obo/GO_0042541) (hemoglobin biosynthetic process), [GO:0042542](http://purl.obolibrary.org/obo/GO_0042542) (response to hydrogen peroxide), [GO:0030539](http://purl.obolibrary.org/obo/GO_0030539) (male genitalia development), [GO:0016240](http://purl.obolibrary.org/obo/GO_0016240) (autophagosome membrane docking), [GO:0016241](http://purl.obolibrary.org/obo/GO_0016241) (regulation of macroautophagy), [GO:0016242](http://purl.obolibrary.org/obo/GO_0016242) (negative regulation of macroautophagy), [GO:0016243](http://purl.obolibrary.org/obo/GO_0016243) (regulation of autophagosome size), [GO:0030532](http://purl.obolibrary.org/obo/GO_0030532) (small nuclear ribonucleoprotein complex), [GO:0030534](http://purl.obolibrary.org/obo/GO_0030534) (adult behavior), [GO:0016247](http://purl.obolibrary.org/obo/GO_0016247) (channel regulator activity), [GO:0042558](http://purl.obolibrary.org/obo/GO_0042558) (pteridine-containing compound metabolic process), [GO:0042559](http://purl.obolibrary.org/obo/GO_0042559) (pteridine-containing compound biosynthetic process), [GO:0016229](http://purl.obolibrary.org/obo/GO_0016229) (steroid dehydrogenase activity), [GO:0102704](http://purl.obolibrary.org/obo/GO_0102704) (GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity), [GO:0042551](http://purl.obolibrary.org/obo/GO_0042551) (neuron maturation), [GO:0042552](http://purl.obolibrary.org/obo/GO_0042552) (myelination), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0042554](http://purl.obolibrary.org/obo/GO_0042554) (superoxide anion generation), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0042555](http://purl.obolibrary.org/obo/GO_0042555) (MCM complex), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0031857](http://purl.obolibrary.org/obo/GO_0031857) (type 1 parathyroid hormone receptor binding), [GO:0031856](http://purl.obolibrary.org/obo/GO_0031856) (parathyroid hormone receptor binding), [GO:0030529](http://purl.obolibrary.org/obo/GO_0030529) (intracellular ribonucleoprotein complex), [GO:0043890](http://purl.obolibrary.org/obo/GO_0043890) (N-acetylgalactosamine-6-sulfatase activity), [GO:0016231](http://purl.obolibrary.org/obo/GO_0016231) (beta-N-acetylglucosaminidase activity), [GO:0016233](http://purl.obolibrary.org/obo/GO_0016233) (telomere capping), [GO:0030521](http://purl.obolibrary.org/obo/GO_0030521) (androgen receptor signaling pathway), [GO:0016234](http://purl.obolibrary.org/obo/GO_0016234) (inclusion body), [GO:0016235](http://purl.obolibrary.org/obo/GO_0016235) (aggresome), [GO:0030520](http://purl.obolibrary.org/obo/GO_0030520) (intracellular estrogen receptor signaling pathway), [GO:0016236](http://purl.obolibrary.org/obo/GO_0016236) (macroautophagy), [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding), [GO:0016237](http://purl.obolibrary.org/obo/GO_0016237) (lysosomal microautophagy), [GO:0030522](http://purl.obolibrary.org/obo/GO_0030522) (intracellular receptor signaling pathway), [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer), [GO:0004252](http://purl.obolibrary.org/obo/GO_0004252) (serine-type endopeptidase activity), [GO:0042562](http://purl.obolibrary.org/obo/GO_0042562) (hormone binding), [GO:0005585](http://purl.obolibrary.org/obo/GO_0005585) (collagen type II trimer), [GO:0005587](http://purl.obolibrary.org/obo/GO_0005587) (collagen type IV trimer), [GO:0030514](http://purl.obolibrary.org/obo/GO_0030514) (negative regulation of BMP signaling pathway), [GO:0030513](http://purl.obolibrary.org/obo/GO_0030513) (positive regulation of BMP signaling pathway), [GO:0030516](http://purl.obolibrary.org/obo/GO_0030516) (regulation of axon extension), [GO:0030515](http://purl.obolibrary.org/obo/GO_0030515) (snoRNA binding), [GO:0030518](http://purl.obolibrary.org/obo/GO_0030518) (intracellular steroid hormone receptor signaling pathway), [GO:0030517](http://purl.obolibrary.org/obo/GO_0030517) (negative regulation of axon extension), [GO:0031848](http://purl.obolibrary.org/obo/GO_0031848) (protection from non-homologous end joining at telomere), [GO:0031849](http://purl.obolibrary.org/obo/GO_0031849) (olfactory receptor binding), [GO:0030510](http://purl.obolibrary.org/obo/GO_0030510) (regulation of BMP signaling pathway), [GO:0030512](http://purl.obolibrary.org/obo/GO_0030512) (negative regulation of transforming growth factor beta receptor signaling pathway), [GO:0030511](http://purl.obolibrary.org/obo/GO_0030511) (positive regulation of transforming growth factor beta receptor signaling pathway), [GO:0016226](http://purl.obolibrary.org/obo/GO_0016226) (iron-sulfur cluster assembly), [GO:0072385](http://purl.obolibrary.org/obo/GO_0072385) (minus-end-directed organelle transport along microtubule), [GO:0097682](http://purl.obolibrary.org/obo/GO_0097682) (intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity), [GO:0016290](http://purl.obolibrary.org/obo/GO_0016290) (palmitoyl-CoA hydrolase activity), [GO:0071051](http://purl.obolibrary.org/obo/GO_0071051) (polyadenylation-dependent snoRNA 3'-end processing), [GO:0072383](http://purl.obolibrary.org/obo/GO_0072383) (plus-end-directed vesicle transport along microtubule), [GO:0072382](http://purl.obolibrary.org/obo/GO_0072382) (minus-end-directed vesicle transport along microtubule), [GO:0072389](http://purl.obolibrary.org/obo/GO_0072389) (flavin adenine dinucleotide catabolic process), [GO:0030586](http://purl.obolibrary.org/obo/GO_0030586) ([methionine synthase] reductase activity), [GO:1900182](http://purl.obolibrary.org/obo/GO_1900182) (positive regulation of protein localization to nucleus), [GO:0060399](http://purl.obolibrary.org/obo/GO_0060399) (positive regulation of growth hormone receptor signaling pathway), [GO:0000706](http://purl.obolibrary.org/obo/GO_0000706) (meiotic DNA double-strand break processing), [GO:1900186](http://purl.obolibrary.org/obo/GO_1900186) (negative regulation of clathrin-dependent endocytosis), [GO:0060393](http://purl.obolibrary.org/obo/GO_0060393) (regulation of pathway-restricted SMAD protein phosphorylation), [GO:0060394](http://purl.obolibrary.org/obo/GO_0060394) (negative regulation of pathway-restricted SMAD protein phosphorylation), [GO:0060395](http://purl.obolibrary.org/obo/GO_0060395) (SMAD protein signal transduction), [GO:0000701](http://purl.obolibrary.org/obo/GO_0000701) (purine-specific mismatch base pair DNA N-glycosylase activity), [GO:0042500](http://purl.obolibrary.org/obo/GO_0042500) (aspartic endopeptidase activity, intramembrane cleaving), [GO:0071042](http://purl.obolibrary.org/obo/GO_0071042) (nuclear polyadenylation-dependent mRNA catabolic process), [GO:0097694](http://purl.obolibrary.org/obo/GO_0097694) (establishment of RNA localization to telomere), [GO:0030579](http://purl.obolibrary.org/obo/GO_0030579) (ubiquitin-dependent SMAD protein catabolic process), [GO:0071041](http://purl.obolibrary.org/obo/GO_0071041) (antisense RNA transcript catabolic process), [GO:0097695](http://purl.obolibrary.org/obo/GO_0097695) (establishment of macromolecular complex localization to telomere), [GO:0016281](http://purl.obolibrary.org/obo/GO_0016281) (eukaryotic translation initiation factor 4F complex), [GO:0071044](http://purl.obolibrary.org/obo/GO_0071044) (histone mRNA catabolic process), [GO:0030574](http://purl.obolibrary.org/obo/GO_0030574) (collagen catabolic process), [GO:0016287](http://purl.obolibrary.org/obo/GO_0016287) (glycerone-phosphate O-acyltransferase activity), [GO:0071049](http://purl.obolibrary.org/obo/GO_0071049) (nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription), [GO:1900180](http://purl.obolibrary.org/obo/GO_1900180) (regulation of protein localization to nucleus), [GO:0043849](http://purl.obolibrary.org/obo/GO_0043849) (Ras palmitoyltransferase activity), [GO:0098993](http://purl.obolibrary.org/obo/GO_0098993) (anchored component of synaptic vesicle membrane), [GO:0016274](http://purl.obolibrary.org/obo/GO_0016274) (protein-arginine N-methyltransferase activity), [GO:0016277](http://purl.obolibrary.org/obo/GO_0016277) ([myelin basic protein]-arginine N-methyltransferase activity), [GO:0016279](http://purl.obolibrary.org/obo/GO_0016279) (protein-lysine N-methyltransferase activity), [GO:0071071](http://purl.obolibrary.org/obo/GO_0071071) (regulation of phospholipid biosynthetic process), [GO:0043855](http://purl.obolibrary.org/obo/GO_0043855) (cyclic nucleotide-gated ion channel activity), [GO:0097680](http://purl.obolibrary.org/obo/GO_0097680) (double-strand break repair via classical nonhomologous end joining), [GO:0072393](http://purl.obolibrary.org/obo/GO_0072393) (microtubule anchoring at microtubule organizing center), [GO:0016264](http://purl.obolibrary.org/obo/GO_0016264) (gap junction assembly), [GO:0031883](http://purl.obolibrary.org/obo/GO_0031883) (taste receptor binding), [GO:0030552](http://purl.obolibrary.org/obo/GO_0030552) (cAMP binding), [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding), [GO:0030553](http://purl.obolibrary.org/obo/GO_0030553) (cGMP binding), [GO:0042495](http://purl.obolibrary.org/obo/GO_0042495) (detection of triacyl bacterial lipopeptide), [GO:0042497](http://purl.obolibrary.org/obo/GO_0042497) (triacyl lipopeptide binding), [GO:0001941](http://purl.obolibrary.org/obo/GO_0001941) (postsynaptic membrane organization), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0001949](http://purl.obolibrary.org/obo/GO_0001949) (sebaceous gland cell differentiation), [GO:0090107](http://purl.obolibrary.org/obo/GO_0090107) (regulation of high-density lipoprotein particle assembly), [GO:0090104](http://purl.obolibrary.org/obo/GO_0090104) (pancreatic epsilon cell differentiation), [GO:0090102](http://purl.obolibrary.org/obo/GO_0090102) (cochlea development), [GO:0090103](http://purl.obolibrary.org/obo/GO_0090103) (cochlea morphogenesis), [GO:0001952](http://purl.obolibrary.org/obo/GO_0001952) (regulation of cell-matrix adhesion), [GO:0001953](http://purl.obolibrary.org/obo/GO_0001953) (negative regulation of cell-matrix adhesion), [GO:0001954](http://purl.obolibrary.org/obo/GO_0001954) (positive regulation of cell-matrix adhesion), [GO:0001956](http://purl.obolibrary.org/obo/GO_0001956) (positive regulation of neurotransmitter secretion), [GO:0001957](http://purl.obolibrary.org/obo/GO_0001957) (intramembranous ossification), [GO:0001958](http://purl.obolibrary.org/obo/GO_0001958) (endochondral ossification), [GO:0030497](http://purl.obolibrary.org/obo/GO_0030497) (fatty acid elongation), [GO:0030496](http://purl.obolibrary.org/obo/GO_0030496) (midbody), [GO:0030492](http://purl.obolibrary.org/obo/GO_0030492) (hemoglobin binding), [GO:0016191](http://purl.obolibrary.org/obo/GO_0016191) (synaptic vesicle uncoating), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0001921](http://purl.obolibrary.org/obo/GO_0001921) (positive regulation of receptor recycling), [GO:0016197](http://purl.obolibrary.org/obo/GO_0016197) (endosomal transport), [GO:0016199](http://purl.obolibrary.org/obo/GO_0016199) (axon midline choice point recognition), [GO:0030485](http://purl.obolibrary.org/obo/GO_0030485) (smooth muscle contractile fiber), [GO:0030488](http://purl.obolibrary.org/obo/GO_0030488) (tRNA methylation), [GO:0050908](http://purl.obolibrary.org/obo/GO_0050908) (detection of light stimulus involved in visual perception), [GO:0050909](http://purl.obolibrary.org/obo/GO_0050909) (sensory perception of taste), [GO:0050907](http://purl.obolibrary.org/obo/GO_0050907) (detection of chemical stimulus involved in sensory perception), [GO:0050905](http://purl.obolibrary.org/obo/GO_0050905) (neuromuscular process), [GO:0016182](http://purl.obolibrary.org/obo/GO_0016182) (synaptic vesicle budding from endosome), [GO:0001932](http://purl.obolibrary.org/obo/GO_0001932) (regulation of protein phosphorylation), [GO:0001933](http://purl.obolibrary.org/obo/GO_0001933) (negative regulation of protein phosphorylation), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0016185](http://purl.obolibrary.org/obo/GO_0016185) (synaptic vesicle budding from presynaptic endocytic zone membrane), [GO:0001935](http://purl.obolibrary.org/obo/GO_0001935) (endothelial cell proliferation), [GO:0030473](http://purl.obolibrary.org/obo/GO_0030473) (nuclear migration along microtubule), [GO:0001936](http://purl.obolibrary.org/obo/GO_0001936) (regulation of endothelial cell proliferation), [GO:0001937](http://purl.obolibrary.org/obo/GO_0001937) (negative regulation of endothelial cell proliferation), [GO:0050900](http://purl.obolibrary.org/obo/GO_0050900) (leukocyte migration), [GO:0016188](http://purl.obolibrary.org/obo/GO_0016188) (synaptic vesicle maturation), [GO:0001938](http://purl.obolibrary.org/obo/GO_0001938) (positive regulation of endothelial cell proliferation), [GO:0030474](http://purl.obolibrary.org/obo/GO_0030474) (spindle pole body duplication), [GO:0050901](http://purl.obolibrary.org/obo/GO_0050901) (leukocyte tethering or rolling), [GO:0030476](http://purl.obolibrary.org/obo/GO_0030476) (ascospore wall assembly), [GO:0030479](http://purl.obolibrary.org/obo/GO_0030479) (actin cortical patch), [GO:0043783](http://purl.obolibrary.org/obo/GO_0043783) (oxidoreductase activity, oxidizing metal ions with flavin as acceptor), [GO:0001988](http://purl.obolibrary.org/obo/GO_0001988) (positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure), [GO:0042461](http://purl.obolibrary.org/obo/GO_0042461) (photoreceptor cell development), [GO:0042462](http://purl.obolibrary.org/obo/GO_0042462) (eye photoreceptor cell development), [GO:0009008](http://purl.obolibrary.org/obo/GO_0009008) (DNA-methyltransferase activity), [GO:0042470](http://purl.obolibrary.org/obo/GO_0042470) (melanosome), [GO:0042471](http://purl.obolibrary.org/obo/GO_0042471) (ear morphogenesis), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0042473](http://purl.obolibrary.org/obo/GO_0042473) (outer ear morphogenesis), [GO:0042474](http://purl.obolibrary.org/obo/GO_0042474) (middle ear morphogenesis), [GO:0042475](http://purl.obolibrary.org/obo/GO_0042475) (odontogenesis of dentin-containing tooth), [GO:0042476](http://purl.obolibrary.org/obo/GO_0042476) (odontogenesis), [GO:0001963](http://purl.obolibrary.org/obo/GO_0001963) (synaptic transmission, dopaminergic), [GO:0001964](http://purl.obolibrary.org/obo/GO_0001964) (startle response), [GO:0001965](http://purl.obolibrary.org/obo/GO_0001965) (G-protein alpha-subunit binding), [GO:0042481](http://purl.obolibrary.org/obo/GO_0042481) (regulation of odontogenesis), [GO:0001966](http://purl.obolibrary.org/obo/GO_0001966) (thigmotaxis), [GO:0001967](http://purl.obolibrary.org/obo/GO_0001967) (suckling behavior), [GO:0042487](http://purl.obolibrary.org/obo/GO_0042487) (regulation of odontogenesis of dentin-containing tooth), [GO:0001980](http://purl.obolibrary.org/obo/GO_0001980) (regulation of systemic arterial blood pressure by ischemic conditions), [GO:0001971](http://purl.obolibrary.org/obo/GO_0001971) (negative regulation of activation of membrane attack complex), [GO:0001972](http://purl.obolibrary.org/obo/GO_0001972) (retinoic acid binding), [GO:0001974](http://purl.obolibrary.org/obo/GO_0001974) (blood vessel remodeling), [GO:0042490](http://purl.obolibrary.org/obo/GO_0042490) (mechanoreceptor differentiation), [GO:0042491](http://purl.obolibrary.org/obo/GO_0042491) (inner ear auditory receptor cell differentiation), [GO:0001975](http://purl.obolibrary.org/obo/GO_0001975) (response to amphetamine), [GO:0001976](http://purl.obolibrary.org/obo/GO_0001976) (neurological system process involved in regulation of systemic arterial blood pressure), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0090179](http://purl.obolibrary.org/obo/GO_0090179) (planar cell polarity pathway involved in neural tube closure), [GO:0090177](http://purl.obolibrary.org/obo/GO_0090177) (establishment of planar polarity involved in neural tube closure), [GO:1902710](http://purl.obolibrary.org/obo/GO_1902710) (GABA receptor complex), [GO:0022006](http://purl.obolibrary.org/obo/GO_0022006) (zona limitans intrathalamica formation), [GO:0090175](http://purl.obolibrary.org/obo/GO_0090175) (regulation of establishment of planar polarity), [GO:0048635](http://purl.obolibrary.org/obo/GO_0048635) (negative regulation of muscle organ development), [GO:1902711](http://purl.obolibrary.org/obo/GO_1902711) (GABA-A receptor complex), [GO:0061615](http://purl.obolibrary.org/obo/GO_0061615) (glycolytic process through fructose-6-phosphate), [GO:0022007](http://purl.obolibrary.org/obo/GO_0022007) (convergent extension involved in neural plate elongation), [GO:0022008](http://purl.obolibrary.org/obo/GO_0022008) (neurogenesis), [GO:0048633](http://purl.obolibrary.org/obo/GO_0048633) (positive regulation of skeletal muscle tissue growth), [GO:0090171](http://purl.obolibrary.org/obo/GO_0090171) (chondrocyte morphogenesis), [GO:0061611](http://purl.obolibrary.org/obo/GO_0061611) (mannose to fructose-6-phosphate metabolic process), [GO:0048639](http://purl.obolibrary.org/obo/GO_0048639) (positive regulation of developmental growth), [GO:0048638](http://purl.obolibrary.org/obo/GO_0048638) (regulation of developmental growth), [GO:0090170](http://purl.obolibrary.org/obo/GO_0090170) (regulation of Golgi inheritance), [GO:0022010](http://purl.obolibrary.org/obo/GO_0022010) (central nervous system myelination), [GO:0022011](http://purl.obolibrary.org/obo/GO_0022011) (myelination in peripheral nervous system), [GO:0048643](http://purl.obolibrary.org/obo/GO_0048643) (positive regulation of skeletal muscle tissue development), [GO:0061618](http://purl.obolibrary.org/obo/GO_0061618) (sublamina densa), [GO:0048642](http://purl.obolibrary.org/obo/GO_0048642) (negative regulation of skeletal muscle tissue development), [GO:0061619](http://purl.obolibrary.org/obo/GO_0061619) (glycolytic process from mannose through fructose-6-phosphate), [GO:0048641](http://purl.obolibrary.org/obo/GO_0048641) (regulation of skeletal muscle tissue development), [GO:0048640](http://purl.obolibrary.org/obo/GO_0048640) (negative regulation of developmental growth), [GO:0050957](http://purl.obolibrary.org/obo/GO_0050957) (equilibrioception), [GO:0050955](http://purl.obolibrary.org/obo/GO_0050955) (thermoception), [GO:0050953](http://purl.obolibrary.org/obo/GO_0050953) (sensory perception of light stimulus), [GO:0035313](http://purl.obolibrary.org/obo/GO_0035313) (wound healing, spreading of epidermal cells), [GO:0050954](http://purl.obolibrary.org/obo/GO_0050954) (sensory perception of mechanical stimulus), [GO:0035315](http://purl.obolibrary.org/obo/GO_0035315) (hair cell differentiation), [GO:0010033](http://purl.obolibrary.org/obo/GO_0010033) (response to organic substance), [GO:0098908](http://purl.obolibrary.org/obo/GO_0098908) (regulation of neuronal action potential), [GO:0090188](http://purl.obolibrary.org/obo/GO_0090188) (negative regulation of pancreatic juice secretion), [GO:0048646](http://purl.obolibrary.org/obo/GO_0048646) (anatomical structure formation involved in morphogenesis), [GO:0090184](http://purl.obolibrary.org/obo/GO_0090184) (positive regulation of kidney development), [GO:0048645](http://purl.obolibrary.org/obo/GO_0048645) (animal organ formation), [GO:0009048](http://purl.obolibrary.org/obo/GO_0009048) (dosage compensation by inactivation of X chromosome), [GO:0048644](http://purl.obolibrary.org/obo/GO_0048644) (muscle organ morphogenesis), [GO:1902723](http://purl.obolibrary.org/obo/GO_1902723) (negative regulation of skeletal muscle satellite cell proliferation), [GO:0090181](http://purl.obolibrary.org/obo/GO_0090181) (regulation of cholesterol metabolic process), [GO:0090190](http://purl.obolibrary.org/obo/GO_0090190) (positive regulation of branching involved in ureteric bud morphogenesis), [GO:0047323](http://purl.obolibrary.org/obo/GO_0047323) ([3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity), [GO:0050968](http://purl.obolibrary.org/obo/GO_0050968) (detection of chemical stimulus involved in sensory perception of pain), [GO:0035307](http://purl.obolibrary.org/obo/GO_0035307) (positive regulation of protein dephosphorylation), [GO:0050966](http://purl.obolibrary.org/obo/GO_0050966) (detection of mechanical stimulus involved in sensory perception of pain), [GO:0098900](http://purl.obolibrary.org/obo/GO_0098900) (regulation of action potential), [GO:0035301](http://purl.obolibrary.org/obo/GO_0035301) (Hedgehog signaling complex), [GO:0050965](http://purl.obolibrary.org/obo/GO_0050965) (detection of temperature stimulus involved in sensory perception of pain), [GO:0035303](http://purl.obolibrary.org/obo/GO_0035303) (regulation of dephosphorylation), [GO:0010025](http://purl.obolibrary.org/obo/GO_0010025) (wax biosynthetic process), [GO:0061630](http://purl.obolibrary.org/obo/GO_0061630) (ubiquitin protein ligase activity), [GO:0009013](http://purl.obolibrary.org/obo/GO_0009013) (succinate-semialdehyde dehydrogenase [NAD(P)+] activity), [GO:0090158](http://purl.obolibrary.org/obo/GO_0090158) (endoplasmic reticulum membrane organization), [GO:0090156](http://purl.obolibrary.org/obo/GO_0090156) (cellular sphingolipid homeostasis), [GO:0090153](http://purl.obolibrary.org/obo/GO_0090153) (regulation of sphingolipid biosynthetic process), [GO:0060306](http://purl.obolibrary.org/obo/GO_0060306) (regulation of membrane repolarization), [GO:0060307](http://purl.obolibrary.org/obo/GO_0060307) (regulation of ventricular cardiac muscle cell membrane repolarization), [GO:0061632](http://purl.obolibrary.org/obo/GO_0061632) (RNA lariat debranching enzyme activator activity), [GO:0090150](http://purl.obolibrary.org/obo/GO_0090150) (establishment of protein localization to membrane), [GO:0060302](http://purl.obolibrary.org/obo/GO_0060302) (negative regulation of cytokine activity), [GO:0009019](http://purl.obolibrary.org/obo/GO_0009019) (tRNA (guanine-N1-)-methyltransferase activity), [GO:0060303](http://purl.obolibrary.org/obo/GO_0060303) (regulation of nucleosome density), [GO:0060304](http://purl.obolibrary.org/obo/GO_0060304) (regulation of phosphatidylinositol dephosphorylation), [GO:0061635](http://purl.obolibrary.org/obo/GO_0061635) (regulation of protein complex stability), [GO:0048659](http://purl.obolibrary.org/obo/GO_0048659) (smooth muscle cell proliferation), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0048660](http://purl.obolibrary.org/obo/GO_0048660) (regulation of smooth muscle cell proliferation), [GO:0048665](http://purl.obolibrary.org/obo/GO_0048665) (neuron fate specification), [GO:0048664](http://purl.obolibrary.org/obo/GO_0048664) (neuron fate determination), [GO:0048663](http://purl.obolibrary.org/obo/GO_0048663) (neuron fate commitment), [GO:0048662](http://purl.obolibrary.org/obo/GO_0048662) (negative regulation of smooth muscle cell proliferation), [GO:0050976](http://purl.obolibrary.org/obo/GO_0050976) (detection of mechanical stimulus involved in sensory perception of touch), [GO:0050973](http://purl.obolibrary.org/obo/GO_0050973) (detection of mechanical stimulus involved in equilibrioception), [GO:0050974](http://purl.obolibrary.org/obo/GO_0050974) (detection of mechanical stimulus involved in sensory perception), [GO:0009020](http://purl.obolibrary.org/obo/GO_0009020) (tRNA (guanosine-2'-O-)-methyltransferase activity), [GO:0090166](http://purl.obolibrary.org/obo/GO_0090166) (Golgi disassembly), [GO:0048669](http://purl.obolibrary.org/obo/GO_0048669) (collateral sprouting in absence of injury), [GO:0061626](http://purl.obolibrary.org/obo/GO_0061626) (pharyngeal arch artery morphogenesis), [GO:0048668](http://purl.obolibrary.org/obo/GO_0048668) (collateral sprouting), [GO:1902741](http://purl.obolibrary.org/obo/GO_1902741) (positive regulation of interferon-alpha secretion), [GO:0048667](http://purl.obolibrary.org/obo/GO_0048667) (cell morphogenesis involved in neuron differentiation), [GO:0090162](http://purl.obolibrary.org/obo/GO_0090162) (establishment of epithelial cell polarity), [GO:0048666](http://purl.obolibrary.org/obo/GO_0048666) (neuron development), [GO:1902742](http://purl.obolibrary.org/obo/GO_1902742) (apoptotic process involved in development), [GO:1902747](http://purl.obolibrary.org/obo/GO_1902747) (negative regulation of lens fiber cell differentiation), [GO:0090160](http://purl.obolibrary.org/obo/GO_0090160) (Golgi to lysosome transport), [GO:0061621](http://purl.obolibrary.org/obo/GO_0061621) (canonical glycolysis), [GO:1902748](http://purl.obolibrary.org/obo/GO_1902748) (positive regulation of lens fiber cell differentiation), [GO:0090161](http://purl.obolibrary.org/obo/GO_0090161) (Golgi ribbon formation), [GO:0061623](http://purl.obolibrary.org/obo/GO_0061623) (glycolytic process from galactose), [GO:0050982](http://purl.obolibrary.org/obo/GO_0050982) (detection of mechanical stimulus), [GO:0048672](http://purl.obolibrary.org/obo/GO_0048672) (positive regulation of collateral sprouting), [GO:0046010](http://purl.obolibrary.org/obo/GO_0046010) (positive regulation of circadian sleep/wake cycle, non-REM sleep), [GO:0048670](http://purl.obolibrary.org/obo/GO_0048670) (regulation of collateral sprouting), [GO:0061629](http://purl.obolibrary.org/obo/GO_0061629) (RNA polymerase II sequence-specific DNA binding transcription factor binding), [GO:0048675](http://purl.obolibrary.org/obo/GO_0048675) (axon extension), [GO:0010008](http://purl.obolibrary.org/obo/GO_0010008) (endosome membrane), [GO:0010002](http://purl.obolibrary.org/obo/GO_0010002) (cardioblast differentiation), [GO:0010001](http://purl.obolibrary.org/obo/GO_0010001) (glial cell differentiation), [GO:0090139](http://purl.obolibrary.org/obo/GO_0090139) (mitochondrial DNA packaging), [GO:0009074](http://purl.obolibrary.org/obo/GO_0009074) (aromatic amino acid family catabolic process), [GO:0050919](http://purl.obolibrary.org/obo/GO_0050919) (negative chemotaxis), [GO:0009072](http://purl.obolibrary.org/obo/GO_0009072) (aromatic amino acid family metabolic process), [GO:0090138](http://purl.obolibrary.org/obo/GO_0090138) (regulation of actin cytoskeleton organization by cell-cell adhesion), [GO:0050917](http://purl.obolibrary.org/obo/GO_0050917) (sensory perception of umami taste), [GO:0050918](http://purl.obolibrary.org/obo/GO_0050918) (positive chemotaxis), [GO:0090136](http://purl.obolibrary.org/obo/GO_0090136) (epithelial cell-cell adhesion), [GO:0050916](http://purl.obolibrary.org/obo/GO_0050916) (sensory perception of sweet taste), [GO:0090131](http://purl.obolibrary.org/obo/GO_0090131) (mesenchyme migration), [GO:0090132](http://purl.obolibrary.org/obo/GO_0090132) (epithelium migration), [GO:0050913](http://purl.obolibrary.org/obo/GO_0050913) (sensory perception of bitter taste), [GO:0050910](http://purl.obolibrary.org/obo/GO_0050910) (detection of mechanical stimulus involved in sensory perception of sound), [GO:0009070](http://purl.obolibrary.org/obo/GO_0009070) (serine family amino acid biosynthetic process), [GO:0035357](http://purl.obolibrary.org/obo/GO_0035357) (peroxisome proliferator activated receptor signaling pathway), [GO:0035359](http://purl.obolibrary.org/obo/GO_0035359) (negative regulation of peroxisome proliferator activated receptor signaling pathway), [GO:0009086](http://purl.obolibrary.org/obo/GO_0009086) (methionine biosynthetic process), [GO:0009085](http://purl.obolibrary.org/obo/GO_0009085) (lysine biosynthetic process), [GO:0048609](http://purl.obolibrary.org/obo/GO_0048609) (multicellular organismal reproductive process), [GO:0090148](http://purl.obolibrary.org/obo/GO_0090148) (membrane fission), [GO:0035354](http://purl.obolibrary.org/obo/GO_0035354) (Toll-like receptor 1-Toll-like receptor 2 protein complex), [GO:0009083](http://purl.obolibrary.org/obo/GO_0009083) (branched-chain amino acid catabolic process), [GO:0048608](http://purl.obolibrary.org/obo/GO_0048608) (reproductive structure development), [GO:0090149](http://purl.obolibrary.org/obo/GO_0090149) (mitochondrial membrane fission), [GO:0009088](http://purl.obolibrary.org/obo/GO_0009088) (threonine biosynthetic process), [GO:0009087](http://purl.obolibrary.org/obo/GO_0009087) (methionine catabolic process), [GO:0050927](http://purl.obolibrary.org/obo/GO_0050927) (positive regulation of positive chemotaxis), [GO:0090140](http://purl.obolibrary.org/obo/GO_0090140) (regulation of mitochondrial fission), [GO:0090141](http://purl.obolibrary.org/obo/GO_0090141) (positive regulation of mitochondrial fission), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0022037](http://purl.obolibrary.org/obo/GO_0022037) (metencephalon development), [GO:0022038](http://purl.obolibrary.org/obo/GO_0022038) (corpus callosum development), [GO:0006801](http://purl.obolibrary.org/obo/GO_0006801) (superoxide metabolic process), [GO:0006807](http://purl.obolibrary.org/obo/GO_0006807) (nitrogen compound metabolic process), [GO:0006805](http://purl.obolibrary.org/obo/GO_0006805) (xenobiotic metabolic process), [GO:0006808](http://purl.obolibrary.org/obo/GO_0006808) (regulation of nitrogen utilization), [GO:0006809](http://purl.obolibrary.org/obo/GO_0006809) (nitric oxide biosynthetic process), [GO:0050921](http://purl.obolibrary.org/obo/GO_0050921) (positive regulation of chemotaxis), [GO:0010042](http://purl.obolibrary.org/obo/GO_0010042) (response to manganese ion), [GO:0009052](http://purl.obolibrary.org/obo/GO_0009052) (pentose-phosphate shunt, non-oxidative branch), [GO:0010044](http://purl.obolibrary.org/obo/GO_0010044) (response to aluminum ion), [GO:0090116](http://purl.obolibrary.org/obo/GO_0090116) (C-5 methylation of cytosine), [GO:0010043](http://purl.obolibrary.org/obo/GO_0010043) (response to zinc ion), [GO:0090114](http://purl.obolibrary.org/obo/GO_0090114) (COPII-coated vesicle budding), [GO:0009055](http://purl.obolibrary.org/obo/GO_0009055) (electron transfer activity), [GO:0050938](http://purl.obolibrary.org/obo/GO_0050938) (regulation of xanthophore differentiation), [GO:0022028](http://purl.obolibrary.org/obo/GO_0022028) (tangential migration from the subventricular zone to the olfactory bulb), [GO:0090110](http://purl.obolibrary.org/obo/GO_0090110) (cargo loading into COPII-coated vesicle), [GO:0022029](http://purl.obolibrary.org/obo/GO_0022029) (telencephalon cell migration), [GO:0009058](http://purl.obolibrary.org/obo/GO_0009058) (biosynthetic process), [GO:0048618](http://purl.obolibrary.org/obo/GO_0048618) (post-embryonic foregut morphogenesis), [GO:0048617](http://purl.obolibrary.org/obo/GO_0048617) (embryonic foregut morphogenesis), [GO:0022027](http://purl.obolibrary.org/obo/GO_0022027) (interkinetic nuclear migration), [GO:0050935](http://purl.obolibrary.org/obo/GO_0050935) (iridophore differentiation), [GO:0010039](http://purl.obolibrary.org/obo/GO_0010039) (response to iron ion), [GO:0035338](http://purl.obolibrary.org/obo/GO_0035338) (long-chain fatty-acyl-CoA biosynthetic process), [GO:0010038](http://purl.obolibrary.org/obo/GO_0010038) (response to metal ion), [GO:0050936](http://purl.obolibrary.org/obo/GO_0050936) (xanthophore differentiation), [GO:0035339](http://purl.obolibrary.org/obo/GO_0035339) (SPOTS complex), [GO:0010035](http://purl.obolibrary.org/obo/GO_0010035) (response to inorganic substance), [GO:0050931](http://purl.obolibrary.org/obo/GO_0050931) (pigment cell differentiation), [GO:0035335](http://purl.obolibrary.org/obo/GO_0035335) (peptidyl-tyrosine dephosphorylation), [GO:0035336](http://purl.obolibrary.org/obo/GO_0035336) (long-chain fatty-acyl-CoA metabolic process), [GO:0050930](http://purl.obolibrary.org/obo/GO_0050930) (induction of positive chemotaxis), [GO:0035330](http://purl.obolibrary.org/obo/GO_0035330) (regulation of hippo signaling), [GO:0090129](http://purl.obolibrary.org/obo/GO_0090129) (positive regulation of synapse maturation), [GO:0035332](http://purl.obolibrary.org/obo/GO_0035332) (positive regulation of hippo signaling), [GO:0009062](http://purl.obolibrary.org/obo/GO_0009062) (fatty acid catabolic process), [GO:0009061](http://purl.obolibrary.org/obo/GO_0009061) (anaerobic respiration), [GO:0009069](http://purl.obolibrary.org/obo/GO_0009069) (serine family amino acid metabolic process), [GO:0035327](http://purl.obolibrary.org/obo/GO_0035327) (transcriptionally active chromatin), [GO:0035329](http://purl.obolibrary.org/obo/GO_0035329) (hippo signaling), [GO:0009060](http://purl.obolibrary.org/obo/GO_0009060) (aerobic respiration), [GO:0010045](http://purl.obolibrary.org/obo/GO_0010045) (response to nickel cation), [GO:0035325](http://purl.obolibrary.org/obo/GO_0035325) (Toll-like receptor binding), [GO:0035326](http://purl.obolibrary.org/obo/GO_0035326) (enhancer binding), [GO:0060484](http://purl.obolibrary.org/obo/GO_0060484) (lung-associated mesenchyme development), [GO:0060486](http://purl.obolibrary.org/obo/GO_0060486) (Clara cell differentiation), [GO:0060487](http://purl.obolibrary.org/obo/GO_0060487) (lung epithelial cell differentiation), [GO:1901341](http://purl.obolibrary.org/obo/GO_1901341) (positive regulation of store-operated calcium channel activity), [GO:0034198](http://purl.obolibrary.org/obo/GO_0034198) (cellular response to amino acid starvation), [GO:0034197](http://purl.obolibrary.org/obo/GO_0034197) (triglyceride transport), [GO:0004300](http://purl.obolibrary.org/obo/GO_0004300) (enoyl-CoA hydratase activity), [GO:0060488](http://purl.obolibrary.org/obo/GO_0060488) (orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis), [GO:1900017](http://purl.obolibrary.org/obo/GO_1900017) (positive regulation of cytokine production involved in inflammatory response), [GO:0034191](http://purl.obolibrary.org/obo/GO_0034191) (apolipoprotein A-I receptor binding), [GO:0060489](http://purl.obolibrary.org/obo/GO_0060489) (planar dichotomous subdivision of terminal units involved in lung branching morphogenesis), [GO:0006956](http://purl.obolibrary.org/obo/GO_0006956) (complement activation), [GO:0046185](http://purl.obolibrary.org/obo/GO_0046185) (aldehyde catabolic process), [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell), [GO:0046186](http://purl.obolibrary.org/obo/GO_0046186) (acetaldehyde biosynthetic process), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0005628](http://purl.obolibrary.org/obo/GO_0005628) (prospore membrane), [GO:0006959](http://purl.obolibrary.org/obo/GO_0006959) (humoral immune response), [GO:0060490](http://purl.obolibrary.org/obo/GO_0060490) (lateral sprouting involved in lung morphogenesis), [GO:0034185](http://purl.obolibrary.org/obo/GO_0034185) (apolipoprotein binding), [GO:0034184](http://purl.obolibrary.org/obo/GO_0034184) (positive regulation of maintenance of mitotic sister chromatid cohesion), [GO:0034188](http://purl.obolibrary.org/obo/GO_0034188) (apolipoprotein A-I receptor activity), [GO:0060471](http://purl.obolibrary.org/obo/GO_0060471) (cortical granule exocytosis), [GO:0034186](http://purl.obolibrary.org/obo/GO_0034186) (apolipoprotein A-I binding), [GO:0006970](http://purl.obolibrary.org/obo/GO_0006970) (response to osmotic stress), [GO:1900025](http://purl.obolibrary.org/obo/GO_1900025) (negative regulation of substrate adhesion-dependent cell spreading), [GO:0006971](http://purl.obolibrary.org/obo/GO_0006971) (hypotonic response), [GO:0005640](http://purl.obolibrary.org/obo/GO_0005640) (nuclear outer membrane), [GO:1902686](http://purl.obolibrary.org/obo/GO_1902686) (mitochondrial outer membrane permeabilization involved in programmed cell death), [GO:1900027](http://purl.obolibrary.org/obo/GO_1900027) (regulation of ruffle assembly), [GO:1900026](http://purl.obolibrary.org/obo/GO_1900026) (positive regulation of substrate adhesion-dependent cell spreading), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0004311](http://purl.obolibrary.org/obo/GO_0004311) (farnesyltranstransferase activity), [GO:1900029](http://purl.obolibrary.org/obo/GO_1900029) (positive regulation of ruffle assembly), [GO:0005642](http://purl.obolibrary.org/obo/GO_0005642) (annulate lamellae), [GO:1900028](http://purl.obolibrary.org/obo/GO_1900028) (negative regulation of ruffle assembly), [GO:0005641](http://purl.obolibrary.org/obo/GO_0005641) (nuclear envelope lumen), [GO:0006975](http://purl.obolibrary.org/obo/GO_0006975) (DNA damage induced protein phosphorylation), [GO:0006972](http://purl.obolibrary.org/obo/GO_0006972) (hyperosmotic response), [GO:0005643](http://purl.obolibrary.org/obo/GO_0005643) (nuclear pore), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0031901](http://purl.obolibrary.org/obo/GO_0031901) (early endosome membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031902](http://purl.obolibrary.org/obo/GO_0031902) (late endosome membrane), [GO:0006968](http://purl.obolibrary.org/obo/GO_0006968) (cellular defense response), [GO:0004303](http://purl.obolibrary.org/obo/GO_0004303) (estradiol 17-beta-dehydrogenase activity), [GO:0005637](http://purl.obolibrary.org/obo/GO_0005637) (nuclear inner membrane), [GO:0004305](http://purl.obolibrary.org/obo/GO_0004305) (ethanolamine kinase activity), [GO:0005639](http://purl.obolibrary.org/obo/GO_0005639) (integral component of nuclear inner membrane), [GO:0004308](http://purl.obolibrary.org/obo/GO_0004308) (exo-alpha-sialidase activity), [GO:0005638](http://purl.obolibrary.org/obo/GO_0005638) (lamin filament), [GO:0004309](http://purl.obolibrary.org/obo/GO_0004309) (exopolyphosphatase activity), [GO:0043923](http://purl.obolibrary.org/obo/GO_0043923) (positive regulation by host of viral transcription), [GO:1902692](http://purl.obolibrary.org/obo/GO_1902692) (regulation of neuroblast proliferation), [GO:0043928](http://purl.obolibrary.org/obo/GO_0043928) (exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay), [GO:1900037](http://purl.obolibrary.org/obo/GO_1900037) (regulation of cellular response to hypoxia), [GO:0006941](http://purl.obolibrary.org/obo/GO_0006941) (striated muscle contraction), [GO:0006942](http://purl.obolibrary.org/obo/GO_0006942) (regulation of striated muscle contraction), [GO:0006940](http://purl.obolibrary.org/obo/GO_0006940) (regulation of smooth muscle contraction), [GO:0006935](http://purl.obolibrary.org/obo/GO_0006935) (chemotaxis), [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane), [GO:2001108](http://purl.obolibrary.org/obo/GO_2001108) (positive regulation of Rho guanyl-nucleotide exchange factor activity), [GO:0005605](http://purl.obolibrary.org/obo/GO_0005605) (basal lamina), [GO:0071157](http://purl.obolibrary.org/obo/GO_0071157) (negative regulation of cell cycle arrest), [GO:0006936](http://purl.obolibrary.org/obo/GO_0006936) (muscle contraction), [GO:0006937](http://purl.obolibrary.org/obo/GO_0006937) (regulation of muscle contraction), [GO:0097745](http://purl.obolibrary.org/obo/GO_0097745) (mitochondrial tRNA 5'-end processing), [GO:0071158](http://purl.obolibrary.org/obo/GO_0071158) (positive regulation of cell cycle arrest), [GO:2001107](http://purl.obolibrary.org/obo/GO_2001107) (negative regulation of Rho guanyl-nucleotide exchange factor activity), [GO:0097749](http://purl.obolibrary.org/obo/GO_0097749) (membrane tubulation), [GO:0043934](http://purl.obolibrary.org/obo/GO_0043934) (sporulation), [GO:0034162](http://purl.obolibrary.org/obo/GO_0034162) (toll-like receptor 9 signaling pathway), [GO:0035497](http://purl.obolibrary.org/obo/GO_0035497) (cAMP response element binding), [GO:0042605](http://purl.obolibrary.org/obo/GO_0042605) (peptide antigen binding), [GO:1900042](http://purl.obolibrary.org/obo/GO_1900042) (positive regulation of interleukin-2 secretion), [GO:1901373](http://purl.obolibrary.org/obo/GO_1901373) (lipid hydroperoxide transport), [GO:0034166](http://purl.obolibrary.org/obo/GO_0034166) (toll-like receptor 10 signaling pathway), [GO:0035493](http://purl.obolibrary.org/obo/GO_0035493) (SNARE complex assembly), [GO:0042609](http://purl.obolibrary.org/obo/GO_0042609) (CD4 receptor binding), [GO:1901379](http://purl.obolibrary.org/obo/GO_1901379) (regulation of potassium ion transmembrane transport), [GO:0006952](http://purl.obolibrary.org/obo/GO_0006952) (defense response), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0006950](http://purl.obolibrary.org/obo/GO_0006950) (response to stress), [GO:0043931](http://purl.obolibrary.org/obo/GO_0043931) (ossification involved in bone maturation), [GO:0071141](http://purl.obolibrary.org/obo/GO_0071141) (SMAD protein complex), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005614](http://purl.obolibrary.org/obo/GO_0005614) (interstitial matrix), [GO:0097755](http://purl.obolibrary.org/obo/GO_0097755) (positive regulation of blood vessel diameter), [GO:0071149](http://purl.obolibrary.org/obo/GO_0071149) (TEAD-2-YAP complex), [GO:0097756](http://purl.obolibrary.org/obo/GO_0097756) (negative regulation of blood vessel diameter), [GO:0071148](http://purl.obolibrary.org/obo/GO_0071148) (TEAD-1-YAP complex), [GO:2001111](http://purl.obolibrary.org/obo/GO_2001111) (positive regulation of lens epithelial cell proliferation), [GO:0060440](http://purl.obolibrary.org/obo/GO_0060440) (trachea formation), [GO:0016327](http://purl.obolibrary.org/obo/GO_0016327) (apicolateral plasma membrane), [GO:0060441](http://purl.obolibrary.org/obo/GO_0060441) (epithelial tube branching involved in lung morphogenesis), [GO:0016328](http://purl.obolibrary.org/obo/GO_0016328) (lateral plasma membrane), [GO:0060442](http://purl.obolibrary.org/obo/GO_0060442) (branching involved in prostate gland morphogenesis), [GO:1902630](http://purl.obolibrary.org/obo/GO_1902630) (regulation of membrane hyperpolarization), [GO:0004340](http://purl.obolibrary.org/obo/GO_0004340) (glucokinase activity), [GO:0060449](http://purl.obolibrary.org/obo/GO_0060449) (bud elongation involved in lung branching), [GO:0048798](http://purl.obolibrary.org/obo/GO_0048798) (swim bladder inflation), [GO:0003011](http://purl.obolibrary.org/obo/GO_0003011) (involuntary skeletal muscle contraction), [GO:0003012](http://purl.obolibrary.org/obo/GO_0003012) (muscle system process), [GO:0060444](http://purl.obolibrary.org/obo/GO_0060444) (branching involved in mammary gland duct morphogenesis), [GO:0005675](http://purl.obolibrary.org/obo/GO_0005675) (holo TFIIH complex), [GO:0060445](http://purl.obolibrary.org/obo/GO_0060445) (branching involved in salivary gland morphogenesis), [GO:0003014](http://purl.obolibrary.org/obo/GO_0003014) (renal system process), [GO:0005677](http://purl.obolibrary.org/obo/GO_0005677) (chromatin silencing complex), [GO:0060447](http://purl.obolibrary.org/obo/GO_0060447) (bud outgrowth involved in lung branching), [GO:1902636](http://purl.obolibrary.org/obo/GO_1902636) (kinociliary basal body), [GO:0031956](http://purl.obolibrary.org/obo/GO_0031956) (medium-chain fatty acid-CoA ligase activity), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0030623](http://purl.obolibrary.org/obo/GO_0030623) (U5 snRNA binding), [GO:0004336](http://purl.obolibrary.org/obo/GO_0004336) (galactosylceramidase activity), [GO:0031957](http://purl.obolibrary.org/obo/GO_0031957) (very long-chain fatty acid-CoA ligase activity), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0031954](http://purl.obolibrary.org/obo/GO_0031954) (positive regulation of protein autophosphorylation), [GO:0006998](http://purl.obolibrary.org/obo/GO_0006998) (nuclear envelope organization), [GO:1903959](http://purl.obolibrary.org/obo/GO_1903959) (regulation of anion transmembrane transport), [GO:0006999](http://purl.obolibrary.org/obo/GO_0006999) (nuclear pore organization), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0003009](http://purl.obolibrary.org/obo/GO_0003009) (skeletal muscle contraction), [GO:0030628](http://purl.obolibrary.org/obo/GO_0030628) (pre-mRNA 3'-splice site binding), [GO:0046146](http://purl.obolibrary.org/obo/GO_0046146) (tetrahydrobiopterin metabolic process), [GO:0016331](http://purl.obolibrary.org/obo/GO_0016331) (morphogenesis of embryonic epithelium), [GO:0072423](http://purl.obolibrary.org/obo/GO_0072423) (response to DNA damage checkpoint signaling), [GO:0030620](http://purl.obolibrary.org/obo/GO_0030620) (U2 snRNA binding), [GO:0031952](http://purl.obolibrary.org/obo/GO_0031952) (regulation of protein autophosphorylation), [GO:0030622](http://purl.obolibrary.org/obo/GO_0030622) (U4atac snRNA binding), [GO:0030621](http://purl.obolibrary.org/obo/GO_0030621) (U4 snRNA binding), [GO:2001141](http://purl.obolibrary.org/obo/GO_2001141) (regulation of RNA biosynthetic process), [GO:0060430](http://purl.obolibrary.org/obo/GO_0060430) (lung saccule development), [GO:0061762](http://purl.obolibrary.org/obo/GO_0061762) (CAMKK-AMPK signaling cascade), [GO:0015002](http://purl.obolibrary.org/obo/GO_0015002) (heme-copper terminal oxidase activity), [GO:0005682](http://purl.obolibrary.org/obo/GO_0005682) (U5 snRNP), [GO:0060437](http://purl.obolibrary.org/obo/GO_0060437) (lung growth), [GO:0004351](http://purl.obolibrary.org/obo/GO_0004351) (glutamate decarboxylase activity), [GO:0060438](http://purl.obolibrary.org/obo/GO_0060438) (trachea development), [GO:0005681](http://purl.obolibrary.org/obo/GO_0005681) (spliceosomal complex), [GO:0004350](http://purl.obolibrary.org/obo/GO_0004350) (glutamate-5-semialdehyde dehydrogenase activity), [GO:1903976](http://purl.obolibrary.org/obo/GO_1903976) (negative regulation of glial cell migration), [GO:0004353](http://purl.obolibrary.org/obo/GO_0004353) (glutamate dehydrogenase [NAD(P)+] activity), [GO:0060439](http://purl.obolibrary.org/obo/GO_0060439) (trachea morphogenesis), [GO:0004352](http://purl.obolibrary.org/obo/GO_0004352) (glutamate dehydrogenase (NAD+) activity), [GO:0005686](http://purl.obolibrary.org/obo/GO_0005686) (U2 snRNP), [GO:0060433](http://purl.obolibrary.org/obo/GO_0060433) (bronchus development), [GO:0005685](http://purl.obolibrary.org/obo/GO_0005685) (U1 snRNP), [GO:0005687](http://purl.obolibrary.org/obo/GO_0005687) (U4 snRNP), [GO:0004356](http://purl.obolibrary.org/obo/GO_0004356) (glutamate-ammonia ligase activity), [GO:0003016](http://purl.obolibrary.org/obo/GO_0003016) (respiratory system process), [GO:0004348](http://purl.obolibrary.org/obo/GO_0004348) (glucosylceramidase activity), [GO:0047484](http://purl.obolibrary.org/obo/GO_0047484) (regulation of response to osmotic stress), [GO:0031943](http://purl.obolibrary.org/obo/GO_0031943) (regulation of glucocorticoid metabolic process), [GO:0004349](http://purl.obolibrary.org/obo/GO_0004349) (glutamate 5-kinase activity), [GO:0097731](http://purl.obolibrary.org/obo/GO_0097731) (9+0 non-motile cilium), [GO:0097730](http://purl.obolibrary.org/obo/GO_0097730) (non-motile cilium), [GO:0030619](http://purl.obolibrary.org/obo/GO_0030619) (U1 snRNA binding), [GO:0046154](http://purl.obolibrary.org/obo/GO_0046154) (rhodopsin metabolic process), [GO:0097733](http://purl.obolibrary.org/obo/GO_0097733) (photoreceptor cell cilium), [GO:0047485](http://purl.obolibrary.org/obo/GO_0047485) (protein N-terminus binding), [GO:0031941](http://purl.obolibrary.org/obo/GO_0031941) (filamentous actin), [GO:0016322](http://purl.obolibrary.org/obo/GO_0016322) (neuron remodeling), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0031942](http://purl.obolibrary.org/obo/GO_0031942) (i-AAA complex), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:2001135](http://purl.obolibrary.org/obo/GO_2001135) (regulation of endocytic recycling), [GO:0060463](http://purl.obolibrary.org/obo/GO_0060463) (lung lobe morphogenesis), [GO:0016307](http://purl.obolibrary.org/obo/GO_0016307) (phosphatidylinositol phosphate kinase activity), [GO:0016308](http://purl.obolibrary.org/obo/GO_0016308) (1-phosphatidylinositol-4-phosphate 5-kinase activity), [GO:0060460](http://purl.obolibrary.org/obo/GO_0060460) (left lung morphogenesis), [GO:1903980](http://purl.obolibrary.org/obo/GO_1903980) (positive regulation of microglial cell activation), [GO:1903984](http://purl.obolibrary.org/obo/GO_1903984) (positive regulation of TRAIL-activated apoptotic signaling pathway), [GO:0004322](http://purl.obolibrary.org/obo/GO_0004322) (ferroxidase activity), [GO:0060466](http://purl.obolibrary.org/obo/GO_0060466) (activation of meiosis involved in egg activation), [GO:0061798](http://purl.obolibrary.org/obo/GO_0061798) (GTP 3',8'-cyclase activity), [GO:0006986](http://purl.obolibrary.org/obo/GO_0006986) (response to unfolded protein), [GO:0005652](http://purl.obolibrary.org/obo/GO_0005652) (nuclear lamina), [GO:0061799](http://purl.obolibrary.org/obo/GO_0061799) (cyclic pyranopterin monophosphate synthase activity), [GO:0006983](http://purl.obolibrary.org/obo/GO_0006983) (ER overload response), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0006979](http://purl.obolibrary.org/obo/GO_0006979) (response to oxidative stress), [GO:0031932](http://purl.obolibrary.org/obo/GO_0031932) (TORC2 complex), [GO:0006977](http://purl.obolibrary.org/obo/GO_0006977) (DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest), [GO:0047499](http://purl.obolibrary.org/obo/GO_0047499) (calcium-independent phospholipase A2 activity), [GO:0031938](http://purl.obolibrary.org/obo/GO_0031938) (regulation of chromatin silencing at telomere), [GO:0031939](http://purl.obolibrary.org/obo/GO_0031939) (negative regulation of chromatin silencing at telomere), [GO:0047497](http://purl.obolibrary.org/obo/GO_0047497) (mitochondrion transport along microtubule), [GO:0031936](http://purl.obolibrary.org/obo/GO_0031936) (negative regulation of chromatin silencing), [GO:0046166](http://purl.obolibrary.org/obo/GO_0046166) (glyceraldehyde-3-phosphate biosynthetic process), [GO:0047496](http://purl.obolibrary.org/obo/GO_0047496) (vesicle transport along microtubule), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0031930](http://purl.obolibrary.org/obo/GO_0031930) (mitochondria-nucleus signaling pathway), [GO:0031931](http://purl.obolibrary.org/obo/GO_0031931) (TORC1 complex), [GO:0016314](http://purl.obolibrary.org/obo/GO_0016314) (phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity), [GO:0060459](http://purl.obolibrary.org/obo/GO_0060459) (left lung development), [GO:0031929](http://purl.obolibrary.org/obo/GO_0031929) (TOR signaling), [GO:0005662](http://purl.obolibrary.org/obo/GO_0005662) (DNA replication factor A complex), [GO:1900004](http://purl.obolibrary.org/obo/GO_1900004) (negative regulation of serine-type endopeptidase activity), [GO:0004333](http://purl.obolibrary.org/obo/GO_0004333) (fumarate hydratase activity), [GO:0005664](http://purl.obolibrary.org/obo/GO_0005664) (nuclear origin of replication recognition complex), [GO:0006996](http://purl.obolibrary.org/obo/GO_0006996) (organelle organization), [GO:0006997](http://purl.obolibrary.org/obo/GO_0006997) (nucleus organization), [GO:0003002](http://purl.obolibrary.org/obo/GO_0003002) (regionalization), [GO:0005666](http://purl.obolibrary.org/obo/GO_0005666) (DNA-directed RNA polymerase III complex), [GO:0004335](http://purl.obolibrary.org/obo/GO_0004335) (galactokinase activity), [GO:1901339](http://purl.obolibrary.org/obo/GO_1901339) (regulation of store-operated calcium channel activity), [GO:0060458](http://purl.obolibrary.org/obo/GO_0060458) (right lung development), [GO:0006995](http://purl.obolibrary.org/obo/GO_0006995) (cellular response to nitrogen starvation), [GO:1902669](http://purl.obolibrary.org/obo/GO_1902669) (positive regulation of axon guidance), [GO:0004334](http://purl.obolibrary.org/obo/GO_0004334) (fumarylacetoacetase activity), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0005656](http://purl.obolibrary.org/obo/GO_0005656) (nuclear pre-replicative complex), [GO:0006987](http://purl.obolibrary.org/obo/GO_0006987) (activation of signaling protein activity involved in unfolded protein response), [GO:0005658](http://purl.obolibrary.org/obo/GO_0005658) (alpha DNA polymerase:primase complex), [GO:0004329](http://purl.obolibrary.org/obo/GO_0004329) (formate-tetrahydrofolate ligase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0097718](http://purl.obolibrary.org/obo/GO_0097718) (disordered domain specific binding), [GO:0016303](http://purl.obolibrary.org/obo/GO_0016303) (1-phosphatidylinositol-3-kinase activity), [GO:0015036](http://purl.obolibrary.org/obo/GO_0015036) (disulfide oxidoreductase activity), [GO:0015035](http://purl.obolibrary.org/obo/GO_0015035) (protein disulfide oxidoreductase activity), [GO:1900095](http://purl.obolibrary.org/obo/GO_1900095) (regulation of dosage compensation by inactivation of X chromosome), [GO:2001170](http://purl.obolibrary.org/obo/GO_2001170) (negative regulation of ATP biosynthetic process), [GO:0004382](http://purl.obolibrary.org/obo/GO_0004382) (guanosine-diphosphatase activity), [GO:2001171](http://purl.obolibrary.org/obo/GO_2001171) (positive regulation of ATP biosynthetic process), [GO:0039003](http://purl.obolibrary.org/obo/GO_0039003) (pronephric field specification), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0015030](http://purl.obolibrary.org/obo/GO_0015030) (Cajal body), [GO:0004383](http://purl.obolibrary.org/obo/GO_0004383) (guanylate cyclase activity), [GO:0004386](http://purl.obolibrary.org/obo/GO_0004386) (helicase activity), [GO:0004385](http://purl.obolibrary.org/obo/GO_0004385) (guanylate kinase activity), [GO:0003056](http://purl.obolibrary.org/obo/GO_0003056) (regulation of vascular smooth muscle contraction), [GO:0043985](http://purl.obolibrary.org/obo/GO_0043985) (histone H4-R3 methylation), [GO:0043984](http://purl.obolibrary.org/obo/GO_0043984) (histone H4-K16 acetylation), [GO:0043987](http://purl.obolibrary.org/obo/GO_0043987) (histone H3-S10 phosphorylation), [GO:0030667](http://purl.obolibrary.org/obo/GO_0030667) (secretory granule membrane), [GO:0031998](http://purl.obolibrary.org/obo/GO_0031998) (regulation of fatty acid beta-oxidation), [GO:0031999](http://purl.obolibrary.org/obo/GO_0031999) (negative regulation of fatty acid beta-oxidation), [GO:0030669](http://purl.obolibrary.org/obo/GO_0030669) (clathrin-coated endocytic vesicle membrane), [GO:0030660](http://purl.obolibrary.org/obo/GO_0030660) (Golgi-associated vesicle membrane), [GO:0031996](http://purl.obolibrary.org/obo/GO_0031996) (thioesterase binding), [GO:0030665](http://purl.obolibrary.org/obo/GO_0030665) (clathrin-coated vesicle membrane), [GO:2001184](http://purl.obolibrary.org/obo/GO_2001184) (positive regulation of interleukin-12 secretion), [GO:2001186](http://purl.obolibrary.org/obo/GO_2001186) (negative regulation of CD8-positive, alpha-beta T cell activation), [GO:0040001](http://purl.obolibrary.org/obo/GO_0040001) (establishment of mitotic spindle localization), [GO:0042660](http://purl.obolibrary.org/obo/GO_0042660) (positive regulation of cell fate specification), [GO:0043991](http://purl.obolibrary.org/obo/GO_0043991) (histone H2B-S14 phosphorylation), [GO:0004396](http://purl.obolibrary.org/obo/GO_0004396) (hexokinase activity), [GO:0042664](http://purl.obolibrary.org/obo/GO_0042664) (negative regulation of endodermal cell fate specification), [GO:0043996](http://purl.obolibrary.org/obo/GO_0043996) (histone acetyltransferase activity (H4-K8 specific)), [GO:0040008](http://purl.obolibrary.org/obo/GO_0040008) (regulation of growth), [GO:0043995](http://purl.obolibrary.org/obo/GO_0043995) (histone acetyltransferase activity (H4-K5 specific)), [GO:0040007](http://purl.obolibrary.org/obo/GO_0040007) (growth), [GO:0031987](http://purl.obolibrary.org/obo/GO_0031987) (locomotion involved in locomotory behavior), [GO:0030659](http://purl.obolibrary.org/obo/GO_0030659) (cytoplasmic vesicle membrane), [GO:0030658](http://purl.obolibrary.org/obo/GO_0030658) (transport vesicle membrane), [GO:0042670](http://purl.obolibrary.org/obo/GO_0042670) (retinal cone cell differentiation), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0016363](http://purl.obolibrary.org/obo/GO_0016363) (nuclear matrix), [GO:0031985](http://purl.obolibrary.org/obo/GO_0031985) (Golgi cisterna), [GO:2001178](http://purl.obolibrary.org/obo/GO_2001178) (positive regulation of mediator complex assembly), [GO:0040016](http://purl.obolibrary.org/obo/GO_0040016) (embryonic cleavage), [GO:0015016](http://purl.obolibrary.org/obo/GO_0015016) ([heparan sulfate]-glucosamine N-sulfotransferase activity), [GO:0040015](http://purl.obolibrary.org/obo/GO_0040015) (negative regulation of multicellular organism growth), [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0015014](http://purl.obolibrary.org/obo/GO_0015014) (heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process), [GO:0040012](http://purl.obolibrary.org/obo/GO_0040012) (regulation of locomotion), [GO:0015012](http://purl.obolibrary.org/obo/GO_0015012) (heparan sulfate proteoglycan biosynthetic process), [GO:0040011](http://purl.obolibrary.org/obo/GO_0040011) (locomotion), [GO:0004360](http://purl.obolibrary.org/obo/GO_0004360) (glutamine-fructose-6-phosphate transaminase (isomerizing) activity), [GO:0005690](http://purl.obolibrary.org/obo/GO_0005690) (U4atac snRNP), [GO:0004361](http://purl.obolibrary.org/obo/GO_0004361) (glutaryl-CoA dehydrogenase activity), [GO:0004364](http://purl.obolibrary.org/obo/GO_0004364) (glutathione transferase activity), [GO:0005694](http://purl.obolibrary.org/obo/GO_0005694) (chromosome), [GO:0005697](http://purl.obolibrary.org/obo/GO_0005697) (telomerase holoenzyme complex), [GO:0040019](http://purl.obolibrary.org/obo/GO_0040019) (positive regulation of embryonic development), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0040017](http://purl.obolibrary.org/obo/GO_0040017) (positive regulation of locomotion), [GO:0003029](http://purl.obolibrary.org/obo/GO_0003029) (detection of hypoxic conditions in blood by carotid body chemoreceptor signaling), [GO:0030644](http://purl.obolibrary.org/obo/GO_0030644) (cellular chloride ion homeostasis), [GO:0016358](http://purl.obolibrary.org/obo/GO_0016358) (dendrite development), [GO:0030643](http://purl.obolibrary.org/obo/GO_0030643) (cellular phosphate ion homeostasis), [GO:0040020](http://purl.obolibrary.org/obo/GO_0040020) (regulation of meiotic nuclear division), [GO:0015020](http://purl.obolibrary.org/obo/GO_0015020) (glucuronosyltransferase activity), [GO:0004375](http://purl.obolibrary.org/obo/GO_0004375) (glycine dehydrogenase (decarboxylating) activity), [GO:0004377](http://purl.obolibrary.org/obo/GO_0004377) (GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity), [GO:0004376](http://purl.obolibrary.org/obo/GO_0004376) (glycolipid mannosyltransferase activity), [GO:0040029](http://purl.obolibrary.org/obo/GO_0040029) (regulation of gene expression, epigenetic), [GO:0004378](http://purl.obolibrary.org/obo/GO_0004378) (GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane), [GO:0042692](http://purl.obolibrary.org/obo/GO_0042692) (muscle cell differentiation), [GO:0016340](http://purl.obolibrary.org/obo/GO_0016340) (calcium-dependent cell-matrix adhesion), [GO:0016342](http://purl.obolibrary.org/obo/GO_0016342) (catenin complex), [GO:0015019](http://purl.obolibrary.org/obo/GO_0015019) (heparan-alpha-glucosaminide N-acetyltransferase activity), [GO:0042613](http://purl.obolibrary.org/obo/GO_0042613) (MHC class II protein complex), [GO:1901381](http://purl.obolibrary.org/obo/GO_1901381) (positive regulation of potassium ion transmembrane transport), [GO:1900050](http://purl.obolibrary.org/obo/GO_1900050) (negative regulation of histone exchange), [GO:1900052](http://purl.obolibrary.org/obo/GO_1900052) (regulation of retinoic acid biosynthetic process), [GO:0003091](http://purl.obolibrary.org/obo/GO_0003091) (renal water homeostasis), [GO:0015079](http://purl.obolibrary.org/obo/GO_0015079) (potassium ion transmembrane transporter activity), [GO:0015078](http://purl.obolibrary.org/obo/GO_0015078) (hydrogen ion transmembrane transporter activity), [GO:1901385](http://purl.obolibrary.org/obo/GO_1901385) (regulation of voltage-gated calcium channel activity), [GO:0043949](http://purl.obolibrary.org/obo/GO_0043949) (regulation of cAMP-mediated signaling), [GO:0003093](http://purl.obolibrary.org/obo/GO_0003093) (regulation of glomerular filtration), [GO:1900053](http://purl.obolibrary.org/obo/GO_1900053) (negative regulation of retinoic acid biosynthetic process), [GO:0000815](http://purl.obolibrary.org/obo/GO_0000815) (ESCRT III complex), [GO:0003094](http://purl.obolibrary.org/obo/GO_0003094) (glomerular filtration), [GO:0015075](http://purl.obolibrary.org/obo/GO_0015075) (ion transmembrane transporter activity), [GO:1901386](http://purl.obolibrary.org/obo/GO_1901386) (negative regulation of voltage-gated calcium channel activity), [GO:0000813](http://purl.obolibrary.org/obo/GO_0000813) (ESCRT I complex), [GO:0000812](http://purl.obolibrary.org/obo/GO_0000812) (Swr1 complex), [GO:0071174](http://purl.obolibrary.org/obo/GO_0071174) (mitotic spindle checkpoint), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron), [GO:0015087](http://purl.obolibrary.org/obo/GO_0015087) (cobalt ion transmembrane transporter activity), [GO:0015086](http://purl.obolibrary.org/obo/GO_0015086) (cadmium ion transmembrane transporter activity), [GO:0015085](http://purl.obolibrary.org/obo/GO_0015085) (calcium ion transmembrane transporter activity), [GO:0000822](http://purl.obolibrary.org/obo/GO_0000822) (inositol hexakisphosphate binding), [GO:0042622](http://purl.obolibrary.org/obo/GO_0042622) (photoreceptor outer segment membrane), [GO:0042623](http://purl.obolibrary.org/obo/GO_0042623) (ATPase activity, coupled), [GO:0071162](http://purl.obolibrary.org/obo/GO_0071162) (CMG complex), [GO:0071168](http://purl.obolibrary.org/obo/GO_0071168) (protein localization to chromatin), [GO:0071166](http://purl.obolibrary.org/obo/GO_0071166) (ribonucleoprotein complex localization), [GO:0030695](http://purl.obolibrary.org/obo/GO_0030695) (GTPase regulator activity), [GO:0071169](http://purl.obolibrary.org/obo/GO_0071169) (establishment of protein localization to chromatin), [GO:0043967](http://purl.obolibrary.org/obo/GO_0043967) (histone H4 acetylation), [GO:0043966](http://purl.obolibrary.org/obo/GO_0043966) (histone H3 acetylation), [GO:0039023](http://purl.obolibrary.org/obo/GO_0039023) (pronephric duct morphogenesis), [GO:0039022](http://purl.obolibrary.org/obo/GO_0039022) (pronephric duct development), [GO:1900075](http://purl.obolibrary.org/obo/GO_1900075) (positive regulation of neuromuscular synaptic transmission), [GO:0003073](http://purl.obolibrary.org/obo/GO_0003073) (regulation of systemic arterial blood pressure), [GO:0039021](http://purl.obolibrary.org/obo/GO_0039021) (pronephric glomerulus development), [GO:0042632](http://purl.obolibrary.org/obo/GO_0042632) (cholesterol homeostasis), [GO:0042633](http://purl.obolibrary.org/obo/GO_0042633) (hair cycle), [GO:0042634](http://purl.obolibrary.org/obo/GO_0042634) (regulation of hair cycle), [GO:0030686](http://purl.obolibrary.org/obo/GO_0030686) (90S preribosome), [GO:0030687](http://purl.obolibrary.org/obo/GO_0030687) (preribosome, large subunit precursor), [GO:0000808](http://purl.obolibrary.org/obo/GO_0000808) (origin recognition complex), [GO:0015068](http://purl.obolibrary.org/obo/GO_0015068) (glycine amidinotransferase activity), [GO:1900087](http://purl.obolibrary.org/obo/GO_1900087) (positive regulation of G1/S transition of mitotic cell cycle), [GO:0015067](http://purl.obolibrary.org/obo/GO_0015067) (amidinotransferase activity), [GO:0003084](http://purl.obolibrary.org/obo/GO_0003084) (positive regulation of systemic arterial blood pressure), [GO:0003085](http://purl.obolibrary.org/obo/GO_0003085) (negative regulation of systemic arterial blood pressure), [GO:0000800](http://purl.obolibrary.org/obo/GO_0000800) (lateral element), [GO:0042640](http://purl.obolibrary.org/obo/GO_0042640) (anagen), [GO:0042643](http://purl.obolibrary.org/obo/GO_0042643) (actomyosin, actin portion), [GO:0042645](http://purl.obolibrary.org/obo/GO_0042645) (mitochondrial nucleoid), [GO:0030678](http://purl.obolibrary.org/obo/GO_0030678) (mitochondrial ribonuclease P complex), [GO:0030673](http://purl.obolibrary.org/obo/GO_0030673) (axolemma), [GO:0030672](http://purl.obolibrary.org/obo/GO_0030672) (synaptic vesicle membrane), [GO:0030674](http://purl.obolibrary.org/obo/GO_0030674) (protein binding, bridging), [GO:0039008](http://purl.obolibrary.org/obo/GO_0039008) (pronephric nephron tubule morphogenesis), [GO:0090212](http://purl.obolibrary.org/obo/GO_0090212) (negative regulation of establishment of blood-brain barrier), [GO:0000735](http://purl.obolibrary.org/obo/GO_0000735) (removal of nonhomologous ends), [GO:0000733](http://purl.obolibrary.org/obo/GO_0000733) (DNA strand renaturation), [GO:0000732](http://purl.obolibrary.org/obo/GO_0000732) (strand displacement), [GO:0000731](http://purl.obolibrary.org/obo/GO_0000731) (DNA synthesis involved in DNA repair), [GO:0090218](http://purl.obolibrary.org/obo/GO_0090218) (positive regulation of lipid kinase activity), [GO:0090222](http://purl.obolibrary.org/obo/GO_0090222) (centrosome-templated microtubule nucleation), [GO:0000743](http://purl.obolibrary.org/obo/GO_0000743) (nuclear migration involved in conjugation with cellular fusion), [GO:0000742](http://purl.obolibrary.org/obo/GO_0000742) (karyogamy involved in conjugation with cellular fusion), [GO:0000741](http://purl.obolibrary.org/obo/GO_0000741) (karyogamy), [GO:0000715](http://purl.obolibrary.org/obo/GO_0000715) (nucleotide-excision repair, DNA damage recognition), [GO:0000712](http://purl.obolibrary.org/obo/GO_0000712) (resolution of meiotic recombination intermediates), [GO:0000710](http://purl.obolibrary.org/obo/GO_0000710) (meiotic mismatch repair), [GO:0048709](http://purl.obolibrary.org/obo/GO_0048709) (oligodendrocyte differentiation), [GO:0048708](http://purl.obolibrary.org/obo/GO_0048708) (astrocyte differentiation), [GO:0000729](http://purl.obolibrary.org/obo/GO_0000729) (DNA double-strand break processing), [GO:0090201](http://purl.obolibrary.org/obo/GO_0090201) (negative regulation of release of cytochrome c from mitochondria), [GO:0000727](http://purl.obolibrary.org/obo/GO_0000727) (double-strand break repair via break-induced replication), [GO:0090200](http://purl.obolibrary.org/obo/GO_0090200) (positive regulation of release of cytochrome c from mitochondria), [GO:0000724](http://purl.obolibrary.org/obo/GO_0000724) (double-strand break repair via homologous recombination), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0000723](http://purl.obolibrary.org/obo/GO_0000723) (telomere maintenance), [GO:0000722](http://purl.obolibrary.org/obo/GO_0000722) (telomere maintenance via recombination), [GO:0048706](http://purl.obolibrary.org/obo/GO_0048706) (embryonic skeletal system development), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0030593](http://purl.obolibrary.org/obo/GO_0030593) (neutrophil chemotaxis), [GO:0030595](http://purl.obolibrary.org/obo/GO_0030595) (leukocyte chemotaxis), [GO:0090209](http://purl.obolibrary.org/obo/GO_0090209) (negative regulation of triglyceride metabolic process), [GO:0090207](http://purl.obolibrary.org/obo/GO_0090207) (regulation of triglyceride metabolic process), [GO:0009116](http://purl.obolibrary.org/obo/GO_0009116) (nucleoside metabolic process), [GO:0042572](http://purl.obolibrary.org/obo/GO_0042572) (retinol metabolic process), [GO:0000779](http://purl.obolibrary.org/obo/GO_0000779) (condensed chromosome, centromeric region), [GO:0000778](http://purl.obolibrary.org/obo/GO_0000778) (condensed nuclear chromosome kinetochore), [GO:0042573](http://purl.obolibrary.org/obo/GO_0042573) (retinoic acid metabolic process), [GO:0042574](http://purl.obolibrary.org/obo/GO_0042574) (retinal metabolic process), [GO:0000777](http://purl.obolibrary.org/obo/GO_0000777) (condensed chromosome kinetochore), [GO:0009113](http://purl.obolibrary.org/obo/GO_0009113) (purine nucleobase biosynthetic process), [GO:0000776](http://purl.obolibrary.org/obo/GO_0000776) (kinetochore), [GO:0000775](http://purl.obolibrary.org/obo/GO_0000775) (chromosome, centromeric region), [GO:0042577](http://purl.obolibrary.org/obo/GO_0042577) (lipid phosphatase activity), [GO:0000774](http://purl.obolibrary.org/obo/GO_0000774) (adenyl-nucleotide exchange factor activity), [GO:0042578](http://purl.obolibrary.org/obo/GO_0042578) (phosphoric ester hydrolase activity), [GO:0009117](http://purl.obolibrary.org/obo/GO_0009117) (nucleotide metabolic process), [GO:0000781](http://purl.obolibrary.org/obo/GO_0000781) (chromosome, telomeric region), [GO:0000780](http://purl.obolibrary.org/obo/GO_0000780) (condensed nuclear chromosome, centromeric region), [GO:0042582](http://purl.obolibrary.org/obo/GO_0042582) (azurophil granule), [GO:0000786](http://purl.obolibrary.org/obo/GO_0000786) (nucleosome), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0000784](http://purl.obolibrary.org/obo/GO_0000784) (nuclear chromosome, telomeric region), [GO:0000783](http://purl.obolibrary.org/obo/GO_0000783) (nuclear telomere cap complex), [GO:0000793](http://purl.obolibrary.org/obo/GO_0000793) (condensed chromosome), [GO:0000792](http://purl.obolibrary.org/obo/GO_0000792) (heterochromatin), [GO:0000791](http://purl.obolibrary.org/obo/GO_0000791) (euchromatin), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0010107](http://purl.obolibrary.org/obo/GO_0010107) (potassium ion import), [GO:0042594](http://purl.obolibrary.org/obo/GO_0042594) (response to starvation), [GO:0000755](http://purl.obolibrary.org/obo/GO_0000755) (cytogamy), [GO:0042596](http://purl.obolibrary.org/obo/GO_0042596) (fear response), [GO:0000754](http://purl.obolibrary.org/obo/GO_0000754) (adaptation of signaling pathway by response to pheromone involved in conjugation with cellular fusion), [GO:0042599](http://purl.obolibrary.org/obo/GO_0042599) (lamellar body), [GO:0000750](http://purl.obolibrary.org/obo/GO_0000750) (pheromone-dependent signal transduction involved in conjugation with cellular fusion), [GO:0009101](http://purl.obolibrary.org/obo/GO_0009101) (glycoprotein biosynthetic process), [GO:0009100](http://purl.obolibrary.org/obo/GO_0009100) (glycoprotein metabolic process), [GO:0009102](http://purl.obolibrary.org/obo/GO_0009102) (biotin biosynthetic process), [GO:0009108](http://purl.obolibrary.org/obo/GO_0009108) (coenzyme biosynthetic process), [GO:0009107](http://purl.obolibrary.org/obo/GO_0009107) (lipoate biosynthetic process), [GO:0009152](http://purl.obolibrary.org/obo/GO_0009152) (purine ribonucleotide biosynthetic process), [GO:0035441](http://purl.obolibrary.org/obo/GO_0035441) (cell migration involved in vasculogenesis), [GO:0010142](http://purl.obolibrary.org/obo/GO_0010142) (farnesyl diphosphate biosynthetic process, mevalonate pathway), [GO:0009156](http://purl.obolibrary.org/obo/GO_0009156) (ribonucleoside monophosphate biosynthetic process), [GO:0034112](http://purl.obolibrary.org/obo/GO_0034112) (positive regulation of homotypic cell-cell adhesion), [GO:0009154](http://purl.obolibrary.org/obo/GO_0009154) (purine ribonucleotide catabolic process), [GO:1903920](http://purl.obolibrary.org/obo/GO_1903920) (positive regulation of actin filament severing), [GO:0060406](http://purl.obolibrary.org/obo/GO_0060406) (positive regulation of penile erection), [GO:0048755](http://purl.obolibrary.org/obo/GO_0048755) (branching morphogenesis of a nerve), [GO:0048754](http://purl.obolibrary.org/obo/GO_0048754) (branching morphogenesis of an epithelial tube), [GO:0061732](http://purl.obolibrary.org/obo/GO_0061732) (mitochondrial acetyl-CoA biosynthetic process from pyruvate), [GO:0047429](http://purl.obolibrary.org/obo/GO_0047429) (nucleoside-triphosphate diphosphatase activity), [GO:0090290](http://purl.obolibrary.org/obo/GO_0090290) (positive regulation of osteoclast proliferation), [GO:0060402](http://purl.obolibrary.org/obo/GO_0060402) (calcium ion transport into cytosol), [GO:0061734](http://purl.obolibrary.org/obo/GO_0061734) (parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization), [GO:0046101](http://purl.obolibrary.org/obo/GO_0046101) (hypoxanthine biosynthetic process), [GO:0061739](http://purl.obolibrary.org/obo/GO_0061739) (protein lipidation involved in autophagosome assembly), [GO:0048763](http://purl.obolibrary.org/obo/GO_0048763) (calcium-induced calcium release activity), [GO:0048762](http://purl.obolibrary.org/obo/GO_0048762) (mesenchymal cell differentiation), [GO:1903919](http://purl.obolibrary.org/obo/GO_1903919) (negative regulation of actin filament severing), [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process), [GO:0034109](http://purl.obolibrary.org/obo/GO_0034109) (homotypic cell-cell adhesion), [GO:0010133](http://purl.obolibrary.org/obo/GO_0010133) (proline catabolic process to glutamate), [GO:0035435](http://purl.obolibrary.org/obo/GO_0035435) (phosphate ion transmembrane transport), [GO:0009165](http://purl.obolibrary.org/obo/GO_0009165) (nucleotide biosynthetic process), [GO:1902600](http://purl.obolibrary.org/obo/GO_1902600) (hydrogen ion transmembrane transport), [GO:0046103](http://purl.obolibrary.org/obo/GO_0046103) (inosine biosynthetic process), [GO:0009168](http://purl.obolibrary.org/obo/GO_0009168) (purine ribonucleoside monophosphate biosynthetic process), [GO:0046104](http://purl.obolibrary.org/obo/GO_0046104) (thymidine metabolic process), [GO:1903935](http://purl.obolibrary.org/obo/GO_1903935) (response to sodium arsenite), [GO:0048769](http://purl.obolibrary.org/obo/GO_0048769) (sarcomerogenesis), [GO:0048771](http://purl.obolibrary.org/obo/GO_0048771) (tissue remodeling), [GO:0035426](http://purl.obolibrary.org/obo/GO_0035426) (extracellular matrix-cell signaling), [GO:0035428](http://purl.obolibrary.org/obo/GO_0035428) (hexose transmembrane transport), [GO:0061750](http://purl.obolibrary.org/obo/GO_0061750) (acid sphingomyelin phosphodiesterase activity), [GO:0060420](http://purl.obolibrary.org/obo/GO_0060420) (regulation of heart growth), [GO:0061752](http://purl.obolibrary.org/obo/GO_0061752) (telomeric repeat-containing RNA binding), [GO:0090279](http://purl.obolibrary.org/obo/GO_0090279) (regulation of calcium ion import), [GO:0090277](http://purl.obolibrary.org/obo/GO_0090277) (positive regulation of peptide hormone secretion), [GO:0060426](http://purl.obolibrary.org/obo/GO_0060426) (lung vasculature development), [GO:0090272](http://purl.obolibrary.org/obo/GO_0090272) (negative regulation of fibroblast growth factor production), [GO:0060428](http://purl.obolibrary.org/obo/GO_0060428) (lung epithelium development), [GO:0060429](http://purl.obolibrary.org/obo/GO_0060429) (epithelium development), [GO:0000798](http://purl.obolibrary.org/obo/GO_0000798) (nuclear cohesin complex), [GO:0060422](http://purl.obolibrary.org/obo/GO_0060422) (peptidyl-dipeptidase inhibitor activity), [GO:0000795](http://purl.obolibrary.org/obo/GO_0000795) (synaptonemal complex), [GO:0060425](http://purl.obolibrary.org/obo/GO_0060425) (lung morphogenesis), [GO:0061756](http://purl.obolibrary.org/obo/GO_0061756) (leukocyte adhesion to vascular endothelial cell), [GO:0000794](http://purl.obolibrary.org/obo/GO_0000794) (condensed nuclear chromosome), [GO:1902608](http://purl.obolibrary.org/obo/GO_1902608) (positive regulation of large conductance calcium-activated potassium channel activity), [GO:0048786](http://purl.obolibrary.org/obo/GO_0048786) (presynaptic active zone), [GO:0046122](http://purl.obolibrary.org/obo/GO_0046122) (purine deoxyribonucleoside metabolic process), [GO:0035418](http://purl.obolibrary.org/obo/GO_0035418) (protein localization to synapse), [GO:0035411](http://purl.obolibrary.org/obo/GO_0035411) (catenin import into nucleus), [GO:0035412](http://purl.obolibrary.org/obo/GO_0035412) (regulation of catenin import into nucleus), [GO:0035413](http://purl.obolibrary.org/obo/GO_0035413) (positive regulation of catenin import into nucleus), [GO:0035410](http://purl.obolibrary.org/obo/GO_0035410) (dihydrotestosterone 17-beta-dehydrogenase activity), [GO:0090287](http://purl.obolibrary.org/obo/GO_0090287) (regulation of cellular response to growth factor stimulus), [GO:0009143](http://purl.obolibrary.org/obo/GO_0009143) (nucleoside triphosphate catabolic process), [GO:0009142](http://purl.obolibrary.org/obo/GO_0009142) (nucleoside triphosphate biosynthetic process), [GO:0060415](http://purl.obolibrary.org/obo/GO_0060415) (muscle tissue morphogenesis), [GO:1902622](http://purl.obolibrary.org/obo/GO_1902622) (regulation of neutrophil migration), [GO:0090286](http://purl.obolibrary.org/obo/GO_0090286) (cytoskeletal anchoring at nuclear membrane), [GO:0048788](http://purl.obolibrary.org/obo/GO_0048788) (cytoskeleton of presynaptic active zone), [GO:0048787](http://purl.obolibrary.org/obo/GO_0048787) (presynaptic active zone membrane), [GO:0060411](http://purl.obolibrary.org/obo/GO_0060411) (cardiac septum morphogenesis), [GO:0060412](http://purl.obolibrary.org/obo/GO_0060412) (ventricular septum morphogenesis), [GO:0090282](http://purl.obolibrary.org/obo/GO_0090282) (positive regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:1903955](http://purl.obolibrary.org/obo/GO_1903955) (positive regulation of protein targeting to mitochondrion), [GO:0090280](http://purl.obolibrary.org/obo/GO_0090280) (positive regulation of calcium ion import), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0048791](http://purl.obolibrary.org/obo/GO_0048791) (calcium ion-regulated exocytosis of neurotransmitter), [GO:1902618](http://purl.obolibrary.org/obo/GO_1902618) (cellular response to fluoride), [GO:0060419](http://purl.obolibrary.org/obo/GO_0060419) (heart growth), [GO:0048797](http://purl.obolibrary.org/obo/GO_0048797) (swim bladder formation), [GO:0048795](http://purl.obolibrary.org/obo/GO_0048795) (swim bladder morphogenesis), [GO:0048794](http://purl.obolibrary.org/obo/GO_0048794) (swim bladder development), [GO:0035403](http://purl.obolibrary.org/obo/GO_0035403) (histone kinase activity (H3-T6 specific)), [GO:0090259](http://purl.obolibrary.org/obo/GO_0090259) (regulation of retinal ganglion cell axon guidance), [GO:0010181](http://purl.obolibrary.org/obo/GO_0010181) (FMN binding), [GO:0034154](http://purl.obolibrary.org/obo/GO_0034154) (toll-like receptor 7 signaling pathway), [GO:0048712](http://purl.obolibrary.org/obo/GO_0048712) (negative regulation of astrocyte differentiation), [GO:0048711](http://purl.obolibrary.org/obo/GO_0048711) (positive regulation of astrocyte differentiation), [GO:0048715](http://purl.obolibrary.org/obo/GO_0048715) (negative regulation of oligodendrocyte differentiation), [GO:0048714](http://purl.obolibrary.org/obo/GO_0048714) (positive regulation of oligodendrocyte differentiation), [GO:0006913](http://purl.obolibrary.org/obo/GO_0006913) (nucleocytoplasmic transport), [GO:0006910](http://purl.obolibrary.org/obo/GO_0006910) (phagocytosis, recognition), [GO:0006911](http://purl.obolibrary.org/obo/GO_0006911) (phagocytosis, engulfment), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0006919](http://purl.obolibrary.org/obo/GO_0006919) (activation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process), [GO:0035479](http://purl.obolibrary.org/obo/GO_0035479) (angioblast cell migration from lateral mesoderm to midline), [GO:0035473](http://purl.obolibrary.org/obo/GO_0035473) (lipase binding), [GO:0035474](http://purl.obolibrary.org/obo/GO_0035474) (selective angioblast sprouting), [GO:0035470](http://purl.obolibrary.org/obo/GO_0035470) (positive regulation of vascular wound healing), [GO:0090265](http://purl.obolibrary.org/obo/GO_0090265) (positive regulation of immune complex clearance by monocytes and macrophages), [GO:0034142](http://purl.obolibrary.org/obo/GO_0034142) (toll-like receptor 4 signaling pathway), [GO:0090263](http://purl.obolibrary.org/obo/GO_0090263) (positive regulation of canonical Wnt signaling pathway), [GO:0006924](http://purl.obolibrary.org/obo/GO_0006924) (activation-induced cell death of T cells), [GO:0048731](http://purl.obolibrary.org/obo/GO_0048731) (system development), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0006925](http://purl.obolibrary.org/obo/GO_0006925) (inflammatory cell apoptotic process), [GO:0034138](http://purl.obolibrary.org/obo/GO_0034138) (toll-like receptor 3 signaling pathway), [GO:0034137](http://purl.obolibrary.org/obo/GO_0034137) (positive regulation of toll-like receptor 2 signaling pathway), [GO:0006929](http://purl.obolibrary.org/obo/GO_0006929) (substrate-dependent cell migration), [GO:0035469](http://purl.obolibrary.org/obo/GO_0035469) (determination of pancreatic left/right asymmetry), [GO:0035462](http://purl.obolibrary.org/obo/GO_0035462) (determination of left/right asymmetry in diencephalon), [GO:0090238](http://purl.obolibrary.org/obo/GO_0090238) (positive regulation of arachidonic acid secretion), [GO:0034130](http://purl.obolibrary.org/obo/GO_0034130) (toll-like receptor 1 signaling pathway), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0034134](http://purl.obolibrary.org/obo/GO_0034134) (toll-like receptor 2 signaling pathway), [GO:0090232](http://purl.obolibrary.org/obo/GO_0090232) (positive regulation of spindle checkpoint), [GO:0061713](http://purl.obolibrary.org/obo/GO_0061713) (anterior neural tube closure), [GO:0061714](http://purl.obolibrary.org/obo/GO_0061714) (folic acid receptor activity), [GO:0090231](http://purl.obolibrary.org/obo/GO_0090231) (regulation of spindle checkpoint), [GO:0048732](http://purl.obolibrary.org/obo/GO_0048732) (gland development), [GO:0048739](http://purl.obolibrary.org/obo/GO_0048739) (cardiac muscle fiber development), [GO:0048738](http://purl.obolibrary.org/obo/GO_0048738) (cardiac muscle tissue development), [GO:0048741](http://purl.obolibrary.org/obo/GO_0048741) (skeletal muscle fiber development), [GO:0010159](http://purl.obolibrary.org/obo/GO_0010159) (specification of animal organ position), [GO:0035455](http://purl.obolibrary.org/obo/GO_0035455) (response to interferon-alpha), [GO:0010155](http://purl.obolibrary.org/obo/GO_0010155) (regulation of proton transport), [GO:0035458](http://purl.obolibrary.org/obo/GO_0035458) (cellular response to interferon-beta), [GO:0090245](http://purl.obolibrary.org/obo/GO_0090245) (axis elongation involved in somitogenesis), [GO:0010172](http://purl.obolibrary.org/obo/GO_0010172) (embryonic body morphogenesis), [GO:0034121](http://purl.obolibrary.org/obo/GO_0034121) (regulation of toll-like receptor signaling pathway), [GO:0009187](http://purl.obolibrary.org/obo/GO_0009187) (cyclic nucleotide metabolic process), [GO:0090243](http://purl.obolibrary.org/obo/GO_0090243) (fibroblast growth factor receptor signaling pathway involved in somitogenesis), [GO:0090244](http://purl.obolibrary.org/obo/GO_0090244) (Wnt signaling pathway involved in somitogenesis), [GO:0010171](http://purl.obolibrary.org/obo/GO_0010171) (body morphogenesis), [GO:0061702](http://purl.obolibrary.org/obo/GO_0061702) (inflammasome complex), [GO:0090241](http://purl.obolibrary.org/obo/GO_0090241) (negative regulation of histone H4 acetylation), [GO:0048745](http://purl.obolibrary.org/obo/GO_0048745) (smooth muscle tissue development), [GO:0048743](http://purl.obolibrary.org/obo/GO_0048743) (positive regulation of skeletal muscle fiber development), [GO:0048749](http://purl.obolibrary.org/obo/GO_0048749) (compound eye development), [GO:0061700](http://purl.obolibrary.org/obo/GO_0061700) (GATOR2 complex), [GO:0048747](http://purl.obolibrary.org/obo/GO_0048747) (muscle fiber development), [GO:1903912](http://purl.obolibrary.org/obo/GO_1903912) (negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation), [GO:1903904](http://purl.obolibrary.org/obo/GO_1903904) (negative regulation of establishment of T cell polarity), [GO:1903905](http://purl.obolibrary.org/obo/GO_1903905) (positive regulation of establishment of T cell polarity), [GO:0048753](http://purl.obolibrary.org/obo/GO_0048753) (pigment granule organization), [GO:0006906](http://purl.obolibrary.org/obo/GO_0006906) (vesicle fusion), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:0061708](http://purl.obolibrary.org/obo/GO_0061708) (tRNA-5-taurinomethyluridine 2-sulfurtransferase), [GO:0006903](http://purl.obolibrary.org/obo/GO_0006903) (vesicle targeting), [GO:0006904](http://purl.obolibrary.org/obo/GO_0006904) (vesicle docking involved in exocytosis), [GO:0061709](http://purl.obolibrary.org/obo/GO_0061709) (reticulophagy), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:0034116](http://purl.obolibrary.org/obo/GO_0034116) (positive regulation of heterotypic cell-cell adhesion), [GO:0006907](http://purl.obolibrary.org/obo/GO_0006907) (pinocytosis), [GO:0009181](http://purl.obolibrary.org/obo/GO_0009181) (purine ribonucleoside diphosphate catabolic process), [GO:0035445](http://purl.obolibrary.org/obo/GO_0035445) (borate transmembrane transport), [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0002244](http://purl.obolibrary.org/obo/GO_0002244) (hematopoietic progenitor cell differentiation), [GO:0002237](http://purl.obolibrary.org/obo/GO_0002237) (response to molecule of bacterial origin), [GO:0002238](http://purl.obolibrary.org/obo/GO_0002238) (response to molecule of fungal origin), [GO:0016890](http://purl.obolibrary.org/obo/GO_0016890) (site-specific endodeoxyribonuclease activity, specific for altered base), [GO:0015562](http://purl.obolibrary.org/obo/GO_0015562) (efflux transmembrane transporter activity), [GO:0002250](http://purl.obolibrary.org/obo/GO_0002250) (adaptive immune response), [GO:0002253](http://purl.obolibrary.org/obo/GO_0002253) (activation of immune response), [GO:0002246](http://purl.obolibrary.org/obo/GO_0002246) (wound healing involved in inflammatory response), [GO:0070392](http://purl.obolibrary.org/obo/GO_0070392) (detection of lipoteichoic acid), [GO:0016881](http://purl.obolibrary.org/obo/GO_0016881) (acid-amino acid ligase activity), [GO:0016866](http://purl.obolibrary.org/obo/GO_0016866) (intramolecular transferase activity), [GO:0016868](http://purl.obolibrary.org/obo/GO_0016868) (intramolecular transferase activity, phosphotransferases), [GO:0004882](http://purl.obolibrary.org/obo/GO_0004882) (androgen receptor activity), [GO:1905606](http://purl.obolibrary.org/obo/GO_1905606) (regulation of presynapse assembly), [GO:0002218](http://purl.obolibrary.org/obo/GO_0002218) (activation of innate immune response), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0016874](http://purl.obolibrary.org/obo/GO_0016874) (ligase activity), [GO:0016857](http://purl.obolibrary.org/obo/GO_0016857) (racemase and epimerase activity, acting on carbohydrates and derivatives), [GO:0004890](http://purl.obolibrary.org/obo/GO_0004890) (GABA-A receptor activity), [GO:0002230](http://purl.obolibrary.org/obo/GO_0002230) (positive regulation of defense response to virus by host), [GO:1905612](http://purl.obolibrary.org/obo/GO_1905612) (positive regulation of mRNA cap binding), [GO:1905618](http://purl.obolibrary.org/obo/GO_1905618) (positive regulation of miRNA mediated inhibition of translation), [GO:0002224](http://purl.obolibrary.org/obo/GO_0002224) (toll-like receptor signaling pathway), [GO:0004887](http://purl.obolibrary.org/obo/GO_0004887) (thyroid hormone receptor activity), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0002281](http://purl.obolibrary.org/obo/GO_0002281) (macrophage activation involved in immune response), [GO:0002283](http://purl.obolibrary.org/obo/GO_0002283) (neutrophil activation involved in immune response), [GO:0093001](http://purl.obolibrary.org/obo/GO_0093001) (glycolysis from storage polysaccharide through glucose-1-phosphate), [GO:0002286](http://purl.obolibrary.org/obo/GO_0002286) (T cell activation involved in immune response), [GO:0071696](http://purl.obolibrary.org/obo/GO_0071696) (ectodermal placode development), [GO:0044088](http://purl.obolibrary.org/obo/GO_0044088) (regulation of vacuole organization), [GO:0070368](http://purl.obolibrary.org/obo/GO_0070368) (positive regulation of hepatocyte differentiation), [GO:0071699](http://purl.obolibrary.org/obo/GO_0071699) (olfactory placode morphogenesis), [GO:0071698](http://purl.obolibrary.org/obo/GO_0071698) (olfactory placode development), [GO:0002292](http://purl.obolibrary.org/obo/GO_0002292) (T cell differentiation involved in immune response), [GO:0071681](http://purl.obolibrary.org/obo/GO_0071681) (cellular response to indole-3-methanol), [GO:0071688](http://purl.obolibrary.org/obo/GO_0071688) (striated muscle myosin thick filament assembly), [GO:0070358](http://purl.obolibrary.org/obo/GO_0070358) (actin polymerization-dependent cell motility), [GO:0044092](http://purl.obolibrary.org/obo/GO_0044092) (negative regulation of molecular function), [GO:0002260](http://purl.obolibrary.org/obo/GO_0002260) (lymphocyte homeostasis), [GO:0002265](http://purl.obolibrary.org/obo/GO_0002265) (astrocyte activation involved in immune response), [GO:0070382](http://purl.obolibrary.org/obo/GO_0070382) (exocytic vesicle), [GO:0070384](http://purl.obolibrary.org/obo/GO_0070384) (Harderian gland development), [GO:0038202](http://purl.obolibrary.org/obo/GO_0038202) (TORC1 signaling), [GO:0039530](http://purl.obolibrary.org/obo/GO_0039530) (MDA-5 signaling pathway), [GO:0002275](http://purl.obolibrary.org/obo/GO_0002275) (myeloid cell activation involved in immune response), [GO:0002276](http://purl.obolibrary.org/obo/GO_0002276) (basophil activation involved in immune response), [GO:0070371](http://purl.obolibrary.org/obo/GO_0070371) (ERK1 and ERK2 cascade), [GO:0070372](http://purl.obolibrary.org/obo/GO_0070372) (regulation of ERK1 and ERK2 cascade), [GO:0070373](http://purl.obolibrary.org/obo/GO_0070373) (negative regulation of ERK1 and ERK2 cascade), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:1903007](http://purl.obolibrary.org/obo/GO_1903007) (positive regulation of Lys63-specific deubiquitinase activity), [GO:1904339](http://purl.obolibrary.org/obo/GO_1904339) (negative regulation of dopaminergic neuron differentiation), [GO:0051250](http://purl.obolibrary.org/obo/GO_0051250) (negative regulation of lymphocyte activation), [GO:1903006](http://purl.obolibrary.org/obo/GO_1903006) (positive regulation of protein K63-linked deubiquitination), [GO:0051246](http://purl.obolibrary.org/obo/GO_0051246) (regulation of protein metabolic process), [GO:0051247](http://purl.obolibrary.org/obo/GO_0051247) (positive regulation of protein metabolic process), [GO:1990246](http://purl.obolibrary.org/obo/GO_1990246) (uniplex complex), [GO:1904343](http://purl.obolibrary.org/obo/GO_1904343) (positive regulation of colon smooth muscle contraction), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:1904349](http://purl.obolibrary.org/obo/GO_1904349) (positive regulation of small intestine smooth muscle contraction), [GO:0009725](http://purl.obolibrary.org/obo/GO_0009725) (response to hormone), [GO:0051256](http://purl.obolibrary.org/obo/GO_0051256) (mitotic spindle midzone assembly), [GO:0010701](http://purl.obolibrary.org/obo/GO_0010701) (positive regulation of norepinephrine secretion), [GO:0051259](http://purl.obolibrary.org/obo/GO_0051259) (protein oligomerization), [GO:1903022](http://purl.obolibrary.org/obo/GO_1903022) (positive regulation of phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands), [GO:1903025](http://purl.obolibrary.org/obo/GO_1903025) (regulation of RNA polymerase II regulatory region sequence-specific DNA binding), [GO:1904356](http://purl.obolibrary.org/obo/GO_1904356) (regulation of telomere maintenance via telomere lengthening), [GO:1904355](http://purl.obolibrary.org/obo/GO_1904355) (positive regulation of telomere capping), [GO:0051270](http://purl.obolibrary.org/obo/GO_0051270) (regulation of cellular component movement), [GO:1904358](http://purl.obolibrary.org/obo/GO_1904358) (positive regulation of telomere maintenance via telomere lengthening), [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration), [GO:0051267](http://purl.obolibrary.org/obo/GO_0051267) (CP2 mannose-ethanolamine phosphotransferase activity), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:1903033](http://purl.obolibrary.org/obo/GO_1903033) (positive regulation of microtubule plus-end binding), [GO:1903036](http://purl.obolibrary.org/obo/GO_1903036) (positive regulation of response to wounding), [GO:1905696](http://purl.obolibrary.org/obo/GO_1905696) (regulation of polysome binding), [GO:0051281](http://purl.obolibrary.org/obo/GO_0051281) (positive regulation of release of sequestered calcium ion into cytosol), [GO:0051279](http://purl.obolibrary.org/obo/GO_0051279) (regulation of release of sequestered calcium ion into cytosol), [GO:0051276](http://purl.obolibrary.org/obo/GO_0051276) (chromosome organization), [GO:0008422](http://purl.obolibrary.org/obo/GO_0008422) (beta-glucosidase activity), [GO:0008420](http://purl.obolibrary.org/obo/GO_0008420) (CTD phosphatase activity), [GO:0009757](http://purl.obolibrary.org/obo/GO_0009757) (hexose mediated signaling), [GO:0008426](http://purl.obolibrary.org/obo/GO_0008426) (protein kinase C inhibitor activity), [GO:0009755](http://purl.obolibrary.org/obo/GO_0009755) (hormone-mediated signaling pathway), [GO:1905627](http://purl.obolibrary.org/obo/GO_1905627) (regulation of serotonin biosynthetic process), [GO:0034707](http://purl.obolibrary.org/obo/GO_0034707) (chloride channel complex), [GO:0034706](http://purl.obolibrary.org/obo/GO_0034706) (sodium channel complex), [GO:0010739](http://purl.obolibrary.org/obo/GO_0010739) (positive regulation of protein kinase A signaling), [GO:0034705](http://purl.obolibrary.org/obo/GO_0034705) (potassium channel complex), [GO:0009749](http://purl.obolibrary.org/obo/GO_0009749) (response to glucose), [GO:0034704](http://purl.obolibrary.org/obo/GO_0034704) (calcium channel complex), [GO:0010738](http://purl.obolibrary.org/obo/GO_0010738) (regulation of protein kinase A signaling), [GO:0010737](http://purl.obolibrary.org/obo/GO_0010737) (protein kinase A signaling), [GO:0051209](http://purl.obolibrary.org/obo/GO_0051209) (release of sequestered calcium ion into cytosol), [GO:0010730](http://purl.obolibrary.org/obo/GO_0010730) (negative regulation of hydrogen peroxide biosynthetic process), [GO:0051204](http://purl.obolibrary.org/obo/GO_0051204) (protein insertion into mitochondrial membrane), [GO:0051205](http://purl.obolibrary.org/obo/GO_0051205) (protein insertion into membrane), [GO:1905631](http://purl.obolibrary.org/obo/GO_1905631) (cellular response to glyceraldehyde), [GO:0007100](http://purl.obolibrary.org/obo/GO_0007100) (mitotic centrosome separation), [GO:0008432](http://purl.obolibrary.org/obo/GO_0008432) (JUN kinase binding), [GO:0008431](http://purl.obolibrary.org/obo/GO_0008431) (vitamin E binding), [GO:0051213](http://purl.obolibrary.org/obo/GO_0051213) (dioxygenase activity), [GO:0008429](http://purl.obolibrary.org/obo/GO_0008429) (phosphatidylethanolamine binding), [GO:0010749](http://purl.obolibrary.org/obo/GO_0010749) (regulation of nitric oxide mediated signal transduction), [GO:0010748](http://purl.obolibrary.org/obo/GO_0010748) (negative regulation of plasma membrane long-chain fatty acid transport), [GO:0051219](http://purl.obolibrary.org/obo/GO_0051219) (phosphoprotein binding), [GO:0010745](http://purl.obolibrary.org/obo/GO_0010745) (negative regulation of macrophage derived foam cell differentiation), [GO:0052548](http://purl.obolibrary.org/obo/GO_0052548) (regulation of endopeptidase activity), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:1904315](http://purl.obolibrary.org/obo/GO_1904315) (transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential), [GO:0010718](http://purl.obolibrary.org/obo/GO_0010718) (positive regulation of epithelial to mesenchymal transition), [GO:0051225](http://purl.obolibrary.org/obo/GO_0051225) (spindle assembly), [GO:0051222](http://purl.obolibrary.org/obo/GO_0051222) (positive regulation of protein transport), [GO:0010719](http://purl.obolibrary.org/obo/GO_0010719) (negative regulation of epithelial to mesenchymal transition), [GO:0010712](http://purl.obolibrary.org/obo/GO_0010712) (regulation of collagen metabolic process), [GO:0051229](http://purl.obolibrary.org/obo/GO_0051229) (meiotic spindle disassembly), [GO:1904322](http://purl.obolibrary.org/obo/GO_1904322) (cellular response to forskolin), [GO:0009743](http://purl.obolibrary.org/obo/GO_0009743) (response to carbohydrate), [GO:0008412](http://purl.obolibrary.org/obo/GO_0008412) (4-hydroxybenzoate octaprenyltransferase activity), [GO:0008408](http://purl.obolibrary.org/obo/GO_0008408) (3'-5' exonuclease activity), [GO:0051233](http://purl.obolibrary.org/obo/GO_0051233) (spindle midzone), [GO:0008406](http://purl.obolibrary.org/obo/GO_0008406) (gonad development), [GO:0010725](http://purl.obolibrary.org/obo/GO_0010725) (regulation of primitive erythrocyte differentiation), [GO:0051232](http://purl.obolibrary.org/obo/GO_0051232) (meiotic spindle elongation), [GO:0010724](http://purl.obolibrary.org/obo/GO_0010724) (regulation of definitive erythrocyte differentiation), [GO:0010722](http://purl.obolibrary.org/obo/GO_0010722) (regulation of ferrochelatase activity), [GO:0007010](http://purl.obolibrary.org/obo/GO_0007010) (cytoskeleton organization), [GO:0008340](http://purl.obolibrary.org/obo/GO_0008340) (determination of adult lifespan), [GO:0007014](http://purl.obolibrary.org/obo/GO_0007014) (actin ubiquitination), [GO:0007015](http://purl.obolibrary.org/obo/GO_0007015) (actin filament organization), [GO:0008345](http://purl.obolibrary.org/obo/GO_0008345) (larval locomotory behavior), [GO:0008344](http://purl.obolibrary.org/obo/GO_0008344) (adult locomotory behavior), [GO:0007018](http://purl.obolibrary.org/obo/GO_0007018) (microtubule-based movement), [GO:0007019](http://purl.obolibrary.org/obo/GO_0007019) (microtubule depolymerization), [GO:0008349](http://purl.obolibrary.org/obo/GO_0008349) (MAP kinase kinase kinase kinase activity), [GO:0007016](http://purl.obolibrary.org/obo/GO_0007016) (cytoskeletal anchoring at plasma membrane), [GO:0008347](http://purl.obolibrary.org/obo/GO_0008347) (glial cell migration), [GO:0007017](http://purl.obolibrary.org/obo/GO_0007017) (microtubule-based process), [GO:0007009](http://purl.obolibrary.org/obo/GO_0007009) (plasma membrane organization), [GO:0034628](http://purl.obolibrary.org/obo/GO_0034628) ('de novo' NAD biosynthetic process from aspartate), [GO:0010659](http://purl.obolibrary.org/obo/GO_0010659) (cardiac muscle cell apoptotic process), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0019003](http://purl.obolibrary.org/obo/GO_0019003) (GDP binding), [GO:0035955](http://purl.obolibrary.org/obo/GO_0035955) (negative regulation of dipeptide transport by negative regulation of transcription from RNA polymerase II promoter), [GO:0019002](http://purl.obolibrary.org/obo/GO_0019002) (GMP binding), [GO:0010657](http://purl.obolibrary.org/obo/GO_0010657) (muscle cell apoptotic process), [GO:0019005](http://purl.obolibrary.org/obo/GO_0019005) (SCF ubiquitin ligase complex), [GO:0010656](http://purl.obolibrary.org/obo/GO_0010656) (negative regulation of muscle cell apoptotic process), [GO:0034626](http://purl.obolibrary.org/obo/GO_0034626) (fatty acid elongation, polyunsaturated fatty acid), [GO:0034625](http://purl.obolibrary.org/obo/GO_0034625) (fatty acid elongation, monounsaturated fatty acid), [GO:0035952](http://purl.obolibrary.org/obo/GO_0035952) (negative regulation of oligopeptide transport by negative regulation of transcription from RNA polymerase II promoter), [GO:0019008](http://purl.obolibrary.org/obo/GO_0019008) (molybdopterin synthase complex), [GO:0008353](http://purl.obolibrary.org/obo/GO_0008353) (RNA polymerase II carboxy-terminal domain kinase activity), [GO:0007021](http://purl.obolibrary.org/obo/GO_0007021) (tubulin complex assembly), [GO:0008352](http://purl.obolibrary.org/obo/GO_0008352) (katanin complex), [GO:0009682](http://purl.obolibrary.org/obo/GO_0009682) (induced systemic resistance), [GO:0007020](http://purl.obolibrary.org/obo/GO_0007020) (microtubule nucleation), [GO:0046622](http://purl.obolibrary.org/obo/GO_0046622) (positive regulation of organ growth), [GO:0007026](http://purl.obolibrary.org/obo/GO_0007026) (negative regulation of microtubule depolymerization), [GO:0047953](http://purl.obolibrary.org/obo/GO_0047953) (glycerol 2-dehydrogenase (NADP+) activity), [GO:0046620](http://purl.obolibrary.org/obo/GO_0046620) (regulation of organ growth), [GO:0007023](http://purl.obolibrary.org/obo/GO_0007023) (post-chaperonin tubulin folding pathway), [GO:0008354](http://purl.obolibrary.org/obo/GO_0008354) (germ cell migration), [GO:0046621](http://purl.obolibrary.org/obo/GO_0046621) (negative regulation of organ growth), [GO:0007029](http://purl.obolibrary.org/obo/GO_0007029) (endoplasmic reticulum organization), [GO:0046627](http://purl.obolibrary.org/obo/GO_0046627) (negative regulation of insulin receptor signaling pathway), [GO:0046624](http://purl.obolibrary.org/obo/GO_0046624) (sphingolipid transporter activity), [GO:0046625](http://purl.obolibrary.org/obo/GO_0046625) (sphingolipid binding), [GO:0034618](http://purl.obolibrary.org/obo/GO_0034618) (arginine binding), [GO:0034617](http://purl.obolibrary.org/obo/GO_0034617) (tetrahydrobiopterin binding), [GO:0060914](http://purl.obolibrary.org/obo/GO_0060914) (heart formation), [GO:0035947](http://purl.obolibrary.org/obo/GO_0035947) (regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter), [GO:0010669](http://purl.obolibrary.org/obo/GO_0010669) (epithelial structure maintenance), [GO:0060916](http://purl.obolibrary.org/obo/GO_0060916) (mesenchymal cell proliferation involved in lung development), [GO:0010666](http://purl.obolibrary.org/obo/GO_0010666) (positive regulation of cardiac muscle cell apoptotic process), [GO:0010667](http://purl.obolibrary.org/obo/GO_0010667) (negative regulation of cardiac muscle cell apoptotic process), [GO:0034614](http://purl.obolibrary.org/obo/GO_0034614) (cellular response to reactive oxygen species), [GO:0034613](http://purl.obolibrary.org/obo/GO_0034613) (cellular protein localization), [GO:0010664](http://purl.obolibrary.org/obo/GO_0010664) (negative regulation of striated muscle cell apoptotic process), [GO:0034612](http://purl.obolibrary.org/obo/GO_0034612) (response to tumor necrosis factor), [GO:0046639](http://purl.obolibrary.org/obo/GO_0046639) (negative regulation of alpha-beta T cell differentiation), [GO:0009651](http://purl.obolibrary.org/obo/GO_0009651) (response to salt stress), [GO:0022626](http://purl.obolibrary.org/obo/GO_0022626) (cytosolic ribosome), [GO:0008320](http://purl.obolibrary.org/obo/GO_0008320) (protein transmembrane transporter activity), [GO:0022627](http://purl.obolibrary.org/obo/GO_0022627) (cytosolic small ribosomal subunit), [GO:0008324](http://purl.obolibrary.org/obo/GO_0008324) (cation transmembrane transporter activity), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0022625](http://purl.obolibrary.org/obo/GO_0022625) (cytosolic large ribosomal subunit), [GO:0009652](http://purl.obolibrary.org/obo/GO_0009652) (thigmotropism), [GO:0008328](http://purl.obolibrary.org/obo/GO_0008328) (ionotropic glutamate receptor complex), [GO:0099132](http://purl.obolibrary.org/obo/GO_0099132) (ATP hydrolysis coupled cation transmembrane transport), [GO:0099133](http://purl.obolibrary.org/obo/GO_0099133) (ATP hydrolysis coupled anion transmembrane transport), [GO:0008327](http://purl.obolibrary.org/obo/GO_0008327) (methyl-CpG binding), [GO:0046638](http://purl.obolibrary.org/obo/GO_0046638) (positive regulation of alpha-beta T cell differentiation), [GO:0046635](http://purl.obolibrary.org/obo/GO_0046635) (positive regulation of alpha-beta T cell activation), [GO:0034605](http://purl.obolibrary.org/obo/GO_0034605) (cellular response to heat), [GO:0060947](http://purl.obolibrary.org/obo/GO_0060947) (cardiac vascular smooth muscle cell differentiation), [GO:0046641](http://purl.obolibrary.org/obo/GO_0046641) (positive regulation of alpha-beta T cell proliferation), [GO:0010633](http://purl.obolibrary.org/obo/GO_0010633) (negative regulation of epithelial cell migration), [GO:0010632](http://purl.obolibrary.org/obo/GO_0010632) (regulation of epithelial cell migration), [GO:0010634](http://purl.obolibrary.org/obo/GO_0010634) (positive regulation of epithelial cell migration), [GO:0034604](http://purl.obolibrary.org/obo/GO_0034604) (pyruvate dehydrogenase (NAD+) activity), [GO:0034602](http://purl.obolibrary.org/obo/GO_0034602) (oxoglutarate dehydrogenase (NAD+) activity), [GO:0008331](http://purl.obolibrary.org/obo/GO_0008331) (high voltage-gated calcium channel activity), [GO:0022615](http://purl.obolibrary.org/obo/GO_0022615) (protein to membrane docking), [GO:0007004](http://purl.obolibrary.org/obo/GO_0007004) (telomere maintenance via telomerase), [GO:0008333](http://purl.obolibrary.org/obo/GO_0008333) (endosome to lysosome transport), [GO:0008332](http://purl.obolibrary.org/obo/GO_0008332) (low voltage-gated calcium channel activity), [GO:0007007](http://purl.obolibrary.org/obo/GO_0007007) (inner mitochondrial membrane organization), [GO:0007005](http://purl.obolibrary.org/obo/GO_0007005) (mitochondrion organization), [GO:0007006](http://purl.obolibrary.org/obo/GO_0007006) (mitochondrial membrane organization), [GO:0060931](http://purl.obolibrary.org/obo/GO_0060931) (sinoatrial node cell development), [GO:0046651](http://purl.obolibrary.org/obo/GO_0046651) (lymphocyte proliferation), [GO:0035927](http://purl.obolibrary.org/obo/GO_0035927) (RNA import into mitochondrion), [GO:0035928](http://purl.obolibrary.org/obo/GO_0035928) (rRNA import into mitochondrion), [GO:0010644](http://purl.obolibrary.org/obo/GO_0010644) (cell communication by electrical coupling), [GO:0035924](http://purl.obolibrary.org/obo/GO_0035924) (cellular response to vascular endothelial growth factor stimulus), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0007051](http://purl.obolibrary.org/obo/GO_0007051) (spindle organization), [GO:0008381](http://purl.obolibrary.org/obo/GO_0008381) (mechanosensitive ion channel activity), [GO:0008380](http://purl.obolibrary.org/obo/GO_0008380) (RNA splicing), [GO:1904251](http://purl.obolibrary.org/obo/GO_1904251) (regulation of bile acid metabolic process), [GO:0008385](http://purl.obolibrary.org/obo/GO_0008385) (IkappaB kinase complex), [GO:0034672](http://purl.obolibrary.org/obo/GO_0034672) (anterior/posterior pattern specification involved in pronephros development), [GO:0007052](http://purl.obolibrary.org/obo/GO_0007052) (mitotic spindle organization), [GO:0007059](http://purl.obolibrary.org/obo/GO_0007059) (chromosome segregation), [GO:0051170](http://purl.obolibrary.org/obo/GO_0051170) (nuclear import), [GO:0051169](http://purl.obolibrary.org/obo/GO_0051169) (nuclear transport), [GO:0032009](http://purl.obolibrary.org/obo/GO_0032009) (early phagosome), [GO:0035998](http://purl.obolibrary.org/obo/GO_0035998) (7,8-dihydroneopterin 3'-triphosphate biosynthetic process), [GO:0033334](http://purl.obolibrary.org/obo/GO_0033334) (fin morphogenesis), [GO:0035999](http://purl.obolibrary.org/obo/GO_0035999) (tetrahydrofolate interconversion), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0019048](http://purl.obolibrary.org/obo/GO_0019048) (modulation by virus of host morphology or physiology), [GO:0032007](http://purl.obolibrary.org/obo/GO_0032007) (negative regulation of TOR signaling), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0035994](http://purl.obolibrary.org/obo/GO_0035994) (response to muscle stretch), [GO:0035995](http://purl.obolibrary.org/obo/GO_0035995) (detection of muscle stretch), [GO:0032008](http://purl.obolibrary.org/obo/GO_0032008) (positive regulation of TOR signaling), [GO:0010694](http://purl.obolibrary.org/obo/GO_0010694) (positive regulation of alkaline phosphatase activity), [GO:0032006](http://purl.obolibrary.org/obo/GO_0032006) (regulation of TOR signaling), [GO:0035990](http://purl.obolibrary.org/obo/GO_0035990) (tendon cell differentiation), [GO:0007062](http://purl.obolibrary.org/obo/GO_0007062) (sister chromatid cohesion), [GO:0035993](http://purl.obolibrary.org/obo/GO_0035993) (deltoid tuberosity development), [GO:1904262](http://purl.obolibrary.org/obo/GO_1904262) (negative regulation of TORC1 signaling), [GO:0032000](http://purl.obolibrary.org/obo/GO_0032000) (positive regulation of fatty acid beta-oxidation), [GO:0008396](http://purl.obolibrary.org/obo/GO_0008396) (oxysterol 7-alpha-hydroxylase activity), [GO:0008395](http://purl.obolibrary.org/obo/GO_0008395) (steroid hydroxylase activity), [GO:0007064](http://purl.obolibrary.org/obo/GO_0007064) (mitotic sister chromatid cohesion), [GO:0051181](http://purl.obolibrary.org/obo/GO_0051181) (cofactor transport), [GO:0020018](http://purl.obolibrary.org/obo/GO_0020018) (ciliary pocket membrane), [GO:0051180](http://purl.obolibrary.org/obo/GO_0051180) (vitamin transport), [GO:0051177](http://purl.obolibrary.org/obo/GO_0051177) (meiotic sister chromatid cohesion), [GO:0051174](http://purl.obolibrary.org/obo/GO_0051174) (regulation of phosphorus metabolic process), [GO:0019034](http://purl.obolibrary.org/obo/GO_0019034) (viral replication complex), [GO:0035988](http://purl.obolibrary.org/obo/GO_0035988) (chondrocyte proliferation), [GO:0035989](http://purl.obolibrary.org/obo/GO_0035989) (tendon development), [GO:0033328](http://purl.obolibrary.org/obo/GO_0033328) (peroxisome membrane targeting sequence binding), [GO:0033327](http://purl.obolibrary.org/obo/GO_0033327) (Leydig cell differentiation), [GO:0035984](http://purl.obolibrary.org/obo/GO_0035984) (cellular response to trichostatin A), [GO:0008360](http://purl.obolibrary.org/obo/GO_0008360) (regulation of cell shape), [GO:0007032](http://purl.obolibrary.org/obo/GO_0007032) (endosome organization), [GO:0007033](http://purl.obolibrary.org/obo/GO_0007033) (vacuole organization), [GO:0007030](http://purl.obolibrary.org/obo/GO_0007030) (Golgi organization), [GO:0008361](http://purl.obolibrary.org/obo/GO_0008361) (regulation of cell size), [GO:0007031](http://purl.obolibrary.org/obo/GO_0007031) (peroxisome organization), [GO:0020003](http://purl.obolibrary.org/obo/GO_0020003) (symbiont-containing vacuole), [GO:0007037](http://purl.obolibrary.org/obo/GO_0007037), [GO:0060900](http://purl.obolibrary.org/obo/GO_0060900) (embryonic camera-type eye formation), [GO:0007034](http://purl.obolibrary.org/obo/GO_0007034) (vacuolar transport), [GO:0060901](http://purl.obolibrary.org/obo/GO_0060901) (regulation of hair cycle by canonical Wnt signaling pathway), [GO:0008366](http://purl.obolibrary.org/obo/GO_0008366) (axon ensheathment), [GO:0007035](http://purl.obolibrary.org/obo/GO_0007035) (vacuolar acidification), [GO:0007039](http://purl.obolibrary.org/obo/GO_0007039) (protein catabolic process in the vacuole), [GO:0034649](http://purl.obolibrary.org/obo/GO_0034649) (histone demethylase activity (H3-monomethyl-K4 specific)), [GO:1990226](http://purl.obolibrary.org/obo/GO_1990226) (histone methyltransferase binding), [GO:0051186](http://purl.obolibrary.org/obo/GO_0051186) (cofactor metabolic process), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:0033313](http://purl.obolibrary.org/obo/GO_0033313) (meiotic cell cycle checkpoint), [GO:0035977](http://purl.obolibrary.org/obo/GO_0035977) (protein deglycosylation involved in glycoprotein catabolic process), [GO:0034648](http://purl.obolibrary.org/obo/GO_0034648) (histone demethylase activity (H3-dimethyl-K4 specific)), [GO:0035973](http://purl.obolibrary.org/obo/GO_0035973) (aggrephagy), [GO:0034645](http://purl.obolibrary.org/obo/GO_0034645) (cellular macromolecule biosynthetic process), [GO:0007040](http://purl.obolibrary.org/obo/GO_0007040) (lysosome organization), [GO:0010693](http://purl.obolibrary.org/obo/GO_0010693) (negative regulation of alkaline phosphatase activity), [GO:0035970](http://purl.obolibrary.org/obo/GO_0035970) (peptidyl-threonine dephosphorylation), [GO:0008375](http://purl.obolibrary.org/obo/GO_0008375) (acetylglucosaminyltransferase activity), [GO:0007043](http://purl.obolibrary.org/obo/GO_0007043) (cell-cell junction assembly), [GO:0008374](http://purl.obolibrary.org/obo/GO_0008374) (O-acyltransferase activity), [GO:0007041](http://purl.obolibrary.org/obo/GO_0007041) (lysosomal transport), [GO:0008373](http://purl.obolibrary.org/obo/GO_0008373) (sialyltransferase activity), [GO:0007042](http://purl.obolibrary.org/obo/GO_0007042) (lysosomal lumen acidification), [GO:1904288](http://purl.obolibrary.org/obo/GO_1904288) (BAT3 complex binding), [GO:0008379](http://purl.obolibrary.org/obo/GO_0008379) (thioredoxin peroxidase activity), [GO:0046600](http://purl.obolibrary.org/obo/GO_0046600) (negative regulation of centriole replication), [GO:0008378](http://purl.obolibrary.org/obo/GO_0008378) (galactosyltransferase activity), [GO:0046601](http://purl.obolibrary.org/obo/GO_0046601) (positive regulation of centriole replication), [GO:0008376](http://purl.obolibrary.org/obo/GO_0008376) (acetylgalactosaminyltransferase activity), [GO:0046605](http://purl.obolibrary.org/obo/GO_0046605) (regulation of centrosome cycle), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:1990234](http://purl.obolibrary.org/obo/GO_1990234) (transferase complex), [GO:0034638](http://purl.obolibrary.org/obo/GO_0034638) (phosphatidylcholine catabolic process), [GO:0019012](http://purl.obolibrary.org/obo/GO_0019012) (virion), [GO:1990239](http://purl.obolibrary.org/obo/GO_1990239) (steroid hormone binding), [GO:0034633](http://purl.obolibrary.org/obo/GO_0034633) (retinol transport), [GO:0035965](http://purl.obolibrary.org/obo/GO_0035965) (cardiolipin acyl-chain remodeling), [GO:0019013](http://purl.obolibrary.org/obo/GO_0019013) (viral nucleocapsid), [GO:0034632](http://purl.obolibrary.org/obo/GO_0034632) (retinol transmembrane transporter activity), [GO:1904283](http://purl.obolibrary.org/obo/GO_1904283) (negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I), [GO:0033306](http://purl.obolibrary.org/obo/GO_0033306) (phytol metabolic process), [GO:0007094](http://purl.obolibrary.org/obo/GO_0007094) (mitotic spindle assembly checkpoint), [GO:0007093](http://purl.obolibrary.org/obo/GO_0007093) (mitotic cell cycle checkpoint), [GO:0007098](http://purl.obolibrary.org/obo/GO_0007098) (centrosome cycle), [GO:0007099](http://purl.obolibrary.org/obo/GO_0007099) (centriole replication), [GO:0007096](http://purl.obolibrary.org/obo/GO_0007096) (regulation of exit from mitosis), [GO:0016805](http://purl.obolibrary.org/obo/GO_0016805) (dipeptidase activity), [GO:0007097](http://purl.obolibrary.org/obo/GO_0007097) (nuclear migration), [GO:0004812](http://purl.obolibrary.org/obo/GO_0004812) (aminoacyl-tRNA ligase activity), [GO:0004814](http://purl.obolibrary.org/obo/GO_0004814) (arginine-tRNA ligase activity), [GO:0004813](http://purl.obolibrary.org/obo/GO_0004813) (alanine-tRNA ligase activity), [GO:0004815](http://purl.obolibrary.org/obo/GO_0004815) (aspartate-tRNA ligase activity), [GO:0070324](http://purl.obolibrary.org/obo/GO_0070324) (thyroid hormone binding), [GO:0004818](http://purl.obolibrary.org/obo/GO_0004818) (glutamate-tRNA ligase activity), [GO:0070325](http://purl.obolibrary.org/obo/GO_0070325) (lipoprotein particle receptor binding), [GO:0032048](http://purl.obolibrary.org/obo/GO_0032048) (cardiolipin metabolic process), [GO:0004817](http://purl.obolibrary.org/obo/GO_0004817) (cysteine-tRNA ligase activity), [GO:0032045](http://purl.obolibrary.org/obo/GO_0032045) (guanyl-nucleotide exchange factor complex), [GO:0004819](http://purl.obolibrary.org/obo/GO_0004819) (glutamine-tRNA ligase activity), [GO:0007091](http://purl.obolibrary.org/obo/GO_0007091) (metaphase/anaphase transition of mitotic cell cycle), [GO:0070326](http://purl.obolibrary.org/obo/GO_0070326) (very-low-density lipoprotein particle receptor binding), [GO:0032049](http://purl.obolibrary.org/obo/GO_0032049) (cardiolipin biosynthetic process), [GO:0070327](http://purl.obolibrary.org/obo/GO_0070327) (thyroid hormone transport), [GO:0032040](http://purl.obolibrary.org/obo/GO_0032040) (small-subunit processome), [GO:0060993](http://purl.obolibrary.org/obo/GO_0060993) (kidney morphogenesis), [GO:0032041](http://purl.obolibrary.org/obo/GO_0032041) (NAD-dependent histone deacetylase activity (H3-K14 specific)), [GO:0032042](http://purl.obolibrary.org/obo/GO_0032042) (mitochondrial DNA metabolic process), [GO:0060998](http://purl.obolibrary.org/obo/GO_0060998) (regulation of dendritic spine development), [GO:0060999](http://purl.obolibrary.org/obo/GO_0060999) (positive regulation of dendritic spine development), [GO:0060996](http://purl.obolibrary.org/obo/GO_0060996) (dendritic spine development), [GO:0060997](http://purl.obolibrary.org/obo/GO_0060997) (dendritic spine morphogenesis), [GO:0004821](http://purl.obolibrary.org/obo/GO_0004821) (histidine-tRNA ligase activity), [GO:0004820](http://purl.obolibrary.org/obo/GO_0004820) (glycine-tRNA ligase activity), [GO:0004823](http://purl.obolibrary.org/obo/GO_0004823) (leucine-tRNA ligase activity), [GO:0004822](http://purl.obolibrary.org/obo/GO_0004822) (isoleucine-tRNA ligase activity), [GO:0004825](http://purl.obolibrary.org/obo/GO_0004825) (methionine-tRNA ligase activity), [GO:0004824](http://purl.obolibrary.org/obo/GO_0004824) (lysine-tRNA ligase activity), [GO:0004826](http://purl.obolibrary.org/obo/GO_0004826) (phenylalanine-tRNA ligase activity), [GO:0032036](http://purl.obolibrary.org/obo/GO_0032036) (myosin heavy chain binding), [GO:0004829](http://purl.obolibrary.org/obo/GO_0004829) (threonine-tRNA ligase activity), [GO:0070314](http://purl.obolibrary.org/obo/GO_0070314) (G1 to G0 transition), [GO:0019079](http://purl.obolibrary.org/obo/GO_0019079) (viral genome replication), [GO:0033365](http://purl.obolibrary.org/obo/GO_0033365) (protein localization to organelle), [GO:0070315](http://purl.obolibrary.org/obo/GO_0070315) (G1 to G0 transition involved in cell differentiation), [GO:0032039](http://purl.obolibrary.org/obo/GO_0032039) (integrator complex), [GO:0007076](http://purl.obolibrary.org/obo/GO_0007076) (mitotic chromosome condensation), [GO:0033364](http://purl.obolibrary.org/obo/GO_0033364) (mast cell secretory granule organization), [GO:0007074](http://purl.obolibrary.org/obo/GO_0007074) (positive regulation of transcription involved in exit from mitosis, from RNA polymerase II promoter), [GO:0007079](http://purl.obolibrary.org/obo/GO_0007079) (mitotic chromosome movement towards spindle pole), [GO:0071670](http://purl.obolibrary.org/obo/GO_0071670) (smooth muscle cell chemotaxis), [GO:0032025](http://purl.obolibrary.org/obo/GO_0032025) (response to cobalt ion), [GO:0019068](http://purl.obolibrary.org/obo/GO_0019068) (virion assembly), [GO:0071678](http://purl.obolibrary.org/obo/GO_0071678) (olfactory bulb axon guidance), [GO:0032026](http://purl.obolibrary.org/obo/GO_0032026) (response to magnesium ion), [GO:0070345](http://purl.obolibrary.org/obo/GO_0070345) (negative regulation of fat cell proliferation), [GO:0032024](http://purl.obolibrary.org/obo/GO_0032024) (positive regulation of insulin secretion), [GO:0032029](http://purl.obolibrary.org/obo/GO_0032029) (myosin tail binding), [GO:0071679](http://purl.obolibrary.org/obo/GO_0071679) (commissural neuron axon guidance), [GO:0007084](http://purl.obolibrary.org/obo/GO_0007084) (mitotic nuclear envelope reassembly), [GO:0033353](http://purl.obolibrary.org/obo/GO_0033353) (S-adenosylmethionine cycle), [GO:0007088](http://purl.obolibrary.org/obo/GO_0007088) (regulation of mitotic nuclear division), [GO:0007089](http://purl.obolibrary.org/obo/GO_0007089) (traversing start control point of mitotic cell cycle), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0070330](http://purl.obolibrary.org/obo/GO_0070330) (aromatase activity), [GO:0004807](http://purl.obolibrary.org/obo/GO_0004807) (triose-phosphate isomerase activity), [GO:0004806](http://purl.obolibrary.org/obo/GO_0004806) (triglyceride lipase activity), [GO:0032012](http://purl.obolibrary.org/obo/GO_0032012) (regulation of ARF protein signal transduction), [GO:0033344](http://purl.obolibrary.org/obo/GO_0033344) (cholesterol efflux), [GO:0007080](http://purl.obolibrary.org/obo/GO_0007080) (mitotic metaphase plate congression), [GO:0032094](http://purl.obolibrary.org/obo/GO_0032094) (response to food), [GO:0032095](http://purl.obolibrary.org/obo/GO_0032095) (regulation of response to food), [GO:0032092](http://purl.obolibrary.org/obo/GO_0032092) (positive regulation of protein binding), [GO:0071617](http://purl.obolibrary.org/obo/GO_0071617) (lysophospholipid acyltransferase activity), [GO:0016849](http://purl.obolibrary.org/obo/GO_0016849) (phosphorus-oxygen lyase activity), [GO:0046655](http://purl.obolibrary.org/obo/GO_0046655) (folic acid metabolic process), [GO:0045324](http://purl.obolibrary.org/obo/GO_0045324) (late endosome to vacuole transport), [GO:0046656](http://purl.obolibrary.org/obo/GO_0046656) (folic acid biosynthetic process), [GO:0046653](http://purl.obolibrary.org/obo/GO_0046653) (tetrahydrofolate metabolic process), [GO:0045322](http://purl.obolibrary.org/obo/GO_0045322) (unmethylated CpG binding), [GO:0046654](http://purl.obolibrary.org/obo/GO_0046654) (tetrahydrofolate biosynthetic process), [GO:0004861](http://purl.obolibrary.org/obo/GO_0004861) (cyclin-dependent protein serine/threonine kinase inhibitor activity), [GO:0004860](http://purl.obolibrary.org/obo/GO_0004860) (protein kinase inhibitor activity), [GO:0032091](http://purl.obolibrary.org/obo/GO_0032091) (negative regulation of protein binding), [GO:0046658](http://purl.obolibrary.org/obo/GO_0046658) (anchored component of plasma membrane), [GO:0004853](http://purl.obolibrary.org/obo/GO_0004853) (uroporphyrinogen decarboxylase activity), [GO:0045332](http://purl.obolibrary.org/obo/GO_0045332) (phospholipid translocation), [GO:0004857](http://purl.obolibrary.org/obo/GO_0004857) (enzyme inhibitor activity), [GO:0046661](http://purl.obolibrary.org/obo/GO_0046661) (male sex differentiation), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0015501](http://purl.obolibrary.org/obo/GO_0015501) (glutamate:sodium symporter activity), [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity), [GO:0045335](http://purl.obolibrary.org/obo/GO_0045335) (phagocytic vesicle), [GO:0045333](http://purl.obolibrary.org/obo/GO_0045333) (cellular respiration), [GO:0060956](http://purl.obolibrary.org/obo/GO_0060956) (endocardial cell differentiation), [GO:0045334](http://purl.obolibrary.org/obo/GO_0045334) (clathrin-coated endocytic vesicle), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:1900744](http://purl.obolibrary.org/obo/GO_1900744) (regulation of p38MAPK cascade), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:1900746](http://purl.obolibrary.org/obo/GO_1900746) (regulation of vascular endothelial growth factor signaling pathway), [GO:0046668](http://purl.obolibrary.org/obo/GO_0046668) (regulation of retinal cell programmed cell death), [GO:1900745](http://purl.obolibrary.org/obo/GO_1900745) (positive regulation of p38MAPK cascade), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0004866](http://purl.obolibrary.org/obo/GO_0004866) (endopeptidase inhibitor activity), [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity), [GO:0060958](http://purl.obolibrary.org/obo/GO_0060958) (endocardial cell development), [GO:0045340](http://purl.obolibrary.org/obo/GO_0045340) (mercury ion binding), [GO:0046671](http://purl.obolibrary.org/obo/GO_0046671) (negative regulation of retinal cell programmed cell death), [GO:0071600](http://purl.obolibrary.org/obo/GO_0071600) (otic vesicle morphogenesis), [GO:0032079](http://purl.obolibrary.org/obo/GO_0032079) (positive regulation of endodeoxyribonuclease activity), [GO:0071603](http://purl.obolibrary.org/obo/GO_0071603) (endothelial cell-cell adhesion), [GO:0071639](http://purl.obolibrary.org/obo/GO_0071639) (positive regulation of monocyte chemotactic protein-1 production), [GO:0060981](http://purl.obolibrary.org/obo/GO_0060981) (cell migration involved in coronary angiogenesis), [GO:0070309](http://purl.obolibrary.org/obo/GO_0070309) (lens fiber cell morphogenesis), [GO:0060982](http://purl.obolibrary.org/obo/GO_0060982) (coronary artery morphogenesis), [GO:0032077](http://purl.obolibrary.org/obo/GO_0032077) (positive regulation of deoxyribonuclease activity), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0046677](http://purl.obolibrary.org/obo/GO_0046677) (response to antibiotic), [GO:0060988](http://purl.obolibrary.org/obo/GO_0060988) (lipid tube assembly), [GO:0046676](http://purl.obolibrary.org/obo/GO_0046676) (negative regulation of insulin secretion), [GO:0045348](http://purl.obolibrary.org/obo/GO_0045348) (positive regulation of MHC class II biosynthetic process), [GO:0004832](http://purl.obolibrary.org/obo/GO_0004832) (valine-tRNA ligase activity), [GO:1900748](http://purl.obolibrary.org/obo/GO_1900748) (positive regulation of vascular endothelial growth factor signaling pathway), [GO:0004831](http://purl.obolibrary.org/obo/GO_0004831) (tyrosine-tRNA ligase activity), [GO:0046684](http://purl.obolibrary.org/obo/GO_0046684) (response to pyrethroid), [GO:0046685](http://purl.obolibrary.org/obo/GO_0046685) (response to arsenic-containing substance), [GO:0044020](http://purl.obolibrary.org/obo/GO_0044020) (histone methyltransferase activity (H4-R3 specific)), [GO:0045351](http://purl.obolibrary.org/obo/GO_0045351) (type I interferon biosynthetic process), [GO:0004838](http://purl.obolibrary.org/obo/GO_0004838) (L-tyrosine:2-oxoglutarate aminotransferase activity), [GO:0004839](http://purl.obolibrary.org/obo/GO_0004839) (ubiquitin activating enzyme activity), [GO:0070300](http://purl.obolibrary.org/obo/GO_0070300) (phosphatidic acid binding), [GO:0070301](http://purl.obolibrary.org/obo/GO_0070301) (cellular response to hydrogen peroxide), [GO:0070306](http://purl.obolibrary.org/obo/GO_0070306) (lens fiber cell differentiation), [GO:0070307](http://purl.obolibrary.org/obo/GO_0070307) (lens fiber cell development), [GO:0071635](http://purl.obolibrary.org/obo/GO_0071635) (negative regulation of transforming growth factor beta production), [GO:0016831](http://purl.obolibrary.org/obo/GO_0016831) (carboxy-lyase activity), [GO:0016810](http://purl.obolibrary.org/obo/GO_0016810) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds), [GO:0016811](http://purl.obolibrary.org/obo/GO_0016811) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides), [GO:0016812](http://purl.obolibrary.org/obo/GO_0016812) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides), [GO:0033391](http://purl.obolibrary.org/obo/GO_0033391) (chromatoid body), [GO:0060971](http://purl.obolibrary.org/obo/GO_0060971) (embryonic heart tube left/right pattern formation), [GO:0032060](http://purl.obolibrary.org/obo/GO_0032060) (bleb assembly), [GO:0071629](http://purl.obolibrary.org/obo/GO_0071629) (cytoplasm protein quality control by the ubiquitin-proteasome system), [GO:0016817](http://purl.obolibrary.org/obo/GO_0016817) (hydrolase activity, acting on acid anhydrides), [GO:0060976](http://purl.obolibrary.org/obo/GO_0060976) (coronary vasculature development), [GO:0046688](http://purl.obolibrary.org/obo/GO_0046688) (response to copper ion), [GO:0016818](http://purl.obolibrary.org/obo/GO_0016818) (hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides), [GO:0044025](http://purl.obolibrary.org/obo/GO_0044025) (histone kinase activity (H2B-S14 specific)), [GO:0045358](http://purl.obolibrary.org/obo/GO_0045358) (negative regulation of interferon-beta biosynthetic process), [GO:0046689](http://purl.obolibrary.org/obo/GO_0046689) (response to mercury ion), [GO:0060977](http://purl.obolibrary.org/obo/GO_0060977) (coronary vasculature morphogenesis), [GO:0046686](http://purl.obolibrary.org/obo/GO_0046686) (response to cadmium ion), [GO:0060978](http://purl.obolibrary.org/obo/GO_0060978) (angiogenesis involved in coronary vascular morphogenesis), [GO:0044027](http://purl.obolibrary.org/obo/GO_0044027) (hypermethylation of CpG island), [GO:0060979](http://purl.obolibrary.org/obo/GO_0060979) (vasculogenesis involved in coronary vascular morphogenesis), [GO:0044026](http://purl.obolibrary.org/obo/GO_0044026) (DNA hypermethylation), [GO:0060972](http://purl.obolibrary.org/obo/GO_0060972) (left/right pattern formation), [GO:0060973](http://purl.obolibrary.org/obo/GO_0060973) (cell migration involved in heart development), [GO:0004852](http://purl.obolibrary.org/obo/GO_0004852) (uroporphyrinogen-III synthase activity), [GO:0045359](http://purl.obolibrary.org/obo/GO_0045359) (positive regulation of interferon-beta biosynthetic process), [GO:0060975](http://purl.obolibrary.org/obo/GO_0060975) (cardioblast migration to the midline involved in heart field formation), [GO:0004843](http://purl.obolibrary.org/obo/GO_0004843) (thiol-dependent ubiquitin-specific protease activity), [GO:0046691](http://purl.obolibrary.org/obo/GO_0046691) (intracellular canaliculus), [GO:0004842](http://purl.obolibrary.org/obo/GO_0004842) (ubiquitin-protein transferase activity), [GO:0044030](http://purl.obolibrary.org/obo/GO_0044030) (regulation of DNA methylation), [GO:0019098](http://purl.obolibrary.org/obo/GO_0019098) (reproductive behavior), [GO:0046695](http://purl.obolibrary.org/obo/GO_0046695) (SLIK (SAGA-like) complex), [GO:0071627](http://purl.obolibrary.org/obo/GO_0071627) (integral component of fungal-type vacuolar membrane), [GO:0071625](http://purl.obolibrary.org/obo/GO_0071625) (vocalization behavior), [GO:0015671](http://purl.obolibrary.org/obo/GO_0015671) (oxygen transport), [GO:0015670](http://purl.obolibrary.org/obo/GO_0015670) (carbon dioxide transport), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0003691](http://purl.obolibrary.org/obo/GO_0003691) (double-stranded telomeric DNA binding), [GO:0003692](http://purl.obolibrary.org/obo/GO_0003692) (left-handed Z-DNA binding), [GO:0001026](http://purl.obolibrary.org/obo/GO_0001026) (TFIIIB-type transcription factor activity), [GO:0003697](http://purl.obolibrary.org/obo/GO_0003697) (single-stranded DNA binding), [GO:0003688](http://purl.obolibrary.org/obo/GO_0003688) (DNA replication origin binding), [GO:0001034](http://purl.obolibrary.org/obo/GO_0001034) (RNA polymerase III transcription factor activity, sequence-specific DNA binding), [GO:0016997](http://purl.obolibrary.org/obo/GO_0016997) (alpha-sialidase activity), [GO:0002371](http://purl.obolibrary.org/obo/GO_0002371) (dendritic cell cytokine production), [GO:0002374](http://purl.obolibrary.org/obo/GO_0002374) (cytokine secretion involved in immune response), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0001046](http://purl.obolibrary.org/obo/GO_0001046) (core promoter sequence-specific DNA binding), [GO:0001042](http://purl.obolibrary.org/obo/GO_0001042) (RNA polymerase I core binding), [GO:0052629](http://purl.obolibrary.org/obo/GO_0052629) (phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity), [GO:0015679](http://purl.obolibrary.org/obo/GO_0015679) (plasma membrane copper ion transport), [GO:0015677](http://purl.obolibrary.org/obo/GO_0015677) (copper ion import), [GO:0015651](http://purl.obolibrary.org/obo/GO_0015651) (quaternary ammonium group transmembrane transporter activity), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0002344](http://purl.obolibrary.org/obo/GO_0002344) (B cell affinity maturation), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0051302](http://purl.obolibrary.org/obo/GO_0051302) (regulation of cell division), [GO:0001012](http://purl.obolibrary.org/obo/GO_0001012) (RNA polymerase II regulatory region DNA binding), [GO:0001011](http://purl.obolibrary.org/obo/GO_0001011) (transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting), [GO:0004999](http://purl.obolibrary.org/obo/GO_0004999) (vasoactive intestinal polypeptide receptor activity), [GO:0051300](http://purl.obolibrary.org/obo/GO_0051300) (spindle pole body organization), [GO:0016992](http://purl.obolibrary.org/obo/GO_0016992) (lipoate synthase activity), [GO:0051306](http://purl.obolibrary.org/obo/GO_0051306) (mitotic sister chromatid separation), [GO:0051303](http://purl.obolibrary.org/obo/GO_0051303) (establishment of chromosome localization), [GO:0003680](http://purl.obolibrary.org/obo/GO_0003680) (AT DNA binding), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0003678](http://purl.obolibrary.org/obo/GO_0003678) (DNA helicase activity), [GO:0051310](http://purl.obolibrary.org/obo/GO_0051310) (metaphase plate congression), [GO:0051315](http://purl.obolibrary.org/obo/GO_0051315) (attachment of mitotic spindle microtubules to kinetochore), [GO:0070481](http://purl.obolibrary.org/obo/GO_0070481) (nuclear-transcribed mRNA catabolic process, non-stop decay), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001076](http://purl.obolibrary.org/obo/GO_0001076) (transcription factor activity, RNA polymerase II transcription factor binding), [GO:0001075](http://purl.obolibrary.org/obo/GO_0001075) (transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly), [GO:0001087](http://purl.obolibrary.org/obo/GO_0001087) (transcription factor activity, TFIIB-class binding), [GO:0070474](http://purl.obolibrary.org/obo/GO_0070474) (positive regulation of uterine smooth muscle contraction), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0070475](http://purl.obolibrary.org/obo/GO_0070475) (rRNA base methylation), [GO:0070478](http://purl.obolibrary.org/obo/GO_0070478) (nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay), [GO:0015698](http://purl.obolibrary.org/obo/GO_0015698) (inorganic anion transport), [GO:0015697](http://purl.obolibrary.org/obo/GO_0015697) (quaternary ammonium group transport), [GO:0015696](http://purl.obolibrary.org/obo/GO_0015696) (ammonium transport), [GO:0015693](http://purl.obolibrary.org/obo/GO_0015693) (magnesium ion transport), [GO:0015691](http://purl.obolibrary.org/obo/GO_0015691) (cadmium ion transport), [GO:0002381](http://purl.obolibrary.org/obo/GO_0002381) (immunoglobulin production involved in immunoglobulin mediated immune response), [GO:0001047](http://purl.obolibrary.org/obo/GO_0001047) (core promoter binding), [GO:0001056](http://purl.obolibrary.org/obo/GO_0001056) (RNA polymerase III activity), [GO:0001054](http://purl.obolibrary.org/obo/GO_0001054) (RNA polymerase I activity), [GO:0070492](http://purl.obolibrary.org/obo/GO_0070492) (oligosaccharide binding), [GO:0001068](http://purl.obolibrary.org/obo/GO_0001068) (transcription regulatory region RNA binding), [GO:0070491](http://purl.obolibrary.org/obo/GO_0070491) (repressing transcription factor binding), [GO:0070495](http://purl.obolibrary.org/obo/GO_0070495) (negative regulation of thrombin-activated receptor signaling pathway), [GO:0070498](http://purl.obolibrary.org/obo/GO_0070498) (interleukin-1-mediated signaling pathway), [GO:0051371](http://purl.obolibrary.org/obo/GO_0051371) (muscle alpha-actinin binding), [GO:0008504](http://purl.obolibrary.org/obo/GO_0008504) (monoamine transmembrane transporter activity), [GO:1990130](http://purl.obolibrary.org/obo/GO_1990130) (GATOR1 complex), [GO:0010817](http://purl.obolibrary.org/obo/GO_0010817) (regulation of hormone levels), [GO:0009826](http://purl.obolibrary.org/obo/GO_0009826) (unidimensional cell growth), [GO:1990124](http://purl.obolibrary.org/obo/GO_1990124) (messenger ribonucleoprotein complex), [GO:0052692](http://purl.obolibrary.org/obo/GO_0052692) (raffinose alpha-galactosidase activity), [GO:0010811](http://purl.obolibrary.org/obo/GO_0010811) (positive regulation of cell-substrate adhesion), [GO:0086002](http://purl.obolibrary.org/obo/GO_0086002) (cardiac muscle cell action potential involved in contraction), [GO:0086001](http://purl.obolibrary.org/obo/GO_0086001) (cardiac muscle cell action potential), [GO:0086006](http://purl.obolibrary.org/obo/GO_0086006) (voltage-gated sodium channel activity involved in cardiac muscle cell action potential), [GO:0086004](http://purl.obolibrary.org/obo/GO_0086004) (regulation of cardiac muscle cell contraction), [GO:0086005](http://purl.obolibrary.org/obo/GO_0086005) (ventricular cardiac muscle cell action potential), [GO:0086008](http://purl.obolibrary.org/obo/GO_0086008) (voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization), [GO:0008514](http://purl.obolibrary.org/obo/GO_0008514) (organic anion transmembrane transporter activity), [GO:1990143](http://purl.obolibrary.org/obo/GO_1990143) (CoA-synthesizing protein complex), [GO:0051378](http://purl.obolibrary.org/obo/GO_0051378) (serotonin binding), [GO:0010828](http://purl.obolibrary.org/obo/GO_0010828) (positive regulation of glucose transport), [GO:0051379](http://purl.obolibrary.org/obo/GO_0051379) (epinephrine binding), [GO:0009838](http://purl.obolibrary.org/obo/GO_0009838) (abscission), [GO:0008506](http://purl.obolibrary.org/obo/GO_0008506) (sucrose:proton symporter activity), [GO:0051377](http://purl.obolibrary.org/obo/GO_0051377) (mannose-ethanolamine phosphotransferase activity), [GO:0010824](http://purl.obolibrary.org/obo/GO_0010824) (regulation of centrosome duplication), [GO:1990138](http://purl.obolibrary.org/obo/GO_1990138) (neuron projection extension), [GO:0010826](http://purl.obolibrary.org/obo/GO_0010826) (negative regulation of centrosome duplication), [GO:0051373](http://purl.obolibrary.org/obo/GO_0051373) (FATZ binding), [GO:0008509](http://purl.obolibrary.org/obo/GO_0008509) (anion transmembrane transporter activity), [GO:0010820](http://purl.obolibrary.org/obo/GO_0010820) (positive regulation of T cell chemotaxis), [GO:0010822](http://purl.obolibrary.org/obo/GO_0010822) (positive regulation of mitochondrion organization), [GO:0010821](http://purl.obolibrary.org/obo/GO_0010821) (regulation of mitochondrion organization), [GO:0086010](http://purl.obolibrary.org/obo/GO_0086010) (membrane depolarization during action potential), [GO:1904231](http://purl.obolibrary.org/obo/GO_1904231) (positive regulation of succinate dehydrogenase activity), [GO:1904234](http://purl.obolibrary.org/obo/GO_1904234) (positive regulation of aconitate hydratase activity), [GO:1904238](http://purl.obolibrary.org/obo/GO_1904238) (pericyte cell differentiation), [GO:0050061](http://purl.obolibrary.org/obo/GO_0050061) (long-chain-aldehyde dehydrogenase activity), [GO:0051388](http://purl.obolibrary.org/obo/GO_0051388) (positive regulation of neurotrophin TRK receptor signaling pathway), [GO:0051386](http://purl.obolibrary.org/obo/GO_0051386) (regulation of neurotrophin TRK receptor signaling pathway), [GO:0001096](http://purl.obolibrary.org/obo/GO_0001096) (TFIIF-class transcription factor binding), [GO:0051384](http://purl.obolibrary.org/obo/GO_0051384) (response to glucocorticoid), [GO:0001094](http://purl.obolibrary.org/obo/GO_0001094) (TFIID-class transcription factor binding), [GO:0001093](http://purl.obolibrary.org/obo/GO_0001093) (TFIIB-class transcription factor binding), [GO:1905574](http://purl.obolibrary.org/obo/GO_1905574) (ganglioside GM2 binding), [GO:1905573](http://purl.obolibrary.org/obo/GO_1905573) (ganglioside GM1 binding), [GO:1905572](http://purl.obolibrary.org/obo/GO_1905572) (ganglioside GM1 transport to membrane), [GO:1904247](http://purl.obolibrary.org/obo/GO_1904247) (positive regulation of polynucleotide adenylyltransferase activity), [GO:0039694](http://purl.obolibrary.org/obo/GO_0039694) (viral RNA genome replication), [GO:1905577](http://purl.obolibrary.org/obo/GO_1905577) (ganglioside GP1c binding), [GO:1905576](http://purl.obolibrary.org/obo/GO_1905576) (ganglioside GT1b binding), [GO:1905575](http://purl.obolibrary.org/obo/GO_1905575) (ganglioside GM3 binding), [GO:0050072](http://purl.obolibrary.org/obo/GO_0050072) (m7G(5')pppN diphosphatase activity), [GO:1990165](http://purl.obolibrary.org/obo/GO_1990165) (single-strand break-containing DNA binding), [GO:0010808](http://purl.obolibrary.org/obo/GO_0010808) (positive regulation of synaptic vesicle priming), [GO:0010807](http://purl.obolibrary.org/obo/GO_0010807) (regulation of synaptic vesicle priming), [GO:0010801](http://purl.obolibrary.org/obo/GO_0010801) (negative regulation of peptidyl-threonine phosphorylation), [GO:0010804](http://purl.obolibrary.org/obo/GO_0010804) (negative regulation of tumor necrosis factor-mediated signaling pathway), [GO:0010800](http://purl.obolibrary.org/obo/GO_0010800) (positive regulation of peptidyl-threonine phosphorylation), [GO:0008540](http://purl.obolibrary.org/obo/GO_0008540) (proteasome regulatory particle, base subcomplex), [GO:0022848](http://purl.obolibrary.org/obo/GO_0022848) (acetylcholine-gated cation-selective channel activity), [GO:0021517](http://purl.obolibrary.org/obo/GO_0021517) (ventral spinal cord development), [GO:0007212](http://purl.obolibrary.org/obo/GO_0007212) (dopamine receptor signaling pathway), [GO:0008544](http://purl.obolibrary.org/obo/GO_0008544) (epidermis development), [GO:0021511](http://purl.obolibrary.org/obo/GO_0021511) (spinal cord patterning), [GO:0008543](http://purl.obolibrary.org/obo/GO_0008543) (fibroblast growth factor receptor signaling pathway), [GO:0007213](http://purl.obolibrary.org/obo/GO_0007213) (G-protein coupled acetylcholine receptor signaling pathway), [GO:0022843](http://purl.obolibrary.org/obo/GO_0022843) (voltage-gated cation channel activity), [GO:0021513](http://purl.obolibrary.org/obo/GO_0021513) (spinal cord dorsal/ventral patterning), [GO:0008542](http://purl.obolibrary.org/obo/GO_0008542) (visual learning), [GO:0021514](http://purl.obolibrary.org/obo/GO_0021514) (ventral spinal cord interneuron differentiation), [GO:0007216](http://purl.obolibrary.org/obo/GO_0007216) (G-protein coupled glutamate receptor signaling pathway), [GO:1990174](http://purl.obolibrary.org/obo/GO_1990174) (phosphodiesterase decapping endonuclease activity), [GO:0007214](http://purl.obolibrary.org/obo/GO_0007214) (gamma-aminobutyric acid signaling pathway), [GO:0022840](http://purl.obolibrary.org/obo/GO_0022840) (leak channel activity), [GO:0021510](http://purl.obolibrary.org/obo/GO_0021510) (spinal cord development), [GO:0007215](http://purl.obolibrary.org/obo/GO_0007215) (glutamate receptor signaling pathway), [GO:0022841](http://purl.obolibrary.org/obo/GO_0022841) (potassium ion leak channel activity), [GO:0051321](http://purl.obolibrary.org/obo/GO_0051321) (meiotic cell cycle), [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process), [GO:0052650](http://purl.obolibrary.org/obo/GO_0052650) (NADP-retinol dehydrogenase activity), [GO:0052651](http://purl.obolibrary.org/obo/GO_0052651) (monoacylglycerol catabolic process), [GO:0019201](http://purl.obolibrary.org/obo/GO_0019201) (nucleotide kinase activity), [GO:0019200](http://purl.obolibrary.org/obo/GO_0019200) (carbohydrate kinase activity), [GO:0019206](http://purl.obolibrary.org/obo/GO_0019206) (nucleoside kinase activity), [GO:0052657](http://purl.obolibrary.org/obo/GO_0052657) (guanine phosphoribosyltransferase activity), [GO:0021508](http://purl.obolibrary.org/obo/GO_0021508) (floor plate formation), [GO:0009881](http://purl.obolibrary.org/obo/GO_0009881) (photoreceptor activity), [GO:0007220](http://purl.obolibrary.org/obo/GO_0007220) (Notch receptor processing), [GO:0009880](http://purl.obolibrary.org/obo/GO_0009880) (embryonic pattern specification), [GO:1990180](http://purl.obolibrary.org/obo/GO_1990180) (mitochondrial tRNA 3'-end processing), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0021501](http://purl.obolibrary.org/obo/GO_0021501) (prechordal plate formation), [GO:1905515](http://purl.obolibrary.org/obo/GO_1905515) (non-motile cilium assembly), [GO:0022832](http://purl.obolibrary.org/obo/GO_0022832) (voltage-gated channel activity), [GO:1990182](http://purl.obolibrary.org/obo/GO_1990182) (exosomal secretion), [GO:0008559](http://purl.obolibrary.org/obo/GO_0008559) (xenobiotic transmembrane transporting ATPase activity), [GO:0007228](http://purl.obolibrary.org/obo/GO_0007228) (positive regulation of hh target transcription factor activity), [GO:0009889](http://purl.obolibrary.org/obo/GO_0009889) (regulation of biosynthetic process), [GO:0009888](http://purl.obolibrary.org/obo/GO_0009888) (tissue development), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0052666](http://purl.obolibrary.org/obo/GO_0052666) (tRNA (cytosine-2'-O-)-methyltransferase activity), [GO:0007218](http://purl.obolibrary.org/obo/GO_0007218) (neuropeptide signaling pathway), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0010868](http://purl.obolibrary.org/obo/GO_0010868) (negative regulation of triglyceride biosynthetic process), [GO:0010863](http://purl.obolibrary.org/obo/GO_0010863) (positive regulation of phospholipase C activity), [GO:0010862](http://purl.obolibrary.org/obo/GO_0010862) (positive regulation of pathway-restricted SMAD protein phosphorylation), [GO:0022824](http://purl.obolibrary.org/obo/GO_0022824) (transmitter-gated ion channel activity), [GO:1990190](http://purl.obolibrary.org/obo/GO_1990190) (peptide-glutamate-N-acetyltransferase activity), [GO:0022820](http://purl.obolibrary.org/obo/GO_0022820) (potassium ion symporter activity), [GO:0008521](http://purl.obolibrary.org/obo/GO_0008521) (acetyl-CoA transmembrane transporter activity), [GO:0008526](http://purl.obolibrary.org/obo/GO_0008526) (phosphatidylinositol transporter activity), [GO:0008525](http://purl.obolibrary.org/obo/GO_0008525) (phosphatidylcholine transporter activity), [GO:0008519](http://purl.obolibrary.org/obo/GO_0008519) (ammonium transmembrane transporter activity), [GO:1990189](http://purl.obolibrary.org/obo/GO_1990189) (peptide-serine-N-acetyltransferase activity), [GO:0010838](http://purl.obolibrary.org/obo/GO_0010838) (positive regulation of keratinocyte proliferation), [GO:0051343](http://purl.obolibrary.org/obo/GO_0051343) (positive regulation of cyclic-nucleotide phosphodiesterase activity), [GO:0008517](http://purl.obolibrary.org/obo/GO_0008517) (folic acid transmembrane transporter activity), [GO:0010835](http://purl.obolibrary.org/obo/GO_0010835) (regulation of protein ADP-ribosylation), [GO:0110008](http://purl.obolibrary.org/obo/GO_0110008) (ncRNA deadenylation), [GO:0010837](http://purl.obolibrary.org/obo/GO_0010837) (regulation of keratinocyte proliferation), [GO:0010836](http://purl.obolibrary.org/obo/GO_0010836) (negative regulation of protein ADP-ribosylation), [GO:0010831](http://purl.obolibrary.org/obo/GO_0010831) (positive regulation of myotube differentiation), [GO:0010830](http://purl.obolibrary.org/obo/GO_0010830) (regulation of myotube differentiation), [GO:0010833](http://purl.obolibrary.org/obo/GO_0010833) (telomere maintenance via telomere lengthening), [GO:0010832](http://purl.obolibrary.org/obo/GO_0010832) (negative regulation of myotube differentiation), [GO:0051349](http://purl.obolibrary.org/obo/GO_0051349) (positive regulation of lyase activity), [GO:0051348](http://purl.obolibrary.org/obo/GO_0051348) (negative regulation of transferase activity), [GO:0007202](http://purl.obolibrary.org/obo/GO_0007202) (activation of phospholipase C activity), [GO:1905537](http://purl.obolibrary.org/obo/GO_1905537) (positive regulation of eukaryotic translation initiation factor 4F complex assembly), [GO:0007200](http://purl.obolibrary.org/obo/GO_0007200) (phospholipase C-activating G-protein coupled receptor signaling pathway), [GO:0007205](http://purl.obolibrary.org/obo/GO_0007205) (protein kinase C-activating G-protein coupled receptor signaling pathway), [GO:0008535](http://purl.obolibrary.org/obo/GO_0008535) (respiratory chain complex IV assembly), [GO:0007204](http://purl.obolibrary.org/obo/GO_0007204) (positive regulation of cytosolic calcium ion concentration), [GO:0051353](http://purl.obolibrary.org/obo/GO_0051353) (positive regulation of oxidoreductase activity), [GO:0051351](http://purl.obolibrary.org/obo/GO_0051351) (positive regulation of ligase activity), [GO:0010842](http://purl.obolibrary.org/obo/GO_0010842) (retina layer formation), [GO:0052689](http://purl.obolibrary.org/obo/GO_0052689) (carboxylic ester hydrolase activity), [GO:0009790](http://purl.obolibrary.org/obo/GO_0009790) (embryo development), [GO:0007131](http://purl.obolibrary.org/obo/GO_0007131) (reciprocal meiotic recombination), [GO:0009792](http://purl.obolibrary.org/obo/GO_0009792) (embryo development ending in birth or egg hatching), [GO:0009791](http://purl.obolibrary.org/obo/GO_0009791) (post-embryonic development), [GO:0007130](http://purl.obolibrary.org/obo/GO_0007130) (synaptonemal complex assembly), [GO:0008460](http://purl.obolibrary.org/obo/GO_0008460) (dTDP-glucose 4,6-dehydratase activity), [GO:0008466](http://purl.obolibrary.org/obo/GO_0008466) (glycogenin glucosyltransferase activity), [GO:0008469](http://purl.obolibrary.org/obo/GO_0008469) (histone-arginine N-methyltransferase activity), [GO:0010792](http://purl.obolibrary.org/obo/GO_0010792) (DNA double-strand break processing involved in repair via single-strand annealing), [GO:0008474](http://purl.obolibrary.org/obo/GO_0008474) (palmitoyl-(protein) hydrolase activity), [GO:0007143](http://purl.obolibrary.org/obo/GO_0007143) (female meiotic nuclear division), [GO:0007141](http://purl.obolibrary.org/obo/GO_0007141) (male meiosis I), [GO:0045410](http://purl.obolibrary.org/obo/GO_0045410) (positive regulation of interleukin-6 biosynthetic process), [GO:0008475](http://purl.obolibrary.org/obo/GO_0008475) (procollagen-lysine 5-dioxygenase activity), [GO:0045416](http://purl.obolibrary.org/obo/GO_0045416) (positive regulation of interleukin-8 biosynthetic process), [GO:1904183](http://purl.obolibrary.org/obo/GO_1904183) (negative regulation of pyruvate dehydrogenase activity), [GO:0045429](http://purl.obolibrary.org/obo/GO_0045429) (positive regulation of nitric oxide biosynthetic process), [GO:0046755](http://purl.obolibrary.org/obo/GO_0046755) (viral budding), [GO:0008443](http://purl.obolibrary.org/obo/GO_0008443) (phosphofructokinase activity), [GO:0008449](http://purl.obolibrary.org/obo/GO_0008449) (N-acetylglucosamine-6-sulfatase activity), [GO:0007117](http://purl.obolibrary.org/obo/GO_0007117) (budding cell bud growth), [GO:0007118](http://purl.obolibrary.org/obo/GO_0007118) (budding cell apical bud growth), [GO:0034728](http://purl.obolibrary.org/obo/GO_0034728) (nucleosome organization), [GO:0034727](http://purl.obolibrary.org/obo/GO_0034727) (piecemeal microautophagy of the nucleus), [GO:0010759](http://purl.obolibrary.org/obo/GO_0010759) (positive regulation of macrophage chemotaxis), [GO:1901919](http://purl.obolibrary.org/obo/GO_1901919) (positive regulation of exoribonuclease activity), [GO:0019102](http://purl.obolibrary.org/obo/GO_0019102) (male somatic sex determination), [GO:0071711](http://purl.obolibrary.org/obo/GO_0071711) (basement membrane organization), [GO:0034720](http://purl.obolibrary.org/obo/GO_0034720) (histone H3-K4 demethylation), [GO:0019101](http://purl.obolibrary.org/obo/GO_0019101) (female somatic sex determination), [GO:0071712](http://purl.obolibrary.org/obo/GO_0071712) (ER-associated misfolded protein catabolic process), [GO:0007120](http://purl.obolibrary.org/obo/GO_0007120) (axial cellular bud site selection), [GO:0007121](http://purl.obolibrary.org/obo/GO_0007121) (bipolar cellular bud site selection), [GO:0071709](http://purl.obolibrary.org/obo/GO_0071709) (membrane assembly), [GO:0007124](http://purl.obolibrary.org/obo/GO_0007124) (pseudohyphal growth), [GO:0008456](http://purl.obolibrary.org/obo/GO_0008456) (alpha-N-acetylgalactosaminidase activity), [GO:0009786](http://purl.obolibrary.org/obo/GO_0009786) (regulation of asymmetric cell division), [GO:0008455](http://purl.obolibrary.org/obo/GO_0008455) (alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity), [GO:0007129](http://purl.obolibrary.org/obo/GO_0007129) (synapsis), [GO:0007119](http://purl.obolibrary.org/obo/GO_0007119) (budding cell isotropic bud growth), [GO:0034719](http://purl.obolibrary.org/obo/GO_0034719) (SMN-Sm protein complex), [GO:0010765](http://purl.obolibrary.org/obo/GO_0010765) (positive regulation of sodium ion transport), [GO:0010766](http://purl.obolibrary.org/obo/GO_0010766) (negative regulation of sodium ion transport), [GO:0071704](http://purl.obolibrary.org/obo/GO_0071704) (organic substance metabolic process), [GO:0071701](http://purl.obolibrary.org/obo/GO_0071701) (regulation of MAPK export from nucleus), [GO:0010763](http://purl.obolibrary.org/obo/GO_0010763) (positive regulation of fibroblast migration), [GO:0010762](http://purl.obolibrary.org/obo/GO_0010762) (regulation of fibroblast migration), [GO:0007175](http://purl.obolibrary.org/obo/GO_0007175) (negative regulation of epidermal growth factor-activated receptor activity), [GO:0007176](http://purl.obolibrary.org/obo/GO_0007176) (regulation of epidermal growth factor-activated receptor activity), [GO:0007173](http://purl.obolibrary.org/obo/GO_0007173) (epidermal growth factor receptor signaling pathway), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0051292](http://purl.obolibrary.org/obo/GO_0051292) (nuclear pore complex assembly), [GO:0007178](http://purl.obolibrary.org/obo/GO_0007178) (transmembrane receptor protein serine/threonine kinase signaling pathway), [GO:0051290](http://purl.obolibrary.org/obo/GO_0051290) (protein heterotetramerization), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0051287](http://purl.obolibrary.org/obo/GO_0051287) (NAD binding), [GO:0007182](http://purl.obolibrary.org/obo/GO_0007182) (common-partner SMAD protein phosphorylation), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0032120](http://purl.obolibrary.org/obo/GO_0032120) (ascospore-type prospore membrane assembly), [GO:0007184](http://purl.obolibrary.org/obo/GO_0007184) (SMAD protein import into nucleus), [GO:0007188](http://purl.obolibrary.org/obo/GO_0007188) (adenylate cyclase-modulating G-protein coupled receptor signaling pathway), [GO:0007189](http://purl.obolibrary.org/obo/GO_0007189) (adenylate cyclase-activating G-protein coupled receptor signaling pathway), [GO:2000969](http://purl.obolibrary.org/obo/GO_2000969) (positive regulation of AMPA receptor activity), [GO:0051298](http://purl.obolibrary.org/obo/GO_0051298) (centrosome duplication), [GO:0034776](http://purl.obolibrary.org/obo/GO_0034776) (response to histamine), [GO:0004908](http://purl.obolibrary.org/obo/GO_0004908) (interleukin-1 receptor activity), [GO:0034774](http://purl.obolibrary.org/obo/GO_0034774) (secretory granule lumen), [GO:0019158](http://purl.obolibrary.org/obo/GO_0019158) (mannokinase activity), [GO:0032116](http://purl.obolibrary.org/obo/GO_0032116) (SMC loading complex), [GO:0046718](http://purl.obolibrary.org/obo/GO_0046718) (viral entry into host cell), [GO:0046716](http://purl.obolibrary.org/obo/GO_0046716) (muscle cell cellular homeostasis), [GO:0046717](http://purl.obolibrary.org/obo/GO_0046717) (acid secretion), [GO:0008484](http://purl.obolibrary.org/obo/GO_0008484) (sulfuric ester hydrolase activity), [GO:0007154](http://purl.obolibrary.org/obo/GO_0007154) (cell communication), [GO:0008483](http://purl.obolibrary.org/obo/GO_0008483) (transaminase activity), [GO:0034770](http://purl.obolibrary.org/obo/GO_0034770) (histone H4-K20 methylation), [GO:0008482](http://purl.obolibrary.org/obo/GO_0008482) (sulfite oxidase activity), [GO:0007157](http://purl.obolibrary.org/obo/GO_0007157) (heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules), [GO:0007158](http://purl.obolibrary.org/obo/GO_0007158) (neuron cell-cell adhesion), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0007156](http://purl.obolibrary.org/obo/GO_0007156) (homophilic cell adhesion via plasma membrane adhesion molecules), [GO:0046715](http://purl.obolibrary.org/obo/GO_0046715) (active borate transmembrane transporter activity), [GO:0046713](http://purl.obolibrary.org/obo/GO_0046713) (borate transport), [GO:2000977](http://purl.obolibrary.org/obo/GO_2000977) (regulation of forebrain neuron differentiation), [GO:1990108](http://purl.obolibrary.org/obo/GO_1990108) (protein linear deubiquitination), [GO:0034765](http://purl.obolibrary.org/obo/GO_0034765) (regulation of ion transmembrane transport), [GO:2000973](http://purl.obolibrary.org/obo/GO_2000973) (regulation of pro-B cell differentiation), [GO:0010794](http://purl.obolibrary.org/obo/GO_0010794) (regulation of dolichol biosynthetic process), [GO:0010793](http://purl.obolibrary.org/obo/GO_0010793) (regulation of mRNA export from nucleus), [GO:0010796](http://purl.obolibrary.org/obo/GO_0010796) (regulation of multivesicular body size), [GO:1905480](http://purl.obolibrary.org/obo/GO_1905480) (positive regulation of glutamate-ammonia ligase activity), [GO:0034767](http://purl.obolibrary.org/obo/GO_0034767) (positive regulation of ion transmembrane transport), [GO:0034766](http://purl.obolibrary.org/obo/GO_0034766) (negative regulation of ion transmembrane transport), [GO:0010795](http://purl.obolibrary.org/obo/GO_0010795) (regulation of ubiquinone biosynthetic process), [GO:0007160](http://purl.obolibrary.org/obo/GO_0007160) (cell-matrix adhesion), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0034760](http://purl.obolibrary.org/obo/GO_0034760) (negative regulation of iron ion transmembrane transport), [GO:0008495](http://purl.obolibrary.org/obo/GO_0008495) (protoheme IX farnesyltransferase activity), [GO:0007162](http://purl.obolibrary.org/obo/GO_0007162) (negative regulation of cell adhesion), [GO:0007163](http://purl.obolibrary.org/obo/GO_0007163) (establishment or maintenance of cell polarity), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0046725](http://purl.obolibrary.org/obo/GO_0046725) (negative regulation by virus of viral protein levels in host cell), [GO:0046726](http://purl.obolibrary.org/obo/GO_0046726) (positive regulation by virus of viral protein levels in host cell), [GO:2000987](http://purl.obolibrary.org/obo/GO_2000987) (positive regulation of behavioral fear response), [GO:2000984](http://purl.obolibrary.org/obo/GO_2000984) (negative regulation of ATP citrate synthase activity), [GO:2000980](http://purl.obolibrary.org/obo/GO_2000980) (regulation of inner ear receptor cell differentiation), [GO:0016925](http://purl.obolibrary.org/obo/GO_0016925) (protein sumoylation), [GO:1901987](http://purl.obolibrary.org/obo/GO_1901987) (regulation of cell cycle phase transition), [GO:0004931](http://purl.obolibrary.org/obo/GO_0004931) (extracellularly ATP-gated cation channel activity), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0004935](http://purl.obolibrary.org/obo/GO_0004935) (adrenergic receptor activity), [GO:0071773](http://purl.obolibrary.org/obo/GO_0071773) (cellular response to BMP stimulus), [GO:0045494](http://purl.obolibrary.org/obo/GO_0045494) (photoreceptor cell maintenance), [GO:0004936](http://purl.obolibrary.org/obo/GO_0004936) (alpha-adrenergic receptor activity), [GO:0070445](http://purl.obolibrary.org/obo/GO_0070445) (regulation of oligodendrocyte progenitor proliferation), [GO:0004938](http://purl.obolibrary.org/obo/GO_0004938) (alpha2-adrenergic receptor activity), [GO:0033499](http://purl.obolibrary.org/obo/GO_0033499) (galactose catabolic process via UDP-galactose), [GO:0070444](http://purl.obolibrary.org/obo/GO_0070444) (oligodendrocyte progenitor proliferation), [GO:0070447](http://purl.obolibrary.org/obo/GO_0070447) (positive regulation of oligodendrocyte progenitor proliferation), [GO:0032160](http://purl.obolibrary.org/obo/GO_0032160) (septin filament array), [GO:1901990](http://purl.obolibrary.org/obo/GO_1901990) (regulation of mitotic cell cycle phase transition), [GO:0032165](http://purl.obolibrary.org/obo/GO_0032165) (prospore septin filament array), [GO:0016917](http://purl.obolibrary.org/obo/GO_0016917) (GABA receptor activity), [GO:0016918](http://purl.obolibrary.org/obo/GO_0016918) (retinal binding), [GO:1901998](http://purl.obolibrary.org/obo/GO_1901998) (toxin transport), [GO:0004950](http://purl.obolibrary.org/obo/GO_0004950) (chemokine receptor activity), [GO:0070431](http://purl.obolibrary.org/obo/GO_0070431) (nucleotide-binding oligomerization domain containing 2 signaling pathway), [GO:0071763](http://purl.obolibrary.org/obo/GO_0071763) (nuclear membrane organization), [GO:0007193](http://purl.obolibrary.org/obo/GO_0007193) (adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway), [GO:0007194](http://purl.obolibrary.org/obo/GO_0007194) (negative regulation of adenylate cyclase activity), [GO:0007191](http://purl.obolibrary.org/obo/GO_0007191) (adenylate cyclase-activating dopamine receptor signaling pathway), [GO:0032154](http://purl.obolibrary.org/obo/GO_0032154) (cleavage furrow), [GO:0033484](http://purl.obolibrary.org/obo/GO_0033484) (nitric oxide homeostasis), [GO:0007195](http://purl.obolibrary.org/obo/GO_0007195) (adenylate cyclase-inhibiting dopamine receptor signaling pathway), [GO:0007196](http://purl.obolibrary.org/obo/GO_0007196) (adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway), [GO:0007199](http://purl.obolibrary.org/obo/GO_0007199) (G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger), [GO:0071791](http://purl.obolibrary.org/obo/GO_0071791) (chemokine (C-C motif) ligand 5 binding), [GO:0044183](http://purl.obolibrary.org/obo/GO_0044183) (protein binding involved in protein folding), [GO:0019187](http://purl.obolibrary.org/obo/GO_0019187) (beta-1,4-mannosyltransferase activity), [GO:0032147](http://purl.obolibrary.org/obo/GO_0032147) (activation of protein kinase activity), [GO:0071799](http://purl.obolibrary.org/obo/GO_0071799) (cellular response to prostaglandin D stimulus), [GO:0071797](http://purl.obolibrary.org/obo/GO_0071797) (LUBAC complex), [GO:0007190](http://purl.obolibrary.org/obo/GO_0007190) (activation of adenylate cyclase activity), [GO:0032148](http://purl.obolibrary.org/obo/GO_0032148) (activation of protein kinase B activity), [GO:0070469](http://purl.obolibrary.org/obo/GO_0070469) (respiratory chain), [GO:0032142](http://purl.obolibrary.org/obo/GO_0032142) (single guanine insertion binding), [GO:0032143](http://purl.obolibrary.org/obo/GO_0032143) (single thymine insertion binding), [GO:0071782](http://purl.obolibrary.org/obo/GO_0071782) (endoplasmic reticulum tubular network), [GO:0071787](http://purl.obolibrary.org/obo/GO_0071787) (endoplasmic reticulum tubular network formation), [GO:0032135](http://purl.obolibrary.org/obo/GO_0032135) (DNA insertion or deletion binding), [GO:0071786](http://purl.obolibrary.org/obo/GO_0071786) (endoplasmic reticulum tubular network organization), [GO:0032139](http://purl.obolibrary.org/obo/GO_0032139) (dinucleotide insertion or deletion binding), [GO:0070458](http://purl.obolibrary.org/obo/GO_0070458) (cellular detoxification of nitrogen compound), [GO:0032137](http://purl.obolibrary.org/obo/GO_0032137) (guanine/thymine mispair binding), [GO:0032138](http://purl.obolibrary.org/obo/GO_0032138) (single base insertion or deletion binding), [GO:0015631](http://purl.obolibrary.org/obo/GO_0015631) (tubulin binding), [GO:0015630](http://purl.obolibrary.org/obo/GO_0015630) (microtubule cytoskeleton), [GO:0045445](http://purl.obolibrary.org/obo/GO_0045445) (myoblast differentiation), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0004980](http://purl.obolibrary.org/obo/GO_0004980) (melanocyte-stimulating hormone receptor activity), [GO:0045444](http://purl.obolibrary.org/obo/GO_0045444) (fat cell differentiation), [GO:0002320](http://purl.obolibrary.org/obo/GO_0002320) (lymphoid progenitor cell differentiation), [GO:0004977](http://purl.obolibrary.org/obo/GO_0004977) (melanocortin receptor activity), [GO:0045453](http://purl.obolibrary.org/obo/GO_0045453) (bone resorption), [GO:0002318](http://purl.obolibrary.org/obo/GO_0002318) (myeloid progenitor cell differentiation), [GO:0015629](http://purl.obolibrary.org/obo/GO_0015629) (actin cytoskeleton), [GO:0071732](http://purl.obolibrary.org/obo/GO_0071732) (cellular response to nitric oxide), [GO:0071733](http://purl.obolibrary.org/obo/GO_0071733) (transcriptional activation by promoter-enhancer looping), [GO:0070402](http://purl.obolibrary.org/obo/GO_0070402) (NADPH binding), [GO:0016971](http://purl.obolibrary.org/obo/GO_0016971) (flavin-linked sulfhydryl oxidase activity), [GO:0016972](http://purl.obolibrary.org/obo/GO_0016972) (thiol oxidase activity), [GO:0016973](http://purl.obolibrary.org/obo/GO_0016973) (poly(A)+ mRNA export from nucleus), [GO:0070403](http://purl.obolibrary.org/obo/GO_0070403) (NAD+ binding), [GO:0070404](http://purl.obolibrary.org/obo/GO_0070404) (NADH binding), [GO:0015643](http://purl.obolibrary.org/obo/GO_0015643) (toxic substance binding), [GO:0071727](http://purl.obolibrary.org/obo/GO_0071727) (cellular response to triacyl bacterial lipopeptide), [GO:0045454](http://purl.obolibrary.org/obo/GO_0045454) (cell redox homeostasis), [GO:0046785](http://purl.obolibrary.org/obo/GO_0046785) (microtubule polymerization), [GO:0046786](http://purl.obolibrary.org/obo/GO_0046786) (viral replication complex formation and maintenance), [GO:0001002](http://purl.obolibrary.org/obo/GO_0001002) (RNA polymerase III type 1 promoter sequence-specific DNA binding), [GO:0004985](http://purl.obolibrary.org/obo/GO_0004985) (opioid receptor activity), [GO:0002327](http://purl.obolibrary.org/obo/GO_0002327) (immature B cell differentiation), [GO:0002328](http://purl.obolibrary.org/obo/GO_0002328) (pro-B cell differentiation), [GO:0044130](http://purl.obolibrary.org/obo/GO_0044130) (negative regulation of growth of symbiont in host), [GO:0002329](http://purl.obolibrary.org/obo/GO_0002329) (pre-B cell differentiation), [GO:0071723](http://purl.obolibrary.org/obo/GO_0071723) (lipopeptide binding), [GO:0032194](http://purl.obolibrary.org/obo/GO_0032194) (ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate), [GO:1901964](http://purl.obolibrary.org/obo/GO_1901964) (positive regulation of cell proliferation involved in outflow tract morphogenesis), [GO:0004962](http://purl.obolibrary.org/obo/GO_0004962) (endothelin receptor activity), [GO:0045471](http://purl.obolibrary.org/obo/GO_0045471) (response to ethanol), [GO:0004952](http://purl.obolibrary.org/obo/GO_0004952) (dopamine neurotransmitter receptor activity), [GO:0045475](http://purl.obolibrary.org/obo/GO_0045475) (locomotor rhythm), [GO:0070427](http://purl.obolibrary.org/obo/GO_0070427) (nucleotide-binding oligomerization domain containing 1 signaling pathway), [GO:0032183](http://purl.obolibrary.org/obo/GO_0032183) (SUMO binding), [GO:0032180](http://purl.obolibrary.org/obo/GO_0032180) (ubiquinone biosynthetic process from tyrosine), [GO:0070419](http://purl.obolibrary.org/obo/GO_0070419) (nonhomologous end joining complex), [GO:0016934](http://purl.obolibrary.org/obo/GO_0016934) (extracellularly glycine-gated chloride channel activity), [GO:0032181](http://purl.obolibrary.org/obo/GO_0032181) (dinucleotide repeat insertion binding), [GO:0032186](http://purl.obolibrary.org/obo/GO_0032186) (cellular bud neck septin ring organization), [GO:0016936](http://purl.obolibrary.org/obo/GO_0016936) (galactoside binding), [GO:0016937](http://purl.obolibrary.org/obo/GO_0016937) (short-branched-chain-acyl-CoA dehydrogenase activity), [GO:0044146](http://purl.obolibrary.org/obo/GO_0044146) (negative regulation of growth of symbiont involved in interaction with host), [GO:0004971](http://purl.obolibrary.org/obo/GO_0004971) (AMPA glutamate receptor activity), [GO:0004970](http://purl.obolibrary.org/obo/GO_0004970) (ionotropic glutamate receptor activity), [GO:0002302](http://purl.obolibrary.org/obo/GO_0002302) (CD8-positive, alpha-beta T cell differentiation involved in immune response), [GO:0004966](http://purl.obolibrary.org/obo/GO_0004966) (galanin receptor activity), [GO:0070412](http://purl.obolibrary.org/obo/GO_0070412) (R-SMAD binding), [GO:0070410](http://purl.obolibrary.org/obo/GO_0070410) (co-SMAD binding), [GO:0015616](http://purl.obolibrary.org/obo/GO_0015616) (DNA translocase activity), [GO:0070417](http://purl.obolibrary.org/obo/GO_0070417) (cellular response to cold), [GO:1990090](http://purl.obolibrary.org/obo/GO_1990090) (cellular response to nerve growth factor stimulus), [GO:1990091](http://purl.obolibrary.org/obo/GO_1990091) (sodium-dependent self proteolysis), [GO:0004663](http://purl.obolibrary.org/obo/GO_0004663) (Rab geranylgeranyltransferase activity), [GO:0003333](http://purl.obolibrary.org/obo/GO_0003333) (amino acid transmembrane transport), [GO:0002003](http://purl.obolibrary.org/obo/GO_0002003) (angiotensin maturation), [GO:0003334](http://purl.obolibrary.org/obo/GO_0003334) (keratinocyte development), [GO:0071493](http://purl.obolibrary.org/obo/GO_0071493) (cellular response to UV-B), [GO:0004655](http://purl.obolibrary.org/obo/GO_0004655) (porphobilinogen synthase activity), [GO:0071494](http://purl.obolibrary.org/obo/GO_0071494) (cellular response to UV-C), [GO:0005989](http://purl.obolibrary.org/obo/GO_0005989) (lactose biosynthetic process), [GO:0004657](http://purl.obolibrary.org/obo/GO_0004657) (proline dehydrogenase activity), [GO:0071492](http://purl.obolibrary.org/obo/GO_0071492) (cellular response to UV-A), [GO:0030947](http://purl.obolibrary.org/obo/GO_0030947) (regulation of vascular endothelial growth factor receptor signaling pathway), [GO:0070166](http://purl.obolibrary.org/obo/GO_0070166) (enamel mineralization), [GO:0004659](http://purl.obolibrary.org/obo/GO_0004659) (prenyltransferase activity), [GO:0071498](http://purl.obolibrary.org/obo/GO_0071498) (cellular response to fluid shear stress), [GO:0030949](http://purl.obolibrary.org/obo/GO_0030949) (positive regulation of vascular endothelial growth factor receptor signaling pathway), [GO:0030948](http://purl.obolibrary.org/obo/GO_0030948) (negative regulation of vascular endothelial growth factor receptor signaling pathway), [GO:0016651](http://purl.obolibrary.org/obo/GO_0016651) (oxidoreductase activity, acting on NAD(P)H), [GO:0016653](http://purl.obolibrary.org/obo/GO_0016653) (oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor), [GO:0016655](http://purl.obolibrary.org/obo/GO_0016655) (oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor), [GO:0016638](http://purl.obolibrary.org/obo/GO_0016638) (oxidoreductase activity, acting on the CH-NH2 group of donors), [GO:0016639](http://purl.obolibrary.org/obo/GO_0016639) (oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0003341](http://purl.obolibrary.org/obo/GO_0003341) (cilium movement), [GO:0003342](http://purl.obolibrary.org/obo/GO_0003342) (proepicardium development), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0003344](http://purl.obolibrary.org/obo/GO_0003344) (pericardium morphogenesis), [GO:0004675](http://purl.obolibrary.org/obo/GO_0004675) (transmembrane receptor protein serine/threonine kinase activity), [GO:0071482](http://purl.obolibrary.org/obo/GO_0071482) (cellular response to light stimulus), [GO:0070152](http://purl.obolibrary.org/obo/GO_0070152) (mitochondrial isoleucyl-tRNA aminoacylation), [GO:0003337](http://purl.obolibrary.org/obo/GO_0003337) (mesenchymal to epithelial transition involved in metanephros morphogenesis), [GO:0071480](http://purl.obolibrary.org/obo/GO_0071480) (cellular response to gamma radiation), [GO:0070150](http://purl.obolibrary.org/obo/GO_0070150) (mitochondrial glycyl-tRNA aminoacylation), [GO:0071481](http://purl.obolibrary.org/obo/GO_0071481) (cellular response to X-ray), [GO:0003338](http://purl.obolibrary.org/obo/GO_0003338) (metanephros morphogenesis), [GO:0002009](http://purl.obolibrary.org/obo/GO_0002009) (morphogenesis of an epithelium), [GO:0070156](http://purl.obolibrary.org/obo/GO_0070156) (mitochondrial phenylalanyl-tRNA aminoacylation), [GO:0070154](http://purl.obolibrary.org/obo/GO_0070154) (mitochondrial lysyl-tRNA aminoacylation), [GO:0070159](http://purl.obolibrary.org/obo/GO_0070159) (mitochondrial threonyl-tRNA aminoacylation), [GO:0015319](http://purl.obolibrary.org/obo/GO_0015319) (sodium:inorganic phosphate symporter activity), [GO:0016624](http://purl.obolibrary.org/obo/GO_0016624) (oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor), [GO:0016627](http://purl.obolibrary.org/obo/GO_0016627) (oxidoreductase activity, acting on the CH-CH group of donors), [GO:0016628](http://purl.obolibrary.org/obo/GO_0016628) (oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor), [GO:0003310](http://purl.obolibrary.org/obo/GO_0003310) (pancreatic A cell differentiation), [GO:0005971](http://purl.obolibrary.org/obo/GO_0005971) (ribonucleoside-diphosphate reductase complex), [GO:0003311](http://purl.obolibrary.org/obo/GO_0003311) (pancreatic D cell differentiation), [GO:0004643](http://purl.obolibrary.org/obo/GO_0004643) (phosphoribosylaminoimidazolecarboxamide formyltransferase activity), [GO:0042953](http://purl.obolibrary.org/obo/GO_0042953) (lipoprotein transport), [GO:0004634](http://purl.obolibrary.org/obo/GO_0004634) (phosphopyruvate hydratase activity), [GO:0070184](http://purl.obolibrary.org/obo/GO_0070184) (mitochondrial tyrosyl-tRNA aminoacylation), [GO:0003303](http://purl.obolibrary.org/obo/GO_0003303) (BMP signaling pathway involved in heart jogging), [GO:0005967](http://purl.obolibrary.org/obo/GO_0005967) (mitochondrial pyruvate dehydrogenase complex), [GO:0070182](http://purl.obolibrary.org/obo/GO_0070182) (DNA polymerase binding), [GO:0005968](http://purl.obolibrary.org/obo/GO_0005968) (Rab-protein geranylgeranyltransferase complex), [GO:0070186](http://purl.obolibrary.org/obo/GO_0070186) (growth hormone activity), [GO:0003309](http://purl.obolibrary.org/obo/GO_0003309) (type B pancreatic cell differentiation), [GO:0070187](http://purl.obolibrary.org/obo/GO_0070187) (shelterin complex), [GO:0015301](http://purl.obolibrary.org/obo/GO_0015301) (anion:anion antiporter activity), [GO:0033194](http://purl.obolibrary.org/obo/GO_0033194) (response to hydroperoxide), [GO:0016614](http://purl.obolibrary.org/obo/GO_0016614) (oxidoreductase activity, acting on CH-OH group of donors), [GO:0016615](http://purl.obolibrary.org/obo/GO_0016615) (malate dehydrogenase activity), [GO:0016616](http://purl.obolibrary.org/obo/GO_0016616) (oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor), [GO:0033198](http://purl.obolibrary.org/obo/GO_0033198) (response to ATP), [GO:0016618](http://purl.obolibrary.org/obo/GO_0016618) (hydroxypyruvate reductase activity), [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development), [GO:0005980](http://purl.obolibrary.org/obo/GO_0005980) (glycogen catabolic process), [GO:0004652](http://purl.obolibrary.org/obo/GO_0004652) (polynucleotide adenylyltransferase activity), [GO:0003322](http://purl.obolibrary.org/obo/GO_0003322) (pancreatic A cell development), [GO:0004654](http://purl.obolibrary.org/obo/GO_0004654) (polyribonucleotide nucleotidyltransferase activity), [GO:0003323](http://purl.obolibrary.org/obo/GO_0003323) (type B pancreatic cell development), [GO:0030910](http://purl.obolibrary.org/obo/GO_0030910) (olfactory placode formation), [GO:0004645](http://purl.obolibrary.org/obo/GO_0004645) (phosphorylase activity), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0005978](http://purl.obolibrary.org/obo/GO_0005978) (glycogen biosynthetic process), [GO:0003315](http://purl.obolibrary.org/obo/GO_0003315) (heart rudiment formation), [GO:0004647](http://purl.obolibrary.org/obo/GO_0004647) (phosphoserine phosphatase activity), [GO:0005977](http://purl.obolibrary.org/obo/GO_0005977) (glycogen metabolic process), [GO:0030911](http://purl.obolibrary.org/obo/GO_0030911) (TPR domain binding), [GO:0005979](http://purl.obolibrary.org/obo/GO_0005979) (regulation of glycogen biosynthetic process), [GO:0003318](http://purl.obolibrary.org/obo/GO_0003318) (cell migration to the midline involved in heart development), [GO:0004648](http://purl.obolibrary.org/obo/GO_0004648) (O-phospho-L-serine:2-oxoglutarate aminotransferase activity), [GO:0030913](http://purl.obolibrary.org/obo/GO_0030913) (paranodal junction assembly), [GO:0030916](http://purl.obolibrary.org/obo/GO_0030916) (otic vesicle formation), [GO:0003319](http://purl.obolibrary.org/obo/GO_0003319) (cardioblast migration to the midline involved in heart rudiment formation), [GO:0030915](http://purl.obolibrary.org/obo/GO_0030915) (Smc5-Smc6 complex), [GO:0014025](http://purl.obolibrary.org/obo/GO_0014025) (neural keel formation), [GO:0003370](http://purl.obolibrary.org/obo/GO_0003370) (cell-cell adhesion involved in mesendodermal cell migration), [GO:0002040](http://purl.obolibrary.org/obo/GO_0002040) (sprouting angiogenesis), [GO:0002043](http://purl.obolibrary.org/obo/GO_0002043) (blood vessel endothelial cell proliferation involved in sprouting angiogenesis), [GO:0003374](http://purl.obolibrary.org/obo/GO_0003374) (dynamin family protein polymerization involved in mitochondrial fission), [GO:0003376](http://purl.obolibrary.org/obo/GO_0003376) (sphingosine-1-phosphate signaling pathway), [GO:0002046](http://purl.obolibrary.org/obo/GO_0002046) (opsin binding), [GO:0002037](http://purl.obolibrary.org/obo/GO_0002037) (negative regulation of L-glutamate transport), [GO:0002038](http://purl.obolibrary.org/obo/GO_0002038) (positive regulation of L-glutamate transport), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0045171](http://purl.obolibrary.org/obo/GO_0045171) (intercellular bridge), [GO:0045177](http://purl.obolibrary.org/obo/GO_0045177) (apical part of cell), [GO:0045178](http://purl.obolibrary.org/obo/GO_0045178) (basal part of cell), [GO:0071454](http://purl.obolibrary.org/obo/GO_0071454) (cellular response to anoxia), [GO:0070121](http://purl.obolibrary.org/obo/GO_0070121) (Kupffer's vesicle development), [GO:0045176](http://purl.obolibrary.org/obo/GO_0045176) (apical protein localization), [GO:0070127](http://purl.obolibrary.org/obo/GO_0070127) (tRNA aminoacylation for mitochondrial protein translation), [GO:0071455](http://purl.obolibrary.org/obo/GO_0071455) (cellular response to hyperoxia), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0030983](http://purl.obolibrary.org/obo/GO_0030983) (mismatched DNA binding), [GO:0015349](http://purl.obolibrary.org/obo/GO_0015349) (thyroid hormone transmembrane transporter activity), [GO:0071459](http://purl.obolibrary.org/obo/GO_0071459) (protein localization to chromosome, centromeric region), [GO:0014016](http://purl.obolibrary.org/obo/GO_0014016) (neuroblast differentiation), [GO:0014037](http://purl.obolibrary.org/obo/GO_0014037) (Schwann cell differentiation), [GO:0014036](http://purl.obolibrary.org/obo/GO_0014036) (neural crest cell fate specification), [GO:0014033](http://purl.obolibrary.org/obo/GO_0014033) (neural crest cell differentiation), [GO:0042903](http://purl.obolibrary.org/obo/GO_0042903) (tubulin deacetylase activity), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0014031](http://purl.obolibrary.org/obo/GO_0014031) (mesenchymal cell development), [GO:0003382](http://purl.obolibrary.org/obo/GO_0003382) (epithelial cell morphogenesis), [GO:0002052](http://purl.obolibrary.org/obo/GO_0002052) (positive regulation of neuroblast proliferation), [GO:0002053](http://purl.obolibrary.org/obo/GO_0002053) (positive regulation of mesenchymal cell proliferation), [GO:0045184](http://purl.obolibrary.org/obo/GO_0045184) (establishment of protein localization), [GO:0003379](http://purl.obolibrary.org/obo/GO_0003379) (establishment of cell polarity involved in gastrulation cell migration), [GO:0030976](http://purl.obolibrary.org/obo/GO_0030976) (thiamine pyrophosphate binding), [GO:0045182](http://purl.obolibrary.org/obo/GO_0045182) (translation regulator activity), [GO:0071442](http://purl.obolibrary.org/obo/GO_0071442) (positive regulation of histone H3-K14 acetylation), [GO:0045188](http://purl.obolibrary.org/obo/GO_0045188) (regulation of circadian sleep/wake cycle, non-REM sleep), [GO:0071440](http://purl.obolibrary.org/obo/GO_0071440) (regulation of histone H3-K14 acetylation), [GO:0045187](http://purl.obolibrary.org/obo/GO_0045187) (regulation of circadian sleep/wake cycle, sleep), [GO:0071441](http://purl.obolibrary.org/obo/GO_0071441) (negative regulation of histone H3-K14 acetylation), [GO:0042908](http://purl.obolibrary.org/obo/GO_0042908) (xenobiotic transport), [GO:0030970](http://purl.obolibrary.org/obo/GO_0030970) (retrograde protein transport, ER to cytosol), [GO:0014029](http://purl.obolibrary.org/obo/GO_0014029) (neural crest formation), [GO:0030971](http://purl.obolibrary.org/obo/GO_0030971) (receptor tyrosine kinase binding), [GO:0014028](http://purl.obolibrary.org/obo/GO_0014028) (notochord formation), [GO:0030974](http://purl.obolibrary.org/obo/GO_0030974) (thiamine pyrophosphate transmembrane transport), [GO:0014004](http://purl.obolibrary.org/obo/GO_0014004) (microglia differentiation), [GO:0014003](http://purl.obolibrary.org/obo/GO_0014003) (oligodendrocyte development), [GO:0016668](http://purl.obolibrary.org/obo/GO_0016668) (oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor), [GO:0014002](http://purl.obolibrary.org/obo/GO_0014002) (astrocyte development), [GO:0003350](http://purl.obolibrary.org/obo/GO_0003350) (pulmonary myocardium development), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0004683](http://purl.obolibrary.org/obo/GO_0004683) (calmodulin-dependent protein kinase activity), [GO:0002021](http://purl.obolibrary.org/obo/GO_0002021) (response to dietary excess), [GO:0071472](http://purl.obolibrary.org/obo/GO_0071472) (cellular response to salt stress), [GO:0070141](http://purl.obolibrary.org/obo/GO_0070141) (response to UV-A), [GO:0003347](http://purl.obolibrary.org/obo/GO_0003347) (epicardial cell to mesenchymal cell transition), [GO:0002016](http://purl.obolibrary.org/obo/GO_0002016) (regulation of blood volume by renin-angiotensin), [GO:0071470](http://purl.obolibrary.org/obo/GO_0071470) (cellular response to osmotic stress), [GO:0004679](http://purl.obolibrary.org/obo/GO_0004679) (AMP-activated protein kinase activity), [GO:0070144](http://purl.obolibrary.org/obo/GO_0070144) (mitochondrial arginyl-tRNA aminoacylation), [GO:0071476](http://purl.obolibrary.org/obo/GO_0071476) (cellular hypotonic response), [GO:0030968](http://purl.obolibrary.org/obo/GO_0030968) (endoplasmic reticulum unfolded protein response), [GO:0070145](http://purl.obolibrary.org/obo/GO_0070145) (mitochondrial asparaginyl-tRNA aminoacylation), [GO:0045197](http://purl.obolibrary.org/obo/GO_0045197) (establishment or maintenance of epithelial cell apical/basal polarity), [GO:0045198](http://purl.obolibrary.org/obo/GO_0045198) (establishment of epithelial cell apical/basal polarity), [GO:0070143](http://purl.obolibrary.org/obo/GO_0070143) (mitochondrial alanyl-tRNA aminoacylation), [GO:0016671](http://purl.obolibrary.org/obo/GO_0016671) (oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor), [GO:0070149](http://purl.obolibrary.org/obo/GO_0070149) (mitochondrial glutamyl-tRNA aminoacylation), [GO:0071477](http://purl.obolibrary.org/obo/GO_0071477) (cellular hypotonic salinity response), [GO:0070146](http://purl.obolibrary.org/obo/GO_0070146) (mitochondrial aspartyl-tRNA aminoacylation), [GO:0030961](http://purl.obolibrary.org/obo/GO_0030961) (peptidyl-arginine hydroxylation), [GO:0045190](http://purl.obolibrary.org/obo/GO_0045190) (isotype switching), [GO:0014015](http://purl.obolibrary.org/obo/GO_0014015) (positive regulation of gliogenesis), [GO:0014014](http://purl.obolibrary.org/obo/GO_0014014) (negative regulation of gliogenesis), [GO:0014013](http://purl.obolibrary.org/obo/GO_0014013) (regulation of gliogenesis), [GO:0014010](http://purl.obolibrary.org/obo/GO_0014010) (Schwann cell proliferation), [GO:0002031](http://purl.obolibrary.org/obo/GO_0002031) (G-protein coupled receptor internalization), [GO:0004693](http://purl.obolibrary.org/obo/GO_0004693) (cyclin-dependent protein serine/threonine kinase activity), [GO:0004698](http://purl.obolibrary.org/obo/GO_0004698) (calcium-dependent protein kinase C activity), [GO:0004697](http://purl.obolibrary.org/obo/GO_0004697) (protein kinase C activity), [GO:0003357](http://purl.obolibrary.org/obo/GO_0003357) (noradrenergic neuron differentiation), [GO:0002026](http://purl.obolibrary.org/obo/GO_0002026) (regulation of the force of heart contraction), [GO:0030954](http://purl.obolibrary.org/obo/GO_0030954) (astral microtubule nucleation), [GO:0004689](http://purl.obolibrary.org/obo/GO_0004689) (phosphorylase kinase activity), [GO:0003358](http://purl.obolibrary.org/obo/GO_0003358) (noradrenergic neuron development), [GO:0002027](http://purl.obolibrary.org/obo/GO_0002027) (regulation of heart rate), [GO:0003359](http://purl.obolibrary.org/obo/GO_0003359) (noradrenergic neuron fate commitment), [GO:0002028](http://purl.obolibrary.org/obo/GO_0002028) (regulation of sodium ion transport), [GO:0030955](http://purl.obolibrary.org/obo/GO_0030955) (potassium ion binding), [GO:0030957](http://purl.obolibrary.org/obo/GO_0030957) (Tat protein binding), [GO:0070131](http://purl.obolibrary.org/obo/GO_0070131) (positive regulation of mitochondrial translation), [GO:0071468](http://purl.obolibrary.org/obo/GO_0071468) (cellular response to acidic pH), [GO:0071466](http://purl.obolibrary.org/obo/GO_0071466) (cellular response to xenobiotic stimulus), [GO:0071467](http://purl.obolibrary.org/obo/GO_0071467) (cellular response to pH), [GO:0014009](http://purl.obolibrary.org/obo/GO_0014009) (glial cell proliferation), [GO:0030950](http://purl.obolibrary.org/obo/GO_0030950) (establishment or maintenance of actin cytoskeleton polarity), [GO:0014005](http://purl.obolibrary.org/obo/GO_0014005) (microglia development), [GO:0038037](http://purl.obolibrary.org/obo/GO_0038037) (G-protein coupled receptor dimeric complex), [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0038036](http://purl.obolibrary.org/obo/GO_0038036) (sphingosine-1-phosphate receptor activity), [GO:0014068](http://purl.obolibrary.org/obo/GO_0014068) (positive regulation of phosphatidylinositol 3-kinase signaling), [GO:0014067](http://purl.obolibrary.org/obo/GO_0014067) (negative regulation of phosphatidylinositol 3-kinase signaling), [GO:0090611](http://purl.obolibrary.org/obo/GO_0090611) (ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway), [GO:0038038](http://purl.obolibrary.org/obo/GO_0038038) (G-protein coupled receptor homodimeric complex), [GO:0038033](http://purl.obolibrary.org/obo/GO_0038033) (positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway), [GO:0014065](http://purl.obolibrary.org/obo/GO_0014065) (phosphatidylinositol 3-kinase signaling), [GO:0002082](http://purl.obolibrary.org/obo/GO_0002082) (regulation of oxidative phosphorylation), [GO:0002083](http://purl.obolibrary.org/obo/GO_0002083) (4-hydroxybenzoate decaprenyltransferase activity), [GO:0002084](http://purl.obolibrary.org/obo/GO_0002084) (protein depalmitoylation), [GO:0014061](http://purl.obolibrary.org/obo/GO_0014061) (regulation of norepinephrine secretion), [GO:1905426](http://purl.obolibrary.org/obo/GO_1905426) (positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation), [GO:0002086](http://purl.obolibrary.org/obo/GO_0002086) (diaphragm contraction), [GO:0002087](http://purl.obolibrary.org/obo/GO_0002087) (regulation of respiratory gaseous exchange by neurological system process), [GO:0002088](http://purl.obolibrary.org/obo/GO_0002088) (lens development in camera-type eye), [GO:0002089](http://purl.obolibrary.org/obo/GO_0002089) (lens morphogenesis in camera-type eye), [GO:1990001](http://purl.obolibrary.org/obo/GO_1990001) (inhibition of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0051000](http://purl.obolibrary.org/obo/GO_0051000) (positive regulation of nitric-oxide synthase activity), [GO:0051001](http://purl.obolibrary.org/obo/GO_0051001) (negative regulation of nitric-oxide synthase activity), [GO:1990009](http://purl.obolibrary.org/obo/GO_1990009) (retinal cell apoptotic process), [GO:0051006](http://purl.obolibrary.org/obo/GO_0051006) (positive regulation of lipoprotein lipase activity), [GO:0038026](http://purl.obolibrary.org/obo/GO_0038026) (reelin-mediated signaling pathway), [GO:1904100](http://purl.obolibrary.org/obo/GO_1904100) (positive regulation of protein O-linked glycosylation), [GO:0038027](http://purl.obolibrary.org/obo/GO_0038027) (apolipoprotein A-I-mediated signaling pathway), [GO:0002091](http://purl.obolibrary.org/obo/GO_0002091) (negative regulation of receptor internalization), [GO:0002092](http://purl.obolibrary.org/obo/GO_0002092) (positive regulation of receptor internalization), [GO:0002093](http://purl.obolibrary.org/obo/GO_0002093) (auditory receptor cell morphogenesis), [GO:0014074](http://purl.obolibrary.org/obo/GO_0014074) (response to purine-containing compound), [GO:0002094](http://purl.obolibrary.org/obo/GO_0002094) (polyprenyltransferase activity), [GO:1904106](http://purl.obolibrary.org/obo/GO_1904106) (protein localization to microvillus), [GO:0002098](http://purl.obolibrary.org/obo/GO_0002098) (tRNA wobble uridine modification), [GO:0014070](http://purl.obolibrary.org/obo/GO_0014070) (response to organic cyclic compound), [GO:1904109](http://purl.obolibrary.org/obo/GO_1904109) (positive regulation of cholesterol import), [GO:0051015](http://purl.obolibrary.org/obo/GO_0051015) (actin filament binding), [GO:0051016](http://purl.obolibrary.org/obo/GO_0051016) (barbed-end actin filament capping), [GO:0051013](http://purl.obolibrary.org/obo/GO_0051013) (microtubule severing), [GO:0051014](http://purl.obolibrary.org/obo/GO_0051014) (actin filament severing), [GO:0051011](http://purl.obolibrary.org/obo/GO_0051011) (microtubule minus-end binding), [GO:0051010](http://purl.obolibrary.org/obo/GO_0051010) (microtubule plus-end binding), [GO:0051019](http://purl.obolibrary.org/obo/GO_0051019) (mitogen-activated protein kinase binding), [GO:0051017](http://purl.obolibrary.org/obo/GO_0051017) (actin filament bundle assembly), [GO:0015379](http://purl.obolibrary.org/obo/GO_0015379) (potassium:chloride symporter activity), [GO:0014047](http://purl.obolibrary.org/obo/GO_0014047) (glutamate secretion), [GO:0015377](http://purl.obolibrary.org/obo/GO_0015377) (cation:chloride symporter activity), [GO:0015375](http://purl.obolibrary.org/obo/GO_0015375) (glycine:sodium symporter activity), [GO:1904115](http://purl.obolibrary.org/obo/GO_1904115) (axon cytoplasm), [GO:0014044](http://purl.obolibrary.org/obo/GO_0014044) (Schwann cell development), [GO:0014043](http://purl.obolibrary.org/obo/GO_0014043) (negative regulation of neuron maturation), [GO:0014042](http://purl.obolibrary.org/obo/GO_0014042) (positive regulation of neuron maturation), [GO:0002062](http://purl.obolibrary.org/obo/GO_0002062) (chondrocyte differentiation), [GO:0002063](http://purl.obolibrary.org/obo/GO_0002063) (chondrocyte development), [GO:0002064](http://purl.obolibrary.org/obo/GO_0002064) (epithelial cell development), [GO:1904117](http://purl.obolibrary.org/obo/GO_1904117) (cellular response to vasopressin), [GO:1990030](http://purl.obolibrary.org/obo/GO_1990030) (pericellular basket), [GO:0002068](http://purl.obolibrary.org/obo/GO_0002068) (glandular epithelial cell development), [GO:0051026](http://purl.obolibrary.org/obo/GO_0051026) (chiasma assembly), [GO:1990023](http://purl.obolibrary.org/obo/GO_1990023) (mitotic spindle midzone), [GO:0051024](http://purl.obolibrary.org/obo/GO_0051024) (positive regulation of immunoglobulin secretion), [GO:0051023](http://purl.obolibrary.org/obo/GO_0051023) (regulation of immunoglobulin secretion), [GO:0051020](http://purl.obolibrary.org/obo/GO_0051020) (GTPase binding), [GO:0051028](http://purl.obolibrary.org/obo/GO_0051028) (mRNA transport), [GO:0015369](http://purl.obolibrary.org/obo/GO_0015369) (calcium:proton antiporter activity), [GO:0014059](http://purl.obolibrary.org/obo/GO_0014059) (regulation of dopamine secretion), [GO:1904121](http://purl.obolibrary.org/obo/GO_1904121) (phosphatidylethanolamine transporter activity), [GO:0038006](http://purl.obolibrary.org/obo/GO_0038006) (netrin receptor activity involved in chemoattraction), [GO:0014056](http://purl.obolibrary.org/obo/GO_0014056) (regulation of acetylcholine secretion, neurotransmission), [GO:0015386](http://purl.obolibrary.org/obo/GO_0015386) (potassium:proton antiporter activity), [GO:0002070](http://purl.obolibrary.org/obo/GO_0002070) (epithelial cell maturation), [GO:0015385](http://purl.obolibrary.org/obo/GO_0015385) (sodium:proton antiporter activity), [GO:0014054](http://purl.obolibrary.org/obo/GO_0014054) (positive regulation of gamma-aminobutyric acid secretion), [GO:0038002](http://purl.obolibrary.org/obo/GO_0038002) (endocrine signaling), [GO:0038001](http://purl.obolibrary.org/obo/GO_0038001) (paracrine signaling), [GO:0002072](http://purl.obolibrary.org/obo/GO_0002072) (optic cup morphogenesis involved in camera-type eye development), [GO:0014051](http://purl.obolibrary.org/obo/GO_0014051) (gamma-aminobutyric acid secretion), [GO:0002074](http://purl.obolibrary.org/obo/GO_0002074) (extraocular skeletal muscle development), [GO:0002076](http://purl.obolibrary.org/obo/GO_0002076) (osteoblast development), [GO:1990042](http://purl.obolibrary.org/obo/GO_1990042) (glycerol dehydrogenase [NAD(P)+] activity), [GO:1990037](http://purl.obolibrary.org/obo/GO_1990037) (Lewy body core), [GO:1990038](http://purl.obolibrary.org/obo/GO_1990038) (Lewy body corona), [GO:0030992](http://purl.obolibrary.org/obo/GO_0030992) (intraciliary transport particle B), [GO:0030991](http://purl.obolibrary.org/obo/GO_0030991) (intraciliary transport particle A), [GO:0090606](http://purl.obolibrary.org/obo/GO_0090606) (single-species surface biofilm formation), [GO:0042974](http://purl.obolibrary.org/obo/GO_0042974) (retinoic acid receptor binding), [GO:0042975](http://purl.obolibrary.org/obo/GO_0042975) (peroxisome proliferator activated receptor binding), [GO:0042987](http://purl.obolibrary.org/obo/GO_0042987) (amyloid precursor protein catabolic process), [GO:0042989](http://purl.obolibrary.org/obo/GO_0042989) (sequestering of actin monomers), [GO:0038066](http://purl.obolibrary.org/obo/GO_0038066) (p38MAPK cascade), [GO:0038061](http://purl.obolibrary.org/obo/GO_0038061) (NIK/NF-kappaB signaling), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0038063](http://purl.obolibrary.org/obo/GO_0038063) (collagen-activated tyrosine kinase receptor signaling pathway), [GO:0042985](http://purl.obolibrary.org/obo/GO_0042985) (negative regulation of amyloid precursor protein biosynthetic process), [GO:0010508](http://purl.obolibrary.org/obo/GO_0010508) (positive regulation of autophagy), [GO:0010507](http://purl.obolibrary.org/obo/GO_0010507) (negative regulation of autophagy), [GO:0070197](http://purl.obolibrary.org/obo/GO_0070197) (meiotic attachment of telomere to nuclear envelope), [GO:0010506](http://purl.obolibrary.org/obo/GO_0010506) (regulation of autophagy), [GO:0070198](http://purl.obolibrary.org/obo/GO_0070198) (protein localization to chromosome, telomeric region), [GO:0010501](http://purl.obolibrary.org/obo/GO_0010501) (RNA secondary structure unwinding), [GO:0042992](http://purl.obolibrary.org/obo/GO_0042992) (negative regulation of transcription factor import into nucleus), [GO:0042993](http://purl.obolibrary.org/obo/GO_0042993) (positive regulation of transcription factor import into nucleus), [GO:0038052](http://purl.obolibrary.org/obo/GO_0038052) (RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding), [GO:0042994](http://purl.obolibrary.org/obo/GO_0042994) (cytoplasmic sequestering of transcription factor), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:1990075](http://purl.obolibrary.org/obo/GO_1990075) (periciliary membrane compartment), [GO:0038042](http://purl.obolibrary.org/obo/GO_0038042) (dimeric G-protein coupled receptor signaling pathway), [GO:1990086](http://purl.obolibrary.org/obo/GO_1990086) (lens fiber cell apoptotic process), [GO:0047708](http://purl.obolibrary.org/obo/GO_0047708) (biotinidase activity), [GO:0090575](http://purl.obolibrary.org/obo/GO_0090575) (RNA polymerase II transcription factor complex), [GO:0022408](http://purl.obolibrary.org/obo/GO_0022408) (negative regulation of cell-cell adhesion), [GO:1904058](http://purl.obolibrary.org/obo/GO_1904058) (positive regulation of sensory perception of pain), [GO:0022409](http://purl.obolibrary.org/obo/GO_0022409) (positive regulation of cell-cell adhesion), [GO:0008104](http://purl.obolibrary.org/obo/GO_0008104) (protein localization), [GO:0009435](http://purl.obolibrary.org/obo/GO_0009435) (NAD biosynthetic process), [GO:0022405](http://purl.obolibrary.org/obo/GO_0022405) (hair cycle process), [GO:0008108](http://purl.obolibrary.org/obo/GO_0008108) (UDP-glucose:hexose-1-phosphate uridylyltransferase activity), [GO:0009437](http://purl.obolibrary.org/obo/GO_0009437) (carnitine metabolic process), [GO:0022400](http://purl.obolibrary.org/obo/GO_0022400) (regulation of rhodopsin mediated signaling pathway), [GO:0035716](http://purl.obolibrary.org/obo/GO_0035716) (chemokine (C-C motif) ligand 12 binding), [GO:0035717](http://purl.obolibrary.org/obo/GO_0035717) (chemokine (C-C motif) ligand 7 binding), [GO:0035715](http://purl.obolibrary.org/obo/GO_0035715) (chemokine (C-C motif) ligand 2 binding), [GO:1904050](http://purl.obolibrary.org/obo/GO_1904050) (positive regulation of spontaneous neurotransmitter secretion), [GO:0009443](http://purl.obolibrary.org/obo/GO_0009443) (pyridoxal 5'-phosphate salvage), [GO:0009449](http://purl.obolibrary.org/obo/GO_0009449) (gamma-aminobutyric acid biosynthetic process), [GO:0009448](http://purl.obolibrary.org/obo/GO_0009448) (gamma-aminobutyric acid metabolic process), [GO:0035705](http://purl.obolibrary.org/obo/GO_0035705) (T-helper 17 cell chemotaxis), [GO:0010424](http://purl.obolibrary.org/obo/GO_0010424) (DNA methylation on cytosine within a CG sequence), [GO:0035701](http://purl.obolibrary.org/obo/GO_0035701) (hematopoietic stem cell migration), [GO:0090557](http://purl.obolibrary.org/obo/GO_0090557) (establishment of endothelial intestinal barrier), [GO:0090555](http://purl.obolibrary.org/obo/GO_0090555) (phosphatidylethanolamine-translocating ATPase activity), [GO:0090556](http://purl.obolibrary.org/obo/GO_0090556) (phosphatidylserine-translocating ATPase activity), [GO:0090554](http://purl.obolibrary.org/obo/GO_0090554) (phosphatidylcholine-translocating ATPase activity), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:0060704](http://purl.obolibrary.org/obo/GO_0060704) (acinar cell differentiation involved in salivary gland development), [GO:0009410](http://purl.obolibrary.org/obo/GO_0009410) (response to xenobiotic stimulus), [GO:1901800](http://purl.obolibrary.org/obo/GO_1901800) (positive regulation of proteasomal protein catabolic process), [GO:0009416](http://purl.obolibrary.org/obo/GO_0009416) (response to light stimulus), [GO:0060709](http://purl.obolibrary.org/obo/GO_0060709) (glycogen cell differentiation involved in embryonic placenta development), [GO:0009409](http://purl.obolibrary.org/obo/GO_0009409) (response to cold), [GO:0009408](http://purl.obolibrary.org/obo/GO_0009408) (response to heat), [GO:0060706](http://purl.obolibrary.org/obo/GO_0060706) (cell differentiation involved in embryonic placenta development), [GO:0060707](http://purl.obolibrary.org/obo/GO_0060707) (trophoblast giant cell differentiation), [GO:1904086](http://purl.obolibrary.org/obo/GO_1904086) (regulation of epiboly involved in gastrulation with mouth forming second), [GO:0046403](http://purl.obolibrary.org/obo/GO_0046403) (polynucleotide 3'-phosphatase activity), [GO:0046404](http://purl.obolibrary.org/obo/GO_0046404) (ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity), [GO:1901805](http://purl.obolibrary.org/obo/GO_1901805) (beta-glucoside catabolic process), [GO:0010460](http://purl.obolibrary.org/obo/GO_0010460) (positive regulation of heart rate), [GO:0008140](http://purl.obolibrary.org/obo/GO_0008140) (cAMP response element binding protein binding), [GO:0090533](http://purl.obolibrary.org/obo/GO_0090533) (cation-transporting ATPase complex), [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding), [GO:0033100](http://purl.obolibrary.org/obo/GO_0033100) (NuA3 histone acetyltransferase complex), [GO:0008143](http://purl.obolibrary.org/obo/GO_0008143) (poly(A) binding), [GO:0008142](http://purl.obolibrary.org/obo/GO_0008142) (oxysterol binding), [GO:0008146](http://purl.obolibrary.org/obo/GO_0008146) (sulfotransferase activity), [GO:0010457](http://purl.obolibrary.org/obo/GO_0010457) (centriole-centriole cohesion), [GO:0010458](http://purl.obolibrary.org/obo/GO_0010458) (exit from mitosis), [GO:0034421](http://purl.obolibrary.org/obo/GO_0034421) (post-translational protein acetylation), [GO:0010453](http://purl.obolibrary.org/obo/GO_0010453) (regulation of cell fate commitment), [GO:0034427](http://purl.obolibrary.org/obo/GO_0034427) (nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'), [GO:0035753](http://purl.obolibrary.org/obo/GO_0035753) (maintenance of DNA trinucleotide repeats), [GO:0010452](http://purl.obolibrary.org/obo/GO_0010452) (histone H3-K36 methylation), [GO:0035754](http://purl.obolibrary.org/obo/GO_0035754) (B cell chemotaxis), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0010470](http://purl.obolibrary.org/obo/GO_0010470) (regulation of gastrulation), [GO:1904021](http://purl.obolibrary.org/obo/GO_1904021) (negative regulation of G-protein coupled receptor internalization), [GO:0035751](http://purl.obolibrary.org/obo/GO_0035751) (regulation of lysosomal lumen pH), [GO:0008154](http://purl.obolibrary.org/obo/GO_0008154) (actin polymerization or depolymerization), [GO:0090543](http://purl.obolibrary.org/obo/GO_0090543) (Flemming body), [GO:1905356](http://purl.obolibrary.org/obo/GO_1905356) (regulation of snRNA pseudouridine synthesis), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0008158](http://purl.obolibrary.org/obo/GO_0008158) (hedgehog receptor activity), [GO:0008156](http://purl.obolibrary.org/obo/GO_0008156) (negative regulation of DNA replication), [GO:0034418](http://purl.obolibrary.org/obo/GO_0034418) (urate biosynthetic process), [GO:0035749](http://purl.obolibrary.org/obo/GO_0035749) (myelin sheath adaxonal region), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0010467](http://purl.obolibrary.org/obo/GO_0010467) (gene expression), [GO:0010464](http://purl.obolibrary.org/obo/GO_0010464) (regulation of mesenchymal cell proliferation), [GO:0010463](http://purl.obolibrary.org/obo/GO_0010463) (mesenchymal cell proliferation), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0010465](http://purl.obolibrary.org/obo/GO_0010465) (nerve growth factor receptor activity), [GO:0008121](http://purl.obolibrary.org/obo/GO_0008121) (ubiquinol-cytochrome-c reductase activity), [GO:0009451](http://purl.obolibrary.org/obo/GO_0009451) (RNA modification), [GO:0009450](http://purl.obolibrary.org/obo/GO_0009450) (gamma-aminobutyric acid catabolic process), [GO:0008124](http://purl.obolibrary.org/obo/GO_0008124) (4-alpha-hydroxytetrahydrobiopterin dehydratase activity), [GO:0035735](http://purl.obolibrary.org/obo/GO_0035735) (intraciliary transport involved in cilium assembly), [GO:0035736](http://purl.obolibrary.org/obo/GO_0035736) (cell proliferation involved in compound eye morphogenesis), [GO:0034405](http://purl.obolibrary.org/obo/GO_0034405) (response to fluid shear stress), [GO:0010430](http://purl.obolibrary.org/obo/GO_0010430) (fatty acid omega-oxidation), [GO:1904042](http://purl.obolibrary.org/obo/GO_1904042) (negative regulation of cystathionine beta-synthase activity), [GO:0090521](http://purl.obolibrary.org/obo/GO_0090521) (glomerular visceral epithelial cell migration), [GO:1904047](http://purl.obolibrary.org/obo/GO_1904047) (S-adenosyl-L-methionine binding), [GO:0008131](http://purl.obolibrary.org/obo/GO_0008131) (primary amine oxidase activity), [GO:0008137](http://purl.obolibrary.org/obo/GO_0008137) (NADH dehydrogenase (ubiquinone) activity), [GO:0022414](http://purl.obolibrary.org/obo/GO_0022414) (reproductive process), [GO:0008135](http://purl.obolibrary.org/obo/GO_0008135) (translation factor activity, RNA binding), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0008139](http://purl.obolibrary.org/obo/GO_0008139) (nuclear localization sequence binding), [GO:0008138](http://purl.obolibrary.org/obo/GO_0008138) (protein tyrosine/serine/threonine phosphatase activity), [GO:1990000](http://purl.obolibrary.org/obo/GO_1990000) (amyloid fibril formation), [GO:0035723](http://purl.obolibrary.org/obo/GO_0035723) (interleukin-15-mediated signaling pathway), [GO:0035725](http://purl.obolibrary.org/obo/GO_0035725) (sodium ion transmembrane transport), [GO:0035726](http://purl.obolibrary.org/obo/GO_0035726) (common myeloid progenitor cell proliferation), [GO:0010447](http://purl.obolibrary.org/obo/GO_0010447) (response to acidic pH), [GO:1905370](http://purl.obolibrary.org/obo/GO_1905370) (serine-type endopeptidase complex), [GO:0035721](http://purl.obolibrary.org/obo/GO_0035721) (intraciliary retrograde transport), [GO:0035722](http://purl.obolibrary.org/obo/GO_0035722) (interleukin-12-mediated signaling pathway), [GO:0008184](http://purl.obolibrary.org/obo/GO_0008184) (glycogen phosphorylase activity), [GO:0060760](http://purl.obolibrary.org/obo/GO_0060760) (positive regulation of response to cytokine stimulus), [GO:0034475](http://purl.obolibrary.org/obo/GO_0034475) (U4 snRNA 3'-end processing), [GO:0033144](http://purl.obolibrary.org/obo/GO_0033144) (negative regulation of intracellular steroid hormone receptor signaling pathway), [GO:0033143](http://purl.obolibrary.org/obo/GO_0033143) (regulation of intracellular steroid hormone receptor signaling pathway), [GO:0034473](http://purl.obolibrary.org/obo/GO_0034473) (U1 snRNA 3'-end processing), [GO:0008186](http://purl.obolibrary.org/obo/GO_0008186) (RNA-dependent ATPase activity), [GO:0034472](http://purl.obolibrary.org/obo/GO_0034472) (snRNA 3'-end processing), [GO:0033141](http://purl.obolibrary.org/obo/GO_0033141) (positive regulation of peptidyl-serine phosphorylation of STAT protein), [GO:0060768](http://purl.obolibrary.org/obo/GO_0060768) (regulation of epithelial cell proliferation involved in prostate gland development), [GO:0060769](http://purl.obolibrary.org/obo/GO_0060769) (positive regulation of epithelial cell proliferation involved in prostate gland development), [GO:0047787](http://purl.obolibrary.org/obo/GO_0047787) (delta4-3-oxosteroid 5beta-reductase activity), [GO:0045124](http://purl.obolibrary.org/obo/GO_0045124) (regulation of bone resorption), [GO:0045128](http://purl.obolibrary.org/obo/GO_0045128) (negative regulation of reciprocal meiotic recombination), [GO:0046459](http://purl.obolibrary.org/obo/GO_0046459) (short-chain fatty acid metabolic process), [GO:0005901](http://purl.obolibrary.org/obo/GO_0005901) (caveola), [GO:0005903](http://purl.obolibrary.org/obo/GO_0005903) (brush border), [GO:0046464](http://purl.obolibrary.org/obo/GO_0046464) (acylglycerol catabolic process), [GO:0005902](http://purl.obolibrary.org/obo/GO_0005902) (microvillus), [GO:0045134](http://purl.obolibrary.org/obo/GO_0045134) (uridine-diphosphatase activity), [GO:0005905](http://purl.obolibrary.org/obo/GO_0005905) (clathrin-coated pit), [GO:0033135](http://purl.obolibrary.org/obo/GO_0033135) (regulation of peptidyl-serine phosphorylation), [GO:0008180](http://purl.obolibrary.org/obo/GO_0008180) (COP9 signalosome), [GO:0033138](http://purl.obolibrary.org/obo/GO_0033138) (positive regulation of peptidyl-serine phosphorylation), [GO:0010498](http://purl.obolibrary.org/obo/GO_0010498) (proteasomal protein catabolic process), [GO:0035799](http://purl.obolibrary.org/obo/GO_0035799) (ureter maturation), [GO:0008195](http://purl.obolibrary.org/obo/GO_0008195) (phosphatidate phosphatase activity), [GO:0035793](http://purl.obolibrary.org/obo/GO_0035793) (positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway), [GO:0060750](http://purl.obolibrary.org/obo/GO_0060750) (epithelial cell proliferation involved in mammary gland duct elongation), [GO:0035794](http://purl.obolibrary.org/obo/GO_0035794) (positive regulation of mitochondrial membrane permeability), [GO:0008199](http://purl.obolibrary.org/obo/GO_0008199) (ferric iron binding), [GO:0034464](http://purl.obolibrary.org/obo/GO_0034464) (BBSome), [GO:0008198](http://purl.obolibrary.org/obo/GO_0008198) (ferrous iron binding), [GO:0035791](http://purl.obolibrary.org/obo/GO_0035791) (platelet-derived growth factor receptor-beta signaling pathway), [GO:0033130](http://purl.obolibrary.org/obo/GO_0033130) (acetylcholine receptor binding), [GO:0046466](http://purl.obolibrary.org/obo/GO_0046466) (membrane lipid catabolic process), [GO:0045136](http://purl.obolibrary.org/obo/GO_0045136) (development of secondary sexual characteristics), [GO:1901879](http://purl.obolibrary.org/obo/GO_1901879) (regulation of protein depolymerization), [GO:0060754](http://purl.obolibrary.org/obo/GO_0060754) (positive regulation of mast cell chemotaxis), [GO:0046471](http://purl.obolibrary.org/obo/GO_0046471) (phosphatidylglycerol metabolic process), [GO:0045141](http://purl.obolibrary.org/obo/GO_0045141) (meiotic telomere clustering), [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction), [GO:0005911](http://purl.obolibrary.org/obo/GO_0005911) (cell-cell junction), [GO:0046470](http://purl.obolibrary.org/obo/GO_0046470) (phosphatidylcholine metabolic process), [GO:0045144](http://purl.obolibrary.org/obo/GO_0045144) (meiotic sister chromatid segregation), [GO:0046475](http://purl.obolibrary.org/obo/GO_0046475) (glycerophospholipid catabolic process), [GO:0005913](http://purl.obolibrary.org/obo/GO_0005913) (cell-cell adherens junction), [GO:0005916](http://purl.obolibrary.org/obo/GO_0005916) (fascia adherens), [GO:0005915](http://purl.obolibrary.org/obo/GO_0005915) (zonula adherens), [GO:0046474](http://purl.obolibrary.org/obo/GO_0046474) (glycerophospholipid biosynthetic process), [GO:0045143](http://purl.obolibrary.org/obo/GO_0045143) (homologous chromosome segregation), [GO:0035789](http://purl.obolibrary.org/obo/GO_0035789) (metanephric mesenchymal cell migration), [GO:0071400](http://purl.obolibrary.org/obo/GO_0071400) (cellular response to oleic acid), [GO:0034454](http://purl.obolibrary.org/obo/GO_0034454) (microtubule anchoring at centrosome), [GO:0071406](http://purl.obolibrary.org/obo/GO_0071406) (cellular response to methylmercury), [GO:0008191](http://purl.obolibrary.org/obo/GO_0008191) (metalloendopeptidase inhibitor activity), [GO:0071407](http://purl.obolibrary.org/obo/GO_0071407) (cellular response to organic cyclic compound), [GO:0008190](http://purl.obolibrary.org/obo/GO_0008190) (eukaryotic initiation factor 4E binding), [GO:0033128](http://purl.obolibrary.org/obo/GO_0033128) (negative regulation of histone phosphorylation), [GO:0071404](http://purl.obolibrary.org/obo/GO_0071404) (cellular response to low-density lipoprotein particle stimulus), [GO:0035787](http://purl.obolibrary.org/obo/GO_0035787) (cell migration involved in kidney development), [GO:0071405](http://purl.obolibrary.org/obo/GO_0071405) (cellular response to methanol), [GO:0010482](http://purl.obolibrary.org/obo/GO_0010482) (regulation of epidermal cell division), [GO:0010481](http://purl.obolibrary.org/obo/GO_0010481) (epidermal cell division), [GO:0060782](http://purl.obolibrary.org/obo/GO_0060782) (regulation of mesenchymal cell proliferation involved in prostate gland development), [GO:0010484](http://purl.obolibrary.org/obo/GO_0010484) (H3 histone acetyltransferase activity), [GO:0060783](http://purl.obolibrary.org/obo/GO_0060783) (mesenchymal smoothened signaling pathway involved in prostate gland development), [GO:0034453](http://purl.obolibrary.org/obo/GO_0034453) (microtubule anchoring), [GO:0034452](http://purl.obolibrary.org/obo/GO_0034452) (dynactin binding), [GO:0033120](http://purl.obolibrary.org/obo/GO_0033120) (positive regulation of RNA splicing), [GO:0034451](http://purl.obolibrary.org/obo/GO_0034451) (centriolar satellite), [GO:0034450](http://purl.obolibrary.org/obo/GO_0034450) (ubiquitin-ubiquitin ligase activity), [GO:0060789](http://purl.obolibrary.org/obo/GO_0060789) (hair follicle placode formation), [GO:0008168](http://purl.obolibrary.org/obo/GO_0008168) (methyltransferase activity), [GO:0046477](http://purl.obolibrary.org/obo/GO_0046477) (glycosylceramide catabolic process), [GO:0060788](http://purl.obolibrary.org/obo/GO_0060788) (ectodermal placode formation), [GO:0046486](http://purl.obolibrary.org/obo/GO_0046486) (glycerolipid metabolic process), [GO:0034446](http://purl.obolibrary.org/obo/GO_0034446) (substrate adhesion-dependent cell spreading), [GO:0071435](http://purl.obolibrary.org/obo/GO_0071435) (potassium ion export), [GO:0071433](http://purl.obolibrary.org/obo/GO_0071433) (cell wall repair), [GO:0035774](http://purl.obolibrary.org/obo/GO_0035774) (positive regulation of insulin secretion involved in cellular response to glucose stimulus), [GO:0071439](http://purl.obolibrary.org/obo/GO_0071439) (clathrin complex), [GO:0035775](http://purl.obolibrary.org/obo/GO_0035775) (pronephric glomerulus morphogenesis), [GO:0035776](http://purl.obolibrary.org/obo/GO_0035776) (pronephric proximal tubule development), [GO:0033116](http://purl.obolibrary.org/obo/GO_0033116) (endoplasmic reticulum-Golgi intermediate compartment membrane), [GO:0035777](http://purl.obolibrary.org/obo/GO_0035777) (pronephric distal tubule development), [GO:0008171](http://purl.obolibrary.org/obo/GO_0008171) (O-methyltransferase activity), [GO:0010494](http://purl.obolibrary.org/obo/GO_0010494) (cytoplasmic stress granule), [GO:0008170](http://purl.obolibrary.org/obo/GO_0008170) (N-methyltransferase activity), [GO:0008177](http://purl.obolibrary.org/obo/GO_0008177) (succinate dehydrogenase (ubiquinone) activity), [GO:0008175](http://purl.obolibrary.org/obo/GO_0008175) (tRNA methyltransferase activity), [GO:0046488](http://purl.obolibrary.org/obo/GO_0046488) (phosphatidylinositol metabolic process), [GO:1901897](http://purl.obolibrary.org/obo/GO_1901897) (regulation of relaxation of cardiac muscle), [GO:0008179](http://purl.obolibrary.org/obo/GO_0008179) (adenylate cyclase binding), [GO:0045162](http://purl.obolibrary.org/obo/GO_0045162) (clustering of voltage-gated sodium channels), [GO:0071420](http://purl.obolibrary.org/obo/GO_0071420) (cellular response to histamine), [GO:0046498](http://purl.obolibrary.org/obo/GO_0046498) (S-adenosylhomocysteine metabolic process), [GO:0071421](http://purl.obolibrary.org/obo/GO_0071421) (manganese ion transmembrane transport), [GO:0045165](http://purl.obolibrary.org/obo/GO_0045165) (cell fate commitment), [GO:0034435](http://purl.obolibrary.org/obo/GO_0034435) (cholesterol esterification), [GO:0035767](http://purl.obolibrary.org/obo/GO_0035767) (endothelial cell chemotaxis), [GO:0071425](http://purl.obolibrary.org/obo/GO_0071425) (hematopoietic stem cell proliferation), [GO:0033101](http://purl.obolibrary.org/obo/GO_0033101) (cellular bud membrane), [GO:0033108](http://purl.obolibrary.org/obo/GO_0033108) (mitochondrial respiratory chain complex assembly), [GO:0010485](http://purl.obolibrary.org/obo/GO_0010485) (H4 histone acetyltransferase activity), [GO:0071426](http://purl.obolibrary.org/obo/GO_0071426) (ribonucleoprotein complex export from nucleus), [GO:0072757](http://purl.obolibrary.org/obo/GO_0072757) (cellular response to camptothecin), [GO:0033184](http://purl.obolibrary.org/obo/GO_0033184) (positive regulation of histone ubiquitination), [GO:0016601](http://purl.obolibrary.org/obo/GO_0016601) (Rac protein signal transduction), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0016605](http://purl.obolibrary.org/obo/GO_0016605) (PML body), [GO:0016607](http://purl.obolibrary.org/obo/GO_0016607) (nuclear speck), [GO:0033185](http://purl.obolibrary.org/obo/GO_0033185) (dolichol-phosphate-mannose synthase complex), [GO:0030906](http://purl.obolibrary.org/obo/GO_0030906) (retromer, cargo-selective complex), [GO:0033180](http://purl.obolibrary.org/obo/GO_0033180) (proton-transporting V-type ATPase, V1 domain), [GO:0046416](http://purl.obolibrary.org/obo/GO_0046416) (D-amino acid metabolic process), [GO:0004620](http://purl.obolibrary.org/obo/GO_0004620) (phospholipase activity), [GO:0005942](http://purl.obolibrary.org/obo/GO_0005942) (phosphatidylinositol 3-kinase complex), [GO:0030901](http://purl.obolibrary.org/obo/GO_0030901) (midbrain development), [GO:0004614](http://purl.obolibrary.org/obo/GO_0004614) (phosphoglucomutase activity), [GO:0005945](http://purl.obolibrary.org/obo/GO_0005945) (6-phosphofructokinase complex), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0005944](http://purl.obolibrary.org/obo/GO_0005944) (phosphatidylinositol 3-kinase complex, class IB), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0005947](http://purl.obolibrary.org/obo/GO_0005947) (mitochondrial alpha-ketoglutarate dehydrogenase complex), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0047751](http://purl.obolibrary.org/obo/GO_0047751) (cholestenone 5-alpha-reductase activity), [GO:0004615](http://purl.obolibrary.org/obo/GO_0004615) (phosphomannomutase activity), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0047750](http://purl.obolibrary.org/obo/GO_0047750) (cholestenol delta-isomerase activity), [GO:0004618](http://purl.obolibrary.org/obo/GO_0004618) (phosphoglycerate kinase activity), [GO:0030904](http://purl.obolibrary.org/obo/GO_0030904) (retromer complex), [GO:0004617](http://purl.obolibrary.org/obo/GO_0004617) (phosphoglycerate dehydrogenase activity), [GO:0004619](http://purl.obolibrary.org/obo/GO_0004619) (phosphoglycerate mutase activity), [GO:0033179](http://purl.obolibrary.org/obo/GO_0033179) (proton-transporting V-type ATPase, V0 domain), [GO:0060715](http://purl.obolibrary.org/obo/GO_0060715) (syncytiotrophoblast cell differentiation involved in labyrinthine layer development), [GO:0004630](http://purl.obolibrary.org/obo/GO_0004630) (phospholipase D activity), [GO:0005960](http://purl.obolibrary.org/obo/GO_0005960) (glycine cleavage complex), [GO:0046426](http://purl.obolibrary.org/obo/GO_0046426) (negative regulation of JAK-STAT cascade), [GO:0003300](http://purl.obolibrary.org/obo/GO_0003300) (cardiac muscle hypertrophy), [GO:0060710](http://purl.obolibrary.org/obo/GO_0060710) (chorio-allantoic fusion), [GO:0047757](http://purl.obolibrary.org/obo/GO_0047757) (chondroitin-glucuronate 5-epimerase activity), [GO:0046427](http://purl.obolibrary.org/obo/GO_0046427) (positive regulation of JAK-STAT cascade), [GO:0004623](http://purl.obolibrary.org/obo/GO_0004623) (phospholipase A2 activity), [GO:0004622](http://purl.obolibrary.org/obo/GO_0004622) (lysophospholipase activity), [GO:1901827](http://purl.obolibrary.org/obo/GO_1901827) (zeaxanthin biosynthetic process), [GO:0005955](http://purl.obolibrary.org/obo/GO_0005955) (calcineurin complex), [GO:0060716](http://purl.obolibrary.org/obo/GO_0060716) (labyrinthine layer blood vessel development), [GO:0005958](http://purl.obolibrary.org/obo/GO_0005958) (DNA-dependent protein kinase-DNA ligase 4 complex), [GO:0060717](http://purl.obolibrary.org/obo/GO_0060717) (chorion development), [GO:0033169](http://purl.obolibrary.org/obo/GO_0033169) (histone H3-K9 demethylation), [GO:0016600](http://purl.obolibrary.org/obo/GO_0016600) (flotillin complex), [GO:0033162](http://purl.obolibrary.org/obo/GO_0033162) (melanosome membrane), [GO:0033160](http://purl.obolibrary.org/obo/GO_0033160) (positive regulation of protein import into nucleus, translocation), [GO:0060740](http://purl.obolibrary.org/obo/GO_0060740) (prostate gland epithelium morphogenesis), [GO:0034497](http://purl.obolibrary.org/obo/GO_0034497) (protein localization to phagophore assembly site), [GO:0033165](http://purl.obolibrary.org/obo/GO_0033165) (interphotoreceptor matrix), [GO:0033164](http://purl.obolibrary.org/obo/GO_0033164) (glycolipid 6-alpha-mannosyltransferase activity), [GO:0045104](http://purl.obolibrary.org/obo/GO_0045104) (intermediate filament cytoskeleton organization), [GO:0060745](http://purl.obolibrary.org/obo/GO_0060745) (mammary gland branching involved in pregnancy), [GO:0090594](http://purl.obolibrary.org/obo/GO_0090594) (inflammatory response to wounding), [GO:0060748](http://purl.obolibrary.org/obo/GO_0060748) (tertiary branching involved in mammary gland duct morphogenesis), [GO:0045103](http://purl.obolibrary.org/obo/GO_0045103) (intermediate filament-based process), [GO:0045109](http://purl.obolibrary.org/obo/GO_0045109) (intermediate filament organization), [GO:0060742](http://purl.obolibrary.org/obo/GO_0060742) (epithelial cell differentiation involved in prostate gland development), [GO:1901843](http://purl.obolibrary.org/obo/GO_1901843) (positive regulation of high voltage-gated calcium channel activity), [GO:0005930](http://purl.obolibrary.org/obo/GO_0005930) (axoneme), [GO:0005921](http://purl.obolibrary.org/obo/GO_0005921) (gap junction), [GO:0047770](http://purl.obolibrary.org/obo/GO_0047770) (carboxylate reductase activity), [GO:0005923](http://purl.obolibrary.org/obo/GO_0005923) (bicellular tight junction), [GO:0005922](http://purl.obolibrary.org/obo/GO_0005922) (connexin complex), [GO:1901838](http://purl.obolibrary.org/obo/GO_1901838) (positive regulation of transcription of nucleolar large rRNA by RNA polymerase I), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0060749](http://purl.obolibrary.org/obo/GO_0060749) (mammary gland alveolus development), [GO:0045111](http://purl.obolibrary.org/obo/GO_0045111) (intermediate filament cytoskeleton), [GO:0005927](http://purl.obolibrary.org/obo/GO_0005927) (muscle tendon junction), [GO:0045110](http://purl.obolibrary.org/obo/GO_0045110) (intermediate filament bundle assembly), [GO:0005929](http://purl.obolibrary.org/obo/GO_0005929) (cilium), [GO:0033157](http://purl.obolibrary.org/obo/GO_0033157) (regulation of intracellular protein transport), [GO:0072721](http://purl.obolibrary.org/obo/GO_0072721) (cellular response to dithiothreitol), [GO:0033151](http://purl.obolibrary.org/obo/GO_0033151) (V(D)J recombination), [GO:0033153](http://purl.obolibrary.org/obo/GO_0033153) (T cell receptor V(D)J recombination), [GO:0033152](http://purl.obolibrary.org/obo/GO_0033152) (immunoglobulin V(D)J recombination), [GO:0060736](http://purl.obolibrary.org/obo/GO_0060736) (prostate gland growth), [GO:0060731](http://purl.obolibrary.org/obo/GO_0060731) (positive regulation of intestinal epithelial structure maintenance), [GO:0004610](http://purl.obolibrary.org/obo/GO_0004610) (phosphoacetylglucosamine mutase activity), [GO:0060732](http://purl.obolibrary.org/obo/GO_0060732) (positive regulation of inositol phosphate biosynthetic process), [GO:0046449](http://purl.obolibrary.org/obo/GO_0046449) (creatinine metabolic process), [GO:0004601](http://purl.obolibrary.org/obo/GO_0004601) (peroxidase activity), [GO:0005934](http://purl.obolibrary.org/obo/GO_0005934) (cellular bud tip), [GO:0005933](http://purl.obolibrary.org/obo/GO_0005933) (cellular bud), [GO:0060738](http://purl.obolibrary.org/obo/GO_0060738) (epithelial-mesenchymal signaling involved in prostate gland development), [GO:0005935](http://purl.obolibrary.org/obo/GO_0005935) (cellular bud neck), [GO:0045123](http://purl.obolibrary.org/obo/GO_0045123) (cellular extravasation), [GO:0005938](http://purl.obolibrary.org/obo/GO_0005938) (cell cortex), [GO:0045120](http://purl.obolibrary.org/obo/GO_0045120) (pronucleus), [GO:0004607](http://purl.obolibrary.org/obo/GO_0004607) (phosphatidylcholine-sterol O-acyltransferase activity), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0005937](http://purl.obolibrary.org/obo/GO_0005937) (mating projection), [GO:0046452](http://purl.obolibrary.org/obo/GO_0046452) (dihydrofolate metabolic process), [GO:0033148](http://purl.obolibrary.org/obo/GO_0033148) (positive regulation of intracellular estrogen receptor signaling pathway), [GO:0033147](http://purl.obolibrary.org/obo/GO_0033147) (negative regulation of intracellular estrogen receptor signaling pathway), [GO:0033146](http://purl.obolibrary.org/obo/GO_0033146) (regulation of intracellular estrogen receptor signaling pathway), [GO:0034476](http://purl.obolibrary.org/obo/GO_0034476) (U5 snRNA 3'-end processing), [GO:0033149](http://purl.obolibrary.org/obo/GO_0033149) (FFAT motif binding), [GO:0016768](http://purl.obolibrary.org/obo/GO_0016768) (spermine synthase activity), [GO:0015432](http://purl.obolibrary.org/obo/GO_0015432) (bile acid-exporting ATPase activity), [GO:0015431](http://purl.obolibrary.org/obo/GO_0015431) (glutathione S-conjugate-exporting ATPase activity), [GO:0004784](http://purl.obolibrary.org/obo/GO_0004784) (superoxide dismutase activity), [GO:0070290](http://purl.obolibrary.org/obo/GO_0070290) (N-acylphosphatidylethanolamine-specific phospholipase D activity), [GO:0002121](http://purl.obolibrary.org/obo/GO_0002121) (inter-male aggressive behavior), [GO:0004777](http://purl.obolibrary.org/obo/GO_0004777) (succinate-semialdehyde dehydrogenase (NAD+) activity), [GO:0002115](http://purl.obolibrary.org/obo/GO_0002115) (store-operated calcium entry), [GO:0004776](http://purl.obolibrary.org/obo/GO_0004776) (succinate-CoA ligase (GDP-forming) activity), [GO:0070285](http://purl.obolibrary.org/obo/GO_0070285) (pigment cell development), [GO:0016772](http://purl.obolibrary.org/obo/GO_0016772) (transferase activity, transferring phosphorus-containing groups), [GO:0016773](http://purl.obolibrary.org/obo/GO_0016773) (phosphotransferase activity, alcohol group as acceptor), [GO:0016757](http://purl.obolibrary.org/obo/GO_0016757) (transferase activity, transferring glycosyl groups), [GO:0016758](http://purl.obolibrary.org/obo/GO_0016758) (transferase activity, transferring hexosyl groups), [GO:0004797](http://purl.obolibrary.org/obo/GO_0004797) (thymidine kinase activity), [GO:0002134](http://purl.obolibrary.org/obo/GO_0002134) (UTP binding), [GO:0070273](http://purl.obolibrary.org/obo/GO_0070273) (phosphatidylinositol-4-phosphate binding), [GO:0002127](http://purl.obolibrary.org/obo/GO_0002127) (tRNA wobble base cytosine methylation), [GO:0002128](http://purl.obolibrary.org/obo/GO_0002128) (tRNA nucleoside ribose methylation), [GO:0015439](http://purl.obolibrary.org/obo/GO_0015439) (heme-transporting ATPase activity), [GO:0016765](http://purl.obolibrary.org/obo/GO_0016765) (transferase activity, transferring alkyl or aryl (other than methyl) groups), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0016747](http://purl.obolibrary.org/obo/GO_0016747) (transferase activity, transferring acyl groups other than amino-acyl groups), [GO:0002102](http://purl.obolibrary.org/obo/GO_0002102) (podosome), [GO:0004757](http://purl.obolibrary.org/obo/GO_0004757) (sepiapterin reductase activity), [GO:0003428](http://purl.obolibrary.org/obo/GO_0003428) (chondrocyte intercalation involved in growth plate cartilage morphogenesis), [GO:0004758](http://purl.obolibrary.org/obo/GO_0004758) (serine C-palmitoyltransferase activity), [GO:0004775](http://purl.obolibrary.org/obo/GO_0004775) (succinate-CoA ligase (ADP-forming) activity), [GO:0004774](http://purl.obolibrary.org/obo/GO_0004774) (succinate-CoA ligase activity), [GO:0004767](http://purl.obolibrary.org/obo/GO_0004767) (sphingomyelin phosphodiesterase activity), [GO:0004769](http://purl.obolibrary.org/obo/GO_0004769) (steroid delta-isomerase activity), [GO:0070296](http://purl.obolibrary.org/obo/GO_0070296) (sarcoplasmic reticulum calcium ion transport), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016743](http://purl.obolibrary.org/obo/GO_0016743) (carboxyl- or carbamoyltransferase activity), [GO:1900452](http://purl.obolibrary.org/obo/GO_1900452) (regulation of long term synaptic depression), [GO:1900451](http://purl.obolibrary.org/obo/GO_1900451) (positive regulation of glutamate receptor signaling pathway), [GO:0002161](http://purl.obolibrary.org/obo/GO_0002161) (aminoacyl-tRNA editing activity), [GO:1900454](http://purl.obolibrary.org/obo/GO_1900454) (positive regulation of long term synaptic depression), [GO:0002162](http://purl.obolibrary.org/obo/GO_0002162) (dystroglycan binding), [GO:0045294](http://purl.obolibrary.org/obo/GO_0045294) (alpha-catenin binding), [GO:0002158](http://purl.obolibrary.org/obo/GO_0002158) (osteoclast proliferation), [GO:0002159](http://purl.obolibrary.org/obo/GO_0002159) (desmosome assembly), [GO:0045295](http://purl.obolibrary.org/obo/GO_0045295) (gamma-catenin binding), [GO:0045292](http://purl.obolibrary.org/obo/GO_0045292) (mRNA cis splicing, via spliceosome), [GO:0045298](http://purl.obolibrary.org/obo/GO_0045298) (tubulin complex), [GO:0070243](http://purl.obolibrary.org/obo/GO_0070243) (regulation of thymocyte apoptotic process), [GO:0070244](http://purl.obolibrary.org/obo/GO_0070244) (negative regulation of thymocyte apoptotic process), [GO:0045299](http://purl.obolibrary.org/obo/GO_0045299) (otolith mineralization), [GO:0045296](http://purl.obolibrary.org/obo/GO_0045296) (cadherin binding), [GO:0071578](http://purl.obolibrary.org/obo/GO_0071578) (zinc II ion transmembrane import), [GO:0071579](http://purl.obolibrary.org/obo/GO_0071579) (regulation of zinc ion transport), [GO:0071577](http://purl.obolibrary.org/obo/GO_0071577) (zinc II ion transmembrane transport), [GO:0038109](http://purl.obolibrary.org/obo/GO_0038109) (Kit signaling pathway), [GO:0038108](http://purl.obolibrary.org/obo/GO_0038108) (negative regulation of appetite by leptin-mediated signaling pathway), [GO:0015485](http://purl.obolibrary.org/obo/GO_0015485) (cholesterol binding), [GO:1900460](http://purl.obolibrary.org/obo/GO_1900460) (negative regulation of invasive growth in response to glucose limitation by negative regulation of transcription from RNA polymerase II promoter), [GO:1900462](http://purl.obolibrary.org/obo/GO_1900462) (negative regulation of pseudohyphal growth by negative regulation of transcription from RNA polymerase II promoter), [GO:1901799](http://purl.obolibrary.org/obo/GO_1901799) (negative regulation of proteasomal protein catabolic process), [GO:0002178](http://purl.obolibrary.org/obo/GO_0002178) (palmitoyltransferase complex), [GO:0071560](http://purl.obolibrary.org/obo/GO_0071560) (cellular response to transforming growth factor beta stimulus), [GO:0070233](http://purl.obolibrary.org/obo/GO_0070233) (negative regulation of T cell apoptotic process), [GO:0071564](http://purl.obolibrary.org/obo/GO_0071564) (npBAF complex), [GO:0071561](http://purl.obolibrary.org/obo/GO_0071561) (nucleus-vacuole junction), [GO:0071565](http://purl.obolibrary.org/obo/GO_0071565) (nBAF complex), [GO:0071566](http://purl.obolibrary.org/obo/GO_0071566) (UFM1 activating enzyme activity), [GO:0071569](http://purl.obolibrary.org/obo/GO_0071569) (protein ufmylation), [GO:0016788](http://purl.obolibrary.org/obo/GO_0016788) (hydrolase activity, acting on ester bonds), [GO:0002141](http://purl.obolibrary.org/obo/GO_0002141) (stereocilia ankle link), [GO:0002142](http://purl.obolibrary.org/obo/GO_0002142) (stereocilia ankle link complex), [GO:0002143](http://purl.obolibrary.org/obo/GO_0002143) (tRNA wobble position uridine thiolation), [GO:0070262](http://purl.obolibrary.org/obo/GO_0070262) (peptidyl-serine dephosphorylation), [GO:0002138](http://purl.obolibrary.org/obo/GO_0002138) (retinoic acid biosynthetic process), [GO:0070260](http://purl.obolibrary.org/obo/GO_0070260) (5'-tyrosyl-DNA phosphodiesterase activity), [GO:0071596](http://purl.obolibrary.org/obo/GO_0071596) (ubiquitin-dependent protein catabolic process via the N-end rule pathway), [GO:0070265](http://purl.obolibrary.org/obo/GO_0070265) (necrotic cell death), [GO:0070266](http://purl.obolibrary.org/obo/GO_0070266) (necroptotic process), [GO:0016791](http://purl.obolibrary.org/obo/GO_0016791) (phosphatase activity), [GO:0070269](http://purl.obolibrary.org/obo/GO_0070269) (pyroptosis), [GO:0071598](http://purl.obolibrary.org/obo/GO_0071598) (neuronal ribonucleoprotein granule), [GO:0016793](http://purl.obolibrary.org/obo/GO_0016793) (triphosphoric monoester hydrolase activity), [GO:0071599](http://purl.obolibrary.org/obo/GO_0071599) (otic vesicle development), [GO:0016798](http://purl.obolibrary.org/obo/GO_0016798) (hydrolase activity, acting on glycosyl bonds), [GO:0015467](http://purl.obolibrary.org/obo/GO_0015467) (G-protein activated inward rectifier potassium channel activity), [GO:0016779](http://purl.obolibrary.org/obo/GO_0016779) (nucleotidyltransferase activity), [GO:0015464](http://purl.obolibrary.org/obo/GO_0015464) (acetylcholine receptor activity), [GO:0002151](http://purl.obolibrary.org/obo/GO_0002151) (G-quadruplex RNA binding), [GO:0002154](http://purl.obolibrary.org/obo/GO_0002154) (thyroid hormone mediated signaling pathway), [GO:0071585](http://purl.obolibrary.org/obo/GO_0071585) (detoxification of cadmium ion), [GO:0070252](http://purl.obolibrary.org/obo/GO_0070252) (actin-mediated cell contraction), [GO:0016780](http://purl.obolibrary.org/obo/GO_0016780) (phosphotransferase activity, for other substituted phosphate groups), [GO:0016783](http://purl.obolibrary.org/obo/GO_0016783) (sulfurtransferase activity), [GO:0016785](http://purl.obolibrary.org/obo/GO_0016785) (transferase activity, transferring selenium-containing groups), [GO:0015459](http://purl.obolibrary.org/obo/GO_0015459) (potassium channel regulator activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0051123](http://purl.obolibrary.org/obo/GO_0051123) (RNA polymerase II transcriptional preinitiation complex assembly), [GO:0051124](http://purl.obolibrary.org/obo/GO_0051124) (synaptic growth at neuromuscular junction), [GO:0051122](http://purl.obolibrary.org/obo/GO_0051122) (hepoxilin biosynthetic process), [GO:0051120](http://purl.obolibrary.org/obo/GO_0051120) (hepoxilin A3 synthase activity), [GO:1905312](http://purl.obolibrary.org/obo/GO_1905312) (positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis), [GO:0038145](http://purl.obolibrary.org/obo/GO_0038145) (macrophage colony-stimulating factor signaling pathway), [GO:0051131](http://purl.obolibrary.org/obo/GO_0051131) (chaperone-mediated protein complex assembly), [GO:0051138](http://purl.obolibrary.org/obo/GO_0051138) (positive regulation of NK T cell differentiation), [GO:0038132](http://purl.obolibrary.org/obo/GO_0038132) (neuregulin binding), [GO:0002181](http://purl.obolibrary.org/obo/GO_0002181) (cytoplasmic translation), [GO:0089720](http://purl.obolibrary.org/obo/GO_0089720) (caspase binding), [GO:0051150](http://purl.obolibrary.org/obo/GO_0051150) (regulation of smooth muscle cell differentiation), [GO:1905329](http://purl.obolibrary.org/obo/GO_1905329) (sphingoid long-chain base transport), [GO:0015491](http://purl.obolibrary.org/obo/GO_0015491) (cation:cation antiporter activity), [GO:1905327](http://purl.obolibrary.org/obo/GO_1905327) (tracheoesophageal septum formation), [GO:0002189](http://purl.obolibrary.org/obo/GO_0002189) (ribose phosphate diphosphokinase complex), [GO:0051147](http://purl.obolibrary.org/obo/GO_0051147) (regulation of muscle cell differentiation), [GO:0051145](http://purl.obolibrary.org/obo/GO_0051145) (smooth muscle cell differentiation), [GO:0051146](http://purl.obolibrary.org/obo/GO_0051146) (striated muscle cell differentiation), [GO:0090722](http://purl.obolibrary.org/obo/GO_0090722) (receptor-receptor interaction), [GO:0038127](http://purl.obolibrary.org/obo/GO_0038127) (ERBB signaling pathway), [GO:1904009](http://purl.obolibrary.org/obo/GO_1904009) (cellular response to monosodium glutamate), [GO:0002196](http://purl.obolibrary.org/obo/GO_0002196) (Ser-tRNA(Ala) hydrolase activity), [GO:0002199](http://purl.obolibrary.org/obo/GO_0002199) (zona pellucida receptor complex), [GO:0051156](http://purl.obolibrary.org/obo/GO_0051156) (glucose 6-phosphate metabolic process), [GO:0051155](http://purl.obolibrary.org/obo/GO_0051155) (positive regulation of striated muscle cell differentiation), [GO:0090729](http://purl.obolibrary.org/obo/GO_0090729) (toxin activity), [GO:0090724](http://purl.obolibrary.org/obo/GO_0090724) (central region of growth cone), [GO:0008301](http://purl.obolibrary.org/obo/GO_0008301) (DNA binding, bending), [GO:0089709](http://purl.obolibrary.org/obo/GO_0089709) (L-histidine transmembrane transport), [GO:0008306](http://purl.obolibrary.org/obo/GO_0008306) (associative learning), [GO:0009636](http://purl.obolibrary.org/obo/GO_0009636) (response to toxic substance), [GO:0008305](http://purl.obolibrary.org/obo/GO_0008305) (integrin complex), [GO:0038191](http://purl.obolibrary.org/obo/GO_0038191) (neuropilin binding), [GO:0035914](http://purl.obolibrary.org/obo/GO_0035914) (skeletal muscle cell differentiation), [GO:0035912](http://purl.obolibrary.org/obo/GO_0035912) (dorsal aorta morphogenesis), [GO:0010613](http://purl.obolibrary.org/obo/GO_0010613) (positive regulation of cardiac muscle hypertrophy), [GO:0089711](http://purl.obolibrary.org/obo/GO_0089711) (L-glutamate transmembrane transport), [GO:0089712](http://purl.obolibrary.org/obo/GO_0089712) (L-aspartate transmembrane transport), [GO:0008312](http://purl.obolibrary.org/obo/GO_0008312) (7S RNA binding), [GO:0009642](http://purl.obolibrary.org/obo/GO_0009642) (response to light intensity), [GO:0009648](http://purl.obolibrary.org/obo/GO_0009648) (photoperiodism), [GO:0038180](http://purl.obolibrary.org/obo/GO_0038180) (nerve growth factor signaling pathway), [GO:0035907](http://purl.obolibrary.org/obo/GO_0035907) (dorsal aorta development), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0035909](http://purl.obolibrary.org/obo/GO_0035909) (aorta morphogenesis), [GO:0008307](http://purl.obolibrary.org/obo/GO_0008307) (structural constituent of muscle), [GO:0010626](http://purl.obolibrary.org/obo/GO_0010626) (negative regulation of Schwann cell proliferation), [GO:0035904](http://purl.obolibrary.org/obo/GO_0035904) (aorta development), [GO:0010625](http://purl.obolibrary.org/obo/GO_0010625) (positive regulation of Schwann cell proliferation), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0010623](http://purl.obolibrary.org/obo/GO_0010623) (programmed cell death involved in cell development), [GO:0035902](http://purl.obolibrary.org/obo/GO_0035902) (response to immobilization stress), [GO:0009611](http://purl.obolibrary.org/obo/GO_0009611) (response to wounding), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0009612](http://purl.obolibrary.org/obo/GO_0009612) (response to mechanical stimulus), [GO:0051103](http://purl.obolibrary.org/obo/GO_0051103) (DNA ligation involved in DNA repair), [GO:0009607](http://purl.obolibrary.org/obo/GO_0009607) (response to biotic stimulus), [GO:0051101](http://purl.obolibrary.org/obo/GO_0051101) (regulation of DNA binding), [GO:0051102](http://purl.obolibrary.org/obo/GO_0051102) (DNA ligation involved in DNA recombination), [GO:0038162](http://purl.obolibrary.org/obo/GO_0038162) (erythropoietin-mediated signaling pathway), [GO:0010608](http://purl.obolibrary.org/obo/GO_0010608) (posttranscriptional regulation of gene expression), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0010603](http://purl.obolibrary.org/obo/GO_0010603) (regulation of cytoplasmic mRNA processing body assembly), [GO:0010606](http://purl.obolibrary.org/obo/GO_0010606) (positive regulation of cytoplasmic mRNA processing body assembly), [GO:0051119](http://purl.obolibrary.org/obo/GO_0051119) (sugar transmembrane transporter activity), [GO:0051117](http://purl.obolibrary.org/obo/GO_0051117) (ATPase binding), [GO:0090694](http://purl.obolibrary.org/obo/GO_0090694) (Scc2-Scc4 cohesin loading complex), [GO:0051096](http://purl.obolibrary.org/obo/GO_0051096) (positive regulation of helicase activity), [GO:0060803](http://purl.obolibrary.org/obo/GO_0060803) (BMP signaling pathway involved in mesodermal cell fate specification), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0008219](http://purl.obolibrary.org/obo/GO_0008219) (cell death), [GO:0051088](http://purl.obolibrary.org/obo/GO_0051088) (PMA-inducible membrane protein ectodomain proteolysis), [GO:0051089](http://purl.obolibrary.org/obo/GO_0051089) (constitutive protein ectodomain proteolysis), [GO:0051087](http://purl.obolibrary.org/obo/GO_0051087) (chaperone binding), [GO:0034501](http://purl.obolibrary.org/obo/GO_0034501) (protein localization to kinetochore), [GO:0034504](http://purl.obolibrary.org/obo/GO_0034504) (protein localization to nucleus), [GO:1905279](http://purl.obolibrary.org/obo/GO_1905279) (regulation of retrograde transport, endosome to Golgi), [GO:0008236](http://purl.obolibrary.org/obo/GO_0008236) (serine-type peptidase activity), [GO:0046501](http://purl.obolibrary.org/obo/GO_0046501) (protoporphyrinogen IX metabolic process), [GO:0009566](http://purl.obolibrary.org/obo/GO_0009566) (fertilization), [GO:0046502](http://purl.obolibrary.org/obo/GO_0046502) (uroporphyrinogen III metabolic process), [GO:0008234](http://purl.obolibrary.org/obo/GO_0008234) (cysteine-type peptidase activity), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0046500](http://purl.obolibrary.org/obo/GO_0046500) (S-adenosylmethionine metabolic process), [GO:0008239](http://purl.obolibrary.org/obo/GO_0008239) (dipeptidyl-peptidase activity), [GO:0008238](http://purl.obolibrary.org/obo/GO_0008238) (exopeptidase activity), [GO:0008237](http://purl.obolibrary.org/obo/GO_0008237) (metallopeptidase activity), [GO:0075044](http://purl.obolibrary.org/obo/GO_0075044) (autophagy of host cells involved in interaction with symbiont), [GO:0035826](http://purl.obolibrary.org/obo/GO_0035826) (rubidium ion transport), [GO:0047840](http://purl.obolibrary.org/obo/GO_0047840) (dCTP diphosphatase activity), [GO:0035827](http://purl.obolibrary.org/obo/GO_0035827) (rubidium ion transmembrane transporter activity), [GO:0010544](http://purl.obolibrary.org/obo/GO_0010544) (negative regulation of platelet activation), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0046512](http://purl.obolibrary.org/obo/GO_0046512) (sphingosine biosynthetic process), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0046513](http://purl.obolibrary.org/obo/GO_0046513) (ceramide biosynthetic process), [GO:0060823](http://purl.obolibrary.org/obo/GO_0060823) (canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation), [GO:0090671](http://purl.obolibrary.org/obo/GO_0090671) (telomerase RNA localization to Cajal body), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0060825](http://purl.obolibrary.org/obo/GO_0060825) (fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation), [GO:0038091](http://purl.obolibrary.org/obo/GO_0038091) (positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway), [GO:0008206](http://purl.obolibrary.org/obo/GO_0008206) (bile acid metabolic process), [GO:0038093](http://purl.obolibrary.org/obo/GO_0038093) (Fc receptor signaling pathway), [GO:0038092](http://purl.obolibrary.org/obo/GO_0038092) (nodal signaling pathway), [GO:0060821](http://purl.obolibrary.org/obo/GO_0060821) (inactivation of X chromosome by DNA methylation), [GO:0035815](http://purl.obolibrary.org/obo/GO_0035815) (positive regulation of renal sodium excretion), [GO:0060828](http://purl.obolibrary.org/obo/GO_0060828) (regulation of canonical Wnt signaling pathway), [GO:0010518](http://purl.obolibrary.org/obo/GO_0010518) (positive regulation of phospholipase activity), [GO:0010512](http://purl.obolibrary.org/obo/GO_0010512) (negative regulation of phosphatidylinositol biosynthetic process), [GO:0035810](http://purl.obolibrary.org/obo/GO_0035810) (positive regulation of urine volume), [GO:0008210](http://purl.obolibrary.org/obo/GO_0008210) (estrogen metabolic process), [GO:0038084](http://purl.obolibrary.org/obo/GO_0038084) (vascular endothelial growth factor signaling pathway), [GO:0038083](http://purl.obolibrary.org/obo/GO_0038083) (peptidyl-tyrosine autophosphorylation), [GO:0038085](http://purl.obolibrary.org/obo/GO_0038085) (vascular endothelial growth factor binding), [GO:0046527](http://purl.obolibrary.org/obo/GO_0046527) (glucosyltransferase activity), [GO:0008217](http://purl.obolibrary.org/obo/GO_0008217) (regulation of blood pressure), [GO:0008215](http://purl.obolibrary.org/obo/GO_0008215) (spermine metabolic process), [GO:0008209](http://purl.obolibrary.org/obo/GO_0008209) (androgen metabolic process), [GO:0010527](http://purl.obolibrary.org/obo/GO_0010527) (positive regulation of transposition, RNA-mediated), [GO:0046530](http://purl.obolibrary.org/obo/GO_0046530) (photoreceptor cell differentiation), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:0060816](http://purl.obolibrary.org/obo/GO_0060816) (random inactivation of X chromosome), [GO:0035800](http://purl.obolibrary.org/obo/GO_0035800) (deubiquitinase activator activity), [GO:0010525](http://purl.obolibrary.org/obo/GO_0010525) (regulation of transposition, RNA-mediated), [GO:0010524](http://purl.obolibrary.org/obo/GO_0010524) (positive regulation of calcium ion transport into cytosol), [GO:0010521](http://purl.obolibrary.org/obo/GO_0010521) (telomerase inhibitor activity), [GO:0035880](http://purl.obolibrary.org/obo/GO_0035880) (embryonic nail plate morphogenesis), [GO:0090657](http://purl.obolibrary.org/obo/GO_0090657) (telomeric loop disassembly), [GO:0035881](http://purl.obolibrary.org/obo/GO_0035881) (amacrine cell differentiation), [GO:0034551](http://purl.obolibrary.org/obo/GO_0034551) (mitochondrial respiratory chain complex III assembly), [GO:0009593](http://purl.obolibrary.org/obo/GO_0009593) (detection of chemical stimulus), [GO:0008266](http://purl.obolibrary.org/obo/GO_0008266) (poly(U) RNA binding), [GO:0051044](http://purl.obolibrary.org/obo/GO_0051044) (positive regulation of membrane protein ectodomain proteolysis), [GO:0035877](http://purl.obolibrary.org/obo/GO_0035877) (death effector domain binding), [GO:0035879](http://purl.obolibrary.org/obo/GO_0035879) (plasma membrane lactate transport), [GO:0010574](http://purl.obolibrary.org/obo/GO_0010574) (regulation of vascular endothelial growth factor production), [GO:0035873](http://purl.obolibrary.org/obo/GO_0035873) (lactate transmembrane transport), [GO:0010573](http://purl.obolibrary.org/obo/GO_0010573) (vascular endothelial growth factor production), [GO:0090658](http://purl.obolibrary.org/obo/GO_0090658) (cone matrix sheath), [GO:0090659](http://purl.obolibrary.org/obo/GO_0090659) (walking behavior), [GO:0010575](http://purl.obolibrary.org/obo/GO_0010575) (positive regulation of vascular endothelial growth factor production), [GO:0010592](http://purl.obolibrary.org/obo/GO_0010592) (positive regulation of lamellipodium assembly), [GO:0008272](http://purl.obolibrary.org/obo/GO_0008272) (sulfate transport), [GO:0008271](http://purl.obolibrary.org/obo/GO_0008271) (secondary active sulfate transmembrane transporter activity), [GO:0035870](http://purl.obolibrary.org/obo/GO_0035870) (dITP diphosphatase activity), [GO:0010591](http://purl.obolibrary.org/obo/GO_0010591) (regulation of lamellipodium assembly), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0010594](http://purl.obolibrary.org/obo/GO_0010594) (regulation of endothelial cell migration), [GO:0090666](http://purl.obolibrary.org/obo/GO_0090666) (scaRNA localization to Cajal body), [GO:0033210](http://purl.obolibrary.org/obo/GO_0033210) (leptin-mediated signaling pathway), [GO:0090661](http://purl.obolibrary.org/obo/GO_0090661) (box H/ACA telomerase RNP complex), [GO:0008273](http://purl.obolibrary.org/obo/GO_0008273) (calcium, potassium:sodium antiporter activity), [GO:0008278](http://purl.obolibrary.org/obo/GO_0008278) (cohesin complex), [GO:0008277](http://purl.obolibrary.org/obo/GO_0008277) (regulation of G-protein coupled receptor protein signaling pathway), [GO:0051059](http://purl.obolibrary.org/obo/GO_0051059) (NF-kappaB binding), [GO:0051057](http://purl.obolibrary.org/obo/GO_0051057) (positive regulation of small GTPase mediated signal transduction), [GO:0033209](http://purl.obolibrary.org/obo/GO_0033209) (tumor necrosis factor-mediated signaling pathway), [GO:0051058](http://purl.obolibrary.org/obo/GO_0051058) (negative regulation of small GTPase mediated signal transduction), [GO:0051056](http://purl.obolibrary.org/obo/GO_0051056) (regulation of small GTPase mediated signal transduction), [GO:0051054](http://purl.obolibrary.org/obo/GO_0051054) (positive regulation of DNA metabolic process), [GO:0035869](http://purl.obolibrary.org/obo/GO_0035869) (ciliary transition zone), [GO:0090669](http://purl.obolibrary.org/obo/GO_0090669) (telomerase RNA stabilization), [GO:0033204](http://purl.obolibrary.org/obo/GO_0033204) (ribonuclease P RNA binding), [GO:1905243](http://purl.obolibrary.org/obo/GO_1905243) (cellular response to 3,3',5-triiodo-L-thyronine), [GO:0047805](http://purl.obolibrary.org/obo/GO_0047805) (cytidylate cyclase activity), [GO:0035861](http://purl.obolibrary.org/obo/GO_0035861) (site of double-strand break), [GO:0090630](http://purl.obolibrary.org/obo/GO_0090630) (activation of GTPase activity), [GO:0008240](http://purl.obolibrary.org/obo/GO_0008240) (tripeptidyl-peptidase activity), [GO:0035859](http://purl.obolibrary.org/obo/GO_0035859) (Seh1-associated complex), [GO:0051066](http://purl.obolibrary.org/obo/GO_0051066) (dihydrobiopterin metabolic process), [GO:0010559](http://purl.obolibrary.org/obo/GO_0010559) (regulation of glycoprotein biosynthetic process), [GO:0035855](http://purl.obolibrary.org/obo/GO_0035855) (megakaryocyte development), [GO:0035854](http://purl.obolibrary.org/obo/GO_0035854) (eosinophil fate commitment), [GO:0008250](http://purl.obolibrary.org/obo/GO_0008250) (oligosaccharyltransferase complex), [GO:0090646](http://purl.obolibrary.org/obo/GO_0090646) (mitochondrial tRNA processing), [GO:0035850](http://purl.obolibrary.org/obo/GO_0035850) (epithelial cell differentiation involved in kidney development), [GO:0009585](http://purl.obolibrary.org/obo/GO_0009585) (red, far-red light phototransduction), [GO:0009584](http://purl.obolibrary.org/obo/GO_0009584) (detection of visible light), [GO:0008253](http://purl.obolibrary.org/obo/GO_0008253) (5'-nucleotidase activity), [GO:0009583](http://purl.obolibrary.org/obo/GO_0009583) (detection of light stimulus), [GO:0051085](http://purl.obolibrary.org/obo/GO_0051085) (chaperone cofactor-dependent protein refolding), [GO:0051082](http://purl.obolibrary.org/obo/GO_0051082) (unfolded protein binding), [GO:0047812](http://purl.obolibrary.org/obo/GO_0047812) (D-amino-acid N-acetyltransferase activity), [GO:0034517](http://purl.obolibrary.org/obo/GO_0034517) (ribophagy), [GO:0035844](http://purl.obolibrary.org/obo/GO_0035844) (cloaca development), [GO:0035845](http://purl.obolibrary.org/obo/GO_0035845) (photoreceptor cell outer segment organization), [GO:0010569](http://purl.obolibrary.org/obo/GO_0010569) (regulation of double-strand break repair via homologous recombination), [GO:0034516](http://purl.obolibrary.org/obo/GO_0034516) (response to vitamin B6), [GO:0035841](http://purl.obolibrary.org/obo/GO_0035841) (new growing cell tip), [GO:0090647](http://purl.obolibrary.org/obo/GO_0090647) (modulation of age-related behavioral decline), [GO:0090648](http://purl.obolibrary.org/obo/GO_0090648) (response to environmental enrichment), [GO:0034513](http://purl.obolibrary.org/obo/GO_0034513) (box H/ACA snoRNA binding), [GO:0034590](http://purl.obolibrary.org/obo/GO_0034590) (L-hydroxyproline transmembrane transporter activity), [GO:0033265](http://purl.obolibrary.org/obo/GO_0033265) (choline binding), [GO:0034596](http://purl.obolibrary.org/obo/GO_0034596) (phosphatidylinositol phosphate 4-phosphatase activity), [GO:0034595](http://purl.obolibrary.org/obo/GO_0034595) (phosphatidylinositol phosphate 5-phosphatase activity), [GO:1901741](http://purl.obolibrary.org/obo/GO_1901741) (positive regulation of myoblast fusion), [GO:0046579](http://purl.obolibrary.org/obo/GO_0046579) (positive regulation of Ras protein signal transduction), [GO:0046577](http://purl.obolibrary.org/obo/GO_0046577) (long-chain-alcohol oxidase activity), [GO:1900407](http://purl.obolibrary.org/obo/GO_1900407) (regulation of cellular response to oxidative stress), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0045254](http://purl.obolibrary.org/obo/GO_0045254) (pyruvate dehydrogenase complex), [GO:0070200](http://purl.obolibrary.org/obo/GO_0070200) (establishment of protein localization to telomere), [GO:0045252](http://purl.obolibrary.org/obo/GO_0045252) (oxoglutarate dehydrogenase complex), [GO:0095500](http://purl.obolibrary.org/obo/GO_0095500) (acetylcholine receptor signaling pathway), [GO:0034589](http://purl.obolibrary.org/obo/GO_0034589) (hydroxyproline transport), [GO:0070201](http://purl.obolibrary.org/obo/GO_0070201) (regulation of establishment of protein localization), [GO:0070202](http://purl.obolibrary.org/obo/GO_0070202) (regulation of establishment of protein localization to chromosome), [GO:0070207](http://purl.obolibrary.org/obo/GO_0070207) (protein homotrimerization), [GO:0071539](http://purl.obolibrary.org/obo/GO_0071539) (protein localization to centrosome), [GO:0070208](http://purl.obolibrary.org/obo/GO_0070208) (protein heterotrimerization), [GO:0070206](http://purl.obolibrary.org/obo/GO_0070206) (protein trimerization), [GO:0060872](http://purl.obolibrary.org/obo/GO_0060872) (semicircular canal development), [GO:0060876](http://purl.obolibrary.org/obo/GO_0060876) (semicircular canal formation), [GO:0004702](http://purl.obolibrary.org/obo/GO_0004702) (signal transducer, downstream of receptor, with serine/threonine kinase activity), [GO:0004703](http://purl.obolibrary.org/obo/GO_0004703) (G-protein coupled receptor kinase activity), [GO:0045263](http://purl.obolibrary.org/obo/GO_0045263) (proton-transporting ATP synthase complex, coupling factor F(o)), [GO:0004708](http://purl.obolibrary.org/obo/GO_0004708) (MAP kinase kinase activity), [GO:0004709](http://purl.obolibrary.org/obo/GO_0004709) (MAP kinase kinase kinase activity), [GO:0071526](http://purl.obolibrary.org/obo/GO_0071526) (semaphorin-plexin signaling pathway), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0008286](http://purl.obolibrary.org/obo/GO_0008286) (insulin receptor signaling pathway), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0099093](http://purl.obolibrary.org/obo/GO_0099093) (mitochondrial calcium release), [GO:0046599](http://purl.obolibrary.org/obo/GO_0046599) (regulation of centriole replication), [GO:1900436](http://purl.obolibrary.org/obo/GO_1900436) (positive regulation of filamentous growth of a population of unicellular organisms in response to starvation), [GO:0045273](http://purl.obolibrary.org/obo/GO_0045273) (respiratory chain complex II), [GO:0045277](http://purl.obolibrary.org/obo/GO_0045277) (respiratory chain complex IV), [GO:0045275](http://purl.obolibrary.org/obo/GO_0045275) (respiratory chain complex III), [GO:0071557](http://purl.obolibrary.org/obo/GO_0071557) (histone H3-K27 demethylation), [GO:0033234](http://purl.obolibrary.org/obo/GO_0033234) (negative regulation of protein sumoylation), [GO:0071555](http://purl.obolibrary.org/obo/GO_0071555) (cell wall organization), [GO:0010596](http://purl.obolibrary.org/obo/GO_0010596) (negative regulation of endothelial cell migration), [GO:0010595](http://purl.obolibrary.org/obo/GO_0010595) (positive regulation of endothelial cell migration), [GO:0071558](http://purl.obolibrary.org/obo/GO_0071558) (histone demethylase activity (H3-K27 specific)), [GO:0035898](http://purl.obolibrary.org/obo/GO_0035898) (parathyroid hormone secretion), [GO:0008294](http://purl.obolibrary.org/obo/GO_0008294) (calcium- and calmodulin-responsive adenylate cyclase activity), [GO:0008292](http://purl.obolibrary.org/obo/GO_0008292) (acetylcholine biosynthetic process), [GO:0008298](http://purl.obolibrary.org/obo/GO_0008298) (intracellular mRNA localization), [GO:0008296](http://purl.obolibrary.org/obo/GO_0008296) (3'-5'-exodeoxyribonuclease activity), [GO:0008299](http://purl.obolibrary.org/obo/GO_0008299) (isoprenoid biosynthetic process), [GO:0060896](http://purl.obolibrary.org/obo/GO_0060896) (neural plate pattern specification), [GO:1900449](http://purl.obolibrary.org/obo/GO_1900449) (regulation of glutamate receptor signaling pathway), [GO:0060898](http://purl.obolibrary.org/obo/GO_0060898) (eye field cell fate commitment involved in camera-type eye formation), [GO:0045281](http://purl.obolibrary.org/obo/GO_0045281) (succinate dehydrogenase complex), [GO:0070210](http://purl.obolibrary.org/obo/GO_0070210) (Rpd3L-Expanded complex), [GO:0071542](http://purl.obolibrary.org/obo/GO_0071542) (dopaminergic neuron differentiation), [GO:0070211](http://purl.obolibrary.org/obo/GO_0070211) (Snt2C complex), [GO:0035889](http://purl.obolibrary.org/obo/GO_0035889) (otolith tethering), [GO:0034553](http://purl.obolibrary.org/obo/GO_0034553) (mitochondrial respiratory chain complex II assembly), [GO:0071549](http://purl.obolibrary.org/obo/GO_0071549) (cellular response to dexamethasone stimulus), [GO:0035886](http://purl.obolibrary.org/obo/GO_0035886) (vascular smooth muscle cell differentiation), [GO:0071548](http://purl.obolibrary.org/obo/GO_0071548) (response to dexamethasone), [GO:0035887](http://purl.obolibrary.org/obo/GO_0035887) (aortic smooth muscle cell differentiation), [GO:0016723](http://purl.obolibrary.org/obo/GO_0016723) (oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor), [GO:0016726](http://purl.obolibrary.org/obo/GO_0016726) (oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor), [GO:0099073](http://purl.obolibrary.org/obo/GO_0099073) (mitochondrion-derived vesicle), [GO:0060844](http://purl.obolibrary.org/obo/GO_0060844) (arterial endothelial cell fate commitment), [GO:0045203](http://purl.obolibrary.org/obo/GO_0045203) (integral component of cell outer membrane), [GO:0046534](http://purl.obolibrary.org/obo/GO_0046534) (positive regulation of photoreceptor cell differentiation), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0060840](http://purl.obolibrary.org/obo/GO_0060840) (artery development), [GO:0046538](http://purl.obolibrary.org/obo/GO_0046538) (2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity), [GO:0004740](http://purl.obolibrary.org/obo/GO_0004740) (pyruvate dehydrogenase (acetyl-transferring) kinase activity), [GO:0060841](http://purl.obolibrary.org/obo/GO_0060841) (venous blood vessel development), [GO:0046539](http://purl.obolibrary.org/obo/GO_0046539) (histamine N-methyltransferase activity), [GO:0004742](http://purl.obolibrary.org/obo/GO_0004742) (dihydrolipoyllysine-residue acetyltransferase activity), [GO:0060842](http://purl.obolibrary.org/obo/GO_0060842) (arterial endothelial cell differentiation), [GO:0004741](http://purl.obolibrary.org/obo/GO_0004741) ([pyruvate dehydrogenase (lipoamide)] phosphatase activity), [GO:0004733](http://purl.obolibrary.org/obo/GO_0004733) (pyridoxamine-phosphate oxidase activity), [GO:0003401](http://purl.obolibrary.org/obo/GO_0003401) (axis elongation), [GO:0003402](http://purl.obolibrary.org/obo/GO_0003402) (planar cell polarity pathway involved in axis elongation), [GO:0004735](http://purl.obolibrary.org/obo/GO_0004735) (pyrroline-5-carboxylate reductase activity), [GO:0003404](http://purl.obolibrary.org/obo/GO_0003404) (optic vesicle morphogenesis), [GO:0045211](http://purl.obolibrary.org/obo/GO_0045211) (postsynaptic membrane), [GO:0003406](http://purl.obolibrary.org/obo/GO_0003406) (retinal pigment epithelium development), [GO:0004739](http://purl.obolibrary.org/obo/GO_0004739) (pyruvate dehydrogenase (acetyl-transferring) activity), [GO:0003407](http://purl.obolibrary.org/obo/GO_0003407) (neural retina development), [GO:0046540](http://purl.obolibrary.org/obo/GO_0046540) (U4/U6 x U5 tri-snRNP complex), [GO:0004738](http://purl.obolibrary.org/obo/GO_0004738) (pyruvate dehydrogenase activity), [GO:0033299](http://purl.obolibrary.org/obo/GO_0033299) (secretion of lysosomal enzymes), [GO:0016712](http://purl.obolibrary.org/obo/GO_0016712) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen), [GO:0033292](http://purl.obolibrary.org/obo/GO_0033292) (T-tubule organization), [GO:0016714](http://purl.obolibrary.org/obo/GO_0016714) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen), [GO:0016715](http://purl.obolibrary.org/obo/GO_0016715) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen), [GO:0016716](http://purl.obolibrary.org/obo/GO_0016716) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen), [GO:0045214](http://purl.obolibrary.org/obo/GO_0045214) (sarcomere organization), [GO:0060836](http://purl.obolibrary.org/obo/GO_0060836) (lymphatic endothelial cell differentiation), [GO:0099083](http://purl.obolibrary.org/obo/GO_0099083) (retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission), [GO:0046549](http://purl.obolibrary.org/obo/GO_0046549) (retinal cone cell development), [GO:0004751](http://purl.obolibrary.org/obo/GO_0004751) (ribose-5-phosphate isomerase activity), [GO:0060830](http://purl.obolibrary.org/obo/GO_0060830) (ciliary receptor clustering involved in smoothened signaling pathway), [GO:0045216](http://purl.obolibrary.org/obo/GO_0045216) (cell-cell junction organization), [GO:0060831](http://purl.obolibrary.org/obo/GO_0060831) (smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:0046548](http://purl.obolibrary.org/obo/GO_0046548) (retinal rod cell development), [GO:0045217](http://purl.obolibrary.org/obo/GO_0045217) (cell-cell junction maintenance), [GO:0004744](http://purl.obolibrary.org/obo/GO_0004744) (retinal isomerase activity), [GO:0003412](http://purl.obolibrary.org/obo/GO_0003412) (establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis), [GO:0004745](http://purl.obolibrary.org/obo/GO_0004745) (retinol dehydrogenase activity), [GO:0060837](http://purl.obolibrary.org/obo/GO_0060837) (blood vessel endothelial cell differentiation), [GO:0003416](http://purl.obolibrary.org/obo/GO_0003416) (endochondral bone growth), [GO:0046552](http://purl.obolibrary.org/obo/GO_0046552) (photoreceptor cell fate commitment), [GO:0004748](http://purl.obolibrary.org/obo/GO_0004748) (ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor), [GO:0003417](http://purl.obolibrary.org/obo/GO_0003417) (growth plate cartilage development), [GO:0004749](http://purl.obolibrary.org/obo/GO_0004749) (ribose phosphate diphosphokinase activity), [GO:0003419](http://purl.obolibrary.org/obo/GO_0003419) (growth plate cartilage chondrocyte proliferation), [GO:0016702](http://purl.obolibrary.org/obo/GO_0016702) (oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen), [GO:0033280](http://purl.obolibrary.org/obo/GO_0033280) (response to vitamin D), [GO:0016705](http://purl.obolibrary.org/obo/GO_0016705) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen), [GO:0016706](http://purl.obolibrary.org/obo/GO_0016706) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors), [GO:0046556](http://purl.obolibrary.org/obo/GO_0046556) (alpha-L-arabinofuranosidase activity), [GO:0016709](http://purl.obolibrary.org/obo/GO_0016709) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen), [GO:0046554](http://purl.obolibrary.org/obo/GO_0046554) (malate dehydrogenase (NADP+) activity), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0004712](http://purl.obolibrary.org/obo/GO_0004712) (protein serine/threonine/tyrosine kinase activity), [GO:0004715](http://purl.obolibrary.org/obo/GO_0004715) (non-membrane spanning protein tyrosine kinase activity), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0004716](http://purl.obolibrary.org/obo/GO_0004716) (signal transducer, downstream of receptor, with protein tyrosine kinase activity), [GO:0033278](http://purl.obolibrary.org/obo/GO_0033278) (cell proliferation in midbrain), [GO:0033277](http://purl.obolibrary.org/obo/GO_0033277) (abortive mitotic cell cycle), [GO:0071514](http://purl.obolibrary.org/obo/GO_0071514) (genetic imprinting), [GO:0071507](http://purl.obolibrary.org/obo/GO_0071507) (MAPK cascade involved in conjugation with cellular fusion), [GO:0033270](http://purl.obolibrary.org/obo/GO_0033270) (paranode region of axon), [GO:0071508](http://purl.obolibrary.org/obo/GO_0071508) (activation of MAPK activity involved in conjugation with cellular fusion), [GO:0033275](http://purl.obolibrary.org/obo/GO_0033275) (actin-myosin filament sliding), [GO:0060855](http://purl.obolibrary.org/obo/GO_0060855) (venous endothelial cell migration involved in lymph vessel development), [GO:0060856](http://purl.obolibrary.org/obo/GO_0060856) (establishment of blood-brain barrier), [GO:0045234](http://purl.obolibrary.org/obo/GO_0045234) (protein palmitoleylation), [GO:0045239](http://purl.obolibrary.org/obo/GO_0045239) (tricarboxylic acid cycle enzyme complex), [GO:0004722](http://purl.obolibrary.org/obo/GO_0004722) (protein serine/threonine phosphatase activity), [GO:0004721](http://purl.obolibrary.org/obo/GO_0004721) (phosphoprotein phosphatase activity), [GO:0004724](http://purl.obolibrary.org/obo/GO_0004724) (magnesium-dependent protein serine/threonine phosphatase activity), [GO:0004726](http://purl.obolibrary.org/obo/GO_0004726) (non-membrane spanning protein tyrosine phosphatase activity), [GO:0004725](http://purl.obolibrary.org/obo/GO_0004725) (protein tyrosine phosphatase activity), [GO:0045244](http://purl.obolibrary.org/obo/GO_0045244) (succinate-CoA ligase complex (GDP-forming)), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0033268](http://purl.obolibrary.org/obo/GO_0033268) (node of Ranvier), [GO:0004729](http://purl.obolibrary.org/obo/GO_0004729) (oxygen-dependent protoporphyrinogen oxidase activity), [GO:0071506](http://purl.obolibrary.org/obo/GO_0071506) (cellular response to mycophenolic acid), [GO:1903400](http://purl.obolibrary.org/obo/GO_1903400) (L-arginine transmembrane transport), [GO:0036010](http://purl.obolibrary.org/obo/GO_0036010) (protein localization to endosome), [GO:1903401](http://purl.obolibrary.org/obo/GO_1903401) (L-lysine transmembrane transport), [GO:0051642](http://purl.obolibrary.org/obo/GO_0051642) (centrosome localization), [GO:0000062](http://purl.obolibrary.org/obo/GO_0000062) (fatty-acyl-CoA binding), [GO:0000060](http://purl.obolibrary.org/obo/GO_0000060) (protein import into nucleus, translocation), [GO:0048002](http://purl.obolibrary.org/obo/GO_0048002) (antigen processing and presentation of peptide antigen), [GO:0051648](http://purl.obolibrary.org/obo/GO_0051648) (vesicle localization), [GO:0051646](http://purl.obolibrary.org/obo/GO_0051646) (mitochondrion localization), [GO:2000594](http://purl.obolibrary.org/obo/GO_2000594) (positive regulation of metanephric DCT cell differentiation), [GO:0036006](http://purl.obolibrary.org/obo/GO_0036006) (cellular response to macrophage colony-stimulating factor stimulus), [GO:2000597](http://purl.obolibrary.org/obo/GO_2000597) (positive regulation of optic nerve formation), [GO:0036002](http://purl.obolibrary.org/obo/GO_0036002) (pre-mRNA binding), [GO:0036003](http://purl.obolibrary.org/obo/GO_0036003) (positive regulation of transcription from RNA polymerase II promoter in response to stress), [GO:0048009](http://purl.obolibrary.org/obo/GO_0048009) (insulin-like growth factor receptor signaling pathway), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0048007](http://purl.obolibrary.org/obo/GO_0048007) (antigen processing and presentation, exogenous lipid antigen via MHC class Ib), [GO:0050321](http://purl.obolibrary.org/obo/GO_0050321) (tau-protein kinase activity), [GO:0048012](http://purl.obolibrary.org/obo/GO_0048012) (hepatocyte growth factor receptor signaling pathway), [GO:0048011](http://purl.obolibrary.org/obo/GO_0048011) (neurotrophin TRK receptor signaling pathway), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0048010](http://purl.obolibrary.org/obo/GO_0048010) (vascular endothelial growth factor receptor signaling pathway), [GO:0000076](http://purl.obolibrary.org/obo/GO_0000076) (DNA replication checkpoint), [GO:0048016](http://purl.obolibrary.org/obo/GO_0048016) (inositol phosphate-mediated signaling), [GO:0051650](http://purl.obolibrary.org/obo/GO_0051650) (establishment of vesicle localization), [GO:0000073](http://purl.obolibrary.org/obo/GO_0000073) (spindle pole body separation), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0000070](http://purl.obolibrary.org/obo/GO_0000070) (mitotic sister chromatid segregation), [GO:0051659](http://purl.obolibrary.org/obo/GO_0051659) (maintenance of mitochondrion location), [GO:1903421](http://purl.obolibrary.org/obo/GO_1903421) (regulation of synaptic vesicle recycling), [GO:1903422](http://purl.obolibrary.org/obo/GO_1903422) (negative regulation of synaptic vesicle recycling), [GO:0048019](http://purl.obolibrary.org/obo/GO_0048019) (receptor antagonist activity), [GO:0048018](http://purl.obolibrary.org/obo/GO_0048018) (receptor ligand activity), [GO:1903423](http://purl.obolibrary.org/obo/GO_1903423) (positive regulation of synaptic vesicle recycling), [GO:0048017](http://purl.obolibrary.org/obo/GO_0048017) (inositol lipid-mediated signaling), [GO:1904754](http://purl.obolibrary.org/obo/GO_1904754) (positive regulation of vascular associated smooth muscle cell migration), [GO:0000038](http://purl.obolibrary.org/obo/GO_0000038) (very long-chain fatty acid metabolic process), [GO:1903427](http://purl.obolibrary.org/obo/GO_1903427) (negative regulation of reactive oxygen species biosynthetic process), [GO:1903428](http://purl.obolibrary.org/obo/GO_1903428) (positive regulation of reactive oxygen species biosynthetic process), [GO:0000045](http://purl.obolibrary.org/obo/GO_0000045) (autophagosome assembly), [GO:0048023](http://purl.obolibrary.org/obo/GO_0048023) (positive regulation of melanin biosynthetic process), [GO:0000042](http://purl.obolibrary.org/obo/GO_0000042) (protein targeting to Golgi), [GO:0048020](http://purl.obolibrary.org/obo/GO_0048020) (CCR chemokine receptor binding), [GO:0048027](http://purl.obolibrary.org/obo/GO_0048027) (mRNA 5'-UTR binding), [GO:0048026](http://purl.obolibrary.org/obo/GO_0048026) (positive regulation of mRNA splicing, via spliceosome), [GO:0048025](http://purl.obolibrary.org/obo/GO_0048025) (negative regulation of mRNA splicing, via spliceosome), [GO:0051666](http://purl.obolibrary.org/obo/GO_0051666) (actin cortical patch localization), [GO:1904768](http://purl.obolibrary.org/obo/GO_1904768) (all-trans-retinol binding), [GO:0048029](http://purl.obolibrary.org/obo/GO_0048029) (monosaccharide binding), [GO:1903435](http://purl.obolibrary.org/obo/GO_1903435) (positive regulation of constitutive secretory pathway), [GO:0000049](http://purl.obolibrary.org/obo/GO_0000049) (tRNA binding), [GO:1902109](http://purl.obolibrary.org/obo/GO_1902109) (negative regulation of mitochondrial membrane permeability involved in apoptotic process), [GO:1903438](http://purl.obolibrary.org/obo/GO_1903438) (positive regulation of mitotic cytokinetic process), [GO:0048034](http://purl.obolibrary.org/obo/GO_0048034) (heme O biosynthetic process), [GO:0000056](http://purl.obolibrary.org/obo/GO_0000056) (ribosomal small subunit export from nucleus), [GO:0000055](http://purl.obolibrary.org/obo/GO_0000055) (ribosomal large subunit export from nucleus), [GO:0048038](http://purl.obolibrary.org/obo/GO_0048038) (quinone binding), [GO:0048037](http://purl.obolibrary.org/obo/GO_0048037) (cofactor binding), [GO:0000050](http://purl.obolibrary.org/obo/GO_0000050) (urea cycle), [GO:0036057](http://purl.obolibrary.org/obo/GO_0036057) (slit diaphragm), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0051604](http://purl.obolibrary.org/obo/GO_0051604) (protein maturation), [GO:0051602](http://purl.obolibrary.org/obo/GO_0051602) (response to electrical stimulus), [GO:0051603](http://purl.obolibrary.org/obo/GO_0051603) (proteolysis involved in cellular protein catabolic process), [GO:0080182](http://purl.obolibrary.org/obo/GO_0080182) (histone H3-K4 trimethylation), [GO:0036042](http://purl.obolibrary.org/obo/GO_0036042) (long-chain fatty acyl-CoA binding), [GO:0007502](http://purl.obolibrary.org/obo/GO_0007502) (digestive tract mesoderm development), [GO:0007500](http://purl.obolibrary.org/obo/GO_0007500) (mesodermal cell fate determination), [GO:0008832](http://purl.obolibrary.org/obo/GO_0008832) (dGTPase activity), [GO:0007501](http://purl.obolibrary.org/obo/GO_0007501) (mesodermal cell fate specification), [GO:0008828](http://purl.obolibrary.org/obo/GO_0008828) (dATP pyrophosphohydrolase activity), [GO:0036038](http://purl.obolibrary.org/obo/GO_0036038) (MKS complex), [GO:0036035](http://purl.obolibrary.org/obo/GO_0036035) (osteoclast development), [GO:0080154](http://purl.obolibrary.org/obo/GO_0080154) (regulation of fertilization), [GO:0036033](http://purl.obolibrary.org/obo/GO_0036033) (mediator complex binding), [GO:1904717](http://purl.obolibrary.org/obo/GO_1904717) (regulation of AMPA glutamate receptor clustering), [GO:1904715](http://purl.obolibrary.org/obo/GO_1904715) (negative regulation of chaperone-mediated autophagy), [GO:0000079](http://purl.obolibrary.org/obo/GO_0000079) (regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:1904714](http://purl.obolibrary.org/obo/GO_1904714) (regulation of chaperone-mediated autophagy), [GO:0000086](http://purl.obolibrary.org/obo/GO_0000086) (G2/M transition of mitotic cell cycle), [GO:1904707](http://purl.obolibrary.org/obo/GO_1904707) (positive regulation of vascular smooth muscle cell proliferation), [GO:0000083](http://purl.obolibrary.org/obo/GO_0000083) (regulation of transcription involved in G1/S transition of mitotic cell cycle), [GO:0000082](http://purl.obolibrary.org/obo/GO_0000082) (G1/S transition of mitotic cell cycle), [GO:0008802](http://purl.obolibrary.org/obo/GO_0008802) (betaine-aldehyde dehydrogenase activity), [GO:0061056](http://purl.obolibrary.org/obo/GO_0061056) (sclerotome development), [GO:0045806](http://purl.obolibrary.org/obo/GO_0045806) (negative regulation of endocytosis), [GO:0019516](http://purl.obolibrary.org/obo/GO_0019516) (lactate oxidation), [GO:0061052](http://purl.obolibrary.org/obo/GO_0061052) (negative regulation of cell growth involved in cardiac muscle cell development), [GO:0061053](http://purl.obolibrary.org/obo/GO_0061053) (somite development), [GO:0045807](http://purl.obolibrary.org/obo/GO_0045807) (positive regulation of endocytosis), [GO:0021837](http://purl.obolibrary.org/obo/GO_0021837) (motogenic signaling involved in postnatal olfactory bulb interneuron migration), [GO:0061055](http://purl.obolibrary.org/obo/GO_0061055) (myotome development), [GO:0036092](http://purl.obolibrary.org/obo/GO_0036092) (phosphatidylinositol-3-phosphate biosynthetic process), [GO:0021830](http://purl.obolibrary.org/obo/GO_0021830) (interneuron migration from the subpallium to the cortex), [GO:0021831](http://purl.obolibrary.org/obo/GO_0021831) (embryonic olfactory bulb interneuron precursor migration), [GO:0036093](http://purl.obolibrary.org/obo/GO_0036093) (germ cell proliferation), [GO:0036094](http://purl.obolibrary.org/obo/GO_0036094) (small molecule binding), [GO:0007530](http://purl.obolibrary.org/obo/GO_0007530) (sex determination), [GO:0007535](http://purl.obolibrary.org/obo/GO_0007535) (donor selection), [GO:0008865](http://purl.obolibrary.org/obo/GO_0008865) (fructokinase activity), [GO:0007533](http://purl.obolibrary.org/obo/GO_0007533) (mating type switching), [GO:0006203](http://purl.obolibrary.org/obo/GO_0006203) (dGTP catabolic process), [GO:0007528](http://purl.obolibrary.org/obo/GO_0007528) (neuromuscular junction development), [GO:0097001](http://purl.obolibrary.org/obo/GO_0097001) (ceramide binding), [GO:0007529](http://purl.obolibrary.org/obo/GO_0007529) (establishment of synaptic specificity at neuromuscular junction), [GO:0033814](http://purl.obolibrary.org/obo/GO_0033814) (propanoyl-CoA C-acyltransferase activity), [GO:0097002](http://purl.obolibrary.org/obo/GO_0097002) (mitochondrial inner boundary membrane), [GO:0097006](http://purl.obolibrary.org/obo/GO_0097006) (regulation of plasma lipoprotein particle levels), [GO:0097009](http://purl.obolibrary.org/obo/GO_0097009) (energy homeostasis), [GO:0061061](http://purl.obolibrary.org/obo/GO_0061061) (muscle structure development), [GO:0021828](http://purl.obolibrary.org/obo/GO_0021828) (gonadotrophin-releasing hormone neuronal migration to the hypothalamus), [GO:0061047](http://purl.obolibrary.org/obo/GO_0061047) (positive regulation of branching involved in lung morphogenesis), [GO:0045814](http://purl.obolibrary.org/obo/GO_0045814) (negative regulation of gene expression, epigenetic), [GO:0061048](http://purl.obolibrary.org/obo/GO_0061048) (negative regulation of branching involved in lung morphogenesis), [GO:0061041](http://purl.obolibrary.org/obo/GO_0061041) (regulation of wound healing), [GO:1902165](http://purl.obolibrary.org/obo/GO_1902165) (regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:1902166](http://purl.obolibrary.org/obo/GO_1902166) (negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0045813](http://purl.obolibrary.org/obo/GO_0045813) (positive regulation of Wnt signaling pathway, calcium modulating pathway), [GO:0097011](http://purl.obolibrary.org/obo/GO_0097011) (cellular response to granulocyte macrophage colony-stimulating factor stimulus), [GO:0006207](http://purl.obolibrary.org/obo/GO_0006207) ('de novo' pyrimidine nucleobase biosynthetic process), [GO:0019511](http://purl.obolibrary.org/obo/GO_0019511) (peptidyl-proline hydroxylation), [GO:0061051](http://purl.obolibrary.org/obo/GO_0061051) (positive regulation of cell growth involved in cardiac muscle cell development), [GO:0019510](http://purl.obolibrary.org/obo/GO_0019510) (S-adenosylhomocysteine catabolic process), [GO:0021819](http://purl.obolibrary.org/obo/GO_0021819) (layer formation in cerebral cortex), [GO:0061074](http://purl.obolibrary.org/obo/GO_0061074) (regulation of neural retina development), [GO:1902178](http://purl.obolibrary.org/obo/GO_1902178) (fibroblast growth factor receptor apoptotic signaling pathway), [GO:0061075](http://purl.obolibrary.org/obo/GO_0061075) (positive regulation of neural retina development), [GO:1902176](http://purl.obolibrary.org/obo/GO_1902176) (negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway), [GO:0036076](http://purl.obolibrary.org/obo/GO_0036076) (ligamentous ossification), [GO:0061077](http://purl.obolibrary.org/obo/GO_0061077) (chaperone-mediated protein folding), [GO:0045823](http://purl.obolibrary.org/obo/GO_0045823) (positive regulation of heart contraction), [GO:0045824](http://purl.obolibrary.org/obo/GO_0045824) (negative regulation of innate immune response), [GO:0007512](http://purl.obolibrary.org/obo/GO_0007512) (adult heart development), [GO:0045822](http://purl.obolibrary.org/obo/GO_0045822) (negative regulation of heart contraction), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0099641](http://purl.obolibrary.org/obo/GO_0099641) (anterograde axonal protein transport), [GO:0045839](http://purl.obolibrary.org/obo/GO_0045839) (negative regulation of mitotic nuclear division), [GO:0021801](http://purl.obolibrary.org/obo/GO_0021801) (cerebral cortex radial glia guided migration), [GO:0036064](http://purl.obolibrary.org/obo/GO_0036064) (ciliary basal body), [GO:1902188](http://purl.obolibrary.org/obo/GO_1902188) (positive regulation of viral release from host cell), [GO:0007520](http://purl.obolibrary.org/obo/GO_0007520) (myoblast fusion), [GO:0045830](http://purl.obolibrary.org/obo/GO_0045830) (positive regulation of isotype switching), [GO:0036060](http://purl.obolibrary.org/obo/GO_0036060) (slit diaphragm assembly), [GO:0007521](http://purl.obolibrary.org/obo/GO_0007521) (muscle cell fate determination), [GO:0021800](http://purl.obolibrary.org/obo/GO_0021800) (cerebral cortex tangential migration), [GO:0007525](http://purl.obolibrary.org/obo/GO_0007525) (somatic muscle development), [GO:0045835](http://purl.obolibrary.org/obo/GO_0045835) (negative regulation of meiotic nuclear division), [GO:0007522](http://purl.obolibrary.org/obo/GO_0007522) (visceral muscle development), [GO:0008853](http://purl.obolibrary.org/obo/GO_0008853) (exodeoxyribonuclease III activity), [GO:0007517](http://purl.obolibrary.org/obo/GO_0007517) (muscle organ development), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0061072](http://purl.obolibrary.org/obo/GO_0061072) (iris morphogenesis), [GO:0061073](http://purl.obolibrary.org/obo/GO_0061073) (ciliary body morphogenesis), [GO:0061014](http://purl.obolibrary.org/obo/GO_0061014) (positive regulation of mRNA catabolic process), [GO:0007571](http://purl.obolibrary.org/obo/GO_0007571) (age-dependent general metabolic decline), [GO:0006241](http://purl.obolibrary.org/obo/GO_0006241) (CTP biosynthetic process), [GO:0021879](http://purl.obolibrary.org/obo/GO_0021879) (forebrain neuron differentiation), [GO:1903441](http://purl.obolibrary.org/obo/GO_1903441) (protein localization to ciliary membrane), [GO:0061010](http://purl.obolibrary.org/obo/GO_0061010) (gall bladder development), [GO:1903445](http://purl.obolibrary.org/obo/GO_1903445) (protein transport from ciliary membrane to plasma membrane), [GO:0021877](http://purl.obolibrary.org/obo/GO_0021877) (forebrain neuron fate commitment), [GO:0048039](http://purl.obolibrary.org/obo/GO_0048039) (ubiquinone binding), [GO:0021871](http://purl.obolibrary.org/obo/GO_0021871) (forebrain regionalization), [GO:0032528](http://purl.obolibrary.org/obo/GO_0032528) (microvillus organization), [GO:0033859](http://purl.obolibrary.org/obo/GO_0033859) (furaldehyde metabolic process), [GO:0032526](http://purl.obolibrary.org/obo/GO_0032526) (response to retinoic acid), [GO:0032527](http://purl.obolibrary.org/obo/GO_0032527) (protein exit from endoplasmic reticulum), [GO:0048048](http://purl.obolibrary.org/obo/GO_0048048) (embryonic eye morphogenesis), [GO:0018230](http://purl.obolibrary.org/obo/GO_0018230) (peptidyl-L-cysteine S-palmitoylation), [GO:0019563](http://purl.obolibrary.org/obo/GO_0019563) (glycerol catabolic process), [GO:0019568](http://purl.obolibrary.org/obo/GO_0019568) (arabinose catabolic process), [GO:0032525](http://purl.obolibrary.org/obo/GO_0032525) (somite rostral/caudal axis specification), [GO:0061001](http://purl.obolibrary.org/obo/GO_0061001) (regulation of dendritic spine morphogenesis), [GO:0061002](http://purl.obolibrary.org/obo/GO_0061002) (negative regulation of dendritic spine morphogenesis), [GO:1904781](http://purl.obolibrary.org/obo/GO_1904781) (positive regulation of protein localization to centrosome), [GO:0061003](http://purl.obolibrary.org/obo/GO_0061003) (positive regulation of dendritic spine morphogenesis), [GO:1904784](http://purl.obolibrary.org/obo/GO_1904784) (NLRP1 inflammasome complex assembly), [GO:0061009](http://purl.obolibrary.org/obo/GO_0061009) (common bile duct development), [GO:0007586](http://purl.obolibrary.org/obo/GO_0007586) (digestion), [GO:0007584](http://purl.obolibrary.org/obo/GO_0007584) (response to nutrient), [GO:0021865](http://purl.obolibrary.org/obo/GO_0021865) (symmetric radial glial cell division in forebrain), [GO:0007585](http://purl.obolibrary.org/obo/GO_0007585) (respiratory gaseous exchange), [GO:1903457](http://purl.obolibrary.org/obo/GO_1903457) (lactate catabolic process), [GO:0006259](http://purl.obolibrary.org/obo/GO_0006259) (DNA metabolic process), [GO:0021860](http://purl.obolibrary.org/obo/GO_0021860) (pyramidal neuron development), [GO:0007588](http://purl.obolibrary.org/obo/GO_0007588) (excretion), [GO:0061008](http://purl.obolibrary.org/obo/GO_0061008) (hepaticobiliary system development), [GO:0006258](http://purl.obolibrary.org/obo/GO_0006258) (UDP-glucose catabolic process), [GO:0032516](http://purl.obolibrary.org/obo/GO_0032516) (positive regulation of phosphoprotein phosphatase activity), [GO:0051693](http://purl.obolibrary.org/obo/GO_0051693) (actin filament capping), [GO:0051694](http://purl.obolibrary.org/obo/GO_0051694) (pointed-end actin filament capping), [GO:0099634](http://purl.obolibrary.org/obo/GO_0099634) (postsynaptic specialization membrane), [GO:0032510](http://purl.obolibrary.org/obo/GO_0032510) (endosome to lysosome transport via multivesicular body sorting pathway), [GO:0048050](http://purl.obolibrary.org/obo/GO_0048050) (post-embryonic eye morphogenesis), [GO:0032511](http://purl.obolibrary.org/obo/GO_0032511) (late endosome to vacuole transport via multivesicular body sorting pathway), [GO:0061034](http://purl.obolibrary.org/obo/GO_0061034) (olfactory bulb mitral cell layer development), [GO:0061035](http://purl.obolibrary.org/obo/GO_0061035) (regulation of cartilage development), [GO:0061036](http://purl.obolibrary.org/obo/GO_0061036) (positive regulation of cartilage development), [GO:0061037](http://purl.obolibrary.org/obo/GO_0061037) (negative regulation of cartilage development), [GO:1903465](http://purl.obolibrary.org/obo/GO_1903465) (positive regulation of mitotic cell cycle DNA replication), [GO:0061031](http://purl.obolibrary.org/obo/GO_0061031) (endodermal digestive tract morphogenesis), [GO:0061032](http://purl.obolibrary.org/obo/GO_0061032) (visceral serous pericardium development), [GO:0021852](http://purl.obolibrary.org/obo/GO_0021852) (pyramidal neuron migration), [GO:0021853](http://purl.obolibrary.org/obo/GO_0021853) (cerebral cortex GABAergic interneuron migration), [GO:0021854](http://purl.obolibrary.org/obo/GO_0021854) (hypothalamus development), [GO:0021855](http://purl.obolibrary.org/obo/GO_0021855) (hypothalamus cell migration), [GO:1903468](http://purl.obolibrary.org/obo/GO_1903468) (positive regulation of DNA replication initiation), [GO:1904798](http://purl.obolibrary.org/obo/GO_1904798) (positive regulation of core promoter binding), [GO:0006221](http://purl.obolibrary.org/obo/GO_0006221) (pyrimidine nucleotide biosynthetic process), [GO:0061038](http://purl.obolibrary.org/obo/GO_0061038) (uterus morphogenesis), [GO:0048066](http://purl.obolibrary.org/obo/GO_0048066) (developmental pigmentation), [GO:0032508](http://purl.obolibrary.org/obo/GO_0032508) (DNA duplex unwinding), [GO:0048069](http://purl.obolibrary.org/obo/GO_0048069) (eye pigmentation), [GO:0099606](http://purl.obolibrary.org/obo/GO_0099606) (microtubule plus-end directed mitotic chromosome migration), [GO:0099607](http://purl.obolibrary.org/obo/GO_0099607) (lateral attachment of mitotic spindle microtubules to kinetochore), [GO:0099604](http://purl.obolibrary.org/obo/GO_0099604) (ligand-gated calcium channel activity), [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process), [GO:0033833](http://purl.obolibrary.org/obo/GO_0033833) (hydroxymethylfurfural reductase (NADH) activity), [GO:0018216](http://purl.obolibrary.org/obo/GO_0018216) (peptidyl-arginine methylation), [GO:0061024](http://purl.obolibrary.org/obo/GO_0061024) (membrane organization), [GO:0061025](http://purl.obolibrary.org/obo/GO_0061025) (membrane fusion), [GO:0061026](http://purl.obolibrary.org/obo/GO_0061026) (cardiac muscle tissue regeneration), [GO:0021846](http://purl.obolibrary.org/obo/GO_0021846) (cell proliferation in forebrain), [GO:0021847](http://purl.obolibrary.org/obo/GO_0021847) (ventricular zone neuroblast division), [GO:0007565](http://purl.obolibrary.org/obo/GO_0007565) (female pregnancy), [GO:0007568](http://purl.obolibrary.org/obo/GO_0007568) (aging), [GO:0061028](http://purl.obolibrary.org/obo/GO_0061028) (establishment of endothelial barrier), [GO:0007569](http://purl.obolibrary.org/obo/GO_0007569) (cell aging), [GO:0061029](http://purl.obolibrary.org/obo/GO_0061029) (eyelid development in camera-type eye), [GO:0007566](http://purl.obolibrary.org/obo/GO_0007566) (embryo implantation), [GO:0007567](http://purl.obolibrary.org/obo/GO_0007567) (parturition), [GO:0006228](http://purl.obolibrary.org/obo/GO_0006228) (UTP biosynthetic process), [GO:0048076](http://purl.obolibrary.org/obo/GO_0048076) (regulation of compound eye pigmentation), [GO:0019531](http://purl.obolibrary.org/obo/GO_0019531) (oxalate transmembrane transporter activity), [GO:0048070](http://purl.obolibrary.org/obo/GO_0048070) (regulation of developmental pigmentation), [GO:0019530](http://purl.obolibrary.org/obo/GO_0019530) (taurine metabolic process), [GO:0099615](http://purl.obolibrary.org/obo/GO_0099615) ((D)-2-hydroxyglutarate-pyruvate transhydrogenase activity), [GO:0019532](http://purl.obolibrary.org/obo/GO_0019532) (oxalate transport), [GO:0033823](http://purl.obolibrary.org/obo/GO_0033823) (procollagen glucosyltransferase activity), [GO:0018205](http://purl.obolibrary.org/obo/GO_0018205) (peptidyl-lysine modification), [GO:0070728](http://purl.obolibrary.org/obo/GO_0070728) (leucine binding), [GO:0006163](http://purl.obolibrary.org/obo/GO_0006163) (purine nucleotide metabolic process), [GO:0032450](http://purl.obolibrary.org/obo/GO_0032450) (maltose alpha-glucosidase activity), [GO:0006164](http://purl.obolibrary.org/obo/GO_0006164) (purine nucleotide biosynthetic process), [GO:0031120](http://purl.obolibrary.org/obo/GO_0031120) (snRNA pseudouridine synthesis), [GO:0032451](http://purl.obolibrary.org/obo/GO_0032451) (demethylase activity), [GO:0007492](http://purl.obolibrary.org/obo/GO_0007492) (endoderm development), [GO:0021797](http://purl.obolibrary.org/obo/GO_0021797) (forebrain anterior/posterior pattern specification), [GO:0006167](http://purl.obolibrary.org/obo/GO_0006167) (AMP biosynthetic process), [GO:0007498](http://purl.obolibrary.org/obo/GO_0007498) (mesoderm development), [GO:0007499](http://purl.obolibrary.org/obo/GO_0007499) (ectoderm and mesoderm interaction), [GO:0021798](http://purl.obolibrary.org/obo/GO_0021798) (forebrain dorsal/ventral pattern formation), [GO:0006168](http://purl.obolibrary.org/obo/GO_0006168) (adenine salvage), [GO:0045765](http://purl.obolibrary.org/obo/GO_0045765) (regulation of angiogenesis), [GO:0006165](http://purl.obolibrary.org/obo/GO_0006165) (nucleoside diphosphate phosphorylation), [GO:0043103](http://purl.obolibrary.org/obo/GO_0043103) (hypoxanthine salvage), [GO:0045762](http://purl.obolibrary.org/obo/GO_0045762) (positive regulation of adenylate cyclase activity), [GO:0006166](http://purl.obolibrary.org/obo/GO_0006166) (purine ribonucleoside salvage), [GO:0007497](http://purl.obolibrary.org/obo/GO_0007497) (posterior midgut development), [GO:0021794](http://purl.obolibrary.org/obo/GO_0021794) (thalamus development), [GO:0021795](http://purl.obolibrary.org/obo/GO_0021795) (cerebral cortex cell migration), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0006169](http://purl.obolibrary.org/obo/GO_0006169) (adenosine salvage), [GO:0021796](http://purl.obolibrary.org/obo/GO_0021796) (cerebral cortex regionalization), [GO:0032449](http://purl.obolibrary.org/obo/GO_0032449) (CBM complex), [GO:0031118](http://purl.obolibrary.org/obo/GO_0031118) (rRNA pseudouridine synthesis), [GO:0031119](http://purl.obolibrary.org/obo/GO_0031119) (tRNA pseudouridine synthesis), [GO:0019482](http://purl.obolibrary.org/obo/GO_0019482) (beta-alanine metabolic process), [GO:0032443](http://purl.obolibrary.org/obo/GO_0032443) (regulation of ergosterol biosynthetic process), [GO:0031113](http://purl.obolibrary.org/obo/GO_0031113) (regulation of microtubule polymerization), [GO:0031110](http://purl.obolibrary.org/obo/GO_0031110) (regulation of microtubule polymerization or depolymerization), [GO:0032447](http://purl.obolibrary.org/obo/GO_0032447) (protein urmylation), [GO:0031116](http://purl.obolibrary.org/obo/GO_0031116) (positive regulation of microtubule polymerization), [GO:0032448](http://purl.obolibrary.org/obo/GO_0032448) (DNA hairpin binding), [GO:0032445](http://purl.obolibrary.org/obo/GO_0032445) (fructose import), [GO:0070723](http://purl.obolibrary.org/obo/GO_0070723) (response to cholesterol), [GO:0006171](http://purl.obolibrary.org/obo/GO_0006171) (cAMP biosynthetic process), [GO:0070715](http://purl.obolibrary.org/obo/GO_0070715) (sodium-dependent organic cation transport), [GO:0006175](http://purl.obolibrary.org/obo/GO_0006175) (dATP biosynthetic process), [GO:0006178](http://purl.obolibrary.org/obo/GO_0006178) (guanine salvage), [GO:0045776](http://purl.obolibrary.org/obo/GO_0045776) (negative regulation of blood pressure), [GO:0043111](http://purl.obolibrary.org/obo/GO_0043111) (replication fork arrest), [GO:0045773](http://purl.obolibrary.org/obo/GO_0045773) (positive regulation of axon extension), [GO:0043114](http://purl.obolibrary.org/obo/GO_0043114) (regulation of vascular permeability), [GO:0006177](http://purl.obolibrary.org/obo/GO_0006177) (GMP biosynthetic process), [GO:0043113](http://purl.obolibrary.org/obo/GO_0043113) (receptor clustering), [GO:0021782](http://purl.obolibrary.org/obo/GO_0021782) (glial cell development), [GO:0045777](http://purl.obolibrary.org/obo/GO_0045777) (positive regulation of blood pressure), [GO:0021784](http://purl.obolibrary.org/obo/GO_0021784) (postganglionic parasympathetic fiber development), [GO:0045778](http://purl.obolibrary.org/obo/GO_0045778) (positive regulation of ossification), [GO:0021785](http://purl.obolibrary.org/obo/GO_0021785) (branchiomotor neuron axon guidance), [GO:0031109](http://purl.obolibrary.org/obo/GO_0031109) (microtubule polymerization or depolymerization), [GO:0032438](http://purl.obolibrary.org/obo/GO_0032438) (melanosome organization), [GO:0045780](http://purl.obolibrary.org/obo/GO_0045780) (positive regulation of bone resorption), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0032432](http://purl.obolibrary.org/obo/GO_0032432) (actin filament bundle), [GO:0031102](http://purl.obolibrary.org/obo/GO_0031102) (neuron projection regeneration), [GO:0032433](http://purl.obolibrary.org/obo/GO_0032433) (filopodium tip), [GO:0018146](http://purl.obolibrary.org/obo/GO_0018146) (keratan sulfate biosynthetic process), [GO:0032431](http://purl.obolibrary.org/obo/GO_0032431) (activation of phospholipase A2 activity), [GO:0032436](http://purl.obolibrary.org/obo/GO_0032436) (positive regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0031105](http://purl.obolibrary.org/obo/GO_0031105) (septin complex), [GO:0018149](http://purl.obolibrary.org/obo/GO_0018149) (peptide cross-linking), [GO:0032437](http://purl.obolibrary.org/obo/GO_0032437) (cuticular plate), [GO:0031103](http://purl.obolibrary.org/obo/GO_0031103) (axon regeneration), [GO:0032434](http://purl.obolibrary.org/obo/GO_0032434) (regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0032435](http://purl.obolibrary.org/obo/GO_0032435) (negative regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0021779](http://purl.obolibrary.org/obo/GO_0021779) (oligodendrocyte cell fate commitment), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0021775](http://purl.obolibrary.org/obo/GO_0021775) (smoothened signaling pathway involved in ventral spinal cord interneuron specification), [GO:0043122](http://purl.obolibrary.org/obo/GO_0043122) (regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0021776](http://purl.obolibrary.org/obo/GO_0021776) (smoothened signaling pathway involved in spinal cord motor neuron cell fate specification), [GO:0006144](http://purl.obolibrary.org/obo/GO_0006144) (purine nucleobase metabolic process), [GO:0021778](http://purl.obolibrary.org/obo/GO_0021778) (oligodendrocyte cell fate specification), [GO:0045785](http://purl.obolibrary.org/obo/GO_0045785) (positive regulation of cell adhesion), [GO:0043124](http://purl.obolibrary.org/obo/GO_0043124) (negative regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0044458](http://purl.obolibrary.org/obo/GO_0044458) (motile cilium assembly), [GO:0021772](http://purl.obolibrary.org/obo/GO_0021772) (olfactory bulb development), [GO:0043129](http://purl.obolibrary.org/obo/GO_0043129) (surfactant homeostasis), [GO:0021773](http://purl.obolibrary.org/obo/GO_0021773) (striatal medium spiny neuron differentiation), [GO:0032429](http://purl.obolibrary.org/obo/GO_0032429) (regulation of phospholipase A2 activity), [GO:0045793](http://purl.obolibrary.org/obo/GO_0045793) (positive regulation of cell size), [GO:0043130](http://purl.obolibrary.org/obo/GO_0043130) (ubiquitin binding), [GO:0045794](http://purl.obolibrary.org/obo/GO_0045794) (negative regulation of cell volume), [GO:0045792](http://purl.obolibrary.org/obo/GO_0045792) (negative regulation of cell size), [GO:0032421](http://purl.obolibrary.org/obo/GO_0032421) (stereocilium bundle), [GO:0070742](http://purl.obolibrary.org/obo/GO_0070742) (C2H2 zinc finger domain binding), [GO:0019464](http://purl.obolibrary.org/obo/GO_0019464) (glycine decarboxylation via glycine cleavage system), [GO:0032422](http://purl.obolibrary.org/obo/GO_0032422) (purine-rich negative regulatory element binding), [GO:0055103](http://purl.obolibrary.org/obo/GO_0055103) (ligase regulator activity), [GO:0070740](http://purl.obolibrary.org/obo/GO_0070740) (tubulin-glutamic acid ligase activity), [GO:0032420](http://purl.obolibrary.org/obo/GO_0032420) (stereocilium), [GO:0055105](http://purl.obolibrary.org/obo/GO_0055105) (ubiquitin-protein transferase inhibitor activity), [GO:0032425](http://purl.obolibrary.org/obo/GO_0032425) (positive regulation of mismatch repair), [GO:0032426](http://purl.obolibrary.org/obo/GO_0032426) (stereocilium tip), [GO:0021768](http://purl.obolibrary.org/obo/GO_0021768) (nucleus accumbens development), [GO:0021769](http://purl.obolibrary.org/obo/GO_0021769) (orbitofrontal cortex development), [GO:0055120](http://purl.obolibrary.org/obo/GO_0055120) (striated muscle dense body), [GO:0021764](http://purl.obolibrary.org/obo/GO_0021764) (amygdala development), [GO:0021766](http://purl.obolibrary.org/obo/GO_0021766) (hippocampus development), [GO:0006154](http://purl.obolibrary.org/obo/GO_0006154) (adenosine catabolic process), [GO:0043138](http://purl.obolibrary.org/obo/GO_0043138) (3'-5' DNA helicase activity), [GO:0043137](http://purl.obolibrary.org/obo/GO_0043137) (DNA replication, removal of RNA primer), [GO:0021762](http://purl.obolibrary.org/obo/GO_0021762) (substantia nigra development), [GO:0021763](http://purl.obolibrary.org/obo/GO_0021763) (subthalamic nucleus development), [GO:0043139](http://purl.obolibrary.org/obo/GO_0043139) (5'-3' DNA helicase activity), [GO:1990682](http://purl.obolibrary.org/obo/GO_1990682) (CSF1-CSF1R complex), [GO:0032418](http://purl.obolibrary.org/obo/GO_0032418) (lysosome localization), [GO:0032417](http://purl.obolibrary.org/obo/GO_0032417) (positive regulation of sodium:proton antiporter activity), [GO:0043141](http://purl.obolibrary.org/obo/GO_0043141) (ATP-dependent 5'-3' DNA helicase activity), [GO:0043140](http://purl.obolibrary.org/obo/GO_0043140) (ATP-dependent 3'-5' DNA helicase activity), [GO:0043142](http://purl.obolibrary.org/obo/GO_0043142) (single-stranded DNA-dependent ATPase activity), [GO:0055113](http://purl.obolibrary.org/obo/GO_0055113) (epiboly involved in gastrulation with mouth forming second), [GO:0032411](http://purl.obolibrary.org/obo/GO_0032411) (positive regulation of transporter activity), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0055117](http://purl.obolibrary.org/obo/GO_0055117) (regulation of cardiac muscle contraction), [GO:0033745](http://purl.obolibrary.org/obo/GO_0033745) (L-methionine-(R)-S-oxide reductase activity), [GO:0018126](http://purl.obolibrary.org/obo/GO_0018126) (protein hydroxylation), [GO:0055119](http://purl.obolibrary.org/obo/GO_0055119) (relaxation of cardiac muscle), [GO:0033743](http://purl.obolibrary.org/obo/GO_0033743) (peptide-methionine (R)-S-oxide reductase activity), [GO:0070734](http://purl.obolibrary.org/obo/GO_0070734) (histone H3-K27 methylation), [GO:0045726](http://purl.obolibrary.org/obo/GO_0045726) (positive regulation of integrin biosynthetic process), [GO:0045727](http://purl.obolibrary.org/obo/GO_0045727) (positive regulation of translation), [GO:0032494](http://purl.obolibrary.org/obo/GO_0032494) (response to peptidoglycan), [GO:0032495](http://purl.obolibrary.org/obo/GO_0032495) (response to muramyl dipeptide), [GO:0031161](http://purl.obolibrary.org/obo/GO_0031161) (phosphatidylinositol catabolic process), [GO:1902078](http://purl.obolibrary.org/obo/GO_1902078) (positive regulation of lateral motor column neuron migration), [GO:0032493](http://purl.obolibrary.org/obo/GO_0032493) (response to bacterial lipoprotein), [GO:0045720](http://purl.obolibrary.org/obo/GO_0045720) (negative regulation of integrin biosynthetic process), [GO:0099590](http://purl.obolibrary.org/obo/GO_0099590) (neurotransmitter receptor internalization), [GO:0045721](http://purl.obolibrary.org/obo/GO_0045721) (negative regulation of gluconeogenesis), [GO:0045724](http://purl.obolibrary.org/obo/GO_0045724) (positive regulation of cilium assembly), [GO:0045725](http://purl.obolibrary.org/obo/GO_0045725) (positive regulation of glycogen biosynthetic process), [GO:0045722](http://purl.obolibrary.org/obo/GO_0045722) (positive regulation of gluconeogenesis), [GO:0045723](http://purl.obolibrary.org/obo/GO_0045723) (positive regulation of fatty acid biosynthetic process), [GO:1990683](http://purl.obolibrary.org/obo/GO_1990683) (DNA double-strand break attachment to nuclear envelope), [GO:0018193](http://purl.obolibrary.org/obo/GO_0018193) (peptidyl-amino acid modification), [GO:0015909](http://purl.obolibrary.org/obo/GO_0015909) (long-chain fatty acid transport), [GO:0015908](http://purl.obolibrary.org/obo/GO_0015908) (fatty acid transport), [GO:0003923](http://purl.obolibrary.org/obo/GO_0003923) (GPI-anchor transamidase activity), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:1902072](http://purl.obolibrary.org/obo/GO_1902072) (negative regulation of hypoxia-inducible factor-1alpha signaling pathway), [GO:0045739](http://purl.obolibrary.org/obo/GO_0045739) (positive regulation of DNA repair), [GO:0032480](http://purl.obolibrary.org/obo/GO_0032480) (negative regulation of type I interferon production), [GO:0045737](http://purl.obolibrary.org/obo/GO_0045737) (positive regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:0032481](http://purl.obolibrary.org/obo/GO_0032481) (positive regulation of type I interferon production), [GO:0045732](http://purl.obolibrary.org/obo/GO_0045732) (positive regulation of protein catabolic process), [GO:0045730](http://purl.obolibrary.org/obo/GO_0045730) (respiratory burst), [GO:0045736](http://purl.obolibrary.org/obo/GO_0045736) (negative regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:2000607](http://purl.obolibrary.org/obo/GO_2000607) (negative regulation of cell proliferation involved in mesonephros development), [GO:1990696](http://purl.obolibrary.org/obo/GO_1990696) (USH2 complex), [GO:1990698](http://purl.obolibrary.org/obo/GO_1990698) (palmitoleoyltransferase activity), [GO:0003934](http://purl.obolibrary.org/obo/GO_0003934) (GTP cyclohydrolase I activity), [GO:0015918](http://purl.obolibrary.org/obo/GO_0015918) (sterol transport), [GO:0003937](http://purl.obolibrary.org/obo/GO_0003937) (IMP cyclohydrolase activity), [GO:0031145](http://purl.obolibrary.org/obo/GO_0031145) (anaphase-promoting complex-dependent catabolic process), [GO:0003938](http://purl.obolibrary.org/obo/GO_0003938) (IMP dehydrogenase activity), [GO:0015914](http://purl.obolibrary.org/obo/GO_0015914) (phospholipid transport), [GO:0031146](http://purl.obolibrary.org/obo/GO_0031146) (SCF-dependent proteasomal ubiquitin-dependent protein catabolic process), [GO:0032474](http://purl.obolibrary.org/obo/GO_0032474) (otolith morphogenesis), [GO:0031143](http://purl.obolibrary.org/obo/GO_0031143) (pseudopodium), [GO:2000601](http://purl.obolibrary.org/obo/GO_2000601) (positive regulation of Arp2/3 complex-mediated actin nucleation), [GO:0032475](http://purl.obolibrary.org/obo/GO_0032475) (otolith formation), [GO:0015910](http://purl.obolibrary.org/obo/GO_0015910) (peroxisomal long-chain fatty acid import), [GO:0006182](http://purl.obolibrary.org/obo/GO_0006182) (cGMP biosynthetic process), [GO:0032472](http://purl.obolibrary.org/obo/GO_0032472) (Golgi calcium ion transport), [GO:0006183](http://purl.obolibrary.org/obo/GO_0006183) (GTP biosynthetic process), [GO:0032470](http://purl.obolibrary.org/obo/GO_0032470) (positive regulation of endoplasmic reticulum calcium ion concentration), [GO:0032471](http://purl.obolibrary.org/obo/GO_0032471) (negative regulation of endoplasmic reticulum calcium ion concentration), [GO:0006189](http://purl.obolibrary.org/obo/GO_0006189) ('de novo' IMP biosynthetic process), [GO:0045742](http://purl.obolibrary.org/obo/GO_0045742) (positive regulation of epidermal growth factor receptor signaling pathway), [GO:0045743](http://purl.obolibrary.org/obo/GO_0045743) (positive regulation of fibroblast growth factor receptor signaling pathway), [GO:0045740](http://purl.obolibrary.org/obo/GO_0045740) (positive regulation of DNA replication), [GO:0006188](http://purl.obolibrary.org/obo/GO_0006188) (IMP biosynthetic process), [GO:0099572](http://purl.obolibrary.org/obo/GO_0099572) (postsynaptic specialization), [GO:0045746](http://purl.obolibrary.org/obo/GO_0045746) (negative regulation of Notch signaling pathway), [GO:0045747](http://purl.obolibrary.org/obo/GO_0045747) (positive regulation of Notch signaling pathway), [GO:0045744](http://purl.obolibrary.org/obo/GO_0045744) (negative regulation of G-protein coupled receptor protein signaling pathway), [GO:0045745](http://purl.obolibrary.org/obo/GO_0045745) (positive regulation of G-protein coupled receptor protein signaling pathway), [GO:0099565](http://purl.obolibrary.org/obo/GO_0099565) (chemical synaptic transmission, postsynaptic), [GO:2000617](http://purl.obolibrary.org/obo/GO_2000617) (positive regulation of histone H3-K9 acetylation), [GO:0099566](http://purl.obolibrary.org/obo/GO_0099566) (regulation of postsynaptic cytosolic calcium ion concentration), [GO:2000615](http://purl.obolibrary.org/obo/GO_2000615) (regulation of histone H3-K9 acetylation), [GO:2000616](http://purl.obolibrary.org/obo/GO_2000616) (negative regulation of histone H3-K9 acetylation), [GO:0032465](http://purl.obolibrary.org/obo/GO_0032465) (regulation of cytokinesis), [GO:0031134](http://purl.obolibrary.org/obo/GO_0031134) (sister chromatid biorientation), [GO:0032466](http://purl.obolibrary.org/obo/GO_0032466) (negative regulation of cytokinesis), [GO:0032463](http://purl.obolibrary.org/obo/GO_0032463) (negative regulation of protein homooligomerization), [GO:2000611](http://purl.obolibrary.org/obo/GO_2000611) (positive regulation of thyroid hormone generation), [GO:2000612](http://purl.obolibrary.org/obo/GO_2000612) (regulation of thyroid-stimulating hormone secretion), [GO:0031133](http://purl.obolibrary.org/obo/GO_0031133) (regulation of axon diameter), [GO:0032469](http://purl.obolibrary.org/obo/GO_0032469) (endoplasmic reticulum calcium ion homeostasis), [GO:0031138](http://purl.obolibrary.org/obo/GO_0031138) (negative regulation of conjugation with cellular fusion), [GO:0003909](http://purl.obolibrary.org/obo/GO_0003909) (DNA ligase activity), [GO:0070700](http://purl.obolibrary.org/obo/GO_0070700) (BMP receptor binding), [GO:0032467](http://purl.obolibrary.org/obo/GO_0032467) (positive regulation of cytokinesis), [GO:0032468](http://purl.obolibrary.org/obo/GO_0032468) (Golgi calcium ion homeostasis), [GO:0006193](http://purl.obolibrary.org/obo/GO_0006193) (ITP catabolic process), [GO:0045759](http://purl.obolibrary.org/obo/GO_0045759) (negative regulation of action potential), [GO:0032461](http://purl.obolibrary.org/obo/GO_0032461) (positive regulation of protein oligomerization), [GO:0006198](http://purl.obolibrary.org/obo/GO_0006198) (cAMP catabolic process), [GO:0099583](http://purl.obolibrary.org/obo/GO_0099583) (neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration), [GO:0003910](http://purl.obolibrary.org/obo/GO_0003910) (DNA ligase (ATP) activity), [GO:0018160](http://purl.obolibrary.org/obo/GO_0018160) (peptidyl-pyrromethane cofactor linkage), [GO:0045760](http://purl.obolibrary.org/obo/GO_0045760) (positive regulation of action potential), [GO:2000627](http://purl.obolibrary.org/obo/GO_2000627) (positive regulation of miRNA catabolic process), [GO:0032454](http://purl.obolibrary.org/obo/GO_0032454) (histone demethylase activity (H3-K9 specific)), [GO:0031124](http://purl.obolibrary.org/obo/GO_0031124) (mRNA 3'-end processing), [GO:0003917](http://purl.obolibrary.org/obo/GO_0003917) (DNA topoisomerase type I activity), [GO:0032452](http://purl.obolibrary.org/obo/GO_0032452) (histone demethylase activity), [GO:0031122](http://purl.obolibrary.org/obo/GO_0031122) (cytoplasmic microtubule organization), [GO:2000623](http://purl.obolibrary.org/obo/GO_2000623) (negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay), [GO:0032453](http://purl.obolibrary.org/obo/GO_0032453) (histone demethylase activity (H3-K4 specific)), [GO:0003919](http://purl.obolibrary.org/obo/GO_0003919) (FMN adenylyltransferase activity), [GO:0031128](http://purl.obolibrary.org/obo/GO_0031128) (developmental induction), [GO:0032456](http://purl.obolibrary.org/obo/GO_0032456) (endocytic recycling), [GO:0031126](http://purl.obolibrary.org/obo/GO_0031126) (snoRNA 3'-end processing), [GO:0033787](http://purl.obolibrary.org/obo/GO_0033787) (cyanocobalamin reductase (cyanide-eliminating) activity), [GO:0080130](http://purl.obolibrary.org/obo/GO_0080130) (L-phenylalanine:2-oxoglutarate aminotransferase activity), [GO:0080132](http://purl.obolibrary.org/obo/GO_0080132) (fatty acid alpha-hydroxylase activity), [GO:0001308](http://purl.obolibrary.org/obo/GO_0001308) (negative regulation of chromatin silencing involved in replicative cell aging), [GO:0001306](http://purl.obolibrary.org/obo/GO_0001306) (age-dependent response to oxidative stress), [GO:0001302](http://purl.obolibrary.org/obo/GO_0001302) (replicative cell aging), [GO:0001300](http://purl.obolibrary.org/obo/GO_0001300) (chronological cell aging), [GO:0043194](http://purl.obolibrary.org/obo/GO_0043194) (axon initial segment), [GO:0003964](http://purl.obolibrary.org/obo/GO_0003964) (RNA-directed DNA polymerase activity), [GO:0002634](http://purl.obolibrary.org/obo/GO_0002634) (regulation of germinal center formation), [GO:0043196](http://purl.obolibrary.org/obo/GO_0043196) (varicosity), [GO:0043195](http://purl.obolibrary.org/obo/GO_0043195) (terminal bouton), [GO:0043198](http://purl.obolibrary.org/obo/GO_0043198) (dendritic shaft), [GO:0043197](http://purl.obolibrary.org/obo/GO_0043197) (dendritic spine), [GO:0002639](http://purl.obolibrary.org/obo/GO_0002639) (positive regulation of immunoglobulin production), [GO:2000630](http://purl.obolibrary.org/obo/GO_2000630) (positive regulation of miRNA metabolic process), [GO:0043199](http://purl.obolibrary.org/obo/GO_0043199) (sulfate binding), [GO:0003974](http://purl.obolibrary.org/obo/GO_0003974) (UDP-N-acetylglucosamine 4-epimerase activity), [GO:0003975](http://purl.obolibrary.org/obo/GO_0003975) (UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity), [GO:0003976](http://purl.obolibrary.org/obo/GO_0003976) (UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity), [GO:0003978](http://purl.obolibrary.org/obo/GO_0003978) (UDP-glucose 4-epimerase activity), [GO:2000647](http://purl.obolibrary.org/obo/GO_2000647) (negative regulation of stem cell proliferation), [GO:2000648](http://purl.obolibrary.org/obo/GO_2000648) (positive regulation of stem cell proliferation), [GO:2000649](http://purl.obolibrary.org/obo/GO_2000649) (regulation of sodium ion transmembrane transporter activity), [GO:0052905](http://purl.obolibrary.org/obo/GO_0052905) (tRNA (guanine(9)-N(1))-methyltransferase activity), [GO:2000643](http://purl.obolibrary.org/obo/GO_2000643) (positive regulation of early endosome to late endosome transport), [GO:2000645](http://purl.obolibrary.org/obo/GO_2000645) (negative regulation of receptor catabolic process), [GO:2000641](http://purl.obolibrary.org/obo/GO_2000641) (regulation of early endosome to late endosome transport), [GO:0052917](http://purl.obolibrary.org/obo/GO_0052917) (dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity), [GO:0052918](http://purl.obolibrary.org/obo/GO_0052918) (dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity), [GO:0003940](http://purl.obolibrary.org/obo/GO_0003940) (L-iduronidase activity), [GO:0003943](http://purl.obolibrary.org/obo/GO_0003943) (N-acetylgalactosamine-4-sulfatase activity), [GO:0003945](http://purl.obolibrary.org/obo/GO_0003945) (N-acetyllactosamine synthase activity), [GO:0015929](http://purl.obolibrary.org/obo/GO_0015929) (hexosaminidase activity), [GO:0003948](http://purl.obolibrary.org/obo/GO_0003948) (N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity), [GO:0031174](http://purl.obolibrary.org/obo/GO_0031174) (lifelong otolith mineralization), [GO:0031175](http://purl.obolibrary.org/obo/GO_0031175) (neuron projection development), [GO:0003951](http://purl.obolibrary.org/obo/GO_0003951) (NAD+ kinase activity), [GO:0003954](http://purl.obolibrary.org/obo/GO_0003954) (NADH dehydrogenase activity), [GO:0002626](http://purl.obolibrary.org/obo/GO_0002626) (negative regulation of T cell antigen processing and presentation), [GO:0003958](http://purl.obolibrary.org/obo/GO_0003958) (NADPH-hemoprotein reductase activity), [GO:0015937](http://purl.obolibrary.org/obo/GO_0015937) (coenzyme A biosynthetic process), [GO:2000664](http://purl.obolibrary.org/obo/GO_2000664) (positive regulation of interleukin-5 secretion), [GO:0052926](http://purl.obolibrary.org/obo/GO_0052926) (dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity), [GO:0032499](http://purl.obolibrary.org/obo/GO_0032499) (detection of peptidoglycan), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:2000667](http://purl.obolibrary.org/obo/GO_2000667) (positive regulation of interleukin-13 secretion), [GO:0032497](http://purl.obolibrary.org/obo/GO_0032497) (detection of lipopolysaccharide), [GO:0052925](http://purl.obolibrary.org/obo/GO_0052925) (dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity), [GO:0015992](http://purl.obolibrary.org/obo/GO_0015992) (proton transport), [GO:0015991](http://purl.obolibrary.org/obo/GO_0015991) (ATP hydrolysis coupled proton transport), [GO:0015990](http://purl.obolibrary.org/obo/GO_0015990) (electron transport coupled proton transport), [GO:0043149](http://purl.obolibrary.org/obo/GO_0043149) (stress fiber assembly), [GO:0000015](http://purl.obolibrary.org/obo/GO_0000015) (phosphopyruvate hydratase complex), [GO:0000014](http://purl.obolibrary.org/obo/GO_0000014) (single-stranded DNA endodeoxyribonuclease activity), [GO:0000022](http://purl.obolibrary.org/obo/GO_0000022) (mitotic spindle elongation), [GO:2000679](http://purl.obolibrary.org/obo/GO_2000679) (positive regulation of transcription regulatory region DNA binding), [GO:0070761](http://purl.obolibrary.org/obo/GO_0070761) (pre-snoRNP complex), [GO:0043154](http://purl.obolibrary.org/obo/GO_0043154) (negative regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0043153](http://purl.obolibrary.org/obo/GO_0043153) (entrainment of circadian clock by photoperiod), [GO:0055123](http://purl.obolibrary.org/obo/GO_0055123) (digestive system development), [GO:2000675](http://purl.obolibrary.org/obo/GO_2000675) (negative regulation of type B pancreatic cell apoptotic process), [GO:0070765](http://purl.obolibrary.org/obo/GO_0070765) (gamma-secretase complex), [GO:2000678](http://purl.obolibrary.org/obo/GO_2000678) (negative regulation of transcription regulatory region DNA binding), [GO:2000671](http://purl.obolibrary.org/obo/GO_2000671) (regulation of motor neuron apoptotic process), [GO:2000672](http://purl.obolibrary.org/obo/GO_2000672) (negative regulation of motor neuron apoptotic process), [GO:0055129](http://purl.obolibrary.org/obo/GO_0055129) (L-proline biosynthetic process), [GO:0015986](http://purl.obolibrary.org/obo/GO_0015986) (ATP synthesis coupled proton transport), [GO:2000691](http://purl.obolibrary.org/obo/GO_2000691) (negative regulation of cardiac muscle cell myoblast differentiation), [GO:0002690](http://purl.obolibrary.org/obo/GO_0002690) (positive regulation of leukocyte chemotaxis), [GO:0000026](http://purl.obolibrary.org/obo/GO_0000026) (alpha-1,2-mannosyltransferase activity), [GO:0000033](http://purl.obolibrary.org/obo/GO_0000033) (alpha-1,3-mannosyltransferase activity), [GO:0002687](http://purl.obolibrary.org/obo/GO_0002687) (positive regulation of leukocyte migration), [GO:0043161](http://purl.obolibrary.org/obo/GO_0043161) (proteasome-mediated ubiquitin-dependent protein catabolic process), [GO:0000032](http://purl.obolibrary.org/obo/GO_0000032) (cell wall mannoprotein biosynthetic process), [GO:0000030](http://purl.obolibrary.org/obo/GO_0000030) (mannosyltransferase activity), [GO:0043162](http://purl.obolibrary.org/obo/GO_0043162) (ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway), [GO:2000683](http://purl.obolibrary.org/obo/GO_2000683) (regulation of cellular response to X-ray), [GO:0043169](http://purl.obolibrary.org/obo/GO_0043169) (cation binding), [GO:0003994](http://purl.obolibrary.org/obo/GO_0003994) (aconitate hydratase activity), [GO:0000001](http://purl.obolibrary.org/obo/GO_0000001) (mitochondrion inheritance), [GO:0003985](http://purl.obolibrary.org/obo/GO_0003985) (acetyl-CoA C-acetyltransferase activity), [GO:0043171](http://purl.obolibrary.org/obo/GO_0043171) (peptide catabolic process), [GO:0003988](http://purl.obolibrary.org/obo/GO_0003988) (acetyl-CoA C-acyltransferase activity), [GO:0043176](http://purl.obolibrary.org/obo/GO_0043176) (amine binding), [GO:0015966](http://purl.obolibrary.org/obo/GO_0015966) (diadenosine tetraphosphate biosynthetic process), [GO:0000009](http://purl.obolibrary.org/obo/GO_0000009) (alpha-1,6-mannosyltransferase activity), [GO:0043178](http://purl.obolibrary.org/obo/GO_0043178) (alcohol binding), [GO:0043179](http://purl.obolibrary.org/obo/GO_0043179) (rhythmic excitation), [GO:0000002](http://purl.obolibrary.org/obo/GO_0000002) (mitochondrial genome maintenance), [GO:0002674](http://purl.obolibrary.org/obo/GO_0002674) (negative regulation of acute inflammatory response), [GO:0000012](http://purl.obolibrary.org/obo/GO_0000012) (single strand break repair), [GO:0003995](http://purl.obolibrary.org/obo/GO_0003995) (acyl-CoA dehydrogenase activity), [GO:0043181](http://purl.obolibrary.org/obo/GO_0043181) (vacuolar sequestering), [GO:0000011](http://purl.obolibrary.org/obo/GO_0000011) (vacuole inheritance), [GO:0000010](http://purl.obolibrary.org/obo/GO_0000010) (trans-hexaprenyltranstransferase activity), [GO:0003997](http://purl.obolibrary.org/obo/GO_0003997) (acyl-CoA oxidase activity), [GO:0043185](http://purl.obolibrary.org/obo/GO_0043185) (vascular endothelial growth factor receptor 3 binding), [GO:0070772](http://purl.obolibrary.org/obo/GO_0070772) (PAS complex), [GO:1990635](http://purl.obolibrary.org/obo/GO_1990635) (proximal dendrite), [GO:0070776](http://purl.obolibrary.org/obo/GO_0070776) (MOZ/MORF histone acetyltransferase complex), [GO:0070779](http://purl.obolibrary.org/obo/GO_0070779) (D-aspartate import), [GO:0015976](http://purl.obolibrary.org/obo/GO_0015976) (carbon utilization), [GO:0000178](http://purl.obolibrary.org/obo/GO_0000178) (exosome (RNase complex)), [GO:0050431](http://purl.obolibrary.org/obo/GO_0050431) (transforming growth factor beta binding), [GO:0000187](http://purl.obolibrary.org/obo/GO_0000187) (activation of MAPK activity), [GO:0051764](http://purl.obolibrary.org/obo/GO_0051764) (actin crosslink formation), [GO:0000186](http://purl.obolibrary.org/obo/GO_0000186) (activation of MAPKK activity), [GO:0000185](http://purl.obolibrary.org/obo/GO_0000185) (activation of MAPKKK activity), [GO:0000184](http://purl.obolibrary.org/obo/GO_0000184) (nuclear-transcribed mRNA catabolic process, nonsense-mediated decay), [GO:0000183](http://purl.obolibrary.org/obo/GO_0000183) (chromatin silencing at rDNA), [GO:0000182](http://purl.obolibrary.org/obo/GO_0000182) (rDNA binding), [GO:2000473](http://purl.obolibrary.org/obo/GO_2000473) (positive regulation of hematopoietic stem cell migration), [GO:0050435](http://purl.obolibrary.org/obo/GO_0050435) (amyloid-beta metabolic process), [GO:0036126](http://purl.obolibrary.org/obo/GO_0036126) (sperm flagellum), [GO:0050434](http://purl.obolibrary.org/obo/GO_0050434) (positive regulation of viral transcription), [GO:2000474](http://purl.obolibrary.org/obo/GO_2000474) (regulation of opioid receptor signaling pathway), [GO:0036128](http://purl.obolibrary.org/obo/GO_0036128) (CatSper complex), [GO:0036122](http://purl.obolibrary.org/obo/GO_0036122) (BMP binding), [GO:2000491](http://purl.obolibrary.org/obo/GO_2000491) (positive regulation of hepatic stellate cell activation), [GO:0036120](http://purl.obolibrary.org/obo/GO_0036120) (cellular response to platelet-derived growth factor stimulus), [GO:1904628](http://purl.obolibrary.org/obo/GO_1904628) (cellular response to phorbol 13-acetate 12-myristate), [GO:0051775](http://purl.obolibrary.org/obo/GO_0051775) (response to redox state), [GO:0050444](http://purl.obolibrary.org/obo/GO_0050444) (aquacobalamin reductase (NADPH) activity), [GO:0000196](http://purl.obolibrary.org/obo/GO_0000196) (MAPK cascade involved in cell wall organization or biogenesis), [GO:2000484](http://purl.obolibrary.org/obo/GO_2000484) (positive regulation of interleukin-8 secretion), [GO:0036117](http://purl.obolibrary.org/obo/GO_0036117) (hyaluranon cable), [GO:0036111](http://purl.obolibrary.org/obo/GO_0036111) (very long-chain fatty-acyl-CoA metabolic process), [GO:0036112](http://purl.obolibrary.org/obo/GO_0036112) (medium-chain fatty-acyl-CoA metabolic process), [GO:1905962](http://purl.obolibrary.org/obo/GO_1905962) (glutamatergic neuron differentiation), [GO:0000159](http://purl.obolibrary.org/obo/GO_0000159) (protein phosphatase type 2A complex), [GO:1903307](http://purl.obolibrary.org/obo/GO_1903307) (positive regulation of regulated secretory pathway), [GO:1904637](http://purl.obolibrary.org/obo/GO_1904637) (cellular response to ionomycin), [GO:0000156](http://purl.obolibrary.org/obo/GO_0000156) (phosphorelay response regulator activity), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0000165](http://purl.obolibrary.org/obo/GO_0000165) (MAPK cascade), [GO:0048143](http://purl.obolibrary.org/obo/GO_0048143) (astrocyte activation), [GO:0000164](http://purl.obolibrary.org/obo/GO_0000164) (protein phosphatase type 1 complex), [GO:0051781](http://purl.obolibrary.org/obo/GO_0051781) (positive regulation of cell division), [GO:0048148](http://purl.obolibrary.org/obo/GO_0048148) (behavioral response to cocaine), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:0048147](http://purl.obolibrary.org/obo/GO_0048147) (negative regulation of fibroblast proliferation), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0000160](http://purl.obolibrary.org/obo/GO_0000160) (phosphorelay signal transduction system), [GO:0051780](http://purl.obolibrary.org/obo/GO_0051780) (behavioral response to nutrient), [GO:0036105](http://purl.obolibrary.org/obo/GO_0036105) (peroxisome membrane class-1 targeting sequence binding), [GO:0051787](http://purl.obolibrary.org/obo/GO_0051787) (misfolded protein binding), [GO:0061100](http://purl.obolibrary.org/obo/GO_0061100) (lung neuroendocrine cell differentiation), [GO:0061102](http://purl.obolibrary.org/obo/GO_0061102) (stomach neuroendocrine cell differentiation), [GO:0061103](http://purl.obolibrary.org/obo/GO_0061103) (carotid body glomus cell differentiation), [GO:1904646](http://purl.obolibrary.org/obo/GO_1904646) (cellular response to amyloid-beta), [GO:1904645](http://purl.obolibrary.org/obo/GO_1904645) (response to amyloid-beta), [GO:0048149](http://purl.obolibrary.org/obo/GO_0048149) (behavioral response to ethanol), [GO:0061104](http://purl.obolibrary.org/obo/GO_0061104) (adrenal chromaffin cell differentiation), [GO:0000169](http://purl.obolibrary.org/obo/GO_0000169) (activation of MAPK activity involved in osmosensory signaling pathway), [GO:0051796](http://purl.obolibrary.org/obo/GO_0051796) (negative regulation of timing of catagen), [GO:0000177](http://purl.obolibrary.org/obo/GO_0000177) (cytoplasmic exosome (RNase complex)), [GO:0000176](http://purl.obolibrary.org/obo/GO_0000176) (nuclear exosome (RNase complex)), [GO:0000175](http://purl.obolibrary.org/obo/GO_0000175) (3'-5'-exoribonuclease activity), [GO:0051795](http://purl.obolibrary.org/obo/GO_0051795) (positive regulation of timing of catagen), [GO:0048156](http://purl.obolibrary.org/obo/GO_0048156) (tau protein binding), [GO:0051798](http://purl.obolibrary.org/obo/GO_0051798) (positive regulation of hair follicle development), [GO:0021915](http://purl.obolibrary.org/obo/GO_0021915) (neural tube development), [GO:0021918](http://purl.obolibrary.org/obo/GO_0021918) (regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment), [GO:0021912](http://purl.obolibrary.org/obo/GO_0021912) (regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification), [GO:0021913](http://purl.obolibrary.org/obo/GO_0021913) (regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification), [GO:0008940](http://purl.obolibrary.org/obo/GO_0008940) (nitrate reductase activity), [GO:0007612](http://purl.obolibrary.org/obo/GO_0007612) (learning), [GO:0007613](http://purl.obolibrary.org/obo/GO_0007613) (memory), [GO:0007610](http://purl.obolibrary.org/obo/GO_0007610) (behavior), [GO:0007611](http://purl.obolibrary.org/obo/GO_0007611) (learning or memory), [GO:0007605](http://purl.obolibrary.org/obo/GO_0007605) (sensory perception of sound), [GO:0007606](http://purl.obolibrary.org/obo/GO_0007606) (sensory perception of chemical stimulus), [GO:0007603](http://purl.obolibrary.org/obo/GO_0007603) (phototransduction, visible light), [GO:0008934](http://purl.obolibrary.org/obo/GO_0008934) (inositol monophosphate 1-phosphatase activity), [GO:0007608](http://purl.obolibrary.org/obo/GO_0007608) (sensory perception of smell), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0051721](http://purl.obolibrary.org/obo/GO_0051721) (protein phosphatase 2A binding), [GO:0021904](http://purl.obolibrary.org/obo/GO_0021904) (dorsal/ventral neural tube patterning), [GO:0021905](http://purl.obolibrary.org/obo/GO_0021905) (forebrain-midbrain boundary formation), [GO:0021902](http://purl.obolibrary.org/obo/GO_0021902) (commitment of neuronal cell to specific neuron type in forebrain), [GO:0021903](http://purl.obolibrary.org/obo/GO_0021903) (rostrocaudal neural tube patterning), [GO:0007620](http://purl.obolibrary.org/obo/GO_0007620) (copulation), [GO:0007623](http://purl.obolibrary.org/obo/GO_0007623) (circadian rhythm), [GO:0007622](http://purl.obolibrary.org/obo/GO_0007622) (rhythmic behavior), [GO:0007616](http://purl.obolibrary.org/obo/GO_0007616) (long-term memory), [GO:0051731](http://purl.obolibrary.org/obo/GO_0051731) (polynucleotide 5'-hydroxyl-kinase activity), [GO:0007617](http://purl.obolibrary.org/obo/GO_0007617) (mating behavior), [GO:1905908](http://purl.obolibrary.org/obo/GO_1905908) (positive regulation of amyloid fibril formation), [GO:0007614](http://purl.obolibrary.org/obo/GO_0007614) (short-term memory), [GO:1905907](http://purl.obolibrary.org/obo/GO_1905907) (negative regulation of amyloid fibril formation), [GO:1905906](http://purl.obolibrary.org/obo/GO_1905906) (regulation of amyloid fibril formation), [GO:0051736](http://purl.obolibrary.org/obo/GO_0051736) (ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity), [GO:0051733](http://purl.obolibrary.org/obo/GO_0051733) (polydeoxyribonucleotide kinase activity), [GO:1905923](http://purl.obolibrary.org/obo/GO_1905923) (positive regulation of acetylcholine biosynthetic process), [GO:1905920](http://purl.obolibrary.org/obo/GO_1905920) (positive regulation of CoA-transferase activity), [GO:0048103](http://purl.obolibrary.org/obo/GO_0048103) (somatic stem cell division), [GO:0048102](http://purl.obolibrary.org/obo/GO_0048102) (autophagic cell death), [GO:0036146](http://purl.obolibrary.org/obo/GO_0036146) (cellular response to mycotoxin), [GO:0048105](http://purl.obolibrary.org/obo/GO_0048105) (establishment of body hair planar orientation), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0007602](http://purl.obolibrary.org/obo/GO_0007602) (phototransduction), [GO:0007600](http://purl.obolibrary.org/obo/GO_0007600) (sensory perception), [GO:0050421](http://purl.obolibrary.org/obo/GO_0050421) (nitrite reductase (NO-forming) activity), [GO:0051754](http://purl.obolibrary.org/obo/GO_0051754) (meiotic sister chromatid cohesion, centromeric), [GO:0045926](http://purl.obolibrary.org/obo/GO_0045926) (negative regulation of growth), [GO:1904693](http://purl.obolibrary.org/obo/GO_1904693) (midbrain morphogenesis), [GO:0045927](http://purl.obolibrary.org/obo/GO_0045927) (positive regulation of growth), [GO:0061179](http://purl.obolibrary.org/obo/GO_0061179) (negative regulation of insulin secretion involved in cellular response to glucose stimulus), [GO:0021955](http://purl.obolibrary.org/obo/GO_0021955) (central nervous system neuron axonogenesis), [GO:1902035](http://purl.obolibrary.org/obo/GO_1902035) (positive regulation of hematopoietic stem cell proliferation), [GO:0021956](http://purl.obolibrary.org/obo/GO_0021956) (central nervous system interneuron axonogenesis), [GO:1902036](http://purl.obolibrary.org/obo/GO_1902036) (regulation of hematopoietic stem cell differentiation), [GO:0021957](http://purl.obolibrary.org/obo/GO_0021957) (corticospinal tract morphogenesis), [GO:0021952](http://purl.obolibrary.org/obo/GO_0021952) (central nervous system projection neuron axonogenesis), [GO:0021953](http://purl.obolibrary.org/obo/GO_0021953) (central nervous system neuron differentiation), [GO:0021954](http://purl.obolibrary.org/obo/GO_0021954) (central nervous system neuron development), [GO:1902038](http://purl.obolibrary.org/obo/GO_1902038) (positive regulation of hematopoietic stem cell differentiation), [GO:0006325](http://purl.obolibrary.org/obo/GO_0006325) (chromatin organization), [GO:0045920](http://purl.obolibrary.org/obo/GO_0045920) (negative regulation of exocytosis), [GO:0045921](http://purl.obolibrary.org/obo/GO_0045921) (positive regulation of exocytosis), [GO:0061180](http://purl.obolibrary.org/obo/GO_0061180) (mammary gland epithelium development), [GO:0097129](http://purl.obolibrary.org/obo/GO_0097129) (cyclin D2-CDK4 complex), [GO:0018315](http://purl.obolibrary.org/obo/GO_0018315) (molybdenum incorporation into molybdenum-molybdopterin complex), [GO:0019646](http://purl.obolibrary.org/obo/GO_0019646) (aerobic electron transport chain), [GO:1903373](http://purl.obolibrary.org/obo/GO_1903373) (positive regulation of endoplasmic reticulum tubular network organization), [GO:1902042](http://purl.obolibrary.org/obo/GO_1902042) (negative regulation of extrinsic apoptotic signaling pathway via death domain receptors), [GO:1902043](http://purl.obolibrary.org/obo/GO_1902043) (positive regulation of extrinsic apoptotic signaling pathway via death domain receptors), [GO:1903377](http://purl.obolibrary.org/obo/GO_1903377) (negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway), [GO:0021940](http://purl.obolibrary.org/obo/GO_0021940) (positive regulation of cerebellar granule cell precursor proliferation), [GO:0045930](http://purl.obolibrary.org/obo/GO_0045930) (negative regulation of mitotic cell cycle), [GO:0006333](http://purl.obolibrary.org/obo/GO_0006333) (chromatin assembly or disassembly), [GO:0021943](http://purl.obolibrary.org/obo/GO_0021943) (formation of radial glial scaffolds), [GO:0005004](http://purl.obolibrary.org/obo/GO_0005004) (GPI-linked ephrin receptor activity), [GO:0006337](http://purl.obolibrary.org/obo/GO_0006337) (nucleosome disassembly), [GO:0005003](http://purl.obolibrary.org/obo/GO_0005003) (ephrin receptor activity), [GO:0045931](http://purl.obolibrary.org/obo/GO_0045931) (positive regulation of mitotic cell cycle), [GO:0006334](http://purl.obolibrary.org/obo/GO_0006334) (nucleosome assembly), [GO:0045932](http://purl.obolibrary.org/obo/GO_0045932) (negative regulation of muscle contraction), [GO:0097132](http://purl.obolibrary.org/obo/GO_0097132) (cyclin D2-CDK6 complex), [GO:0044615](http://purl.obolibrary.org/obo/GO_0044615) (nuclear pore nuclear basket), [GO:0021938](http://purl.obolibrary.org/obo/GO_0021938) (smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation), [GO:0070903](http://purl.obolibrary.org/obo/GO_0070903) (mitochondrial tRNA thio-modification), [GO:0021934](http://purl.obolibrary.org/obo/GO_0021934) (hindbrain tangential cell migration), [GO:0061196](http://purl.obolibrary.org/obo/GO_0061196) (fungiform papilla development), [GO:0061197](http://purl.obolibrary.org/obo/GO_0061197) (fungiform papilla morphogenesis), [GO:0021935](http://purl.obolibrary.org/obo/GO_0021935) (cerebellar granule cell precursor tangential migration), [GO:0061198](http://purl.obolibrary.org/obo/GO_0061198) (fungiform papilla formation), [GO:0045940](http://purl.obolibrary.org/obo/GO_0045940) (positive regulation of steroid metabolic process), [GO:0007631](http://purl.obolibrary.org/obo/GO_0007631) (feeding behavior), [GO:0021930](http://purl.obolibrary.org/obo/GO_0021930) (cerebellar granule cell precursor proliferation), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0007634](http://purl.obolibrary.org/obo/GO_0007634) (optokinetic behavior), [GO:0006303](http://purl.obolibrary.org/obo/GO_0006303) (double-strand break repair via nonhomologous end joining), [GO:0045945](http://purl.obolibrary.org/obo/GO_0045945) (positive regulation of transcription by RNA polymerase III), [GO:0007635](http://purl.obolibrary.org/obo/GO_0007635) (chemosensory behavior), [GO:0006304](http://purl.obolibrary.org/obo/GO_0006304) (DNA modification), [GO:0006301](http://purl.obolibrary.org/obo/GO_0006301) (postreplication repair), [GO:0007632](http://purl.obolibrary.org/obo/GO_0007632) (visual behavior), [GO:0044613](http://purl.obolibrary.org/obo/GO_0044613) (nuclear pore central transport channel), [GO:0008963](http://purl.obolibrary.org/obo/GO_0008963) (phospho-N-acetylmuramoyl-pentapeptide-transferase activity), [GO:0006302](http://purl.obolibrary.org/obo/GO_0006302) (double-strand break repair), [GO:0045943](http://purl.obolibrary.org/obo/GO_0045943) (positive regulation of transcription by RNA polymerase I), [GO:0007628](http://purl.obolibrary.org/obo/GO_0007628) (adult walking behavior), [GO:0007625](http://purl.obolibrary.org/obo/GO_0007625) (grooming behavior), [GO:0007626](http://purl.obolibrary.org/obo/GO_0007626) (locomotory behavior), [GO:0097105](http://purl.obolibrary.org/obo/GO_0097105) (presynaptic membrane assembly), [GO:0097108](http://purl.obolibrary.org/obo/GO_0097108) (hedgehog family protein binding), [GO:0097107](http://purl.obolibrary.org/obo/GO_0097107) (postsynaptic density assembly), [GO:0070901](http://purl.obolibrary.org/obo/GO_0070901) (mitochondrial tRNA methylation), [GO:0061188](http://purl.obolibrary.org/obo/GO_0061188) (negative regulation of chromatin silencing at rDNA), [GO:0061189](http://purl.obolibrary.org/obo/GO_0061189) (positive regulation of sclerotome development), [GO:0021924](http://purl.obolibrary.org/obo/GO_0021924) (cell proliferation in external granule layer), [GO:0006310](http://purl.obolibrary.org/obo/GO_0006310) (DNA recombination), [GO:0006311](http://purl.obolibrary.org/obo/GO_0006311) (meiotic gene conversion), [GO:0045956](http://purl.obolibrary.org/obo/GO_0045956) (positive regulation of calcium ion-dependent exocytosis), [GO:0097120](http://purl.obolibrary.org/obo/GO_0097120) (receptor localization to synapse), [GO:0006312](http://purl.obolibrary.org/obo/GO_0006312) (mitotic recombination), [GO:0045953](http://purl.obolibrary.org/obo/GO_0045953) (negative regulation of natural killer cell mediated cytotoxicity), [GO:0007638](http://purl.obolibrary.org/obo/GO_0007638) (mechanosensory behavior), [GO:0097110](http://purl.obolibrary.org/obo/GO_0097110) (scaffold protein binding), [GO:0097113](http://purl.obolibrary.org/obo/GO_0097113) (AMPA glutamate receptor clustering), [GO:0006306](http://purl.obolibrary.org/obo/GO_0006306) (DNA methylation), [GO:0097112](http://purl.obolibrary.org/obo/GO_0097112) (gamma-aminobutyric acid receptor clustering), [GO:0097114](http://purl.obolibrary.org/obo/GO_0097114) (NMDA glutamate receptor clustering), [GO:0097117](http://purl.obolibrary.org/obo/GO_0097117) (guanylate kinase-associated protein clustering), [GO:0006309](http://purl.obolibrary.org/obo/GO_0006309) (apoptotic DNA fragmentation), [GO:0097119](http://purl.obolibrary.org/obo/GO_0097119) (postsynaptic density protein 95 clustering), [GO:0061193](http://purl.obolibrary.org/obo/GO_0061193) (taste bud development), [GO:1903392](http://purl.obolibrary.org/obo/GO_1903392) (negative regulation of adherens junction organization), [GO:0061133](http://purl.obolibrary.org/obo/GO_0061133) (endopeptidase activator activity), [GO:0021999](http://purl.obolibrary.org/obo/GO_0021999) (neural plate anterior/posterior regionalization), [GO:0006361](http://purl.obolibrary.org/obo/GO_0006361) (transcription initiation from RNA polymerase I promoter), [GO:0006362](http://purl.obolibrary.org/obo/GO_0006362) (transcription elongation from RNA polymerase I promoter), [GO:0005030](http://purl.obolibrary.org/obo/GO_0005030) (neurotrophin receptor activity), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0006363](http://purl.obolibrary.org/obo/GO_0006363) (termination of RNA polymerase I transcription), [GO:0021997](http://purl.obolibrary.org/obo/GO_0021997) (neural plate axis specification), [GO:0006364](http://purl.obolibrary.org/obo/GO_0006364) (rRNA processing), [GO:0006369](http://purl.obolibrary.org/obo/GO_0006369) (termination of RNA polymerase II transcription), [GO:0061138](http://purl.obolibrary.org/obo/GO_0061138) (morphogenesis of a branching epithelium), [GO:0006367](http://purl.obolibrary.org/obo/GO_0006367) (transcription initiation from RNA polymerase II promoter), [GO:0006368](http://purl.obolibrary.org/obo/GO_0006368) (transcription elongation from RNA polymerase II promoter), [GO:1904659](http://purl.obolibrary.org/obo/GO_1904659) (glucose transmembrane transport), [GO:1903329](http://purl.obolibrary.org/obo/GO_1903329) (regulation of iron-sulfur cluster assembly), [GO:0032648](http://purl.obolibrary.org/obo/GO_0032648) (regulation of interferon-beta production), [GO:0048169](http://purl.obolibrary.org/obo/GO_0048169) (regulation of long-term neuronal synaptic plasticity), [GO:0048168](http://purl.obolibrary.org/obo/GO_0048168) (regulation of neuronal synaptic plasticity), [GO:0017020](http://purl.obolibrary.org/obo/GO_0017020) (myosin phosphatase regulator activity), [GO:0048167](http://purl.obolibrary.org/obo/GO_0048167) (regulation of synaptic plasticity), [GO:0019682](http://purl.obolibrary.org/obo/GO_0019682) (glyceraldehyde-3-phosphate metabolic process), [GO:0017022](http://purl.obolibrary.org/obo/GO_0017022) (myosin binding), [GO:0017025](http://purl.obolibrary.org/obo/GO_0017025) (TBP-class protein binding), [GO:0032640](http://purl.obolibrary.org/obo/GO_0032640) (tumor necrosis factor production), [GO:0031314](http://purl.obolibrary.org/obo/GO_0031314) (extrinsic component of mitochondrial inner membrane), [GO:0031315](http://purl.obolibrary.org/obo/GO_0031315) (extrinsic component of mitochondrial outer membrane), [GO:0031313](http://purl.obolibrary.org/obo/GO_0031313) (extrinsic component of endosome membrane), [GO:0005042](http://purl.obolibrary.org/obo/GO_0005042) (netrin receptor activity), [GO:1902001](http://purl.obolibrary.org/obo/GO_1902001) (fatty acid transmembrane transport), [GO:0005044](http://purl.obolibrary.org/obo/GO_0005044) (scavenger receptor activity), [GO:0021984](http://purl.obolibrary.org/obo/GO_0021984) (adenohypophysis development), [GO:0006376](http://purl.obolibrary.org/obo/GO_0006376) (mRNA splice site selection), [GO:1904669](http://purl.obolibrary.org/obo/GO_1904669) (ATP export), [GO:1904668](http://purl.obolibrary.org/obo/GO_1904668) (positive regulation of ubiquitin protein ligase activity), [GO:0021985](http://purl.obolibrary.org/obo/GO_0021985) (neurohypophysis development), [GO:0021986](http://purl.obolibrary.org/obo/GO_0021986) (habenula development), [GO:1902004](http://purl.obolibrary.org/obo/GO_1902004) (positive regulation of amyloid-beta formation), [GO:0021987](http://purl.obolibrary.org/obo/GO_0021987) (cerebral cortex development), [GO:0021982](http://purl.obolibrary.org/obo/GO_0021982) (pineal gland development), [GO:0006378](http://purl.obolibrary.org/obo/GO_0006378) (mRNA polyadenylation), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0006379](http://purl.obolibrary.org/obo/GO_0006379) (mRNA cleavage), [GO:0031307](http://purl.obolibrary.org/obo/GO_0031307) (integral component of mitochondrial outer membrane), [GO:0031305](http://purl.obolibrary.org/obo/GO_0031305) (integral component of mitochondrial inner membrane), [GO:0031306](http://purl.obolibrary.org/obo/GO_0031306) (intrinsic component of mitochondrial outer membrane), [GO:0050482](http://purl.obolibrary.org/obo/GO_0050482) (arachidonic acid secretion), [GO:0031309](http://purl.obolibrary.org/obo/GO_0031309) (integral component of nuclear outer membrane), [GO:0033962](http://purl.obolibrary.org/obo/GO_0033962) (cytoplasmic mRNA processing body assembly), [GO:0018343](http://purl.obolibrary.org/obo/GO_0018343) (protein farnesylation), [GO:0019674](http://purl.obolibrary.org/obo/GO_0019674) (NAD metabolic process), [GO:0019673](http://purl.obolibrary.org/obo/GO_0019673) (GDP-mannose metabolic process), [GO:0018345](http://purl.obolibrary.org/obo/GO_0018345) (protein palmitoylation), [GO:0019676](http://purl.obolibrary.org/obo/GO_0019676) (ammonia assimilation cycle), [GO:0018344](http://purl.obolibrary.org/obo/GO_0018344) (protein geranylgeranylation), [GO:0017015](http://purl.obolibrary.org/obo/GO_0017015) (regulation of transforming growth factor beta receptor signaling pathway), [GO:0048172](http://purl.obolibrary.org/obo/GO_0048172) (regulation of short-term neuronal synaptic plasticity), [GO:0017016](http://purl.obolibrary.org/obo/GO_0017016) (Ras GTPase binding), [GO:0031304](http://purl.obolibrary.org/obo/GO_0031304) (intrinsic component of mitochondrial inner membrane), [GO:0031301](http://purl.obolibrary.org/obo/GO_0031301) (integral component of organelle membrane), [GO:0048170](http://purl.obolibrary.org/obo/GO_0048170) (positive regulation of long-term neuronal synaptic plasticity), [GO:0061155](http://purl.obolibrary.org/obo/GO_0061155) (pulmonary artery endothelial tube morphogenesis), [GO:0061156](http://purl.obolibrary.org/obo/GO_0061156) (pulmonary artery morphogenesis), [GO:0061157](http://purl.obolibrary.org/obo/GO_0061157) (mRNA destabilization), [GO:0061151](http://purl.obolibrary.org/obo/GO_0061151) (BMP signaling pathway involved in renal system segmentation), [GO:0021978](http://purl.obolibrary.org/obo/GO_0021978) (telencephalon regionalization), [GO:1904674](http://purl.obolibrary.org/obo/GO_1904674) (positive regulation of somatic stem cell population maintenance), [GO:0061153](http://purl.obolibrary.org/obo/GO_0061153) (trachea gland development), [GO:0021979](http://purl.obolibrary.org/obo/GO_0021979) (hypothalamus cell differentiation), [GO:0045907](http://purl.obolibrary.org/obo/GO_0045907) (positive regulation of vasoconstriction), [GO:0061154](http://purl.obolibrary.org/obo/GO_0061154) (endothelial tube morphogenesis), [GO:1902017](http://purl.obolibrary.org/obo/GO_1902017) (regulation of cilium assembly), [GO:1903348](http://purl.obolibrary.org/obo/GO_1903348) (positive regulation of bicellular tight junction assembly), [GO:0005011](http://purl.obolibrary.org/obo/GO_0005011) (macrophage colony-stimulating factor receptor activity), [GO:0006342](http://purl.obolibrary.org/obo/GO_0006342) (chromatin silencing), [GO:1903347](http://purl.obolibrary.org/obo/GO_1903347) (negative regulation of bicellular tight junction assembly), [GO:0006348](http://purl.obolibrary.org/obo/GO_0006348) (chromatin silencing at telomere), [GO:0045901](http://purl.obolibrary.org/obo/GO_0045901) (positive regulation of translational elongation), [GO:0005017](http://purl.obolibrary.org/obo/GO_0005017) (platelet-derived growth factor-activated receptor activity), [GO:0006346](http://purl.obolibrary.org/obo/GO_0006346) (methylation-dependent chromatin silencing), [GO:0005008](http://purl.obolibrary.org/obo/GO_0005008) (hepatocyte growth factor-activated receptor activity), [GO:0005007](http://purl.obolibrary.org/obo/GO_0005007) (fibroblast growth factor-activated receptor activity), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0019661](http://purl.obolibrary.org/obo/GO_0019661) (glucose catabolic process to lactate via pyruvate), [GO:0017005](http://purl.obolibrary.org/obo/GO_0017005) (3'-tyrosyl-DNA phosphodiesterase activity), [GO:0032621](http://purl.obolibrary.org/obo/GO_0032621) (interleukin-18 production), [GO:0061144](http://purl.obolibrary.org/obo/GO_0061144) (alveolar secondary septum development), [GO:0045916](http://purl.obolibrary.org/obo/GO_0045916) (negative regulation of complement activation), [GO:0061146](http://purl.obolibrary.org/obo/GO_0061146) (Peyer's patch morphogenesis), [GO:0061140](http://purl.obolibrary.org/obo/GO_0061140) (lung secretory cell differentiation), [GO:0021966](http://purl.obolibrary.org/obo/GO_0021966) (corticospinal neuron axon guidance), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0005020](http://purl.obolibrary.org/obo/GO_0005020) (stem cell factor receptor activity), [GO:0061143](http://purl.obolibrary.org/obo/GO_0061143) (alveolar primary septum development), [GO:0045918](http://purl.obolibrary.org/obo/GO_0045918) (negative regulation of cytolysis), [GO:0006354](http://purl.obolibrary.org/obo/GO_0006354) (DNA-templated transcription, elongation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005021](http://purl.obolibrary.org/obo/GO_0005021) (vascular endothelial growth factor-activated receptor activity), [GO:0006352](http://purl.obolibrary.org/obo/GO_0006352) (DNA-templated transcription, initiation), [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity), [GO:0021965](http://purl.obolibrary.org/obo/GO_0021965) (spinal cord ventral commissure morphogenesis), [GO:0006353](http://purl.obolibrary.org/obo/GO_0006353) (DNA-templated transcription, termination), [GO:0061149](http://purl.obolibrary.org/obo/GO_0061149) (BMP signaling pathway involved in ureter morphogenesis), [GO:0005025](http://purl.obolibrary.org/obo/GO_0005025) (transforming growth factor beta receptor activity, type I), [GO:0006359](http://purl.obolibrary.org/obo/GO_0006359) (regulation of transcription by RNA polymerase III), [GO:0021960](http://purl.obolibrary.org/obo/GO_0021960) (anterior commissure morphogenesis), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0045910](http://purl.obolibrary.org/obo/GO_0045910) (negative regulation of DNA recombination), [GO:0005019](http://purl.obolibrary.org/obo/GO_0005019) (platelet-derived growth factor beta-receptor activity), [GO:0006349](http://purl.obolibrary.org/obo/GO_0006349) (regulation of gene expression by genetic imprinting), [GO:0032610](http://purl.obolibrary.org/obo/GO_0032610) (interleukin-1 alpha production), [GO:0032611](http://purl.obolibrary.org/obo/GO_0032611) (interleukin-1 beta production), [GO:0006281](http://purl.obolibrary.org/obo/GO_0006281) (DNA repair), [GO:0043229](http://purl.obolibrary.org/obo/GO_0043229) (intracellular organelle), [GO:0070847](http://purl.obolibrary.org/obo/GO_0070847) (core mediator complex), [GO:0070848](http://purl.obolibrary.org/obo/GO_0070848) (response to growth factor), [GO:0006284](http://purl.obolibrary.org/obo/GO_0006284) (base-excision repair), [GO:0032570](http://purl.obolibrary.org/obo/GO_0032570) (response to progesterone), [GO:0006283](http://purl.obolibrary.org/obo/GO_0006283) (transcription-coupled nucleotide-excision repair), [GO:0006289](http://purl.obolibrary.org/obo/GO_0006289) (nucleotide-excision repair), [GO:0097091](http://purl.obolibrary.org/obo/GO_0097091) (synaptic vesicle clustering), [GO:0097094](http://purl.obolibrary.org/obo/GO_0097094) (craniofacial suture morphogenesis), [GO:0006287](http://purl.obolibrary.org/obo/GO_0006287) (base-excision repair, gap-filling), [GO:0097095](http://purl.obolibrary.org/obo/GO_0097095) (frontonasal suture morphogenesis), [GO:0045887](http://purl.obolibrary.org/obo/GO_0045887) (positive regulation of synaptic growth at neuromuscular junction), [GO:0097089](http://purl.obolibrary.org/obo/GO_0097089) (methyl-branched fatty acid metabolic process), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:1990523](http://purl.obolibrary.org/obo/GO_1990523) (bone regeneration), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0031233](http://purl.obolibrary.org/obo/GO_0031233) (intrinsic component of external side of plasma membrane), [GO:0031234](http://purl.obolibrary.org/obo/GO_0031234) (extrinsic component of cytoplasmic side of plasma membrane), [GO:1990527](http://purl.obolibrary.org/obo/GO_1990527) (Tec1p-Ste12p-Dig1p complex), [GO:0070842](http://purl.obolibrary.org/obo/GO_0070842) (aggresome assembly), [GO:0018279](http://purl.obolibrary.org/obo/GO_0018279) (protein N-linked glycosylation via asparagine), [GO:0031231](http://purl.obolibrary.org/obo/GO_0031231) (intrinsic component of peroxisomal membrane), [GO:0070840](http://purl.obolibrary.org/obo/GO_0070840) (dynein complex binding), [GO:0031232](http://purl.obolibrary.org/obo/GO_0031232) (extrinsic component of external side of plasma membrane), [GO:0031235](http://purl.obolibrary.org/obo/GO_0031235) (intrinsic component of the cytoplasmic side of the plasma membrane), [GO:0033897](http://purl.obolibrary.org/obo/GO_0033897) (ribonuclease T2 activity), [GO:0032567](http://purl.obolibrary.org/obo/GO_0032567) (dGTP binding), [GO:0070838](http://purl.obolibrary.org/obo/GO_0070838) (divalent metal ion transport), [GO:0070836](http://purl.obolibrary.org/obo/GO_0070836) (caveola assembly), [GO:0006290](http://purl.obolibrary.org/obo/GO_0006290) (pyrimidine dimer repair), [GO:0006295](http://purl.obolibrary.org/obo/GO_0006295) (nucleotide-excision repair, DNA incision, 3'-to lesion), [GO:0006296](http://purl.obolibrary.org/obo/GO_0006296) (nucleotide-excision repair, DNA incision, 5'-to lesion), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0006297](http://purl.obolibrary.org/obo/GO_0006297) (nucleotide-excision repair, DNA gap filling), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0006298](http://purl.obolibrary.org/obo/GO_0006298) (mismatch repair), [GO:0044565](http://purl.obolibrary.org/obo/GO_0044565) (dendritic cell proliferation), [GO:0043237](http://purl.obolibrary.org/obo/GO_0043237) (laminin-1 binding), [GO:0043236](http://purl.obolibrary.org/obo/GO_0043236) (laminin binding), [GO:0045899](http://purl.obolibrary.org/obo/GO_0045899) (positive regulation of RNA polymerase II transcriptional preinitiation complex assembly), [GO:0031228](http://purl.obolibrary.org/obo/GO_0031228) (intrinsic component of Golgi membrane), [GO:0043240](http://purl.obolibrary.org/obo/GO_0043240) (Fanconi anaemia nuclear complex), [GO:1990535](http://purl.obolibrary.org/obo/GO_1990535) (neuron projection maintenance), [GO:0043242](http://purl.obolibrary.org/obo/GO_0043242) (negative regulation of protein complex disassembly), [GO:0070830](http://purl.obolibrary.org/obo/GO_0070830) (bicellular tight junction assembly), [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding), [GO:0070831](http://purl.obolibrary.org/obo/GO_0070831) (basement membrane assembly), [GO:0031223](http://purl.obolibrary.org/obo/GO_0031223) (auditory behavior), [GO:0031226](http://purl.obolibrary.org/obo/GO_0031226) (intrinsic component of plasma membrane), [GO:0031227](http://purl.obolibrary.org/obo/GO_0031227) (intrinsic component of endoplasmic reticulum membrane), [GO:0032558](http://purl.obolibrary.org/obo/GO_0032558) (adenyl deoxyribonucleotide binding), [GO:0031224](http://purl.obolibrary.org/obo/GO_0031224) (intrinsic component of membrane), [GO:0031225](http://purl.obolibrary.org/obo/GO_0031225) (anchored component of membrane), [GO:0006260](http://purl.obolibrary.org/obo/GO_0006260) (DNA replication), [GO:0006261](http://purl.obolibrary.org/obo/GO_0006261) (DNA-dependent DNA replication), [GO:0006266](http://purl.obolibrary.org/obo/GO_0006266) (DNA ligation), [GO:0097070](http://purl.obolibrary.org/obo/GO_0097070) (ductus arteriosus closure), [GO:0043243](http://purl.obolibrary.org/obo/GO_0043243) (positive regulation of protein complex disassembly), [GO:0006267](http://purl.obolibrary.org/obo/GO_0006267) (pre-replicative complex assembly involved in nuclear cell cycle DNA replication), [GO:0021897](http://purl.obolibrary.org/obo/GO_0021897) (forebrain astrocyte development), [GO:0007595](http://purl.obolibrary.org/obo/GO_0007595) (lactation), [GO:0006264](http://purl.obolibrary.org/obo/GO_0006264) (mitochondrial DNA replication), [GO:0007596](http://purl.obolibrary.org/obo/GO_0007596) (blood coagulation), [GO:0006265](http://purl.obolibrary.org/obo/GO_0006265) (DNA topological change), [GO:0021892](http://purl.obolibrary.org/obo/GO_0021892) (cerebral cortex GABAergic interneuron differentiation), [GO:0043248](http://purl.obolibrary.org/obo/GO_0043248) (proteasome assembly), [GO:0043247](http://purl.obolibrary.org/obo/GO_0043247) (telomere maintenance in response to DNA damage), [GO:0006268](http://purl.obolibrary.org/obo/GO_0006268) (DNA unwinding involved in DNA replication), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:0021895](http://purl.obolibrary.org/obo/GO_0021895) (cerebral cortex neuron differentiation), [GO:0097067](http://purl.obolibrary.org/obo/GO_0097067) (cellular response to thyroid hormone stimulus), [GO:0097066](http://purl.obolibrary.org/obo/GO_0097066) (response to thyroid hormone), [GO:0032549](http://purl.obolibrary.org/obo/GO_0032549) (ribonucleoside binding), [GO:0070860](http://purl.obolibrary.org/obo/GO_0070860) (RNA polymerase I core factor complex), [GO:0031211](http://purl.obolibrary.org/obo/GO_0031211) (endoplasmic reticulum palmitoyltransferase complex), [GO:0032543](http://purl.obolibrary.org/obo/GO_0032543) (mitochondrial translation), [GO:0032541](http://purl.obolibrary.org/obo/GO_0032541) (cortical endoplasmic reticulum), [GO:0031210](http://purl.obolibrary.org/obo/GO_0031210) (phosphatidylcholine binding), [GO:0031214](http://purl.obolibrary.org/obo/GO_0031214) (biomineral tissue development), [GO:0006270](http://purl.obolibrary.org/obo/GO_0006270) (DNA replication initiation), [GO:0006273](http://purl.obolibrary.org/obo/GO_0006273) (lagging strand elongation), [GO:0021889](http://purl.obolibrary.org/obo/GO_0021889) (olfactory bulb interneuron differentiation), [GO:0006272](http://purl.obolibrary.org/obo/GO_0006272) (leading strand elongation), [GO:0021885](http://purl.obolibrary.org/obo/GO_0021885) (forebrain cell migration), [GO:0006278](http://purl.obolibrary.org/obo/GO_0006278) (RNA-dependent DNA biosynthetic process), [GO:0043254](http://purl.obolibrary.org/obo/GO_0043254) (regulation of protein complex assembly), [GO:0006275](http://purl.obolibrary.org/obo/GO_0006275) (regulation of DNA replication), [GO:0006276](http://purl.obolibrary.org/obo/GO_0006276) (plasmid maintenance), [GO:0021881](http://purl.obolibrary.org/obo/GO_0021881) (Wnt-activated signaling pathway involved in forebrain neuron fate commitment), [GO:0097084](http://purl.obolibrary.org/obo/GO_0097084) (vascular smooth muscle cell development), [GO:0006279](http://purl.obolibrary.org/obo/GO_0006279) (premeiotic DNA replication), [GO:0021884](http://purl.obolibrary.org/obo/GO_0021884) (forebrain neuron development), [GO:0043262](http://purl.obolibrary.org/obo/GO_0043262) (adenosine-diphosphatase activity), [GO:0018242](http://purl.obolibrary.org/obo/GO_0018242) (protein O-linked glycosylation via serine), [GO:0044594](http://purl.obolibrary.org/obo/GO_0044594) (17-beta-hydroxysteroid dehydrogenase (NAD+) activity), [GO:0032532](http://purl.obolibrary.org/obo/GO_0032532) (regulation of microvillus length), [GO:0031201](http://purl.obolibrary.org/obo/GO_0031201) (SNARE complex), [GO:0070851](http://purl.obolibrary.org/obo/GO_0070851) (growth factor receptor binding), [GO:0032535](http://purl.obolibrary.org/obo/GO_0032535) (regulation of cellular component size), [GO:0032536](http://purl.obolibrary.org/obo/GO_0032536) (regulation of cell projection size), [GO:0031205](http://purl.obolibrary.org/obo/GO_0031205) (endoplasmic reticulum Sec complex), [GO:0031284](http://purl.obolibrary.org/obo/GO_0031284) (positive regulation of guanylate cyclase activity), [GO:0061098](http://purl.obolibrary.org/obo/GO_0061098) (positive regulation of protein tyrosine kinase activity), [GO:0031282](http://purl.obolibrary.org/obo/GO_0031282) (regulation of guanylate cyclase activity), [GO:0031283](http://purl.obolibrary.org/obo/GO_0031283) (negative regulation of guanylate cyclase activity), [GO:0045841](http://purl.obolibrary.org/obo/GO_0045841) (negative regulation of mitotic metaphase/anaphase transition), [GO:0045842](http://purl.obolibrary.org/obo/GO_0045842) (positive regulation of mitotic metaphase/anaphase transition), [GO:0045840](http://purl.obolibrary.org/obo/GO_0045840) (positive regulation of mitotic nuclear division), [GO:0045843](http://purl.obolibrary.org/obo/GO_0045843) (negative regulation of striated muscle tissue development), [GO:0097053](http://purl.obolibrary.org/obo/GO_0097053) (L-kynurenine catabolic process), [GO:1990569](http://purl.obolibrary.org/obo/GO_1990569) (UDP-N-acetylglucosamine transmembrane transport), [GO:0031275](http://purl.obolibrary.org/obo/GO_0031275) (regulation of lateral pseudopodium assembly), [GO:1903281](http://purl.obolibrary.org/obo/GO_1903281) (positive regulation of calcium:sodium antiporter activity), [GO:0045859](http://purl.obolibrary.org/obo/GO_0045859) (regulation of protein kinase activity), [GO:0061085](http://purl.obolibrary.org/obo/GO_0061085) (regulation of histone H3-K27 methylation), [GO:0031274](http://purl.obolibrary.org/obo/GO_0031274) (positive regulation of pseudopodium assembly), [GO:1903298](http://purl.obolibrary.org/obo/GO_1903298) (negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway), [GO:0061088](http://purl.obolibrary.org/obo/GO_0061088) (regulation of sequestering of zinc ion), [GO:0097061](http://purl.obolibrary.org/obo/GO_0097061) (dendritic spine organization), [GO:0097060](http://purl.obolibrary.org/obo/GO_0097060) (synaptic membrane), [GO:0045851](http://purl.obolibrary.org/obo/GO_0045851) (pH reduction), [GO:0097062](http://purl.obolibrary.org/obo/GO_0097062) (dendritic spine maintenance), [GO:0097064](http://purl.obolibrary.org/obo/GO_0097064) (ncRNA export from nucleus), [GO:0097056](http://purl.obolibrary.org/obo/GO_0097056) (selenocysteinyl-tRNA(Sec) biosynthetic process), [GO:0097058](http://purl.obolibrary.org/obo/GO_0097058) (CRLF-CLCF1 complex), [GO:0045860](http://purl.obolibrary.org/obo/GO_0045860) (positive regulation of protein kinase activity), [GO:0002725](http://purl.obolibrary.org/obo/GO_0002725) (negative regulation of T cell cytokine production), [GO:0014707](http://purl.obolibrary.org/obo/GO_0014707) (branchiomeric skeletal muscle development), [GO:0014706](http://purl.obolibrary.org/obo/GO_0014706) (striated muscle tissue development), [GO:0061092](http://purl.obolibrary.org/obo/GO_0061092) (positive regulation of phospholipid translocation), [GO:0014704](http://purl.obolibrary.org/obo/GO_0014704) (intercalated disc), [GO:0031267](http://purl.obolibrary.org/obo/GO_0031267) (small GTPase binding), [GO:0002728](http://purl.obolibrary.org/obo/GO_0002728) (negative regulation of natural killer cell cytokine production), [GO:0032596](http://purl.obolibrary.org/obo/GO_0032596) (protein transport into membrane raft), [GO:0014701](http://purl.obolibrary.org/obo/GO_0014701) (junctional sarcoplasmic reticulum membrane), [GO:0044539](http://purl.obolibrary.org/obo/GO_0044539) (long-chain fatty acid import), [GO:0032590](http://purl.obolibrary.org/obo/GO_0032590) (dendrite membrane), [GO:0043209](http://purl.obolibrary.org/obo/GO_0043209) (myelin sheath), [GO:0070829](http://purl.obolibrary.org/obo/GO_0070829) (heterochromatin maintenance), [GO:0032592](http://purl.obolibrary.org/obo/GO_0032592) (integral component of mitochondrial membrane), [GO:0031261](http://purl.obolibrary.org/obo/GO_0031261) (DNA replication preinitiation complex), [GO:0043200](http://purl.obolibrary.org/obo/GO_0043200) (response to amino acid), [GO:0044530](http://purl.obolibrary.org/obo/GO_0044530) (supraspliceosomal complex), [GO:0043202](http://purl.obolibrary.org/obo/GO_0043202) (lysosomal lumen), [GO:0045861](http://purl.obolibrary.org/obo/GO_0045861) (negative regulation of proteolysis), [GO:0045862](http://purl.obolibrary.org/obo/GO_0045862) (positive regulation of proteolysis), [GO:0043204](http://purl.obolibrary.org/obo/GO_0043204) (perikaryon), [GO:1990592](http://purl.obolibrary.org/obo/GO_1990592) (protein K69-linked ufmylation), [GO:0043203](http://purl.obolibrary.org/obo/GO_0043203) (axon hillock), [GO:1990584](http://purl.obolibrary.org/obo/GO_1990584) (cardiac Troponin complex), [GO:0018293](http://purl.obolibrary.org/obo/GO_0018293) (protein-FAD linkage), [GO:0097026](http://purl.obolibrary.org/obo/GO_0097026) (dendritic cell dendrite assembly), [GO:0097028](http://purl.obolibrary.org/obo/GO_0097028) (dendritic cell differentiation), [GO:0018298](http://purl.obolibrary.org/obo/GO_0018298) (protein-chromophore linkage), [GO:0032587](http://purl.obolibrary.org/obo/GO_0032587) (ruffle membrane), [GO:0031256](http://purl.obolibrary.org/obo/GO_0031256) (leading edge membrane), [GO:0032584](http://purl.obolibrary.org/obo/GO_0032584) (growth cone membrane), [GO:0031253](http://purl.obolibrary.org/obo/GO_0031253) (cell projection membrane), [GO:0032585](http://purl.obolibrary.org/obo/GO_0032585) (multivesicular body membrane), [GO:0070821](http://purl.obolibrary.org/obo/GO_0070821) (tertiary granule membrane), [GO:0032588](http://purl.obolibrary.org/obo/GO_0032588) (trans-Golgi network membrane), [GO:0031258](http://purl.obolibrary.org/obo/GO_0031258) (lamellipodium membrane), [GO:0032589](http://purl.obolibrary.org/obo/GO_0032589) (neuron projection membrane), [GO:0043218](http://purl.obolibrary.org/obo/GO_0043218) (compact myelin), [GO:0070814](http://purl.obolibrary.org/obo/GO_0070814) (hydrogen sulfide biosynthetic process), [GO:0031252](http://purl.obolibrary.org/obo/GO_0031252) (cell leading edge), [GO:0032580](http://purl.obolibrary.org/obo/GO_0032580) (Golgi cisterna membrane), [GO:0032581](http://purl.obolibrary.org/obo/GO_0032581) (ER-dependent peroxisome organization), [GO:0045875](http://purl.obolibrary.org/obo/GO_0045875) (negative regulation of sister chromatid cohesion), [GO:0045872](http://purl.obolibrary.org/obo/GO_0045872) (positive regulation of rhodopsin gene expression), [GO:0044546](http://purl.obolibrary.org/obo/GO_0044546) (NLRP3 inflammasome complex assembly), [GO:0045879](http://purl.obolibrary.org/obo/GO_0045879) (negative regulation of smoothened signaling pathway), [GO:0045876](http://purl.obolibrary.org/obo/GO_0045876) (positive regulation of sister chromatid cohesion), [GO:0097042](http://purl.obolibrary.org/obo/GO_0097042) (extrinsic component of fungal-type vacuolar membrane), [GO:2000507](http://purl.obolibrary.org/obo/GO_2000507) (positive regulation of energy homeostasis), [GO:0097034](http://purl.obolibrary.org/obo/GO_0097034) (mitochondrial respiratory chain complex IV biogenesis), [GO:0097033](http://purl.obolibrary.org/obo/GO_0097033) (mitochondrial respiratory chain complex III biogenesis), [GO:0097036](http://purl.obolibrary.org/obo/GO_0097036) (regulation of plasma membrane sterol distribution), [GO:0097038](http://purl.obolibrary.org/obo/GO_0097038) (perinuclear endoplasmic reticulum), [GO:1990599](http://purl.obolibrary.org/obo/GO_1990599) (3' overhang single-stranded DNA endodeoxyribonuclease activity), [GO:0018283](http://purl.obolibrary.org/obo/GO_0018283) (iron incorporation into metallo-sulfur cluster), [GO:0097037](http://purl.obolibrary.org/obo/GO_0097037) (heme export), [GO:0043220](http://purl.obolibrary.org/obo/GO_0043220) (Schmidt-Lanterman incisure), [GO:0045880](http://purl.obolibrary.org/obo/GO_0045880) (positive regulation of smoothened signaling pathway), [GO:0032575](http://purl.obolibrary.org/obo/GO_0032575) (ATP-dependent 5'-3' RNA helicase activity), [GO:2000502](http://purl.obolibrary.org/obo/GO_2000502) (negative regulation of natural killer cell chemotaxis), [GO:0102009](http://purl.obolibrary.org/obo/GO_0102009) (proline dipeptidase activity), [GO:0002761](http://purl.obolibrary.org/obo/GO_0002761) (regulation of myeloid leukocyte differentiation), [GO:0002755](http://purl.obolibrary.org/obo/GO_0002755) (MyD88-dependent toll-like receptor signaling pathway), [GO:0002756](http://purl.obolibrary.org/obo/GO_0002756) (MyD88-independent toll-like receptor signaling pathway), [GO:0014736](http://purl.obolibrary.org/obo/GO_0014736) (negative regulation of muscle atrophy), [GO:0014734](http://purl.obolibrary.org/obo/GO_0014734) (skeletal muscle hypertrophy), [GO:0000105](http://purl.obolibrary.org/obo/GO_0000105) (histidine biosynthetic process), [GO:0000104](http://purl.obolibrary.org/obo/GO_0000104) (succinate dehydrogenase activity), [GO:0000111](http://purl.obolibrary.org/obo/GO_0000111) (nucleotide-excision repair factor 2 complex), [GO:0002763](http://purl.obolibrary.org/obo/GO_0002763) (positive regulation of myeloid leukocyte differentiation), [GO:0000110](http://purl.obolibrary.org/obo/GO_0000110) (nucleotide-excision repair factor 1 complex), [GO:0001403](http://purl.obolibrary.org/obo/GO_0001403) (invasive growth in response to glucose limitation), [GO:0001402](http://purl.obolibrary.org/obo/GO_0001402) (signal transduction involved in filamentous growth), [GO:0001400](http://purl.obolibrary.org/obo/GO_0001400) (mating projection base), [GO:0002740](http://purl.obolibrary.org/obo/GO_0002740) (negative regulation of cytokine secretion involved in immune response), [GO:0014719](http://purl.obolibrary.org/obo/GO_0014719) (skeletal muscle satellite cell activation), [GO:0014718](http://purl.obolibrary.org/obo/GO_0014718) (positive regulation of satellite cell activation involved in skeletal muscle regeneration), [GO:0031297](http://purl.obolibrary.org/obo/GO_0031297) (replication fork processing), [GO:0031298](http://purl.obolibrary.org/obo/GO_0031298) (replication fork protection complex), [GO:0051702](http://purl.obolibrary.org/obo/GO_0051702) (interaction with symbiont), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0031295](http://purl.obolibrary.org/obo/GO_0031295) (T cell costimulation), [GO:0031293](http://purl.obolibrary.org/obo/GO_0031293) (membrane protein intracellular domain proteolysis), [GO:0002741](http://purl.obolibrary.org/obo/GO_0002741) (positive regulation of cytokine secretion involved in immune response), [GO:0014728](http://purl.obolibrary.org/obo/GO_0014728) (regulation of the force of skeletal muscle contraction), [GO:2000543](http://purl.obolibrary.org/obo/GO_2000543) (positive regulation of gastrulation), [GO:0051716](http://purl.obolibrary.org/obo/GO_0051716) (cellular response to stimulus), [GO:0051717](http://purl.obolibrary.org/obo/GO_0051717) (inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity), [GO:2000546](http://purl.obolibrary.org/obo/GO_2000546) (positive regulation of endothelial cell chemotaxis to fibroblast growth factor), [GO:0051712](http://purl.obolibrary.org/obo/GO_0051712) (positive regulation of killing of cells of other organism), [GO:0014722](http://purl.obolibrary.org/obo/GO_0014722) (regulation of skeletal muscle contraction by calcium ion signaling), [GO:2000541](http://purl.obolibrary.org/obo/GO_2000541) (positive regulation of protein geranylgeranylation), [GO:2000560](http://purl.obolibrary.org/obo/GO_2000560) (positive regulation of CD24 biosynthetic process), [GO:0044597](http://purl.obolibrary.org/obo/GO_0044597) (daunorubicin metabolic process), [GO:0043266](http://purl.obolibrary.org/obo/GO_0043266) (regulation of potassium ion transport), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0043268](http://purl.obolibrary.org/obo/GO_0043268) (positive regulation of potassium ion transport), [GO:0044599](http://purl.obolibrary.org/obo/GO_0044599) (AP-5 adaptor complex), [GO:0043267](http://purl.obolibrary.org/obo/GO_0043267) (negative regulation of potassium ion transport), [GO:0000138](http://purl.obolibrary.org/obo/GO_0000138) (Golgi trans cisterna), [GO:0044598](http://purl.obolibrary.org/obo/GO_0044598) (doxorubicin metabolic process), [GO:0000137](http://purl.obolibrary.org/obo/GO_0000137) (Golgi cis cisterna), [GO:0000144](http://purl.obolibrary.org/obo/GO_0000144) (cellular bud neck septin ring), [GO:0000142](http://purl.obolibrary.org/obo/GO_0000142) (cellular bud neck contractile ring), [GO:0043274](http://purl.obolibrary.org/obo/GO_0043274) (phospholipase binding), [GO:0070880](http://purl.obolibrary.org/obo/GO_0070880) (fungal-type cell wall beta-glucan biosynthetic process), [GO:0070886](http://purl.obolibrary.org/obo/GO_0070886) (positive regulation of calcineurin-NFAT signaling cascade), [GO:0070883](http://purl.obolibrary.org/obo/GO_0070883) (pre-miRNA binding), [GO:0070888](http://purl.obolibrary.org/obo/GO_0070888) (E-box binding), [GO:2000553](http://purl.obolibrary.org/obo/GO_2000553) (positive regulation of T-helper 2 cell cytokine production), [GO:0043277](http://purl.obolibrary.org/obo/GO_0043277) (apoptotic cell clearance), [GO:0043276](http://purl.obolibrary.org/obo/GO_0043276) (anoikis), [GO:0000149](http://purl.obolibrary.org/obo/GO_0000149) (SNARE binding), [GO:0043278](http://purl.obolibrary.org/obo/GO_0043278) (response to morphine), [GO:0000146](http://purl.obolibrary.org/obo/GO_0000146) (microfilament motor activity), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0000155](http://purl.obolibrary.org/obo/GO_0000155) (phosphorelay sensor kinase activity), [GO:0000154](http://purl.obolibrary.org/obo/GO_0000154) (rRNA modification), [GO:0043282](http://purl.obolibrary.org/obo/GO_0043282) (pharyngeal muscle development), [GO:0043281](http://purl.obolibrary.org/obo/GO_0043281) (regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0000151](http://purl.obolibrary.org/obo/GO_0000151) (ubiquitin ligase complex), [GO:2000582](http://purl.obolibrary.org/obo/GO_2000582) (positive regulation of ATP-dependent microtubule motor activity, plus-end-directed), [GO:0000118](http://purl.obolibrary.org/obo/GO_0000118) (histone deacetylase complex), [GO:0000112](http://purl.obolibrary.org/obo/GO_0000112) (nucleotide-excision repair factor 3 complex), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0043291](http://purl.obolibrary.org/obo/GO_0043291) (RAVE complex), [GO:0043292](http://purl.obolibrary.org/obo/GO_0043292) (contractile fiber), [GO:0043295](http://purl.obolibrary.org/obo/GO_0043295) (glutathione binding), [GO:0043297](http://purl.obolibrary.org/obo/GO_0043297) (apical junction assembly), [GO:0043296](http://purl.obolibrary.org/obo/GO_0043296) (apical junction complex), [GO:2000573](http://purl.obolibrary.org/obo/GO_2000573) (positive regulation of DNA biosynthetic process), [GO:2000574](http://purl.obolibrary.org/obo/GO_2000574) (regulation of microtubule motor activity), [GO:2000591](http://purl.obolibrary.org/obo/GO_2000591) (positive regulation of metanephric mesenchymal cell migration), [GO:0000126](http://purl.obolibrary.org/obo/GO_0000126) (transcription factor TFIIIB complex), [GO:0000124](http://purl.obolibrary.org/obo/GO_0000124) (SAGA complex), [GO:0000123](http://purl.obolibrary.org/obo/GO_0000123) (histone acetyltransferase complex), [GO:0000132](http://purl.obolibrary.org/obo/GO_0000132) (establishment of mitotic spindle orientation), [GO:0002787](http://purl.obolibrary.org/obo/GO_0002787) (negative regulation of antibacterial peptide production), [GO:0000131](http://purl.obolibrary.org/obo/GO_0000131) (incipient cellular bud site), [GO:0102084](http://purl.obolibrary.org/obo/GO_0102084) (L-dopa O-methyltransferase activity), [GO:0070893](http://purl.obolibrary.org/obo/GO_0070893) (transposon integration), [GO:0070891](http://purl.obolibrary.org/obo/GO_0070891) (lipoteichoic acid binding), [GO:0070897](http://purl.obolibrary.org/obo/GO_0070897) (DNA-templated transcriptional preinitiation complex assembly), [GO:2000583](http://purl.obolibrary.org/obo/GO_2000583) (regulation of platelet-derived growth factor receptor-alpha signaling pathway), [GO:0070898](http://purl.obolibrary.org/obo/GO_0070898) (RNA polymerase III transcriptional preinitiation complex assembly), [GO:0070899](http://purl.obolibrary.org/obo/GO_0070899) (mitochondrial tRNA wobble uridine modification), [GO:0001147](http://purl.obolibrary.org/obo/GO_0001147) (transcription termination site sequence-specific DNA binding), [GO:0001156](http://purl.obolibrary.org/obo/GO_0001156) (TFIIIC-class transcription factor binding), [GO:0001152](http://purl.obolibrary.org/obo/GO_0001152) (transcription factor activity, RNA polymerase III type 1 promoter sequence-specific binding, TFIIIC recruiting), [GO:0051402](http://purl.obolibrary.org/obo/GO_0051402) (neuron apoptotic process), [GO:0051403](http://purl.obolibrary.org/obo/GO_0051403) (stress-activated MAPK cascade), [GO:0001158](http://purl.obolibrary.org/obo/GO_0001158) (enhancer sequence-specific DNA binding), [GO:1904506](http://purl.obolibrary.org/obo/GO_1904506) (negative regulation of telomere maintenance in response to DNA damage), [GO:0001162](http://purl.obolibrary.org/obo/GO_0001162) (RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding), [GO:0001161](http://purl.obolibrary.org/obo/GO_0001161) (intronic transcription regulatory region sequence-specific DNA binding), [GO:0052745](http://purl.obolibrary.org/obo/GO_0052745) (inositol phosphate phosphatase activity), [GO:0015798](http://purl.obolibrary.org/obo/GO_0015798) (myo-inositol transport), [GO:0015770](http://purl.obolibrary.org/obo/GO_0015770) (sucrose transport), [GO:0003786](http://purl.obolibrary.org/obo/GO_0003786) (actin lateral binding), [GO:0001134](http://purl.obolibrary.org/obo/GO_0001134) (transcription factor activity, transcription factor recruiting), [GO:0002455](http://purl.obolibrary.org/obo/GO_0002455) (humoral immune response mediated by circulating immunoglobulin), [GO:0001133](http://purl.obolibrary.org/obo/GO_0001133) (RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding), [GO:0002456](http://purl.obolibrary.org/obo/GO_0002456) (T cell mediated immunity), [GO:0051428](http://purl.obolibrary.org/obo/GO_0051428) (peptide hormone receptor binding), [GO:0051425](http://purl.obolibrary.org/obo/GO_0051425) (PTB domain binding), [GO:0001139](http://purl.obolibrary.org/obo/GO_0001139) (transcription factor activity, core RNA polymerase II recruiting), [GO:0001135](http://purl.obolibrary.org/obo/GO_0001135) (transcription factor activity, RNA polymerase II transcription factor recruiting), [GO:1904527](http://purl.obolibrary.org/obo/GO_1904527) (negative regulation of microtubule binding), [GO:0051434](http://purl.obolibrary.org/obo/GO_0051434) (BH3 domain binding), [GO:0002467](http://purl.obolibrary.org/obo/GO_0002467) (germinal center formation), [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding), [GO:0001198](http://purl.obolibrary.org/obo/GO_0001198) (negative regulation of mating-type specific transcription from RNA polymerase II promoter), [GO:0001195](http://purl.obolibrary.org/obo/GO_0001195) (maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase III promoter), [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding), [GO:0001190](http://purl.obolibrary.org/obo/GO_0001190) (transcriptional activator activity, RNA polymerase II transcription factor binding), [GO:0009922](http://purl.obolibrary.org/obo/GO_0009922) (fatty acid elongase activity), [GO:0010907](http://purl.obolibrary.org/obo/GO_0010907) (positive regulation of glucose metabolic process), [GO:0009914](http://purl.obolibrary.org/obo/GO_0009914) (hormone transport), [GO:0009913](http://purl.obolibrary.org/obo/GO_0009913) (epidermal cell differentiation), [GO:0009918](http://purl.obolibrary.org/obo/GO_0009918) (sterol delta7 reductase activity), [GO:1905802](http://purl.obolibrary.org/obo/GO_1905802) (regulation of cellular response to manganese ion), [GO:0001178](http://purl.obolibrary.org/obo/GO_0001178) (regulation of transcriptional start site selection at RNA polymerase II promoter), [GO:1903243](http://purl.obolibrary.org/obo/GO_1903243) (negative regulation of cardiac muscle hypertrophy in response to stress), [GO:1903244](http://purl.obolibrary.org/obo/GO_1903244) (positive regulation of cardiac muscle hypertrophy in response to stress), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0051491](http://purl.obolibrary.org/obo/GO_0051491) (positive regulation of filopodium assembly), [GO:0051492](http://purl.obolibrary.org/obo/GO_0051492) (regulation of stress fiber assembly), [GO:0009950](http://purl.obolibrary.org/obo/GO_0009950) (dorsal/ventral axis specification), [GO:0008625](http://purl.obolibrary.org/obo/GO_0008625) (extrinsic apoptotic signaling pathway via death domain receptors), [GO:0009954](http://purl.obolibrary.org/obo/GO_0009954) (proximal/distal pattern formation), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0009949](http://purl.obolibrary.org/obo/GO_0009949) (polarity specification of anterior/posterior axis), [GO:0009948](http://purl.obolibrary.org/obo/GO_0009948) (anterior/posterior axis specification), [GO:0008615](http://purl.obolibrary.org/obo/GO_0008615) (pyridoxine biosynthetic process), [GO:0009946](http://purl.obolibrary.org/obo/GO_0009946) (proximal/distal axis specification), [GO:0051482](http://purl.obolibrary.org/obo/GO_0051482) (positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway), [GO:1903251](http://purl.obolibrary.org/obo/GO_1903251) (multi-ciliated epithelial cell differentiation), [GO:0046907](http://purl.obolibrary.org/obo/GO_0046907) (intracellular transport), [GO:0008631](http://purl.obolibrary.org/obo/GO_0008631) (intrinsic apoptotic signaling pathway in response to oxidative stress), [GO:0008630](http://purl.obolibrary.org/obo/GO_0008630) (intrinsic apoptotic signaling pathway in response to DNA damage), [GO:0009967](http://purl.obolibrary.org/obo/GO_0009967) (positive regulation of signal transduction), [GO:0009966](http://purl.obolibrary.org/obo/GO_0009966) (regulation of signal transduction), [GO:0046902](http://purl.obolibrary.org/obo/GO_0046902) (regulation of mitochondrial membrane permeability), [GO:0008635](http://purl.obolibrary.org/obo/GO_0008635) (activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c), [GO:0051497](http://purl.obolibrary.org/obo/GO_0051497) (negative regulation of stress fiber assembly), [GO:0008627](http://purl.obolibrary.org/obo/GO_0008627) (intrinsic apoptotic signaling pathway in response to osmotic stress), [GO:0009957](http://purl.obolibrary.org/obo/GO_0009957) (epidermal cell fate specification), [GO:0051496](http://purl.obolibrary.org/obo/GO_0051496) (positive regulation of stress fiber assembly), [GO:0010944](http://purl.obolibrary.org/obo/GO_0010944) (negative regulation of transcription by competitive promoter binding), [GO:0051493](http://purl.obolibrary.org/obo/GO_0051493) (regulation of cytoskeleton organization), [GO:0010941](http://purl.obolibrary.org/obo/GO_0010941) (regulation of cell death), [GO:0010942](http://purl.obolibrary.org/obo/GO_0010942) (positive regulation of cell death), [GO:0046914](http://purl.obolibrary.org/obo/GO_0046914) (transition metal ion binding), [GO:0022904](http://purl.obolibrary.org/obo/GO_0022904) (respiratory electron transport chain), [GO:0022900](http://purl.obolibrary.org/obo/GO_0022900) (electron transport chain), [GO:0046912](http://purl.obolibrary.org/obo/GO_0046912) (transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer), [GO:0009931](http://purl.obolibrary.org/obo/GO_0009931) (calcium-dependent protein serine/threonine kinase activity), [GO:0010916](http://purl.obolibrary.org/obo/GO_0010916) (negative regulation of very-low-density lipoprotein particle clearance), [GO:0009925](http://purl.obolibrary.org/obo/GO_0009925) (basal plasma membrane), [GO:0010918](http://purl.obolibrary.org/obo/GO_0010918) (positive regulation of mitochondrial membrane potential), [GO:0046928](http://purl.obolibrary.org/obo/GO_0046928) (regulation of neurotransmitter secretion), [GO:0086100](http://purl.obolibrary.org/obo/GO_0086100) (endothelin receptor signaling pathway), [GO:0046929](http://purl.obolibrary.org/obo/GO_0046929) (negative regulation of neurotransmitter secretion), [GO:0008610](http://purl.obolibrary.org/obo/GO_0008610) (lipid biosynthetic process), [GO:0008611](http://purl.obolibrary.org/obo/GO_0008611) (ether lipid biosynthetic process), [GO:0010923](http://purl.obolibrary.org/obo/GO_0010923) (negative regulation of phosphatase activity), [GO:0050185](http://purl.obolibrary.org/obo/GO_0050185) (phosphatidylinositol deacylase activity), [GO:0008609](http://purl.obolibrary.org/obo/GO_0008609) (alkylglycerone-phosphate synthase activity), [GO:0008608](http://purl.obolibrary.org/obo/GO_0008608) (attachment of spindle microtubules to kinetochore), [GO:0019318](http://purl.obolibrary.org/obo/GO_0019318) (hexose metabolic process), [GO:0021636](http://purl.obolibrary.org/obo/GO_0021636) (trigeminal nerve morphogenesis), [GO:1903202](http://purl.obolibrary.org/obo/GO_1903202) (negative regulation of oxidative stress-induced cell death), [GO:0006002](http://purl.obolibrary.org/obo/GO_0006002) (fructose 6-phosphate metabolic process), [GO:1903206](http://purl.obolibrary.org/obo/GO_1903206) (negative regulation of hydrogen peroxide-induced cell death), [GO:0021633](http://purl.obolibrary.org/obo/GO_0021633) (optic nerve structural organization), [GO:0021634](http://purl.obolibrary.org/obo/GO_0021634) (optic nerve formation), [GO:1904535](http://purl.obolibrary.org/obo/GO_1904535) (positive regulation of telomeric loop disassembly), [GO:0006000](http://purl.obolibrary.org/obo/GO_0006000) (fructose metabolic process), [GO:1903204](http://purl.obolibrary.org/obo/GO_1903204) (negative regulation of oxidative stress-induced neuron death), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:0007338](http://purl.obolibrary.org/obo/GO_0007338) (single fertilization), [GO:0006004](http://purl.obolibrary.org/obo/GO_0006004) (fucose metabolic process), [GO:0021631](http://purl.obolibrary.org/obo/GO_0021631) (optic nerve morphogenesis), [GO:1903208](http://purl.obolibrary.org/obo/GO_1903208) (negative regulation of hydrogen peroxide-induced neuron death), [GO:0051444](http://purl.obolibrary.org/obo/GO_0051444) (negative regulation of ubiquitin-protein transferase activity), [GO:0033617](http://purl.obolibrary.org/obo/GO_0033617) (mitochondrial respiratory chain complex IV assembly), [GO:0010977](http://purl.obolibrary.org/obo/GO_0010977) (negative regulation of neuron projection development), [GO:0033619](http://purl.obolibrary.org/obo/GO_0033619) (membrane protein proteolysis), [GO:0010976](http://purl.obolibrary.org/obo/GO_0010976) (positive regulation of neuron projection development), [GO:0010975](http://purl.obolibrary.org/obo/GO_0010975) (regulation of neuron projection development), [GO:0010970](http://purl.obolibrary.org/obo/GO_0010970) (transport along microtubule), [GO:0033613](http://purl.obolibrary.org/obo/GO_0033613) (activating transcription factor binding), [GO:0010972](http://purl.obolibrary.org/obo/GO_0010972) (negative regulation of G2/M transition of mitotic cell cycle), [GO:0010971](http://purl.obolibrary.org/obo/GO_0010971) (positive regulation of G2/M transition of mitotic cell cycle), [GO:0007341](http://purl.obolibrary.org/obo/GO_0007341) (penetration of zona pellucida), [GO:0021628](http://purl.obolibrary.org/obo/GO_0021628) (olfactory nerve formation), [GO:1905872](http://purl.obolibrary.org/obo/GO_1905872) (negative regulation of protein localization to cell leading edge), [GO:0006013](http://purl.obolibrary.org/obo/GO_0006013) (mannose metabolic process), [GO:0006014](http://purl.obolibrary.org/obo/GO_0006014) (D-ribose metabolic process), [GO:0021623](http://purl.obolibrary.org/obo/GO_0021623) (oculomotor nerve formation), [GO:0006011](http://purl.obolibrary.org/obo/GO_0006011) (UDP-glucose metabolic process), [GO:0006012](http://purl.obolibrary.org/obo/GO_0006012) (galactose metabolic process), [GO:0007343](http://purl.obolibrary.org/obo/GO_0007343) (egg activation), [GO:1903215](http://purl.obolibrary.org/obo/GO_1903215) (negative regulation of protein targeting to mitochondrion), [GO:0006015](http://purl.obolibrary.org/obo/GO_0006015) (5-phosphoribose 1-diphosphate biosynthetic process), [GO:0007346](http://purl.obolibrary.org/obo/GO_0007346) (regulation of mitotic cell cycle), [GO:0007339](http://purl.obolibrary.org/obo/GO_0007339) (binding of sperm to zona pellucida), [GO:0051453](http://purl.obolibrary.org/obo/GO_0051453) (regulation of intracellular pH), [GO:0033605](http://purl.obolibrary.org/obo/GO_0033605) (positive regulation of catecholamine secretion), [GO:0051451](http://purl.obolibrary.org/obo/GO_0051451) (myoblast migration), [GO:0010988](http://purl.obolibrary.org/obo/GO_0010988) (regulation of low-density lipoprotein particle clearance), [GO:0051452](http://purl.obolibrary.org/obo/GO_0051452) (intracellular pH reduction), [GO:0051450](http://purl.obolibrary.org/obo/GO_0051450) (myoblast proliferation), [GO:0033602](http://purl.obolibrary.org/obo/GO_0033602) (negative regulation of dopamine secretion), [GO:0051457](http://purl.obolibrary.org/obo/GO_0051457) (maintenance of protein location in nucleus), [GO:0033600](http://purl.obolibrary.org/obo/GO_0033600) (negative regulation of mammary gland epithelial cell proliferation), [GO:0021615](http://purl.obolibrary.org/obo/GO_0021615) (glossopharyngeal nerve morphogenesis), [GO:0008643](http://purl.obolibrary.org/obo/GO_0008643) (carbohydrate transport), [GO:0021610](http://purl.obolibrary.org/obo/GO_0021610) (facial nerve morphogenesis), [GO:0008641](http://purl.obolibrary.org/obo/GO_0008641) (ubiquitin-like modifier activating enzyme activity), [GO:0021612](http://purl.obolibrary.org/obo/GO_0021612) (facial nerve structural organization), [GO:0051466](http://purl.obolibrary.org/obo/GO_0051466) (positive regulation of corticotropin-releasing hormone secretion), [GO:0052795](http://purl.obolibrary.org/obo/GO_0052795) (exo-alpha-(2->6)-sialidase activity), [GO:0051464](http://purl.obolibrary.org/obo/GO_0051464) (positive regulation of cortisol secretion), [GO:0008637](http://purl.obolibrary.org/obo/GO_0008637) (apoptotic mitochondrial changes), [GO:0052796](http://purl.obolibrary.org/obo/GO_0052796) (exo-alpha-(2->8)-sialidase activity), [GO:0009968](http://purl.obolibrary.org/obo/GO_0009968) (negative regulation of signal transduction), [GO:0052794](http://purl.obolibrary.org/obo/GO_0052794) (exo-alpha-(2->3)-sialidase activity), [GO:0051463](http://purl.obolibrary.org/obo/GO_0051463) (negative regulation of cortisol secretion), [GO:0010951](http://purl.obolibrary.org/obo/GO_0010951) (negative regulation of endopeptidase activity), [GO:0010954](http://purl.obolibrary.org/obo/GO_0010954) (positive regulation of protein processing), [GO:1903232](http://purl.obolibrary.org/obo/GO_1903232) (melanosome assembly), [GO:0051480](http://purl.obolibrary.org/obo/GO_0051480) (regulation of cytosolic calcium ion concentration), [GO:1903238](http://purl.obolibrary.org/obo/GO_1903238) (positive regulation of leukocyte tethering or rolling), [GO:0008654](http://purl.obolibrary.org/obo/GO_0008654) (phospholipid biosynthetic process), [GO:0051481](http://purl.obolibrary.org/obo/GO_0051481) (negative regulation of cytosolic calcium ion concentration), [GO:0007323](http://purl.obolibrary.org/obo/GO_0007323) (peptide pheromone maturation), [GO:0008652](http://purl.obolibrary.org/obo/GO_0008652) (cellular amino acid biosynthetic process), [GO:0009982](http://purl.obolibrary.org/obo/GO_0009982) (pseudouridine synthase activity), [GO:0021602](http://purl.obolibrary.org/obo/GO_0021602) (cranial nerve morphogenesis), [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0010969](http://purl.obolibrary.org/obo/GO_0010969) (regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion), [GO:0010961](http://purl.obolibrary.org/obo/GO_0010961) (cellular magnesium ion homeostasis), [GO:0010960](http://purl.obolibrary.org/obo/GO_0010960) (magnesium ion homeostasis), [GO:0007252](http://purl.obolibrary.org/obo/GO_0007252) (I-kappaB phosphorylation), [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0033540](http://purl.obolibrary.org/obo/GO_0033540) (fatty acid beta-oxidation using acyl-CoA oxidase), [GO:0007253](http://purl.obolibrary.org/obo/GO_0007253) (cytoplasmic sequestering of NF-kappaB), [GO:0007250](http://purl.obolibrary.org/obo/GO_0007250) (activation of NF-kappaB-inducing kinase activity), [GO:0008582](http://purl.obolibrary.org/obo/GO_0008582) (regulation of synaptic growth at neuromuscular junction), [GO:0007256](http://purl.obolibrary.org/obo/GO_0007256) (activation of JNKK activity), [GO:0021555](http://purl.obolibrary.org/obo/GO_0021555) (midbrain-hindbrain boundary morphogenesis), [GO:0007257](http://purl.obolibrary.org/obo/GO_0007257) (activation of JUN kinase activity), [GO:0046854](http://purl.obolibrary.org/obo/GO_0046854) (phosphatidylinositol phosphorylation), [GO:0007254](http://purl.obolibrary.org/obo/GO_0007254) (JNK cascade), [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development), [GO:0021551](http://purl.obolibrary.org/obo/GO_0021551) (central nervous system morphogenesis), [GO:0046855](http://purl.obolibrary.org/obo/GO_0046855) (inositol phosphate dephosphorylation), [GO:0021553](http://purl.obolibrary.org/obo/GO_0021553) (olfactory nerve development), [GO:0046856](http://purl.obolibrary.org/obo/GO_0046856) (phosphatidylinositol dephosphorylation), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0008589](http://purl.obolibrary.org/obo/GO_0008589) (regulation of smoothened signaling pathway), [GO:0033539](http://purl.obolibrary.org/obo/GO_0033539) (fatty acid beta-oxidation using acyl-CoA dehydrogenase), [GO:0021561](http://purl.obolibrary.org/obo/GO_0021561) (facial nerve development), [GO:0019240](http://purl.obolibrary.org/obo/GO_0019240) (citrulline biosynthetic process), [GO:1990402](http://purl.obolibrary.org/obo/GO_1990402) (embryonic liver development), [GO:1990403](http://purl.obolibrary.org/obo/GO_1990403) (embryonic brain development), [GO:0019243](http://purl.obolibrary.org/obo/GO_0019243) (methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione), [GO:1990405](http://purl.obolibrary.org/obo/GO_1990405) (protein antigen binding), [GO:0019244](http://purl.obolibrary.org/obo/GO_0019244) (lactate biosynthetic process from pyruvate), [GO:0032202](http://purl.obolibrary.org/obo/GO_0032202) (telomere assembly), [GO:0010898](http://purl.obolibrary.org/obo/GO_0010898) (positive regulation of triglyceride catabolic process), [GO:0032205](http://purl.obolibrary.org/obo/GO_0032205) (negative regulation of telomere maintenance), [GO:0010893](http://purl.obolibrary.org/obo/GO_0010893) (positive regulation of steroid biosynthetic process), [GO:0019249](http://purl.obolibrary.org/obo/GO_0019249) (lactate biosynthetic process), [GO:0032206](http://purl.obolibrary.org/obo/GO_0032206) (positive regulation of telomere maintenance), [GO:0032203](http://purl.obolibrary.org/obo/GO_0032203) (telomere formation via telomerase), [GO:0071812](http://purl.obolibrary.org/obo/GO_0071812) (positive regulation of fever generation by positive regulation of prostaglandin secretion), [GO:0071806](http://purl.obolibrary.org/obo/GO_0071806) (protein transmembrane transport), [GO:0044209](http://purl.obolibrary.org/obo/GO_0044209) (AMP salvage), [GO:0044208](http://purl.obolibrary.org/obo/GO_0044208) ('de novo' AMP biosynthetic process), [GO:0071804](http://purl.obolibrary.org/obo/GO_0071804) (cellular potassium ion transport), [GO:0071805](http://purl.obolibrary.org/obo/GO_0071805) (potassium ion transmembrane transport), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0008594](http://purl.obolibrary.org/obo/GO_0008594) (photoreceptor cell morphogenesis), [GO:0007264](http://purl.obolibrary.org/obo/GO_0007264) (small GTPase mediated signal transduction), [GO:0008593](http://purl.obolibrary.org/obo/GO_0008593) (regulation of Notch signaling pathway), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0007268](http://purl.obolibrary.org/obo/GO_0007268) (chemical synaptic transmission), [GO:0021545](http://purl.obolibrary.org/obo/GO_0021545) (cranial nerve development), [GO:0007265](http://purl.obolibrary.org/obo/GO_0007265) (Ras protein signal transduction), [GO:0007266](http://purl.obolibrary.org/obo/GO_0007266) (Rho protein signal transduction), [GO:2000808](http://purl.obolibrary.org/obo/GO_2000808) (negative regulation of synaptic vesicle clustering), [GO:0044205](http://purl.obolibrary.org/obo/GO_0044205) ('de novo' UMP biosynthetic process), [GO:0021540](http://purl.obolibrary.org/obo/GO_0021540) (corpus callosum morphogenesis), [GO:0021542](http://purl.obolibrary.org/obo/GO_0021542) (dentate gyrus development), [GO:0007269](http://purl.obolibrary.org/obo/GO_0007269) (neurotransmitter secretion), [GO:0021543](http://purl.obolibrary.org/obo/GO_0021543) (pallium development), [GO:2000806](http://purl.obolibrary.org/obo/GO_2000806) (positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled), [GO:0019230](http://purl.obolibrary.org/obo/GO_0019230) (proprioception), [GO:0045540](http://purl.obolibrary.org/obo/GO_0045540) (regulation of cholesterol biosynthetic process), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0045541](http://purl.obolibrary.org/obo/GO_0045541) (negative regulation of cholesterol biosynthetic process), [GO:2000802](http://purl.obolibrary.org/obo/GO_2000802) (positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation), [GO:1990414](http://purl.obolibrary.org/obo/GO_1990414) (replication-born double-strand break repair via sister chromatid exchange), [GO:0046870](http://purl.obolibrary.org/obo/GO_0046870) (cadmium ion binding), [GO:1990415](http://purl.obolibrary.org/obo/GO_1990415) (Pex17p-Pex14p docking complex), [GO:0033522](http://purl.obolibrary.org/obo/GO_0033522) (histone H2A ubiquitination), [GO:0019233](http://purl.obolibrary.org/obo/GO_0019233) (sensory perception of pain), [GO:0019236](http://purl.obolibrary.org/obo/GO_0019236) (response to pheromone), [GO:0086091](http://purl.obolibrary.org/obo/GO_0086091) (regulation of heart rate by cardiac conduction), [GO:0086092](http://purl.obolibrary.org/obo/GO_0086092) (regulation of the force of heart contraction by cardiac conduction), [GO:0019237](http://purl.obolibrary.org/obo/GO_0019237) (centromeric DNA binding), [GO:0071803](http://purl.obolibrary.org/obo/GO_0071803) (positive regulation of podosome assembly), [GO:0071800](http://purl.obolibrary.org/obo/GO_0071800) (podosome assembly), [GO:0019239](http://purl.obolibrary.org/obo/GO_0019239) (deaminase activity), [GO:0070509](http://purl.obolibrary.org/obo/GO_0070509) (calcium ion import), [GO:0071837](http://purl.obolibrary.org/obo/GO_0071837) (HMG box domain binding), [GO:0010880](http://purl.obolibrary.org/obo/GO_0010880) (regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum), [GO:0070506](http://purl.obolibrary.org/obo/GO_0070506) (high-density lipoprotein particle receptor activity), [GO:0070507](http://purl.obolibrary.org/obo/GO_0070507) (regulation of microtubule cytoskeleton organization), [GO:0086056](http://purl.obolibrary.org/obo/GO_0086056) (voltage-gated calcium channel activity involved in AV node cell action potential), [GO:0021537](http://purl.obolibrary.org/obo/GO_0021537) (telencephalon development), [GO:0021538](http://purl.obolibrary.org/obo/GO_0021538) (epithalamus development), [GO:0007231](http://purl.obolibrary.org/obo/GO_0007231) (osmosensory signaling pathway), [GO:0021539](http://purl.obolibrary.org/obo/GO_0021539) (subthalamus development), [GO:0086059](http://purl.obolibrary.org/obo/GO_0086059) (voltage-gated calcium channel activity involved SA node cell action potential), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0021533](http://purl.obolibrary.org/obo/GO_0021533) (cell differentiation in hindbrain), [GO:0046875](http://purl.obolibrary.org/obo/GO_0046875) (ephrin receptor binding), [GO:0008565](http://purl.obolibrary.org/obo/GO_0008565) (protein transporter activity), [GO:0021534](http://purl.obolibrary.org/obo/GO_0021534) (cell proliferation in hindbrain), [GO:0045545](http://purl.obolibrary.org/obo/GO_0045545) (syndecan binding), [GO:0021535](http://purl.obolibrary.org/obo/GO_0021535) (cell migration in hindbrain), [GO:0046873](http://purl.obolibrary.org/obo/GO_0046873) (metal ion transmembrane transporter activity), [GO:0045542](http://purl.obolibrary.org/obo/GO_0045542) (positive regulation of cholesterol biosynthetic process), [GO:0007232](http://purl.obolibrary.org/obo/GO_0007232) (osmosensory signaling pathway via Sho1 osmosensor), [GO:0021536](http://purl.obolibrary.org/obo/GO_0021536) (diencephalon development), [GO:0044213](http://purl.obolibrary.org/obo/GO_0044213) (intronic transcription regulatory region DNA binding), [GO:0008569](http://purl.obolibrary.org/obo/GO_0008569) (ATP-dependent microtubule motor activity, minus-end-directed), [GO:0021530](http://purl.obolibrary.org/obo/GO_0021530) (spinal cord oligodendrocyte cell fate specification), [GO:0008568](http://purl.obolibrary.org/obo/GO_0008568) (microtubule-severing ATPase activity), [GO:0009898](http://purl.obolibrary.org/obo/GO_0009898) (cytoplasmic side of plasma membrane), [GO:0021532](http://purl.obolibrary.org/obo/GO_0021532) (neural tube patterning), [GO:0045547](http://purl.obolibrary.org/obo/GO_0045547) (dehydrodolichyl diphosphate synthase activity), [GO:0007229](http://purl.obolibrary.org/obo/GO_0007229) (integrin-mediated signaling pathway), [GO:2000811](http://purl.obolibrary.org/obo/GO_2000811) (negative regulation of anoikis), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:1990426](http://purl.obolibrary.org/obo/GO_1990426) (mitotic recombination-dependent replication fork processing), [GO:0019220](http://purl.obolibrary.org/obo/GO_0019220) (regulation of phosphate metabolic process), [GO:0045550](http://purl.obolibrary.org/obo/GO_0045550) (geranylgeranyl reductase activity), [GO:0046881](http://purl.obolibrary.org/obo/GO_0046881) (positive regulation of follicle-stimulating hormone secretion), [GO:0010875](http://purl.obolibrary.org/obo/GO_0010875) (positive regulation of cholesterol efflux), [GO:0086060](http://purl.obolibrary.org/obo/GO_0086060) (voltage-gated sodium channel activity involved in AV node cell action potential), [GO:0086061](http://purl.obolibrary.org/obo/GO_0086061) (voltage-gated sodium channel activity involved in bundle of His cell action potential), [GO:0010874](http://purl.obolibrary.org/obo/GO_0010874) (regulation of cholesterol efflux), [GO:0019222](http://purl.obolibrary.org/obo/GO_0019222) (regulation of metabolic process), [GO:1990429](http://purl.obolibrary.org/obo/GO_1990429) (peroxisomal importomer complex), [GO:0019227](http://purl.obolibrary.org/obo/GO_0019227) (neuronal action potential propagation), [GO:0019226](http://purl.obolibrary.org/obo/GO_0019226) (transmission of nerve impulse), [GO:0010873](http://purl.obolibrary.org/obo/GO_0010873) (positive regulation of cholesterol esterification), [GO:0086062](http://purl.obolibrary.org/obo/GO_0086062) (voltage-gated sodium channel activity involved in Purkinje myocyte action potential), [GO:0019229](http://purl.obolibrary.org/obo/GO_0019229) (regulation of vasoconstriction), [GO:0019228](http://purl.obolibrary.org/obo/GO_0019228) (neuronal action potential), [GO:0086063](http://purl.obolibrary.org/obo/GO_0086063) (voltage-gated sodium channel activity involved in SA node cell action potential), [GO:0019209](http://purl.obolibrary.org/obo/GO_0019209) (kinase activator activity), [GO:0019208](http://purl.obolibrary.org/obo/GO_0019208) (phosphatase regulator activity), [GO:0010891](http://purl.obolibrary.org/obo/GO_0010891) (negative regulation of sequestering of triglyceride), [GO:0086067](http://purl.obolibrary.org/obo/GO_0086067) (AV node cell to bundle of His cell communication), [GO:0022857](http://purl.obolibrary.org/obo/GO_0022857) (transmembrane transporter activity), [GO:0021526](http://purl.obolibrary.org/obo/GO_0021526) (medial motor column neuron differentiation), [GO:0021527](http://purl.obolibrary.org/obo/GO_0021527) (spinal cord association neuron differentiation), [GO:0021529](http://purl.obolibrary.org/obo/GO_0021529) (spinal cord oligodendrocyte cell differentiation), [GO:0021522](http://purl.obolibrary.org/obo/GO_0021522) (spinal cord motor neuron differentiation), [GO:0046886](http://purl.obolibrary.org/obo/GO_0046886) (positive regulation of hormone biosynthetic process), [GO:0021523](http://purl.obolibrary.org/obo/GO_0021523) (somatic motor neuron differentiation), [GO:0046887](http://purl.obolibrary.org/obo/GO_0046887) (positive regulation of hormone secretion), [GO:0008574](http://purl.obolibrary.org/obo/GO_0008574) (ATP-dependent microtubule motor activity, plus-end-directed), [GO:0044224](http://purl.obolibrary.org/obo/GO_0044224) (juxtaparanode region of axon), [GO:0007249](http://purl.obolibrary.org/obo/GO_0007249) (I-kappaB kinase/NF-kappaB signaling), [GO:0022850](http://purl.obolibrary.org/obo/GO_0022850) (serotonin-gated cation-selective channel activity), [GO:0021520](http://purl.obolibrary.org/obo/GO_0021520) (spinal cord motor neuron cell fate specification), [GO:0022851](http://purl.obolibrary.org/obo/GO_0022851) (GABA-gated chloride ion channel activity), [GO:0046888](http://purl.obolibrary.org/obo/GO_0046888) (negative regulation of hormone secretion), [GO:0046889](http://purl.obolibrary.org/obo/GO_0046889) (positive regulation of lipid biosynthetic process), [GO:1990440](http://purl.obolibrary.org/obo/GO_1990440) (positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress), [GO:0021521](http://purl.obolibrary.org/obo/GO_0021521) (ventral spinal cord interneuron specification), [GO:2000822](http://purl.obolibrary.org/obo/GO_2000822) (regulation of behavioral fear response), [GO:1990435](http://purl.obolibrary.org/obo/GO_1990435) (upper tip-link density), [GO:0010888](http://purl.obolibrary.org/obo/GO_0010888) (negative regulation of lipid storage), [GO:2000821](http://purl.obolibrary.org/obo/GO_2000821) (regulation of grooming behavior), [GO:0019213](http://purl.obolibrary.org/obo/GO_0019213) (deacetylase activity), [GO:0010882](http://purl.obolibrary.org/obo/GO_0010882) (regulation of cardiac muscle contraction by calcium ion signaling), [GO:0019216](http://purl.obolibrary.org/obo/GO_0019216) (regulation of lipid metabolic process), [GO:0033504](http://purl.obolibrary.org/obo/GO_0033504) (floor plate development), [GO:0019215](http://purl.obolibrary.org/obo/GO_0019215) (intermediate filament binding), [GO:0033503](http://purl.obolibrary.org/obo/GO_0033503) (HULC complex), [GO:0010881](http://purl.obolibrary.org/obo/GO_0010881) (regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion), [GO:0086073](http://purl.obolibrary.org/obo/GO_0086073) (bundle of His cell-Purkinje myocyte adhesion involved in cell communication), [GO:0019217](http://purl.obolibrary.org/obo/GO_0019217) (regulation of fatty acid metabolic process), [GO:0086036](http://purl.obolibrary.org/obo/GO_0086036) (regulation of cardiac muscle cell membrane potential), [GO:0007296](http://purl.obolibrary.org/obo/GO_0007296) (vitellogenesis), [GO:0086037](http://purl.obolibrary.org/obo/GO_0086037) (sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential), [GO:0021599](http://purl.obolibrary.org/obo/GO_0021599) (abducens nerve formation), [GO:1990450](http://purl.obolibrary.org/obo/GO_1990450) (linear polyubiquitin binding), [GO:0046811](http://purl.obolibrary.org/obo/GO_0046811) (histone deacetylase inhibitor activity), [GO:0019287](http://purl.obolibrary.org/obo/GO_0019287) (isopentenyl diphosphate biosynthetic process, mevalonate pathway), [GO:0033577](http://purl.obolibrary.org/obo/GO_0033577) (protein glycosylation in endoplasmic reticulum), [GO:2000830](http://purl.obolibrary.org/obo/GO_2000830) (positive regulation of parathyroid hormone secretion), [GO:0033574](http://purl.obolibrary.org/obo/GO_0033574) (response to testosterone), [GO:0086043](http://purl.obolibrary.org/obo/GO_0086043) (bundle of His cell action potential), [GO:1904491](http://purl.obolibrary.org/obo/GO_1904491) (protein localization to ciliary transition zone), [GO:0086046](http://purl.obolibrary.org/obo/GO_0086046) (membrane depolarization during SA node cell action potential), [GO:0086047](http://purl.obolibrary.org/obo/GO_0086047) (membrane depolarization during Purkinje myocyte cell action potential), [GO:0046827](http://purl.obolibrary.org/obo/GO_0046827) (positive regulation of protein export from nucleus), [GO:0086045](http://purl.obolibrary.org/obo/GO_0086045) (membrane depolarization during AV node cell action potential), [GO:0086048](http://purl.obolibrary.org/obo/GO_0086048) (membrane depolarization during bundle of His cell action potential), [GO:0021588](http://purl.obolibrary.org/obo/GO_0021588) (cerebellum formation), [GO:0046825](http://purl.obolibrary.org/obo/GO_0046825) (regulation of protein export from nucleus), [GO:0021587](http://purl.obolibrary.org/obo/GO_0021587) (cerebellum morphogenesis), [GO:0021591](http://purl.obolibrary.org/obo/GO_0021591) (ventricular system development), [GO:0021592](http://purl.obolibrary.org/obo/GO_0021592) (fourth ventricle development), [GO:0021593](http://purl.obolibrary.org/obo/GO_0021593) (rhombomere morphogenesis), [GO:0019276](http://purl.obolibrary.org/obo/GO_0019276) (UDP-N-acetylgalactosamine metabolic process), [GO:0021590](http://purl.obolibrary.org/obo/GO_0021590) (cerebellum maturation), [GO:1990459](http://purl.obolibrary.org/obo/GO_1990459) (transferrin receptor binding), [GO:0032232](http://purl.obolibrary.org/obo/GO_0032232) (negative regulation of actin filament bundle assembly), [GO:0033564](http://purl.obolibrary.org/obo/GO_0033564) (anterior/posterior axon guidance), [GO:0032233](http://purl.obolibrary.org/obo/GO_0032233) (positive regulation of actin filament bundle assembly), [GO:0032237](http://purl.obolibrary.org/obo/GO_0032237) (activation of store-operated calcium channel activity), [GO:0033567](http://purl.obolibrary.org/obo/GO_0033567) (DNA replication, Okazaki fragment processing), [GO:0007270](http://purl.obolibrary.org/obo/GO_0007270) (neuron-neuron synaptic transmission), [GO:0086013](http://purl.obolibrary.org/obo/GO_0086013) (membrane repolarization during cardiac muscle cell action potential), [GO:0007271](http://purl.obolibrary.org/obo/GO_0007271) (synaptic transmission, cholinergic), [GO:0086014](http://purl.obolibrary.org/obo/GO_0086014) (atrial cardiac muscle cell action potential), [GO:0086011](http://purl.obolibrary.org/obo/GO_0086011) (membrane repolarization during action potential), [GO:0086012](http://purl.obolibrary.org/obo/GO_0086012) (membrane depolarization during cardiac muscle cell action potential), [GO:0007274](http://purl.obolibrary.org/obo/GO_0007274) (neuromuscular synaptic transmission), [GO:0032230](http://purl.obolibrary.org/obo/GO_0032230) (positive regulation of synaptic transmission, GABAergic), [GO:0033561](http://purl.obolibrary.org/obo/GO_0033561) (regulation of water loss via skin), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0086018](http://purl.obolibrary.org/obo/GO_0086018) (SA node cell to atrial cardiac muscle cell signaling), [GO:0086015](http://purl.obolibrary.org/obo/GO_0086015) (SA node cell action potential), [GO:0086016](http://purl.obolibrary.org/obo/GO_0086016) (AV node cell action potential), [GO:0021578](http://purl.obolibrary.org/obo/GO_0021578) (hindbrain maturation), [GO:0046835](http://purl.obolibrary.org/obo/GO_0046835) (carbohydrate phosphorylation), [GO:0045505](http://purl.obolibrary.org/obo/GO_0045505) (dynein intermediate chain binding), [GO:0021575](http://purl.obolibrary.org/obo/GO_0021575) (hindbrain morphogenesis), [GO:0045503](http://purl.obolibrary.org/obo/GO_0045503) (dynein light chain binding), [GO:0046834](http://purl.obolibrary.org/obo/GO_0046834) (lipid phosphorylation), [GO:0021576](http://purl.obolibrary.org/obo/GO_0021576) (hindbrain formation), [GO:0032229](http://purl.obolibrary.org/obo/GO_0032229) (negative regulation of synaptic transmission, GABAergic), [GO:1990467](http://purl.obolibrary.org/obo/GO_1990467) (NuA3a histone acetyltransferase complex), [GO:1990468](http://purl.obolibrary.org/obo/GO_1990468) (NuA3b histone acetyltransferase complex), [GO:0033555](http://purl.obolibrary.org/obo/GO_0033555) (multicellular organismal response to stress), [GO:0032224](http://purl.obolibrary.org/obo/GO_0032224) (positive regulation of synaptic transmission, cholinergic), [GO:0032222](http://purl.obolibrary.org/obo/GO_0032222) (regulation of synaptic transmission, cholinergic), [GO:0032227](http://purl.obolibrary.org/obo/GO_0032227) (negative regulation of synaptic transmission, dopaminergic), [GO:0032228](http://purl.obolibrary.org/obo/GO_0032228) (regulation of synaptic transmission, GABAergic), [GO:0033558](http://purl.obolibrary.org/obo/GO_0033558) (protein deacetylase activity), [GO:0032225](http://purl.obolibrary.org/obo/GO_0032225) (regulation of synaptic transmission, dopaminergic), [GO:0007281](http://purl.obolibrary.org/obo/GO_0007281) (germ cell development), [GO:0046849](http://purl.obolibrary.org/obo/GO_0046849) (bone remodeling), [GO:0086023](http://purl.obolibrary.org/obo/GO_0086023) (adrenergic receptor signaling pathway involved in heart process), [GO:0007286](http://purl.obolibrary.org/obo/GO_0007286) (spermatid development), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0086027](http://purl.obolibrary.org/obo/GO_0086027) (AV node cell to bundle of His cell signaling), [GO:0022898](http://purl.obolibrary.org/obo/GO_0022898) (regulation of transmembrane transporter activity), [GO:0021568](http://purl.obolibrary.org/obo/GO_0021568) (rhombomere 2 development), [GO:0007288](http://purl.obolibrary.org/obo/GO_0007288) (sperm axoneme assembly), [GO:0021569](http://purl.obolibrary.org/obo/GO_0021569) (rhombomere 3 development), [GO:0021562](http://purl.obolibrary.org/obo/GO_0021562) (vestibulocochlear nerve development), [GO:1990481](http://purl.obolibrary.org/obo/GO_1990481) (mRNA pseudouridine synthesis), [GO:0046847](http://purl.obolibrary.org/obo/GO_0046847) (filopodium assembly), [GO:0021570](http://purl.obolibrary.org/obo/GO_0021570) (rhombomere 4 development), [GO:0021571](http://purl.obolibrary.org/obo/GO_0021571) (rhombomere 5 development), [GO:0032218](http://purl.obolibrary.org/obo/GO_0032218) (riboflavin transport), [GO:0021572](http://purl.obolibrary.org/obo/GO_0021572) (rhombomere 6 development), [GO:0046850](http://purl.obolibrary.org/obo/GO_0046850) (regulation of bone remodeling), [GO:0032212](http://purl.obolibrary.org/obo/GO_0032212) (positive regulation of telomere maintenance via telomerase), [GO:0019255](http://purl.obolibrary.org/obo/GO_0019255) (glucose 1-phosphate metabolic process), [GO:0032210](http://purl.obolibrary.org/obo/GO_0032210) (regulation of telomere maintenance via telomerase), [GO:0032211](http://purl.obolibrary.org/obo/GO_0032211) (negative regulation of telomere maintenance via telomerase), [GO:0032216](http://purl.obolibrary.org/obo/GO_0032216) (glucosaminyl-phosphotidylinositol O-acyltransferase activity), [GO:0032217](http://purl.obolibrary.org/obo/GO_0032217) (riboflavin transmembrane transporter activity), [GO:0032290](http://purl.obolibrary.org/obo/GO_0032290) (peripheral nervous system myelin formation), [GO:0003730](http://purl.obolibrary.org/obo/GO_0003730) (mRNA 3'-UTR binding), [GO:0003720](http://purl.obolibrary.org/obo/GO_0003720) (telomerase activity), [GO:0003721](http://purl.obolibrary.org/obo/GO_0003721) (telomerase RNA reverse transcriptase activity), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0071893](http://purl.obolibrary.org/obo/GO_0071893) (BMP signaling pathway involved in nephric duct formation), [GO:0003724](http://purl.obolibrary.org/obo/GO_0003724) (RNA helicase activity), [GO:0003725](http://purl.obolibrary.org/obo/GO_0003725) (double-stranded RNA binding), [GO:0071894](http://purl.obolibrary.org/obo/GO_0071894) (histone H2B conserved C-terminal lysine ubiquitination), [GO:0003726](http://purl.obolibrary.org/obo/GO_0003726) (double-stranded RNA adenosine deaminase activity), [GO:0003727](http://purl.obolibrary.org/obo/GO_0003727) (single-stranded RNA binding), [GO:0071897](http://purl.obolibrary.org/obo/GO_0071897) (DNA biosynthetic process), [GO:0003729](http://purl.obolibrary.org/obo/GO_0003729) (mRNA binding), [GO:0070567](http://purl.obolibrary.org/obo/GO_0070567) (cytidylyltransferase activity), [GO:0032287](http://purl.obolibrary.org/obo/GO_0032287) (peripheral nervous system myelin maintenance), [GO:0032288](http://purl.obolibrary.org/obo/GO_0032288) (myelin assembly), [GO:0015701](http://purl.obolibrary.org/obo/GO_0015701) (bicarbonate transport), [GO:0032281](http://purl.obolibrary.org/obo/GO_0032281) (AMPA glutamate receptor complex), [GO:0032280](http://purl.obolibrary.org/obo/GO_0032280) (symmetric synapse), [GO:0032286](http://purl.obolibrary.org/obo/GO_0032286) (central nervous system myelin maintenance), [GO:0044292](http://purl.obolibrary.org/obo/GO_0044292) (dendrite terminus), [GO:0044291](http://purl.obolibrary.org/obo/GO_0044291) (cell-cell contact zone), [GO:0003735](http://purl.obolibrary.org/obo/GO_0003735) (structural constituent of ribosome), [GO:0044295](http://purl.obolibrary.org/obo/GO_0044295) (axonal growth cone), [GO:0071880](http://purl.obolibrary.org/obo/GO_0071880) (adenylate cyclase-activating adrenergic receptor signaling pathway), [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body), [GO:0015718](http://purl.obolibrary.org/obo/GO_0015718) (monocarboxylic acid transport), [GO:0070550](http://purl.obolibrary.org/obo/GO_0070550) (rDNA condensation), [GO:0070555](http://purl.obolibrary.org/obo/GO_0070555) (response to interleukin-1), [GO:0032279](http://purl.obolibrary.org/obo/GO_0032279) (asymmetric synapse), [GO:0015711](http://purl.obolibrary.org/obo/GO_0015711) (organic anion transport), [GO:0070557](http://purl.obolibrary.org/obo/GO_0070557) (PCNA-p21 complex), [GO:0071889](http://purl.obolibrary.org/obo/GO_0071889) (14-3-3 protein binding), [GO:0032270](http://purl.obolibrary.org/obo/GO_0032270) (positive regulation of cellular protein metabolic process), [GO:0044299](http://purl.obolibrary.org/obo/GO_0044299) (C-fiber), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0070584](http://purl.obolibrary.org/obo/GO_0070584) (mitochondrion morphogenesis), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0070588](http://purl.obolibrary.org/obo/GO_0070588) (calcium ion transmembrane transport), [GO:0033599](http://purl.obolibrary.org/obo/GO_0033599) (regulation of mammary gland epithelial cell proliferation), [GO:0032268](http://purl.obolibrary.org/obo/GO_0032268) (regulation of cellular protein metabolic process), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0033598](http://purl.obolibrary.org/obo/GO_0033598) (mammary gland epithelial cell proliferation), [GO:0070586](http://purl.obolibrary.org/obo/GO_0070586) (cell-cell adhesion involved in gastrulation), [GO:0003708](http://purl.obolibrary.org/obo/GO_0003708) (retinoic acid receptor activity), [GO:0032266](http://purl.obolibrary.org/obo/GO_0032266) (phosphatidylinositol-3-phosphate binding), [GO:0070587](http://purl.obolibrary.org/obo/GO_0070587) (regulation of cell-cell adhesion involved in gastrulation), [GO:0033596](http://purl.obolibrary.org/obo/GO_0033596) (TSC1-TSC2 complex), [GO:0032269](http://purl.obolibrary.org/obo/GO_0032269) (negative regulation of cellular protein metabolic process), [GO:0032264](http://purl.obolibrary.org/obo/GO_0032264) (IMP salvage), [GO:0033593](http://purl.obolibrary.org/obo/GO_0033593) (BRCA2-MAGE-D1 complex), [GO:0033592](http://purl.obolibrary.org/obo/GO_0033592) (RNA strand annealing activity), [GO:0070570](http://purl.obolibrary.org/obo/GO_0070570) (regulation of neuron projection regeneration), [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity), [GO:0003713](http://purl.obolibrary.org/obo/GO_0003713) (transcription coactivator activity), [GO:0070574](http://purl.obolibrary.org/obo/GO_0070574) (cadmium ion transmembrane transport), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0033588](http://purl.obolibrary.org/obo/GO_0033588) (Elongator holoenzyme complex), [GO:0070577](http://purl.obolibrary.org/obo/GO_0070577) (lysine-acetylated histone binding), [GO:0070578](http://purl.obolibrary.org/obo/GO_0070578) (RISC-loading complex), [GO:0032258](http://purl.obolibrary.org/obo/GO_0032258) (protein localization by the Cvt pathway), [GO:0032259](http://purl.obolibrary.org/obo/GO_0032259) (methylation), [GO:0070528](http://purl.obolibrary.org/obo/GO_0070528) (protein kinase C signaling), [GO:0001106](http://purl.obolibrary.org/obo/GO_0001106) (RNA polymerase II transcription corepressor activity), [GO:0001105](http://purl.obolibrary.org/obo/GO_0001105) (RNA polymerase II transcription coactivator activity), [GO:0044237](http://purl.obolibrary.org/obo/GO_0044237) (cellular metabolic process), [GO:0001104](http://purl.obolibrary.org/obo/GO_0001104) (RNA polymerase II transcription cofactor activity), [GO:0001103](http://purl.obolibrary.org/obo/GO_0001103) (RNA polymerase II repressing transcription factor binding), [GO:0003774](http://purl.obolibrary.org/obo/GO_0003774) (motor activity), [GO:0001102](http://purl.obolibrary.org/obo/GO_0001102) (RNA polymerase II activating transcription factor binding), [GO:0002443](http://purl.obolibrary.org/obo/GO_0002443) (leukocyte mediated immunity), [GO:0001112](http://purl.obolibrary.org/obo/GO_0001112) (DNA-templated transcriptional open complex formation), [GO:0044241](http://purl.obolibrary.org/obo/GO_0044241) (lipid digestion), [GO:0071850](http://purl.obolibrary.org/obo/GO_0071850) (mitotic cell cycle arrest), [GO:0002439](http://purl.obolibrary.org/obo/GO_0002439) (chronic inflammatory response to antigenic stimulus), [GO:0044242](http://purl.obolibrary.org/obo/GO_0044242) (cellular lipid catabolic process), [GO:0070522](http://purl.obolibrary.org/obo/GO_0070522) (ERCC4-ERCC1 complex), [GO:0015746](http://purl.obolibrary.org/obo/GO_0015746) (citrate transport), [GO:0070527](http://purl.obolibrary.org/obo/GO_0070527) (platelet aggregation), [GO:0015744](http://purl.obolibrary.org/obo/GO_0015744) (succinate transport), [GO:0071848](http://purl.obolibrary.org/obo/GO_0071848) (positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling), [GO:0045578](http://purl.obolibrary.org/obo/GO_0045578) (negative regulation of B cell differentiation), [GO:0045576](http://purl.obolibrary.org/obo/GO_0045576) (mast cell activation), [GO:0044249](http://purl.obolibrary.org/obo/GO_0044249) (cellular biosynthetic process), [GO:0003785](http://purl.obolibrary.org/obo/GO_0003785) (actin monomer binding), [GO:0045580](http://purl.obolibrary.org/obo/GO_0045580) (regulation of T cell differentiation), [GO:0003777](http://purl.obolibrary.org/obo/GO_0003777) (microtubule motor activity), [GO:0002446](http://purl.obolibrary.org/obo/GO_0002446) (neutrophil mediated immunity), [GO:0003779](http://purl.obolibrary.org/obo/GO_0003779) (actin binding), [GO:0045582](http://purl.obolibrary.org/obo/GO_0045582) (positive regulation of T cell differentiation), [GO:0039706](http://purl.obolibrary.org/obo/GO_0039706) (co-receptor binding), [GO:0015758](http://purl.obolibrary.org/obo/GO_0015758) (glucose transport), [GO:0039702](http://purl.obolibrary.org/obo/GO_0039702) (viral budding via host ESCRT complex), [GO:0071847](http://purl.obolibrary.org/obo/GO_0071847) (TNFSF11-mediated signaling pathway), [GO:0070513](http://purl.obolibrary.org/obo/GO_0070513) (death domain binding), [GO:0015755](http://purl.obolibrary.org/obo/GO_0015755) (fructose transport), [GO:0044255](http://purl.obolibrary.org/obo/GO_0044255) (cellular lipid metabolic process), [GO:0044257](http://purl.obolibrary.org/obo/GO_0044257) (cellular protein catabolic process), [GO:0003743](http://purl.obolibrary.org/obo/GO_0003743) (translation initiation factor activity), [GO:0045595](http://purl.obolibrary.org/obo/GO_0045595) (regulation of cell differentiation), [GO:0071871](http://purl.obolibrary.org/obo/GO_0071871) (response to epinephrine), [GO:0003746](http://purl.obolibrary.org/obo/GO_0003746) (translation elongation factor activity), [GO:0044262](http://purl.obolibrary.org/obo/GO_0044262) (cellular carbohydrate metabolic process), [GO:0045596](http://purl.obolibrary.org/obo/GO_0045596) (negative regulation of cell differentiation), [GO:0071872](http://purl.obolibrary.org/obo/GO_0071872) (cellular response to epinephrine stimulus), [GO:0044265](http://purl.obolibrary.org/obo/GO_0044265) (cellular macromolecule catabolic process), [GO:0071875](http://purl.obolibrary.org/obo/GO_0071875) (adrenergic receptor signaling pathway), [GO:0070544](http://purl.obolibrary.org/obo/GO_0070544) (histone H3-K36 demethylation), [GO:0071874](http://purl.obolibrary.org/obo/GO_0071874) (cellular response to norepinephrine stimulus), [GO:0015723](http://purl.obolibrary.org/obo/GO_0015723) (bilirubin transport), [GO:0015722](http://purl.obolibrary.org/obo/GO_0015722) (canalicular bile acid transport), [GO:0015721](http://purl.obolibrary.org/obo/GO_0015721) (bile acid and bile salt transport), [GO:0045599](http://purl.obolibrary.org/obo/GO_0045599) (negative regulation of fat cell differentiation), [GO:0044267](http://purl.obolibrary.org/obo/GO_0044267) (cellular protein metabolic process), [GO:0045597](http://purl.obolibrary.org/obo/GO_0045597) (positive regulation of cell differentiation), [GO:0045598](http://purl.obolibrary.org/obo/GO_0045598) (regulation of fat cell differentiation), [GO:0003755](http://purl.obolibrary.org/obo/GO_0003755) (peptidyl-prolyl cis-trans isomerase activity), [GO:0044271](http://purl.obolibrary.org/obo/GO_0044271) (cellular nitrogen compound biosynthetic process), [GO:0003756](http://purl.obolibrary.org/obo/GO_0003756) (protein disulfide isomerase activity), [GO:0070530](http://purl.obolibrary.org/obo/GO_0070530) (K63-linked polyubiquitin modification-dependent protein binding), [GO:0071864](http://purl.obolibrary.org/obo/GO_0071864) (positive regulation of cell proliferation in bone marrow), [GO:0015739](http://purl.obolibrary.org/obo/GO_0015739) (sialic acid transport), [GO:0070534](http://purl.obolibrary.org/obo/GO_0070534) (protein K63-linked ubiquitination), [GO:0032298](http://purl.obolibrary.org/obo/GO_0032298) (positive regulation of DNA-dependent DNA replication initiation), [GO:0032299](http://purl.obolibrary.org/obo/GO_0032299) (ribonuclease H2 complex), [GO:0070538](http://purl.obolibrary.org/obo/GO_0070538) (oleic acid binding), [GO:0071866](http://purl.obolibrary.org/obo/GO_0071866) (negative regulation of apoptotic process in bone marrow), [GO:0070535](http://purl.obolibrary.org/obo/GO_0070535) (histone H2A K63-linked ubiquitination), [GO:0051533](http://purl.obolibrary.org/obo/GO_0051533) (positive regulation of NFAT protein import into nucleus), [GO:0051538](http://purl.obolibrary.org/obo/GO_0051538) (3 iron, 4 sulfur cluster binding), [GO:0051539](http://purl.obolibrary.org/obo/GO_0051539) (4 iron, 4 sulfur cluster binding), [GO:0051536](http://purl.obolibrary.org/obo/GO_0051536) (iron-sulfur cluster binding), [GO:0051537](http://purl.obolibrary.org/obo/GO_0051537) (2 iron, 2 sulfur cluster binding), [GO:0052866](http://purl.obolibrary.org/obo/GO_0052866) (phosphatidylinositol phosphate phosphatase activity), [GO:0015893](http://purl.obolibrary.org/obo/GO_0015893) (drug transport), [GO:0051542](http://purl.obolibrary.org/obo/GO_0051542) (elastin biosynthetic process), [GO:1905719](http://purl.obolibrary.org/obo/GO_1905719) (protein localization to perinuclear region of cytoplasm), [GO:0002579](http://purl.obolibrary.org/obo/GO_0002579) (positive regulation of antigen processing and presentation), [GO:0140018](http://purl.obolibrary.org/obo/GO_0140018) (regulation of cytoplasmic translational fidelity), [GO:0051549](http://purl.obolibrary.org/obo/GO_0051549) (positive regulation of keratinocyte migration), [GO:0140016](http://purl.obolibrary.org/obo/GO_0140016) (D-aspartate import across plasma membrane), [GO:0051548](http://purl.obolibrary.org/obo/GO_0051548) (negative regulation of keratinocyte migration), [GO:0015888](http://purl.obolibrary.org/obo/GO_0015888) (thiamine transport), [GO:0015886](http://purl.obolibrary.org/obo/GO_0015886) (heme transport), [GO:0052885](http://purl.obolibrary.org/obo/GO_0052885) (all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity), [GO:0002588](http://purl.obolibrary.org/obo/GO_0002588) (positive regulation of antigen processing and presentation of peptide antigen via MHC class II), [GO:0052884](http://purl.obolibrary.org/obo/GO_0052884) (all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity), [GO:0140009](http://purl.obolibrary.org/obo/GO_0140009) (L-aspartate import across plasma membrane), [GO:0055091](http://purl.obolibrary.org/obo/GO_0055091) (phospholipid homeostasis), [GO:0052814](http://purl.obolibrary.org/obo/GO_0052814) (medium-chain-aldehyde dehydrogenase activity), [GO:0008705](http://purl.obolibrary.org/obo/GO_0008705) (methionine synthase activity), [GO:0140059](http://purl.obolibrary.org/obo/GO_0140059) (dendrite arborization), [GO:0052834](http://purl.obolibrary.org/obo/GO_0052834) (inositol monophosphate phosphatase activity), [GO:0052832](http://purl.obolibrary.org/obo/GO_0052832) (inositol monophosphate 3-phosphatase activity), [GO:0052833](http://purl.obolibrary.org/obo/GO_0052833) (inositol monophosphate 4-phosphatase activity), [GO:0140052](http://purl.obolibrary.org/obo/GO_0140052) (cellular response to oxidised low-density lipoprotein particle stimulus), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:1904457](http://purl.obolibrary.org/obo/GO_1904457) (positive regulation of neuronal action potential), [GO:0007412](http://purl.obolibrary.org/obo/GO_0007412) (axon target recognition), [GO:0007413](http://purl.obolibrary.org/obo/GO_0007413) (axonal fasciculation), [GO:0007405](http://purl.obolibrary.org/obo/GO_0007405) (neuroblast proliferation), [GO:0007406](http://purl.obolibrary.org/obo/GO_0007406) (negative regulation of neuroblast proliferation), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0019402](http://purl.obolibrary.org/obo/GO_0019402) (galactitol metabolic process), [GO:0021707](http://purl.obolibrary.org/obo/GO_0021707) (cerebellar granule cell differentiation), [GO:0021702](http://purl.obolibrary.org/obo/GO_0021702) (cerebellar Purkinje cell differentiation), [GO:1903136](http://purl.obolibrary.org/obo/GO_1903136) (cuprous ion binding), [GO:0021703](http://purl.obolibrary.org/obo/GO_0021703) (locus ceruleus development), [GO:1904465](http://purl.obolibrary.org/obo/GO_1904465) (negative regulation of matrix metallopeptidase secretion), [GO:0050291](http://purl.obolibrary.org/obo/GO_0050291) (sphingosine N-acyltransferase activity), [GO:0007422](http://purl.obolibrary.org/obo/GO_0007422) (peripheral nervous system development), [GO:1904469](http://purl.obolibrary.org/obo/GO_1904469) (positive regulation of tumor necrosis factor secretion), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:1990381](http://purl.obolibrary.org/obo/GO_1990381) (ubiquitin-specific protease binding), [GO:0008757](http://purl.obolibrary.org/obo/GO_0008757) (S-adenosylmethionine-dependent methyltransferase activity), [GO:0007423](http://purl.obolibrary.org/obo/GO_0007423) (sensory organ development), [GO:0007418](http://purl.obolibrary.org/obo/GO_0007418) (ventral midline development), [GO:0007416](http://purl.obolibrary.org/obo/GO_0007416) (synapse assembly), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:1990379](http://purl.obolibrary.org/obo/GO_1990379) (lipid transport across blood brain barrier), [GO:1903142](http://purl.obolibrary.org/obo/GO_1903142) (positive regulation of establishment of endothelial barrier), [GO:1903140](http://purl.obolibrary.org/obo/GO_1903140) (regulation of establishment of endothelial barrier), [GO:1903146](http://purl.obolibrary.org/obo/GO_1903146) (regulation of autophagy of mitochondrion), [GO:1990391](http://purl.obolibrary.org/obo/GO_1990391) (DNA repair complex), [GO:0045703](http://purl.obolibrary.org/obo/GO_0045703) (ketoreductase activity), [GO:0099526](http://purl.obolibrary.org/obo/GO_0099526) (presynapse to nucleus signaling pathway), [GO:0045717](http://purl.obolibrary.org/obo/GO_0045717) (negative regulation of fatty acid biosynthetic process), [GO:0045716](http://purl.obolibrary.org/obo/GO_0045716) (positive regulation of low-density lipoprotein particle receptor biosynthetic process), [GO:0045719](http://purl.obolibrary.org/obo/GO_0045719) (negative regulation of glycogen biosynthetic process), [GO:0007400](http://purl.obolibrary.org/obo/GO_0007400) (neuroblast fate determination), [GO:0099530](http://purl.obolibrary.org/obo/GO_0099530) (G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential), [GO:0099536](http://purl.obolibrary.org/obo/GO_0099536) (synaptic signaling), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0006120](http://purl.obolibrary.org/obo/GO_0006120) (mitochondrial electron transport, NADH to ubiquinone), [GO:0021759](http://purl.obolibrary.org/obo/GO_0021759) (globus pallidus development), [GO:0006123](http://purl.obolibrary.org/obo/GO_0006123) (mitochondrial electron transport, cytochrome c to oxygen), [GO:0021754](http://purl.obolibrary.org/obo/GO_0021754) (facial nucleus development), [GO:0006121](http://purl.obolibrary.org/obo/GO_0006121) (mitochondrial electron transport, succinate to ubiquinone), [GO:0021756](http://purl.obolibrary.org/obo/GO_0021756) (striatum development), [GO:0006122](http://purl.obolibrary.org/obo/GO_0006122) (mitochondrial electron transport, ubiquinol to cytochrome c), [GO:0021750](http://purl.obolibrary.org/obo/GO_0021750) (vestibular nucleus development), [GO:1904417](http://purl.obolibrary.org/obo/GO_1904417) (positive regulation of xenophagy), [GO:0032407](http://purl.obolibrary.org/obo/GO_0032407) (MutSalpha complex binding), [GO:0032405](http://purl.obolibrary.org/obo/GO_0032405) (MutLalpha complex binding), [GO:0051563](http://purl.obolibrary.org/obo/GO_0051563) (smooth endoplasmic reticulum calcium ion homeostasis), [GO:0006119](http://purl.obolibrary.org/obo/GO_0006119) (oxidative phosphorylation), [GO:0051561](http://purl.obolibrary.org/obo/GO_0051561) (positive regulation of mitochondrial calcium ion concentration), [GO:0051562](http://purl.obolibrary.org/obo/GO_0051562) (negative regulation of mitochondrial calcium ion concentration), [GO:0019441](http://purl.obolibrary.org/obo/GO_0019441) (tryptophan catabolic process to kynurenine), [GO:0051560](http://purl.obolibrary.org/obo/GO_0051560) (mitochondrial calcium ion homeostasis), [GO:0032400](http://purl.obolibrary.org/obo/GO_0032400) (melanosome localization), [GO:0019442](http://purl.obolibrary.org/obo/GO_0019442) (tryptophan catabolic process to acetyl-CoA), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0051569](http://purl.obolibrary.org/obo/GO_0051569) (regulation of histone H3-K4 methylation), [GO:0051567](http://purl.obolibrary.org/obo/GO_0051567) (histone H3-K9 methylation), [GO:0032402](http://purl.obolibrary.org/obo/GO_0032402) (melanosome transport), [GO:0051568](http://purl.obolibrary.org/obo/GO_0051568) (histone H3-K4 methylation), [GO:1904427](http://purl.obolibrary.org/obo/GO_1904427) (positive regulation of calcium ion transmembrane transport), [GO:1904426](http://purl.obolibrary.org/obo/GO_1904426) (positive regulation of GTP binding), [GO:0051580](http://purl.obolibrary.org/obo/GO_0051580) (regulation of neurotransmitter uptake), [GO:0006139](http://purl.obolibrary.org/obo/GO_0006139) (nucleobase-containing compound metabolic process), [GO:0021740](http://purl.obolibrary.org/obo/GO_0021740) (principal sensory nucleus of trigeminal nerve development), [GO:0007468](http://purl.obolibrary.org/obo/GO_0007468) (regulation of rhodopsin gene expression), [GO:0051572](http://purl.obolibrary.org/obo/GO_0051572) (negative regulation of histone H3-K4 methylation), [GO:0051573](http://purl.obolibrary.org/obo/GO_0051573) (negative regulation of histone H3-K9 methylation), [GO:0019430](http://purl.obolibrary.org/obo/GO_0019430) (removal of superoxide radicals), [GO:0051571](http://purl.obolibrary.org/obo/GO_0051571) (positive regulation of histone H3-K4 methylation), [GO:0099518](http://purl.obolibrary.org/obo/GO_0099518) (vesicle cytoskeletal trafficking), [GO:0019432](http://purl.obolibrary.org/obo/GO_0019432) (triglyceride biosynthetic process), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0018105](http://purl.obolibrary.org/obo/GO_0018105) (peptidyl-serine phosphorylation), [GO:0018107](http://purl.obolibrary.org/obo/GO_0018107) (peptidyl-threonine phosphorylation), [GO:1904430](http://purl.obolibrary.org/obo/GO_1904430) (negative regulation of t-circle formation), [GO:1904434](http://purl.obolibrary.org/obo/GO_1904434) (positive regulation of ferrous iron binding), [GO:0006101](http://purl.obolibrary.org/obo/GO_0006101) (citrate metabolic process), [GO:0006102](http://purl.obolibrary.org/obo/GO_0006102) (isocitrate metabolic process), [GO:1904437](http://purl.obolibrary.org/obo/GO_1904437) (positive regulation of transferrin receptor binding), [GO:0051591](http://purl.obolibrary.org/obo/GO_0051591) (response to cAMP), [GO:0008761](http://purl.obolibrary.org/obo/GO_0008761) (UDP-N-acetylglucosamine 2-epimerase activity), [GO:0006105](http://purl.obolibrary.org/obo/GO_0006105) (succinate metabolic process), [GO:0006106](http://purl.obolibrary.org/obo/GO_0006106) (fumarate metabolic process), [GO:0006103](http://purl.obolibrary.org/obo/GO_0006103) (2-oxoglutarate metabolic process), [GO:0007435](http://purl.obolibrary.org/obo/GO_0007435) (salivary gland morphogenesis), [GO:0006104](http://purl.obolibrary.org/obo/GO_0006104) (succinyl-CoA metabolic process), [GO:0050254](http://purl.obolibrary.org/obo/GO_0050254) (rhodopsin kinase activity), [GO:0051586](http://purl.obolibrary.org/obo/GO_0051586) (positive regulation of dopamine uptake involved in synaptic transmission), [GO:0050251](http://purl.obolibrary.org/obo/GO_0050251) (retinol isomerase activity), [GO:0051583](http://purl.obolibrary.org/obo/GO_0051583) (dopamine uptake involved in synaptic transmission), [GO:0051584](http://purl.obolibrary.org/obo/GO_0051584) (regulation of dopamine uptake involved in synaptic transmission), [GO:1904440](http://purl.obolibrary.org/obo/GO_1904440) (positive regulation of ferrous iron import across plasma membrane), [GO:0019408](http://purl.obolibrary.org/obo/GO_0019408) (dolichol biosynthetic process), [GO:1905776](http://purl.obolibrary.org/obo/GO_1905776) (positive regulation of DNA helicase activity), [GO:1905774](http://purl.obolibrary.org/obo/GO_1905774) (regulation of DNA helicase activity), [GO:1905773](http://purl.obolibrary.org/obo/GO_1905773) (8-hydroxy-2'-deoxyguanosine DNA binding), [GO:0006110](http://purl.obolibrary.org/obo/GO_0006110) (regulation of glycolytic process), [GO:0007442](http://purl.obolibrary.org/obo/GO_0007442) (hindgut morphogenesis), [GO:0021723](http://purl.obolibrary.org/obo/GO_0021723) (medullary reticular formation development), [GO:0006107](http://purl.obolibrary.org/obo/GO_0006107) (oxaloacetate metabolic process), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0006108](http://purl.obolibrary.org/obo/GO_0006108) (malate metabolic process), [GO:0051592](http://purl.obolibrary.org/obo/GO_0051592) (response to calcium ion), [GO:0051593](http://purl.obolibrary.org/obo/GO_0051593) (response to folic acid), [GO:0033700](http://purl.obolibrary.org/obo/GO_0033700) (phospholipid efflux), [GO:0044319](http://purl.obolibrary.org/obo/GO_0044319) (wound healing, spreading of cells), [GO:1903087](http://purl.obolibrary.org/obo/GO_1903087) (mitotic spindle pole body duplication), [GO:0071939](http://purl.obolibrary.org/obo/GO_0071939) (vitamin A import), [GO:0006042](http://purl.obolibrary.org/obo/GO_0006042) (glucosamine biosynthetic process), [GO:0032330](http://purl.obolibrary.org/obo/GO_0032330) (regulation of chondrocyte differentiation), [GO:0034991](http://purl.obolibrary.org/obo/GO_0034991) (nuclear meiotic cohesin complex), [GO:0034990](http://purl.obolibrary.org/obo/GO_0034990) (nuclear mitotic cohesin complex), [GO:0046974](http://purl.obolibrary.org/obo/GO_0046974) (histone methyltransferase activity (H3-K9 specific)), [GO:0006047](http://purl.obolibrary.org/obo/GO_0006047) (UDP-N-acetylglucosamine metabolic process), [GO:0046975](http://purl.obolibrary.org/obo/GO_0046975) (histone methyltransferase activity (H3-K36 specific)), [GO:0046972](http://purl.obolibrary.org/obo/GO_0046972) (histone acetyltransferase activity (H4-K16 specific)), [GO:0021678](http://purl.obolibrary.org/obo/GO_0021678) (third ventricle development), [GO:0006044](http://purl.obolibrary.org/obo/GO_0006044) (N-acetylglucosamine metabolic process), [GO:0021679](http://purl.obolibrary.org/obo/GO_0021679) (cerebellar molecular layer development), [GO:0045647](http://purl.obolibrary.org/obo/GO_0045647) (negative regulation of erythrocyte differentiation), [GO:0045648](http://purl.obolibrary.org/obo/GO_0045648) (positive regulation of erythrocyte differentiation), [GO:0044317](http://purl.obolibrary.org/obo/GO_0044317) (rod spherule), [GO:0046976](http://purl.obolibrary.org/obo/GO_0046976) (histone methyltransferase activity (H3-K27 specific)), [GO:0006048](http://purl.obolibrary.org/obo/GO_0006048) (UDP-N-acetylglucosamine biosynthetic process), [GO:0007379](http://purl.obolibrary.org/obo/GO_0007379) (segment specification), [GO:0044316](http://purl.obolibrary.org/obo/GO_0044316) (cone cell pedicle), [GO:0021675](http://purl.obolibrary.org/obo/GO_0021675) (nerve development), [GO:0045646](http://purl.obolibrary.org/obo/GO_0045646) (regulation of erythrocyte differentiation), [GO:0021680](http://purl.obolibrary.org/obo/GO_0021680) (cerebellar Purkinje cell layer development), [GO:0021681](http://purl.obolibrary.org/obo/GO_0021681) (cerebellar granular layer development), [GO:0032328](http://purl.obolibrary.org/obo/GO_0032328) (alanine transport), [GO:0045650](http://purl.obolibrary.org/obo/GO_0045650) (negative regulation of macrophage differentiation), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0044320](http://purl.obolibrary.org/obo/GO_0044320) (cellular response to leptin stimulus), [GO:0019363](http://purl.obolibrary.org/obo/GO_0019363) (pyridine nucleotide biosynthetic process), [GO:0071930](http://purl.obolibrary.org/obo/GO_0071930) (negative regulation of transcription involved in G1/S transition of mitotic cell cycle), [GO:0019368](http://purl.obolibrary.org/obo/GO_0019368) (fatty acid elongation, unsaturated fatty acid), [GO:0034982](http://purl.obolibrary.org/obo/GO_0034982) (mitochondrial protein processing), [GO:0019367](http://purl.obolibrary.org/obo/GO_0019367) (fatty acid elongation, saturated fatty acid), [GO:0070603](http://purl.obolibrary.org/obo/GO_0070603) (SWI/SNF superfamily-type complex), [GO:0071934](http://purl.obolibrary.org/obo/GO_0071934) (thiamine transmembrane transport), [GO:0019369](http://purl.obolibrary.org/obo/GO_0019369) (arachidonic acid metabolic process), [GO:0032324](http://purl.obolibrary.org/obo/GO_0032324) (molybdopterin cofactor biosynthetic process), [GO:0034986](http://purl.obolibrary.org/obo/GO_0034986) (iron chaperone activity), [GO:1903082](http://purl.obolibrary.org/obo/GO_1903082) (positive regulation of C-C chemokine receptor CCR7 signaling pathway), [GO:0006054](http://purl.obolibrary.org/obo/GO_0006054) (N-acetylneuraminate metabolic process), [GO:0045654](http://purl.obolibrary.org/obo/GO_0045654) (positive regulation of megakaryocyte differentiation), [GO:0044322](http://purl.obolibrary.org/obo/GO_0044322) (endoplasmic reticulum quality control compartment), [GO:0007389](http://purl.obolibrary.org/obo/GO_0007389) (pattern specification process), [GO:0044321](http://purl.obolibrary.org/obo/GO_0044321) (response to leptin), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0045652](http://purl.obolibrary.org/obo/GO_0045652) (regulation of megakaryocyte differentiation), [GO:0044323](http://purl.obolibrary.org/obo/GO_0044323) (retinoic acid-responsive element binding), [GO:0021661](http://purl.obolibrary.org/obo/GO_0021661) (rhombomere 4 morphogenesis), [GO:0044326](http://purl.obolibrary.org/obo/GO_0044326) (dendritic spine neck), [GO:0044325](http://purl.obolibrary.org/obo/GO_0044325) (ion channel binding), [GO:0021663](http://purl.obolibrary.org/obo/GO_0021663) (rhombomere 4 formation), [GO:0045656](http://purl.obolibrary.org/obo/GO_0045656) (negative regulation of monocyte differentiation), [GO:0044327](http://purl.obolibrary.org/obo/GO_0044327) (dendritic spine head), [GO:0021670](http://purl.obolibrary.org/obo/GO_0021670) (lateral ventricle development), [GO:0045661](http://purl.obolibrary.org/obo/GO_0045661) (regulation of myoblast differentiation), [GO:0045662](http://purl.obolibrary.org/obo/GO_0045662) (negative regulation of myoblast differentiation), [GO:0018024](http://purl.obolibrary.org/obo/GO_0018024) (histone-lysine N-methyltransferase activity), [GO:0032311](http://purl.obolibrary.org/obo/GO_0032311) (angiogenin-PRI complex), [GO:0018026](http://purl.obolibrary.org/obo/GO_0018026) (peptidyl-lysine monomethylation), [GO:0018027](http://purl.obolibrary.org/obo/GO_0018027) (peptidyl-lysine dimethylation), [GO:0034976](http://purl.obolibrary.org/obo/GO_0034976) (response to endoplasmic reticulum stress), [GO:0071921](http://purl.obolibrary.org/obo/GO_0071921) (cohesin loading), [GO:0034975](http://purl.obolibrary.org/obo/GO_0034975) (protein folding in endoplasmic reticulum), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0070628](http://purl.obolibrary.org/obo/GO_0070628) (proteasome binding), [GO:0006020](http://purl.obolibrary.org/obo/GO_0006020) (inositol metabolic process), [GO:0021658](http://purl.obolibrary.org/obo/GO_0021658) (rhombomere 3 morphogenesis), [GO:0006021](http://purl.obolibrary.org/obo/GO_0006021) (inositol biosynthetic process), [GO:0008681](http://purl.obolibrary.org/obo/GO_0008681) (2-octaprenyl-6-methoxyphenol hydroxylase activity), [GO:0021654](http://purl.obolibrary.org/obo/GO_0021654) (rhombomere boundary formation), [GO:0045665](http://purl.obolibrary.org/obo/GO_0045665) (negative regulation of neuron differentiation), [GO:0006024](http://purl.obolibrary.org/obo/GO_0006024) (glycosaminoglycan biosynthetic process), [GO:0045666](http://purl.obolibrary.org/obo/GO_0045666) (positive regulation of neuron differentiation), [GO:0044332](http://purl.obolibrary.org/obo/GO_0044332) (Wnt signaling pathway involved in dorsal/ventral axis specification), [GO:0043001](http://purl.obolibrary.org/obo/GO_0043001) (Golgi to plasma membrane protein transport), [GO:0045663](http://purl.obolibrary.org/obo/GO_0045663) (positive regulation of myoblast differentiation), [GO:0045664](http://purl.obolibrary.org/obo/GO_0045664) (regulation of neuron differentiation), [GO:0045669](http://purl.obolibrary.org/obo/GO_0045669) (positive regulation of osteoblast differentiation), [GO:0021650](http://purl.obolibrary.org/obo/GO_0021650) (vestibulocochlear nerve formation), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0044336](http://purl.obolibrary.org/obo/GO_0044336) (canonical Wnt signaling pathway involved in negative regulation of apoptotic process), [GO:0006029](http://purl.obolibrary.org/obo/GO_0006029) (proteoglycan metabolic process), [GO:0043008](http://purl.obolibrary.org/obo/GO_0043008) (ATP-dependent protein binding), [GO:0045667](http://purl.obolibrary.org/obo/GO_0045667) (regulation of osteoblast differentiation), [GO:0006027](http://purl.obolibrary.org/obo/GO_0006027) (glycosaminoglycan catabolic process), [GO:0045668](http://purl.obolibrary.org/obo/GO_0045668) (negative regulation of osteoblast differentiation), [GO:0043007](http://purl.obolibrary.org/obo/GO_0043007) (maintenance of rDNA), [GO:0034969](http://purl.obolibrary.org/obo/GO_0034969) (histone arginine methylation), [GO:0034968](http://purl.obolibrary.org/obo/GO_0034968) (histone lysine methylation), [GO:0045672](http://purl.obolibrary.org/obo/GO_0045672) (positive regulation of osteoclast differentiation), [GO:0045670](http://purl.obolibrary.org/obo/GO_0045670) (regulation of osteoclast differentiation), [GO:1990304](http://purl.obolibrary.org/obo/GO_1990304) (MUB1-RAD6-UBR2 ubiquitin ligase complex), [GO:0044342](http://purl.obolibrary.org/obo/GO_0044342) (type B pancreatic cell proliferation), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0045671](http://purl.obolibrary.org/obo/GO_0045671) (negative regulation of osteoclast differentiation), [GO:0010996](http://purl.obolibrary.org/obo/GO_0010996) (response to auditory stimulus), [GO:0019344](http://purl.obolibrary.org/obo/GO_0019344) (cysteine biosynthetic process), [GO:0032300](http://purl.obolibrary.org/obo/GO_0032300) (mismatch repair complex), [GO:0032301](http://purl.obolibrary.org/obo/GO_0032301) (MutSalpha complex), [GO:0019343](http://purl.obolibrary.org/obo/GO_0019343) (cysteine biosynthetic process via cystathionine), [GO:0071953](http://purl.obolibrary.org/obo/GO_0071953) (elastic fiber), [GO:0019346](http://purl.obolibrary.org/obo/GO_0019346) (transsulfuration), [GO:0033630](http://purl.obolibrary.org/obo/GO_0033630) (positive regulation of cell adhesion mediated by integrin), [GO:0010997](http://purl.obolibrary.org/obo/GO_0010997) (anaphase-promoting complex binding), [GO:0019348](http://purl.obolibrary.org/obo/GO_0019348) (dolichol metabolic process), [GO:0010992](http://purl.obolibrary.org/obo/GO_0010992) (ubiquitin recycling), [GO:0034967](http://purl.obolibrary.org/obo/GO_0034967) (Set3 complex), [GO:0070626](http://purl.obolibrary.org/obo/GO_0070626) ((S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity), [GO:0010994](http://purl.obolibrary.org/obo/GO_0010994) (free ubiquitin chain polymerization), [GO:0032302](http://purl.obolibrary.org/obo/GO_0032302) (MutSbeta complex), [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding), [GO:0055001](http://purl.obolibrary.org/obo/GO_0055001) (muscle cell development), [GO:0044344](http://purl.obolibrary.org/obo/GO_0044344) (cellular response to fibroblast growth factor stimulus), [GO:0021644](http://purl.obolibrary.org/obo/GO_0021644) (vagus nerve morphogenesis), [GO:0043015](http://purl.obolibrary.org/obo/GO_0043015) (gamma-tubulin binding), [GO:0043014](http://purl.obolibrary.org/obo/GO_0043014) (alpha-tubulin binding), [GO:0007368](http://purl.obolibrary.org/obo/GO_0007368) (determination of left/right symmetry), [GO:0007369](http://purl.obolibrary.org/obo/GO_0007369) (gastrulation), [GO:0021642](http://purl.obolibrary.org/obo/GO_0021642) (trochlear nerve formation), [GO:0033629](http://purl.obolibrary.org/obo/GO_0033629) (negative regulation of cell adhesion mediated by integrin), [GO:0033628](http://purl.obolibrary.org/obo/GO_0033628) (regulation of cell adhesion mediated by integrin), [GO:0033627](http://purl.obolibrary.org/obo/GO_0033627) (cell adhesion mediated by integrin), [GO:0043020](http://purl.obolibrary.org/obo/GO_0043020) (NADPH oxidase complex), [GO:0044351](http://purl.obolibrary.org/obo/GO_0044351) (macropinocytosis), [GO:1990314](http://purl.obolibrary.org/obo/GO_1990314) (cellular response to insulin-like growth factor stimulus), [GO:0043022](http://purl.obolibrary.org/obo/GO_0043022) (ribosome binding), [GO:2000703](http://purl.obolibrary.org/obo/GO_2000703) (negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation), [GO:0043021](http://purl.obolibrary.org/obo/GO_0043021) (ribonucleoprotein complex binding), [GO:1990316](http://purl.obolibrary.org/obo/GO_1990316) (Atg1/ULK1 kinase complex), [GO:0018002](http://purl.obolibrary.org/obo/GO_0018002) (N-terminal peptidyl-glutamic acid acetylation), [GO:0071942](http://purl.obolibrary.org/obo/GO_0071942) (XPC complex), [GO:0071940](http://purl.obolibrary.org/obo/GO_0071940) (fungal-type cell wall assembly), [GO:0033625](http://purl.obolibrary.org/obo/GO_0033625) (positive regulation of integrin activation), [GO:0070615](http://purl.obolibrary.org/obo/GO_0070615) (nucleosome-dependent ATPase activity), [GO:0071944](http://purl.obolibrary.org/obo/GO_0071944) (cell periphery), [GO:0032370](http://purl.obolibrary.org/obo/GO_0032370) (positive regulation of lipid transport), [GO:0006083](http://purl.obolibrary.org/obo/GO_0006083) (acetate metabolic process), [GO:0046939](http://purl.obolibrary.org/obo/GO_0046939) (nucleotide phosphorylation), [GO:0045605](http://purl.obolibrary.org/obo/GO_0045605) (negative regulation of epidermal cell differentiation), [GO:0045606](http://purl.obolibrary.org/obo/GO_0045606) (positive regulation of epidermal cell differentiation), [GO:0006081](http://purl.obolibrary.org/obo/GO_0006081) (cellular aldehyde metabolic process), [GO:0006086](http://purl.obolibrary.org/obo/GO_0006086) (acetyl-CoA biosynthetic process from pyruvate), [GO:0032374](http://purl.obolibrary.org/obo/GO_0032374) (regulation of cholesterol transport), [GO:0045600](http://purl.obolibrary.org/obo/GO_0045600) (positive regulation of fat cell differentiation), [GO:0045603](http://purl.obolibrary.org/obo/GO_0045603) (positive regulation of endothelial cell differentiation), [GO:0046935](http://purl.obolibrary.org/obo/GO_0046935) (1-phosphatidylinositol-3-kinase regulator activity), [GO:0046933](http://purl.obolibrary.org/obo/GO_0046933) (proton-transporting ATP synthase activity, rotational mechanism), [GO:0045602](http://purl.obolibrary.org/obo/GO_0045602) (negative regulation of endothelial cell differentiation), [GO:2000719](http://purl.obolibrary.org/obo/GO_2000719) (negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric), [GO:0032366](http://purl.obolibrary.org/obo/GO_0032366) (intracellular sterol transport), [GO:0032367](http://purl.obolibrary.org/obo/GO_0032367) (intracellular cholesterol transport), [GO:0031034](http://purl.obolibrary.org/obo/GO_0031034) (myosin filament assembly), [GO:0033699](http://purl.obolibrary.org/obo/GO_0033699) (DNA 5'-adenosine monophosphate hydrolase activity), [GO:0045618](http://purl.obolibrary.org/obo/GO_0045618) (positive regulation of keratinocyte differentiation), [GO:0046949](http://purl.obolibrary.org/obo/GO_0046949) (fatty-acyl-CoA biosynthetic process), [GO:0033690](http://purl.obolibrary.org/obo/GO_0033690) (positive regulation of osteoblast proliferation), [GO:0006094](http://purl.obolibrary.org/obo/GO_0006094) (gluconeogenesis), [GO:1904385](http://purl.obolibrary.org/obo/GO_1904385) (cellular response to angiotensin), [GO:1903052](http://purl.obolibrary.org/obo/GO_1903052) (positive regulation of proteolysis involved in cellular protein catabolic process), [GO:0006091](http://purl.obolibrary.org/obo/GO_0006091) (generation of precursor metabolites and energy), [GO:0046947](http://purl.obolibrary.org/obo/GO_0046947) (hydroxylysine biosynthetic process), [GO:0045617](http://purl.obolibrary.org/obo/GO_0045617) (negative regulation of keratinocyte differentiation), [GO:0006097](http://purl.obolibrary.org/obo/GO_0006097) (glyoxylate cycle), [GO:0006098](http://purl.obolibrary.org/obo/GO_0006098) (pentose-phosphate shunt), [GO:0031032](http://purl.obolibrary.org/obo/GO_0031032) (actomyosin structure organization), [GO:0033693](http://purl.obolibrary.org/obo/GO_0033693) (neurofilament bundle assembly), [GO:1903056](http://purl.obolibrary.org/obo/GO_1903056) (regulation of melanosome organization), [GO:1904388](http://purl.obolibrary.org/obo/GO_1904388) (negative regulation of ncRNA transcription associated with protein coding gene TSS/TES), [GO:0006096](http://purl.obolibrary.org/obo/GO_0006096) (glycolytic process), [GO:0033691](http://purl.obolibrary.org/obo/GO_0033691) (sialic acid binding), [GO:0006099](http://purl.obolibrary.org/obo/GO_0006099) (tricarboxylic acid cycle), [GO:2000727](http://purl.obolibrary.org/obo/GO_2000727) (positive regulation of cardiac muscle cell differentiation), [GO:2000729](http://purl.obolibrary.org/obo/GO_2000729) (positive regulation of mesenchymal cell proliferation involved in ureter development), [GO:0003810](http://purl.obolibrary.org/obo/GO_0003810) (protein-glutamine gamma-glutamyltransferase activity), [GO:0019395](http://purl.obolibrary.org/obo/GO_0019395) (fatty acid oxidation), [GO:0018063](http://purl.obolibrary.org/obo/GO_0018063) (cytochrome c-heme linkage), [GO:0032355](http://purl.obolibrary.org/obo/GO_0032355) (response to estradiol), [GO:0033686](http://purl.obolibrary.org/obo/GO_0033686) (positive regulation of luteinizing hormone secretion), [GO:0032353](http://purl.obolibrary.org/obo/GO_0032353) (negative regulation of hormone biosynthetic process), [GO:0031023](http://purl.obolibrary.org/obo/GO_0031023) (microtubule organizing center organization), [GO:1904382](http://purl.obolibrary.org/obo/GO_1904382) (mannose trimming involved in glycoprotein ERAD pathway), [GO:0006090](http://purl.obolibrary.org/obo/GO_0006090) (pyruvate metabolic process), [GO:1904380](http://purl.obolibrary.org/obo/GO_1904380) (endoplasmic reticulum mannose trimming), [GO:0032357](http://purl.obolibrary.org/obo/GO_0032357) (oxidized purine DNA binding), [GO:1904396](http://purl.obolibrary.org/obo/GO_1904396) (regulation of neuromuscular junction development), [GO:0071914](http://purl.obolibrary.org/obo/GO_0071914) (prominosome), [GO:0045627](http://purl.obolibrary.org/obo/GO_0045627) (positive regulation of T-helper 1 cell differentiation), [GO:1904395](http://purl.obolibrary.org/obo/GO_1904395) (positive regulation of skeletal muscle acetylcholine-gated channel clustering), [GO:0046959](http://purl.obolibrary.org/obo/GO_0046959) (habituation), [GO:0033683](http://purl.obolibrary.org/obo/GO_0033683) (nucleotide-excision repair, DNA incision), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0006068](http://purl.obolibrary.org/obo/GO_0006068) (ethanol catabolic process), [GO:0006069](http://purl.obolibrary.org/obo/GO_0006069) (ethanol oxidation), [GO:0006066](http://purl.obolibrary.org/obo/GO_0006066) (alcohol metabolic process), [GO:0007398](http://purl.obolibrary.org/obo/GO_0007398) (ectoderm development), [GO:0045620](http://purl.obolibrary.org/obo/GO_0045620) (negative regulation of lymphocyte differentiation), [GO:0006067](http://purl.obolibrary.org/obo/GO_0006067) (ethanol metabolic process), [GO:0021695](http://purl.obolibrary.org/obo/GO_0021695) (cerebellar cortex development), [GO:0021696](http://purl.obolibrary.org/obo/GO_0021696) (cerebellar cortex morphogenesis), [GO:0021697](http://purl.obolibrary.org/obo/GO_0021697) (cerebellar cortex formation), [GO:2000738](http://purl.obolibrary.org/obo/GO_2000738) (positive regulation of stem cell differentiation), [GO:2000734](http://purl.obolibrary.org/obo/GO_2000734) (negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation), [GO:1990349](http://purl.obolibrary.org/obo/GO_1990349) (gap junction-mediated intercellular transport), [GO:2000737](http://purl.obolibrary.org/obo/GO_2000737) (negative regulation of stem cell differentiation), [GO:0019388](http://purl.obolibrary.org/obo/GO_0019388) (galactose catabolic process), [GO:0031013](http://purl.obolibrary.org/obo/GO_0031013) (troponin I binding), [GO:0031014](http://purl.obolibrary.org/obo/GO_0031014) (troponin T binding), [GO:0031011](http://purl.obolibrary.org/obo/GO_0031011) (Ino80 complex), [GO:0033674](http://purl.obolibrary.org/obo/GO_0033674) (positive regulation of kinase activity), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0033673](http://purl.obolibrary.org/obo/GO_0033673) (negative regulation of kinase activity), [GO:1903061](http://purl.obolibrary.org/obo/GO_1903061) (positive regulation of protein lipidation), [GO:0031017](http://purl.obolibrary.org/obo/GO_0031017) (exocrine pancreas development), [GO:0031018](http://purl.obolibrary.org/obo/GO_0031018) (endocrine pancreas development), [GO:0071910](http://purl.obolibrary.org/obo/GO_0071910) (determination of liver left/right asymmetry), [GO:0031016](http://purl.obolibrary.org/obo/GO_0031016) (pancreas development), [GO:0071911](http://purl.obolibrary.org/obo/GO_0071911) (synchronous neurotransmitter secretion), [GO:1903076](http://purl.obolibrary.org/obo/GO_1903076) (regulation of protein localization to plasma membrane), [GO:0006071](http://purl.obolibrary.org/obo/GO_0006071) (glycerol metabolic process), [GO:0044308](http://purl.obolibrary.org/obo/GO_0044308) (axonal spine), [GO:0045638](http://purl.obolibrary.org/obo/GO_0045638) (negative regulation of myeloid cell differentiation), [GO:0006070](http://purl.obolibrary.org/obo/GO_0006070) (octanol metabolic process), [GO:0044309](http://purl.obolibrary.org/obo/GO_0044309) (neuron spine), [GO:0071909](http://purl.obolibrary.org/obo/GO_0071909) (determination of stomach left/right asymmetry), [GO:1903078](http://purl.obolibrary.org/obo/GO_1903078) (positive regulation of protein localization to plasma membrane), [GO:0071907](http://purl.obolibrary.org/obo/GO_0071907) (determination of digestive tract left/right asymmetry), [GO:0071908](http://purl.obolibrary.org/obo/GO_0071908) (determination of intestine left/right asymmetry), [GO:0046961](http://purl.obolibrary.org/obo/GO_0046961) (proton-transporting ATPase activity, rotational mechanism), [GO:0045630](http://purl.obolibrary.org/obo/GO_0045630) (positive regulation of T-helper 2 cell differentiation), [GO:0044304](http://purl.obolibrary.org/obo/GO_0044304) (main axon), [GO:0045636](http://purl.obolibrary.org/obo/GO_0045636) (positive regulation of melanocyte differentiation), [GO:0045637](http://purl.obolibrary.org/obo/GO_0045637) (regulation of myeloid cell differentiation), [GO:0046965](http://purl.obolibrary.org/obo/GO_0046965) (retinoid X receptor binding), [GO:0045634](http://purl.obolibrary.org/obo/GO_0045634) (regulation of melanocyte differentiation), [GO:0044306](http://purl.obolibrary.org/obo/GO_0044306) (neuron projection terminus), [GO:0046966](http://purl.obolibrary.org/obo/GO_0046966) (thyroid hormone receptor binding), [GO:0021692](http://purl.obolibrary.org/obo/GO_0021692) (cerebellar Purkinje cell layer morphogenesis), [GO:0021693](http://purl.obolibrary.org/obo/GO_0021693) (cerebellar Purkinje cell layer structural organization), [GO:1990357](http://purl.obolibrary.org/obo/GO_1990357) (terminal web), [GO:0019372](http://purl.obolibrary.org/obo/GO_0019372) (lipoxygenase pathway), [GO:0019377](http://purl.obolibrary.org/obo/GO_0019377) (glycolipid catabolic process), [GO:0032331](http://purl.obolibrary.org/obo/GO_0032331) (negative regulation of chondrocyte differentiation), [GO:0031000](http://purl.obolibrary.org/obo/GO_0031000) (response to caffeine), [GO:0034993](http://purl.obolibrary.org/obo/GO_0034993) (LINC complex), [GO:0032332](http://purl.obolibrary.org/obo/GO_0032332) (positive regulation of chondrocyte differentiation), [GO:0071901](http://purl.obolibrary.org/obo/GO_0071901) (negative regulation of protein serine/threonine kinase activity), [GO:0071902](http://purl.obolibrary.org/obo/GO_0071902) (positive regulation of protein serine/threonine kinase activity), [GO:1903073](http://purl.obolibrary.org/obo/GO_1903073) (negative regulation of death-inducing signaling complex assembly), [GO:1903071](http://purl.obolibrary.org/obo/GO_1903071) (positive regulation of ER-associated ubiquitin-dependent protein catabolic process), [GO:0031083](http://purl.obolibrary.org/obo/GO_0031083) (BLOC-1 complex), [GO:0031086](http://purl.obolibrary.org/obo/GO_0031086) (nuclear-transcribed mRNA catabolic process, deadenylation-independent decay), [GO:0031087](http://purl.obolibrary.org/obo/GO_0031087) (deadenylation-independent decapping of nuclear-transcribed mRNA), [GO:0031084](http://purl.obolibrary.org/obo/GO_0031084) (BLOC-2 complex), [GO:0031085](http://purl.obolibrary.org/obo/GO_0031085) (BLOC-3 complex), [GO:0055056](http://purl.obolibrary.org/obo/GO_0055056) (D-glucose transmembrane transporter activity), [GO:0043068](http://purl.obolibrary.org/obo/GO_0043068) (positive regulation of programmed cell death), [GO:0043067](http://purl.obolibrary.org/obo/GO_0043067) (regulation of programmed cell death), [GO:0043069](http://purl.obolibrary.org/obo/GO_0043069) (negative regulation of programmed cell death), [GO:0080019](http://purl.obolibrary.org/obo/GO_0080019) (fatty-acyl-CoA reductase (alcohol-forming) activity), [GO:0003841](http://purl.obolibrary.org/obo/GO_0003841) (1-acylglycerol-3-phosphate O-acyltransferase activity), [GO:0003842](http://purl.obolibrary.org/obo/GO_0003842) (1-pyrroline-5-carboxylate dehydrogenase activity), [GO:0003844](http://purl.obolibrary.org/obo/GO_0003844) (1,4-alpha-glucan branching enzyme activity), [GO:0015828](http://purl.obolibrary.org/obo/GO_0015828) (tyrosine transport), [GO:0015826](http://purl.obolibrary.org/obo/GO_0015826) (threonine transport), [GO:0015825](http://purl.obolibrary.org/obo/GO_0015825) (L-serine transport), [GO:0015824](http://purl.obolibrary.org/obo/GO_0015824) (proline transport), [GO:0015820](http://purl.obolibrary.org/obo/GO_0015820) (leucine transport), [GO:0015840](http://purl.obolibrary.org/obo/GO_0015840) (urea transport), [GO:0031072](http://purl.obolibrary.org/obo/GO_0031072) (heat shock protein binding), [GO:0055062](http://purl.obolibrary.org/obo/GO_0055062) (phosphate ion homeostasis), [GO:0055064](http://purl.obolibrary.org/obo/GO_0055064) (chloride ion homeostasis), [GO:0031076](http://purl.obolibrary.org/obo/GO_0031076) (embryonic camera-type eye development), [GO:0031073](http://purl.obolibrary.org/obo/GO_0031073) (cholesterol 26-hydroxylase activity), [GO:0080025](http://purl.obolibrary.org/obo/GO_0080025) (phosphatidylinositol-3,5-bisphosphate binding), [GO:0003860](http://purl.obolibrary.org/obo/GO_0003860) (3-hydroxyisobutyryl-CoA hydrolase activity), [GO:0003854](http://purl.obolibrary.org/obo/GO_0003854) (3-beta-hydroxy-delta5-steroid dehydrogenase activity), [GO:0002523](http://purl.obolibrary.org/obo/GO_0002523) (leukocyte migration involved in inflammatory response), [GO:0043083](http://purl.obolibrary.org/obo/GO_0043083) (synaptic cleft), [GO:0043086](http://purl.obolibrary.org/obo/GO_0043086) (negative regulation of catalytic activity), [GO:2000767](http://purl.obolibrary.org/obo/GO_2000767) (positive regulation of cytoplasmic translation), [GO:2000768](http://purl.obolibrary.org/obo/GO_2000768) (positive regulation of nephron tubule epithelial cell differentiation), [GO:0070673](http://purl.obolibrary.org/obo/GO_0070673) (response to interleukin-18), [GO:0043085](http://purl.obolibrary.org/obo/GO_0043085) (positive regulation of catalytic activity), [GO:0002526](http://purl.obolibrary.org/obo/GO_0002526) (acute inflammatory response), [GO:0003857](http://purl.obolibrary.org/obo/GO_0003857) (3-hydroxyacyl-CoA dehydrogenase activity), [GO:0043087](http://purl.obolibrary.org/obo/GO_0043087) (regulation of GTPase activity), [GO:0070676](http://purl.obolibrary.org/obo/GO_0070676) (intralumenal vesicle formation), [GO:0031069](http://purl.obolibrary.org/obo/GO_0031069) (hair follicle morphogenesis), [GO:0070679](http://purl.obolibrary.org/obo/GO_0070679) (inositol 1,4,5 trisphosphate binding), [GO:0032391](http://purl.obolibrary.org/obo/GO_0032391) (photoreceptor connecting cilium), [GO:0031060](http://purl.obolibrary.org/obo/GO_0031060) (regulation of histone methylation), [GO:0055072](http://purl.obolibrary.org/obo/GO_0055072) (iron ion homeostasis), [GO:2000780](http://purl.obolibrary.org/obo/GO_2000780) (negative regulation of double-strand break repair), [GO:0055074](http://purl.obolibrary.org/obo/GO_0055074) (calcium ion homeostasis), [GO:0055075](http://purl.obolibrary.org/obo/GO_0055075) (potassium ion homeostasis), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0055077](http://purl.obolibrary.org/obo/GO_0055077) (gap junction hemi-channel activity), [GO:0031062](http://purl.obolibrary.org/obo/GO_0031062) (positive regulation of histone methylation), [GO:0055078](http://purl.obolibrary.org/obo/GO_0055078) (sodium ion homeostasis), [GO:0055070](http://purl.obolibrary.org/obo/GO_0055070) (copper ion homeostasis), [GO:0018095](http://purl.obolibrary.org/obo/GO_0018095) (protein polyglutamylation), [GO:2000778](http://purl.obolibrary.org/obo/GO_2000778) (positive regulation of interleukin-6 secretion), [GO:0015809](http://purl.obolibrary.org/obo/GO_0015809) (arginine transport), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0015808](http://purl.obolibrary.org/obo/GO_0015808) (L-alanine transport), [GO:2000774](http://purl.obolibrary.org/obo/GO_2000774) (positive regulation of cellular senescence), [GO:0032388](http://purl.obolibrary.org/obo/GO_0032388) (positive regulation of intracellular transport), [GO:0055069](http://purl.obolibrary.org/obo/GO_0055069) (zinc ion homeostasis), [GO:0032389](http://purl.obolibrary.org/obo/GO_0032389) (MutLalpha complex), [GO:0015804](http://purl.obolibrary.org/obo/GO_0015804) (neutral amino acid transport), [GO:0032386](http://purl.obolibrary.org/obo/GO_0032386) (regulation of intracellular transport), [GO:0032387](http://purl.obolibrary.org/obo/GO_0032387) (negative regulation of intracellular transport), [GO:2000772](http://purl.obolibrary.org/obo/GO_2000772) (regulation of cellular senescence), [GO:2000773](http://purl.obolibrary.org/obo/GO_2000773) (negative regulation of cellular senescence), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0031054](http://purl.obolibrary.org/obo/GO_0031054) (pre-miRNA processing), [GO:0032385](http://purl.obolibrary.org/obo/GO_0032385) (positive regulation of intracellular cholesterol transport), [GO:0055088](http://purl.obolibrary.org/obo/GO_0055088) (lipid homeostasis), [GO:0032383](http://purl.obolibrary.org/obo/GO_0032383) (regulation of intracellular cholesterol transport), [GO:0080008](http://purl.obolibrary.org/obo/GO_0080008) (Cul4-RING E3 ubiquitin ligase complex), [GO:0055081](http://purl.obolibrary.org/obo/GO_0055081) (anion homeostasis), [GO:0080009](http://purl.obolibrary.org/obo/GO_0080009) (mRNA methylation), [GO:0003831](http://purl.obolibrary.org/obo/GO_0003831) (beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity), [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II), [GO:0015819](http://purl.obolibrary.org/obo/GO_0015819) (lysine transport), [GO:0003837](http://purl.obolibrary.org/obo/GO_0003837) (beta-ureidopropionase activity), [GO:0015816](http://purl.obolibrary.org/obo/GO_0015816) (glycine transport), [GO:2000785](http://purl.obolibrary.org/obo/GO_2000785) (regulation of autophagosome assembly), [GO:2000786](http://purl.obolibrary.org/obo/GO_2000786) (positive regulation of autophagosome assembly), [GO:0031047](http://purl.obolibrary.org/obo/GO_0031047) (gene silencing by RNA), [GO:0015813](http://purl.obolibrary.org/obo/GO_0015813) (L-glutamate transport), [GO:0031045](http://purl.obolibrary.org/obo/GO_0031045) (dense core granule), [GO:0015812](http://purl.obolibrary.org/obo/GO_0015812) (gamma-aminobutyric acid transport), [GO:0015811](http://purl.obolibrary.org/obo/GO_0015811) (L-cystine transport), [GO:0015810](http://purl.obolibrary.org/obo/GO_0015810) (aspartate transport), [GO:0015874](http://purl.obolibrary.org/obo/GO_0015874) (norepinephrine transport), [GO:0015872](http://purl.obolibrary.org/obo/GO_0015872) (dopamine transport), [GO:0015871](http://purl.obolibrary.org/obo/GO_0015871) (choline transport), [GO:0055010](http://purl.obolibrary.org/obo/GO_0055010) (ventricular cardiac muscle tissue morphogenesis), [GO:0055012](http://purl.obolibrary.org/obo/GO_0055012) (ventricular cardiac muscle cell differentiation), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0045685](http://purl.obolibrary.org/obo/GO_0045685) (regulation of glial cell differentiation), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0001227](http://purl.obolibrary.org/obo/GO_0001227) (transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0043028](http://purl.obolibrary.org/obo/GO_0043028) (cysteine-type endopeptidase regulator activity involved in apoptotic process), [GO:0043027](http://purl.obolibrary.org/obo/GO_0043027) (cysteine-type endopeptidase inhibitor activity involved in apoptotic process), [GO:0001223](http://purl.obolibrary.org/obo/GO_0001223) (transcription coactivator binding), [GO:0043029](http://purl.obolibrary.org/obo/GO_0043029) (T cell homeostasis), [GO:0003886](http://purl.obolibrary.org/obo/GO_0003886) (DNA (cytosine-5-)-methyltransferase activity), [GO:0003887](http://purl.obolibrary.org/obo/GO_0003887) (DNA-directed DNA polymerase activity), [GO:0070640](http://purl.obolibrary.org/obo/GO_0070640) (vitamin D3 metabolic process), [GO:0043032](http://purl.obolibrary.org/obo/GO_0043032) (positive regulation of macrophage activation), [GO:0055002](http://purl.obolibrary.org/obo/GO_0055002) (striated muscle cell development), [GO:0055003](http://purl.obolibrary.org/obo/GO_0055003) (cardiac myofibril assembly), [GO:0055004](http://purl.obolibrary.org/obo/GO_0055004) (atrial cardiac myofibril assembly), [GO:0055005](http://purl.obolibrary.org/obo/GO_0055005) (ventricular cardiac myofibril assembly), [GO:0015868](http://purl.obolibrary.org/obo/GO_0015868) (purine ribonucleotide transport), [GO:0015867](http://purl.obolibrary.org/obo/GO_0015867) (ATP transport), [GO:0055007](http://purl.obolibrary.org/obo/GO_0055007) (cardiac muscle cell differentiation), [GO:2000793](http://purl.obolibrary.org/obo/GO_2000793) (cell proliferation involved in heart valve development), [GO:0015866](http://purl.obolibrary.org/obo/GO_0015866) (ADP transport), [GO:0055008](http://purl.obolibrary.org/obo/GO_0055008) (cardiac muscle tissue morphogenesis), [GO:0055009](http://purl.obolibrary.org/obo/GO_0055009) (atrial cardiac muscle tissue morphogenesis), [GO:0015884](http://purl.obolibrary.org/obo/GO_0015884) (folic acid transport), [GO:0055020](http://purl.obolibrary.org/obo/GO_0055020) (positive regulation of cardiac muscle fiber development), [GO:0015881](http://purl.obolibrary.org/obo/GO_0015881) (creatine transport), [GO:0043034](http://purl.obolibrary.org/obo/GO_0043034) (costamere), [GO:0043039](http://purl.obolibrary.org/obo/GO_0043039) (tRNA aminoacylation), [GO:0002572](http://purl.obolibrary.org/obo/GO_0002572) (pro-T cell differentiation), [GO:0002573](http://purl.obolibrary.org/obo/GO_0002573) (myeloid leukocyte differentiation), [GO:0002574](http://purl.obolibrary.org/obo/GO_0002574) (thrombocyte differentiation), [GO:0002566](http://purl.obolibrary.org/obo/GO_0002566) (somatic diversification of immune receptors via somatic mutation), [GO:0003899](http://purl.obolibrary.org/obo/GO_0003899) (DNA-directed 5'-3' RNA polymerase activity), [GO:0043044](http://purl.obolibrary.org/obo/GO_0043044) (ATP-dependent chromatin remodeling), [GO:0044375](http://purl.obolibrary.org/obo/GO_0044375) (regulation of peroxisome size), [GO:0055013](http://purl.obolibrary.org/obo/GO_0055013) (cardiac muscle cell development), [GO:0055015](http://purl.obolibrary.org/obo/GO_0055015) (ventricular cardiac muscle cell development), [GO:0055016](http://purl.obolibrary.org/obo/GO_0055016) (hypochord development), [GO:0015879](http://purl.obolibrary.org/obo/GO_0015879) (carnitine transport), [GO:0015876](http://purl.obolibrary.org/obo/GO_0015876) (acetyl-CoA transport), [GO:0015851](http://purl.obolibrary.org/obo/GO_0015851) (nucleobase transport), [GO:0043046](http://purl.obolibrary.org/obo/GO_0043046) (DNA methylation involved in gamete generation), [GO:0001208](http://purl.obolibrary.org/obo/GO_0001208) (histone H2A-H2B dimer displacement), [GO:0043045](http://purl.obolibrary.org/obo/GO_0043045) (DNA methylation involved in embryo development), [GO:0001207](http://purl.obolibrary.org/obo/GO_0001207) (histone displacement), [GO:0001206](http://purl.obolibrary.org/obo/GO_0001206) (transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0001205](http://purl.obolibrary.org/obo/GO_0001205) (transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0043047](http://purl.obolibrary.org/obo/GO_0043047) (single-stranded telomeric DNA binding), [GO:0043049](http://purl.obolibrary.org/obo/GO_0043049) (otic placode formation), [GO:0003872](http://purl.obolibrary.org/obo/GO_0003872) (6-phosphofructokinase activity), [GO:0003865](http://purl.obolibrary.org/obo/GO_0003865) (3-oxo-5-alpha-steroid 4-dehydrogenase activity), [GO:0002534](http://purl.obolibrary.org/obo/GO_0002534) (cytokine production involved in inflammatory response), [GO:0003867](http://purl.obolibrary.org/obo/GO_0003867) (4-aminobutyrate transaminase activity), [GO:0055026](http://purl.obolibrary.org/obo/GO_0055026) (negative regulation of cardiac muscle tissue development), [GO:0031099](http://purl.obolibrary.org/obo/GO_0031099) (regeneration), [GO:0070664](http://purl.obolibrary.org/obo/GO_0070664) (negative regulation of leukocyte proliferation), [GO:0015846](http://purl.obolibrary.org/obo/GO_0015846) (polyamine transport), [GO:0015844](http://purl.obolibrary.org/obo/GO_0015844) (monoamine transport), [GO:0015842](http://purl.obolibrary.org/obo/GO_0015842) (aminergic neurotransmitter loading into synaptic vesicle), [GO:0070668](http://purl.obolibrary.org/obo/GO_0070668) (positive regulation of mast cell proliferation), [GO:0031094](http://purl.obolibrary.org/obo/GO_0031094) (platelet dense tubular network), [GO:0031092](http://purl.obolibrary.org/obo/GO_0031092) (platelet alpha granule membrane), [GO:0031098](http://purl.obolibrary.org/obo/GO_0031098) (stress-activated protein kinase signaling cascade), [GO:0044387](http://purl.obolibrary.org/obo/GO_0044387) (negative regulation of protein kinase activity by regulation of protein phosphorylation), [GO:0043056](http://purl.obolibrary.org/obo/GO_0043056) (forward locomotion), [GO:0044389](http://purl.obolibrary.org/obo/GO_0044389) (ubiquitin-like protein ligase binding), [GO:0002551](http://purl.obolibrary.org/obo/GO_0002551) (mast cell chemotaxis), [GO:0031090](http://purl.obolibrary.org/obo/GO_0031090) (organelle membrane), [GO:0002553](http://purl.obolibrary.org/obo/GO_0002553) (histamine secretion by mast cell), [GO:0001222](http://purl.obolibrary.org/obo/GO_0001222) (transcription corepressor binding), [GO:0043060](http://purl.obolibrary.org/obo/GO_0043060) (meiotic metaphase I plate congression), [GO:0003874](http://purl.obolibrary.org/obo/GO_0003874) (6-pyruvoyltetrahydropterin synthase activity), [GO:0003876](http://purl.obolibrary.org/obo/GO_0003876) (AMP deaminase activity), [GO:0003877](http://purl.obolibrary.org/obo/GO_0003877) (ATP adenylyltransferase activity), [GO:0070650](http://purl.obolibrary.org/obo/GO_0070650) (actin filament bundle distribution), [GO:0002548](http://purl.obolibrary.org/obo/GO_0002548) (monocyte chemotaxis), [GO:0070651](http://purl.obolibrary.org/obo/GO_0070651) (nonfunctional rRNA decay), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0070654](http://purl.obolibrary.org/obo/GO_0070654) (sensory epithelium regeneration), [GO:0071985](http://purl.obolibrary.org/obo/GO_0071985) (multivesicular body sorting pathway), [GO:0055037](http://purl.obolibrary.org/obo/GO_0055037) (recycling endosome), [GO:0015858](http://purl.obolibrary.org/obo/GO_0015858) (nucleoside transport), [GO:0031088](http://purl.obolibrary.org/obo/GO_0031088) (platelet dense granule membrane), [GO:0055038](http://purl.obolibrary.org/obo/GO_0055038) (recycling endosome membrane), [GO:0071988](http://purl.obolibrary.org/obo/GO_0071988) (protein localization to spindle pole body), 

**Class expressions from DL-Learner:**

- Thing 91.90%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 72.52%
- [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process) 55.26%
- [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) 53.66%
- [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process) 51.74%
- [GO:0065007](http://purl.obolibrary.org/obo/GO_0065007) (biological regulation) 51.29%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 50.77%
- [GO:0044464](http://purl.obolibrary.org/obo/GO_0044464) (cell part) 50.62%
- [GO:0043232](http://purl.obolibrary.org/obo/GO_0043232) (intracellular non-membrane-bounded organelle) and [GO:0044444](http://purl.obolibrary.org/obo/GO_0044444) (cytoplasmic part) 50.16%
- [GO:0043228](http://purl.obolibrary.org/obo/GO_0043228) (non-membrane-bounded organelle) and [GO:0044444](http://purl.obolibrary.org/obo/GO_0044444) (cytoplasmic part) 50.16%
- [GO:0044449](http://purl.obolibrary.org/obo/GO_0044449) (contractile fiber part) 50.15%
- [GO:0033267](http://purl.obolibrary.org/obo/GO_0033267) (axon part) 50.14%
- [GO:0007005](http://purl.obolibrary.org/obo/GO_0007005) (mitochondrion organization) 50.14%
- [GO:0072330](http://purl.obolibrary.org/obo/GO_0072330) (monocarboxylic acid biosynthetic process) 50.13%
- [GO:1990391](http://purl.obolibrary.org/obo/GO_1990391) (DNA repair complex) 50.12%


